PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Grela, A; Jamrozek, I; Hubisz, M; Iwanicki, A; Hinc, K; Kazmierkiewicz, R; Obuchowski, M				Grela, Anna; Jamrozek, Inga; Hubisz, Marta; Iwanicki, Adam; Hinc, Krzysztof; Kazmierkiewicz, Rajmund; Obuchowski, Michel			Positions 299 and 302 of the GerAA subunit are important for function of the GerA spore germination receptor in Bacillus subtilis	PLOS ONE			English	Article							NUTRIENT RECEPTORS; INNER MEMBRANE; PROTEINS; SEQUENCE; LOCALIZATION; TOPOLOGY; STRAINS	Bacillus subtilis, as a model spore-forming Gram-positive bacterium, has been extensively used for spore germination research. Within this field, nutrient-dependent germination with specific germinant receptors (GerA, responding to L-alanine or L-valine; GerB and GerK, acting together to start spore germination process in response to AGFK) has been the most studied. There are three different variants of the GerAA subunit (299T/302S, 299A/302P, 299A/302S) of the GerA germination receptor present in B. subtilis subs. subtilis laboratory strains. According to our research, the 299A/302P one, unlike the others, interferes with the spore's ability to germinate in L-alanine as assessed by the measurement of DPA release upon stimulation with the germinant. Multiple genetic manipulations described in this work followed by spore germination tests, together with secondary structure predictions led us to the following conclusions. First, position 302 of GerAA protein is crucial in terms of GerA germination receptor functionality; a proline residue at this position renders the GerA receptor non-functional, most probably due to a change in the protein secondary structure. Second, the 302P GerAA variant has most probably an impaired affinity to other components of GerA receptor. Together, these may explain the loss of GerA receptor's function. Analysis of the GerAA protein should get us closer to understanding the mechanism of GerA receptor function.	[Grela, Anna; Hubisz, Marta] Univ Gdansk, Intercollegiate Fac Biotechnol UG & MUG, Dept Med Biotechnol, Lab Mol Bacteriol, Gdansk, Poland; [Jamrozek, Inga; Kazmierkiewicz, Rajmund] Univ Gdansk, Intercollegiate Fac Biotechnol UG & MUG, Lab Biomol Syst Simulat, Gdansk, Poland; [Iwanicki, Adam; Hinc, Krzysztof; Obuchowski, Michel] Med Univ Gdansk, Intercollegiate Fac Biotechnol UG & MUG, Dept Med Biotechnol, Lab Mol Bacteriol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Obuchowski, M (corresponding author), Med Univ Gdansk, Intercollegiate Fac Biotechnol UG & MUG, Dept Med Biotechnol, Lab Mol Bacteriol, Gdansk, Poland.	michel.obuchowski@biotech.ug.edu.pl	Obuchowski, Michał/F-5836-2011; Iwanicki, Adam/R-1767-2017; Obuchowski, Michał/N-1118-2019; Hinc, Krzysztof/B-9543-2014	Obuchowski, Michał/0000-0001-5410-2350; Iwanicki, Adam/0000-0001-7882-5529; Obuchowski, Michał/0000-0001-5410-2350; Hinc, Krzysztof/0000-0002-6067-7852; Kazmierkiewicz, Rajmund/0000-0002-7066-3518; Jamrozek, Inga/0000-0003-1858-3753	National Science Centre, Poland [2014/13/N/NZ1/00993, 2014/14/M/NZ1/00446]	National Science Centre, Poland(National Science Centre, Poland)	The study was supported by the National Science Centre (https://www.ncn.gov.pl/), Poland grant numbers: 2014/13/N/NZ1/00993 (AG) and 2014/14/M/NZ1/00446 (MO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzahrani OM, 2014, J APPL MICROBIOL, V117, P741, DOI 10.1111/jam.12566; BURKHOLDER PR, 1947, AM J BOT, V34, P345, DOI 10.2307/2437147; Cabrera-Martinez RM, 2003, J BACTERIOL, V185, P2457, DOI 10.1128/JB.185.8.2457-2464.2003; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hudson KD, 2001, J BACTERIOL, V183, P4317, DOI 10.1128/JB.183.14.4317-4322.2001; Igarashi T, 2005, J BACTERIOL, V187, P2513, DOI 10.1128/JB.187.7.2513-2518.2005; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; Korza G, 2013, J BACTERIOL, V195, P1484, DOI 10.1128/JB.02262-12; Krawczyk AO, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.03122-16, 10.1128/AEM.03122-16]; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Micado P., 1997, COMPUT APPL BIOSCI, V13, P431; MOIR A, 1994, J APPL BACTERIOL, V76, pS9, DOI 10.1111/j.1365-2672.1994.tb04353.x; Mongkolthanaruk W, 2011, J BACTERIOL, V193, P2268, DOI 10.1128/JB.01398-10; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001; R Development Core Team, 2008, R LANG ENV STAT COMP; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Setlow P, 2014, J BACTERIOL, V196, P1297, DOI 10.1128/JB.01455-13; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Stewart KAV, 2013, J BACTERIOL, V195, P3575, DOI 10.1128/JB.00377-13; Wilson MJ, 2012, J BACTERIOL, V194, P1369, DOI 10.1128/JB.06538-11; Yi XA, 2010, J BACTERIOL, V192, P3424, DOI 10.1128/JB.00326-10; YUAN G, 1995, J BACTERIOL, V177, P5427, DOI 10.1128/jb.177.19.5427-5433.1995; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	29	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198561	10.1371/journal.pone.0198561	http://dx.doi.org/10.1371/journal.pone.0198561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856851	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800138
J	Ray, MH; Hanlon, E; McDannald, MA				Ray, Madelyn H.; Hanlon, Emma; McDannald, Michael A.			Lateral orbitofrontal cortex partitions mechanisms for fear regulation and alcohol consumption	PLOS ONE			English	Article							ORBITAL PREFRONTAL CORTEX; PSYCHIATRIC-DISORDERS; ETHANOL-CONSUMPTION; NUCLEUS-ACCUMBENS; CONDITIONED FEAR; COGNITIVE MAPS; LESIONS; REVERSAL; AMYGDALA; EXTINCTION	Anxiety disorders and alcohol use disorder are highly comorbid, yet identifying neural dysfunction driving comorbidity has been challenging. Lateral orbitofrontal cortex (lOFC) dysfunction has been independently observed in each disorder. Here we tested the hypothesis that the lOFC is essential to partition mechanisms for fear regulation and alcohol consumption. Specifically, the capacity to regulate fear and the propensity to consume alcohol are unrelated when lOFC is intact, but become linked through lOFC dysfunction. Male Long Evans rats received bilateral, neurotoxic lOFC lesions or sham surgery. Fear regulation was determined by establishing discrimination to danger, uncertainty, and safety cues then shifting the shock probability of the uncertainty cue. Alcohol consumption was assessed through voluntary, intermittent access to 20% ethanol. The neurotoxic lesion approach ensured lOFC dysfunction spanned testing in fear regulation and alcohol consumption. LOFC-lesioned rats demonstrated maladaptive fear generalization during probability shifts, inverting normal prediction error assignment, and subsequently consumed more alcohol. Most novel, fear regulation and alcohol consumption were inextricably linked only in lOFC-lesioned rats: extreme fear regulation predicted excessive alcohol consumption. The results reveal the lOFC is essential to partition mechanisms for fear regulation and alcohol consumption and uncover a plausible source of neural dysfunction contributing to comorbid anxiety disorders and alcohol use disorder.	[Ray, Madelyn H.; Hanlon, Emma; McDannald, Michael A.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Boston College	Ray, MH (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	madelyn.ray@bc.edu		Ray, Madelyn/0000-0002-6692-7090	National Institute on Drug Abuse [DA034010]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA034010] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by National Institute on Drug Abuse DA034010 awarded to Michael A. McDannald https://www.drugabuse.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Arico C, 2014, BEHAV NEUROSCI, V128, P199, DOI 10.1037/a0036133; Berg BA, 2014, EUR J NEUROSCI, V40, P3096, DOI 10.1111/ejn.12676; Chang YH, 2018, NEUROBIOL LEARN MEM, V148, P30, DOI 10.1016/j.nlm.2017.12.011; Chaudhri N, 2010, NEUROPSYCHOPHARMACOL, V35, P783, DOI 10.1038/npp.2009.187; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Claus ED, 2011, NEUROPSYCHOPHARMACOL, V36, P2086, DOI 10.1038/npp.2011.99; Corbit LH, 2007, ALCOHOL CLIN EXP RES, V31, P766, DOI 10.1111/j.1530-0277.2007.00359.x; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; den Hartog C, 2016, NEUROPHARMACOLOGY, V107, P451, DOI 10.1016/j.neuropharm.2016.03.031; DiLeo A, 2016, LEARN MEMORY, V23, P618, DOI 10.1101/lm.043257.116; DiLeo A, 2015, BEHAV NEUROSCI, V129, P371, DOI 10.1037/bne0000075; Dom G, 2005, BRIT J PSYCHIAT, V187, P209, DOI 10.1192/bjp.187.3.209; Doremus TL, 2005, ALCOHOL CLIN EXP RES, V29, P1796, DOI 10.1097/01.alc.0000183007.65998.aa; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Gabbott PLA, 2003, BRAIN RES, V993, P59, DOI 10.1016/j.brainres.2003.08.056; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gilpin NW, 2015, BIOL PSYCHIAT, V77, P859, DOI 10.1016/j.biopsych.2014.09.008; Gilpin NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031466; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2017, J NEUROSCI, V37, P10529, DOI 10.1523/JNEUROSCI.1678-17.2017; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KAPP BS, 1979, PHYSIOL BEHAV, V23, P1109, DOI 10.1016/0031-9384(79)90304-4; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Liberti WA, 2016, NAT NEUROSCI, V19, P1665, DOI 10.1038/nn.4405; Lopatina N, 2017, BEHAV NEUROSCI, V131, P201, DOI 10.1037/bne0000195; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Mill DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079824; Mitchell JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002902; Moaddab M, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110151; Morris JS, 2004, NEUROIMAGE, V22, P372, DOI 10.1016/j.neuroimage.2004.01.012; Muschamp JW, 2011, J NEUROSCI, V31, P3095, DOI 10.1523/JNEUROSCI.5973-10.2011; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Petrakis IL, 2002, ALCOHOL RES HEALTH, V26, P81; Pickens CL, 2009, BIOL PSYCHIAT, V65, P881, DOI 10.1016/j.biopsych.2008.12.010; Pickens CL, 2003, J NEUROSCI, V23, P11078; Remedios J, 2014, BRAIN BEHAV, V4, P278, DOI 10.1002/brb3.216; Sarlitto MC, 2018, NEUROSCIENCE, V379, P350, DOI 10.1016/j.neuroscience.2018.03.037; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schuck NW, 2016, NEURON, V91, P1402, DOI 10.1016/j.neuron.2016.08.019; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Smith JP, 2010, ADDICT BEHAV, V35, P42, DOI 10.1016/j.addbeh.2009.07.002; Spoormaker VI, 2011, NEUROIMAGE, V54, P2250, DOI 10.1016/j.neuroimage.2010.09.042; Stalnaker TA, 2015, NAT NEUROSCI, V18, P620, DOI 10.1038/nn.3982; Tabbert K, 2005, INT J PSYCHOPHYSIOL, V57, P15, DOI 10.1016/j.ijpsycho.2005.01.007; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; Trow JE, 2017, NEUROSCIENCE, V345, P49, DOI 10.1016/j.neuroscience.2016.10.017; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Walton ME, 2011, ANN NY ACAD SCI, V1239, P14, DOI 10.1111/j.1749-6632.2011.06257.x; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Wikenheiser AM, 2017, NEURON, V95, P1197, DOI 10.1016/j.neuron.2017.08.003; Wikenheiser AM, 2016, NAT REV NEUROSCI, V17, P513, DOI 10.1038/nrn.2016.56; Willcocks AL, 2013, EUR J NEUROSCI, V37, P259, DOI 10.1111/ejn.12031; Wright CI, 1996, NEUROSCIENCE, V73, P359, DOI 10.1016/0306-4522(95)00592-7; Wright KM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00227; Zacharias RA, BEHAV NEUROSCIENCE; Zelinski EL, 2010, EXP BRAIN RES, V203, P285, DOI 10.1007/s00221-010-2228-0; Zimmermann KS, 2018, NEUROPSYCHOPHARMACOL, V43, P674, DOI 10.1038/npp.2017.219	65	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198043	10.1371/journal.pone.0198043	http://dx.doi.org/10.1371/journal.pone.0198043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856796	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800063
J	Roley, SS; Duncan, DS; Liang, D; Garoutte, A; Jackson, RD; Tiedje, JM; Robertson, GP				Roley, Sarah S.; Duncan, David S.; Liang, Di; Garoutte, Aaron; Jackson, Randall D.; Tiedje, James M.; Robertson, G. Philip			Associative nitrogen fixation (ANF) in switchgrass (Panicum virgatum) across a nitrogen input gradient	PLOS ONE			English	Article							BIOENERGY CROPPING SYSTEMS; TALLGRASS PRAIRIE; FERTILIZER ADDITION; DIVERSITY; GRASSES; NITRIFICATION; MANAGEMENT; GROWTH; CORN	Associative N fixation (ANF), the process by which dinitrogen gas is converted to ammonia by bacteria in casual association with plants, has not been well-studied in temperate ecosystems. We examined the ANF potential of switchgrass (Panicum virgatum L.), a North American prairie grass whose productivity is often unresponsive to N fertilizer addition, via separate short-term N-15(2) incubations of rhizosphere soils and excised roots four times during the growing season. Measurements occurred along N fertilization gradients at two sites with contrasting soil fertility (Wisconsin, USA Mollisols and Michigan, USA Alfisols). In general, we found that ANF potentials declined with long-term N addition, corresponding with increased soil N availability. Although we hypothesized that ANF potential would track plant N demand through the growing season, the highest root fixation rates occurred after plants senesced, suggesting that root diazotrophs exploit carbon (C) released during senescence, as C is translocated from aboveground tissues to roots for wintertime storage. Measured ANF potentials, coupled with mass balance calculations, suggest that ANF appears to be an important source of N to unfertilized switchgrass, and, by extension, to temperate grasslands in general.	[Roley, Sarah S.; Liang, Di; Robertson, G. Philip] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Roley, Sarah S.; Liang, Di; Garoutte, Aaron; Tiedje, James M.; Robertson, G. Philip] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Duncan, David S.; Jackson, Randall D.] Univ Wisconsin, Dept Agron, Madison, WI USA; [Duncan, David S.; Jackson, Randall D.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Liang, Di; Robertson, G. Philip] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Garoutte, Aaron; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Roley, Sarah S.] Washington State Univ, Sch Environm, Richland, WA 99354 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Michigan State University; Washington State University	Roley, SS (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA.; Roley, SS (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.; Roley, SS (corresponding author), Washington State Univ, Sch Environm, Richland, WA 99354 USA.	sarah.roley@wsu.edu	Robertson, G Philip/H-3885-2011; Jackson, Randall/AAE-5573-2022	Robertson, G Philip/0000-0001-9771-9895; Roley, Sarah/0000-0002-6733-9338	United States Department of Energy (DOE) Office of Science [DE-FCO2-07ER64494]; Office of Energy Efficiency and Renewable Energy [DE-ACO5-76RL01830]; National Science Foundation Long-term Ecological Research Program [DEB 1027253]; Michigan State University AgBioResearch	United States Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); National Science Foundation Long-term Ecological Research Program(National Science Foundation (NSF)); Michigan State University AgBioResearch	This study was supported by the United States Department of Energy (DOE) Office of Science (DE-FCO2-07ER64494) and Office of Energy Efficiency and Renewable Energy (DE-ACO5-76RL01830) to the DOE Great Lakes Bioenergy Research Center, by the National Science Foundation Long-term Ecological Research Program (DEB 1027253), and by Michigan State University AgBioResearch (GPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; [Anonymous], NAT WEATH SERV WISC; Bahulikar RA, 2014, APPL ENVIRON MICROB, V80, P5636, DOI 10.1128/AEM.02091-14; Binkley D, 2000, ECOSYSTEMS, V3, P321, DOI 10.1007/s100210000029; BODDEY RM, 1988, PLANT SOIL, V108, P53, DOI 10.1007/BF02370099; Borken W, 2016, SCI REP-UK, V6, DOI 10.1038/srep39072; BORMANN BT, 1993, ECOLOGY, V74, P583, DOI 10.2307/1939318; Bottomley PJ, 2015, SOIL MICROBIOLOGY EC; Casler MD, 2012, SWITCHGRASS, P29, DOI [10.1007/978-1-4471-2903-5, DOI 10.1007/978-1-4471-2903-5_2]; CERRATO ME, 1990, AGRON J, V82, P138, DOI 10.2134/agronj1990.00021962008200010030x; CHAPMAN H. D., 1949, HILGARDIA, V19, P57; Cook PLM, 2015, MAR ECOL PROG SER, V525, P41, DOI 10.3354/meps11247; Dabundo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110335; DEPOLLI H, 1977, SOIL BIOL BIOCHEM, V9, P119, DOI 10.1016/0038-0717(77)90047-5; Dijkstra FA, 2005, PLANT SOIL, V272, P41, DOI 10.1007/s11104-004-3848-6; DOBEREINER J, 1972, PLANT SOIL, V37, P191, DOI 10.1007/BF01578494; Duran BEL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151919; Gelfand I, 2015, BIOGEOCHEMISTRY, V123, P175, DOI 10.1007/s10533-014-0061-4; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; Gupta VVSR, 2014, CROP PASTURE SCI, V65, P1044, DOI 10.1071/CP14109; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; HETRICK BAD, 1988, CAN J BOT, V66, P1376, DOI 10.1139/b88-193; Jach-Smith LC, 2018, SOIL BIOL BIOCHEM, V116, P148, DOI 10.1016/j.soilbio.2017.10.009; Jach-Smith LC, 2015, AGR ECOSYST ENVIRON, V204, P62, DOI 10.1016/j.agee.2015.02.006; Jarrell WM, 1999, LT EC RES NETWK SER, V2, P55; Jesus ED, 2016, GCB BIOENERGY, V8, P481, DOI 10.1111/gcbb.12289; Ladha JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19355; Liu XJA, 2017, APPL SOIL ECOL, V114, P105, DOI 10.1016/j.apsoil.2017.03.011; Markham JH, 2009, OECOLOGIA, V161, P353, DOI 10.1007/s00442-009-1391-0; McGlathery KJ, 1998, MAR ECOL PROG SER, V168, P245, DOI 10.3354/meps168245; McLauchlan KK, 2014, ECOLOGY, V95, P1225, DOI 10.1890/13-1068.1; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Millar N., 2015, ECOLOGY AGR LANDSCAP, P213; Mitchell JS, 2009, ECOSCIENCE, V16, P341, DOI 10.2980/16-3-3236; MORRIS DR, 1985, SOIL BIOL BIOCHEM, V17, P87, DOI 10.1016/0038-0717(85)90094-X; NCDC (National Climatic Data Center), 2013, SUMM MONTHL NORM 198; Oates LG, 2016, AGR ECOSYST ENVIRON, V233, P396, DOI 10.1016/j.agee.2016.09.008; Oelze J, 2000, FEMS MICROBIOL REV, V24, P321, DOI 10.1111/j.1574-6976.2000.tb00545.x; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Perakis SS, 2011, ECOLOGY, V92, P1481, DOI 10.1890/10-1642.1; Postgate J., 1998, NITROGEN FIXATION; R Core Team, 2013, R LANG ENV STAT COMP; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Robertson G.P., 2015, ECOLOGY AGR LANDSCAP, P1; Robertson GP, 2017, SCIENCE, V356, DOI 10.1126/science.aal2324; ROBERTSON GP, 1981, ECOLOGY, V62, P376, DOI 10.2307/1936712; ROBERTSON GP, 1982, PHILOS T ROY SOC B, V296, P445, DOI 10.1098/rstb.1982.0019; ROBSON RL, 1980, ANNU REV MICROBIOL, V34, P183, DOI 10.1146/annurev.mi.34.100180.001151; Roley SS, 2018, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.60bn81v, DOI 10.5061/DRYAD.60BN81V]; Rothballer M, 2009, MICROBIOL MONOGR, V8, P273, DOI 10.1007/7171_2007_103; Ruan LL, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/6/064007; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Sanford GR, 2016, AGR ECOSYST ENVIRON, V216, P344, DOI 10.1016/j.agee.2015.10.018; Schipanski ME, 2010, PLANT SOIL, V329, P379, DOI 10.1007/s11104-009-0165-0; Stark JM, 2015, OECOLOGIA, V177, P799, DOI 10.1007/s00442-014-3093-5; Syswerda SP, 2011, SOIL SCI SOC AM J, V75, P92, DOI 10.2136/sssaj2009.0414; TJEPKEMA JD, 1976, PLANT SOIL, V45, P81, DOI 10.1007/BF00011131; Urquiaga S, 2012, PLANT SOIL, V356, P5, DOI 10.1007/s11104-011-1016-3; Valdez ZP, 2017, BIOENERG RES, V10, P456, DOI 10.1007/s12155-016-9810-7; Van Dommelen A, 2007, BIOLOGY OF THE NITROGEN CYCLE, P179, DOI 10.1016/B978-044452857-5.50013-8; Warembourg F. R., 1993, NITROGEN ISOTOPE TEC; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wood S., 2016, PACKAGE MGCV; Zuur Alain F., 2009, P1	64	46	46	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197320	10.1371/journal.pone.0197320	http://dx.doi.org/10.1371/journal.pone.0197320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856843	Green Published, gold			2022-12-26	WOS:000433900800018
J	Sellens, E; Norris, JM; Dhand, NK; Heller, J; Hayes, L; Gidding, HF; Willaby, H; Wood, N; Bosward, KL				Sellens, Emily; Norris, Jacqueline M.; Dhand, Navneet K.; Heller, Jane; Hayes, Lynne; Gidding, Heather F.; Willaby, Harold; Wood, Nicholas; Bosward, Katrina L.			Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance	PLOS ONE			English	Article							COXIELLA-BURNETII; OLDER-ADULTS; RISK-FACTORS; FOLLOW-UP; OUTBREAK; PNEUMONIA; INFECTION; PROGRAM; IMPLEMENTATION; MANAGEMENT	Q fever vaccine uptake among veterinary nurses in Australia is low, suggesting veterinarians are not recommending the vaccination to veterinary personnel. This study aimed to determine the willingness of veterinarians to recommend Q fever vaccination to veterinary personnel and to identify factors influencing Q fever vaccine uptake by veterinary nurses in Australia. An online cross sectional survey targeted veterinarians and veterinary nurses in Australia in 2014. Responses were analysed using multivariable logistic regression. Factors significantly (p<0.05) associated with a willingness to recommend the vaccination, expressed by 35% (95% CI 31-38%) of veterinarians (n = 828), were (1) being very concerned for colleagues regarding Coxiella burnetii (OR 4.73), (2) disagreeing the vaccine is harmful (OR 3.80), (3) high Q fever knowledge (OR 2.27), (4) working within small animal practice (OR 1.67), (5) disagreeing the vaccine is expensive (OR 1.55), and (6) age, with veterinarians under 39 years most likely to recommend vaccination. Of the veterinary nursing cohort who reported a known Q fever vaccination status (n = 688), 29% (95% CI 26-33%) had sought vaccination. This was significantly (p< 0.05) associated with (1) agreeing the vaccine is important (OR 8.34), (2) moderate/high Q fever knowledge (OR 5.51), (3) working in Queensland (OR 4.00), (4) working within livestock/mixed animal practice (OR 3.24), (5) disagreeing the vaccine is expensive (OR 1.86), (6) strong reliance on work culture for biosecurity information (OR 2.5), (7) perceiving personal exposure to Coxiella burnetii to be at least low/moderate (OR 2.14), and (8) both agreeing the vaccine is safe and working within a corporate practice structure (OR 4.28). The study identified the need for veterinarians to take greater responsibility for workplace health and safety promotion, and calls for better education of veterinary personnel to raise awareness of the potential for occupational exposure to C. burnetii and improve the perception of the Q fever vaccine as being important, safe and cost-effective.	[Sellens, Emily; Norris, Jacqueline M.; Dhand, Navneet K.; Bosward, Katrina L.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia; [Heller, Jane; Hayes, Lynne] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Gidding, Heather F.; Wood, Nicholas] Natl Ctr Immunisat Res & Surveillance, Westmead, NSW, Australia; [Gidding, Heather F.] Univ New South Wales, Univ New South Wales Med, Sch Publ Hlth & Community Med, Kensington, NSW, Australia; [Willaby, Harold] Univ Sydney, Sydney Sch Publ Hlth, Camperdown, NSW, Australia; [Wood, Nicholas] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Camperdown, NSW, Australia	University of Sydney; Charles Sturt University; University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Sellens, E (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia.	emily.sellens@sydney.edu.au	Heller, Jane/H-9596-2016; Dhand, Navneet K/H-5762-2019; Bosward, Katrina/ABF-5091-2020	Heller, Jane/0000-0003-3993-0160; Dhand, Navneet K/0000-0002-4362-3596; Bosward, Katrina/0000-0002-7561-2162; Norris, Jacqueline/0000-0002-0003-6930; Hayes, Lynne/0000-0002-5172-0281; Gidding, Heather/0000-0001-7595-9281	National Health and Medical Research Council of Australia [APP1049558, 1049558]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia [NW; grant number APP1049558; http://www.ncirs.edu.au]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the veterinarians and veterinary nurses who participated in this study. This study was fully funded by a National Health and Medical Research Council Grant (No: 1049558) 2012. Q fever: How common is it and how can we best prevent it? Research to inform Q fever vaccine policy in Australia and Internationally.	ABS Labour Force Surve, 2014, VET NURS COMM AUSTR; ABS Labour Force Survey, 2014, VET COMM AUSTR; Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Angelakis E, 2011, IRAN J PUBLIC HEALTH, V40, P1; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; [Anonymous], AUSTR NAT NOT DIS SU; [Anonymous], 2014, OCC DIS IND REP 2014; [Anonymous], 2016, Q VAX Q FEV VACC Q V; [Anonymous], WORK HLTH SAF ACT NE; Australian Government Department of Health, 2013, AUSTR IMM HDB; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; DERRICK E. H., 1937, Medical Journal of Australia, V2, P281; Dhand NK, 2009, SAS MACROS STAT MODE; Dhand NK, 2010, J STAT SOFTW, V35, P1; Dowd K, 2013, PREV VET MED, V111, P17, DOI 10.1016/j.prevetmed.2013.04.002; Forland F, 2010, RISK ASSESSMENT Q FE; Gefenaite G, 2011, VACCINE, V29, P395, DOI 10.1016/j.vaccine.2010.11.008; Gibbons GC, 2014, ZOONOSES 2014; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; Gunaratnam P, 2014, AUST FAM PHYSICIAN, V43, P123; Healy B, 2011, CLIN INFECT DIS, V52, P1013, DOI 10.1093/cid/cir132; Isaacson N, 2009, FAM MED, V41, P202; Isken LD, 2013, VACCINE, V31, P2617, DOI 10.1016/j.vaccine.2013.03.062; Karki S, 2015, MED J AUSTRALIA, V203, DOI 10.5694/mja15.00391; Kermode M, 2003, AUST NZ J PUBL HEAL, V27, P390, DOI 10.1111/j.1467-842X.2003.tb00415.x; Kersh GJ, 2013, APPL ENVIRON MICROB, V79, P1697, DOI 10.1128/AEM.03472-12; Komiya Tomoyoshi, 2003, Journal of Infection and Chemotherapy, V9, P151; Kopecny L, 2013, J FELINE MED SURG, V15, P1037, DOI 10.1177/1098612X13487360; KOSATSKY T, 1984, LANCET, V2, P1447; Marmion B, 2007, MED J AUSTRALIA, V186, P164, DOI 10.5694/j.1326-5377.2007.tb00853.x; MARMION BP, 1990, EPIDEMIOL INFECT, V104, P275, DOI 10.1017/S0950268800059458; Marrie TJ, 2010, INFECT DIS CLIN N AM, V24, P27, DOI 10.1016/j.idc.2009.10.004; MARRIE TJ, 1989, EPIDEMIOL INFECT, V102, P119, DOI 10.1017/S0950268800029757; Million M, 2015, J INFECTION, V71, pS2, DOI 10.1016/j.jinf.2015.04.024; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Ruiz S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00726; Schoffelen T, 2014, VACCINE, V32, P6622, DOI 10.1016/j.vaccine.2014.09.061; Schoffelen T, 2013, J INFECTION, V67, P565, DOI 10.1016/j.jinf.2013.08.008; Sellens E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146819; SPELMAN DW, 1982, MED J AUSTRALIA, V1, P547, DOI 10.5694/j.1326-5377.1982.tb124169.x; St Leonards NSW, 2014, AUSTR VET WORKF SURV; Tozer SJ, 2014, ZOONOSES PUBLIC HLTH, V61, P105, DOI 10.1111/zph.12051; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; van der Hoek W, 2011, CLIN INFECT DIS, V52, P1431, DOI 10.1093/cid/cir234; Wilson LE, 2010, ZOONOSES PUBLIC HLTH, V57, P493, DOI 10.1111/j.1863-2378.2009.01251.x; Yassi A, 2010, CAN J PUBLIC HEALTH, V101, pS41, DOI 10.1007/BF03403845	46	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198421	10.1371/journal.pone.0198421	http://dx.doi.org/10.1371/journal.pone.0198421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856835	Green Published, gold			2022-12-26	WOS:000433900800122
J	Wang, C; Tallian, C; Su, J; Vielnascher, R; Silva, C; Cavaco-Paulo, A; Guebitz, GM; Fu, JJ				Wang, Cheng; Tallian, Claudia; Su, Jing; Vielnascher, Robert; Silva, Carla; Cavaco-Paulo, Artur; Guebitz, Georg M.; Fu, Jiajia			Ultrasound-assisted extraction of hemicellulose and phenolic compounds from bamboo bast fiber powder	PLOS ONE			English	Article							HOT-WATER EXTRACTION; LIGNIN; REACTORS; OIL; FRACTIONATION; POLYPHENOLS; BIOMASS; STRAW; WOOD	Ultrasound-assisted extraction of hemicellulose and phenolic compounds from bamboo bast fibre powder was investigated. The effect of ultrasonic probe depth and power input parameters on the type and amount of products extracted was assessed. The results of input energy and radical formation correlated with the calculated values for the anti-nodal point (lambda/4; 16.85 mm, maximum amplitude) of the ultrasonic wave in aqueous medium. Ultrasonic treatment at optimum probe depth of 15 mm improve 2.6-fold the extraction efficiencies of hemicellulose and phenolic lignin compounds from bamboo bast fibre powder. LC-Ms-Tof (liquid chromatography-mass spectrometry-time of flight) analysis indicated that ultrasound led to the extraction of coniferyl alcohol, sinapyl alcohol, vanillic acid, cellobiose, in contrast to boiling water extraction only. At optimized conditions, ultrasound caused the formation of radicals confirmed by the presence of (+)-pinoresinol which resulted from the radical coupling of coniferyl alcohol. Ultrasounds revealed to be an efficient methodology for the extraction of hemicellulosic and phenolic compounds from woody bamboo without the addition of harmful solvents.	[Wang, Cheng; Su, Jing; Cavaco-Paulo, Artur; Fu, Jiajia] Jiangnan Univ, Int Joint Res Lab Text & Fiber Bioproc, Wuxi, Peoples R China; [Tallian, Claudia; Vielnascher, Robert; Guebitz, Georg M.] Univ Nat Resources & Life Sci, Vienna BOKU, Dept Agrobiotechnol IFA Tulin, Inst Environm Biotechnol, Tulin An Der Donau, Austria; [Su, Jing; Silva, Carla; Cavaco-Paulo, Artur] Univ Minho, Ctr Biol Engn, Campus Gualtar, Braga, Portugal; [Vielnascher, Robert; Guebitz, Georg M.] Austrian Ctr Ind Biotechnol, Tulin An Der Donau, Austria; [Fu, Jiajia] Jiangnan Univ, Jiangsu Engn Technol Res Ctr Funct Text, Wuxi, Peoples R China	Jiangnan University; University of Natural Resources & Life Sciences, Vienna; Universidade do Minho; Austrian Centre of Industrial Biotechnology; Jiangnan University	Fu, JJ (corresponding author), Jiangnan Univ, Int Joint Res Lab Text & Fiber Bioproc, Wuxi, Peoples R China.; Fu, JJ (corresponding author), Jiangnan Univ, Jiangsu Engn Technol Res Ctr Funct Text, Wuxi, Peoples R China.	jiajiafu@jiangnan.edu.cn	Guebitz, Georg/AAW-1868-2021; da Silva, Carla Manuela Pereira Marinho/AAC-4547-2020; Su, Jing/B-9671-2017; Cavaco-Paulo, Artur/N-7898-2013	Guebitz, Georg/0000-0003-2262-487X; da Silva, Carla Manuela Pereira Marinho/0000-0001-6252-8693; Su, Jing/0000-0001-6176-2007; Vielnascher, Robert/0000-0002-5160-8070; Tallian, Claudia/0000-0002-0790-3881; Cavaco-Paulo, Artur/0000-0001-7204-2064	OeAD-GmbH; Austrian Federal Ministry of Science, Research and Economy Scientific and Technological Cooperation Programme [CN 03/2016]; Chinese Foundation Key projects of governmental cooperation in international scientific and technological innovation [2016 YFE0115700]; National Natural Science Foundation of China [31470509]; Portuguese Foundation for Science and Technology (FCT) [UID/BIO/04469/2013 unit]; COMPETE 2020 - European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte [POCI-01-0145-FEDER-006684]; BioTecNorte operation - European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte [NORTE-01-0145-FEDER-000004];  [B17021]	OeAD-GmbH; Austrian Federal Ministry of Science, Research and Economy Scientific and Technological Cooperation Programme; Chinese Foundation Key projects of governmental cooperation in international scientific and technological innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); COMPETE 2020 - European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte; BioTecNorte operation - European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte; 	This work has received financial funding from the OeAD-GmbH and the Austrian Federal Ministry of Science, Research and Economy Scientific and Technological Cooperation Programme under the grant number CN 03/2016. The authors would like to thank to Chinese Foundation Key projects of governmental cooperation in international scientific and technological innovation (No. 2016 YFE0115700), the National Natural Science Foundation of China (Grant No. 31470509), and the project (No. B17021). The authors would like also to thank to Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER-006684) and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2000, IND ENG CHEM RES, V39, P3688, DOI 10.1021/ie0000257; Asgharzadehahmadi S, 2016, RENEW SUST ENERG REV, V63, P302, DOI 10.1016/j.rser.2016.05.030; Bai YY, 2013, INT J MOL SCI, V14, P21394, DOI 10.3390/ijms141121394; BJORKMAN A, 1954, NATURE, V174, P1057, DOI 10.1038/1741057a0; Brauns, 1960, CHEM LIGNIN SUPPLEME; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Da Porto C, 2013, ULTRASON SONOCHEM, V20, P1076, DOI 10.1016/j.ultsonch.2012.12.002; DAVIN LB, 1992, PHYTOCHEMISTRY, V31, P3869, DOI 10.1016/S0031-9422(00)97544-7; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; Gogate PR, 2008, CHEM ENG PROCESS, V47, P515, DOI 10.1016/j.cep.2007.09.014; Goncalves I, 2014, ULTRASON SONOCHEM, V21, P774, DOI 10.1016/j.ultsonch.2013.08.006; Higuchi T., 1969, Wood Research, P1; Iskalieva A, 2012, ULTRASON SONOCHEM, V19, P984, DOI 10.1016/j.ultsonch.2012.02.007; Laine J. E., 1977, CELL CHEM TECHNOL, V11, P561; Li HZ, 2004, FOOD RES INT, V37, P731, DOI 10.1016/j.foodres.2004.02.016; Li MF, 2012, ULTRASON SONOCHEM, V19, P243, DOI 10.1016/j.ultsonch.2011.06.018; Li ZQ, 2013, BIORESOURCES, V8, P5690; Liese W., 1986, ANATOMY PROPERTIES B, P196; Little C, 2007, ULTRASON SONOCHEM, V14, P375, DOI 10.1016/j.ultsonch.2006.07.009; MAEKAWA E, 1975, AGR BIOL CHEM TOKYO, V39, P2281, DOI 10.1080/00021369.1975.10861959; Marczak W, 1997, J ACOUST SOC AM, V102, P2776, DOI 10.1121/1.420332; Monteil-Rivera F, 2012, BIORESOURCE TECHNOL, V104, P775, DOI 10.1016/j.biortech.2011.11.079; Peng H, 2012, BIORESOURCES, V7, P374; Pingret D, 2012, J FOOD ENG, V111, P73, DOI 10.1016/j.jfoodeng.2012.01.026; Silva R, 2010, ULTRASON SONOCHEM, V17, P628, DOI 10.1016/j.ultsonch.2009.10.010; Song T, 2012, BIORESOURCES, V7, P4214; Suparno O, 2005, RESOUR CONSERV RECY, V45, P114, DOI 10.1016/j.resconrec.2005.02.005; Vinatoru M, 2001, ULTRASON SONOCHEM, V8, P303, DOI 10.1016/S1350-4177(01)00071-2; Wen JL, 2011, CARBOHYD RES, V346, P111, DOI 10.1016/j.carres.2010.10.006; Xu F, 2013, APPL ENERG, V104, P801, DOI 10.1016/j.apenergy.2012.12.019; Zhang ZS, 2008, SEP PURIF TECHNOL, V62, P192, DOI 10.1016/j.seppur.2008.01.014	31	10	12	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197537	10.1371/journal.pone.0197537	http://dx.doi.org/10.1371/journal.pone.0197537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856764	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800029
J	Seridi, L; Leo, GC; Dohm, GL; Pories, WJ; Lenhard, J				Seridi, Loqmane; Leo, Gregory C.; Dohm, G. Lynis; Pories, Walter J.; Lenhard, James			Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NORMAL GLUCOSE-TOLERANCE; LONGITUDINAL CHANGES; INSULIN-RESISTANCE; GUT MICROBIOME; FOOD-INTAKE; MASS INDEX; OBESITY; MICE; SURGERY	Roux-en-Y gastric bypass (RYGB) is an effective way to lose weight and reverse type 2 diabetes. We profiled the metabolome of 18 obese patients (nine euglycemic and nine diabetics) that underwent RYGB surgery and seven lean subjects. Plasma samples from the obese patients were collected before the surgery and one week and three months after the surgery. We analyzed the metabolome in association to five hormones (Adiponectin, Insulin, Ghrelin, Leptin, and Resistin), four peptide hormones (GIP, Glucagon, GLP1, and PYY), and two cytokines (IL-6 and TNF). PCA showed samples cluster by surgery time and many microbially driven metabolites (indoles in particular) correlated with the three months after the surgery. Network analysis of metabolites revealed a connection between carbohydrate (mannosamine and glucosamine) and glyoxylate and confirms glyoxylate association to diabetes. Only leptin and IL-6 had a significant association with the measured metabolites. Leptin decreased immediately after RYGB (before significant weight loss), whereas IL-6 showed no consistent response to RYGB. Moreover, leptin associated with tryptophan in support of the possible role of leptin in the regulation of serotonin synthesis pathways in the gut. These results suggest a potential link between gastric leptin and microbial-derived metabolites in the context of obesity and diabetes.	[Seridi, Loqmane; Leo, Gregory C.; Lenhard, James] Janssen Res & Dev LLC, Spring House, PA 19477 USA; [Dohm, G. Lynis; Pories, Walter J.] East Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; University of North Carolina; East Carolina University	Seridi, L (corresponding author), Janssen Res & Dev LLC, Spring House, PA 19477 USA.	lseridi@its.jnj.com		Seridi, Loqmane/0000-0001-7028-3024	Janssen Research & Development, LLC	Janssen Research & Development, LLC	JL, GCL, and LS are employees of Janssen Research & Development, LLC and funded by it. The funder provided support in the form of salaries for authors JL, GCL, and LS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arora T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126401; Beckman LM, 2010, J AM DIET ASSOC, V110, P571, DOI 10.1016/j.jada.2009.12.023; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bloomgarden ZT, 2006, DIABETES CARE, V29, P450, DOI 10.2337/diacare.29.02.06.dc06-0006; Cammisotto P, 2012, ANAT CELL BIOL, V45, P1, DOI 10.5115/acb.2012.45.1.1; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danpure CJ, 2005, NEPHROL DIAL TRANSPL, V20, P1525, DOI 10.1093/ndt/gfh923; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Elshorbagy AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044166; Ensign SA, 2006, MOL MICROBIOL, V61, P274, DOI 10.1111/j.1365-2958.2006.05247.x; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Hebebrand J, 2007, MOL PSYCHIATR, V12, P23, DOI 10.1038/sj.mp.4001909; Heneghan HM, 2013, SURG OBES RELAT DIS, V9, P100, DOI 10.1016/j.soard.2011.11.018; Huang H, 2011, OBESITY, V19, P2235, DOI 10.1038/oby.2011.107; Jennis M, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13178; Kerley-Hamilton JS, 2012, ENVIRON HEALTH PERSP, V120, P1252, DOI 10.1289/ehp.1205003; Laimer M, 2002, INT J OBESITY, V26, P659, DOI 10.1038/sj.ijo.0801970; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Beyec J, 2014, INT J OBESITY, V38, P1357, DOI 10.1038/ijo.2014.14; Levy JR, 2000, AM J PHYSIOL-ENDOC M, V278, pE892, DOI 10.1152/ajpendo.2000.278.5.E892; Lindegaard KK, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0012-9; Lips MA, 2014, DIABETES CARE, V37, P3150, DOI 10.2337/dc14-0195; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Magkos F, 2013, DIABETES, V62, P2757, DOI 10.2337/db13-0185; Mao XB, 2013, BRIT J NUTR, V110, P256, DOI 10.1017/S0007114512004849; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Marwarha Gurdeep, 2012, Am J Neurodegener Dis, V1, P245; McGill JRB, 2004, DIABETES CARE, V27, P1859, DOI 10.2337/diacare.27.8.1859; Miller GD, 2011, SURG OBES RELAT DIS, V7, P618, DOI 10.1016/j.soard.2011.03.006; Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Nikiforova VJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/685204; Organization WH, 2016, OB FACTS FIG WORLD H; Padberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085082; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rajala MW, 2014, ENDOCRINOLOGY, V155, P748, DOI 10.1210/en.2013-1085; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reed MA, 2011, J CLIN ENDOCR METAB, V96, P2525, DOI 10.1210/jc.2011-0165; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Sainsbury A, 2008, CANCER EPIDEM BIOMAR, V17, P1401, DOI 10.1158/1055-9965.EPI-07-2874; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHWENK WF, 1987, DIABETES, V36, P199, DOI 10.2337/diabetes.36.2.199; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solomon JC, 2003, CELL DEATH DIFFER, V10, P193, DOI 10.1038/sj.cdd.4401136; Swarbrick MM, 2008, DIABETOLOGIA, V51, P1901, DOI 10.1007/s00125-008-1118-5; Takashina C, 2016, NUTR METAB, V13, DOI 10.1186/s12986-015-0059-5; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Tobias M, 2011, LANCET, V378, P3, DOI 10.1016/S0140-6736(11)60604-1; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xu CX, 2015, INT J OBESITY, V39, P1300, DOI 10.1038/ijo.2015.63; Yuan XW, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.27373; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang HW, 2007, DOMEST ANIM ENDOCRIN, V33, P47, DOI 10.1016/j.domaniend.2006.04.005; Zhang LM, 2015, ENVIRON SCI TECHNOL, V49, P8067, DOI 10.1021/acs.est.5b01389	67	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198156	10.1371/journal.pone.0198156	http://dx.doi.org/10.1371/journal.pone.0198156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851973	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200035
J	Adair, T; Lopez, AD				Adair, Tim; Lopez, Alan D.			Estimating the completeness of death registration: An empirical method	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; MORTALITY; DISEASE	Introduction Many national and subnational governments need to routinely measure the completeness of death registration for monitoring and statistical purposes. Existing methods, such as death distribution and capture-recapture methods, have a number of limitations such as inaccuracy and complexity that prevent widespread application. This paper presents a novel empirical method to estimate completeness of death registration at the national and subnational level. Methods Random-effects models to predict the logit of death registration completeness were developed from 2,451 country-years in 110 countries from 1970 +/- 2015 using the Global Burden of Disease 2015 database. Predictors include the registered crude death rate, under-five mortality rate, population age structure and under-five death registration completeness. Models were developed separately for males, females and both sexes. Findings All variables are highly significant and reliably predict completeness of registration across a wide range of registered crude death rates (R-squared 0.85). Mean error is highest at medium levels of observed completeness. The models show quite close agreement between predicted and observed completeness for populations outside the dataset. There is high concordance with the Hybrid death distribution method in Brazilian states. Uncertainty in the under-five mortality rate, assessed using the dataset and in Colombian departmentos, has minimal impact on national level predicted completeness, but a larger effect at the subnational level. Conclusions The method demonstrates sufficient flexibility to predict a wide range of completeness levels at a given registered crude death rate. The method can be applied utilising data readily available at the subnational level, and can be used to assess completeness of deaths reported from health facilities, censuses and surveys. Its utility is diminished where the adult mortality rate is unusually high for a given under-five mortality rate. The method overcomes the considerable limitations of existing methods and has considerable potential for widespread application by national and subnational governments.	[Adair, Tim; Lopez, Alan D.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia	University of Melbourne	Adair, T (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia.	timothy.adair@unimelb.edu.au	Lopez, Alan/AAA-2734-2022; Adair, Tim/O-3494-2019; Lopez, Alan D/F-1487-2010	Adair, Tim/0000-0002-1562-4452; Lopez, Alan D/0000-0001-5818-6512	Bloomberg Philanthropies	Bloomberg Philanthropies	This study was funded under an award from Bloomberg Philanthropies to the University of Melbourne to support the Data for Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded under an award from Bloomberg Philanthropies to the University of Melbourne to support the Data for Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Haidong Wang and Joe Mikesell of the Institute of Health Metrics and Evaluation, University of Washington for preparing and making available the GBD data used in this study.	AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8; BENNETT NG, 1984, DEMOGRAPHY, V21, P217, DOI 10.2307/2061041; Brass W., 1975, LAB POPULATION STAT; Carter KL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-9; Departamento Administrativo Nacional de Estad A o stica (DANE), 2017, PROYECC POBL; Departamento Administrativo Nacional de Estad A o stica (DANE), 2017, DEF TAT 2014; Departamento de Informatica do SUS (DATASUS), 2018, EST VIT; Dorrington R., 2013, TOOLS DEMOGRAPHIC ES, P196; Dorrington RE., 2013, TOOLS DEMOGRAPHIC ES, P275; Dorrington RE., 2013, TOOLS DEMOGRAPHIC ES, P258; Health Metrics Network, 2013, STRENGTH CIV REG VIT; Hill K, 1987, Asian Pac Popul Forum, V1, P8; Hill K., 2017, 201702 UN NAT POP DI; Hill K, 2009, DEMOGR RES, V21, P235, DOI 10.4054/DemRes.2009.21.9; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2013, PROJ POP BRAS SEX 20; Lopez AD, 2017, GUIDANCE ASSESSING I; Minsalud, 2016, ENC NAC DEM SAL 2015; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Phillips DE, 2015, LANCET, V386, P1386, DOI 10.1016/S0140-6736(15)60172-6; PRESTON S, 1980, POPUL INDEX, V46, P179, DOI 10.2307/2736122; Profamilia, 2011, ENC NAC DEM SAL 2010; Queiroz Bernardo Lanza, 2017, Rev. bras. epidemiol., V20, P21, DOI 10.1590/1980-5497201700050003; Rao Chalapati, 2010, BMC Res Notes, V3, P325, DOI 10.1186/1756-0500-3-325; StataCorp, STATA 13 0; Timaeus I.M., 2013, TOOLS DEMOGRAPHIC ES, P191; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X	32	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197047	10.1371/journal.pone.0197047	http://dx.doi.org/10.1371/journal.pone.0197047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847573	Green Submitted, gold, Green Published			2022-12-26	WOS:000433634800016
J	Alvarenga, GC; Ramalho, EE; Baccaro, FB; da Rocha, DG; Ferreira-Ferreira, J; Bobrowiec, PED				Alvarenga, Guilherme Costa; Ramalho, Emiliano Esterci; Baccaro, Fabricio Beggiato; da Rocha, Daniel Gomes; Ferreira-Ferreira, Jefferson; Dineli Bobrowiec, Paulo Estefano			Spatial patterns of medium and large size mammal assemblages in varzea and terra firme forests, Central Amazonia, Brazil	PLOS ONE			English	Article							COATI NASUA-NASUA; COMMUNITY STRUCTURE; HABITAT LOSS; HOME-RANGE; LANDSCAPE; VEGETATION; DISPERSAL; FUTURE; ASSOCIATIONS; FLOODPLAINS	Varzea forests account for 17% of the Amazon basin and endure an annual inundation that can reach 14 m deep during 6-8 months. This flood pulse in combination with topography directly influences the varzea vegetation cover. Assemblages of several taxa differ significantly between unflooded terra firme and flooded varzea forests, but little is known about the distribution of medium and large sized terrestrial mammals in varzea habitats. Therefore, our goal was to understand how those habitats influence mammalian species distribution during the dry season. Specifically, we: (1) compared the species composition between a terra firme (Amana Sustainable Development Reserve) and a varzea forest (Mamiraua A Sustainable Development Reserve); and (2) tested the influence of the varzea habitat classes on the number of records, occurrence and species composition of mammalian assemblages. The sampling design in each reserve consisted of 50 baited camera trap stations, with an overall sampling effort of 5015 camera trap days. We used Non-Metric Multidimension Scaling (NMDS) to compare species composition between terra firme and varzea forests, and used Generalized Linear Models (GLM) to assess how habitat types and a habitat diversity index affect mammal distributions. We recorded 21 medium and large sized mammalian species, including 20 species in terra firme and only six in varzea (3443 records). Flood pulse and isolation in varzea forest drove the dissimilarity between these two forest types. In varzea forest, medium size mammals, in general, avoided habitats associated with long flooding periods, while jaguars (Panthera onca) appeared to prefer aquatic/terrestrial transition zones. Habitats that remain dry for longer periods showed more mammalian occurrence, suggesting that dispersion via soil is important even for semi-arboreal species. This is the first study to evaluate differential use of varzea habitats by terrestrial mammalian assemblages.	[Alvarenga, Guilherme Costa; Baccaro, Fabricio Beggiato; Dineli Bobrowiec, Paulo Estefano] INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Alvarenga, Guilherme Costa; Ramalho, Emiliano Esterci; Ferreira-Ferreira, Jefferson] IDSM, Tefe, Amazonas, Brazil; [Baccaro, Fabricio Beggiato] Univ Fed Amazonas UFAM, Dept Biol, Manaus, Amazonas, Brazil; [da Rocha, Daniel Gomes] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Grad Grp Ecol, Davis, CA 95616 USA; [Ferreira-Ferreira, Jefferson] Univ Estadual Paulista Unesp, Ecosyst Dynam Observ, Inst Geociencias & Ciencias Exatas, Rio Claro, SP, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas; University of California System; University of California Davis; Universidade Estadual Paulista	Alvarenga, GC (corresponding author), INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.; Alvarenga, GC (corresponding author), IDSM, Tefe, Amazonas, Brazil.	gcalvarenga.bio@gmail.com	Baccaro, Fabricio/HIR-4297-2022; Baccaro, Fabricio/H-3885-2012; Bobrowiec, Paulo Estefano D./A-2630-2013; Ferreira Ferreira, Jefferson/I-1785-2014	Baccaro, Fabricio/0000-0003-4747-1857; Baccaro, Fabricio/0000-0003-4747-1857; Ferreira Ferreira, Jefferson/0000-0003-2582-4391	Mamiraua Sustainable Development Institute - Ministerio da Ciencia, Tecnologia, Inovacao e Comunicacao; National Counsel of Technological and Scientific Development; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Doutorado Pleno no Exterior [88881.128140/2016-01]	Mamiraua Sustainable Development Institute - Ministerio da Ciencia, Tecnologia, Inovacao e Comunicacao; National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Doutorado Pleno no Exterior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study had logistic and financial support of Mamiraua Sustainable Development Institute (financed by Ministerio da Ciencia, Tecnologia, Inovacao e Comunicacao). Beyond that, GCA had a master degree scholarship by National Counsel of Technological and Scientific Development and DGR received a scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Doutorado Pleno no Exterior/ no:88881.128140/2016-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Costa CP, 2004, J MAMMAL, V85, P478, DOI 10.1644/1545-1542(2004)085<0478:VITDOT>2.0.CO;2; Anderson M. J., 2005, PERMANOVA FORTRAN CO; Antunes AP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600936; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Ayres JM., 1986, UAKARIS AMAZONIAN FL; AYRES JM, 1993, MATAS VARZEA MAMIRAU; Barnett AA, 2013, CAM S BIO EVOL ANTHR, V65, P179; Beisiegel BM, 2006, J ZOOL, V269, P77, DOI 10.1111/j.1469-7998.2006.00083.x; Beja P, 2010, BIODIVERS CONSERV, V19, P129, DOI 10.1007/s10531-009-9711-6; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Bobrowiec PED, 2014, BIOTROPICA, V46, P312, DOI 10.1111/btp.12102; BODMER RE, 1990, J TROP ECOL, V6, P191, DOI 10.1017/S0266467400004314; Bodmer R, 2018, CONSERV BIOL, V32, P333, DOI 10.1111/cobi.12993; Borges LHM, 2014, ABUNDANCIA MAMIFEROS; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Branch LC, 1983, BRAZIL PRIMATES, V24, P424; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Castello L, 2008, ECOL FRESHW FISH, V17, P38, DOI 10.1111/j.1600-0633.2007.00255.x; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; CHARLESDOMINIQUE P, 1981, TERRE VIE-REV ECOL A, V35, P341; Chiarello AG, 2008, LIVRO VERMELHO FAUNA, P261; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; da Rocha DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154624; Da Silveira R, 2010, J HERPETOL, V44, P418, DOI 10.1670/08-340.1; de Assis RL, 2011, FLORA, V206, P251, DOI 10.1016/j.flora.2010.11.002; de Oliveira TG, 1998, LEOPARDUS WIEDII MAM, P1; de Queiroz HL, 1995, PREGUICAS GUARIBAS M; Martins SD, 2007, BIODIVERS CONSERV, V16, P857, DOI 10.1007/s10531-006-9094-x; ESTRADA A, 1994, ECOGRAPHY, V17, P229, DOI 10.1111/j.1600-0587.1994.tb00098.x; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Feer F, 1997, NEOTROPICAL RAINFORE; Ferreira LV, 2000, BIODIVERS CONSERV, V9, P1, DOI 10.1023/A:1008989811637; Ferreira-Ferreira J, 2015, WETL ECOL MANAG, V23, P41, DOI 10.1007/s11273-014-9359-1; Flores BM, 2017, P NATL ACAD SCI USA, V114, P4442, DOI 10.1073/pnas.1617988114; FORD L S, 1988, Mammalian Species, P1, DOI 10.2307/3504086; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Gascon C, 1996, BIOTROPICA, V28, P136, DOI 10.2307/2388779; Gompper Matthew E., 1998, Mammalian Species, V580, P1; Gorresen PM, 2005, ECOL APPL, V15, P2126, DOI 10.1890/04-0532; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Haugaasen T, 2008, PRIMATES, V49, P219, DOI 10.1007/s10329-008-0081-6; Haugaasen T, 2007, BIODIVERS CONSERV, V16, P4165, DOI 10.1007/s10531-007-9217-z; Haugaasen T, 2009, PRIMATES, V50, P239, DOI 10.1007/s10329-009-0135-4; Hess LL, 2003, REMOTE SENS ENVIRON, V87, P404, DOI 10.1016/j.rse.2003.04.001; Irion G., 1997, CENTRAL AMAZON FLOOD, P22, DOI DOI 10.1007/978-3-662-03416-3_2; IUCN, 2014, IUCN RED LIST THREAT; Jackman SD, 2015, PSCL CLASSES METHODS; Jackson HB, 2012, LANDSCAPE ECOL, V27, P929, DOI 10.1007/s10980-012-9757-9; Janson C.H., 1990, P314; Junk WJ, 2002, ENVIRON CONSERV, V29, P414, DOI 10.1017/S0376892902000310; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Junk WJ, 2010, ECOL STUD-ANAL SYNTH, V210, P3, DOI 10.1007/978-90-481-8725-6_1; Paredes OSL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174049; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Luize BG, 2015, BIOTROPICA, V47, P137, DOI 10.1111/btp.12203; McGarigal K, 2016, LANDSCAPE ECOL, V31, P1161, DOI 10.1007/s10980-016-0374-x; Melack J.M., 2010, AMAZONIAN FLOODPLAIN, P43, DOI DOI 10.1007/978-90-481-8725-6_3; Michalski LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126114; Miguet P, 2016, LANDSCAPE ECOL, V31, P1177, DOI 10.1007/s10980-015-0314-1; MILES MA, 1981, J ZOOL, V195, P331, DOI 10.1111/j.1469-7998.1981.tb03469.x; Munari DP, 2011, MAMM BIOL, V76, P401, DOI 10.1016/j.mambio.2011.02.007; Muylaert RL, 2016, ECOL APPL, V26, P1854, DOI 10.1890/15-1757.1; Oksanen, 2015, MULTIVARIATE ANAL EC; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PAGLIA A. P., 2012, OCCASIONAL PAPERS CO, V6; Paim FP, 2018, PRIMATES, P1, DOI [10.1007/s10329-017-0639-2, DOI 10.1007/S10329-017-0639-2]; Palomares F, 2017, MAMMAL RES, V62, P241, DOI 10.1007/s13364-017-0311-7; Peres C.A., 1999, MAMMALS NEOTROPICS, V3, P564; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Peres CA, 1997, J TROP ECOL, V13, P381, DOI 10.1017/S0266467400010580; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Pickles RSA, 2011, BIOTA NEOTROP, V11, P237, DOI 10.1590/S1676-06032011000300021; Polisar J, 2008, STUD NEOTROP FAUNA E, V43, P85, DOI 10.1080/01650520701726075; Pontes ARM, 2007, J ZOOL, V273, P257, DOI 10.1111/j.1469-7998.2007.00323.x; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; QGIS Development Team, 2018, QGIS GEOGR INF SYST; Queiroz HL, 2005, CORREDORES ECOLOGICO, P246; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Quesnelle PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090926; R Core Team, 2021, R LANGUAGE ENV STAT; Rabelo RM, 2014, PRIMATES, V55, P167, DOI 10.1007/s10329-014-0409-3; Ramalho E.E., 2012, THESIS U FLORIDA; Ramalho EE., 2010, UAKARI, V5, P61, DOI DOI 10.4322/ACTALB.2011.023; Ramalho EE, 2008, UAKARI, V4, P33, DOI DOI 10.31420/UAKARI.V4I2.41; Pereira MJR, 2009, J ANIM ECOL, V78, P1163, DOI 10.1111/j.1365-2656.2009.01591.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Roberts M., 1987, International Zoo Yearbook, V26, P265; Roze U, 2012, PORC AN ANSW GUID, P24; Salvador S, 2011, MAMM BIOL, V76, P115, DOI 10.1016/j.mambio.2010.04.007; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Sociedade Civil Mamiraua, 1996, PLAN MAN RES DES SUS; Sunquist M.E., 1989, P283; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Thornton D, 2011, ECOL APPL, V21, P817, DOI 10.1890/10-0549.1; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Valsecchi J., 2005, DIVERSIDADE MAMIFERO; Vieira E.M., 2012, MARSUPIAIS BRASIL BI, P347, DOI DOI 10.20873/UFT.2179-3948.2018V9N3P290; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060; Wittmann F, 2002, J TROP ECOL, V18, P805, DOI 10.1017/S0266467402002523; Wittmann F., 2010, JUNK WJ, P61; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	106	20	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198120	10.1371/journal.pone.0198120	http://dx.doi.org/10.1371/journal.pone.0198120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847606	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800055
J	Breen, NE; Lowenstein, J; Metivier, R; Andrade, L; Rhyne, AL				Breen, Nancy E.; Lowenstein, Julie; Metivier, Rebecca; Andrade, Lawrence; Rhyne, Andrew L.			Can excreted thiocyanate be used to detect cyanide exposure in live reef fish?	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY	Cyanide fishing, where a solution of sodium or potassium cyanide is used to stun reef fish for easy capture for the marine aquarium and live fish food trades, continues to be pervasive despite being illegal in many countries and destructive to coral reef ecosystems. Currently, there is no easy, reliable and universally accepted method to detect if a fish has been exposed to cyanide during the capture process. A promising non-invasive technique for detecting thiocyanate ions, the metabolic byproduct excreted by exposed fish, has been reported in the literature. In an effort to validate this method, four cyanide exposure studies on Amphiprion ocellaris (common clownfish) were carried out over three years. Fish were either exposed to the same (25 ppm) or twice the concentration (50 ppm) as the previsouly published method. Over 100 water samples of fish exposed to cyanide were analyzed by reverse phase HPLC with a C-30 column treated with polyethylene glycol and UV detector operating at 220 nm. No thiocyanate was detected beyond the analytical standards and positive controls prepared in seawater. As an alternate means of detecting thiocyanate, water samples and thiocyanate standards from these exposures were derivatized with monobromobimane (MBB) for LC-MS/MS analysis. Thiocyanate was detected in standards with concentrations as low as 0.6 mu g/L and quantified to 1 mu g/L, but thiocyanate could not be detected in any of the water samples from fish exposed to cyanide with this method either, confirming the HPLC results. Further, we calculated both the mass balance of thiocyanate and the resultant plausible dosage of cyanide from the data reported in the previously published method. These calculations, along with the known lethal dosage of cyanide, further suggests that the detection of thiocyanate in aquarium water is not a viable method for assessing fish exposure to cyanide.	[Breen, Nancy E.; Metivier, Rebecca] Roger Williams Univ, Dept Chem & Phys, Bristol, RI 02809 USA; [Lowenstein, Julie; Metivier, Rebecca; Rhyne, Andrew L.] Roger Williams Univ, Dept Biol Marine Biol & Environm Sci, Bristol, RI 02809 USA; [Andrade, Lawrence] Domin Diagnost, North Kingstown, RI USA		Rhyne, AL (corresponding author), Roger Williams Univ, Dept Biol Marine Biol & Environm Sci, Bristol, RI 02809 USA.	arhyne@rwu.edu		Loewenstein, Julie/0000-0003-4618-5277; Rhyne, Andrew/0000-0001-7252-3431	Dominion Diagnostics; Olazul and Trust for Conservation Innovation; National Science Foundation EPSCoR Cooperative Agreement [EPS-1004057]	Dominion Diagnostics; Olazul and Trust for Conservation Innovation; National Science Foundation EPSCoR Cooperative Agreement(National Science Foundation (NSF))	The funder Dominion Diagnostics provided support in the form of a salary for LA, who is an employee. The specific roles of these authors are articulated in the 'author contributions' section. The funder also provided at no cost LC MS/MS resources and time for this study. The authors are grateful to Ms. Jos Hill, formerly of Olazul and Trust for Conservation Innovation, for funding this work. This material is based upon work supported in part by the National Science Foundation EPSCoR Cooperative Agreement #EPS-1004057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Andrade J., 2015, EFFECTS CYANIDE EXPO; Barber CV, 1998, CORAL REEFS CHALLENG, P39; Bellwood DR., 1981, FRESHWATER MARINE MA, P31; Bellwood DR, 1981, FRESHWATER MARINE MA, P75; Bhandari RK, 2014, ANAL BIOANAL CHEM, V406, P727, DOI 10.1007/s00216-013-7536-3; BROWN DG, 1995, ECOTOX ENVIRON SAFE, V30, P302, DOI 10.1006/eesa.1995.1034; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; EGEKEZE JO, 1980, VET QUART, V2, P104, DOI 10.1080/01652176.1980.9693766; FRANT MS, 1972, ANAL CHEM, V44, P2227, DOI 10.1021/ac60321a038; Frey JB, 2012, THESIS, P125; Herz Nicole, 2016, SPC Live Reef Fish Information Bulletin, V21, P8; Ikebukuro K, 2013, HDB WATER ANAL, P365; Lilley R., 2007, SPC LIVE REEF FISH I, V17, P11; Logue BA, 2010, CRIT REV ANAL CHEM, V40, P122, DOI 10.1080/10408340903535315; Mak KKW, 2005, BIOSENS BIOELECTRON, V20, P2581, DOI 10.1016/j.bios.2004.09.015; Ramzy EM, 2014, WATER SCI, V28, P42, DOI DOI 10.1016/J.WSJ.2014.09.002; Roberts G., 2008, P INT CYAN DET TEST, P164; Rong L, 2005, CHROMATOGRAPHIA, V61, P371, DOI 10.1365/s10337-005-0501-3; Rubec P.J., 1986, P297; Rubec P. J., 2001, AQUARIUM SCI CONSERV, V3, P37, DOI DOI 10.1023/A:1011370106291; Rubec PJ, 2008, MAR ORNAM SPECIES CO, P325, DOI [10.1002/9780470752722.ch24, DOI 10.1002/9780470752722.CH24]; Silva LIB, 2011, J ENVIRON MONITOR, V13, P1811, DOI 10.1039/c1em10043b; Vaz MCM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04940-x; Vaz MCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035355	25	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0196841	10.1371/journal.pone.0196841	http://dx.doi.org/10.1371/journal.pone.0196841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847597	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800013
J	Haraldsdottir, A; Torfadottir, JE; Valdimarsdottir, UA; Adami, HO; Aspelund, T; Tryggvadottir, L; Thordardottir, M; Birgisdottir, BE; Harris, TB; Launer, LJ; Gudnason, V; Steingrimsdottir, L				Haraldsdottir, Alfheidur; Torfadottir, Johanna E.; Valdimarsdottir, Unnur A.; Adami, Hans-Olov; Aspelund, Thor; Tryggvadottir, Laufey; Thordardottir, Marianna; Birgisdottir, Bryndis E.; Harris, Tamara B.; Launer, Lenore J.; Gudnason, Vilmundur; Steingrimsdottir, Laufey			Dietary habits in adolescence and midlife and risk of breast cancer in older women	PLOS ONE			English	Article							ADVANCED PROSTATE-CANCER; HIGH-FIBER DIET; EARLY-LIFE; PREMENOPAUSAL WOMEN; GRAIN CONSUMPTION; PHYSICAL-ACTIVITY; EATING PATTERNS; PROCESSED MEAT; DAIRY INTAKE; HUMAN HEALTH	Recent studies indicate that lifestyle factors in early life affect breast cancer risk. We therefore explored the association of high consumption of meat, milk, and whole grain products in adolescence and midlife, on breast cancer risk. We used data from the population based AGES-Reykjavik cohort (2002-2006), where 3,326 women with a mean age of 77 years (SD 6.0) participated. For food items and principal component derived dietary patterns we used Cox proportional models to calculate multivariate hazard ratios (HR) with 95% confidence intervals (95% CI). During a mean follow-up of 8.8 years, 97 women were diagnosed with breast cancer. For both adolescence and midlife, daily consumption of rye bread was positively associated with breast cancer (HR 1.7, 95% CI 1.1-2.6 and HR 1.8, 95% CI 1.1-2.9, respectively). In contrast, persistent high consumption of oatmeal was negatively associated with breast cancer (0.4, 95% CI 0.2-0.9). No association was found for other food items or dietary patterns that included rye bread. High rye bread consumption in adolescence and midlife may increase risk of late-life breast cancer whilst persistent consumption of oatmeal may reduce the risk.	[Haraldsdottir, Alfheidur; Birgisdottir, Bryndis E.; Steingrimsdottir, Laufey] Univ Iceland, Fac Food Sci & Human Nutr, Reykjavik, Iceland; [Haraldsdottir, Alfheidur; Torfadottir, Johanna E.; Valdimarsdottir, Unnur A.; Aspelund, Thor] Univ Iceland, Ctr Publ Hlth Sci, Fac Med, Reykjavik, Iceland; [Valdimarsdottir, Unnur A.; Adami, Hans-Olov] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Valdimarsdottir, Unnur A.; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [Tryggvadottir, Laufey; Thordardottir, Marianna; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Birgisdottir, Bryndis E.; Steingrimsdottir, Laufey] Univ Iceland, Unit Nutr Res, Reykjavik, Iceland; [Birgisdottir, Bryndis E.; Steingrimsdottir, Laufey] Landspitali Natl Univ Hosp, Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, Bethesda, MD 20892 USA; [Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland	University of Iceland; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; University of Iceland; University of Iceland; Landspitali National University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icelandic Heart Association	Haraldsdottir, A (corresponding author), Univ Iceland, Fac Food Sci & Human Nutr, Reykjavik, Iceland.; Haraldsdottir, A (corresponding author), Univ Iceland, Ctr Publ Hlth Sci, Fac Med, Reykjavik, Iceland.	alh1@hi.is	Aspelund, Thor/K-7022-2019; Þórðardóttir, Maríanna/Q-6096-2019; Gudnason, Vilmundur/AAE-7126-2019	Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Valdimarsdottir, Unnur/0000-0001-5382-946X; Birgisdottir, Bryndis Eva/0000-0002-5788-4551; Thordardottir, Marianna/0000-0002-1273-3493	NIH [N01-AG-12100]; Intramural Research Program of the National Institute on Aging; Icelandic Heart Association; Icelandic Parliament; The Icelandic Centre for Research, RANNIS grant [152495051]; Public Health Fund of the Icelandic Directorate of Health; National Institute on Aging; Icelandic Parlament	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Icelandic Heart Association; Icelandic Parliament; The Icelandic Centre for Research, RANNIS grant; Public Health Fund of the Icelandic Directorate of Health; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Icelandic Parlament	The AGES-Reykjavik Study was funded by NIH contract N01-AG-12100, the Intramural Research Program of the National Institute on Aging, by the Icelandic Heart Association and the Icelandic Parliament. This work was supported by the The Icelandic Centre for Research, RANNIS grant number: 152495051, (http://en.rannis.is/) (A. Haraldsdottir) and the Public Health Fund of the Icelandic Directorate of Health (A. Haraldsdottir). The funding agencies (National Institute on Aging, Icelandic Heart Association and Icelandic Parlament,) for the AGES-Reykjavik Study, RANNIS, or Directorate of Health had no role in the design, analysis or writing of this article.	Abid Z, 2014, AM J CLIN NUTR, V100, p386S, DOI 10.3945/ajcn.113.071597; Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942; Adlercreutz H, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5231; Aleem E, 2013, ANTI-CANCER AGENT ME, V13, P709, DOI 10.2174/1871520611313050005; Barnard RJ, 2006, NUTR CANCER, V55, P28, DOI 10.1207/s15327914nc5501_4; Belobrajdic DP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-62; Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.001; Bjornson GBO, 1982, REPORT ABC 24 HLTH S; Breneman CB, 2013, BRIT J NUTR, V110, P375, DOI 10.1017/S0007114512004953; Chatenoud L, 1998, INT J CANCER, V77, P24, DOI 10.1002/(SICI)1097-0215(19980703)77:1&lt;24::AID-IJC5&gt;3.0.CO;2-1; Choromanska A, 2015, INT J BIOL MACROMOL, V80, P23, DOI 10.1016/j.ijbiomac.2015.05.035; COLDITZ GA, 1995, CANCER EPIDEM BIOMAR, V4, P567; Colditz GA, 2014, BREAST CANCER RES TR, V145, P567, DOI 10.1007/s10549-014-2993-8; Dong JY, 2011, BREAST CANCER RES TR, V127, P23, DOI 10.1007/s10549-011-1467-5; Dwyer JT, 1997, AM J CLIN NUTR, V65, P1153; Egeberg R, 2009, INT J CANCER, V124, P745, DOI 10.1002/ijc.23992; Eysteinsdottir T, 2011, J NUTR HEALTH AGING, V15, P809, DOI 10.1007/s12603-011-0067-8; Eysteinsdottir T, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-12; Farvid MS, 2016, BREAST CANCER RES TR, V159, P335, DOI 10.1007/s10549-016-3910-0; Farvid MS, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1226; Farvid MS, 2015, INT J CANCER, V136, P1909, DOI 10.1002/ijc.29218; FARVID MS, 2014, BMJ CLIN RES ED, V348, DOI DOI 10.1136/BMJ.G3437; FRIEDENREICH CM, 1992, EPIDEMIOL REV, V14, P177, DOI 10.1093/oxfordjournals.epirev.a036086; Fuemmeler BF, 2009, OBESITY FACTS, V2, P179, DOI 10.1159/000220605; Guo JY, 2015, BREAST CANCER RES TR, V151, P191, DOI 10.1007/s10549-015-3380-9; Hallmans G, 2003, P NUTR SOC, V62, P193, DOI 10.1079/PNS2002229; Hankinson SE, 2007, J STEROID BIOCHEM, V106, P24, DOI 10.1016/j.jsbmb.2007.05.012; Haraldsdottir A, 2017, CANCER EPIDEM BIOMAR, V26, P346, DOI 10.1158/1055-9965.EPI-16-0473-T; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; HISLOP TG, 1986, CANCER DETECT PREV, V9, P47; Hjartaker A, 2010, CANCER CAUSE CONTROL, V21, P1875, DOI 10.1007/s10552-010-9615-5; Inoue-Choi M, 2016, INT J CANCER, V138, P1609, DOI 10.1002/ijc.29901; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Linos E, 2008, CANCER EPIDEM BIOMAR, V17, P2146, DOI 10.1158/1055-9965.EPI-08-0037; Liu Y, 2014, BREAST CANCER RES TR, V145, P461, DOI 10.1007/s10549-014-2953-3; Mourouti N, 2016, J AM COLL NUTR, V35, P143, DOI 10.1080/07315724.2014.963899; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Nicodemus KK, 2001, CANCER CAUSE CONTROL, V12, P917, DOI 10.1023/A:1013746719385; Potischman N, 1998, J NATL CANCER I, V90, P226, DOI 10.1093/jnci/90.3.226; Rice S, 2006, ENDOCR-RELAT CANCER, V13, P995, DOI 10.1677/erc.1.01159; ROSE DP, 1991, AM J CLIN NUTR, V54, P520, DOI 10.1093/ajcn/54.3.520; Rossi RE, 2014, ANTICANCER RES, V34, P6861; Sigurdardottir LG, 2012, ACTA ONCOL, V51, P880, DOI 10.3109/0284186X.2012.698751; Sigurjonsson J, 1943, SURVEY DIET HLTH ICE; Smeds AI, 2007, J AGR FOOD CHEM, V55, P1337, DOI 10.1021/jf0629134; Thanos J, 2006, CANCER CAUSE CONTROL, V17, P1253, DOI 10.1007/s10552-006-0062-2; Torfadottir JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059799; Torfadottir JE, 2012, CANCER CAUSE CONTROL, V23, P941, DOI 10.1007/s10552-012-9965-2; Torfadottir JE, 2012, AM J EPIDEMIOL, V175, P144, DOI 10.1093/aje/kwr289; van der Pols JC, 2007, AM J CLIN NUTR, V86, P1722; Zang JJ, 2015, J BREAST CANCER, V18, P313, DOI 10.4048/jbc.2015.18.4.313	53	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198017	10.1371/journal.pone.0198017	http://dx.doi.org/10.1371/journal.pone.0198017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847592	Green Published, gold			2022-12-26	WOS:000433634800048
J	Rounaghi, I; Yousefkhani, SSH				Rounaghi, Iman; Yousefkhani, Seyyed Saeed Hosseinian			Effects of climate change on niche shifts of Pseudotrapelus dhofarensis and Pseudotrapelus jensvindumi (Reptilia: Agamidae) in Western Asia	PLOS ONE			English	Article							DIVERSITY; PREDICT; CONSEQUENCES; CONSERVATISM; BIOGEOGRAPHY; EVOLUTION; SQUAMATA; SAURIA; MODELS; RANGE	Genus Pseudotrapelus has a wide distribution in North Africa and in the Middle East. In the present study, we modeled the habitat suitability of two Omani species of the genus (Pseudotrapelus dhofarensis and Pseudotrapelus jensvindumi) to evaluate the potential effects of climate change on their distribution. Mean diurnal range and precipitation of wettest quarter are the most highly contributed variables for P. jensvindumi and P. dhofarensis, respectively. The potential distribution for P. dhofarensis in the current time covers the southern coastal regions of Oman, Yemen, the Horn of Africa, and Socotra Island, but the suitable regions were reduced in the future prediction and limited to Yemen, Socotra Island, and Oman. There have not been any records of the species outside of Oman. Analysis of habitat suitability for P. jensvindumi indicated that the species is restricted to the Al Hajar Mountain of Oman and the southeast coastal region of Iran, but there are no records of the species from Iran. Because mean diurnal range will not be influenced by climate change in future, the potential distribution of the species is not expected to be changed in 2050. All predicted models were performed with the highest AUC (more than 0.97) using the Maxent method. Investigation to find unknown populations of these two species in Iran, Yemen, and Socotra Island is essential for developing conservation programs in the future.	[Rounaghi, Iman; Yousefkhani, Seyyed Saeed Hosseinian] Islamic Azad Univ, Shirvan Branch, Young Researchers & Elite Club, Shirvan, Iran	Islamic Azad University	Yousefkhani, SSH (corresponding author), Islamic Azad Univ, Shirvan Branch, Young Researchers & Elite Club, Shirvan, Iran.	mesalina.watsonana@gmail.com		Hosseinian Yousefkhani, Saeed/0000-0002-4871-6206				Baha El Din S., 2006, GUIDE REPTILES AMPHI; Brown JL, 2015, ECOL EVOL, V5, P1131, DOI 10.1002/ece3.1418; Connell J, 2017, DIVERS DISTRIB, V23, P1078, DOI 10.1111/ddi.12597; Dakhteh Seyyed Mohammad Hashem, 2008, Russian Journal of Herpetology, V14, P229; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Guevara L, 2018, GLOBAL CHANGE BIOL, V24, P1511, DOI 10.1111/gcb.13992; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Inoue K, 2017, GLOBAL CHANGE BIOL, V23, P94, DOI 10.1111/gcb.13369; Kabir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187027; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Krockenberger AK, 2012, OECOLOGIA, V168, P889, DOI 10.1007/s00442-011-2146-2; Lambeck K, 1996, EARTH PLANET SC LETT, V142, P43, DOI 10.1016/0012-821X(96)00069-6; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Melnikov D, 2015, RUSS J HERPETOL, V22; Melnikov Daniel, 2012, Sovremennaya Gerpetologiya, V12, P143; Melnikov Daniel, 2013, Trudy Zoologicheskogo Instituta, V317, P438; Moran-Ordonez A, 2018, ECOGRAPHY, V41, P308, DOI 10.1111/ecog.02850; Oke TA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175978; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Smeraldo S, 2017, J NAT CONSERV, V37, P12, DOI 10.1016/j.jnc.2017.02.008; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tamar K, 2016, MOL PHYLOGENET EVOL, V97, P55, DOI 10.1016/j.ympev.2015.12.021; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Walsh CJ, 2016, FRESHW SCI, V35, P398, DOI 10.1086/685284; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Yousefkhani SSH, 2017, BELG J ZOOL, V147, P137, DOI 10.26496/bjz.2017.11; Yousofi S, 2015, TURK J ZOOL, V39, P447, DOI 10.3906/zoo-1403-6	33	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197884	10.1371/journal.pone.0197884	http://dx.doi.org/10.1371/journal.pone.0197884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847557	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800043
J	Jehle, J; Schone, B; Bagheri, S; Avraamidou, E; Danisch, M; Frank, I; Pfeifer, P; Bindila, L; Lutz, B; Lutjohann, D; Zimmer, A; Nickenig, G				Jehle, Julian; Schoene, Benedikt; Bagheri, Sayeh; Avraamidou, Elina; Danisch, Melina; Frank, Imke; Pfeifer, Philipp; Bindila, Laura; Lutz, Beat; Luetjohann, Dieter; Zimmer, Andreas; Nickenig, Georg			Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE(-/-) mice	PLOS ONE			English	Article							CANNABINOID CB2 RECEPTOR; KNOCKOUT MICE; ATHEROSCLEROSIS; CELLS; ENDOCANNABINOIDS; BRAIN; INFLAMMATION; INVOLVEMENT; INHIBITION; METABOLISM	Background The endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) is a known modulator of inflammation and ligand to both, pro-inflammatory cannabinoid receptor 1 (CB1) and anti-inflammatory CB2. While the role of both receptors in atherogenesis has been studied extensively, the significance of 2-AG for atherogenesis is less well characterized. Methods The impact of 2-AG on atherogenesis was studied in two treatment groups of ApoE(-/-) mice. One group received the monoacylglycerol lipase (MAGL)-inhibitor JZL184 [5 mg/kg i.p.], which impairs 2-AG degradation and thus causes elevated 2-AG levels, the other group received vehicle for four weeks. Simultaneously, both groups were fed a high-cholesterol diet. The atherosclerotic plaque burden was assessed in frozen sections through the aortic sinus following oil red O staining and infiltrating macrophages were detected by immunofluorescence targeting CD68. In vitro, the effect of 2-AG on B6MCL macrophage migration was assessed by Boyden chamber experiments. Transcription of adhesion molecules and chemokine receptors in macrophages was assessed by qPCR. Results As expected, application of the MAGL-inhibitor JZL184 resulted in a significant increase in 2-AG levels in vascular tissue (98.2 +/- 16.1 nmol/g vs. 27.3 +/- 4.5 nmol/g; n = 14 +/- 16; p < 0.001). ApoE(-/-) mice with elevated 2-AG levels displayed a significantly increased plaque burden compared to vehicle treated controls (0.44 +/- 0.03 vs. 0.31 +/- 0.04; n = 14; p = 0.0117). This was accompanied by a significant increase in infiltrating macrophages within the atherosclerotic vessel wall (0.33 +/- 0.02 vs. 0.27 +/- 0.01; n = 13 +/- 14; p = 0.0076). While there was no alteration to the white blood counts of JZL184-treated animals, 2-AG enhanced macrophage migration in vitro by 1.8 +/- 0.2 -fold (n = 4 +/- 6; p = 0.0393) compared to vehicle, which was completely abolished by co-administration of either CB1- or CB2-receptor-antagonists. qPCR analyses of 2-AG-stimulated macrophages showed an enhanced transcription of the chemokine CCL5 (1.59 +/- 0.23 +/- fold; n = 5 +/- 6; p = 0.0589) and its corresponding receptors CCR1 (2.04 +/- 0.46 -fold; n = 10 +/- 11; p = 0.0472) and CCR5 (2.45 +/- 0.62 +/- fold; n = 5 +/- 6; p = 0.0554). Conclusion Taken together, elevated 2-AG levels appear to promote atherogenesis in vivo. Our data suggest that 2-AG promotes macrophage migration, possibly by the CCL5-CCR5/CCR1 axis, and thereby contributes to vascular inflammation. Thus, decreasing vascular 2-AG levels might represent a promising therapeutic strategy in patients suffering from atherosclerosis and coronary heart disease.	[Jehle, Julian; Schoene, Benedikt; Bagheri, Sayeh; Avraamidou, Elina; Danisch, Melina; Frank, Imke; Pfeifer, Philipp; Nickenig, Georg] Univ Hosp Bonn, Dept Internal Med Cardiol 2, Pneumol, Angiol, Bonn, Germany; [Bindila, Laura; Lutz, Beat] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany; [Luetjohann, Dieter] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Zimmer, Andreas] Univ Hosp Bonn, Dept Mol Psychiat, Bonn, Germany	University of Bonn; Johannes Gutenberg University of Mainz; University of Bonn; University of Bonn	Jehle, J (corresponding author), Univ Hosp Bonn, Dept Internal Med Cardiol 2, Pneumol, Angiol, Bonn, Germany.	julian.jehle@ukbonn.de	Lutz, Beat/AAG-4538-2022; Lutz, Beat/AFK-6229-2022; Zimmer, Andreas/B-8357-2009		Rheinische Friedrich-Wilhelms-Universitat Bonn Bonfor program [0109.0050]; German Heart Foundation	Rheinische Friedrich-Wilhelms-Universitat Bonn Bonfor program; German Heart Foundation	This work was supported by the Rheinische Friedrich-Wilhelms-Universitat Bonn Bonfor program 0109.0050 (scholarship to JJ) and by the German Heart Foundation (scholarships to BS, SB and MD).	Bindila L, 2016, METHODS MOL BIOL, V1412, P9, DOI 10.1007/978-1-4939-3539-0_2; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Hoyer FF, 2014, J MOL CELL CARDIOL, V66, P126, DOI 10.1016/j.yjmcc.2013.11.013; Hoyer FF, 2011, J MOL CELL CARDIOL, V51, P1007, DOI 10.1016/j.yjmcc.2011.08.008; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P714, DOI 10.1161/01.ATV.0000261873.86623.e1; Jehle J, 2017, ARCH MED SCI, V13, P930, DOI 10.5114/aoms.2017.68239; Jehle J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146267; Jiang LS, 2009, CARDIOVASC RES, V81, P805, DOI 10.1093/cvr/cvn344; Kirkham TC, 2005, BEHAV PHARMACOL, V16, P297, DOI 10.1097/00008877-200509000-00004; Kishimoto S, 2003, J BIOL CHEM, V278, P24469, DOI 10.1074/jbc.M301359200; Lomazzo E, 2015, NEUROPSYCHOPHARMACOL, V40, P488, DOI 10.1038/npp.2014.198; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marazzi J, 2011, J IMMUNOL METHODS, V373, P219, DOI 10.1016/j.jim.2011.08.021; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mimura T, 2012, INT ARCH ALLERGY IMM, V159, P149, DOI 10.1159/000336167; Montecucco F, 2009, ATHEROSCLEROSIS, V205, P433, DOI 10.1016/j.atherosclerosis.2008.12.040; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Nowbar AN, 2014, INT J CARDIOL, V174, P293, DOI 10.1016/j.ijcard.2014.04.096; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pihlaja R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0305-9; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Soehnlein O, 2013, EMBO MOL MED, V5, P471, DOI 10.1002/emmm.201201717; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Vujic N, 2016, ATHEROSCLEROSIS, V244, P9, DOI 10.1016/j.atherosclerosis.2015.10.109; Weingartner O, 2009, EUR HEART J, V30, P404, DOI 10.1093/eurheartj/ehn580	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197751	10.1371/journal.pone.0197751	http://dx.doi.org/10.1371/journal.pone.0197751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813086	Green Submitted, gold, Green Published			2022-12-26	WOS:000433521800031
J	May, CK; Carroll, CW				May, Christopher K.; Carroll, Christopher W.			Differential incorporation of SUN-domain proteins into LINC complexes is coupled to gene expression	PLOS ONE			English	Article							NUCLEAR-MEMBRANE PROTEIN; ACTIN DYNAMICS; SKELETAL-MUSCLE; ENVELOPE; LAMIN; CYTOSKELETON; COACTIVATOR; DISEASE; EMERIN; NESPRIN-3	LInkers of Nucleoskeleton and Cytoskeleton (LINC) complexes, composed of SUN and KASH-domain proteins, span the nuclear envelope and physically connect the nuclear interior to cytoskeletal elements. Most human cells contain two SUN proteins, Sun1 and Sun2, and several KASH-proteins suggesting that multiple functionally distinct LINC complexes co-exist in the nuclear envelope. We show here, however, that while Sun1 and Sun2 in HeLa cells are each able to bind KASH-domains, Sun1 is more efficiently incorporated into LINC complexes under normal growth conditions. Furthermore, the balance of Sun1 and Sun2 incorporated into LINC complexes is cell type-specific and is correlated with SRF/Mkl1-dependent gene expression. In addition, we found that Sun1 has a LINC complex-independent role in transcriptional control, possibly by regulating the SRF/Mkl1 pathway. Together, these data reveal novel insights into the mechanisms of LINC complex regulation and demonstrate that Sun1 modulates gene expression independently of its incorporation into LINC complexes.	[May, Christopher K.; Carroll, Christopher W.] Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Carroll, Christopher W.] Celgene Corp, San Diego, CA 92121 USA	Yale University; Bristol-Myers Squibb; Celgene Corporation	Carroll, CW (corresponding author), Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Carroll, CW (corresponding author), Celgene Corp, San Diego, CA 92121 USA.	ccarroll@celgene.com						Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Capelson M, 2010, COLD SH Q B, V75, P585, DOI 10.1101/sqb.2010.75.059; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chang W, 2015, NUCLEUS-PHILA, V6, P77, DOI 10.1080/19491034.2015.1004947; Chang W, 2015, J CELL BIOL, V208, P11, DOI 10.1083/jcb.201409047; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Folker ES, 2011, P NATL ACAD SCI USA, V108, P131, DOI 10.1073/pnas.1000824108; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hieda M, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6010003; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Isermann P, 2013, CURR BIOL, V23, pR1113, DOI 10.1016/j.cub.2013.11.009; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nie S, 2016, STRUCTURE, V24, P80, DOI 10.1016/j.str.2015.10.024; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Plessner M, 2015, J BIOL CHEM, V290, P11209, DOI 10.1074/jbc.M114.627166; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Stewart RM, 2015, J CELL BIOL, V209, P403, DOI 10.1083/jcb.201502024; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Thakar K, 2017, MOL BIOL CELL, V28, P182, DOI 10.1091/mbc.E16-06-0467; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Willer MK, 2017, J CELL SCI, V130, P2111, DOI 10.1242/jcs.197517; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543; Zhu RJ, 2017, CURR BIOL, V27, P3097, DOI 10.1016/j.cub.2017.08.073	43	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197621	10.1371/journal.pone.0197621	http://dx.doi.org/10.1371/journal.pone.0197621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813079	gold, Green Published, Green Submitted			2022-12-26	WOS:000433521800023
J	Hsieh, YS; Kwon, S; Lee, HS; Seol, GH				Hsieh, Yu Shan; Kwon, Soonho; Lee, Hui Su; Seol, Geun Hee			Linalyl acetate prevents hypertension-related ischemic injury	PLOS ONE			English	Article							NEURONAL CELL-DEATH; HYPOXIA-ISCHEMIA; ESSENTIAL OIL; RISK-FACTOR; IN-VITRO; STROKE; CHANNELS; CALCIUM; ASPIRIN; THROMBOLYSIS	Ischemic stroke remains an important cause of disability and mortality. Hypertension is a critical risk factor for the development of ischemic stroke. Control of risk factors, including hypertension, is therefore important for the prevention of ischemic stroke. Linalyl acetate (LA) has been reported to have therapeutic effects in ischemic stroke by modulating intracellular Ca2+ concentration and having anti-oxidative properties. The preventive efficacy of LA has not yet been determined. This study therefore investigated the preventive efficacy of LA in rat aortas exposed to hypertension related-ischemic injury, and the mechanism of action of LA.Hypertension was induced in vivo following ischemic injury to the aorta induced by oxygen-glucose deprivation and reoxygenation in vitro. Effects of LA were assayed by western blotting, by determining concentrations of lactate dehydrogenase (LDH) and reactive oxygen species (ROS) and by vascular contractility assays. LA significantly reduced systolic blood pressure in vivo. In vitro, LA suppressed ischemic injury-induced expression of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit p47(Phox), as well as ROS production, LDH release, and ROS-induced endothelial nitric oxide synthase suppression. These findings indicate that LA has anti-hypertensive properties that can prevent hypertension-related ischemic injury and can prevent NADPH oxidase-induced production of ROS.	[Hsieh, Yu Shan; Kwon, Soonho; Lee, Hui Su; Seol, Geun Hee] Korea Univ, Sch Nursing, Dept Basic Nursing Sci, Seoul, South Korea	Korea University	Seol, GH (corresponding author), Korea Univ, Sch Nursing, Dept Basic Nursing Sci, Seoul, South Korea.	ghseol@korea.ac.kr	Seol, Geun Hee/ABB-6189-2020	hsieh, yu-shan/0000-0001-7726-3819; Seol, Geun Hee/0000-0002-2986-9688	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03931081]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03931081).	Bagchi D, 1995, TOXICOLOGY, V104, P1; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Campbell BCV, 2014, INT J STROKE, V9, P126, DOI 10.1111/ijs.12206; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Fugate JE, 2015, NEUROHOSPITALIST, V5, P110, DOI 10.1177/1941874415578532; Gasser R, 1993, INT J ANGIOL, V2, P22; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Han AY, 2018, PHYTOMEDICINE, V39, P119, DOI 10.1016/j.phymed.2017.12.028; Hu G, 2005, STROKE, V36, P2538, DOI 10.1161/01.STR.0000190894.30964.75; Ittaman SV, 2014, CLIN MED RES, V12, P147, DOI 10.3121/cmr.2013.1197; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Joseph LN, 1999, STROKE, V30, P16, DOI 10.1161/01.STR.30.1.16; Kang P, 2013, J PHARM PHARMACOL, V65, P745, DOI 10.1111/jphp.12031; Khayyam N, 1999, NEUROREPORT, V10, P371, DOI 10.1097/00001756-199902050-00029; Kim ES, 2012, PEDIATR RES, V72, P277, DOI 10.1038/pr.2012.71; Kim JR, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0651-6; Kolesarova M, 2006, CELL MOL NEUROBIOL, V26, P1281, DOI 10.1007/s10571-006-9032-1; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Liu YX, 2005, HEARING RES, V205, P271, DOI 10.1016/j.heares.2005.03.028; Lu Q, 2012, FREE RADICAL BIO MED, V53, P1139, DOI 10.1016/j.freeradbiomed.2012.06.012; Martin LJ, 2000, NEUROBIOL DIS, V7, P169, DOI 10.1006/nbdi.2000.0282; MCCRAE RR, 1978, BRIT J SOC CLIN PSYC, V17, P269, DOI 10.1111/j.2044-8260.1978.tb00277.x; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Ou HC, 2012, J VASC SURG, V55, P1104, DOI 10.1016/j.jvs.2011.10.011; Paulson JR, 2010, J PHARMACOL EXP THER, V332, P371, DOI 10.1124/jpet.109.157776; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Schroeder EB, 2000, STROKE, V31, P2591, DOI 10.1161/01.STR.31.11.2591; Sparrenberger F, 2009, J HUM HYPERTENS, V23, P12, DOI 10.1038/jhh.2008.74; STAMLER JS, 1994, CIRCULATION, V89, P2035, DOI 10.1161/01.CIR.89.5.2035; Tilley BC, 1997, ARCH NEUROL-CHICAGO, V54, P1466, DOI 10.1001/archneur.1997.00550240020008; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Wang YW, 2016, BIOMOL THER, V24, P371, DOI 10.4062/biomolther.2015.130; WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025; World Health Organization, WHO METH DAT SOURC C; Yao ST, 2016, NEUROPSYCH DIS TREAT, V12, P3083, DOI 10.2147/NDT.S121183; You JH, 2013, J CARDIOVASC PHARM, V61, P324, DOI 10.1097/FJC.0b013e3182834681	39	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0198082	10.1371/journal.pone.0198082	http://dx.doi.org/10.1371/journal.pone.0198082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799836	Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400038
J	Bekele, F; Belay, T; Zeynudin, A; Hailu, A				Bekele, Fitsum; Belay, Tariku; Zeynudin, Ahmed; Hailu, Asrat			Visceral leishmaniasis in selected communities of Hamar and Banna-Tsamai districts in Lower Omo Valley, South West Ethiopia: Sero-epidemological and Leishmanin Skin Test Surveys	PLOS ONE			English	Article							DIRECT AGGLUTINATION-TEST; FOCUS	Background Visceral leishmaniasis [VL] is a debilitating parasitic disease which invariably kills untreated patients. The disease is caused by Leishmania (L.) donovani or L. infantum, and transmitted by the bite of female phlebotomine sandflies. VL often remains subclinical but can become symptomatic with an acute/subacute or chronic course. Globally, the Eastern Africa region is one of the main VL endemic areas. The disease is prevalent in numerous foci within Eritrea, Ethiopia, Kenya, Somalia, Sudan South Sudan, and Uganda. In Ethiopia, the Lower Omo plain is one of the many VL endemic regions. Objectives The objective of this study was to determine the prevalence of asymptomatic visceral leish-maniasisin Hamar and Banna-Tsamai districts of the South Omo plains where VL is becoming an emerging health problem of neglected communities. Methods A community based cross-sectional survey was conducted in 2013 between 25th of July and 14th of August. A total of 1682 individuals living in 404 households were included in the study. Socio-demographic and clinical data were collected from each of the participants and venous blood was also collected for the detection of antibodies to visceral leishmaniasis using Direct Agglutination Test. Leishmanin Skin Test was performed to detect the exposure to the parasite. Results The surveys included 14 villages located in areas where VL had been reported. In a study population of 1682 individuals, the overall positive leishmanian skin test and sero-prevalence rates respectively were 8.6% and 1.8%. A statistically significant variation in the rate of positive LST response was observed in different study sites and age groups. Positive LST response showed an increasing trend with age. The sero-prevalence rate also showed a statistically significant variation among different study sites. Higher rates of sero-prevalence were observed in children and adolescents. The LST and sero-prevalence rates in Hamar District exceeded significantly that of Banna-Tsamai District (10.7% versus 5.8% for LST; and 2.6% versus 0.7% for sero-prevalence). Conclusion The prevalence of asymptomatic VL infection in Hamar and Banna-Tsamai districts during the study period in 2013 was low compared to rates previously reported in other endemic areas of Ethiopia. This could be due to the fact that the disease is emerging in Hamar and Banna-Tsamai districts. Based on records of a nearby Hospital, increasing numbers of active VL cases have been reported in these districts through the years 2006-2012, especially in Hamar District. Both districts are important destinations of tourism, and thus the importance of surveillance should be emphasized. Detailed epidemiological and entomological studies are recommended.	[Bekele, Fitsum] Wolkite Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Wolkite, Ethiopia; [Belay, Tariku; Zeynudin, Ahmed] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Hailu, Asrat] Addis Ababa Univ, Fac Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia	Jimma University; Addis Ababa University	Bekele, F (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Wolkite, Ethiopia.; Hailu, A (corresponding author), Addis Ababa Univ, Fac Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.	fbt1019@yahoo.com; hailu_a2004@yahoo.com	Bekele, Fitsum/AAO-2843-2020; Hailu, Asrat/AAM-6982-2020	Bekele, Fitsum/0000-0002-2611-5370; Kasim, Ahmed Zeynudin/0000-0002-0552-1783	Leishmaniasis research and diagnosisi laboratory in Addis Ababa University; Jimma University	Leishmaniasis research and diagnosisi laboratory in Addis Ababa University; Jimma University	The study was supported by Leishmaniasis research and diagnosisi laboratory in Addis Ababa University, FB was sponsored by Jimma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Ali, 2004, Ethiopian Journal of Health Development, V18, P159; Ali A, 2002, ETHIOP J HEALTH DEV, V16, P157; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Balkew M, 1999, ETHIOPIAN MED J, V37, P31; Berhe N, 1998, ETHIOPIAN MED J, V36, P113; COLE A. C. E., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P25, DOI 10.1016/S0035-9203(42)90053-1; de Menezes JP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1540-3; FMOH(Federal Minstry of health), 2013, GUID DIAGN TREATM PR; Gadisa E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0987-y; Gadisa E, 2012, AM J TROP MED HYG, V86, P792, DOI 10.4269/ajtmh.2012.11-0196; Gebre-Michael T, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-6; GRAMICCIA M, 1990, T ROY SOC TROP MED H, V84, P371, DOI 10.1016/0035-9203(90)90322-6; Hailu A, 1997, E AFR MED J, V74, P41; Hailu A, 1996, ETHIOPIAN MED J, V34, P33; Hailu A, 2009, ANN TROP MED PARASIT, V103, P659, DOI 10.1179/000349809X12554106963555; Hailu A, 1996, ETHIOPIAN MED J, V34, P11; HAILU A, 1990, T ROY SOC TROP MED H, V84, P673, DOI 10.1016/0035-9203(90)90141-Z; Hailu A, 2016, NEGLECT TROP DIS, P87, DOI 10.1007/978-3-319-25471-5_5; Khalil EAG, 2002, TROP MED INT HEALTH, V7, P35, DOI 10.1046/j.1365-3156.2002.00832.x; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742, DOI 10.1128/JCM.33.7.1742-1745.1995; Silva Eduardo S, 2005, Kinetoplastid Biol Dis, V4, P4, DOI 10.1186/1475-9292-4-4	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197430	10.1371/journal.pone.0197430	http://dx.doi.org/10.1371/journal.pone.0197430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795589	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300041
J	Guzman, GEC; Sato, JR; Vidal, MC; Fujita, A				Guzman, Grover E. C.; Sato, Joao R.; Vidal, Maciel C.; Fujita, Andre			Identification of alterations associated with age in the clustering structure of functional bra in networks	PLOS ONE			English	Article							RESTING-STATE NETWORKS; DEFAULT MODE; CONNECTIVITY; ORGANIZATION; CENTRALITY; PSYCHOPATHOLOGY; ADOLESCENCE; CONNECTOME; CHILDHOOD; CHILDREN	Initial studies using resting-state functional magnetic resonance imaging on the trajectories of the brain network from childhood to adulthood found evidence of functional integration and segregation over time. The comprehension of how healthy individuals' functional integration and segregation occur is crucial to enhance our understanding of possible deviations that may lead to brain disorders. Recent approaches have focused on the framework wherein the functional brain network is organized into spatially distributed modules that have been associated with specific cognitive functions. Here, we tested the hypothesis that the clustering structure of brain networks evolves during development. To address this hypothesis, we defined a measure of how well a brain region is clustered (network fitness index), and developed a method to evaluate its association with age. Then, we applied this method to a functional magnetic resonance imaging data set composed of 397 males under 31 years of age collected as part of the Autism Brain Imaging Data Exchange Consortium. As results, we identified two brain regions for which the clustering change over time, namely, the left middle temporal gyrus and the left putamen. Since the network fitness index is associated with both integration and segregation, our finding suggests that the identified brain region plays a role in the development of brain systems.	[Guzman, Grover E. C.; Vidal, Maciel C.; Fujita, Andre] Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil; [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Fujita, A (corresponding author), Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil.	fujita@ime.usp.br	Fujita, Andre/Q-1271-2019	Fujita, Andre/0000-0002-7756-7051; Sato, Joao Ricardo/0000-0002-7503-9781	Sao Paulo Research Foundation [2015/01587-0, 2016/13422-9]; Conselho Nacional de Ciencia e Tecnologia [304876/2016-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NAP-eScience-PRP-USP	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Ciencia e Tecnologia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NAP-eScience-PRP-USP	Thi work was supported by Sao Paulo Research Foundation 2015/01587-0 and 2016/13422-9: AF; Conselho Nacional de Ciencia e Tecnologia 304876/2016-0: AF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: GG, MV; and NAP-eScience-PRP-USP: AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Di Martino A, 2014, NEURON, V83, P1335, DOI 10.1016/j.neuron.2014.08.050; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sato JR, 2015, HUM BRAIN MAPP, V36, P4926, DOI 10.1002/hbm.22985; Sato JR, 2016, J CHILD PSYCHOL PSYC, V57, P55, DOI 10.1111/jcpp.12444; Sato JR, 2015, NEUROIMAGE, V104, P44, DOI 10.1016/j.neuroimage.2014.09.063; Sato JR, 2014, J PSYCHIATR RES, V58, P89, DOI 10.1016/j.jpsychires.2014.07.004; Sato JR, 2015, IEEE ACM T COMPUT BI; Sato JR, 2015, J PSYCHIATR NEUROSCI, V1; Sporns O., 2011, NETWORKS BRAIN; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Turner RS, 2003, J NEUROPHYSIOL, V90, P3958, DOI 10.1152/jn.00323.2003; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Vaid J., 2002, ENCY HUMAN BRAIN; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Yamada H, 2004, J NEUROSCI, V24, P3500, DOI 10.1523/JNEUROSCI.0068-04.2004; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	49	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0195906	10.1371/journal.pone.0195906	http://dx.doi.org/10.1371/journal.pone.0195906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795565	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300003
J	Kuleape, JA; Tagoe, EA; Puplampu, P; Bonney, EY; Quaye, O				Kuleape, Joshua Agbemefa; Tagoe, Emmanuel Ayitey; Puplampu, Peter; Bonney, Evelyn Yayra; Quaye, Osbourne			Homozygous deletion of both GSTM1 and GSTT1 genes is associated with higher CD4(+) T cell counts in Ghanaian HIV patients	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; BREAST-CANCER; POLYMORPHISM; METAANALYSIS; SUPPRESSION; FREQUENCIES; POPULATION; CHALLENGE; CHILDREN; THERAPY	Glutathione S-transferase (GST) family of enzymes are involved in a two-stage detoxification process of a wide range of environmental toxins, carcinogens and xenobiotics. The GST enzymes play important roles in oxidative stress pathways, and polymorphisms in the GSTM1 and GSTT1 genes mediate susceptibility and outcome in different diseases. Human immunodeficiency virus (HIV) infection is associated with oxidative stress, but there is limited data on the frequency of deleted GSTM1 and GSTT1 genes in HIV/AIDS patients and their effect on progression among Ghanaians. This study sought to investigate the association between homozygous deletion of GSTM1 and GSTT1 genes (both null deletion) with HIV/AIDS disease progression in Ghanaian patients. HIV-infected individuals on antiretroviral therapy (ART), ART-naive HIV patients, and HIV seronegative individuals were recruited for the study. HIV/AIDS disease progression was assessed by measuring CD4(+) cell count and viral load of the patients, and GST polymorphism was determined by amplifying the GSTT1 and GSTM1 genes using multiplex PCR, with CYP1A1 gene as an internal control. The mean CD4(+) count of patients that were naive to ART (298 +/- 243 cells/mm(3)) was significantly lower than that of patients on ART (604 +/- 294 cells/mm(3)), and viral load was significantly lower in the ART-experienced group (30379 +/- 15073 copies/mm(3)) compared to the ART-naive group (209882 +/- 75045 copies/mm(3)). Frequencies of GSTM1 and GSTT1 deletions were shown to be 21.9% and 19.8%, respectively, in the HIV patients, and patients with homozygous deletion of both GSTM1 and GSTT1 were more likely to have their CD4(+) count rising above 350 cells/mm(3) (OR = 6.44, 95% CI = 0.81-51.49, p = 0.039) suggesting that patients with homozygous deletion of GSTM1 and GSTT1 genes have slower disease progression. The findings of this study show that double deletion of glutathione S-transferases M1 and T1 is statistically associated with normal CD4(+) count in patients diagnosed with HIV/AIDS. Further study is required to investigate the clinical importance of the both null deletion in HIV patients.	[Kuleape, Joshua Agbemefa; Tagoe, Emmanuel Ayitey; Quaye, Osbourne] Univ Ghana, Dept Biochem Cell & Mol Biol, WACCBIP, Legon, Accra, Ghana; [Puplampu, Peter] Korle Bu Teaching Hosp, Dept Med, Accra, Ghana; [Bonney, Evelyn Yayra] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Accra, Ghana	University of Ghana; University of Ghana	Quaye, O (corresponding author), Univ Ghana, Dept Biochem Cell & Mol Biol, WACCBIP, Legon, Accra, Ghana.	OQuaye@ug.edu.gh		Kuleape, Joshua/0000-0002-0162-6529; Quaye, Osbourne/0000-0002-0621-876X	WACCBIP-World Bank ACE Masters/PhD fellowship [ACE02-WACCBIP]; DELTAS Africa [DEL-15-007]; New Partnership for Africas Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107755/Z/15/Z]; UK government; Bill and Melinda Gates Foundation (BMGF) [OPP52155]; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP); Noguchi Memorial Institute for Medical Research	WACCBIP-World Bank ACE Masters/PhD fellowship; DELTAS Africa; New Partnership for Africas Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government; Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); West African Centre for Cell Biology of Infectious Pathogens (WACCBIP); Noguchi Memorial Institute for Medical Research	Joshua Agbemefa Kuleape was supported by a WACCBIP-World Bank ACE Masters/PhD fellowship (ACE02-WACCBIP: Awandare) and a DELTAS Africa grant (DEL-15-007: Awandare). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africas Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (107755/Z/15/Z: Awandare) and the UK government. This work was also supported by the Bill and Melinda Gates Foundation (BMGF) under the Postdoctoral and Postgraduate Training in Infectious Diseases Research awarded to the Noguchi Memorial Institute for Medical Research (NMIMR) (Global Health grant number OPP52155). The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust, the UK government, BMGF or NMIMR.; We thank the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) and the Noguchi Memorial Institute for Medical Research for their financial support. We also appreciate the patients who consented for sampling, the staff at the Fevers Unit of the Korle Bu Teaching Hospital, and staff at Medical Biochemistry Department, School of Biomedical and Allied Health Sciences, University of Ghana.	Adams CH, 2003, CLIN CHEM LAB MED, V41, P600, DOI 10.1515/CCLM.2003.090; Barahmani N, 2009, NEURO-ONCOLOGY, V11, P292, DOI 10.1215/15228517-2008-089; Bhattacharjee P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02704; BoYum A, 2016, SCANDINAVIAN J IMMUN, V43, P228; CDC, 2013, HIV SURV REP, V23; Chikezie P, 2009, J APPL SCI ENV MANAG, V13; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Costagliola D, 2014, J INT AIDS SOC, V17, P2, DOI 10.7448/IAS.17.4.19481; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; DeMarini DM, 1997, ENVIRON MOL MUTAGEN, V30, P440, DOI 10.1002/(SICI)1098-2280(1997)30:4<440::AID-EM9>3.0.CO;2-M; Ebeshi BU, 2011, J MED GENET GENOMICS, V3, P56; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; Gattas GJF, 2004, BRAZ J MED BIOL RES, V37, P451, DOI 10.1590/S0100-879X2004000400002; Gronau S, 2003, OTOLARYNG HEAD NECK, V128, P674, DOI 10.1016/S0194-5998(03)00176-1; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; HIV/AIDS JUNPo, 2016, GLOB AIDS UPD 2016; Josephy P.D., 2010, HUM GENOMICS PROTEOM, P1, DOI 10.4061/2010/876940; Khabaz M, 2016, GENET MOL RES, V15, P1; Konig-Greger D, 2004, OTOLARYNG HEAD NECK, V130, P718, DOI 10.1016/j.otohns.2003.10.011; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Mokhtar GM, 2016, HEMATOLOGY, V21, P46, DOI 10.1179/1607845415Y.0000000046; Moulik NR, 2014, J HUM GENET, V59, P529, DOI 10.1038/jhg.2014.66; Nielsen HG, 2016, J SPORTS MED, V2016; Ntais C, 2005, CANCER EPIDEM BIOMAR, V14, P176; Parsons M, 2013, J AIDS CLIN RES, V4; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Quaye IK, 2000, J INFECT DIS, V181, P1483, DOI [10.1086/315377, DOI 10.1086/315377]; Singh HO, 2017, PHARMACOGENOMICS J, V17, P53, DOI 10.1038/tpj.2015.88; Soto-Quintana O, 2015, GENET MOL RES, V14, P13066, DOI 10.4238/2015.October.26.2; Sullivan PS, 2000, AIDS, V14, P2781, DOI 10.1097/00002030-200012010-00018; Sun F-C, 2014, J MED BIOCHEM, V33, DOI [10.2478/tomb-2013-0028, DOI 10.2478/T0MB-2013-0028]; *UNAIDS, 2004, AIDS EP UPD; Wang J, 2015, GENET MOL RES, V14, P11126, DOI 10.4238/2015.September.22.6; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175; Zhao LJ, 2000, P NATL ACAD SCI USA, V97, P6356, DOI 10.1073/pnas.97.12.6356	36	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0195954	10.1371/journal.pone.0195954	http://dx.doi.org/10.1371/journal.pone.0195954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795558	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300004
J	McKendrick, M; Butler, SH; Grealy, MA				McKendrick, Mel; Butler, Stephen H.; Grealy, Madeleine A.			Socio-cognitive load and social anxiety in an emotional anti-saccade task	PLOS ONE			English	Article							ATTENTIONAL BIAS; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; PSYCHOMETRIC PROPERTIES; NEURAL MECHANISMS; PHOBIA INVENTORY; ANGRY FACES; THREAT; MAINTENANCE; STIMULI	The anti-saccade task has been used to measure attentional control related to general anxiety but less so with social anxiety specifically. Previous research has not been conclusive in suggesting that social anxiety may lead to difficulties in inhibiting faces. It is possible that static face paradigms do not convey a sufficient social threat to elicit an inhibitory response in socially anxious individuals. The aim of the current study was twofold. We investigated the effect of social anxiety on performance in an anti-saccade task with neutral or emotional faces preceded either by a social stressor (Experiment 1), or valenced sentence primes designed to increase the social salience of the task (Experiment 2). Our results indicated that latencies were significantly longer for happy than angry faces. Additionally, and surprisingly, high anxious participants made more erroneous anti-saccades to neutral than angry and happy faces, whilst the low anxious groups exhibited a trend in the opposite direction. Results are consistent with a general approach-avoidance response for positive and threatening social information. However increased socio-cognitive load may alter attentional control with high anxious individuals avoiding emotional faces, but finding it more difficult to inhibit ambiguous faces. The effects of social sentence primes on attention appear to be subtle but suggest that the anti-saccade task will only elicit socially relevant responses where the paradigm is more ecologically valid.	[McKendrick, Mel] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Butler, Stephen H.; Grealy, Madeleine A.] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland	Heriot Watt University; University of Strathclyde	McKendrick, M (corresponding author), Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland.	M.McKendrick@hw.ac.uk	Butler, Stephen H/R-2584-2017	Butler, Stephen H/0000-0002-2103-0773; Grealy, Madeleine/0000-0002-2823-8841; McKendrick, Mel/0000-0002-7798-4381	Scottish Funding Council	Scottish Funding Council	This study was supported by the Scottish Funding Council.	Amir N, 2003, BEHAV RES THER, V41, P1325, DOI 10.1016/S0005-7967(03)00039-1; Amir N, 2005, BIOL PSYCHIAT, V57, P975, DOI 10.1016/j.biopsych.2005.01.044; Amir N, 2011, J ABNORM PSYCHOL, V120, P504, DOI 10.1037/a0022849; Antony MM, 2006, BEHAV RES THER, V44, P1177, DOI 10.1016/j.brat.2005.08.013; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Baddeley A. D, 1986, WORKING MEMORY; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; Bogels SM, 2004, CLIN PSYCHOL REV, V24, P827, DOI 10.1016/j.cpr.2004.06.005; Brown V, 1997, PERCEPTION, V26, P1555, DOI 10.1068/p261555; Butler SH, 2009, NEUROPSYCHOLOGIA, V47, P2488, DOI 10.1016/j.neuropsychologia.2009.04.022; Carleton RN, 2007, J ANXIETY DISORD, V21, P131, DOI 10.1016/j.janxdis.2006.03.010; Carver C, 1988, ANXIETY RES, V1, P17, DOI DOI 10.1080/10615808808248217; Celeghin A, 2015, CONSCIOUS COGN, V36, P414, DOI 10.1016/j.concog.2015.05.007; Chen YP, 2002, BEHAV RES THER, V40, P677, DOI 10.1016/S0005-7967(01)00086-9; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; D'Argembeau A, 2006, MEMORY, V14, P637, DOI 10.1080/09658210600747183; de Gelder B, 2015, CORTEX, V72, P15, DOI 10.1016/j.cortex.2014.11.009; Derakshan N, 2009, EXP PSYCHOL, V56, P48, DOI 10.1027/1618-3169.56.1.48; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Diano M, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02029; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Eysenck MW, 2011, PERS INDIV DIFFER, V50, P955, DOI 10.1016/j.paid.2010.08.019; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Furlan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158337; Gamble AL, 2009, J ANXIETY DISORD, V23, P841, DOI 10.1016/j.janxdis.2009.04.001; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Georgy L, 2016, CORTEX, V81, P151, DOI 10.1016/j.cortex.2016.04.018; Gilchrist ID, 2006, EXP BRAIN RES, V173, P708, DOI 10.1007/s00221-006-0455-1; Glascher J, 2003, J NEUROSCI, V23, P10274; Gray JR, 2002, COGN AFFECT BEHAV NE, V2, P64, DOI 10.3758/CABN.2.1.64; Guastella AJ, 2009, PSYCHONEUROENDOCRINO, V34, P220, DOI 10.1016/j.psyneuen.2008.09.001; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hardee JE, 2008, SOC COGN AFFECT NEUR, V3, P47, DOI 10.1093/scan/nsn001; Helfinstein SM, 2008, BEHAV RES THER, V46, P799, DOI 10.1016/j.brat.2008.03.011; Horenstein M, 1997, PSYCHOPATHOLOGY, V30, P25, DOI 10.1159/000285025; Howell DC, 2007, STAT METHODS PSYCHOL; Kanai Y, 2012, BIOL PSYCHOL, V89, P591, DOI 10.1016/j.biopsycho.2012.01.005; Kessler RC, 1999, PSYCHOL MED, V29, P555, DOI 10.1017/S0033291799008375; Klumpp H, 2009, ANXIETY STRESS COPIN, V22, P283, DOI 10.1080/10615800802449602; Lapate R.C., 2016, NATURE SCI REPORTS; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Lee HJ, 2008, BEHAV RES THER, V46, P819, DOI 10.1016/j.brat.2008.04.001; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; Mansell W, 2003, BEHAV RES THER, V41, P555, DOI 10.1016/S0005-7967(02)00029-3; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McKendrick M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155576; MILLER LC, 1981, J PERS SOC PSYCHOL, V41, P397, DOI 10.1037/0022-3514.41.2.397; Nguyen MN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00085; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mogg K, 2004, J ABNORM PSYCHOL, V113, P160, DOI 10.1037/0021-843X.113.1.160; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Mullins DT, 2004, J NONVERBAL BEHAV, V28, P3; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Pineles SL, 2005, J ABNORM PSYCHOL, V114, P314, DOI 10.1037/0021-843X.114.2.314; Pishyar R, 2004, ANXIETY STRESS COPIN, V17, P23, DOI 10.1080/10615800310001601458; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; SCHLENKER BR, 1982, PSYCHOL BULL, V92, P641, DOI 10.1037/0033-2909.92.3.641; Schultz LT, 2008, CLIN PSYCHOL REV, V28, P1206, DOI 10.1016/j.cpr.2008.04.003; Silvia PJ, 2006, J SOC CLIN PSYCHOL, V25, P585, DOI 10.1521/jscp.2006.25.6.585; Sposari JA, 2007, COGNITIVE THER RES, V31, P23, DOI 10.1007/s10608-006-9073-2; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251; Stirling LJ, 2006, J CLIN CHILD ADOLESC, V35, P440, DOI 10.1207/s15374424jccp3503_9; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; van Peer JM, 2010, COGNITION EMOTION, V24, P863, DOI 10.1080/02699930902935485; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Weary G, 2001, PERS SOC PSYCHOL B, V27, P562, DOI 10.1177/0146167201275005; Wieser MJ, 2009, COGN AFFECT BEHAV NE, V9, P314, DOI 10.3758/CABN.9.3.314	79	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197749	10.1371/journal.pone.0197749	http://dx.doi.org/10.1371/journal.pone.0197749			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795619	Green Published, gold, Green Accepted			2022-12-26	WOS:000433084300068
J	Raihan, MJ; Briskin, E; Mahfuz, M; Islam, MM; Mondal, D; Hossain, MI; Ahmed, AMS; Haque, R; Ahmed, T				Raihan, Mohammad Jyoti; Briskin, Emily; Mahfuz, Mustafa; Islam, M. Munirul; Mondal, Dinesh; Hossain, Md Iqbal; Ahmed, A. M. Shamsir; Haque, Rashidul; Ahmed, Tahmeed			Examining the relationship between blood lead level and stunting, wasting and underweight- A cross-sectional study of children under 2 years-of-age in a Bangladeshi slum	PLOS ONE			English	Article							SOUTH-WESTERN POLAND; YOUNG-CHILDREN; GROWTH STATUS; COPPER BASIN; RISK-FACTORS; EXPOSURE; NUTRITION; IMMUNOTOXICITY; SCHOOLCHILDREN; HEALTH	Elevated blood lead level (BLL) is known to cause cardiac, immune, and cognitive damage but had not been thoroughly studied in relation to stunting among children under two years of age. We primarily aimed to assess the relationship between elevated BLL, the accumulation of concerned amount of the metal lead in blood and stunting and secondarily-wasting and underweight amongst Bangladeshi children less than two years of age. For this cross-sectional study, BLL measurements, anthropometric data, and socioeconomic indicator information were collected and analyzed for 729 children under two years of age upon enrollment in the MAL-ED study conducted in a Bangladeshi slum area. Univariate, bivariate and multivariate analyses were carried out to observe the proportion and mean and contribution of elevated BLL and other relevant variables in explaining the occurrence of stunting. Of the enrolled subjects, 39.0% were stunted [length-for-age z score (LAZ<-2)], 50.3% were male, and 86.6% had an elevated BLL (>5 mu g/dL). Mean BLL of stunted children was 8.47 +/- 3.37 mu g/dL and 8.10 +/- 3.80 mu g/dL for non-stunted children. Proportion of children with elevated BLL was not significantly different between the stunted and non-stunted groups (p>0.05). When adjusted for other variables, elevated BLL was found to be a significant predictor of stunting and underweight (p<0.05) but not wasting (p>0.05). Elevated BLL (p<0.01), child's gender and weight (p<0.001), maternal body mass index (BMI) (p<0.05) and severe household food insecurity (p<0.05) were all significantly associated with stunting in the multivariate model. Increased odds of stunting was also observed for increased BLL. The findings suggest that chronic lead poisoning is significantly associated with high level of stunting among child slum dwellers in Bangladesh. These findings strengthen the argument for improved lead reduction efforts in Bangladesh, where lead poisoning and stunting are both highly prevalent.	[Raihan, Mohammad Jyoti; Mahfuz, Mustafa; Islam, M. Munirul; Mondal, Dinesh; Hossain, Md Iqbal; Ahmed, A. M. Shamsir; Haque, Rashidul; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Briskin, Emily] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Ahmed, A. M. Shamsir] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Yale University; University of Queensland	Ahmed, T (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.	tahmeed@icddrb.org	Mahfuz, Mustafa/H-5923-2017	Mahfuz, Mustafa/0000-0002-4090-785X; Briskin, Emily/0000-0002-3100-750X	University of Virginia (UVA); Foundation of National Institute of Health (FNIH); Fogarty International Centre (FIC); Bill & Melinda Gates Foundation(BMGF)	University of Virginia (UVA); Foundation of National Institute of Health (FNIH); Fogarty International Centre (FIC); Bill & Melinda Gates Foundation(BMGF)(Bill & Melinda Gates Foundation)	This research protocol is funded by University of Virginia (UVA) with support from MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC) with overall support from the Bill & Melinda Gates Foundation(BMGF). icddr,b also gratefully acknowledges the following donors which provide unrestricted support: Government of the People's Republic of Bangladesh, Global Affairs Canada (GAC), Canada; Swedish International Development Cooperation Agency (Sida) and the Department for International Development, (UK Aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afeiche M, 2012, J PEDIATR-US, V160, P1044, DOI 10.1016/j.jpeds.2011.12.022; Aguayo VM, 2016, MATERN CHILD NUTR, V12, P121, DOI 10.1111/mcn.12259; Ahamed M, 2007, CLIN NUTR, V26, P400, DOI 10.1016/j.clnu.2007.03.010; Ahmed T, 2014, CLIN INFECT DIS, V59, pS280, DOI 10.1093/cid/ciu458; ANDREWS KW, 1994, AM J IND MED, V26, P13, DOI 10.1002/ajim.4700260103; [Anonymous], 2013, GLOB DAT CHILD GROWT; [Anonymous], 2018, DHS MOD QUEST; Anticona C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22888; Ballew C, 1999, J PEDIATR-US, V134, P623, DOI 10.1016/S0022-3476(99)70250-7; BANNON DI, 1994, CLIN CHEM, V40, P1730; Betts KS, 2012, ENVIRON HEALTH PERSP, V120, pA268, DOI 10.1289/ehp.120-a268; Boman J, 2005, X-RAY SPECTROM, V34, P460, DOI 10.1002/xrs.864; Cantoral A, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0086-8; Centers for Disease Control, 1991, PREV LEAD POIS YOUNG; Chen SP, 2004, J TOXICOL ENV HEAL A, V67, P495, DOI 10.1080/15287390490276520; Coates J., 2007, HOUSEHOLD FOOD INSEC, V34; Corsi DJ, 2016, SOC SCI MED, V157, P165, DOI 10.1016/j.socscimed.2015.11.014; De la Burde B, 1973, Am J Public Health, V63, P737, DOI 10.2105/AJPH.63.8.737; Dekker LH, 2010, FOOD NUTR BULL, V31, P242, DOI 10.1177/156482651003100207; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dietert RR, 2006, ENVIRON HEALTH PERSP, V114, P477, DOI 10.1289/ehp.8566; ESDO IPEN, 2013, NAT REP LEAD NEW EN; Felisbino-Mendes MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087486; Garcia-Leston J, 2012, J TOXICOL ENV HEAL A, V75, P807, DOI 10.1080/15287394.2012.690327; Gardner SN, 2013, WHO CHILD GROWTH STA, V8; Gould E., 2009, Environmental Health Perspectives, V117, P1162, DOI 10.1289/ehp.0800408; Ignasiak Z, 2006, ANN HUM BIOL, V33, P401, DOI 10.1080/03014460600730752; Ignasiak Z, 2007, ANN HUM BIOL, V34, P329, DOI 10.1080/03014460701251112; Kattula D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005404; Khaliquzzaman M, 1995, TRACE ELEMENT COMPOS; Khan NZ, 2009, J TROP PEDIATRICS, V55, P177, DOI 10.1093/tropej/fmn108; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lewendon G, 2001, ARCH DIS CHILD, V85, P286, DOI 10.1136/adc.85.4.286; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; LITTLE BB, 1990, AM J HUM BIOL, V2, P265, DOI 10.1002/ajhb.1310020308; Little BB, 2005, AM PUBL HLTH ASS 133; Liu JH, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-28; MAHAFFEY KR, 1995, ENVIRON HEALTH PERSP, V103, P191; McClure LF, 2016, J PEDIAT; Ministry of Health and Family Welfare, 2012, HLTH POP NUTR SECT D; Mitra AK, 2012, J HEALTH POPUL NUTR, V30, P404; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Organization WH, 2009, GLOB HLTH RISKS MORT; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; Program NT, 2012, NTP MON HLTH EFF LOW; Psaki S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-24; Raihan MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172134; Santos IS, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-71; SCHWARTZ J, 1986, PEDIATRICS, V77, P281; SHUKLA R, 1991, PEDIATRICS, V88, P886; SHUKLA R, 1989, PEDIATRICS, V84, P604; Vevey S, 2009, EMERGING SOC COEXISE; Who W. H. O., 2011, BRIEF GUIDE ANAL MET; World Health Organization, 2010, CHILDH LEAD POIS	55	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197856	10.1371/journal.pone.0197856	http://dx.doi.org/10.1371/journal.pone.0197856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795643	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300083
J	Horvat, A; Noto, JM; Ramatchandirin, B; Zaika, E; Palrasu, M; Wei, JX; Schneider, BG; El-Rifai, W; Peek, RM; Zaika, AI				Horvat, Andela; Noto, Jennifer M.; Ramatchandirin, Balamurugan; Zaika, Elena; Palrasu, Manikandan; Wei, Jinxiong; Schneider, Barbara G.; El-Rifai, Wael; Peek, Richard M., Jr.; Zaika, Alexander I.			Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells	ONCOGENE			English	Article							CAGA PROTEIN; ARF; CANCER; P53; ACTIVATION; HYPERMETHYLATION; DEGRADATION; EXPRESSION; RESPONSES; DOMAIN	Infection with Helicobacter pylori is one of the strongest risk factors for development of gastric cancer. Although these bacteria infect approximately half of the world's population, only a small fraction of infected individuals develops gastric malignancies. Interactions between host and bacterial virulence factors are complex and interrelated, making it difficult to elucidate specific processes associated with H. pylori-induced tumorigenesis. In this study, we found that H. pylori inhibits p14ARF tumor suppressor by inducing its degradation. This effect was found to be strain-specific. Downregulation of p14ARF induced by H. pylori leads to inhibition of autophagy in a p53-independent manner in infected cells. We identified TRIP12 protein as E3 ubiquitin ligase that is upregulated by H. pylori, inducing ubiquitination and subsequent degradation of p14ARF protein. Using isogenic H. pylori mutants, we found that induction of TRIP12 is mediated by bacterial virulence factor CagA. Increased expression of TRIP12 protein was found in infected gastric epithelial cells in vitro and human gastric mucosa of H. pylori-infected individuals. In conclusion, our data demonstrate a new mechanism of ARF inhibition that may affect host-bacteria interactions and facilitate tumorigenic transformation in the stomach.	[Horvat, Andela; Ramatchandirin, Balamurugan; Wei, Jinxiong; Zaika, Alexander I.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Horvat, Andela; Ramatchandirin, Balamurugan; Wei, Jinxiong; Zaika, Alexander I.] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Noto, Jennifer M.; Schneider, Barbara G.; Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN USA; [Zaika, Elena; Palrasu, Manikandan; El-Rifai, Wael; Zaika, Alexander I.] Univ Miami, Dept Surg, Miami, FL 33136 USA; [Zaika, Alexander I.] Miami VA Healthcare Syst, Dept Vet Affairs, Miami, FL 33125 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Miami	Zaika, AI (corresponding author), Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA.; Zaika, AI (corresponding author), Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.; Zaika, AI (corresponding author), Univ Miami, Dept Surg, Miami, FL 33136 USA.; Zaika, AI (corresponding author), Miami VA Healthcare Syst, Dept Vet Affairs, Miami, FL 33125 USA.	axz353@med.miami.edu	Ramatchandirin, Balamurugan/AAB-7958-2020	Ramatchandirin, Balamurugan/0000-0003-0390-1878; Horvat, Andela/0000-0002-5771-2434	National Cancer Institute [CA206564, R01 CA138833]; Department of Veterans Affairs [BX002115]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485, P01CA116087, R01CA077955, R01CA206564, R01CA138833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587, P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002115] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Drs. Maria B. Piazuelo and Alberto G. Delgado for help with tissue processing. This work was supported by grants from the National Cancer Institute CA206564, R01 CA138833, the Department of Veterans Affairs BX002115, Vanderbilt Ingram Cancer Center (P30 CA68485), and the Vanderbilt Digestive Disease Research Center (DK058404). The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Veterans Affairs, National Institutes of Health, Vanderbilt University, or University of Miami Health Centers.	Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; Balaburski GM, 2010, TRENDS CELL BIOL, V20, P363, DOI 10.1016/j.tcb.2010.02.007; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Budina-Kolomets A, 2013, AUTOPHAGY, V9, P1553, DOI 10.4161/auto.25831; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fox JG, 2003, CANCER RES, V63, P942; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Iida S, 2000, INT J CANCER, V87, P654, DOI 10.1002/1097-0215(20000901)87:5<654::AID-IJC6>3.0.CO;2-P; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Ko A, 2012, JNCI-J NATL CANCER I, V104, P1660, DOI 10.1093/jnci/djs424; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Kuo ML, 2004, CELL CYCLE, V3, P1367, DOI 10.4161/cc.3.11.1244; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Peek RM, 1999, CANCER RES, V59, P6124; Pimkina J, 2009, AUTOPHAGY, V5, P397, DOI 10.4161/auto.5.3.7782; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 2012, WIRES DEV BIOL, V1, P731, DOI 10.1002/wdev.40; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wang XW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2533; Wei JX, 2015, GUT, V64, P1040, DOI 10.1136/gutjnl-2014-307295; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551	33	22	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5054	5065		10.1038/s41388-018-0343-8	http://dx.doi.org/10.1038/s41388-018-0343-8			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29849123	Green Accepted			2022-12-26	WOS:000444405300002
J	Pedrote, MM; de Oliveira, GAP; Felix, AL; Mota, MF; Marques, MD; Soares, IN; Iqbal, A; Norberto, DR; Gomes, AMO; Gratton, E; Cino, EA; Silva, JL				Pedrote, Murilo M.; de Oliveira, Guilherme A. P.; Felix, Adriani L.; Mota, Michelle F.; Marques, Mayra de A.; Soares, Iaci N.; Iqbal, Anwar; Norberto, Douglas R.; Gomes, Andre M. O.; Gratton, Enrico; Cino, Elio A.; Silva, Jerson L.			Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; protein aggregation; p53; amyloid; cancer; tumor suppressor; fluorescence spectroscopy; hydrostatic pressure; molten globule	TUMOR-SUPPRESSOR P53; WILD-TYPE P53; MUTANT P53; HIGH-PRESSURE; DESIGNED PEPTIDE; STRUCTURAL BASIS; PROTEIN; MECHANISM; RESCUE; INTERMEDIATE	The functionality of the tumor suppressor p53 is altered in more than 50% of human cancers, and many individuals with cancer exhibit amyloid-like buildups of aggregated p53. An understanding of what triggers the pathogenic amyloid conversion of p53 is required for the further development of cancer therapies. Here, perturbation of the p53 core domain (p53C) with subdenaturing concentrations of guanidine hydrochloride and high hydrostatic pressure revealed native-like molten globule (MG) states, a subset of which were highly prone to amyloidogenic aggregation. We found that MG conformers of p53C, probably representing population-weighted averages of multiple states, have different volumetric properties, as determined by pressure perturbation and size-exclusion chromatography. We also found that they bind the fluorescent dye 4,4-dianilino-1,1-binaphthyl-5,5-disulfonic acid (bis-ANS) and have a native-like tertiary structure that occludes the single Trp residue in p53. Fluorescence experiments revealed conformational changes of the single Trp and Tyr residues before p53 unfolding and the presence of MG conformers, some of which were highly prone to aggregation. p53C exhibited marginal unfolding cooperativity, which could be modulated from unfolding to aggregation pathways with chemical or physical forces. We conclude that trapping amyloid precursor states in solution is a promising approach for understanding p53 aggregation in cancer. Our findings support the use of single-Trp fluorescence as a probe for evaluating p53 stability, effects of mutations, and the efficacy of therapeutics designed to stabilize p53.	[Pedrote, Murilo M.; de Oliveira, Guilherme A. P.; Felix, Adriani L.; Mota, Michelle F.; Marques, Mayra de A.; Soares, Iaci N.; Iqbal, Anwar; Norberto, Douglas R.; Gomes, Andre M. O.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Programa Biol Estrutural,Inst Bioquim Med Leopold, BR-21941901 Rio De Janeiro, RJ, Brazil; [de Oliveira, Guilherme A. P.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92697 USA; [Cino, Elio A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; University of Virginia; University of California System; University of California Irvine; Universidade Federal de Minas Gerais	de Oliveira, GAP; Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Programa Biol Estrutural,Inst Bioquim Med Leopold, BR-21941901 Rio De Janeiro, RJ, Brazil.; de Oliveira, GAP (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	gaugusto@bioqmed.ufrj.br; jerson@bioqmed.ufrj.br	SILVA, JERSON Lima/GRF-1442-2022; de Oliveira, Guilherme A. P./O-1192-2013; Norberto, Douglas/AAV-6754-2020; Silva, Jerson/J-8984-2014; Gomes, Andre M.O./C-4009-2014; Marques, Mayra/AAN-3130-2021	SILVA, JERSON Lima/0000-0001-9523-9441; de Oliveira, Guilherme A. P./0000-0002-0063-5888; Silva, Jerson/0000-0001-9523-9441; Gomes, Andre M.O./0000-0003-1052-8004; Marques, Mayra/0000-0002-4131-4634; Pedrote, Murilo/0000-0001-6744-9572; Gratton, Enrico/0000-0002-6450-7391	National Council of Technological and Scientific Development; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro Grant [E-26/201.817/2015]; Pew Charitable Trusts Foundation; National Institutes of Health [P41-GM103540, P50-GM076516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro Grant; Pew Charitable Trusts Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Council of Technological and Scientific Development and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (to J.L.S.). This work was also aided by the Cancer Foundation and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro Grant E-26/201.817/2015 (to G.A.P.d.O. and J.L.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a doctoral fellowship from the National Council of Technological and Scientific Development.; Recipient of a fellowship from the Pew Charitable Trusts Foundation.; Supported in part by National Institutes of Health Grants P41-GM103540 and P50-GM076516.	Acharya N, 2016, J PHYS CHEM LETT, V7, P173, DOI 10.1021/acs.jpclett.5b02545; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Baldwin RL, 2010, PROTEINS, V78, P2725, DOI 10.1002/prot.22803; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Borgohain G, 2018, J MOL LIQ, V251, P378, DOI 10.1016/j.molliq.2017.12.054; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Canning P, 2012, J MOL BIOL, V423, P515, DOI 10.1016/j.jmb.2012.08.005; Ceru S, 2008, FEBS LETT, V582, P203, DOI 10.1016/j.febslet.2007.12.002; Cho SS, 2008, P NATL ACAD SCI USA, V105, P118, DOI 10.1073/pnas.0709376104; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Cino EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32535; Costa DCF, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023614; Das A, 2009, J PHYS CHEM B, V113, P12816, DOI 10.1021/jp906350s; Dasgupta A, 2014, J PHYS CHEM B, V118, P6380, DOI 10.1021/jp410019f; de Oliveira GAP, 2017, BIOPHYS CHEM, V231, P20, DOI 10.1016/j.bpc.2017.03.007; de Oliveira GAP, 2015, P NATL ACAD SCI USA, V112, pE2775, DOI 10.1073/pnas.1500352112; De Smet F, 2017, J PATHOL, V242, P24, DOI 10.1002/path.4872; Enthart A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26707; Friedler A, 2004, J MOL BIOL, V336, P187, DOI 10.1016/j.jmb.2003.12.005; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Ghosh S, 2017, CELL DEATH DIFFER, V24, P1784, DOI 10.1038/cdd.2017.105; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; James NG, 2011, ANAL BIOCHEM, V410, P70, DOI 10.1016/j.ab.2010.11.011; Jha SK, 2014, P NATL ACAD SCI USA, V111, P4856, DOI 10.1073/pnas.1315453111; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2015, STRUCTURE, V23, P2246, DOI 10.1016/j.str.2015.10.016; Karamanos TK, 2016, J AM CHEM SOC, V138, P6271, DOI 10.1021/jacs.6b02464; Kovachev PS, 2017, J BIOL CHEM, V292, P9345, DOI 10.1074/jbc.M116.762096; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Malacrida L, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/4/047001; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Munoz V, 2016, CURR OPIN STRUC BIOL, V36, P58, DOI 10.1016/j.sbi.2015.12.001; Neumaier S, 2014, J MOL BIOL, V426, P2520, DOI 10.1016/j.jmb.2014.04.022; Reiner A, 2010, P NATL ACAD SCI USA, V107, P4955, DOI 10.1073/pnas.0910001107; Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Silva JL, 2018, ACCOUNTS CHEM RES, V51, P181, DOI 10.1021/acs.accounts.7b00473; Silva JL, 2014, CHEM REV, V114, P7239, DOI 10.1021/cr400204z; Skora L, 2010, J AM CHEM SOC, V132, P9223, DOI 10.1021/ja100453e; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Wang GZ, 2017, P NATL ACAD SCI USA, V114, pE2634, DOI 10.1073/pnas.1700308114; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2437, DOI 10.1073/pnas.1500243112; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; Yang J, 2001, J AGR FOOD CHEM, V49, P3236, DOI 10.1021/jf001226o; Yang-Hartwich Y, 2015, ONCOGENE, V34, P3605, DOI 10.1038/onc.2014.296; Zhou RH, 2011, J PHYS CHEM B, V115, P1323, DOI 10.1021/jp105160a	53	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11374	11387		10.1074/jbc.RA118.003285	http://dx.doi.org/10.1074/jbc.RA118.003285			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29853637	Green Published, hybrid			2022-12-26	WOS:000439449700009
J	Czech, B; Fraszczak, M; Mielczarek, M; Szyda, J				Czech, Bartosz; Fraszczak, Magdalena; Mielczarek, Magda; Szyda, Joanna			Identification and annotation of breed-specific single nucleotide polymorphisms in Bos taurus genomes	PLOS ONE			English	Article							MUTATION	In Bos taurus the universality of the reference genome is biased towards genetic variation represented by only two related individuals representing the same Hereford breed. Therefore, results of genetic analyses based on this reference may not be reliable. The 1000 Bull Genomes resource allows for identification of breed-specific polymorphisms and for the construction of breed-specific reference genomes. Whole-genome sequences or 936 bulls allowed us to construct seven breed specific reference genomes of Bos taurus for Angus, Brown Swiss, Fleckvieh, Hereford, Jersey, Limousin and Simmental. In order to identify breed-specific variants all detected SNPs were filtered within-breed to satisfy criteria of the number of missing genotypes not higher than 7% and the alternative allele frequency equal to unity. The highest number of breed-specific SNPs was identified for Jersey (130,070) and the lowest D for the Simmental breed (197). Such breed-specific polymorphisms were annotated to coding regions overlapping with 78 genes in Angus, 140 in Brown Swiss, 132 in Fleckvieh, 100 in Hereford, 643 in Jersey, 10 in Limousin and no genes in Simmental. For most of the breeds, the majority of breed-specific variants from coding regions was synonymous. However, most of Fleckvieh-specific and Hereford-specific polymorphisms were missense mutations. Since the identified variants are characteristic for the analysed breeds, they form the basis of phenotypic differences observed between them, which result from different breeding programmes. Breed-specific reference genomes can enhance the accuracy of SNP driven inferences such as Genome-wide Association Studies or SNP genotype imputation.	[Czech, Bartosz; Fraszczak, Magdalena; Mielczarek, Magda; Szyda, Joanna] Wroclaw Univ Environm & Life Sci, Dept Genet, Biostat Grp, Wroclaw, Poland; [Mielczarek, Magda; Szyda, Joanna] Inst Anim Breeding, Balice, Poland	Wroclaw University of Environmental & Life Sciences	Szyda, J (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Genet, Biostat Grp, Wroclaw, Poland.; Szyda, J (corresponding author), Inst Anim Breeding, Balice, Poland.	joanna.szyda@upwr.edu.pl	Frąszczak, Magdalena/A-2614-2017; Czech, Bartosz/AAZ-4115-2020	Czech, Bartosz/0000-0002-9908-3007; Mielczarek, Magda/0000-0002-1086-9119; Fraszczak, Magdalena/0000-0002-8012-4980	Polish National Science Centre (NCN) [2014/13/B/NZ9/02016]; Leading National Research Centre (KNOW) [04/KNOW2/2014]	Polish National Science Centre (NCN); Leading National Research Centre (KNOW)	This work was supported by the Polish National Science Centre (NCN) (www.ncn.gov.pl), grant number 2014/13/B/NZ9/02016, grant recipient: JS; and the Leading National Research Centre (KNOW) (know.wroc.pl), grant number 04/KNOW2/2014, grant recipients: JS, MF, MM, BC. Computations were carried out at the Poznan Supercomputing and Networking Centre. Data was provided within the frame of the 1000 Bull Genomes project.r The research was supported by the Polish National Science Centre (NCN) grant 2014/13/B/NZ9/02016, and by The Leading National Research Centre (KNOW) grant number 04/KNOW2/2014. Computations were carried out at the Poznan Supercomputing and Networking Centre. Data was provided within the frame of the 1000 Bull Genomes project.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boitard S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005877; Chambaz A, 2003, MEAT SCI, V63, P491, DOI 10.1016/S0309-1740(02)00109-2; Cho YS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13637; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Hayes BJ, 2012, PLANT ANIMAL GENOME; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maretty L, 2017, NATURE, V548, P87, DOI 10.1038/nature23264; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Menoud A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038823; Menzi F, 2016, ANIM GENET, V47, P253, DOI 10.1111/age.12410; Pausch H, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0458-2; RICKETTS MH, 1987, P NATL ACAD SCI USA, V84, P3181, DOI 10.1073/pnas.84.10.3181; Sartelet A, 2015, ANIM GENET, V46, P566, DOI 10.1111/age.12342; Schwarzenbacher H, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0207-z; Tammen I, 2002, ANG CATTL P 28 INT C, P70; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	25	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198419	10.1371/journal.pone.0198419	http://dx.doi.org/10.1371/journal.pone.0198419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856873	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800120
J	Hurter, AL; Fort, S; Cottaz, S; Hedrich, R; Geiger, D; Roelfsema, MRG				Huerter, Anna-Lena; Fort, Sebastien; Cottaz, Sylvain; Hedrich, Rainer; Geiger, Dietmar; Roelfsema, M. Rob G.			Mycorrhizal lipochitinoligosaccharides (LCOs) depolarize root hairs of Medicago truncatula	PLOS ONE			English	Article							SYMBIOTIC HOST-SPECIFICITY; RECEPTOR KINASE GENE; CALCIUM SPIKING; RHIZOBIUM-MELILOTI; DIFFUSIBLE SIGNALS; LYSM-TYPE; NODULATION; RECOGNITION; RESPONSES; ELICITOR	Arbuscular Mycorrhiza and Root Nodule Symbiosis are symbiotic interactions with a high benefit for plant growth and crop production. Thus, it is of great interest to understand the developmental process of these symbioses in detail. We analysed very early symbiotic responses of Medicago truncatula root hair cells, by stimulation with lipochitinoligosacchar-ides specific for the induction of nodules (Nod-LCOs), or the interaction with mycorrhiza (Myc-LCOs). Intracellular micro electrodes were used, in combination with Ca2+ sensitive reporter dyes, to study the relations between cytosolic Ca2+ signals and membrane potential changes. We found that sulfated Myc-as well as Nod-LCOs initiate a membrane depolarization, which depends on the chemical composition of these signaling molecules, as well as the genotype of the plants that were studied. A successive application of sulfated Myc-LCOs and Nod-LCOs resulted only in a single transient depolarization, indicating that Myc-LCOs can repress plasma membrane responses to Nod-LCOs. In contrast to current models, the Nod-LCO-induced depolarization precedes changes in the cytosolic Ca2+ level of root hair cells. The Nod-LCO induced membrane depolarization thus is most likely independent of cytosolic Ca2+ signals and nuclear Ca2+ spiking.	[Huerter, Anna-Lena; Hedrich, Rainer; Geiger, Dietmar; Roelfsema, M. Rob G.] Wurzburg Univ, Bioctr, Julius von Sachs Inst Biosci, Mol Plant Physiol & Biophys, Wurzburg, Germany; [Fort, Sebastien; Cottaz, Sylvain] Univ Grenoble Alpes, CERMAV, CNRS, Grenoble, France	University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Roelfsema, MRG (corresponding author), Wurzburg Univ, Bioctr, Julius von Sachs Inst Biosci, Mol Plant Physiol & Biophys, Wurzburg, Germany.	roelfsema@botanik.uni-wuerzburg.de	Geiger, Dietmar/AAH-8140-2019; Hedrich, Rainer/G-8771-2011; Roelfsema, Rob/AAN-3942-2020; Fort, Sebastien/A-9906-2012	Geiger, Dietmar/0000-0003-0715-5710; Hedrich, Rainer/0000-0003-3224-1362; Fort, Sebastien/0000-0002-6133-9900; cottaz, sylvain/0000-0001-8674-0162; Roelfsema, Rob/0000-0002-4076-4246	Germany Science Foundation (DFG) "Pathogate": Stomatal control of pathogenic microbe infestation [HE 1640/34-1, RO 2381/6-1]; German Research Foundation (DFG); University of Wuerzburg	Germany Science Foundation (DFG) "Pathogate": Stomatal control of pathogenic microbe infestation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by grants of the Germany Science Foundation (DFG) "Pathogate": Stomatal control of pathogenic microbe infestation (HE 1640/34-1; RO 2381/6-1) to RH and MRGR. This publication was also funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Capoen W, 2009, PLANT CELL, V21, P1526, DOI 10.1105/tpc.109.066233; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; Dempster J., 2001, LAB COMPUTER PRACTIC; Dempster J., 1993, COMPUTER ANAL ELECTR; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Felle HH, 1999, PLANTA, V209, P207, DOI 10.1007/s004250050624; FELLE HH, 1995, PLANT J, V7, P939, DOI 10.1046/j.1365-313X.1995.07060939.x; Felle HH, 1998, PLANT J, V13, P455, DOI 10.1046/j.1365-313X.1998.00041.x; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Koers S, 2011, PLANT J, V68, P670, DOI 10.1111/j.1365-313X.2011.04719.x; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; KURKDJIAN AC, 1995, PLANT PHYSIOL, V107, P783, DOI 10.1104/pp.107.3.783; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Levchenko V, 2008, PROTOPLASMA, V233, P61, DOI 10.1007/s00709-008-0307-x; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Miller JB, 2012, SIGNAL COMMUN PLANTS, P1, DOI 10.1007/978-3-642-20966-6_1; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Miwa H, 2006, PLANT J, V48, P883, DOI 10.1111/j.1365-313X.2006.02926.x; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Morieri G, 2013, NEW PHYTOL, V200, P656, DOI 10.1111/nph.12475; Mus F, 2016, APPL ENVIRON MICROB, V82, P3698, DOI 10.1128/AEM.01055-16; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Pimprikar P, 2016, CURR BIOL, V26, P987, DOI [10.1016/j.cub.2016.04.021, 10.1016/j.cub.2016.01.069]; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Rasmussen MO, 2004, ORG BIOMOL CHEM, V2, P1908, DOI 10.1039/b403575e; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; Roelfsema MRG, 2012, TRENDS PLANT SCI, V17, P221, DOI 10.1016/j.tplants.2012.01.009; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Sun JH, 2015, PLANT CELL, V27, P823, DOI 10.1105/tpc.114.131326; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; Trieu AT, 2000, PLANT J, V22, P531, DOI 10.1046/j.1365-313x.2000.00757.x; TRINICK MJ, 1979, CAN J MICROBIOL, V25, P565, DOI 10.1139/m79-082; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Wais RJ, 2002, PLANT PHYSIOL, V129, P211, DOI 10.1104/pp.010690; Wendehenne D, 2002, PLANT CELL, V14, P1937, DOI 10.1105/tpc.002295; Ye WX, 2013, PLANT PHYSIOL, V163, P591, DOI 10.1104/pp.113.224055	51	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198126	10.1371/journal.pone.0198126	http://dx.doi.org/10.1371/journal.pone.0198126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851976	Green Submitted, Green Published, gold			2022-12-26	WOS:000433893200033
J	Jaeger, A; Lebarbenchon, C; Bourret, V; Bastien, M; Lagadec, E; Thiebot, JB; Boulinier, T; Delord, K; Barbraud, C; Marteau, C; Dellagi, K; Tortosa, P; Weimerskirch, H				Jaeger, Audrey; Lebarbenchon, Camille; Bourret, Vincent; Bastien, Matthieu; Lagadec, Erwan; Thiebot, Jean-Baptiste; Boulinier, Thierry; Delord, Karine; Barbraud, Christophe; Marteau, Cedric; Dellagi, Koussay; Tortosa, Pablo; Weimerskirch, Henri			Avian cholera outbreaks threaten seabird species on Amsterdam Island	PLOS ONE			English	Article							PASTEURELLA-MULTOCIDA INFECTION; ERYSIPELOTHRIX-RHUSIOPATHIAE; DISEASE; CONSERVATION; VIRUS; IDENTIFICATION; CORONAVIRUSES; EPIDEMIOLOGY; POPULATIONS; STRATEGIES	Infectious diseases may be particularly critical for the conservation of endangered species. A striking example is the recurrent outbreaks that have been occurring in seabirds on Amsterdam Island for the past 30 years, threatening populations of three Endangered seabird species and of the endemic, Critically Endangered Amsterdam albatross Diomedea amsterdamensis. The bacteria Pasteurella multocida (avian cholera causative agent), and to a lesser extent Erysipelothrix rhusiopathiae (erysipelas causative agent), were both suspected to be responsible for these epidemics. Despite this critical situation, demographic trends were not available for these threatened populations, and the occurrence and characterization of potential causative agents of epizootics remain poorly known. The aims of the current study were to (i) provide an update of population trends for four threatened seabird species monitored on Amsterdam Island, (ii) assess the occurrence of P. multocida, and E. rhusiopathiae in live birds from five species, (iii) search for other infectious agents in these samples and, (iv) isolate and genotype the causative agent(s) of epizooties from dead birds. Our study shows that the demographic situation has worsened substantially in three seabird species during the past decade, with extremely low reproductive success and declining populations for Indian yellow-nosed albatrosses Thalassarche carteri, sooty albatrosses Phoebetria fusca, and northern rockhopper penguins Eudyptes moseleyi. Pasteurella multocida or E. rhusiopathiae were detected by PCR in live birds of all five investigated species, while results were negative for eight additional infectious agents. A single strain of P. multocida was repeatedly cultured from dead birds, while no E. rhusiopathiae could be isolated. These results highlight the significance of P. multocida in this particular eco-epidemiological system as the main agent responsible for epizootics. The study stresses the urgent need to implement mitigation measures to alter the course of avian cholera outbreaks threatening the persistence of seabird populations on Amsterdam Island.	[Jaeger, Audrey; Lebarbenchon, Camille; Lagadec, Erwan; Dellagi, Koussay; Tortosa, Pablo] Univ La Reunion, UMR PIMIT Proc Infect Milieu Insulaire Trop, CNRS 9192, NSERM 1187,IRD 249,GIP CYROI, St Denis, Reunion, France; [Jaeger, Audrey] Univ La Reunion, UMR ENTROPIE, UR, IRD,CNRS, St Denis, Reunion, France; [Jaeger, Audrey; Lebarbenchon, Camille; Bastien, Matthieu; Lagadec, Erwan; Dellagi, Koussay; Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien, GIP CYROI, St Clotilde, Reunion, France; [Bourret, Vincent; Boulinier, Thierry] Univ Montpellier, CNRS, Ctr Ecol Fonct & Evolut, Montpellier, France; [Bastien, Matthieu; Lagadec, Erwan; Thiebot, Jean-Baptiste; Marteau, Cedric] Reserve Nat Natl Terres Australes Francaises, Terres Australes & Antarctiques Francaises, Rue Gabriel Dejean, St Pierre, Reunion, France; [Thiebot, Jean-Baptiste; Delord, Karine; Barbraud, Christophe; Weimerskirch, Henri] Univ La Rochelle, Ctr Etud Biol Chize, CNRS, UMR 7372, Villiers En Bois, France; [Thiebot, Jean-Baptiste] Natl Inst Polar Res, Tachikawa, Tokyo, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of La Reunion; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Jaeger, A (corresponding author), Univ La Reunion, UMR PIMIT Proc Infect Milieu Insulaire Trop, CNRS 9192, NSERM 1187,IRD 249,GIP CYROI, St Denis, Reunion, France.; Jaeger, A (corresponding author), Univ La Reunion, UMR ENTROPIE, UR, IRD,CNRS, St Denis, Reunion, France.; Jaeger, A (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien, GIP CYROI, St Clotilde, Reunion, France.	audrey.jaeger@univ-reunion.fr	Barbraud, Christophe/A-5870-2012; Lebarbenchon, Camille/H-7245-2013; Weimerskirch, Henri/K-7306-2019; Lebarbenchon, Camille/GLQ-7287-2022; Weimerskirch, Henri/F-5562-2013	Barbraud, Christophe/0000-0003-0146-212X; Lebarbenchon, Camille/0000-0002-0922-7573; Weimerskirch, Henri/0000-0002-0457-586X; Lebarbenchon, Camille/0000-0002-0922-7573; Bourret, Vincent/0000-0002-7153-8612; Tortosa, Pablo/0000-0002-7928-7264; BOULINIER, Thierry/0000-0002-5898-7667; Jaeger, Audrey/0000-0002-5649-0315	French Polar Institute (IPEV program) [ORNITHOECO-109]; le Ministere des Outre-Mer [MOM-2013]; French National Research Agency [ANR EVEMATA 11 BSV7 003]; les Terres Australes et Antarctiques Frangaises; la Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE); CeMEBLabEx post-doctoral fellowship	French Polar Institute (IPEV program); le Ministere des Outre-Mer; French National Research Agency(French National Research Agency (ANR)); les Terres Australes et Antarctiques Frangaises; la Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE); CeMEBLabEx post-doctoral fellowship	This research was supported by the French Polar Institute (IPEV program ORNITHOECO-109 to HW), le Ministere des Outre-Mer (MOM-2013 to AJ), the French National Research Agency (ANR EVEMATA 11 BSV7 003 to TB), les Terres Australes et Antarctiques Frangaises and la Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE). VB is supported through a CeMEBLabEx post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2013, AM NAT, V181, P674, DOI 10.1086/670024; Barbosa A, 2009, POLAR BIOL, V32, P1095, DOI 10.1007/s00300-009-0640-3; Bastien M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097185; BirdLife International, 2017, IUCN RED LIST THREAT; Bisgaard M, 2013, MICROBIOL-SGM, V159, P580, DOI 10.1099/mic.0.063461-0; BOTZLER RG, 1991, J WILDLIFE DIS, V27, P367, DOI 10.7589/0090-3558-27.3.367; Bourret V, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12443; Brooke CJ, 1999, J MED MICROBIOL, V48, P789, DOI 10.1099/00222615-48-9-789; Bunbury N, 2008, BIOL CONSERV, V141, P153, DOI 10.1016/j.biocon.2007.09.008; Caughley G, 1980, ANAL VERTEBRATE POPU; Cooper John, 2009, Marine Ornithology, V37, P193; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; CURTIS PE, 1980, VET REC, V107, P326, DOI 10.1136/vr.107.14.326; CURTIS PE, 1983, VET REC, V113, P133, DOI 10.1136/vr.113.6.133; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; DELISLE GW, 1990, J WILDLIFE DIS, V26, P283, DOI 10.7589/0090-3558-26.2.283; Delord K, 2013, ATLAS TOP PREDATORS; Dietrich M, 2014, EMERG INFECT DIS, V20, P838, DOI 10.3201/eid2005.131088; Duriez Olivier, 2012, Ornithos, V19, P162; Guinard E, 1998, COLON WATERBIRD, V21, P222, DOI 10.2307/1521909; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; Jaeger A, 2016, EPIDEMIOL INFECT, V144, P652, DOI 10.1017/S0950268815001661; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones ME, 2007, ECOHEALTH, V4, P326, DOI 10.1007/s10393-007-0120-6; Jouventin Pierre, 1994, Birdlife Conservation Series, V1, P122; Kim LM, 2008, J VET DIAGN INVEST, V20, P414, DOI 10.1177/104063870802000402; Lebarbenchon C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004925; Lebarbenchon C, 2013, J WILDLIFE DIS, V49, P1056, DOI 10.7589/2012-09-227; Leotta GA, 2006, J WILDLIFE DIS, V42, P259, DOI 10.7589/0090-3558-42.2.259; Leotta GA, 2003, J WILDLIFE DIS, V39, P732, DOI 10.7589/0090-3558-39.3.732; MAKINO SI, 1994, J CLIN MICROBIOL, V32, P1526, DOI 10.1128/JCM.32.6.1526-1531.1994; Manning PJ, 1989, PASTURELLA PASTEUREL; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Muradrasoli S, 2009, J VIROL METHODS, V159, P277, DOI 10.1016/j.jviromet.2009.04.022; Mwankon E. S., 2009, African Journal of Clinical and Experimental Microbiology, V10, P2; Parmelee D.F., 1979, Antarctic Journal of the United States, V14, P168; Petersen KD, 2001, MICROBIOL-SGM, V147, P2739, DOI 10.1099/00221287-147-10-2739; Rivalan P, 2010, IBIS, V152, P6, DOI 10.1111/j.1474-919X.2009.00977.x; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Rolland V, 2009, BIOL CONSERV, V142, P1084, DOI 10.1016/j.biocon.2008.12.030; Samuel MD, 2004, J WILDLIFE DIS, V40, P377, DOI 10.7589/0090-3558-40.3.377; Samuel Michael D., 2007, P239, DOI 10.1002/9780470344668.ch12; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Subaaharan S, 2010, VET MICROBIOL, V141, P354, DOI 10.1016/j.vetmic.2010.01.017; Thiebot JB, 2014, ENDANGER SPECIES RES, V23, P263, DOI 10.3354/esr00564; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Uhart MM, 2018, BIRD CONSERV INT, V28, P169, DOI 10.1017/S0959270916000629; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Wang QN, 2010, VET MICROBIOL, V140, P405, DOI 10.1016/j.vetmic.2009.08.012; Weimerskirch H, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P84; Weimerskirch H, 2004, POLAR BIOL, V27, P374, DOI 10.1007/s00300-004-0600-x; Wilkinson DA, 2014, APPL ENVIRON MICROB, V80, P3327, DOI 10.1128/AEM.00477-14; Wille M, 2016, J WILDLIFE DIS, V52, P793, DOI 10.7589/2015-12-342; Wille M, 2015, INFECT GENET EVOL, V29, P129, DOI 10.1016/j.meegid.2014.11.014; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	60	22	22	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197291	10.1371/journal.pone.0197291	http://dx.doi.org/10.1371/journal.pone.0197291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847561	Green Published, gold			2022-12-26	WOS:000433634800026
J	Goryacheva, I; Blekhman, A; Andrianov, B; Romanov, D; Zakharov, I				Goryacheva, Irina; Blekhman, Alla; Andrianov, Boris; Romanov, Denis; Zakharov, Ilya			Spiroplasma infection in Harmonia axyridis - Diversity and multiple infection	PLOS ONE			English	Article							MALE-KILLING MICROORGANISMS; WOLBACHIA DENSITY; ADALIA-BIPUNCTATA; COLEOPTERA; LADYBIRD; RECOMBINATION; POPULATIONS; PREVALENCE; AGENT; CLASSIFICATION	The heritable endosymbiotic bacterium Spiroplasma is found in the harlequin ladybird Harmonia axyridis. The proportion of beetles infected with Spiroplasma in different native H. axyridis populations varies from 2% to 49%. We investigated the polymorphism of Spiroplasma strains in samples from individual beetles from Kyoto, Vladivostok, Troitsa Bay, Novosibirsk, and Gorno-Altaisk. To identify Spiroplasma strains, we analyzed nucleotide polymorphisms of the 16S rRNA gene and the ribosomal internal transcribed spacer (ITS1). The majority of infected beetles were infected with two or more Spiroplasma strains. We measured Spiroplasma density in beetles with different infection status using quantitative PCR. The abundance of Spiroplasma in samples with a single infection is an order of magnitude lower than in samples with multiple infections. Density dependent biological effects of Spiroplasma are discussed.	[Goryacheva, Irina; Andrianov, Boris; Romanov, Denis; Zakharov, Ilya] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Blekhman, Alla] Russian Acad Sci, Koltsov Inst Dev Biol, Moscow, Russia	Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Andrianov, B (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	andrianovb@mail.ru	Andrianov, Boris/V-2530-2019; Goryacheva, Irina Igorevna/R-5736-2016; Romanov, Denis/M-1025-2013; Romanov, Denis/AAU-8160-2021	Andrianov, Boris/0000-0002-0064-4696; Goryacheva, Irina Igorevna/0000-0003-1913-5987; Romanov, Denis/0000-0003-3340-9278	Russian Foundation of Basic Research [16-06-00-223]; Faculty of Life Sciences, University of Vienna [IP 547012]; Austrian Science Fund, FWF [P29397]; German Science Foundation, DFG [FI1450/7-2]; Leibniz ScienceCampus Primate Cognition (BF); University of Vienna; Russian Foundation for Basic Research [15-04-07466_A]; Russian Science Foundation [16-16-00079];  [0108-2017-0010]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Faculty of Life Sciences, University of Vienna; Austrian Science Fund, FWF(Austrian Science Fund (FWF)); German Science Foundation, DFG(German Research Foundation (DFG)); Leibniz ScienceCampus Primate Cognition (BF); University of Vienna; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); 	This work was supported by the Russian Foundation of Basic Research, 16-06-00-223 (MLB and DK); Faculty of Life Sciences, University of Vienna, IP 547012 (KS); Austrian Science Fund, FWF, P29397 (SW); German Science Foundation, DFG, FI1450/7-2 and Leibniz ScienceCampus Primate Cognition (BF). Open access funding provided by the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to M. Ya. Orlova-Ben'kovskaya, L. V. Frisman, V. P. Korablev, and A.V. Zimenko for providing them with the H. axyridis collections. We used the materials of the Coccinellidae Collection of the Koltzov Institute of Developmental Biology of RAS. The Collection is supported by the contract 0108-2017-0010. We also used the materials of the Genetic Collection of Insects Models for biomedical and population-genetic studies of the Vavilov Institute of General Genetics RAS. The study of Spiroplasma in western group of populations of H.axyridis was supported by the Russian Foundation for Basic Research (Project No. 15-04-07466_A). The study of Spiroplasma in eastern group of populations of H.axyridis -the source of the global invasion, was supported by the Russian Science Foundation (Project No. 16-16-00079.	Ammar E, 2005, ANN ENTOMOL SOC AM, V98, P820, DOI 10.1603/0013-8746(2005)098[0820:UOICLS]2.0.CO;2; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Camacho M, 2017, BIOL OPEN, V6, P1074, DOI 10.1242/bio.023895; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; CHASTEL C, 1987, ISRAEL J MED SCI, V23, P683; Chastel C, 1985, C R ACAD SCI PARIS S; Chrostek E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002065; Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896; CLARK TB, 1987, ISRAEL J MED SCI, V23, P687; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; DOBZHANS.T, 1973, P NATL ACAD SCI USA, V70, P680, DOI 10.1073/pnas.70.3.680; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Elnagdy S, 2013, J EVOLUTION BIOL, V26, P1816, DOI 10.1111/jeb.12186; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gao XM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050247, 10.1371/journal.pone.0061801]; Gasparich GE, 2004, INT J SYST EVOL MICR, V54, P893, DOI 10.1099/ijs.0.02688-0; Ghosh S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0425-5; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Goryacheva II, 2015, RUSS J GENET+, V51, P731, DOI 10.1134/S1022795415080037; Goryacheva I, 2017, BIOL INVASIONS, V19, P493, DOI 10.1007/s10530-016-1298-8; Hackett K.J., 1989, MYCOPLASMAS 5 SPIROP, P113, DOI [10.1016/B978-0-12-078405-9.50012-4, DOI 10.1016/B978-0-12-078405-9.50012-4]; Haselkorn TS, 2015, MOL ECOL, V24, P3752, DOI 10.1111/mec.13261; Haselkorn TS, 2013, FLY, V7, P204, DOI 10.4161/fly.25469; Hayashi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155794; Herren JK, 2013, MBIO, V4, DOI 10.1128/mBio.00532-12; Hurst GDD, 1999, INSECT MOL BIOL, V8, P133, DOI 10.1046/j.1365-2583.1999.810133.x; Ikeda T, 2003, ZOOL SCI, V20, P153, DOI 10.2108/zsj.20.153; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; KONAI M, 1995, INT J SYST BACTERIOL, V45, P203, DOI 10.1099/00207713-45-2-203; Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; Majerus MEN, 2000, HEREDITY, V84, P605, DOI 10.1046/j.1365-2540.2000.00710.x; Majerus MEN, 2003, SEX WARS GENES BACTE; Majerus TMO, 1998, HEREDITY, V81, P683, DOI 10.1046/j.1365-2540.1998.00438.x; Majerus TMO, 1999, INSECT MOL BIOL, V8, P551, DOI 10.1046/j.1365-2583.1999.00151.x; Majerus TMO, 2002, THESIS; Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369; MATSUKA M, 1975, Applied Entomology and Zoology, V10, P84; Mayr E, 1970, POPULATIONS SPECIES; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; MOUCHES C, 1984, ANN INST PASTEUR MIC, VA135, P151, DOI 10.1016/S0769-2609(84)80072-1; MOUCHES C, 1983, ANN INST PASTEUR MIC, VA134, P383, DOI 10.1016/S0769-2609(83)80063-5; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; Mouton L, 2004, GENETICS, V168, P181, DOI 10.1534/genetics.104.026716; Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590; Nakamura K, 2005, ANN ENTOMOL SOC AM, V98, P96, DOI 10.1603/0013-8746(2005)098[0096:POIMMI]2.0.CO;2; Niijima K., 1981, B FAC AGR TAMAGAWA U, V21, P59; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Poinsot D, 1998, GENETICS, V150, P227; POULSON DF, 1961, SCIENCE, V133, P1489, DOI 10.1126/science.133.3463.1489; Regassa LB, 2009, CAN J MICROBIOL, V55, P1347, DOI 10.1139/W09-097; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; Ros VID, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S13; Sanada-Morimura S, 2013, J HERED, V104, P821, DOI 10.1093/jhered/est052; SAURA A, 1973, HEREDITAS, V75, P33; Serbus LR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004777; SHAIKH AA, 1987, J AM MOSQUITO CONTR, V3, P289; Simon JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021831; Slaff M., 1982, Journal of the Florida Anti-Mosquito Association, V53, P19; Tabata J, 2011, MICROB ECOL, V61, P254, DOI 10.1007/s00248-010-9799-y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; Tsugeno Y, 2017, J HERED, V108, P553, DOI 10.1093/jhered/esx049; Verne S, 2007, GENE, V397, P58, DOI 10.1016/j.gene.2007.04.006; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; Williamson DL, 1997, INT J SYST BACTERIOL, V47, P763, DOI 10.1099/00207713-47-3-763; Williamson DL, 1999, INT J SYST BACTERIOL, V49, P611, DOI 10.1099/00207713-49-2-611; Williamson DL, 1979, THE MYCOPLASMAS III, P176; Zakharov I. A., 1999, Genetika, V35, P771; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhu DT, 2016, INSECT SCI, V23, P531, DOI 10.1111/1744-7917.12367; Zinkevich N. S., 2000, Ontogenez, V31, P57	78	7	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198190	10.1371/journal.pone.0198190	http://dx.doi.org/10.1371/journal.pone.0198190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813113	gold, Green Published, Green Submitted			2022-12-26	WOS:000433521800054
J	De Pascalis, R; Hahn, A; Brook, HM; Ryden, P; Donart, N; Mittereder, L; Frey, B; Wu, TH; Elkins, KL				De Pascalis, Roberto; Hahn, Andrew; Brook, Helen M.; Ryden, Patrik; Donart, Nathaniel; Mittereder, Lara; Frey, Blake; Wu, Terry H.; Elkins, Karen L.			A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis	PLOS ONE			English	Article							T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; GAMMA-INTERFERON; IMMUNE-RESPONSES; STRAIN LVS; LIVE; TULAREMIA; INFECTION; SUBPOPULATIONS; BACTERIA	There are no defined correlates of protection for any intracellular pathogen, including the bacterium Francisella tularensis, which causes tularemia. Evaluating vaccine efficacy against sporadic diseases like tularemia using field trials is problematic, and therefore alternative strategies to test vaccine candidates like the Francisella Live Vaccine Strain (LVS), such as testing in animals and applying correlate measurements, are needed. Recently, we described a promising correlate strategy that predicted the degree of vaccine-induced protection in mice given parenteral challenges, primarily when using an attenuated Francisella strain. Here, we demonstrate that using peripheral blood lymphocytes (PBLs) in this approach predicts LVS-mediated protection against respiratory challenge of Fischer 344 rats with fully virulent F. tularensis, with exceptional sensitivity and specificity. Rats were vaccinated with a panel of LVS-derived vaccines and subsequently given lethal respiratory challenges with Type A F. tularensis. In parallel, PBLs from vaccinated rats were evaluated for their functional ability to control intramacrophage Francisella growth in in vitro co-culture assays. PBLs recovered from co-cultures were also evaluated for relative gene expression using a large panel of genes identified in murine studies. In vitro control of LVS intramacrophage replication reflected the hierarchy of protection. Further, despite variability between individuals, 22 genes were significantly more up-regulated in PBLs from rats vaccinated with LVS compared to those from rats vaccinated with the variant LVS-R or heat killed LVS, which were poorly protective. These genes included IFN-gamma, IL-21, NOS2, LTA, T-bet, IL-12r beta 2, and CCL5. Most importantly, combining quantifications of intramacrophage growth control with 5-7 gene expression levels using multivariate analyses discriminated protected from non-protected individuals with greater than 95% sensitivity and specificity. The results therefore support translation of this approach to non-human primates and people to evaluate new vaccines against Francisella and other intracellular pathogens.	[De Pascalis, Roberto; Brook, Helen M.; Mittereder, Lara; Frey, Blake; Elkins, Karen L.] US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Hahn, Andrew; Donart, Nathaniel; Wu, Terry H.] Univ New Mexico, Ctr Infect Dis & Immun, Albuquerque, NM 87131 USA; [Ryden, Patrik] Umea Univ, Dept Math & Math Stat, Umea, Sweden; [Wu, Terry H.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Mittereder, Lara] NIAID, Parasit Dis Lab, NIH, Bethesda, MD USA; [Frey, Blake] Univ Alabama Birmingham, Birmingham, AL USA	US Food & Drug Administration (FDA); University of New Mexico; Umea University; University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Alabama System; University of Alabama Birmingham	De Pascalis, R; Elkins, KL (corresponding author), US FDA, Lab Mucosal Pathogens & Cellular Immunol, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	roberto.depascalis@fda.hhs.gov; karen.elkins@fda.hhs.gov	Rydén, Patrik/I-4201-2016	Rydén, Patrik/0000-0002-0577-123X; Donart, Nathaniel/0000-0003-2596-6832; Mittereder, Lara/0000-0003-3558-0140; De Pascalis, Roberto/0000-0002-9663-7756; Frey, Blake/0000-0003-3003-6904	FDA (U.S. Food and Drug Administration)	FDA (U.S. Food and Drug Administration)	The studies were supported by institutional research funds from the FDA (U.S. Food and Drug Administration). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt K, 2015, CLIN VACCINE IMMUNOL, V22, P258, DOI 10.1128/CVI.00721-14; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Conlan J Wayne, 2011, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1914s93; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08; De Pascalis R, 2016, INFECT IMMUN, V84, P1054, DOI 10.1128/IAI.01348-15; De Pascalis R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126570; De Pascalis R, 2014, MBIO, V5, DOI 10.1128/mBio.00936-13; De Pascalis R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002494; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Elkins KL, 2016, EXPERT REV VACCINES, V15, P1183, DOI 10.1586/14760584.2016.1170601; Elkins Karen L, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1425s93; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Eneslatt K, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00027; Eneslatt K, 2011, EUR J IMMUNOL, V41, P974, DOI 10.1002/eji.201040923; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Holcomb ZE, 2017, J CLIN MICROBIOL, V55, P360, DOI [10.1128/jcm.01057-16, 10.1128/JCM.01057-16]; Hornick RB, 1966, BACTERIOL REV, V30, P49; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kurtz SL, 2015, CLIN VACCINE IMMUNOL, V22, P1096, DOI 10.1128/CVI.00301-15; Mara-Koosham G, 2011, INFECT IMMUN, V79, P1770, DOI 10.1128/IAI.00605-10; Mollenkopf HJ, 2006, MICROBES INFECT, V8, P136, DOI 10.1016/j.micinf.2005.06.015; Paranavitana C, 2008, FEMS IMMUNOL MED MIC, V54, P92, DOI 10.1111/j.1574-695X.2008.00456.x; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; Petersen JM, 2010, FUTURE MICROBIOL, V5, P649, DOI 10.2217/FMB.10.17; Ray HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009952; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Snoy PJ, 2010, VET PATHOL, V47, P774, DOI 10.1177/0300985810372506; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; TARNVIK A, 1992, IMMUNOLOGY, V76, P349; Twine S, 2012, VACCINE, V30, P3634, DOI 10.1016/j.vaccine.2012.03.036; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060; Yee D, 1996, J IMMUNOL, V157, P5042	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0198140	10.1371/journal.pone.0198140	http://dx.doi.org/10.1371/journal.pone.0198140			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799870	Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400040
J	Ostendorf, BN; Flenner, E; Florcken, A; Westermann, J				Ostendorf, Benjamin N.; Flenner, Eva; Floercken, Anne; Westermann, Joerg			Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; LECTIN-LIKE MOLECULE-1; HEMATOPOIETIC-CELLS; SURFACE; MARKER; EXPRESSION; ANTIBODY; TARGETS; CD44	Recent reports have revealed myelodysplastic syndromes (MDS) to arise from cancer stem cells phenotypically similar to physiological hematopoietic stem cells. Myelodysplastic hematopoiesis maintains a hierarchical organization, but the proportion of several hematopoietic compartments is skewed and multiple surface markers are aberrantly expressed. These aberrant antigen expression patterns hold diagnostic and therapeutic promise. However, eradication of MDS requires targeting of early myelodysplasia propagating stem cells. This warrants an exact assessment of the differentiation stage at which aberrant expression occurs in transformed hematopoiesis. Here, we report results on the prospective and extensive dissection of the hematopoietic hierarchy in 20 patients with either low-risk MDS or MDS with excess blasts and compare it to hematopoiesis in patients with non-malignancy associated cytopenia or B cell lymphoma without bone marrow infiltration. We found patients with MDS with excess blasts to exhibit characteristic expansions of specific immature progenitor compartments. We also identified the aberrant expression of several markers including ALDH, CLL-1, CD44, and CD47 to be specific features of hematopoiesis in MDS with excess blasts. We show that amongst these, aberrant CLL-1 expression manifested at the early uncommitted hematopoietic stem cell level, suggesting a potential role as a therapeutic target.	[Ostendorf, Benjamin N.; Flenner, Eva; Floercken, Anne; Westermann, Joerg] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Campus Virchow Klinikum, Berlin, Germany; [Ostendorf, Benjamin N.; Flenner, Eva; Floercken, Anne; Westermann, Joerg] Lab Berlin Charite Vivantes GmbH, Berlin, Germany; [Ostendorf, Benjamin N.] Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Labor Berlin - Charite Vivantes GmbH; Rockefeller University	Ostendorf, BN; Westermann, J (corresponding author), Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Campus Virchow Klinikum, Berlin, Germany.; Ostendorf, BN; Westermann, J (corresponding author), Lab Berlin Charite Vivantes GmbH, Berlin, Germany.; Ostendorf, BN (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA.	bostendorf@rockefeller.edu; joerg.westermann@charite.de	Floercken, Anne/F-3311-2019; Ostendorf, Benjamin Nils/AAA-2109-2022	Floercken, Anne/0000-0001-6462-7214; Ostendorf, Benjamin Nils/0000-0003-4492-9252				Bakker ABH, 2004, CANCER RES, V64, P8443, DOI 10.1158/0008-5472.CAN-04-1659; Barreyro L, 2012, BLOOD, V120, P1290, DOI 10.1182/blood-2012-01-404699; Chung SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2025; Elias HK, 2014, ONCOGENE, V33, P5139, DOI 10.1038/onc.2013.520; Florian S, 2006, LEUKEMIA LYMPHOMA, V47, P207, DOI 10.1080/10428190500272507; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Jiang HJ, 2013, LEUKEMIA RES, V37, P907, DOI 10.1016/j.leukres.2013.04.008; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kussick SJ, 2003, AM J CLIN PATHOL, V120, P854, DOI 10.1309/CAUT52HJ535P9UG2; Laranjeira P, 2015, LEUKEMIA RES, V39, P361, DOI 10.1016/j.leukres.2014.12.009; Legras S, 1998, BLOOD, V91, P3401, DOI 10.1182/blood.V91.9.3401.3401_3401_3413; Lu H, 2014, ANGEW CHEM INT EDIT, V53, P9841, DOI 10.1002/anie.201405353; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Matarraz S, 2008, LEUKEMIA, V22, P1175, DOI 10.1038/leu.2008.49; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Ogata K, 2002, BLOOD, V100, P3887, DOI 10.1182/blood-2002-01-0222; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Schuurhuis GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078897; Shastri A, 2017, BLOOD, V129, P1586, DOI 10.1182/blood-2016-10-696062; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Toft-Petersen M, 2016, BRIT J HAEMATOL, V175, P393, DOI 10.1111/bjh.14270; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Xie W, 2010, CYTOM PART A, V77A, P840, DOI 10.1002/cyto.a.20929	29	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197823	10.1371/journal.pone.0197823	http://dx.doi.org/10.1371/journal.pone.0197823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799854	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400025
J	Southern, J; Andrews, N; Sandu, P; Sheppard, CL; Weight, PA; Fry, NK; Van Hoek, AJ; Miller, E				Southern, Jo; Andrews, Nick; Sandu, Pamela; Sheppard, Carmen L.; Weight, Pauline A.; Fry, Norman K.; Van Hoek, Albert Jan; Miller, Elizabeth			Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; OBSERVATIONAL COHORT; SEROTYPES; DISEASE; COLONIZATION; IMPACT; WALES	Background In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the infant immunisation schedule in England and Wales. Despite limited serotype replacement in invasive pneumococcal disease (IPD) during the first four post-PCV13 years, non-vaccine type (NVT) IPD increased substantially in 2014/15. We undertook a carriage study in 2015/16 to help understand the reasons for this increase. Methods and findings Families with a child aged <5 years attending a participating general practice in Gloucestershire or Hertfordshire were invited to provide nasopharyngeal swabs from all consenting members. Swabs from 650 individuals (293 under five, 73 five to twenty and 284 >twenty years) were cultured and serotyped for Streptococcus pneumoniae. Results were compared with those from three previous household studies conducted in the same populations between 2001 to 2013, and with the serotypes causing IPD to estimate case-carrier ratios (CCRs). Overall carriage prevalence did not differ between the four carriage studies with reductions in vaccine-type carriage offset by increases in NVT carriage. While no individual NVT serotype showed an increase in CCR from 2012/13, the composition of the serotypes comprising the NVT group differed such that the overall CCR of the NVT group had significantly increased since 2012/13. Carriage of two PCV13 serotypes, 3 and 19A, was found in 2015/16 (3/650 = 0.5% and 2/650 = 0.3% respectively) with no overall reduction in carriage prevalence of PCV13-7 serotypes since 2012/13, though 6C prevalence, a vaccine-related serotype, had reduced from 1.8% in 2012/13 to 2/648 (0.3%) in 2015/16, p = 0.013. Conclusions There was continuing evolution in carried NVTs six years after PCV13 introduction which, in addition to being vaccine-driven, could also reflect natural secular changes in certain NVTs. This poses challenges in predicting future trends in IPD. Elimination of carriage and disease due to serotypes 3 and 19A may not be achieved by PCV13.	[Southern, Jo; Weight, Pauline A.; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, Natl Infect Serv, London, England; [Andrews, Nick] Publ Hlth England, Natl Infect Serv, Stat Modelling & Econ Dept, London, England; [Sandu, Pamela; Sheppard, Carmen L.; Fry, Norman K.] Publ Hlth England, Resp & Vaccine Preventable Bacteria Reference Uni, Natl Infect Serv, London, England; [Van Hoek, Albert Jan] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	Public Health England; Public Health England; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Southern, J (corresponding author), Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, Natl Infect Serv, London, England.	jo.southern@phe.gov.uk		Sheppard, Carmen/0000-0002-2699-9057; Fry, Norman/0000-0003-4862-6507	NIHR Policy Research Programme (National Vaccine Evaluation Consortium) [039/0031]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene & Tropical Medicine in partnership with Public Health England (PHE) [HPRU-2012-10096]	NIHR Policy Research Programme (National Vaccine Evaluation Consortium); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene & Tropical Medicine in partnership with Public Health England (PHE)	The report is based on independent research commissioned and funded by the NIHR Policy Research Programme (National Vaccine Evaluation Consortium, Grant number 039/0031 - grant holder EM). Albert Jan van Hoek's research is partly supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene & Tropical Medicine in partnership with Public Health England (PHE), grant number HPRU-2012-10096. The views expressed in the publication are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, arms' length bodies, other government departments, the London School of Hygiene & Tropical Medicine or Public Health England. The funders had no input study design, analysis of the data or writing of the manuscript.	Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2015, PHE REPORT SURVEILLA; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Foster D, 2008, J MED MICROBIOL, V57, P480, DOI 10.1099/jmm.0.47690-0; Grant LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074906; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hedlund J, 2003, SCAND J INFECT DIS, V35, P452, DOI 10.1080/00365540310013315; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Kapatai G, 2016, PEERJ, V4, DOI 10.7717/peerj.2477; Ladhani Shamez N, 2018, LANCET INFECT D 0118; McFarland M, 2017, VACCINE, V35, P4389, DOI 10.1016/j.vaccine.2017.06.047; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Norman Fry N, ISPPD 2016; Nurhonen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056079; Paulo AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176723; Sheppard C, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.50.30423; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; Yildirim I, 2017, VACCINE, V35, P4002, DOI 10.1016/j.vaccine.2017.05.077	28	56	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0195799	10.1371/journal.pone.0195799	http://dx.doi.org/10.1371/journal.pone.0195799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799839	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000433153400003
J	Tural, U; Aker, AT; Onder, E; Sodan, HT; Unver, H; Akansel, G				Tural, Umit; Aker, Ahmet Tamer; Onder, Emin; Sodan, Hatice Turan; Unver, Hatice; Akansel, Gur			Neurotrophic factors and hippocampal activity in PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; SCRIPT-DRIVEN IMAGERY; CEREBRAL-BLOOD-FLOW; PSYCHOPHYSIOLOGICAL ASSESSMENT; TRAUMATIC MEMORIES; BRAIN ACTIVATION; SERUM-LEVELS; OPEN-LABEL; DEPRESSION	Although numerous studies have investigated the neurotrophic factors and hippocampal activity in posttraumatic stress disorder (PTSD) separately each other, it is unclear whether an association between neurotrophic factors and hippocampal activity is present. The aim of this study was to evaluate the functional changes in hippocampus before and after treatment with escitalopram and to associate these changes with peptides related to neuronal growth in patients with chronic PTSD and trauma survivors without PTSD. Fifteen earthquake survivors with chronic PTSD and thirteen drug nave trauma exposed individuals without PTSD underwent fMRI scans in a block design. Serum levels of Nerve Growth Factor (NGF) and Brain Derived Neurotrophic Factor (BDNF) were measured before and after 12 weeks treatment with escitalopram. Baseline median serum level of NGF was significantly lower in patients with chronic PTSD than trauma survivors; however, 12 weeks of treatment with escitalopram significantly increased it. Higher activation was found both in left and right hippocampus for chronic PTSD group than trauma survivors. Treatment with escitalopram was significantly associated with suppression of the hyperactivation in left hippocampus in patients with chronic PTSD. Bilateral hyperactivation in hippocampus and lowered NGF may associate with neurobiological disarrangements in chronic PTSD. Treatment with escitalopram was significantly associated with both improvement in the severity of PTSD symptoms and biological alterations. Patients diagnosed with PTSD may have further and complicated deteriorations in hippocampal networks and neurotransmitter systems than individuals who had not been diagnosed with PTSD following the same traumatic experience.	[Tural, Umit] Nathan S Kline Psychiat Res Inst, Orangeburg, NY 10962 USA; [Tural, Umit; Aker, Ahmet Tamer; Onder, Emin; Sodan, Hatice Turan] Kocaeli Univ, Fac Med, Dept Psychiat, Kocaeli, Turkey; [Unver, Hatice] Marmara Univ, Fac Med, Dept Child & Adolescent Psychiat, Istanbul, Turkey; [Akansel, Gur] Kocaeli Univ, Fac Med, Dept Radiol, Kocaeli, Turkey	Nathan Kline Institute for Psychiatric Research; Kocaeli University; Marmara University; Kocaeli University	Tural, U (corresponding author), Nathan S Kline Psychiat Res Inst, Orangeburg, NY 10962 USA.; Tural, U (corresponding author), Kocaeli Univ, Fac Med, Dept Psychiat, Kocaeli, Turkey.	umit.tural@nki.rfmh.org	Tural, Ümit/AAL-7036-2020; Ünver, Hatice/P-2960-2016	Tural, Ümit/0000-0002-1593-2180; Unver, Hatice/0000-0003-2067-9770	Lundbeck, Denmark [10978]	Lundbeck, Denmark(Lundbeck Corporation)	This is an investigator-motivated/initiated (UT) study which has been fully funded by Lundbeck, Denmark (grant #10978). Lundbeck did not have any involvement in study design, data collection, analysis, and interpretation, preparation of the manuscript or any editorial intervention. None of the authors has been supported directly or indirectly in the form of salary, employment, fees, dividends, etc.	Aker AT, 1999, TURK PSIKIYATR DERG, V10, P286; Alleva E, 1996, PHARMACOL BIOCHEM BE, V54, P65, DOI 10.1016/0091-3057(95)02111-6; Angelucci F, 2014, BRAIN COGNITION, V84, P118, DOI 10.1016/j.bandc.2013.11.012; Arbone DL, 2013, NEUROSCIENCE, V239, P295, DOI [10.1016/j.neuroscience.2012.10, DOI 10.1016/J.NEUROSCIENCE.2012.10]; Berger W, 2010, PROG NEURO-PSYCHOPH, V34, P1279, DOI 10.1016/j.pnpbp.2010.07.008; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Carey PD, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-30; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Dotta-Panichi RM, 2015, REV BRAS PSIQUIATR, V37, P113, DOI 10.1590/1516-4446-2014-1421; FISCHER W, 1991, J NEUROSCI, V11, P1889; Geuze E, 2008, J PSYCHIATR RES, V42, P659, DOI 10.1016/j.jpsychires.2007.06.007; Hauck S, 2010, PROG NEURO-PSYCHOPH, V34, P459, DOI 10.1016/j.pnpbp.2010.01.010; Hauck S, 2009, REV BRAS PSIQUIATR, V31, P48, DOI 10.1590/S1516-44462009000100012; Hensley PL, 2009, J AFFECT DISORDERS, V113, P142, DOI 10.1016/j.jad.2008.05.016; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Jockers-Scherubl MC, 2007, PROG NEURO-PSYCHOPH, V31, P200, DOI 10.1016/j.pnpbp.2006.09.006; Lang UE, 2008, PHARMACOPSYCHIATRY, V41, P196, DOI 10.1055/s-0028-1082070; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lee SJ, 2015, CLIN PSYCHOPHARM NEU, V13, P283, DOI 10.9758/cpn.2015.13.3.283; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lipov E, 2012, MED HYPOTHESES, V79, P750, DOI 10.1016/j.mehy.2012.08.019; Matrisciano F, 2008, J PSYCHIATR RES, V43, P247, DOI 10.1016/j.jpsychires.2008.03.014; Matsuoka Y, 2013, NEUROPSYCHOBIOLOGY, V68, P44, DOI 10.1159/000350950; Nurjono Milawaty, 2012, Clin Psychopharmacol Neurosci, V10, P61, DOI 10.9758/cpn.2012.10.2.61; Onder E, 2006, SOC PSYCH PSYCH EPID, V41, P868, DOI 10.1007/s00127-006-0107-6; Orr SP, 1998, J CONSULT CLIN PSYCH, V66, P906, DOI 10.1037/0022-006X.66.6.906; Osuch EA, 2001, BIOL PSYCHIAT, V50, P246, DOI 10.1016/S0006-3223(01)01107-6; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; PITMAN RK, 1990, J ABNORM PSYCHOL, V99, P49, DOI 10.1037/0021-843X.99.1.49; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; Pitman RK, 2001, J CLIN PSYCHIAT, V62, P47; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Robert S, 2006, J CLIN PSYCHIAT, V67, P1522, DOI 10.4088/JCP.v67n1005; Sachinvala N, 2000, MIL MED, V165, P473, DOI 10.1093/milmed/165.6.473; Semple WE, 2000, PSYCHIATRY, V63, P65, DOI 10.1080/00332747.2000.11024895; Shi YY, 2010, PSYCHIAT CLIN NEUROS, V64, P249, DOI 10.1111/j.1440-1819.2010.02074.x; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Shin LM, 1997, ARCH GEN PSYCHIAT, V54, P233; Smith MA, 1996, BEHAV BRAIN RES, V78, P25, DOI 10.1016/0166-4328(95)00220-0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Suliman S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00055; Thomaes K, 2009, PSYCHIAT RES-NEUROIM, V171, P44, DOI 10.1016/j.pscychresns.2008.03.003; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Werner NS, 2008, J PSYCHIATR RES, V43, P309, DOI 10.1016/j.jpsychires.2008.03.011; Whalley MG, 2009, BRAIN COGNITION, V69, P98, DOI 10.1016/j.bandc.2008.05.008; YAN Q, 1988, NEURON, V1, P335	53	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197889	10.1371/journal.pone.0197889	http://dx.doi.org/10.1371/journal.pone.0197889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH1HI	29799860	Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400030
J	Bala, U; Leong, MPY; Lim, CL; Shahar, HK; Othman, F; Lai, MI; Law, ZK; Ramli, K; Htwe, O; Ling, KH; Cheah, PS				Bala, Usman; Leong, Melody Pui-Yee; Lim, Chai Ling; Shahar, Hayati Kadir; Othman, Fauziah; Lai, Mei-I; Law, Zhe-Kang; Ramli, Khairunnisa; Htwe, Ohnmar; Ling, King-Hwa; Cheah, Pike-See			Defects in nerve conduction velocity and different muscle fibre-type specificity contribute to muscle weakness in Ts1Cje Down syndrome mouse model	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MENTAL-RETARDATION; MOTOR DYSFUNCTION; CHILDREN; MICE; ABNORMALITIES; COORDINATION; PHENOTYPES; TRISOMY; DYRK1A	Background Down syndrome (DS) is a genetic disorder caused by presence of extra copy of human chromosome 21. It is characterised by several clinical phenotypes. Motor dysfunction due to hypotonia is commonly seen in individuals with DS and its etiology is yet unknown. Ts1Cje, which has a partial trisomy (Mmu16) homologous to Hsa21, is well reported to exhibit various typical neuropathological features seen in individuals with DS. This study investigated the role of skeletal muscles and peripheral nerve defects in contributing to muscle weakness in Ts1Cje mice. Results Assessment of the motor performance showed that, the forelimb grip strength was significantly (P<0.0001) greater in the WT mice compared to Ts1Cje mice regardless of gender. The average survival time of the WT mice during the hanging wire test was significantly (P<0.0001) greater compared to the Ts1Cje mice. Also, the WT mice performed significantly (P<0.05) better than the Ts1Cje mice in the latency to maintain a coordinated motor movement against the rotating rod. Adult Ts1Cje mice exhibited significantly (P<0.001) lower nerve conduction velocity compared with their aged matched WT mice. Further analysis showed a significantly (P<0.001) higher population of type l fibres in WT compared to Ts1Cje mice. Also, there was significantly (P<0.01) higher population of COX deficient fibres in Ts1Cje mice. Expression of Myf5 was significantly (P<0.05) reduced in triceps of Ts1Cje mice while MyoD expression was significantly (P<0.05) increased in quadriceps of Ts1Cje mice. Conclusion Ts1 Cje mice exhibited weaker muscle strength. The lower population of the type I fibres and higher population of COX deficient fibres in Ts1 Cje mice may contribute to the muscle weakness seen in this mouse model for DS.	[Bala, Usman; Lim, Chai Ling; Othman, Fauziah; Cheah, Pike-See] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia; [Bala, Usman; Leong, Melody Pui-Yee; Lim, Chai Ling; Othman, Fauziah; Lai, Mei-I; Ling, King-Hwa; Cheah, Pike-See] Univ Putra Malaysia, Fac Med & Hlth Sci, GRMRC, Serdang, Selangor, Malaysia; [Bala, Usman] Gombe State Univ, Coll Med Sci, Dept Human Anat, Gombe, Nigeria; [Leong, Melody Pui-Yee; Ling, King-Hwa] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang, Selangor, Malaysia; [Shahar, Hayati Kadir] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang, Selangor, Malaysia; [Lai, Mei-I] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Pathol, Serdang, Selangor, Malaysia; [Law, Zhe-Kang] UKM Med Ctr, Dept Med, Jalan Yaakob Latif, Kuala Lumpur, Malaysia; [Ramli, Khairunnisa] UKM Med Ctr, Tissue Engn Ctr, Jalan Yaakob Latif, Kuala Lumpur, Malaysia; [Htwe, Ohnmar] UKM Med Ctr, Dept Orthopaed & Traumatol, Jalan Yaakob Latif, Kuala Lumpur, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Cheah, PS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia.; Cheah, PS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, GRMRC, Serdang, Selangor, Malaysia.	cheahpikesee@upm.edu.my	Melody Pui-Yee, Leong/AAA-4434-2020; RAMLI, KHAIRUNNISA/S-6268-2019; Law, Zhe Kang/ABC-6224-2020; Cheah, Pike-See/F-4978-2014; Ling, King-Hwa/M-2349-2018; Lai, Mei I/N-5767-2018	Melody Pui-Yee, Leong/0000-0002-1481-5644; Law, Zhe Kang/0000-0002-7900-9037; Ling, King-Hwa/0000-0002-3968-7263; Lai, Mei I/0000-0002-5992-9397; Bala, Usman/0000-0002-4634-1252; Cheah, Pike See/0000-0003-2181-2502	Ministry of Health Malaysia, Fundamental Research Grant Scheme [04-01-15-1663FR]; University Putra Malaysia, Geran Putra IPT [UPM/700/2/1/GP-IPT/2013/9409500]; University Putra Malaysia Geran Putra IPS [UPM/700/2/1/GP-IPS/2014/9448800]; University Putra Malaysia Research University Grant Scheme [04-02-12-2102RU]; Ministry of Science and technology, ScienceFund [02-01-04-SF2336]	Ministry of Health Malaysia, Fundamental Research Grant Scheme; University Putra Malaysia, Geran Putra IPT; University Putra Malaysia Geran Putra IPS; University Putra Malaysia Research University Grant Scheme; Ministry of Science and technology, ScienceFund	This work was supported in part by funding from the Ministry of Health Malaysia, Fundamental Research Grant Scheme (04-01-15-1663FR), University Putra Malaysia, Geran Putra IPT (UPM/700/2/1/GP-IPT/2013/9409500) and University Putra Malaysia Geran Putra IPS (UPM/700/2/1/GP-IPS/2014/9448800) awarded to Cheah Pike-See. Also, the work was funded by University Putra Malaysia Research University Grant Scheme (04-02-12-2102RU) and Ministry of Science and technology, ScienceFund (02-01-04-SF2336) awarded to Ling King-Hwa.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Anderson JS, 2013, NEUROIMAGE-CLIN, V2, P703, DOI 10.1016/j.nicl.2013.05.006; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Arbuzova S, 2002, BIOESSAYS, V24, P681, DOI 10.1002/bies.10138; AVRAHAM KB, 1991, J NEUROCYTOL, V20, P208, DOI 10.1007/BF01186993; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Brown R, 2001, Downs Syndr Res Pract, V6, P111, DOI 10.3104/case-studies.101; Buckley S., 2002, SOCIAL DEV INDIVIDUA; Chang KT, 2009, P NATL ACAD SCI USA, V106, P17117, DOI 10.1073/pnas.0904397106; Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Coskun P.E., 2012, CURR GERONTOL GERIAT; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; Cowley PM, 2012, AM J PHYSIOL-REG I, V303, P1251; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Deacon RMJ, 2013, JOVE-J VIS EXP, P2; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; Galdzicki Z, 2001, BRAIN RES REV, V35, P115, DOI 10.1016/S0926-6410(00)00074-4; Galli M, 2008, GAIT POSTURE, V28, P502, DOI 10.1016/j.gaitpost.2008.03.001; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Guidi S, 2011, BRAIN PATHOL, V21, P361, DOI 10.1111/j.1750-3639.2010.00459.x; Hagiwara N., 2014, NEW J SCI, V2014, P21; Jover M, 2010, DEV PSYCHOBIOL, V52, P782, DOI 10.1002/dev.20474; Kasari C, 2001, AM J MENT RETARD, V106, P253, DOI 10.1352/0895-8017(2001)106<0253:TRSBIC>2.0.CO;2; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kraemer BR, 2003, MENT RETARD, V41, P250, DOI 10.1352/0047-6765(2003)41<250:QOLFYA>2.0.CO;2; Lana-Elola E, 2011, DIS MODEL MECH, V4, P586, DOI 10.1242/dmm.008078; Latash ML, 2002, EXP BRAIN RES, V146, P345, DOI 10.1007/s00221-002-1189-3; Luca A De, 2014, USE GRIP STRENGTH ME, P1; Malak R, 2013, ANN AGR ENV MED, V20, P803; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Palisano RJ, 2001, ARCH PHYS MED REHAB, V82, P494, DOI 10.1053/apmr.2001.21956; Patterson D, 2005, NAT REV GENET, V6, P137, DOI 10.1038/nrg1525; Phillips AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084031; Pinter JD, 2001, AM J PSYCHIAT, V158, P1659, DOI 10.1176/appi.ajp.158.10.1659; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; Rigoldi C, 2011, RES DEV DISABIL, V32, P170, DOI 10.1016/j.ridd.2010.09.007; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Schulz A, 2014, J SCH VIOLENCE, P1, DOI DOI 10.1080/15388220.2014.961067; Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004; Unterberger U, 2003, J NEURAL TRANSM-SUPP, P159; van Putten M., 2012, TREAT NMD EU, V4, P1; Walsh ME, 2015, J GERONTOL A-BIOL, V70, P1312, DOI 10.1093/gerona/glu208; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; WISNIEWSKI KE, 1994, DEV BRAIN DYSFUNCT, V7, P289; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392	49	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197711	10.1371/journal.pone.0197711	http://dx.doi.org/10.1371/journal.pone.0197711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795634	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300063
J	Nakanishi, K; Shishido, K; Kumata, C; Ito, K; Nakashima, Y; Wakasa, M				Nakanishi, Kazushige; Shishido, Kanji; Kumata, Chiaki; Ito, Kae; Nakashima, Yutaka; Wakasa, Mikio			Bone density of the femoral neck in patients on maintenance dialysis	PLOS ONE			English	Article							MINERAL DENSITY; HEMODIALYSIS-PATIENTS; HIP FRACTURE; BIOCHEMICAL MARKERS; ALKALINE-PHOSPHATASE; SKELETAL FRACTURES; RISK; MORTALITY; DISEASE; CKD	Background Our institution recently started using the femoral neck (FN), as well as the non-shunted distal radius (Rd), to measure bone mineral density (BMD) in patients with chronic kidney disease. We examined the utility and characteristics of this measurement in patients on maintenance dialysis. Methods We selected 293 patients on chronic dialysis. We measured Rd and FN BMD using dual-energy X-ray absorptiometry, and we reviewed blood test findings, which included hemoglobin, albumin, blood urea nitrogen, creatinine, adjusted calcium, phosphorus, alkaline phosphatase, and intact parathyroid hormone. We conducted a multiple linear regression analysis that was stratified according to sex, age, body weight, height, and dialysis vintage. The Rd and FN BMD values were the dependent variables, and the blood test findings were the independent variables. We compared the areas under the curve (AUCs) of Rd and FN BMD using receiver operating characteristic curve analysis to differentiate between patients with and without fractures. Results FN BMD was significantly lower than Rd BMD. The general risk factors for osteoporosis, such as low body weight, older age, muscle mass loss, and malnutrition, influenced FN BMD. FN and Rd BMD were not correlated with calcium, phosphorous, or intact parathyroid hormone, whereas a significant, negative correlation with alkaline phosphatase was detected. Both men and women with a history of fragility fractures had significantly lower Rd and FN BMDs than patients without such a history. However, there was no significant difference between the AUCs of FN and Rd BMD for fractures in both men and women. Conclusions FN BMD was significantly lower than Rd BMD. Additionally, FN BMD was not inferior to Rd BMD for assessing the risk of fracture in patients on maintenance dialysis.	[Nakanishi, Kazushige; Shishido, Kanji; Kumata, Chiaki; Ito, Kae; Nakashima, Yutaka; Wakasa, Mikio] Sekishin Kai Kawasaki Clin, Internal Med, Kawasaki, Kanagawa, Japan; [Nakanishi, Kazushige] Showa Womens Univ, Dept Food Sci & Nutr, Setagaya Ku, Tokyo, Japan		Nakanishi, K (corresponding author), Sekishin Kai Kawasaki Clin, Internal Med, Kawasaki, Kanagawa, Japan.; Nakanishi, K (corresponding author), Showa Womens Univ, Dept Food Sci & Nutr, Setagaya Ku, Tokyo, Japan.	kazunaka@med.toho-u.ac.jp			Showa Women's University	Showa Women's University	The source of support was the faculty research expenses in Showa Women's University. No authors received a salary from the faculty research expenses in Showa Women's University. Additionally,the funder had no role in study design, data collection and analysis,decision to publish,or preparation of the manuscript.	Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Ambrus C, 2010, INT UROL NEPHROL, V42, P723, DOI 10.1007/s11255-009-9666-2; Benyahia M, 2004, NEPHROL DIAL TRANSPL, V19, P2153, DOI 10.1093/ndt/gfh339; Blayney MJ, 2008, KIDNEY INT, V74, P655, DOI 10.1038/ki.2008.248; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Fisher E S, 1991, Epidemiology, V2, P116, DOI 10.1097/00001648-199103000-00005; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Ketteler M, 2017, KIDNEY INT, V92, P26, DOI 10.1016/j.kint.2017.04.006; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; Maruyama Y, 2014, NEPHROL DIAL TRANSPL, V29, P1532, DOI 10.1093/ndt/gfu055; Morita A, 1993, KIDNEY METAB BONE DI, V6, P101; Muraki S, 2006, J BONE MINER METAB, V24, P100, DOI 10.1007/s00774-005-0654-z; Najar MS, 2017, SAUDI J KIDNEY DIS T, V28, P538, DOI 10.4103/1319-2442.206439; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; Pitto R., 1994, J SOC INT CHIRURG OR, V18, P109, DOI DOI 10.1007/BF02484420; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; Suzuki T, 2010, OSTEOPOROSIS INT, V21, P71, DOI 10.1007/s00198-009-0970-6; Urena P, 2003, NEPHROL DIAL TRANSPL, V18, P2325, DOI 10.1093/ndt/gfg403; Wakasugi M, 2013, J BONE MINER METAB, V31, P315, DOI 10.1007/s00774-012-0411-z; Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211	23	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197965	10.1371/journal.pone.0197965	http://dx.doi.org/10.1371/journal.pone.0197965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795652	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300106
J	Slama, A; Mallek-Maalej, E; Ben Mohamed, H; Rhim, T; Radhouane, L				Slama, Amor; Mallek-Maalej, Elhem; Ben Mohamed, Hatem; Rhim, Thouraya; Radhouane, Leila			A return to the genetic heritage of durum wheat to cope with drought heightened by climate change	PLOS ONE			English	Article							CHLOROPHYLL-A FLUORESCENCE; WATER-DEFICIT; PROLINE ACCUMULATION; ELECTROLYTE LEAKAGE; SELECTION CRITERION; MEMBRANE INTEGRITY; OSMOTIC ADJUSTMENT; GRAIN-YIELD; RAPID TOOL; STRESS	The objective of this work was to perform a comparative analysis of the physiological, biochemical and agronomical parameters of recent and heritage durum wheat cultivars (Triticum durum Desf.) under water-deficit conditions. Five cultivars were grown under irrigated (control) and rainfall (stressed) conditions. Different agro-physiological and biochemical parameters were studied: electrolyte leakage, relative water content, chlorophyll fluorescence, proline, soluble sugars, specific peroxidase activity, yield and drought stress indices. It was revealed that a water deficit increased proline content, electrolyte leakage, soluble sugars and specific peroxidase activity and decreased relative water content, fluorescence and grain yield. According to these parameters and drought stress indices, our investigation indicated that old cultivars are the best-adapted to local conditions and showed characteristics of drought tolerance, while recent cultivars showed more drought susceptibility. Therefore, local cultivars of each country should be kept by farmers and plant breeders to preserve their genetic heritage.	[Slama, Amor; Mallek-Maalej, Elhem] Carthage Univ, Sci Fac Bizerte, Bizerte, Tunisia; [Ben Mohamed, Hatem] Arid Reg Inst Medenine, Arid & Oases Cropping Lab, Medenine, Tunisia; [Rhim, Thouraya] Natl Inst Agron Res, Hort Lab, Ariana, Tunisia; [Radhouane, Leila] Natl Inst Agron Res, Plant Physiol Lab, Ariana, Tunisia	Universite de Carthage; Institut des Regions Arides	Slama, A (corresponding author), Carthage Univ, Sci Fac Bizerte, Bizerte, Tunisia.	slamaamor@yahoo.fr			Horticulture laboratory of National Institute of Agronomic Research - Tunisia (INRAT); Plant physiology laboratory of National Institute of Agronomic Research - Tunisia (INRAT)	Horticulture laboratory of National Institute of Agronomic Research - Tunisia (INRAT); Plant physiology laboratory of National Institute of Agronomic Research - Tunisia (INRAT)	This study was supported by the Horticulture laboratory and the Plant physiology laboratory of National Institute of Agronomic Research - Tunisia (INRAT).; This study was supported by the horticulture laboratory and the plant physiology laboratory of National Institute of Agronomic Research Tunisia (INRAT). The authors would like to thank all their colleagues for their help and cooperation.	Ac A, 2015, REMOTE SENS ENVIRON, V168, P420, DOI 10.1016/j.rse.2015.07.022; Ammar K, 2011, WORLD WHEAT BOOK HIS, P443; Araus JL, 1998, FIELD CROP RES, V55, P209, DOI 10.1016/S0378-4290(97)00079-8; Arias-Baldrich C, 2015, J PLANT PHYSIOL, V183, P121, DOI 10.1016/j.jplph.2015.05.016; Bajji M, 2001, PLANT SCI, V160, P669, DOI 10.1016/S0168-9452(00)00443-X; Dabrowski P, 2016, J PHOTOCH PHOTOBIO B, V157, P22, DOI 10.1016/j.jphotobiol.2016.02.001; de Almeida ML, 2004, SCI AGR, V61, P266, DOI 10.1590/S0103-90162004000300004; DEGHAIS M, 2007, VARIETES CEREALES CU; Dewes CF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174045; FALES FW, 1951, J BIOL CHEM, V193, P113; Faraloni C, 2011, ENVIRON EXP BOT, V73, P49, DOI 10.1016/j.envexpbot.2010.10.011; Gameiro C, 2016, AGR WATER MANAGE, V164, P127, DOI 10.1016/j.agwat.2015.09.008; Gao ML, 2016, CHEMOSPHERE, V151, P76, DOI 10.1016/j.chemosphere.2016.02.061; Ilker E, 2011, TURK J FIELD CROPS, V16, P59; Lamhamdi M, 2011, CR BIOL, V334, P118, DOI 10.1016/j.crvi.2010.12.006; Lotfi R, 2015, CROP J, V3, P434, DOI 10.1016/j.cj.2015.05.006; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Manuchehri R, 2014, S AFR J BOT, V92, P83, DOI 10.1016/j.sajb.2014.02.006; Mishra KB, 2012, PLANT SCI, V182, P79, DOI 10.1016/j.plantsci.2011.03.022; Nayyar H, 2006, ENVIRON EXP BOT, V58, P106, DOI 10.1016/j.envexpbot.2005.06.021; Nazar R, 2015, S AFR J BOT, V98, P84, DOI 10.1016/j.sajb.2015.02.005; Quilambo OA, 2004, S AFR J BOT, V70, P227, DOI 10.1016/S0254-6299(15)30239-8; Radhouane L., 2013, SCI INT, V1, P64; Raoudha A, 2007, J CELL MOL BIOL, V6, P19; Rolny N, 2011, PLANT PHYSIOL BIOCH, V49, P1220, DOI 10.1016/j.plaphy.2011.06.010; Salehi A, 2016, ASIAN PAC J TROP BIO, V6, P886, DOI 10.1016/j.apjtb.2016.08.009; Sanchez-Blanco MJ, 2002, PLANT SCI, V162, P107, DOI 10.1016/S0168-9452(01)00540-4; Slabbert MM, 2014, S AFR J BOT, V95, P123, DOI 10.1016/j.sajb.2014.08.008; Slama Amor, 2005, Secheresse (Montrouge), V16, P225; Takele A, 2010, AGR SCI CHINA, V9, P813, DOI 10.1016/S1671-2927(09)60159-0; TROLL W, 1955, J BIOL CHEM, V215, P655; Uzilday B, 2012, PLANT SCI, V182, P59, DOI 10.1016/j.plantsci.2011.03.015; VANRENSBURG L, 1993, J PLANT PHYSIOL, V141, P188, DOI 10.1016/S0176-1617(11)80758-3; Worku T., 1995, WATER RETENTION CAPA, V182, P2105; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Zhang J, 1999, GENETIC ANAL OSMOTIC; Zivcak M, 2015, J PHOTOCH PHOTOBIO B, V152, P318, DOI 10.1016/j.jphotobiol.2015.08.024	37	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196873	10.1371/journal.pone.0196873	http://dx.doi.org/10.1371/journal.pone.0196873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795584	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300016
J	Taga, M; Mouton-Liger, F; Sadoune, M; Gourmaud, S; Norman, J; Tible, M; Thomasseau, S; Paquet, C; Nicoll, JAR; Boche, D; Hugon, J				Taga, Mariko; Mouton-Liger, Francois; Sadoune, Malha; Gourmaud, Sarah; Norman, Jenny; Tible, Marion; Thomasseau, Sylvie; Paquet, Claire; Nicoll, James A. R.; Boche, Delphine; Hugon, Jacques			PKR modulates abnormal brain signaling in experimental obesity	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; INSULIN-RESISTANCE; COGNITIVE FUNCTION; CELL FUNCTION; RNA; ACTIVATION; INFLAMMATION; DECLINE	Metabolic disorders including obesity and type 2 diabetes are known to be associated with chronic inflammation and are obvious risk factors for Alzheimer's disease. Recent evidences concerning obesity and diabetes suggest that the metabolic inflammasome ("metaflammasome") mediates chronic inflammation. The double-stranded RNA-dependent protein kinase (PKR) is a central component of the metaflammasome. In wild type (WT) and PKR-/- mice, blood glucose, insulin and lipid levels and the brain expression of the phosphorylated components of the metaflammasome-PKR, JNK, IRS1 and IKKbeta-were studied after the induction of obesity by a high fat diet (HFD). The results showed significant increased levels of activated brain metaflammasome proteins in exposed WT mice but the changes were not significant in PKR-/- mice. In addition, gain weight was observed in WT mice and also in PKR-/- mice exposed to HFD. Increased blood insulin level was more accentuated in PKR-/- mice. The modulation of PKR activity could be an appropriate therapeutic approach, aimed at reducing abnormal brain metabolism and inflammation linked to metabolic disorders in order to reduce the risk of neurodegeneration.	[Taga, Mariko; Nicoll, James A. R.; Boche, Delphine] Univ Southampton, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England; [Taga, Mariko; Mouton-Liger, Francois; Sadoune, Malha; Gourmaud, Sarah; Tible, Marion; Thomasseau, Sylvie; Paquet, Claire; Hugon, Jacques] INSERM, Units U942, Paris, France; [Norman, Jenny] Univ Southampton, Histochem Res Unit, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Paquet, Claire; Hugon, Jacques] Univ Paris Diderot, Lariboisiere Hosp, AP HP, Ctr Cognit Neurol, Paris, France; [Nicoll, James A. R.] Univ Hosp Southampton NHS Fdn Trust, Dept Cellular Pathol, Southampton, Hants, England	University of Southampton; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Southampton; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Southampton; University Hospital Southampton NHS Foundation Trust	Taga, M (corresponding author), Univ Southampton, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England.; Taga, M (corresponding author), INSERM, Units U942, Paris, France.	mt3203@cumc.columbia.edu	Boche, Delphine/A-7589-2011; Nicoll, James/I-9253-2017	Boche, Delphine/0000-0002-5884-130X; Taga, Mariko/0000-0003-3780-7054; Mouton-Liger, Francois/0000-0001-8172-6548; Tible, Marion/0000-0001-5067-3711; Nicoll, James/0000-0002-9444-7246	Alzheimer's Research UK [ART-PhD2011-22]	Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	Alzheimer's Research UK (ART-PhD2011-22) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Alzheimer's Research UK (ART-PhD2011-22). We thank Inserm U942 staffs, Paris, France for their technical assistance and for animal housing.	Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; Barbagallo M, 2014, WORLD J DIABETES, V5, P889, DOI 10.4239/wjd.v5.i6.889; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Carret-Rebillat AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08489; Carvalho MA, 2012, ENDOCRINOLOGY, V153, P5261, DOI 10.1210/en.2012-1400; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chen SS, 2014, BIOCHEM BIOPH RES CO, V443, P814, DOI 10.1016/j.bbrc.2013.12.051; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dumurgier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053587; Feng ZC, 2012, DIABETOLOGIA, V55, P2214, DOI 10.1007/s00125-012-2566-5; Gourmaud S, 2015, J PSYCHIATR NEUROSCI, V40, P151, DOI 10.1503/jpn.140062; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kadereit S, 2000, J IMMUNOL, V165, P6896, DOI 10.4049/jimmunol.165.12.6896; Lancaster GI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10626; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Mouton-Liger F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.552; Mouton-Liger F, 2012, BIOL PSYCHIAT, V71, P829, DOI 10.1016/j.biopsych.2011.11.031; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Suen KC, 2003, J BIOL CHEM, V278, P49819, DOI 10.1074/jbc.M306503200; Taga M, 2017, BRAIN PATHOL, V27, P266, DOI 10.1111/bpa.12388; Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Vargas NB, 2009, J LIPID RES, V50, P386, DOI 10.1194/jlr.M800316-JLR200; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014	33	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196983	10.1371/journal.pone.0196983	http://dx.doi.org/10.1371/journal.pone.0196983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795582	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300020
J	Cai, H; Cho, EA; Li, Y; Sockler, J; Parish, CR; Chong, BH; Edwards, J; Dodds, TJ; Ferguson, PM; Wilmott, JS; Scolyer, RA; Halliday, GM; Khachigian, LM				Cai, Hong; Cho, Eun-Ae; Li, Yue; Sockler, Jim; Parish, Christopher R.; Chong, Beng H.; Edwards, Jarem; Dodds, Tristan J.; Ferguson, Peter M.; Wilmott, James S.; Scolyer, Richard A.; Halliday, Gary M.; Khachigian, Levon M.			Melanoma protective antitumor immunity activated by catalytic DNA	ONCOGENE			English	Article							CD4 T-CELLS; C-JUN; EXPRESSION; INHIBITION; SURVIVAL; DNAZYME; GROWTH; GENE; CARCINOMA; MUTATION	Melanoma incidence is increasing worldwide, and although drugs such as BRAF/MEK small-molecule inhibitors and immune checkpoint antibodies improve patient outcomes, most patients ultimately fail these therapies and alternative treatment strategies are urgently needed. DNAzymes have recently undergone clinical trials with signs of efficacy and no serious adverse events attributable to the DNAzyme. Here we investigated c-Jun expression in human primary and metastatic melanoma. We also explored the role of T cell immunity in DNAzyme inhibition of primary melanoma growth and the prevention of growth in non-treated tumors after the cessation of treatment in a mouse model. c-Jun was expressed in 80% of melanoma cells in human primary melanomas (n = 17) and in 83% of metastatic melanoma cells (n = 38). In contrast, c-Jun was expressed in only 11% of melanocytes in benign nevi (n = 24). Dz13, a DNAzyme targeting c-Jun/AP-1, suppressed both Dz13-injected and untreated B16F10 melanoma growth in the same mice, an abscopal effect relieved in each case by administration of anti-CD4/anti-CD8 antibodies. Dz13 increased levels of cleaved caspase-3 within the tumors. New, untreated melanomas grew poorly in mice previously treated with Dz13. Administration of anti-CD4/anti-CD8 antibodies ablated this inhibitory effect and the tumors grew rapidly. Dz13 inhibited c-Jun expression, reduced intratumoral vascularity (vascular lumina area defined by CD31 staining), and increased CD4(+) cells within the tumors. This study provides the first demonstration of an abscopal effect of a DNAzyme on tumor growth and shows that Dz13 treatment prevents growth of subsequent new tumors in the same animal. Dz13 may be useful clinically as a therapeutic antitumor agent by preventing tumor relapse through adaptive immunity.	[Cai, Hong; Li, Yue; Khachigian, Levon M.] Univ New South Wales, Sch Med Sci, Vasc Biol & Translat Res, Sydney, NSW 2052, Australia; [Cai, Hong; Li, Yue; Khachigian, Levon M.] Univ New South Wales, UNSW Med, Sydney, NSW 2052, Australia; [Cho, Eun-Ae; Halliday, Gary M.] Univ Sydney, Dermatol Res Labs, Sydney, NSW 2006, Australia; [Cho, Eun-Ae; Halliday, Gary M.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Sockler, Jim] Datapharm Australia, Stat Operat & Programming, Sydney, NSW 2047, Australia; [Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Canc & Vasc Biol Grp, Bldg 131,Garran Rd, Canberra, ACT 2601, Australia; [Chong, Beng H.] Univ New South Wales, St George Clin Sch, Kogarah, NSW 2217, Australia; [Chong, Beng H.] St George Hosp, Dept Haematol, Kogarah, NSW 2217, Australia; [Edwards, Jarem; Dodds, Tristan J.; Ferguson, Peter M.; Wilmott, James S.; Scolyer, Richard A.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2050, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; Australian National University; John Curtin School of Medical Research; University of New South Wales Sydney; St George Hospital; Melanoma Institute Australia; University of Sydney	Khachigian, LM (corresponding author), Univ New South Wales, Sch Med Sci, Vasc Biol & Translat Res, Sydney, NSW 2052, Australia.; Khachigian, LM (corresponding author), Univ New South Wales, UNSW Med, Sydney, NSW 2052, Australia.	L.Khachigian@unsw.edu.au	Scolyer, Richard/AAE-8511-2019; Wilmott, James/AGA-8227-2022; Chong, Beng/AAE-2617-2019; Chong, Beng/AAM-9010-2021; Khachigian, Levon/AAZ-7458-2020; Li, Yue/AAB-3024-2019	Scolyer, Richard/0000-0002-8991-0013; Wilmott, James/0000-0002-6750-5244; Ferguson, Peter M./0000-0002-8335-0406; Li, Yue/0000-0002-5304-9188; Parish, Christopher/0000-0001-7740-0430	Translational Program Grant from Cancer Institute of New South Wales; National Health and Medical Research Council of Australia	Translational Program Grant from Cancer Institute of New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a Translational Program Grant from Cancer Institute of New South Wales, and Program and Fellowship support from National Health and Medical Research Council of Australia.	Apalla Zoe, 2017, Dermatol Pract Concept, V7, P1, DOI 10.5826/dpc.0702a01; BARTH A, 1995, J AM COLL SURGEONS, V181, pA193; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Bhindi R, 2007, AM J PATHOL, V171, P1079, DOI 10.2353/ajpath.2007.070120; Cai H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003960; Cao Y, 2014, MOL THER, V22, P371, DOI 10.1038/mt.2013.257; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cho EA, 2013, LANCET, V381, P1835, DOI 10.1016/S0140-6736(12)62166-7; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Garg AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00588; Hoefer F, 2017, ANAL METHODS-UK, V9, P697, DOI 10.1039/c6ay03061k; Hooijkaas AI, 2012, ONCOIMMUNOLOGY, V1, P609, DOI 10.4161/onci.20226; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Johnson DB, 2015, JAMA ONCOL, V1, P380, DOI 10.1001/jamaoncol.2015.0565; Kahan-Hanum M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01535; Kakavand H, 2015, MODERN PATHOL, V28, P1535, DOI 10.1038/modpathol.2015.110; Kappelmann M, 2014, EUR J CELL BIOL, V93, P76, DOI 10.1016/j.ejcb.2013.10.003; Khachigian LM, 2000, J CLIN INVEST, V106, P1189, DOI 10.1172/JCI11620; Khachigian LM, 2002, J BIOL CHEM, V277, P22985, DOI 10.1074/jbc.M200977200; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Lardone RD, 2016, ONCOTARGET, V7, P14415, DOI 10.18632/oncotarget.7361; Li Y, 2013, INT J CARDIOL, V168, P3659, DOI 10.1016/j.ijcard.2013.05.092; Liu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21319; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Madore J, 2016, CLIN CANCER RES, V22, P3915, DOI 10.1158/1078-0432.CCR-15-1714; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; Melanoma-Institute-Australia, 2015, MEL FACTS STAT; Nedergaard BS, 2007, BRIT J CANCER, V97, P1135, DOI 10.1038/sj.bjc.6604001; Perales MA, 2004, ANN SURG ONCOL, V11, P881, DOI 10.1245/ASO.2004.08.911; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shklovskaya E, 2016, IMMUNOL CELL BIOL, V94, P593, DOI 10.1038/icb.2016.14; Tan ML, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-9; Xie JJ, 2014, BBA-MOL BASIS DIS, V1842, P2479, DOI 10.1016/j.bbadis.2014.04.017; Yan SF, 2016, ANTICANCER RES, V36, P6449, DOI 10.21873/anticanres.11243; Zanetti M, 2015, J IMMUNOL, V194, P2049, DOI 10.4049/jimmunol.1402669; Zhang G, 2006, ONCOGENE, V25, P7260, DOI 10.1038/sj.onc.1209726; Zhang GS, 2004, JNCI-J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120; Zhang ZP, 2017, MICROB PATHOGENESIS, V103, P155, DOI 10.1016/j.micpath.2016.12.024	42	9	10	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5115	5126		10.1038/s41388-018-0306-0	http://dx.doi.org/10.1038/s41388-018-0306-0			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29844573				2022-12-26	WOS:000444405300007
J	Sudom, A; Talreja, S; Danao, J; Bragg, E; Kegel, R; Min, XS; Richardson, J; Zhang, ZQ; Sharkov, N; Marcora, E; Thibault, S; Bradley, J; Wood, S; Lim, AC; Chen, H; Wang, SL; Foltz, IN; Sambashivan, S; Wang, ZL				Sudom, Athena; Talreja, Santosh; Danao, Jean; Bragg, Eric; Kegel, Rob; Min, Xiaoshan; Richardson, Jason; Zhang, Zhongqi; Sharkov, Nikolai; Marcora, Edoardo; Thibault, Steve; Bradley, Jodi; Wood, Steve; Lim, Ai-Ching; Chen, Hang; Wang, Songli; Foltz, Ian N.; Sambashivan, Shilpa; Wang, Zhulun			Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; neuroinflammation; X-ray crystallography; lipid-binding protein; scavenger receptor; TREM2; R47H; neurodegeneration; microglia; antibody; myeloid cell; structure; triggering receptor expressed on myeloid cells 2	BINDS; PHOSPHATIDYLSERINE; CLEAVAGE; SUSTAINS; IMPAIRS; LIGAND; MICE	Triggering receptor expressed on myeloid cells 2 (TREM2) is an immune receptor expressed on the surface of microglia, macrophages, dendritic cells, and osteoclasts. The R47H TREM2 variant is a significant risk factor for late-onset Alzheimer's disease (AD), and the molecular basis of R47H TREM2 loss of function is an emerging area of TREM2 biology. Here, we report three high-resolution structures of the extracellular ligand-binding domains (ECDs) of R47H TREM2, apo-WT, and phosphatidylserine (PS)-bound WT TREM2 at 1.8, 2.2, and 2.2 , respectively. The structures reveal that Arg(47) plays a critical role in maintaining the structural features of the complementarity-determining region 2 (CDR2) loop and the putative positive ligand-interacting surface (PLIS), stabilizing conformations capable of ligand interaction. This is exemplified in the PS-bound structure, in which the CDR2 loop and PLIS drive critical interactions with PS via surfaces that are disrupted in the variant. Together with in vitro and in vivo characterization, our structural findings elucidate the molecular mechanism underlying loss of ligand binding, putative oligomerization, and functional activity of R47H TREM2. They also help unravel how decreased in vitro and in vivo stability of TREM2 contribute to loss of function in disease.	[Sudom, Athena; Talreja, Santosh; Danao, Jean; Bragg, Eric; Kegel, Rob; Min, Xiaoshan; Sharkov, Nikolai; Marcora, Edoardo; Thibault, Steve; Lim, Ai-Ching; Chen, Hang; Wang, Songli; Sambashivan, Shilpa; Wang, Zhulun] Amgen Inc, Amgen Discovery Res, San Francisco, CA 94080 USA; [Richardson, Jason; Zhang, Zhongqi; Bradley, Jodi; Wood, Steve] Amgen Inc, Amgen Discovery Res, Thousand Oaks, CA 91320 USA; [Foltz, Ian N.] Amgen Inc, Amgen Discovery Res, Burnaby, BC V5A 1V7, Canada; [Kegel, Rob] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Sharkov, Nikolai] NGM Biopharmaceut, San Francisco, CA 94080 USA; [Marcora, Edoardo] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Marcora, Edoardo] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Hang] Denali Therapeut, San Francisco, CA 94080 USA	Amgen; Amgen; Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sudom, A; Wang, ZL (corresponding author), Amgen Inc, Amgen Discovery Res, San Francisco, CA 94080 USA.; Sambashivan, S (corresponding author), Proneurotech Inc, San Francisco, CA 94080 USA.	asudom@amgen.com; shilpashivan@gmail.com; zwang@amgen.com		Marcora, Edoardo/0000-0002-3829-4927	United States Department of Energy at the Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]	United States Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	We thank Fernando Garces and Sheree Johnstone for critical reading of the manuscript. We also thank Roman Shimanovich for some liposome preparations. X-ray diffraction experiments were performed on beamline 5.0.2 at the Advanced Light Source with support from the United States Department of Energy under Contract DE-AC03-76SF00098 at the Lawrence Berkeley National Laboratory.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Chen QX, 2013, AM J RESP CRIT CARE, V188, P201, DOI 10.1164/rccm.201211-1967OC; Cheng QW, 2018, J BIOL CHEM, V293, P12620, DOI 10.1074/jbc.RA118.001848; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Iborra S, 2015, IMMUNOBIOLOGY, V220, P175, DOI 10.1016/j.imbio.2014.09.013; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Kober DL, 2014, PROTEIN EXPRES PURIF, V96, P32, DOI 10.1016/j.pep.2014.01.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Read CB, 2015, J IMMUNOL, V194, P1417, DOI 10.4049/jimmunol.1402303; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Shah B, 2014, J AM SOC MASS SPECTR, V25, P999, DOI 10.1007/s13361-014-0858-3; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Tietjen GT, 2014, P NATL ACAD SCI USA, V111, pE1463, DOI 10.1073/pnas.1320174111; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhang ZQ, 2010, ANAL CHEM, V82, P10194, DOI 10.1021/ac102359u; Zhang ZQ, 2009, ANAL CHEM, V81, P8354, DOI 10.1021/ac901193n; Zhao YJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.200	33	54	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12634	12646		10.1074/jbc.RA118.002352	http://dx.doi.org/10.1074/jbc.RA118.002352			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29794134	Green Published, hybrid			2022-12-26	WOS:000441408500027
J	White, MD; Kamps, JJAG; East, S; Kearney, LJT; Flashman, E				White, Mark D.; Kamps, Jos J. A. G.; East, Samuel; Kearney, Leah J. Taylor; Flashman, Emily			The plant cysteine oxidases from Arabidopsis thaliana are kinetically tailored to act as oxygen sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; END RULE PATHWAY; ETHYLENE RESPONSE FACTORS; HYDROXYLASE DOMAIN 2; LOW INTERNAL OXYGEN; PROLYL 4-HYDROXYLASES; ANAEROBIC STRESS; RESONANCE; RAP2.2; ASSAY	Group VII ethylene response factors (ERF-VIIs) regulate transcriptional adaptation to flooding-induced hypoxia in plants. ERF-VII stability is controlled in an O-2-dependent manner by the Cys/Arg branch of the N-end rule pathway whereby oxidation of a conserved N-terminal cysteine residue initiates target degradation. This oxidation is catalyzed by plant cysteine oxidases (PCOs), which use O-2 as cosubstrate to generate Cys-sulfinic acid. The PCOs directly link O-2 availability to ERF-VII stability and anaerobic adaptation, leading to the suggestion that they act as plant O-2 sensors. However, their ability to respond to fluctuations in O-2 concentration has not been established. Here, we investigated the steady-state kinetics of Arabidopsis thaliana PCOs 1-5 to ascertain whether their activities are sensitive to O-2 levels. We found that the most catalytically competent isoform is AtPCO4, both in terms of responding to O-2 and oxidizing AtRAP2.2/2,12 (two of the most prominent ERF-VIIs responsible for promoting the hypoxic response), which suggests that AtPCO4 plays a central role in ERF-VII regulation. Furthermore, we found that AtPCO activity is susceptible to decreases in pH and that the hypoxia-inducible AtPCOs 1/2 and the noninducible AtPCOs 4/5 have discrete AtERF-VII substrate preferences. Pertinently, the AtPCOs had K-m(app)(O2)values in a physiologically relevant range, which should enable them to sensitively react to changes in O-2 availability. This work validates an O-2-sensing role for the PCOs and suggests that differences in expression pattern, ERF-VII selectivity, and catalytic capability may enable the different isoforms to have distinct biological functions. Individual PCOs could therefore be targeted to manipulate ERF-VII levels and improve stress tolerance in plants.	[White, Mark D.; Kamps, Jos J. A. G.; East, Samuel; Kearney, Leah J. Taylor; Flashman, Emily] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Oxford	White, MD; Flashman, E (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	mark.white@chem.ox.ac.uk; emily.flashman@chem.ox.ac.uk		Taylor-Kearney, Leah/0000-0001-7530-7670; Flashman, Emily/0000-0002-4169-4278; White, Mark/0000-0002-1431-0339	Biotechnology and Biological Sciences Research Council (UK) [BB/M024458/1]; BBSRC [BB/M024458/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council (UK) New Investigator Grant BB/M024458/1 (to E. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Borisjuk L, 2009, NEW PHYTOL, V182, P17, DOI 10.1111/j.1469-8137.2008.02752.x; Bui LT, 2015, PLANT SCI, V236, P37, DOI 10.1016/j.plantsci.2015.03.008; Dao JH, 2009, ANAL BIOCHEM, V384, P213, DOI 10.1016/j.ab.2008.09.052; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Gasch P, 2016, PLANT CELL, V28, P160, DOI 10.1105/tpc.15.00866; Geigenberger P, 2000, BIOL CHEM, V381, P723, DOI 10.1515/BC.2000.093; Gibbs DJ, 2016, NEW PHYTOL, V211, P1188, DOI 10.1111/nph.14105; Gibbs DJ, 2015, PLANT PHYSIOL, V169, P23, DOI 10.1104/pp.15.00338; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Giuntoli B, 2018, PLANT PHYSIOL, V176, P1143, DOI 10.1104/pp.17.01225; Gout E, 2001, PLANT PHYSIOL, V125, P912, DOI 10.1104/pp.125.2.912; Hancock RL, 2017, ACS CHEM BIOL, V12, P1011, DOI 10.1021/acschembio.6b00958; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Ho QT, 2010, J EXP BOT, V61, P2745, DOI 10.1093/jxb/erq108; Imsand EM, 2012, ARCH BIOCHEM BIOPHYS, V521, P10, DOI 10.1016/j.abb.2012.03.006; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Mendiondo GM, 2016, PLANT BIOTECHNOL J, V14, P40, DOI 10.1111/pbi.12334; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Ober ES, 1996, J EXP BOT, V47, P447, DOI 10.1093/jxb/47.3.447; Rolletschek H, 2007, J EXP BOT, V58, P3171, DOI 10.1093/jxb/erm154; Schmidt RR, 2018, PLANT PHYSIOL, V176, P1131, DOI 10.1104/pp.17.01394; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Tarhonskaya H, 2014, BIOCHEM J, V463, P363, DOI 10.1042/BJ20140779; van Dongen JT, 2015, ANNU REV PLANT BIOL, V66, P345, DOI 10.1146/annurev-arplant-043014-114813; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Vicente J, 2017, CURR BIOL, V27, P3183, DOI 10.1016/j.cub.2017.09.006; Wang FF, 2017, PLANT CELL PHYSIOL, V58, P1126, DOI 10.1093/pcp/pcx079; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; White MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14690; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Zhao Y, 2012, NEW PHYTOL, V195, P450, DOI 10.1111/j.1469-8137.2012.04160.x	41	49	49	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11786	11795		10.1074/jbc.RA118.003496	http://dx.doi.org/10.1074/jbc.RA118.003496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29848548	Green Published, hybrid			2022-12-26	WOS:000440134500013
J	Morin-Moncet, O; Latulipe-Loiselle, A; Therrien-Blanchet, JM; Theoret, H				Morin-Moncet, Olivier; Latulipe-Loiselle, Alexandre; Therrien-Blanchet, Jean-Marc; Theoret, Hugo			BDNF Val66Met polymorphism is associated with altered activity-dependent modulation of short-interval intracortical inhibition in bilateral M1	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; THETA BURST STIMULATION; LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; INTERMANUAL TRANSFER; INTERHEMISPHERIC INHIBITION; 2 PHASES; GABAERGIC SYNAPSES; GABA RELEASE	The BDNF Val66Met polymorphism is associated with impaired short-term plasticity in the motor cortex, short-term motor learning, and intermanual transfer of a procedural motor skill. Here, we investigated the impact of the Val66Met polymorphism on the modulation of cortical excitability and interhemispheric inhibition through sensorimotor practice of simple dynamic skills with the right and left first dorsal interosseous (FDI) muscles. To that end, we compared motor evoked potentials (MEP) amplitudes and short-interval intracortical inhibition (SICI) in the bilateral representations of the FDI muscle in the primary motor cortex (M1), and interhemispheric inhibition (IHI) from the left to right M1, before and after right and left FDI muscle training in an alternated sequence. Val66Met participants did not differ from their Val66Val counterparts on motor performance at baseline and following motor training, or on measures of MEP amplitude and IHI. However, while the Val66Val group displayed significant SICI reduction in the bilateral M1 in response to motor training, SICI remained unchanged in the Val66Met group. Further, Val66Val group's SICI decrease in the left M1, which was also observed following unimanual training with the right hand in the Control Right group, was correlated with motor improvement with the left hand. The potential interaction between left and right M1 activity during bimanual training and the implications of altered activity-dependent cortical excitability on short-term motor learning in Val66Met carriers are discussed.	[Morin-Moncet, Olivier; Latulipe-Loiselle, Alexandre; Therrien-Blanchet, Jean-Marc; Theoret, Hugo] Univ Montreal, Montreal, PQ, Canada; [Theoret, Hugo] Hop St Justine, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Morin-Moncet, O (corresponding author), Univ Montreal, Montreal, PQ, Canada.	oliver.morin-moncet@umontreal.ca		Therrien-Blanchet, Jean-Marc/0000-0003-1867-1606; Theoret, Hugo/0000-0002-7458-8797	Natural Sciences and Engineering Research of Canada [RGPIN-2016-05079]	Natural Sciences and Engineering Research of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grant from the Natural Sciences and Engineering Research of Canada, RGPIN-2016-05079 (http://www.nserc-crsng.gc.ca/index_eng.asp) to HT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Ausenda CD, 2011, EUR J PHYS REHAB MED, V47, P417; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Biabani M, 2018, NEUROSCI LETT, V674, P94, DOI 10.1016/j.neulet.2018.03.026; Camus M, 2009, CLIN NEUROPHYSIOL, V120, P1859, DOI 10.1016/j.clinph.2009.08.013; Carballedo A, 2012, AM J MED GENET B, V159B, P537, DOI 10.1002/ajmg.b.32060; Carroll TJ, 2008, J APPL PHYSIOL, V104, P1656, DOI 10.1152/japplphysiol.01351.2007; Carvalho AL, 2008, BRIT J PHARMACOL, V153, pS310, DOI 10.1038/sj.bjp.0707509; Cash R, 2017, BRAIN STIMUL, V10, P502; Chaieb L, 2014, NEUROGENETICS, V15, P1, DOI 10.1007/s10048-014-0393-1; Chase C, 2008, EXP BRAIN RES, V190, P317, DOI 10.1007/s00221-008-1472-z; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Cheng Q, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00075; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cirillo J, 2012, EUR J NEUROSCI, V36, P2640, DOI 10.1111/j.1460-9568.2012.08177.x; Cirillo J, 2011, EUR J NEUROSCI, V34, P1847, DOI 10.1111/j.1460-9568.2011.07870.x; Coxon JP, 2014, J NEUROPHYSIOL, V112, P156, DOI 10.1152/jn.00893.2013; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Fayers P, 2011, ADV HEALTH SCI EDUC, V16, P291, DOI 10.1007/s10459-011-9283-6; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; Fleming MK, 2012, IEEE T NEUR SYS REH, V20, P617, DOI 10.1109/TNSRE.2012.2202692; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Fujii S, 2009, MOTOR CONTROL, V13, P237, DOI 10.1123/mcj.13.3.237; Ghacibeh GA, 2007, CLIN NEUROPHYSIOL, V118, P325, DOI 10.1016/j.clinph.2006.10.003; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Hollerbach J.M., 1990, VISUAL COGNITION ACT, V2, P151; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Hortobagyi T, 2011, MED SCI SPORT EXER, V43, P1188, DOI 10.1249/MSS.0b013e31820a94b8; Howatson G, 2011, EUR J NEUROSCI, V33, P978, DOI 10.1111/j.1460-9568.2010.07567.x; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ioffe M, 1996, EXP BRAIN RES, V109, P450; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Karabanov A, 2015, BRAIN STIMUL, V8, P993, DOI 10.1016/j.brs.2015.06.017; Karabanov A, 2012, J PHYSIOL-LONDON, V590, P5557, DOI 10.1113/jphysiol.2012.244749; KARNI A, 1995, NATURE, V377, P155; Kennedy KM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.019.2009; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Koeneke S, 2006, EXP BRAIN RES, V174, P199, DOI 10.1007/s00221-006-0440-8; Koeneke S, 2009, J MOTOR BEHAV, V41, P347, DOI 10.3200/JMBR.41.4.347-356; Kuczewski N, 2008, J PHYSIOL-LONDON, V586, P5119, DOI 10.1113/jphysiol.2008.158550; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Langlois A, 2013, CEREB CORTEX, V23, P1085, DOI 10.1093/cercor/bhs071; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Liang N, 2008, NEUROSCI LETT, V433, P135, DOI 10.1016/j.neulet.2007.12.058; Liang N, 2007, EXP BRAIN RES, V182, P459, DOI 10.1007/s00221-007-1004-2; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Maeda F, 2002, CLIN NEUROPHYSIOL, V113, P376, DOI 10.1016/S1388-2457(02)00008-1; Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McDonald J.H., 2014, HDB BIOL STAT; McHughen SA, 2011, EXP BRAIN RES, V213, P415, DOI 10.1007/s00221-011-2791-z; McHughen SA, 2010, CEREB CORTEX, V20, P1254, DOI 10.1093/cercor/bhp189; Mooney RA, 2017, J NEUROPHYSIOL, V118, P425, DOI 10.1152/jn.00199.2017; Morin-Moncet O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169013; Morin-Moncet O, 2014, J NEUROPHYSIOL, V111, P2094, DOI 10.1152/jn.00388.2013; Morishita T, 2011, BRAIN RES, V1371, P65, DOI 10.1016/j.brainres.2010.11.049; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Murakami T, 2012, J PHYSIOL-LONDON, V590, P5765, DOI 10.1113/jphysiol.2012.238519; Nelson AJ, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-31; Neva JL, 2014, BEHAV BRAIN RES, V269, P138, DOI 10.1016/j.bbr.2014.04.041; Ngomo S, 2012, J NEUROSCI METH, V205, P65, DOI 10.1016/j.jneumeth.2011.12.012; Ni Z, 2009, CEREB CORTEX, V19, P1654, DOI 10.1093/cercor/bhn201; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; Pal PK, 2005, J NEUROPHYSIOL, V94, P1668, DOI 10.1152/jn.01306.2004; Parikh PJ, 2013, EXP BRAIN RES, V227, P9, DOI 10.1007/s00221-013-3451-2; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Park JH, 2002, J MOTOR BEHAV, V34, P253, DOI 10.1080/00222890209601944; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pattwell SS, 2012, J NEUROSCI, V32, P2410, DOI 10.1523/JNEUROSCI.5205-11.2012; Pereira EAH, 2011, AM J PHYS MED REHAB, V90, P25, DOI 10.1097/PHM.0b013e3181fc7f6f; Perez M.A., 2012, CORTICAL CONNECTIVIT, P165; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ragert P, 2009, J NEUROPHYSIOL, V102, P766, DOI 10.1152/jn.00274.2009; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Ridding MC, 2000, EXP BRAIN RES, V133, P249, DOI 10.1007/s002210000428; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ruddy KL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00397; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sathian K, 1998, EXP BRAIN RES, V118, P131, DOI 10.1007/s002210050263; Sattler V, 2012, EXP BRAIN RES, V221, P449, DOI 10.1007/s00221-012-3187-4; Schulze K, 2002, CORTEX, V38, P805, DOI 10.1016/S0010-9452(08)70047-9; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Smolders R, 2012, BRAIN BEHAV, V2, P726, DOI 10.1002/brb3.83; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Strube W, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu040; Sugawara K, 2012, NEUROREPORT, V23, P663, DOI 10.1097/WNR.0b013e3283556522; Tazoe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114244; Teixeira LA, 2003, EXP BRAIN RES, V149, P312, DOI 10.1007/s00221-002-1363-7; Teixeira LA, 2000, BRAIN COGNITION, V44, P455, DOI 10.1006/brcg.1999.1205; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; Uematsu A, 2010, EXP BRAIN RES, V206, P59, DOI 10.1007/s00221-010-2397-x; Voti PL, 2011, EXP BRAIN RES, V212, P91, DOI 10.1007/s00221-011-2700-5; Wardle RA, 2003, J NEUROSCI, V23, P8722; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Woo NH, 2009, ENCY NEUROSCIENCE, P135; Yamada MK, 2002, J NEUROSCI, V22, P7580; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; Ziemann U, 2001, CLIN NEUROPHYSIOL, V112, P107, DOI 10.1016/S1388-2457(00)00502-2; Ziemann Ulf, 2006, Suppl Clin Neurophysiol, V59, P19; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028	122	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197505	10.1371/journal.pone.0197505	http://dx.doi.org/10.1371/journal.pone.0197505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856758	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800026
J	Mogren, I; Lindqvist, M; Petersson, K; Nilses, C; Small, R; Granasen, G; Edvardsson, K				Mogren, Ingrid; Lindqvist, Maria; Petersson, Kerstin; Nilses, Carin; Small, Rhonda; Granasen, Gabriel; Edvardsson, Kristina			Maternal height and risk of caesarean section in singleton births in Sweden D-A population-based study using data from the Swedish Pregnancy Register 2011 to 2016	PLOS ONE			English	Article							DELIVERY; WEIGHT; LABOR; ASTHMA; IMPACT; RATES; WOMEN; SIZE; AGE	Caesarean section (CS) has short and long term adverse health consequences, and should therefore only be undertaken when necessary. Risk factors such as maternal age, maternal body mass index (BMI) and fetal weight have been extensively investigated in relation to CS, but the significance of maternal height has been less explored in Sweden. The aim was to investigate the significance of maternal height on risk of CS in a representative, population-based sample from Sweden, also taking into account confounders. Data on singleton births in the Swedish Pregnancy Register 2011 to 2016 were collected, including women with heights of 140 cm and above, constituting a sample of 581,844 women. Data were analysed with epidemiological and biostatistical methods. Mean height was 166.1 cm. Women born outside Sweden were significantly shorter than women born in Sweden (162.8 cm vs. 167.1 cm, p < 0.001). There was a decreasing risk of CS with increasing maternal height. This effect remained after adjustment for other risk factors for CS such as maternal age, BMI, gestational age, parity, high birth weight and country of birth. Frequency of CS was higher among women born outside Sweden compared with Swedish-born women (17.3% vs. 16.0%), however, in a multiple regression model country of birth outside Sweden diminished as a risk factor for CS. Maternal height of 178-179 cm was associated with the lowest risk of CS (OR = 0.76, CI95% 0.71-0.81), whereas height below 160 cm explained 7% of CS cases. BMI and maternal age are established factors involved in clinical assessments related to birth, and maternal height should increasingly enjoy a similar status in these considerations. Moreover, when healthcare professionals are counselling pregnant women, taller stature should be more emphasized as a positive indicator for successful vaginal birth to increase pregnant women's confidence in giving birth vaginally, with possible positive impacts for lowering CS rates.	[Mogren, Ingrid; Lindqvist, Maria; Petersson, Kerstin; Edvardsson, Kristina] Umea Univ, Dept Clin Sci, Obstet & Gynecol, Umea, Sweden; [Mogren, Ingrid; Small, Rhonda; Edvardsson, Kristina] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Nilses, Carin] Vasternorrland Cty Hosp, Dept Obstet & Gynecol, Sundsvall, Sweden; [Small, Rhonda] Karolinska Inst, Div Reprod Hlth, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Granasen, Gabriel] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden	Umea University; La Trobe University; Karolinska Institutet; Umea University	Mogren, I (corresponding author), Umea Univ, Dept Clin Sci, Obstet & Gynecol, Umea, Sweden.; Mogren, I (corresponding author), La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia.	ingrid.mogren@umu.se	Edvardsson, Kristina/AAX-4810-2020; Edvardsson, Kristina/GOP-2054-2022	Edvardsson, Kristina/0000-0001-6883-3664; Edvardsson, Kristina/0000-0001-6883-3664; Mogren, Ingrid/0000-0003-2985-1135; Small, Rhonda/0000-0003-0345-4676; Granasen, Gabriel/0000-0003-0081-1156	Umea University	Umea University	This work was supported from Umea University to IM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, LANCET, V2, P436; Basso O, 2004, INT J EPIDEMIOL, V33, P858, DOI 10.1093/ije/dyh116; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Betran AP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0043-6; BRESLER JB, 1962, AM J PHYS ANTHROPOL, V20, P515, DOI 10.1002/ajpa.1330200412; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cedergren MI, 2007, OBSTET GYNECOL, V110, P759, DOI 10.1097/01.AOG.0000279450.85198.b2; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; CHALMERS B, 1992, BRIT J OBSTET GYNAEC, V99, P709, DOI 10.1111/j.1471-0528.1992.tb13867.x; Chan BCP, 2009, J OBSTET GYNAECOL RE, V35, P307, DOI 10.1111/j.1447-0756.2008.00939.x; Chan BCP, 2009, AUST NZ J OBSTET GYN, V49, P388, DOI 10.1111/j.1479-828X.2009.01006.x; Cnattingius R, 1998, OBSTET GYNECOL, V92, P501, DOI 10.1016/S0029-7844(98)00244-0; Conner P, 2015, ACTA OBSTET GYN SCAN, V94, P368, DOI 10.1111/aogs.12579; Derraik JGB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154304; Desai M, 2015, INT J OBESITY, V39, P633, DOI 10.1038/ijo.2015.13; Dickey RP, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.052; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004224.pub3; Edwards MO, 2013, PAEDIATR RESPIR REV, V14, P29, DOI 10.1016/j.prrv.2012.02.002; Han Z, 2012, J OBSTET GYNAECOL CA, V34, P721, DOI 10.1016/S1701-2163(16)35337-3; HARPER DM, 1995, ARCH GYNECOL OBSTET, V256, P67, DOI 10.1007/s004040050071; Johnson CC, 2017, TRANSL RES, V179, P60, DOI 10.1016/j.trsl.2016.06.010; KAPPEL B, 1987, ACTA OBSTET GYN SCAN, V66, P153, DOI 10.3109/00016348709083038; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Khunpradit S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005528.pub2; Kirchengast S., 2007, ACTA MED LITU, V14, P1; Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029; Lavender T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004660.pub3; Liljestrom L, 2018, ACTA OBSTET GYN SCAN, V97, P615, DOI 10.1111/aogs.13316; Liston WA, 2003, J ROY SOC MED, V96, P559, DOI 10.1258/jrsm.96.11.559; MAHMOOD TA, 1988, BMJ-BRIT MED J, V297, P515, DOI 10.1136/bmj.297.6647.515; McGuinness BJ, 1999, AUST NZ J OBSTET GYN, V39, P152, DOI 10.1111/j.1479-828X.1999.tb03360.x; Merchant KM, 2001, BRIT J OBSTET GYNAEC, V108, P689, DOI 10.1111/j.1471-0528.2001.00181.x; Merry L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-27; Myklestad K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-33; O'Shea TM, 2010, SEMIN PERINATOL, V34, P281, DOI 10.1053/j.semperi.2010.03.008; Ogawa K, 2017, PAEDIATR PERINAT EP, V31, P198, DOI 10.1111/ppe.12351; Peregrine E, 2006, OBSTET GYNECOL, V107, P227, DOI 10.1097/01.AOG.0000196508.11431.c0; Perkins JM, 2016, NUTR REV, V74, P149, DOI 10.1093/nutrit/nuv105; Petersson K, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1165-8; Petersson K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0613-2; Petersson K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-364; Polzlberger E, 2017, J BIOSOC SCI, V49, P392, DOI 10.1017/S0021932016000493; Prasad M, 2002, J Obstet Gynaecol, V22, P513, DOI 10.1080/0144361021000003654; READ AW, 1994, AM J PUBLIC HEALTH, V84, P37, DOI 10.2105/AJPH.84.1.37; Sevelsted A, 2016, J PEDIATR-US, V171, P38, DOI 10.1016/j.jpeds.2015.12.066; Shachar BZ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.005; Stephansson O, 2018, ACTA OBSTET GYN SCAN, V97, P466, DOI 10.1111/aogs.13266; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Sumikura H, 2016, J ANESTH, V30, P268, DOI 10.1007/s00540-015-2099-4; Zetterstrom K, 2007, BJOG-INT J OBSTET GY, V114, P319, DOI 10.1111/j.1471-0528.2006.01231.x; Zhang G, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001865	51	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198124	10.1371/journal.pone.0198124	http://dx.doi.org/10.1371/journal.pone.0198124			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813118	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800045
J	Blanco, RY; Loureiro, CL; Villalba, JA; Sulbaran, YF; Maes, M; de Waard, JH; Rangel, HR; Jaspe, RC; Pujol, FH				Blanco, Ruth Y.; Loureiro, Carmen L.; Villalba, Julian A.; Sulbaran, Yoneira F.; Maes, Mailis; de Waard, Jacobus H.; Rangel, Hector R.; Jaspe, Rossana C.; Pujol, Flor H.			Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela	PLOS ONE			English	Article							GENETIC DIVERSITY; SURFACE-ANTIGEN; LIVER-DISEASE; BLOOD-DONORS; AMERINDIANS; MUTATIONS; GENOTYPES; EPIDEMIOLOGY; PROTEIN; IMPACT	Prevalence and molecular epidemiology studies for hepatitis B (HBV) and C (HCV) virus are scarce in Warao Amerindians from Venezuela, where an epidemic of human immunodeficiency virus type 1 (HIV-1) has recently been documented. To carry out a molecular epidemiology analysis of hepatitis B (HBV) and C (HCV) virus in Warao individuals from the Delta Amacuro State of Venezuela. A total of 548 sera were tested for serological and molecular markers for HBV and HCV. The prevalence of active infection (presence of HBV surface antigen, HBsAg), exposure to HBV (presence of Antibody to HBV core antigen, anti-HBc) and anti-HCV, was 1.8%, 13% and 0% respectively. HBV exposure was significantly lower in men below 18 years old and also lower than rates previously reported in other Amerindian communities from Venezuela. Thirty one percent (31%, 25/80) of individuals without evidence of HBV infection exhibited anti-HBs titer >= 10U.I/ml, being significantly more frequent in individuals younger than 20 years. A higher HBV exposure was observed among HIV-1 positive individuals (33% vs 11%, p<0.005). A high prevalence of occult HBV infection was also observed (5.6%, 11/195). Phylogenetic analysis of S gene and complete HBV genomes showed that F3 is the only circulating subgenotype, different from the F2 subgenotype found in 1991 in this population. These results suggest a recent introduction of subgenotype F3, with a low divergence among the isolates. These results highlight the importance of molecular epidemiology studies for viral control, and support the effectiveness of vaccination in reducing transmission of HBV.	[Blanco, Ruth Y.; Loureiro, Carmen L.; Sulbaran, Yoneira F.; Rangel, Hector R.; Jaspe, Rossana C.; Pujol, Flor H.] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Virol Mol, Caracas, Venezuela; [Villalba, Julian A.; Maes, Mailis; de Waard, Jacobus H.] Univ Cent Venezuela, Inst Biomed, Lab TB, Caracas, Venezuela; [Villalba, Julian A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [Maes, Mailis] Univ Cambridge, Dept Med, Cambridge, England	Venezuelan Institute Science Research; University of Central Venezuela; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Cambridge	Jaspe, RC (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Virol Mol, Caracas, Venezuela.	rossanajaspe@gmail.com	de Waard, Jacobus/AGM-8709-2022; Rangel, Hector R/E-5575-2010; Villalba, Julian/AAK-4222-2020; Pujol, Flor H/E-5687-2010	Rangel, Hector R/0000-0001-5937-9690; Villalba, Julian/0000-0001-9230-8747; de Waard, Jacobus H./0000-0003-4118-1015; Maes, Mailis/0000-0002-0266-6557; Pujol, Flor H/0000-0001-6086-6883; Blanco, Ruth/0000-0001-5676-1130; Jaspe, Rossana/0000-0002-4816-1378	Institute Venezolano de Investigaciones Cientificas, Venezuela [650, 1108]	Institute Venezolano de Investigaciones Cientificas, Venezuela	This work was supported by Grants 650 to FHP and 1108 to RCJ from Institute Venezolano de Investigaciones Cientificas, Venezuela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar José Ivan, 2002, Braz J Infect Dis, V6, P269, DOI 10.1590/S1413-86702002000500010; Aguilar MS, 2001, ANN TROP MED PARASIT, V95, P187, DOI 10.1080/00034980120042944; Allard O, 2013, SEXOLOGIA Y SOC, V19, P64; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017; Ariza H, 2009, REV PANAM INFECTOL, V11, P27; Ayala Lafee C, 2008, MUJER WARAO RECOLECT; Bautista-Amorocho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114272; Biswas S, 2013, J VIROL, V87, P7882, DOI 10.1128/JVI.00710-13; BLITZDORFMAN L, 1994, J MED VIROL, V43, P287, DOI 10.1002/jmv.1890430317; Briggs C., 2002, STORIES TIME CHOLERA; Briggs Charles L., 2008, POETICAS VIDA ESPACI; Cardona Chorro NE, 2015, B VENEZ INFECTOL, V26, P131; Cardona NE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-527; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chemin I, 2005, J CLIN VIROL, V34, pS15, DOI 10.1016/S1386-6532(05)80005-8; Coimbra CEA, 1996, SOC SCI MED, V42, P1735, DOI 10.1016/0277-9536(95)00295-2; Covolo L, 2013, DIGEST LIVER DIS, V45, P238, DOI 10.1016/j.dld.2012.09.021; de Paula VS, 2001, MEM I OSWALDO CRUZ, V96, P1123, DOI 10.1590/S0074-02762001000800016; Delfino CM, 2012, J CLIN VIROL, V54, P223, DOI 10.1016/j.jcv.2012.04.014; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; Devesa M, 2004, J MED VIROL, V72, P377, DOI 10.1002/jmv.20015; Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004; Duarte MC, 2010, TROP MED INT HEALTH, V15, P924, DOI 10.1111/j.1365-3156.2010.02560.x; El Chaar M, 2010, HEPATOLOGY, V52, P1600, DOI 10.1002/hep.23886; Flores J, 1989, BIONOTAS, V10, P34; Flores JDR, 1997, REV I NAC HIG RAFAEL, V28, P18; GUNTHER S, 1995, J VIROL, V69, P5437; Gutierrez C, 2004, J MED VIROL, V73, P200, DOI 10.1002/jmv.20076; Gutierrez C, 1999, CLIN DIAGN LAB IMMUN, V6, P768; Hollinger FB, 2010, J VIRAL HEPATITIS, V17, P1, DOI 10.1111/j.1365-2893.2009.01245.x; Hu XL, 2000, P NATL ACAD SCI USA, V97, P1661, DOI 10.1073/pnas.97.4.1661; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Instituto Nacional de Estadistica, 2011, 13 CENS NAC POBL VIV; Jaspe RC, 2014, J MED MICROBIOL, V63, P1099, DOI 10.1099/jmm.0.067496-0; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Layrisse M., 1977, ANTHROPOLOGICA, V46-48, P45; Maes M, 2008, TUBERCULOSIS, V88, P490, DOI 10.1016/j.tube.2008.04.003; Martinez AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103545; Monsalve-Castillo F, 2008, CAD SAUDE PUBLICA, V24, P1183, DOI 10.1590/S0102-311X2008000500028; Nakano T, 2001, J GEN VIROL, V82, P359, DOI 10.1099/0022-1317-82-2-359; Navas MC, 2013, AM SOC VIR M, pP31; Orlando R, 2015, EUR J CLIN MICROBIOL, V34, P1059, DOI 10.1007/s10096-015-2341-x; Puche ML, 2016, INVEST CLIN, V57, P38; Pujol FH, 2016, JSM HEPAT, V1, P1004; Pujol FH, 2000, ACTA CIENT SOC VENEZ, V6, P5; Pujol FH, 2007, J CLIN GASTROENTEROL, V41, P518, DOI 10.1097/01.mcg.0000248010.55149.ce; Rangel HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040626; Rojo AEV, 2000, MANIFESTACIONES RELI; Squadrito G, 2013, J HEPATOL, V59, P696, DOI 10.1016/j.jhep.2013.05.043; TORRES JR, 1991, REV INFECT DIS, V13, P52; Trigo C, 2016, J VIRAL HEPATITIS, V23, P1027, DOI 10.1111/jvh.12583; Verhagen LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077581; Villalba JA, 2013, AIDS, V27, P1783, DOI 10.1097/QAD.0b013e3283601bdb; WHO, 2017, WHO PUBLISHES LIST B; Zampino R, 2015, WORLD J GASTROENTERO, V21, P11941, DOI 10.3748/wjg.v21.i42.11941; Zhu HL, 2016, WORLD J GASTROENTERO, V22, P3531, DOI 10.3748/wjg.v22.i13.3531	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197662	10.1371/journal.pone.0197662	http://dx.doi.org/10.1371/journal.pone.0197662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799873	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400019
J	Shimada, Y; Shimura, H; Tanaka, R; Yamashiro, K; Koike, M; Uchiyama, Y; Urabe, T; Hattori, N				Shimada, Yoshiaki; Shimura, Hideki; Tanaka, Ryota; Yamashiro, Kazuo; Koike, Masato; Uchiyama, Yasuo; Urabe, Takao; Hattori, Nobutaka			Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HEAT-SHOCK PROTEINS; ENHANCED HEMORRHAGIC TRANSFORMATION; FREE-RADICAL SCAVENGER; EXTRACELLULAR HSP27; ARTERY OCCLUSION; CELL-DEATH; HEAT-SHOCK-PROTEIN-27; INJURY; MODEL	Loss of integrity of the blood-brain barrier (BBB) in ischemic stroke victims initiates a devastating cascade of events causing brain damage. Maintaining the BBB is important to preserve brain function in ischemic stroke. Unfortunately, recombinant tissue plasminogen activator (tPA), the only effective fibrinolytic treatment at the acute stage of ischemic stroke, also injures the BBB and increases the risk of brain edema and secondary hemorrhagic transformation. Thus, it is important to identify compounds that maintain BBB integrity in the face of ischemic injury in patients with stroke. We previously demonstrated that intravenously injected phosphorylated recombinant heat shock protein 27 (prHSP27) protects the brains of mice with transient middle cerebral artery occlusion (tMCAO), an animal stroke model. Here, we determined whether prHSP27, in addition to attenuating brain injury, also decreases BBB damage in hyperglycemic tMCAO mice that had received tPA. After induction of hyperglycemia and tMCAO, we examined 4 treatment groups: 1) bovine serum albumin (BSA), 2) prHSP27, 3) tPA, 4) tPA plus prHSP27. We examined the effects of prHSP27 by comparing the BSA and prHSP27 groups and the tPA and tPA plus prHSP27 groups. Twenty-four hours after injection, prHSP27 reduced infarct volume, brain swelling, neurological deficits, the loss of microvessel proteins and endothelial cell walls, and mortality. It also reduced the rates of hemorrhagic transformation, extravasation of endogenous IgG, and MMP-9 activity, signs of BBB damage. Therefore, prHSP27 injection attenuated brain damage and preserved the BBB in tPA-injected, hyperglycemic tMCAO experimental stroke model mice, in which the BBB is even more severely damaged than in simple tMCAO mice. The attenuation of brain damage and BBB disruption in the presence of tPA suggests the effectiveness of prHSP27 and tPA as a combination therapy. prHSP27 may be a novel therapeutic agent for ischemic stroke patients whose BBBs are injured following tPA injections.	[Shimada, Yoshiaki; Shimura, Hideki] Juntendo Univ, Dept Neurol, Urayasu Hosp, Chiba, Japan; [Shimura, Hideki] Juntendo Univ, Sch Med, Inst Environm & Gender Specif Med, Chiba, Japan; [Tanaka, Ryota; Yamashiro, Kazuo] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Dept Cell Biol & Neurosci, Sch Med, Tokyo, Japan; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Shimura, H (corresponding author), Juntendo Univ, Dept Neurol, Urayasu Hosp, Chiba, Japan.; Shimura, H (corresponding author), Juntendo Univ, Sch Med, Inst Environm & Gender Specif Med, Chiba, Japan.	miurashimura@yahoo.co.jp	Koike, Masato/F-9584-2010; Hattori, Nobutaka/ACR-0069-2022; shimura, hideki/AAA-2864-2020	Koike, Masato/0000-0002-3174-5684; 				Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Badin RA, 2006, J CEREBR BLOOD F MET, V26, P371, DOI 10.1038/sj.jcbfm.9600190; Badin RA, 2009, J CEREBR BLOOD F MET, V29, P254, DOI 10.1038/jcbfm.2008.106; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Efthymiou CA, 2004, BASIC RES CARDIOL, V99, P392, DOI 10.1007/s00395-004-0483-6; Garcia-Yebenes I, 2011, STROKE, V42, P196, DOI 10.1161/STROKEAHA.110.600452; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Huang JY, 2013, BRAIN RES, V1535, P148, DOI 10.1016/j.brainres.2013.08.057; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jin CH, 2014, MOL MED, V20, P280, DOI 10.2119/molmed.2014.00058; KATO H, 1995, NEUROSCIENCE, V68, P65, DOI 10.1016/0306-4522(95)00141-5; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Kuroki T, 2016, STROKE, V47, P1328, DOI 10.1161/STROKEAHA.116.012934; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Leak RK, 2013, CNS NEUROL DISORD-DR, V12, P325, DOI 10.2174/1871527311312030006; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Ma XL, 2014, FASEB J, V28, P594, DOI 10.1096/fj.13-230417; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Platten M, 2012, HAND CLINIC, V104, P53, DOI 10.1016/B978-0-444-52138-5.00005-0; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shimada Y, 2014, NEUROSCIENCE, V278, P113, DOI 10.1016/j.neuroscience.2014.07.073; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Soejima Y, 2013, EXP NEUROL, V247, P737, DOI 10.1016/j.expneurol.2013.03.019; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Teramoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066001; Thuringer D, 2013, FASEB J, V27, P4169, DOI 10.1096/fj.12-226977; Ueno Y, 2009, NEUROSCIENCE, V162, P317, DOI 10.1016/j.neuroscience.2009.04.065; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; Wang LX, 2013, ANN NEUROL, V73, P189, DOI 10.1002/ana.23762; Xiao F, 2002, ACAD EMERG MED, V9, P933, DOI 10.1111/j.1553-2712.2002.tb02196.x	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198039	10.1371/journal.pone.0198039	http://dx.doi.org/10.1371/journal.pone.0198039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795667	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300121
J	Wen, JP; Hao, J; Zhang, Y; Liang, YB; Li, SZ; Wang, FH; Duan, XR; Yang, XH; Cao, K; Wang, BS; Lu, XX; Wang, NL				Wen, Jiangping; Hao, Jie; Zhang, Ye; Liang, Yuanbo; Li, Sizhen; Wang, Fenghua; Duan, Xinrong; Yang, Xiaohui; Cao, Kai; Wang, Bingsong; Lu, Xinxin; Wang, Ningli			Fresh fruit consumption and risk of incident albuminuria among rural Chinese adults: A village-based prospective cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; DIETARY PATTERNS; COLLABORATIVE METAANALYSIS; VEGETABLE CONSUMPTION; DIABETES-MELLITUS; ALL-CAUSE; MICROALBUMINURIA; POPULATION; PREVALENCE	Background Recent studies showed that increased fresh fruit consumption is significantly associated with lower risks of diabetes, hypertension, and cardiovascular disease (CVD); other studies suggested that albuminuria is associated with diabetes, hypertension, and CVD. Therefore, we hypothesized that lower fresh fruit consumption is associated with higher risk of incident albuminuria among Chinese adults in rural areas, where fresh fruit consumption level is very low and prevalence of albuminuria is high. Methods We tested the hypothesis in a village-based cohort study of 3574 participants aged >= 30 years from the Handan Eye Study conducted from 2006 to 2013. Albuminuria was defined as urinary albumin-to-creatinine ratio >= 30 mg/g. Results Overall, 35.4% of the participants never or rarely consumed fresh fruits, and 33.9, 21.6, and 9.1% consumed fresh fruits 1-3 times/month, 1-2 times/week, and >= 3 times/week, respectively. During a median follow-up period of 5.6 years, albuminuria developed in 17.6% (n = 629) of the participants. Compared with participants who consumed fresh fruits >= 3 times/ week, the multivariable adjustment odds ratios (ORs) for incident albuminuria associated with fruit consumption 1-2 times/week, 1-3 times/month, and no or rare consumption were 1.58 (95% confidence intervals (CI), 1.05-2.40), 1.74 (95% CI, 1.17-2.58), and 1.78 (95% CI, 1.20-2.64), respectively. After excluding participants with diabetes, the association remained significant. Conclusions Lower fresh fruit consumption was significantly associated with higher risk of incident albuminuria, and fresh fruit consumption frequency could be an essential intervention target to prevent albuminuria in rural China.	[Wen, Jiangping; Lu, Xinxin] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing, Peoples R China; [Hao, Jie; Zhang, Ye; Wang, Fenghua; Duan, Xinrong; Yang, Xiaohui; Cao, Kai; Wang, Bingsong; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Hao, Jie; Yang, Xiaohui; Cao, Kai; Wang, Bingsong; Wang, Ningli] Beijing Eye Inst, Beijing, Peoples R China; [Liang, Yuanbo] Wenzhou Med Univ, Affiliated Eye Hosp, Clin & Epidemiol Res Ctr, Wenzhou, Peoples R China; [Li, Sizhen] Nanjing Aier Eye Hosp, Nanjing, Jiangsu, Peoples R China	Capital Medical University; Capital Medical University; Wenzhou Medical University	Lu, XX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing, Peoples R China.; Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.; Wang, NL (corresponding author), Beijing Eye Inst, Beijing, Peoples R China.	luxinxin2009@126.com; wningli@vip.163.com	Zhang, Ye/AAF-2989-2020		National Basic Research Program of China (973 Program); Ministry of Science and Technology of China [2007C6512201]; Key Technologies R&D Program from Bureau of Science and Technology of Handan City [2006-10903]; Foundation of Beijing Tongren Hospital [2005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Key Technologies R&D Program from Bureau of Science and Technology of Handan City; Foundation of Beijing Tongren Hospital	This study was supported by the National Basic Research Program of China (973 Program), the Ministry of Science and Technology of China (grant 2007C6512201), and the Key Technologies R&D Program from Bureau of Science and Technology of Handan City (no. 2006-10903). Additional support was provided by the Foundation of Beijing Tongren Hospital (grant 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Borgi L, 2016, HYPERTENSION, V67, P288, DOI 10.1161/HYPERTENSIONAHA.115.06497; Chang A, 2013, AM J KIDNEY DIS, V62, P267, DOI 10.1053/j.ajkd.2013.02.363; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Du HD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002279; Du HD, 2016, NEW ENGL J MED, V374, P1332, DOI 10.1056/NEJMoa1501451; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493; Hu D, 2014, STROKE, V45, P1613, DOI 10.1161/STROKEAHA.114.004836; Jacobs DR, 2009, AM J KIDNEY DIS, V53, P638, DOI 10.1053/j.ajkd.2008.10.048; Jiang LP, 2010, NEPHRON CLIN PRACT, V114, pC295, DOI 10.1159/000276582; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang YB, 2009, OPHTHAL EPIDEMIOL, V16, P115, DOI 10.1080/09286580902738159; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; National Bureau of Statistics of the People's Republic of China, 2007, CHIN STAT YB 2007; Nettleton JA, 2008, AM J CLIN NUTR, V87, P1825, DOI 10.1093/ajcn/87.6.1825; O'Seaghdha CM, 2010, AM J KIDNEY DIS, V56, P852, DOI 10.1053/j.ajkd.2010.04.013; PEDRINELLI R, 1994, LANCET, V344, P14, DOI 10.1016/S0140-6736(94)91047-2; ROWE DJF, 1990, ANN CLIN BIOCHEM, V27, P297, DOI 10.1177/000456329002700404; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	32	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197917	10.1371/journal.pone.0197917	http://dx.doi.org/10.1371/journal.pone.0197917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795700	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300096
J	Wang, KX; Ji, WX; Yu, YF; Li, ZM; Niu, XM; Xia, WL; Lu, S				Wang, Kaixuan; Ji, Wenxiang; Yu, Yongfeng; Li, Ziming; Niu, Xiaomin; Xia, Weiliang; Lu, Shun			FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer	ONCOGENE			English	Article							FACTOR RECEPTOR 1; FGFR1 AMPLIFICATION; GROWTH; SOX2; STEM; INHIBITOR; MECHANISMS; SURVIVAL; GENE; EMT	Epithelial-mesenchymal transition (EMT) is an important process for cancer metastasis, drug resistance, and cancer stem cells. Activation of fibroblast growth factor receptor 1 (FGFR1) was found to promote EMT and metastasis in prostate and breast cancers, but the effects and mechanisms in lung cancer was unclear. In this study, we aimed to explore whether and how activation of FGFR1 promotes EMT and metastasis in FGFR1-amplified lung cancer. We show that activation of FGFR1 by its ligand fibroblast growth factor 2 (FGF2) promoted proliferation, EMT, migration, and invasion in FGFR1-amplified lung cancer cell lines H1581 and DMS114, whereas inhibition of FGFR1 suppressed these processes. FGFR1 activation upregulated expression of Sry-related HMG box 2 (SOX2) by downstream phosphorylated ERK1/2; moreover, the upregulation of SOX2 by autophosphorylation variant ERK2_R67S plasmid transfection was not suppressed by FGFR1 inhibitor AZD4547 or MEK/ERK inhibitor AZD6244 in vitro. And SOX2 expression was also significantly upregulated in ERK2_R67S lentivirus-transfected stable cell lines in vivo. Overexpression of SOX2 promoted cell proliferation, EMT, migration, and invasion. Importantly, activation of FGFR1 could not promote these processes in SOX2-silenced stable cell lines. In orthotopic and subcutaneous lung cancer xenograft models, inhibition of FGFR1 suppressed tumor growth, SOX2 expression, EMT, and metastasis in vivo; however, these processes caused by SOX2-overexpressing stable cell lines were not suppressed by FGFR1 inhibition. Higher expression of FGFR1 and SOX2 were positively correlated, and both were associated with shorter survival in lung cancer patients. In conclusion, our findings reveal that activation of FGFR1 promotes cell proliferation, EMT, and metastasis by the newly defined FGFR1-ERK1/2-SOX2 axis in FGFR1-amplified lung cancer.	[Wang, Kaixuan; Ji, Wenxiang; Yu, Yongfeng; Li, Ziming; Niu, Xiaomin; Lu, Shun] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, West Huaihai Rd 241, Shanghai 200030, Peoples R China; [Wang, Kaixuan; Xia, Weiliang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Huashan Rd 1954, Shanghai 200030, Peoples R China; [Wang, Kaixuan; Xia, Weiliang] Shanghai Jiao Tong Univ, MedX Res Inst, Huashan Rd 1954, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, S (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, West Huaihai Rd 241, Shanghai 200030, Peoples R China.; Xia, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Huashan Rd 1954, Shanghai 200030, Peoples R China.; Xia, WL (corresponding author), Shanghai Jiao Tong Univ, MedX Res Inst, Huashan Rd 1954, Shanghai 200030, Peoples R China.	wlxia@sjtu.edu.cn; shunlu@sjtu.edu.cn	Lu, Shun/ABF-8341-2021; XIA, WEILIANG/AEA-0835-2022	XIA, WEILIANG/0000-0002-0256-4219	National Key R&D Program of China [2016YFC1303300]; National Natural Science Foundation of China [81672272, 81773115]; National Key Grant of China [2016YFC0906400]; Shanghai Health & Family Planning Commission [201540365]; Shanghai Municipal Science & Technology Commission [17431906103]; Shanghai Scientific Research Projects [14140902800]; AstraZeneca	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Grant of China; Shanghai Health & Family Planning Commission; Shanghai Municipal Science & Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Scientific Research Projects; AstraZeneca(AstraZeneca)	This work was funded by the National Key R&D Program of China (2016YFC1303300 to S.L.), the National Natural Science Foundation of China (81672272 to S.L. and 81773115 to W.X.), the National Key Grant of China (2016YFC0906400 to W.X.), the Key Project of Shanghai Health & Family Planning Commission (201540365 to S.L.), Shanghai Municipal Science & Technology Commission Research Project (17431906103 to S.L.), and Shanghai Scientific Research Projects (14140902800 to S.L.) We thank Wangxi Hai and Med-X Ruijin Hospital Micro PET/CT Research Center for the microCT scan and analysis. We thank AstraZeneca Pharmaceutical Company for kindly supply of AZD4547 and AstraZeneca Research Funding.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Adachi Y, 2017, CARCINOGENESIS, V38, P1063, DOI 10.1093/carcin/bgx091; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Brewer JR, 2016, GENE DEV, V30, P751, DOI 10.1101/gad.277137.115; Brown WS, 2016, MOL CANCER THER, V15, P2096, DOI 10.1158/1535-7163.MCT-16-0136; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen F, 2017, ONCOGENE, V36, P1384, DOI 10.1038/onc.2016.303; Chen YJ, 2014, BIOMATERIALS, V35, P10058, DOI 10.1016/j.biomaterials.2014.09.003; Datta J, 2017, MOL CANCER THER, V16, P614, DOI 10.1158/1535-7163.MCT-15-1010; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Goke F, 2015, CLIN CANCER RES, V21, P4356, DOI 10.1158/1078-0432.CCR-14-3357; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanna N, 2017, J CLIN ONCOL, V35, P3484, DOI 10.1200/JCO.2017.74.6065; Hu YP, 2016, ONCOTARGET, V7, P87124, DOI 10.18632/oncotarget.13547; Jakobsen KR, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.17; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Ji WX, 2016, ONCOTARGET, V7, P15118, DOI 10.18632/oncotarget.7701; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katoh M, 2016, TRENDS PHARMACOL SCI, V37, P1081, DOI 10.1016/j.tips.2016.10.003; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kim HR, 2017, ANN ONCOL, V28, P1250, DOI 10.1093/annonc/mdx098; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kim M, 2017, ONCOGENE, V36, P5199, DOI 10.1038/onc.2017.4; Kotani H, 2016, ONCOGENE, V35, P3587, DOI 10.1038/onc.2015.426; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lewis DR, 2014, CANCER-AM CANCER SOC, V120, P2883, DOI 10.1002/cncr.28749; Lim SH, 2016, CANCER-AM CANCER SOC, V122, P3024, DOI 10.1002/cncr.30135; Maehara O, 2017, CARCINOGENESIS, V38, P1073, DOI 10.1093/carcin/bgx095; Malchers F, 2017, CLIN CANCER RES, V23, P5527, DOI 10.1158/1078-0432.CCR-17-0478; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Mandal R, 2016, ONCOGENE, V35, P2547, DOI 10.1038/onc.2015.329; Nogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048; Paik PK, 2017, CLIN CANCER RES, V23, P5366, DOI 10.1158/1078-0432.CCR-17-0645; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Peng L, 2014, NANOMED-NANOTECHNOL, V10, P1497, DOI 10.1016/j.nano.2014.03.016; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schultheis AM, 2014, MODERN PATHOL, V27, P214, DOI 10.1038/modpathol.2013.141; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singleton KR, 2015, CANCER RES, V75, P4398, DOI 10.1158/0008-5472.CAN-15-0509; Sousa V, 2016, VIRCHOWS ARCH, V469, P173, DOI 10.1007/s00428-016-1954-5; Tan Q, 2016, ONCOTARGET, V7, P18394, DOI 10.18632/oncotarget.7817; Taniguchi J, 2017, NUCLEIC ACIDS RES, V45, P9219, DOI 10.1093/nar/gkx693; Terry S, 2017, MOL ONCOL, V11, P824, DOI 10.1002/1878-0261.12093; Thomas A, 2014, J THORAC ONCOL, V9, P567, DOI 10.1097/JTO.0000000000000089; Toschi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095303; Tripathi SC, 2017, CANCER RES, V77, P4414, DOI 10.1158/0008-5472.CAN-16-2874; Wang L, 2016, ONCOGENE, V35, P867, DOI 10.1038/onc.2015.141; Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yuan H, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0534-0; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694	68	78	81	1	29	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5340	5354		10.1038/s41388-018-0311-3	http://dx.doi.org/10.1038/s41388-018-0311-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29858603				2022-12-26	WOS:000445759700007
J	Chen, J; Li, WJ; Cui, K; Ji, KY; Xu, SX; Xu, Y				Chen, Jian; Li, Wenjuan; Cui, Ke; Ji, Kaiyuan; Xu, Shuxiang; Xu, Yang			Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway	ONCOGENE			English	Article							II-BETA; COLORECTAL-CANCER; STRAND BREAKS; CELLS; ANTICANCER; INHIBITION; DOXORUBICIN; PROTECTS; TARGET	Cancer chemotherapeutic agents such as doxorubicin are DNA damage inducers that also kill normal cells, making them highly toxic to cancer patients. To improve the efficacy and safety of chemotherapy, it is important to develop new chemotherapeutic agents that selectively kill cancer cells. Here we demonstrate that artemisitene (ATT), a natural derivative of the antimalarial drug artemisinin, selectively induces DNA double-stranded breaks (DSBs) and apoptosis in various human cancer cells by suppressing the expression of topoisomerases in human cancer cells. ATT effectively kills human cancer cells without apparent cytotoxicity on normal human cells or mouse liver and kidney. We discovered that c-Myc induces the expression of topoisomerases to prevent accumulation of DNA damage in human cancer cells. ATT selectively destabilizes c-Myc in human cancer cells by promoting the ubiquitination of c-Myc through the specific induction of the c-Myc E3 ligase NEDD4. Therefore, ATT represents a promising new chemotherapeutic drug candidate that can eliminate human cancer cells with minimized cytotoxic effects on normal cells.	[Chen, Jian; Ji, Kaiyuan; Xu, Shuxiang; Xu, Yang] Southern Med Univ, Sch Basic Med Sci, Canc Res Inst, Guangdong Prov Key Lab Tumor Immunotherapy, Guangzhou 510515, Guangdong, Peoples R China; [Li, Wenjuan; Cui, Ke; Xu, Yang] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Acad Chinese Med Sci, Ctr Regenerat & Translat Med, Guangzhou 510632, Guangdong, Peoples R China; [Xu, Yang] Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA	Southern Medical University - China; Guangzhou University of Chinese Medicine; University of California System; University of California San Diego	Xu, Y (corresponding author), Southern Med Univ, Sch Basic Med Sci, Canc Res Inst, Guangdong Prov Key Lab Tumor Immunotherapy, Guangzhou 510515, Guangdong, Peoples R China.; Xu, Y (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Acad Chinese Med Sci, Ctr Regenerat & Translat Med, Guangzhou 510632, Guangdong, Peoples R China.; Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu		Xu, Yang/0000-0001-5574-921X; Chen, Jian/0000-0001-7535-6499	Postdoctoral Science Foundation of China [2015M582371]; NSFC [81430032, U1601222, 81502595]; Guangdong Provincial Key Laboratory of Cancer Immunotherapy; Guangzhou Key Laboratory of Tumor Immunology Research; Guangdong Provincial Key Special Science and Technology Project [2015B020225004]; Guangdong NSF Major basic research developmental project; California Institute for Regenerative Medicine	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Cancer Immunotherapy; Guangzhou Key Laboratory of Tumor Immunology Research; Guangdong Provincial Key Special Science and Technology Project; Guangdong NSF Major basic research developmental project; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	Wenjuan Li was supported by a fellowship from Postdoctoral Science Foundation of China (2015M582371). This study was supported by NSFC (nos. 81430032, U1601222, 81502595), Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Guangzhou Key Laboratory of Tumor Immunology Research, Guangdong Provincial Key Special Science and Technology Project (2015B020225004), Guangdong NSF Major basic research developmental project, and grants from California Institute for Regenerative Medicine.	Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bandi S, 2011, AM J PATHOL, V178, P161, DOI 10.1016/j.ajpath.2010.11.001; Bhandari A, 2017, J INVEST MED, V65, P311, DOI 10.1136/jim-2016-000229; Bollimpelli VS, 2017, ARCH BIOCHEM BIOPHYS, V633, P78, DOI 10.1016/j.abb.2017.06.021; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen WM, 2016, FASEB J, V30, P2500, DOI 10.1096/fj.201500109R; Chen Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11057; Choi WH, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030030; Chong CM, 2016, REDOX BIOL, V9, P50, DOI 10.1016/j.redox.2016.06.002; Chumduri C, 2013, CELL HOST MICROBE, V13, P746, DOI 10.1016/j.chom.2013.05.010; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Cuya SM, 2017, CANCER CHEMOTH PHARM, V80, P1, DOI 10.1007/s00280-017-3334-5; Damiani RM, 2016, ARCH TOXICOL, V90, P2063, DOI 10.1007/s00204-016-1759-y; Efferth T, 2011, PHYTOMEDICINE, V18, P959, DOI 10.1016/j.phymed.2011.06.008; Ezoe S, 2012, INT J ENV RES PUB HE, V9, P2444, DOI 10.3390/ijerph9072444; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Gilbert DC, 2012, BRIT J CANCER, V106, P18, DOI 10.1038/bjc.2011.498; Hoffman B, 1998, ONCOGENE, V17, P3351, DOI 10.1038/sj.onc.1202592; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Jadaun A, 2017, J PHOTOCH PHOTOBIO B, V167, P299, DOI 10.1016/j.jphotobiol.2017.01.010; Jiang JH, 2011, CANCER RES, V71, P5546, DOI 10.1158/0008-5472.CAN-10-3423; Kim EJ, 2017, TOXICOL APPL PHARM, V330, P84, DOI 10.1016/j.taap.2017.07.007; Kim J, 2017, ONCOGENE, V36, P6472, DOI 10.1038/onc.2017.265; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Lake BB, 2012, STEM CELLS, V30, P888, DOI 10.1002/stem.1054; Li T, 2012, INT IMMUNOPHARMACOL, V12, P144, DOI 10.1016/j.intimp.2011.11.004; Liu Q, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0654-3; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Matsumoto Y, 2005, J MED INVESTIG, V52, P41, DOI 10.2152/jmi.52.41; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ooko E, 2015, PHYTOMEDICINE, V22, P1045, DOI 10.1016/j.phymed.2015.08.002; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Posner GH, 2002, BIOORGAN MED CHEM, V10, P227, DOI 10.1016/S0968-0896(01)00270-X; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rubin EH, 2000, HUM PATHOL, V31, P631, DOI 10.1053/hupa.2000.8629; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singh S, 2012, FREE RADICAL BIO MED, V53, P1782, DOI 10.1016/j.freeradbiomed.2012.07.025; Slezakova S, 2017, ANTICANCER RES, V37, P5995, DOI 10.21873/anticanres.12046; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; Xu SM, 2016, PROTEIN CELL, V7, P684, DOI 10.1007/s13238-016-0297-y; Zhang P, 2010, BRIT J CANCER, V102, P862, DOI 10.1038/sj.bjc.6605572	44	18	19	2	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5079	5087		10.1038/s41388-018-0331-z	http://dx.doi.org/10.1038/s41388-018-0331-z			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29795406				2022-12-26	WOS:000444405300004
J	Kipper, K; Eremina, N; Marklund, E; Tubasum, S; Mao, GZ; Lehmann, LC; Elf, J; Deindl, S				Kipper, Kalle; Eremina, Nadja; Marklund, Emil; Tubasum, Sumera; Mao, Guanzhong; Lehmann, Laura Christina; Elf, Johan; Deindl, Sebastian			Structure-guided approach to site-specific fluorophore labeling of the lac repressor LacI	PLOS ONE			English	Article							DIFFUSION-DRIVEN MECHANISMS; PROTEIN-DNA COMPLEXES; ESCHERICHIA-COLI; LACTOSE REPRESSOR; SINGLE-MOLECULE; OPERATOR INTERACTION; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; QUATERNARY STRUCTURE; BINDING PARAMETERS	The lactose operon repressor protein LacI has long served as a paradigm of the bacterial transcription factors. However, the mechanisms whereby LacI rapidly locates its cognate binding site on the bacterial chromosome are still elusive. Single-molecule fluorescence imaging approaches are well suited for the study of these mechanisms but rely on a functionally compatible fluorescence labeling of LacI. Particularly attractive for protein fluorescence labeling are synthetic fluorophores due to their small size and favorable photophysical characteristics. Synthetic fluorophores are often conjugated to natively occurring cysteine residues using maleimide chemistry. For a site-specific and functionally compatible labeling with maleimide fluorophores, the target protein often needs to be redesigned to remove unwanted native cysteines and to introduce cysteines at locations better suited for fluorophore attachment. Biochemical screens can then be employed to probe for the functional activity of the redesigned protein both before and after dye labeling. Here, we report a mutagenesis- based redesign of LacI to enable a functionally compatible labeling with maleimide fluorophores. To provide an easily accessible labeling site in LacI, we introduced a single cysteine residue at position 28 in the DNA-binding headpiece of LacI and replaced two native cysteines with alanines where derivatization with bulky substituents is known to compromise the protein's activity. We find that the redesigned LacI retains a robust activity in vitro and in vivo, provided that the third native cysteine at position 281 is retained in LacI. In a total internal reflection microscopy assay, we observed individual Cy3-labeled LacI molecules bound to immobilized DNA harboring the cognate O-1 operator sequence, indicating that the dye-labeled LacI is functionally active. We have thus been able to generate a functional fluorescently labeled LacI that can be used to unravel mechanistic details of LacI target search at the single molecule level.	[Kipper, Kalle; Eremina, Nadja; Marklund, Emil; Tubasum, Sumera; Mao, Guanzhong; Lehmann, Laura Christina; Elf, Johan; Deindl, Sebastian] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Uppsala University	Deindl, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden.	sebastian.deindl@icm.uu.se	Tubasum, Sumera/AAF-6474-2020	Lehmann, Laura C./0000-0003-2518-5606; elf, johan/0000-0001-5522-1810; Marklund, Emil/0000-0002-1150-7304; Deindl, Sebastian/0000-0001-6807-8654	European Research Council (ERC Starting Grant) [714068]; Swedish Research Council [VR 2015-04568]; Knut and Alice Wallenberg Foundation (Wallenberg Academy Fellows program) [WAF 2014.0183]; SciLifeLab; European Research Council (ERC) Starting Grant	European Research Council (ERC Starting Grant)(European Research Council (ERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation (Wallenberg Academy Fellows program); SciLifeLab; European Research Council (ERC) Starting Grant(European Research Council (ERC))	The author(s) received funding for this work from the European Research Council (ERC Starting Grant 714068 to SD; https://erc.europa.eu), the Swedish Research Council (VR 2015-04568 to SD; https://www.vr.se), and the Knut and Alice Wallenberg Foundation (Wallenberg Academy Fellows program, WAF 2014.0183 to SD; http://kaw.wallenberg.org), and the SciLifeLab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Anton Sabantsev for discussions and Prune Leroy for providing us with the Lad deletion strain; S.D. acknowledges support from a European Research Council (ERC) Starting Grant, the Swedish Research Council (VR 2015-04568), the Knut and Alice Wallenberg Foundation (Wallenberg Academy Fellows program, WAF 2014.0183), and the SciLifeLab.	ALBERTI S, 1991, NEW BIOL, V3, P57; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BESSE M, 1986, EMBO J, V5, P1377, DOI 10.1002/j.1460-2075.1986.tb04370.x; BRENOWITZ M, 1991, J BIOL CHEM, V266, P1281; BROWN RD, 1979, J BIOL CHEM, V254, P5128; Caccianini L, 2015, FARADAY DISCUSS, V184, P393, DOI 10.1039/c5fd00112a; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P22206; CHEN J, 1992, J BIOL CHEM, V267, P13843; CHEN J, 1994, BIOCHEMISTRY-US, V33, P8728, DOI 10.1021/bi00195a014; Crawford R, 2013, BIOPHYS J, V105, P2439, DOI 10.1016/j.bpj.2013.09.057; CULARD F, 1981, NUCLEIC ACIDS RES, V9, P5175, DOI 10.1093/nar/9.19.5175; Daber R, 2007, J MOL BIOL, V370, P609, DOI 10.1016/j.jmb.2007.04.028; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5479, DOI 10.1021/bi00367a020; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5468, DOI 10.1021/bi00367a018; DALY TJ, 1986, BIOCHEMISTRY-US, V25, P5474, DOI 10.1021/bi00367a019; Datsenko KA, 2000, ONE STEP INACTIVATIO, V97, P6640, DOI [10.1073/pnas.120163297, DOI 10.1073/PNAS.120163297]; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dong FM, 1999, J MOL BIOL, V290, P653, DOI 10.1006/jmbi.1999.2902; DUNAWAY M, 1980, J BIOL CHEM, V255, P120; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; GEISLER N, 1976, P NATL ACAD SCI USA, V73, P3103, DOI 10.1073/pnas.73.9.3103; GEISLER N, 1978, FEBS LETT, V87, P215, DOI 10.1016/0014-5793(78)80335-4; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; HABER R, 1988, P NATL ACAD SCI USA, V85, P9683, DOI 10.1073/pnas.85.24.9683; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; JOVIN TM, 1977, NATURE, V269, P668, DOI 10.1038/269668a0; KANIA J, 1977, EUR J BIOCHEM, V79, P381, DOI 10.1111/j.1432-1033.1977.tb11819.x; KHOURY AM, 1991, J MOL BIOL, V219, P623, DOI 10.1016/0022-2836(91)90659-T; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Li GW, 2009, FEBS LETT, V583, P3979, DOI 10.1016/j.febslet.2009.11.035; MANDAL N, 1990, GENE DEV, V4, P410, DOI 10.1101/gad.4.3.410; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Monico C, 2014, J VIS EXP; Nikic I, 2015, NAT PROTOC, V10, P780, DOI 10.1038/nprot.2015.045; Nikic I, 2014, ANGEW CHEM INT EDIT, V53, P2245, DOI 10.1002/anie.201309847; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; OGATA RT, 1978, P NATL ACAD SCI USA, V75, P5851, DOI 10.1073/pnas.75.12.5851; OGORMAN RB, 1980, J BIOL CHEM, V255, P107; OGORMAN RB, 1980, J BIOL CHEM, V255, P100; Pace HC, 1997, TRENDS BIOCHEM SCI, V22, P334, DOI 10.1016/S0968-0004(97)01104-3; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Plass T, 2011, ANGEW CHEM INT EDIT, V50, P3878, DOI 10.1002/anie.201008178; PLATT T, 1972, P NATL ACAD SCI USA, V69, P897, DOI 10.1073/pnas.69.4.897; PLATT T, 1973, J BIOL CHEM, V248, P110; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Romanuka J, 2009, J MOL BIOL, V390, P478, DOI 10.1016/j.jmb.2009.05.022; Rutkauskas D, 2009, P NATL ACAD SCI USA, V106, P16627, DOI 10.1073/pnas.0904617106; SCHMITZ A, 1976, J BIOL CHEM, V251, P3359; Schuler B, 2016, ANNU REV BIOPHYS, V45, P207, DOI 10.1146/annurev-biophys-062215-010915; Schuler Benjamin, 2007, V350, P115; Spott S, 2000, J MOL BIOL, V296, P673, DOI 10.1006/jmbi.1999.3469; Stenberg KAE, 2009, PROTEINS, V75, P748, DOI 10.1002/prot.22284; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Swint-Kruse L, 2001, PROTEIN SCI, V10, P262, DOI 10.1110/ps.35801; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; WHITSON PA, 1987, J BIOL CHEM, V262, P14592; WHITSON PA, 1987, J BIOL CHEM, V262, P4943; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029	76	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198416	10.1371/journal.pone.0198416	http://dx.doi.org/10.1371/journal.pone.0198416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856839	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800119
J	Mathur, D; Singh, S; Mehta, A; Agrawal, P; Raghava, GPS				Mathur, Deepika; Singh, Sandeep; Mehta, Ayesha; Agrawal, Piyush; Raghava, Gajendra P. S.			In silico approaches for predicting the half-life of natural and modified peptides in blood	PLOS ONE			English	Article							ANTIHYPERTENSIVE PEPTIDES; THERAPEUTIC PEPTIDES; STABILITY; DELIVERY; PROTEINS; PLATFORM; DATABASE	This paper describes a web server developed for designing therapeutic peptides with desired half-life in blood. In this study, we used 163 natural and 98 modified peptides whose half-life has been determined experimentally in mammalian blood, for developing in silico models. Firstly, models have been developed on 261 peptides containing natural and modified residues, using different chemical descriptors. The best model using 43 PaDEL descriptors got a maximum correlation of 0.692 between the predicted and the actual half-life peptides. Secondly, models were developed on 163 natural peptides using amino acid composition feature of peptides and achieved a maximum correlation of 0.643. Thirdly, models were developed on 163 natural peptides using chemical descriptors and attained a maximum correlation of 0.743 using 45 selected PaDEL descriptors. In order to assist researchers in the prediction and designing of half-life of peptides, the models developed have been integrated into PlifePred web server.	[Mathur, Deepika; Singh, Sandeep; Mehta, Ayesha; Agrawal, Piyush; Raghava, Gajendra P. S.] CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Raghava, Gajendra P. S.] Indraprastha Inst Informat Technol, Computat Biol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Indraprastha Institute of Information Technology Delhi	Raghava, GPS (corresponding author), CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.; Raghava, GPS (corresponding author), Indraprastha Inst Informat Technol, Computat Biol, New Delhi, India.	raghava@imtech.res.in	Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022; Mathur, Deepika/O-6963-2014; Agrawal, Piyush/AAK-7313-2020	Raghava, Gajendra P.S./0000-0002-8902-2876; Mathur, Deepika/0000-0002-2591-4170; Singh, Sandeep/0000-0001-5361-4303; Agrawal, Piyush/0000-0003-2075-1111	Council of Scientific and Industrial Research, Department of Science and Technology (DST INSPIRE) Govt. of India [BSC0121]	Council of Scientific and Industrial Research, Department of Science and Technology (DST INSPIRE) Govt. of India	Authors are thankful to funding agencies Council of Scientific and Industrial Research (project Open Source Drug Discovery and GENESIS BSC0121), Department of Science and Technology (DST INSPIRE) Govt. of India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00323; Agrawal P, 2016, NUCLEIC ACIDS RES, V44, pD1098, DOI 10.1093/nar/gkv1266; Agu RU, 2001, RESP RES, V2, P198; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; Campbell C, 2012, THER DELIV, V3, P557, DOI 10.4155/TDE.12.12; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Gautam A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26278; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Gorris HH, 2009, ANAL CHEM, V81, P1580, DOI 10.1021/ac802324f; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Jitendra, 2011, INDIAN J PHARM SCI, V73, P367, DOI 10.4103/0250-474X.95608; Kapoor P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035187; Kumar R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12512; Kumar R, 2015, NUCLEIC ACIDS RES, V43, pD956, DOI 10.1093/nar/gku1141; Lazaro E, 2011, J CLIN INVEST, V121, P2480, DOI 10.1172/JCI44932; Mathur D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190134; Mathur D, 2016, SCI REP-UK, V6, DOI 10.1038/srep36617; Mehta Divya, 2014, Database (Oxford), V2014, DOI 10.1093/database/bau051; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012684; PANG SC, 1991, REGUL PEPTIDES, V33, P1, DOI 10.1016/0167-0115(91)90009-6; Philippart M, 2016, DRUG RES, V66, P113, DOI 10.1055/s-0035-1559654; Sharma A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-282; Singh S, 2016, NUCLEIC ACIDS RES, V44, pD1119, DOI 10.1093/nar/gkv1114; Song XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027836; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Tyagi A, 2015, NUCLEIC ACIDS RES, V43, pD837, DOI 10.1093/nar/gku892; Usmani SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181748; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wilkins MR, 1999, METH MOL B, V112, P531; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zompra AA, 2009, FUTURE MED CHEM, V1, P361, DOI 10.4155/FMC.09.23	33	39	39	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0196829	10.1371/journal.pone.0196829	http://dx.doi.org/10.1371/journal.pone.0196829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856745	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800008
J	Noordadi, M; Mehrnejad, F; Sajedi, RH; Jafari, M; Ranjbar, B				Noordadi, Maryam; Mehrnejad, Faramarz; Sajedi, Reza H.; Jafari, Majid; Ranjbar, Bijan			The potential impact of carboxylic-functionalized multi-walled carbon nanotubes on trypsin: A Comprehensive spectroscopic and molecular dynamics simulation study	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; DNA OLIGONUCLEOTIDES; SECONDARY STRUCTURE; GOLD NANOPARTICLES; CIRCULAR-DICHROISM; PROTEIN ADSORPTION; ACTIVATION; STABILITY; TOXICITY; SYSTEMS	In this study, we report a detailed experimental, binding free energy calculation and molecular dynamics (MD) simulation investigation of the interactions of carboxylic-functionalized multi-walled carbon nanotubes (COOH-f-MWCNTs) with porcine trypsin (pTry). The enzyme exhibits decreased thermostability at 330K in the presence of COOH-f-MWCNTs. Furthermore, the activity of pTry also decreases in the presence of COOH-f-MWCNTs. The restricted diffusion of the substrate to the active site of the enzyme was observed in the experiment. The MD simulation analysis suggested that this could be because of the blocking of the S1 pocket of pTry, which plays a vital role in the substrate selectivity. The intrinsic fluorescence of pTry is quenched with increase in the COOH-f-MWCNTs concentration. Circular dichroism (CD) and UV-visible absorption spectroscopies indicate the ability of COOH-f-MWCNTs to experience conformational change in the native structure of the enzyme. The binding free energy calculations also show that electrostatics, pi-cation, and pi-pi stacking interactions play important roles in the binding of the carboxylated CNTs with pTry. The MD simulation results demonstrated that the carboxylated CNTs adsorb to the enzyme stronger than the CNT without the - COOH groups. Our observations can provide an example of the nanoscale toxicity of COOH-f-MWCNTs for proteins, which is a critical issue for in vivo application of COOH-f-MWCNTs.	[Noordadi, Maryam; Mehrnejad, Faramarz; Jafari, Majid] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran; [Sajedi, Reza H.] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran; [Ranjbar, Bijan] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran	University of Tehran; Tarbiat Modares University; Tarbiat Modares University	Mehrnejad, F (corresponding author), Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran.	Mehrnejad@ut.ac.ir	H. Sajedi, Reza/AAA-8355-2022; Jafari, Majid/AAA-8934-2020; Mehrnejad, Faramarz/AAU-1526-2020	Mehrnejad, Faramarz/0000-0002-2991-3079; noordadi, maryam/0000-0002-9561-5192; Jafari, Majid/0000-0001-5233-6882				Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Asghari SM, 2010, PROTEIN ENG DES SEL, V23, P599, DOI 10.1093/protein/gzq031; Baker SE, 2002, NANO LETT, V2, P1413, DOI 10.1021/nl025729f; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k; Bonab MI, 2015, J COMPUT THEOR NANOS, V12, P2077, DOI 10.1166/jctn.2015.3988; Bussy C, 2016, NANOSCALE, V8, P590, DOI 10.1039/c5nr06625e; Calvaresi M, 2012, CHEM-EUR J, V18, P4308, DOI 10.1002/chem.201102703; Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100; Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b; Cheng XX, 2009, SPECTROCHIM ACTA A, V72, P922, DOI 10.1016/j.saa.2008.12.003; Chi ZX, 2010, BIOMACROMOLECULES, V11, P2454, DOI 10.1021/bm100633h; Costa PM, 2016, TOXICOL APPL PHARM, V299, P101, DOI 10.1016/j.taap.2015.12.014; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Deepthi S, 2001, ACTA CRYSTALLOGR D, V57, P1506, DOI 10.1107/S0907444901011143; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; El-Sayed R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21316; Fadel TR, 2013, SMALL, V9, P666, DOI 10.1002/smll.201201684; Gao HJ, 2003, NANO LETT, V3, P471, DOI 10.1021/nl025967a; Gentili PL, 2008, J PHYS CHEM B, V112, P16793, DOI 10.1021/jp805922g; Gombos L, 2008, BIOCHEMISTRY-US, V47, P1675, DOI 10.1021/bi701454e; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gu Z, 2015, SCI REPORTS, V5; Guan J, 2015, LUMINESCENCE, V30, P693, DOI 10.1002/bio.2807; Guan YH, 2014, SPECTROCHIM ACTA A, V124, P556, DOI 10.1016/j.saa.2014.01.058; Gull N, 2009, LANGMUIR, V25, P11686, DOI 10.1021/la901639h; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinterwirth H, 2012, ANAL CHIM ACTA, V733, P90, DOI 10.1016/j.aca.2012.04.036; Hirano A, 2014, CHEM-EUR J, V20, P4922, DOI 10.1002/chem.201400003; Homaei AA, 2010, AMINO ACIDS, V38, P937, DOI 10.1007/s00726-009-0302-3; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khadem-Maaref M, 2012, J COMPUT THEOR NANOS, V9, P783, DOI 10.1166/jctn.2012.2096; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; LASKOWSKI M, 1955, METHOD ENZYMOL, V2, P26, DOI 10.1016/S0076-6879(55)02167-8; Li H, 2013, SPECTROCHIM ACTA A, V115, P1, DOI 10.1016/j.saa.2013.06.025; Li LL, 2013, SPECTROCHIM ACTA A, V105, P45, DOI 10.1016/j.saa.2012.11.111; Liu YF, 2007, NAT NANOTECHNOL, V2, P20, DOI 10.1038/nnano.2006.188; Lou K, 2016, CHEM-BIOL INTERACT, V243, P54, DOI 10.1016/j.cbi.2015.11.020; Marchesan S, 2015, CHEM COMMUN, V51, P4347, DOI 10.1039/c4cc09173f; Mu QX, 2009, NANO LETT, V9, P4370, DOI 10.1021/nl902647x; Naveenraj S, 2010, J PHARMACEUT BIOMED, V53, P804, DOI 10.1016/j.jpba.2010.03.039; Nepal D, 2007, SMALL, V3, P1259, DOI 10.1002/smll.200600511; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b; Quan-Tao D, 2012, CHINESE PHYS LETT, V29; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Rutherglen C, 2009, NAT NANOTECHNOL, V4, P811, DOI [10.1038/NNANO.2009.355, 10.1038/nnano.2009.355]; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Sekar G, 2016, J LUMIN, V170, P141, DOI 10.1016/j.jlumin.2015.10.045; Sekar G, 2015, COLLOID SURFACE B, V128, P315, DOI 10.1016/j.colsurfb.2015.02.006; Shannahan JH, 2013, SMALL, V9, P2171, DOI 10.1002/smll.201202243; Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023; Tonelli FMP, 2015, NANOMEDICINE-UK, V10, P2423, DOI [10.2217/NNM.15.65, 10.2217/nnm.15.65]; Wang S, 2008, ANAL CHIM ACTA, V612, P182, DOI 10.1016/j.aca.2008.02.035; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Wang WR, 2011, BIOL TRACE ELEM RES, V142, P435, DOI 10.1007/s12011-010-8823-x; Wilson NR, 2009, NAT NANOTECHNOL, V4, P483, DOI [10.1038/NNANO.2009.154, 10.1038/nnano.2009.154]; Wu E, 2015, LANGMUIR, V31, P1683, DOI 10.1021/la5043553; Xu ZH, 2016, NANOSCALE, V8, P12143, DOI 10.1039/c6nr00410e; Yang WR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/412001; Zhao DH, 2017, PHYS CHEM CHEM PHYS, V19, P986, DOI 10.1039/c6cp04962a; Zhao XC, 2015, ACS APPL MATER INTER, V7, P18880, DOI 10.1021/acsami.5b05895; Zhao XC, 2015, J HAZARD MATER, V292, P98, DOI 10.1016/j.jhazmat.2015.03.023; Zhao XC, 2010, J PHYS CHEM B, V114, P5625, DOI 10.1021/jp100903x; Zuo GH, 2013, SMALL, V9, P1546, DOI 10.1002/smll.201201381	77	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198519	10.1371/journal.pone.0198519	http://dx.doi.org/10.1371/journal.pone.0198519			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856868	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800135
J	Okada, M; Otaga, M; Tsutsui, T; Tachimori, H; Kitamura, S; Higuchi, S; Mishima, K				Okada, Masakazu; Otaga, Masaaki; Tsutsui, Takako; Tachimori, Hisateru; Kitamura, Shingo; Higuchi, Shigekazu; Mishima, Kazuo			Association of sleep with emotional and behavioral problems among abused children and adolescents admitted to residential care facilities in Japan	PLOS ONE			English	Article							MENTAL-HEALTH; DIFFICULTIES QUESTIONNAIRE; CHILDHOOD MALTREATMENT; PSYCHIATRIC-DISORDERS; SCHOOL YEARS; SYSTEM; PREVALENCE; DEPRESSION; ADULTHOOD; STRENGTHS	Background The psychological care of abused children in the child protection system is an urgent issue in Japan. Child abuse has a serious impact on children's emotion and behavior, but there is virtually no evidence about how child abuse affects sleep, which is closely related to behavioral and emotional control. In this study, we sought to identify sleep habits and suspected sleep disorders among abused children and adolescents admitted to residential care facilities in Japan and to investigate their association with emotional and behavioral problems. Methods The study targeted 273 abused children and adolescents (age range: 4 to 15 years) who had been admitted to a residential care facility in Japan. They were assessed by physicians and other personnel at facilities with expertise in childcare and abuse. Respondents completed a brief sleep questionnaire on the incidence of problematic sleep habits and suspected sleep disorders as well as a questionnaire on emotional and behavioral issues. Results Approximately 40% of the abused children and adolescents had some sleep-related symptoms at bedtime and waking, and 19% had suspected sleep disorder. Abused children with emotional and behavioral problems had a significantly higher incidence of suspected sleep disorders than abused children without such problems, and this incidence was particularly high among those with antisocial behavior and depressive behavior. Our predictive model also showed that antisocial behavior and depressive behavior were significant predictors of suspected sleep disorders. Conclusion Careful assessment and appropriate therapeutic intervention for sleep disorders are required in abused children and adolescents with emotional and behavioral problems.	[Okada, Masakazu] Kyushu Univ, Grad Sch Integrated Frontier Sci, Dept Kansei Sci, Minami Ku, 4-9-1 Shiobaru, Fukuoka, Japan; [Okada, Masakazu; Kitamura, Shingo; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, 4-1-1 Ogawa Higashi, Kodaira, Tokyo, Japan; [Otaga, Masaaki] Natl Inst Publ Hlth, Dept Hlth & Social Serv, 2-3-6 Minami, Wako, Saitama, Japan; [Tsutsui, Takako] Univ Hyogo, Grad Sch Business, Nishi Ku, 8-2-1 Gakuen Nishimachi, Kobe, Hyogo, Japan; [Tachimori, Hisateru] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, 4-1-1 Ogawahigashicho, Kodaira, Tokyo, Japan; [Higuchi, Shigekazu] Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, 4-9-1 Shiobaru, Fukuoka, Japan	Kyushu University; National Center for Neurology & Psychiatry - Japan; National Institute of Public Health - Japan; University of Hyogo; National Center for Neurology & Psychiatry - Japan; Kyushu University	Mishima, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, 4-1-1 Ogawa Higashi, Kodaira, Tokyo, Japan.	mishima@ncnp.go.jp	Kitamura, Shingo/G-6727-2013; HIGUCHI, Shigekazu/AAM-5800-2020	Kitamura, Shingo/0000-0001-9607-1812; higuchi, shigekazu/0000-0001-7131-0792; MISHIMA, KAZUO/0000-0003-1182-1181	National Center of Neurology and Psychiatry [26-2, 29-1]	National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan)	This study was supported in part by Intramural Research Grants for Neurological and Psychiatric Disorders (#26-2 and #29-1) from the National Center of Neurology and Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; [Anonymous], 2017, PRES SIT CHILD PROT; [Anonymous], 2017, NUMB INC CHILD AB DE; Arnow BA, 2004, J CLIN PSYCHIAT, V65, P10; Burge P, 2007, CAN J PSYCHIAT, V52, P305, DOI 10.1177/070674370705200505; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Fearon RMP, 2011, J CHILD PSYCHOL PSYC, V52, P782, DOI 10.1111/j.1469-7610.2010.02350.x; Fergusson DM, 2008, CHILD ABUSE NEGLECT, V32, P607, DOI 10.1016/j.chiabu.2006.12.018; Flett GL, 2012, J RATION-EMOT COGN-B, V30, P118, DOI 10.1007/s10942-011-0132-6; Ford T, 2014, PSYCHIAT DISORDER BR, P319, DOI [10.1192/bjp.bp.106.025023, DOI 10.1192/BJP.BP.106.025023]; Fredriksen K, 2004, CHILD DEV, V75, P84, DOI 10.1111/j.1467-8624.2004.00655.x; Glod CA, 1997, J AM ACAD CHILD PSY, V36, P1236, DOI 10.1097/00004583-199709000-00016; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greenfield EA, 2011, ANN BEHAV MED, V42, P245, DOI 10.1007/s12160-011-9285-x; Greger HK, 2015, CHILD ABUSE NEGLECT, V45, P122, DOI 10.1016/j.chiabu.2015.05.003; Gregory AM, 2012, SLEEP MED REV, V16, P129, DOI 10.1016/j.smrv.2011.03.007; Hager AD, 2012, CHILD ABUSE NEGLECT, V36, P393, DOI 10.1016/j.chiabu.2012.02.002; Heiler S, 2011, MED HYPOTHESES, V77, P692, DOI 10.1016/j.mehy.2011.07.019; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; HOLM S, 1979, SCAND J STAT, V6, P65; Jozefiak T, 2016, EUR CHILD ADOLES PSY, V25, P33, DOI 10.1007/s00787-015-0700-x; Kajeepeta S, 2015, SLEEP MED, V16, P320, DOI 10.1016/j.sleep.2014.12.013; Kamio Y., ANN REPORT RES SUPPO; Kotch JB, 2008, PEDIATRICS, V121, P725, DOI 10.1542/peds.2006-3622; Maas C, 2008, TRAUMA VIOLENCE ABUS, V9, P56, DOI 10.1177/1524838007311105; Majer M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-61; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; McMillen JC, 2005, J AM ACAD CHILD PSY, V44, P88, DOI 10.1097/01.chi.0000145806.24274.d2; McPhie ML, 2014, CHILD ABUSE NEGLECT, V38, P2044, DOI 10.1016/j.chiabu.2014.07.009; Mizuta A, 2017, SOC PSYCH PSYCH EPID, V52, P211, DOI 10.1007/s00127-016-1320-6; Moturi Sricharan, 2010, Psychiatry (Edgmont), V7, P24; Noll JG, 2006, J PEDIATR PSYCHOL, V31, P469, DOI 10.1093/jpepsy/jsj040; Okada M, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0151-9; Olds T, 2010, SLEEP, V33, P1381, DOI 10.1093/sleep/33.10.1381; Ramtekkar U, 2015, SEMIN PEDIATR NEUROL, V22, P148, DOI 10.1016/j.spen.2015.04.004; Rhodes AE, 2013, CHILD ABUSE NEGLECT, V37, P139, DOI 10.1016/j.chiabu.2012.07.009; SADEH A, 1995, J AM ACAD CHILD PSY, V34, P813, DOI 10.1097/00004583-199506000-00023; Sadeh A, 2014, CURR OPIN PSYCHIATR, V27, P453, DOI 10.1097/YCO.0000000000000109; Shin SH, 2005, CHILD YOUTH SERV REV, V27, P1071, DOI 10.1016/j.childyouth.2004.12.027; Shipman K, 2009, PEDIATR CLIN N AM, V56, P417, DOI 10.1016/j.pcl.2009.02.002; Singh K, 2015, SEMIN PEDIATR NEUROL, V22, P113, DOI 10.1016/j.spen.2015.03.006; Steele JS, 2008, PEDIATRICS, V122, pE703, DOI 10.1542/peds.2008-0360; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Tsai MH, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0711-4; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Yurasek AM, 2012, ALCOHOL EXP RES, V36	47	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198123	10.1371/journal.pone.0198123	http://dx.doi.org/10.1371/journal.pone.0198123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856806	gold, Green Submitted, Green Published			2022-12-26	WOS:000433900800073
J	Cygan, M; Szemien, M; Krompiec, S				Cygan, Magdalena; Szemien, Mariusz; Krompiec, Stanislaw			Statistical screening analysis of the chemical composition and kinetic study of phenol formaldehyde resins synthesized in the presence of polyamines as co-catalysts	PLOS ONE			English	Article							CATALYZED SELF-CONDENSATION; MECHANISMS; 2,4-DIHYDROXYMETHYLPHENOL	The physico-chemical and application properties of phenol-formaldehyde resins used in the production of laminated plastics depend on such factors as: type and amount of catalyst, formaldehyde-to-phenol mole ratio, temperature and time of the synthesis process. The special impact on the reaction mechanism and kinetics, e.g. on the formation of mono-, di- and trihydroxymethyl derivatives of phenol (PhOH) is a consequence of the type and amount of the catalyst. This paper presents the results of optimisation research of resol resin synthesis catalysed by trimethylamine (TEA) carried out according to 32 experimental design. The aim of the research was to determine the synthesis conditions under which it is possible to achieve products with reduced content of unconverted formaldehyde (CH2O), phenol and its hydroxymetyl derivatives, while maintaining the required physico-chemical properties. The process employing selected polyamines as well as TEA together with polyamine co-catalysts i.e. diethylenetriamine (DETA) and triethylenetetraamine (TETA) was also studied. The results were compared with those of the resins which were synthesised with the use of classic catalysts ammonia (NH3) and triethylamine for which the content of CH2O, PhOH and its hydroxymethyl derivatives was respectively: NH3-5.13% and 46.27%, TEA-0.33% and 52.41%. In the case DETA was added, the content of phenol and its hydroxymethyl derivatives could be reduced by 52.49% in relation to the resin obtained with the use of TEA and by 46.19% in relation to the resin obtained with the use of ammonia. The formaldehyde content was reduced by 78.79% and 98.64%, respectively. When TETA was added as a co-catalyst, the content of phenol and its derivatives was reduced by 48.04% versus triethylamine-catalysed resin and by 41.15% versus ammonia-catalysed material. The reduction in formaldehyde content reached 84.85% and 99.03%, respectively. The results of kinetic study were also presented, the prediction accuracy of the proposed kinetic model is more than 98% for all the catalysts in the state variable space. Polyamine co-catalysts gave much higher rate constants (0.50 and 0.45 for TETA and DETA, respectively).	[Cygan, Magdalena; Szemien, Mariusz] Pfleiderer Silekol Sp Zoo, Kedzierzyn Kozle, Poland; [Cygan, Magdalena; Krompiec, Stanislaw] Univ Silesia, Inst Chem, Katowice, Poland	University of Silesia in Katowice	Cygan, M (corresponding author), Pfleiderer Silekol Sp Zoo, Kedzierzyn Kozle, Poland.; Cygan, M (corresponding author), Univ Silesia, Inst Chem, Katowice, Poland.	magdalena.cygan@silekol.pl		Krompiec, Stanislaw/0000-0003-3516-4235	Ministry of Science and Higher Education Republic of Poland	Ministry of Science and Higher Education Republic of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education Republic of Poland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EL STAT TXB; Astarloa-Aierbe G, 1998, POLYMER, V39, P3147, DOI 10.1016/S0032-3861(97)10055-6; Astarloa-Aierbe G, 1999, POLYMER, V40, P5873, DOI 10.1016/S0032-3861(98)00816-7; Cygan M, DECREASE CONTENTS HY; Fischer K., 2003, P AS PAC LAM WORKSH; FREEMAN JH, 1954, J AM CHEM SOC, V76, P2080, DOI 10.1021/ja01637a014; Gabilondo N, 2006, J APPL POLYM SCI, V102, P2623, DOI 10.1002/app.24017; GrenierLoustalot MF, 1996, POLYMER, V37, P1363, DOI 10.1016/0032-3861(96)81133-5; Higuchi M, 2001, POLYM J, V33, P799; Higuchi M, 2001, POLYMER, V42, P4563, DOI 10.1016/S0032-3861(00)00808-9; Kamo N, 2004, J WOOD SCI, V50, P236, DOI 10.1007/s10086-003-0564-4; Kamo N, 2004, J WOOD SCI, V50, P68, DOI 10.1007/s10086-003-0535-9; Kamo N, 2002, J WOOD SCI, V48, P491, DOI 10.1007/BF00766645; Kamo N, 2006, J WOOD SCI, V52, P325, DOI 10.1007/s10086-005-0767-y; Kane J.F., 1998, US patent, Patent No. [5,736,619, 5736619]; Montgomery D.C., 2012, DESIGN ANAL EXPT; Montgomery D. C., 2010, ENG STAT, P96; Pham H., 2006, HDB ENG STAT; Ryan T. P., 2007, MODERN EXPT DESIGN; Shea L. E., 2004, U. S. patent application, Patent No. 20040036056; Taylor J. G., 1995, WATER BASED PHENOLIC; Toutenburg Shalabh, 2010, STAT AN DES EXP; Yakul S. A., 2001, INT J SC TECH, V6, P3; Yong L., 2006, J APPL POLYM SCI, V102, p[4, 3774 ]	24	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0195069	10.1371/journal.pone.0195069	http://dx.doi.org/10.1371/journal.pone.0195069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851953	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200002
J	Ho, YF; Chao, A; Chen, KJ; Chao, AN; Wang, NK; Liu, L; Chen, YP; Hwang, YS; Wu, WC; Lai, CC; Chen, TL				Ho, Yeen-Fey; Chao, Anne; Chen, Kuan-Jen; Chao, An-Ning; Wang, Nan-Kai; Liu, Laura; Chen, Yen-Po; Hwang, Yih-Shiou; Wu, Wei-Chi; Lai, Chi-Chun; Chen, Tun-Lu			Clinical outcomes and predictors of response to photodynamic therapy in symptomatic circumscribed choroidal hemangioma: A retrospective case series	PLOS ONE			English	Article							VERTEPORFIN	Background To investigate the treatment outcomes and predictors of response to photodynamic therapy (PDT) in patients with symptomatic circumscribed hemangioma (CCH). Methods This retrospective case series examined 20 patients with symptomatic CCH (10 submacular CCHs and10 juxtapapillary CCHs) who underwent standard PDT (wavelength: 662 nm; light dose: 50J/cm(2); exposure time: 83 sec) with verteporfin (6mg/m(2)), either as monotherapy (n = 9) or in association with other treatments (n =11), of which 7 received intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF). A post-PDT improvement of at least two lines in best-corrected visual acuity (BCVA) was the primary outcome measure. Predictors of response were investigated with binary logistic regression analysis. Results Seventeen (85%) patients received one PDT session, and three patients (15%) underwent PDT at least twice. Ten patients (50%) achieved the primary outcome of a post-PDT BCVA improvement of at least two lines. Macular atrophy and recalcitrant cystoid macular edema in 2 patients. Binary logistic regression analysis revealed that younger age (< 50 years) (P= 0.033), pre-PDT >= BCVA of >= 20/200 (P= 0.013), exudative retinal detachment resolved within one month after PDT (P = 0.007), and a thinner post-PDT tumor thickness (P = 0.015) were associated with the achievement of a post-PDT BCVA improvement. Additional treatments to PDT including IVI anti-VEGF did not appear to improve visual and anatomical outcomes. Conclusions Symptomatic CCHs respond generally well to PDT. Patients with younger age (< 50 years), pretreatment BCVA >= 20/200, and thinner foveal edema are most likely to benefit from this approach.	[Ho, Yeen-Fey; Chen, Kuan-Jen; Chao, An-Ning; Wang, Nan-Kai; Liu, Laura; Chen, Yen-Po; Hwang, Yih-Shiou; Wu, Wei-Chi; Lai, Chi-Chun; Chen, Tun-Lu] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou Med Ctr, Taoyuan, Taiwan; [Ho, Yeen-Fey; Chen, Kuan-Jen; Chao, An-Ning; Wang, Nan-Kai; Liu, Laura; Chen, Yen-Po; Hwang, Yih-Shiou; Wu, Wei-Chi; Lai, Chi-Chun; Chen, Tun-Lu] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Ho, Yeen-Fey] Yeezen Gen Hosp, Dept Ophthalmol, Taoyuan, Taiwan; [Chao, Anne] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Chao, AN (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Linkou Med Ctr, Taoyuan, Taiwan.; Chao, AN (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	anning@cgmh.org.tw	Wang, Nan-Kai/D-6608-2011; Wang, Nan-Kai/AAO-6559-2020	Wang, Nan-Kai/0000-0002-6277-9879; Wang, Nan-Kai/0000-0002-6277-9879; Chen, Kuan-Jen/0000-0002-4994-8391; Lai, Chi-Chun/0000-0001-9547-7212	Chang Gung Medical Foundation [CIRPD1D0031]	Chang Gung Medical Foundation	This study is supported by Chang Gung Medical Foundation (CIRPD1D0031). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Arch Ophthalmol, V115, P886; [Anonymous], 1999, Arch Ophthalmol, V117, P1329; Blasi MA, 2010, OPHTHALMOLOGY, V117, P1630, DOI 10.1016/j.ophtha.2009.12.033; Boixadera A, 2009, OPHTHALMOLOGY, V116, P100, DOI 10.1016/j.ophtha.2008.08.029; Cerman E, 2015, SURV OPHTHALMOL, V60, P557, DOI 10.1016/j.survophthal.2015.05.004; Chan LW, 2014, OPTOMETRY VISION SCI, V91, pE226, DOI 10.1097/OPX.0000000000000349; Jurklies B, 2003, BRIT J OPHTHALMOL, V87, P84, DOI 10.1136/bjo.87.1.84; Kwon HJ, 2012, AM J OPHTHALMOL, V154, P137, DOI 10.1016/j.ajo.2012.01.007; Mandal S, 2011, INDIAN J OPHTHALMOL, V59, P248, DOI 10.4103/0301-4738.81051; Mashayekhi Arman, 2003, Curr Opin Ophthalmol, V14, P142, DOI 10.1097/00055735-200306000-00006; Mashayekhi Arman, 2013, Middle East Afr J Ophthalmol, V20, P83, DOI 10.4103/0974-9233.106400; Michels S, 2005, RETINA-J RET VIT DIS, V25, P697, DOI 10.1097/00006982-200509000-00003; Pinheiro-Costa J, 2015, PHOTODIAGN PHOTODYN, V12, P317, DOI 10.1016/j.pdpdt.2015.02.003; PRUETT RC, 1987, AM J OPHTHALMOL, V103, P537, DOI 10.1016/S0002-9394(14)74277-1; Ruiz-Moreno JM, 2003, BRIT J OPHTHALMOL, V87, P856, DOI 10.1136/bjo.87.7.856; Sagong Min, 2009, Korean J Ophthalmol, V23, P127, DOI 10.3341/kjo.2009.23.2.127; Schmidt-Erfurth UM, 2002, OPHTHALMOLOGY, V109, P2284, DOI 10.1016/S0161-6420(02)01454-9; Shields CL, 2001, OPHTHALMOLOGY, V108, P2237, DOI 10.1016/S0161-6420(01)00812-0; Singh AD, 2005, EYE, V19, P365, DOI 10.1038/sj.eye.6701474; Tsipursky MS, 2011, SURV OPHTHALMOL, V56, P68, DOI 10.1016/j.survophthal.2010.08.002; Verbraak FD, 2003, GRAEF ARCH CLIN EXP, V241, P891, DOI 10.1007/s00417-003-0765-y; Vicuna-Kojchen J, 2006, OPHTHALMOLOGICA, V220, P351, DOI 10.1159/000095859; WITSCHEL H, 1976, Survey of Ophthalmology, V20, P415, DOI 10.1016/0039-6257(76)90067-9; Zeisberg A, 2014, GRAEF ARCH CLIN EXP, V252, P1165, DOI 10.1007/s00417-014-2635-1	24	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197088	10.1371/journal.pone.0197088	http://dx.doi.org/10.1371/journal.pone.0197088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851977	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200010
J	Cayrou, C; Akinduko, AA; Mirkes, EM; Lucidarme, J; Clark, SA; Green, LR; Cooper, HJ; Morrissey, J; Borrow, R; Bayliss, CD				Cayrou, Caroline; Akinduko, Ayodeji A.; Mirkes, Evgeny M.; Lucidarme, Jay; Clark, Stephen A.; Green, Luke R.; Cooper, Helen J.; Morrissey, Julie; Borrow, Ray; Bayliss, Christopher D.			Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; BEXSERO(R); SERUM; FHBP	Factor H binding protein (fHbp) is a major protective antigen in 4C-MenB (Bexsero (R)) and Trumenba (R), two serogroup B meningococcal vaccines, wherein expression level is a determinant of protection. Examination of promoter-containing intergenic region (IGR) sequences indicated that nine fHbp IGR alleles covered 92% of 1,032 invasive meningococcal strains with variant 1 fHbp alleles. Relative expression values for fHbp were determined for 79 meningococcal isolates covering ten IGR alleles by quantitative reverse transcriptase polymerase chain reaction (qRT PCR). Derivation of expression clusters of IGR sequences by linear regression identified five expression clusters with five nucleotides and one insertion showing statistically associations with differences in expression level. Sequence analysis of 273 isolates examined by the Meningococcal Antigen Typing Scheme, a sandwich ELISA, found that coverage depended on the IGR expression cluster and vaccine peptide homology combination. Specific fHbp peptide-IGR expression cluster combinations were designated as 'at risk' for coverage by 4C-MenB and were detected in multiple invasive meningococcal disease cases confirmed by PCR alone and occurring in partially-vaccinated infants. We conclude that sequence-based analysis of IGR sequences is informative for assessing protein expression and has utility for culture-independent assessments of strain coverage by protein-based vaccines.	[Cayrou, Caroline; Green, Luke R.; Morrissey, Julie; Bayliss, Christopher D.] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England; [Akinduko, Ayodeji A.; Mirkes, Evgeny M.] Univ Leicester, Dept Math, Leicester, Leics, England; [Lucidarme, Jay; Clark, Stephen A.; Borrow, Ray] Manchester Royal Infirm, Publ Hlth England, Meningococcal Reference Unit, Manchester, Lancs, England; [Cooper, Helen J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Leicester; University of Leicester; Public Health England; University of Manchester; University of Birmingham	Cayrou, C; Bayliss, CD (corresponding author), Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England.	cc447@le.ac.uk; cdb12@le.ac.uk	Mirkes, Evgeny/Y-9614-2018	Mirkes, Evgeny/0000-0003-1474-1734; Bayliss, Christopher/0000-0002-5564-2145; morrissey, julie/0000-0001-9115-2218	Meningitis Research Foundation [1507.0]; Medical Research Council [MR/M020193/1]; MRC [MC_PC_16051, MR/M020193/1] Funding Source: UKRI	Meningitis Research Foundation(Meningitis Research Foundation (MRF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Meningitis Research Foundation [1507.0 to CDB and CC]; and Medical Research Council [MR/M020193/1 to CDB and LRG]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. In addition, CDB reports grants from GlaxoSmithKline, Roche and Sanofi Pasteur MSD, outside the submitted work. RB reports grants for contract research on behalf of Public Health England (formerly the Health Protection Agency) for GlaxoSmithKline, Novartis Vaccines, Pfizer, and Sanofi Pasteur MSD, outside the submitted work. SAC has performed contract research on behalf of Public Health England for Pfizer., outside the submitted work. JL has performed contract research on behalf of Public Health England for GSK, Pfizer and Sanofi Pasteur, outside the submitted work.; We acknowledge Prof. Christoph Tang for provision of a polyclonal fHbp serum, Charlene Rodrigues, Keith Jolley and Martin Maiden for assistance with development of allele schemes within the Neisseria PubMLST database and Shamez Ladhani, Sydel Parikh and Helen Campbell (Public Health England) for provision of vaccination status for the vaccine eligible cases. This publication made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.meningitis.oegkesearch/genorne) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration and funded by Meningitis Research Foundation.	Bayliss CD, 2016, LANCET, V387, P531, DOI 10.1016/S0140-6736(16)00218-X; Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; Biagini M, 2016, P NATL ACAD SCI USA, V113, P2714, DOI 10.1073/pnas.1521142113; Clark SA, 2016, J INFECTION, V73, P63, DOI 10.1016/j.jinf.2016.03.012; Clark SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089921; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Gandhi A, 2016, POSTGRAD MED, V128, P548, DOI 10.1080/00325481.2016.1203238; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heinsbroek E, 2013, J INFECTION, V67, P385, DOI 10.1016/j.jinf.2013.06.007; Hill DMC, 2015, LANCET INFECT DIS, V15, P1420, DOI 10.1016/S1473-3099(15)00267-4; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Ladhani SN, 2015, J INFECTION, V71, P611, DOI 10.1016/j.jinf.2015.09.035; Lemee L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107240; Loh E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005794; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Oriente F, 2010, J BACTERIOL, V192, P691, DOI 10.1128/JB.01308-09; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Parikh SR, 2017, LANCET INFECT DIS, V17, P754, DOI 10.1016/S1473-3099(17)30170-6; Sanders H, 2012, MICROBIOL-SGM, V158, P869, DOI 10.1099/mic.0.054957-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seib KL, 2009, INFECT IMMUN, V77, P292, DOI 10.1128/IAI.01071-08; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vernikos G, 2014, PATHOG GLOB HEALTH, V108, P305, DOI 10.1179/2047773214Y.0000000162; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994; Yu CX, 2012, J BACTERIOL, V194, P6372, DOI 10.1128/JB.00262-12	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197186	10.1371/journal.pone.0197186	http://dx.doi.org/10.1371/journal.pone.0197186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847547	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800022
J	Kwon, MS; Koo, BC; Kim, D; Nam, YH; Cui, XS; Kim, NH; Kim, T				Kwon, Mo Sun; Koo, Bon Chul; Kim, Dohyang; Nam, Yu Hwa; Cui, Xiang-Shun; Kim, Nam-Hyung; Kim, Teoan			Generation of transgenic chickens expressing the human erythropoietin (hEPO) gene in an oviduct-specific manner: Production of transgenic chicken eggs containing human erythropoietin in egg whites	PLOS ONE			English	Article							GENETICALLY MANIPULATED CHICKENS; FUSION PROTEIN; VECTOR	The transgenic chicken has been considered as a prospective bioreactor for large-scale production of costly pharmaceutical proteins. In the present study, we report successful generation of transgenic hens that lay eggs containing a high concentration of human erythropoietin (hEPO) in the ovalbumin. Using a feline immunodeficiency virus (FIV)-based pseudotyped lentivirus vector enveloped with G glycoproteins of the vesicular stomatitis virus, the replication-defective vector virus carrying the hEPO gene under the control of the chicken ovalbumin promoter was microinjected to the subgerminal cavity of freshly laid chicken eggs (stage X). Stable germline transmission of the hEPO transgene to the G1 progeny, which were nonmosaic and hemizygous for the hEPO gene under the ovalbumin promoter, was confirmed by mating of a G(0) rooster with non-transgenic hens. Quantitative analysis of hEPO in the egg whites and in the blood samples taken from G(1) transgenic chickens showed 4,810 similar to 6,600 IU/ml (40.1 similar to 55.0 mu g/ml) and almost no detectable concentration, respectively, indicating tightly regulated oviduct-specific expression of the hEPO transgene. In terms of biological activity, there was no difference between the recombinant hEPO contained in the transgenic egg white and the commercially available counterpart, in vitro. We suggest that these results imply an important step toward efficient production of human cytokines from a transgenic animal bioreactor.	[Kwon, Mo Sun; Koo, Bon Chul; Kim, Dohyang; Nam, Yu Hwa; Kim, Teoan] Dept Physiol, Daegu, South Korea; [Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea	Chungbuk National University	Kim, T (corresponding author), Dept Physiol, Daegu, South Korea.	takim@cu.ac.kr			Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011178]	Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by the Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, and by a grant from the Next Generation BioGreen 21 Program (No. PJ011178), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, and by a grant from the Next-Generation BioGreen 21 Program (No. PJ011178), Rural Development Administration, Republic of Korea.	Coffin J. M., 1990, VIROLOGY, P1437; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Ivarie R, 2003, TRENDS BIOTECHNOL, V21, P14, DOI 10.1016/S0167-7799(02)00009-4; Jelkmann W, 2008, BRIT J HAEMATOL, V141, P287, DOI 10.1111/j.1365-2141.2007.06948.x; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kodama D, 2008, BIOCHEM BIOPH RES CO, V367, P834, DOI 10.1016/j.bbrc.2008.01.020; Koo BC, 2014, PINKERT CABT TAT, V3rd, P167; Koo BC, 2017, BIOTECHNOL BIOPROC E, V22, P22, DOI 10.1007/s12257-016-0590-x; Koo BC, 2010, TRANSGENIC RES, V19, P437, DOI 10.1007/s11248-009-9327-3; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Longhurst H, 2008, CURR OPIN INVEST DR, V9, P310; Marsden JT, 2006, ANN CLIN BIOCHEM, V43, P97, DOI 10.1258/000456306776021553; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Penno CA, 2010, TRANSGENIC RES, V19, P187, DOI 10.1007/s11248-009-9310-z; PETITTE JN, 2002, TRANSGENIC ANIMAL TE, P279, DOI DOI 10.1016/B978-0-08-057480-6.50015-0; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rapp JC, 2003, TRANSGENIC RES, V12, P569, DOI 10.1023/A:1025854217349; Saenz Dyana T, 2012, Cold Spring Harb Protoc, V2012, P71, DOI 10.1101/pdb.ip067579; Xu YN, 2013, J GENET GENOMICS, V40, P37, DOI 10.1016/j.jgg.2012.11.001; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	24	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0194721	10.1371/journal.pone.0194721	http://dx.doi.org/10.1371/journal.pone.0194721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847554	Green Submitted, Green Published, gold			2022-12-26	WOS:000433634800005
J	Nan, FR; Feng, J; Lv, JP; Liu, Q; Xie, SL				Nan, Fangru; Feng, Jia; Lv, Junping; Liu, Qi; Xie, Shulian			Transcriptome analysis of the typical freshwater rhodophytes Sheathia arcuata grown under different light intensities	PLOS ONE			English	Article							GRACILARIA-CHANGII RHODOPHYTA; RNA-SEQ DATA; ENVIRONMENT; COMPLEX; CHLOROPLASTS; EVOLUTIONARY; ANNOTATION; PROTEINS; STRESSES; PACKAGE	The Rhodophyta Sheathia arcuata is exclusively distributed in freshwater, constituting an important component in freshwater flora. This study presents the first transcriptome profiling of freshwater Rhodophyta taxa. A total of 161,483 assembled transcripts were identified, annotated and classified into different biological categories and pathways based on BLAST against diverse databases. Different gene expression patterns were caused principally by different irradiances considering the similar water conditions of the sampling site when the specimens were collected. Comparison results of gene expression levels under different irradiances revealed that photosynthesis-related pathways significantly up-regulated under the weak light. Molecular responses for improved photosynthetic activity include the transcripts corresponding to antenna proteins (LHCA1 and LHCA4), photosynthetic apparatus proteins (PSBU, PETB, PETC, PETH and beta and gamma subunits of ATPase) and metabolic enzymes in the carbon fixation. Along with photosynthesis, other metabolic activities were also regulated to optimize the growing and development of S. arcuata under appropriate sunlight. Protein-protein interactive networks revealed the most responsive up-expressed transcripts were ribosomal proteins. The de-novo transcriptome assembly of S. arcuata provides a foundation for further investigation on the molecular mechanism of photosynthesis and environmental adaption for freshwater Rhodophyta.	[Nan, Fangru; Feng, Jia; Lv, Junping; Liu, Qi; Xie, Shulian] Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China	Shanxi University	Xie, SL (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China.	xiesl@sxu.edu.cn		Xie, Shulian/0000-0003-2349-2071	National Natural Science Foundation of China [31670208]; Fund for Shanxi "1331 Project" Key Innovative Research Team	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Shanxi "1331 Project" Key Innovative Research Team	We are grateful to the National Natural Science Foundation of China (grant number 31670208 to Shulian Xie) and the Fund for Shanxi "1331 Project" Key Innovative Research Team for funding this project.	AKAGAWA H, 1972, BOT MAR, V15, P126, DOI 10.1515/botm.1972.15.3.126; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANDERSON JM, 1986, ANNU REV PLANT PHYS, V37, P93, DOI 10.1146/annurev.arplant.37.1.93; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Collen J, 2007, NEW PHYTOL, V176, P45, DOI 10.1111/j.1469-8137.2007.02152.x; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Enami I, 2008, PHOTOSYNTH RES, V98, P349, DOI 10.1007/s11120-008-9343-9; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FOYER C, 1990, PHOTOSYNTH RES, V25, P83, DOI 10.1007/BF00035457; Gohin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-18; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gould SB, 2012, NATURE, V492, P46, DOI 10.1038/nature11759; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grabowski B, 2001, P NATL ACAD SCI USA, V98, P2911, DOI 10.1073/pnas.031587198; Grossman AR, 2001, J BIOL CHEM, V276, P11449, DOI 10.1074/jbc.R100003200; Guiry MD, ALGAEBASE; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Hartwell J, 1996, PLANT J, V10, P1071, DOI 10.1046/j.1365-313X.1996.10061071.x; Ho CL, 2009, MAR BIOTECHNOL, V11, P513, DOI 10.1007/s10126-008-9166-x; HOLMES DS, 1973, BIOCHEMISTRY-US, V12, P2330, DOI 10.1021/bi00736a023; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lim EL, 2016, MAR BIOTECHNOL, V18, P189, DOI 10.1007/s10126-015-9680-6; Lu FH, 2011, SCI HORTIC-AMSTERDAM, V129, P38, DOI 10.1016/j.scienta.2011.03.003; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Necchi O, 2005, AQUAT BOT, V82, P193, DOI 10.1016/j.aquabot.2005.02.010; Park S, 2010, PLANTA, V231, P349, DOI 10.1007/s00425-009-1044-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheath R.G., 1984, PROGR PHYCOLOGICAL R, P89; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sun PP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1586-1; Vis ML, 2010, PHYCOLOGIA, V49, P545, DOI 10.2216/10-04.1; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wehr J.D., 2015, FRESHWATER ALGAE N A; Whitford LA, 1963, HYDROBIOLOGIA, V22, P133, DOI DOI 10.1007/BF00039686; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Wu SX, 2014, ACTA OCEANOL SIN, V33, P1, DOI 10.1007/s13131-014-0435-4; Xie CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-107; Xie Shulian, 2004, Yingyong Shengtai Xuebao, V15, P1931; Zucchi Marcelo Ribeiro, 2001, Phycological Research, V49, P103, DOI 10.1046/j.1440-1835.2001.00230.x	52	9	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197729	10.1371/journal.pone.0197729	http://dx.doi.org/10.1371/journal.pone.0197729			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813098	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800028
J	Seo, SU; Woo, SM; Lee, HS; Kim, SH; Min, KJ; Kwon, TK				Seo, Seung Un; Woo, Seon Min; Lee, Hyun-Shik; Kim, Sang Hyun; Min, Kyoung-jin; Kwon, Taeg Kyu			mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy	ONCOGENE			English	Article							RENAL-CELL CARCINOMA; BCL-X-L; DOWN-REGULATION; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; MAMMALIAN TARGET; GLIOMA-CELLS; CANCER-CELLS; MOLECULAR-MECHANISMS; SELECTIVE AUTOPHAGY	mTOR is an important regulator of cell growth and forms two complexes, mTORC1/2. In cancer, mTOR signaling is highly activated, and the regulation of this signaling, as an anti-cancer strategy, has been emphasized. However, PP242 (inhibitor of mTORC1 and mTORC2) alone did not induce human renal carcinoma cell death. In this study, we found that PP242 alone did not alter cell viability, but combined curcumin and PP242 treatment induced cell death. Combined PP242 and curcumin treatment induced Bax activation and decreased expression of Mcl-1 and Bcl-2. Furthermore, co-treatment with PP242 and curcumin-induced the downregulation of the Rictor (an mTORC2 complex protein) and Akt protein levels, and ectopic overexpression of Rictor or Akt inhibited PP242 plus curcumin induced cell death. Downregulation of Rictor increased cytosolic Ca2+ release from endoplasmic reticulum, which led to lysosomal damage in PP242 plus curcumin-treated cells. Furthermore, damaged lysosomes induced autophagy. Autophagy inhibitors markedly inhibited cell death. Finally, combined curcumin and PP242 treatment reduced tumor growth and induced cell death in xenograft models. Altogether, our results reveal that combined PP242 and curcumin treatment could induce autophagy-mediated cell death by reducing the expression of Rictor and Akt in renal carcinoma cells.	[Seo, Seung Un; Woo, Seon Min; Min, Kyoung-jin; Kwon, Taeg Kyu] Keimyung Univ, Sch Med, Dept Immunol, 2800 Dalgubeoldaero, Daegu 704701, South Korea; [Lee, Hyun-Shik] KNU, Coll Nat Sci, Plus KNU Creat BioRes Grp BK21, Sch Life Sci,Ctr Nonlinear Dynam, Daegu 41566, South Korea; [Kim, Sang Hyun] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 41944, South Korea	Keimyung University; Kyungpook National University	Min, KJ; Kwon, TK (corresponding author), Keimyung Univ, Sch Med, Dept Immunol, 2800 Dalgubeoldaero, Daegu 704701, South Korea.	kyoungjin.min@gmail.com; kwontk@dsmc.or.kr			NRF grant - Korea Government (MSIP) [2014R1A5A2010008, NRF-2016R1A2B2013393, NRF-2016R1D1A1B03933568]	NRF grant - Korea Government (MSIP)	We appreciate critical reading of the manuscript by Jae Man Lee (Kyungpook national university). This work was supported by an NRF grant funded by the Korea Government (MSIP) (2014R1A5A2010008, NRF-2016R1A2B2013393 and NRF-2016R1D1A1B03933568).	Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Chen H, 1999, ANTICANCER RES, V19, P3675; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Deeb D, 2003, MOL CANCER THER, V2, P95; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fei Y, 2016, BRAIN RES, V1646, P580, DOI 10.1016/j.brainres.2016.06.046; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Fu ZP, 2015, ONCOTARGET, V6, P19469, DOI 10.18632/oncotarget.3625; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gao XH, 2005, J EXP THER ONCOL, V5, P39; Go DH, 2017, ONCOTARGET, V8, P58790, DOI 10.18632/oncotarget.17732; Han MA, 2015, CHEM-BIOL INTERACT, V228, P69, DOI 10.1016/j.cbi.2015.01.020; Han SS, 1999, CLIN IMMUNOL, V93, P152, DOI 10.1006/clim.1999.4769; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jo Y, 2017, BMB REP, V50, P379, DOI 10.5483/BMBRep.2017.50.7.063; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Moragoda L, 2001, ANTICANCER RES, V21, P873; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; OLSSON GM, 1989, VIRCHOWS ARCH B, V56, P263; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Park YS, 2017, TOX RESEARCH, V33, P211, DOI 10.5487/TR.2017.33.3.211; Peyerl FW, 2007, CELL DEATH DIFFER, V14, P447, DOI 10.1038/sj.cdd.4402025; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Seo SU, 2017, REDOX BIOL, V13, P608, DOI 10.1016/j.redox.2017.07.017; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Sirohi VK, 2017, J NUTR BIOCHEM, V44, P60, DOI 10.1016/j.jnutbio.2016.12.021; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Vijayaraghavan S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15916; Vinod BS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.26; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073175; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Woo SM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.472; Woo SM, 2016, ONCOTARGET, V7, P61520, DOI 10.18632/oncotarget.11137; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230	60	34	39	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5205	5220		10.1038/s41388-018-0345-6	http://dx.doi.org/10.1038/s41388-018-0345-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29849119	Green Published, hybrid			2022-12-26	WOS:000445093100005
J	Hytting-Andreasen, R; Balk-Moller, E; Hartmann, B; Pedersen, J; Windelov, JA; Holst, JJ; Kissow, H				Hytting-Andreasen, Rasmus; Balk-Moller, Emilie; Hartmann, Bolette; Pedersen, Jens; Windelov, Johanne Agerlin; Holst, Jens Juul; Kissow, Hannelouise			Endogenous glucagon-like peptide-1 and 2 are essential for regeneration after acute intestinal injury in mice	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED MUCOSITIS; IMPAIRED GLUCOSE-TOLERANCE; STEM-CELL TRANSPLANTATION; CONDITIONING CHEMOTHERAPY; INSULIN-SECRETION; INCRETIN HORMONES; IV INHIBITION; RATS; GROWTH; PANCREAS	Objective Mucositis is a side effect of chemotherapy seen in the digestive tract, with symptoms including pain, diarrhoea, inflammation and ulcerations. Our aim was to investigate whether endogenous glucagon-like peptide -1 and -2 (GLP-1 and GLP-2) are implicated in intestinal healing after chemotherapy-induced mucositis. Design We used a transgenic mouse model Tg(GCG.DTR)(Tg) expressing the human diphtheria toxin receptor in the proglucagon-producing cells. Injections with diphtheria toxin ablated the GLP-1 and GLP-2 producing L-cells in Tg mice with no effect in wild-type (WT) mice. Mice were injected with 5-fluorouracil or saline and received vehicle, exendin-4, teduglutide (gly2-GLP-2), or exendin-4/teduglutide in combination. The endpoints were body weight change, small intestinal weight, morphology, histological scoring of mucositis and myeloperoxidase levels. Results Ablation of L-cells led to impaired GLP-2 secretion; increased loss of body weight; lower small intestinal weight; lower crypt depth, villus height and mucosal area; and increased the mucositis severity score in mice given 5-fluorouracil. WT mice showed compensatory hyperproliferation as a sign of regeneration in the recovery phase. Co-treatment with exendin-4 and teduglutide rescued the body weight of the Tg mice and led to a hyperproliferation in the small intestine, whereas single treatment was less effective. Conclusion The ablation of L-cells leads to severe mucositis and insufficient intestinal healing, shown by severe body weight loss and lack of compensatory hyperproliferation in the recovery phase. Co-treatment with exendin-4 and teduglutide could prevent this. Because both peptides were needed, we can conclude that both GLP-1 and GLP-2 are essential for intestinal healing in mice.	[Hytting-Andreasen, Rasmus; Balk-Moller, Emilie; Hartmann, Bolette; Pedersen, Jens; Windelov, Johanne Agerlin; Holst, Jens Juul; Kissow, Hannelouise] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Hytting-Andreasen, Rasmus; Balk-Moller, Emilie; Hartmann, Bolette; Pedersen, Jens; Windelov, Johanne Agerlin; Holst, Jens Juul; Kissow, Hannelouise] Univ Copenhagen, NNF Ctr Basic Metab Res, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Kissow, H (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.; Kissow, H (corresponding author), Univ Copenhagen, NNF Ctr Basic Metab Res, Copenhagen, Denmark.	kissow@sund.ku.dk	Kissow, Hannelouise/AAW-2119-2020; Holst, Jens/AAA-8022-2022	Kissow, Hannelouise/0000-0001-9351-8885; Holst, Jens Juul/0000-0001-6853-3805; Hartmann, Bolette/0000-0001-8509-2036; Windelov, johanne agerlin/0000-0002-9194-7886	Oda and Hans Svenningsens Foundation; A. P. Moller Foundation; Krista and Viggo Petersen Foundation	Oda and Hans Svenningsens Foundation; A. P. Moller Foundation; Krista and Viggo Petersen Foundation	This work was supported from grants received from Oda and Hans Svenningsens Foundation (http://homannlaw.dk/da/artikel/oda-og-hans-svenningsens-fond), A. P. Moller Foundation (https://www.apmollerfonde.dk) and Krista and Viggo Petersen Foundation (http://www.kv-fonden.dk) (to Hannelouise Kissow). The funders provided support in the form of research materials, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did not provide salaries for authors.	Anbazhagan AN, NANOMEDICINE NANOTEC, V13, P659; Bahrami J, 2010, GASTROENTEROLOGY, V138, P2447, DOI 10.1053/j.gastro.2010.03.006; Bang-Berthelsen CH, 2016, INFLAMM BOWEL DIS, V22, P2078, DOI 10.1097/MIB.0000000000000847; BELL GI, 1983, NATURE, V302, P716, DOI 10.1038/302716a0; Binker MG, 2010, WORLD J GASTROENTERO, V16, P5565, DOI 10.3748/wjg.v16.i44.5565; Blijlevens N, 2008, J CLIN ONCOL, V26, P1519, DOI 10.1200/JCO.2007.13.6028; Burrin DG, 2000, AM J PHYSIOL-GASTR L, V279, pG1249, DOI 10.1152/ajpgi.2000.279.6.G1249; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Chance WT, 2006, PEPTIDES, V27, P883, DOI 10.1016/j.peptides.2005.09.012; Chen J, 2015, WORLD J GASTROENTERO, V21, P484, DOI 10.3748/wjg.v21.i2.484; Costa LJ, 2008, BRIT J HAEMATOL, V143, P268, DOI 10.1111/j.1365-2141.2008.07342.x; Dong CX, 2014, ENDOCRINOLOGY, V155, P370, DOI 10.1210/en.2013-1871; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Dube PE, 2006, GASTROENTEROLOGY, V131, P589, DOI 10.1053/j.gastro.2006.05.055; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Elting LS, 2003, CLIN EC OUTCOMES CHE; Faerch K, 2015, DIABETES, V64, P2513, DOI 10.2337/db14-1751; Gurney H, 2002, BRIT J CANCER, V86, P1297, DOI 10.1038/sj.bjc.6600139; Hartmann B, 2000, ENDOCRINOLOGY, V141, P4013, DOI 10.1210/en.141.11.4013; Hirotani Y, 2006, BIOL PHARM BULL, V29, P2327, DOI 10.1248/bpb.29.2327; HOLST JJ, 1994, J BIOL CHEM, V269, P18827; Howarth GS, 1996, J NUTR, V126, P2519, DOI 10.1093/jn/126.10.2519; Itou M, 2008, J GASTROEN HEPATOL, V23, P244, DOI 10.1111/j.1440-1746.2007.05183.x; Kissow H, 2013, GUT, V62, P1724, DOI 10.1136/gutjnl-2012-303280; Kissow H, 2012, REGUL PEPTIDES, V179, P91, DOI 10.1016/j.regpep.2012.08.016; Kissow H, 2012, CANCER CHEMOTH PHARM, V70, P39, DOI 10.1007/s00280-012-1882-2; Koehler JA, 2015, CELL METAB, V21, P379, DOI 10.1016/j.cmet.2015.02.005; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Lee SJ, 2012, ENDOCRINOLOGY; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Murphy BA, 2009, J PAIN SYMPTOM MANAG, V38, P522, DOI 10.1016/j.jpainsymman.2008.12.004; Navarro WH, 2003, BONE MARROW TRANSPL, V31, P961, DOI 10.1038/sj.bmt.1704052; Nelson DW, 2008, AM J PHYSIOL-REG I, V294, pR1175, DOI 10.1152/ajpregu.00238.2007; NOVAK U, 1987, EUR J BIOCHEM, V164, P553, DOI 10.1111/j.1432-1033.1987.tb11162.x; Orskov C, 2005, REGUL PEPTIDES, V124, P105, DOI 10.1016/j.regpep.2004.07.009; Orskov C, 1996, SCAND J GASTROENTERO, V31, P665, DOI 10.3109/00365529609009147; Pedersen J, 2013, AM J PHYSIOL-ENDOC M, V304, pE60, DOI 10.1152/ajpendo.00547.2011; Rask E, 2004, METABOLISM, V53, P624, DOI 10.1016/j.metabol.2003.11.011; Shin ED, 2005, GASTROENTEROLOGY, V128, P1340, DOI 10.1053/j.gastro.2005.02.033; Simonsen L, 2007, AM J PHYSIOL-GASTR L, V293, pG288, DOI 10.1152/ajpgi.00453.2006; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis Stephen T, 2004, J Support Oncol, V2, P21; Sucak GT, 2012, INT J HEMATOL, V95, P95, DOI 10.1007/s12185-011-0980-y; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Tsai CH, 1997, AM J PHYSIOL-GASTR L, V272, pG662, DOI 10.1152/ajpgi.1997.272.3.G662; Tsai CH, 1997, AM J PHYSIOL-ENDOC M, V273, pE77, DOI 10.1152/ajpendo.1997.273.1.E77; Xiao Q, 2000, AM J PHYSIOL-REG I, V278, pR1057, DOI 10.1152/ajpregu.2000.278.4.R1057	49	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198046	10.1371/journal.pone.0198046	http://dx.doi.org/10.1371/journal.pone.0198046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864142	Green Published, gold, Green Submitted			2022-12-26	WOS:000434097100018
J	Kirkeby, L; Frost, P; Hansen, TB; Svendsen, SW				Kirkeby, Lone; Frost, Poul; Hansen, Torben Baek; Svendsen, Susanne Wulff			Disability and return to work after MRI on suspicion of scaphoid fracture: Influence of MRI pathology and occupational mechanical exposures	PLOS ONE			English	Article							NEUROPATHY-LIKE SYMPTOMS; ABILITY INDEX; HAND INJURY; BIOMECHANICAL EXPOSURES; FUNCTIONAL OUTCOMES; GENERAL-POPULATION; ULNAR NEUROPATHY; DANISH VERSION; SICK LEAVE; LIFE-STYLE	Objectives We aimed to determine the prognosis after early MRI on clinical suspicion of scaphoid fracture, hypothesising that MRI pathology is associated with more disability and that MRI pathology and high occupational mechanical hand-arm exposures are associated with slower return to work (RTW). Methods We conducted a follow-up study of a cohort of 469 patients, who were scanned in the period 2006 to 2010. The respondents constituted our cohort for disability analysis and the subset that was in the labour market at the time of the trauma constituted our sub-cohort for RTW analysis. Questionnaires included disability scores, job title, and lifestyle factors. Job titles were linked with a job exposure matrix to estimate occupational exposures. Register information was obtained on time until RTW. We used logistic regression analysis of disability and Cox regression analysis of time until RTW. Results The proportion that responded was 53% (249/469) for the disability analysis and 59% (125/212) for the RTW analysis. The mean age at follow up was 43.5 years, the mean time since trauma was 4.8 years, 53% had injury of the dominant hand, and 54% had MRI pathology. Men constituted 43% of the cohort and 56% of the sub-cohort. MRI pathology was not associated with more disability [e.g., for a 'Disabilities of the Arm Shoulder and Hand'-score >= 20 the odds ratio was 0.58 (95% confidence interval 0.26-1.17)]. Patients without MRI pathology and with low occupational exposures were off work for an average of four weeks. Patients with MRI pathology or high occupational exposures were off work for twice as long time. Conclusion MRI pathology was not associated with more disability. For patients, who were in the labour market at the time of the trauma, MRI pathology and high occupational mechanical handarm exposures were associated with slower RTW.	[Kirkeby, Lone; Hansen, Torben Baek] Aarhus Univ, Univ Clin Hand Hip & Knee Surg, Reg Hosp Holstebro, Holstebro, Denmark; [Frost, Poul] Aarhus Univ Hosp, Danish Ramazzini Ctr, Dept Occupat Med, Aarhus, Denmark; [Svendsen, Susanne Wulff] Univ Res Clin, Reg Hosp West Jutland, Dept Occupat Med, Danish Ramazzini Ctr, Herning, Denmark	Aarhus University; Aarhus University	Kirkeby, L (corresponding author), Aarhus Univ, Univ Clin Hand Hip & Knee Surg, Reg Hosp Holstebro, Holstebro, Denmark.	lonekirk@rm.dk	Hansen, Torben Bæk/O-2455-2019	Hansen, Torben Bæk/0000-0003-1678-3612; Kirkeby, Lone/0000-0002-6941-3116				Aasheim T, 2014, J HAND SURG-EUR VOL, V39, P140, DOI 10.1177/1753193413481302; Ahlstrom L, 2013, J OCCUP REHABIL, V23, P248, DOI 10.1007/s10926-012-9391-z; Ahlstrom L, 2010, SCAND J WORK ENV HEA, V36, P404, DOI 10.5271/sjweh.2917; Bae DS, 2016, J PEDIATR ORTHOPED, V36, P13, DOI 10.1097/BPO.0000000000000406; Beaton D E, 2001, J Hand Ther, V14, P128; Bedi A, 2007, J HAND SURG-AM, V32A, P326, DOI 10.1016/j.jhsa.2007.01.002; Biering K, 2013, J OCCUP REHABIL, V23, P400, DOI 10.1007/s10926-012-9405-x; Breitenseher MJ, 1997, RADIOLOGY, V203, P245, DOI 10.1148/radiology.203.1.9122402; Dinah AF, 2007, INT ORTHOP, V31, P503, DOI 10.1007/s00264-006-0231-7; El Fassi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-305; Euler S, 2014, ARCH ORTHOP TRAUM SU, V134, P1023, DOI 10.1007/s00402-014-2007-7; Gould R., 2008, DIMENSIONS WORK ABIL; Hansen TB, 2009, J HAND SURG-EUR VOL, V34E, P627, DOI 10.1177/1753193409105322; Hernandez RK, 2012, ACTA ORTHOP, V83, P653, DOI 10.3109/17453674.2012.747054; Herup Alex, 2010, Ugeskr Laeger, V172, P3333; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JOHNS AM, 1981, INJURY, V12, P417, DOI 10.1016/0020-1383(81)90015-2; Khalid M, 2010, EMERG MED J, V27, P266, DOI 10.1136/emj.2008.058750; Kinnunen U, 2018, SCAND J PUBLIC HEALT, V46, P321, DOI 10.1177/1403494817745190; Kirkeby L, 2013, J HAND SURG-EUR VOL, V38, P571, DOI 10.1177/1753193412471008; Kuijer PPFM, 2012, SCAND J WORK ENV HEA, V38, P600, DOI 10.5271/sjweh.3302; Lee RJ, 2013, CLIN ORTHOP RELAT R, V471, P1208, DOI 10.1007/s11999-012-2626-7; Little CP, 2006, J HAND SURG-BRIT EUR, V31B, P252, DOI 10.1016/j.jhsb.2005.12.010; Lundin A, 2017, SCAND J PUBLIC HEALT, V45, P350, DOI 10.1177/1403494817702759; Lundquist CB, 2014, DAN MED J, V61; MacDermid J C, 1996, J Hand Ther, V9, P178; MacDermid JC, 1998, J ORTHOP TRAUMA, V12, P577, DOI 10.1097/00005131-199811000-00009; McCullough NP, 2011, EUR J EMERG MED, V18, P133, DOI 10.1097/MEJ.0b013e32833edb59; Megerle K, 2008, J HAND SURG-EUR VOL, V33E, P179, DOI 10.1177/1753193408087030; MOORE JS, 1995, AM IND HYG ASSOC J, V56, P443; Mulders MAM, 2018, J HAND THER, V31, P287, DOI 10.1016/j.jht.2017.10.007; Rubak TS, 2014, ARTHRIT CARE RES, V66, P1496, DOI 10.1002/acr.22326; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schonnemann JO, 2013, J PLAST SURG HAND SU, V47, P489, DOI 10.3109/2000656X.2013.787934; Schouten LS, 2016, EUR J PUBLIC HEALTH, V26, P301, DOI 10.1093/eurpub/ckv198; Scolaro JA, 2014, J BONE JOINT SURG AM, V96A, P674, DOI 10.2106/JBJS.M.00081; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Smith JE, 2016, EUR J EMERG MED, V23, P190, DOI 10.1097/MEJ.0000000000000228; Sommer TG, 2015, INT ARCH OCC ENV HEA, V88, P1099, DOI 10.1007/s00420-015-1036-z; Sorensen AA, 2013, J HAND SURG-AM, V38A, P641, DOI 10.1016/j.jhsa.2012.12.032; Stapelfeldt CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-661; Svendsen SW, 2012, SCAND J RHEUMATOL, V41, P59, DOI 10.3109/03009742.2011.595375; Svendsen SW, 2013, SCAND J WORK ENV HEA, V39, P506, DOI 10.5271/sjweh.3352; Svendsen SW, 2012, OCCUP ENVIRON MED, V69, P773, DOI 10.1136/oemed-2011-100499; Wong JYP, 2008, J HAND SURG-AM, V33A, P718, DOI 10.1016/j.jhsa.2008.01.015	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197978	10.1371/journal.pone.0197978	http://dx.doi.org/10.1371/journal.pone.0197978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI0YU	29864121	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100014
J	Alonso, AC; Ribeiro, SM; Luna, NMS; Peterson, MD; Bocalini, DS; Serra, MM; Brech, GC; Greve, JMDA; Garcez-Leme, LE				Alonso, Angelica Castilho; Ribeiro, Samia Maria; Silva Luna, Natalia Mariana; Peterson, Mark D.; Bocalini, Danilo Sales; Serra, Marcos Mauricio; Brech, Guilherme Carlos; Andrea Greve, Julia Maria D.; Garcez-Leme, Luiz Eugenio			Association between handgrip strength, balance, and knee flexion/extension strength in older adults	PLOS ONE			English	Article							EXTENSION STRENGTH; MUSCLE STRENGTH; PERFORMANCE; HEALTH; RISK; MASS; DISABILITY; PREDICTOR; MORTALITY	The objective of the study was to examine the association between handgrip strength (HGS), knee flexion and extension strength, and static and dynamic balance in older women. One hundred and ten women with a mean age of 67.4 +/- 5.9 years were assessed for dynamic postural balance using the Time Up & Go Test (TUG) with and without cognitive tasks. Semi-static balance was assessed by means of a force platform; knee flexor and extensor muscle strength was calculated using an isokinetic dynamometer; and HGS using a hand held dynamometer. Weaker HGS was significantly correlated with worse performance in dynamic postural balance, as well as performance with TUG with and without cognitive tasks; however, there was no correlation between HGS and static balance. There was a moderate positive correlation between knee flexion/extension strength and HGS. This suggests that HGS could be used as a proxy indicator of overall strength capacity for clinical screening among older women.	[Alonso, Angelica Castilho; Ribeiro, Samia Maria; Silva Luna, Natalia Mariana; Bocalini, Danilo Sales; Brech, Guilherme Carlos] Sao Judas Tadeu Univ USJT, Program Aging Sci, Sao Paulo, Brazil; [Alonso, Angelica Castilho; Silva Luna, Natalia Mariana; Serra, Marcos Mauricio; Brech, Guilherme Carlos; Andrea Greve, Julia Maria D.; Garcez-Leme, Luiz Eugenio] Univ Sao Paulo, Fac Med, Inst Orthoped & Traumatol, Lab Study Movement, Sao Paulo, Brazil; [Ribeiro, Samia Maria] State Univ Vale Acarau UVA, Sobral, Ceara, Brazil; [Peterson, Mark D.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Universidade Sao Judas Tadeu; Universidade de Sao Paulo; University of Michigan System; University of Michigan	Alonso, AC (corresponding author), Sao Judas Tadeu Univ USJT, Program Aging Sci, Sao Paulo, Brazil.; Alonso, AC (corresponding author), Univ Sao Paulo, Fac Med, Inst Orthoped & Traumatol, Lab Study Movement, Sao Paulo, Brazil.	angelicacastilho@msn.com	Brech, Guilherme C/I-6100-2012; /J-7743-2012; GREVE, JULIA/A-7849-2013; Brech, Guilherme Carlos/ABE-7994-2021; Peterson, Mark/ABD-3853-2020; Garcez Leme, Luiz/C-6759-2009	Brech, Guilherme C/0000-0002-0403-0632; /0000-0002-9644-5068; GREVE, JULIA/0000-0003-1778-0448; Brech, Guilherme Carlos/0000-0002-0403-0632; Peterson, Mark/0000-0002-9861-4275; Garcez Leme, Luiz/0000-0002-9738-5466				Alonso AC, 2016, EXP GERONTOL, V85, P13, DOI 10.1016/j.exger.2016.09.006; Alonso Angélica Castilho, 2014, MedicalExpress (São Paulo, online), V1, P298, DOI 10.5935/MedicalExpress.2014.06.03; Alonso AC, 2012, CLINICS, V67, P1433, DOI 10.6061/clinics/2012(12)14; Bohannon RW, 2012, PERCEPT MOTOR SKILL, V114, P514, DOI 10.2466/03.26.PMS.114.2.514-518; Brech GC, 2011, MATURITAS, V70, P379, DOI 10.1016/j.maturitas.2011.09.004; Caporrino FA., 1998, REV BRAS ORTOP, V33, P150; Cawthon PM, 2009, J AM GERIATR SOC, V57, P1411, DOI 10.1111/j.1532-5415.2009.02366.x; Chan OYA, 2014, AGE, V36, DOI 10.1007/s11357-014-9714-4; den Ouden MEM, 2013, EXP GERONTOL, V48, P437, DOI 10.1016/j.exger.2013.02.002; Fragala MS, 2016, J AM GERIATR SOC, V64, P144, DOI 10.1111/jgs.13871; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Karvonen-Gutierrez C, AGE AGEING; Koopman JJE, 2015, AGE AGEING, V44, P465, DOI 10.1093/ageing/afu165; Lourenco RA, 2006, REV SAUDE PUBL, V40, P712, DOI 10.1590/S0034-89102006000500023; Mathiowetz Virgil, 2002, Occup Ther Int, V9, P201, DOI 10.1002/oti.165; Matsudo SM., 2002, REV BRAS CIENC MOV, V10, P41; McGrath RP, 2017, J AGING HEALTH; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Peterson M, 2017, J GERONTOL A; Peterson MD, 2016, J AM MED DIR ASSOC, V17, P933, DOI 10.1016/j.jamda.2016.06.007; Serra MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166105; Stel VS, 2003, J CLIN EPIDEMIOL, V56, P659, DOI 10.1016/S0895-4356(03)00082-9; Stevens PJ, 2012, J NUTR HEALTH AGING, V16, P769, DOI 10.1007/s12603-012-0388-2; Sugiura Y, 2013, ARCH GERONTOL GERIAT, V57, P319, DOI 10.1016/j.archger.2013.06.006; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022	25	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198185	10.1371/journal.pone.0198185	http://dx.doi.org/10.1371/journal.pone.0198185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856802	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800080
J	Perez-Losada, J; Fort, J				Perez-Losada, Joaquim; Fort, Joaquim			A serial founder effect model of phonemic diversity based on phonemic loss in low-density populations	PLOS ONE			English	Article							LANGUAGE EVOLUTION; INVENTORY SIZE; HOMO-SAPIENS; DISPERSAL; DISTANCE; AFRICA; TRANSITION; DRIFT	It has been observed that the number of phonemes in languages in use today tends to decrease with increasing distance from Africa. A previous formal model has recently reproduced the observed cline, but under two strong assumptions. Here we tackle the question of whether an alternative explanation for the worldwide phonemic cline is possible, by using alternative assumptions. The answer is affirmative. We show this by formalizing a proposal, following Atkinson, that this pattern may be due to a repeated bottleneck effect and phonemic loss. In our simulations, low-density populations lose phonemes during the Out-of-Africa dispersal of modern humans. Our results reproduce the observed global cline for the number of phonemes. In addition, we also detect a cline of phonemic diversity and reproduce it using our simulation model. We suggest how future work could determine whether the previous model or the new one (or even a combination of them) is valid. Simulations also show that the clines can still be present even 300 kyr after the Out-of-Africa dispersal, which is contrary to some previous claims which were not supported by numerical simulations.	[Perez-Losada, Joaquim; Fort, Joaquim] Univ Girona, Complex Syst Lab, Maria Aurelia Capmany 61, Girona, Catalonia, Spain; [Fort, Joaquim] Catalan Inst Res & Adv Studies ICREA, Lluis Co 23, Barcelona, Catalonia, Spain	Universitat de Girona; ICREA	Perez-Losada, J (corresponding author), Univ Girona, Complex Syst Lab, Maria Aurelia Capmany 61, Girona, Catalonia, Spain.	joaquim.perez@udg.edu		Perez-Losada, Joaquim/0000-0002-8590-2155	Agencia de Gestio d'Ajuts Universitaris i de Recerca [2017-SGR-243]; Ministerio de Economia, Industria y Competividad (MINECO) [FIS-2016-80200-P]; Ministerio de Economia, Industria y Competividad (MINECO) [FIS-2016-80200-P]; Institucio Catalana de Recerca i Estudis Avancats (ICREA)	Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Economia, Industria y Competividad (MINECO); Ministerio de Economia, Industria y Competividad (MINECO); Institucio Catalana de Recerca i Estudis Avancats (ICREA)(ICREA)	This work received support from the following sources: 1. - Agencia de Gestio d'Ajuts Universitaris i de Recerca. Award Number: 2017-SGR-243. Recipient: Joaquim Fort; 2. - Agencia de Gestio d'Ajuts Universitaris i de Recerca. Award Number: 2017-SGR-243. Recipient: Joaquim Perez-Losada; 3. Ministerio de Economia, Industria y Competividad (MINECO). Award Number: FIS-2016-80200-P. Recipient: Joaquim Fort; 4. Ministerio de Economia, Industria y Competividad (MINECO). Award Number: FIS-2016-80200-P. Recipient: Joaquim Perez-Losada; and 5. Institucio Catalana de Recerca i Estudis Avancats (ICREA). Award Number: Academia Humanities award 2014. Recipient: Joaquim Fort.	[Anonymous], 1987, EVOLUTION HUMAN SOC; Atkinson QD., 2011, LINGUIST TYPOL, V15, P321, DOI [DOI 10.1515/LITY.2011.022, 10.1515/lity.2011.022]; Atkinson QD, 2012, SCIENCE, V335, DOI 10.1126/science.1210005; Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; Bowern C, 2011, LINGUIST TYPOL, V15, P207, DOI DOI 10.1515/LITY.2011.015); Bromham L, 2017, BIOL PHILOS, V32, P855, DOI 10.1007/s10539-017-9594-y; Bromham L, 2015, P NATL ACAD SCI USA, V112, P2097, DOI 10.1073/pnas.1419704112; Bybee Joan, 2011, LINGUIST TYPOL, V15, P147, DOI [10.1515/lity.2011.009, DOI 10.1515/LITY.2011.009]; Collard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072628; Concolly J, 2008, J ARCHAEOL SCI, V35, P2797, DOI 10.1016/j.jas.2008.05.006; Corballis MC, 2002, HAND MOUTH ORIGINS L; Coupe A C, 2005, LANG ACQUIS, P153; Coupe Christophe, 2013, EASTWARD FLOWS GREAT, P75; Creanza N, 2015, P NATL ACAD SCI USA, V112, P1265, DOI 10.1073/pnas.1424033112; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cysouw M, 2012, SCIENCE, V335, DOI 10.1126/science.1208841; Dahl O, 2011, LINGUIST TYPOL, V15, P171, DOI DOI 10.1515/LITY.2011.012); Daniel Nettle, 1999, LINGUISTIC DIVERSITY; Davison K, 2006, J ARCHAEOL SCI, V33, P641, DOI 10.1016/j.jas.2005.09.017; de Boer B, 2000, J PHONETICS, V28, P441, DOI 10.1006/jpho.2000.0125; Derex M, 2013, NATURE, V503, P389, DOI 10.1038/nature12774; Deshpande O, 2009, P ROY SOC B-BIOL SCI, V276, P291, DOI 10.1098/rspb.2008.0750; Dixon Robert, 1976, TRIBES BOUNDARIES AU, P207; Donohue M, 2011, LINGUIST TYPOL, V15, P161, DOI [10.1515/lity.2011.011, DOI 10.1515/LITY.2011.011, DOI 10.1515/LITY.20]; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Fleming L, 2017, J LANG EVOL, V2, P52, DOI 10.1093/jole/lzx010; Fort J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031913; Fort J, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0185; Fort J, 2012, P NATL ACAD SCI USA, V109, P18669, DOI 10.1073/pnas.1200662109; Fort J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/8/086001; Fort J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031913; Gray R, 2005, SCIENCE, V309, P2007, DOI 10.1126/science.1119276; Greenhill SJ, 2016, J LANG EVOL, V1, P30, DOI 10.1093/jole/lzv007; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Grove M, 2015, J HUM EVOL, V87, P32, DOI 10.1016/j.jhevol.2015.07.007; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Haspelmath M., 2013, WORLD ATLAS LANGUAGE; HASSAN FA, 1981, DEMOGRAPHIC ARCHAEOL; Hay J, 2007, LANGUAGE, V83, P388, DOI 10.1353/lan.2007.0071; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Henrich J, 2016, P NATL ACAD SCI USA, V113, pE6724, DOI 10.1073/pnas.1610005113; Hunley K, 2015, P NATL ACAD SCI USA, V112, P1919, DOI 10.1073/pnas.1425000112; Hunley K, 2012, P ROY SOC B-BIOL SCI, V279, P2281, DOI 10.1098/rspb.2011.2296; Johanna Brugman, 2009, THESIS CORNELL U ITH; Kacprzak S, 2013, P 19 NAT C APPL MATH, P48; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Maddieson I, 2011, UCLA WORKING PAPERS, V74, P104; Maddieson I, 2011, LINGUIST TYPOL, V15, P267, DOI 10.1515/LITY.2011.020; Munroe RL, 2009, CROSS-CULT RES, V43, P123, DOI 10.1177/1069397109331485; NEIMAN FD, 1995, AM ANTIQUITY, V60, P7, DOI 10.2307/282074; Nichols J, 2013, OXFORD HDB LANGUAGE, P559; O'Connell JF, 2012, AUST ARCHAEOL, P5; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Pagel M, 2017, PSYCHON B REV, V24, P151, DOI 10.3758/s13423-016-1072-z; Pakendorf B, 2014, CURR OPIN GENET DEV, V29, P39, DOI 10.1016/j.gde.2014.07.006; Perez-Losada J, 2011, J ARCHAEOL SCI, V38, P1294, DOI 10.1016/j.jas.2011.01.004; Pericliev V, 2011, LINGUISTIC TYPOLOGY, V15, P217, DOI [10.1515/lity.2011.016, DOI 10.1515/LITY.2011.016]; Perreault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035289; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reali F, 2010, P ROY SOC B-BIOL SCI, V277, P429, DOI 10.1098/rspb.2009.1513; Reyes-Centeno H, 2016, SCI REP-UK, V6, DOI 10.1038/srep36645; Reyes-Centeno H, 2016, QUATERN INT, V416, P249, DOI 10.1016/j.quaint.2015.11.063; Ringe D., 2011, LINGUISTIC TYPOLOGY, V15, P223; Ritt Nikolaus, 2004, SELFISH SOUNDS LINGU; Romanowska I, 2017, QUATERN INT, V431, P53, DOI 10.1016/j.quaint.2016.01.016; Ruhlen M., 1994, ORIGIN LANGUAGE TRAC; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; Shennan SJ, 2001, AM ANTIQUITY, V66, P577, DOI 10.2307/2694174; Sproat R., 2011, LINGUIST TYPOL, V15, P199, DOI DOI 10.1515/LITY.2011.014); Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Trudgill P, 2011, LINGUIST TYPOL, V15, P155, DOI DOI 10.1515/LITY.2011.010); Trudgill Peter, 2004, LINGUIST TYPOL, V8, P305, DOI DOI 10.1515/LITY.2004.8.3.305; Vaesen K, 2016, P NATL ACAD SCI USA, V113, pE6726, DOI 10.1073/pnas.1613074113; Vaesen K, 2016, P NATL ACAD SCI USA, V113, pE2241, DOI 10.1073/pnas.1520288113; Van Tuyl R, 2012, SCIENCE, V335, DOI 10.1126/science.1209176; Wang CC, 2012, SCIENCE, V335, DOI 10.1126/science.1207846; Wichmann Soren, 2011, LINGUIST TYPOL, V2011, P177, DOI DOI 10.1515/LITY.2011.013	81	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198346	10.1371/journal.pone.0198346	http://dx.doi.org/10.1371/journal.pone.0198346			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856877	gold, Green Published			2022-12-26	WOS:000433900800107
J	Bryce, CL; Chang, CCH; Ren, Y; Yabes, J; Zenarosa, G; Iyer, A; Tomko, H; Squires, RH; Roberts, MS				Bryce, Cindy L.; Chang, Chung Chou H.; Ren, Yi; Yabes, Jonathan; Zenarosa, Gabriel; Iyer, Aditya; Tomko, Heather; Squires, Robert H.; Roberts, Mark S.			Using time-varying models to estimate post-transplant survival in pediatric liver transplant recipients	PLOS ONE			English	Article							FAILURE STUDY-GROUP; DISEASE SCORE; UNITED-STATES; CHILDREN; PATIENT; SYSTEM; MELD	Purpose To distinguish clinical factors that have time-varying (as opposed to constant) impact upon patient and graft survival among pediatric liver transplant recipients. Methods Using national data from 2002 through 2013, we examined potential clinical and demographic covariates using Gray's piecewise constant time-varying coefficients (TVC) models. For both patient and graft survival, we estimated univariable and multivariable Gray's TVC, retaining significant covariates based on backward selection. We then estimated the same specification using traditional Cox proportional hazards (PH) models and compared our findings. Results For patient survival, covariates included recipient diagnosis, age, race/ethnicity, ventilator support, encephalopathy, creatinine levels, use of living donor, and donor age. Only the effects of recipient diagnosis and donor age were constant; effects of other covariates varied over time. We retained identical covariates in the graft survival model but found several differences in their impact. Conclusion The flexibility afforded by Gray's TVC estimation methods identify several covariates that do not satisfy constant proportionality assumptions of the Cox PH model. Incorporating better survival estimates is critical for improving risk prediction tools used by the transplant community to inform organ allocation decisions.	[Bryce, Cindy L.; Tomko, Heather; Roberts, Mark S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA; [Bryce, Cindy L.; Chang, Chung Chou H.; Yabes, Jonathan; Iyer, Aditya; Roberts, Mark S.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Bryce, Cindy L.; Chang, Chung Chou H.; Yabes, Jonathan; Roberts, Mark S.] Univ Pittsburgh, Sch Med, Dept Clin & Translat Sci, Pittsburgh, PA 15260 USA; [Chang, Chung Chou H.; Ren, Yi; Zenarosa, Gabriel] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Zenarosa, Gabriel; Roberts, Mark S.] Univ Pittsburgh, Swanson Sch Engn, Dept Ind Engn, Pittsburgh, PA USA; [Squires, Robert H.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Squires, Robert H.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bryce, CL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA.; Bryce, CL (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA.; Bryce, CL (corresponding author), Univ Pittsburgh, Sch Med, Dept Clin & Translat Sci, Pittsburgh, PA 15260 USA.	bryce99@pitt.edu	Zenarosa, Gabriel L./AAQ-9918-2021	Zenarosa, Gabriel L./0000-0003-1096-3559	National Institute of Diabetes and Digestive and Kidney Disease NIDDK [U01 DK072146]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072146] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institute of Diabetes and Digestive and Kidney Disease NIDDK U01 DK072146 (CLB, C-CHC, YR, JY, GZ, AI, HT, RHS, MSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078202; Brown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340; COX DR, 1972, J R STAT SOC B, V34, P187; GRAY RJ, 1994, BIOMETRICS, V50, P640, DOI 10.2307/2532779; Habib S, 2006, LIVER TRANSPLANT, V12, P440, DOI 10.1002/lt.20721; Hayashi PH, 2003, LIVER TRANSPLANT, V9, P737, DOI 10.1053/jlts.2003.50122; Israni AK, 2014, J AM SOC NEPHROL, V25, P1842, DOI 10.1681/ASN.2013070784; Klein KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080661; Li R, 2016, J PEDIATR-US, V171, P163, DOI 10.1016/j.jpeds.2015.12.065; Liu E, 2006, J HEPATOL, V44, P134, DOI 10.1016/j.jhep.2005.06.021; Lu BR, 2013, J PEDIATR-US, V162, P1010, DOI 10.1016/j.jpeds.2012.11.021; Lutfi R, 2017, J PEDIATR GASTR NUTR, V64, P660, DOI 10.1097/MPG.0000000000001441; McDiarmid SV, 2002, TRANSPLANTATION, V74, P173, DOI 10.1097/00007890-200207270-00006; Network OPaT, POL 9 ALL LIV LIV IN; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Onaca NN, 2003, LIVER TRANSPLANT, V9, P117, DOI 10.1053/jlts.2003.50027; OPTN: Organ Procurement and Transplantation Network Health Resources and Services Administration U.S. Department of Health & Human Services. The New Kidney Allocation System (KAS), NEW KIDN ALL SYST KA; Ren Y, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/719389; Roberts MS, 2004, LIVER TRANSPLANT, V10, P886, DOI 10.1002/lt.20137; Shechter SM, 2005, MED DECIS MAKING, V25, P199, DOI 10.1177/0272989X04268956; Sorensen LG, 2015, J PEDIATR GASTR NUTR, V60, P75, DOI 10.1097/MPG.0000000000000575; Squires RH, 2014, J PEDIATR GASTR NUTR, V59, P537, DOI 10.1097/MPG.0000000000000456; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Sundaram V, 2013, J PEDIATR-US, V162, P319, DOI 10.1016/j.jpeds.2012.07.002; UNOS, POL DEV UN NETW ORG; UNOS, US ORG PROC TRANSPL; UNOS, 2005, MELD PELD CALC DOC; UNOS, QUEST ANSW TRANSPL C	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5								10.1371/journal.pone.0198132	http://dx.doi.org/10.1371/journal.pone.0198132			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851966	Green Submitted, Green Published, gold			2022-12-26	WOS:000433893200034
J	Dahlman, D; Berge, J; Bjtorkman, P; Nilsson, AC; Hakansson, A				Dahlman, Disa; Berge, Jonas; Bjtorkman, Per; Nilsson, Anna C.; Hakansson, Anders			Both localized and systemic bacterial infections are predicted by injection drug use: A prospective follow-up study in Swedish criminal justice clients	PLOS ONE			English	Article							ADDICTION SEVERITY INDEX; SOFT-TISSUE INFECTIONS; QUALITY-OF-LIFE; AMPHETAMINE USERS; VIRUS-INFECTION; RISK-FACTORS; PEOPLE; SWEDEN; SKIN; ASSOCIATIONS	Background Both skin and soft tissue infections (SSTI) and systemic bacterial infections are common in people who inject drugs (PWID), but data on incidence and risk factors are lacking. We compared registered diagnoses for such infections in Swedish criminal justice clients with regard to injecting drug use. Methods Baseline interview data from the Swedish Prison and Probation Service on drug use in PWID and non-PWID with problematic alcohol use were linked to follow-up data from national Swedish registers on hospital diagnoses and/or death. Associations between drug use and later diagnosis of SSTI and systemic bacterial infection (septicemia or bacterial infection of the heart, bone/joints or central nervous system) were analyzed by Cox regression. Results Incidence rates of SSTI was 28.3 per 1,000 person-years for PWID (n = 2,444) and 10.0 for non-PWID with problematic alcohol use (n = 735). Incidence rates of systemic bacterial infection was 9.1 per 1,000 person-years for PWID and 2.7 per 1,000 person-years for non-PWID. Injection drug use was associated with a significantly increased risk of bacterial infections, for main drugs heroin (SSTI: Hazard ratio [HR] 2.45; systemic infection: HR 2.75), amphetamine (SSTI: HR 1.60; systemic infection: HR 2.19), and polysubstance use (SSTI: HR 1.92; systemic infection: HR 2.01). In relation to injection use of amphetamine and poly substance use, PWID mainly using heroin had higher risk of SSTI. Conclusions Injection drug use predicted both SSTI and systemic bacterial infection, with a particularly high risk of SSTI in PWID mainly using heroin. The results imply the need for increased attention to bacterial infections among PWID, in terms of clinical management, prevention and research.	[Dahlman, Disa; Berge, Jonas; Hakansson, Anders] Lund Univ, Dept Clin Sci Lund, Div Psychiat, Lund, Sweden; [Dahlman, Disa; Berge, Jonas; Hakansson, Anders] Malmo Addict Ctr, Malmo, Sweden; [Bjtorkman, Per; Nilsson, Anna C.] Lund Univ, Dept Translat Med Malmo, Infect Dis Res Unit, Lund, Sweden	Lund University; Lund University	Dahlman, D (corresponding author), Lund Univ, Dept Clin Sci Lund, Div Psychiat, Lund, Sweden.; Dahlman, D (corresponding author), Malmo Addict Ctr, Malmo, Sweden.	disa.dahlman@med.lu.se		Dahlman, Disa/0000-0003-0507-8758				Aitken CK, 2017, EPIDEMIOL INFECT, V145, P796, DOI 10.1017/S0950268816002892; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 20048 SOSFS; Blome MA, 2011, J VIRAL HEPATITIS, V18, P831, DOI 10.1111/j.1365-2893.2010.01400.x; Chang Z, 2015, LANCET PSYCHIAT, V2, P422, DOI 10.1016/S2215-0366(15)00088-7; Ciccarone D, 2016, DRUG ALCOHOL DEPEN, V163, P126, DOI 10.1016/j.drugalcdep.2016.04.009; Dahlman D, 2017, SUBST ABUS, V38, P105, DOI 10.1080/08897077.2016.1263592; Dwyer R, 2009, DRUG ALCOHOL DEPEN, V100, P9, DOI 10.1016/j.drugalcdep.2008.08.016; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Hakansson A, 2007, EUR ADDICT RES, V13, P207, DOI 10.1159/000104883; Hakansson A, 2013, DRUG ALCOHOL DEPEN, V132, P499, DOI 10.1016/j.drugalcdep.2013.03.014; Hakansson A, 2011, DRUG ALCOHOL DEPEN, V118, P5, DOI 10.1016/j.drugalcdep.2011.02.014; Hakansson A, 2009, EUR ADDICT RES, V15, P10, DOI 10.1159/000173004; Hope V, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-120; Jarlais DCD, 2007, AIDS BEHAV, V11, pS78, DOI 10.1007/s10461-007-9227-6; Johansson LA, 2009, J CLIN EPIDEMIOL, V62, P1202, DOI 10.1016/j.jclinepi.2009.01.010; Kak V, 2002, INFECT DIS CLIN N AM, V16, P681, DOI 10.1016/S0891-5520(02)00016-8; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Larney S, 2017, DRUG ALCOHOL DEPEN, V171, P39, DOI [10.1016/j.drugalcdep.2016.11.029, 10.1016/j.drugalcdep.2016.08.320]; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316; Mitchell SG, 2015, J PSYCHOACTIVE DRUGS, V47, P149, DOI 10.1080/02791072.2015.1014948; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Nystrom S, 2010, J SUBST USE, V15, P330, DOI 10.3109/14659890903431629; Ortiz-Bautista C, 2015, INT J CARDIOL, V187, P472, DOI 10.1016/j.ijcard.2015.03.368; Padaiga Z, 2007, MEDICINA-LITHUANIA, V43, P235, DOI 10.3390/medicina43030029; Phillips KT, 2013, SUBST USE MISUSE, V48, P54, DOI 10.3109/10826084.2012.722159; Phillips KT, 2010, AM J DRUG ALCOHOL AB, V36, P92, DOI 10.3109/00952991003592311; Richert T., 2011, SOCIALVETENSKAPLIG T, V18, P144, DOI [10.3384/SVT.2011.18.2.2468, DOI 10.3384/SVT.2011.18.2.2468]; Rotily M, 2001, EUR J PUBLIC HEALTH, V11, P243, DOI 10.1093/eurpub/11.3.243; Spijkerman IJB, 1996, J CLIN EPIDEMIOL, V49, P1149, DOI 10.1016/0895-4356(96)00180-1; STOFFELMAYR BE, 1994, J SUBST ABUSE TREAT, V11, P373, DOI 10.1016/0740-5472(94)90048-5; Swedish National Board of Health and Welfare, 2015, NAT PAT REG; Tengvald K., 2004, J SUBST USE, V9, P163, DOI [10.1080/14659890410001697505, DOI 10.1080/14659890410001697505]; Ternhag A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067519; The Swedish National Board of Health and Welfare, 2010, DODS HIST PROD TILLF	39	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5								10.1371/journal.pone.0196944	http://dx.doi.org/10.1371/journal.pone.0196944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29851980	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200009
J	Wilk, RJ; Lesmeister, DB; Forsman, ED				Wilk, Randall J.; Lesmeister, Damon B.; Forsman, Eric D.			Nest trees of northern spotted owls (Strix occidentalis caurina) in Washington and Oregon, USA	PLOS ONE			English	Article							WESTERN OLYMPIC PENINSULA; DOUGLAS-FIR FORESTS; DWARF MISTLETOE; NORTHWESTERN CALIFORNIA; HABITAT SELECTION; CLIMATE; DEMOGRAPHY; DISPERSAL; WILDLIFE; SITES	The northern spotted owl (Strix occidentalis caurina) is a federally-threatened subspecies in the United States associated with late-successional forests. In mesic forests it nests primarily in tree cavities, but also uses various types of external platform nests in drier forests. We describe 1717 northern spotted owl nests in 16 different tree species in five study areas in Washington and Oregon in the Pacific Northwest, USA. The vast majority of nests (87%) were in Douglas-fir (Pseudotsuga menziesii) trees, except on the Olympic Peninsula, Washington, where nests were about equally abundant in Douglas-fir, western red cedar (Thuja plicata), and western hemlock (Tsuga heterophylla) trees. Distribution of nests was 57.9% in top cavities of trees with broken tops, 20.3% in side cavities of hollow tree trunks, and 21.8% on external platforms of trees. Platforms were most common in the two driest study areas in the Eastern Cascades Physiographic Province, Washington (89% of nests), and the Klamath Province, Oregon (32%). The vast majority (89%) of nests were in trees with intact or declining crowns. Nests in dead trees were most common on the Olympic Peninsula. Nest trees with top and side cavities were larger and much more prevalent in study areas where annual precipitation was highest (Olympic Peninsula, Oregon Coast Range). Large nest cavities and platforms used by northern spotted owls occur almost exclusively in old forest. Managing for the retention of such forests and for their replacement is a significant challenge for land managers, especially in the face of climate change and an increasing human population, but will likely be required for the persistence of viable populations of northern spotted owls.	[Wilk, Randall J.] US Forest Serv, Dept Agr, Forestry Sci Lab, Pacific Northwest Res Stn, Olympia, WA 98502 USA; [Lesmeister, Damon B.; Forsman, Eric D.] US Forest Serv, Dept Agr, Forestry Sci Lab, Corvallis, OR USA; [Lesmeister, Damon B.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Wilk, RJ (corresponding author), US Forest Serv, Dept Agr, Forestry Sci Lab, Pacific Northwest Res Stn, Olympia, WA 98502 USA.	rwilk@fs.fed.us		Wilk, Randall/0000-0001-8050-8303	USDA Forest Service Region 6; Pacific Northwest Research Station (PNW); USDI Bureau of Land Management	USDA Forest Service Region 6; Pacific Northwest Research Station (PNW); USDI Bureau of Land Management	Funding and support for collection of data was provided by USDA Forest Service Region 6 and Pacific Northwest Research Station (PNW), and USDI Bureau of Land Management. PNW contributed to the study design of the manuscript, data collection and analysis, decision to publish, and preparation of the manuscript. Other funds had no role in the design of this study, data organization and analysis, decision to publish, or preparation of the manuscript.	AGEE JK, 1984, ECOLOGY, V65, P810, DOI 10.2307/1938054; Anthony RG, 2006, WILDLIFE MONOGR, P1; Bennetts RE, 1996, ECOL APPL, V6, P899, DOI 10.2307/2269493; BUCHANAN JB, 1995, J WILDLIFE MANAGE, V59, P301, DOI 10.2307/3808943; Buchanan JB, 1999, NORTHWEST SCI, V73, P255; BUCHANAN JB, 1993, J RAPTOR RES, V27, P1; Buchanan Joseph B., 1998, Northwestern Naturalist, V79, P33, DOI 10.2307/3536815; Bull EL, 2004, WEST J APPL FOR, V19, P133, DOI 10.1093/wjaf/19.2.133; Bunnell Fred L., 2002, U S Forest Service General Technical Report PSW, V181, P717; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLINE SP, 1980, J WILDLIFE MANAGE, V44, P773, DOI 10.2307/3808305; Cumming G., 2013, UNDERSTANDING NEW ST; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Dugger KM, 2016, CONDOR, V118, P57, DOI 10.1650/CONDOR-15-24.1; Dugger KM, 2005, CONDOR, V107, P863, DOI 10.1650/7824.1; Fidler F, 2009, Z PSYCHOL, V217, P27, DOI 10.1027/0044-3409.217.1.27; Folliard LB, 1993, THESIS; Forsman E.D., 1983, PNWGTR162 USDA FOR S; Forsman E.D., 1984, WILDLIFE MONOGR, V87, P64; Forsman ED, 2004, NORTHWEST SCI, V78, P294; Forsman ED, 2004, J RAPTOR RES, V38, P214; Forsman ED, 2002, WILDLIFE MONOGR, P1; Forsman ED, 1997, WILSON BULL, V109, P28; Forsman ED, 2001, J RAPTOR RES, V35, P141; FORSMAN ED, 1995, CONDOR, V97, P1078, DOI 10.2307/1369551; Forsman ED, 2015, J RAPTOR RES, V49, P109, DOI 10.3356/rapt-49-02-109-128.1; Forsman ED, 2011, STUD AVIAN BIOL, P1; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Franklin Alan B., 1996, Studies in Avian Biology, V17, P12; Franklin J.F., 1988, US DEP AGR FOR SERV, P8; Franklin J.F., 1981, PNWGTR118 USDA FOR S; Gavin DG, 2013, ECOL MONOGR, V83, P471, DOI 10.1890/12-1742.1; Guetterman J. H., 1991, PNWGTR272 USDA FOR S; Hadfield JS, FOREST INSECT DIS LE, V54; Hedwall SJ, 2006, WEST N AM NATURALIST, V66, P450, DOI 10.3398/1527-0904(2006)66[450:WUODDM]2.0.CO;2; Hershey KT, 1998, J WILDLIFE MANAGE, V62, P1398, DOI 10.2307/3802006; Hinkle D.E., 2003, APPL STAT BEHAV SCI; HOLTHAUSEN RS, 1995, PNWGTR352 USDA FOR S; Irwin LL, 2012, J WILDLIFE MANAGE, V76, P200, DOI 10.1002/jwmg.218; LaHaye W.S., 1995, BIRDS N AM LIFE HIST; LaHaye WS, 1999, CONDOR, V101, P324, DOI 10.2307/1369995; Lesmeister DB, SYNTHESIS SCI INFORM; Lint J, 1999, PNWGTR440; MANNAN RW, 1980, J WILDLIFE MANAGE, V44, P787, DOI 10.2307/3808306; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; Parks Catherine G., 1999, Western Journal of Applied Forestry, V14, P100; Price Amy L., 2015, Northwestern Naturalist, V96, P37; Shaw DC, 2005, CAN J FOREST RES, V35, P990, DOI 10.1139/X05-022; SOLIS DM, 1990, CONDOR, V92, P739, DOI 10.2307/1368693; Sovern SG, 2015, J WILDLIFE MANAGE, V79, P254, DOI 10.1002/jwmg.834; Sovern Stan G., 2011, Northwestern Naturalist, V92, P101; SPIES TA, 1991, US FOR SERV T R PNW, V285, P91; United States Fish Wildlife Service [USFWS], 2011, REV REC PLAN NO SPOT; USFWS, 1990, FED REGISTER, V55, P26114; Wiens JD, 2014, WILDLIFE MONOGR, V185, P1, DOI 10.1002/wmon.1009; Wiens JD, 2011, J WILDLIFE MANAGE, V75, P531, DOI 10.1002/jwmg.82; WRCC, 2016, W REG CLIM CTR REP S	58	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197887	10.1371/journal.pone.0197887	http://dx.doi.org/10.1371/journal.pone.0197887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852017	gold, Green Submitted, Green Published			2022-12-26	WOS:000433893200022
J	Hung, CF; Wilson, CL; Chow, YH; Schnapp, LM				Hung, Chi F.; Wilson, Carole L.; Chow, Yu-Hua; Schnapp, Lynn M.			Role of integrin alpha8 in murine model of lung fibrosis	PLOS ONE			English	Article							ACTIVATES LATENT TGF-BETA-1; PULMONARY-FIBROSIS; DEFICIENT MICE; ALPHA-8-BETA-1; EXPRESSION; CELLS; BINDS; GENE; BETA	Background Integrin a8 (ITGA8) heterodimerizes with integrin beta 1 and is highly expressed in stromal cells of the lung. Platelet-derived growth factor receptor beta (PDGFR beta+) cells constitute a major population of contractile myofibroblasts in the lung following bleomycin-induced fibrosis. Integrin alpha 8 beta 1 is upregulated in fibrotic foci in bleomycin-induced lung injury. However, the functional role of ITGA8 in fibrogenesis has not been characterized. In this study, we examined whether genetic deletion of ITGA8 from PDGFR beta+ cells in the lung altered fibrosis. Methods Pdgfrb-Cre/+; Itga8(flox/-)or Pdgfrb-Cre/+; Itga8(flox/flox) (Cre+) and control mice (Cre-) were used for in vitro and in vivo studies. Primary cultures of PDGFR beta+ cells were exposed to TGF beta, followed by RNA isolation for qPCR. For in vivo studies, Cre+ and Cre-mice were characterized at baseline and after bleomycin-induced fibrosis. Results PDGFR beta-selected cells from Cre+ animals showed higher levels of Col1a1 expression after treatment with TGF beta. However, Cre-and Cre+ animals showed no significant difference in measures of acute lung injury or fibrosis following bleomycin challenge. Conclusion While ITGA8 deletion in lung PDGFR beta+ stromal cells showed evidence of greater Col1a1 mRNA expression after TGF beta treatment in vitro, no functional difference was detected in vivo.	[Hung, Chi F.; Chow, Yu-Hua] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Wilson, Carole L.; Schnapp, Lynn M.] Med Univ South Carolina, Div Pulm Crit Care Allergy & Sleep Med, Charleston, SC 29425 USA	University of Washington; University of Washington Seattle; Medical University of South Carolina	Hung, CF (corresponding author), Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA.	cfhung@uw.edu			NIH National Heart, Lung, and Blood Institute [K08HL127075]	NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH National Heart, Lung, and Blood Institute (K08HL127075) (CH) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bouzeghrane F, 2004, J MOL CELL CARDIOL, V36, P343, DOI 10.1016/j.yjmcc.2003.11.007; Du YN, 2015, THORAX, V70, P1092, DOI 10.1136/thoraxjnl-2015-207035; Haas CS, 2003, J AM SOC NEPHROL, V14, P2288, DOI 10.1097/01.ASN.0000082999.46030.FE; Hartner A, 1999, KIDNEY INT, V56, P1468, DOI 10.1046/j.1523-1755.1999.00662.x; Hartner A, 2002, NEPHROL DIAL TRANSPL, V17, P71, DOI 10.1093/ndt/17.suppl_9.71; Hartner A, 2008, AM J NEPHROL, V28, P168, DOI 10.1159/000110022; Hartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048362; Hartner A, 2009, AM J HYPERTENS, V22, P92, DOI 10.1038/ajh.2008.309; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Hung CF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-102; Levine D, 2000, AM J PATHOL, V156, P1927, DOI 10.1016/S0002-9440(10)65066-3; Lu M, 2002, J CELL SCI, V115, P4641, DOI 10.1242/jcs.00145; Marek I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150471; Marek I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-102; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; SCHNAPP LM, 1995, J CELL SCI, V108, P537; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042	25	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197937	10.1371/journal.pone.0197937	http://dx.doi.org/10.1371/journal.pone.0197937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813125	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800036
J	Panse, M; Kluth, O; Lorza-Gil, E; Kaiser, G; Muhlbauer, E; Schurmann, A; Haring, HU; Ullrich, S; Gerst, F				Panse, Madhura; Kluth, Oliver; Lorza-Gil, Estela; Kaiser, Gabriele; Muehlbauer, Eckhard; Schuermann, Annette; Haering, Hans-Ulrich; Ullrich, Susanne; Gerst, Felicia			Palmitate and insulin counteract glucose-induced thioredoxin interacting protein (TXNIP) expression in insulin secreting cells via distinct mechanisms	PLOS ONE			English	Article							PANCREATIC-BETA-CELLS; ENDOPLASMIC-RETICULUM STRESS; ELEMENT-BINDING PROTEIN; CARBOHYDRATE RESPONSE ELEMENT; ACID RECEPTOR 1; OXIDATIVE STRESS; SKELETAL-MUSCLE; APOPTOSIS; PHOSPHORYLATION; DYSFUNCTION	Glucose and palmitate synergistically stimulate insulin secretion, but chronically elevated they induce apoptotic beta-cell death. The glucotoxic effect has been attributed, at least partly, to the upregulation of the oxidative stress marker thioredoxin interacting protein (TXNIP). Palmitate downregulates TXNIP expression, the functional significance of which is still under debate. This study examines the mechanism and consequence of palmitate-mediated TXNIP regulation in insulin secreting cells. Palmitate (600 mu M) reduced TXNIP mRNA levels in isolated human and mouse islets independently of FFAR1/GPR40. Similar effects of palmitate were observed in INS-1E cells and mimicked by other long chain fatty acids. The lowering of TXNIP mRNA was significant already 1 h after addition of palmitate, persisted for 24 h and was directly translated to changes in TXNIP protein. The pharmacological inhibition of palmitate-induced phosphorylation of AMPK, ERK1/2, JNK and PKC alpha/beta by BML-275, PD98059, SP600125 and Go E 6976, respectively, did not abolish palmitate-mediated TXNIP downregulation. The effect of palmitate was superimposed by a time-dependent (8 h and 24 h) decline of TXNIP mRNA and protein. This decline correlated with accumulation of secreted insulin into the medium. Accordingly, exogenously added insulin reduced TXNIP mRNA and protein levels, an effect counteracted by the insulin/IGF-1 receptor antagonist linsitinib. The inhibition of PI3K and Akt/PKB increased TXNIP mRNA levels. The histone deacetylase (HDAC1/2/3) inhibitor MS-275 completely abrogated the time-dependent, insulin-mediated reduction of TXNIP, leaving the effect of palmitate unaltered. Acute stimulation of insulin secretion and chronic accentuation of cell death by palmitate occurred independently of TXNIP regulation. On the contrary, palmitate antagonized glucose-augmented ROS production. In conclusion, glucose-induced TXNIP expression is efficiently antagonized by two independent mechanisms, namely via an autocrine activation of insulin/IGF-1 receptors involving HDAC and by palmitate attenuating oxidative stress of beta-cells.	[Panse, Madhura; Lorza-Gil, Estela; Kaiser, Gabriele; Haering, Hans-Ulrich; Ullrich, Susanne; Gerst, Felicia] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Tubingen, Germany; [Panse, Madhura; Kluth, Oliver; Lorza-Gil, Estela; Kaiser, Gabriele; Muehlbauer, Eckhard; Schuermann, Annette; Haering, Hans-Ulrich; Ullrich, Susanne; Gerst, Felicia] German Ctr Diabet Res DZD, Munich, Germany; [Kluth, Oliver; Muehlbauer, Eckhard; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Diabetol, Potsdam, Germany; [Lorza-Gil, Estela; Kaiser, Gabriele; Haering, Hans-Ulrich; Ullrich, Susanne; Gerst, Felicia] Univ Tubingen IDM, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany	Eberhard Karls University of Tubingen; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ullrich, S (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Tubingen, Germany.; Ullrich, S (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.; Ullrich, S (corresponding author), Univ Tubingen IDM, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany.	susanne.ullrich@med.uni-tuebingen.de	Ullrich, Susanne/GWV-5256-2022	Panse, Madhura/0000-0002-3751-1782; Schurmann, Annette/0000-0002-4113-4377	German Research Foundation (DFG) [GRK1302]; German Federal Ministry of Education and Research (BMBF) [01GI0925]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	MP was a fellow of the International Graduate Program funded by the German Research Foundation (DFG, GRK1302). This study was supported by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.).	Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen JQ, 2016, AM J PHYSIOL-HEART C, V311, pH64, DOI 10.1152/ajpheart.00151.2016; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Christiansen E, 2010, ACS MED CHEM LETT, V1, P345, DOI 10.1021/ml100106c; Citro S, 2015, J MOL CELL BIOL, V7, P132, DOI 10.1093/jmcb/mjv021; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cnop M, 2017, MOL METAB, V6, P1024, DOI 10.1016/j.molmet.2017.06.001; DeBalsi KL, 2014, J BIOL CHEM, V289, P8106, DOI 10.1074/jbc.M113.511535; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Gowda N, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-28; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li N, 2017, REDOX BIOL, V13, P541, DOI 10.1016/j.redox.2017.07.012; Mandala A, 2016, BIOCHEM BIOPH RES CO, V479, P933, DOI 10.1016/j.bbrc.2016.09.168; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Noordeen NA, 2012, DIABETES, V61, P574, DOI 10.2337/db10-1329; Panse M, 2015, CELL PHYSIOL BIOCHEM, V35, P1537, DOI 10.1159/000373969; Schulz N, 2013, INT J MOL SCI, V14, P18989, DOI 10.3390/ijms140918989; Shaked M, 2009, DIABETOLOGIA, V52, P636, DOI 10.1007/s00125-009-1274-2; Shaked M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028804; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; Ullrich S., 2013, ISLETS LANGERHANS, V2, P1, DOI [10.1007/978-94-007-6884-0_26-2, DOI 10.1007/978-94-007-6884-0_26-2]; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Wagner R, 2013, DIABETES, V62, P2106, DOI 10.2337/db12-1249	30	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198016	10.1371/journal.pone.0198016	http://dx.doi.org/10.1371/journal.pone.0198016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813102	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800039
J	Reneaux, M; Gupta, R				Reneaux, Melissa; Gupta, Rahul			Prefronto-cortical dopamine D1 receptor sensitivity can critically influence working memory maintenance during delayed response tasks	PLOS ONE			English	Article							MONKEY CEREBRAL-CORTEX; D-1 RECEPTORS; EXTRACELLULAR DOPAMINE; PYRAMIDAL NEURONS; FRONTAL-CORTEX; NETWORK MODEL; NOREPINEPHRINE TRANSPORTER; SUBSYNAPTIC DISTRIBUTION; COGNITIVE FUNCTION; PERIOD ACTIVITY	The dopamine (DA) hypothesis of cognitive deficits suggests that too low or too high extracellular DA concentration in the prefrontal cortex (PFC) can severely impair the working memory (WM) maintenance during delay period. Thus, there exists only an optimal range of DA where the sustained-firing activity, the neural correlate of WM maintenance, in the cortex possesses optimal firing frequency as well as robustness against noisy distractions. Empirical evidences demonstrate changes even in the D1 receptor (D1R)-sensitivity to extracellular DA, collectively manifested through D1R density and DA-binding affinity, in the PFC under neuropsychiatric conditions such as ageing and schizophrenia. However, the impact of alterations in the cortical D1R-sensitivity on WM maintenance has yet remained poorly addressed. Using a quantitative neural mass model of the prefronto-mesoprefrontal system, the present study reveals that higher D1R-sensitivity may not only effectuate shrunk optimal DA range but also shift of the range to lower concentrations. Moreover, higher sensitivity may significantly reduce the WM-robustness even within the optimal DA range and exacerbates the decline at abnormal DA levels. These findings project important clinical implications, such as dosage precision and variability of DA-correcting drugs across patients, and failure in acquiring healthy WM maintenance even under drug-controlled normal cortical DA levels.	[Reneaux, Melissa; Gupta, Rahul] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi	Reneaux, M; Gupta, R (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India.	meliss14_sit@jnu.ac.in; rahuI35_sit@jnu.ac.in		Reneaux, Melissa/0000-0002-9850-8464	Council of Scientific and Industrial Research, India [09/263(0991)/2013-EMR-I, 09/263(1057)/2015-EMR-I]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	MR received funding from Council of Scientific and Industrial Research, India (grant no. 09/263(0991)/2013-EMR-I, www.csirhrdg.res.in). RG received funding from Council of Scientific and Industrial Research, India (grant no. 09/263(1057)/2015-EMR-I, www.csirhrdg.res.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Abi-Dargham A, 2003, NEUROSCIENTIST, V9, P404, DOI 10.1177/1073858403252674; Abi-Dargham A, 2012, J PSYCHOPHARMACOL, V26, P794, DOI 10.1177/0269881111409265; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 2017, BIOL PSYCHIAT, V81, P67, DOI 10.1016/j.biopsych.2015.12.028; Arnsten AFT, 2016, ANNU REV PHARMACOL, V56, P339, DOI 10.1146/annurev-pharmtox-010715-103617; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Backman L, 2011, NEUROBIOL AGING, V32, P1849, DOI 10.1016/j.neurobiolaging.2009.10.018; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Bernard V, 1997, J NEUROSCI, V17, P819; Bernard V, 1998, EUR J NEUROSCI, V10, P3721, DOI 10.1046/j.1460-9568.1998.00380.x; Bjorklund A, 1984, HANDBOOK OF CHEMICAL; Bourdy R, 2012, TRENDS NEUROSCI, V35, P681, DOI 10.1016/j.tins.2012.06.007; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buicel MA, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/03/P03003; Christophel TB, 2017, TRENDS COGN SCI, V21, P111, DOI 10.1016/j.tics.2016.12.007; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 2016, NAT REV NEUROSCI, V17, P438, DOI 10.1038/nrn.2016.43; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Deco G, 2003, EUR J NEUROSCI, V18, P2374, DOI 10.1046/j.1460-9568.2003.02956.x; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Dreher JC, 2002, NEURAL NETWORKS, V15, P583, DOI 10.1016/S0893-6080(02)00051-5; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; GOLDMANRAKIC PS, 1981, NEUROSCIENCE, V6, P177, DOI 10.1016/0306-4522(81)90053-1; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1984, J NEUROSCI, V4, P2866; Grace AA, 2016, NAT REV NEUROSCI, V17, P524, DOI 10.1038/nrn.2016.57; Jedema HP, 2014, J NEUROCHEM, V130, P490, DOI 10.1111/jnc.12743; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Knable MB, 1996, BIOL PSYCHIAT, V40, P1191, DOI 10.1016/S0006-3223(96)00116-3; Kodama T, 2002, EXP BRAIN RES, V145, P133, DOI 10.1007/s00221-002-1084-y; KORNHUBER J, 1984, BRAIN RES, V322, P124, DOI 10.1016/0006-8993(84)91189-2; Lachowicz JE, 1997, PHARMACOL TOXICOL, V81, P105, DOI 10.1111/j.1600-0773.1997.tb00039.x; Lara AH, 2014, NAT NEUROSCI, V17, P876, DOI 10.1038/nn.3702; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Lidow MS, 1997, J PHARMACOL EXP THER, V281, P597; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; Martin KAC, 2013, EUR J NEUROSCI, V37, P1061, DOI 10.1111/ejn.12124; Miller Earl K, 2013, Dialogues Clin Neurosci, V15, P411; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Muly EC, 1998, J NEUROSCI, V18, P10553; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Okimura T, 2015, NEUROSCIENCE, V295, P80, DOI 10.1016/j.neuroscience.2015.03.039; Peters Y, 2004, SYNAPSE, V52, P143, DOI 10.1002/syn.20015; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Reneaux M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144378; Riley MR, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00181; Schacht JP, 2016, PHARMACOGENOMICS J, V16, P430, DOI 10.1038/tpj.2016.43; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sesack SR, 1998, J NEUROSCI, V18, P2697; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Slifstein M, 2015, JAMA PSYCHIAT, V72, P316, DOI 10.1001/jamapsychiatry.2014.2414; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; SMILEY JF, 1992, J COMP NEUROL, V321, P325, DOI 10.1002/cne.903210302; Spuhler IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071615; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; SUHARA T, 1991, PSYCHOPHARMACOLOGY, V103, P41, DOI 10.1007/BF02244071; Takahata Y, 1998, J NEUROCHEM, V71, P1443; Tanaka S, 2006, NEUROSCIENCE, V139, P153, DOI 10.1016/j.neuroscience.2005.08.070; Tanaka S, 1999, NEUROCOMPUTING, V26-7, P891, DOI 10.1016/S0925-2312(98)00134-9; Tsujimoto S, 2004, EUR J NEUROSCI, V19, P447, DOI 10.1111/j.0953-816X.2003.03130.x; Valentini V, 2004, J NEUROCHEM, V88, P917, DOI 10.1046/j.1471-4159.2003.02238.x; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243; Watanabe K, 2007, CEREB CORTEX, V17, pI88, DOI 10.1093/cercor/bhm102; Watanabe K, 2014, NAT NEUROSCI, V17, P601, DOI 10.1038/nn.3667; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Yang CR, 1999, NEUROPSYCHOPHARMACOL, V21, P161, DOI 10.1016/S0893-133X(98)00112-2; Zahrt J, 1997, J NEUROSCI, V17, P8528	99	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198136	10.1371/journal.pone.0198136	http://dx.doi.org/10.1371/journal.pone.0198136			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813109	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800049
J	Hegde, M; Strand, C; Hanna, RE; Doench, JG				Hegde, Mudra; Strand, Christine; Hanna, Ruth E.; Doench, John G.			Uncoupling of sgRNAs from their associated barcodes during PCR amplification of combinatorial CRISPR screens	PLOS ONE			English	Article							GENETIC SCREENS; REGULATORY ELEMENTS; RECOMBINATION; HETERODUPLEXES; CONSEQUENCE; EXPRESSION; ARTIFACTS; ERROR	Many implementations of pooled screens in mammalian cells rely on linking an element of interest to a barcode, with the latter subsequently quantitated by next generation sequencing. However, substantial uncoupling between these paired elements during lentiviral production has been reported, especially as the distance between elements increases. We detail that PCR amplification is another major source of uncoupling, and becomes more pronounced with increased amounts of DNA template molecules and PCR cycles. To lessen uncoupling in systems that use paired elements for detection, we recommend minimizing the distance between elements, using low and equal template DNA inputs for plasmid and genomic DNA during PCR, and minimizing the number of PCR cycles. We also present a vector design for conducting combinatorial CRISPR screens that enables accurate barcode-based detection with a single short sequencing read and minimal uncoupling.	[Hegde, Mudra; Strand, Christine; Hanna, Ruth E.; Doench, John G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Doench, JG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jdoench@broadinstitute.org	Doench, John/ABE-6251-2020; Doench, John G/HCI-9570-2022	Doench, John/0000-0002-3707-9889; Doench, John G/0000-0002-3707-9889; Hegde, Mudra/0000-0003-4530-4633; Strand, Christine/0000-0001-5783-6667; Hanna, Ruth/0000-0001-5586-2300				Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Boettcher M, 2018, NAT BIOTECHNOL, V36, P170, DOI 10.1038/nbt.4062; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2018, NAT REV GENET, V19, P67, DOI 10.1038/nrg.2017.97; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Feldman D., 2018, LENTIVIRAL COPACKAGI, DOI [10.1101/262121, DOI 10.1101/262121]; Gasperini M, 2017, AM J HUM GENET, V101, P192, DOI 10.1016/j.ajhg.2017.06.010; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Hill AJ, 2018, NAT METHODS, V15, P271, DOI [10.1038/NMETH.4604, 10.1038/nmeth.4604]; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Maricque BB, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw942; Melnikov A, 2014, JOVE-J VIS EXP, DOI 10.3791/51719; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Michlits G, 2017, NAT METHODS, V14, P1191, DOI [10.1038/NMETH.4466, 10.1038/nmeth.4466]; Najm FJ, 2017, NAT BIOTECHNOL, DOI [10.1038/nbt, DOI 10.1038/NBT]; O'Connell DJ, 2016, CELL SYST, V2, P323, DOI 10.1016/j.cels.2016.04.011; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; PAABO S, 1990, J BIOL CHEM, V265, P4718; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Sack LM, 2016, G3-GENES GENOM GENET, V6, P2781, DOI 10.1534/g3.116.030973; Schmierer B, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177834; Shen JP, 2017, NAT METHODS, V14, P573, DOI 10.1038/nmeth.4225; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Wang GCY, 1996, MICROBIOL-SGM, V142, P1107, DOI 10.1099/13500872-142-5-1107; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Xie S, 2018, BIORXIV, DOI [10.1101/255638, DOI 10.1101/255638]; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	33	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197547	10.1371/journal.pone.0197547	http://dx.doi.org/10.1371/journal.pone.0197547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799876	Green Submitted, Green Published, gold			2022-12-26	WOS:000433153400017
J	Fagerholm, ED; Dinov, M; Knopfel, T; Leech, R				Fagerholm, Erik D.; Dinov, Martin; Knopfel, Thomas; Leech, Robert			The characteristic patterns of neuronal avalanches in mice under anesthesia and at rest: An investigation using constrained artificial neural networks	PLOS ONE			English	Article							DYNAMICS; CORTEX; BRAIN; CRITICALITY; INFORMATION; MOUSE; NOISE	Local perturbations within complex dynamical systems can trigger cascade-like events that spread across significant portions of the system. Cascades of this type have been observed across a broad range of scales in the brain. Studies of these cascades, known as neuronal avalanches, usually report the statistics of large numbers of avalanches, without probing the characteristic patterns produced by the avalanches themselves. This is partly due to limitations in the extent or spatiotemporal resolution of commonly used neuroimaging techniques. In this study, we overcome these limitations by using optical voltage (genetically encoded voltage indicators) imaging. This allows us to record cortical activity in vivo across an entire cortical hemisphere, at both high spatial (similar to 30um) and temporal (similar to 20ms) resolution in mice that are either in an anesthetized or awake state. We then use artificial neural networks to identify the characteristic patterns created by neuronal avalanches in our data. The avalanches in the anesthetized cortex are most accurately classified by an artificial neural network architecture that simultaneously connects spatial and temporal information. This is in contrast with the awake cortex, in which avalanches are most accurately classified by an architecture that treats spatial and temporal information separately, due to the increased levels of spatiotemporal complexity. This is in keeping with reports of higher levels of spatiotemporal complexity in the awake brain coinciding with features of a dynamical system operating close to criticality.	[Fagerholm, Erik D.; Leech, Robert] Kings Coll London, Ctr Neuroimaging Sci, London, England; [Dinov, Martin] Imperial Coll London, Div Brain Sci, Ctr Neurosci, Computat Cognit & Clin Neuroimaging Lab, Hammersmith Hosp Campus, London, England; [Knopfel, Thomas] Imperial Coll London, Inst Biomed Engn, Ctr Neurotechnol, South Kensington Campus, London, England	University of London; King's College London; Imperial College London; Imperial College London	Leech, R (corresponding author), Kings Coll London, Ctr Neuroimaging Sci, London, England.	robertleech6@gmail.com	Leech, Robert/AAE-8254-2019; Knöpfel, Thomas/B-1128-2008; Sharp, David J/A-2119-2013	Leech, Robert/0000-0002-5801-6318; Knöpfel, Thomas/0000-0002-5718-0765; 	Medical Research Council [MR/R005370/1]; Defence Science and Technology Laboratory [DSTLX-1000083275]; National Institutes of Health [1U01MH109091]; Leverhulme Trust [RPG-2013-258]; MRC [MR/R005370/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109091] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Defence Science and Technology Laboratory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by: Medical Research Council, url: https://mrc.ukri.org, grant no: MR/R005370/1, (EDF), Defence Science and Technology Laboratory, url: https://www.gov.uk/government/organisations/defence-science-and-technology-laboratory, grant no: DSTLX-1000083275, (MD); National Institutes of Health, url: https://www.nih.gov/, grant no: 1U01MH109091, (TK); Leverhulme Trust, url: https//www.leverhulme.ac.uk/, grant no: RPG-2013-258 (RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02231; Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Castelvecchi D, 2016, NATURE, V537, P20, DOI 10.1038/538020a; Chen W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-3; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Dehghani N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00302; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Fagerholm ED, 2016, CEREB CORTEX, V26, P3945, DOI 10.1093/cercor/bhw200; Fagerholm ED, 2015, J NEUROSCI, V35, P4626, DOI 10.1523/JNEUROSCI.3694-14.2015; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; Hjelm RD, 2014, NEUROIMAGE, V96, P245, DOI 10.1016/j.neuroimage.2014.03.048; Lombardi F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228703; Meisel C, 2013, J NEUROSCI, V33, P17363, DOI 10.1523/JNEUROSCI.1516-13.2013; Palm RB, 2012, PREDICTION CANDIDATE, P5; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Ribeiro TL, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00016; Scarpetta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064162; SCHMIDHUBER J, 1992, NEURAL COMPUT, V4, P234, DOI 10.1162/neco.1992.4.2.234; Scott G, 2014, J NEUROSCI, V34, P16611, DOI 10.1523/JNEUROSCI.3474-14.2014; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Smolensky P., 1986, DTIC DOCUMENT; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Zheng W- L, 2014, MULT EXP ICME 2014 I; Zhigalov A, 2017, NETW NEUROSCI, V1, P143, DOI [10.1162/NETN_a_00008, 10.1162/netn_a_00008]	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197893	10.1371/journal.pone.0197893	http://dx.doi.org/10.1371/journal.pone.0197893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795654	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300090
J	Holsken, A; Schwarz, M; Gillmann, C; Pfister, C; Uder, M; Doerfler, A; Buchfelder, M; Schlaffer, S; Fahlbusch, R; Buslei, R; Bauerle, T				Hoelsken, Annett; Schwarz, Marc; Gillmann, Clarissa; Pfister, Christina; Uder, Michael; Doerfler, Arnd; Buchfelder, Michael; Schlaffer, Sven; Fahlbusch, Rudolf; Buslei, Rolf; Baeuerle, Tobias			Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; BETA-CATENIN; TUMOR; BRAIN; MOUSE; RAT; DIFFERENTIATION; IDENTIFICATION; CHEMOTHERAPY; PREDICTOR	Purpose Adamantinomatous craniopharyngiomas (ACP) as benign sellar brain tumors are challenging to treat. In order to develop robust in vivo drug testing methodology, the murine orthotopic craniopharyngioma model (PDX) was characterized by magnetic resonance imaging (MRI) and histology in xenografts from three patients (ACP1-3). Methods In ACP PDX, multiparametric MRI was conducted to assess morphologic characteristics such as contrast-enhancing tumor volume (CETV) as well as functional parameters from dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted imaging (DWI) including area-under-the-curve (AUC), peak enhancement (PE), time-to-peak (TTP) and apparent diffusion coefficient (ADC). These MRI parameters evaluated in 27 ACP PDX were correlated to histological features and percentage of vital tumor cell content. Results Qualitative analysis of MRI and histology from PDX revealed a similar phenotype as seen in patients, although the MRI appearance in mice resulted in a more solid tumor growth than in humans. CETV were significantly higher in ACP2 xenografts relative to ACP1 and ACP3 which correspond to respective average vitality of 41%, <10% and 26% determined histologically. Importantly, CETV prove tumor growth of ACP2 PDX as it significantly increases in longitudinal follow-up of 110 days. Furthermore, xenografts from ACP2 revealed a significantly higher AUC, PE and TTP in comparison to ACP3, and significantly increased ADC relative to ACP1 and ACP3 respectively. Overall, DCE-MRI and DWI can be used to distinguish vital from non-vital grafts, when using a cut off value of 15% for vital tumor cell content. Conclusions MRI enables the assessment of craniopharyngioma PDX vitality in vivo as validated histologically.	[Hoelsken, Annett; Pfister, Christina] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany; [Schwarz, Marc; Gillmann, Clarissa; Uder, Michael; Baeuerle, Tobias] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Schwarz, Marc; Doerfler, Arnd] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neuroradiol, Erlangen, Germany; [Buchfelder, Michael; Schlaffer, Sven] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Neurosurg, Erlangen, Germany; [Fahlbusch, Rudolf] Int Neurosci Inst INI Hannover, Hannover, Germany; [Buslei, Rolf] Sozialstiftung Bamberg, Dept Pathol, Bamberg, Germany; [Hoelsken, Annett] Med Ctr Coburg, Dept Pathol, Coburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Klinikum Coburg	Bauerle, T (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany.	tobias.baeuerle@uk-erlangen.de		Bauerle, Tobias/0000-0002-0206-6199	German Research Foundation DFG [NP-DFG_BU 2878/2-1]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing, Internationale Stiftung Neurobionik	German Research Foundation DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing, Internationale Stiftung Neurobionik	This work was funded by the German Research Foundation DFG (NP-DFG_BU 2878/2-1). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing, Internationale Stiftung Neurobionik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agozzino L, 2006, ULTRASTRUCT PATHOL, V30, P143, DOI 10.1080/01913120500408018; Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Ashraf A, 2015, TRANSL ONCOL, V8, P154, DOI 10.1016/j.tranon.2015.03.005; BENITEZ WI, 1988, J COMPUT ASSIST TOMO, V12, P1068, DOI 10.1097/00004728-198811000-00034; Boult JKR, 2018, BRAIN PATHOL, V28, P475, DOI 10.1111/bpa.12525; Burghaus S, 2010, VIRCHOWS ARCH, V456, P287, DOI 10.1007/s00428-009-0873-0; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; Buslei R, 2007, ACTA NEUROPATHOL, V113, P585, DOI 10.1007/s00401-006-0184-3; Gaddikeri S, 2016, J NEUROIMAGING, V26, P618, DOI 10.1111/jon.12351; Gump JM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0211-5; Hald JK, 1996, ACTA RADIOL, V37, P806; Hartmann J, 2016, STRAHLENTHER ONKOL, V192, P806, DOI 10.1007/s00066-016-1014-8; HEIDER K, 1986, VET PATHOL, V23, P522, DOI 10.1177/030098588602300427; Holsken A, 2017, BRAIN PATHOL, V27, P358, DOI 10.1111/bpa.12499; Holsken A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0287-6; Holsken A, 2011, CLIN CANCER RES, V17, P4367, DOI 10.1158/1078-0432.CCR-10-2811; Holsken A, 2009, BRAIN PATHOL, V19, P357, DOI 10.1111/j.1750-3639.2008.00180.x; Jung BC, 2016, J NEUROIMAGING, V26, P240, DOI 10.1111/jon.12281; Kamal R, 1999, NEUROL RES, V21, P796, DOI 10.1080/01616412.1999.11741017; Karavitaki N, 2006, ENDOCR REV, V27, P371, DOI 10.1210/er.2006-0002; Kinoshita Y, 2016, NEUROSURG REV, V39, P207, DOI 10.1007/s10143-015-0660-0; Kunii N, 2007, ACTA NEUROCHIR, V149, P759, DOI 10.1007/s00701-007-1234-x; Tena-Suck ML, 2014, ACTA HISTOCHEM, V116, P448, DOI 10.1016/j.acthis.2013.10.002; Louis, 2016, WHO CLASSIFICATION G; Mahmoud OM, 2010, EUR J RADIOL, V74, P420, DOI 10.1016/j.ejrad.2009.03.031; Martinez-Barbera JP, 2015, J PEDIATR ENDOCR MET, V28, P7, DOI 10.1515/jpem-2014-0442; Mortini P, 2016, ENDOCRINE, V51, P148, DOI 10.1007/s12020-015-0683-x; Muller HL, 2014, ENDOCR REV, V35, P513, DOI 10.1210/er.2013-1115; Orman G, 2015, J NEUROIMAGING, V25, P785, DOI 10.1111/jon.12199; Pace V, 1997, VET PATHOL, V34, P146, DOI 10.1177/030098589703400207; Ringelstein A, 2010, ROFO-FORTSCHR RONTG, V182, P868, DOI 10.1055/s-0029-1245570; Rossi A, 2006, J PEDIATR ENDOCR MET, V19, P299; SartorettiSchefer S, 1997, AM J NEURORADIOL, V18, P77; Schwarz MA, 2013, NEURORADIOLOGY, V55, P709, DOI 10.1007/s00234-013-1149-6; Sekine S, 2002, AM J PATHOL, V161, P1997, DOI 10.1016/S0002-9440(10)64477-X; Sener RN, 2002, COMPUT MED IMAG GRAP, V26, P199, DOI 10.1016/S0895-6111(01)00043-X; Stache C, 2015, BRAIN PATHOL, V25, P1, DOI 10.1111/bpa.12148; Tsuda M, 1997, EUR RADIOL, V7, P464, DOI 10.1007/s003300050184; Watanabe Y, 2013, EUR J RADIOL, V82, P658, DOI 10.1016/j.ejrad.2012.11.037; Xu JG, 2006, J NEUROSURG, V105, P306, DOI 10.3171/ped.2006.105.4.306; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338; Zulfiqar M, 2013, AM J ROENTGENOL, V200, P624, DOI 10.2214/AJR.12.8679	42	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197895	10.1371/journal.pone.0197895	http://dx.doi.org/10.1371/journal.pone.0197895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795641	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300091
J	Kuan, TC; Lin, PC; Yang, SH; Lin, CC; Lan, YT; Lin, HH; Liang, WY; Chen, WS; Lin, JK; Jiang, JK; Chang, SC				Kuan, Tai-Chuan; Lin, Pei-Ching; Yang, Shung-Haur; Lin, Chun-Chi; Lan, Yuan-Tzu; Lin, Hung-Hsin; Liang, Wen-Yi; Chen, Wei-Shone; Lin, Jen-Kou; Jiang, Jeng-Kai; Chang, Shih-Ching			Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients	PLOS ONE			English	Article							GLOBAL DNA METHYLATION; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; RETROTRANSPOSITION; ADENOCARCINOMA; CARCINOMAS; PROGNOSIS; PATHWAYS; MUCOSA; GENOME	Recent studies suggest that aberrant DNA methylation might occur early and commonly in colorectal tumorigenesis. In 111 normal subjects, the mean LINE-1 methylation level of peripheral blood was 81.0 +/- 5.7%. Of 143 colorectal cancer (CRC) patients, the mean level of LINE-1 methylation was 60.5 +/- 12.5%. We defined below 60% as cut-off value of LINE-1 hypomethylation, and 93 cases (65.0%) had LINE-1 hypomethylation in the tumor tissue. LINE-1 hypomethylation was not associated with any other clinical features. There was a trend that LINE-1 hypomethylation tumors were associated with advanced disease, but it did not reach statistical significance. There was no significant association between mutations of 12 genes, MSI-high, EMAST, and LINE-1 hypomethylation level. The median follow-up was 61.2 months. Five-year disease-free survival (DFS) and overall survival curves of patients with LINE-1 hypomethylation tumors were significantly lower than those of patients with normal LINE-1 methylation tumors (p = 0.032 and 0.001, respectively). Multivariate analysis showed that only TNM staging was an independent prognostic factor for CRC patients including DFS and overall survival (OS). LINE-1 did not impact patients' outcomes in multivariate analysis including DFS and OS. In conclusion, LINE-1 hypomethylation is marginally related to advanced stage CRC and impacts patients' outcomes in univariate analysis.	[Kuan, Tai-Chuan; Yang, Shung-Haur; Lin, Chun-Chi; Lan, Yuan-Tzu; Lin, Hung-Hsin; Chen, Wei-Shone; Lin, Jen-Kou; Jiang, Jeng-Kai; Chang, Shih-Ching] Taipei Vet Gen Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan; [Kuan, Tai-Chuan; Yang, Shung-Haur; Lin, Chun-Chi; Lan, Yuan-Tzu; Lin, Hung-Hsin; Chen, Wei-Shone; Lin, Jen-Kou; Jiang, Jeng-Kai; Chang, Shih-Ching] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei, Taiwan; [Lin, Pei-Ching] Taipei City Hosp, Yang Ming Branch, Dept Clin Pathol, Taipei, Taiwan; [Lin, Pei-Ching] Univ Taipei, Dept Hlth & Welf, Taipei, Taiwan; [Liang, Wen-Yi] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; University of Taipei; Taipei Veterans General Hospital	Jiang, JK; Chang, SC (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan.; Jiang, JK; Chang, SC (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei, Taiwan.	jkjiang@vghtpe.gov.tw; changsc@vghtpe.gov.tw		Lin, Hung-Hsin/0000-0003-1730-8530	Taipei Veterans General Hospital [V105C-043, V106C-027, V107C-004]; Ministry of Science and Technology, Taiwan [105-2314-B-075-010-MY2]; Taipei City Hospital [10601-62-059, 10701-62-050]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital	The funding supports were from Taipei Veterans General Hospital (V105C-043, V106C-027, V107C-004, recipient: Shih-Ching Chang), Ministry of Science and Technology, Taiwan (105-2314-B-075-010-MY2, recipient: Shih-Ching Chang) and Taipei City Hospital (10601-62-059, 10701-62-050, recipient: Pei-Ching Lin). The study design, data collection, and analysis are independent from the funding providers.	Ardeljan D, 2017, CLIN CHEM, V63, P816, DOI 10.1373/clinchem.2016.257444; Barchitta M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3582-0; Barchitta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109478; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belshaw NJ, 2010, CARCINOGENESIS, V31, P1158, DOI 10.1093/carcin/bgq077; Benard A, 2013, BRIT J CANCER, V109, P3073, DOI 10.1038/bjc.2013.654; Chan AOO, 2002, AM J PATHOL, V160, P1823, DOI 10.1016/S0002-9440(10)61128-5; Chang SC, 2016, ANN SURG ONCOL, V23, P849, DOI 10.1245/s10434-015-4899-z; Chang SC, 2010, SURGERY, V147, P720, DOI 10.1016/j.surg.2009.10.069; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; Pereira BMD, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0431-6; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Harada K, 2015, ANN SURG ONCOL, V22, P1280, DOI 10.1245/s10434-014-4134-3; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; Ikeda K, 2013, ANN THORAC SURG, V96, P1790, DOI 10.1016/j.athoracsur.2013.06.035; Inamura K, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju195; Jeyapalan JN, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0323-6; Joyce BT, 2016, BRIT J CANCER, V115, P465, DOI 10.1038/bjc.2016.205; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; Kiss NB, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-83; Kitkumthorn N, 2012, CLIN CHIM ACTA, V413, P869, DOI 10.1016/j.cca.2012.01.024; Kupcinskas J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05143-0; Lan YT, 2015, J SURG ONCOL, V111, P905, DOI 10.1002/jso.23895; Lee Suk-yeol, 2010, [The Journal of Educational Research, 교육종합연구], V8, P1; Levine AJ, 2016, CANCER EPIDEM BIOMAR, V25, P68, DOI 10.1158/1055-9965.EPI-15-0935; Lin JK, 2003, ANN SURG ONCOL, V10, P1086, DOI 10.1245/ASO.2003.12.014; Liu J, 2012, CANCER PREV RES, V5, P921, DOI 10.1158/1940-6207.CAPR-11-0577; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Mima K, 2016, ONCOTARGET, V7, P55098, DOI 10.18632/oncotarget.10398; Murata A, 2013, BRIT J CANCER, V109, P408, DOI 10.1038/bjc.2013.289; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Sahnane N, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0165-2; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; The Department of Health, 2013, HLTH STAT CANC REG A; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Venderbosch S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124538; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Xu XR, 2012, FASEB J, V26, P2657, DOI 10.1096/fj.11-197251; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	52	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197681	10.1371/journal.pone.0197681	http://dx.doi.org/10.1371/journal.pone.0197681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795620	Green Submitted, gold, Green Published			2022-12-26	WOS:000433084300059
J	Liu, B; Chen, W; Zhang, Q; Yan, XL; Zhang, F; Dong, TH; Yang, G; Zhang, YZ				Liu, Bo; Chen, Wei; Zhang, Qi; Yan, Xiaoli; Zhang, Fei; Dong, Tianhua; Yang, Guang; Zhang, Yingze			Proximal fibular osteotomy to treat medial compartment knee osteoarthritis: Preoperational factors for short-term prognosis	PLOS ONE			English	Article							HIGH TIBIAL OSTEOTOMY; ARTHROSCOPIC EVIDENCE; CARTILAGE; ALIGNMENT	Objective The purpose of this study was to determine the association between preoperational factors and patients' short-term outcome after proximal fibular osteotomy (PFO) and to provide a basis for detailed surgical indication and patient selection. Methods This was a retrospective study of patients undergoing PFO between January 2015 and December 2015. Preoperational clinical data including gender, age, duration of disease, visual analogue score (VAS) and American Knee Society (KSS) score were collected. The radiological factors including hip-knee-ankle angle (HKA angle), condyle-plateau angle (CP angle), Kellgren and Lawrence grade (KL grade), joint space width of both compartments and settlement value were also considered. Patients were followed for at 12 months postoperatively. Both clinical and functional KSS scores were obtained. The outcome of interest was divided into clinical outcome and functional outcome. For each, two criteria were defined: satisfaction and significant improvement. Satisfaction is characterized by a KSS clinical or functional score over 70 points (excellent and good results); significant improvement refers to an increase in KSS scores of more than 15 points. Bivariate logistic regression for the association between preoperational factors and outcomes of interest was performed. Multivariable logistic regression analyses were used to detect the independent factors affecting the outcomes. Results A total of 84 patients and 111 knees were followed-up. Of these, 17 knees were from males and 94 were from females. The average age was 59.45 +/- 8.82 years. The average preoperational VAS score, KSS clinical and functional score were 7.08 +/- 1.41 points, 49.14 +/- 10.95 points and 44.97 +/- 17.71 points, respectively. According to KL grading, there were 17 knees of grade 2, 47 knees of grade 3, and 47 knees of grade 4. In clinical outcomes, there were 51 knees in the satisfaction group and 77 knees in the significant improvement group. In functional outcomes, 43 knees were in the satisfaction group and 76 knees in the significant improvement group. KSS clinical score (OR = 1.134, 95%CI= 1.067-1.205, P = 0.000) was the independent factor associated with clinical satisfaction. Age (OR = 1.072, 95%CI= 1.000-1.150, P = 0.048), VAS score (OR = 1.679, 95%CI= 1.041-2.706, P = 0.033), KSS clinical (OR = 1.072, 95%CI = 1.005-1.144, P = 0.034) and functional (OR = 1.100, 95%CI = 1.044-1.159, P = 0.000) score, HKA angle (OR = 1.345, 95%CI = 1.119-1.617, P = 0.002) and settlement value (OR = 7.540, 95%CI = 1.307-43.484, P = 0.024) were the independent factors associated with functional satisfaction. KSS clinical (OR = 0.905, 95%CI = 0.8500.963, P = 0.002) score, CP angle (OR = 0.760, 95%CI = 0.593-0.973, P = 0.030) and medial joint space width (OR = 0.001, 95%CI = 0.000-0.107, P = 0.003) were the independent factors associated with significant clinical improvement; VAS score (OR = 1.582, 95%CI = 1.042-2.402, P = 0.031), KSS functional (OR = 0.888, 95%CI = 0.838-0.942, P = 0.000) score, HKA angle (OR = 1.292, 95%CI = 1.101-1.518, P = 0.002) and settlement value (OR = 9.990, 95%CI = 1.485-67.197, P = 0.018) were the independent factors associated with significant functional improvement. Conclusions The independent factors affecting postoperative clinical outcome after PFO were KSS clinical score, CP angle and medial joint space width. In addition, the independent factors that influenced functional outcome included age, VAS score, KSS score, HKA angle and settlement value. As objective radiological evidence, HKA angle and settlement value could be used as an important basis for patient selection for PFO.	[Liu, Bo; Chen, Wei; Zhang, Qi; Yan, Xiaoli; Zhang, Fei; Dong, Tianhua; Yang, Guang; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China; [Liu, Bo; Chen, Wei; Zhang, Qi; Yan, Xiaoli; Zhang, Fei; Dong, Tianhua; Yang, Guang; Zhang, Yingze] Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China.	cthhmu@foxmail.com	Liu, Bo/K-6843-2019; Chen, Wei/GRX-2231-2022	Zhang, YIngze/0000-0001-8042-6105				Adams JG, 1999, CLIN RADIOL, V54, P502, DOI 10.1016/S0009-9260(99)90846-2; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Amendola A, 2010, INT ORTHOP, V34, P155, DOI 10.1007/s00264-009-0889-8; Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; BRANDT KD, 1991, ARTHRITIS RHEUM, V34, P1381; Cooke D, 1997, OSTEOARTHR CARTILAGE, V5, P39, DOI 10.1016/S1063-4584(97)80030-1; Dong TH, 2016, CLIN RHEUMATOL, V35, P1573, DOI 10.1007/s10067-015-3146-0; FIFE RS, 1991, ARTHRITIS RHEUM-US, V34, P377, DOI 10.1002/art.1780340402; Ghinelli D, 2016, EUR J ORTHOP SURG TR, V26, P1; Giagounidis EM, 1999, ARCH ORTHOP TRAUM SU, V119, P445, DOI 10.1007/s004020050018; Helminen HJ, 2009, SCAND J MED SCI SPOR, V19, P143, DOI 10.1111/j.1600-0838.2008.00881.x; Hunter DJ, 2009, OSTEOARTHR CARTILAGE, V17, P1170, DOI 10.1016/j.joca.2009.04.001; Hunter DJ, 2009, RHEUM DIS CLIN N AM, V35, P465, DOI 10.1016/j.rdc.2009.08.002; Hunter DJ, 2005, J RHEUMATOL, V32, P2192; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Kanamiya T, 2002, ARTHROSCOPY, V18, P725, DOI 10.1053/jars.2002.35258; Tang WM, 2000, J BONE JOINT SURG AM, V82A, P1603, DOI 10.2106/00004623-200011000-00014; Tourville TW, 2013, AM J SPORT MED, V41, P769, DOI 10.1177/0363546513477838; Wang XH, 2017, J INT MED RES, V45, P282, DOI 10.1177/0300060516676630; Yang ZY, 2015, ORTHOPEDICS, V38, pE1110, DOI 10.3928/01477447-20151120-08; Yokoyama M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1745-0; Zhang YZ, 2015, CHINESE MED J-PEKING, V128, P2841, DOI 10.4103/0366-6999.168015	22	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197980	10.1371/journal.pone.0197980	http://dx.doi.org/10.1371/journal.pone.0197980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795669	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300108
J	Sangineto, M; Graziano, G; D'Amore, S; Salvia, R; Palasciano, G; Sabba, C; Vacca, M; Cariello, M				Sangineto, Moris; Graziano, Giusi; D'Amore, Simona; Salvia, Roberto; Palasciano, Giuseppe; Sabba, Carlo; Vacca, Michele; Cariello, Marica			Identification of peculiar gene expression profile in peripheral blood mononuclear cells (PBMC) of celiac patients on gluten free diet	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MAP KINASES; DISEASE; CANCER; RECEPTORS; RISK; ATHEROSCLEROSIS; ASSOCIATION; MORTALITY; RESPONSES	Celiac disease (CD) is a systemic disorder characterized by an immune-mediated reaction to gluten and a wide spectrum of clinical manifestations. Currently, the main treatment of CD is represented by adherence to a gluten-free diet (GFD) which determines the resolution of symptoms, and the normalization of the serology and of the duodenal villous atrophy. In the present study, we aimed to identify changes in gene expression in peripheral blood mononuclear cells (PBMCs) of celiac patients on GFD for at least 2 years, in order to identify novel disease biomarkers and candidate targets for putative therapeutic approaches. Microarray analysis was performed on PBMCs from 17 celiac patients on long-term GFD and 20 healthy controls. We identified 517 annotated genes that were significantly modulated between celiac patients and controls. Significant biological pathways were functionally clustered using the Core Function of Ingenuity System Pathway Analysis (IPA). Intriguingly, despite being on a GFD, celiac patients exhibited a peculiar PBMC profile characterized by an aberrant expression of genes involved in the regulation of immunity, inflammatory response, metabolism, and cell proliferation. Random forest algorithm was then used to validate the prediction ability of core genes as classifiers of the "celiac status". In conclusion, our study identified a characteristic PBMCs signature profile in clinically asymptomatic celiac patient.	[Sangineto, Moris; D'Amore, Simona; Salvia, Roberto; Sabba, Carlo; Vacca, Michele; Cariello, Marica] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Bari, Italy; [Graziano, Giusi] IRCCS Oncol Giovanni Paolo II, Natl Canc Res Ctr, Bari, Italy; [Palasciano, Giuseppe] Aldo Moro Univ Bari, Clin Med A Murri, Dept Biomed Sci & Human Oncol, Bari, Italy; [Cariello, Marica] INBB, Rome, Italy	Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro	Cariello, M (corresponding author), Aldo Moro Univ Bari, Dept Interdisciplinary Med, Bari, Italy.; Cariello, M (corresponding author), INBB, Rome, Italy.	maricacariello@gmail.com	Vacca, Michele/B-4736-2013; Salvia, Roberto/J-1773-2018; Cariello, Marica/K-4064-2018; Sangineto, Moris/AAJ-8889-2021	Vacca, Michele/0000-0002-1973-224X; Sangineto, Moris/0000-0002-0936-8843; D'Amore, Simona/0000-0002-5432-8808				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Arts RJW, 2013, J LEUKOCYTE BIOL, V93, P209, DOI 10.1189/jlb.0312145; Bai JC, 2013, J CLIN GASTROENTEROL, V47, P121, DOI 10.1097/MCG.0b013e31827a6f83; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidmon-Fliegenschnee B, 2015, PEDIATR RES, V78, P358, DOI 10.1038/pr.2015.112; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Broide E, 2009, DIGEST DIS SCI, V54, P1270, DOI 10.1007/s10620-008-0480-y; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Cariello M, 2012, ANTIOXID REDOX SIGN, V16, P428, DOI 10.1089/ars.2011.4062; Chowers Y, 1997, CLIN EXP IMMUNOL, V107, P141, DOI 10.1046/j.1365-2249.1997.d01-892.x; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; D'Amore S, 2013, BBA-MOL BASIS DIS, V1832, P2289, DOI 10.1016/j.bbadis.2013.09.006; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Dumpe ML, 1998, NURS ECON, V16, P170; Fan DP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040498; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Fernandez-Jimenez N, 2014, HUM MOL GENET, V23, P1298, DOI 10.1093/hmg/ddt520; Green PHR, 2015, J ALLERGY CLIN IMMUN, V135, P1099, DOI 10.1016/j.jaci.2015.01.044; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Kalliomaki M, 2012, J PEDIATR GASTR NUTR, V54, P727, DOI 10.1097/MPG.0b013e318241cfa8; Kurien M, 2016, DIABETES CARE, V39, P371, DOI 10.2337/dc15-2117; Lazaris AC, 1997, BREAST CANCER RES TR, V43, P43, DOI 10.1023/A:1005706110275; Lebwohl B, 2013, ALIMENT PHARM THER, V37, P332, DOI 10.1111/apt.12164; Liu QZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S1; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Manavalan JS, 2010, HUM IMMUNOL, V71, P50, DOI 10.1016/j.humimm.2009.09.351; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Palova-Jelinkova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062426; PARTANEN J, 1993, TISSUE ANTIGENS, V41, P15, DOI 10.1111/j.1399-0039.1993.tb01971.x; Ramos-Arroyo MA, 2001, HUM IMMUNOL, V62, P821, DOI 10.1016/S0198-8859(01)00277-4; Rueda B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-29; Rybak A, 2014, NUTRIENTS, V6, P2718, DOI 10.3390/nu6072718; See Jacalyn, 2006, Nutr Clin Pract, V21, P1, DOI 10.1177/011542650602100101; Setty M, 2015, GASTROENTEROLOGY, V149, P681, DOI 10.1053/j.gastro.2015.05.013; Silvester JA, 2016, NUTRITION, V32, P777, DOI 10.1016/j.nut.2016.01.021; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Vacca M, 2016, CARDIOVASC RES, V109, P228, DOI 10.1093/cvr/cvv266; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197915	10.1371/journal.pone.0197915	http://dx.doi.org/10.1371/journal.pone.0197915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795662	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300094
J	Nunes, MRT; de Souza, WM; Acrani, GO; Cardoso, JF; da Silva, SP; Badra, SJ; Figueiredo, LTM; Vasconcelos, PFD				Teixeira Nunes, Marcio Roberto; de Souza, William Marciel; Acrani, Gustavo Olszanski; Cardoso, Jedson Ferreira; da Silva, Sandro Patroca; Badra, Soraya Jabur; Moraes Figueiredo, Luiz Tadeu; da Costa Vasconcelos, Pedro Fernando			Revalidation and genetic characterization of new members of Group C (Orthobunyavirus genus, Peribunyaviridae family) isolated in the Americas	PLOS ONE			English	Article							ARTHROPOD-BORNE VIRUSES; IDENTIFICATION; BUNYAMWERA; BUNYAVIRIDAE; GC	Group C serogroup includes members of the Orthobunyavirus genus (family Peribunyaviridae) and comprises 15 arboviruses that can be associated with febrile illness in humans. Although previous studies described the genome characterization of Group C orthobunyavirus, there is a gap in genomic information about the other viruses in this group. Therefore, in this study, complete genomes of members of Group C serogroup were sequenced or resequenced and used for genetic characterization, as well as to understand their phylogenetic and evolutionary aspects. Thus, our study reported the genomes of three new members in Group C virus (Apeu strain BeAn848, ltaqui strain BeAn12797 and Nepuyo strain BeAn10709), as well as re-sequencing of original strains of five members: Caraparu (strain BeAn3994), Madrid (strain BT4075), Murucutu (strain BeAn974), Oriboca (strain BeAn17), and Marituba (strain BeAn15). These viruses presented a typical genomic organization related to members of the Orthobunyavirus genus. Interestingly, all viruses of this serogroup showed an open reading frame (ORF) that encodes the putative nonstructural NSs protein that precedes the nucleoprotein ORF, an unprecedented fact in Group C virus. Also, we confirmed the presence of natural reassortment events. This study expands the genomic information of Group C viruses, as well as revalidates the genomic organization of viruses that were previously reported.	[Teixeira Nunes, Marcio Roberto; Cardoso, Jedson Ferreira; da Silva, Sandro Patroca] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil; [Teixeira Nunes, Marcio Roberto] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [de Souza, William Marciel; Badra, Soraya Jabur; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Sch Med Ribeirao Preto, Virol Res Ctr, Ribeirao Preto, SP, Brazil; [Acrani, Gustavo Olszanski] Univ Fed Fronteira Sul, Campus Passo Fundo, Chapeco, RS, Brazil; [da Costa Vasconcelos, Pedro Fernando] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil	Instituto Evandro Chagas; University of Texas System; University of Texas Medical Branch Galveston; Universidade de Sao Paulo; Universidade Federal da Fronteira Sul; Instituto Evandro Chagas	Nunes, MRT (corresponding author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil.; Nunes, MRT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Vasconcelos, PFD (corresponding author), Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.	marcionunesbrasil@yahoo.com.br; pedrovasconcelos@iec.pa.gov.br	Vasconcelos, Pedro/AAH-3142-2019; de Souza, William Marciel/D-3044-2017	de Souza, William Marciel/0000-0002-0025-8293; Patroca da Silva, Sandro/0000-0001-7185-4538	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302987/2008-8, 302584/2015-3, 457664/2013-4, 303999/2016-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil [12/24150-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Work in Brazil was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grants 302987/2008-8, 302584/2015-3 (MRTN). WMS is supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (Scholarships No. 12/24150-9). PFCV was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grants, 457664/2013-4 and 303999/2016-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315; [Anonymous], 2005, Nat Methods, V2, P629; Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; CALISHER CH, 1983, AM J TROP MED HYG, V32, P877, DOI 10.4269/ajtmh.1983.32.877; CASALS J, 1961, AM J TROP MED HYG, V10, P250, DOI 10.4269/ajtmh.1961.10.250; Magalhaes CLD, 2011, ARCH VIROL, V156, P1173, DOI 10.1007/s00705-011-0976-1; de Souza WM, 2016, INFECT GENET EVOL, V40, P47, DOI 10.1016/j.meegid.2016.02.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forshey BM, 2014, J VIROL, V88, P3052, DOI 10.1128/JVI.03295-13; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Hang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092114; Hedil M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070208; Hontz RD, 2015, EMERG INFECT DIS, V21, P781, DOI 10.3201/eid2105.141368; Lanciotti RS, 2013, VIROLOGY, V444, P55, DOI 10.1016/j.virol.2013.05.031; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005; Palacios G, 2011, J VIROL, V85, P3811, DOI 10.1128/JVI.02275-10; Pinheiro FP, 1981, CRC HDB SERIES ZOO B; Plassmeyer ML, 2007, VIROLOGY, V358, P273, DOI 10.1016/j.virol.2006.08.050; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; RHIM JS, 1969, P SOC EXP BIOL MED, V132, P670, DOI 10.3181/00379727-132-34285; Scherer W F, 1975, Bull Pan Am Health Organ, V9, P19; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; Shi XH, 2016, P NATL ACAD SCI USA, V113, P8825, DOI 10.1073/pnas.1603364113; SHOPE RE, 1962, AM J TROP MED HYG, V11, P283, DOI 10.4269/ajtmh.1962.11.283; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Vijaykrishna D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004902; Yamada Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006130; Yanase T, 2012, ARCH VIROL, V157, P1611, DOI 10.1007/s00705-012-1341-8	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197294	10.1371/journal.pone.0197294	http://dx.doi.org/10.1371/journal.pone.0197294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795585	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300035
J	Wei, S; Wang, J; Oyinlade, O; Ma, D; Wang, SY; Kratz, L; Lal, B; Xu, QF; Liu, SQ; Shah, SR; Zhang, H; Li, YQ; Quinones-Hinojosa, A; Zhu, H; Huang, ZY; Cheng, LZ; Qian, J; Xia, SL				Wei, Shuang; Wang, Jie; Oyinlade, Olutobi; Ma, Ding; Wang, Shuyan; Kratz, Lisa; Lal, Bachchu; Xu, Qingfu; Liu, Senquan; Shah, Sagar R.; Zhang, Hao; Li, Yunqing; Quinones-Hinojosa, Alfredo; Zhu, Heng; Huang, Zhi-yong; Cheng, Linzhao; Qian, Jiang; Xia, Shuli			Heterozygous IDH1(R132H/WT) created by "single base editing" inhibits human astroglial cell growth by downregulating YAP	ONCOGENE			English	Article							INTEGRATED GENOMIC ANALYSIS; IDH1 MUTATION; GLIOMA-CELLS; DNA METHYLATION; GENE-EXPRESSION; ACTIVATION; CANCER; PROLIFERATION; D-2-HYDROXYGLUTARATE; CRISPR-CAS9	Mutations in the isocitrate dehydrogenase 1 (IDH1) gene have been identified in a number of cancer types, including brain cancer. The Cancer Genome Atlas project has revealed that IDH1 mutations occur in 70-80% of grade II and grade III gliomas. Until recently, most of the functional studies of IDH1 mutations in cellular models have been conducted in overexpression systems with the IDH1 wild type background. In this study, we employed a modified CRISPR/Cas9 genome editing technique called "single base editing", and efficiently introduced heterozygous IDH1 R132H mutation (IDH1(R132H/WT)) in human astroglial cells. Global DNA methylation profiling revealed hypermethylation as well as hypomethylation induced by IDH1(R132H/WT). Global gene expression analysis identified molecular targets and pathways altered by IDH1(R132H/WT), including cell proliferation, extracellular matrix (ECM), and cell migration. Our phenotype analysis indicated that compared with IDH1 wild type cells, IDH1(R132H/WT) promoted cell migration by upregulating integrin beta 4 (ITGB4); and significantly inhibited cell proliferation. Using our mutated IDH1 models generated by "single base editing", we identified novel molecular targets of IDH1(R132H/WT), namely Yes-associated protein (YAP) and its downstream signaling pathway Notch, to mediate the cell growth-inhibiting effect of IDH1(R132H/WT). In summary, the "single base editing" strategy has successfully created heterozygous IDH1 R132H mutation that recapitulates the naturally occurring IDH1 mutation. Our isogenic cellular systems that differ in a single nucleotide in one allele of the IDH1 gene provide a valuable model for novel discoveries of IDH1(R132H/WT)-driven biological events.	[Wei, Shuang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Resp & Crit Care Med, Wuhan 430030, Hubei, Peoples R China; [Wei, Shuang; Oyinlade, Olutobi; Ma, Ding; Wang, Shuyan; Kratz, Lisa; Lal, Bachchu; Xu, Qingfu; Li, Yunqing; Xia, Shuli] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Wei, Shuang; Ma, Ding; Wang, Shuyan; Lal, Bachchu; Xu, Qingfu; Li, Yunqing; Xia, Shuli] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wang, Jie; Qian, Jiang] Johns Hopkins Sch Med, Dept Wilmer Eye Inst, Baltimore, MD 21205 USA; [Oyinlade, Olutobi; Zhu, Heng] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Liu, Senquan; Cheng, Linzhao] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA; [Shah, Sagar R.; Quinones-Hinojosa, Alfredo] Mayo Clin, Dept Neurol Surg, Jacksonville, FL 32224 USA; [Shah, Sagar R.] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Zhang, Hao] Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Zhu, Heng] Johns Hopkins Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA; [Huang, Zhi-yong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gen Surg, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Huazhong University of Science & Technology	Xia, SL (corresponding author), Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA.; Xia, SL (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	xia@kennedykrieger.org	Wei, Shuang/AAA-4031-2019	Wang, Jie/0000-0002-7491-7001; Huang, Zhiyong/0000-0002-2239-0674	NIH [R01NS091165, EY024580, EY023188, GM111514, T32 GM007445]; Ford Foundation predoctoral fellowship program; NATIONAL EYE INSTITUTE [R01EY023188, R01EY024580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM111514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091165] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation predoctoral fellowship program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. G. Major from NIH/NINDS for SVG cells, and Dr. Mingyao Ying from Kennedy Krieger Institute for YAP constructs. We thank Dr. John Laterra and Dr. Hernando Lopez for comments on this work. This work was supported by grants from NIH R01NS091165 (S.X.), NIH EY024580 (J.Q.), NIH EY023188 (J.Q.), and NIH GM111514 (H.Z. and J.Q.), Ford Foundation predoctoral fellowship program (O.O.) and NIH T32 GM007445 (O.O.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; BARGONETTI J, 1992, GENE DEV, V6, P1886, DOI 10.1101/gad.6.10.1886; Cui DM, 2016, INT J BIOCHEM CELL B, V73, P72, DOI 10.1016/j.biocel.2016.02.007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Ferenczy MW, 2013, J NEUROIMMUNE PHARM, V8, P1303, DOI 10.1007/s11481-013-9499-8; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fu YJ, 2012, BIOTECHNOL LETT, V34, P441, DOI 10.1007/s10529-011-0800-8; Goodwin CR, 2010, CANCER RES, V70, P2932, DOI 10.1158/0008-5472.CAN-09-3570; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Licciardello MP, 2015, ONCOGENE, V34, P3780, DOI 10.1038/onc.2014.319; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luchman HA, 2012, NEURO-ONCOLOGY, V14, P184, DOI 10.1093/neuonc/nor207; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Ma SH, 2015, ONCOTARGET, V6, P8606, DOI 10.18632/oncotarget.3330; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Miroshnikova YA, 2016, NAT CELL BIOL, V18, P1336, DOI 10.1038/ncb3429; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sabit H, 2014, BRAIN TUMOR PATHOL, V31, P242, DOI 10.1007/s10014-013-0172-y; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Shah SR, 2017, CELL REP, V21, P495, DOI 10.1016/j.celrep.2017.09.057; Shi JL, 2014, NEUROL SCI, V35, P839, DOI 10.1007/s10072-013-1607-2; Sulkowski PL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2463; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wan J, 2017, ELIFE, V6, DOI 10.7554/eLife.20068; Wang GL, 2014, MOL MED REP, V9, P1799, DOI 10.3892/mmr.2014.2052; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xia SL, 2016, NEURO-ONCOLOGY, V18, P507, DOI 10.1093/neuonc/nov171; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	44	19	20	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5160	5174		10.1038/s41388-018-0334-9	http://dx.doi.org/10.1038/s41388-018-0334-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29849122	Green Accepted			2022-12-26	WOS:000445093100002
J	Abdoul-Azize, S; Buquet, C; Li, H; Picquenot, JM; Vannier, JP				Abdoul-Azize, Souleymane; Buquet, Catherine; Li, Hong; Picquenot, Jean-Michel; Vannier, Jean-Pierre			Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin	ONCOGENE			English	Article							CANCER-CELLS; INDUCED CARDIOTOXICITY; NEURONAL APOPTOSIS; LEUKEMIA-CELLS; STATINS; STORE; BIM; ACTIVATION; PATHWAY; INDUCE	Recent studies have suggested that the lipid-lowering agent simvastatin holds great promise as a cancer therapeutic; it inhibits the growth of multiple tumors, including triple-negative breast cancer. Doxorubicin-and simvastatin-induced cytotoxicity has been associated with the modulation of Ca2+ signaling, but the underlying mechanisms remain incompletely understood. Here we identify how Ca2+ signaling regulates the breast tumor cell response to doxorubicin and simvastatin. These two drugs inhibit cell survival while increasing apoptosis in two human breast cancer cell lines and five primary breast tumor specimens through the modulation of Ca2+ signaling. Signal transduction and functional studies revealed that both simvastatin and doxorubicin trigger persistent cytosolic Ca2+ release, thereby stimulating the proapoptotic BIM pathway and mitochondrial Ca2+ overload, which are responsible for metabolic dysfunction and apoptosis induction. Simvastatin and doxorubicin suppress the prosurvival ERK1/2 pathway in a Ca2+-independent and Ca2+-dependent manner, respectively. In addition, reduction of the Ca2+ signal by chelation or pharmacological inhibition significantly prevents drug-mediated anticancer signaling. Unexpectedly, a scratch-wound assay indicated that these two drugs induce rapid cell migration, while inhibiting cell invasion and colony formation in a Ca2+-dependent manner. Further, the in vivo data for MDA-MB-231 xenografts demonstrate that upon chelation of Ca2+, the ability of both drugs to reduce the tumor burden was significantly reduced via caspase-3 deactivation. Our results establish a calcium-based mechanism as crucial for executing the cell death process triggered by simvastatin and doxorubicin, and suggest that combining simvastatin with doxorubicin may be an effective regimen for the treatment of breast cancer.	[Abdoul-Azize, Souleymane; Buquet, Catherine; Li, Hong; Vannier, Jean-Pierre] Univ Rouen, Fac Med & Pharm, IRIB, Unite Inserm,U1234, F-76183 Rouen, France; [Picquenot, Jean-Michel] Ctr Henri Becquerel Lutte Canc CLCC Normandie, Serv Anat & Cytol Pathol, F-76038 Rouen 1, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Abdoul-Azize, S (corresponding author), Univ Rouen, Fac Med & Pharm, IRIB, Unite Inserm,U1234, F-76183 Rouen, France.	souleymane.abdoul-azize@univ-rouen.fr	Abdoul-Azize, Souleymane/AAB-2181-2021	Abdoul-Azize, Souleymane/0000-0003-2065-9091	French Ministry of Higher Education and Research; Association Vie et Espoir	French Ministry of Higher Education and Research; Association Vie et Espoir	This work was supported by grants from the French Ministry of Higher Education and Research, and the Association Vie et Espoir. We thank members of the LIONS CLUB Les Andelys association for their support with equipment.	Abdoul-Azize S, 2017, ONCOTARGET, V8, P27339, DOI 10.18632/oncotarget.16039; Ansari L, 2017, CANCER GENE THER, V24, P189, DOI 10.1038/cgt.2017.9; Borahay MA, 2014, J BIOL CHEM, V289, P35075, DOI 10.1074/jbc.M114.583575; Buranrat B, 2017, ONCOL LETT, V14, P6243, DOI 10.3892/ol.2017.6783; Burridge PW, 2016, NAT MED, V22, P547, DOI 10.1038/nm.4087; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Cheng HY, 2016, ONCOTARGET, V7, P16866, DOI 10.18632/oncotarget.7619; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; David L, 2004, MATRIX BIOL, V23, P183, DOI 10.1016/j.matbio.2004.05.005; David L, 2008, ACTA BIOMATER, V4, P256, DOI 10.1016/j.actbio.2007.08.012; Einbond LS, 2016, FITOTERAPIA, V109, P146, DOI 10.1016/j.fitote.2015.12.005; Gajek Arkadiusz, 2015, Asian Pac J Cancer Prev, V16, P8503; Gao JQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168219; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Giorgi C, 2015, P NATL ACAD SCI USA, V112, P1779, DOI 10.1073/pnas.1410723112; Gogebakan B, 2014, TUMOR BIOL, V35, P8033, DOI 10.1007/s13277-014-1752-0; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Huang XX, 2015, CURR CANCER DRUG TAR, V15, P481, DOI 10.2174/156800961506150805151905; Kato S, 2010, J CELL MOL MED, V14, P1180, DOI 10.1111/j.1582-4934.2009.00771.x; Katz MS, 2005, NAT CLIN PRACT ONCOL, V2, P82, DOI 10.1038/ncponc0097; Lavik AR, 2015, ONCOTARGET, V6, P27388, DOI 10.18632/oncotarget.4489; Leung YM, 1999, JPN J PHARMACOL, V81, P253, DOI 10.1254/jjp.81.253; Li Y, 2013, INT J MOL MED, V31, P1234, DOI 10.3892/ijmm.2013.1292; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liu CX, 2016, ONCOTARGET, V7, P7534, DOI 10.18632/oncotarget.7183; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Marchi S, 2016, CURR OPIN PHARMACOL, V29, P1, DOI 10.1016/j.coph.2016.03.002; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MORTIMER JE, 2003, P AN M AM SOC CLIN, V22, P93; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Ouadid-Ahidouch H, 2013, TRENDS MOL MED, V19, P117, DOI 10.1016/j.molmed.2012.11.004; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rambal AA, 2009, LEUKEMIA, V23, P1744, DOI 10.1038/leu.2009.80; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Safwat S, 2017, J PHARM PHARMACOL, V69, P613, DOI 10.1111/jphp.12707; Shi J, 2017, J PHYSIOL-LONDON, V595, P1039, DOI 10.1113/JP273302; Simon T, 2014, NEUROMOL MED, V16, P752, DOI 10.1007/s12017-014-8324-8; Szwed M, 2016, CELL ONCOL, V39, P107, DOI 10.1007/s13402-015-0256-2; Tanwar J, 2018, CELL CALCIUM, V69, P19, DOI 10.1016/j.ceca.2017.06.002; Tiwari M, 2017, J CELL PHYSIOL, V232, P976, DOI 10.1002/jcp.25670; Tombal B, 2002, CELL DEATH DIFFER, V9, P561, DOI 10.1038/sj.cdd.4400999; Vashisht A, 2015, AM J PHYSIOL-CELL PH, V309, pC457, DOI 10.1152/ajpcell.00064.2015; Wu QJ, 2015, ONCOTARGET, V6, P42988, DOI 10.18632/oncotarget.5557; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yao H, 2017, ONCOTARGET, V8, P1913, DOI 10.18632/oncotarget.12284; Zhang HT, 2016, CELL PHYSIOL BIOCHEM, V40, P1079, DOI 10.1159/000453163; Zhang S, 2016, MOL NEUROBIOL, V53, P7078, DOI 10.1007/s12035-015-9573-8; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	51	22	23	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					4979	4993		10.1038/s41388-018-0329-6	http://dx.doi.org/10.1038/s41388-018-0329-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29795329				2022-12-26	WOS:000443823600006
J	Plouffe, SW; Lin, KC; Moore, JL; Tan, FE; Ma, SH; Ye, Z; Qiu, YJ; Ren, B; Guan, KL				Plouffe, Steven W.; Lin, Kimberly C.; Moore, Jerrell L., III; Tan, Frederick E.; Ma, Shenghong; Ye, Zhen; Qiu, Yunjiang; Ren, Bing; Guan, Kun-Liang			The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEAD; MICE; TRANSCRIPTION; DEGRADATION; DEFECTS; TARGETS	The Hippo pathway plays an important role in regulating tissue homeostasis, and its effectors, the transcriptional co-activators Yes-associated protein (YAP) and WW domain-containing transcription regulator 1 (WWTR1 or TAZ), are responsible for mediating the vast majority of its physiological functions. Although YAP and TAZ are thought to be largely redundant and similarly regulated by Hippo signaling, they have developmental, structural, and physiological differences that suggest they may differ in their regulation and downstream functions. To better understand the functions of YAP and TAZ in the Hippo pathway, using CRISPR/Cas9, we generated YAP KO, TAZ KO, and YAP/TAZ KO cell lines in HEK293A cells. We evaluated them in response to many environmental conditions and stimuli and used RNA-Seq to compare their transcriptional profiles. We found that YAP inactivation has a greater effect on cellular physiology (namely, cell spreading, volume, granularity, glucose uptake, proliferation, and migration) than TAZ inactivation. However, functional redundancy between YAP and TAZ was also observed. In summary, our findings confirm that the Hippo pathway effectors YAP and TAZ are master regulators for multiple cellular processes but also reveal that YAP has a stronger influence than TAZ.	[Plouffe, Steven W.; Lin, Kimberly C.; Moore, Jerrell L., III; Ma, Shenghong; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Plouffe, Steven W.; Lin, Kimberly C.; Moore, Jerrell L., III; Ma, Shenghong; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Tan, Frederick E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Qiu, Yunjiang] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Ye, Zhen; Qiu, Yunjiang; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Qiu, Yunjiang/AAC-1395-2019	Qiu, Yunjiang/0000-0002-0539-9714	National Institutes of Health [R35CA196878, R01GM51586, R01DE015964]; NATIONAL CANCER INSTITUTE [R35CA196878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35CA196878, R01GM51586, and R01DE015964 (to K.-L.G.). K.-L.G. is a co-founder of and has an equity interest in Vivace Therapeutics, Inc. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Dai YY, 2017, J THORAC DIS, V9, P2246, DOI 10.21037/jtd.2017.07.18; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Kaan HYK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02219-9; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lin KC, 2017, NAT CELL BIOL, V19, P996, DOI 10.1038/ncb3581; Liu XF, 2016, CELL REP, V14, P1169, DOI 10.1016/j.celrep.2015.12.104; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Santucci M, 2015, J MED CHEM, V58, P4857, DOI 10.1021/jm501615v; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216	28	121	123	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11230	11240		10.1074/jbc.RA118.002715	http://dx.doi.org/10.1074/jbc.RA118.002715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802201	Green Published, hybrid			2022-12-26	WOS:000438882800033
J	Schrod, N; Vanhecke, D; Laugks, U; Stein, V; Fukuda, Y; Schaffer, M; Baumeister, W; Lucic, V				Schrod, Nikolas; Vanhecke, Dimitri; Laugks, Ulrike; Stein, Valentin; Fukuda, Yoshiyuki; Schaffer, Miroslava; Baumeister, Wolfgang; Lucic, Vladan			Pleomorphic linkers as ubiquitous structural organizers of vesicles in axons	PLOS ONE			English	Article							PRESYNAPTIC ACTIVE ZONE; DENSE-CORE VESICLES; CRYOELECTRON TOMOGRAPHY REVEALS; CULTURED HIPPOCAMPAL-NEURONS; SMOOTH ENDOPLASMIC-RETICULUM; CENTRAL-NERVOUS-SYSTEM; SYNAPTIC VESICLES; ELECTRON TOMOGRAPHY; QUANTITATIVE-ANALYSIS; TRANSPORT VESICLES	Many cellular processes depend on a precise structural organization of molecular components. Here, we established that neurons grown in culture provide a suitable system for in situ structural investigations of cellular structures by cryo-electron tomography, a method that allows high resolution, three-dimensional imaging of fully hydrated, vitrified cellular samples. A higher level of detail of cellular components present in our images allowed us to quantitatively characterize presynaptic and cytoskeletal organization, as well as structures involved in axonal transport and endocytosis. In this way we provide a structural framework into which information from other methods need to fit. Importantly, we show that short pleomorphic linkers (tethers and connectors) extensively interconnect different types of spherical vesicles and other lipid membranes in neurons imaged in a close-to-native state. These linkers likely serve to organize and precisely position vesicles involved in endocytosis, axonal transport and synaptic release. Hence, structural interactions via short linkers may serve as ubiquitous vesicle organizers in neuronal cells.	[Schrod, Nikolas; Vanhecke, Dimitri; Laugks, Ulrike; Fukuda, Yoshiyuki; Schaffer, Miroslava; Baumeister, Wolfgang; Lucic, Vladan] Max Planck Inst Biochem, Klopferspitz 18, Martinsried, Germany; [Stein, Valentin] Univ Bonn, Inst Physiol 2, Bonn, Germany	Max Planck Society; University of Bonn	Lucic, V (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, Martinsried, Germany.	vladan@biochem.mpg.de	Lucic, Vladan/AAA-8128-2020; Vanhecke, Dimitri/Y-2203-2019	Lucic, Vladan/0000-0003-3698-7436; Schaffer, Miroslava/0000-0001-8748-1748	Marie Curie fellowship	Marie Curie fellowship(European Commission)	This work was supported by Marie Curie fellowship, recipient DV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.V. was supported by Marie Curie fellowship. We would like to thank Gabriela J. Greif and Marion Jasnin for critical reading of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Andreae LC, 2012, J NEUROSCI, V32, P1867, DOI 10.1523/JNEUROSCI.5181-11.2012; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Bicek AD, 2007, METHOD CELL BIOL, V83, P237, DOI 10.1016/S0091-679X(07)83010-X; Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x; BODIAN D, 1970, J CELL BIOL, V44, P115, DOI 10.1083/jcb.44.1.115; Bouchet-Marquis C, 2007, BIOL CELL, V99, P45, DOI 10.1042/BC20060081; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Bury LAD, 2016, NEUROSCIENTIST, V22, P372, DOI 10.1177/1073858415596131; Bury LAD, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-24; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Cole AA, 2016, J NEUROSCI, V36, P3222, DOI 10.1523/JNEUROSCI.2939-15.2016; Cyrklaff M, 2007, J EXP MED, V204, P1281, DOI 10.1084/jem.20062405; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Dubochet J, 2001, MICRON, V32, P91, DOI 10.1016/S0968-4328(00)00026-3; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010; Fernandez JJ, 2016, BIOPHYS J, V110, P850, DOI 10.1016/j.bpj.2015.10.043; Fernandez-Busnadiego R, 2013, J CELL BIOL, V201, P725, DOI 10.1083/jcb.201206063; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Fukuda Y, 2015, J STRUCT BIOL, V190, P143, DOI 10.1016/j.jsb.2015.03.004; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Garvalov BK, 2006, J CELL BIOL, V174, P759, DOI 10.1083/jcb.200606074; Goslin K., 1991, CULTURING NERVE CELL, P251; Gundelfinger Eckart D, 2015, Front Synaptic Neurosci, V7, P19, DOI 10.3389/fnsyn.2015.00019; Gustafsson JS, 2002, J COMP NEUROL, V450, P167, DOI 10.1002/cne.10310; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Jasnin M, 2013, P NATL ACAD SCI USA, V110, P20521, DOI 10.1073/pnas.1320155110; Jones E., 2001, SCIPY OPEN SOURCE SC; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Klumperman J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016857; Koning RI, 2008, J STRUCT BIOL, V161, P459, DOI 10.1016/j.jsb.2007.08.011; Korkhov VM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-59; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Korogod N, 2015, ELIFE, V4, DOI 10.7554/eLife.05793; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Li Y, 2017, EXP CELL RES, V358, P253, DOI 10.1016/j.yexcr.2017.06.022; Lucic V, 2007, J STRUCT BIOL, V160, P146, DOI 10.1016/j.jsb.2007.08.014; Lucic V, 2016, J STRUCT BIOL, V196, P503, DOI 10.1016/j.jsb.2016.10.004; Lucic V, 2013, J CELL BIOL, V202, P407, DOI 10.1083/jcb.201304193; Maeder CI, 2014, CURR OPIN NEUROBIOL, V27, P165, DOI 10.1016/j.conb.2014.03.015; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Maurer UE, 2008, P NATL ACAD SCI USA, V105, P10559, DOI 10.1073/pnas.0801674105; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022; Murk JLAN, 2003, J MICROSC-OXFORD, V212, P81, DOI 10.1046/j.1365-2818.2003.01238.x; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Odde DJ, 1999, J CELL SCI, V112, P3283; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Petzoldt AG, 2016, CURR OPIN NEUROBIOL, V39, P69, DOI 10.1016/j.conb.2016.04.009; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; PICKEL VM, 1995, SYNAPSE, V19, P160, DOI 10.1002/syn.890190303; Ratnayaka A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1534; Renvoise B, 2010, CURR OPIN NEUROBIOL, V20, P531, DOI 10.1016/j.conb.2010.07.001; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Rigort A, 2012, J STRUCT BIOL, V177, P135, DOI 10.1016/j.jsb.2011.08.012; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Scott DA, 2011, NEURON, V70, P441, DOI 10.1016/j.neuron.2011.03.022; Shahmoradian SH, 2014, JOVE-J VIS EXP, DOI 10.3791/50783; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Siksou L, 2013, EUR J NEUROSCI, V37, P1631, DOI 10.1111/ejn.12199; Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x; Sorra KE, 2006, NEUROSCIENCE, V141, P2097, DOI 10.1016/j.neuroscience.2006.05.033; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stein V, 2003, J NEUROSCI, V23, P5503; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; Tao-Cheng JH, 2007, NEUROSCIENCE, V150, P575, DOI 10.1016/j.neuroscience.2007.09.031; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Vargas KJ, 2017, CELL REP, V18, P161, DOI 10.1016/j.celrep.2016.12.023; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang Z, 2011, MOL BIOL CELL, V22, P2324, DOI 10.1091/mbc.E11-02-0159	91	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197886	10.1371/journal.pone.0197886	http://dx.doi.org/10.1371/journal.pone.0197886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864134	Green Submitted, Green Published, gold			2022-12-26	WOS:000434097100011
J	Gomar-Vercher, S; Simon-Soro, A; Montiel-Company, JM; Almerich-Silla, JM; Mira, A				Gomar-Vercher, Sonia; Simon-Soro, Aurea; Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose; Mira, Alex			Stimulated and unstimulated saliva samples have significantly different bacterial profiles	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; ORAL MICROBIOTA; RIBOSOMAL-RNA; DENTAL-CARIES; DIVERSITY; DENTITION; ADULTS; PCR; PREVALENCE; COMMUNITY	Epidemiological studies use saliva on a regular basis as a non-invasive and easy-to-take sample, which is assumed to be a microbial representative of the oral cavity ecosystem. However, comparative studies between different kinds of saliva samples normally used in microbial studies are scarce. The aim of the current study was to compare oral microbiota composition between two different saliva samples collected simultaneously: non-stimulated saliva with paper points and stimulated saliva collected after chewing paraffin gum. DNA was extracted from saliva samples of ten individuals, then analyzed by 16S rRNA pyrosequencing to describe bacterial diversity. The results demonstrate significant differences between the microbiota of these two kinds of saliva. Stimulated saliva was found to contain an estimated number of species over three times higher than unstimulated saliva. In addition, bacterial composition at the class and genus level was radically different between both types of samples. When compared to other oral niches, both types of saliva showed some similarity to tongue and buccal mucosa, but they do not correlate at all with the bacterial composition described in supra-or sub-gingival dental plaque, questioning their use in etiological and epidemiological studies of oral diseases of microbial origin.	[Gomar-Vercher, Sonia; Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose] Univ Valencia, Stomatol Dept, Gasco Oliag 1, Valencia, Spain; [Simon-Soro, Aurea; Mira, Alex] CSISP FISABIO, Ctr Adv Res Publ Hlth, Dept Genom & Hlth, Valencia, Spain	University of Valencia	Almerich-Silla, JM (corresponding author), Univ Valencia, Stomatol Dept, Gasco Oliag 1, Valencia, Spain.	jose.m.almerich@uv.es	Simon-Soro, Aurea/CAF-7784-2022; Montiel-Company, José María/S-1836-2018	Simon-Soro, Aurea/0000-0003-3656-6834; Montiel-Company, José María/0000-0002-3952-7681; Mira, Alex/0000-0002-9127-3877; Almerich-Silla, Jose Manuel/0000-0001-9605-3833	Valencian Health Department [DOCV.6175, of 30.12.2009]; University of Valencia Grant [UV-INV-AE11-40221]; Generalitat Valenciana [016/2010]	Valencian Health Department; University of Valencia Grant; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	Funded by projects DOCV.6175, of 30.12.2009 from the Valencian Health Department; University of Valencia Grant UV-INV-AE11-40221; and project 016/2010 from Generalitat Valenciana. Recipient Prof. Jose Manuel Almerich-Silla.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Bachrach G, 2003, LETT APPL MICROBIOL, V36, P50, DOI 10.1046/j.1472-765X.2003.01262.x; Belstrom D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182992; Belstrom D, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30112; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Darout IA, 2002, J CLIN PERIODONTOL, V29, P411, DOI 10.1034/j.1600-051X.2002.290505.x; EMILSON CG, 1983, SCAND J DENT RES, V91, P26; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Hart TC, 2011, INT J DENT, V2011, DOI 10.1155/2011/196721; Hausen H, 1997, COMMUNITY DENT ORAL, V25, P87, DOI 10.1111/j.1600-0528.1997.tb00904.x; He XS, 2012, MICROB ECOL, V63, P532, DOI 10.1007/s00248-011-9989-2; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang QZ, 2012, MOL CELL BIOCHEM, V365, P159, DOI 10.1007/s11010-012-1255-5; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; LINDQUIST B, 1990, J DENT RES, V69, P1160, DOI 10.1177/00220345900690050801; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Matto J, 1998, J CLIN MICROBIOL, V36, P157; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Nyvad B, 2013, CARIES RES, V47, P89, DOI 10.1159/000345367; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; Raghavendran K, 2007, PERIODONTOL 2000, V44, P164, DOI 10.1111/j.1600-0757.2006.00206.x; Rudney JD, 2009, ARCH ORAL BIOL, V54, P91, DOI 10.1016/j.archoralbio.2008.08.007; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Tellez M, 2013, J EVID-BASED DENT PR, V13, P58, DOI 10.1016/j.jebdp.2013.04.002; Vitorino R, 2005, BIOMED CHROMATOGR, V19, P214, DOI 10.1002/bmc.438; Wilson M., 2005, MICROBIAL INHABITANT; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yoshida A, 2003, J CLIN MICROBIOL, V41, P4438, DOI 10.1128/JCM.41.9.4438-4441.2003; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	40	31	34	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198021	10.1371/journal.pone.0198021	http://dx.doi.org/10.1371/journal.pone.0198021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856779	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800061
J	Rios, R; Pineda, C; Lopez, I; Munoz-Castaneda, J; Rodriguez, M; Aguilera-Tejero, E; Raya, AI				Rios, Rafael; Pineda, Carmen; Lopez, Ignacio; Munoz-Castaneda, Juan; Rodriguez, Mariano; Aguilera-Tejero, Escolastico; Raya, Ana, I			Phosphorus restriction does not prevent the increase in fibroblast growth factor 23 elicited by high fat diet	PLOS ONE			English	Article							OBESITY; FGF23; RATS; INFLAMMATION; METABOLISM; MECHANISMS; EXPRESSION; DISEASE; LEPTIN; KLOTHO	This study was designed to evaluate the influence of phosphorus (P) restriction on the deleterious effects of high fat diets on mineral metabolism. Twenty-four rats were allotted to 3 groups (n = 8 each) that were fed different diets for 7 months. Rats in group 1 were fed normal fat-normal P (0.6%) diet (NF-NP), rats in group 2 were fed high fat-normal P diet (HF-NP) and rats in group 3 were fed high fat-low P (0.2%) diet (HF-LP). Blood, urine and tissues were collected at the end of the experiments. When compared with the control group (NF-NP), rats fed HF diets showed increases in body weight, and in plasma concentrations of triglycerides and leptin, and decreased plasma calcitriol concentrations. In rats fed HF-NP plasma fibroblast growth factor 23 (FGF23) was higher (279.6 +/- 39.4 pg/ml vs 160.6 +/- 25.0 pg/ml, p = 0.018) and renal klotho (ratio klotho/GAPDH) was lower (0.75 +/- 0.06 vs 1.06 +/- 0.08, p<0.01) than in rats fed NF-NP. Phosphorus restriction did not normalize plasma FGF23 or renal klotho; in fact, rats fed HF-LP, that only ingested an average of 22.9 mg/day of P, had higher FGF23 (214.7 +/- 32.4 pg/ml) concentrations than rats fed NF-NP (160.6 +/- 25.0 pg/ml), that ingested and average of 74.4 mg/day of P over a 7 month period. In conclusion, our results demonstrate that severe P restriction over a prolonged period of time (7 months) does not normalize the increase in circulating FGF23 induced by HF diets. These data indicate that the deleterious effects of high fat diet on the FGF23/klotho axis are not eliminated by reduced P intake.	[Rios, Rafael; Pineda, Carmen; Lopez, Ignacio; Aguilera-Tejero, Escolastico; Raya, Ana, I] Univ Cordoba, Dept Anim Med & Surg, Campus Univ Rabanales, Cordoba, Spain; [Rios, Rafael; Pineda, Carmen; Lopez, Ignacio; Munoz-Castaneda, Juan; Rodriguez, Mariano; Aguilera-Tejero, Escolastico; Raya, Ana, I] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba	Aguilera-Tejero, E (corresponding author), Univ Cordoba, Dept Anim Med & Surg, Campus Univ Rabanales, Cordoba, Spain.; Aguilera-Tejero, E (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain.	eaguilera@uco.es	Raya, Ana I/A-9548-2017; Pineda, Carmen/AAF-4385-2020; Varo, Rafael Ríos/W-4962-2018; Muñoz-Castañeda, Juan R./AFQ-3443-2022	Raya, Ana I/0000-0002-4489-9447; Varo, Rafael Ríos/0000-0003-2505-3910; Pineda Martos, Carmen Maria/0000-0002-3664-8699; Rodriguez, Mariano/0000-0002-9380-6614	Institute de Salud Carlos III [PI17/00169]	Institute de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by the Institute de Salud Carlos III, Grant Number PI17/00169. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8; Bourgeois S, 2013, PFLUG ARCH EUR J PHY, V465, P1557, DOI 10.1007/s00424-013-1298-9; di Giuseppe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133580; Frommelt L, 2014, NUTRITION, V30, P869, DOI 10.1016/j.nut.2013.11.017; Kanbay M, 2017, CALCIFIED TISSUE INT, V100, P217, DOI 10.1007/s00223-016-0206-7; Kestenbaum B, 2014, CIRC-HEART FAIL, V7, P409, DOI 10.1161/CIRCHEARTFAILURE.113.000952; Kovesdy CP, 2016, AM J PHYSIOL-RENAL, V310, pF1168, DOI 10.1152/ajprenal.00606.2015; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Marsell R, 2009, OSTEOPOROSIS INT, V20, P1167, DOI 10.1007/s00198-008-0780-2; Miyazaki TTT, 2010, TRACE NUTR RES, V27, P92; Munoz-Castaneda JR, 2017, FASEB J, V31, P3858, DOI 10.1096/fj.201700006R; Panwar B, 2015, STROKE, V46, P322, DOI 10.1161/STROKEAHA.114.007489; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Poret JM, 2018, INT J OBESITY, V42, P535, DOI 10.1038/ijo.2017.280; Raya AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36881; Razzaque MS, 2012, NAT REV ENDOCRINOL, V8, P579, DOI 10.1038/nrendo.2012.75; Rios R, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0790-4; Saini RK, 2013, CALCIFIED TISSUE INT, V92, P339, DOI 10.1007/s00223-012-9683-5; Sarathy S, 2008, J RENAL NUTR, V18, P466, DOI 10.1053/j.jrn.2008.05.007; Sastre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083713; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Tsuji K, 2010, J BONE MINER RES, V25, P1711, DOI 10.1002/jbmr.65; Uribarri J, 2003, SEMIN DIALYSIS, V16, P186, DOI 10.1046/j.1525-139X.2003.16037.x; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006	26	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198481	10.1371/journal.pone.0198481	http://dx.doi.org/10.1371/journal.pone.0198481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856857	Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800129
J	Zhang, XY; Nakajima, T; Kim, M; Yamaguchi, A; Lamid-Ochir, O; Huong, NT; Bhattarai, A; Hanaoka, H; Tsushima, Y				Zhang, Xieyi; Nakajima, Takahito; Kim, Mai; Yamaguchi, Aiko; Lamid-Ochir, Oyunbold; Huong Nguyen-Thu; Bhattarai, Anu; Hanaoka, Hirofumi; Tsushima, Yoshito			Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SURGERY; EGFR; PANITUMUMAB; ANTIBODIES; NAVIGATION; GEFITINIB; HEAD	It is important to detect mediastinal lymph node metastases in patients with lung cancer to improve outcomes, and it is possible that activatable fluorescence imaging with indocyanine green (ICG) can help visualize metastatic lymph nodes. Therefore, we investigated the feasibility of applying this method to mediastinal lymph node metastases in an epidermal growth factor receptor (EGFR)-positive squamous cell carcinoma of the lung. Tumors were formed by injecting H226 (EGFR-positive) and H520 (EGFR-negative) cell lines directly in the lung parenchyma of five mice each. When computed tomography revealed tumors exceeding 8 mm at their longest or atelectasis that occupied more than half of lateral lung fields, a panitumumab (Pan)-ICG conjugate was injected in the tail vein (50 mu g/100 mu L). The mice were then sacrificed 48 hours after injection and their chests were opened for fluorescent imaging acquisition. Lymph node metastases with the five highest fluorescent signal intensities per mouse were chosen for statistical analysis of the average signal ratios against the liver. Regarding the quenching capacity, the Pan-ICG conjugate had almost no fluorescence in phosphate-buffered saline, but there was an approximate 61.8-fold increase in vitro after treatment with 1% sodium dodecyl sulfate. Both the fluorescent microscopy and the flow cytometry showed specific binding between the conjugate and H226, but almost no specific binding with H520. The EGFR-positive mediastinal lymph node metastases showed significantly higher average fluorescence signal ratios than the EGFR-negative ones (n = 25 per group) 48 hours after conjugate administration (70.1% +/- 4.5% vs. 13.3% +/- 1.8%; p < 0.05). Thus, activatable fluorescence imaging using the Pan -ICG conjugate detected EGFR-positive mediastinal lymph node metastases with high specificity.	[Zhang, Xieyi; Nakajima, Takahito; Kim, Mai; Lamid-Ochir, Oyunbold; Huong Nguyen-Thu; Bhattarai, Anu; Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma, Japan; [Yamaguchi, Aiko; Hanaoka, Hirofumi] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gunma, Japan; [Tsushima, Yoshito] Gunma Univ, Initiat Adv Res, Div Integrated Oncol Res, Res Program Diagnost & Mol Imaging, Maebashi, Gunma, Japan	Gunma University; Gunma University; Gunma University	Nakajima, T (corresponding author), Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma, Japan.	gunma_radtech@yahoo.co.jp	Oyunbold, Lamid-Ochir/AAA-2109-2020; Hanaoka, Hirofumi/T-6261-2019; Zhang, Xieyi/W-6527-2019; Nakajima, Takahito/AAG-9167-2021; Yamaguchi, Aiko/AAJ-1588-2021	Hanaoka, Hirofumi/0000-0003-2421-7397; Nakajima, Takahito/0000-0001-6704-2297; Yamaguchi, Aiko/0000-0002-7631-3164	Otsuka Toshimi Scholarship Foundation	Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical)	The first author had a financial support for his stay in Japan from the Otsuka Toshimi Scholarship Foundation. However, this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Cetin K, 2014, LUNG CANCER, V86, P247, DOI 10.1016/j.lungcan.2014.08.022; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Cohen AS, 2017, ONCOTARGET, V8, P113373, DOI 10.18632/oncotarget.23009; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Ellis PM, 2015, CURR ONCOL, V22, pE183, DOI 10.3747/co.22.2566; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Giusti RM, 2007, ONCOLOGIST, V12, P577, DOI 10.1634/theoncologist.12-5-577; Karunanithi S, 2015, NUCL MED REV, V18, P37, DOI 10.5603/NMR.2015.0009; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Liu XM, 2017, ONCOTARGET, V8, P50209, DOI 10.18632/oncotarget.16854; Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma Qianli, 2016, J Vis Surg, V2, P46, DOI 10.21037/jovs.2016.02.14; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Nakajima T, 2011, BIOCONJUGATE CHEM, V22, P1700, DOI 10.1021/bc2002715; Namikawa T, 2015, SURG TODAY, V45, P1467, DOI 10.1007/s00595-015-1158-7; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Oh HS, 2014, GASTRIC CANCER, V17, P402, DOI 10.1007/s10120-013-0288-0; Porcu EP, 2016, BIOTECHNOL ADV, V34, P768, DOI 10.1016/j.biotechadv.2016.04.001; Prabhakar CN, 2015, TRANSL LUNG CANCER R, V4, P110, DOI 10.3978/j.issn.2218-6751.2015.01.01; Reinersman JM, 2016, ANN CARDIOTHORAC SUR, V5, P112, DOI 10.21037/acs.2016.03.08; Rosenthal EL, 2015, CLIN CANCER RES, V21, P3658, DOI 10.1158/1078-0432.CCR-14-3284; Sano K, 2013, BIOCONJUGATE CHEM, V24, P811, DOI 10.1021/bc400050k; Sano K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3167; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Socinski MA, 2007, CLIN CANCER RES, V13, p4597S, DOI 10.1158/1078-0432.CCR-07-0335; Spigel DR, 2017, CANCER INVEST, V35, P541, DOI 10.1080/07357907.2017.1344698; Toh U, 2015, BREAST CANCER RES TR, V153, P337, DOI 10.1007/s10549-015-3542-9; van Dijk LK, 2015, CLIN CANCER RES, V21, P3602, DOI 10.1158/1078-0432.CCR-15-0348; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Yoo SB, 2010, LUNG CANCER, V67, P301, DOI 10.1016/j.lungcan.2009.05.002	34	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198224	10.1371/journal.pone.0198224	http://dx.doi.org/10.1371/journal.pone.0198224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856819	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800091
J	Rao, DD; Luo, XQ; Wang, ZH; Jay, CM; Brunicardi, FC; Maltese, W; Manning, L; Senzer, N; Nemunaitis, J				Rao, Donald D.; Luo, Xiuquan; Wang, Zhaohui; Jay, Christopher M.; Brunicardi, Francis C.; Maltese, William; Manning, Luisa; Senzer, Neil; Nemunaitis, John			KRAS mutant allele -specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex	PLOS ONE			English	Article							K-RAS; FEEDBACK-REGULATION; PATHWAY INHIBITORS; ONCOGENIC KRAS; TUMOR-CELLS; GROWTH; COMBINATION; PROTEINS; SIRNA	The KRAS oncogene, present in over 90% of pancreatic ductal adenocarcinomas, is most frequently the result of one of three gain-of-function substitution mutations of codon 12 glycine. Thus far, RAS mutations have been clinically refractory to both direct and selective inhibition by systemic therapeutics. This report presents the results of pre-clinical assessment of a lipoplex comprising a plasmid-encoded, modular bi-functional shRNA (bi-shRNA), which executes selective and multi-mutant allelic KRAS(G12mut) gene silencing, encased within a fusogenic liposome systemic delivery vehicle. Using both a dual luciferase reporter system and a Restriction Fragment Length Polymorphism (RFLP) assay, selective discrimination of KRAS(G12mut) from KRAS(wt) was confirmed in vitro in PANC1 cells. Subsequently, systemic administration of the bi-shRNA(KRAs) fusogenic lipoplex into female athymic Nu/Nu mice bearing PANC1 xenografts demonstrated intratumoral plasmid delivery, KRAS(G12mut) knockdown, and inhibition of tumor growth, without adverse effect. Clinical trials with the bishRNA lipoplex have been implemented.	[Rao, Donald D.; Luo, Xiuquan; Wang, Zhaohui; Jay, Christopher M.; Senzer, Neil; Nemunaitis, John] Strike Bio, Dallas, TX 75201 USA; [Brunicardi, Francis C.; Maltese, William; Nemunaitis, John] Univ Toledo, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Manning, Luisa; Senzer, Neil; Nemunaitis, John] Gradalis Inc, Dallas, TX 75201 USA	University System of Ohio; University of Toledo	Nemunaitis, J (corresponding author), Strike Bio, Dallas, TX 75201 USA.; Nemunaitis, J (corresponding author), Univ Toledo, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.; Nemunaitis, J (corresponding author), Gradalis Inc, Dallas, TX 75201 USA.	johnnemunaits@gmail.com						Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bedard PL, 2015, CLIN CANCER RES, V21, P730, DOI 10.1158/1078-0432.CCR-14-1814; Bentley C, 2013, BIOCHEM J, V452, P313, DOI 10.1042/BJ20121578; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cicenas J, 2017, CANCERS, V9, DOI 10.3390/cancers9050042; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Cleary JM, 2010, CURR ONCOL REP, V12, P87, DOI 10.1007/s11912-010-0091-6; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; Ebi H, 2014, CANCER SCI, V105, P499, DOI 10.1111/cas.12383; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; Fritsche-Guenther R, 2016, ONCOTARGET, V7, P7960, DOI 10.18632/oncotarget.6959; Geng CM, 2011, CHINESE MED J-PEKING, V124, P106, DOI 10.3760/cma.j.issn.0366-6999.2011.01.020; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Golan T, 2015, ONCOTARGET, V6, P24560, DOI 10.18632/oncotarget.4183; Gradiz R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21648; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez-Valladares M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17307; Hetmanski JHR, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004909; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; Kulemann B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04601-z; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; Le Rolle AF, 2016, ONCOTARGET, V7, P2159, DOI 10.18632/oncotarget.6818; Lennerz Jochen K, 2015, Oncologist, V20, pe8, DOI 10.1634/theoncologist.2014-0408; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Long GV, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9011; Mann KM, 2016, PHARMACOL THERAPEUT, V168, P29, DOI 10.1016/j.pharmthera.2016.09.003; Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188; McCormick F, 2016, J MOL MED, V94, P253, DOI 10.1007/s00109-016-1382-7; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Rao DD, 2010, CANCER GENE THER, V17, P780, DOI 10.1038/cgt.2010.35; Rao Donald D, 2013, Methods Mol Biol, V942, P259, DOI 10.1007/978-1-62703-119-6_14; Riquelme E, 2016, CANCER RES, V76, P675, DOI 10.1158/0008-5472.CAN-15-1141; Ross SJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5253; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tatarian T, 2016, SURG CLIN N AM, V96, P1207, DOI 10.1016/j.suc.2016.07.014; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Vartanian S, 2013, J BIOL CHEM, V288, P2403, DOI 10.1074/jbc.M112.394130; Wang ZH, 2017, TOXICOL SCI, V155, P400, DOI 10.1093/toxsci/kfw223; Zhu H, 2006, CANCER BIOL THER, V5, P1693, DOI 10.4161/cbt.5.12.3466	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0193644	10.1371/journal.pone.0193644	http://dx.doi.org/10.1371/journal.pone.0193644			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851957	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200001
J	Kromme, NMH; Ahaus, KTB; Gans, ROB; vam de Wiel, HBM				Kromme, Nicolien M. H.; Ahaus, Kees T. B.; Gans, Reinold O. B.; van de Wiel, Harry B. M.			Internists' dilemmas in their interactions with chronically ill patients; A comparison of their interaction strategies and dilemmas in two different medical contexts	PLOS ONE			English	Article							UNEXPLAINED PHYSICAL SYMPTOMS; CHRONIC ILLNESS; HEALTH-CARE; GENERAL-PRACTITIONERS; OLDER-ADULTS; COMMUNICATION; OUTCOMES; DOCTORS; MODEL; ACTIVATION	Background Internists appear to define productive interactions, key concept of the Chronic Care Model, as goal-directed, catalyzed by achieving rapport, and depending on the medical context: i.e. medically explained symptoms (MES) or medically unexplained symptoms (MUS). Objective To explore internists' interaction strategy discourses in the context of MES and MUS. Methods We interviewed twenty internists working in a Dutch academic hospital, identified relevant text fragments in the interview transcripts and analyzed the data based on a discourse analysis approach. Results We identified four interaction strategy discourses: relating, structuring, exploring, and influencing. Each was characterized by a dilemma: relating by 'creating nearness versus keeping distance'; structuring by 'giving space versus taking control'; exploring by 'asking for physical versus psychosocial causes'; and influencing by 'taking responsibility versus accepting a patient's choice. The balance sought in these dilemmas depended on whether the patient's symptoms were medically explained or unexplained (MES or MUS). Towards MUS the internists tended to maintain greater distance, take more control, ask more cautiously questions related to psychosocial causes, and take less responsibility for shared decision making. Discussion and conclusions Adopting a basic distinction between MES and MUS, the internists in our study appeared to seek a different balance in each of four rather fundamental clinical dilemmas. Balancing these dilemmas seemed more difficult regarding MUS where the internists seemed more distancing and controlling, and tended to draw on their medical expertise. Moving in this direction is counterproductive and in contradiction to guidelines which emphasize that MUS patients warrant emotional support requiring a shift towards interpersonal, empathic communication.	[Kromme, Nicolien M. H.] Univ Groningen, Univ Med Ctr Groningen, SectorA Chron & Vasc Dis, Groningen, Netherlands; [Ahaus, Kees T. B.] Univ Groningen, Fac Econ & Business, Ctr Expertise Healthwise, Groningen, Netherlands; [Ahaus, Kees T. B.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Gans, Reinold O. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [van de Wiel, Harry B. M.] Univ Groningen, Univ Med Ctr Groningen, Wenckebach Inst, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kromme, NMH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, SectorA Chron & Vasc Dis, Groningen, Netherlands.	n.m.h.kromme@umcg.nl		Gans, Reinold/0000-0001-5481-2387; van de Wiel, Harry/0000-0001-7179-6649				Anderson M, 2008, FAM MED, V40, P111; Asbring P, 2003, SOC SCI MED, V57, P711, DOI 10.1016/S0277-9536(02)00420-3; Balint E, 1969, J R Coll Gen Pract, V17, P269; Barsky AJ, 2006, MED CARE, V44, P803, DOI 10.1097/01.mlr.0000228028.07069.59; Bodenheimer Thomas, 2005, Dis Manag, V8, P319, DOI 10.1089/dis.2005.8.319; Boxer Harriet, 2009, Fam Pract Manag, V16, P12; Brownell AKW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012379; Brundage MD, 2010, ACTA ONCOL, V49, P136, DOI 10.3109/02841860903483684; Burt RS, 2005, BROKERAGE CLOSURE IN; Chew-Graham C, 2005, J PSYCHOSOM RES, V59, P261, DOI 10.1016/j.jpsychores.2005.03.006; DAndrade RG, 2005, FINDING CULTURE TALK, V1e, P83; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Elliott RA, 2007, J GEN INTERN MED, V22, P805, DOI 10.1007/s11606-007-0193-5; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Epstein RM, 2007, J GEN INTERN MED, V22, P1731, DOI 10.1007/s11606-007-0416-9; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gee J.P., 2014, DO DISCOURSE ANAL TO, Vsecond; Gee J. P., 2011, DISCOURSE ANAL TOOLK, DOI [10.4324/9780203850992, DOI 10.4324/9780203850992]; Gerber LM, 2011, J AMBUL CARE MANAG, V34, P292, DOI 10.1097/JAC.0b013e31821c63b1; Giroldi E, 2016, FAM PRACT, V33, P100, DOI 10.1093/fampra/cmv094; Groopman J, 2007, DOCTORS THINK; Haidet P, 2007, ANN FAM MED, V5, P164, DOI 10.1370/afm.624; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Hinchey SA, 2011, J GEN INTERN MED, V26, P588, DOI 10.1007/s11606-010-1620-6; Hulsman RL, 2009, PATIENT EDUC COUNS, V74, P302, DOI 10.1016/j.pec.2008.12.001; Hunter C, 2015, HEALTH EXPECT, V18, P1995, DOI 10.1111/hex.12304; Hupperts C, 2004, ARISTOTELES ETHICA N; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Koven S, 2016, NEW ENGL J MED, V374, P608, DOI 10.1056/NEJMp1513708; Kromme NMH, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1430-6; Kurtz S, 2003, ACAD MED, V78, P802, DOI 10.1097/00001888-200308000-00011; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Matthys J, 2009, BRIT J GEN PRACT, V59, P29, DOI 10.3399/bjgp09X394833; May C, 2004, SOCIOL HEALTH ILL, V26, P135, DOI 10.1111/j.1467-9566.2004.00384.x; Michie S, 2003, PATIENT EDUC COUNS, V51, P197, DOI 10.1016/S0738-3991(02)00194-5; Moir F, 2009, J PRIM HEALTH CARE, V1, P67, DOI 10.1071/HC09067; Molleman E, 2008, HEALTH CARE ANAL, V16, P329, DOI 10.1007/s10728-007-0080-6; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Ofri D., 2013, WHAT DOCTORS FEEL EM; Peters R M, 1994, Arch Fam Med, V3, P760, DOI 10.1001/archfami.3.9.760; Peters S, 1998, SOC SCI MED, V46, P559, DOI 10.1016/S0277-9536(97)00200-1; Pichelstorfer A., 2012, CULTURE UNBOUND, V4, P533; Pietrantonio F, 2015, EUR J INTERN MED, V26, P759, DOI 10.1016/j.ejim.2015.08.011; Quinn N., 2005, FINDING CULTURE TALK, V1st ed; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; Ring A, 2004, BMJ-BRIT MED J, V328, P1057, DOI 10.1136/bmj.38057.622639.EE; RODIN AE, 1994, J ROY SOC MED, V87, P758; Rosenbaum L, 2015, NEW ENGL J MED, V373, P589, DOI 10.1056/NEJMp1508418; Roter D, 2000, PATIENT EDUC COUNS, V39, P5, DOI 10.1016/S0738-3991(99)00086-5; Roter DL, 2001, MAYO CLIN PROC, V76, P673, DOI 10.4065/76.7.673; Rumke HC, 1954, PSYCHIAT DEEL 1; Salmon P, 2005, J PSYCHOSOM RES, V59, P255, DOI 10.1016/j.jpsychores.2005.03.004; Salmon P, 2007, GEN HOSP PSYCHIAT, V29, P454, DOI 10.1016/j.genhosppsych.2007.06.003; Schuermeyer IN, 2017, CLEV CLIN J MED, V84, P535, DOI 10.3949/ccjm.84a.15130; Smith RC, 2013, PATIENT EDUC COUNS, V91, P265, DOI 10.1016/j.pec.2012.12.010; SMITH S, 1995, POSTGRAD MED J, V71, P653, DOI 10.1136/pgmj.71.841.653; Speckens AEM, 1996, PSYCHOL MED, V26, P745, DOI 10.1017/S0033291700037764; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Strauss Claudia., 1997, COGNITIVE THEORY CUL, V9; Strous RD, 2006, EUR J INTERN MED, V17, P387, DOI 10.1016/j.ejim.2006.04.002; Talen MR, 2008, FAM SYST HEALTH, V26, P58, DOI DOI 10.1037/1091-7527.26.1.58; van der Feltz-Cornelis CM, 2012, J PSYCHOSOM RES, V72, P168, DOI 10.1016/j.jpsychores.2011.11.007; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Weiland A, 2012, PERSPECT MED EDUC, V1, P192, DOI 10.1007/s40037-012-0025-0; Zuiches James Daniel, 2013, COMMUNICATING DIFFIC	71	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0194133	10.1371/journal.pone.0194133	http://dx.doi.org/10.1371/journal.pone.0194133			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847552	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800002
J	Lopez-Rojo, N; Martinez, A; Perez, J; Basaguren, A; Pozo, J; Boyero, L				Lopez-Rojo, Naiara; Martinez, Aingeru; Perez, Javier; Basaguren, Ana; Pozo, Jesus; Boyero, Luz			Leaf traits drive plant diversity effects on litter decomposition and FPOM production in streams	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; TROPICAL STREAMS; TROPHIC LEVELS; PROCESS RATES; TOP-DOWN; FOOD-WEB; BIODIVERSITY; SHREDDERS; DETRITUS; MACROINVERTEBRATES	Biodiversity loss in riparian forests has the potential to alter rates of leaf litter decomposition in stream ecosystems. However, studies have reported the full range of positive, negative and no effects of plant diversity loss on decomposition, and there is currently no explanation for such inconsistent results. Furthermore, it is uncertain whether plant diversity loss affects other ecological processes related to decomposition, such as fine particulate organic matter production or detritivore growth, which precludes a thorough understanding of how detrital stream food webs are impacted by plant diversity loss. We used a microcosm experiment to examine the effects of plant diversity loss on litter decomposition, fine particulate organic matter production, and growth of a dominant leaf-shredding detritivore, using litter mixtures varying in species composition. We hypothesized that plant diversity loss would decrease the rates of all studied processes, but such effects would depend on the leaf traits present in litter mixtures (both their average values and their variability). Our findings partly supported our hypotheses, showing that plant diversity loss had a consistently negative effect on litter decomposition and fine particulate organic matter production (but not on detritivore growth) across litter mixtures, which was mediated by detritivores. Importantly, the magnitude of the diversity effect and the relative importance of different mechanisms underlying this effect (i.e., complementarity vs. selection) varied depending on the species composition of litter mixtures, mainly because of differences in litter nutritional quality and trait variability. Complementarity was prevalent but varied in size, with positive selection effects also occurring in some mixtures. Our results support the notion that loss of riparian plant species is detrimental to key stream ecosystem processes that drive detrital food webs, but that the magnitude of such effects largely depends on the the order of species loss.	[Lopez-Rojo, Naiara; Martinez, Aingeru; Perez, Javier; Basaguren, Ana; Pozo, Jesus; Boyero, Luz] Univ Basque Country UPV EHU, Lab Stream Ecol, Dept Plant Biol & Ecol, Bilbao, Spain; [Boyero, Luz] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Boyero, Luz] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia	University of Basque Country; Basque Foundation for Science; James Cook University	Lopez-Rojo, N (corresponding author), Univ Basque Country UPV EHU, Lab Stream Ecol, Dept Plant Biol & Ecol, Bilbao, Spain.	naiara.lopez@ehu.es	Basaguren, Ana/AAD-3732-2019; Boyero, Luz/N-1719-2019; Pozo, Jesús/B-4719-2013; Martínez, Aingeru/R-5531-2019; López-Rojo, Naiara/AAF-4102-2021; Pérez, Javier/K-6205-2012; Basaguren, Ana/K-8435-2014	Basaguren, Ana/0000-0001-9691-2554; Boyero, Luz/0000-0001-7366-9299; Pozo, Jesús/0000-0003-3104-5423; Martínez, Aingeru/0000-0002-7888-1798; López-Rojo, Naiara/0000-0002-5952-6950; Pérez, Javier/0000-0001-6305-4151; Basaguren, Ana/0000-0002-2790-7388	Spanish Ministry of Economy and Competitiveness (MINECO) [CGL2014-52779-P]; FEDER; Basque Government funds [IT302-16]; Ikerbasque start-up funds; Basque Government; University of the Basque Country	Spanish Ministry of Economy and Competitiveness (MINECO); FEDER(European Commission); Basque Government funds(Basque Government); Ikerbasque start-up funds; Basque Government(Basque Government); University of the Basque Country	This study was funded by the 'BIOFUNCTION' project (CGL2014-52779-P) from the Spanish Ministry of Economy and Competitiveness (MINECO) and FEDER to LB and JPo, Basque Government funds (IT302-16) to JPo, and Ikerbasque start-up funds to LB. NLR and AM were supported by a predoctoral fellowship from the Basque Government and a postdoctoral contract from the University of the Basque Country, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balseiro E, 2006, J N AM BENTHOL SOC, V25, P607, DOI 10.1899/0887-3593(2006)25[607:CMITLL]2.0.CO;2; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bastian M, 2008, AUSTRAL ECOL, V33, P301, DOI 10.1111/j.1442-9993.2007.01817.x; Boyero L, 2011, ECOLOGY, V92, P1839, DOI 10.1890/10-2244.1; Bundschuh M, 2016, FRESHWATER BIOL, V61, P2063, DOI 10.1111/fwb.12608; CANHOTO C, 1995, FRESHWATER BIOL, V34, P209, DOI 10.1111/j.1365-2427.1995.tb00881.x; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; CUMMINS KW, 1979, ANNU REV ECOL SYST, V10, P147, DOI 10.1146/annurev.es.10.110179.001051; Dang CK, 2005, ECOL LETT, V8, P1129, DOI 10.1111/j.1461-0248.2005.00815.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Evans-White MA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01184; Fernandes I, 2015, MAR FRESHWATER RES, V66, P449, DOI 10.1071/MF14089; Ferreira V, 2012, FRESHW SCI, V31, P945, DOI 10.1899/11-062.1; Frainer A, 2016, OIKOS, V125, P861, DOI 10.1111/oik.02687; Franson M.A.H., 1998, STANDARD METHODS EXA, V20, P148; FRIBERG N, 1994, FRESHWATER BIOL, V32, P133, DOI 10.1111/j.1365-2427.1994.tb00873.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Graca Manuel A S, 2002, ScientificWorldJournal, V2, P1173; Graca MAS, 2001, FRESHWATER BIOL, V46, P947, DOI 10.1046/j.1365-2427.2001.00729.x; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jonsson M, 2003, OECOLOGIA, V134, P554, DOI 10.1007/s00442-002-1148-5; Jonsson M, 2002, P ROY SOC B-BIOL SCI, V269, P1047, DOI 10.1098/rspb.2002.1979; Joyce P, 2007, FRESHWATER BIOL, V52, P1868, DOI 10.1111/j.1365-2427.2007.01828.x; Lecerf A, 2010, RIVER RES APPL, V26, P45, DOI 10.1002/rra.1286; Lecerf A, 2007, ECOLOGY, V88, P219, DOI 10.1890/0012-9658(2007)88[219:DODLMI]2.0.CO;2; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Leroy CJ, 2006, FRESHWATER BIOL, V51, P605, DOI 10.1111/j.1365-2427.2006.01512.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Moles AT, 2013, NEW PHYTOL, V198, P252, DOI 10.1111/nph.12116; Rosemond AD, 2001, ECOLOGY, V82, P2279, DOI 10.1890/0012-9658(2001)082[2279:ATOTDA]2.0.CO;2; Sanpera-Calbet I, 2009, FRESHWATER BIOL, V54, P1671, DOI 10.1111/j.1365-2427.2009.02216.x; Schindler MH, 2009, ECOLOGY, V90, P1641, DOI 10.1890/08-1597.1; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor BR, 2007, HYDROBIOLOGIA, V592, P405, DOI 10.1007/s10750-007-0778-3; Tonin AM, 2017, FUNCT ECOL, V31, P1471, DOI 10.1111/1365-2435.12837; Wallace JB, 1996, ANNU REV ENTOMOL, V41, P115, DOI 10.1146/annurev.en.41.010196.000555; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102	42	18	20	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198243	10.1371/journal.pone.0198243	http://dx.doi.org/10.1371/journal.pone.0198243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813129	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000433521800060
J	Vendruscolo, CD; Moreira, JJ; Seidel, SRT; Fulber, J; Neuenschwander, HM; Bonagura, G; Agreste, FR; Baccarin, RYA				Vendruscolo, Cynthia do Prado; Moreira, Juliana Junqueira; Torquato Seidel, Sarah Raphaela; Fulber, Joice; Neuenschwander, Henrique Macedo; Bonagura, Giancarlo; Agreste, Fernanda Rodrigues; Arantes Baccarin, Raquel Yvonne			Effects of medical ozone upon healthy equine joints: Clinical and laboratorial aspects	PLOS ONE			English	Article							MOLECULAR-WEIGHT DISTRIBUTION; PROSTAGLANDIN E-2 SYNTHESIS; SYNOVIAL-FLUID; RHEUMATOID-ARTHRITIS; SUBSTANCE-P; OXIDATIVE STRESS; INTRAARTICULAR INJECTION; CALVARIAL DEFECTS; KNEE-JOINT; OSTEOARTHRITIS	Objective The aim of this study was to verify whether transient inflammatory reactions induced by intra-articular medicinal ozone administration affect joint components, by in vivo evaluation of inflammatory (prostaglandin E-2, Substance P, Interleukin-6, Interleukine-1, Tumor Necrosis Factor), anti-inflammatory (Interleukin-10) and oxidative (superoxide dismutase activity and oxidative burst) biomarkers and extracellular matrix degradation products (chondroitin sulphate and hyaluronic acid) in synovial fluid. Methods The effects of medicinal ozone were analyzed at two ozone concentrations (groups A and B, 20 and 40 mu g/ml, respectively), using oxygen-injected joints as controls (group C); each group received ten treatments (15 ml gas per treatment). Physical evaluation, evaluation of lameness, ultrasonography, and synovial fluid analysis were performed. Results All joints presented mild and transient effusion throughout the study. Group B exhibited the highest lameness score on day 14 (P<0.05), detected by the lameness measurement system, probably because of the higher ozone concentration. All groups exhibited increased ultrasonography scores on day 14 (P<0.05). Groups A and B exhibited increased proteins concentrations on day 21 (P<0.05). There was no change in hyaluronic acid concentration or the percentage of high-molecular weight hyaluronic acid throughout the experiment. Chondroitin sulfate concentrations decreased in group B, and did not change in group A and C, indicating that neither treatment provoked extracellular matrix catabolism. Cytokine and eicosanoid concentrations were not significantly changed. Conclusions The ozonetherapy did not cause significant inflammation process or cartilage degradation, therefore, ozonetherapy is safe at both evaluated doses.	[Vendruscolo, Cynthia do Prado; Moreira, Juliana Junqueira; Torquato Seidel, Sarah Raphaela; Fulber, Joice; Neuenschwander, Henrique Macedo; Agreste, Fernanda Rodrigues; Arantes Baccarin, Raquel Yvonne] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Clin Med, Sao Paulo, SP, Brazil; [Bonagura, Giancarlo] Anhembi Morumbi Univ, Dept Large Anim Clin, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Anhembi Morumbi	Vendruscolo, CD (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Clin Med, Sao Paulo, SP, Brazil.	cpvendruscolo@usp.br	Baccarin, Raquel Yvonne Arantes/AAC-8797-2022; Fülber, Joice/U-1112-2019; Baccarin, Raquel Y/F-8598-2012; Fülber, Joice/Y-7923-2019; MOREIRA, JULIANA/HHZ-2094-2022	Baccarin, Raquel Yvonne Arantes/0000-0001-9730-0840; Baccarin, Raquel Y/0000-0001-9730-0840; Fülber, Joice/0000-0001-8989-6779; R. Agreste, Fernanda/0000-0003-3106-8967	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, SP, Brazil [15/04006-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, SP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, SP, Brazil grant # 15/04006-9. This sponsor did not have any influence on the study design or on the data collection, analysis and interpretation.	ALWAN WH, 1991, EQUINE VET J, V23, P44, DOI 10.1111/j.2042-3306.1991.tb02712.x; Apuzzo D, 2014, FUNCT NEUROL, V29, P31, DOI 10.11138/FNeur/2014.29.1.031; Baccarin RYA, 2014, CAN J VET RES, V78, P50; Baxter GM., 2020, ADAMS STASHAKS LAMEN, P1240; Bayrak O, 2014, UROL ANNALS, V6, P122, DOI 10.4103/0974-7796.130553; Bertone AL, 2001, VET SURG, V30, P528, DOI 10.1053/jvet.2001.28430; Bocci, 2014, AM J CLIN EXP MED, V2, P9, DOI DOI 10.11648/J.AJCEM.20140202.11; BOCCI V., 2005, OZONE NEW MED DRUG; Bocci VA, 2006, ARCH MED RES, V37, P425, DOI 10.1016/j.arcmed.2005.08.006; Bocci V, 2012, FREE RADICAL RES, V46, P1068, DOI 10.3109/10715762.2012.693609; Buric J, 2014, INT J SPINE SURG, V8, DOI 10.14444/1017; Camelia C, 2014, ARS MED TOMITANA, V20, P25, DOI [10.2478/arsm-2014-0005, DOI 10.2478/ARSM-2014-0005]; Cardelli R., 2008, INT J OZONE THER, V7, P66; Chang JDS, 2005, RHEUMATOL INT, V26, P142, DOI 10.1007/s00296-004-0526-1; Chen HQ, 2013, RHEUMATOL INT, V33, P1223, DOI 10.1007/s00296-012-2529-7; Daif ET, 2012, OR SURG OR MED OR PA, V113, pE10, DOI 10.1016/j.tripleo.2011.08.006; de Grauw JC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2640; Magalhaes FND, 2013, NEUROPSYCH DIS TREAT, V9, P1759, DOI 10.2147/NDT.S48663; de Souza YM, 2010, CLINICS, V65, P195, DOI 10.1590/S1807-59322010000200012; Vaillant JD, 2013, EUR J PHARMACOL, V714, P318, DOI 10.1016/j.ejphar.2013.07.034; Fiorela C, 2013, REV ESPANOLA OZONIOT, V3, P21; Fuller CJ, 2001, OSTEOARTHR CARTILAGE, V9, P49, DOI 10.1053/joca.2000.0349; HART PH, 1995, IMMUNOLOGY, V84, P536; HAWKINS DL, 1995, AM J VET RES, V56, P1292; Hernanz A, 2003, REGUL PEPTIDES, V115, P19, DOI 10.1016/S0167-0115(03)00127-7; Iliakis E, 2001, RIV NEURORADIOL, V14, P23, DOI 10.1177/19714009010140S105; Jani P, 2012, INDIAN J PHYS MED RE, V2, P196; Kay AT, 2008, AM J VET RES, V69, P1646, DOI 10.2460/ajvr.69.12.1646; Kazancioglu HO, 2013, J CRANIOFAC SURG, V24, P2141, DOI 10.1097/SCS.0b013e3182a244ae; Kidd J. A., 2014, ATLAS EQUINE ULTRASO, P94; LAM FY, 1993, NEUROSCIENCE, V52, P443, DOI 10.1016/0306-4522(93)90170-K; Lamprecht ED, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/920932; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Ley C, 2011, CONNECT TISSUE RES, V52, P290, DOI 10.3109/03008207.2010.523803; Lintas G, 2013, IEEE ENG MED BIO, P6171, DOI 10.1109/EMBC.2013.6610962; de Jesus CCL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179185; LOTZ M, 1987, SCIENCE, V235, P893, DOI 10.1126/science.2433770; Calunga JL, 2012, OZONE-SCI ENG, V34, P469, DOI 10.1080/01919512.2012.719120; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Martinez-Sanchez G, 2012, EUR J PHARMACOL, V691, P156, DOI 10.1016/j.ejphar.2012.07.010; Matayoshi T, 2005, BIOCHEM BIOPH RES CO, V327, P756, DOI 10.1016/j.bbrc.2004.12.055; McIlwraith CW, 2010, EQUINE VET J, V42, P563, DOI 10.1111/j.2042-3306.2010.00095.x; McIlwraith CW, 2005, EQUINE VET J, V37, P473, DOI 10.2746/042516405774480102; MCILWRAITH CW, 1979, AM J VET RES, V40, P11; MENKES CJ, 1993, J RHEUMATOL, V20, P714; Mishra S.K., 2011, INDIAN J PHYS MED RE, P65; Moller I, 2008, OSTEOARTHR CARTILAGE, V16, pS4, DOI 10.1016/j.joca.2008.06.005; Moraes APL, 2015, CAN VET J, V56, P831; Moreira JJ, 2015, J VET SCI, V16, P47, DOI [10.4142/jvs.2015.16.1.47, 10.4142/jvs.2015.16.1.37]; MORRIS EA, 1990, AM J VET RES, V51, P59; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nabil Mawsouf M, 2011, REV ESPANOLA OZONOTE, V1, P32; Neimark AI, 2014, B EXP BIOL MED+, V156, P399, DOI 10.1007/s10517-014-2358-7; Oguz E, 2011, J SURG RES, V171, pE61, DOI 10.1016/j.jss.2011.06.029; Ostalowska A, 2006, OSTEOARTHR CARTILAGE, V14, P139, DOI 10.1016/j.joca.2005.08.009; Ozdemir H, 2013, J PERIODONTAL RES, V48, P722, DOI 10.1111/jre.12060; PALMER JL, 1995, CAN J VET RES, V59, P205; Paoloni M, 2009, SPINE, V34, P1337, DOI 10.1097/BRS.0b013e3181a3c18d; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Pecorelli A, 2013, TOXICOL APPL PHARM, V267, P30, DOI 10.1016/j.taap.2012.12.001; Rousseau JC, 2012, BONE, V51, P265, DOI 10.1016/j.bone.2012.04.001; Sagai M, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-29; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Schwartz A, 2012, OZONE THER, V2, P199; Steel CM, 2008, VET CLIN N AM-EQUINE, V24, P437, DOI 10.1016/j.cveq.2008.05.004; Surapaneni Krishna Mohan, 2007, Indian J Med Sci, V61, P9; Sutton S, 2009, VET J, V179, P10, DOI 10.1016/j.tvjl.2007.08.013; Takafuji VA, 2002, AM J VET RES, V63, P551, DOI 10.2460/ajvr.2002.63.551; Trumble TN, 2005, VET CLIN N AM-EQUINE, V21, P575, DOI 10.1016/j.cveq.2005.08.004; TULAMO RM, 1994, AM J VET RES, V55, P710; VANPELT RW, 1974, J AM VET MED ASSOC, V165, P91; Viebahn-Hansler R, 2012, OZONE-SCI ENG, V34, P408, DOI 10.1080/01919512.2012.717847; WHEAT J. D., 1955, JOUR AMER VET MED ASSOC, V127, P64; Xi-bing GU, 2010, CHIN MED J, V123, P2510; Yang Lin, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P98; Yu B, 2010, INT J OZONE THERAPY, V9, P14; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	77	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197736	10.1371/journal.pone.0197736	http://dx.doi.org/10.1371/journal.pone.0197736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813093	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800029
J	Antonopoulou, I; Hunt, C; Cerullo, G; Varriale, S; Gerogianni, A; Faraco, V; Rova, U; Christakopoulos, P				Antonopoulou, Io; Hunt, Cameron; Cerullo, Gabriella; Varriale, Simona; Gerogianni, Alexandra; Faraco, Vincenza; Rova, Ulrika; Christakopoulos, Paul			Tailoring the specificity of the type C feruloyl esterase FoFaeC from Fusarium oxysporum towards methyl sinapate by rational redesign based on small molecule docking simulations	PLOS ONE			English	Article							ASPERGILLUS-NIGER; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; CLASSIFICATION; FAMILY; PURIFICATION; DEGRADATION; RELEASE; SYSTEM; ENZYME	The type C feruloyl esterase FoFaeC from Fusarium oxysporum is a newly discovered enzyme with high potential for use in the hydrolysis of lignocellulosic biomass but it shows low activity towards sinapates. In this work, small molecule docking simulations were employed in order to identify important residues for the binding of the four model methyl esters of hydroxycinnamic acids, methyl ferulate/caffeate/sinapate/p-coumarate, to the predicted structure of FoFaeC. Subsequently rational redesign was applied to the enzyme' active site in order to improve its specificity towards methyl sinapate. A double mutation (F230H/T202V) was considered to provide hydrophobic environment for stabilization of the methoxy substitution on sinapate and a larger binding pocket. Five mutant clones and the wild type were produced in Pichia pastoris and biochemically characterized. All clones showed improved activity, substrate affinity, catalytic efficiency and turnover rate compared to the wild type against methyl sinapate, with clone P13 showing a 5-fold improvement in catalytic efficiency. Although the affinity of all mutant clones was improved against the four model substrates, the catalytic efficiency and turnover rate decreased for the substrates containing a hydroxyl substitution.	[Antonopoulou, Io; Hunt, Cameron; Gerogianni, Alexandra; Rova, Ulrika; Christakopoulos, Paul] Lulea Univ Technol, Biochem Proc Engn, Div Chem Engn, Dept Civil Environm & Nat Resources Engn, Lulea, Sweden; [Cerullo, Gabriella; Varriale, Simona; Faraco, Vincenza] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	Lulea University of Technology; University of Naples Federico II	Christakopoulos, P (corresponding author), Lulea Univ Technol, Biochem Proc Engn, Div Chem Engn, Dept Civil Environm & Nat Resources Engn, Lulea, Sweden.	paul.christakopoulos@ltu.se	Hunt, Cameron/D-3589-2019; Christakopoulos, Paul/O-4841-2019; Varriale, Simona/AAG-3580-2020	Hunt, Cameron/0000-0002-8495-0542; Varriale, Simona/0000-0003-3054-3375; Gerogianni, Alexandra/0000-0002-6194-6903; Christakopoulos, Paul/0000-0003-0079-5950; Antonopoulou, Io/0000-0002-7754-9398	European Union-Large scale integrating project targeted to SMEs "Optimized esterase biocatalysts for cost-effective industrial production (OPTIBIOCAT)" [613868]; FP7 Knowledge Based Bio-Economy (KBBE)	European Union-Large scale integrating project targeted to SMEs "Optimized esterase biocatalysts for cost-effective industrial production (OPTIBIOCAT)"; FP7 Knowledge Based Bio-Economy (KBBE)	This work was supported by grant from European Union-Large scale integrating project targeted to SMEs "Optimized esterase biocatalysts for cost-effective industrial production (OPTIBIOCAT)" grant agreement no. 613868, co-funded within the FP7 Knowledge Based Bio-Economy (KBBE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant from European Union-Large scale integrating project targeted to SMEs "Optimized esterase biocatalysts for cost-effective industrial production (OPTI- BIOCAT)" grant agreement no. 613868, co-funded within the FP7 Knowledge Based Bio-Economy (KBBE). Dr. Peter Jutten (Taros Chemicals GmbH & Co. KG, Dortmund, Germany) is acknowledged for providing substrates 4NTC-Fe and pNP-Fe.	Antonopoulou I, 2016, APPL MICROBIOL BIOT, V100, P6519, DOI 10.1007/s00253-016-7647-9; Benoit I, 2008, BIOTECHNOL LETT, V30, P387, DOI 10.1007/s10529-007-9564-6; Benoit I, 2006, CARBOHYD RES, V341, P1820, DOI 10.1016/j.carres.2006.04.020; Crepin VF, 2004, APPL MICROBIOL BIOT, V63, P647, DOI 10.1007/s00253-003-1476-3; de Vries RP, 2002, BIOCHEM J, V363, P377, DOI 10.1042/bj3630377; deVries RP, 1997, APPL ENVIRON MICROB, V63, P4638, DOI 10.1128/AEM.63.12.4638-4644.1997; Dilokpimol A, 2017, NEW BIOTECHNOL, V37, P200, DOI 10.1016/j.nbt.2017.02.007; Dilokpimol A, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0651-6; Durrant JD, 2014, J CHEM THEORY COMPUT, V10, P5047, DOI 10.1021/ct500381c; FAULDS CB, 1993, BIOTECHNOL APPL BIOC, V17, P349; Garcia-Conesa MT, 2004, J BIOTECHNOL, V108, P227, DOI 10.1016/j.jbiotec.2003.12.003; Gherbovet O, 2016, J MOL CATAL B-ENZYM, V126, P24, DOI 10.1016/j.molcatb.2016.01.012; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Harris JL, 1998, CURR OPIN CHEM BIOL, V2, P127, DOI 10.1016/S1367-5931(98)80044-6; Hermoso JA, 2004, J MOL BIOL, V338, P495, DOI 10.1016/j.jmb.2004.03.003; Holland J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043294; Jeffrey G. A., 1997, INTRO HYDROGEN BONDI; Katsimpouras C, 2016, BIOFUEL BIOREFIN TEC, V3, P79, DOI 10.1007/978-3-319-43679-1_5; Koseki T, 2009, APPL MICROBIOL BIOT, V83, P689, DOI 10.1007/s00253-009-1913-z; Kumar CG, 2013, BIOTECHNOL PROGR, V29, P924, DOI 10.1002/btpr.1729; Magnusson AO, 2005, CHEMBIOCHEM, V6, P1051, DOI 10.1002/cbic.200400410; Mastihuba V, 2002, ANAL BIOCHEM, V309, P96, DOI 10.1016/S0003-2697(02)00241-5; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moukouli M, 2008, APPL MICROBIOL BIOT, V79, P245, DOI 10.1007/s00253-008-1432-3; Olivares-Hernandez R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012781; ONUFFER JJ, 1995, PROTEIN SCI, V4, P1750, DOI 10.1002/pro.5560040910; Suzuki K, 2014, PROTEINS, V82, P2857, DOI 10.1002/prot.24649; Topakas E, 2007, PROCESS BIOCHEM, V42, P497, DOI 10.1016/j.procbio.2007.01.007; Udatha DBRKG, 2011, BIOTECHNOL ADV, V29, P94, DOI 10.1016/j.biotechadv.2010.09.003; Xiros C, 2009, BIORESOURCE TECHNOL, V100, P5917, DOI 10.1016/j.biortech.2009.06.018	30	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198127	10.1371/journal.pone.0198127	http://dx.doi.org/10.1371/journal.pone.0198127			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795702	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300128
J	Augustin, M; Blome, C; Forschner, A; Gutzmer, R; Hauschild, A; Heinzerling, L; Livingstone, E; Loquai, C; Schadendorf, D; Utikal, J; Wagner, T; Wilden, S; Kahler, KC				Augustin, Matthias; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Wilden, Sophia; Kaehler, Katharina C.			Willingness to pay for a cure of low-risk melanoma patients in Germany	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATE UTILITIES; CANCER-PATIENTS; PSORIASIS; IMPACT	Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be willing to make for a sustainable cure, both as absolute sums and as percentages of monthly income. The median WTP based on one-time payment was (sic)10,000 for patients and (sic)100,000 for physicians; relative numbers were 100% versus 300% of monthly income. For continuous monthly payments, WTP was (sic)500 for patients and (sic)1000 for physicians, relative numbers 25% and 50% of income, respectively. Even after controlling for income differences, there was a significantly higher WTP in physicians for all four questions. Compared to patients with chronic skin diseases such as vitiligo, rosacea, atopic eczema and psoriasis, patients with low-risk melanoma showed a significantly higher WTP. Our data suggest that there is a relevant burden of disease even in patients with low-risk tumors. Higher WTP of physicians underlines the prevalence of differences in disease perception.	[Augustin, Matthias; Blome, Christine; Wagner, Tobias] Univ Med Ctr Hamburg, Inst Hlth Serv Res Dermatol & Nursing IVDP, Hamburg, Germany; [Forschner, Andrea] Eberhard Karls Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Gutzmer, Ralf] Hannover Med Sch, Dept Dermatol, Skin Canc Ctr Hannover, Hannover, Germany; [Hauschild, Axel; Kaehler, Katharina C.] Univ Hosp Schleswig Holstein UKSH, Dept Dermatol, Skin Canc Ctr, Campus Kiel, Kiel, Germany; [Heinzerling, Lucie] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [Livingstone, Elisabeth; Schadendorf, Dirk] Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Loquai, Carmen; Wilden, Sophia] Johannes Gutenberg Univ Mainz, Dept Dermatol, Mainz, Germany; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Utikal, Jochen] Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital; University of Erlangen Nuremberg; University of Duisburg Essen; Johannes Gutenberg University of Mainz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kahler, KC (corresponding author), Univ Hosp Schleswig Holstein UKSH, Dept Dermatol, Skin Canc Ctr, Campus Kiel, Kiel, Germany.	kkaehler@dermatology.uni-kiel.de	Loquai, Carmen/AAW-9241-2020; Schadendorf, Dirk/AAE-8206-2019; Livingstone, Elisabeth/AHE-9171-2022; Blome, Christine/G-8378-2016	, lucie/0000-0003-4587-007X; Wagner, Tobias/0000-0003-3124-1870; Utikal, Jochen/0000-0001-5316-0241; Blome, Christine/0000-0002-1163-1639; Schadendorf, Dirk/0000-0003-3524-7858	Merck Co.	Merck Co.(Merck & Company)	The study was sponsored by Merck & Co. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala MV, 1999, PHARMACOECONOMICS, V15, P9, DOI 10.2165/00019053-199915010-00002; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Beikert FC, 2014, ARCH DERMATOL RES, V306, P279, DOI 10.1007/s00403-013-1402-1; Beikert FC, 2013, J EUR ACAD DERMATOL, V27, P734, DOI 10.1111/j.1468-3083.2012.04549.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cham PMH, 2007, BRIT J DERMATOL, V156, P922, DOI 10.1111/j.1365-2133.2006.07740.x; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; GIBERTINI M, 1992, ANN PLAS SURG, V28, P17, DOI 10.1097/00000637-199201000-00007; Holterhues C, 2011, ARCH DERMATOL, V147, P177, DOI 10.1001/archdermatol.2010.433; Jenkins Valerie A, 2011, JRSM Short Rep, V2, P69, DOI 10.1258/shorts.2011.011050; Kaehler KC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005375; Kahler KC, 2016, J DTSCH DERMATOL GES, V14, P662; Kasparian NA, 2009, ARCH DERMATOL, V145, P1415, DOI 10.1001/archdermatol.2009.308; Kasparian NA, 2013, CLIN DERMATOL, V31, P41, DOI 10.1016/j.clindermatol.2011.11.005; Krammer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111237; Lakdawalla DN, 2012, HEALTH AFFAIR, V31, P676, DOI 10.1377/hlthaff.2011.1300; Langenbruch AK, 2012, EUR J DERMATOL, V22, P518, DOI 10.1684/ejd.2012.1740; Lundberg L, 1999, BRIT J DERMATOL, V141, P1067, DOI 10.1046/j.1365-2133.1999.03207.x; Mols F, 2010, EUR J CANCER, V46, P573, DOI 10.1016/j.ejca.2009.09.016; MOTLEY RJ, 1989, CLIN EXP DERMATOL, V14, P194, DOI 10.1111/j.1365-2230.1989.tb00930.x; Oh DY, 2012, ASIA-PAC J CLIN ONCO, V8, P282, DOI 10.1111/j.1743-7563.2012.01546.x; Olsen JA, 2001, HEALTH ECON, V10, P39, DOI 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E; Radtke MA, 2009, BRIT J DERMATOL, V161, P134, DOI 10.1111/j.1365-2133.2009.09091.x; Schmitt J, 2008, BRIT J DERMATOL, V158, P351, DOI 10.1111/j.1365-2133.2007.08354.x; Trask PC, 2001, J CLIN ONCOL, V19, P2844, DOI 10.1200/JCO.2001.19.11.2844; Ugurel S, 2017, EUR J CANCER, V83, P247, DOI 10.1016/j.ejca.2017.06.028; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong YN, 2010, ONCOLOGIST, V15, P566, DOI 10.1634/theoncologist.2009-0307; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197780	10.1371/journal.pone.0197780	http://dx.doi.org/10.1371/journal.pone.0197780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795621	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300074
J	Hasan, S; Junnikkala, S; Peltoniemi, O; Paulin, L; Lyyski, A; Vuorenmaa, J; Oliviero, C				Hasan, Shah; Junnikkala, Sami; Peltoniemi, Olli; Paulin, Lars; Lyyski, Annina; Vuorenmaa, Juhani; Oliviero, Claudio			Dietary supplementation with yeast hydrolysate in pregnancy influences colostrum yield and gut microbiota of sows and piglets after birth	PLOS ONE			English	Article							MANNAN-OLIGOSACCHARIDE SUPPLEMENTATION; SULFATE-REDUCING BACTERIA; GROWTH-PERFORMANCE; NUTRIENT DIGESTIBILITY; ULCERATIVE-COLITIS; HUMAN FECES; PIG NUTRITION; WEANING PIGS; WEANED PIGS; HUMAN COLON	Dietary supplementation with yeast derivatives (YD) contributes to the health and physiology of sows and piglets, but few studies have focused on how it influences gut health and performance of sows and piglets. The goal was therefore to examine whether YD, based on brewer's yeast hydrolysate added to pregnancy diet, would affect colostrum composition, yield (CY) and gut microbiota of sows and piglets. Sows were allocated to either a control diet (n = 19) or a control diet supplemented with 2g YD/kg (n = 18) during the pregnancy. Piglets suckling belonging to the control sows (n = 114) and supplemented sows (n = 108) were also included in the study. Gut microbiota populations of sows at farrowing and piglets at one and four weeks of age were assessed using 16S rRNA gene sequencing. Colostrum samples were examined for nutritional composition and immunoglobulin (Ig) content. All piglets were individually weighed at birth and 24 hours later in order to calculate CY, and later at four weeks to calculate average daily gain (ADG). Protein, lactose and dry matter content of colostrum did not significantly differ between the two groups, while sows fed YD had higher levels of fat in their colostrum (P< 0.05). Immunoglobulin A, IgM and IgG levels in colostrum did not differ between the two groups (P>0.05). Colostrum yield was lower in the control than that in YD group (3701g vs. 4581 g; P<0.05). Although the YD supplementation did not change fecal bacteria diversity in sow, more beneficial and fermentative bacteria (Roseburia, Paraprevotella, Eubacterium) were found in the YD fed group (P <0.01) while, some opportunistic pathogens, including Proteobacteria, especially the genera Desulfovibrio, Escherichia/Shigella and Helicobacter, were suppressed. Piglets at one week of age from sows fed YD had more beneficial microbial populations with significant diversity and fewer opportunistic pathogens. Additionally, we established a Pearson's correlations between CY, colostrum components, piglet birth weight and fecal microbiota. Therefore, YD added to the sow diet during pregnancy increases colostrum availability and its energy content for neonate piglets, also promoting beneficial maternal microbial sources for neonate.	[Hasan, Shah; Peltoniemi, Olli; Oliviero, Claudio] Univ Helsinki, Fac Vet Med, Dept Prod Anim Med, Saarentaus, Finland; [Junnikkala, Sami] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Paulin, Lars; Lyyski, Annina] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Vuorenmaa, Juhani] Hankkija Oy, Peltokuumolantie 4, Hyvinkaa, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Hasan, S (corresponding author), Univ Helsinki, Fac Vet Med, Dept Prod Anim Med, Saarentaus, Finland.	shah.hasan@helsinki.fi	Hasam, Shah/B-4781-2017	Hasam, Shah/0000-0003-4404-9642; Lyyski, Annina/0000-0002-3778-5118; Oliviero, Claudio/0000-0001-8910-9595; Peloniemi, Olli/0000-0002-9481-1837	Finnish Ministry of Agriculture and Forestry (COLPIMO project) [1803/312/2014]; Finnish Veterinary Foundation; Hankkija Oy	Finnish Ministry of Agriculture and Forestry (COLPIMO project); Finnish Veterinary Foundation; Hankkija Oy	This research was financially supported by the Finnish Ministry of Agriculture and Forestry (COLPIMO project, 1803/312/2014, URL: www.mmm.fl), the recipient was CO and Finnish Veterinary Foundation (URL: www.etts.fi, recipient CO, SH). The commercial partner JV was a member of the research consortium of the project similar to the other co-authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hankkija Oy provided support in the form of salaries for author JV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Babidge W, 1998, MOL CELL BIOCHEM, V181, P117, DOI 10.1023/A:1006838231432; Bolet G., 1986, Embryonic mortality in farm animals., P12; Burkey TE, 2004, J ANIM SCI, V82, P397; Caine WR, 2001, ALTERNATIVES ANTIBIO, P33; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Castillo M, 2008, J ANIM SCI, V86, P94, DOI 10.2527/jas.2005-686; Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x; Close W.H., 2010, FEEDSTUFFS, V82, P12; Cole JR, 2013, NUCLEIC ACIDS RES, V42, pD642; Czech A, 2010, POL J VET SCI, V13, P525; De Cock HEV, 2004, J CLIN MICROBIOL, V42, P2752, DOI 10.1128/JCM.42.6.2752-2758.2004; Decaluwe R, 2013, ANIMAL, V7, P1999, DOI 10.1017/S1751731113001791; Devillers N, 2004, ANIM SCI, V78, P305, DOI 10.1017/S1357729800054096; Devillers N, 2011, ANIMAL, V5, P1605, DOI 10.1017/S175173111100067X; Dividich J. le, 2009, Journees de la Recherche Porcine en France, V41, P249; Duan XD, 2016, ANIM FEED SCI TECH, V218, P17, DOI 10.1016/j.anifeedsci.2016.05.002; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Farmer C, 2009, J ANIM SCI, V87, P56, DOI 10.2527/jas.2008-1203; Ferket P.R., 2002, PROCEEDING 63 MINNES, P169; Ferrari CV, 2014, PREV VET MED, V114, P259, DOI 10.1016/j.prevetmed.2014.02.013; Foisnet A, 2010, J ANIM SCI, V88, P1672, DOI 10.2527/jas.2009-2562; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; Halas Veronika, 2012, Animals (Basel), V2, P261, DOI 10.3390/ani2020261; Hasan SMK, 2016, ANIMAL, V10, P1728, DOI 10.1017/S1751731116000896; Iji PA, 2001, J SCI FOOD AGR, V81, P1186, DOI 10.1002/jsfa.925; Jost T, 2014, ENVIRON MICROBIOL, V16, P2891, DOI 10.1111/1462-2920.12238; Kogan G, 2007, LIVEST SCI, V109, P161, DOI 10.1016/j.livsci.2007.01.134; Lazarevic M, 2010, ANIMAL, V4, P938, DOI 10.1017/S1751731110000194; Lemley CO, 2010, J ENDOCRINOL, V205, P233, DOI 10.1677/JOE-10-0042; Li B, 2017, EFFECT INULIN SUPPLE; Liu P, 2008, J ANIM SCI, V86, P2609, DOI 10.2527/jas.2007-0668; Loisel F, 2013, J ANIM SCI, V91, P5269, DOI 10.2527/jas.2013-6526; Loubinoux J, 2002, FEMS MICROBIOL ECOL, V40, P107, DOI 10.1111/j.1574-6941.2002.tb00942.x; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Miguel JC, 2004, J SWINE HEALTH PROD, V12, P296; Morotomi M, 2009, INT J SYST EVOL MICR, V59, P1895, DOI 10.1099/ijs.0.008169-0; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Nochta I, 2010, J ANIM PHYSIOL AN N, V94, P747, DOI 10.1111/j.1439-0396.2009.00957.x; O'Quinn PR., 2001, J ANIM SCI, V79, P212; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pereira PAB, 2017, PARKINSONISM RELAT D, V38, P61, DOI 10.1016/j.parkreldis.2017.02.026; Pettigrew J. E., 2005, Nutritional biotechnology in the feed and food industries. Proceedings of Alltech's 21st Annual Symposium, Lexington, Kentucky, USA, 22-25 May 2005, P213; Pitcher MCL, 1996, GUT, V39, P1, DOI 10.1136/gut.39.1.1; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Rekiel A., 2007, Archiv fur Tierzucht, V50, P172; Rettedal E, 2009, APPL ENVIRON MICROB, V75, P5489, DOI 10.1128/AEM.02220-08; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Salyers A, 2002, BACTERIAL PATHOGENES; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Spring P., 2015, Journal of Applied Animal Nutrition, V2015, pe8; Tan CQ, 2015, ANIM FEED SCI TECH, V210, P254, DOI 10.1016/j.anifeedsci.2015.10.013; Taylor-Pickard J., 2017, ANIM NUTR, V5, pE1, DOI [10.1017/Jan.2017.2, DOI 10.1017/JAN.2017.2]; White LA, 2002, J ANIM SCI, V80, P2619; Xu HY, 2017, SCI BULL, V62, P767, DOI 10.1016/j.scib.2017.04.019; Yang Y, 2008, J ANIM PHYSIOL AN N, V92, P650, DOI 10.1111/j.1439-0396.2007.00761.x; Yu HF, 2008, J ANIM FEED SCI, V17, P61, DOI 10.22358/jafs/66470/2008; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725	62	35	38	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197586	10.1371/journal.pone.0197586	http://dx.doi.org/10.1371/journal.pone.0197586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795617	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300053
J	Oda, T; Yamazumi, Y; Hiroko, T; Kamiya, A; Kiriya, S; Suyama, S; Shiozaki-Sato, Y; Akiyama, T				Oda, Takeaki; Yamazumi, Yusuke; Hiroko, Takatoshi; Kamiya, Atsushi; Kiriya, Saori; Suyama, Saki; Shiozaki-Sato, Yumi; Akiyama, Tetsu			Mex-3B induces apoptosis by inhibiting miR-92a access to the Bim-3 ' UTR	ONCOGENE			English	Article							RNA-BINDING PROTEIN; COLORECTAL-CANCER CELLS; AU-RICH ELEMENT; MESSENGER-RNA; P53; EXPRESSION; MICRORNAS; GENE; IDENTIFICATION; DISEASE	Cells respond to a variety of cellular stresses, including DNA damage, by regulating genes whose expression modulates cell cycle arrest, DNA repair, senescence, and/or apoptosis. MicroRNAs (miRNAs) play essential roles in both normal development and disease pathogenesis by destabilizing mRNAs and inhibiting translation. In turn, miRNA biogenesis, turnover, and activity can be regulated by specific RNA-binding proteins. Here we show that Mex-3B, an hnRNP K homology (KH) domain-containing RNA-binding protein, critically modulates DNA stress-induced apoptosis by posttranscriptionally upregulating the pro-apoptotic BH3 (Bcl-2 homology region 3)-only family member Bim. Furthermore, our data indicate that binding of Mex-3B to the 3'-untranslated region (3'UTR) of Bim interferes with the interaction of an Argonaute (Ago)-miR-92a complex with a miR-92a target site present in the Bim RNA. Our results provide novel insights into the posttranscriptional mechanisms that are critical for cellular stress responses.	[Oda, Takeaki; Yamazumi, Yusuke; Hiroko, Takatoshi; Kamiya, Atsushi; Kiriya, Saori; Suyama, Saki; Shiozaki-Sato, Yumi; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan	University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	akiyama@iam.u-tokyo.ac.jp			P-CREATE (Project for Cancer Research and Therapeutic Evolution) from the Japan Agency for Medical Research and Development [17cm0106103h0002]; P-DIRECT (Project for Development of Innovative Research on Cancer Therapeutics) from the Japan Agency for Medical Research and Development [15cm0106016h0005]; MEXT, Japan [17H06325]	P-CREATE (Project for Cancer Research and Therapeutic Evolution) from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); P-DIRECT (Project for Development of Innovative Research on Cancer Therapeutics) from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to Y Nakamura for adenovirus expressing p53. This work was supported by P-CREATE (Project for Cancer Research and Therapeutic Evolution: Grant No. 17cm0106103h0002) and P-DIRECT (Project for Development of Innovative Research on Cancer Therapeutics: Grant No. 15cm0106016h0005) grants from the Japan Agency for Medical Research and Development, and Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Analysis and Regulation of Cellular Diversity: Grant No. 17H06325) from MEXT, Japan.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cano F, 2013, MOL IMMUNOL, V55, P135, DOI 10.1016/j.molimm.2012.10.015; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Donnini M, 2004, J BIOL CHEM, V279, P20154, DOI 10.1074/jbc.M314071200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Le Borgne M, 2014, DEVELOPMENT, V141, P2096, DOI 10.1242/dev.108514; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nishida N, 2012, ANN SURG ONCOL, V19, P3065, DOI 10.1245/s10434-012-2246-1; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pereira B, 2013, NUCLEIC ACIDS RES, V41, P3986, DOI 10.1093/nar/gkt087; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamazumi Y, 2016, CELL REP, V16, P2456, DOI 10.1016/j.celrep.2016.07.062; Yang Y, 2016, CELL RES, V26, P288, DOI 10.1038/cr.2016.16; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	48	8	8	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5233	5247		10.1038/s41388-018-0336-7	http://dx.doi.org/10.1038/s41388-018-0336-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29849121				2022-12-26	WOS:000445093100007
J	Arakawa, T; Uchiyama, D; Ohgami, T; Ohgami, R; Murata, T; Honma, Y; Hamada, H; Kuroda, Y; Taguchi, K; Kitazaki, K; Kubo, T				Arakawa, Takumi; Uchiyama, Daisuke; Ohgami, Takashi; Ohgami, Ryo; Murata, Tomoki; Honma, Yujiro; Hamada, Hiroyuki; Kuroda, Yosuke; Taguchi, Kazunori; Kitazaki, Kazuyoshi; Kubo, Tomohiko			A fertility-restoring genotype of beet (Beta vulgaris L.) is composed of a weak restorer-of-fertility gene and a modifier gene tightly linked to the Rf1 locus	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; PENTATRICOPEPTIDE REPEAT PROTEINS; MOLECULAR VARIANTS; LINKAGE MAP; MITOCHONDRIAL; RESTORATION; IDENTIFICATION; ALLELE	Cytoplasmic male sterility (CMS) is a plant trait that involves interactions between nuclearand mitochondrial genomes. In CMS, the nuclear restorer-of-fertility gene (Rf), a suppressor of male-sterility inducing mitochondria, is one of the best known genetic factors. Other unidentified genetic factors may exist but have not been well characterized. In sugar beet (Beta vulgaris L.), CMS is used for hybrid seed production, but few male-sterility inducing nuclear genotypes exist. Such genotypes could be introduced from a closely related plant such as leaf beet, but first the fertility restoring genotype of the related plant must be characterized. Here, we report the discovery of a Japanese leaf beet accession 'Fukkoku-ouba' that has both male-sterility inducing and fertility restoring genotypes. We crossed the leaf beet accession with a sugar beet CMS line, developed succeeding generations, and examined the segregation of two DNA markers that are linked to two sugar beet Rfs, Rf1 and Rf2. Only the Rf2 marker co-segregated with fertility restoration in every generation, implying that the Rf1 locus in leaf beet is occupied by a non-restoring allele. Fertility restoration was incomplete without a genetic factor closely linked to Rf1, leading to the assumption that the Rf1 locus encodes a modifier that cannot restore fertility by itself but perhaps strengthens another Rf. We sequenced the apparently non-restoring 'Fukkoku-ouba' rf1 gene-coding region and found that it closely resembles a restoring allele. The protein product demonstrated its potential to suppress CMS in transgenic suspension cells. In contrast, 'Fukkokuouba' rf1 transcript abundance was highly reduced compared to that of the restoring Rf1. Consistently, changes in protein complexes containing CMS-associated mitochondrial protein in anthers were very minor. Accordingly, we concluded that ` Fukkoku-ouba' rf1 is a hypomorph that acts as a non-restoring allele but has the potential to support another Rf, i.e. it is a modifier candidate.	[Arakawa, Takumi; Uchiyama, Daisuke; Ohgami, Takashi; Ohgami, Ryo; Murata, Tomoki; Honma, Yujiro; Hamada, Hiroyuki; Kitazaki, Kazuyoshi; Kubo, Tomohiko] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Kuroda, Yosuke; Taguchi, Kazunori] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Memuro, Hokkaido, Japan; [Honma, Yujiro] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido, Japan	Hokkaido University; National Agriculture & Food Research Organization - Japan; Kitami Institute of Technology	Kubo, T (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan.	tomohiko@abs.agr.hokudai.ac.jp	Taguchi, Kazunori/ABF-5346-2020; Ohgami, R/AAE-1448-2019	Arakawa, Takumi/0000-0002-8069-9581; Kitazaki, Kazuyoshi/0000-0003-3012-0604	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); JSPS KAKENHI [25292001]; Suhara Memorial Foundation; JSPS Research Fellowship for Young Scientists;  [16J01146]	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suhara Memorial Foundation; JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by: Grants-in-Aid for Scientific Research from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) (TK); JSPS KAKENHI Grant Number 25292001 (TK); Suhara Memorial Foundation (TK); and Grant-in-Aid for JSPS Fellows 16J01146 (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Genebank, National Agriculture and Food Research Organization, Japan, for providing 'Fukkoku-ouba' seeds. TA is a recipient of a JSPS Research Fellowship for Young Scientists.	ABAD AR, 1995, PLANT CELL, V7, P271, DOI 10.1105/tpc.7.3.271; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bosemark NO, 2006, WORLD AGRIC SER, P50; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Cheng DY, 2011, GENET RESOUR CROP EV, V58, P553, DOI 10.1007/s10722-010-9598-9; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ducos E, 2001, PLANT J, V26, P171, DOI 10.1046/j.1365-313x.2001.01017.x; Duroc Y, 2005, BIOCHIMIE, V87, P1089, DOI 10.1016/j.biochi.2005.05.009; DUVICK DONALD N., 1965, ADVANCE GENET, V13, P1, DOI 10.1016/S0065-2660(08)60046-2; FISCHER HE, 1989, EUPHYTICA, V41, P75, DOI 10.1007/BF00022414; Fujii S, 2008, PLANT CELL PHYSIOL, V49, P1484, DOI 10.1093/pcp/pcn102; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; HE S, 1995, THEOR APPL GENET, V90, P1056, DOI 10.1007/BF00222921; Hjerdin-Panagopoulos A, 2002, CROP SCI, V42, P540, DOI 10.2135/cropsci2002.0540; HOGABOAM G. J., 1957, JOUR AMER SOC SUGAR BEET TECHNOL, V9, P457, DOI 10.5274/jsbr.9.5.457; Honma Y, 2014, THEOR APPL GENET, V127, P2567, DOI 10.1007/s00122-014-2398-4; Kagami H, 2016, HEREDITAS, V153, DOI 10.1186/s41065-016-0015-z; Kagami H, 2015, METHODS MOL BIOL, V1223, P335, DOI 10.1007/978-1-4939-1695-5_27; Kato H, 2007, HEREDITY, V99, P516, DOI 10.1038/sj.hdy.6801026; Kaul, 1988, MALE STERILITY HIGHE; Kitazaki K, 2015, PLANT J, V83, P290, DOI 10.1111/tpj.12888; Kitazaki K, 2011, PLANT J, V68, P262, DOI 10.1111/j.1365-313X.2011.04684.x; KRISHNASAMY S, 1994, PLANT MOL BIOL, V26, P935, DOI 10.1007/BF00028860; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; Levytskyy RM, 2017, BIOCHEMISTRY-US, V56, P4737, DOI 10.1021/acs.biochem.7b00663; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Matsuhira H, 2012, GENETICS, V192, P1347, DOI 10.1534/genetics.112.145409; Melonek J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35152; Moritani M, 2013, MOL BREEDING, V32, P91, DOI 10.1007/s11032-013-9854-8; Ohgami T, 2016, THEOR APPL GENET, V129, P675, DOI 10.1007/s00122-015-2656-0; Owen F. V., 1945, JOUR AGRIC RES, V71, P423; PETERSON PA, 1958, AM NAT, V92, P111, DOI 10.1086/282017; PILLEN K, 1993, PLANT BREEDING, V111, P265, DOI 10.1111/j.1439-0523.1993.tb00641.x; Rhoads DM, 1998, ARCH BIOCHEM BIOPHYS, V354, P158, DOI 10.1006/abbi.1998.0671; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Schondelmaier J, 1997, THEOR APPL GENET, V95, P590, DOI 10.1007/s001220050600; Stone JD, 2017, J EXP BOT, V68, P1599, DOI 10.1093/jxb/erx057; Taguchi K, 2014, CROP SCI, V54, P1407, DOI 10.2135/cropsci2013.11.0731; TAHIR CM, 1969, JPN J GENET, V44, P1, DOI 10.1266/jjg.44.1; Touzet P, 2012, ADV BOT RES, V63, P71, DOI 10.1016/B978-0-12-394279-1.00004-1; Uyttewaal M, 2008, PLANT CELL, V20, P3331, DOI 10.1105/tpc.107.057208; VRANCEANU AV, 1978, EUPHYTICA, V27, P617, DOI 10.1007/BF00043193; Yamamoto MP, 2005, MOL GENET GENOMICS, V273, P342, DOI 10.1007/s00438-005-1140-y; Zhang CY, 2017, DEVELOPMENT, V144, P2490, DOI 10.1242/dev.151951	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198409	10.1371/journal.pone.0198409	http://dx.doi.org/10.1371/journal.pone.0198409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856854	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800118
J	Chen, L; Heng, JY; Qin, SY; Bian, K				Chen, Liang; Heng, Junying; Qin, Suya; Bian, Ke			A comprehensive understanding of the biocontrol potential of Bacillus velezensis LM2303 against Fusarium head blight	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SECONDARY METABOLITES; BIOLOGICAL-CONTROL; BIOFILM FORMATION; GENE CLUSTERS; SUBTILIS; SURFACTIN; ANTIBIOTICS; BIOSYNTHESIS; BACTERIAL	Fusarium head blight (FHB) mainly caused by F. graminearum, always brings serious damage to wheat production worldwide. In this study, we found that strain LM2303 had strong antagonist activity against F. graminearum and significantly reduced disease severity of FHB with the control efficiency of 72.3% under field conditions. To gain a comprehensive understanding of the biocontrol potential of strain LM2303 against FHB, an integrated approach of genome mining and chemical analysis was employed. The whole genome of strain LM2303 was obtained and analyzed, showing the largest number of genes/gene clusters associated with biocontrol functions as compared with the known biocontrol strains (FZB42, M75, CAU B946). And strain LM2303 was accurately determined as a member of the B. velezensis clade using the phylogenomic analysis of single-copy core genes. Through genome mining, 13 biosynthetic gene clusters(BGCs) encoding secondary metabolites with biocontrol functions were identified, which were further confirmed through chemical analyses such as UHPLC-ESI-MS, including three antifungal metabolites (fengycin B, iturin A, and surfactin A), eight antibacterial metabolites (surfactin A, butirosin, plantazolicin and hydrolyzed plantazolicin, kijanimicin, bacilysin, difficidin, bacillaene A and bacillaene B, 7-o-malonyl macrolactin A and 7-o-succinyl macrolactin A), the siderophore bacillibactin, molybdenum cofactor and teichuronic acid. In addition, genes/gene clusters involved in plant colonization, plant growth promotion and induced systemic resistance were also found and analyzed, along with the corresponding metabolites. Finally, four different mechanisms of strain LM2303 involved in the biocontrol of FHB were putatively obtained. This work provides better insights into a mechanistic understanding of strain LM2303 in control of FHB, reinforcing the higher potential of this strain as a powerful biocontrol strain agent (BCA) for FHB control. The results also provide scientific reference and comparison for other biocontrol strains.	[Chen, Liang; Heng, Junying; Qin, Suya; Bian, Ke] Henan Univ Technol, Coll Bioengn, Prov Key Lab Transformat & Utilizat Cereal Resour, Zhengzhou, Henan, Peoples R China; [Chen, Liang; Bian, Ke] Collaborat Innovat Ctr Grain Storage Secur Henan, Zhengzhou, Henan, Peoples R China	Henan University of Technology	Chen, L; Bian, K (corresponding author), Henan Univ Technol, Coll Bioengn, Prov Key Lab Transformat & Utilizat Cereal Resour, Zhengzhou, Henan, Peoples R China.; Chen, L; Bian, K (corresponding author), Collaborat Innovat Ctr Grain Storage Secur Henan, Zhengzhou, Henan, Peoples R China.	chen_liang.cl@163.com; kebian@163.com	chen, liang/D-8135-2018; chen, liang/K-5531-2019	chen, liang/0000-0002-2357-0925	National Natural Science Foundation of China [31401543, U1304332]; National Top Youth Talent Support Program for Grain Industry [LQ2016101]; Key Technology Research Project of Henan Province [162102210043]; National Modern Agricultural Industry Technology System Construction Program [CARS-03, CARS-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Top Youth Talent Support Program for Grain Industry; Key Technology Research Project of Henan Province; National Modern Agricultural Industry Technology System Construction Program	This work was financially supported by National Natural Science Foundation of China (31401543, U1304332) (http: /www.nsfc.gov.cn/), National Top Youth Talent Support Program for Grain Industry (LQ2016101) (http //www.chinagrain.gov.cn/), Key Technology Research Project of Henan Province (162102210043) (http:// www.hnkjt.gov.cn/) and National Modern Agricultural Industry Technology System Construction Program (CARS-03, CARS-13) (http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari TB, 2011, PLANT DIS, V95, P582, DOI 10.1094/PDIS-10-10-0760; Arguelles-Arias A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-63; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Bird C, 2003, APPL ENVIRON MICROB, V69, P7009, DOI 10.1128/AEM.69.12.7009-7018.2003; Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4; Cawoy H, 2014, MOL PLANT MICROBE IN, V27, P87, DOI 10.1094/MPMI-09-13-0262-R; Chen L, 2017, CHINA PLANT PROT, V37, P12; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen XH, 2009, J MOL MICROB BIOTECH, V16, P14, DOI 10.1159/000142891; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Dunlap CA, 2016, INT J SYST EVOL MICR, V66, P1212, DOI 10.1099/ijsem.0.000858; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Garcia-Gutierrez L, 2013, MICROB BIOTECHNOL, V6, P264, DOI 10.1111/1751-7915.12028; Guo SY, 2015, J IND MICROBIOL BIOT, V42, P925, DOI 10.1007/s10295-015-1612-y; HECKELS JE, 1977, BIOCHEM J, V162, P359, DOI 10.1042/bj1620359; Henry G, 2011, CELL MICROBIOL, V13, P1824, DOI 10.1111/j.1462-5822.2011.01664.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jiang J, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0645-3; Khezri M, 2011, J PLANT PATHOL, V93, P373; Khong N G, 2012, Commun Agric Appl Biol Sci, V77, P39; Kim SY, 2017, J BIOTECHNOL, V241, P112, DOI 10.1016/j.jbiotec.2016.11.023; Lee J, 2013, P NATL ACAD SCI USA, V110, P12954, DOI 10.1073/pnas.1306101110; Li Jing, 2013, Journal of South China Agricultural University, V34, P62; Liu ZZ, 2013, APPL MICROBIOL BIOT, V97, P10081, DOI 10.1007/s00253-013-5247-5; Llewellyn NM, 2007, CHEM BIOL, V14, P379, DOI 10.1016/j.chembiol.2007.02.005; M HX, 2008, CEREAL RES COMMUN, V36, P203, DOI 10.1556/CRC.36.2008.Suppl.B.16; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Ministry of agriculture of the People's Republic of China, 2007, 146415 NYT MIN AGR P; Mishra S, 2012, WORLD J MICROB BIOT, V28, P693, DOI 10.1007/s11274-011-0865-5; Niazi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104651; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Pal KK, 2000, MICROBIOL RES, V155, P233, DOI 10.1016/S0944-5013(00)80038-5; Palazzini JM, 2016, MICROBIOL RES, V192, P30, DOI 10.1016/j.micres.2016.06.002; PATEL PS, 1995, J ANTIBIOT, V48, P997, DOI 10.7164/antibiotics.48.997; Nguyen PA, 2017, BIOL CONTROL, V104, P10, DOI 10.1016/j.biocontrol.2016.10.004; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Ruiz-Garcia C, 2005, INT J SYST EVOL MICR, V55, P191, DOI 10.1099/ijs.0.63310-0; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Schneider K, 2007, J NAT PROD, V70, P1417, DOI 10.1021/np070070k; Scholz R, 2011, J BACTERIOL, V193, P215, DOI 10.1128/JB.00784-10; Snook ME, 2009, J AGR FOOD CHEM, V57, P4287, DOI 10.1021/jf900164h; Tendulkar SR, 2007, J APPL MICROBIOL, V103, P2331, DOI 10.1111/j.1365-2672.2007.03501.x; Tsuge K, 2001, J BACTERIOL, V183, P6265, DOI 10.1128/JB.183.21.6265-6273.2001; Wang LY, 2015, MICROBIOL RES, V177, P34, DOI 10.1016/j.micres.2015.05.005; Wang QY, 2017, J BIOBASED MATER BIO, V11, P210, DOI 10.1166/jbmb.2017.1665; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Woo Sang-Min, 2008, Korean Journal of Microbiology and Biotechnology, V36, P326; Wu LM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12975; Xiong HQ, 2015, RSC ADV, V5, P82042, DOI 10.1039/c5ra13142a; Yu XM, 2011, EUR J SOIL BIOL, V47, P138, DOI 10.1016/j.ejsobi.2010.11.001; Yuan J, 2012, J AGR FOOD CHEM, V60, P2976, DOI 10.1021/jf204868z; Zalila-Kolsi I, 2016, MICROBIOL RES, V192, P148, DOI 10.1016/j.micres.2016.06.012; Zeriouh H, 2014, ENVIRON MICROBIOL, V16, P2196, DOI 10.1111/1462-2920.12271; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854; Zhang JB, 2013, PLANT PATHOL, V62, P92, DOI 10.1111/j.1365-3059.2012.02639.x; ZIMMERMAN SB, 1987, J ANTIBIOT, V40, P1677, DOI 10.7164/antibiotics.40.1677	59	65	73	14	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198560	10.1371/journal.pone.0198560	http://dx.doi.org/10.1371/journal.pone.0198560			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856856	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800137
J	Le Borgne, P; Maestraggi, Q; Couraud, S; Lefebvre, F; Herbrecht, JE; Boivin, A; Michard, B; Castelain, V; Kaltenbach, G; Bilbault, P; Schneider, F				Le Borgne, Pierrick; Maestraggi, Quentin; Couraud, Sophie; Lefebvre, Francois; Herbrecht, Jean-Etienne; Boivin, Alexandra; Michard, Baptiste; Castelain, Vincent; Kaltenbach, Georges; Bilbault, Pascal; Schneider, Francis			Critically ill elderly patients (>= 90 years): Clinical characteristics, outcome and financial implications	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PATIENTS AGED 80; ACUTE PHYSIOLOGY; MULTICENTER; MORTALITY; ADMISSION; FRAILTY; COHORT; ICU; TRIAGE	Background Patients aged over 90 are being admitted to intensive care units (ICUs) with increasing frequency. The appropriateness of such decisions still remains controversial due to questionable outcome, limited resources and costs. Our objective was to determine the clinical characteristics and outcome in elderly patients (>= 90 years) admitted in a medical ICU, with an additional focus on medico-economic implications. Methods We reviewed the charts of all patients (>= 90 years) admitted to our ICU. We compared them with all other ICU patients (< 90 years), sought to identify ICU mortality predictors and also performed a long-term survival follow-up. Results In the study group of 317 stays: median age was 92 years (IQR: 91-94 years); most patients were female (71.3%.). Acute respiratory failure (52.4%) was the main admission diagnosis; mean SAPS II was 55.6 +/- 21.3; half the stays (49.2%) required mechanical ventilation (duration: 7.2 +/- 8.8 days); withholding and withdrawing decisions were made for 33.4% of all stays. ICU and hospital mortality rates were 35.7% and 42.6% respectively. Mechanical ventilation (OR = 4.83, CI95%: 1.59-15.82) was an independent predictor of ICU mortality whereas age was not (OR = 0.88, CI95%: 0.72-1.08). Social security reimbursement was significantly lower in the study group compared with all other ICU stays, both per stay (13,160 vs 22,092 Euros, p< 0.01) and per day of stay (p = 0.03). Conclusion Among critically ill elderly patients (>= 90 years), chronological age was not an independent factor of ICU mortality. ICU care-related costs in this population should not be considered as a limiting factor for ICU admission.	[Le Borgne, Pierrick; Couraud, Sophie; Bilbault, Pascal] Univ Hosp Strasbourg, Hautepierre Hosp, Emergency Dept, Strasbourg, France; [Le Borgne, Pierrick; Bilbault, Pascal] Univ Strasbourg, Federat Med Translat FMTS, Regenerat NanoMed RNM, INSERM French Natl Inst Hlth & Med Res,UMR 1260, Strasbourg, France; [Maestraggi, Quentin; Herbrecht, Jean-Etienne; Boivin, Alexandra; Michard, Baptiste; Castelain, Vincent; Schneider, Francis] Univ Hosp Strasbourg, Hautepierre Hosp, Med Intens Care Unit, Strasbourg, France; [Maestraggi, Quentin; Herbrecht, Jean-Etienne; Boivin, Alexandra; Michard, Baptiste; Castelain, Vincent; Schneider, Francis] Univ Hosp Strasbourg, Hautepierre Hosp, UMR 1121, Strasbourg, France; [Lefebvre, Francois] Univ Hosp Strasbourg, Dept Publ Hlth, Strasbourg, France; [Kaltenbach, Georges] Univ Hosp Strasbourg, Dept Geriatr, Strasbourg, France	CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Strasbourg; CHU Strasbourg; CHU Strasbourg	Le Borgne, P (corresponding author), Univ Hosp Strasbourg, Hautepierre Hosp, Emergency Dept, Strasbourg, France.; Le Borgne, P (corresponding author), Univ Strasbourg, Federat Med Translat FMTS, Regenerat NanoMed RNM, INSERM French Natl Inst Hlth & Med Res,UMR 1260, Strasbourg, France.	pierrick_med@yahoo.fr	Castelain, Vincent/ABG-9778-2020	Le Borgne, Pierrick/0000-0001-9141-6439; Castelain, Vincent/0000-0002-9354-6525				[Anonymous], 2016, TABL MORT FRANC AIS; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7768; Becker S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0097-1; Boumendil A, 2005, J AM GERIATR SOC, V53, P88, DOI 10.1111/j.1532-5415.2005.53016.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chin-Yee N, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1689-y; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; de Rooij SE, 2005, CRIT CARE, V9, pR307, DOI 10.1186/cc3536; Docherty AB, 2016, CRIT CARE MED, V44, P3, DOI 10.1097/CCM.0000000000001377; Flaatten H, 2017, INTENS CARE MED, V43, P1319, DOI 10.1007/s00134-017-4718-z; Flaatten H, 2017, INTENS CARE MED, V43, P1820, DOI 10.1007/s00134-017-4940-8; Garrouste-Orgeas M, 2013, INTENS CARE MED, V39, P1574, DOI 10.1007/s00134-013-2977-x; Garrouste-Orgeas M, 2009, CRIT CARE MED, V37, P2919, DOI 10.1097/CCM.0b013e3181b019f0; Guidet B, 2018, ACTA ANAESTH SCAND, V62, P207, DOI 10.1111/aas.13021; Guidet B, 2015, INTENS CARE MED, V41, P1838, DOI 10.1007/s00134-015-3988-6; Guidet B, 2017, JAMA-J AM MED ASSOC, V318, P1450, DOI 10.1001/jama.2017.13889; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; Howden LM, 2011, SEX COMPOSITION; Hwabejire JO, 2014, JAMA SURG, V149, P1054, DOI 10.1001/jamasurg.2014.473; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Le Guen J, 2016, AGE AGEING, V45, P303, DOI 10.1093/ageing/afv191; Leblanc G, 2017, INTENS CARE MED, V43, P217, DOI 10.1007/s00134-016-4477-2; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0; Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856; Peigne V, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0107-y; Philippart F, 2013, INTENS CARE MED, V39, P1565, DOI 10.1007/s00134-013-2976-y; Sprung CL, 2012, CRIT CARE MED, V40, P132, DOI 10.1097/CCM.0b013e318232d6b0; Zeng A, 2015, J GERONTOL A-BIOL, V70, P1586, DOI 10.1093/gerona/glv084	30	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198360	10.1371/journal.pone.0198360	http://dx.doi.org/10.1371/journal.pone.0198360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856809	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800108
J	Matsumoto, M; Kimura, K; Inoue, K; Kashima, S; Koike, S; Tazuma, S				Matsumoto, Masatoshi; Kimura, Kazuki; Inoue, Kazuo; Kashima, Saori; Koike, Soichi; Tazuma, Susumu			Aging of hospital physicians in rural Japan: A longitudinal study based on national census data	PLOS ONE			English	Article							QUALITY-OF-CARE; HEALTH-CARE; MORTALITY; VOLUME; AREAS; OUTCOMES; ASSOCIATION; RETENTION; IMPACT	Background The disparity in the number of urban and rural physicians is a social problem in Japan. There may also be a disparity in the age of physicians. This study longitudinally examines both geographic and age distributions of physicians. Methods Individual data from the Survey of Physicians, Dentists and Pharmacists in 1994, 2004 and 2014 and municipality data from the National Population Census were used. The 2015 municipality border was applied to all years, and all municipalities were classified into equalsize quintiles based on population density. Both municipalities and physicians were longitudinally observed. Results Between 1994 and 2014, the number of physicians per 100,000 population increased by 31.8% in the most urban group of municipalities and 17.4% in the most rural group. The average age of physicians was highest in the most rural and lowest in the most urban group. The difference in average age between the urban and rural physicians widened from 2.1 years in 1994 to 6.0 years in 2014. This disparity is particularly pronounced among hospital physicians (from 1.5 years in 1994 to 7.6 years in 2014). In the most rural group, the number of hospital physicians younger than 40 years old has decreased by 59.4%, while the number of those 55-70 has grown by 153% and the number older than 70 years old by 41.0%. Between 1994 and 2004, only 23.0% of hospital physicians younger than 40 years old were retained in the most rural group; the retention rate fell to 19.3% between 2004 and 2014, while the rates increased in older physicians. Conclusions The uneven distribution of physicians is increasing in Japan, as is the aging of rural hospital physicians. Shortage of physicians in rural areas may be more serious than that shown as their headcount.	[Matsumoto, Masatoshi; Kimura, Kazuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Community Based Med Syst, Hiroshima, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Kashima, Saori] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Koike, Soichi] Jichi Med Univ, Ctr Community Med, Div Hlth Policy & Management, Shimotsuke, Tochigi, Japan; [Tazuma, Susumu] Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan	Hiroshima University; Teikyo University; Hiroshima University; Jichi Medical University; Hiroshima University	Matsumoto, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Community Based Med Syst, Hiroshima, Japan.	matmo10@hiroshima-u.ac.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [16K09145]	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 16K09145 (http://www.jsps.go.jp/english/e-grants/index.html) (KI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ASAHI SHINBUN NEWSPA; Barnighausen T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-86; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Brooks RG, 2002, ACAD MED, V77, P790, DOI 10.1097/00001888-200208000-00008; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Doescher M, 2009, AGING RURAL PHYS WOR; Fordyce MA., 2013, AGING RURAL PRIMARY; Gibson OR, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-336; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hara K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013922; Hatano Y, 2017, INT J INTEGR CARE, V17, DOI 10.5334/ijic.2451; Inoue K, 2009, RURAL REMOTE HEALTH, V9; Inoue K, 2004, CLIN TEACHER, V1, P39; Ismael A, 2015, JURNAL INTELEK, V6, P17; Japan Association of City Mayors, 2017, KOK FUZ SHINS SEID W; Japanese Medical Specialty Board, 2017, SENM SEID SHINS UN; Japanese Medical Specialty Board, 2016, SENM SEID SHINS; KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; Lasswell SM, 2010, JAMA-J AM MED ASSOC, V304, P992, DOI 10.1001/jama.2010.1226; Matsumoto M, 2010, RURAL REMOTE HEALTH, V10; Matsumoto M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019418; Matsumoto M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011165; Matsumoto M, 2011, LANCET, V378, pE17, DOI 10.1016/S0140-6736(11)61841-2; Matsumoto M, 2010, SOC SCI MED, V71, P667, DOI 10.1016/j.socscimed.2010.05.006; Matsumoto M, 2010, HEALTH POLICY, V96, P255, DOI 10.1016/j.healthpol.2010.02.012; Ministry of Education Culture Sports Science and Technology, 2011, KOR IG NYUG TEN TOR; Ministry of Health Labour and Welfare, 2016, HEIS 28NEN IR CHOS; Ministry of Health Labour and Welfare, 2016, SHAK HOS SHING IR DA; Ministry of Health Labour and Welfare, 2017, ISH KINM OYOB HAT IK; Ministry of Health Labour and Welfare, 2012, RINS DOUN GA CHIIK N; Ministry of Health Labour and Welfare, 2017, CHIIK HOUK CAR SYST; Moist LM, 2008, AM J KIDNEY DIS, V51, P641, DOI 10.1053/j.ajkd.2007.12.021; National Institute for Research Advancement, 2009, KOUR WA KYOUIK KAG M; National University Hospital Council of Japan, 2012, KOK KONG AR GAT WO M; National University Hospital Council of Japan, 2007, KONG CHIIK NIOK KOK; Organization for Economic Cooperation and Development, OECD DAT HOSP BEDS; Population Division Department of Economic and Social Affairs United Nations, 2016, 2015 REV WORLD POP P; Regenbogen SE, 2012, J AM COLL SURGEONS, V215, P758, DOI 10.1016/j.jamcollsurg.2012.07.011; Rucker D, 2011, KIDNEY INT, V79, P210, DOI 10.1038/ki.2010.376; Sakai R, 2016, HEALTH SERV RES, V51, P530, DOI 10.1111/1475-6773.12354; Shimada Naoki, 2004, Nihon Koshu Eisei Zasshi, V51, P117; Snowden JM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.09.029; Statistics Bureau Ministry of Internal Affairs and Communications, 2017, HEIS 27 17 7 NEN KOK; Tanihara S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-260; Tonelli M, 2007, CAN MED ASSOC J, V177, P1039, DOI 10.1503/cmaj.070343; Toyabe S, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-5; Tsugawa Y, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1797; Urbach DR, 2004, BRIT MED J, V328, P737, DOI 10.1136/bmj.38030.642963.AE; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Xu HW, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-36; Yuji K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050410	51	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198317	10.1371/journal.pone.0198317	http://dx.doi.org/10.1371/journal.pone.0198317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856807	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800100
J	Pandey, N; Vinod, PK				Pandey, Nishtha; Vinod, P. K.			Mathematical modelling of reversible transition between quiescence and proliferation	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; CELL-CYCLE CONTROL; RESTRICTION POINT; UBIQUITIN LIGASE; S-PHASE; RB/E2F PATHWAY; G1; PHOSPHORYLATION; DEGRADATION; ACCUMULATION	Cells switch between quiescence and proliferation states for maintaining tissue homeostasis and regeneration. At the restriction point (R-point), cells become irreversibly committed to the completion of the cell cycle independent of mitogen. The mechanism involving hyper-phosphorylation of retinoblastoma (Rb) and activation of transcription factor E2F is linked to the R-point passage. However, stress stimuli trigger exit from the cell cycle back to the mitogen- sensitive quiescent state after Rb hyper-phosphorylation but only until APC/C-Cdh1 inactivation. In this study, we developed a mathematical model to investigate the reversible transition between quiescence and proliferation in mammalian cells with respect to mitogen and stress signals. The model integrates the current mechanistic knowledge and accounts for the recent experimental observations with cells exiting quiescence and proliferating cells. We show that Cyclin E:Cdk2 couples Rb-E2F and APC/C-Cdh1 bistable switches and temporally segregates the R-point and the G1/S transition. A redox-dependent mutual antagonism between APC/C-Cdh1 and its inhibitor Emi1 makes the inactivation of APC/C-Cdh1 bistable. We show that the levels of Cdk inhibitor (CKI) and mitogen control the reversible transition between quiescence and proliferation. Further, we propose that shifting of the mitogen-induced transcriptional program to G2-phase in proliferating cells might result in an intermediate Cdk2 activity at the mitotic exit and in the immediate inactivation of APC/C-Cdh1. Our study builds a coherent framework and generates hypotheses that can be further explored by experiments.	[Pandey, Nishtha; Vinod, P. K.] Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, India	International Institute of Information Technology Hyderabad	Vinod, PK (corresponding author), Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, India.	vinod.pk@iiit.ac.in		Vinod, P K/0000-0003-2968-498X	Early Career Research Award Scheme, Science and Engineering Research Board, India [ECR/2016/000488]	Early Career Research Award Scheme, Science and Engineering Research Board, India	Financial support was received from the Early Career Research Award Scheme (ECR/2016/000488), Science and Engineering Research Board, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PKV acknowledges financial support from the Early Career Research Award Scheme (ECR/2016/000488), Science and Engineering Research Board, DST, India.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Arora M, 2017, CELL REP, V19, P1351, DOI 10.1016/j.celrep.2017.04.055; Barr AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14728; Barr AR, 2016, CELL SYST, V2, P27, DOI 10.1016/j.cels.2016.01.001; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cappell SD, 2016, CELL, V166, P167, DOI 10.1016/j.cell.2016.05.077; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Dong P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0185637; Dong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5750; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Fisher Robert P, 2016, F1000Res, V5, P2374; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; Gookin S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003268; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Heldt FS, 2018, P NATL ACAD SCI USA, V115, P2532, DOI 10.1073/pnas.1715345115; Hitomi M, 1999, MOL CELL BIOL, V19, P4623; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Johnson A, 2013, CURR OPIN CELL BIOL, V25, P717, DOI 10.1016/j.ceb.2013.07.010; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kwon JS, 2017, CELL REP, V20, P3223, DOI 10.1016/j.celrep.2017.09.007; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Martinsson HS, 2005, EXP CELL RES, V305, P383, DOI 10.1016/j.yexcr.2005.01.023; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matson JP, 2017, FEBS J, V284, P362, DOI 10.1111/febs.13898; Merrick KA, 2011, MOL CELL, V42, P624, DOI 10.1016/j.molcel.2011.03.031; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Naetar N, 2014, MOL CELL, V54, P932, DOI 10.1016/j.molcel.2014.04.023; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yang HW, 2017, NATURE, V549, P404, DOI 10.1038/nature23880; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zerjatke T, 2017, CELL REP, V19, P1953, DOI 10.1016/j.celrep.2017.05.022; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	57	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198420	10.1371/journal.pone.0198420	http://dx.doi.org/10.1371/journal.pone.0198420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856829	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800121
J	Prager, M; Kiechle, M; Stollenwerk, B; Hinzen, C; Glatz, J; Vogl, M; Leidl, R				Praeger, Maximilian; Kiechle, Marion; Stollenwerk, Bjoern; Hinzen, Christoph; Glatz, Juergen; Vogl, Matthias; Leidl, Reiner			Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment	PLOS ONE			English	Article							BREAST-CONSERVING SURGERY; ENDOTHELIAL GROWTH-FACTOR; POSITIVE MARGINS; RE-EXCISION; CONSERVATION SURGERY; LOCAL RECURRENCE; CANCER SURGERY; THERAPY; RISK; BEVACIZUMAB	Introduction Successful breast conserving cancer surgeries come along with tumor free resection margins and account for cosmetic outcome. Positive margins increase the likelihood of tumor recurrence. Intra-operative fluorescence molecular imaging (IFMI) aims to focus surgery on malignant tissue thus substantially lowering the presence of positive margins as compared with standard techniques of breast conservation (ST). A goal of this paper is to assess the incremental number of surgeries and costs of IFMI vs. ST. Methods We developed a decision analytical model and applied it for an early evaluation approach. Given uncertainty we considered that IFMI might reduce the proportion of positive margins found by ST from all to none and this proportion is assumed to be reduced to 10% for the base case. Inputs included data from the literature and a range of effect estimates. For the costs of IFMI, respective cost components were added to those of ST. Results The base case reduction lowered number of surgeries (mean [95% confidence interval]) by 0.22 [0.15; 0.30] and changed costs (mean [95% confidence interval]) by (SIC)-663 [(SIC)-1,584; (SIC)50]. A tornado diagram identified the Diagnosis Related Group (DRG) costs, the proportion of positive margins of ST, the staff time saving factor and the duration of frozen section analysis (FSA) as important determinants of this cost. Conclusions These early results indicate that IFMI may be more effective than ST and through the reduction of positive margins it is possible to save follow-up surgeries-indicating further health risk-and to save costs through this margin reduction and the avoidance of FSA.	[Praeger, Maximilian; Stollenwerk, Bjoern; Vogl, Matthias; Leidl, Reiner] Helmholtz Zentrum Munchen GmbH, Inst Hlth Econ & Hlth Care Management, German Res Ctr Environm Hlth, Neuherberg, Germany; [Kiechle, Marion] Tech Univ Munich, Ctr Hereditary Breast & Ovarian Canc, Dept Gynecol, Klinikum Rechts Isar, Munich, Germany; [Kiechle, Marion] CCCM, Munich, Germany; [Hinzen, Christoph; Glatz, Juergen] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Biol & Med Imaging, Neuherberg, Germany; [Hinzen, Christoph; Glatz, Juergen] Tech Univ Munich, Chair Biol Imaging, Munich, Germany; [Leidl, Reiner] Ludwig Maximilians Univ Munchen, Munich Ctr Hlth Sci, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich	Prager, M (corresponding author), Helmholtz Zentrum Munchen GmbH, Inst Hlth Econ & Hlth Care Management, German Res Ctr Environm Hlth, Neuherberg, Germany.	maximilian.praeger@helmholtz-muenchen.de	Leidl, Reiner M/B-7209-2009; Leidl, Reiner/GQY-7389-2022	Leidl, Reiner M/0000-0002-7115-7510; Stollenwerk, Bjorn/0000-0002-3189-409X; Prager, Maximilian/0000-0003-2329-8279				Akahane K, 2014, NAGOYA J MED SCI, V76, P315; [Anonymous], 2021, LANG ENV STAT COMP; Biglia N, 2014, BREAST, V23, P870, DOI 10.1016/j.breast.2014.09.009; Boyd O, 2005, CRIT CARE, V9, P390, DOI 10.1186/cc3057; Briggs A, 2006, DECISION MODELLING H; Bundesministerium der Finanzen, 2000, AF TAB E R DIE ALLG; Butler-Henderson K, 2014, BREAST, V23, P112, DOI 10.1016/j.breast.2014.01.002; Childs SK, 2012, INT J RADIAT ONCOL, V84, P1133, DOI 10.1016/j.ijrobp.2012.02.048; Cil TD, 2016, ANN SURG ONCOL, V23, P3266, DOI 10.1245/s10434-016-5477-8; ClinicalTrials. gov, 2000, VAL UPTAK VEGF TARG; Clough KB, 2015, ANN SURG ONCOL, V22, P4247, DOI 10.1245/s10434-015-4514-3; Corsi F, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/793819; Curigliano G, 2014, PROG TUMOR RES, V41, P15, DOI 10.1159/000355896; Diaby V, 2014, BREAST CANCER RES TR, V147, P433, DOI 10.1007/s10549-014-3042-3; DRG Research Group, 2017, G DRG WEBGR; Esbona K, 2012, ANN SURG ONCOL, V19, P3236, DOI 10.1245/s10434-012-2492-2; Heijblom M, 2011, TECHNOL CANCER RES T, V10, P607, DOI 10.7785/tcrt.2012.500227; Institut fur das Entgeltsystem im Krankenhaus gGmbH, 2017, G DRG REP BROWS; Jacobs L, 2008, ANN SURG ONCOL, V15, P1271, DOI 10.1245/s10434-007-9766-0; Jorns JM, 2012, AM J CLIN PATHOL, V138, P657, DOI 10.1309/AJCP4IEMXCJ1GDTS; Josephson L, 2013, J NUCL MED, V54, P329, DOI 10.2967/jnumed.112.107615; Koch M, 2017, CANCER RES, V77, P623, DOI 10.1158/0008-5472.CAN-16-1773; Koch M, 2016, ANNU REV MED, V67, P153, DOI 10.1146/annurev-med-051914-022043; Kupstas A, 2018, AM J SURG, V215, P400, DOI 10.1016/j.amjsurg.2017.11.023; Lamberts LE, 2017, CLIN CANCER RES, V23, P2730, DOI 10.1158/1078-0432.CCR-16-0437; Li Fang, 2015, Hepatogastroenterology, V62, P797; Lupe K, 2011, INT J RADIAT ONCOL, V81, pE561, DOI 10.1016/j.ijrobp.2011.02.021; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Moo TA, 2014, ANN SURG ONCOL, V21, P86, DOI 10.1245/s10434-013-3257-2; Nasir N, 2003, EUR J SURG ONCOL, V29, P718, DOI 10.1016/j.ejso.2003.08.002; Organisation for Economic Co-operation and Development, 2016, PPPS EXCH RAT 2016; Paudyal B, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-35; Philips Z, 2006, PHARMACOECONOMICS, V24, P355, DOI 10.2165/00019053-200624040-00006; Pilewskie M, 2014, ANN SURG ONCOL, V21, P1209, DOI 10.1245/s10434-013-3416-5; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Prekeges J, 2012, J NUCL MED TECHNOL, V40, P71, DOI 10.2967/jnmt.111.097410; Robert Koch Institute, 2015, KREBS DEUTSCHL 2011; Ruiterkamp J, 2011, EUR J CANCER, V47, pS6, DOI 10.1016/S0959-8049(11)70142-3; Scheller-Kreinsen D, 2013, BREAST, V22, P723, DOI 10.1016/j.breast.2012.11.001; Seyyedi S, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/250689; Statistisches Bundesamt, 2010, DURCHSCHN STUND VON; Statistisches Bundesamt, 2011, AUSG HLTE TAB ZENS M; Subhas G, 2011, INT SURG, V96, P18, DOI 10.9738/1340.1; Tan MP, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/715404; Thill M, 2014, J SURG ONCOL, V110, P15, DOI 10.1002/jso.23634; Thill M, 2012, BREAST CARE, V7, P370, DOI 10.1159/000343660; Universitatsklinikum Dusseldorf, 2011, AUSZ AUS DEM STRUKT; Universitatsklinikum Ulm, 2011, KLIN FRAU GEB; van Scheltinga AGTT, 2011, J NUCL MED, V52, P1778, DOI 10.2967/jnumed.111.092833; Vogl M, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-15; Welte R, 2004, PHARMACOECONOMICS, V22, P857, DOI 10.2165/00019053-200422130-00004	51	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198137	10.1371/journal.pone.0198137	http://dx.doi.org/10.1371/journal.pone.0198137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856875	gold, Green Submitted, Green Published			2022-12-26	WOS:000433900800075
J	Rainey, L; van der Waal, D; Donnelly, LS; Evans, DG; Wengstrom, Y; Broeders, M				Rainey, Linda; van der Waal, Danielle; Donnelly, Louise S.; Evans, D. Gareth; Wengstrom, Yvonne; Broeders, Mireille			Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals	PLOS ONE			English	Article							PROSTATE-CANCER; CHEMOPREVENTION; TAMOXIFEN; MODEL; UK	Introduction Increased knowledge of breast cancer risk factors may enable a paradigm shift from one-size-fits-all breast cancer screening to screening and subsequent prevention guided by a woman's individual risk of breast cancer. Professionals will play a key role in informing women about this new personalised screening and prevention programme. Therefore, it is essential to explore professionals' views of the acceptability of this new programme, since this may affect shared decision-making. Methods Professionals from three European countries (the Netherlands, United Kingdom, and Sweden) participated in digital concept mapping, a systematic mixed methods approach used to explore complex multidimensional constructs. Results Across the three countries, professionals prioritised the following five themes which may impact decision-making from the perspective of eligible women: (1) Anxiety/worry; (2) Proactive approach; (3) Reassurance; (4) Lack of knowledge; and (5) Organisation of risk assessment and feedback. Furthermore, Dutch and British professionals expressed concerns regarding the acceptability of a heterogeneous screening policy, suggesting women will question their risk feedback and assigned pathway of care. Swedish professionals emphasised the potential impact of the programme on family relations. Conclusions The perspectives of Dutch, British, and Swedish professionals of women's decision-making regarding personalised breast cancer screening and prevention generally appear in line with women's own views of acceptability as previously reported. This will facilitate shared decision-making. However, concerns regarding potential consequences of this new programme for screening outcomes and organisation need to be addressed, since this may affect how professionals communicate the programme to eligible women.	[Rainey, Linda; van der Waal, Danielle; Broeders, Mireille] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Donnelly, Louise S.; Evans, D. Gareth] Manchester Univ NHS Fdn Trust, Nightingale Ctr, Prevent Breast Canc Res Unit, Manchester, Lancs, England; [Evans, D. Gareth] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Evolut & Gen Sci, Genom Med, Manchester, Lancs, England; [Evans, D. Gareth] Christie NHS Fdn Trust, Manchester, Lancs, England; [Wengstrom, Yvonne] Karolinska Univ Hosp, Karolinska Inst, Div Nursing, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Wengstrom, Yvonne] Karolinska Univ Hosp, Theme Canc, Huddinge, Sweden; [Broeders, Mireille] Dutch Expert Ctr Screening, Nijmegen, Netherlands	Radboud University Nijmegen; University of Manchester; Christie NHS Foundation Trust; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Rainey, L (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands.	Linda.Rainey@Radboudumc.nl	Evans, D Gareth/AAB-4308-2022; Broeders, Mireille JM/C-8820-2015; van der Waal, Danielle/A-1386-2016	Evans, D Gareth/0000-0002-8482-5784; Broeders, Mireille JM/0000-0002-8741-8148; Gorman, Louise/0000-0002-6570-7272; van der Waal, Danielle/0000-0002-5850-8814	Netherlands Organisation for Health Research and Development (ZonMW) [200500004]; Dutch Cancer Society [KUN2015-7626]; Radboud Institute of Health Sciences (RIHS), Nijmegen, the Netherlands; All Manchester NIHR Biomedical Research Centre	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Dutch Cancer Society(KWF Kankerbestrijding); Radboud Institute of Health Sciences (RIHS), Nijmegen, the Netherlands(Netherlands Government); All Manchester NIHR Biomedical Research Centre	This work was supported by the Netherlands Organisation for Health Research and Development (ZonMW) under Grant 200500004; the Dutch Cancer Society under Grant KUN2015-7626; and the Radboud Institute of Health Sciences (RIHS), Nijmegen, the Netherlands (Grant not applicable). D Gareth Evans is an NIHR Senior investigator and is supported by the All Manchester NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2013, CANCER PREV RES, V6, P165, DOI 10.1158/1940-6207.CAPR-12-0385; Chowdhury S, 2013, GENET MED, V15, P423, DOI 10.1038/gim.2012.167; Collins IM, 2014, BREAST, V23, P644, DOI 10.1016/j.breast.2014.06.014; Corbelli J, 2014, J WOMENS HEALTH, V23, P746, DOI 10.1089/jwh.2014.4742; Crew KD, 2014, AM SOC CLIN ONC M, pe50; Dillard AJ, 2013, SOC SCI MED, V77, P13, DOI 10.1016/j.socscimed.2012.10.009; Donnelly LS, 2014, BRIT J CANCER, V110, P1681, DOI 10.1038/bjc.2014.109; Evans DGR, 2016, BRIT J CANCER, V114, P1045, DOI 10.1038/bjc.2016.56; Fagerlin A, 2010, BREAST CANCER RES TR, V119, P613, DOI 10.1007/s10549-009-0618-4; Feinstein AR, 1987, CLINIMETRICS; Heisey R, 2006, Can Fam Physician, V52, P624; Henneman L, 2011, PUBLIC HEALTH GENOM, V14, P238, DOI 10.1159/000276543; Holmberg C, 2015, MED DECIS MAKING, V35, P1010, DOI 10.1177/0272989X15594382; Holmberg Christine, 2010, J Nurs Healthc Chronic Illn, V2, P271, DOI 10.1111/j.1752-9824.2010.01068.x; Howell A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0446-2; Kane M, 2007, CONCEPT MAPPING PLAN; Kaplan CP, 2005, PREV MED, V41, P7, DOI 10.1016/j.ypmed.2004.09.041; Koitsalu M, 2016, ACTA ONCOL, V55, P45, DOI 10.3109/0284186X.2015.1043024; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Meisel SF, 2015, BREAST, V24, P237, DOI 10.1016/j.breast.2015.02.001; O'Doherty K, 2007, J Genet Couns, V16, P409, DOI 10.1007/s10897-006-9077-9; Orlando LA, 2013, PERS MED, V10, P295, DOI [10.2217/PME.13.20, 10.2217/pme.13.20]; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Phelps C, 2007, J Genet Couns, V16, P505, DOI 10.1007/s10897-007-9086-3; Phillips KA, 2016, AUST J PRIM HEALTH, V22, P255, DOI 10.1071/PY14156; Schwartz Lisa M., 1999, Journal of the National Cancer Institute Monographs, P124; Tjia J, 2008, BREAST CANCER RES TR, V108, P435, DOI 10.1007/s10549-007-9614-8; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5	29	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197772	10.1371/journal.pone.0197772	http://dx.doi.org/10.1371/journal.pone.0197772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856760	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800040
J	Schorn, D; Vogler, T; Gosheger, G; Schneider, K; Klingebiel, S; Rickert, C; Andreou, D; Liem, D				Schorn, Dominik; Vogler, Tim; Gosheger, Georg; Schneider, Kristian; Klingebiel, Sebastian; Rickert, Carolin; Andreou, Dimosthenis; Liem, Dennis			Risk factors for acute injuries and overuse syndromes of the shoulder in amateur triathletes - A retrospective analysis	PLOS ONE			English	Article							MUSCULOSKELETAL INJURIES; TRAINING PATTERNS; PAIN; SWIMMERS; SPECIALIZATION; PREVALENCE	Objectives To investigate the prevalence of shoulder-related acute and overuse injuries in triathletes and examine the role of possible risk factors, in order to identify potential preventive measures. Methods We performed a retrospective epidemiologic study of 193 amateur triathletes between June and August 2013 and evaluated their competition and training habits, as well as the presence of acute and overuse injuries of the shoulder sustained during the past 12 months. Contingency tables were analyzed using Pearson's chi-squared test. Normally distributed data were compared with the independent samples t-test, while non-parametric analyses were performed with the Mann-Whitney U test. Binary logistic regression was used to identify important predictors of injuries. Results 12 participants (6%) sustained acute injuries and 36 athletes experienced an overuse injury. The acute injury rate amounted to 0.11 per 1000 hours of training and the overuse injury rate to 0.33 per 1000 hours of training. There was no association between athletes' age, height, weight, BMI, a history of shoulder complaints or triathlon experience in years and acute or overuse injuries. Male athletes had a trend for sustaining more acute injuries then female athletes (8% vs. 2%, p = 0.079). Athletes with acute injuries spent a significantly higher amount of time per week doing weight training (p = 0.007) and had a trend for a higher weekly duration of cycling training (p = 0.088). Athletes with overuse injuries participated in a significantly higher number of races compared to athletes without overuse injuries (p = 0.005). The regular use of paddles was associated with a significantly higher rate of overuse injuries (24% vs. 10%, p = 0.014). Conclusion The regular use of paddles during swimming training appears to be a risk factor for the development of overuse injuries, while an increased duration of weight and cycling training seems to be associated with a higher rate of acute injuries.	[Schorn, Dominik; Vogler, Tim; Gosheger, Georg; Schneider, Kristian; Klingebiel, Sebastian; Rickert, Carolin; Andreou, Dimosthenis; Liem, Dennis] Munster Univ Hosp, Dept Gen Orthoped & Tumor Orthoped, Munster, Germany	University of Munster	Schorn, D (corresponding author), Munster Univ Hosp, Dept Gen Orthoped & Tumor Orthoped, Munster, Germany.	dominik.schorn@ukmuenster.de						Andersen CA, 2013, BRIT J SPORT MED, V47, P857, DOI 10.1136/bjsports-2013-092397; Askling C, 2002, SCAND J MED SCI SPOR, V12, P230, DOI 10.1034/j.1600-0838.2002.00237.x; Baker J, 2003, J APPL SPORT PSYCHOL, V15, P12, DOI 10.1080/10413200305400; Burns J, 2003, J ORTHOP SPORT PHYS, V33, P177, DOI 10.2519/jospt.2003.33.4.177; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Clarsen B, 2010, AM J SPORT MED, V38, P2494, DOI 10.1177/0363546510376816; Clements K, 1999, BRIT J SPORT MED, V33, P214, DOI 10.1136/bjsm.33.3.214; Egermann M, 2003, INT J SPORTS MED, V24, P271, DOI 10.1055/s-2003-39498; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Gosling CM, 2008, J SCI MED SPORT, V11, P396, DOI 10.1016/j.jsams.2007.07.009; Gosling CM, 2013, PHYS THER SPORT, V14, P207, DOI 10.1016/j.ptsp.2012.09.004; GREIPP JF, 1985, PHYSICIAN SPORTSMED, V13, P92, DOI 10.1080/00913847.1985.11708859; JOHNSON JE, 1987, MAYO CLIN PROC, V62, P289, DOI 10.1016/S0025-6196(12)61906-5; KORKIA PK, 1994, BRIT J SPORT MED, V28, P191, DOI 10.1136/bjsm.28.3.191; Main LC, 2010, J SPORT MED PHYS FIT, V50, P475; Manninen JSO, 1996, BRIT J SPORT MED, V30, P134, DOI 10.1136/bjsm.30.2.134; MAZUR LJ, 1993, SPORTS MED, V16, P57, DOI 10.2165/00007256-199316010-00005; MCMASTER WC, 1993, AM J SPORT MED, V21, P67, DOI 10.1177/036354659302100112; Memmert D, 2010, HIGH ABIL STUD, V21, P3, DOI 10.1080/13598139.2010.488083; Moesch K, 2011, SCAND J MED SCI SPOR, V21, pE282, DOI 10.1111/j.1600-0838.2010.01280.x; O'Donnell CJ, 2005, PHYSICIAN SPORTSMED, V33, P27, DOI 10.3810/psm.2005.09.195; Sein ML, 2010, BRIT J SPORT MED, V44, P105, DOI 10.1136/bjsm.2008.047282; Shaw T, 2004, J SCI MED SPORT, V7, P446, DOI 10.1016/S1440-2440(04)80262-7; Sikic M, 2009, MED J AUSTRALIA, V190, P353, DOI 10.5694/j.1326-5377.2009.tb02446.x; Silberman MR, 2013, CURR SPORT MED REP, V12, P337, DOI 10.1249/JSR.0b013e3182a4bab7; Tate A, 2012, J ATHL TRAINING, V47, P149; Tovin Brian J, 2006, N Am J Sports Phys Ther, V1, P166; Vleck V, 2014, SPORTS MED, V44, P1659, DOI 10.1007/s40279-014-0244-0; Vleck VE, 2010, J STRENGTH COND RES, V24, P30, DOI 10.1519/JSC.0b013e3181bd4cc8	29	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198168	10.1371/journal.pone.0198168	http://dx.doi.org/10.1371/journal.pone.0198168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856780	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800077
J	Kossow, A; Stuhmer, B; Schaumburg, F; Becker, K; Glatz, B; Mollers, M; Kampmeier, S; Mellmann, A				Kossow, Annelene; Stuehmer, Bianca; Schaumburg, Frieder; Becker, Karsten; Glatz, Birgit; Moellers, Mareike; Kampmeier, Stefanie; Mellmann, Alexander			High prevalence of MRSA and multi-resistant gram-negative bacteria in refugees admitted to the hospital-But no hint of transmission	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MOLECULAR CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; POPULATION; CARRIAGE; GERMANY	With high numbers of refugees arriving in Europe uncertainty exists as to whether multidrug-resistant organisms are imported into the healthcare system. In our study, we identified 383 refugee-inpatients admitted to the University Hospital Munster, Germany between September 2015 and September 2016. For this patient cohort screening for Methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Gram-negative bacteria (MDR-GNB) and Vancomycin-resistant enterococci (VRE) was recommended in our institution. Until May 2016 pre-emptive isolation was applied to all refugee-inpatients until the exclusion of these multidrug-resistant organisms. MRSA were found in 34 refugee-patients (9.8%), MDR-GNB in 25 refugee-patients (12.9%) and VRE in none of the refugee patients. We did not find any strains carrying carbapenemases. Whole genome sequencing (WGS) data demonstrated that the respective isolates were genetically heterogeneous and revealed no transmission of refugee-patient isolates to other patients. We therefore omitted pre-emptive isolation as an infection control measure for this group of patients. Furthermore, molecular typing did not show evidence for nosocomial transmission from refugee-patients to other patients. Standard hygiene measures successfully prevented the transmission of refugee-patient isolates to other patients and as a result introduction into the healthcare system. This underlines that any multidrug-resistant organisms present within this cohort are not of any extraordinary concern for health systems.	[Kossow, Annelene; Kampmeier, Stefanie; Mellmann, Alexander] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Stuehmer, Bianca] Univ Hosp Munster, Int Patient Management, Munster, Germany; [Schaumburg, Frieder; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Glatz, Birgit; Moellers, Mareike] Univ Hosp Munster, Clin Gynecol & Obstet, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Kossow, A (corresponding author), Univ Hosp Munster, Inst Hyg, Munster, Germany.	annelene.kossow@ukmuenster.de	Becker, Karsten/O-2302-2018; Kampmeier, Stefanie/GNW-3599-2022; Möllers, Mareike/AAZ-4077-2021	Becker, Karsten/0000-0002-6391-1341; Kampmeier, Stefanie/0000-0002-5013-159X; Moellers, Mareike/0000-0003-2331-2317	"MRE-Netrwerk Nordwest"; "EurHealth-1Health" Interreg [EU/INTERREG VA-681377]	"MRE-Netrwerk Nordwest"; "EurHealth-1Health" Interreg	This work was supported in part by the "MRE-Netrwerk Nordwest" and the "EurHealth-1Health" [EU/INTERREG VA-681377] Interreg-funded project (KB) (https://www.deutschland-nederland.eu/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; Alzoubi HM, 2014, J EGYPT PUBLIC HEAL, V89, P114, DOI 10.1097/01.EPX.0000454671.83406.e8; [Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; Becker K, 2017, INT J MED MICROBIOL, V307, P21, DOI 10.1016/j.ijmm.2016.11.007; Beerheide R, 2016, DEUTSCHES A, V113, P477; de Been M, 2015, J CLIN MICROBIOL, V53, P3788, DOI 10.1128/JCM.01946-15; Die Bundesregierung, INF FLUCHTL AS BERL; ECDC, 2015, GUARDIAN; Folsch UR, 2016, INTERNIST, V57, P822, DOI 10.1007/s00108-016-0103-1; Franco A, 2011, J ANTIMICROB CHEMOTH, V66, P1231, DOI 10.1093/jac/dkr115; Heudorf U, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.2.30109; Heudorf U, 2016, GMS HYG INFECT CONTR, V11, DOI 10.3205/dgkh000276; Hussein NR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124920; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Kade C., 2015, KLIN KLAGEN BELASTUN; Kempf VA, 2016, EUROSURVEILLANCE, V21, P34, DOI 10.2807/1560-7917.ES.2016.21.7.30138; Kock R, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010011; Kriegeskorte A, 2012, EMERG INFECT DIS, V18, P1016, DOI 10.3201/eid1806.110910; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Mellmann A, 2016, J CLIN MICROBIOL, V54, P2874, DOI 10.1128/JCM.00790-16; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Oelmeier de Murcia K, 2016, GEBURTSHILFE FRAUENH, V76; Razum O, 2016, DTSCH ARZTEBL, V113, P130; Reinheimer C, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.2.30110; Robert Koch Institut, 2016, STELL R KOCH I FRAG; Robert Koch-Institut, 2016, STELL R KOCH I FRAG, P3; Robert Koch-Institut, 2014, EPIBUL, V2014; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Seybold U, 2016, J HOSP INFECT, V92, P229, DOI 10.1016/j.jhin.2015.11.014; Walter J, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.7.30137; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198103	10.1371/journal.pone.0198103	http://dx.doi.org/10.1371/journal.pone.0198103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851962	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200032
J	Walter, RFH; Rozynek, P; Casjens, S; Werner, R; Mairinger, FD; Speel, EJM; Zur Hausen, A; Meier, S; Wohlschlaeger, J; Theegarten, D; Behrens, T; Schmid, KW; Bruning, T; Johnen, G				Walter, R. F. H.; Rozynek, P.; Casjens, S.; Werner, R.; Mairinger, F. D.; Speel, E. J. M.; Zur Hausen, A.; Meier, S.; Wohlschlaeger, J.; Theegarten, D.; Behrens, T.; Schmid, K. W.; Bruening, T.; Johnen, G.			Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer	PLOS ONE			English	Article							PROMOTER METHYLATION; TUMOR-SUPPRESSOR; CDKN2A; DNA	Background Lung cancer is the major cause of cancer-related deaths worldwide. Differential diagnosis can be difficult, especially when only small samples are available. Epigenetic changes are frequently tissue-specific events in carcinogenesis and hence may serve as diagnostic biomarkers. Material and methods 138 representative formalin-fixed, paraffin-embedded (FFPE) tissues (116 lung cancer cases and 22 benign controls) were used for targeted DNA methylation analysis via pyrosequencing of ten literature-derived methylation markers (APC, CDH1, CDKN2A, EFEMP1, FHIT, L1RE1, MGMT, PTEN, RARB, and RASSF1). Methylation levels were analyzed with the Classification and Regression Tree Algorithm (CART), Conditional Interference Trees (ctree) and ROC. Validation was performed with additional 27 lung cancer cases and 38 benign controls. TCGA data for 282 lung cancer cases was included in the analysis. Results CART and ctree analysis identified the combination of L1RE1 and RARB as well as L1RE1 and RASSF1 as independent methylation markers with high discriminative power between tumor and benign tissue (for each combination, 91% specificity and 100% sensitivity). L1RE1 methylation associated significantly with tumor type and grade (p<0.001) with highest methylation in the control group. The opposite was found for RARB (p<0.001). RASSF1methylation increased with tumor type and grade (p<0.001) with strongest methylation in neuroendocrine tumors (NET). Conclusion Hypomethylation of L1RE1 is frequent in tumors compared to benign controls and associates with higher grade, whereas increasing methylation of RARB is an independent marker for tumors and higher grade. RASSF1 hypermethylation was frequent in tumors and most prominent in NET making it an auxiliary marker for separation of NSCLC and NET. L1RE1 in combination with either RARBor RASSF1 could function as biomarkers for separating lung cancer and non -cancerous tissue and could be useful for samples of limited size such as biopsies.	[Walter, R. F. H.] Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Ruhrlandklin, Essen, Germany; [Walter, R. F. H.; Werner, R.; Mairinger, F. D.; Wohlschlaeger, J.; Theegarten, D.; Schmid, K. W.] Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany; [Rozynek, P.; Casjens, S.; Meier, S.; Behrens, T.; Bruening, T.; Johnen, G.] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Speel, E. J. M.; Zur Hausen, A.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Pathol, Med Ctr, Maastricht, Netherlands	University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum; Maastricht University	Rozynek, P (corresponding author), Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany.	rozynek@ipa.ruhr-uni-bochum.de	Johnen, Georg/AFG-8027-2022; Brüning, Thomas/G-8120-2015	Johnen, Georg/0000-0002-3773-5946; Brüning, Thomas/0000-0001-9560-5464; Walter, Robert/0000-0003-3725-7064; Mairinger, Fabian/0000-0003-1067-0051	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	This work was supported by DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TC, 2014, JAMA SURG, V149, P1146, DOI 10.1001/jamasurg.2014.1694; Chen C, 2015, INT J CLIN EXP PATHO, V8, P11560; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Daugaard I, 2015, EXP MOL PATHOL, V99, P632, DOI 10.1016/j.yexmp.2015.11.007; Feng HX, 2016, EXP MOL PATHOL, V100, P109, DOI 10.1016/j.yexmp.2015.12.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang YZ, 2014, ASIAN PAC J CANCER P, V15, P10325, DOI 10.7314/APJCP.2014.15.23.10325; Johnen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064139; Lai ZL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/378358; Ostrow KL, 2010, CLIN CANCER RES, V16, P3463, DOI 10.1158/1078-0432.CCR-09-3304; Pelosi G, 2010, ANTICANCER RES, V30, P4269; Pesch B, 2014, BBA-PROTEINS PROTEOM, V1844, P874, DOI 10.1016/j.bbapap.2013.12.007; Shi H, 2007, EXPERT REV MOL DIAGN, V7, P519, DOI 10.1586/14737159.7.5.519; Stricker I, 2012, ANTICANCER RES, V32, P3699; Team RDC, 2019, R LANG ENV STAT COMP; Terry Therneau BAaBR, 2015, RPART RECURSIVE PART; Travis WD., 2004, TRAVIS WB WHO CLASSI; Walter RFH, 2015, BRIT J CANCER, V112, P883, DOI 10.1038/bjc.2015.27; Wang XX, 2015, BIOCHEM BIOPH RES CO, V457, P514, DOI 10.1016/j.bbrc.2015.01.007; Wielscher M, 2015, EBIOMEDICINE, V2, P929, DOI 10.1016/j.ebiom.2015.06.025; Zeschnigk M, 2003, COMP FUNCT GENOM, V4, P329, DOI 10.1002/cfg.295	21	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0195716	10.1371/journal.pone.0195716	http://dx.doi.org/10.1371/journal.pone.0195716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851970	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200005
J	Breeze, P; Womack, R; Pryce, R; Brennan, A; Goyder, E				Breeze, Penny; Womack, Robert; Pryce, Robert; Brennan, Alan; Goyder, Elizabeth			The impact of a local sugar sweetened beverage health promotion and price increase on sales in public leisure centre facilities	PLOS ONE			English	Article							METAANALYSIS; CONSUMPTION; PURCHASES; TRIAL; TAXES	Background We aimed to evaluate the impact of a local sugar sweetened beverages (SSB) health promotion and 20p price increase in leisure centre venues and estimate the impact on consumption. Method Monthly cold drinks sales data and attendance at leisure centres across the city of Sheffield were analysed over the period January 2015-July 2017. Interrupted time-series methods were employed to estimate changes in consumption per attendance of SSB and non-SSB cold drinks following the introduction of the SSB policy from August 2016 adjusting for seasonal variation and autocorrelation. SSB price elasticities were estimated with fixed effects log-log models by SSB product type (soda can, soda bottle, soda post mix, energy drinks, juice from concentrate). Findings We estimated a 31% (95% CI 4%, 59%) reduction in units of SSB sold per attendance in the year since the policy was introduced. We did not observe substitution effects to fruit juice or water but found sales of other artificially sweetened non- SSB products increased by 27% (95% CI 6%, 47%) after the introduction of the tax. Price elasticity analysis identified that a 1% increase in price alongside health promotion leads to a 3.8% (95% CI 3.1% 4.4%) decrease in demand for SSB's. Price elasticity of demand was highest for child friendly and high caffeine energy drinks. Interpretation Demand for SSB drinks at leisure centre venues is highly responsive to the policy, particularly for child-friendly and high caffeine energy drinks, compared with other SSB tax policy evaluations. The policy also increased purchases of carbonated non-SSB.	[Breeze, Penny; Pryce, Robert; Brennan, Alan; Goyder, Elizabeth] Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Womack, Robert] Sheffield City Trust, Sheffield, S Yorkshire, England		Breeze, P (corresponding author), Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	p.breeze@sheffield.ac.uk		Pryce, Robert/0000-0002-4853-0719; Goyder, Elizabeth/0000-0003-3691-1888; Brennan, Alan/0000-0002-1025-312X; Breeze, Penny/0000-0002-4189-8676	Medical Research Council [MC_PC_15062]; MRC [MC_PC_15062] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (MC_PC_15062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Medical Research Council (MC_PC_15062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Sheffield City Trust for providing access to sales and attendance data for this study.	[Anonymous], SUG RED EV ACT; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Briggs ADM, 2017, LANCET PUBLIC HEALTH, V2, pE15, DOI 10.1016/S2468-2667(16)30037-8; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Cornelsen L, 2017, J EPIDEMIOL COMMUN H, V71, P1107, DOI 10.1136/jech-2017-209947; Cornelsen L, 2015, J PUBLIC HEALTH-UK, V37, P18, DOI 10.1093/pubmed/fdu032; Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329; Guerrero-Lopez CM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4098-x; Hua SV, 2017, J ACAD NUTR DIET, V117, P1057, DOI 10.1016/j.jand.2016.12.006; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Mhurchu CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075934; NatCen Social Research MEWLUCLMS, 2017, NAT DIET NUTR SURV Y; Rutter H, 2017, LANCET; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; StataCorp, 2017, STATA STAT SOFTWARE; Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278; Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049	17	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0194637	10.1371/journal.pone.0194637	http://dx.doi.org/10.1371/journal.pone.0194637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847553	gold, Green Accepted, Green Published			2022-12-26	WOS:000433634800004
J	Gotovina, J; Pranger, CL; Jensen, AN; Wagner, S; Kothgassner, OD; Mothes-Luksch, N; Palme, R; Larenas-Linnemann, D; Singh, J; Mosges, R; Felnhofer, A; Glenk, LM; Jensen-Jarolim, E				Gotovina, Jelena; Pranger, Christina L.; Jensen, Annika N.; Wagner, Stefanie; Kothgassner, Oswald D.; Mothes-Luksch, Nadine; Palme, Rupert; Larenas-Linnemann, Desiree; Singh, Jaswinder; Moesges, Ralph; Felnhofer, Anna; Glenk, Lisa-Maria; Jensen-Jarolim, Erika			Elevated oxytocin and noradrenaline indicate higher stress levels in allergic rhinitis patients: Implications for the skin prick diagnosis in a pilot study	PLOS ONE			English	Article							CORTISOL RESPONSES; PSYCHOLOGICAL STRESS; PSYCHOSOCIAL STRESS; MAST-CELLS; CLINICAL-RELEVANCE; ANXIETY; RELEASE; INFLAMMATION; AXIS; RESPONSIVENESS	Background & Aims The effects of acute stress on allergic symptoms are little understood. The intention of this clinical study was to study the effects of acute stress and related mediators in allergic rhinitis (AR), taking the wheal and flare reaction in skin prick testing (SPT) as a readout. Methods 19 healthy and 21 AR patients were first subjected to SPTs with grass pollen-, birch pollen- and house dust mite allergen extracts, histamine and negative control. Subsequently, participants were exposed to a standardized Trier Social Stress Test (TSST), followed by SPT on the contralateral forearm. Stress responders were identified based on the salivary cortisol levels and State-subscale of State-Trait-Anxiety Inventory (STAI-S). Blood samples were collected before and after TSST and adrenaline, noradrenaline, serotonin, oxytocin, platelet activating factor and prostaglandin D2 were analyzed by enzyme immunoassay (EIA). Results SPT results of 14/21 allergics and 11/19 healthy who responded with stress after TSST were evaluated. No significant differences regarding SPT to allergens or histamine before and after the stress test could be calculated at the group level. But, the wheal and flare sizes after TSST increased or decreased substantially in several individuals, and unmasked sensitization in one "healthy" person, which could not be correlated with any mediator tested. The most significant finding, however, was that, independent of TSST, the baseline levels of oxytocin and noradrenaline were significantly higher in allergics. Conclusion High baseline levels of noradrenaline points toward higher stress levels in allergic patients, which might be counterregulated by elevated oxytocin. Moreover, our data indicate that acute stress may have a significant influence on SPT fidelity in susceptible individuals.	[Gotovina, Jelena; Pranger, Christina L.; Wagner, Stefanie; Glenk, Lisa-Maria; Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med Vienna, Interuniv Messerli Res Inst, Comparat Med, Vienna, Austria; [Gotovina, Jelena; Pranger, Christina L.; Wagner, Stefanie; Glenk, Lisa-Maria; Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria; [Gotovina, Jelena; Pranger, Christina L.; Jensen-Jarolim, Erika] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Vienna, Austria; [Jensen, Annika N.; Mothes-Luksch, Nadine; Jensen-Jarolim, Erika] Allergy Diag & Study Ctr, AllergyCare, Vienna, Austria; [Kothgassner, Oswald D.] Med Univ Vienna, Dept Child & Adolescent Psychiat, Vienna, Austria; [Palme, Rupert] Univ Vet Med Vienna, Unit Physiol Pathophysiol & Expt Endocrinol, Vienna, Austria; [Larenas-Linnemann, Desiree] Hosp Med Sur, Invest Unit, Mexico City, DF, Mexico; [Singh, Jaswinder; Moesges, Ralph] Univ Cologne, Fac Med, Inst Med Stat Informat & Epidemiol, Cologne, Germany; [Felnhofer, Anna] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Cologne; Medical University of Vienna	Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Interuniv Messerli Res Inst, Comparat Med, Vienna, Austria.; Jensen-Jarolim, E (corresponding author), Univ Vienna, Vienna, Austria.; Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Vienna, Austria.; Jensen-Jarolim, E (corresponding author), Allergy Diag & Study Ctr, AllergyCare, Vienna, Austria.	erika.jensen-jarolim@meduniwien.ac.at	Palme, Rupert/A-3499-2008; Kothgassner, Oswald/I-5024-2019; Kothgassner, Oswald David/M-9604-2019; Felnhofer, Anna/D-6458-2017	Palme, Rupert/0000-0001-9466-3662; Kothgassner, Oswald David/0000-0002-3243-0238; Felnhofer, Anna/0000-0002-0081-7489; Pranger, Christina/0000-0002-4232-5730; Gotovina, Jelena/0000-0003-1503-5276; Glenk, Lisa Maria/0000-0002-5814-0546; Larenas Linnemann, Desiree/0000-0002-5713-5331	Austrian Science Fund [W1205-B09, W1248-B30, SFB F4606-B28]	Austrian Science Fund(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund grants to EJJ W1205-B09 (CCHD), W1248-B30 (MCCA), and SFB F4606-B28.	Burbach GJ, 2009, ALLERGY, V64, P1507, DOI 10.1111/j.1398-9995.2009.02089.x; Buske-Kirschbaum A, 2003, PSYCHOSOM MED, V65, P806, DOI 10.1097/01.PSY.0000095916.25975.4F; Buske-Kirschbaum A, 2010, BRAIN BEHAV IMMUN, V24, P1347, DOI 10.1016/j.bbi.2010.06.013; Buske-Kirschbaum A, 2002, J CLIN ENDOCR METAB, V87, P4245, DOI 10.1210/jc.2001-010872; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Chung BY, 2010, ANN DERMATOL, V22, P404, DOI 10.5021/ad.2010.22.4.404; Cuffel B, 1999, PSYCHOSOMATICS, V40, P491, DOI 10.1016/S0033-3182(99)71187-4; Demoly P., 2008, MIDDLETONS ALLERGY P, P1267; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Haahtela T, 2014, CLIN EXP ALLERGY, V44, P407, DOI 10.1111/cea.12240; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; Heffner KL, 2014, ANN ALLERG ASTHMA IM, V113, P13, DOI 10.1016/j.anai.2014.03.008; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3; Jensen-Jarolim E, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0162-3; Kiecolt-Glaser JK, 2009, PSYCHONEUROENDOCRINO, V34, P670, DOI 10.1016/j.psyneuen.2008.11.010; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka B. M., 2007, SOC NEUROSCI-UK, P56, DOI DOI 10.1007/978-1-4614-6852-3; Larenas Linnemann DE., 2016, ALLERGY, V71, P1782, DOI [10.1111/all.12998, DOI 10.1111/ALL.12998]; Larenas-Linnemann D, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0164-1; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; Madden KS, 2003, BRAIN BEHAV IMMUN, V17, pS5; Mosges R, 2007, ALLERGY, V62, P969, DOI 10.1111/j.1398-9995.2007.01440.x; Oida K, 2017, WORLD ALLERGY ORGAN, V10, DOI [10.1186/s40413-017-0154-3, 10.1186/s40413-017-0172-1]; Onaka T, 2003, EUR J NEUROSCI, V18, P3018, DOI 10.1046/j.1460-9568.2003.03037.x; Onaka T, 2004, J NEUROENDOCRINOL, V16, P308, DOI 10.1111/j.0953-8194.2004.01186.x; Palgan K, 2015, INT J IMMUNOPATH PH, V28, P584, DOI 10.1177/0394632015600598; Palme R, 1997, Z SAUGETIERKD, V62, P192; Peters EM, 2009, J DTSCH DERMATOL GES, V7, P924; Peters EMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113552; Pruessner JC, 1997, PSYCHONEUROENDOCRINO, V22, P615, DOI 10.1016/S0306-4530(97)00072-3; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Spielberg C. D., 1983, MANUAL STATE TRAIT A; Stahn C, GENOMIC NONGENOMIC E; Stauder A, 2003, PSYCHOSOM MED, V65, P816, DOI 10.1097/01.PSY.0000088620.66211.B1; Stremnitzer C, 2015, J INVEST DERMATOL, V135, P1790, DOI 10.1038/jid.2015.58; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; The European Academy of Allergy and Clinical Immunology (EAACI), 2016, ADV MAN TACKL ALL CR; Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041; Uvnas-Moberg K, 2005, Z PSYCHOSOM MED PSYC, V51, P57, DOI 10.13109/zptm.2005.51.1.57; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V82, P270, DOI 10.1016/0091-6749(88)91011-1; vanEck MMM, 1996, BIOL PSYCHOL, V43, P69, DOI 10.1016/0301-0511(95)05159-7; Vega E, 2002, ENDOCRINE, V18, P167, DOI 10.1385/ENDO:18:2:167; Weisshaar E, 1997, INFLAMM RES, V46, P412, DOI 10.1007/s000110050213; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282; WILLIAMS RM, 1995, CHEM IMMUNOL, V61, P208; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; Windle RJ, 2004, J NEUROSCI, V24, P2974, DOI 10.1523/JNEUROSCI.3432-03.2004; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Wright RJ, 1998, THORAX, V53, P1066, DOI 10.1136/thx.53.12.1066	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0196879	10.1371/journal.pone.0196879	http://dx.doi.org/10.1371/journal.pone.0196879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813071	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800007
J	Schiffner, R; Bischoff, SJ; Lehmann, T; Rakers, F; Rupprecht, S; Matziolis, G; Schubert, H; Schwab, M; Huber, O; Lemke, C; Schmidt, M				Schiffner, Rene; Bischoff, Sabine Juliane; Lehmann, Thomas; Rakers, Florian; Rupprecht, Sven; Matziolis, Georg; Schubert, Harald; Schwab, Matthias; Huber, Otmar; Lemke, Cornelius; Schmidt, Martin			Underlying mechanism of subcortical brain protection during hypoxia and reoxygenation in a sheep model - Influence of alpha 1-adrenergic signalling	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE SYNTHASE; HEMORRHAGIC-SHOCK; CARDIAC-OUTPUT; RESPONSES; AUTOREGULATION; ISOFLURANE; SERELAXIN; RECEPTORS; ASPHYXIA	While the cerebral autoregulation sufficiently protects subcortical brain regions during hypoxia or asphyxia, the cerebral cortex is not as adequately protected, which suggests that regulation of the cerebral blood flow (CBF) is area-specific. Hypoxia was induced by inhalation of 5% oxygen, for reoxygenation 100% oxygen was used. Cortical and subcortical CBF (by laser Doppler flowmetry), blood gases, mean arterial blood pressure (MABP), heart rate and renal blood flow were constantly monitored. Low dosed urapidil was used for alpha 1A-adrenergic receptor blockade. Western blotting was used to determine adrenergic receptor signalling mediators in brain arterioles. During hypoxia cortical CBF decreased to 72 +/- 11% (mean reduction 11 +/- 3%, p < 0.001) of baseline, whereas subcortical CBF increased to 168 +/- 18% (mean increase 43 +/- 5%, p < 0.001). Reoxygenation led to peak CBF of 194 +/- 27% in the subcortex, and restored cortical CBF. alpha 1A-Adrenergic blockade led to minor changes in cortical CBF, but massively reduced subcortical CBF during hypoxia and reoxygenation +/- almost aligning CBF in both brain regions. Correlation analyses revealed that alpha 1A-adrenergic blockade renders all CBF-responses pressure-passive during hypoxia and reoxygenation, and confirmed the necessity of alpha 1A-adrenergic signalling for coupling of CBF-responses to oxygen saturation. Expression levels and activation state of key signalling- mediators of alpha 1-receptors (NOSs, CREB, ERK1/2) did not differ between cortex and subcortex. The dichotomy between subcortical and cortical CBF during hypoxia and reoxygenation critically depends on alpha 1A-adrenergic receptors, but not on differential expression of signalling-mediators: signalling through the alpha 1A-subtype is a prerequisite for cortical/subcortical redistribution of CBF.	[Schiffner, Rene; Matziolis, Georg] Friedrich Schiller Univ, Jena Univ Hosp, Orthoped Dept, Eisenberg, Germany; [Schiffner, Rene; Rakers, Florian; Rupprecht, Sven; Schwab, Matthias] Friedrich Schiller Univ, Jena Univ Hosp, Dept Neurol, Jena, Germany; [Bischoff, Sabine Juliane; Schubert, Harald] Friedrich Schiller Univ, Jena Univ Hosp, Inst Lab Anim Sci & Welf, Jena, Germany; [Lehmann, Thomas] Friedrich Schiller Univ, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat Sci, Jena, Germany; [Huber, Otmar; Schmidt, Martin] Friedrich Schiller Univ, Jena Univ Hosp, Inst Biochem 2, Jena, Germany; [Lemke, Cornelius] Friedrich Schiller Univ, Jena Univ Hosp, Inst Anat 1, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schiffner, R (corresponding author), Friedrich Schiller Univ, Jena Univ Hosp, Orthoped Dept, Eisenberg, Germany.; Schiffner, R (corresponding author), Friedrich Schiller Univ, Jena Univ Hosp, Dept Neurol, Jena, Germany.	rene.schiffner@md.uni-jena.de	Schwab, Matthias/ABH-7449-2020; Huber, Otmar/AAA-4548-2021	Huber, Otmar/0000-0003-4359-1747; Schiffner, Rene/0000-0001-9546-6273; Schmidt, Martin/0000-0003-3578-4338	European Commission through the Seventh Framework Programme (FP7) [2799281]	European Commission through the Seventh Framework Programme (FP7)	The project was supported by the European Commission through the Seventh Framework Programme (FP7) No. 2799281 to MS.	Aksenov D, 2012, NEUROSCI LETT, V524, P116, DOI 10.1016/j.neulet.2012.07.019; [Anonymous], 2011, GUIDE CARE USE LAB A; Bai J, 2015, INT J STROKE, V10, P143, DOI 10.1111/ijs.12434; Bataille B, 2007, NEUROSURGERY, V60, P761, DOI 10.1227/01.NEU.0000255391.92785.ED; Berridge CW, 2016, BRAIN RES, V1641, P189, DOI 10.1016/j.brainres.2015.11.024; Bischoff SJ, 2016, AM J PHYSIOL-HEART C, V311, pH613, DOI 10.1152/ajpheart.00118.2016; Bischoff SJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12603; Brozickova C, 2013, PHYSIOL RES, V62, pS57, DOI 10.33549/physiolres.932564; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Colville-Ebeling B, 2014, J FORENSIC LEG MED, V22, P33, DOI 10.1016/j.jflm.2013.11.006; Cotecchia S, 2015, CELL SIGNAL, V27, P1984, DOI 10.1016/j.cellsig.2015.06.009; de Andrade CR, 2006, EUR J PHARMACOL, V543, P83, DOI 10.1016/j.ejphar.2006.06.003; Duchemin S, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00051; HANSEN NB, 1984, PEDIATR RES, V18, P1132, DOI 10.1203/00006450-198411000-00015; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Hoiland RL, 2016, AM J PHYSIOL-REG I, V310, pR398, DOI 10.1152/ajpregu.00270.2015; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Jones SC, 2003, J CEREBR BLOOD F MET, V23, P1085, DOI 10.1097/01.WCB.0000081202.00668.FB; JONGEWAARD WR, 1992, J TRAUMA, V32, P28, DOI 10.1097/00005373-199201000-00006; KICK O, 1993, ANESTH ANALG, V77, P737; Kudo Y, 2006, CRIT CARE MED, V34, P2820, DOI 10.1097/01.CCM.0000242522.48734.64; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; Mehra M, 2012, J NEUROINTERV SURG, V4, P307, DOI 10.1136/neurintsurg-2011-010101; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Montes-Tapia F, 2014, PEDIATR EMERG CARE, V30, P114, DOI 10.1097/PEC.0000000000000067; Muller T, 2002, J PHYSIOL-LONDON, V539, P957, DOI 10.1013/jphysiol.2001.012590; Nistor M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112247; Ogoh S, 2013, EXP PHYSIOL, V98, P692, DOI 10.1113/expphysiol.2012.068015; Okamoto H, 1997, AM J PHYSIOL-HEART C, V272, pH559, DOI 10.1152/ajpheart.1997.272.1.H559; Peng B, 2012, BRAIN RES, V1445, P92, DOI 10.1016/j.brainres.2012.01.033; Pernomian L, 2013, J PHARM PHARMACOL, V65, P1337, DOI 10.1111/jphp.12105; Purkayastha S, 2013, EXP PHYSIOL, V98, P451, DOI 10.1113/expphysiol.2012.066118; Purkayastha S, 2011, INDIAN J PHARMACOL, V43, P502, DOI 10.4103/0253-7613.84950; REINHARD M, 2014, J BIOMEDICAL OPTICS, V19, DOI DOI 10.1117/1.JB0.19.9; Sato K, 2012, EXP PHYSIOL, V97, P1272, DOI 10.1113/expphysiol.2012.064774; Schiffner R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112241; Schiffner R, 2017, CLIN HEMORHEOL MICRO, V66, P219, DOI 10.3233/CH-170269; Schiffner R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051031; Scott JF, 2000, AGE AGEING, V29, P197, DOI 10.1093/ageing/29.3.197; Shabeeh H, 2013, AM J PHYSIOL-HEART C, V304, pH1277, DOI 10.1152/ajpheart.00927.2012; Sicard Kenneth M, 2009, Exp Transl Stroke Med, V1, P7, DOI 10.1186/2040-7378-1-7; STONESTREET BS, 1982, EARLY HUM DEV, V7, P81, DOI 10.1016/0378-3782(82)90010-X; Sztamska E, 1997, FOLIA NEUROPATHOL, V35, P60; ter Laan M, 2013, BRIT J ANAESTH, V111, P361, DOI 10.1093/bja/aet122; TERLECKI S, 1967, ACTA NEUROPATHOL, V7, P185, DOI 10.1007/BF00686371; Thebaud B, 1999, INTENS CARE MED, V25, P293, DOI 10.1007/s001340050838; Tomycz ND, 2011, NEUROSURGERY, V68, pN16, DOI 10.1227/01.neu.0000395791.89648.93; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Venkatraman A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00015; Waschke KF, 2004, J TRAUMA, V56, P591, DOI 10.1097/01.TA.0000075335.35705.E2; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Zhu JQ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0211-9	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0196363	10.1371/journal.pone.0196363	http://dx.doi.org/10.1371/journal.pone.0196363			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813077	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800005
J	da Silva, RA; Pereira, LD; Silveira, MC; Jardim, R; de Miranda, AB				da Silva, Rangeline Azevedo; Pereira, Leandro de Mattos; Silveira, Melise Chaves; Jardim, Rodrigo; de Miranda, Antonio Basilio			Mining of potential drug targets through the identification of essential and analogous enzymes in the genomes of pathogens of Glycine max, Zea mays and Solanum lycopersicum	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; CRYPTOCOCCUS-NEOFORMANS; GLYOXALASE PATHWAY; HYDROGEN-PEROXIDE; VIRULENCE FACTORS; ESSENTIAL GENES; PROTEINS; SEQUENCE	Pesticides are one of the most widely used pest and disease control measures in plant crops and their indiscriminate use poses a direct risk to the health of populations and environment around the world. As a result, there is a great need for the development of new, less toxic molecules to be employed against plant pathogens. In this work, we employed an in silico approach to study the genes coding for enzymes of the genomes of three commercially important plants, soybean (Glycine max), tomato (Solanum lycopersicum) and corn (Zea mays), as well as 15 plant pathogens (4 bacteria and 11 fungi), focusing on revealing a set of essential and non-homologous isofunctional enzymes (NISEs) that could be prioritized as drug targets. By combining sequence and structural data, we obtained an initial set of 568 cases of analogy, of which 97 were validated and further refined, revealing a subset of 29 essential enzymatic activities with a total of 119 different structural forms, most belonging to central metabolic routes, including the carbohydrate metabolism, the metabolism of amino acids, among others. Further, another subset of 26 enzymatic activities possess a tertiary structure specific for the pathogen, not present in plants, men and Apis mellifera, which may be of importance for the development of specific enzymatic inhibitors against plant diseases that are less harmful to humans and the environment.	[da Silva, Rangeline Azevedo; Silveira, Melise Chaves; Jardim, Rodrigo; de Miranda, Antonio Basilio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Pereira, Leandro de Mattos] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil	Fundacao Oswaldo Cruz; Pontificia Universidade Catolica Do Rio Grande Do Sul	da Silva, RA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.	rangeline.as@gmail.com	Azevedo da Silva, Rangeline/X-9939-2018; DE MATTOS PEREIRA, LEANDRO/S-9359-2017; da Silva, Rangeline Azevedo/R-4604-2018	Azevedo da Silva, Rangeline/0000-0001-6903-1137; DE MATTOS PEREIRA, LEANDRO/0000-0002-2311-7469; Jardim, Rodrigo/0000-0002-0943-5356	Coordination for the Improvement of Higher Education Personnel, Brazil; CAPES (Coordination for the Improvement of Higher Education Personnel, Brazil)	Coordination for the Improvement of Higher Education Personnel, Brazil; CAPES (Coordination for the Improvement of Higher Education Personnel, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordination for the Improvement of Higher Education Personnel, Brazil (http://www.capes.gov.br/): (RAS, MCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RAS recognizes CAPES (Coordination for the Improvement of Higher Education Personnel, Brazil) for supporting her with a scholarship during her DSc program. The authors also thank the staff of the Laboratory of Systems and Computational Biology in conducting this study and to Dr. Fabio Motta, Dr. Marcos Catanho and Dr. Monete Rajao for their help in the discussions.	ABRASCO, 2015, AL IMP AGR SAUD EPSJ; ABRASCO, 2015, AGR SAUD AMB SUST 2; Aktar M.S., 2009, INTERDISCIPLINARY TO, V2, P1; Alves-Ferreira M, 2009, MEM I OSWALDO CRUZ, V104, P1100, DOI 10.1590/S0074-02762009000800006; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Asogwa EU, 2009, AFR J AGR RES, V4, P675; Baroncelli R, 2015, GENOME ANNOUNC, V3, DOI [10.1128/GENOMEA.00647-15, DOI 10.1128/GENOMEA.00647-15]; Barrett Michael P., 2002, Current Topics in Medicinal Chemistry, V2, P471, DOI 10.2174/1568026024607427; Barrett MP, 1997, PARASITOL TODAY, V13, P11, DOI 10.1016/S0169-4758(96)10075-2; Berny P, 2007, J VET PHARMACOL THER, V30, P93, DOI 10.1111/j.1365-2885.2007.00836.x; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Calmes B, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0462-0; Capriles PVSZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-610; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Carneiro FF, 2012, DOSSIE ABRASCO UM AL; Celis AI, 2015, ARCH BIOCHEM BIOPHYS, V574, P3, DOI 10.1016/j.abb.2015.03.004; Chauhan SC, 2008, CURR DRUG TARGETS, V9, P957, DOI 10.2174/138945008786786082; Chawla Bhavna, 2010, J Parasit Dis, V34, P1, DOI 10.1007/s12639-010-0006-3; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Condon BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003233; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; De Maayer P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00576; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Faustinelli PC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00278-16; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fields FR, 2017, BIOCHEM PHARMACOL, V134, P74, DOI 10.1016/j.bcp.2016.12.002; Fishel F.M., 2011, PESTICIDES EFFECTS N; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Gomes MR, 2011, ENZYME RES, V2011, P8; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Goulson D, 2003, J FOOD AGRIC ENVIRON, V1, P142; Guengerich FP, 2008, AAPS J, V8, P101; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Ishiga Y, 2016, MOL PLANT MICROBE IN, V29, P119, DOI 10.1094/MPMI-09-15-0204-R; *IUBMB, 1992, ENZ NOM; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; KAMOUN S, 1990, J BACTERIOL, V172, P5165, DOI 10.1128/jb.172.9.5165-5172.1990; Kappes B, 2011, BIOCHIM BIOPHYS ACTA, V1814, P567; Karadag H, 2015, BIOTECHNOL BIOTEC EQ, V29, P40, DOI 10.1080/13102818.2014.992740; Katara P, 2012, OMICS, V16, P700, DOI 10.1089/omi.2011.0141; Kaur PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150764; Kim JG, 2006, PLASMID, V56, P79, DOI 10.1016/j.plasmid.2006.03.001; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lehninger AL, 2008, ENZYMES, P191; Li DY, 2009, CANCER BIOTHER RADIO, V24, P81, DOI 10.1089/cbr.2008.0494; LOBKOVSKY E, 1993, P NATL ACAD SCI USA, V90, P11257, DOI 10.1073/pnas.90.23.11257; Loureiro I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003430; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mir AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11831; Mondego JMC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-548; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakasu EYT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0619; Nierman WC, 2015, GENOME ANNOUNC, V6; Nigatu AW, 2016, BMC PUBLIC HEALTH, V16, P1; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Otto TD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-544; Ouaissi M, 2006, J BIOMED BIOTECHNOL, V2006, P1; Pan-Germany, 2012, FACTAND FIG, P1; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Parron T, 2014, TOXICOL LETT, V230, P157, DOI 10.1016/j.toxlet.2013.11.009; Piergiorge RM, 2017, GENOME BIOL EVOL, V9, P1624, DOI 10.1093/gbe/evx119; Pratt AJ, 2015, J BACTERIOL, V197, P3834, DOI 10.1128/JB.00343-15; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Ray SK, 2000, MOL PLANT MICROBE IN, V13, P394, DOI 10.1094/MPMI.2000.13.4.394; Sadras VO, 2016, PRINCIPLES AGRONOMY; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schuttelkopf AW, 2010, BIOORGAN MED CHEM, V18, P8334, DOI 10.1016/j.bmc.2010.09.062; Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2; Silva MS, 2012, INT J MED MICROBIOL, V302, P225, DOI 10.1016/j.ijmm.2012.07.005; Sintchenko V, 2014, METHODS MOL BIOL, V1168, P173, DOI 10.1007/978-1-4939-0847-9_10; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Spiewak R, 2001, ANN AGR ENV MED, V8, P1; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; STALLINGS WC, 1983, P NATL ACAD SCI-BIOL, V80, P3884, DOI 10.1073/pnas.80.13.3884; Thatcher LF, 2012, MOL PLANT MICROBE IN, V25, P180, DOI 10.1094/MPMI-08-11-0212; Tomavo S, 2001, INT J PARASITOL, V31, P1023, DOI 10.1016/S0020-7519(01)00193-X; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Ueker ME, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0667-x; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Warshawsky A, 2001, LANGMUIR, V17, P5621, DOI 10.1021/la010299e; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wyatt PG, 2011, CURR TOP MED CHEM, V11, P1275; Yao SH, 2016, FUNGAL GENET BIOL, V91, P32, DOI 10.1016/j.fgb.2016.03.006; Yu C, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0887-0; Zhang RG, 2003, STRUCTURE, V11, P31, DOI 10.1016/S0969-2126(02)00933-4	107	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197511	10.1371/journal.pone.0197511	http://dx.doi.org/10.1371/journal.pone.0197511			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799863	gold, Green Submitted, Green Published			2022-12-26	WOS:000433153400015
J	Cai, YL; Wu, SJ; Zhao, W; Li, ZG; Wu, ZY; Ji, SB				Cai, Yunliang; Wu, Shaoju; Zhao, Wei; Li, Zhigang; Wu, Zheyang; Ji, Songbai			Concussion classification via deep learning using whole-brain white matter fiber strains	PLOS ONE			English	Article							INJURY PREDICTION; VERIFICATION; RESPONSES	Developing an accurate and reliable injury predictor is central to the biomechanical studies of traumatic brain injury. State-of-the-art efforts continue to rely on empirical, scalar metrics based on kinematics or model-estimated tissue responses explicitly pre-defined in a specific brain region of interest. They could suffer from loss of information. A single training dataset has also been used to evaluate performance but without cross-validation. In this study, we developed a deep learning approach for concussion classification using implicit features of the entire voxel-wise white matter fiber strains. Using reconstructed American National Football League (NFL) injury cases, leave-one-out cross-validation was employed to objectively compare injury prediction performances against two baseline machine learning classifiers (support vector machine (SVM) and random forest (RF)) and four scalar metrics via univariate logistic regression (Brain Injury Criterion (BrIC), cumulative strain damage measure of the whole brain (CSDM-WB) and the corpus callosum (CSDM-CC), and peak fiber strain in the CC). Feature-based machine learning classifiers including deep learning, SVM, and RF consistently outperformed all scalar injury metrics across all performance categories (e.g., leave-one-out accuracy of 0.828-0.862 vs. 0.690-0.776, and .632+ error of 0.148 +/- 0.176 vs. 0.207-0.292). Further, deep learning achieved the best cross-validation accuracy, sensitivity, AUC, and .632+ error. These findings demonstrate the superior performances of deep learning in concussion prediction and suggest its promise for future applications in biomechanical investigations of traumatic brain injury.	[Cai, Yunliang; Wu, Shaoju; Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Li, Zhigang] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA; [Wu, Zheyang] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA	Worcester Polytechnic Institute; Dartmouth College; Worcester Polytechnic Institute; Worcester Polytechnic Institute	Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.; Ji, SB (corresponding author), Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.	sji@wpi.edu	WU, SHAOJU/S-1930-2019; Cai, Yunliang/AAF-2375-2019	Ji, Songbai/0000-0002-2886-5781; Wu, Zheyang/0000-0003-0641-0791	NIH [R01 NS092853, R21 NS088781]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092853, R21NS088781] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding is provided by the NIH grants R01 NS092853 and R21 NS088781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A KB, 2015, ACAD EMERG MED, P22; Anderson Andrew E., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P171, DOI 10.1080/10255840601160484; Beleites C, 2005, CHEMOMETR INTELL LAB, V79, P91, DOI 10.1016/j.chemolab.2005.04.008; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Billones CD, 2016, PROCEEDINGS OF THE 2016 IEEE REGION 10 CONFERENCE (TENCON), P3724, DOI 10.1109/TENCON.2016.7848755; Bishop C. M., 1995, J AM STAT ASSOC, V12, P1235, DOI DOI 10.2307/2965437; Bishop C.M., 2006, PATTERN RECOGN, V4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai Y, 2016, LECT NOTES COMPUT SC, V10154, P259, DOI 10.1007/978-3-319-55524-9_24; CDC, 2015, REP C TRAUM BRAIN IN, DOI [10.1161/HYPERTENSIONAHA.111.186106, DOI 10.1161/HYPERTENSIONAHA.111.186106]; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Eppinger RH, 1995, STAPP CAR CRASH J, V38, P145; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Giordano C, 2014, STAPP CAR CRASH J, P29; Graham R, 2014, SPORTS RELATED CONCU; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Gupta V, 2017, BIORXIV, DOI [10.1007/978-3-319-66182-7_63, DOI 10.1007/978-3-319-66182-7_63]; Guyon I, 2006, STUD FUZZ SOFT COMP, V207, P1; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Ioannidou A, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3042064; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Kamnitsas K, 2016, LECT NOTES COMPUT SC, V10154, P138, DOI 10.1007/978-3-319-55524-9_14; Khvostikov A, 2018, 3D CNN BASED CLASSIF; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A, 2003, IS HEAD INJURY CAUSE; Kingma DP., 2014, ADAM METHOD STOCHAST; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y, 1998, NEURAL NETWORKS TRIC, P1689, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Nair V., 2010, P 27 INT C INT C MAC, P807; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Newman JA., 2000, STAPP CAR CRASH J, V44, P215, DOI DOI 10.4271/2000-01-SC16; Nisbet R., 2009, HDB STAT ANAL DATA M; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ruck D, 1990, IEEE T; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Shi J, 2018, IEEE J BIOMED HEALTH, V22, P173, DOI 10.1109/JBHI.2017.2655720; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tibshirani R, 1996, NEURAL COMPUT, V8, P152, DOI 10.1162/neco.1996.8.1.152; Vu TD, 2017, INT CONF BIG DATA, P309, DOI 10.1109/BIGCOMP.2017.7881683; Wagner R, LEARNING CONVOLUTION; Wang SQ, 2017, LECT NOTES COMPUT SC, V10613, P373, DOI 10.1007/978-3-319-68600-4_43; Wu GR, 2013, LECT NOTES COMPUT SC, V8150, P649, DOI 10.1007/978-3-642-40763-5_80; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	69	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197992	10.1371/journal.pone.0197992	http://dx.doi.org/10.1371/journal.pone.0197992			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795640	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300110
J	Ellis, CR; Kruhlak, NL; Kim, MT; Hawkins, EG; Stavitskaya, L				Ellis, Christopher R.; Kruhlak, Naomi L.; Kim, Marlene T.; Hawkins, Edward G.; Stavitskaya, Lidiya			Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking	PLOS ONE			English	Article							CLINICAL PHARMACOKINETICS; FENTANYL ANALOGS; FURANYL-FENTANYL; DRUG DISCOVERY; ANALGESICS; LIGAND; BENCHMARKING; VARIABILITY; ACTIVATION; INCREASES	Opioids represent a highly-abused and highly potent class of drugs that have become a significant threat to public safety. Often there are little to no pharmacological and toxicological data available for new, illicitly used and abused opioids, and this has resulted in a growing number of serious adverse events, including death. The large influx of new synthetic opioids permeating the street-drug market, including fentanyl and fentanyl analogs, has generated the need for a fast and effective method to evaluate the risk a substance poses to public safety. In response, the US FDA's Center for Drug Evaluation and Research (CDER) has developed a rapidly-deployable, multi-pronged computational approach to assess a drug's risk to public health. A key component of this approach is a molecular docking model to predict the binding affinity of biologically uncharacterized fentanyl analogs to the mu opioid receptor. The model was validated by correlating the docking scores of structurally diverse opioids with experimentally determined binding affinities. Fentanyl derivatives with sub-nanomolar binding affinity at the mu receptor (e.g. carfentanil and lofentanil) have significantly lower binding scores, while less potent fentanyl derivatives have increased binding scores. The strong correlation between the binding scores and the experimental binding affinities suggests that this approach can be used to accurately predict the binding strength of newly identified fentanyl analogs at the mu receptor in the absence of in vitro data and may assist in the temporary scheduling of those substances that pose a risk to public safety.	[Ellis, Christopher R.; Kruhlak, Naomi L.; Kim, Marlene T.; Hawkins, Edward G.; Stavitskaya, Lidiya] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Stavitskaya, L (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	Lidiya.Stavitskaya@fda.hhs.gov	Ellis, Christopher Randall/AAL-3749-2020	Ellis, Christopher Randall/0000-0002-7333-5720; Stavitskaya, Lidiya/0000-0002-6307-2314	US Food and Drug Administration; FDA's Safety Research Interest Group	US Food and Drug Administration; FDA's Safety Research Interest Group	The work was internally funded by the US Food and Drug Administration.; This project was supported by FDA's Safety Research Interest Group and appointment to the Research Participation Programs at the Oak Ridge Institute for Science and Education through an interagency agreement between the Department of Energy and FDA.	Bailey D, 2001, DRUG DISCOV TODAY, V6, P57, DOI 10.1016/S1359-6446(00)01596-8; Case D. A., 2016, AMBER 2016; Casy A.F., 1986, OPIOID ANALGESICS CH, V1st ed, DOI [10.1007/978-1-4899-0585-7, DOI 10.1007/978-1-4899-0585-7]; CASY AF, 1969, J PHARM PHARMACOL, V21, P434, DOI 10.1111/j.2042-7158.1969.tb08284.x; CHEN JC, 1993, LIFE SCI, V52, P389, DOI 10.1016/0024-3205(93)90152-S; Chen XT, 2013, J MED CHEM, V56, P8019, DOI 10.1021/jm4010829; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; DEA, 2016, SCHED CONTR SUBST TE, P85873; Eap CB, 2002, CLIN PHARMACOKINET, V41, P1153, DOI 10.2165/00003088-200241140-00003; Frank RG, 2017, NEW ENGL J MED, V376, P605, DOI 10.1056/NEJMp1615145; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Ghrayeb W, 2016, TRAINING DRUG TARGET; Gladden RM, 2016, MMWR-MORBID MORTAL W, V65, P837, DOI 10.15585/mmwr.mm6533a2; Grosser T, 2017, SCIENCE, V355, P1026, DOI 10.1126/science.aan0088; Hedegaard Holly, 2017, NCHS Data Brief, P1; Helander A, 2016, CLIN TOXICOL, V54, P324, DOI 10.3109/15563650.2016.1139715; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Jain AN, 2006, CURR PROTEIN PEPT SC, V7, P407, DOI 10.2174/138920306778559395; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JANSSEN PAJ, 1982, ACTA ANAESTH SCAND, V26, P262, DOI 10.1111/j.1399-6576.1982.tb01765.x; Kamper SJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h444; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Klar SA, 2016, MMWR-MORBID MORTAL W, V65, P1015, DOI 10.15585/mmwr.mm6537a6; Kristensen Kim, 1995, Life Sciences, V56, pPL45, DOI 10.1016/0024-3205(94)00426-S; MAGUIRE P, 1992, EUR J PHARMACOL, V213, P219, DOI 10.1016/0014-2999(92)90685-W; Matter H, 2011, APPL SUCCESS STORIES, P319, DOI [10.1002/9783527633326.ch12, DOI 10.1002/9783527633326.CH12]; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Mohr ALA, 2016, J ANAL TOXICOL, V40, P709, DOI 10.1093/jat/bkw086; Morris Garrett M., 2008, V443, P365, DOI 10.1007/978-1-59745-177-2_19; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Scholz J, 1996, CLIN PHARMACOKINET, V31, P275, DOI 10.2165/00003088-199631040-00004; Shim J, 2013, J PHYS CHEM B, V117, P7907, DOI 10.1021/jp404238n; Shim J, 2011, J PHYS CHEM B, V115, P7487, DOI 10.1021/jp202542g; Smith A, 2002, NATURE, V418, P453, DOI 10.1038/418453a; TRAYNOR JR, 1995, MOL PHARMACOL, V47, P848; UNODC, 2017, FENT ITS AN 50 YEARS; Varadi A, 2016, J MED CHEM, V59, P8381, DOI 10.1021/acs.jmedchem.6b00748; Vardanyan RS, 2014, FUTURE MED CHEM, V6, P385, DOI 10.4155/fmc.13.215; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626; Volpe DA, 2011, REGUL TOXICOL PHARM, V59, P385, DOI 10.1016/j.yrtph.2010.12.007; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; YEADON M, 1988, J PHARM PHARMACOL, V40, P736, DOI 10.1111/j.2042-7158.1988.tb07008.x	44	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197734	10.1371/journal.pone.0197734	http://dx.doi.org/10.1371/journal.pone.0197734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795628	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300066
J	Wan, MW; Gao, LH; Fang, WH				Wan, Mingwei; Gao, Lianghui; Fang, Weihai			Implicit-solvent dissipative particle dynamics force field based on a four-to-one coarse grained mapping scheme	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; LIPID-BILAYERS; COMPUTER-SIMULATIONS; ANTIMICROBIAL PEPTIDES; MESOSCOPIC SIMULATION; FREE-ENERGY; FLIP-FLOP; MODEL; MARTINI; MEMBRANES	A new set of efficient solvent-free dissipative particle dynamics (DPD) force fields was developed for phospholipids and peptides. To enhance transferability, this model maps around four heavy atoms and their connected hydrogen atoms into a coarse-grained elementary bead based on functional group. The effective hybrid potential between any pair of beads is composed of a short-range repulsive soft-core potential that directly adopts the form of an explicit-solvent DPD model and a long-range attractive hydrophobic potential. The parameters of the attractive potentials for lipid molecules were obtained by fitting the explicit-solvent DPD simulation of one bead of any type in a water box, then finely tuning it until the bilayer membrane properties obtained in the explicit-solvent model were matched. These parameters were further extended to amino acids according to bead type. The structural and elastic properties of bilayer membranes, free energy profiles for a lipid flip-flop and amino acid analogues translocating across the membrane, and membrane pore formation induced by antimicrobial peptides obtained from this solvent-free DPD force field considerably agreed with the explicit-solvent DPD results. Importantly, the efficiency of this method is guaranteed to accelerate the assembly of vesicles composed of several thousand lipids by up to 50-fold, rendering the experimental liposome dynamics as well as membrane-peptide interactions feasible at accessible computational expense.	[Wan, Mingwei; Gao, Lianghui; Fang, Weihai] Beijing Normal Univ, Coll Chem, Key Lab Theoret & Computat Photochem, Minist Educ, Beijing, Peoples R China	Beijing Normal University	Gao, LH (corresponding author), Beijing Normal Univ, Coll Chem, Key Lab Theoret & Computat Photochem, Minist Educ, Beijing, Peoples R China.	lhgao@bnu.edu.cn		Gao, Lianghui/0000-0003-4414-3671	National Natural Science Foundation of China [21673021, 21421003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant Nos. 21673021, 21421003) to LG and WF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China (Grant Nos. 21673021, 21421003).	Arnarez C, 2015, J CHEM THEORY COMPUT, V11, P260, DOI 10.1021/ct500477k; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Baoukina S, 2012, BIOPHYS J, V102, P1866, DOI 10.1016/j.bpj.2012.03.048; BAUMANN G, 1974, Journal of Supramolecular Structure, V2, P538, DOI 10.1002/jss.400020504; Bennett WFD, 2016, J CHEM THEORY COMPUT, V12, P4524, DOI 10.1021/acs.jctc.6b00265; Bennett WFD, 2011, J CHEM THEORY COMPUT, V7, P2981, DOI 10.1021/ct200291v; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Cevc G., 1987, PHOSPHOLIPID BILAYER; Chellam S, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2236302; Chen LC, 2015, J PHYS CHEM B, V119, P850, DOI 10.1021/jp505497k; Chen T, 2008, J PHYS CHEM B, V112, P16357, DOI 10.1021/jp805826a; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; De Nicola A, 2011, J CHEM THEORY COMPUT, V7, P2947, DOI 10.1021/ct200132n; Deserno M, 2009, MACROMOL RAPID COMM, V30, P752, DOI 10.1002/marc.200900090; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; Espanol P, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4979514; Gao LH, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2424698; Gao LH, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3297889; Gao LH, 2009, SOFT MATTER, V5, P3312, DOI 10.1039/b902971k; Grafmuller A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218101; Grafmuller A, 2009, BIOPHYS J, V96, P2658, DOI 10.1016/j.bpj.2008.11.073; Groot RD, 2001, BIOPHYS J, V81, P725, DOI 10.1016/S0006-3495(01)75737-2; Groot RD, 2003, J CHEM PHYS, V118, P11265, DOI 10.1063/1.1574800; Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ibergay C, 2009, J CHEM THEORY COMPUT, V5, P3245, DOI 10.1021/ct900296s; Izvekov S, 2009, J PHYS CHEM B, V113, P4443, DOI 10.1021/jp810440c; Jakobsen AF, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1900725, 10.1063/1.1867374]; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Klein ML, 2008, SCIENCE, V321, P798, DOI 10.1126/science.1157834; Kranenburg M, 2004, PHYS CHEM CHEM PHYS, V6, P4142, DOI 10.1039/b406433j; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Li XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21614; Li XK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160026; Lin JH, 2000, BIOPHYS J, V78, P1714, DOI 10.1016/S0006-3495(00)76723-3; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lisal M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3660209; Lopez CA, 2013, J CHEM THEORY COMPUT, V9, P1694, DOI 10.1021/ct3009655; Lopez CA, 2009, J CHEM THEORY COMPUT, V5, P3195, DOI 10.1021/ct900313w; Lu LY, 2009, J PHYS CHEM B, V113, P1501, DOI 10.1021/jp809604k; Lyubartsev A, 2010, FARADAY DISCUSS, V144, P43, DOI 10.1039/b901511f; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Milano G, 2005, J PHYS CHEM B, V109, P18609, DOI 10.1021/jp0523571; Milano G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142103; Millstone JE, 2006, ADV FUNCT MATER, V16, P1209, DOI 10.1002/adfm.200600066; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Sapay N, 2010, BIOCHEMISTRY-US, V49, P7665, DOI 10.1021/bi100878q; Sapay N, 2009, SOFT MATTER, V5, P3295, DOI 10.1039/b902376c; Sevink GJA, 2014, SOFT MATTER, V10, P5129, DOI 10.1039/c4sm00297k; Sevink GJA, 2013, SOFT MATTER, V9, P2816, DOI 10.1039/c2sm27492b; Shardlow T, 2003, SIAM J SCI COMPUT, V24, P1267, DOI 10.1137/S1064827501392879; Shillcock JC, 2002, J CHEM PHYS, V117, P5048, DOI 10.1063/1.1498463; Silbermann JR, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2161207; SMIT B, 1990, NATURE, V348, P624, DOI 10.1038/348624a0; Soddemann T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046702; Spaeth JR, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3580293; Steltenkamp S, 2006, BIOPHYS J, V91, P217, DOI 10.1529/biophysj.106.081398; Sun HJ, 2015, LANGMUIR, V31, P9105, DOI 10.1021/acs.langmuir.5b01866; Tieleman DP, 2006, J AM CHEM SOC, V128, P12462, DOI 10.1021/ja0624321; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Uusitalo JJ, 2015, J CHEM THEORY COMPUT, V11, P3932, DOI 10.1021/acs.jctc.5b00286; v Gunsteren BWE, 1990, ANGEW CHEM INT EDIT, V21, P992; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vishnyakov A, 2012, J PHYS CHEM LETT, V3, P3081, DOI 10.1021/jz301277b; Wan MW, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/46/465704; Wang ZJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/095004; Wang ZJ, 2010, J PHYS CHEM B, V114, P11207, DOI 10.1021/jp102543j; Warren PB, 1998, CURR OPIN COLLOID IN, V3, P620, DOI 10.1016/S1359-0294(98)80089-7	79	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198049	10.1371/journal.pone.0198049	http://dx.doi.org/10.1371/journal.pone.0198049			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795682	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300122
J	Sugiki, T; Egawa, D; Kumagai, K; Kojima, C; Fujiwara, T; Takeuchi, K; Shimada, I; Hanada, K; Takahashi, H				Sugiki, Toshihiko; Egawa, Daichi; Kumagai, Keigo; Kojima, Chojiro; Fujiwara, Toshimichi; Takeuchi, Koh; Shimada, Ichio; Hanada, Kentaro; Takahashi, Hideo			Phosphoinositide binding by the PH domain in ceramide transfer protein (CERT) is inhibited by hyperphosphorylation of an adjacent serine-repeat motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-APPARATUS REQUIRES; ENDOPLASMIC-RETICULUM; LIPID TRAFFICKING; START DOMAINS; TRANSPORT; PHOSPHORYLATION; SPHINGOMYELIN; ASSOCIATION; ACTIVATION; COMPLEX	Sphingolipids such as ceramide are important constituents of cell membranes. The ceramide transfer protein (CERT) moves ceramide from the endoplasmic reticulum to the Golgi apparatus in a nonvesicular manner. Hyperphosphorylation of the serine-repeat motif (SRM) adjacent to the pleckstrin homology (PH) domain of CERT down-regulates the inter-organelle ceramide transport function of CERT. However, the mechanistic details of this down-regulation remain elusive. Using solution NMR and binding assays, we herein show that a hyperphosphorylation-mimetic CERT variant in which 10 serine/threonine residues of SRM had been replaced with glutamate residues (the 10E variant) displays an intramolecular interaction between SRM and positively charged regions of the PH domain, which are involved in the binding of this domain to phosphatidylinositol 4-monophosphate (PI4P). Of note, the binding of the PH domain to PI4P-embedded membranes was attenuated by the SRM 10E substitutions in cell-free assays. Moreover, the 10E substitutions reduced the Golgi-targeting activity of the PH-SRM construct in living cells. These results indicate that hyperphosphorylated SRM directly interacts with the surface of the PH domain in an intramolecular manner, thereby decreasing the PI4P-binding activity of the PH domain. In light of these findings, we propose that the hyperphosphorylation of SRM may trigger the dissociation of CERT from the Golgi apparatus, resulting in a functionally less active conformation of CERT.	[Sugiki, Toshihiko; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sugiki, Toshihiko] JBiC, Koto Ku, Tokyo 1358073, Japan; [Sugiki, Toshihiko; Takeuchi, Koh; Shimada, Ichio; Takahashi, Hideo] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan; [Sugiki, Toshihiko; Kojima, Chojiro; Fujiwara, Toshimichi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Egawa, Daichi; Kumagai, Keigo; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Kojima, Chojiro] Yokohama Natl Univ, Grad Sch, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Kojima, Chojiro] Yokohama Natl Univ, Fac Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Takahashi, Hideo] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; National Institute of Infectious Diseases (NIID); Yokohama National University; Yokohama National University; Yokohama City University	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan.; Takahashi, H (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hanak@nih.go.jp; hidtak@yokohama-cu.ac.jp	Kojima, Chojiro/AFV-4592-2022; Takeuchi, Koh/B-4971-2010; Kumagai, Keigo/AAG-1385-2021	Takeuchi, Koh/0000-0002-6227-4627; Hanada, Kentaro/0000-0003-1383-2781; Kumagai, Keigo/0000-0002-1663-2905	METI; NEDO, MEXT Scientific Research on Innovative Areas [17H06417]; Platform Project for Supporting Drug Discovery and Life Science Research; AMED; AMED-CREST from AMED of Japan [JP17gm0910005j0003]	METI; NEDO, MEXT Scientific Research on Innovative Areas; Platform Project for Supporting Drug Discovery and Life Science Research; AMED(Japan Agency for Medical Research and Development (AMED)); AMED-CREST from AMED of Japan	This work was primarily supported by METI and NEDO, MEXT Scientific Research on Innovative Areas Grant 17H06417 (to K.H.) and in part by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED and AMED-CREST from AMED under Grant JP17gm0910005j0003 of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Amata I, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00181; Keldysh M V, 1978, Kosm Biol Aviakosm Med, V12, P83; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Capasso S, 2017, EMBO J, V36, P1736, DOI 10.15252/embj.201696048; Charruyer A, 2008, J BIOL CHEM, V283, P16682, DOI 10.1074/jbc.M800799200; Chiapparino A, 2016, PROG LIPID RES, V61, P30, DOI 10.1016/j.plipres.2015.10.004; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Goto A, 2016, J BIOL CHEM, V291, P1336, DOI 10.1074/jbc.M115.682997; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Hurlock AK, 2014, TRAFFIC, V15, P915, DOI 10.1111/tra.12187; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Mandell DJ, 2007, J AM CHEM SOC, V129, P820, DOI 10.1021/ja063019w; Midzak A, 2014, TRAFFIC, V15, P895, DOI 10.1111/tra.12177; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Prashek J, 2017, J BIOL CHEM, V292, P14217, DOI 10.1074/jbc.M117.780007; Prashek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079590; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Sugiki T, 2009, PROTEIN SCI, V18, P1115, DOI 10.1002/pro.92; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200	36	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11206	11217		10.1074/jbc.RA118.002465	http://dx.doi.org/10.1074/jbc.RA118.002465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29848549	Green Published, hybrid			2022-12-26	WOS:000438882800031
J	de Lange, T				de Lange, Titia			What I got wrong about shelterin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						telomere; shelterin; Ras-related protein 1 (Rap1); POT1; TIN2; t-loop; TRF1 (TERF1; telomeric repeat binding factor 1); TRF2 (TERF2; telomeric repeat binding factor 2)	TELOMERE LENGTH; BINDING-PROTEIN; YEAST TELOMERES; DNA-SEQUENCE; TRF1; CHROMATIN; COMPLEX; RAP1; POT1; END	The ASBMB 2018 Bert and Natalie Vallee award in Biomedical Sciences honors our work on shelterin, a protein complex that helps cells distinguish the chromosome ends from sites of DNA damage. Shelterin protects telomeres from all aspects of the DNA damage response, including ATM and ATR serine/threonine kinase signaling and several forms of double-strand break repair. Today, this six-subunit protein complex could easily be identified in one single proteomics step. But, it took us more than 15 years to piece together the entire shelterin complex, one protein at a time. Although we did a lot of things right, here I tell the story of shelterin's discovery with an emphasis on the things that I got wrong along the way.	[de Lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10065 USA.	delange@rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NCI [R35CA210036]; NIA [RO1 AG016642]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R35CA210036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Outstanding Investigator Award R35CA210036 from NCI and Grant RO1 AG016642 from NIA and a grant from the Breast Cancer Research Foundation. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; GOTTSCHLING DE, 1984, CELL, V38, P501, DOI 10.1016/0092-8674(84)90505-1; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; LIPPS HJ, 1982, P NATL ACAD SCI-BIOL, V79, P2495, DOI 10.1073/pnas.79.8.2495; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P1387, DOI 10.1093/nar/20.6.1387; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	38	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10453	10456		10.1074/jbc.AW118.003234	http://dx.doi.org/10.1074/jbc.AW118.003234			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29794139	Green Published, hybrid			2022-12-26	WOS:000437828400006
J	Chu, L; Valencia, IJ; Garvert, DW; Montoya, JG				Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G.			Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: A patient-centered, cross-sectional survey	PLOS ONE			English	Article							POSTEXERTIONAL MALAISE; CASE-DEFINITION; EXERCISE; ATTITUDES; KNOWLEDGE; SEVERITY; CRITERIA; PEOPLE; TRIAL; CARE	Background Post-exertional malaise (PEM) is considered to be the hallmark characteristic of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Yet, patients have rarely been asked in formal studies to describe their experience of PEM. Objectives To describe symptoms associated with and the time course of PEM Methods One hundred and fifty subjects, diagnosed via the 1994 Fukuda CFS criteria, completed a survey concerning 11 symptoms they could experience after exposure to two different types of triggers. We also inquired about onset and duration of PEM and included space for subjects to write in any additional symptoms. Results were summarized with descriptive statistics; McNemar's, paired t-, Fisher's exact and chi-square goodness-of-fit tests were used to assess for statistical significance. Results One hundred and twenty-nine subjects (90%) experienced PEM with both physical and cognitive exertion and emotional distress. Almost all were affected by exertion but 14 (10%) reported no effect with emotion. Fatigue was the most commonly exacerbated symptom but cognitive difficulties, sleep disturbances, headaches, muscle pain, and flu-like feelings were cited by over 30% of subjects. Sixty percent of subjects experienced at least one inflammatory/immune-related symptom. Subjects also cited gastrointestinal, orthostatic, moodrelated, neurologic and other symptoms. Exertion precipitated significantly more symptoms than emotional distress (7 +/- 2.8 vs. 5 +/- 3.3 symptoms (median, standard deviation), p<0.001). Onset and duration of PEM varied for most subjects. However, 11% reported a consistent post-trigger delay of at least 24 hours before onset and 84% endure PEM for 24 hours or more. Conclusions This study provides exact symptom and time patterns for PEM that is generated in the course of patients' lives. PEM involves exacerbation of multiple, atypical symptoms, is occasionally delayed, and persists for extended periods. Highlighting these characteristics may improve diagnosis of ME/CFS. Incorporating them into the design of future research will accelerate our understanding of ME/CFS.	[Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford ME CFS Initiat, Stanford, CA 94305 USA; [Valencia, Ian J.] Genentech Inc, San Francisco, CA 94080 USA	Stanford University; Roche Holding; Genentech	Chu, L (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford ME CFS Initiat, Stanford, CA 94305 USA.	lchu1@stanford.edu		Montoya, Jose G/0000-0002-3378-8071	Stanford ME/CFS Initiative	Stanford ME/CFS Initiative	Our work was funded by the Stanford ME/CFS Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ENGLISH OXFORD LIVIN; [Anonymous], 2011, COCT BURD AUT DIS LA; Arroll MA, 2014, FATIGUE, V2, P57, DOI 10.1080/21641846.2014.892755; Baldwin L, 2014, SOLVE CFS; Bazelmans E, 2005, J PSYCHOSOM RES, V59, P201, DOI 10.1016/j.jpsychores.2005.04.003; Bentall RP, 2002, BRIT J PSYCHIAT, V181, P248, DOI 10.1192/bjp.181.3.248; Black Christopher D, 2005, Dyn Med, V4, P10, DOI 10.1186/1476-5918-4-10; Bowen J, 2005, FAM PRACT, V22, P389, DOI 10.1093/fampra/cmi019; Brimmer DJ, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-28; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Center for Drug Evaluation and Research, 2013, VOIC PAT MYALG ENC C; Chew-Graham C, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-16; Chu L, 2013, INT ASS CHRONIC FATI; Chu L, 2008, PROHEALTH; Cockshell SJ, 2014, NEUROPSYCHOLOGY, V28, P394, DOI 10.1037/neu0000025; Davenport TE, 2011, DISABIL REHABIL, V33, P1768, DOI 10.3109/09638288.2010.546936; Doucleff M, 2017, NATL PUBLIC RADIO; Fagerland MW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-91; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gaab J, 2003, ACTA NEUROPSYCHIATR, V15, P184, DOI 10.1034/j.1601-5215.2003.00033.x; Hall DL, 2014, PSYCHONEUROENDOCRINO, V49, P26, DOI 10.1016/j.psyneuen.2014.06.021; Haywood KL, 2012, QUAL LIFE RES, V21, P35, DOI 10.1007/s11136-011-9921-8; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason L, 2010, AM J BIOCH BIOTECHNO, V6, P120, DOI [DOI 10.3844/AJBBSP.2010.120, DOI 10.3844/AJBBSP.2010.120.135]; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jason LA, 2000, J NERV MENT DIS, V188, P568, DOI 10.1097/00005053-200009000-00002; Jason LA, 2007, J CLIN PSYCHOL MED S, V14, P275, DOI 10.1007/s10880-007-9090-7; Jason LA, 2015, J PREV INTERV COMMUN, V43, P20, DOI 10.1080/10852352.2014.973239; Jason LA, 2014, FATIGUE, V2, P40, DOI 10.1080/21641846.2013.862993; Jason LA, 2010, BEHAV MED, V36, P24, DOI 10.1080/08964280903521370; Keech A, 2015, J PSYCHOSOM RES, V79, P537, DOI 10.1016/j.jpsychores.2015.08.008; Keller BA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-104; King CP, 2001, THESIS; Knapen J, 2013, INT J PSYCHOSOC REHA, V17, P75; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Light AR, 2009, J PAIN, V10, P1099, DOI 10.1016/j.jpain.2009.06.003; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Nijs J, 2010, J INTERN MED, V267, P418, DOI 10.1111/j.1365-2796.2009.02178.x; Nijs J, 2008, CLIN REHABIL, V22, P426, DOI 10.1177/0269215507084410; Ocon AJ, 2012, CLIN SCI, V122, P227, DOI 10.1042/CS20110241; Passos GS, 2012, CLINICS, V67, P653, DOI 10.6061/clinics/2012(06)17; Ramsey M., ME CFS INFORM PAGE; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Schubiner H, 2016, PSYCHOL TODAY UNLEAR; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Snell CR, 2013, PHYS THER, V93, P1484, DOI 10.2522/ptj.20110368; Spotila JM, 2012, SOLVE CFS; Togo F, 2010, MED SCI SPORT EXER, V42, P16, DOI 10.1249/MSS.0b013e3181b11bc7; US Centers for Disease Control and Prevention, 2012, CHR FAT SYNDR SYMPT; Van Oosterwijck J, 2010, J INTERN MED, V268, P265, DOI 10.1111/j.1365-2796.2010.02228.x; VanNess JM, 2010, J WOMENS HEALTH, V19, P239, DOI 10.1089/jwh.2009.1507; Vermeulen RCW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-93; Wagner Dieter, 2005, Popul Health Metr, V3, P8, DOI 10.1186/1478-7954-3-8; White AT, 2010, PSYCHOPHYSIOLOGY, V47, P615, DOI 10.1111/j.1469-8986.2010.00978.x; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Wood B, 1999, J PSYCHOSOM RES, V47, P385, DOI 10.1016/S0022-3999(99)00025-2	58	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197811	10.1371/journal.pone.0197811	http://dx.doi.org/10.1371/journal.pone.0197811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856774	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800042
J	Perrier, M; Desire, N; Storto, A; Todesco, E; Rodriguez, C; Bertine, M; Le Hingrat, Q; Visseaux, B; Calvez, V; Descamps, D; Marcelin, AG; Charpentier, C				Perrier, Marine; Desire, Nathalie; Storto, Alexandre; Todesco, Eve; Rodriguez, Christophe; Bertine, Melanie; Le Hingrat, Quentin; Visseaux, Benoit; Calvez, Vincent; Descamps, Diane; Marcelin, Anne-Genevieve; Charpentier, Charlotte			Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants	PLOS ONE			English	Article							MUTATIONS	Objective Reliable detection of HIV minority resistant variants (MRVs) requires bioinformatics analysis with specific algorithms to obtain good quality alignments. The aim of this study was to analyze ultra-deep sequencing (UDS) data using different analysis pipelines. Methods HIV-1 protease, reverse transcriptase (RT) and integrase sequences from antiretroviral-naive patients were obtained using GS-Junior (R) (Roche) and MiSeq (R) (Illumina) platforms. MRVs were defined as variants harbouring resistance-mutation present at a frequency of 1%-20%. Reads were analyzed using different alignment algorithms: Amplicon Variant Analyzer (R), Geneious (R) compared to SmartGene (R) NGS HIV-1 module. Results 101 protease and 51 RT MRVs identified in 139 protease and 124 RT sequences generated with a GS-Junior (R) platform were analyzed using AVA (R) and SmartGene (R) software. The correlation coefficients for the MRVs were R-2 = 0.974 for protease and R-2 = 0.972 for RT. Discordances (n = 13 in protease and n = 15 in RT) mainly concerned low-level MRVs (i.e., with frequencies of 1%-2%, n = 18/28) and they were located in homopolymeric regions (n = 10/15). Geneious (R) and SmartGene (R) software were used to analyze 143 protease, 45 RT and 26 integrase MRVs identified in 172 protease, 69 RT, and 72 integrase sequences generated with a MiSeq (R) platform. The correlation coefficients for the MRVs were R-2 = 0.987 for protease, R-2 = 0.995 for RT and R-2 = 0.993 for integrase. Discordances (n = 9 in protease, n = 3 in RT, and n = 3 in integrase) mainly concerned low- evel MRVs (n = 13/15). Conclusion We found an excellent correlation between the various UDS analysis pipelines that we tested. However, our results indicate that specific attention should be paid to low-level MRVs, for which the use of two different analysis pipelines and visual inspection of sequences alignments might be beneficial. Thus, our results argue for use of a 2% threshold for MRV detection, rather than the 1% threshold, to minimize misalignments and time-consuming sight reading steps essential to ensure accurate results for MRV frequencies below 2%.	[Perrier, Marine; Storto, Alexandre; Bertine, Melanie; Le Hingrat, Quentin; Visseaux, Benoit; Descamps, Diane; Charpentier, Charlotte] Univ Paris Diderot, Hop Bichat, AP HP, Lab Virol,IAME,UMR 1137,INSERM,Sorbonne Paris Cit, Paris, France; [Desire, Nathalie; Todesco, Eve; Calvez, Vincent; Marcelin, Anne-Genevieve] Sorbonne Univ, IPLESP, INSERM, UPMC Univ Paris 06,UMRS 1136, Paris, France; [Desire, Nathalie; Todesco, Eve; Calvez, Vincent; Marcelin, Anne-Genevieve] Hop La Pitie Salpetriere, Lab Virol, Paris, France; [Rodriguez, Christophe] IMRB Creteil, Next Generat Sequencing Platform pACT, Dept Microbiol, Creteil, France; [Rodriguez, Christophe] Inst Mondor Rech Biomed U955, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Charpentier, C (corresponding author), Univ Paris Diderot, Hop Bichat, AP HP, Lab Virol,IAME,UMR 1137,INSERM,Sorbonne Paris Cit, Paris, France.	charlotte.charpentier@aphp.fr	rodriguez, christophe/B-8024-2012; Rodriguez, Christophe/AAG-5900-2021; Le Hingrat, Quentin/AAC-7439-2021; Charpentier, Charlotte/C-3579-2019; Marcelin, Anne-Genevieve/D-8272-2014	rodriguez, christophe/0000-0001-8128-4030; Rodriguez, Christophe/0000-0002-9817-5006; Le Hingrat, Quentin/0000-0001-9017-4941; Marcelin, Anne-Genevieve/0000-0003-4808-8999	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	The research leading has received funding from the French National Agency for Research on AIDS and Viral Hepatitis (ANRS).	Bellecave P, 2016, AIDS RES HUM RETROV, V32, P85, DOI [10.1089/aid.2015.0201, 10.1089/AID.2015.0201]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; Garcia-Diaz A, 2014, J INT AIDS SOC, V17, P159, DOI 10.7448/IAS.17.4.19752; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Guyen N, 2018, C RETR OPP INF; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; JUNG M, 1992, J ACQ IMMUN DEF SYND, V5, P359; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Morlat P, 2012, PRISE CHARGE ME DICA; Noguera-Julian M, 2017, J INFECT DIS, V216, pS829, DOI 10.1093/infdis/jix397; R Core Team, 2013, R LANG ENV STAT COMP; Raymond S, 2018, CLIN INFECT DIS, V66, P1588, DOI 10.1093/cid/cix1070; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Todesco E, 2017, HIV MED, V18, P696, DOI 10.1111/hiv.12508; Todesco E, 2015, J ANTIMICROB CHEMOTH, V70, P1503, DOI 10.1093/jac/dku557; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098740	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198334	10.1371/journal.pone.0198334	http://dx.doi.org/10.1371/journal.pone.0198334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856864	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800103
J	Stotz, HU; Harvey, PJ; Haddadi, P; Mashanova, A; Kukol, A; Larkan, NJ; Borhan, MH; Fitt, BDL				Stotz, Henrik U.; Harvey, Pascoe J.; Haddadi, Parham; Mashanova, Alla; Kukol, Andreas; Larkan, Nicholas J.; Borhan, M. Hossein; Fitt, Bruce D. L.			Genomic evidence for genes encoding leucine-rich repeat receptors linked to resistance against the eukaryotic extra- and intracellular Brassica napus pathogens Leptosphaeria maculans and Plasmodiophora brassicae	PLOS ONE			English	Article							FUNGAL POLYGALACTURONASES; SCLEROTINIA-SCLEROTIORUM; BLACKLEG RESISTANCE; PROTEIN-STRUCTURE; WEB SERVER; DISEASE; TOMATO; ARABIDOPSIS; PREDICTION; CLONING	Genes coding for nucleotide-binding leucine-rich repeat (LRR) receptors (NLRs) control resistance against intracellular (cell-penetrating) pathogens. However, evidence for a role of genes coding for proteins with LRR domains in resistance against extracellular (apoplastic) fungal pathogens is limited. Here, the distribution of genes coding for proteins with eLRR domains but lacking kinase domains was determined for the Brassica napus genome. Predictions of signal peptide and transmembrane regions divided these genes into 184 coding for receptor-like proteins (RLPs) and 121 coding for secreted proteins (SPs). Together with previously annotated NLRs, a total of 720 LRR genes were found. Leptosphaeria maculans-induced expression during a compatible interaction with cultivar Topas differed between RLP, SP and NLR gene families; NLR genes were induced relatively late, during the necrotrophic phase of pathogen colonization. Seven RLP, one SP and two NLR genes were found in Rlm1 and Rlm3/Rlm4/Rlm7/Rlm9 loci for resistance against L. maculans on chromosome A07 of B. napus. One NLR gene at the Rlm9 locus was positively selected, as was the RLP gene on chromosome A10 with LepR3 and Rlm2 alleles conferring resistance against L. maculans races with corresponding effectors AvrLm1 and AvrLm2, respectively. Known loci for resistance against L. maculans (extracellular hemi-biotrophic fungus), Sclerotinia sclerotiorum (necrotrophic fungus) and Plasmodiophora brassicae (intracellular, obligate biotrophic protist) were examined for presence of RLPs, SPs and NLRs in these regions. Whereas loci for resistance against P. brassicae were enriched for NLRs, no such signature was observed for the other pathogens. These findings demonstrate involvement of (i) NLR genes in resistance against the intracellular pathogen P. brassicae and a putative NLR gene in Rlm9-mediated resistance against the extracellular pathogen L. maculans.	[Stotz, Henrik U.; Harvey, Pascoe J.; Mashanova, Alla; Kukol, Andreas; Fitt, Bruce D. L.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England; [Haddadi, Parham; Borhan, M. Hossein] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Larkan, Nicholas J.] Armatus Genet Inc, Saskatoon, SK, Canada; [Harvey, Pascoe J.] Univ Edinburgh, Dept Quantitat Biol Biochem & Biotechnolgy, Edinburgh, Midlothian, Scotland	University of Hertfordshire; Agriculture & Agri Food Canada; University of Edinburgh	Stotz, HU (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England.	h.stotz@herts.ac.uk	Kukol, Andreas/AAR-4569-2020	Kukol, Andreas/0000-0002-8859-010X; Mashanova, Alla/0000-0003-3273-8184; Haddadi, Parham/0000-0002-1876-4055; Larkan, Nicholas/0000-0002-8653-0242; Stotz, Henrik/0000-0003-2954-8566; Bruce D. L., Fitt/0000-0003-3981-6456	European Commission, FP7-Marie Curie Actions [302202]; Biotechnology and Biological Sciences Research Council (BBSRC)/ERA-CAPS [BB/N005112/1]; University of Hertfordshire; Armatus Genetics Inc.;  [BB/M028348/1];  [BBP00489X/1];  [BB/1017585/2]; BBSRC [BB/D015200/1, BB/P00489X/1, BB/R019819/1, BB/E001610/1, BB/N005112/1, BB/I017585/2, BB/M028348/1, BB/I017585/1] Funding Source: UKRI; EPSRC [TS/I000747/2] Funding Source: UKRI	European Commission, FP7-Marie Curie Actions; Biotechnology and Biological Sciences Research Council (BBSRC)/ERA-CAPS(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Hertfordshire; Armatus Genetics Inc.; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding to HUS, PJH and BDLF was provided by the European Commission, FP7-Marie Curie Actions, Project No: 302202 and by Biotechnology and Biological Sciences Research Council (BBSRC)/ERA-CAPS, Grant Ref: BB/N005112/1. Grants BB/M028348/1, BBP00489X/1 and BB/1017585/2 also provided financial support to BDLF. The University of Hertfordshire also provided salaries for AK, BDLF and HUS. Armatus Genetics Inc. provided support in the form of salary for NJL. Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alamery S, 2018, CROP PASTURE SCI, V69, P79, DOI [10.1071/CP17214, 10.1071/cp17214]; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bashi ZD, 2013, CAN J MICROBIOL, V59, P79, DOI 10.1139/cjm-2012-0352; Becker MG, 2017, PLANT J, V90, P573, DOI 10.1111/tpj.13514; Belfanti E, 2004, P NATL ACAD SCI USA, V101, P886, DOI 10.1073/pnas.0304808101; Catanzariti AM, 2015, NEW PHYTOL, V207, P106, DOI 10.1111/nph.13348; CEA, 2014, GEN CTR NAT SEQ; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chu MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1166; Delourme R, 2004, PHYTOPATHOLOGY, V94, P578, DOI 10.1094/PHYTO.2004.94.6.578; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Dong XB, 2015, PLANT PHYSIOL, V167, P1186, DOI 10.1104/pp.114.254292; Favorov A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002529; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Ghanbarnia K, 2018, MOL PLANT PATHOL, V19, P1754, DOI 10.1111/mpp.12658; Haddadi P, 2016, MOL PLANT PATHOL, V17, P1196, DOI 10.1111/mpp.12356; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; JUKES T H, 1969, P21; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Larkan NJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01771; Larkan NJ, 2015, PLANT BIOTECHNOL J, V13, P983, DOI 10.1111/pbi.12341; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01483; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Mayerhofer R, 2005, GENETICS, V171, P1977, DOI 10.1534/genetics.105.049098; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Raman H., 2013, PLANT BREEDING LAB F; Raman H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01513; Rolfe SA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2597-2; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saintenac C, 2018, NAT GENET, V50, P368, DOI 10.1038/s41588-018-0051-x; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Steuernage B, 2016, NAT BIOTECHNOL, V34, P652, DOI 10.1038/nbt.3543; Stotz HU, 2017, METHODS, V131, P120, DOI 10.1016/j.ymeth.2017.08.019; Stotz HU, 2014, TRENDS PLANT SCI, V19, P491, DOI 10.1016/j.tplants.2014.04.009; STOTZ HU, 1994, PLANT MOL BIOL, V25, P607, DOI 10.1007/BF00029600; Stotz HU, 2000, PHYSIOL MOL PLANT P, V56, P117, DOI 10.1006/pmpp.2000.0258; TOUBART P, 1992, PLANT J, V2, P367; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wu J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01418; Wu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19007; Xiao SY, 2004, MOL BIOL EVOL, V21, P1661, DOI 10.1093/molbev/msh165; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu FQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153218	52	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198201	10.1371/journal.pone.0198201	http://dx.doi.org/10.1371/journal.pone.0198201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856883	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800082
J	Watanabe, H; Nishio, Y; Mamiya, Y; Narita, W; Iizuka, O; Baba, T; Takeda, A; Shimomura, T; Mori, E				Watanabe, Hiroyuki; Nishio, Yoshiyuki; Mamiya, Yasuyuki; Narita, Wataru; Iizuka, Osamu; Baba, Toru; Takeda, Atsushi; Shimomura, Tatsuo; Mori, Etsuro			Negative mood invites psychotic false perception in dementia	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; SYMPTOMS; SCHIZOPHRENIA; DIAGNOSIS; INVENTORY; ANXIETY; STATE	Background There is increasing evidence for predictive coding theories of psychosis, which state that hallucinations arise from abnormal perceptual priors or biases. However, psychological processes that foster abnormal priors/biases in patients suffering hallucinations have been largely unexplored. The widely recognized relationship between affective disorders and psychosis suggests a role for mood and emotion. Methods Thirty-six patients with dementia with Lewy bodies (DLB), a representative condition associated with psychosis of neurological origin, and 12 patients with Alzheimer's disease (AD) were enrolled. After an experimental mood induction, the participants underwent the pareidolia test, in which visual hallucination-like illusions were evoked and measured. Results In DLB patients, the number of pareidolic illusions was doubled under negative mood compared to that under neutral mood. In AD patients, there was no significant difference in the number of pareidolic responses between negative and neutral mood conditions. A signal detection theory analysis demonstrated that the observed affective modulation of pareidolic illusions was mediated through heightened perceptual bias, not sensory deterioration. Conclusions The current findings demonstrated that abnormal perceptual priors in psychotic false perception have an affective nature, which we suggest are a type of cognitive feeling that arises in association with perception and cognition.	[Watanabe, Hiroyuki; Nishio, Yoshiyuki; Mamiya, Yasuyuki; Narita, Wataru; Iizuka, Osamu; Baba, Toru; Mori, Etsuro] Tohoku Univ, Dept Behav Neurol & Cognit Neurosci, Sch Med, Sendai, Miyagi, Japan; [Takeda, Atsushi] Sendai Nishitaga Natl Hosp, Dept Neurol, Sendai, Miyagi, Japan; [Shimomura, Tatsuo] Akita Prefectural Ctr Rehabil & Psychiat Med, Dept Rehabil Med, Daisen, Japan; [Mori, Etsuro] Osaka Univ, United Grad Sch Child Dev, Dept Behav Neurol & Neuropsychiat, Suita, Osaka, Japan	Tohoku University; Osaka University	Nishio, Y (corresponding author), Tohoku Univ, Dept Behav Neurol & Cognit Neurosci, Sch Med, Sendai, Miyagi, Japan.	nishiokov@gmail.com		Baba, Toru/0000-0003-0936-2510	Research Fellowships of the Japan Society for the Promotion of Science [15J04040]; Tohoku University Division for Interdisciplinary Advanced Research and Education; Takeda Psychoanalytic Foundation for Mental Health	Research Fellowships of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University Division for Interdisciplinary Advanced Research and Education; Takeda Psychoanalytic Foundation for Mental Health	This work was supported by a grant from the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists to HW. (15J04040), a grant from the Tohoku University Division for Interdisciplinary Advanced Research and Education to HW, and a grant from the Takeda Psychoanalytic Foundation for Mental Health to YN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Fenelon G, 2011, J NEUROL NEUROSUR PS, V82, P1219, DOI 10.1136/jnnp.2010.234799; Ffytche DH, 2017, NAT REV NEUROL, V13, P81, DOI 10.1038/nrneurol.2016.200; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Greder RC, 2008, MEM COGNITION, V36, P933, DOI 10.3758/MC.36.5.933; Hartley S, 2013, ACTA PSYCHIAT SCAND, V128, P327, DOI 10.1111/acps.12080; Hashimoto Mamoru, 2014, Brain Nerve, V66, P175; Japan Society for Higher Brain Dysfunction, 1997, VIS PERC TEST AGN; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kawata KHD, 2012, DEMENT GER COGN D EX, V2, P29, DOI 10.1159/000336909; Mamiya Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154713; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Nagahama Y, 2007, AM J GERIAT PSYCHIAT, V15, P961, DOI 10.1097/JGP.0b013e3180cc1fdf; Nishio Y, 2017, J NEUROL NEUROSUR PS, V88, P722, DOI 10.1136/jnnp-2017-315741; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Powers AR, 2017, SCIENCE, V357, P596, DOI 10.1126/science.aan3458; Schubert TW, 2009, COMMUN THEOR, V19, P161, DOI 10.1111/j.1468-2885.2009.01340.x; Schwarz N., 1996, SOCIAL PSYCHOL HDB B, V2, P385; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stuke H, 2019, SCHIZOPHRENIA BULL, V45, P80, DOI 10.1093/schbul/sbx189; Teufel C, 2015, P NATL ACAD SCI USA, V112, P13401, DOI 10.1073/pnas.1503916112; Uchiyama M, 2015, PARKINSONISM RELAT D, V21, P603, DOI 10.1016/j.parkreldis.2015.03.020; Warrington EK., 1991, VISUAL OBJECT SPACE; Yokoi K, 2014, NEUROPSYCHOLOGIA, V56, P245, DOI 10.1016/j.neuropsychologia.2014.01.017	28	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197968	10.1371/journal.pone.0197968	http://dx.doi.org/10.1371/journal.pone.0197968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856844	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800056
J	Yang, YK; Liu, QN; Jiang, GL; Chen, S; Zhou, LN; Sakamoto, N; Kuno, T; Fang, Y; Yao, F				Yang, Yikun; Liu, Qiannan; Jiang, Guanglie; Chen, Si; Zhou, Lina; Sakamoto, Norihiro; Kuno, Takayoshi; Fang, Yue; Yao, Fan			Genome-wide screen reveals important roles for ESCRT proteins in drug/ion resistance of fission yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; MEMBRANE TRAFFICKING; TOLERANCE; VACUOLE; SENSITIVITY; COMPLEXES; PATHWAYS	To study sodium homeostasis, we performed a genome-wide screen for deletion strains that show resistance to NaCl. We identified 34 NaCl-resistant strains. Among them, the largest group that consists of 10 genes related to membrane trafficking and 7 out of 10 genes are ESCRT proteins which are involved in cargo transportation into luminal vesicles within the multivesicular body. All of the ESCRT related mutants which showed sodium resistance also showed defects in vacuole fusion. To further understand the role of the ESCRT pathway in various ion homeostasis, we examined sensitivity of these ESCRT mutants to various cation salts other than NaCl, including KCl, LiCl, CaCl2, CoCl2, MgCl2, NiSO4 and MnCl2. While these ESCRT mutants showed resistance to LiCl, CoCl2 and MgCl2, they showed sensitivity to KCl, CaCl2, NiSO4 and MnCl2. Then we examined sensitivity of these ESCRT mutants to various drugs which are known to inhibit the growth of fission yeast cells. While these ESCRT mutants were more or equally sensitive to most of the drugs tested as compared to the wild-type cells, they showed resistance to some drugs such as tamoxifen, fluorouracil and amiodarone. These results suggest that the ESCRT pathway plays important roles in drug/ion resistance of fission yeast.	[Yang, Yikun; Liu, Qiannan; Jiang, Guanglie; Chen, Si; Zhou, Lina; Kuno, Takayoshi; Fang, Yue] China Med Univ, Sch Pharm, Dept Microbial & Biochem Pharm, Shenyang, Liaoning, Peoples R China; [Sakamoto, Norihiro; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Social Community Med & Hlth Sci, Div Food & Drug Evaluat Sci, Kobe, Hyogo, Japan; [Yao, Fan] China Med Univ, Affiliated Hosp 1, Res Unit Gen Surg, Dept Breast Surg & Surg Oncol, Shenyang, Liaoning, Peoples R China	China Medical University; Kobe University; China Medical University	Fang, Y (corresponding author), China Med Univ, Sch Pharm, Dept Microbial & Biochem Pharm, Shenyang, Liaoning, Peoples R China.; Yao, F (corresponding author), China Med Univ, Affiliated Hosp 1, Res Unit Gen Surg, Dept Breast Surg & Surg Oncol, Shenyang, Liaoning, Peoples R China.	yfang@cmu.edu.cn; yaofancmu@hotmail.com			Natural Science Foundations of Liaoning Province of China [2015020723, 2015020501]; Research Fund from the Department of Education of Liaoning province, China [L2015600]	Natural Science Foundations of Liaoning Province of China; Research Fund from the Department of Education of Liaoning province, China	This work was supported by grants from the Natural Science Foundations of Liaoning Province of China (no. 2015020723) to YF, and (no. 2015020501) to FY. This work was also supported by Research Fund from the Department of Education of Liaoning province, China (no. L2015600) to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fang Y, 2012, ANTIMICROB AGENTS CH, V56, P1949, DOI 10.1128/AAC.05126-11; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hoffman CS, 2015, GENETICS, V201, P403, DOI 10.1534/genetics.115.181503; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Hu LL, 2016, FUNGAL GENET BIOL, V93, P17, DOI 10.1016/j.fgb.2016.05.007; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kimura Y, 2014, J BIOL CHEM, V289, P21760, DOI 10.1074/jbc.M114.550871; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Logg K, 2008, BBA-MOL CELL RES, V1783, P974, DOI 10.1016/j.bbamcr.2008.02.022; Luo C, 2016, FEMS YEAST RES, V16, DOI [10.1093/femsyr/fow028, DOI 10.1093/FEMSYR/F0W028]; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023422; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Palmer BF, 2015, NEW ENGL J MED, V373, P548, DOI 10.1056/NEJMra1503102; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Schluter C, 2008, MOL BIOL CELL, V19, P1282, DOI 10.1091/mbc.E07-07-0659; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Serrano R, 1996, INT REV CYTOL, V165, P1, DOI 10.1016/S0074-7696(08)62219-6; Takegawa K, 2003, CELL STRUCT FUNCT, V28, P399, DOI 10.1247/csf.28.399; Toda T, 1996, MOL CELL BIOL, V16, P6752; Weisman LS, 2003, ANNU REV GENET, V37, P435, DOI 10.1146/annurev.genet.37.050203.103207; Zhang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068738; Zhang Xibo, 2015, Kobe J Med Sci, V61, pE54; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065904	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198516	10.1371/journal.pone.0198516	http://dx.doi.org/10.1371/journal.pone.0198516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856841	Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800134
J	Lubberich, RK; Walenda, T; Goecke, TW; Strathmann, K; Isfort, S; Brummendorf, TH; Koschmieder, S; Wagner, W				Lubberich, Richard K.; Walenda, Thomas; Goecke, Tamme W.; Strathmann, Klaus; Isfort, Susanne; Bruemmendorf, Tim H.; Koschmieder, Steffen; Wagner, Wolfgang			Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells	PLOS ONE			English	Article							POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; MYELOFIBROSIS; DIVISION; PATHOGENESIS; DISORDERS; CYTOKINES; DISEASES	Background Myeloproliferative neoplasms (MPN)-such as polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis(MF)-are typically diseases of the elderly caused by acquired somatic mutations. However, it is largely unknown how the malignant clone interferes with normal hematopoiesis. In this study, we analyzed if serum of MPN patients comprises soluble factors that impact on hematopoietic stem and progenitor cells (HPCs). Methods CD34(+) HPCs were cultured in medium supplemented with serum samples of PV, ET, or MF patients, or healthy controls. The impact on proliferation, maintenance of immature hematopoietic surface markers, and colony forming unit (CFU) potential was systematically analyzed. In addition, we compared serum of healthy young (<25 years) and elderly donors (>50 years) to determine how normal aging impacts on the hematopoiesis-supportive function of serum. Results Serum from MF, PV and ET patients significantly increased proliferation as compared to controls. In addition, serum from MF and ET patients attenuated the loss of a primitive immunophenotype during in vitro culture. The CFU counts were significantly higher if HPCs were cultured with serum of MPN patients as compared to controls. Furthermore, serum of healthy young versus old donors did not evoke significant differences in proliferation or immunophenotype of HPCs, whereas the CFU frequency was significantly increased by serum from elderly patients. Conclusion Our results indicate that serum derived from patients with MPN comprises activating feedback signals that stimulate the HPCs-and this stimulatory signal may result in a viscous circle that further accelerates development of the disease.	[Lubberich, Richard K.; Walenda, Thomas; Wagner, Wolfgang] Rhein Westfal TH Aachen, Med Sch, Helmholtz Inst Biomed Engn Stem Cell Biol & Cellu, Aachen, Germany; [Lubberich, Richard K.; Walenda, Thomas; Wagner, Wolfgang] Rhein Westfal TH Aachen, Inst Biomed Engn Cell Biol, Med Sch, Aachen, Germany; [Goecke, Tamme W.] Rhein Westfal TH Aachen, Dept Obstet & Gynecol, Med Sch, Aachen, Germany; [Strathmann, Klaus] Rhein Westfal TH Aachen, Inst Transfus Med, Med Sch, Aachen, Germany; [Isfort, Susanne; Bruemmendorf, Tim H.; Koschmieder, Steffen] Rhein Westfal TH Aachen, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Wagner, W (corresponding author), Rhein Westfal TH Aachen, Med Sch, Helmholtz Inst Biomed Engn Stem Cell Biol & Cellu, Aachen, Germany.; Wagner, W (corresponding author), Rhein Westfal TH Aachen, Inst Biomed Engn Cell Biol, Med Sch, Aachen, Germany.	wwagner@ukaachen.de		Koschmieder, Steffen/0000-0002-1011-8171; Wagner, Wolfgang/0000-0002-1971-3217	Else Kroner-Fresenius-Stiftung [2014_A193]; Bundesministerium fur Bildung und Forschung [01KU1402B]; Interdisciplinary Center for Clinical Research (IZKF) in the Faculty of Medicine at the RWTH Aachen University [O1-1, O1-2]; Deutsche Jose Carreras Leukamie-Stiftung	Else Kroner-Fresenius-Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research (IZKF) in the Faculty of Medicine at the RWTH Aachen University; Deutsche Jose Carreras Leukamie-Stiftung	Materials and Reagents were funded by the Else Kroner-Fresenius-Stiftung (2014_A193 to WW;~www.ekfs.de), the Bundesministerium fur Bildung und Forschung (01KU1402B to WW;~www.bmbf.de) and the Interdisciplinary Center for Clinical Research (IZKF) in the Faculty of Medicine at the RWTH Aachen University (O1-1 to WW and O1-2 to SK;~http://www.medizin.rwth-aachen.de/cms/Medizin/Die-Fakultaet/Einrichtungen/similar to dgun/IZKF-Aachen/). RL received a grant from the Deutsche Jose Carreras Leukamie-Stiftung (http://www.carreras-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbui T, 2013, BLOOD, V122, P2176, DOI 10.1182/blood-2013-03-460154; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chen E, 2014, HEMATOL-AM SOC HEMAT, P268, DOI 10.1182/asheducation-2014.1.268; Cokic VP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/453020; Fleischman AG, 2011, BLOOD, V118, P6392, DOI 10.1182/blood-2011-04-348144; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Gotze KS, 2007, EXP HEMATOL, V35, P1408, DOI 10.1016/j.exphem.2007.05.016; Grasedieck S, 2013, BLOOD, V121, P4977, DOI 10.1182/blood-2013-01-480079; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Hermouet S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/145293; Ho CL, 2007, LEUKEMIA RES, V31, P1389, DOI 10.1016/j.leukres.2006.12.024; Koschmieder S, 2016, LEUKEMIA, V30, P1018, DOI 10.1038/leu.2016.12; Kovtonyuk LV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00502; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lin X, 2013, LEUKEMIA, V27, P344, DOI 10.1038/leu.2012.224; Lu M, 2015, BLOOD, V126, P972, DOI 10.1182/blood-2014-12-618595; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mager LF, 2015, J CLIN INVEST, V125, P2579, DOI 10.1172/JCI77347; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Oostendorp RAJ, 2000, BLOOD, V95, P855, DOI 10.1182/blood.V95.3.855.003k41_855_862; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Panteli KE, 2005, BRIT J HAEMATOL, V130, P709, DOI 10.1111/j.1365-2141.2005.05674.x; Pourcelot E, 2014, EXP HEMATOL, V42, P360, DOI 10.1016/j.exphem.2014.01.006; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Vaidya R, 2012, AM J HEMATOL, V87, P1003, DOI 10.1002/ajh.23295; Walenda T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128231; Walenda T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003599; Walenda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018012; Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011; Walenda T, 2010, J CELL MOL MED, V14, P337, DOI 10.1111/j.1582-4934.2009.00776.x; Zingariello M, 2013, BLOOD, V121, P3345, DOI 10.1182/blood-2012-06-439661	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197233	10.1371/journal.pone.0197233	http://dx.doi.org/10.1371/journal.pone.0197233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851963	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200012
J	Yagasaki, Y; Miyoshi, G; Miyata, M				Yagasaki, Yuki; Miyoshi, Goichi; Miyata, Mariko			Experience-dependent MeCP2 expression in the excitatory cells of mouse visual thalamus	PLOS ONE			English	Article							CRITICAL PERIOD PLASTICITY; METABOTROPIC GLUTAMATE-RECEPTOR; CPG-BINDING PROTEIN-2; LATERAL GENICULATE-NUCLEUS; RETT-SYNDROME BRAIN; RETINOGENICULATE SYNAPSE; DUPLICATION SYNDROME; NEUROLOGICAL SYMPTOMS; CORTEX; MICE	Loss or gain of copy number of the gene encoding the transcription factor methyl-CpG-binding protein 2 (MeCP2) leads to neurodevelopmental disorders (Rett and MeCP2 duplication syndrome), indicating that precisely regulated MeCP2 expression during development is critical for mental health. Consistent with this idea, MeCP2 null mutants exhibit synaptic regression in the dorsal lateral geniculate nucleus (dLGN), the visual relay center in the thalamus, a phenotype resembling that of animals reared in the dark during the visual sensitive period. It remains unclear how MeCP2 expression is regulated during circuit formation and maturation, especially in excitatory and inhibitory populations of neurons. We found that, concomitant with the initiation of the dark-rearing sensitive period, MeCP2 protein levels were elevated in glutamatergic but not GABAergic neurons of the dLGN. Moreover, MeCP2 expression in glutamatergic populations was selectively reduced by dark-rearing. Therefore, we propose that visual experience-dependent MeCP2 induction in glutamatergic populations is essential for synaptic maturation within the dLGN.	[Yagasaki, Yuki; Miyoshi, Goichi; Miyata, Mariko] Tokyo Womens Med Univ, Sch Med, Dept Physiol Neurophysiol 1, Shinjuku Ku, 8-1 Kawada Cho, Tokyo, Japan; [Yagasaki, Yuki] Tokyo Womens Med Univ, Div Women Hlth Care Profess & Researchers Support, Shinjuku Ku, 8-1 Kawada Cho, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Miyata, M (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol Neurophysiol 1, Shinjuku Ku, 8-1 Kawada Cho, Tokyo, Japan.	mmiyata@twmu.ac.jp	Miyoshi, Goichi/O-2029-2019	Miyata, Mariko/0000-0001-5688-654X	JSPS, Japan [26290010, 15H01667, 16H01344, 17H05752, 15K09602, 17K07102]; Aya Irisawa Memorial Promotion Award; Keiko Watanabe Award from SHISEIKAI Scholarship Fund for basic researchers in medical science; Takako Satake Research Grant for Women Medical Researchers from Tokyo Womens Medical University; The Cell Science Research Foundation; The Takeda Science Foundation	JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Aya Irisawa Memorial Promotion Award; Keiko Watanabe Award from SHISEIKAI Scholarship Fund for basic researchers in medical science; Takako Satake Research Grant for Women Medical Researchers from Tokyo Womens Medical University; The Cell Science Research Foundation(Cell Science Research Foundation, Japan); The Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research (26290010, 15H01667, 16H01344, and 17H05752 to M.M.; 15K09602 to Y.Y.; and 17K07102 to G.M.) from JSPS, Japan; by the Aya Irisawa Memorial Promotion Award and the Keiko Watanabe Award from SHISEIKAI Scholarship Fund for basic researchers in medical science (to M.M.); by Takako Satake Research Grant for Women Medical Researchers from Tokyo Womens Medical University (to Y.Y.); by The Cell Science Research Foundation and The Takeda Science Foundation (to GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arcelli P, 1997, BRAIN RES BULL, V42, P27, DOI 10.1016/S0361-9230(96)00107-4; Armstrong DD, 2003, J CHILD NEUROL, V18, P683; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Ben Zeev B, 2002, J CHILD NEUROL, V17, P20, DOI 10.1177/088307380201700105; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Blackman MP, 2012, J NEUROSCI, V32, P13529, DOI 10.1523/JNEUROSCI.3077-12.2012; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2012, NAT NEUROSCI, V15, P176, DOI 10.1038/nn.3027; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Evangelio M, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00027; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Godwin DW, 1996, J NEUROSCI, V16, P8181; Govindaiah G, 2012, J NEUROPHYSIOL, V107, P1157, DOI 10.1152/jn.00401.2011; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; He LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6036; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hooks BM, 2008, J NEUROSCI, V28, P4807, DOI 10.1523/JNEUROSCI.4667-07.2008; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Jain D, 2010, PEDIATR NEUROL, V43, P35, DOI 10.1016/j.pediatrneurol.2010.02.018; Jiang MH, 2013, J NEUROSCI, V33, P19518, DOI 10.1523/JNEUROSCI.1745-13.2013; Krishnan K, 2015, P NATL ACAD SCI USA, V112, pE4782, DOI 10.1073/pnas.1506499112; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Lu H, 2016, NEURON, V91, P739, DOI 10.1016/j.neuron.2016.07.018; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Mahgoub M, 2016, NAT NEUROSCI, V19, P1506, DOI 10.1038/nn.4395; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Na ES, 2013, NEUROPSYCHOPHARMACOL, V38, P212, DOI 10.1038/npp.2012.116; Na ES, 2012, J NEUROSCI, V32, P3109, DOI 10.1523/JNEUROSCI.6000-11.2012; Narushima M, 2016, NEURON, V91, P1097, DOI 10.1016/j.neuron.2016.07.035; Noutel J, 2011, NEURON, V70, P35, DOI 10.1016/j.neuron.2011.03.001; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Song CD, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-17; Sztainberg Y, 2015, NATURE, V528, P123, DOI 10.1038/nature16159; Takeuchi Y, 2014, J NEUROSCI, V34, P1258, DOI 10.1523/JNEUROSCI.3865-13.2014; Ure K, 2016, ELIFE, V5, DOI 10.7554/eLife.14198; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vidnyanszky Z, 1996, EUR J NEUROSCI, V8, P1061, DOI 10.1111/j.1460-9568.1996.tb01273.x; Wang H, 2008, J NEUROSCI, V28, P13621, DOI 10.1523/JNEUROSCI.4785-08.2008	51	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198268	10.1371/journal.pone.0198268	http://dx.doi.org/10.1371/journal.pone.0198268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847590	Green Submitted, gold, Green Published			2022-12-26	WOS:000433634800062
J	Briggs, ADM; Scarborough, P; Wolstenholme, J				Briggs, Adam D. M.; Scarborough, Peter; Wolstenholme, Jane			Estimating comparable English healthcare costs for multiple diseases and unrelated future costs for use in health and public health economic modelling	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BOTTOM-UP; TOP-DOWN; CANCER	Objectives Healthcare interventions, and particularly those in public health may affect multiple diseases and significantly prolong life. No consensus currently exists for how to estimate comparable healthcare costs across multiple diseases for use in health and public health cost-effectiveness models. We aim to describe a method for estimating comparable disease specific English healthcare costs as well as future healthcare costs from diseases unrelated to those modelled. Methods We use routine national datasets including programme budgeting data and cost curves from NHS England to estimate annual per person costs for diseases included in the PRIMEtime model as well as age and sex specific costs due to unrelated diseases. Results The 2013/14 annual cost to NHS England per prevalent case varied between 3,074 pound for pancreatic cancer and 314 pound for liver disease. Costs due to unrelated diseases increase with age except for a secondary peak at 30-34 years for women reflecting maternity resource use. Conclusions The methodology described allows health and public health economic modellers to estimate comparable English healthcare costs for multiple diseases. This facilitates the direct comparison of different health and public health interventions enabling better decision making.	[Briggs, Adam D. M.; Scarborough, Peter; Wolstenholme, Jane] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, Oxon, England; [Briggs, Adam D. M.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Ctr Dr, Lebanon, NH 03756 USA	University of Oxford; Dartmouth College	Briggs, ADM (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, Oxon, England.; Briggs, ADM (corresponding author), Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	adam.briggs@dartmouth.edu	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Wolstenholme, Jane/0000-0001-7493-1850; Briggs, Adam/0000-0002-2314-1039	Wellcome Trust Research Training Fellowship [102730/Z/13/Z]; British Heart Foundation Intermediate Basic Science Research Fellowship [FS/15/34/31656]	Wellcome Trust Research Training Fellowship(Wellcome Trust); British Heart Foundation Intermediate Basic Science Research Fellowship	ADMB completed this work at the University of Oxford and was funded by a Wellcome Trust Research Training Fellowship (https://wellcome.ac.uk; grant number 102730/Z/13/Z). PS was funded by a British Heart Foundation Intermediate Basic Science Research Fellowship (https://www.bhf.org.uk; grant number FS/15/34/31656). No other specific funding was used for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby J, 2011, EXPLAINING VARIATION; Bhimjiyani A, 2016, TECHNICAL REPORT; Blakely T, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001856; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140; Cobiac LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167859; Currie CJ, 1997, DIABETIC MED, V14, P686, DOI 10.1002/(SICI)1096-9136(199708)14:8<686::AID-DIA434>3.0.CO;2-D; Curtis L, 2015, UNIT COSTS HLTH SOCI; Divajeva D, 2014, RISK FACTOR BASED MO; Dolan P, 1999, BREAST, V8, P205, DOI 10.1054/brst.1999.0035; Frew EJ, 2014, BRIT J SPORT MED, V48, P207, DOI 10.1136/bjsports-2012-091202; Gardiner L, 2016, PRIMARY MED CARE NEW; Hay JW, 2010, VALUE HEALTH, V13, P3, DOI 10.1111/j.1524-4733.2009.00663.x; Health and Social Care Information Centre, 2015, HOSP EP STAT; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Mercier G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097290; Morton A, 2016, HEALTH ECON, V25, P933, DOI 10.1002/hec.3366; National Institute for Health and Care Excellence, 2014, DEV NICE GUID MAN; NHS England, 2016, COMMUNICATION; NHS England, 2015, 2013 14 CCG PROGR BU; NHS England, 2013, 2012 13 PROGR BUDG M; NHS England, 2016, TECHN GUID ALL FORM; NHS England, 2012, NHS ALL 2013 14; NHS England, 2015, 2014 15 PROGR BUDG M; Office for National Statistics, 2015, BIRTHS PAR CHAR ENGL; Office for National Statistics, 2012, MID 2009 POP EST EST; OFX, 2016, YEARL AV RAT; Olsson TM, 2011, EUR J HEALTH ECON, V12, P445, DOI 10.1007/s10198-010-0257-z; Trueman P, 2010, INT J CLIN PRACT, V64, P775, DOI 10.1111/j.1742-1241.2010.02349.x; Trueman P, 2013, J PUBLIC HEALTH-UK, V35, P32, DOI 10.1093/pubmed/fds050; UK Government, 2012, HLTH SOC CAR ACT 201; van Baal PHM, 2011, HEALTH ECON, V20, P432, DOI 10.1002/hec.1599; Van Baala P, 2016, HEALTH ECON, V25, P237, DOI 10.1002/hec.3138; Yabroff K. Robin, 2013, Journal of the National Cancer Institute Monographs, P62, DOI 10.1093/jncimonographs/lgt001; York Health Economics Consortium, 2007, BOW CANC SERV COSTS	36	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197257	10.1371/journal.pone.0197257	http://dx.doi.org/10.1371/journal.pone.0197257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795586	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300034
J	Lis, KA; Boulaaba, A; Binder, S; Li, YF; Kehrenberg, C; Zimmermann, JL; Klein, G; Ahlfeld, B				Lis, Karolina Anna; Boulaaba, Annika; Binder, Sylvia; Li, Yangfang; Kehrenberg, Corinna; Zimmermann, Julia Louise; Klein, Guenter; Ahlfeld, Birte			Inactivation of Salmonella Typhimurium and Listeria monocytogenes on ham with nonthermal atmospheric pressure plasma	PLOS ONE			English	Article							COLD-PLASMA; ESCHERICHIA-COLI; GAS PLASMA; PROCESS PARAMETERS; REQUEIJAO-CREMOSO; PROCESSED CHEESE; PATHOGENS; HUMIDITY; SURFACES; IMPACT	The application of cold atmospheric pressure plasma (CAP) for decontamination of sliced ready-to-eat (RTE) meat products (in this case, rolled fillets of ham), inoculated with Salmonella (S.) Typhimurium and Listeria (L.) monocytogenes was investigated. Cold atmospheric plasma (CAP) is an ionised gas that includes highly reactive species and ozone, interacting with cell membranes and DNA of bacteria. The mode of action of CAPs includes penetration and disruption of the outer cell membrane or intracellular destruction of DNA located in the cytoplasm. Inoculated ham was treated for 10 and 20 min with CAP generated by a surface-micro-discharge-plasma source using cost-effective ambient air as working gas with different humidity levels of 45-50 and 90%. The chosen plasma modes had a peak-to-peak voltage of 6.4 or 10 kV and a frequency of 2 and 10 kHz. Under the tested conditions, the direct effectiveness of CAP on microbial inactivation was limited. Although all treated samples showed significant reductions in the microbial load subsequent to plasma treatment, the maximum inactivation of S. Typhimurium was 1.14 Ig steps after 20 min of CAP-treatment (p<0.05), and L. monocytogenes was reduced by 1.02 Ig steps (p<0.05) using high peak-to-peak voltage of 10 kV and a frequency of 2 kHz regardless of moisture content. However, effective inactivation was achieved by a combination of CAP-treatment and cold storage at 8 degrees C +/- 0.5 degrees C for 7 and 14 days after packaging under sealed high nitrogen gas flush (70% N-2, 30% CO2). Synergistic effects of CAP and cold storage for 14 days led to a clearer decrease in the microbial load of 1.84 Ig steps for S. Typhimurium (p<0.05) and 2.55 Ig steps for L. monocytogenes (p<0.05). In the case of L. monocytogenes, subsequent to CAP-treatment (10 kV, 2 kHz) and cold storage, microbial counts were predominantly below the detection limit. Measurement showed that after CAPtreatment, surface temperature of ham did not exceed the room temperature of 22 degrees C +/- 2 degrees C. With the application of humidity levels of 45-50%, the colour distance Delta E increased in CAP treated samples due to a decrease in L* values. In conclusion, effectiveness of CAP-treatment was limited. However, the combination of CAP-treatment and cold storage of samples under modified-atmospheric-conditions up to 14 days could significantly reduce microorganisms on RTE ham. Further investigations are required to improve effectiveness of CAP-treatment.	[Lis, Karolina Anna; Boulaaba, Annika; Kehrenberg, Corinna; Klein, Guenter; Ahlfeld, Birte] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [Binder, Sylvia; Li, Yangfang; Zimmermann, Julia Louise] Terraplasma GmbH, Garching, Germany	University of Veterinary Medicine Hannover, Foundation	Boulaaba, A (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	annika.boulaaba@tiho-hannover.de	Kehrenberg, Corinna/GSI-9835-2022	Li, Yangfang/0000-0002-5346-3741	Fritz-Ahrberg-Foundation, Hannover, Germany [60070026]; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation; terraplasma GmbH	Fritz-Ahrberg-Foundation, Hannover, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation; terraplasma GmbH	This work was supported by the Fritz-Ahrberg-Foundation (Grant No. 60070026), Hannover, Germany (BA). Furthermore, this publication was also supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing (AB). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. terraplasma GmbH provided support in the form of salaries for authors SB, YL and JLZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alkawareek MY, 2014, INT J ANTIMICROB AG, V43, P154, DOI 10.1016/j.ijantimicag.2013.08.022; [Anonymous], 2014, 657912014 ISODIS; [Anonymous], 2017, 112901 ISODIS; [Anonymous], 2008, OXOID PRODUCT SPECIF; [Anonymous], 2016, R KOCH I ADVICE DOCT; [Anonymous], 2017, SALMONELLA; [Anonymous], 2016, R KOCH I INFECTION E; [Anonymous], 2012, MEDIUM; Barba FJ, 2017, TRENDS FOOD SCI TECH, V66, P20, DOI 10.1016/j.tifs.2017.05.011; Bauer A, 2017, MEAT SCI, V128, P77, DOI 10.1016/j.meatsci.2017.02.003; Belsito PC, 2017, CARBOHYD POLYM, V174, P869, DOI 10.1016/j.carbpol.2017.07.021; Bermudez-Aguirre D, 2013, FOOD CONTROL, V34, P149, DOI 10.1016/j.foodcont.2013.04.022; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Burts ML, 2009, AM J INFECT CONTROL, V37, P729, DOI 10.1016/j.ajic.2009.03.010; Cabiscol E., 2010, J INT MICROBIOL, V3, P3; Cappato LP, 2017, TRENDS FOOD SCI TECH, V62, P104, DOI 10.1016/j.tifs.2017.01.010; Coutinho NM, 2018, TRENDS FOOD SCI TECH, V74, P56, DOI 10.1016/j.tifs.2018.02.008; Critzer FJ, 2007, J FOOD PROTECT, V70, P2290, DOI 10.4315/0362-028X-70.10.2290; Dorai R, 2003, J PHYS D APPL PHYS, V36, P666, DOI 10.1088/0022-3727/36/6/309; Farber J, 2000, MICROBIOLOGICAL SAFE, VII; Fernandez A, 2012, FOOD RES INT, V45, P678, DOI 10.1016/j.foodres.2011.04.009; Fernandez A, 2012, INT J FOOD MICROBIOL, V152, P175, DOI 10.1016/j.ijfoodmicro.2011.02.038; Frohling A, 2012, INNOV FOOD SCI EMERG, V16, P381, DOI 10.1016/j.ifset.2012.09.001; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Gaze LV, 2015, J DAIRY SCI, V98, P1443, DOI 10.3168/jds.2014-8470; Gierling R., 2006, COLOR MANAGEMENT, P3; Gweon B, 2009, CURR APPL PHYS, V9, P625, DOI 10.1016/j.cap.2008.06.001; Hahnel M, 2010, PLASMA PROCESS POLYM, V7, P244, DOI 10.1002/ppap.200900076; Han L, 2016, APPL ENVIRON MICROB, V82, P450, DOI 10.1128/AEM.02660-15; Hartrnann T, 2013, FLEISCHWIRTSCHAFT, V93, P95; Keskinen LA, 2008, INT J FOOD MICROBIOL, V127, P298, DOI 10.1016/j.ijfoodmicro.2008.07.021; Kim B, 2011, FOOD MICROBIOL, V28, P9, DOI 10.1016/j.fm.2010.07.022; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Lee H, 2015, FOOD MICROBIOL, V51, P74, DOI 10.1016/j.fm.2015.05.004; Lee HJ, 2011, FOOD MICROBIOL, V28, P1468, DOI 10.1016/j.fm.2011.08.002; Liao XY, 2017, J FOOD PROTECT, V80, P928, DOI 10.4315/0362-028X.JFP-16-499; Lu H, 2014, J APPL MICROBIOL, V116, P784, DOI 10.1111/jam.12426; Mancini RA, 2005, MEAT SCI, V71, P100, DOI 10.1016/j.meatsci.2005.03.003; Messelhausser U., 2010, METHODS CULTURING BA, P5, DOI [10.1007/978-3-642-10716-0_2, DOI 10.1007/978-3-642-10716-0_2]; Moisan M, 2001, VIDE, V56, P15; Montie TC, 2000, IEEE T PLASMA SCI, V28, P41, DOI 10.1109/27.842860; Morfill GE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115019; Muranyi P, 2008, J APPL MICROBIOL, V104, P1659, DOI 10.1111/j.1365-2672.2007.03691.x; Noriega E, 2011, FOOD MICROBIOL, V28, P1293, DOI 10.1016/j.fm.2011.05.007; Patil S, 2014, J HOSP INFECT, V88, P162, DOI 10.1016/j.jhin.2014.08.009; Perni S, 2008, J FOOD PROTECT, V71, P1619, DOI 10.4315/0362-028X-71.8.1619; Reuter S, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/2/024005; Richards GM, 2005, INT J FOOD MICROBIOL, V103, P1, DOI 10.1016/j.ijfoodmicro.2004.05.023; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shimizu T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023026; Shimizu T, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103028; Stolz S., 2011, COMP IN VITRO STUDY; Surowsky B, 2014, INT J FOOD MICROBIOL, V174, P63, DOI 10.1016/j.ijfoodmicro.2013.12.031; Tappi S, 2016, INNOV FOOD SCI EMERG, V33, P225, DOI 10.1016/j.ifset.2015.12.022; Tappi S, 2014, INNOV FOOD SCI EMERG, V21, P114, DOI 10.1016/j.ifset.2013.09.012; Torres FR, 2017, J DAIRY SCI, V100, P6100, DOI 10.3168/jds.2016-12516; Wallhausser C., 1995, STERILIZATION DISINF, P334; Whitehead JC, 2016, COLD PLASMA IN FOOD AND AGRICULTURE: FUNDAMENTALS AND APPLICATIONS, P53, DOI 10.1016/B978-0-12-801365-6.00003-2; Wieser M., 2010, COMP PHYS COLOUR MEA; Wilberg N, 2007, INORGANIC CHEM TXB, P102; Winter J, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/29/295401; Winter T, 2011, PROTEOMICS, V11, P3518, DOI 10.1002/pmic.201000637; Yusupov M, 2013, J PHYS CHEM C, V117, P5993, DOI 10.1021/jp3128516; Ziuzina D, 2014, FOOD MICROBIOL, V42, P109, DOI 10.1016/j.fm.2014.02.007	67	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197773	10.1371/journal.pone.0197773	http://dx.doi.org/10.1371/journal.pone.0197773			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795627	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300072
J	Maru, S; Uchino, H; Osawa, T; Chiba, S; Mouri, G; Sazawa, A				Maru, Shintaro; Uchino, Hideki; Osawa, Takahiro; Chiba, Satoshi; Mouri, Gaku; Sazawa, Ataru			Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy	PLOS ONE			English	Article							SUPPRESSION; CARCINOMA; FLUTAMIDE; TRIAL	Purpose Intermittent androgen deprivation therapy is an effective treatment for metastatic prostate cancer. However, no study to date has evaluated the long-term outcomes of this treatment among patients with prostate cancer after radical prostatectomy. We retrospectively examined the treatment outcomes of patients with prostate-specific antigen recurrence who underwent radical prostatectomy at our department. Materials and methods Of the 690 patients who underwent radical prostatectomy for local prostate cancer between 1988 and 2011, 129 patients who received androgen deprivation therapy for prostate-specific antigen recurrence were included in this study. Patient characteristics, luteinizing hormone-releasing hormone agonist administration, and outcomes were compared between the intermittent androgen deprivation group (n = 66) and the continuous androgen deprivation therapy group (n = 63). The non-recurrence and overall survival rates were compared between groups. Results Thirty-six patients (27.9%) experienced recurrence after luteinizing hormone-releasing hormone agonist administration. The 5-year non-recurrence rate and 10-year overall survival rate were higher in the intermittent group (92.9%) than in the continuous group (92.9 vs 57.9%, P < 0.001; and 95.9% vs 84.3%, P = 0.047, respectively). Furthermore, 63 patients (48.8%) showed a PSA nadir of less than 0.01 ng/mL after initiation of luteinizing hormone-releasing hormone agonist; among these patients, the non-recurrence rate was significantly higher in the intermittent androgen deprivation group (P = 0.003). Conclusions Intermittent androgen deprivation therapy for prostate specific antigen recurrence after radical prostatectomy contributed to improvement of the non-recurrence rate and overall survival, and can be considered an effective therapy for better prognosis.	[Maru, Shintaro; Uchino, Hideki; Chiba, Satoshi; Mouri, Gaku; Sazawa, Ataru] Obihiro Kosei Gen Hosp, Dept Urol, Obihiro, Hokkaido, Japan; [Maru, Shintaro] Jinyukai Hosp, Dept Urol, Sapporo, Hokkaido, Japan; [Osawa, Takahiro] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Hokkaido University	Maru, S (corresponding author), Obihiro Kosei Gen Hosp, Dept Urol, Obihiro, Hokkaido, Japan.; Maru, S (corresponding author), Jinyukai Hosp, Dept Urol, Sapporo, Hokkaido, Japan.	maru@jinyukai.or.jp			Department of Urology, Obihiro-Kosei General Hospital; Jinyukai Hospital	Department of Urology, Obihiro-Kosei General Hospital; Jinyukai Hospital	We acknowledge the support and assistance provided by the staff of the Department of Urology, Obihiro-Kosei General Hospital and Jinyukai Hospital.	BRUCHOVSKY N, 1990, CANCER RES, V50, P2275; Brungs D, 2014, PROSTATE CANCER P D, V17, P105, DOI 10.1038/pcan.2014.10; da Silva FECC, 2009, EUR UROL, V55, P1269, DOI 10.1016/j.eururo.2009.02.016; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; de Leval Jean, 2002, Clin Prostate Cancer, V1, P163, DOI 10.3816/CGC.2002.n.018; DENIS LJ, 1993, UROLOGY, V42, P119, DOI 10.1016/0090-4295(93)90634-M; GITTES RF, 1991, NEW ENGL J MED, V324, P236, DOI 10.1056/NEJM199101243240406; Huggins C, 1941, CANCER RES, V1, P293; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; Kaneko Yoshiyuki, 2006, Hinyokika Kiyo, V52, P259; Laitinen S, 2007, EUR UROL, V52, P725, DOI 10.1016/j.eururo.2006.11.043; Langenhuijsen JF, 2013, UROL ONCOL-SEMIN ORI, V31, P549, DOI 10.1016/j.urolonc.2011.03.008; Mottet N, 2012, BJU INT, V110, P1262, DOI 10.1111/j.1464-410X.2012.11120.x; Niraula S, 2013, J CLIN ONCOL, V31, P2029, DOI 10.1200/JCO.2012.46.5492; Palmberg C, 1999, EUR UROL, V36, P191, DOI 10.1159/000067996; Salonen AJ, 2013, EUR UROL, V63, P111, DOI 10.1016/j.eururo.2012.07.040; Sato N, 1996, J STEROID BIOCHEM, V58, P139, DOI 10.1016/0960-0760(96)00018-0; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Tunn UW, 2012, PROSTATE CANCER P D, V15, P296, DOI 10.1038/pcan.2012.12	20	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197252	10.1371/journal.pone.0197252	http://dx.doi.org/10.1371/journal.pone.0197252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795595	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300033
J	McNeil, MD; Bhuiyan, SA; Berkman, PJ; Croft, BJ; Aitken, KS				McNeil, Meredith D.; Bhuiyan, Shamsul A.; Berkman, Paul J.; Croft, Barry J.; Aitken, Karen S.			Analysis of the resistance mechanisms in sugarcane during Sporisorium scitamineum infection using RNA-seq and microscopy	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; USTILAGO-SCITAMINEA; DEFENSE RESPONSES; GENE-EXPRESSION; PLANT DEFENSE; PSEUDOMONAS-SYRINGAE; SMUT RESISTANCE; REACTIVE OXYGEN; FUNGAL; ARABIDOPSIS	Smut caused by biotrophic fungus Sporisorium scitamineum is a major disease of cultivated sugarcane that can cause considerable yield losses. It has been suggested in literature that there are at least two types of resistance mechanisms in sugarcane plants: an external resistance, due to chemical or physical barriers in the sugarcane bud, and an internal resistance governed by the interaction of plant and fungus within the plant tissue. Detailed molecular studies interrogating these two different resistance mechanisms in sugarcane are scarce. Here, we use light microscopy and global expression profiling with RNA-seq to investigate these mechanisms in sugarcane cultivar CP74-2005, a cultivar that possibly possesses both internal and external defence mechanisms. A total of 861 differentially expressed genes (DEGs) were identified in a comparison between infected and noninfected buds at 48 hours post-inoculation (hpi), with 457 (53%) genes successfully annotated using BLAST2GO software. This includes genes involved in the phenylpropanoid pathway, cell wall biosynthesis, plant hormone signal transduction and disease resistance genes. Finally, the expression of 13 DEGs with putative roles in S. scitamineum resistance were confirmed by quantitative real-time reverse transcription PCR (qRT-PCR) analysis, and the results were consistent with the RNA-seq data. These results highlight that the early sugarcane response to S. scitamineum infection is complex and many of the disease response genes are attenuated in sugarcane cultivar CP74-2005, while others, like genes involved in the phenylpropanoid pathway, are induced. This may point to the role of the different disease resistance mechanisms that operate in cultivars such as CP74-2005, whereby the early response is dominated by external mechanisms and then as the infection progresses, the internal mechanisms are switched on. Identification of genes underlying resistance in sugarcane will increase our knowledge of the sugarcane-S. scitamineum interaction and facilitate the introgression of new resistance genes into commercial sugarcane cultivars.	[McNeil, Meredith D.; Berkman, Paul J.; Aitken, Karen S.] CSIRO Plant Ind, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Bhuiyan, Shamsul A.; Croft, Barry J.] Sugar Res Australia Ltd SRA, Woodford, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	McNeil, MD (corresponding author), CSIRO Plant Ind, Queensland Biosci Precinct, St Lucia, Qld, Australia.	Meredith.McNeil@csiro.au	Bhuiyan, Shamsul/AAB-1407-2021; aitken, karen/I-5817-2012; McNeil, Meredith D/L-6287-2018	Bhuiyan, Shamsul/0000-0001-7245-670X; aitken, karen/0000-0003-4372-0721; McNeil, Meredith D/0000-0003-4671-7210	Sugar Research Australia Ltd [CPI026]	Sugar Research Australia Ltd(Sugar Research Australia)	This work was funded by Sugar Research Australia Ltd (Project: CPI026). The funder provided support in the form of salaries for authors SAB and BJC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adhikari TB, 2007, PHYSIOL MOL PLANT P, V71, P55, DOI 10.1016/j.pmpp.2007.10.004; Alexander K.C., 1980, P INT SOC SUGARCANE, V17, P1452; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Bhuiyan S. A., 2010, Proceedings of the 2010 Conference of the Australian Society of Sugar Cane Technologists held at Bundaberg, Queensland, Australia, 11-14 May 2010, P355; Bhuiyan SA, 2013, CROP PASTURE SCI, V64, P892, DOI 10.1071/CP13286; Blanch M, 2007, COMMUNICATING CURREN, P163; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Bonello P, 2003, PHYSIOL MOL PLANT P, V63, P249, DOI 10.1016/j.pmpp.2004.02.002; Borras-Hidalgo O, 2005, PLANT PHYSIOL BIOCH, V43, P1115, DOI 10.1016/j.plaphy.2005.07.011; Bozkurt TO, 2010, MOL PLANT PATHOL, V11, P625, DOI [10.1111/J.1364-3703.2010.00633.X, 10.1111/j.1364-3703.2010.00633.x]; Butterfield MK, 2004, S AFR J BOT, V70, P167, DOI 10.1016/S0254-6299(15)30277-5; Byther R. S., 1974, Proceedings of the XV Congress of the International Society of Sugar Cane Technologists, 12-29 June, 1974, Durban, South Africa. Vol. 1., P280; Caldo RA, 2006, MOL PLANT MICROBE IN, V19, P939, DOI 10.1094/MPMI-19-0939; Casu RE, 2015, PLANT MOL BIOL, V89, P607, DOI 10.1007/s11103-015-0388-9; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; CHAO CP, 1990, PHYTOPATHOLOGY, V80, P622, DOI 10.1094/Phyto-80-622; Cho SH, 2012, J PLANT BIOL, V55, P64, DOI 10.1007/s12374-011-9190-7; Comstock J.C., 2000, GUIDE SUGARCANE DIS, P181; Coppola M., 2011, THESIS; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Croft BJ, 2008, AUSTRALAS PLANT PATH, V37, P26, DOI 10.1071/AP07083; Croft BJ, 2006, AUSTRALAS PLANT PATH, V35, P113, DOI 10.1071/AP05104; DEAN JL, 1982, PHYTOPATHOLOGY, V72, P1023, DOI 10.1094/Phyto-72-1023; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Ebrahim S, 2011, SCI MICROB PATHOG, V2, P1043, DOI DOI 10.1007/978-3-662-10370-8_7; Fisher RA, 1934, STAT METHODS RES WOR, V5th; Fontaniella B, 2002, PLANT PHYSIOL BIOCH, V40, P881, DOI 10.1016/S0981-9428(02)01443-2; Gallego-Giraldo L, 2011, NEW PHYTOL, V190, P627, DOI 10.1111/j.1469-8137.2010.03621.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gomez LD, 2004, J EXP BOT, V55, P1851, DOI 10.1093/jxb/erh202; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Hancock JT, 2002, PLANT PHYSIOL BIOCH, V40, P611, DOI 10.1016/S0981-9428(02)01403-1; Hano C, 2006, PLANTA, V224, P1291, DOI 10.1007/s00425-006-0308-y; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Heinze B. S., 2001, P S AFR SUG TECHNOL, V75, P88; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; JONGEDIJK E, 1995, EUPHYTICA, V85, P173, DOI 10.1007/BF00023946; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Keller B., 2000, MECH RESISTANCE PLAN, P101, DOI [10.1007/978-94-011-3937-3.5, DOI 10.1007/978-94-011-3937-3.5, DOI 10.1007/978-94-011-3937-3_5]; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Konig S, 2014, NEW PHYTOL, V202, P823, DOI 10.1111/nph.12709; Kolomiets MV, 2000, PLANT PHYSIOL, V124, P1121, DOI 10.1104/pp.124.3.1121; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; Lee-Lovick G., 1978, Review of Plant Pathology, V57, P181; Legaz ME, 1998, ANAL CHIM ACTA, V372, P201, DOI 10.1016/S0003-2670(98)00331-6; Legaz ME, 2011, SCI MICROBIAL PATHOG, P1244, DOI DOI 10.1016/J.CHOM.2016.04.011; Li CX, 2013, ANN APPL BIOL, V163, P209, DOI 10.1111/aab.12047; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang XX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02643-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd H. L., 1980, South African Sugar Journal, V64, P347; LLOYD HL, 1983, PLANT DIS, V67, P1103, DOI 10.1094/PD-67-1103; Lloyd HL, 1981, SUGARCANE PATHOL NEW, V26, P48; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; Magarey R. C., 2008, Proceedings of the 2008 Conference of the Australian Society of Sugar Cane Technologists held at Townsville, Queensland, Australia, 29 April - 2 May 2008, P72; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; MAUCH F, 1993, PLANT PHYSIOL, V102, P1193, DOI 10.1104/pp.102.4.1193; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; McMARTiN A., 1948, South African Sugar Journal, V32, P737; Miedes E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00358; Millanes AM, 2005, J PLANT PHYSIOL, V162, P253, DOI 10.1016/j.jplph.2004.05.017; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Morris SW, 1998, MOL PLANT MICROBE IN, V11, P643, DOI 10.1094/MPMI.1998.11.7.643; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Oliveira MDM, 2016, PHYTOCHEM LETT, V15, P152, DOI 10.1016/j.phytol.2015.12.011; Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Peng Q, 2017, PLANT CELL REP, V36, P1427, DOI 10.1007/s00299-017-2166-4; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Peters LP, 2017, PLANTA, V245, P749, DOI 10.1007/s00425-016-2642-z; Que Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106476, DOI 10.1371/JOURNAL.P0NE.0106476]; Que YX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/989016; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramirez V, 2011, PLANT PHYSIOL, V155, P1920, DOI 10.1104/pp.110.171843; Ravichandran S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-107; Rossi M, 2003, MOL GENET GENOMICS, V269, P406, DOI 10.1007/s00438-003-0849-8; Rusterucci C, 1999, J BIOL CHEM, V274, P36446, DOI 10.1074/jbc.274.51.36446; Santiago R, 2012, PHYSIOL PLANTARUM, V145, P245, DOI 10.1111/j.1399-3054.2012.01577.x; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; Schaker PDC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162237; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Senda K, 2004, PLANT CELL PHYSIOL, V45, P1578, DOI 10.1093/pcp/pch179; SINGH K, 1964, P BIEN C SUG RES DEV, V5, P687; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; SINHA OK, 1982, PLANT DIS, V66, P932, DOI 10.1094/PD-66-932; Smith AH, 2007, FOREST PATHOL, V37, P361, DOI 10.1111/j.1439-0329.2007.00502.x; SNYDER BA, 1990, SCIENCE, V248, P1637, DOI 10.1126/science.248.4963.1637; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Song X., 2013, LIFE SCI J, V10, P3026; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Stoll M, 2003, CAN J BOT, V81, P976, DOI [10.1139/b03-094, 10.1139/B03-094]; Su YC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3146-8; Su YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10708; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Taniguti LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129318; Thokoane L. N., 2001, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P104; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; TRIONE EJ, 1990, MYCOL RES, V94, P489, DOI 10.1016/S0953-7562(10)80008-5; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; WALLER JM, 1970, T BRIT MYCOL SOC, V54, P405, DOI 10.1016/S0007-1536(70)80155-3; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Wei YD, 1998, PLANT MOL BIOL, V36, P101, DOI 10.1023/A:1005955119326; WHITTLE AM, 1982, TROP PEST MANAGE, V28, P228, DOI 10.1080/09670878209370715; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; WU KK, 1988, THEOR APPL GENET, V75, P754, DOI 10.1007/BF00265601; Wu QB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/298920; Xu XM, 1998, PHYTOPATHOLOGY, V88, P1000, DOI 10.1094/PHYTO.1998.88.10.1000; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328	130	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197840	10.1371/journal.pone.0197840	http://dx.doi.org/10.1371/journal.pone.0197840			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795614	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300078
J	Sims, EK; Park, G; Mather, KJ; Mirmira, RG; Liu, ZY; Gupta, SK				Sims, Emily K.; Park, Grace; Mather, Kieren J.; Mirmira, Raghavendra G.; Liu, Ziyue; Gupta, Samir K.			Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-PEPTIDE RATIO; INSULIN-RESISTANCE; DIABETES-MELLITUS; ANTIRETROVIRAL THERAPY; BODY-COMPOSITION; LIFE EXPECTANCY; RISK-FACTORS; GLUCOSE; PROINSULIN	HIV infection has been associated with increased diabetes risk, but prior work has mostly focused on insulin resistance, as opposed to beta cell effects, or included patients on antiretroviral therapies (ART) directly linked to metabolic toxicity. In this analysis, we measured markers of glucose homeostasis and beta cell function, stress, and death in fasting sera from a cross section of HIV+ individuals off ART (n = 43), HIV+ individuals on ART (n = 23), and HIV- controls (n = 39). Markers included glucose, HOMA%S, HOMA%B, proinsulin:Cpeptide ratio (Pl:C ratio), and circulating preproinsulin (INS) DNA. We performed multiple linear regressions with adjustments for age, sex, race, BMI, and smoking status. Compared to HIV- controls, HIV+ participants off ART exhibited similar beta cell function and insulin sensitivity, without increases in markers of beta cell stress or death. Specifically, in HIV+ participants with CD4 counts <350 cells/mu L, Pl:C ratios were lower than in HIV- controls (p<0.01), suggesting a reduction in intrinsic beta cell stress among this group. By contrast, HIV+ participants on ART had higher fasting glucose (p<0.0001) and lower HOMA%B (p<0.001) compared to HIV- controls. Among the entire HIV+ population, higher HIV RNA correlated with lower fasting glucose (r = -0.57, p<0.001), higher HOMA%B (r = 0.40, p = 0.001), and lower Pl:C ratios (r = -0.42, p<0.001), whereas higher CD4 counts correlated with higher Pl:C ratios (r = 0.2, p = 0.00499). Our results suggest that HIV seropositivity in the absence of ART does not worsen beta cell function or glucose homeostasis, but immune reconstitution with ART may be associated with worsened beta cell function.	[Sims, Emily K.; Park, Grace; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Sims, Emily K.; Park, Grace; Mather, Kieren J.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Sims, Emily K.; Park, Grace; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Mather, Kieren J.; Mirmira, Raghavendra G.; Gupta, Samir K.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Liu, Ziyue] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Gupta, Samir K.] Indiana Univ Sch Med, Div Infect Dis, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Sims, EK (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.; Sims, EK (corresponding author), Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA.; Sims, EK (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	eksims@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020; Mather, Kieren/ABE-4117-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Gupta, Samir/0000-0001-6031-8705	National Institutes of Health; National Institute of Diabetes and Digestive Kidney Diseases [K08DK103983]; National Institutes of Health [UC4 DK 104166, R01HL095149]; Diabetes Research Center [P30 DK097512]; National Center for Research Resources; Construction Grant [RR020128]; Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; Gilead Sciences; GlaxoSmithKline/ViiV; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060581, K08DK103983, UC4DK104166, P30DK097512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Construction Grant; Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; Gilead Sciences(Gilead Sciences); GlaxoSmithKline/ViiV; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This manuscript was supported by funding from National Institutes of Health (https://www.nih.gov/), National Institute of Diabetes and Digestive Kidney Diseases (https://www.niddk.nih.gov/), K08DK103983 to E.K.S; National Institutes of Health, UC4 DK 104166 (to R.G.M.); and National Institutes of Health, R01HL095149 (to S. K.G.). This work utilized core services provided by the Diabetes Research Center (https://www.diabetesresearch.org/) grant P30 DK097512 (to Indiana University School of Medicine) and National Center for Research Resources (hops://www.nih.gov/research-traing/research-resources) Construction Grant # RR020128; Indiana Clinical and Translational Sciences Institute (http://iuhealth.org/researchers/research-centers/indiana-clinical-translatianal-sciences-institute/) funded, in part by Award Number UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. Dr. Gupta reports funding from Gilead Sciences (http://www.gilead.com/); advisory board fees from Gilead Sciences and GlaxoSmithKline/ViiV (https://www.gsk.com/en-gb/produpts/viiv-healthcare/); and travel support to present data at scientific conferences from Gilead Sciences and Bristol-Myers Squibb (https://www.bms.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; Alvaro-Meca A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161953; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Blumer RME, 2008, AIDS, V22, P227, DOI 10.1097/QAD.0b013e3282f33557; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Cheney L, 2011, J INFECT DIS, V203, P1824, DOI 10.1093/infdis/jir170; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Dirajlal- Fargo S, 2016, OPEN FORUM INFECT DI; Dysangco A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183511; Engelson ES, 2006, METABOLISM, V55, P1327, DOI 10.1016/j.metabol.2006.05.018; Fisher MM, 2015, DIABETES, V64, P3867, DOI 10.2337/db15-0430; Fisher MM, 2013, ENDOCRINOLOGY, V154, P3476, DOI 10.1210/en.2013-1223; Fleischman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1666, DOI 10.1152/ajpendo.00550.2006; Freitas P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-180; Galli L, 2012, EUR J EPIDEMIOL, V27, P657, DOI 10.1007/s10654-012-9707-5; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Geffner ME, 2011, HORM RES PAEDIAT, V76, P386, DOI 10.1159/000332957; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Gupta SK, 2016, AIDS, V30, P2389, DOI 10.1097/QAD.0000000000001222; Han JH, 2017, DIABETES CARE, V40, P218, DOI 10.2337/dc16-0718; Han JH, 2012, AIDS, V26, P2087, DOI 10.1097/QAD.0b013e328359a8e5; Hernandez-Romieu AC, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000304; Hruz PW, 2011, BEST PRACT RES CL EN, V25, P459, DOI 10.1016/j.beem.2010.10.017; Isa SE, 2016, CLIN INFECT DIS, V63, P830, DOI 10.1093/cid/ciw381; Kaneto H, 2015, CURR DIABETES REV, V11, P2, DOI 10.2174/1573399811666141216160217; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Klein SL, 2012, BIOESSAYS, V34, P1050, DOI 10.1002/bies.201200099; Koeppe J, 2006, CLIN INFECT DIS, V42, pE79, DOI 10.1086/503573; Koethe JR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003634; Koethe JR, 2016, AIDS, V30, P83, DOI 10.1097/QAD.0000000000000893; Koster JC, 2003, DIABETES, V52, P1695, DOI 10.2337/diabetes.52.7.1695; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Limone P, 2003, J INFECTION, V47, P52, DOI 10.1016/S0163-4453(03)00055-0; Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P3047, DOI 10.1007/s00125-011-2322-2; May Margaret, 2011, BMJ, V343, pd6016, DOI 10.1136/bmj.d6016; McMahon CN, 2017, ST VINCENTS HIV DIAB; Mohammed AE, 2015, DIABET METAB SYND OB, V8, P197, DOI 10.2147/DMSO.S80084; Monroe AK, 2011, JAIDS-J ACQ IMM DEF, V58, P173, DOI 10.1097/QAI.0b013e3182278c09; Mynarcik DC, 2000, J ACQ IMMUN DEF SYND, V25, P312, DOI 10.1097/00126334-200012010-00004; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Ofotokun I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9282; Orlowski T, 1986, Pol Tyg Lek, V41, P741; Paik IJ, 2011, BEST PRACT RES CL EN, V25, P469, DOI 10.1016/j.beem.2011.04.003; Press Natasha M, 2004, Endocr Pract, V10, P199; Rasmussen LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044575; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Shrivastav S, 2008, MOL ENDOCRINOL, V22, P234, DOI 10.1210/me.2007-0124; Sims EK, 2016, DIABETES CARE, V39, P1519, DOI 10.2337/dc15-2849; Stanley TL, 2012, J INFECT DIS, V205, pS383, DOI 10.1093/infdis/jis205; Steiner DF, 2011, METHODS MOL BIOL, V768, P3, DOI 10.1007/978-1-61779-204-5_1; Steiniche D, 2016, T ROY SOC TROP MED H, V110, P219, DOI 10.1093/trstmh/trw017; Tersey SA, 2016, JOVE-J VIS EXP, DOI 10.3791/54838; Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0; van der Valk M, 2001, AIDS, V15, P2093, DOI 10.1097/00002030-200111090-00004; Vangipurapu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124028; Voss TS, 2017, DIABETES, V66, P2483, DOI 10.2337/db16-1559; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weitzmann MN, 2017, J INFECT DIS, V216, P1070, DOI 10.1093/infdis/jix444	67	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197080	10.1371/journal.pone.0197080	http://dx.doi.org/10.1371/journal.pone.0197080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795574	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300024
J	Liao, CP; Lin, TP; Li, PC; Geary, LA; Chen, K; Vaikari, VP; Wu, JB; Lin, CH; Gross, ME; Shih, JC				Liao, Chun-Peng; Lin, Tzu-Ping; Li, Pei-Chuan; Geary, Lauren A.; Chen, Kevin; Vaikari, Vijaya Pooja; Wu, Jason Boyang; Lin, Chi-Hung; Gross, Mitchell E.; Shih, Jean C.			Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate	ONCOGENE			English	Article							MONOAMINE-OXIDASE-A; PTEN; MICE; IDENTIFICATION; TUMORIGENESIS; MAINTENANCE; PROGRESSION; FIBROBLASTS; HIF-1-ALPHA; GENERATION	Monoamine oxidase A (MAOA) is a mitochondrial enzyme, which degrades monoamine neurotransmitters and dietary amines and produces H2O2. Recent studies have shown increased MAOA expression in prostate cancer (PCa), glioma, and classical Hodgkin lymphoma. However, the biological function of MAOA in cancer development remains unknown. In this study, we investigated the role of MAOA in the development of prostate adenocarcinoma by creating a prostate-specific Pten/MAOA knockout (KO) mouse model, in which MAOA-floxP mouse was crossed with the conditional Pten KO PCa mouse that develops invasive PCa. In contrast to Pten KO mice, age-matched Pten/MAOA KO mice exhibited a significant decrease in both prostate size and the incidence of invasive cancer. We observed a significant decline in AKT phosphorylation and Ki67 expression in Pten/MAOA KO mice, which reduced epithelial cell growth and proliferation. As cancer stem cells (CSCs) are required for tumor initiation and growth, we investigated expression of OCT4 and NANOG in the setting of decreased MAOA expression. We found that both OCT4 and NANOG were significantly attenuated in the prostate epithelia of Pten/MAOA KO mice compared to Pten KO mice, which was confirmed with targeted knockdown of MAOA with a short-hairpin(sh) vector targeting MAOA compared to cells transfected with a control vector. Expression of other markers associated with the a stem cell phenotype, including CD44, alpha 2 beta 1, and CD133 as well as HIF-1 alpha(+)CD44(+) stem cells were all decreased in shMAOA PCa cells compared with empty vector-transfected control cells. We also found spheroid formation ability in PCa cells was decreased when endogenous MAOA was suppressed by siRNA or MAOA inhibitor clorgyline in a colony formation assay. Using the TCGA database, elevatedMAOA expression was associated with reduced Pten levels in high Gleason grade in patient samples. Further, we found that Pten-positive PCa cells were more resistant to clorgyline treatments than Pten-null cells in tumorigenicity and stemness. Taken together, these studies suggest that MAOA expression promotes PCa development by increasing cell proliferation and CSCs and highlights the potential use of MAOA inhibitors for the treatment of PCa.	[Liao, Chun-Peng; Lin, Tzu-Ping; Li, Pei-Chuan; Geary, Lauren A.; Chen, Kevin; Vaikari, Vijaya Pooja; Shih, Jean C.] Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Liao, Chun-Peng; Lin, Tzu-Ping; Li, Pei-Chuan; Geary, Lauren A.; Chen, Kevin; Vaikari, Vijaya Pooja; Shih, Jean C.] USC, Taiwan Ctr Translat Res, Los Angeles, CA 90089 USA; [Liao, Chun-Peng; Gross, Mitchell E.] Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Los Angeles, CA 90033 USA; [Lin, Tzu-Ping; Lin, Chi-Hung] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 11221, WA, Taiwan; [Wu, Jason Boyang] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA 99210 USA; [Gross, Mitchell E.; Shih, Jean C.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Shih, Jean C.] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Shih, Jean C.] Taipei Med Univ, Coll Pharm, Taipei 11031, Taiwan	University of Southern California; University of Southern California; University of Southern California; National Yang Ming Chiao Tung University; Washington State University; University of Southern California; University of Southern California; Taipei Medical University	Shih, JC (corresponding author), Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.; Shih, JC (corresponding author), USC, Taiwan Ctr Translat Res, Los Angeles, CA 90089 USA.; Shih, JC (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA.; Shih, JC (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA.; Shih, JC (corresponding author), Taipei Med Univ, Coll Pharm, Taipei 11031, Taiwan.	jcshih@usc.edu	Vaikari, Vijaya/GRR-4324-2022; Vaikari, Vijaya/ABH-2110-2021; Chen, Kevin/GYU-8963-2022	Vaikari, Vijaya/0000-0001-9175-3558; Liao, Chun-Peng/0000-0001-8920-4322	Department of Defense Prostate Cancer Research Program [W81XWH-12-1-0282]; Daniel Tsai Family Fund; Boyd and Elsie Welin Professorship	Department of Defense Prostate Cancer Research Program(United States Department of Defense); Daniel Tsai Family Fund; Boyd and Elsie Welin Professorship	This work was supported by the Department of Defense Prostate Cancer Research Program grant W81XWH-12-1-0282, the Daniel Tsai Family Fund, and the Boyd and Elsie Welin Professorship (to JCS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Defense or other funding agency.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Adisetiyo H, 2014, J CELL PHYSIOL, V229, P1170, DOI 10.1002/jcp.24546; Adisetiyo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069484; Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Bortolato M, 2011, NEUROPSYCHOPHARMACOL, V36, P2674, DOI 10.1038/npp.2011.157; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dawood S, 2014, ONCOLOGY-NY, V28, P1101; Dillon LM, 2014, CURR DRUG TARGETS, V15, P65, DOI 10.2174/1389450114666140106100909; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Epstein JI, 2016, EUR UROL, V69, P428, DOI 10.1016/j.eururo.2015.06.046; Forristal CE, 2015, LEUKEMIA, V29, P1366, DOI 10.1038/leu.2015.8; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; GOTTOWIK J, 1993, FEBS LETT, V317, P152, DOI 10.1016/0014-5793(93)81512-X; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Kushal S, 2016, ONCOTARGET, V7, P13842, DOI 10.18632/oncotarget.7283; Lawson DA, 2005, COLD SH Q B, V70, P187, DOI 10.1101/sqb.2005.70.003; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li PC, 2017, J PATHOL, V243, P220, DOI 10.1002/path.4944; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Liao Chun-Peng, 2010, Hormones & Cancer, V1, P297, DOI 10.1007/s12672-010-0051-5; Liao CP, 2010, CANCER RES, V70, P7294, DOI 10.1158/0008-5472.CAN-09-3982; Ma JC, 2002, J BIOCHEM, V131, P107, DOI 10.1093/oxfordjournals.jbchem.a003064; Nikitin AY, 2007, HISTOL HISTOPATHOL, V22, P1043, DOI 10.14670/HH-22.1043; Oliveira DSM, 2016, BOSNIAN J BASIC MED, V16, P8, DOI 10.17305/bjbms.2016.917; Peehl DM, 2008, J UROLOGY, V180, P2206, DOI 10.1016/j.juro.2008.07.019; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Sahlberg SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094621; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh C, 2013, P NATL ACAD SCI USA, V110, P12816, DOI 10.1073/pnas.1308037110; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Ting MC, 2012, DIS MODEL MECH, V5, P366, DOI 10.1242/dmm.008458; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu JB, 2015, J AM CHEM SOC, V137, P2366, DOI 10.1021/ja512613j; Wu JB, 2014, J CLIN INVEST, V124, P2891, DOI 10.1172/JCI70982; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xu S, 2015, BRIT J CANCER, V113, P242, DOI 10.1038/bjc.2015.228	50	31	32	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5175	5190		10.1038/s41388-018-0325-x	http://dx.doi.org/10.1038/s41388-018-0325-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29844571	Green Accepted			2022-12-26	WOS:000445093100003
J	Fong, LK; Yang, MM; Chaves, RD; Reyna, SM; Langness, VF; Woodruff, G; Roberts, EA; Young, JE; Goldstein, LSB				Fong, Lauren K.; Yang, Max M.; Chaves, Rodrigo dos Santos; Reyna, Sol M.; Langness, Vanessa F.; Woodruff, Grace; Roberts, Elizabeth A.; Young, Jessica E.; Goldstein, Lawrence S. B.			Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid- clearance in human astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; amyloid precursor protein (APP); amyloid-beta (A); Alzheimer disease; cholesterol metabolism; induced pluripotent stem cell (iPS cell) (iPSC); lipoprotein receptor; lipoprotein metabolism	RECEPTOR-RELATED PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; PLURIPOTENT STEM-CELLS; BETA-SECRETASE CLEAVAGE; A-BETA; APOLIPOPROTEIN-E; CHOLESTEROL-METABOLISM; AXONAL-TRANSPORT; TRANSGENIC MICE; HUMAN PLASMA	Mounting evidence suggests that alterations in cholesterol homeostasis are involved in Alzheimer's disease (AD) pathogenesis. Amyloid precursor protein (APP) or multiple fragments generated by proteolytic processing of APP have previously been implicated in the regulation of cholesterol metabolism. However, the physiological function of APP in regulating lipoprotein homeostasis in astrocytes, which are responsible for de novo cholesterol biosynthesis and regulation in the brain, remains unclear. To address this, here we used CRISPR/Cas9 genome editing to generate isogenic APP-knockout (KO) human induced pluripotent stem cells (hiPSCs) and differentiated them into human astrocytes. We found that APP-KO astrocytes have reduced cholesterol and elevated levels of sterol regulatory element-binding protein (SREBP) target gene transcripts and proteins, which were both downstream consequences of reduced lipoprotein endocytosis. To elucidate which APP fragments regulate cholesterol homeostasis and to examine whether familial AD mutations in APP affect lipoprotein metabolism, we analyzed an isogenic allelic series harboring the APP Swedish and APP V717F variants. Only astrocytes homozygous for the APP Swedish (APP(Swe/Swe)) mutation, which had reduced full-length APP (FL APP) due to increased -secretase cleavage, recapitulated the APP-KO phenotypes. Astrocytic internalization of -amyloid (A), another ligand for low-density lipoprotein (LDL) receptors, was also impaired in APP-KO and APP(Swe/Swe) astrocytes. Finally, impairing cleavage of FL APP through -secretase inhibition in APP(Swe/Swe) astrocytes reversed the LDL and A endocytosis defects. In conclusion, FL APP is involved in the endocytosis of LDL receptor ligands and is required for proper cholesterol homeostasis and A clearance in human astrocytes.	[Fong, Lauren K.; Yang, Max M.; Chaves, Rodrigo dos Santos; Reyna, Sol M.; Langness, Vanessa F.; Woodruff, Grace; Roberts, Elizabeth A.; Young, Jessica E.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Young, Jessica E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Young, Jessica E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Fong, Lauren K.; Yang, Max M.; Chaves, Rodrigo dos Santos; Reyna, Sol M.; Langness, Vanessa F.; Woodruff, Grace; Roberts, Elizabeth A.; Goldstein, Lawrence S. B.] Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Goldstein, LSB (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu	; Yang, Max/N-1982-2018	dos Santos Chaves, Rodrigo/0000-0003-0762-7634; Yang, Max/0000-0001-9808-0675	National Institutes of Health Predoctoral Training Grant [T32 GM008666]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/18028-9]; National Institutes of Health Grants from NIA [RF1 AG048083-01, 2P50 AG005131-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, RF1AG048083] Funding Source: NIH RePORTER	National Institutes of Health Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health Grants from NIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or part by National Institutes of Health Predoctoral Training Grant T32 GM008666; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 2013/18028-9, and National Institutes of Health Grants RF1 AG048083-01 and 2P50 AG005131-31 from NIA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almenar-Queralt A, 2014, J NEUROSCI, V34, P3320, DOI 10.1523/JNEUROSCI.1503-13.2014; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Chen AK, 2008, ANAL CHEM, V80, P7437, DOI 10.1021/ac8011347; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; D'Antonio M, 2017, STEM CELL REP, V8, P1101, DOI 10.1016/j.stemcr.2017.03.011; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hass S, 1998, J BIOL CHEM, V273, P13892; Holtzman DM, 2011, SCI TRANSL MED, V3; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Knauer MF, 1996, BRAIN RES, V740, P6, DOI 10.1016/S0006-8993(96)00711-1; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nicolas M, 2014, DEVELOPMENT, V141, P2543, DOI 10.1242/dev.108712; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Ryan NS, 2016, LANCET NEUROL, V15, P1326, DOI 10.1016/S1474-4422(16)30193-4; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; TOPPER R, 1995, ACTA NEUROPATHOL, V89, P23; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang W, 2014, FASEB J, V28, P849, DOI 10.1096/fj.13-239301; Woodruff G, 2016, CELL REP, V17, P759, DOI 10.1016/j.celrep.2016.09.034; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; Yamakawa H, 2010, J BIOL CHEM, V285, P1634, DOI 10.1074/jbc.M109.066753; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	78	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11341	11357		10.1074/jbc.RA117.000441	http://dx.doi.org/10.1074/jbc.RA117.000441			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858247	Green Published, hybrid			2022-12-26	WOS:000439449700007
J	Ho, PY; Li, H; Pavlov, TS; Tuerk, RD; Tabares, D; Brunisholz, R; Neumann, D; Staruschenko, A; Hallows, KR				Ho, Pei-Yin; Li, Hui; Pavlov, Tengis S.; Tuerk, Roland D.; Tabares, Diego; Brunisholz, Rene; Neumann, Dietbert; Staruschenko, Alexander; Hallows, Kenneth R.			beta(1)Pix exchange factor stabilizes the ubiquitin ligase Nedd4-2 and plays a critical role in ENaC regulation by AMPK in kidney epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); epithelial sodium channel (ENaC); ubiquitin ligase; sodium transport; 14-3-3 protein; kidney; -Pix	ACTIVATED PROTEIN-KINASE; NA+ CHANNEL; SODIUM-CHANNEL; BETA-PIX; FUNCTIONAL REGULATION; CELLULAR-ENERGY; C-CBL; PHOSPHORYLATION; INHIBITION; SERUM	Our previous work has established that the metabolic sensor AMP-activated protein kinase (AMPK) inhibits the epithelial Na+ channel (ENaC) by promoting its binding to neural precursor cell-expressed, developmentally down-regulated 4-2, E3 ubiquitin protein ligase (Nedd4-2). Here, using MS analysis and in vitro phosphorylation, we show that AMPK phosphorylates Nedd4-2 at the Ser-444 (Xenopus Nedd4-2) site critical for Nedd4-2 stability. We further demonstrate that the Pak-interacting exchange factor (1)Pix is required for AMPK-mediated inhibition of ENaC-dependent currents in both CHO and murine kidney cortical collecting duct (CCD) cells. Short hairpin RNA-mediated knockdown of (1)Pix expression in CCD cells attenuated the inhibitory effect of AMPK activators on ENaC currents. Moreover, overexpression of a (1)Pix dimerization-deficient mutant unable to bind 14-3-3 proteins (602-611) increased ENaC currents in CCD cells, whereas overexpression of WT (1)Pix had the opposite effect. Using additional immunoblotting and co-immunoprecipitation experiments, we found that treatment with AMPK activators promoted the binding of (1)Pix to 14-3-3 proteins in CCD cells. However, the association between Nedd4-2 and 14-3-3 proteins was not consistently affected by AMPK activation, (1)Pix knockdown, or overexpression of WT (1)Pix or the (1)Pix-602-611 mutant. Moreover, we found that (1)Pix is important for phosphorylation of the aforementioned Nedd4-2 site critical for its stability. Overall, these findings elucidate novel molecular mechanisms by which AMPK regulates ENaC. Specifically, they indicate that AMPK promotes the assembly of (1)Pix, 14-3-3 proteins, and Nedd4-2 into a complex that inhibits ENaC by enhancing Nedd4-2 binding to ENaC and its degradation.	[Ho, Pei-Yin; Li, Hui; Tabares, Diego; Hallows, Kenneth R.] Univ Southern Calif, Keck Sch Med, Dept Med, Div Nephrol & Hypertens, Los Angeles, CA 90033 USA; [Ho, Pei-Yin; Li, Hui; Tabares, Diego; Hallows, Kenneth R.] Univ Southern Calif, Keck Sch Med, USC UKRO Kidney Res Ctr, Los Angeles, CA 90033 USA; [Pavlov, Tengis S.] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Detroit, MI 48202 USA; [Pavlov, Tengis S.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Tuerk, Roland D.; Neumann, Dietbert] Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Brunisholz, Rene] Swiss Fed Inst Technol, Funct Genom Ctr, CH-8097 Zurich, Switzerland; [Neumann, Dietbert] Maastricht Univ, Sch Cardiovasc Dis, Dept Pathol, NL-6200 MD Maastricht, Netherlands	University of Southern California; University of Southern California; Henry Ford Health System; Henry Ford Hospital; Medical College of Wisconsin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Maastricht University	Hallows, KR (corresponding author), USC, Keck Sch Med, USC UKRO Kidney Res Ctr, Div Nephrol & Hypertens, 2020 Zonal Ave,IRD 806, Los Angeles, CA 90033 USA.	hallows@usc.edu		Hallows, Kenneth/0000-0002-2964-2440; Neumann, Dietbert/0000-0002-4316-684X; Staruschenko, Alexander/0000-0002-5190-8356	NIDDK, National Institutes of Health [R01 DK075048]; NHLBI, National Institutes of Health [K99/R00 HL116603, R01 HL108880, R35 HL135749]; EU FP6 Contract [LSHM-CT-2004-005272]; Netherlands Organization for Scientific Research VIDI Grant [864.10.007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL116603, R00HL116603, R35HL135749, R01HL108880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EU FP6 Contract; Netherlands Organization for Scientific Research VIDI Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant R01 DK075048 (to K.R.H.); NHLBI, National Institutes of Health Grants K99/R00 HL116603 (to T.S.P.) and R01 HL108880 and R35 HL135749 (to A. S.); EU FP6 Contract LSHM-CT-2004-005272 (EXGENESIS) (to D.N. and R. D. T.); and Netherlands Organization for Scientific Research VIDI Grant 864.10.007 (to D. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almaca J, 2009, PFLUG ARCH EUR J PHY, V458, P713, DOI 10.1007/s00424-009-0660-4; Alzamora R, 2013, AM J PHYSIOL-RENAL, V305, pF943, DOI 10.1152/ajprenal.00303.2013; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Cammisotto PG, 2008, AM J PHYSIOL-RENAL, V294, pF881, DOI 10.1152/ajprenal.00373.2007; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chandran S, 2011, J BIOL CHEM, V286, P37830, DOI 10.1074/jbc.M111.293233; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Frank SR, 2012, CURR BIOL, V22, P1747, DOI 10.1016/j.cub.2012.07.011; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gleason CE, 2015, J CLIN INVEST, V125, P117, DOI 10.1172/JCI73935; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hallows KR, 2010, J BIOL CHEM, V285, P21671, DOI 10.1074/jbc.M109.084731; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Koh CG, 2001, J CELL SCI, V114, P4239; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Mukherjee A, 2017, J BIOL CHEM, V292, P4152, DOI 10.1074/jbc.M117.776146; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Pastor-Soler NM, 2012, CURR OPIN NEPHROL HY, V21, P523, DOI 10.1097/MNH.0b013e3283562390; Pavlov TS, 2010, J AM SOC NEPHROL, V21, P833, DOI 10.1681/ASN.2009080885; Peairs A, 2009, CLIN EXP IMMUNOL, V156, P542, DOI 10.1111/j.1365-2249.2009.03924.x; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00154; Staub O, 2005, J AM SOC NEPHROL, V16, P3167, DOI 10.1681/ASN.2005050454; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Stevens BM, 2014, STEM CELLS, V32, P1124, DOI 10.1002/stem.1644; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	70	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11612	11624		10.1074/jbc.RA118.003082	http://dx.doi.org/10.1074/jbc.RA118.003082			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858246	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000439449700029
J	Jennings, GK; Hsu, MH; Shock, LS; Johnson, EF; Hackett, JC				Jennings, Gareth K.; Hsu, Mei-Hui; Shock, Lisa S.; Johnson, Eric F.; Hackett, John C.			Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; Raman spectroscopy; X-ray crystallography; heme; ultraviolet-visible spectroscopy; CYP4B1; heme distortion; hydrocarbon; resonance raman; regiochemistry; regioselectivity; omega-hydroxylation; substrate specificity	RESONANCE RAMAN-SPECTRA; PROTEIN COVALENT BONDS; OMEGA-HYDROXYLATION; PROSTHETIC HEME; RABBIT CYP4B1; P450 ENZYMES; ACID; METABOLISM; HEMOGLOBIN; MECHANISM	Cytochrome P450 4B1 (4B1) functions in both xenobiotic and endobiotic metabolism. An ester linkage between Glu-310 in 4B1 and the 5-methyl group of heme facilitates preferential hydroxylation of terminal () methyl groups of hydrocarbons (HCs) and fatty acids compared with -1 sites bearing weaker C-H bonds. This preference is retained albeit diminished 4-fold for the E310A mutant, but the reason for this is unclear. Here, a crystal structure of the E310A-octane complex disclosed that noncovalent interactions maintain heme deformation in the absence of the ester linkage. Consistent with the lower symmetry of the heme, resonance Raman (RR) spectroscopy revealed large enhancements of RR peaks for high-spin HC complexes of 4B1 and the E310A mutant relative to P450 3A4. Whereas these enhancements were diminished in RR spectra of a low-spin 4B1-N-hydroxy-N-(4-butyl-2-methylphenyl)formamidine complex, a crystal structure indicated that this inhibitor does not alter heme ruffling. RR spectra of Fe2+-CO HC complexes revealed larger effects of HC length in E310A than in 4B1, suggesting that reduced rigidity probably underlies increased E310A-catalyzed (-1)-hydroxylation. Diminished effects of the HC on the position of the Fe-CO stretching mode in 4B1 suggested that the ester linkage limits substrate access to the CO. Heme ruffling probably facilitates autocatalytic ester formation by reducing inhibitory coordination of Glu-310 with the heme iron. This also positions the 5-methyl for a reaction with the proposed glutamyl radical intermediate and potentially enhances oxo-ferryl intermediate reactivity for generation of the glutamyl radical to initiate ester bond formation and -hydroxylation.	[Jennings, Gareth K.; Shock, Lisa S.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Jennings, Gareth K.; Shock, Lisa S.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Jennings, Gareth K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Virginia Commonwealth University; Virginia Commonwealth University; Scripps Research Institute; University of California System; University of California San Diego	Johnson, EF (corresponding author), Scripps Res Inst, MEM 255,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Hackett, JC (corresponding author), Virginia Commonwealth Univ, Sch Med, 401 Coll St, Richmond, VA 23298 USA.	johnson@scripps.edu; john.hackett@vcuhealth.org	Hackett, John/J-3871-2019	Hackett, John/0000-0002-4923-2668	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM114168, R01GM031001] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health (including Grant P41GM103393).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auer M, 2014, J BIOL CHEM, V289, P31480, DOI 10.1074/jbc.M114.595157; Baer BR, 2005, BIOCHEMISTRY-US, V44, P13914, DOI 10.1021/bi051267j; Baer BR, 2005, CHEM RES TOXICOL, V18, P855, DOI 10.1021/tx0496993; Baer BR, 2007, BIOCHEMISTRY-US, V46, P11598, DOI 10.1021/bi701064b; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; BILLINGTON D, 1978, BIOCHEM PHARMACOL, V27, P2891, DOI 10.1016/0006-2952(78)90205-8; Borbulevych OY, 2014, ACTA CRYSTALLOGR D, V70, P1233, DOI 10.1107/S1399004714002260; BRESSLER R, 1969, PHARMACOL REV, V21, P105; Brogioni S, 2006, J RAMAN SPECTROSC, V37, P263, DOI 10.1002/jrs.1442; Cerda-Colon JF, 1998, J AM CHEM SOC, V120, P9312, DOI 10.1021/ja972654m; Chang TKH, 2006, DRUG METAB REV, V38, P627, DOI 10.1080/03602530600959433; Cheesman MJ, 2003, ARCH BIOCHEM BIOPHYS, V416, P17, DOI 10.1016/S0003-9861(03)00278-9; Chen ZC, 2003, BIOCHEMISTRY-US, V42, P2542, DOI 10.1021/bi027206s; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; CZERWINSKI M, 1991, CANCER RES, V51, P4636; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Dunford HB, 2000, REDOX REP, V5, P169, DOI 10.1179/135100000101535708; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Fisher MB, 1998, BIOCHEM BIOPH RES CO, V248, P352, DOI 10.1006/bbrc.1998.8842; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Gottfried DS, 1996, J PHYS CHEM-US, V100, P12034, DOI 10.1021/jp9609489; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; He X, 2005, J BIOL CHEM, V280, P22697, DOI 10.1074/jbc.M502632200; Henne KR, 2001, BIOCHEMISTRY-US, V40, P12925, DOI 10.1021/bi011171z; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Hsu MH, 2017, J BIOL CHEM, V292, P5610, DOI 10.1074/jbc.M117.775494; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Huang LS, 2006, J BIOL CHEM, V281, P18983, DOI 10.1074/jbc.M602307200; Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V446, P77, DOI 10.1016/j.abb.2005.11.011; Jennings GK, 2016, MOL PHARMACOL, V90, P42, DOI 10.1124/mol.116.103721; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; JUNG C, 1991, BIOCHIM BIOPHYS ACTA, V1076, P130, DOI 10.1016/0167-4838(91)90229-S; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIMURA S, 1981, BIOCHEMISTRY-US, V20, P4632, DOI 10.1021/bi00519a018; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Limburg J, 2005, BIOCHEMISTRY-US, V44, P4091, DOI 10.1021/bi047686i; Mak PJ, 2004, BIOPOLYMERS, V75, P217, DOI 10.1002/bip.20115; MANTHEY JA, 1986, J BIOL CHEM, V261, P6734; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; Peng JT, 2010, ANAL CHIM ACTA, V683, P63, DOI 10.1016/j.aca.2010.08.033; Podstawka E, 2006, BIOPOLYMERS, V83, P455, DOI 10.1002/bip.20573; RETTIE AE, 1995, BIOCHEMISTRY-US, V34, P7889, DOI 10.1021/bi00024a013; ROBERTSON IGC, 1981, MOL PHARMACOL, V20, P662; SCHULZ H, 1983, BIOCHEMISTRY-US, V22, P1827, DOI 10.1021/bi00277a013; Shaik S, 2004, J AM CHEM SOC, V126, P11746, DOI 10.1021/ja047432k; Spiro T. G., 1988, BIOL APPL RAMAN SPEC, V3; Spiro TG, 2008, SMALLEST BIOMOLECULES: DIATOMICS AND THEIR INTERACTIONS WITH HEME PROTEINS, P95, DOI 10.1016/B978-044452839-1.50005-X; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; ThorntonManning J, 1996, J PHARMACOL EXP THER, V276, P21; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VARADARAJAN R, 1989, SCIENCE, V243, P69, DOI 10.1126/science.2563171; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Zbylut SD, 2002, J AM CHEM SOC, V124, P6751, DOI 10.1021/ja012578u; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737	62	11	13	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11433	11446		10.1074/jbc.RA118.004044	http://dx.doi.org/10.1074/jbc.RA118.004044			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858244	Green Published, hybrid			2022-12-26	WOS:000439449700014
J	Evans, S; Clarke, D; Dowell, NG; Tabet, N; King, SL; Hutton, SB; Rusted, JM				Evans, Simon; Clarke, Devin; Dowell, Nicholas G.; Tabet, Naji; King, Sarah L.; Hutton, Samuel B.; Rusted, Jennifer M.			Using event-related fMRI to examine sustained attention processes and effects of APOE epsilon 4 in young adults	PLOS ONE			English	Article							LONG-TERM-MEMORY; ALZHEIMER-DISEASE RISK; APOLIPOPROTEIN-E; BRAIN ACTIVITY; GENETIC RISK; NICOTINE; MECHANISMS; POLYMORPHISM; PATTERNS; CARRIERS	In this study we investigated effects of the APOE epsilon 4 allele (which confers an enhanced risk of poorer cognitive ageing, and Alzheimer's Disease) on sustained attention (vigilance) performance in young adults using the Rapid Visual Information Processing (RVIP) task and event-related fMRI. Previous fMRI work with this task has used block designs: this study is the first to image an extended (6-minute) RVIP task. Participants were 26 carriers of the APOE epsilon 4 allele, and 26 non carriers (aged 18-28). Pupil diameter was measured throughout, as an index of cognitive effort. We compared activity to RVIP task hits to hits on a control task (with similar visual parameters and response requirements but no working memory load): this contrast showed activity in medial frontal, inferior and superior parietal, temporal and visual cortices, consistent with previous work, demonstrating that meaningful neural data can be extracted from the RVIP task over an extended interval and using an event-related design. Behavioural performance was not affected by genotype; however, a genotype by condition (experimental task/control task) interaction on pupil diameter suggested that epsilon 4 carriers deployed more effort to the experimental compared to the control task. fMRI results showed a condition by genotype interaction in the right hippocampal formation: only epsilon 4 carriers showed downregulation of this region to experimental task hits versus control task hits. Experimental task beta values were correlated against hit rate: parietal correlations were seen in epsilon 4 carriers only, frontal correlations in non-carriers only. The data indicate that, in the absence of behavioural differences, young adult epsilon 4 carriers already show a different linkage between functional brain activity and behaviour, as well as aberrant hippocampal recruitment patterns. This may have relevance for genotype differences in cognitive ageing trajectories.	[Evans, Simon; Clarke, Devin; King, Sarah L.; Hutton, Samuel B.; Rusted, Jennifer M.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Evans, Simon] Univ Surrey, Sch Psychol, Guildford, Surrey, England; [Dowell, Nicholas G.; Tabet, Naji] Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of Sussex; University of Surrey; University of Brighton; University of Sussex	Rusted, JM (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	j.rusted@sussex.ac.uk		Dowell, Nicholas/0000-0002-1978-4779; Clarke, Devin/0000-0002-6407-6384; King, Sarah/0000-0002-7412-9558; Tabet, Naji/0000-0003-4629-6196; Rusted, Jennifer/0000-0002-1341-6334	BBSRC project grant [BB/L009242/1]; BBSRC [BB/L009242/1] Funding Source: UKRI	BBSRC project grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by a BBSRC project grant to Jenny Rusted (BB/L009242/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Bailly M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/583931; Beaver JD, 2011, NEUROPSYCHOPHARMACOL, V36, P1792, DOI 10.1038/npp.2011.53; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Davies G, 2014, MOL PSYCHIATR, V19, P76, DOI 10.1038/mp.2012.159; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Evans S, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.612; Evans S, 2014, NEUROBIOL AGING, V35, P1615, DOI 10.1016/j.neurobiolaging.2014.01.145; Evans S, 2013, NEUROPSYCHOPHARMACOL, V38, P655, DOI 10.1038/npp.2012.230; Fennema-Notestine C, 2011, J ALZHEIMERS DIS, V26, P49, DOI 10.3233/JAD-2011-0002; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fleisher AS, 2005, ARCH NEUROL-CHICAGO, V62, P1881, DOI 10.1001/archneur.62.12.1881; Granholm EL, 2017, J ALZHEIMERS DIS, V56, P1419, DOI 10.3233/JAD-161078; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; JUST MA, 1993, CAN J EXP PSYCHOL, V47, P310, DOI 10.1037/h0078820; Kukolja J, 2010, NEUROSCIENCE, V168, P487, DOI 10.1016/j.neuroscience.2010.03.044; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marchant NL, 2010, NEUROPSYCHOPHARMACOL, V35, P1090, DOI 10.1038/npp.2009.214; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Neale C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138994; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Papesh MH, 2012, INT J PSYCHOPHYSIOL, V83, P56, DOI 10.1016/j.ijpsycho.2011.10.002; Protas HD, 2013, JAMA NEUROL, V70, P320, DOI 10.1001/2013.jamaneurol.286; Randall DC, 2005, J CLIN PSYCHOPHARM, V25, P175, DOI 10.1097/01.jcp.0000155816.21467.25; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; Salvato G, 2016, CORTEX, V82, P206, DOI 10.1016/j.cortex.2016.06.002; Salvato G, 2016, CORTEX, V74, P67, DOI 10.1016/j.cortex.2015.10.019; Schlemmer KB, 2005, PSYCHOPHYSIOLOGY, V42, P465, DOI 10.1111/j.1469-8986.2005.00306.x; Shine JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16322; Stokes MG, 2012, P NATL ACAD SCI USA, V109, pE360, DOI 10.1073/pnas.1108555108; Su YY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001734; Summerfield JJ, 2006, NEURON, V49, P905, DOI 10.1016/j.neuron.2006.01.021; Thompson PM, 2003, J NEUROSCI, V23, P994; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.011; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Tuminello Elizabeth R, 2011, Int J Alzheimers Dis, V2011, P726197, DOI 10.4061/2011/726197; WESNES K, 1983, NEUROPSYCHOBIOLOGY, V9, P223, DOI 10.1159/000117969; Wilhelmus MMM, 2017, J PSYCHOPHARMACOL, V31, P222, DOI 10.1177/0269881116668593; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198312	10.1371/journal.pone.0198312	http://dx.doi.org/10.1371/journal.pone.0198312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856823	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800097
J	Arias-Lorza, AM; Bos, D; van der Lugt, A; de Bruijne, M				Arias-Lorza, Andres M.; Bos, Daniel; van der Lugt, Aad; de Bruijne, Marleen			Cooperative carotid artery centerline extraction in MRI	PLOS ONE			English	Article							LUMEN SEGMENTATION; MULTISPECTRAL MRI; ULTRASOUND	Centerline extraction of the carotid artery in MRI is important to analyze the artery geometry and to provide input for further processing such as registration and segmentation. The centerline of the artery bifurcation is often extracted by means of two independent minimum cost paths ranging from the common to the internal and the external carotid artery. Often the cost is not well defined at the artery bifurcation, leading to centerline errors. To solve this problem, we developed a method to cooperatively extract both centerlines, where in the cost to extract each centerline, we integrate a constraint region derived from the estimated position of the neighbor centerline. This method avoids that both centerlines follow the same cheapest path after the bifurcation, which is a common error when the paths are extracted independently. We show that this method results in less error compared to extracting them independently: 10 failed centerlines Vs. 3 failures in a data set of 161 arteries with manual annotations. Additionally, we show that the new method improves the non-cooperative approach in 28 cases (p < 0.0001) in a data set of 3,904 arteries.	[Arias-Lorza, Andres M.; de Bruijne, Marleen] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol & Med Informat, Rotterdam, Netherlands; [Bos, Daniel] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Bos, Daniel; van der Lugt, Aad] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [de Bruijne, Marleen] Univ Copenhagen, Image Sect, Dept Comp Sci, Copenhagen, Denmark	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Copenhagen	Arias-Lorza, AM (corresponding author), Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol & Med Informat, Rotterdam, Netherlands.	xandresariasx@hotmail.com	Bos, Daniel/AAJ-6503-2020; de Bruijne, Marleen/G-2662-2010	de Bruijne, Marleen/0000-0002-6328-902X; Arias, Andres/0000-0003-0239-1060; Bos, Daniel/0000-0001-8979-2603	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by the Netherlands Organization for Scientific Research (NWO).	Antiga L, 2004, IEEE T MED IMAGING, V23, P704, DOI 10.1109/TMI.2004.826946; Arias-Lorza AM, 2016, IEEE T MED IMAGING, V35, P901, DOI 10.1109/TMI.2015.2501751; Aylward SR, 2002, IEEE T MED IMAGING, V21, P61, DOI 10.1109/42.993126; Bahler, 2008, INSIGHT J, V4; Bast H, 2014, MSRTR20144; Bauer C, 2008, NOVEL APPROACH DETEC, P163, DOI 10.1007/978-3-540-69321-5_17; Benmansour F, 2009, J MATH IMAGING VIS, V33, P209, DOI 10.1007/s10851-008-0131-0; Bennewitz M, 2001, P INT S INT ROB SYST; Carvalho DDB, 2017, ULTRASOUND MED BIOL, V43, P273, DOI 10.1016/j.ultrasmedbio.2016.08.031; Carvalho DDB, 2012, INT J COMPUT ASS RAD, V7, P207, DOI 10.1007/s11548-011-0633-x; Cohen LD, 1997, INT J COMPUT VISION, V24, P57, DOI 10.1023/A:1007922224810; Cuisenaire O., 2009, CAROTID LUMEN SEGMEN; de Koning PJH, 2003, MAGN RESON MED, V50, P1189, DOI 10.1002/mrm.10617; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; FISCHLER MA, 1981, COMPUT VISION GRAPH, V15, P201, DOI 10.1016/0146-664X(81)90056-3; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Gulsun MA, 2008, LECT NOTES COMPUT SC, V5241, P602, DOI 10.1007/978-3-540-85988-8_72; Gulsun MA, 2010, SPIE MED IMAGING; Hameeteman K, 2013, PHYS MED BIOL, V58, P1605, DOI 10.1088/0031-9155/58/5/1605; Hameeteman K, 2011, MED IMAGE ANAL, V15, P477, DOI 10.1016/j.media.2011.02.004; Krejza J, 2006, STROKE, V37, P1103, DOI 10.1161/01.STR.0000206440.48756.f7; Pock T., 2005, LECT NOTES COMPUTER, P55, DOI [DOI 10.1007/11499145_49, 10.1007/11499145_49]; Radojevic M, 2015, NEUROINFORMATICS, P1; Schaap M, 2009, MED IMAGE ANAL, V13, P701, DOI 10.1016/j.media.2009.06.003; Sethian JA, 1999, SIAM REV, V41, P199, DOI 10.1137/S0036144598347059; Tang H, 2012, MED IMAGE ANAL, V16, P1202, DOI 10.1016/j.media.2012.05.014; Treuille A, 2006, ACM T GRAPHIC, V25, P1160, DOI 10.1145/1141911.1142008; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Ukwatta E, 2013, IEEE T MED IMAGING, V32, P770, DOI 10.1109/TMI.2013.2237784; van den Bouwhuijsen QJA, 2012, EUR HEART J, V33, P221, DOI 10.1093/eurheartj/ehr227; van Heekeren RJ, 2007, LECT NOTES COMPUT SC, V4522, P263; van'T Klooster R, 2013, MED PHYS, V40, DOI 10.1118/1.4829503; Wang C, 2008, IEEE POW EN SOC GEN, V43, P1, DOI DOI 10.1109/APMC.2008.4958020; WONG W, 2009, MIDAS J; Zhang L, 2014, INT J COMPUT ASS RAD, V9, P127, DOI 10.1007/s11548-013-0917-4	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197180	10.1371/journal.pone.0197180	http://dx.doi.org/10.1371/journal.pone.0197180			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847545	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800020
J	Kalem, MC; Gerasimov, ES; Vu, PK; Zimmer, SL				Kalem, Murat C.; Gerasimov, Evgeny S.; Vu, Pamela K.; Zimmer, Sara L.			Gene expression to mitochondrial metabolism: Variability among cultured Trypanosoma cruzi strains	PLOS ONE			English	Article							AEROBIC GLUCOSE FERMENTATION; PROFILING REVEALS; END-PRODUCTS; COMPLEX I; BRUCEI; DIFFERENTIATION; EPIMASTIGOTES; ADAPTATION; TRANSPORT; SEQUENCE	The insect-transmitted protozoan parasite Trypanosoma cruzi experiences changes in nutrient availability and rate of flux through different metabolic pathways across its life cycle. The species encompasses much genetic diversity of both the nuclear and mitochondrial genomes among isolated strains. The genetic or expression variation of both genomes are likely to impact metabolic responses to environmental stimuli, and even steady state metabolic function, among strains. To begin formal characterization these differences, we compared aspects of metabolism between genetically similar strains CL Brener and Tulahuen with less similar Esmeraldo and Sylvio X10 strains in a culture environment. Epimastigotes of all strains took up glucose at similar rates. However, the degree of medium acidification that could be observed when glucose was absent from the medium varied by strain, indicating potential differences in excreted metabolic byproducts. Our main focus was differences related to electron transport chain function. We observed differences in ATP-coupled respiration and maximal respiratory capacity, mitochondrial membrane potential, and mitochondrial morphology between strains, despite the fact that abundances of two nuclear-encoded proteins of the electron transport chain are similar between strains. RNA sequencing reveals strain-specific differences in abundances of mRNAs encoding proteins of the respiratory chain but also other metabolic processes. From these differences in metabolism and mitochondrial phenotypes we have generated tentative models for the differential metabolic fluxes or differences in gene expression that may underlie these results.	[Kalem, Murat C.; Vu, Pamela K.] Univ Minnesota Duluth, Dept Biol, Duluth, MN USA; [Kalem, Murat C.; Zimmer, Sara L.] Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth Campus, Duluth, MN 55812 USA; [Gerasimov, Evgeny S.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Kalem, Murat C.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota Twin Cities; University of Minnesota Hospital; University of Minnesota System; University of Minnesota Duluth; Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zimmer, SL (corresponding author), Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth Campus, Duluth, MN 55812 USA.	szimmer3@d.umn.edu	Kalem, Murat Can/AAK-8644-2020	Kalem, Murat Can/0000-0003-2415-7435; Gerasimov, Evgeny/0000-0002-0497-1221; Zimmer, Sara/0000-0002-1707-1839	Whiteside Institute for Clinical Research (MN, USA); American Heart Association [16SDG26420019]; National institutes of Health - National Institute of General Medical Sciences [IMSD GM086669]	Whiteside Institute for Clinical Research (MN, USA); American Heart Association(American Heart Association); National institutes of Health - National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported through a Whiteside Institute for Clinical Research (MN, USA) grant to SLZ, and the American Heart Association [grant number 16SDG26420019 to SLZ]. PKV was supported by the National institutes of Health - National Institute of General Medical Sciences [IMSD GM086669]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg CP, 2017, EXP PARASITOL, V176, P8, DOI 10.1016/j.exppara.2017.02.013; Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2016, TRENDS PARASITOL, V32, P144, DOI 10.1016/j.pt.2015.10.004; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; Barison MJ, 2016, J BIOENERG BIOMEMBR, V48, P437, DOI 10.1007/s10863-016-9665-9; Barison MJ, 2017, J BIOL CHEM, V292, P8964, DOI 10.1074/jbc.M117.778522; Belew AT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006767; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRENER Z, 1965, J PARASITOL, V51, P922, DOI 10.2307/3275869; Breniere SF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004792; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; Capewell P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067069; Carranza JC, 2009, J BIOENERG BIOMEMBR, V41, P299, DOI 10.1007/s10863-009-9228-4; CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Creek DJ, 2012, MOL BIOCHEM PARASIT, V181, P73, DOI 10.1016/j.molbiopara.2011.10.003; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; De Lima AR, 2008, EXP PARASITOL, V119, P336, DOI 10.1016/j.exppara.2008.03.003; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duarte M, 2014, J BIOENERG BIOMEMBR, V46, P299, DOI 10.1007/s10863-014-9556-x; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ENGEL JC, 1990, MOL BIOCHEM PARASIT, V39, P69, DOI 10.1016/0166-6851(90)90009-B; ENGEL JC, 1987, MOL BIOCHEM PARASIT, V26, P1, DOI 10.1016/0166-6851(87)90123-X; Ferreira LRP, 2008, AN ACAD BRAS CIENC, V80, P157, DOI 10.1590/S0001-37652008000100011; Genes C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-66; Gerasimov ES, 2018, NUCLEIC ACIDS RES, V46, P765, DOI 10.1093/nar/gkx1202; Gnipova A, 2012, MOL BIOCHEM PARASIT, V184, P90, DOI 10.1016/j.molbiopara.2012.04.013; Goncalves RLS, 2011, J BIOENERG BIOMEMBR, V43, P651, DOI 10.1007/s10863-011-9398-8; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; Hashimi H, 2013, TRENDS PARASITOL, V29, P91, DOI 10.1016/j.pt.2012.11.005; Jimenez V, 2014, RES MICROBIOL, V165, P155, DOI 10.1016/j.resmic.2014.01.006; Kirby LE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005989; Kollien AH, 1998, J EUKARYOT MICROBIOL, V45, P59, DOI 10.1111/j.1550-7408.1998.tb05070.x; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005511; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Reis-Cunha JL, 2018, CURR GENOMICS, V19, P87, DOI 10.2174/1389202918666170911161311; MANCILLA R, 1964, J PROTOZOOL, V11, P509, DOI 10.1111/j.1550-7408.1964.tb01790.x; Marchese L, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020036; Maugeri DA, 2004, FEMS MICROBIOL LETT, V234, P117, DOI 10.1016/j.femsle.2004.03.018; Maugeri DA, 2011, ESSAYS BIOCHEM, V51, P15, DOI [10.1042/BSE0510015, 10.1042/bse0510015]; Messenger LA, 2015, EXPERT REV ANTI-INFE, V13, P995, DOI 10.1586/14787210.2015.1056158; Messenger LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001584; Morales J, 2009, J BIOL CHEM, V284, P7255, DOI 10.1074/jbc.M806623200; Nicholls DG, 2010, ESSAYS BIOCHEM, V47, P25, DOI [10.1042/bse0470025, 10.1042/BSE0470025]; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Penin P, 1998, COMP BIOCHEM PHYS A, V120, P571, DOI 10.1016/S1095-6433(98)10076-4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruvalcaba-Trejo LI, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-58; Sakata-Kato T, 2016, ACS INFECT DIS, V2, P15, DOI 10.1021/acsinfecdis.6b00101; Shah-Simpson S, 2016, MOL BIOCHEM PARASIT, V208, P91, DOI 10.1016/j.molbiopara.2016.07.001; Shaw AK, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00051-16; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Simpson RM, 2016, RNA, V22, P677, DOI 10.1261/rna.055160.115; Smircich P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1563-8; Smith Terry K, 2017, F1000Res, V6, DOI 10.12688/f1000research.10342.2; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; Stebeck CE, MOL BIOCH PARASITOL, V76, P145; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; Thomas S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-133; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Vargas N, 2004, MOL BIOCHEM PARASIT, V138, P131, DOI 10.1016/j.molbiopara.2004.08.005; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Verner Z, 2015, INT REV CEL MOL BIO, V315, P73, DOI 10.1016/bs.ircmb.2014.11.001; Westenberger SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-60; Zikova A, 2008, EUKARYOT CELL, V7, P1994, DOI 10.1128/EC.00204-08; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436; Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016; Zingales B, 2018, ACTA TROP, V184, P38, DOI 10.1016/j.actatropica.2017.09.017; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	82	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197983	10.1371/journal.pone.0197983	http://dx.doi.org/10.1371/journal.pone.0197983			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847594	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800046
J	Yacovino, DA; Martin, LA; Akly, MP; Hain, TC				Yacovino, Dario Andres; Martin, Leigh Alexander; Akly, Manuel Perez; Hain, Timothy Carl			Characteristics of vestibular corrective saccades in patients with slow visual saccades, vestibular disorders and controls: A descriptive analysis	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; HEAD IMPULSE TEST; EYE-MOVEMENTS; OCULAR MOTOR; VESTIBULOOCULAR REFLEX; DISEASE; ATAXIA; VARIABILITY; NYSTAGMUS; ACCURACY	Objective Our aim was to determine whether overt catch up saccades (OS) provoked by vestibular stimuli, as observed in the video head impulse test (vHIT), have comparable metrics as visually triggered horizontal saccades (VS), indicating a common saccadic brainstem generator. Methods Three groups of patients were studied: patients with neurological disorders causing slow saccades (group 1, n = 12), patients with peripheral vestibular lesions (group 2, n = 43), and normal controls (group 3, = 24). All patients underwent vHIT and Videooculographic testing. OS velocity, acceleration, amplitude and duration and VS velocity in this group was compared between the groups. Results There was significant reduction in the velocity of visually guided saccades in group 1, as expected from the patient selection constraints of this study. Group 1 also exhibited saccades which were longer in duration and of reduced acceleration when compared to subjects without saccadic slowing to visual targets (Group 2 and 3). There were significant positive correlations between OS acceleration and amplitude in both normal saccade groups (2 and 3) which was not observed in the slow saccade group (1). Conclusions The metrics of overt saccades measured by the vHIT in patients with slow saccades and normal controls are similar to visually guided saccades. This supports the hypothesis that overt saccades associated with vestibular stimuli and visually triggered saccades share common circuitry that controls metrics.	[Yacovino, Dario Andres; Akly, Manuel Perez] Dr Cesar Milstein Hosp, Dept Neurol, Buenos Aires, DF, Argentina; [Yacovino, Dario Andres] Memory & Balance Clin, Buenos Aires, DF, Argentina; [Martin, Leigh Alexander] Interacoust Acad, Dept Audiol, Middelfart, Denmark; [Hain, Timothy Carl] Northwestern Univ, Chicago, IL 60611 USA	Northwestern University	Yacovino, DA (corresponding author), Dr Cesar Milstein Hosp, Dept Neurol, Buenos Aires, DF, Argentina.; Yacovino, DA (corresponding author), Memory & Balance Clin, Buenos Aires, DF, Argentina.	yac@intramed.net	Hain, Timothy/H-7098-2019; Yacovino, Dario/AAM-1571-2020					ABRAMS RA, 1989, J EXP PSYCHOL HUMAN, V15, P529, DOI 10.1037/0096-1523.15.3.529; Anson ER, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00150; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P317; BAHILL AT, 1981, INVEST OPHTH VIS SCI, V21, P116; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; Burk K, 1999, J NEUROL, V246, P789, DOI 10.1007/s004150050456; Das VE, 2000, VISION RES, V40, P2077, DOI 10.1016/S0042-6989(00)00046-8; Federighi P, 2011, BRAIN, V134, P879, DOI 10.1093/brain/awr009; Garbutt S, 2003, ANN NY ACAD SCI, V1004, P337, DOI 10.1196/annals.1303.031; Garbutt S, 2003, INVEST OPHTH VIS SCI, V44, P3833, DOI 10.1167/iovs.03-0066; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Kaneko CRS, 2006, J NEUROPHYSIOL, V95, P3698, DOI 10.1152/jn.01292.2005; Kaneko CRS, 1996, J NEUROPHYSIOL, V75, P2229, DOI 10.1152/jn.1996.75.6.2229; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; LEIGH RJ, 1983, NEUROLOGY, V33, P1268, DOI 10.1212/WNL.33.10.1268; Lennerstrand G, 1981, P WEBB GREN CTR SMIT; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Luis L, 2016, J VESTIBUL RES-EQUIL, V26, P327, DOI 10.3233/VES-160579; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mossman B, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0081-7; RASCOL O, 1995, MOVEMENT DISORD, V10, P163, DOI 10.1002/mds.870100206; Rivaud-Pechoux S, 2000, NEUROLOGY, V54, P1029, DOI 10.1212/WNL.54.5.1029; Rottach KG, 1997, VISION RES, V37, P3627, DOI 10.1016/S0042-6989(96)00066-1; Rottach KG, 1996, ANN NEUROL, V39, P368, DOI 10.1002/ana.410390314; Strupp M, 2014, J NEUROL, V261, pS542, DOI 10.1007/s00415-014-7385-9; TAKAGI M, 1993, OPHTHALMOLOGICA, V206, P169, DOI 10.1159/000310386; Termsarasab Pichet, 2015, J Clin Mov Disord, V2, P14, DOI 10.1186/s40734-015-0025-4; TROOST BT, 1977, ANN NEUROL, V2, P397, DOI 10.1002/ana.410020509; Weber KP, 2008, NEUROLOGY, V70, P454, DOI 10.1212/01.wnl.0000299117.48935.2e; Yang CJ, 2016, CLIN OTOLARYNGOL, V41, P532, DOI 10.1111/coa.12558	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197079	10.1371/journal.pone.0197079	http://dx.doi.org/10.1371/journal.pone.0197079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847602	gold, Green Published, Green Submitted			2022-12-26	WOS:000433634800017
J	Mastrantonio, V; Crasta, G; Puggioli, A; Bellini, R; Urbanelli, S; Porretta, D				Mastrantonio, Valentina; Crasta, Graziano; Puggioli, Arianna; Bellini, Romeo; Urbanelli, Sandra; Porretta, Daniele			Cannibalism in temporary waters: Simulations and laboratory experiments revealed the role of spatial shape in the mosquito Aedes albopictus	PLOS ONE			English	Article							LARVAL CANNIBALISM; DIPTERA-CULICIDAE; JAPONICUS DIPTERA; BODY-SIZE; PREDATION; BEHAVIOR; EVOLUTION; RESPONSES; VECTORS; BEETLE	Cannibalism is a commonly observed phenomenon in arthropod species having relevant consequences for population dynamics and individual fitness. It is a context-dependent behaviour and an understanding of the factors affecting cannibalism rate is crucial to highlight its ecological relevance. In mosquitoes, cannibalism between larval stages has been widely documented, and the role of density, food availability and length of contact between individuals also ascertained. However, although mosquitoes can develop in temporary water habitats with very heterogeneous topologies, the role of the site shape where cannibals and victims co-occur has been instead overlooked. In this paper, we investigated this issue by using a simulation approach and laboratory cannibalism experiments between old (third-and fourth-instars) and young (first-instar) larvae of the tiger mosquito Aedes albopictus. Three virtual spaces with different shapes were simulated and the number of larval encounters was estimated in each one to assess whether the spatial shape affected the number of encounters between cannibal and victims. Then, experimental trials in containers with similar shapes to those used in the simulations were performed, and the cannibalism rate was estimated at 24 and 48h. Our results showed that the spatial shape plays a role on cannibalism interactions, affecting the number of encounters between individuals. Indeed, in the experimental trials performed, we observed the highest cannibalism rate in the container with the highest number of encounters predicted by the simulations. Interestingly, we found also that spatial shape can affect cannibalism not only by affecting the number of encounters, but also the number of encounters "favorable" for cannibalistic events. Temporary waters are inhabited by several species other than mosquitoes. Our results, showing an influence of the spatial shape on cannibalism in Ae. albopictus larvae, add a new critical factor to those affecting ecological interactions in these habitats.	[Mastrantonio, Valentina; Urbanelli, Sandra; Porretta, Daniele] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy; [Crasta, Graziano] Sapienza Univ Rome, Dept Math, Rome, Italy; [Puggioli, Arianna; Bellini, Romeo] Agr Environm Ctr G Nicoli, Crevalcore, Italy	Sapienza University Rome; Sapienza University Rome	Porretta, D (corresponding author), Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.	daniele.porretta@uniroma1.it	Crasta, Graziano/B-4831-2008; URBANELLI, Sandra/N-8821-2016	Crasta, Graziano/0000-0003-3673-6549; MASTRANTONIO, VALENTINA/0000-0001-7701-4716; URBANELLI, Sandra/0000-0003-1183-0344				Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688; Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106; ANNIS B, 1990, J MED ENTOMOL, V27, P777, DOI 10.1093/jmedent/27.5.777; [Anonymous], [No title captured]; Barkae ED, 2014, BEHAV ECOL, V25, P1311, DOI 10.1093/beheco/aru123; Bellini R, 2002, P 19 IT NAT C ENT CA, VII, P993; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bolivar-Silva DA, 2018, J PEST SCI, V91, P707, DOI 10.1007/s10340-017-0921-5; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Clements A.N., 1999, BIOL MOSQUITOES SENS, P135; EDGERLY JS, 1992, ECOL ENTOMOL, V17, P28, DOI 10.1111/j.1365-2311.1992.tb01035.x; Elgar M., 1992, CANNIBALISM ECOLOGY, V1st; Faria LD, 2004, J INSECT BEHAV, V17, P251, DOI 10.1023/B:JOIR.0000028574.91062.18; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Gonzalez PV, 2016, J MED ENTOMOL, V53, P268, DOI 10.1093/jme/tjv189; Gotifrid Gilbert M., 2014, BMC Research Notes, V7, P231, DOI 10.1186/1756-0500-7-231; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Hawley WA, 1988, J AM MOSQUITO CONTR, P11; Hosmer DW, 2013, WILEY SER PROBAB ST, P1; Johansson F, 1999, ECOLOGY, V80, P1242, DOI 10.2307/177071; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Koenraadt CJM, 2004, ENTOMOL EXP APPL, V112, P125, DOI 10.1111/j.0013-8703.2004.00186.x; Koenraadt CJM, 2003, MED VET ENTOMOL, V17, P61, DOI 10.1046/j.1365-2915.2003.00409.x; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; LIVDAHL TP, 1984, ECOL ENTOMOL, V9, P437, DOI 10.1111/j.1365-2311.1984.tb00841.x; Lounibos LP, 1996, OIKOS, V77, P309, DOI 10.2307/3546070; O'Donnell DL, 2007, J MED ENTOMOL, V44, P984, DOI 10.1603/0022-2585(2007)44[984:COLFBO]2.0.CO;2; OSAWA N, 1993, RES POPUL ECOL, V35, P335, DOI 10.1007/BF02513605; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Porretta D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1850-5; Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515; R Core Team, 2021, R LANGUAGE ENV STAT; Rajavel A. R., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P453; REISEN WK, 1976, MOSQ NEWS, V36, P198; Richardson ML, 2010, ANNU REV ENTOMOL, V55, P39, DOI 10.1146/annurev-ento-112408-085314; Santana AFK, 2012, INSECT BIOECOLOGY AND NUTRITION FOR INTEGRATED PEST MANAGEMENT, P177; Schausberger P, 2003, EXP APPL ACAROL, V29, P173, DOI 10.1023/A:1025839206394; Shapiro LLM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0298; SIH A, 1986, ECOLOGY, V67, P434, DOI 10.2307/1938587; Silberbush A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088650; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Tayeh A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-15; Tsurim I, 2016, ISR J ECOL EVOL, V62, P138, DOI 10.1080/15659801.2015.1065153; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Urbanelli S, 2014, EVOLUTION, V68, P3030, DOI 10.1111/evo.12490; Via S, 1999, HEREDITY, V82, P267, DOI 10.1038/sj.hdy.6884820; Vijendravarma RK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2744; Wasserberg G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092658; Wissinger SA, 1996, ECOLOGY, V77, P2421, DOI 10.2307/2265743	52	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198194	10.1371/journal.pone.0198194	http://dx.doi.org/10.1371/journal.pone.0198194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813108	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800055
J	Fukano, K; Ozawa, K; Kokubu, M; Shimizu, T; Ito, S; Sasaki, Y; Nakamura, A; Yajima, S				Fukano, Kazuhiro; Ozawa, Kunio; Kokubu, Masaya; Shimizu, Tetsu; Ito, Shinsaku; Sasaki, Yasuyuki; Nakamura, Akira; Yajima, Shunsuke			Structural basis of L-glucose oxidation by scyllo-inositol dehydrogenase: Implications for a novel enzyme subfamily classification	PLOS ONE			English	Article							MYOINOSITOL DEHYDROGENASE; FRUCTOSE OXIDOREDUCTASE; ZYMOMONAS-MOBILIS; CRYSTAL-STRUCTURE; SYSTEM	For about 70 years, L-glucose had been considered non-metabolizable by either mammalian or bacterial cells. Recently, however, an L-glucose catabolic pathway has been discovered in Para coccus laeviglucosivorans, and the genes responsible cloned. Scyllo-inositol dehydrogenase is involved in the first step in the pathway that oxidizes L-glucose to produce L-glucono-1,5-lactone with concomitant reduction of NAD(+) dependent manner. Here, we report the crystal structure of the ternary complex of scyllo-inositol dehydrogenase with NAD(+) and L-glucono-1,5-lactone at 1.8 A resolution. The enzyme adopts a homo-tetrameric structure, similar to those of the inositol dehydrogenase family, and the electron densities of the bound sugar was clearly observed, allowing identification of the residues responsible for interaction with the substrate in the catalytic site. In addition to the conserved catalytic residues (Lys106, Asp191, and His195), another residue, His318, located in the loop region of the adjacent subunit, is involved in substrate recognition. Site-directed mutagenesis confirmed the role of these residues in catalytic activity. We also report the complex structures of the enzyme with myo-inositol and scyllo-inosose. The Arg178 residue located in the flexible loop at the entrance of the catalytic site is also involved in substrate recognition, and plays an important role in accepting both L-glucose and inositols as substrates. On the basis of these structural features, which have not been identified in the known inositol dehydrogenases, and a phylogenetic analysis of IDH family enzymes, we suggest a novel subfamily of the GFO/IDH/MocA family. Since many enzymes in this family have not biochemically characterized, our results could promote to find their activities with various substrates.	[Fukano, Kazuhiro; Ozawa, Kunio; Kokubu, Masaya; Ito, Shinsaku; Sasaki, Yasuyuki; Yajima, Shunsuke] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan; [Shimizu, Tetsu; Nakamura, Akira] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan	Tokyo University of Agriculture; University of Tsukuba	Yajima, S (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan.	yshun@nodai.ac.jp		Nakamura, Akira/0000-0001-7250-7175	Japan Society for the Promotion of Science, KAKENHI [16H04895]; JSPS KAKENHI	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, KAKENHI, grant number 16H04895 to AN and SY; JSPS KAKENHI URL: https://www.jsps.go.jp/j- grantsinaid/index.html.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALIZADE MA, 1976, Z NATURFORSCH C, V31, P624; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Dambe TR, 2006, BIOCHEMISTRY-US, V45, P10030, DOI 10.1021/bi052589q; Daniellou R, 2005, ORG BIOMOL CHEM, V3, P401, DOI 10.1039/b417757f; Daniellou R, 2007, BIOCHEMISTRY-US, V46, P7469, DOI 10.1021/bi700281x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura A, 2015, INT J SYST EVOL MICR, V65, P3878, DOI 10.1099/ijsem.0.000508; Nurizzo D, 2001, BIOCHEMISTRY-US, V40, P13857, DOI 10.1021/bi011355d; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAMALEY R, 1979, J BIOL CHEM, V254, P7684; RUDNEY HARRY, 1940, SCIENCE, V92, P112, DOI 10.1126/science.92.2379.112; SASAJIMA KI, 1979, BIOCHIM BIOPHYS ACTA, V571, P120, DOI 10.1016/0005-2744(79)90232-8; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shimizu T, 2014, MICROBIOL-SGM, V160, P623, DOI 10.1099/mic.0.074286-0; Shimizu T, 2012, J BIOL CHEM, V287, P40448, DOI 10.1074/jbc.M112.403055; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Straaten KE, 2010, BIOCHEM J, V432, P237, DOI 10.1042/BJ20101079; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	26	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0198010	10.1371/journal.pone.0198010	http://dx.doi.org/10.1371/journal.pone.0198010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799855	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400035
J	Jacobs, DM; Morice, AHP; Camachon, C; Montagne, G				Jacobs, David M.; Morice, Antoine H. P.; Camachon, Cyril; Montagne, Gilles			Eye position affects flight altitude in visual approach to landing independent of level of expertise of pilot	PLOS ONE			English	Article							FINAL APPROACH PHASE; PERFORMANCE; PERCEPTION; SIMULATOR	The present study addresses the effect of the eye position in the cockpit on the flight altitude during the final approach to landing. Three groups of participants with different levels of expertise (novices, trainees, and certified pilots) were given a laptop with a flight simulator and they were asked to maintain a 3.71 degrees glide slope while landing. Each participant performed 40 approaches to the runway. During 8 of the approaches, the point of view that the flight simulator used to compute the visual scene was slowly raised or lowered with 4 cm with respect to the cockpit, hence moving the projection of the visible part of the cockpit down or up in the visible scene in a hardly noticeable manner. The increases and decreases in the simulated eye height led to increases and decreases in the altitude of the approach trajectories, for all three groups of participants. On the basis of these results, it is argued that the eye position of pilots during visual approaches is a factor that contributes to the risk of black hole accidents.	[Jacobs, David M.] Univ Autonoma Madrid, Fac Psicol, Madrid, Spain; [Morice, Antoine H. P.; Camachon, Cyril; Montagne, Gilles] Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France; [Camachon, Cyril] Ctr Rech Armee Air, Salon De Provence, France	Autonomous University of Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Jacobs, DM (corresponding author), Univ Autonoma Madrid, Fac Psicol, Madrid, Spain.	david.jacobs@uam.es	Jacobs, David M/C-5216-2011; MORICE, Antoine HP/ABC-1445-2021	Jacobs, David M/0000-0003-2954-5293; MORICE, Antoine HP/0000-0002-8454-6742; CAMACHON, Cyril/0000-0003-1712-3480	Delegation Generale pour l'Armement (DGA); Spanish Ministry of Economy and Competitiveness [PSI2013-43742]	Delegation Generale pour l'Armement (DGA); Spanish Ministry of Economy and Competitiveness(Spanish Government)	The participation of Antoine Morice, Cyril Camachon and Gilles Montagne in this research project was supported by a grant from the Delegation Generale pour l'Armement (DGA). The participation of David M. Jacobs was supported by a grant from the Spanish Ministry of Economy and Competitiveness (PSI2013-43742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin J, 2006, J EXP PSYCHOL HUMAN, V32, P964, DOI 10.1037/0096-1523.32.4.964; Benbassat D, 2002, INT J AVIAT PSYCHOL, V12, P137, DOI 10.1207/S15327108IJAP1202_3; Berndt J., 2004, AIAA MOD SIM TECHN C, DOI [10.2514/6.2004-4923, DOI 10.2514/6.2004-4923]; Boeing Commercial Airplanes, 2016, STAT SUMM COMM JET A; de Rugy A, 2001, BEHAV BRAIN RES, V123, P11, DOI 10.1016/S0166-4328(01)00185-1; Diaz-Fortuny J., 2017, 2017 14 INT C SYNTH, P1; Entzinger JO, 2009, P 10 APRU DOCT STUD; Entzinger JO, 2010, AEROSP SCI TECHNOL, V14, P118, DOI 10.1016/j.ast.2009.10.002; Federal Aviation Administration, 2016, FAAH80833B US DEP TR; Galanis G, 1998, INT J AVIAT PSYCHOL, V8, P83, DOI 10.1207/s15327108ijap0802_1; Gibb RW, 2007, AVIAT SPACE ENVIR MD, V78, P801; Gibb R, 2008, HUM FACTORS, V50, P699, DOI 10.1518/001872008X288619; GIBSON J J, 1955, Am J Psychol, V68, P480, DOI 10.2307/1418538; Helmreich R. L., 1998, FLIGHT SAFETY DIGEST, V17, P1; Huet M, 2011, J EXP PSYCHOL HUMAN, V37, P1841, DOI 10.1037/a0024386; Huet M, 2009, HUM FACTORS, V51, P858, DOI 10.1177/0018720809357343; Kasarskis P, 2001, P 11 INT S AVIATION; Langewiesche W, 1944, STICK RUDDER EXPLANA; LINTERN G, 1991, HUM FACTORS, V33, P401, DOI 10.1177/001872089103300403; Lintern G., 1991, INT J AVIAT PSYCHOL, V1, P117; Martinez J, 2017, 17 AUSTR INT AER C A, p619 ; Maxwell S. E., 2004, DESIGNING EXPT ANAL; MERTENS HW, 1982, AVIAT SPACE ENVIR MD, V53, P463; Wilkie RM, 2002, CURR BIOL, V12, P2014, DOI 10.1016/S0960-9822(02)01337-4	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197585	10.1371/journal.pone.0197585	http://dx.doi.org/10.1371/journal.pone.0197585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795618	Green Published, gold			2022-12-26	WOS:000433084300052
J	Pangeson, T; Sanguansermsri, T; Mahingsa, K; Sanguansermsri, P				Pangeson, Tanapat; Sanguansermsri, Torpong; Mahingsa, Khwanruedee; Sanguansermsri, Phanchana			Decreased DNA methylation of a CpG site in the HBAP1 gene in plasma DNA from pregnant women	PLOS ONE			English	Article							FREE FETAL DNA; CELL-FREE DNA; MATERNAL PLASMA; PRENATAL-DIAGNOSIS; ORIGIN; SEX; PCR	Objective The objective of this study is to identify potential CpG site(s) or DNA methylation pattern(s) in the pseudo a-globin 1 gene (HBAP1 gene), the gene which locates in a-thalassemia-1 deletion mutation, to differentiate plasma DNA between pregnant and non-pregnant women. Method DNA methylation profiles of placenta and peripheral blood from the MethBase database were compared to screen differentially methylated regions. This region was confirmed the differential by methylation-sensitive high resolution melt (MS-HRM) analysis. The differential region was used to compare DNA methylation profile of plasma DNA between pregnant and non-pregnant women by bisulfite amplicon sequencing in three levels: overall, individual CpG sites and individual molecules (DNA methylation patterns). Result Using MethBase data, four consecutive CpG sites in the HBAP1 gene were identified as regions of differential DNA methylation between placenta and peripheral blood. The confirmation by MS-HRM showed the differential DNA methylation profile between the placenta and plasma from non-pregnant women. The comparison of DNA methylation profiles between the plasma of pregnant and non-pregnant women showed that, in the overall levels of the four CpG sites, DNA methylation of pregnant women was detected at lower levels than non-pregnant women. In the individual CpG site level, only the second CpG site showed differential DNA methylation between the groups. In the DNA methylation pattern level, there was no strongly significant differences in DNA methylation patterns between the pregnant and non-pregnant groups. Conclusion Our result demonstrated that, in the plasma from pregnant women, only one of the four CpG sites displays a decrease in DNA methylation compared with non-pregnant women. It indicates that this CpG site might be useful for determining the presence or absence of fetal wild-type alpha-globin gene cluster allele in maternal plasma.	[Pangeson, Tanapat; Sanguansermsri, Phanchana] Naresuan Univ, Dept Biochem, Fac Med Sci, Phitsanulok, Thailand; [Pangeson, Tanapat] Univ Phayao, Sch Med Sci, Dept Biochem, Phayao, Thailand; [Sanguansermsri, Torpong; Mahingsa, Khwanruedee] Univ Phayao, Inst Human Genet, Thalassemia Res Unit, Phayao, Thailand	Naresuan University; University of Phayao; University of Phayao	Sanguansermsri, P (corresponding author), Naresuan Univ, Dept Biochem, Fac Med Sci, Phitsanulok, Thailand.	phanchana@hotmail.com		Sanguansermsri, Phanchana/0000-0002-0678-1835; Pangeson, Tanapat/0000-0003-2668-3260	Naresuan University [R25606067]	Naresuan University	Phanchana Sanguansermsri received funding for this work from Naresuan University in 2016 (R25606067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Avent ND, 2006, PRENATAL DIAG, V26, P598, DOI 10.1002/pd.1493; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Ho SSY, 2010, PRENATAL DIAG, V30, P65, DOI 10.1002/pd.2413; Honda H, 2002, HUM GENET, V110, P75, DOI 10.1007/s00439-001-0649-3; Leung TN, 2001, CLIN CHEM, V47, P137; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Mao J, 2014, CLIN CHIM ACTA, V433, P190, DOI 10.1016/j.cca.2014.03.011; Pangeson T, 2017, GENET EPIGENETICS, V9, DOI 10.1177/1179237X17736107; Puszyk WM, 2009, CLIN CHIM ACTA, V400, P107, DOI 10.1016/j.cca.2008.10.018; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Sirichotiyakul S, 2012, PRENATAL DIAG, V32, P45, DOI 10.1002/pd.2892; Skvortsova TE, 2011, CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM, P185, DOI 10.1007/978-90-481-9382-0_25; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Tong YK, 2007, CLIN CHEM, V53, P1906, DOI 10.1373/clinchem.2007.092619; Tungwiwat W, 2006, ANN NY ACAD SCI, V1075, P103, DOI 10.1196/annals.1368.013; Winichagoon P, 2005, INT J HEMATOL, V81, P396, DOI 10.1532/IJH97.A20501; Zhao FX, 2010, PRENATAL DIAG, V30, P778, DOI 10.1002/pd.2546	19	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198165	10.1371/journal.pone.0198165	http://dx.doi.org/10.1371/journal.pone.0198165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795670	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300131
J	Teasdale, CA; Abrams, EJ; Chiasson, MA; Justman, J; Blanchard, K; Jones, HE				Teasdale, Chloe A.; Abrams, Elaine J.; Chiasson, Mary Ann; Justman, Jessica; Blanchard, Kelly; Jones, Heidi E.			Incidence of sexually transmitted infections during pregnancy	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; REPRODUCTIVE-TRACT INFECTIONS; TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; HIV ACQUISITION; SOUTH-AFRICA; HORMONAL CONTRACEPTIVES; SEX-HORMONES; WOMEN; RISK	Prevalence of sexually transmitted infections (STI) is high among pregnant women in certain settings. We estimated STI incidence and compared STI risk in pregnant and non-pregnant women. Data came from the Methods for Improving Reproductive Health in Africa (MIRA) study conducted in South Africa and Zimbabwe 2003-2006. Women aged 18-50 years with at least one follow-up visit within 6 months of enrollment were included. Follow-up visits included laboratory testing for pregnancy, chlamydia, gonorrhea, trichomoniasis, and HIV, as well as self-report of hormonal contraceptive (HC) use, sexual behaviors and intravaginal practices. All visits were classified according to pregnancy status. Incidence of each STI was calculated using follow-up time. Cox proportional hazards models were fitted using pregnancy as a time-varying exposure and sexual behaviors and intravaginal practices as time-varying covariates. Among 4,549 women, 766 (16.8%) had a positive pregnancy test. Median followup time was 18 months [IQR: 12-24]. The overall incidence rate of chlamydia was 6.7 per 100 person years (py) and 9.9/100py during pregnancy; gonorrhea incidence was 2.7/100py and 4.9/100py during pregnancy; trichomoniasis incidence was 7.1/100py overall and 9.2/100py during pregnancy. Overall HIV incidence was 3.9/100py and 3.8/100py during pregnancy. In crude models, pregnancy increased risk for chlamydia (hazard ratio (HR) 1.5, 95%CI: 1.1-1.2), however there was no increased risk of any measured STI in adjusted models. STI Incidence was high during pregnancy however pregnancy did not increase STI risk after adjustment for sexual behaviors. Greater efforts are needed to help pregnant women avoid STIs.	[Teasdale, Chloe A.; Abrams, Elaine J.; Justman, Jessica] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10027 USA; [Teasdale, Chloe A.; Abrams, Elaine J.; Chiasson, Mary Ann; Justman, Jessica] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA; [Jones, Heidi E.] CUNY, Sch Publ Hlth, Dept Epidemiol, New York, NY 10021 USA	Columbia University; Columbia University; City University of New York (CUNY) System	Teasdale, CA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10027 USA.; Teasdale, CA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	ct116@columbia.edu	Jones, Heidi E/ABF-8381-2020; Justman, Jessica/AAA-3572-2020	Jones, Heidi E/0000-0002-4285-3752; 				Ament L A, 1996, J Obstet Gynecol Neonatal Nurs, V25, P657, DOI 10.1111/j.1552-6909.1996.tb01479.x; Banura C, 2008, INT J CANCER, V123, P2180, DOI 10.1002/ijc.23762; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Berggren EK, 2011, SEX TRANSM DIS, V38, P172, DOI 10.1097/OLQ.0b013e3181f41b96; Black V, 2009, OBSTET GYNECOL, V114, P292, DOI 10.1097/AOG.0b013e3181af33e6; Borges-Costa J, 2012, J EUR ACAD DERMATOL, V26, P972, DOI 10.1111/j.1468-3083.2011.04194.x; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; BURKMAN RT, 1994, AM J OBSTET GYNECOL, V170, P1569, DOI 10.1016/S0002-9378(12)91817-7; Chico RM, 2017, CLIN INFECT DIS, V64, P1043, DOI 10.1093/cid/cix026; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Department of Health SA, 2012, 2012 NAT ANT SENT HI; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097547; Feldblum PJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000626; Gardella C, 2005, AM J OBSTET GYNECOL, V193, P1891, DOI 10.1016/j.ajog.2005.07.041; Gray GE, 2007, BRIT MED J, V334, P950, DOI 10.1136/bmj.39176.674977.AD; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; James SH, 2014, J PEDIATR INFECT DIS, V3, pS19, DOI 10.1093/jpids/piu050; Kaydos SC, 2002, J CLIN MICROBIOL, V40, P89, DOI 10.1128/JCM.40.1.89-95.2002; Keating MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039109; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; McCoy SI, 2013, AIDS, V27, P1001, DOI 10.1097/QAD.0b013e32835da401; Menendez C, 2010, INFECT DIS OBSTET GY, V2010; Moench TR, 2001, AIDS, V15, P1595, DOI 10.1097/00002030-200109070-00001; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Morrison CS, 2007, AIDS, V21, P1027, DOI 10.1097/QAD.0b013e3280f00fc4; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Mullick S, 2005, SEX TRANSM INFECT, V81, P294, DOI 10.1136/sti.2002.004077; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Patterson BK, 1998, AM J PATHOL, V153, P481, DOI 10.1016/S0002-9440(10)65591-5; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Sande S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1939-0; Schmeink CE, 2012, J WOMENS HEALTH, V21, P1295, DOI 10.1089/jwh.2012.3502; Shacklett BL, 2011, AM J REPROD IMMUNOL, V65, P230, DOI 10.1111/j.1600-0897.2010.00948.x; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Teasdale CA, 2017, ARCH SEX BEHAV, V46, P539, DOI 10.1007/s10508-016-0818-z; Walter J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-263; Zimmerman RS, 2014, JAIDS-J ACQ IMM DEF, V66, pS285, DOI 10.1097/QAI.0000000000000241	44	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197696	10.1371/journal.pone.0197696	http://dx.doi.org/10.1371/journal.pone.0197696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795625	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300061
J	Temsah, G; Johnson, K; Evans, T; Adams, DK				Temsah, Gheda; Johnson, Kiersten; Evans, Thea; Adams, Diane K.			Benefits of biodiverse marine resources to child nutrition in differing developmental contexts in Hispaniola	PLOS ONE			English	Article							PROTECTED AREAS; SPECIES-DIVERSITY; HUMAN HEALTH; DEVELOPING-WORLD; CORAL-REEFS; FISHERIES; RESERVES; CONSERVATION; COMMUNITIES; PHILIPPINES	There is an urgent need for an improved empirical understanding of the relationship among biodiverse marine resources, human health and development outcomes. Coral reefs are often at this intersection for developing nations in the tropics-an ecosystem targeted for biodiversity conservation and one that provides sustenance and livelihoods for many coastal communities. To explore these relationships, we use the comparative development contexts of Haiti and the Dominican Republic on the island of Hispaniola. We combine child nutrition data from the Demographic Health Survey with coastal proximity and coral reef habitat diversity, and condition to empirically test human benefits of marine natural resources in differing development contexts. Our results indicate that coastal children have a reduced likelihood of severe stunting in Haiti but have increased likelihoods of stunting and reduced dietary diversity in the Dominican Republic. These contrasting results are likely due to the differential in developed infrastructure and market access. Our analyses did not demonstrate an association between more diverse and less degraded coral reefs and better childhood nutrition. The results highlight the complexities of modelling interactions between the health of humans and natural systems, and indicate the next steps needed to support integrated development programming.	[Temsah, Gheda] ICF Int, Fairfax, VA 22031 USA; [Johnson, Kiersten] US Agcy Int Dev, Bur Food Secur, Washington, DC 20523 USA; [Evans, Thea] Blue Raster, DHS Program, Arlington, VA USA; [Adams, Diane K.] US Agcy Int Dev, Off Forestry & Biodivers, Washington, DC 20523 USA; [Adams, Diane K.] Rutgers State Univ, Inst Earth Ocean & Atmospher Sci, Dept Marine & Coastal Sci, New Brunswick, NJ USA	United States Agency for International Development (USAID); United States Agency for International Development (USAID); Rutgers State University New Brunswick	Temsah, G (corresponding author), ICF Int, Fairfax, VA 22031 USA.	gheda.temsah@icf.com	Johnson, Kiersten B./L-2305-2019	Johnson, Kiersten B./0000-0002-7609-802X	United States Agency for International Development, Bureau for Economic Growth, Education, and Environment; Office of Forestry and Biodiversity; ICF	United States Agency for International Development, Bureau for Economic Growth, Education, and Environment(United States Agency for International Development (USAID)); Office of Forestry and Biodiversity; ICF	This work was funded by the United States Agency for International Development, Bureau for Economic Growth, Education, and Environment, Office of Forestry and Biodiversity, which contributed to study design and project management, and provided the funding to cover the PLOS ONE publishing fee. ICF provided support in the form of salaries for G.T. and K.J., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neither Westat nor the US Agency for International Development, Bureau of Food Security provided any support for this work and did not have any additional roles. The specific roles of these authors are articulated in the 'author contributions' section. The views and ideas expressed are entirely the authors' own and do not reflect an official position of USAID	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; Alva S, 2016, POPUL ENVIRON, V37, P341, DOI 10.1007/s11111-015-0240-9; [Anonymous], 2010, NO CAR 2010; [Anonymous], 2013, VAL COR EC; [Anonymous], IND MON IMPL COMPR I; Aswani S, 2007, COAST MANAGE, V35, P545, DOI 10.1080/08920750701593394; Balk D, 2005, FOOD POLICY, V30, P584, DOI 10.1016/j.foodpol.2005.10.007; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bene C., 2007, INCREASING CONTRIBUT; Burke L., 2004, REEFS RISK CARIBBEAN; Caribbean Regional Fisheries Mechanism, 2012, DIAGN STUD DET POV L; Case A, 2010, DEMOGRAPHY, V47, pS65, DOI 10.1353/dem.2010.0007; Cayemittes M., 2007, ENQUETE MORTALITE MO; Centro de Estudios Sociales y Demograficos (CESDEM) y Macro International Inc, 2008, ENC DEM SAL 2007; Chadwick Douglas H., 1999, NATL GEOGR, V195, p[30, 37]; Check R., 2011, REEF CHECK LAUNCHES; CHEN LC, 1981, POPUL DEV REV, V7, P55, DOI 10.2307/1972764; Cordeiro L. S., 2012, J MED ACT PLANTS, V1, P4; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; D'Agnes L, 2010, ENVIRON CONSERV, V37, P398, DOI 10.1017/S0376892910000779; FAO, 2005, PROF PECH PAR PAYS H; Fisher B, 2015, MAR ECOL PROG SER, V530, P233, DOI 10.3354/meps11232; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Food and Agricultural Organization, 2002, LAND RES POT CONSTR; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Geraldes F.X, 2002, STATUS CORAL REEFS D; Gjertsen H, 2005, WORLD DEV, V33, P199, DOI 10.1016/j.worlddev.2004.07.009; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Haas SA, 2007, DEMOGRAPHY, V44, P113, DOI 10.1353/dem.2007.0003; Halpern BS, 2003, ECOL APPL, V13, pS117; Hamylton S, 2012, ESTUAR COAST SHELF S, V111, P151, DOI 10.1016/j.ecss.2012.06.001; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; HLPE, 2020, FOOD SEC NUTR BUILD; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Johnson KB, 2013, GLOB HEALTH-SCI PRAC, V1, P237, DOI 10.9745/GHSP-D-13-00055; Juergens G, 2011, FAA 118 119 TROPICAL; LACK D, 1969, BIRD STUDY, V16, P193, DOI 10.1080/00063656909476244; Leisher C., 2007, NATURES INVESTMENT B; MAC ARTHUR ROBERT H., 1967; Mascia MB, 2010, CONSERV BIOL, V24, P1424, DOI 10.1111/j.1523-1739.2010.01523.x; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McGoodwin, 2001, FAO FISH TECH PAP; Miller MW, 2007, ENVIRON CONSERV, V34, P92, DOI 10.1017/S0376892907003852; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; Pauly D, 1997, GLOB TRENDS FISH MAN; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reytar K, 2011, REEFS RISK REVISITED; Sanciangco JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056245; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh R. J., 2015, HAITI NEW NARRATIVE; Swartley DB, 2006, HAITI COUNTRY ANAL T; Taft-Morales M, 2007, HAITIS DEV NEEDS STA; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Teh LCL, 2013, FISH FISH, V14, P77, DOI 10.1111/j.1467-2979.2011.00450.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; Thummarukudy M., 2010, UNEP HAITI MISSION R; UNICEF, 2015, 2014 ANN RES REP NUT, P70; United Nations Food and Agriculture Organization, 2016, STAT WORLD FISH AQ; USAID, 2007, USAID COUNTR HLTH ST; Weilgus J, 2010, WORKING PAPER	68	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197155	10.1371/journal.pone.0197155	http://dx.doi.org/10.1371/journal.pone.0197155			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795591	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300026
J	Al Shareef, Z; Kardooni, H; Murillo-Garzon, V; Domenici, G; Stylianakis, E; Steel, JH; Rabano, M; Gorrono-Etxebarria, I; Zabalza, I; Vivanco, MD; Waxman, J; Kypta, RM				Al Shareef, Zainab; Kardooni, Hoda; Murillo-Garzon, Virginia; Domenici, Giacomo; Stylianakis, Emmanouil; Steel, Jennifer H.; Rabano, Miriam; Gorrono-Etxebarria, Irantzu; Zabalza, Ignacio; Vivanco, Maria dM; Waxman, Jonathan; Kypta, Robert M.			Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1	ONCOGENE			English	Article							EXTRACELLULAR-MATRIX PROTEIN-1; ACINAR MORPHOGENESIS; DKK-3 EXPRESSION; STEM-CELLS; STEM/PROGENITOR; METASTASIS; ACTIVATION; PROMOTER; INTEGRIN; BENIGN	Aberrant transforming growth factor-beta (TGF-beta) signaling is a hallmark of the stromal microenvironment in cancer. Dickkopf-3 (Dkk-3), shown to inhibit TGF-beta signaling, is downregulated in prostate cancer and upregulated in the stroma in benign prostatic hyperplasia, but the function of stromal Dkk-3 is unclear. Here we show that DKK3 silencing in WPMY-1 prostate stromal cells increases TGF-beta signaling activity and that stromal cell-conditioned media inhibit prostate cancer cell invasion in a Dkk-3-dependent manner. DKK3 silencing increased the level of the cell-adhesion regulator TGF-beta-induced protein (TGFBI) in stromal and epithelial cell-conditioned media, and recombinant TGFBI increased prostate cancer cell invasion. Reduced expression of Dkk-3 in patient tumors was associated with increased expression of TGFBI. DKK3 silencing reduced the level of extracellular matrix protein-1 (ECM-1) in prostate stromal cell-conditioned media but increased it in epithelial cell-conditioned media, and recombinant ECM-1 inhibited TGFBI-induced prostate cancer cell invasion. Increased ECM1 and DKK3 mRNA expression in prostate tumors was associated with increased relapse-free survival. These observations are consistent with a model in which the loss of Dkk-3 in prostate cancer leads to increased secretion of TGFBI and ECM-1, which have tumor-promoting and tumor-protective roles, respectively. Determining how the balance between the opposing roles of extracellular factors influences prostate carcinogenesis will be key to developing therapies that target the tumor microenvironment.	[Al Shareef, Zainab; Kardooni, Hoda; Stylianakis, Emmanouil; Steel, Jennifer H.; Waxman, Jonathan; Kypta, Robert M.] Imperial Coll London, Dept Surg & Canc, London, England; [Murillo-Garzon, Virginia; Domenici, Giacomo; Rabano, Miriam; Gorrono-Etxebarria, Irantzu; Vivanco, Maria dM; Kypta, Robert M.] CIC BioGUNE, Ctr Cooperat Res Biosci, Derio, Spain; [Zabalza, Ignacio] Galdakao Usansolo Hosp, Dept Pathol, Galdakao, Spain	Imperial College London; CIC bioGUNE; Galdakao Hospital	Kypta, RM (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.; Kypta, RM (corresponding author), CIC BioGUNE, Ctr Cooperat Res Biosci, Derio, Spain.	r.kypta@imperial.ac.uk	Kypta, Robert/F-7699-2011; Domenici, Giacomo/AAG-6224-2019; Vivanco, Maria/G-2393-2011	Kypta, Robert/0000-0002-2389-310X; Vivanco, Maria/0000-0002-9540-247X; Stylianakis, Emmanouil/0000-0001-5750-0725; Domenici, Giacomo/0000-0002-3947-5930; Gorrono, Irantzu/0000-0003-4160-6781; Mohamed Mohamed Abdoh AL Shareef, Zainab/0000-0003-4213-1052	UAE Ministry of Presidential Affairs; Harris Family Harvey Spack Memorial Fund; Garfield Weston Foundation; Rosetrees Trust; Basque Department of Education [BFI-2010-129]; Spanish Ministry of Science and Innovation [SAF2014-51966-R, SAF2017-84092-R, SAF2017-84934-R]	UAE Ministry of Presidential Affairs; Harris Family Harvey Spack Memorial Fund; Garfield Weston Foundation; Rosetrees Trust(Rosetrees Trust); Basque Department of Education; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We gratefully acknowledge the UAE Ministry of Presidential Affairs, The Harris Family Harvey Spack Memorial Fund, The Garfield Weston Foundation, Rosetrees Trust, Basque Department of Education (BFI-2010-129), and the Spanish Ministry of Science and Innovation (SAF2014-51966-R and SAF2017-84092-R (RMK) and SAF2017-84934-R (MdMV)) for funding, and the Cancer Research UK Imperial Centre, the Imperial Experimental Cancer Medicine Centre, the National Institute for Health Research Imperial Biomedical Research Centre, the Department of Industry, Tourism and Trade (Elkartek), the Department of Innovation Technology of the Government of the Autonomous Community of the Basque Country, and the Centre of Excellence Severo Ochoa (2017-2021) for infrastructure support.	Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Bauderlique-Le Roy H, 2015, STEM CELLS DEV, V24, P1252, DOI 10.1089/scd.2014.0386; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Bello-DeOcampo D, 2001, MUTAT RES-FUND MOL M, V480, P209, DOI 10.1016/S0027-5107(01)00201-9; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Busceti CL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00111; Chen WY, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam6826; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dutta A, 2015, BIOCHEM J, V466, P525, DOI 10.1042/BJ20140698; Fong D, 2009, CANCER SCI, V100, P1414, DOI 10.1111/j.1349-7006.2009.01208.x; Fu CY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.395012; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Gao F, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0533-9; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5; Kawano Y, 2006, ONCOGENE, V25, P6528, DOI 10.1038/sj.onc.1209661; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kumon H, 2016, CANCER GENE THER, V23, P400, DOI 10.1038/cgt.2016.53; Kumon H, 2015, CLIN MED INSIGHTS-ON, V9, P31, DOI 10.4137/CMO.S23252; Leonard JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181724; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Montecinos VP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029623; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Rohrschneider LR, 2005, DEV BIOL, V283, P503, DOI 10.1016/j.ydbio.2005.04.032; Romero D, 2016, CARCINOGENESIS, V37, P18, DOI 10.1093/carcin/bgv153; Romero Diana, 2013, Bioarchitecture, V3, P42, DOI 10.4161/bioa.25243; Romero D, 2013, J CELL SCI, V126, P1858, DOI 10.1242/jcs.119388; Ross-Adams H, 2015, EBIOMEDICINE, V2, P1133, DOI 10.1016/j.ebiom.2015.07.017; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah JN, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-284; Smits P, 1997, GENOMICS, V45, P487, DOI 10.1006/geno.1997.4918; St Croix B, 2000, SCIENCE, V289, P1197; Su P, 2016, J IMMUNOL, V197, P1054, DOI 10.4049/jimmunol.1502457; THALMANN GN, 1994, CANCER RES, V54, P2577; Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x; Tu Z, 2001, BLOOD, V98, P2028, DOI 10.1182/blood.V98.7.2028; Untergasser G, 2008, INT J CANCER, V122, P1539, DOI 10.1002/ijc.23255; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Wang XC, 2015, J BIOL CHEM, V290, P19844, DOI 10.1074/jbc.M115.641415; Webber JP, 2016, ONCOTARGET, V7, P20124, DOI 10.18632/oncotarget.7716; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Ween MP, 2012, INT J MOL SCI, V13, P10461, DOI 10.3390/ijms130810461; Yu NW, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.061; Zenzmaier C, 2008, PROSTATE, V68, P540, DOI 10.1002/pros.20711; Zenzmaier C, 2013, PROSTATE, V73, P1441, DOI 10.1002/pros.22691; Zhu MJ, 2014, FEBS J, V281, P3766, DOI 10.1111/febs.12902	54	26	27	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5305	5324		10.1038/s41388-018-0294-0	http://dx.doi.org/10.1038/s41388-018-0294-0			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29858602	hybrid, Green Published			2022-12-26	WOS:000445759700005
J	Kim, J; Chen, B; Bru, JL; Huynh, E; Momen, M; Aswad, DW				Kim, Jeungjin; Chen, Baihe; Bru, Jean-Louis; Huynh, Eric; Momen, Mahsa; Aswad, Dana W.			New findings on SNP variants of human protein L-isoaspartyl methyltransferase that affect catalytic activity, thermal stability, and aggregation	PLOS ONE			English	Article							DIRECT LINEAR PLOT; REPAIR; DEFICIENCY; CONSEQUENCES; BRAINS; MICE	Protein L-isoaspartyl methyltransferase (PIMT/PCMT1), a product of the pcmt1 gene, catalyzes repair of abnormal L-isoaspartyl linkages in age-damaged proteins. Pcmt1 knockout mice exhibit a profound neuropathology and die 30-60 days postnatal from an epileptic seizure. Here we characterize four new SNP variants of human PIMT with respect to enzymatic activity, thermal stability, and propensity to aggregation. Under standard assay conditions, L191S, A150V, P174H and A65V showed activity losses of 72%, 64%, 61%, and 11% respectively. By differential scanning fluorimetry, melting temperature deviations were -5.2, -4.5, + 0.5, and -3.4 degrees C. SDS-PAGE of purified protein reveal significant aggregation of L191S, A150V, and P174H, but not A65V. We also report new data on three unusual PIMT variants among the 13 recently characterized by our laboratory. A7P and I58V were previously found to have 1.8-2.0 times the activity of WT PIMT in the standard assay; however, upon kinetic analysis, we find both variants exhibit reduced catalytic efficiency (Vmax/Km) due to weak isoaspartyl substrate binding. The near complete loss of activity (< 1%) seen in R36C was investigated by comparing activity of two artificial variants. R36K shows 4.6X the activity of R36C, while R36A shows no improvement, suggesting the guanidino nitrogens of the R36 play a key role in binding the methyl donor S-adenosyl-L-methionine (AdoMet). The new findings reported here extend the list of human PIMT variants that may contribute to neurological diseases in the young and the decline of CNS function in the aged.	[Kim, Jeungjin; Chen, Baihe; Bru, Jean-Louis; Huynh, Eric; Momen, Mahsa; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dwaswad@uci.edu		Aswad, Dana/0000-0001-5098-3461; Bru, Jean-Louis/0000-0001-8797-6652	UC Irvine	UC Irvine	J-L Bru received an undergraduate research award from UC Irvine to work on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other funding came from the personal income of DWA. The specific roles of this author are articulated in the 'author contributions' section. No additional external funding was received for this study.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arthur JW, 2015, HUM MUTAT, V36, P196, DOI 10.1002/humu.22735; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; CORNISHB.A, 1974, BIOCHEM J, V139, P721, DOI 10.1042/bj1390721; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DeVry CG, 1999, J HUM GENET, V44, P275, DOI 10.1007/s100380050161; Dimitrijevic A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100622; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; Farrar CE, 2004, THESIS; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; JOHNSON BA, 1991, NEUROBIOL AGING, V12, P19, DOI 10.1016/0197-4580(91)90034-H; JOHNSON BA, 1993, NEUROCHEM RES, V18, P87, DOI 10.1007/BF00966926; Juang C, 2017, J BIOL CHEM, V292, P3656, DOI 10.1074/jbc.M116.765222; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Mitchell AA, 2004, BIOINFORMATICS, V20, P1022, DOI 10.1093/bioinformatics/bth034; Qin ZX, 2015, NEUROBIOL AGING, V36, P1029, DOI 10.1016/j.neurobiolaging.2014.10.036; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Vugrek O, 2009, HUM MUTAT, V30, pE555, DOI 10.1002/humu.20985; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198266	10.1371/journal.pone.0198266	http://dx.doi.org/10.1371/journal.pone.0198266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856810	gold, Green Submitted, Green Published			2022-12-26	WOS:000433900800093
J	Mogga, M; Sibiya, J; Shimelis, H; Lamo, J; Yao, N				Mogga, Maurice; Sibiya, Julia; Shimelis, Hussein; Lamo, Jimmy; Yao, Nasser			Diversity analysis and genome-wide association studies of grain shape and eating quality traits in rice (Oryza sativa L.) using DArT markers	PLOS ONE			English	Article							AMYLOSE CONTENT; POPULATION-STRUCTURE; APPEARANCE QUALITY; GENETIC DIVERSITY; LOCI; IDENTIFICATION; GLABERRIMA; SELECTION; SOFTWARE; APPARENT	Microarray-based markers such as Diversity Arrays Technology (DArT) have become the genetic markers of choice for construction of high-density maps, quantitative trait loci (QTL) mapping and genetic diversity analysis based on their efficiency and low cost. More recently, the DArT technology was further developed in combination with high-throughput next-generation sequencing (NGS) technologies to generate the DArTseq platform representing a new sequencing tool of complexity-reduced representations. In this study, we used DArTseq markers to investigate genetic diversity and genome-wide association studies (GWAS) of grain quality traits in rice (Oryza sativa L.). The study was performed using 59 rice genotypes with 525 SNPs derived from DArTseq platform. Population structure analysis revealed only two distinct genetic clusters where genotypes were grouped based on environmental adaptation and pedigree information. Analysis of molecular variance indicated a low degree of differentiation among populations suggesting the need for broadening the genetic base of the current germplasm collection. GWAS revealed 22 significant associations between DArTseq- derived SNP markers and rice grain quality traits in the test genotypes. In general, 2 of the 22 significant associations were in chromosomal regions where the QTLs associated with the given traits had previously been reported, the other 20 significant SNP marker loci were indicative of the likelihood discovery of novel alleles associated with rice grain quality traits. DArTseq-derived SNP markers that include SNP12_100006178, SNP13_3052560 and SNP14_3057360 individually co-localised with two functional gene groups that were associated with QTLs for grain width and grain length to width ratio on chromosome 3, indicating trait dependency or pleiotropic-effect loci. This study demonstrated that DArTseq markers were useful genomic resources for genome-wide association studies of rice grain quality traits to accelerate varietal development and release.	[Mogga, Maurice] Minist Agr & Food Secur, Juba, South Sudan; [Sibiya, Julia; Shimelis, Hussein] Univ KwaZulu Natal, African Ctr Crop Improvement, Sch Agr Sci & Agribusiness, Pietermaritzburg, South Africa; [Lamo, Jimmy] Natl Crops Resources Res Inst NaCRRI, Cereals Program, Kampala, Uganda; [Yao, Nasser] Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya	University of Kwazulu Natal	Mogga, M (corresponding author), Minist Agr & Food Secur, Juba, South Sudan.	mauricemogga@yahoo.com	Shimelis, Hussein/N-5073-2013	Shimelis, Hussein/0000-0003-2793-8392; Sibiya, Julia/0000-0002-2934-9738	Biosciences eastern and central Africa (BecA), Nairobi, Kenya [ABC 149]; Alliance for a Green Revolution in Africa, Nairobi, Kenya [AGRA PASS 060]; International Foundation for Science (IFS), Sweden [C_5828_1]	Biosciences eastern and central Africa (BecA), Nairobi, Kenya; Alliance for a Green Revolution in Africa, Nairobi, Kenya; International Foundation for Science (IFS), Sweden(International Foundation for Science)	The work presented here was led by Maurice Mogga and funded by Biosciences eastern and central Africa (BecA), Nairobi, Kenya (ABC 149); Alliance for a Green Revolution in Africa (AGRA PASS 060), Nairobi, Kenya; International Foundation for Science (IFS), Sweden (C_5828_1).	Anacleto R, 2015, THEOR APPL GENET, V128, P1449, DOI 10.1007/s00122-015-2537-6; Asghar S., 2012, PAKISTAN J FOOD SCI, V22, P128; Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Biselli C, 2014, RICE, V7, DOI 10.1186/1939-8433-7-1; Boutet G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2447-2; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cruz N. Dela, 2000, P15; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; Dai LP, 2016, CROP SCI, V56, P1484, DOI 10.2135/cropsci2015.07.0404; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Demont M, 2013, GLOB FOOD SECUR-AGR, V2, P172, DOI 10.1016/j.gfs.2013.07.001; Dobo M, 2010, J CEREAL SCI, V52, P450, DOI 10.1016/j.jcs.2010.07.010; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Folta K., 2015, PLANT SIGNAL BEHAV, V10, DOI [10.1371/journal.pone.0144960, DOI 10.4161/15592324.2014.991596]; Furuta T, 2017, G3-GENES GENOM GENET, V7, P881, DOI 10.1534/g3.116.038190; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gibson TS, 1997, J CEREAL SCI, V25, P111, DOI 10.1006/jcrs.1996.0086; Govindaraj P, 2009, EUPHYTICA, V166, P165, DOI 10.1007/s10681-008-9808-0; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; [何予卿 He Yuqing], 2003, [分子植物育种, Molecular Plant Breeding], V1, P613; Huang BE, 2012, PLANT BIOTECHNOL J, V10, P826, DOI 10.1111/j.1467-7652.2012.00702.x; Jarquin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-740; Jiang GH, 2005, J INTEGR PLANT BIOL, V47, P1391, DOI 10.1111/j.1744-7909.2005.00089.x; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Juliano BO., 1985, RICE CHEM TECHNOLOGY; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Koutroubas SD, 2004, FIELD CROP RES, V86, P115, DOI 10.1016/S0378-4290(03)00117-5; Lang NT, 2004, OMONRICE, V12, P12; Li JM, 2004, GENETICS, V168, P2187, DOI 10.1534/genetics.104.034165; Li YY, 2015, PLANT BREEDING, V134, P535, DOI 10.1111/pbr.12294; LITTLE RR, 1958, CEREAL CHEM, V35, P111; Lu BY, 2013, EUPHYTICA, V192, P25, DOI 10.1007/s10681-012-0822-x; MORRISON WR, 1983, J CEREAL SCI, V1, P9, DOI 10.1016/S0733-5210(83)80004-6; Muhammad Akram, 2009, Pakistan Journal of Agricultural Research, V22, P154; Ogunbayo SA, 2005, AFR J BIOTECHNOL, V4, P1234; Oloka B. M., 2015, African Journal of Biotechnology, V14, P1533; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanni KA, 2013, REALIZING AFRICA'S RICE PROMISE, P87, DOI 10.1079/9781845938123.0087; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Shen Nian-wei, 2011, Zhongguo Shuidao Kexue, V25, P475, DOI 10.3969/j.issn.1001-7216.2011.05.004; Surapaneni M, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0409-7; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Tang WJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0779-3; Traore V. S. E., 2015, Agricultural Sciences, V6, P943, DOI 10.4236/as.2015.69091; Vanaja T., 2006, Journal of Tropical Agriculture, V44, P61; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wang XQ, 2010, AGR SCI CHINA, V9, P1101, DOI 10.1016/S1671-2927(09)60196-6; Xiao JH, 1998, GENETICS, V150, P899; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang Guang-Heng, 2004, Yichuan, V26, P887	63	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198012	10.1371/journal.pone.0198012	http://dx.doi.org/10.1371/journal.pone.0198012			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856872	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800060
J	Rasmussen, JE; Laurell, G; Rask-Andersen, H; Bergquist, J; Eriksson, PO				Rasmussen, Jesper Edvardsson; Laurell, Goran; Rask-Andersen, Helge; Bergquist, Jonas; Eriksson, Per Olof			The proteome of perilymph in patients with vestibular schwannoma. A possibility to identify biomarkers for tumor associated hearing loss?	PLOS ONE			English	Article								Background Due to the surrounding bone, the human inner ear is relatively inaccessible and difficult to reach for cellular and molecular analyses. However, these types of investigations are needed to better understand the etiology, pathophysiology and progression of several inner ear disorders. Moreover, the fluid from the inner ear cannot be sampled for micro-chemical analyses from healthy individuals in vivo. Therefore, in the present paper, we studied patients with vestibular schwannoma (VS) undergoing trans-labyrinthine surgery (TLS). Our primary aim was to identify perilymph proteins in patients with VS on an individual level. Our second aim was to investigate the proteins identified at a functional level and our final aim was to search for biological markers for tumor-associated hearing loss and tumor diameter. Methods and findings Sixteen patients underwent TLS for sporadic VS. Perilymph was aspirated through the round window before opening the labyrinth. One sample was contaminated and excluded resulting in 15 usable samples. Perilymph samples were analyzed with an online tandem LTQ-Orbitrap mass spectrometer. Data were analyzed with MaxQuant software to identify the total number of proteins and to quantify proteins in individual samples. Protein function was analyzed using the PANTHER Overrepresentation tool. Associations between perilymph protein content, clinical parameters, tumor-associated hearing loss and tumor diameter were assessed using Random Forest and Boruta. In total, 314 proteins were identified; 60 in all 15 patients and 130 proteins only once in 15 patients. Ninety-one proteins were detected in at least 12 out of 15 patients. Random Forest followed by Boruta analysis confirmed that alpha-2-HS-glycoprotein (P02765) was an independent variable for tumor-associated hearing loss. In addition, functional analysis showed that numerous processes were significantly increased in the perilymph. The top three enriched biological processes were: 1) secondary metabolic processes; 2) complement activation and 3) cell recognition. Conclusions The proteome of perilymph in patients with vestibular schwannoma has an inter-individual stable section. However, even in a cohort with homogenous disease, the variation between individuals represented the majority of the detected proteins. Alpha-2-HS-glycoprotein, P02765, was shown to be an independent variable for tumor-associated hearing loss, a finding that needs to be verified in other studies. In pathway analysis perilymph had highly enriched functions, particularly in terms of increased immune and metabolic processes.	[Rasmussen, Jesper Edvardsson; Laurell, Goran; Rask-Andersen, Helge; Eriksson, Per Olof] Uppsala Univ, Dept Surg Sci, Otorhinolaryngol & Head & Neck Surg, Uppsala, Sweden; [Bergquist, Jonas] Uppsala Univ, Dept Chem BMC, Analyt Chem, Uppsala, Sweden	Uppsala University; Uppsala University	Rasmussen, JE (corresponding author), Uppsala Univ, Dept Surg Sci, Otorhinolaryngol & Head & Neck Surg, Uppsala, Sweden.	jesper.rasmussen@surgsci.uu.se		Edvardsson Rasmussen, Jesper/0000-0002-3394-8338; Bergquist, Jonas/0000-0002-4597-041X; Eriksson, Per Olof/0000-0003-1434-4771	Swedish Research Council [2015-4870]; Uppsala county ALF [AS-1905702]; Foundation Acta Otolaryngologica scholarship	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala county ALF; Foundation Acta Otolaryngologica scholarship	Funded by Swedish Research Council, grant 2015-4870, www.vr.se; Uppsala county ALF grant AS-1905702; Foundation Acta Otolaryngologica scholarship granted to Jesper Rasmussen; Private donation from Mr and Mrs Werner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRER E, 1988, ACTA OTO-LARYNGOL, V106, P117, DOI 10.3109/00016488809107378; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; EKVALL L, 1988, ACTA OTO-LARYNGOL, P15; Kirchmann M, 2017, NEUROSURGERY, V80, P49, DOI 10.1227/NEU.0000000000001414; Kshettry VR, 2015, J NEURO-ONCOL, V124, P223, DOI 10.1007/s11060-015-1827-9; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lysaght AC, 2011, J PROTEOME RES, V10, P3845, DOI 10.1021/pr200346q; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Rangel-Castilla L, 2016, REP PRACT ONCOL RADI, V21, P325, DOI 10.1016/j.rpor.2014.09.002; Rask-Andersen H, 1994, Lakartidningen, V91, P2780; Schmitt H, 2018, OTOL NEUROTOL, V39, P37, DOI 10.1097/MAO.0000000000001625; Schmitt HA, 2017, J PROTEOME RES, V16, P1911, DOI 10.1021/acs.jproteome.6b00986; TASAKI I, 1959, J NEUROPHYSIOL, V22, P149, DOI 10.1152/jn.1959.22.2.149; THALMANN I, 1994, OTOLARYNG HEAD NECK, V111, P273, DOI 10.1016/S0194-5998(94)70602-6; VONBEKESY G, 1952, J ACOUST SOC AM, V24, P72; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	20	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198442	10.1371/journal.pone.0198442	http://dx.doi.org/10.1371/journal.pone.0198442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856847	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800126
J	Marcalo, A; Guerreiro, PM; Bentes, L; Rangel, M; Monteiro, P; Oliveira, F; Afonso, CML; Pousao-Ferreira, P; Benoit, HP; Breen, M; Erzini, K; Goncalves, JMS				Marcalo, Ana; Guerreiro, Pedro M.; Bentes, Luis; Rangel, Mafalda; Monteiro, Pedro; Oliveira, Frederico; Afonso, Carlos M. L.; Pousao-Ferreira, Pedro; Benoit, Hugues P.; Breen, Mike; Erzini, Karim; Goncalves, Jorge M. S.			Effects of different slipping methods on the mortality of sardine, Sardina pilchardus, after purse-seine capture off the Portuguese Southern coast (Algarve)	PLOS ONE			English	Article							DISCARD MORTALITY; NORTHERN PORTUGAL; TRAWL FISHERY; RAINBOW-TROUT; SCALE LOSS; BY-CATCH; STRESS; CORTISOL; SEAWATER; DENSITIES	The effects of two different slipping methods on the survival, physical and physiological response of sardines, Sardina pilchardus, captured in a purse-seine fishery were investigated in southern Portugal. Sardines were collected and transferred into holding tanks onboard a commercial fishing vessel after being captured, crowded and deliberately released using two slipping procedures: standard and modified. The standard slipping procedure aggregated fish at high densities and made them "roll over" the floatline, while the modified procedure aggregated the fish at moderate densities and enabled them to escape through an opening created by adding weights to the floatline. Both slipping methods were compared with minimally harmed non-slipped sardines (sardines collected from the loose pocket of the purse seine). Survival rates were monitored in captivity over 28 days using three replicates for each treatment. The estimated survival of sardines was 43.6% for the non-slipped fish, 44.7% for the modified slipping and 11.7% for the standard slipping treatments. Scale loss indicated the level of physical impact experienced, with dead fish from the non-slipped and modified slipping technique showing significantly lower scale loss than those fish from the standard slipping treatment within the same period. Of the physiological indicators of stress measured, cortisol, glucose, lactate and osmolality attained peak values during slipping and up to the first hours after introduction to captivity. This work indicates that although delayed mortality after release may be substantial, appropriately modified slipping techniques significantly enhance survival of slipped sardines.	[Marcalo, Ana; Guerreiro, Pedro M.; Bentes, Luis; Rangel, Mafalda; Monteiro, Pedro; Oliveira, Frederico; Afonso, Carlos M. L.; Erzini, Karim; Goncalves, Jorge M. S.] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Marcalo, Ana] Univ Cadiz, CEI MAR, Plaza Fella, Cadiz, Spain; [Pousao-Ferreira, Pedro] PMA Portuguese Inst Sea & Atmosphere EPPO, Aquaculture Res Stn, Olhao, Portugal; [Benoit, Hugues P.] Fisheries & Oceans Canada, Gulf Fisheries Ctr, Univ Ave, Moncton, NB, Canada; [Breen, Mike] Inst Marine Res, Bergen, Norway	Universidade do Algarve; Universidad de Cadiz; Instituto Portugues do Mar e da Atmosfera; Fisheries & Oceans Canada; Institute of Marine Research - Norway	Marcalo, A (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal.; Marcalo, A (corresponding author), Univ Cadiz, CEI MAR, Plaza Fella, Cadiz, Spain.	amarcalo@ualg.pt	Marçalo, Ana/ABI-5648-2020; Monteiro, Pedro/D-4995-2009; Gonçalves, Jorge MS/G-5206-2011; Rangel, Mafalda/L-5194-2014; Pousao-Ferreira, Pedro/H-3689-2014; Erzini, Karim/M-5216-2013; Bentes, Luis/D-5057-2009	Marçalo, Ana/0000-0002-0485-341X; Monteiro, Pedro/0000-0003-1446-8256; Gonçalves, Jorge MS/0000-0001-7704-8190; Afonso, Carlos/0000-0002-9084-2177; Rangel, Mafalda/0000-0001-5903-5687; Pousao-Ferreira, Pedro/0000-0001-6746-764X; Erzini, Karim/0000-0002-1411-0126; Bentes, Luis/0000-0001-6884-2886; Oliveira, Frederico/0000-0002-4318-604X	FCT [SFRH/BPD/116307/2016]; European Commission's Horizon 2020 Research and Innovation Programme [634495]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission's Horizon 2020 Research and Innovation Programme	Mafalda Rangel would like to acknowledge FCT funding through a post doctoral grant (SFRH/BPD/116307/2016). This research has received funding from the European Commission's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 634495 for the project Science, Technology, and Society Initiative to minimize Unwanted Catches in European Fisheries (MINOUW - EU H2020 - Case study 2.2. - Algarve Purse-seine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Benoit HP, 2015, ICES J MAR SCI, V72, P1834, DOI 10.1093/icesjms/fsv039; Benoit HP, 2012, FISH RES, V125, P318, DOI 10.1016/j.fishres.2011.12.004; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Breen M, ICES CM 2012; Broadhurst MK, 2008, J EXP MAR BIOL ECOL, V364, P54, DOI 10.1016/j.jembe.2008.07.001; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Broadhurst MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106414; Campos A, 2014, DEV MARITIME TRANSPO, V2; CHOPIN FS, 1995, FISH RES, V21, P315, DOI 10.1016/0165-7836(94)00301-C; COM, 425 FINAL 2011; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; DGRM, 111 DGRM; FAO, 957 FAO; Fonseca P, 2005, FISH RES, V71, P223, DOI 10.1016/j.fishres.2004.08.018; Goncalves JMS, 2008, AQUAT LIVING RESOUR, V21, P135, DOI 10.1051/alr:2008023; Grutter AS, 2000, J FISH BIOL, V57, P391, DOI 10.1111/j.1095-8649.2000.tb02179.x; Guerreiro PM, 2006, GEN COMP ENDOCR, V148, P227, DOI 10.1016/j.ygcen.2006.03.004; Guerreiro PM, 2013, FISH PHYSIOL BIOCHEM, V39, P917, DOI 10.1007/s10695-012-9751-9; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; He P., 2015, FISHERIES BYCATCH GL, DOI [10.4027/FBGICS.2015.07, DOI 10.4027/FBGICS.2015.07, 10.4027/fbgics.2015.07]; Huse I, 2010, FISH RES, V106, P54, DOI 10.1016/j.fishres.2010.07.001; ICES, 2014, WORKSH METH EST DISC; IGER Y, 1995, GEN COMP ENDOCR, V97, P188, DOI 10.1006/gcen.1995.1018; JAMES AG, 1988, S AFR J MARINE SCI, V6, P17, DOI 10.2989/025776188784480519; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kelleher K., 2005, FAO FISH TECH PAP, P152, DOI DOI 10.1136/EBMED-2011-0012; Laiz-Carrion R, 2005, J EXP ZOOL PART A, V303A, P563, DOI 10.1002/jez.a.183; Laursen DC, 2013, PHYSIOL BEHAV, V122, P147, DOI 10.1016/j.physbeh.2013.08.026; LEVESQUE JC, 2016, PEERJ, V4, DOI DOI 10.7717/PEERJ.2192; LOCKWOOD SJ, 1983, FISH RES, V2, P129, DOI 10.1016/0165-7836(83)90114-5; Main J, 1990, SCOTT FISH RES REP, P46; Marcalo A, 2008, J FISH BIOL, V72, P103, DOI 10.1111/j.1095-8649.2007.01660.x; Marcalo A, 2013, J FISH BIOL, V83, P480, DOI 10.1111/jfb.12184; Marcalo A, 2006, MAR BIOL, V149, P1509, DOI 10.1007/s00227-006-0277-5; Marcalo A, 2015, ICES J MAR SCI, V72, P2438, DOI 10.1093/icesjms/fsv076; Marcalo A, 2010, ICES J MAR SCI, V67, P334, DOI 10.1093/icesjms/fsp244; Mitchell RW, 2002, FISH RES, V57, P279, DOI 10.1016/S0165-7836(01)00354-X; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Olsen RE, 2012, FISH RES, V129, P21, DOI 10.1016/j.fishres.2012.06.007; Ortuno J, 2001, FISH SHELLFISH IMMUN, V11, P187, DOI 10.1006/fsim.2000.0304; Pawson M.G., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P439; Pottinger TG, 1998, J FISH BIOL, V53, P728, DOI 10.1111/j.1095-8649.1998.tb01828.x; Raby GD, 2015, ECOL APPL, V25, P1757, DOI 10.1890/14-0798.1; Robinson KA, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot015; Rottmann RW, 1992, SO REGIONAL AQUACULT, V1992, P474; Silva A, RESOURCE ASSESSMENT; Stratoudakis Y, 2003, MAR ECOL PROG SER, V265, P235, DOI 10.3354/meps265235; Stratoudakis Y, 2002, ICES J MAR SCI, V59, P1256, DOI 10.1006/jmsc.2002.1314; Suuronen P, 1996, FISH RES, V25, P305, DOI 10.1016/0165-7836(95)00446-7; Tenningen M, 2012, ICES J MAR SCI, V69, P1523, DOI 10.1093/icesjms/fss114; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Uhlmann SS, 2015, FISH FISH, V16, P183, DOI 10.1111/faf.12049; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zydlewski J, 2010, T AM FISH SOC, V139, P129, DOI 10.1577/T09-054.1	56	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5								10.1371/journal.pone.0195433	http://dx.doi.org/10.1371/journal.pone.0195433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851955	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200003
J	Kawashima, S; Ueki, Y; Kato, T; Ito, K; Matsukawa, N				Kawashima, Shoji; Ueki, Yoshino; Kato, Takashi; Ito, Kengo; Matsukawa, Noriyuki			Reduced striatal dopamine release during motor skill acquisition in Parkinson's disease	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; SEQUENTIAL ARM MOVEMENTS; BASAL GANGLIA; FUNCTIONAL MRI; TASK; CONSOLIDATION; CORTEX; REPRESENTATION; CONNECTIVITY	Background Striatal dopamine is functionally important for the acquisition of motor skills. However, it remains controversial as to whether intrinsic processing of motor learning is impaired in patients with Parkinson's disease (PD), and if yes, whether the impairment is associated with altered striatal dopamine release. Additionally, most neuro- imaging studies of patients with PD have focused on motor sequence learning. In contrast, skill acquisition, specifically, the reconstruction of muscle control of isolated movements, has barely been studied. Method In this study, we used a repetitive skill training task to measure the peak acceleration of left thumb movement during a process to achieve fine tuning of motor skill. Using C-11-raclopride (RAC) positron emission tomography, we investigated changes in striatal dopamine levels in two conditions of a skill acquisition task: initial skill training (Day 1) and acquired condition (Day 2) with eight patients with PD and age-matched healthy subjects (HS). Result In HS, the mean acceleration of each session improved through repeated training sessions on Day 1. However, in patients with PD, the training-associated increase was less than that for HS, and this suggests that repetitive skill training does not result in the effective improvement of motor performance. The regions of interest (ROI) analysis revealed that the RACbinding potential (BP) was significantly reduced in the right putamen on Day 1 compared with Day 2 in HS. In patients with PD, BP within the right putamen was unchanged. Further, we found that patients with PD had increased dopamine levels within the right ventral striatum (VST) and right caudate (CAU) on Day 2, which was greater than that in HS. These results suggest the impaired activation of the putamen during skill acquisition in patients with PD and compensated hyperactivation of the VST and CAU for the reduced dopamine release within the dorsal putamen (DPU). Conclusion Our findings suggest that patients with PD had insufficiency in the process to improve motor skills. Different patterns of striatal dopamine release are relevant to the impairment of these motor functions in patients with PD, at the early stage of the disease.	[Kawashima, Shoji; Ueki, Yoshino; Matsukawa, Noriyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Mizuho Ku, Nagoya, Aichi, Japan; [Ueki, Yoshino] Nagoya City Univ, Dept Rehabil Med, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Kato, Takashi; Ito, Kengo] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Brain Sci & Mol Imaging, Obu, Aichi, Japan	Nagoya City University; Nagoya City University; National Center for Geriatrics & Gerontology	Kawashima, S; Ueki, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Mizuho Ku, Nagoya, Aichi, Japan.; Ueki, Y (corresponding author), Nagoya City Univ, Dept Rehabil Med, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi, Japan.	shoji@med.nagoya-cu.ac.jp; yueki@nagoya-cu.ac.jp			 [22790824]		This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas. Grant Number is 22790824 to Yoshino Ueki.; This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas.	AGOSTINO R, 1994, MOVEMENT DISORD, V9, P311, DOI 10.1002/mds.870090305; Agostino R, 1996, J NEUROL SCI, V139, P218; AGOSTINO R, 1992, BRAIN, V115, P1481, DOI 10.1093/brain/115.5.1481; Antonini A, 1997, MOVEMENT DISORD, V12, P33, DOI 10.1002/mds.870120107; Badgaiyan RD, 2007, NEUROIMAGE, V38, P549, DOI 10.1016/j.neuroimage.2007.07.052; Beeler JA, 2010, ANN NEUROL, V67, P639, DOI 10.1002/ana.21947; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Felix K, 2012, PARKINSONS DIS, DOI [10.1152/jn.1997.77.3.1581, DOI 10.1152/JN.1997.77.3.1581]; Floel A, 2005, NEUROLOGY, V65, P472, DOI 10.1212/01.wnl.0000172340.56307.5e; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; FRITH CD, 1986, J NEUROL NEUROSUR PS, V49, P661, DOI 10.1136/jnnp.49.6.661; Goerendt IK, 2003, BRAIN, V126, P312, DOI 10.1093/brain/awg035; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Gupta P, 2002, PSYCHOL REV, V109, P401, DOI 10.1037//0033-295X.109.2.401; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hallett M., 2005, MOTOR LEARNING HIGHE, P123; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652, DOI 10.1152/jn.1995.74.4.1652; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huang P, 2017, MOVEMENT DISORD, V32, P1047, DOI 10.1002/mds.27000; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jessop RT, 2006, NEUROREHAB NEURAL RE, V20, P459, DOI 10.1177/1545968306287107; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Kang SY, 2010, MOVEMENT DISORD, V25, P2148, DOI 10.1002/mds.23251; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kawashima S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031728; Kim JY, 2008, MOVEMENT DISORD, V23, P207, DOI 10.1002/mds.21787; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Kwak Y, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00143; Kwak Y, 2010, J NEUROPHYSIOL, V103, P942, DOI 10.1152/jn.00197.2009; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Matsuzaka Y, 2007, J NEUROPHYSIOL, V97, P1819, DOI 10.1152/jn.00784.2006; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Morrish PK, 1996, BRAIN, V119, P2097, DOI 10.1093/brain/119.6.2097; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Mure H, 2012, J NEUROSCI, V32, P2804, DOI 10.1523/JNEUROSCI.4331-11.2012; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; Nakano K, 2000, J NEUROL, V247, P1; Nieuwboer A, 2009, PARKINSONISM RELAT D, V15, pS53, DOI 10.1016/S1353-8020(09)70781-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pendt LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021669; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Smiley-Oyen AL, 2003, EXP BRAIN RES, V152, P453, DOI 10.1007/s00221-003-1570-x; Smiley-Oyen AL, 2006, MOVEMENT DISORD, V21, P1078, DOI 10.1002/mds.20906; Smith JG, 2004, NEUROPSYCHOLOGY, V18, P679, DOI 10.1037/0894-4105.18.4.679; Soliveri P, 1997, BRAIN, V120, P1325, DOI 10.1093/brain/120.8.1325; Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268; Tissingh G, 1998, J NEUROL, V245, P14; Tremblay PL, 2009, BEHAV BRAIN RES, V198, P231, DOI 10.1016/j.bbr.2008.11.002; Tzvi E, 2015, NEUROIMAGE, V122, P52, DOI 10.1016/j.neuroimage.2015.07.077; WICKENS JR, 1995, SYNAPSE, V20, P281, DOI 10.1002/syn.890200402; Willuhn I, 2008, NEUROSCIENCE, V153, P249, DOI 10.1016/j.neuroscience.2008.01.041; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569	71	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0196661	10.1371/journal.pone.0196661	http://dx.doi.org/10.1371/journal.pone.0196661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847548	gold, Green Published, Green Submitted			2022-12-26	WOS:000433634800010
J	Royan, NRR; Sulong, AB; Yuhana, NY; Chen, RS; Ab Ghani, MH; Ahmad, S				Royan, Nishata Royan Rajendran; Sulong, Abu Bakar; Yuhana, Nor Yuliana; Chen, Ruey Shan; Ab Ghani, Mohd Hafizuddin; Ahmad, Sahrim			UV/O-3 treatment as a surface modification of rice husk towards preparation of novel biocomposites	PLOS ONE			English	Article							WOOD-PLASTIC COMPOSITES; MECHANICAL-PROPERTIES; POLYPROPYLENE COMPOSITES; CARBON NANOTUBES; POLYMER COMPOSITES; CELLULOSIC FIBERS; OZONE TREATMENT; JUTE-FIBER; UV; PERFORMANCE	The use of rice husks (RH) to reinforce polymers in biocomposites are increasing tremendously. However, the incompatibility between the hydrophilic RH fibers and the hydrophobic thermoplastic matrices leads to unsatisfactory biocomposites. Surface modification of the fiber surface was carried out to improve the adhesion between fiber and matrix. In this study, the effect of surface modification of RH via alkali, acid and ultraviolet-ozonolysis (UV/O-3) treatments on the properties of composites recycled high density polyethylene (rHDPE) composites was investigated. The untreated and treated RH were characterized by Fourier Transform Infrared (FTIR) and Scanning Electron Microscope (SEM). The composites containing 30 wt% of RH (treated and untreated) were then prepared via extrusion and followed by compression molding. As compared to untreated RH, all surface treated RH exhibited rougher surface and showed improved adhesion with rHDPE matrix. Tensile strength of UV/O-3-treated RH composites showed an optimum result at 18.37 MPa which improved about 5% in comparison to the composites filled with untreated RH. UV/O-3 treatment promotes shorter processing time and lesser raw material waste during treatment process where this is beneficial for commercialization in the future developments of wood plastic composites (WPCs). Therefore, UV/O-3 treatment can be served as an alternative new method to modify RH surface in order to improve the adhesion between hydrophilic RH fibre and hydrophobic rHDPE polymer matrix.	[Royan, Nishata Royan Rajendran; Sulong, Abu Bakar; Yuhana, Nor Yuliana] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Bangi, Selangor, Malaysia; [Chen, Ruey Shan; Ab Ghani, Mohd Hafizuddin; Ahmad, Sahrim] Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Chen, RS (corresponding author), Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi, Selangor, Malaysia.	rueyshanchen@hotmail.com	Chen, Ruey Shan/C-7376-2017; , Abu Bakar Sulong UKM/AAN-8030-2021; Ab Ghani, Mohd Hafizuddin/AAA-7497-2022; Yuhana, Nor Yuliana/I-8724-2016	Chen, Ruey Shan/0000-0002-2713-942X; , Abu Bakar Sulong UKM/0000-0001-8968-176X; Yuhana, Nor Yuliana/0000-0003-0004-118X; Rajendran Royan, Nishata Royan/0000-0002-5155-0892; Sulong, Abu Bakar/0000-0003-4637-1758	Kementerian Pengajian Tinggi Malaysia under Long Term Research Grant Scheme [LRGS/TD/2012/USM-UKM/PT/05, DIP-2017-001, DIP-2016-023]	Kementerian Pengajian Tinggi Malaysia under Long Term Research Grant Scheme	The authors would like to gratefully acknowledge Kementerian Pengajian Tinggi Malaysia for the financial support under Long Term Research Grant Scheme LRGS/TD/2012/USM-UKM/PT/05, DIP-2017-001 and DIP-2016-023.	Adhikary KB, 2008, CHEM ENG J, V142, P190, DOI 10.1016/j.cej.2007.11.024; Adhikary KB, 2008, COMPOS PART B-ENG, V39, P807, DOI 10.1016/j.compositesb.2007.10.005; Ahmad I, 2012, COMPOS PART B-ENG, V43, P3069, DOI 10.1016/j.compositesb.2012.04.071; Aranberri-Askargorta I, 2003, J COLLOID INTERF SCI, V263, P580, DOI 10.1016/S0021-9797(03)00294-7; Asadi F, 2008, J HAZARD MATER, V154, P451, DOI 10.1016/j.jhazmat.2007.10.046; Ashori A, 2008, BIORESOURCE TECHNOL, V99, P4661, DOI 10.1016/j.biortech.2007.09.043; Ashori A, 2009, WASTE MANAGE, V29, P1291, DOI 10.1016/j.wasman.2008.09.012; Askeland D.R., 2010, SCI ENG MAT, V6th; Chen RS, 2015, BIOCOMPOSITES BASED; Chen RS, 2015, J COMPOS MATER, V49, P1241, DOI 10.1177/0021998314533361; Chen RS, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41494; Daffalla SB, 2012, INT J CHEM ENV ENG, V3; Drzal L.T, 2005, NATURAL FIBRES BIOPO; Espert A, 2004, COMPOS PART A-APPL S, V35, P1267, DOI 10.1016/j.compositesa.2004.04.004; Gassan J, 2000, COMPOS SCI TECHNOL, V60, P2857, DOI 10.1016/S0266-3538(00)00168-8; George J, 2001, POLYM ENG SCI, V41, P1471, DOI 10.1002/pen.10846; Guilbert-Garcia E, 2012, LAT AM APPL RES, V42, P83; Hu R, 2007, J COMPOS MATER, V41, P1655, DOI 10.1177/0021998306069878; Kim HS, 2004, J THERM ANAL CALORIM, V76, P395; Li J, 2007, COMPOS SCI TECHNOL, V67, P296, DOI 10.1016/j.compscitech.2006.08.009; Li X, 2009, APPL ENG AGRIC, V25, P525; Liu LF, 2009, COMPOS PART A-APPL S, V40, P669, DOI 10.1016/j.compositesa.2009.03.002; Macmanus LF, 1999, J POLYM SCI POL CHEM, V37, P2489, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2489::AID-POLA23>3.0.CO;2-G; Malkapuram R, 2009, J REINF PLAST COMP, V28, P1169, DOI 10.1177/0731684407087759; Marcovich NE, 1998, J APPL POLYM SCI, V68, P2069, DOI 10.1002/(SICI)1097-4628(19980627)68:13<2069::AID-APP2>3.0.CO;2-A; Mohanty AK, 2000, COMPOS SCI TECHNOL, V60, P1115, DOI 10.1016/S0266-3538(00)00012-9; Najafi E, 2006, COLLOID SURFACE A, V284, P373, DOI 10.1016/j.colsurfa.2005.11.074; Nakamura Y, 2004, WATER SCI TECHNOL, V50, P167, DOI 10.2166/wst.2004.0188; Ndazi BS, 2007, COMPOS PART A-APPL S, V38, P925, DOI 10.1016/j.compositesa.2006.07.004; Ong ST, 2009, INT J PHYS SCI, V4, P683; Oyawale FA, 2012, INT J APPL SCI ENG R, V1, P663, DOI [10.6088/ijaser.0020101067, DOI 10.6088/IJASER.0020101067]; Prachayawarakorn J, 2005, SONGKLANAKARIN J SCI; Premalal HGB, 2002, POLYM TEST, V21, P833, DOI 10.1016/S0142-9418(02)00018-1; Rahman MR, 2010, BIORESOURCES, V5, P854; Raja M, 2015, FULLER NANOTUB CAR N, V23, P11, DOI 10.1080/1536383X.2014.885960; Royan NRR, 2013, J NANOMATER, V2013, DOI 10.1155/2013/717459; Scida D, 2013, COMPOS PART B-ENG, V48, P51, DOI 10.1016/j.compositesb.2012.12.010; Sham ML, 2006, CARBON, V44, P768, DOI 10.1016/j.carbon.2005.09.013; Slepicka P, 2013, EXPRESS POLYM LETT, V7; Sugashini S, 2013, J ENVIRON CHEM ENG, V1, P79, DOI 10.1016/j.jece.2013.04.003; Sulong AB, 2017, J MECH ENG SCI SI, VSI3, P13; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Svorcik V, 2014, CARBON, V69, P361, DOI 10.1016/j.carbon.2013.12.037; Syafri R, 2011, SAINS MALAYS, V40, P749; Tong JY, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/938961; Trejo-O'Reilly JA, 1997, CELLULOSE, V4, P305, DOI 10.1023/A:1018452310122; WALZAK MJ, 1995, J ADHES SCI TECHNOL, V9, P1229, DOI 10.1163/156856195X01012; Wandera D, 2011, J MEMBRANE SCI, V373, P178, DOI 10.1016/j.memsci.2011.03.010; Wong S, 2004, COMPOS SCI TECHNOL, V64, P1321, DOI 10.1016/j.compscitech.2003.10.012; Yao F, 2011, J APPL POLYM SCI, V119, P2214, DOI 10.1002/app.32946; Zeynab Emdadi, 2015, International Journal of Chemical Engineering and Applications, V6, P273, DOI 10.7763/IJCEA.2015.V6.495; Zini E, 2011, POLYM COMPOSITE, V32, P1905, DOI 10.1002/pc.21224	52	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197345	10.1371/journal.pone.0197345	http://dx.doi.org/10.1371/journal.pone.0197345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847568	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800029
J	Ganesana, M; Venton, BJ				Ganesana, Mallikarjunarao; Venton, B. Jill			Early changes in transient adenosine during cerebral ischemia and reperfusion injury	PLOS ONE			English	Article							EXTRACELLULAR ADENOSINE; NERVOUS-SYSTEM; FOCAL ISCHEMIA; NEUROLOGICAL DEFICIT; ARTERY OCCLUSION; A(2A) RECEPTORS; BRAIN-DAMAGE; RAT; RELEASE; ACTIVATION	Adenosine is an important neuromodulator in the central nervous system, and tissue adenosine levels increase during ischemic events, attenuating excitotoxic neuronal injury. Recently, our lab developed an electrochemical fast-scan cyclic voltammetry (FSCV) method that identified rapid, spontaneous changes in adenosine concentrations that last only about 3 seconds. Here, we investigated the effects of cerebral ischemia and reperfusion on the concentration and frequency of transient adenosine release in the caudate-putamen. In anesthetized rats, data were collected for four hours: two hours of normoxia, 30 min of cerebral ischemia induced by bilateral common carotid artery occlusion, and 90 min of reperfusion. Transient adenosine release was increased during the cerebral ischemia period and remained elevated during reperfusion. The total number of adenosine transients increased by 52% during cerebral ischemia and reperfusion compared to normoxia. The concentration of adenosine per event did not increase but the cumulative adenosine concentration during cerebral ischemia and reperfusion increased by 53% because of the higher frequency of events. Further, we evaluated the role of A(2A) antagonist, SCH442416, a putative neuroprotective agent to affect adenosine transients. SCH442416 significantly decreased the transient frequency during cerebral ischemia-reperfusion by 27% and the cumulative concentration by 31%. Our results demonstrate that this mode of rapid adenosine release increases during early cerebral ischemia-reperfusion injury. Rapid adenosine release could provide fast, local neuromodulation and neuroprotection during cerebral ischemia.	[Ganesana, Mallikarjunarao; Venton, B. Jill] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Venton, B. Jill] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Venton, BJ (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.; Venton, BJ (corresponding author), Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22908 USA.	jventon@virginia.edu	Venton, B. Jill/A-2902-2008; Andreescu, S/D-8088-2011; Ganesana, Mallikarjunarao/B-9743-2011	Venton, B. Jill/0000-0002-5096-9309; Andreescu, S/0000-0003-3382-7939; 	National Institue of Health [R01NS076875]	National Institue of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institue of Health: R01NS076875 (https://proiectreporter.nih.gov/project_info_details.cfm? aids90432048&icde=0). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Yogesh Scindia for his assistance with TEM sample preparation. This work was funded by NIH (R01NS076875) to BJV.	BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; Borman RP, 2017, ACS CHEM NEUROSCI, V8, P386, DOI 10.1021/acschemneuro.6b00262; Chang SY, 2012, MAYO CLIN PROC, V87, P760, DOI 10.1016/j.mayocp.2012.05.006; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Chu S, 2013, ACTA PHARMACOL SIN, V34, P60, DOI 10.1038/aps.2012.127; COYLE P, 1990, STROKE, V21, P316, DOI 10.1161/01.STR.21.2.316; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dale N, 2000, J PHYSIOL-LONDON, V526, P143, DOI 10.1111/j.1469-7793.2000.00143.x; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; DUX E, 1990, BRAIN RES, V516, P248, DOI 10.1016/0006-8993(90)90925-2; Gaur V, 2009, EUR J PHARMACOL, V616, P147, DOI 10.1016/j.ejphar.2009.06.056; HERON A, 1994, BRAIN RES, V641, P217, DOI 10.1016/0006-8993(94)90149-X; Hettinger BD, 2001, J COMP NEUROL, V431, P331, DOI 10.1002/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W; Keithley RB, 2009, TRAC-TREND ANAL CHEM, V28, P1127, DOI 10.1016/j.trac.2009.07.002; Klaasse EC, 2008, PURINERG SIGNAL, V4, P21, DOI 10.1007/s11302-007-9086-7; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Lerner TN, 2010, J NEUROSCI, V30, P2160, DOI 10.1523/JNEUROSCI.5844-09.2010; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; Liu K, 2009, BRAIN RES, V1253, P161, DOI 10.1016/j.brainres.2008.11.096; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; Marcoli M, 2003, NEUROPHARMACOLOGY, V45, P201, DOI 10.1016/S0028-3908(03)00156-4; Melani A, 2006, BRAIN RES, V1073, P470, DOI 10.1016/j.brainres.2005.12.010; Melani A, 2003, BRAIN RES, V959, P243, DOI 10.1016/S0006-8993(02)03753-8; Melani A, 1999, STROKE, V30, P2448, DOI 10.1161/01.STR.30.11.2448; Melani A, 2014, INT REV NEUROBIOL, V119, P309, DOI 10.1016/B978-0-12-801022-8.00013-1; Melani A, 2012, EXP NEUROL, V233, P193, DOI 10.1016/j.expneurol.2011.09.036; Mukherjee PK, 2007, BEHAV BRAIN RES, V178, P221, DOI 10.1016/j.bbr.2006.12.025; Mundell S, 2011, BBA-BIOMEMBRANES, V1808, P1319, DOI 10.1016/j.bbamem.2010.06.007; NEWBY AC, 1990, NEWS PHYSIOL SCI, V5, P67; Nguyen MD, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.189; Nguyen MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087165; Soler EP, 2010, CURR CARDIOL REV, V6, P138, DOI 10.2174/157340310791658785; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pearson T, 2006, J NEUROCHEM, V97, P1357, DOI 10.1111/j.1471-4159.2006.03823.x; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Pedata F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/805198; Phillis JW, 1996, NEUROCHEM INT, V29, P115, DOI 10.1016/0197-0186(95)00154-9; Quartu M, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-016-0389-y; Rebola N, 2005, NEUROSCIENCE, V132, P893, DOI 10.1016/j.neuroscience.2005.01.014; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Robertson NJ, 2013, J NEUROCHEM, V124, P645, DOI 10.1111/jnc.12097; Rocha-Ferreira E, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5763743; Rodrigues RJ, 2005, J NEUROCHEM, V92, P433, DOI 10.1111/j.1471-4159.2004.02887.x; Rosin Diane L., 2003, Neurology, V61, pS12; Ross AE, 2015, J NEUROCHEM, V132, P51, DOI 10.1111/jnc.12946; Ross AE, 2014, J NEUROCHEM, V130, P50, DOI 10.1111/jnc.12711; RUDOLPHI KA, 1992, CEREBROVAS BRAIN MET, V4, P346; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Speetzen LJ, 2013, JOVE-J VIS EXP, DOI 10.3791/4387; Sperlagh B, 2007, NEUROSCIENCE, V149, P99, DOI 10.1016/j.neuroscience.2007.07.035; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Svenningsson P, 1998, J COMP NEUROL, V399, P229, DOI 10.1002/(SICI)1096-9861(19980921)399:2<229::AID-CNE6>3.0.CO;2-2; Swamy BEK, 2007, ANAL CHEM, V79, P744, DOI 10.1021/ac061820i; Tarditi A, 2006, NEUROBIOL DIS, V23, P44, DOI 10.1016/j.nbd.2006.01.014; TOMINAGA K, 1992, NEUROSCI LETT, V145, P67, DOI 10.1016/0304-3940(92)90205-L; Van Gompel JJ, 2014, EPILEPSIA, V55, P233, DOI 10.1111/epi.12511; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; Wang Y, 2017, J NEUROCHEM, V140, P13, DOI 10.1111/jnc.13705; Williams-Karnesky RL, 2009, CURR NEUROPHARMACOL, V7, P217, DOI 10.2174/157015909789152209; WINN HR, 1979, CIRC RES, V45, P486, DOI 10.1161/01.RES.45.4.486; Xia M, 2008, AM J PHYSIOL-REG I, V295, pR1494, DOI 10.1152/ajpregu.90631.2008; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X	64	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0196932	10.1371/journal.pone.0196932	http://dx.doi.org/10.1371/journal.pone.0196932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799858	Green Submitted, Green Published, gold			2022-12-26	WOS:000433153400008
J	Smith, CS; Ito, M; Namba, M; Nakaoka, M				Smith, Carter S.; Ito, Minako; Namba, Mizuho; Nakaoka, Masahiro			Oyster aquaculture impacts Zostera marina epibiont community composition in Akkeshi-ko estuary, Japan	PLOS ONE			English	Article							MULTIPLE STABLE-ISOTOPE; CRASSOSTREA-GIGAS; SEAGRASS; FISH; PRODUCTIVITY; DENSITY; PHOTOSYNTHESIS; CONSERVATION; MANAGEMENT; SETTLEMENT	Coastal fisheries are in decline worldwide, and aquaculture has become an increasingly popular way to meet seafood demand. While finfish aquaculture can have substantial adverse effects on coastal ecosystems due mostly to necessary feed inputs, bivalves graze on natural phytoplankton and are often considered for their positive ecosystem services. We conducted two independent studies to investigate the effects of long-line Crassostrea gigas oyster aquaculture on Zostera marina seagrass beds and associated epibiont communities in Akkeshi-ko estuary, Japan. Results from both studies yielded no evidence of an effect of oyster aquaculture on the morphology, density, or biomass of Z. marina, but significant differences were apparent in the epibiont community. Reference seagrass beds located away from aquaculture had higher seagrass epiphyte loads and higher abundances of amphipods. Conversely, seagrass beds below aquaculture lines had higher sessile polychaete biomass and higher isopod abundances. Our results suggest that the presence of oyster aquaculture may have indirect effects on seagrass by changing epibiont community composition and relative abundances of species. One proposed mechanism is that cultured oysters feed on epiphytic diatoms and epiphyte propagules before they can settle on the seagrass, which reduces epiphyte loads and influences subsequent faunal settlement. If carefully implemented and monitored, long-line oyster aquaculture may be a sustainable option to consider as bivalve aquaculture expands to meet global seafood demand, but further work is needed to fully assess and generalize the community-level effects on seagrass epibionts.	[Smith, Carter S.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA; [Ito, Minako; Namba, Mizuho] Hokkaido Univ, Grad Sch Environm Sci, Akkeshi, Hokkaido, Japan; [Ito, Minako; Namba, Mizuho; Nakaoka, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Akkeshi Marine Stn, Akkeshi, Hokkaido, Japan	University of North Carolina; University of North Carolina Chapel Hill; Hokkaido University; Hokkaido University	Smith, CS (corresponding author), Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA.	scarters@live.unc.edu	Nakaoka, Masahiro/I-9237-2019	Nakaoka, Masahiro/0000-0002-5722-3585; Ito, Minako/0000-0003-1960-1909; Smith, Carter/0000-0002-6652-3010; Namba, Mizuho/0000-0001-7360-5172	National Science Foundation; Japan Society for the Promotion of Science East Asia and Pacific Summer Institutes Grant [OISE-1613161]; Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan [S-15]	National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science East Asia and Pacific Summer Institutes Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan	This research was funded by a joint National Science Foundation and Japan Society for the Promotion of Science East Asia and Pacific Summer Institutes Grant (CSS; OISE-1613161; https://www.nsf.gov/pubs/2013/nsf13593/nsf13593.htm). This research was also partially supported by the Environmental Research and Technology Development Fund (S-15 Predicting and Assessing Natural Capital and Ecosystem Services [PANCES]) of the Ministry of the Environment, Japan (MN; http://www.env.go.jp/policy/kenkyu/suishin/english/kadai/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Best RJ, 2012, MAR ECOL PROG SER, V456, P29, DOI 10.3354/meps09678; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; Bulmer R, 2012, AQUACULT ENV INTERAC, V2, P285, DOI 10.3354/aei00046; Carroll ML, 2003, AQUACULTURE, V226, P165, DOI 10.1016/S0044-8486(03)00475-7; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; DEFUR PL, 1995, ESTUARIES, V18, P2, DOI 10.2307/1352278; Delgado C. L., 2003, Fish to 2020: supply and demand in changing global markets; DIRNBERGER JM, 1990, J EXP MAR BIOL ECOL, V140, P89, DOI 10.1016/0022-0981(90)90084-P; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Dumbauld BR, 2015, AQUACULT ENV INTERAC, V7, P29, DOI 10.3354/aei00131; EVERETT RA, 1995, MAR ECOL PROG SER, V125, P205, DOI 10.3354/meps125205; Food and Agriculture Organization of United Nations (FAO), 2016, STAT WORLD FISH AQ 2; Forrest BM, 2009, AQUACULTURE, V298, P1, DOI 10.1016/j.aquaculture.2009.09.032; Fox GA, 2015, ECOLOGICAL STATISTICS: CONTEMPORARY THEORY AND APPLICATION, P1, DOI 10.1093/acprof:oso/9780199672547.001.0001; FUJIYA M, 1970, HELGOLAND WISS MEER, V20, P464, DOI 10.1007/BF01609922; Goldburg R, 1997, MURKY WATERS ENV EFF; GRANT J, 1995, ESTUARIES, V18, P124, DOI 10.2307/1352288; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Hinrichsen D., 1999, TRENDS FUTURE CHALLE, V22, P27; Hokkaido Research Organization. Fisheries Research Department, 2017, MAR NET HOKK; Honkoop PJC, 2002, AQUACULTURE, V213, P171, DOI 10.1016/S0044-8486(02)00030-3; Inukai T., 1937, J FAC AGR HOKKAIDO I, V40, P1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kasim M, 2006, J OCEANOGR, V62, P267, DOI 10.1007/s10872-006-0051-9; Kasim Ma'Ruf, 2009, Plankton & Benthos Research, V4, P104; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mallet AL, 2006, AQUACULTURE, V255, P362, DOI 10.1016/j.aquaculture.2005.11.054; Mazzola A, 2000, ICES J MAR SCI, V57, P1454, DOI 10.1006/jmsc.2000.0904; Momota K, 2017, PEERJ, V5, DOI 10.7717/peerj.2952; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Nakaoka M., 2012, B0910 ENV RES TECHN; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peterson BJ, 2001, MAR ECOL PROG SER, V213, P143, DOI 10.3354/meps213143; Peterson CH, 2010, ECOSYSTEM CONCEPTS S; Primavera JH, 2000, ECOL ECON, V35, P91, DOI 10.1016/S0921-8009(00)00170-1; RONNBERG O, 1992, AQUAT BOT, V42, P109, DOI 10.1016/0304-3770(92)90002-Z; Rstudio T, 2020, RSTUDIO INT DEV R; Sara G, 2004, AQUACULTURE, V234, P199, DOI 10.1016/j.aquaculture.2003.11.020; Shumway S.E., 2003, WORLD AQUACULT, V34, P8; Skinner MA, 2014, J EXP MAR BIOL ECOL, V459, P169, DOI 10.1016/j.jembe.2014.05.012; Skinner MA, 2013, MAR ECOL PROG SER, V486, P105, DOI 10.3354/meps10345; STEBBING AR, 1972, J MAR BIOL ASSOC UK, V52, P765, DOI 10.1017/S002531540002169X; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Swartz W, 2010, MAR POLICY, V34, P1366, DOI 10.1016/j.marpol.2010.06.011; Tacon AGJ, 2010, REV FISH SCI, V18, P94, DOI 10.1080/10641260903325680; Tallis HM, 2009, J SHELLFISH RES, V28, P251, DOI 10.2983/035.028.0207; Valdez SR, 2017, AQUAT CONSERV, V27, P578, DOI 10.1002/aqc.2722; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Wagner E, 2012, MAR ECOL PROG SER, V468, P149, DOI 10.3354/meps09952; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Wall CC, 2008, MAR ECOL PROG SER, V357, P165, DOI 10.3354/meps07289; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wisehart LM, 2007, MAR ECOL PROG SER, V344, P71, DOI 10.3354/meps06942; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yamada K, 2007, HYDROBIOLOGIA, V592, P345, DOI 10.1007/s10750-007-0767-6	60	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197753	10.1371/journal.pone.0197753	http://dx.doi.org/10.1371/journal.pone.0197753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795609	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300069
J	Sirinian, C; Papanastasiou, AD; Schizas, M; Spella, M; Stathopoulos, GT; Repanti, M; Zarkadis, IK; King, TA; Kalofonos, HP				Sirinian, Chaido; Papanastasiou, Anastasios D.; Schizas, Michail; Spella, Magda; Stathopoulos, Georgios T.; Repanti, Maria; Zarkadis, Ioannis K.; King, Tari A.; Kalofonos, Haralabos P.			RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-kappa B activation and EGFR signaling	ONCOGENE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; RECEPTOR ACTIVATOR; MAMMARY-CANCER; METASTASIS; TUMORS; EXPRESSION; FAMILY; CELLS; DIFFERENTIATION; PROLIFERATION	The RANK/RANKL axis emerges as a key regulator of breast cancer initiation, progression, and metastasis. RANK-c is a RANK receptor isoform produced through alternative splicing of the TNFRSF11A (RANK) gene and a dominant-negative regulator of RANK-induced nuclear factor-kappa B (NF-kappa B) activation. Here we report that RANK-c transcript is expressed in 3.2% of cases in The Cancer Genome Atlas breast cancer cohort evenly between ER-positive and ER-negative cases. Nevertheless, the ratio of RANK to RANK-c (RANK/RANK-c) is increased in ER-negative breast cancer cell lines compared to ER-positive breast cancer cell lines. In addition, forced expression of RANK-c in ER-negative breast cancer cell lines inhibited stimuli-induced NF-kappa B activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells. Further, RANK-c expression in MDA-MB-231 cells inhibited lung metastasis and colonization in vivo. The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-kappa B (NF-kappa B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction. This was further confirmed by a mutated RANK-c that is unable to interact with TRAF2 and abolishes the ability to attenuate NF-kappa B activation, migration, and invasion. Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation. Our findings further elucidate the complex molecular biology of the RANKL/RANK system in breast cancer and provide preliminary data for RANK-c as a possible marker for disease progression and aggressiveness.	[Sirinian, Chaido; Papanastasiou, Anastasios D.; Kalofonos, Haralabos P.] Univ Patras, Div Oncol, Dept Med, Clin & Mol Oncol Lab, Patras, Greece; [Schizas, Michail; King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Spella, Magda; Stathopoulos, Georgios T.] Univ Patras, Dept Physiol, Lab Mol Resp Carcinogenesis, Fac Med, Patras, Greece; [Repanti, Maria] Patras Gen Hosp, Dept Pathol, Patras, Greece; [Zarkadis, Ioannis K.] Univ Patras, Sch Med, Dept Biol, Patras, Greece; [King, Tari A.] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Surg Oncol, Boston, MA USA	University of Patras; Memorial Sloan Kettering Cancer Center; University of Patras; University of Patras; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Papanastasiou, AD (corresponding author), Univ Patras, Div Oncol, Dept Med, Clin & Mol Oncol Lab, Patras, Greece.	apapanasta@upnet.gr	Stathopoulos, Georgios/AAE-6884-2020; Papanastasiou, Anastasios/AAP-5296-2021; Stathopoulos, Georgios/D-6576-2013	Stathopoulos, Georgios/0000-0002-9215-6461	State Scholarships Foundation "IKY Fellowships of Excellence for Postgraduate Studies in Greece-Siemens Programme" [SR 229101]; State Scholarships Foundation [SR 229101]	State Scholarships Foundation "IKY Fellowships of Excellence for Postgraduate Studies in Greece-Siemens Programme"; State Scholarships Foundation	CS is funded by the State Scholarships Foundation "IKY Fellowships of Excellence for Postgraduate Studies in Greece-Siemens Programme" (SR 229101). The research reported was partially funded by the State Scholarships Foundation (SR 229101). The publicly available dataset from the TCGA breast cancer study was retrieved from the TCGA data portal on 05/2017.	Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Eswaran J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01689; Forootan SS, 2016, INT J ONCOL, V48, P130, DOI 10.3892/ijo.2015.3222; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giannou AD, 2015, J CLIN INVEST, V125, P2317, DOI 10.1172/JCI79840; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lacroix M, 2004, ENDOCR-RELAT CANCER, V11, P497, DOI 10.1677/erc.1.00758; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Lopez-Garcia MA, 2010, HISTOPATHOLOGY, V57, P171, DOI 10.1111/j.1365-2559.2010.03568.x; Marazioti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071207; Matsuda N, 2017, EXPERT OPIN INV DRUG, V26, P463, DOI 10.1080/13543784.2017.1299707; Melchor L, 2008, ONCOGENE, V27, P3165, DOI 10.1038/sj.onc.1210975; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nolan E, 2016, NAT MED, V22, P933, DOI 10.1038/nm.4118; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ohtsuka T, 1996, J BIOL CHEM, V271, P1651, DOI 10.1074/jbc.271.3.1651; Palafox M, 2012, CANCER RES, V72, P2879, DOI 10.1158/0008-5472.CAN-12-0044; Papanastasiou Anastasios D, 2014, Curr Mol Pharmacol, V7, P33; Papanastasiou AD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3234; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pfitzner BM, 2014, BREAST CANCER RES TR, V145, P307, DOI 10.1007/s10549-014-2955-1; Rennstam K, 2003, CANCER RES, V63, P8861; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Sebestyen E, 2015, NUCLEIC ACIDS RES, V43, P1345, DOI 10.1093/nar/gku1392; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sigl V, 2016, CELL RES, V26, P761, DOI 10.1038/cr.2016.69; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Sirinian C, 2013, GENE, V525, P124, DOI 10.1016/j.gene.2013.04.075; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tanaka Y, 1996, J VIROL, V70, P8508, DOI 10.1128/JVI.70.12.8508-8517.1996; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoldi G, 2016, CANCER RES, V76, P5857, DOI 10.1158/0008-5472.CAN-15-2745	48	21	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5101	5114		10.1038/s41388-018-0324-y	http://dx.doi.org/10.1038/s41388-018-0324-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29844572				2022-12-26	WOS:000444405300006
J	Xiao, P; Guo, Y; Zhang, H; Zhang, X; Cheng, H; Cao, Q; Ke, Y				Xiao, P.; Guo, Y.; Zhang, H.; Zhang, X.; Cheng, H.; Cao, Q.; Ke, Y.			Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-gamma production in tumor microenvironment	ONCOGENE			English	Article							ELECTROPORATION GENE-THERAPY; DENDRITIC CELLS; BREAST-CANCER; ALTERNATIVE ACTIVATION; CXCR3 LIGANDS; LUNG-CANCER; T-CELLS; CHEMOKINE; MACROPHAGES; CARCINOMA	The Src homology 2 domain-containing protein tyrosine phosphatase 2 (Shp2) is generally considered to be an oncogene owing to its ability in enhancing the malignancy of multiple types of tumor cells; however, its role in modulating tumor immunity remains largely elusive. Here, we reported that myeloid-restricted ablation of Shp2 suppressed melanoma growth. Mechanistically, loss of Shp2 potentiates macrophage production of CXCL9 in response to IFN-gamma and tumor cell-derived cytokines, thereby facilitating the tumor infiltration of IFN-gamma-producing T cells that could in turn support CXCL9 production within tumor microenvironment. Collectively, our findings highlight a causative role of myeloid Shp2 in dampening T cell-mediated antitumor immunity by restraining the macrophage/CXCL9-T cell/IFN-gamma feedback loop. Thus, targeting macrophage Shp2 may help to create a Th1-dominant tumor immune microenvironment.	[Xiao, P.; Cao, Q.] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Xiao, P.; Cao, Q.] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Y.; Zhang, H.; Zhang, X.; Cheng, H.; Ke, Y.] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Program Mol Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Cao, Q (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China.; Cao, Q (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310058, Zhejiang, Peoples R China.; Ke, Y (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Program Mol Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China.	0000232@zju.edu.cn; yke@zju.edu.cn		Xiao, Peng/0000-0003-0075-581X	National Natural Science Foundation of China [81702807]; Key Project of the National Natural Science Foundation of China [81530001]; Key Research and Development Project of Ministry of Science and Technology of China [2016FYA0501800]; Natural Science Foundation of Zhejiang Province [LY16H030009]; Foundation of Health and Family Planning Commission of Zhejiang Province [2016134143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Project of Ministry of Science and Technology of China; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Foundation of Health and Family Planning Commission of Zhejiang Province	We thank G. Feng (University of California, San Diego, CA) for providing the Shp2 flox/flox mice. This study was supported by National Natural Science Foundation of China (81702807 to P. Xiao), Key Project of the National Natural Science Foundation of China (81530001 to Y. Ke), Key Research and Development Project of Ministry of Science and Technology of China (2016FYA0501800 to Y. Ke), Natural Science Foundation of Zhejiang Province (LY16H030009 to Q. Cao), and Foundation of Health and Family Planning Commission of Zhejiang Province (2016134143 to Q. Cao).	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Addison CL, 2000, HUM GENE THER, V11, P247, DOI 10.1089/10430340050015996; Andersson A, 2011, CLIN CANCER RES, V17, P3660, DOI 10.1158/1078-0432.CCR-10-3346; Antonelli A, 2010, CYTOKINE, V50, P260, DOI 10.1016/j.cyto.2010.01.009; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bedognetti D, 2013, BRIT J CANCER, V109, P2412, DOI 10.1038/bjc.2013.557; Bronger H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3115; Caso G, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-7; Cero FT, 2012, EXP LUNG RES, V38, P406, DOI 10.3109/01902148.2012.716903; Chauhan D, 2000, J BIOL CHEM, V275, P27845; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Coma G, 2006, CLIN EXP IMMUNOL, V145, P535, DOI 10.1111/j.1365-2249.2006.03145.x; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Ding Q, 2016, CANCER MED-US, V5, P3246, DOI 10.1002/cam4.934; Fang L, 2008, J LEUKOCYTE BIOL, V84, P965, DOI 10.1189/jlb.1107776; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gustafsson K, 2011, SCAND J IMMUNOL, V74, P318, DOI 10.1111/j.1365-3083.2011.02580.x; Hannesdottir L, 2013, EUR J IMMUNOL, V43, P2718, DOI 10.1002/eji.201242505; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Kunz M, 1999, J PATHOL, V189, P552, DOI 10.1002/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I; Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764; Lazzara MJ, 2010, CANCER RES, V70, P3843, DOI 10.1158/0008-5472.CAN-09-3421; Li S, 2002, GENE THER, V9, P390, DOI 10.1038/sj.gt.3301645; Li SM, 2014, J BIOL CHEM, V289, P34152, DOI 10.1074/jbc.M113.546077; Li SL, 2004, MOL THER, V9, P347, DOI 10.1016/j.ymthe.2003.11.022; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Mikucki ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8458; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pardee AD, 2010, CANCER RES, V70, P9041, DOI 10.1158/0008-5472.CAN-10-1369; Park JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07316-3; Petro M, 2013, J IMMUNOL, V190, P832, DOI 10.4049/jimmunol.1201906; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ran H, 2016, CANCER CELL, V30, P194, DOI 10.1016/j.ccell.2016.07.010; Reckamp KL, 2007, J IMMUNOTHER, V30, P417, DOI 10.1097/CJI.0b013e31802e089a; Reid-Yu SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004648; Roccograndi L, 2017, J NEURO-ONCOL, V135, P487, DOI 10.1007/s11060-017-2610-x; Sausgruber N, 2015, ONCOGENE, V34, P2272, DOI 10.1038/onc.2014.170; Sharma S, 2003, HUM GENE THER, V14, P1511, DOI 10.1089/104303403322495025; Specht K, 2009, BREAST CANCER RES TR, V118, P45, DOI 10.1007/s10549-008-0207-y; Szabo A, 2012, MELANOMA RES, V22, P351, DOI 10.1097/CMR.0b013e328357076c; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Thapa M, 2008, J VIROL, V82, P10295, DOI 10.1128/JVI.00931-08; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Wu ZQ, 2016, BIOMED PHARMACOTHER, V78, P8, DOI 10.1016/j.biopha.2015.12.021; Xie M, 2015, J ALLERGY CLIN IMMUN, V135, P386, DOI 10.1016/j.jaci.2014.08.023; Xu JQ, 2017, J IMMUNOL, V199, P2323, DOI 10.4049/jimmunol.1601696; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Yun JJ, 2002, AM J PATHOL, V161, P1307, DOI 10.1016/S0002-9440(10)64407-0; Zhang J, 2015, J CELL MOL MED, V19, P2075, DOI 10.1111/jcmm.12618; Zhang R, 2006, GENE THER, V13, P1263, DOI 10.1038/sj.gt.3302756; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54	57	23	25	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5088	5100		10.1038/s41388-018-0337-6	http://dx.doi.org/10.1038/s41388-018-0337-6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29795405				2022-12-26	WOS:000444405300005
J	Razidlo, GL; Burton, KM; McNiven, MA				Razidlo, Gina L.; Burton, Kevin M.; McNiven, Mark A.			Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-MESENCHYMAL TRANSITION; STATISTICAL-MODEL; STAT3; PROGRESSION; CYTOSKELETON; IL-6; RHO; CHEMORESISTANCE; INFLAMMATION; METASTASIS	Inflammation is a major driver of tumor progression and metastasis, although the mechanisms by which proinflammatory cytokines drive metastatic invasion are unknown. Interleukin-6 (IL-6) is a potent proinflammatory cytokine that is elevated in individuals with pancreatic cancer (PDAC), is required for PDAC progression in mice, and increases tumor cell invasion in vitro. Here, we provide insights into the mechanisms by which IL-6 activates tumor cell invasion. We found that IL-6 stimulation rapidly and robustly activates the small GTPase cell division cycle 42 (CDC42) in human PDAC cells and promotes the formation of premigratory filopodia. The CDC42 activation was required for IL-6-induced invasion as blocking CDC42 activity rendered the cells insensitive to IL-6's proinvasive effects. Loss of Janus kinase 2 (JAK2) or signal transducer and activator of transcription 3 (STAT3) prevented IL-6-mediated CDC42 activation, indicating that IL-6 activates CDC42 through both JAK2 and STAT3. However, the rapid activation of CDC42 suggested that this activation may be distinct from canonical STAT3-mediated transcriptional activation. Importantly, we observed an interaction between STAT3 and IQ motif-containing GTPase-activating protein 1 (IQGAP1), a scaffolding platform that binds CDC42. STAT3 colocalized with CDC42 and IQGAP1 at the plasma membrane, suggesting cross-talk between IL-6-mediated STAT3 signaling and CDC42 activation. These results suggest that IL-6 promotes metastatic invasion, at least partially, through CDC42 and that, along with its pleiotropic effects on tumor growth and progression, IL-6 signaling also activates proinvasive GTPase signaling, priming tumor cells for metastatic invasion.	[Razidlo, Gina L.; McNiven, Mark A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Razidlo, Gina L.; Burton, Kevin M.; McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Burton, Kevin M.] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Razidlo, GL (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	razidlo.gina@mayo.edu		Razidlo, Gina/0000-0002-9042-2738	National Institutes of Health NCI Cancer Center Support [5P30 CA15083-43C1]; NATIONAL CANCER INSTITUTE [P50CA102701, P30CA015083, R01CA104125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health NCI Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr. Micah Schott and members of the McNiven laboratory for technical support, helpful suggestions, and critical reading of the manuscript. We acknowledge the Mayo Clinic Medical Genome Facility-Proteomics Core and its supporting grant, National Institutes of Health NCI Cancer Center Support Grant 5P30 CA15083-43C1.	Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Huang C, 2011, NEOPLASMA, V58, P396, DOI 10.4149/neo_2011_05_396; Jacquemet G, 2017, J CELL BIOL, V216, P3387, DOI 10.1083/jcb.201704045; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim JH, 2009, J BIOL CHEM, V284, P35425, DOI 10.1074/jbc.M109.051516; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; MATSUGUCHI T, 1995, EMBO J, V14, P257, DOI 10.1002/j.1460-2075.1995.tb06999.x; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nagathihalli NS, 2016, ONCOTARGET, V7, P65982, DOI 10.18632/oncotarget.11786; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Pal K, 2014, MOL CANCER THER, V13, P2264, DOI 10.1158/1535-7163.MCT-14-0291; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Selvaraj BT, 2012, J CELL BIOL, V199, P437, DOI 10.1083/jcb.201203109; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Socoro-Yuste N, 2016, BBA-MOL CELL RES, V1863, P2758, DOI 10.1016/j.bbamcr.2016.08.012; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Toffali L, 2017, J IMMUNOL, V198, P708, DOI 10.4049/jimmunol.1600933; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; Wittchen ES, 2008, METHOD ENZYMOL, V443, P285, DOI 10.1016/S0076-6879(08)02014-4; Zhang YQ, 2013, CANCER RES, V73, P6359, DOI 10.1158/0008-5472.CAN-13-1558-T; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou Z, 2013, CIRCULATION, V127, P476, DOI 10.1161/CIRCULATIONAHA.112.132126	37	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11143	11153		10.1074/jbc.RA118.003276	http://dx.doi.org/10.1074/jbc.RA118.003276			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29853638	hybrid, Green Published			2022-12-26	WOS:000438882800026
J	Gavas, RD; Roy, S; Chatterjee, D; Tripathy, SR; Chakravarty, K; Sinha, A				Gavas, Rahul Dasharath; Roy, Sangheeta; Chatterjee, Debatri; Tripathy, Soumya Ranjan; Chakravarty, Kingshuk; Sinha, Aniruddha			Enhancing the usability of low-cost eye trackers for rehabilitation applications	PLOS ONE			English	Article							TRACKING DATA; KALMAN FILTER; DATA QUALITY; DEFICITS; DESIGN; ERROR	Eye tracking is one of the most widely used technique for assessment, screening and human-machine interaction related applications. There are certain issues which limit the usage of eye trackers in practical scenarios, viz., i) need to perform multiple calibrations and ii) presence of inherent noise in the recorded data. To address these issues, we have proposed a protocol for one-time calibration against the "regular" or the "multiple" calibration phases. It is seen that though it is always desirable to perform multiple calibration, the one-time calibration also produces comparable results and might be better for individuals who are not able to perform multiple calibrations. In that case, "One-time calibration" can also be done by a participant and the calibration results are used for the rest of the participants, provided the chin rest and the eye tracker positions are unaltered. The second major issue is the presence of the inherent noise in the raw gaze data, leading to systematic and variable errors. We have proposed a signal processing chain to remove these two types of errors. Two different psychological stimuli-based tasks, namely, recall-recognition test and number gazing task are used as a case study for the same. It is seen that the proposed approach gives satisfactory results even with one-time calibration. The study is also extended to test the effect of long duration task on the performance of the proposed algorithm and the results confirm that the proposed methods work well in such scenarios too.	[Gavas, Rahul Dasharath; Roy, Sangheeta; Chatterjee, Debatri; Tripathy, Soumya Ranjan; Chakravarty, Kingshuk; Sinha, Aniruddha] Tata Consultancy Serv, TCS Res & Innovat, Embedded Syst & Robot, Kolkata, India; [Tripathy, Soumya Ranjan] TUT, Dept Signal Proc, Tampere, Finland	Tata Sons; Tata Consultancy Services Limited (TCS); Tampere University	Chatterjee, D (corresponding author), Tata Consultancy Serv, TCS Res & Innovat, Embedded Syst & Robot, Kolkata, India.	debatri.chatterjee@tcs.com	Sinha, Aniruddha/W-9930-2019; Sinha, Aniruddha/ABB-2972-2021	Sinha, Aniruddha/0000-0002-4679-3806; Tripathy, Soumya/0000-0002-5523-3325	Tata Consultancy Services Ltd. (TCS)	Tata Consultancy Services Ltd. (TCS)	Tata Consultancy Services Ltd. (TCS) provided support in the form of salaries for all the authors and provided infrastructural support and subjects for data collection, decision to publish and preparation of the manuscript. The clearance on ethical issues for handling and analysis of the data collected has been acquired from Institutional Review Board of TCS. The specific roles of these authors are articulated in the 'author contributions' section.	Abd- Almageed W, 2002, AM CONTR C 2002 P 20, V2; Amaresha AC, 2014, ASIAN J PSYCHIATR, V10, P45, DOI 10.1016/j.ajp.2014.03.010; Aslin RN, 2012, INFANCY, V17, P126, DOI 10.1111/j.1532-7078.2011.00097.x; Barz M, 2015, DFKI RESEARCHREPORTS, V1; Blignaut P, 2017, J EYE MOVEMENT RES, V10, DOI 10.16910/jemr.10.4.1; Blignaut P, 2014, BEHAV RES METHODS, V46, P67, DOI 10.3758/s13428-013-0343-0; Bohme M., 2006, P 2006 C COMM GAZ IN, P12; BRAND AN, 1992, J AFFECT DISORDERS, V25, P77, DOI 10.1016/0165-0327(92)90095-N; Calvo A, 2008, LECT NOTES COMPUT SC, V5105, P70, DOI 10.1007/978-3-540-70540-6_9; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Deng LY, 2010, EXPERT SYST APPL, V37, P3337, DOI 10.1016/j.eswa.2009.10.017; Duchowski A, 2007, EYE TRACKING METHODO, V373; Duchowski AT, 2002, BEHAV RES METH INS C, V34, P455, DOI 10.3758/BF03195475; Elahipanah A, 2011, SCHIZOPHR RES, V127, P137, DOI 10.1016/j.schres.2010.11.018; Faragher R, 2012, IEEE SIGNAL PROC MAG, V29, P128, DOI 10.1109/MSP.2012.2203621; Friedman J. H., 1977, ACM Transactions on Mathematical Software, V3, P209, DOI 10.1145/355744.355745; Fuhl W, 2016, MACH VISION APPL, V27, P1275, DOI 10.1007/s00138-016-0776-4; Gavas R, 2017, ENG MED BIOL SOC EMB; Giroud M, 2014, LANCET, V383, P195, DOI 10.1016/S0140-6736(13)62077-2; Grindinger T., 2006, EYE MOVEMENT ANAL PR; Gu J, 2000, P S EYE TRACK RES AP, P65; Hennessey C., 2010, P 2010 S EYE TRACK R, P81; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; Johansen S.A., 2011, P EXTENDED ABSTR HUM, P1177, DOI DOI 10.1145/1979742.1979744; Kasneci Enkelejda, 2014, P S EYE TRACK RES AP, P323, DOI 10.1145/2578153.2578213; Kasprowski P, 2015, SMART INNOV SYST TEC, V39, P347, DOI 10.1007/978-3-319-19857-6_31; Khasnobish Anwesha, 2017, 2017 IEEE International Conference on Pervasive Computing and Communications Workshops (PerCom Workshops), P382, DOI 10.1109/PERCOMW.2017.7917593; Komogortsev OV, 2007, LECT NOTES COMPUT SC, V4552, P679; Lagun D, 2011, J NEUROSCI METH, V201, P196, DOI 10.1016/j.jneumeth.2011.06.027; Li D., 2006, P 2006 S EYE TRACKIN, P95, DOI [10.1145/1117309.1117350, DOI 10.1145/1117309.1117350]; Lin CS, 2004, OPT LASER ENG, V42, P91, DOI 10.1016/S0143-8166(03)00075-7; Mills TC, 1991, TIME SERIES TECHNIQU; Noris B., 2008, P INT C COMP VIS THE; Nystrom M, 2013, BEHAV RES METHODS, V45, P272, DOI 10.3758/s13428-012-0247-4; Obolensky N., 2002, KALMAN FILTERING MET; Olsson P., 2007, REAL TIME OFFLINE FI; pakov O. S., 2012, P S EYE TRACKING RES, P281, DOI [10.1145/2168556.2168616, DOI 10.1145/2168556.2168616]; Rao S.L., 2004, NIMHANS NEUROPSYCHOL; Raudonis V, 2009, P 2 INT S APPL SCI B, P1; Rhodes MG, 2008, J EXP PSYCHOL GEN, V137, P615, DOI 10.1037/a0013684; Riby DM, 2009, RES AUTISM SPECT DIS, V3, P723, DOI 10.1016/j.rasd.2009.02.001; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Santini T, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P2594, DOI 10.1145/3025453.3025950; SAUTER D, 1991, MED BIOL ENG COMPUT, V29, P63, DOI 10.1007/BF02446297; Sebe N., 2008, ADAPTIVE ALGORITHM E, V57, P716; Sen T., 1984, ADV PSYCHOL, VVolume 22, P103, DOI [10.1016/S0166-4115(08), DOI 10.1016/S0166-4115(08)]; Shuman DI, 2013, IEEE SIGNAL PROC MAG, V30, P83, DOI 10.1109/MSP.2012.2235192; STAMPE DM, 1993, BEHAV RES METH INSTR, V25, P137, DOI 10.3758/BF03204486; Tafaj E, 2012, P S EYE TRACK RES AP, P285, DOI DOI 10.1145/2168556.2168617; Vadillo MA, 2015, BEHAV RES METHODS, V47, P1365, DOI 10.3758/s13428-014-0544-1; van der Kamp Jan, 2011, P 1 C NOV GAZ CONTR, DOI [10.1145/1983302.1983311, DOI 10.1145/1983302.1983311]; Veneri G, 2010, COMPUT HUM BEHAV, V26, P1555, DOI 10.1016/j.chb.2010.05.030; Vidal M, 2013, UBICOMP'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P439, DOI 10.1145/2493432.2493477; WHO, 2017, GLOBAL HLTH AGING; Zhang Y, 2015, EYE TRACKING GAZE IN; Zhang YF, 2011, BEHAV RES METHODS, V43, P834, DOI 10.3758/s13428-011-0073-0; Zugal S, 2014, LECT NOTES BUS INF P, V178, P159	57	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0196348	10.1371/journal.pone.0196348	http://dx.doi.org/10.1371/journal.pone.0196348			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856798	gold, Green Submitted, Green Published			2022-12-26	WOS:000433900800007
J	Kumar, AUA; Browne, LD; Li, X; Adeeb, F; Perez-Ruiz, F; Fraser, AD; Stack, AG				Kumar, Arun A. U.; Browne, Leonard D.; Li, Xia; Adeeb, Fahd; Perez-Ruiz, Fernando; Fraser, Alexander D.; Stack, Austin G.			Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM URIC-ACID; RENAL-DISEASE; GOUT; RISK; PREVALENCE; METAANALYSIS; POPULATION; MANAGEMENT; NUTRITION	Background Elevated serum uric acid (sUA) concentrations are common in the general population and are associated with chronic metabolic conditions and adverse clinical outcomes. We evaluated secular trends in the burden of hyperuricaemia from 2006-2014 within the Irish health system. Methods Data from the National Kidney Disease Surveillance Programme was used to determine the prevalence of elevated sUA in adults, age > 18 years, within the Irish health system. Hyperuricaemia was defined as sUA > 416.4 mu mol/L in men and > 339.06 mu mol/L in women, and prevalence was calculated as the proportion of patients per year with mean sUA levels above sex-specific thresholds. Temporal trends in prevalence were compared from 2006 to 2014 while general estimating equations (GEE) explored variation across calendar years expressed as odds ratios (OR) and 95% Confidence intervals (CI). Results From 2006 to 2014, prevalence of hyperuricaemia increased from 19.7% to 25.0% in men and from 20.5% to 24.1% in women, P<0.001. The corresponding sUA concentrations increased significantly from 314.6 (93.9) in 2006 to 325.6 (96.2) in 2014, P<0.001. Age-specific prevalence increased in all groups from 2006 to 2014, and the magnitude of increase was similar for each age category. Adjusting for baseline demographic characteristics and illness indicators, the likelihood of hyperuricemia was greatest for patients in 2014; OR 1.45 (1.26-1.65) for men and OR 1.47 (1.29-1.67) in women vs 2006 (referent). Factors associated with hyperuricaemia included: worsening kidney function, elevated white cell count, raised serum phosphate and calcium levels, elevated total protein and higher haemoglobin concentrations, all P<0.001. Conclusions The burden of hyperuricaemia is substantial in the Irish health system and has increased in frequency over the past decade. Advancing age, poorer kidney function, measures of nutrition and inflammation, and regional variation all contribute to increasing prevalence, but these do not fully explain emerging trends.	[Kumar, Arun A. U.; Browne, Leonard D.; Stack, Austin G.] Univ Hosp Limerick, Dept Nephrol, Limerick, Ireland; [Kumar, Arun A. U.; Browne, Leonard D.; Adeeb, Fahd; Fraser, Alexander D.; Stack, Austin G.] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Li, Xia] La Trobe Univ, Dept Math & Stat, Melbourne, Vic, Australia; [Adeeb, Fahd; Fraser, Alexander D.] Univ Hosp Limerick, Dept Rheumatol, Limerick, Ireland; [Perez-Ruiz, Fernando] Univ Basque Country, Hosp Univ Cruces, Rheumatol Div, Bilbao, Vizcaya, Spain; [Stack, Austin G.] Univ Limerick, HRI, Limerick, Ireland	University of Limerick; University of Limerick; La Trobe University; University of Limerick; Hospital Universitario Cruces; University of Basque Country; University of Limerick	Stack, AG (corresponding author), Univ Hosp Limerick, Dept Nephrol, Limerick, Ireland.; Stack, AG (corresponding author), Univ Limerick, Grad Entry Med Sch, Limerick, Ireland.; Stack, AG (corresponding author), Univ Limerick, HRI, Limerick, Ireland.	austin.stack@ul.ie	Adeeb, Fahd/I-4454-2019; RUIZ, FERNANDO PEREZ/X-1980-2019; PEREZ-RUIZ, FERNANDO/E-4844-2012	Adeeb, Fahd/0000-0002-9444-0810; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Browne, Leonard/0000-0002-9203-1212	Health Research Board [HRA-2013-PHR-437, HRA-2014-PHR-685]; Midwest Research and Education Foundation (MKid); Menarini International Operations Luxemburg; Grunenthal; Menarini; Cruces Rheumatology Association	Health Research Board; Midwest Research and Education Foundation (MKid); Menarini International Operations Luxemburg(Menarini Group); Grunenthal(HAL Allergy Group); Menarini(Menarini Group); Cruces Rheumatology Association	This study is funded by the Health Research Board (HRA-2013-PHR-437 and HRA-2014-PHR-685), the Midwest Research and Education Foundation (MKid), and an unrestricted educational grant from the Menarini International Operations Luxemburg. Dr Stack and Dr. Fernando Perez-Ruiz have consulted for Menarini and Gruenenthal Pharma. Dr. Fernando Perez-Ruiz has delivered talks sponsored by Grunenthal and Menarini; delivered educational activities for Spanish Foundation for Rheumatology and a recipient of investigation grants from Cruces Rheumatology Association. The other authors have no relevant financial relationships to disclose.	Borghi C, 2015, J HYPERTENS, V33, P1729, DOI 10.1097/HJH.0000000000000701; Chuang SY, 2011, ASIA PAC J CLIN NUTR, V20, P301; Ferguson J, 2018, INT J MED INFORM, V109, P70, DOI 10.1016/j.ijmedinf.2017.10.021; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Hin LY, 2009, STAT MED, V28, P642, DOI 10.1002/sim.3489; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Krishnan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050046; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Murea M, 2012, ADV CHRONIC KIDNEY D, V19, P419, DOI 10.1053/j.ackd.2012.07.008; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Stack A, 2015, Curr Med Res Opin, V31 Suppl 2, P21, DOI 10.1185/03007995.2015.1087984; Stack AG, 2013, QJM-INT J MED, V106, P647, DOI 10.1093/qjmed/hct083; Stack AG, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-185; Trifio G, 2013, ANN RHEUM DIS, V72, P694, DOI 10.1136/annrheumdis-2011-201254; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105125, 10.1371/journal.pone.0114259]; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	22	39	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198197	10.1371/journal.pone.0198197	http://dx.doi.org/10.1371/journal.pone.0198197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852506	Green Submitted, Green Published, gold			2022-12-26	WOS:000433893200040
J	Kooijman, S; Brummelman, J; van Els, CACM; Marino, F; Heck, AJR; van Riet, E; Metz, B; Kersten, GFA; Pennings, JLA; Meiring, HD				Kooijman, Sietske; Brummelman, Jolanda; van Els, Cecile A. C. M.; Marino, Fabio; Heck, Albert J. R.; van Riet, Elly; Metz, Bernard; Kersten, Gideon F. A.; Pennings, Jeroen L. A.; Meiring, Hugo D.			Vaccine antigens modulate the innate response of monocytes to Al(OH)(3)	PLOS ONE			English	Article							ALUMINUM-CONTAINING ADJUVANTS; INFLAMMATORY DENDRITIC CELLS; IL-3 RECEPTOR EXPRESSION; MXA GENE-EXPRESSION; CYTOKINE PRODUCTION; ASPARAGINYL ENDOPEPTIDASE; INTERLEUKIN-1 FAMILY; ADAPTIVE IMMUNITY; TLR4 LIGATION; CUTTING EDGE	Aluminum-based adjuvants have widely been used in human vaccines since 1926. In the absence of antigens, aluminum-based adjuvants can initiate the inflammatory preparedness of innate cells, yet the impact of antigens on this response has not been investigated so far. In this study, we address the modulating effect of vaccine antigens on the monocyte-derived innate response by comparing processes initiated by Al(OH)(3) and by Infanrix, an Al(OH)(3)-adjuvanted trivalent combination vaccine (DTaP), containing diphtheria toxoid (D), tetanus toxoid (T) and acellular pertussis (aP) vaccine antigens. A systems-wide analysis of stimulated monocytes was performed in which full proteome analysis was combined with targeted transcriptome analysis and cytokine analysis. This comprehensive study revealed four major differences in the monocyte response, between plain Al(OH)(3) and DTaP stimulation conditions: (I) DTaP increased the anti-inflammatory cytokine IL-10, whereas Al(OH)(3) did not; (II) Al(OH)(3) increased the gene expression of IFN., IL-2 and IL-17a in contrast to the limited induction or even downregulation by DTaP; (III) increased expression of type I interferons- induced proteins was not observed upon DTaP stimulation, but was observed upon Al(OH)(3) stimulation; (IV) opposing regulation of protein localization pathways was observed for Al(OH)(3) and DTaP stimulation, related to the induction of exocytosis by Al(OH)(3) alone. This study highlights that vaccine antigens can antagonize Al(OH)(3)-induced programming of the innate immune responses at the monocyte level.	[Kooijman, Sietske; van Riet, Elly; Metz, Bernard; Kersten, Gideon F. A.; Meiring, Hugo D.] Intravacc, Bilthoven, Netherlands; [Kooijman, Sietske; Heck, Albert J. R.] Univ Utrecht, Sci Fac, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, Utrecht, Netherlands; [Kooijman, Sietske; Heck, Albert J. R.] Univ Utrecht, Sci Fac, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Brummelman, Jolanda; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Marino, Fabio; Heck, Albert J. R.] Netherlands Prote Ctr, Utrecht, Netherlands; [Kersten, Gideon F. A.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Pennings, Jeroen L. A.] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands; [Brummelman, Jolanda] Humanitas Clin & Res Ctr, Rozzano, Italy; [Marino, Fabio] CHU, Vaudois, Switzerland	Utrecht University; Utrecht University; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment; IRCCS Humanitas Research Hospital	Meiring, HD (corresponding author), Intravacc, Bilthoven, Netherlands.	hugo.meiring@intravacc.nl	van Riet, Elly/V-2921-2018; Brummelman, Jolanda/F-5701-2019; Heck, Albert/D-7098-2011	Brummelman, Jolanda/0000-0003-3581-4816; Heck, Albert/0000-0002-2405-4404; Pennings, Jeroen L.A./0000-0002-9188-6358	Ministry of Health and Welfare, The Netherlands [AS200107]; Ministry of Health and Welfare; Proteins Work, a 628 program of the Netherlands Proteomics Centre - Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands [184.032.201]; Proteins Work	Ministry of Health and Welfare, The Netherlands; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Proteins Work, a 628 program of the Netherlands Proteomics Centre - Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands; Proteins Work	SK is funded by a strategic research grant (SOR) of the Ministry of Health and Welfare, The Netherlands (AS200107). The Ministry of Health and Welfare funded the project and the salary of SK but the Ministry did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. This work was also partly supported by the Proteins Work, a 628 program of the Netherlands Proteomics Centre financed by the Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands (project number 184.032.201). Proteins Work funded the salary of FM but did not have a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brewer JM, 1999, J IMMUNOL, V163, P6448; Brummelman J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25064; Brummelman J, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv067; Brummelman J, 2015, VACCINE, V33, P1483, DOI 10.1016/j.vaccine.2015.01.063; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Rham C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2336; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Ghimire TR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0972-0; Gruenbacher G, 2010, CANCER RES, V70, P9611, DOI 10.1158/0008-5472.CAN-10-1968; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guven E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074445; Haller O, 1980, Ann N Y Acad Sci, V350, P558, DOI 10.1111/j.1749-6632.1980.tb20657.x; Hem SL, 2002, VACCINE, V20, pS40, DOI 10.1016/S0264-410X(02)00170-6; Holt L. B., 1950, DEV DIPTHERIA PROPHY; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Kintaka R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31774; Kooijman S, 2018, J PROTEOMICS; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; KORPELAINEN EI, 1995, BLOOD, V86, P176, DOI 10.1182/blood.V86.1.176.bloodjournal861176; Korpelainen EI, 1996, IMMUNOL CELL BIOL, V74, P1, DOI 10.1038/icb.1996.1; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Meiring HD, 2006, MOL CELL PROTEOMICS, V5, P902, DOI 10.1074/mcp.T500014-MCP200; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Morefield GL, 2004, VACCINE, V22, P1973, DOI 10.1016/j.vaccine.2003.10.040; Moruz L, 2013, ANAL CHEM, V85, P7777, DOI 10.1021/ac401145q; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Pletneva LM, 2008, J GEN VIROL, V89, P261, DOI 10.1099/vir.0.83294-0; Raeven RHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104548; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Rivera A, 2016, NAT IMMUNOL, V17, P356, DOI 10.1038/ni.3375; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Rossi M, 2005, J IMMUNOL, V175, P1373, DOI 10.4049/jimmunol.175.3.1373; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; SIMON A, 1991, J VIROL, V65, P968, DOI 10.1128/JVI.65.2.968-971.1991; Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TAGA K, 1992, J IMMUNOL, V148, P1143; Ulanova M, 2001, INFECT IMMUN, V69, P1151, DOI 10.1128/IAI.69.2.1151-1159.2001; Wolk K, 2005, GENES IMMUN, V6, P452, DOI 10.1038/sj.gene.6364224; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613	65	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197885	10.1371/journal.pone.0197885	http://dx.doi.org/10.1371/journal.pone.0197885			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813132	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800035
J	Liu, J; Yi, Z; Zhao, Y; Qu, B; Zhu, YX				Liu, Jie; Yi, Zhe; Zhao, Yang; Qu, Bo; Zhu, Yaxin			The psychological health and associated factors of men who have sex with men in China: A cross-sectional survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; SOCIAL SUPPORT; ANXIETY DISORDERS; HIV PREVENTION; RISK BEHAVIOR; ORIENTATION; COMMUNITY; SAMPLE; VIRUS	Objectives The psychological health of men who have sex with men (MSM) has received increased attention in recent years. We thus investigated the psychological status and associated factors among MSM in China. Methods A cross-sectional survey of 248 MSM was conducted from April to September 2015 using Symptom Checklist 90 (SCL-90) in Huludao and Zhengzhou, China. Statistical analyses utilized SPSS version 19.0 for Windows. Results All Cronbach's a coefficients of the SCL-90 subscales exceeded 0.7, suggesting acceptable reliability. The coefficient range of the collective validity for all the subscales was >0.4. For the divisional validity, each item correlated better with the hypothetical subscale than with other subscales. Collective validity and divisional validity were both acceptable. The four most frequent types of psychological distress among MSM were depression, obsessive-compulsive behavior, interpersonal sensitivity, and anxiety. Results of the univariate analysis revealed that the following groups had significantly higher SCL-90 scores (P < 0.05): peasantry, married MSM, respondents who reported condomless anal intercourse and a greater number of male partners, and respondents who had not undergone psychosocial counseling and whose family or friends did not know about their sexual identity. In a multivariate logistic regression model, the following parameters were independently associated with higher SCL-90 scores: being married (AOR [adjusted odds ratio] = 3.19; 95% CI [confidence interval]: 1.96 to 5.93), condomless anal intercourse (AOR = 1.16; 95% CI: 1.02 to 1.31), number of male partners (AOR = 1.66 and 1.81; 95% CI: 1.08 to 2.34 and 1.32 to 2.69), family or friends not knowing about sexual identity (AOR = 2.13; 95% CI: 1.17 to 4.92), and lack of psychosocial counseling (AOR = 2.09; 95% CI: 1.06 to 4.09). Conclusions Our results indicate that psychological health problems among MSM in China are of concern. It is thus necessary to strengthen intervention efforts, with more emphasis on intervention programs to improve psychological health among Chinese MSM.	[Liu, Jie; Zhao, Yang; Qu, Bo; Zhu, Yaxin] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Liaoning, Peoples R China; [Yi, Zhe] China Med Univ, Sch Stomatol, Dept Prothodont, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Qu, B (corresponding author), China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Liaoning, Peoples R China.	qubo6666@163.com			National Natural Science Foundation of China [81273186, 71473269]; Natural Science Foundation of Liaoning [2015020469]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning(Natural Science Foundation of Liaoning Province)	This work was supported by Grant number: 81273186 & 71473269, URL: http://www.nsfc.gov.cn/, National Natural Science Foundation of China (CN); BQ received the funding. It was also supported by Grant number: 2015020469, URL: http://kijh.Ininfo.gov.cn/, Natural Science Foundation of Liaoning (CN); JL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvy LM, 2011, AIDS BEHAV, V15, P1171, DOI 10.1007/s10461-010-9678-z; Bastardo YM, 2000, AIDS CARE, V12, P673, DOI 10.1080/095401200750003842; Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942; Bouhnik AD, 2006, JAIDS-J ACQ IMM DEF, V42, P597, DOI 10.1097/01.qai.0000221674.76327.d7; Chae DH, 2010, J SEX RES, V47, P451, DOI 10.1080/00224490903100579; Charles B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-463; Chen GZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-58; Chen HQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1436-8; [陈树林 Chen Shulin], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P323; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Deuba K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058099; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; Fendrich M, 2013, ADDICT BEHAV, V38, P1715, DOI 10.1016/j.addbeh.2012.09.005; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS98, DOI 10.1097/QAI.0b013e3181c7df71; Goldberg AE, 2011, J COUNS PSYCHOL, V58, P139, DOI 10.1037/a0021684; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hirshfield S, 2008, AIDS CARE, V20, P904, DOI 10.1080/09540120701796892; Hou WL, 2014, AIDS CARE, V26, P996, DOI 10.1080/09540121.2013.873764; Houston E, 2012, AIDS BEHAV, V16, P2209, DOI 10.1007/s10461-012-0156-7; Jin C, 2010, HIV MED, V11, P253, DOI 10.1111/j.1468-1293.2009.00770.x; Jin YH, 2012, CURR HIV RES, V10, P546, DOI 10.2174/157016212802429857; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Lasheras C, 2001, EXP AGING RES, V27, P257, DOI 10.1080/036107301300208691; Li DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119977; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li J, 2012, MATERN CHILD HLTH J, V16, P1355, DOI 10.1007/s10995-011-0900-z; Li L, 2015, PHYTOCHEM LETT, V13, P156, DOI 10.1016/j.phytol.2015.05.009; Liao MZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/143738; Liu N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-313; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Miller CT, 2015, ARCH SEX BEHAV, V44, P453, DOI 10.1007/s10508-014-0464-2; Mimiaga MJ, 2013, AIDS CARE, V25, P1109, DOI 10.1080/09540121.2012.749340; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; O'Cleirigh C, 2009, J BEHAV MED, V32, P466, DOI 10.1007/s10865-009-9217-4; Pappas P, 2015, PSYCHOL HEALTH MED, P1; Parker RD, 2015, J AFFECT DISORDERS, V183, P205, DOI 10.1016/j.jad.2015.05.014; Ruan YH, 2009, AIDS PATIENT CARE ST, V23, P315, DOI 10.1089/apc.2008.0199; Safren SA, 2011, AIDS BEHAV, V15, pS30, DOI 10.1007/s10461-011-9898-x; Safren SA, 2009, PSYCHOL HEALTH MED, V14, P705, DOI 10.1080/13548500903334754; Sandfort TGM, 2006, AM J PUBLIC HEALTH, V96, P1119, DOI 10.2105/AJPH.2004.058891; Sivasubramanian M, 2011, PSYCHOL HEALTH MED, V16, P450, DOI 10.1080/13548506.2011.554645; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Sun YH, 2009, INT J STD AIDS, V20, P255, DOI 10.1258/ijsa.2008.008348; Tang QP., 1999, CHIN J CLIN PSYCHOL, V1, P16; Wang R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-292; Wang SJ, 2015, AIDS EDUC PREV, V27, P126, DOI 10.1521/aeap.2015.27.2.126; Wong CF, 2014, PREV SCI, V15, P44, DOI 10.1007/s11121-012-0348-4; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032312; Yan HM, 2014, SEX HEALTH, V11, P285, DOI 10.1071/SH14017; Yi SY, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0342-8; Yu LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050762; Zhang H, 2015, ARCH SEX BEHAV, V44, P375, DOI 10.1007/s10508-014-0396-x; Zhang LL, 2014, NEUROPSYCH DIS TREAT, V10, P123, DOI 10.2147/NDT.S56020; Zhu CY, 2012, QUAL LIFE RES, V21, P495, DOI 10.1007/s11136-011-9950-3; Zhuang SM, 2016, NURS RES, V65, P117, DOI 10.1097/NNR.0000000000000141	58	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197481	10.1371/journal.pone.0197481	http://dx.doi.org/10.1371/journal.pone.0197481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813076	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800017
J	Ochoa-Hein, E; Sifuentes-Osornio, J; de Leon-Garduno, AP; Torres-Gonzalez, P; Granados-Garcia, V; Galindo-Fraga, A				Ochoa-Hein, Eric; Sifuentes-Osornio, Jose; Ponce de Leon-Garduno, Alfredo; Torres-Gonzalez, Pedro; Granados-Garcia, Victor; Galindo-Fraga, Arturo			Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; RISK-FACTORS; DISEASES SOCIETY; EPIDEMIOLOGY; ANTIBIOTICS; ADULTS; ENVIRONMENT; DIARRHEA; UPDATE; STRAIN	Objective To identify clinical and environmental factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI). Design Case-control study. Setting Public, acute care, academic tertiary referral center in Mexico. Patients Adults hospitalized >= 48 hours between January 2015 and December 2016 were included. Cases were patients with a first episode of HO-HCFA CDI. Controls were patients with any other diagnosis; they were randomly selected from the hospital discharge database and matched in a 1:2 manner according to the date of diagnosis of case +/- 10 days. Variables with p<0.1 were considered for multivariable analysis. Results One hundred and fifty-five cases and 310 controls were included. Variables independently associated with HO-HCFA CDI were: exposure to both ciprofloxacin and proton pump inhibitor (PPI) within the last 3 months (OR = 8.07, 95% CI = 1.70-38.16), febrile neutropenia (OR = 4.61, 95% CI = 1.37-15.46), intraabdominal infection (OR = 2.06, 95% CI = 0.95-4.46), referral from other hospitals (OR = 1.99, 95% CI = 0.98-4.05) and an increasing number of antibiotics previously used (OR = 1.28, 95% CI = 1.13-1.46). Conclusions Multiple factors were found to be associated with the first episode of HO-HCFA CDI in the setting of an outbreak; of the modifiable risk factors, prior exposure to both ciprofloxacin and PPI was the most important. Referral from other hospitals was an environmental risk factor that deserves further study.	[Ochoa-Hein, Eric; Galindo-Fraga, Arturo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hosp Epidemiol, Mexico City, DF, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico; [Ponce de Leon-Garduno, Alfredo; Torres-Gonzalez, Pedro] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Microbiol Lab, Mexico City, DF, Mexico; [Granados-Garcia, Victor] Inst Mexicano Seguro Social, Aging Area, Epidemiol & Hlth Serv Res Unit, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Mexicano del Seguro Social	Galindo-Fraga, A (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hosp Epidemiol, Mexico City, DF, Mexico.	arturo.galindof@incmnsz.mx	Granados-García, Víctor/AAR-5788-2020	Granados-García, Víctor/0000-0002-9075-576X; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Galindo-Fraga, Arturo/0000-0002-2818-1160				Aldrete SD, 2015, AM J CLIN PATHOL, V143, P895, DOI 10.1309/AJCP9EWI6QPVTPQY; Garcia-Lecona DA, 2018, AM J INFECT CONTROL, V46, P103, DOI 10.1016/j.ajic.2017.06.006; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Brown KA, 2013, ANTIMICROB AGENTS CH, V57, P2326, DOI 10.1128/AAC.02176-12; Camacho-Ortiz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122627; Camacho-Ortiz A, 2009, REV INVEST CLIN, V61, P371; Caroff DA, 2017, CLIN INFECT DIS, V65, P1232, DOI 10.1093/cid/cix456; Chung P, 2014, AM J INFECT CONTROL, V42, pS264, DOI 10.1016/j.ajic.2014.05.001; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Depestel Daryl D, 2013, J Pharm Pract, V26, P464, DOI 10.1177/0897190013499521; Dingle KE, 2017, LANCET INFECT DIS, V17, P411, DOI 10.1016/S1473-3099(16)30514-X; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Dubberke ER, 2011, INFECT CONT HOSP EP, V32, P360, DOI 10.1086/658944; Fernandez-Gracia J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02245-7; Garcia C, 2007, AM J TROP MED HYG, V77, P802, DOI 10.4269/ajtmh.2007.77.802; Gordon D, 2016, J HOSP INFECT, V92, P173, DOI 10.1016/j.jhin.2015.10.009; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lin HJ, 2015, J MICROBIOL IMMUNOL, V48, P183, DOI 10.1016/j.jmii.2013.08.003; Tamez-Torres KM, 2017, INT J INFECT DIS, V65, P44, DOI 10.1016/j.ijid.2017.09.022; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]; Menendez M, 2016, REV MED URUG, V32, P159; Morfin-Otero R, 2016, BRAZ J INFECT DIS, V20, P8, DOI 10.1016/j.bjid.2015.09.008; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Simmering JE, 2015, INFECT CONT HOSP EP, V36, P1031, DOI 10.1017/ice.2015.130; Stevens V, 2011, PHARMACOEPIDEM DR S, V20, P1035, DOI 10.1002/pds.2198; Weber DJ, 2013, AM J INFECT CONTROL, V41, pS105, DOI 10.1016/j.ajic.2012.12.009; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; World Health Organization (WHO) Collaborating Center for Drug Statistics Methodology, ATC DDD IND 2017	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198212	10.1371/journal.pone.0198212	http://dx.doi.org/10.1371/journal.pone.0198212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813115	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800057
J	Park, SJ; Lim, HS; Sheen, SS; Yang, HM; Seo, KW; Choi, SY; Choi, BJ; Yoon, MH; Tahk, SJ				Park, Se-Jun; Lim, Hong-Seok; Sheen, Seung-Soo; Yang, Hyoung-Mo; Seo, Kyoung-Woo; Choi, So-Yeon; Choi, Byoung-Joo; Yoon, Myeong-Ho; Tahk, Seung-Jea			Impact of body fat distribution on long-term clinical outcomes after drug-eluting stent implantation	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; CORONARY-ARTERY-DISEASE; CENTRAL OBESITY; VISCERAL FAT; MASS INDEX; ATHEROSCLEROSIS; RESTENOSIS; QUANTIFICATION; INFLAMMATION; RELIABILITY	Background and objective The distribution of body fat is closely related to cardiovascular disease and outcomes, although its impact on patient prognosis after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) has not been evaluated. We investigated the impact of truncal fat distribution on long-term clinical outcomes after DES treatment. Methods In 441 DES-treated patients, dual energy X-ray absorptiometry was performed to assess total and regional body fat distribution after index PCI. The ratio of truncal fat to total body fat mass (%FMtrunk/FMtotal was calculated as a representative parameter for truncal fat distribution. trunk- The primary endpoint was major adverse cardiac events (MACE), a composite of ischemia-driven target vessel revascularization (TVR), non-procedural myocardial infarction, cardiac death at 5 years. Results During the median follow-up duration of 1780 days, MACE occurred in 22.0% of patients, with the highest-quartile group of %FMtrunk/FMtotal having a higher rate than the lowest quartile group (27.8% vs. 15.3%; log rank p= 0.026). The difference was driven by a higher rate of ischemia-driven TVR (25.9% vs. 9.9%; log rank p = 0.008). In multivariable Cox regression analyses, %FMtrunk/FMtotal was independently associated with MACE (hazard ratio: 1.075; 95% CI: 1.022-1.131; p = 0.005), but body mass index (BMI) was not. Conclusions In DES-treated patients, truncal fat distribution is associated with unfavorable clinical outcomes and is more clinically relevant than BMI.	[Park, Se-Jun] Hallym Univ, Chun Cheon Sacred Heart Hosp, Cardiovasc Ctr, Div Cardiol,Coll Med, Chunchon, South Korea; [Lim, Hong-Seok; Yang, Hyoung-Mo; Seo, Kyoung-Woo; Choi, So-Yeon; Choi, Byoung-Joo; Yoon, Myeong-Ho; Tahk, Seung-Jea] Ajou Univ, Sch Med, Dept Cardiol, Suwon, South Korea; [Sheen, Seung-Soo] Ajou Univ, Sch Med, Dept Pulm & Crit Care Med, Suwon, South Korea	Hallym University; Ajou University; Ajou University	Lim, HS (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, Suwon, South Korea.	camdhslim@ajou.ac.kr	Sheen, Seungsoo/AAB-4963-2021	Yang, Hyoung-Mo/0000-0003-3602-9772; Lim, Hong-Seok/0000-0002-3127-2071; Park, Se-Jun/0000-0002-3408-6776				Alexopoulos N, 2014, ATHEROSCLEROSIS, V233, P104, DOI 10.1016/j.atherosclerosis.2013.12.023; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Choi YJ, 2015, J CLIN DENSITOM, V18, P192, DOI 10.1016/j.jocd.2015.02.001; Coutinho T, 2013, J AM COLL CARDIOL, V61, P553, DOI 10.1016/j.jacc.2012.10.035; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Habara M, 2013, EUR HEART J-CARD IMG, V14, P276, DOI 10.1093/ehjci/jes183; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Kadakia MB, 2011, HEART, V97, P1782, DOI 10.1136/heartjnl-2011-300231; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kim BJ, 2012, NEUROLOGY, V79, P856, DOI 10.1212/WNL.0b013e318266fad1; Komiyama H, 2015, WORLD J CARDIOL, V7, P776, DOI 10.4330/wjc.v7.i11.776; Kushner RF, 2014, PROG CARDIOVASC DIS, V56, P465, DOI 10.1016/j.pcad.2013.09.005; Lange RA, 2010, NEW ENGLAND J MED; Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008; Lim S, 2013, INT J CARDIOL, V169, P166, DOI 10.1016/j.ijcard.2013.08.077; Lovren F, 2015, CAN J CARDIOL, V31, DOI 10.1016/j.cjca.2014.11.031; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Park JS, 2013, SCAND CARDIOVASC J, V47, P297, DOI 10.3109/14017431.2013.824604; Park SJ, 2016, ATHEROSCLEROSIS, V248, P190, DOI 10.1016/j.atherosclerosis.2016.03.014; Schooling CM, 2013, PREV MED, V57, P247, DOI 10.1016/j.ypmed.2013.05.025; Shiomi H, 2014, CIRC-CARDIOVASC INTE, V7, P343, DOI 10.1161/CIRCINTERVENTIONS.113.001322; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Stovitz SD, 2018, CAN J CARDIOL, V34, P540, DOI 10.1016/j.cjca.2017.10.025; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182	28	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197991	10.1371/journal.pone.0197991	http://dx.doi.org/10.1371/journal.pone.0197991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799868	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400033
J	Becerril, A; Alvarez, S; Brana, AF; Rico, S; Diaz, M; Santamaria, RI; Salas, JA; Mendez, C				Becerril, Adriana; Alvarez, Susana; Brana, Alfredo F.; Rico, Sergio; Diaz, Margarita; Santamaria, Ramon I.; Salas, Jose A.; Mendez, Carmen			Uncovering production of specialized metabolites by Streptomyces argillaceus: Activation of cryptic biosynthesis gene clusters using nutritional and genetic approaches	PLOS ONE			English	Article							III POLYKETIDE SYNTHASE; NATURAL-PRODUCTS; ARGIMYCINS P; STARTER UNIT; ALBUS J1074; GRISEUS; IDENTIFICATION; INHIBITOR; ISORENIERATENE; MITHRAMYCIN	Sequencing of Streptomyces genomes has revealed they harbor a high number of biosynthesis gene cluster (BGC), which uncovered their enormous potentiality to encode specialized metabolites. However, these metabolites are not usually produced under standard laboratory conditions. In this manuscript we report the activation of BGCs for antimycins, carotenoids, germicidins and desferrioxamine compounds in Streptomyces argillaceus, and the identification of the encoded compounds. This was achieved by following different strategies, including changing the growth conditions, heterologous expression of the cluster and inactivating the adpAa or overexpressing the abrC3 global regulatory genes. In addition, three new carotenoid compounds have been identified.	[Becerril, Adriana; Alvarez, Susana; Brana, Alfredo F.; Salas, Jose A.; Mendez, Carmen] Univ Oviedo, Dept Biol Func, Oviedo, Spain; [Becerril, Adriana; Alvarez, Susana; Brana, Alfredo F.; Salas, Jose A.; Mendez, Carmen] Univ Oviedo, IUOPA, Oviedo, Spain; [Becerril, Adriana; Brana, Alfredo F.; Salas, Jose A.; Mendez, Carmen] Inst Invest Sanitaria Asturias ISPA, Oviedo, Spain; [Rico, Sergio; Diaz, Margarita; Santamaria, Ramon I.] Univ Salamanca, Dept Microbiol & Genet, Inst Biol Func & Genom, CSIC, Salamanca, Spain	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Mendez, C (corresponding author), Univ Oviedo, Dept Biol Func, Oviedo, Spain.; Mendez, C (corresponding author), Univ Oviedo, IUOPA, Oviedo, Spain.; Mendez, C (corresponding author), Inst Invest Sanitaria Asturias ISPA, Oviedo, Spain.	cmendezf@uniovi.es	Mendez-Fernandez, Carmen/ABE-5745-2020; Martínez, Margarita Díaz/L-3069-2014; Fernandez-Brana, Alfredo/O-1488-2019; Santamaria, Ramon I/M-9069-2019; Santamaria, Ramon I/K-2870-2014	Mendez-Fernandez, Carmen/0000-0003-2729-841X; Martínez, Margarita Díaz/0000-0003-4286-1506; Fernandez-Brana, Alfredo/0000-0002-3277-9085; Santamaria, Ramon I/0000-0002-2181-6776; Santamaria, Ramon I/0000-0002-2181-6776; Becerril Garcia, Adriana/0000-0002-3306-0611	Spanish Ministry of Economy and Competitiveness, MINECO [BIO2011-25398, BIO2014-56752-R, PIM2010EEI-00752]; grant "Apoyo a grupos de excelencia", Principado de Asturias-FEDER [FC-15-GRUPIN14-014]; MINECO;  [BIO2015-66958-R]	Spanish Ministry of Economy and Competitiveness, MINECO(Spanish Government); grant "Apoyo a grupos de excelencia", Principado de Asturias-FEDER; MINECO(Spanish Government); 	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness, MINECO (Grants BIO2011-25398, BIO2014-56752-R and PIM2010EEI-00752 to CM), and by the grant "Apoyo a grupos de excelencia", Principado de Asturias-FEDER (FC-15-GRUPIN14-014). AB and SA were recipient of predoctoral fellowships from MINECO. RS and MD acknowledge funding from BIO2015-66958-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARCAMONE F, 1969, EXPERIENTIA, V25, P241, DOI 10.1007/BF02034366; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Barona-Gomez F, 2006, MICROBIOL-SGM, V152, P3355, DOI 10.1099/mic.0.29161-0; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI [10.1038/ja.2012.27, 10.1038/ja.2012.54]; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Buckingham J., 2013, DICT NATURAL PRODUCT; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chemler JA, 2012, J AM CHEM SOC, V134, P7359, DOI 10.1021/ja2112228; Cihak M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02495; Fernandez E, 1998, J BACTERIOL, V180, P4929; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Horna DH, 2011, J BACTERIOL, V193, P2647, DOI 10.1128/JB.00108-11; Iftime D, 2016, J IND MICROBIOL BIOT, V43, P277, DOI 10.1007/s10295-015-1685-7; Joynt R, 2018, MICROBIOL-SGM, V164, P28, DOI 10.1099/mic.0.000572; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Krugel H, 1999, BBA-MOL CELL BIOL L, V1439, P57, DOI 10.1016/S1388-1981(99)00075-X; Lee HS, 2001, J MOL MICROB BIOTECH, V3, P95; Liu J, 2016, NAT PROD REP, V33, P1146, DOI 10.1039/c6np00004e; Lombo F, 2004, CHEM BIOL, V11, P1709, DOI 10.1016/j.chembiol.2004.10.007; Lombo F, 1996, GENE, V172, P87, DOI 10.1016/0378-1119(96)00029-7; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Mendez C, 2015, PLANTA MED, V81, P1326, DOI [10.1055/s0035-1557876, 10.1055/s-0035-1557876]; Menendez N, 2006, APPL ENVIRON MICROB, V72, P167, DOI 10.1128/AEM.72.1.167-177.2006; Myronovskyi M, 2014, APPL MICROBIOL BIOT, V98, P795, DOI 10.1007/s00253-013-5440-6; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; Olano C, 2004, CHEM BIOL, V11, P87, DOI 10.1016/j.chembiol.2003.12.018; Olano C., 2014, ANTIMICROBIAL COMPOU, P1, DOI DOI 10.1007/978-3-642-40444-3_1; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Perez-Victoria I, 2016, PLANTA MED, V82, P857, DOI 10.1055/s-0042-101763; PETERSEN F, 1993, J ANTIBIOT, V46, P1126, DOI 10.7164/antibiotics.46.1126; Rico S, 2014, APPL ENVIRON MICROB, V80, P2417, DOI 10.1128/AEM.03378-13; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Sambrook J., 2001, MOL CLONING LAB MANU; Schieber A, 2016, WOODHEAD PUBL FOOD S, V295, P101, DOI 10.1016/B978-0-08-100371-8.00005-1; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Takano H, 2006, J IND MICROBIOL BIOT, V33, P88, DOI 10.1007/s10295-005-0005-z; van Keulen G, 2014, ADV APPL MICROBIOL, V89, P217, DOI 10.1016/B978-0-12-800259-9.00006-8; Wagener S, 2012, FREE RADICAL BIO MED, V53, P457, DOI 10.1016/j.freeradbiomed.2012.05.022; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Xu JJ, 2017, J BIOL CHEM, V292, P19708, DOI 10.1074/jbc.M117.809145; Ye SH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00252; Ye SH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00194; Zhang MZM, 2017, NAT CHEM BIOL, V13, P607, DOI 10.1038/nchembio.2341	45	26	28	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198145	10.1371/journal.pone.0198145	http://dx.doi.org/10.1371/journal.pone.0198145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795673	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300130
J	Stamm, H; Klingler, F; Grossjohann, EM; Muschhammer, J; Vettorazzi, E; Heuser, M; Mock, U; Thol, F; Vohwinkel, G; Latuske, E; Bokemeyer, C; Kischel, R; Dos Santos, C; Stienen, S; Friedrich, M; Lutteropp, M; Nagorsen, D; Wellbrock, J; Fiedler, W				Stamm, Hauke; Klingler, Felix; Grossjohann, Eva-Maria; Muschhammer, Jana; Vettorazzi, Eik; Heuser, Michael; Mock, Ulrike; Thol, Felicitas; Vohwinkel, Gabi; Latuske, Emily; Bokemeyer, Carsten; Kischel, Roman; Dos Santos, Cedric; Stienen, Sabine; Friedrich, Matthias; Lutteropp, Michael; Nagorsen, Dirk; Wellbrock, Jasmin; Fiedler, Walter			Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option	ONCOGENE			English	Article							CELL-ENGAGING ANTIBODY; CD8 T-CELLS; POLIOVIRUS RECEPTOR; NECTIN-2 CD112; TIGIT; CD155; DNAM-1; EXPRESSION; CANCER; IDENTIFICATION	Immune checkpoints are promising targets in cancer therapy. Recently, poliovirus receptor (PVR) and poliovirus receptor-related 2 (PVRL2) have been identified as novel immune checkpoints. In this investigation we show that acute myeloid leukemia (AML) cell lines and AML patient samples highly express the T-cell immunoreceptor with Ig and ITIM domains (TIGIT) ligands PVR and PVRL2. Using two independent patient cohorts, we could demonstrate that high PVR and PVRL2 expression correlates with poor outcome in AML. We show for the first time that antibody blockade of PVR or PVRL2 on AML cell lines or primary AML cells or TIGIT blockade on immune cells increases the anti-leukemic effects mediated by PBMCs or purified CD3(+) cells in vitro. The cytolytic activity of the BiTE (R) antibody construct AMG 330 against leukemic cells could be further enhanced by blockade of the TIGIT-PVR/PVRL2 axis. This increased immune reactivity is paralleled by augmented secretion of Granzyme B by immune cells. Employing CRISPR/Cas9-mediated knockout of PVR and PVRL2 in MV4-11 cells, the cytotoxic effects of antibody blockade could be recapitulated in vitro. In NSG mice reconstituted with human T cells and transplanted with either MV4-11 PVR/PVRL2 knockout or wildtype cells, prolonged survival was observed for the knockout cells. This survival benefit could be further extended by treating the mice with AMG 330. Therefore, targeting the TIGIT-PVR/PVRL2 axis with blocking antibodies might represent a promising future therapeutic option in AML.	[Stamm, Hauke; Klingler, Felix; Grossjohann, Eva-Maria; Muschhammer, Jana; Vohwinkel, Gabi; Latuske, Emily; Bokemeyer, Carsten; Wellbrock, Jasmin; Fiedler, Walter] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Hubertus Wald Univ Canc Ctr, Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Heuser, Michael; Thol, Felicitas] Hannover Med Sch, Hematol Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany; [Mock, Ulrike] Univ Med Ctr Hamburg Eppendorf, Res Dept Cell & Gene Therapy, Clin Stem Cell Transplantat, Hamburg, Germany; [Kischel, Roman; Stienen, Sabine; Friedrich, Matthias; Lutteropp, Michael] Amgen Res Munich GmbH, Munich, Germany; [Dos Santos, Cedric] Amgen Inc, Oncol Biomarkers & Early Clin Dev, San Francisco, CA USA; [Nagorsen, Dirk] Amgen Inc, Global Clin Dev, Thousand Oaks, CA USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Amgen; Amgen Research Munich GmbH; Amgen; Amgen	Fiedler, W (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Hubertus Wald Univ Canc Ctr, Hamburg, Germany.	fiedler@uke.de	Heuser, Michael/S-2363-2017; Vettorazzi, Eik/B-8130-2019	Heuser, Michael/0000-0001-5318-9044; Vettorazzi, Eik/0000-0002-3737-6402; Fiedler, Walter/0000-0003-0275-8803	Lieselotte Beutel Stiftung; AMGEN Inc.	Lieselotte Beutel Stiftung; AMGEN Inc.(Amgen)	We gratefully thank Dr. Daniela Pende (IRCCS AOU San Martino-IST, Genoa, Italy) for scientific discussion and provision of the anti-PVRL2 L14 antibody. We gratefully acknowledge Prof. E. Tolosa of the Institute of Immunology, University Medical Center Hamburg-Eppendorf, Germany, for fruitful scientific discussions and technical support. We are grateful to Prof. C. Hagel, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Germany, for scientific discussions. We would like to thank Dr. Malte Mohme for the scientific discussions and technical support. We would like to thank the members of the Center for Transfusion Medicine for providing buffy coats from healthy donors, the members of the Flow Cytometry UCCH Core Facility for sorting of the CRISPR/Cas9-generated double-knockout cells and the members of the Animal Facility for technical assistance and managing the mouse colonies, all located at the University Medical Center Hamburg-Eppendorf, Germany. The authors thank Prof. R. Schlenk (University Hospital Ulm, Germany) and all participating study centers for providing clinical data on study patients. This work was funded in part by the Lieselotte Beutel Stiftung and by AMGEN Inc.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Callahan MK, 2013, J LEUKOCYTE BIOL, V94, P41, DOI 10.1189/jlb.1212631; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Cella M, 2010, EUR J IMMUNOL, V40, P949, DOI 10.1002/eji.200940234; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Dao T, 2015, NAT BIOTECHNOL, V33, P1079, DOI 10.1038/nbt.3349; DAVER N, 2017, BLOOD S1, V0130; FREISTADT MS, 1993, VIROLOGY, V195, P798, DOI 10.1006/viro.1993.1433; Friedrich M, 2014, MOL CANCER THER, V13, P1549, DOI 10.1158/1535-7163.MCT-13-0956; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Inozume T, 2016, J INVEST DERMATOL, V136, P255, DOI 10.1038/JID.2015.404; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Kohnke T, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0213-6; Kong YX, 2016, CLIN CANCER RES, V22, P3057, DOI 10.1158/1078-0432.CCR-15-2626; Krupka C, 2016, LEUKEMIA, V30, P484, DOI 10.1038/leu.2015.214; Krupka C, 2014, BLOOD, V123, P356, DOI 10.1182/blood-2013-08-523548; Kurtulus S., 2014, J IMMUNOTHERAPY C S3, V2, pO13, DOI DOI 10.1186/2051-1426-2-S3-O13; Laszlo GS, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.68; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Li M, 2014, J BIOL CHEM, V289, P17647, DOI 10.1074/jbc.M114.572420; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Morse MA, 2015, VACCINE, V33, P7377, DOI 10.1016/j.vaccine.2015.10.057; Nishiwada S, 2015, ANTICANCER RES, V35, P2287; NOBIS P, 1985, J GEN VIROL, V66, P2563, DOI 10.1099/0022-1317-66-12-2563; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Pende D, 2005, MOL IMMUNOL, V42, P463, DOI 10.1016/j.molimm.2004.07.028; RAVANDI F, 2017, BLOOD S1, V130; Schlenk RF, 2011, BLOOD, V118, P38, DOI 10.1182/blood.V118.21.80.80; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Yang H, 2014, LEUKEMIA, V28, P1280, DOI 10.1038/leu.2013.355; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu YW, 2016, J EXP MED, V213, P167, DOI 10.1084/jem.20150785; Zugmaier G, 2015, MOL IMMUNOL, V67, P58, DOI 10.1016/j.molimm.2015.02.033	47	46	51	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5269	5280		10.1038/s41388-018-0288-y	http://dx.doi.org/10.1038/s41388-018-0288-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29855615	Green Published, hybrid			2022-12-26	WOS:000445759700002
J	Chow, M; Gao, LN; MacManiman, JD; Bicocca, VT; Chang, BH; Alumkal, JJ; Tyner, JW				Chow, Marilynn; Gao, Lina; MacManiman, Jason D.; Bicocca, Vincent T.; Chang, Bill H.; Alumkal, Joshi J.; Tyner, Jeffrey W.			Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; HEMI-METHYLATED DNA; CELL RECEPTOR; ANTIGEN ROR1; SRA DOMAIN; CANCER; EXPRESSION; NAPHTHAZARIN	Expression of the transmembrane pseudokinase ROR1 is required for survival of t(1;19)-pre-B-cell acute lymphoblastic leukemia (t(1;19) pre-B-ALL), chronic lymphocytic leukemia, and many solid tumors. However, targeting ROR1 with small-molecules has been challenging due to the absence of ROR1 kinase activity. To identify genes that regulate ROR1 expression and may, therefore, serve as surrogate drug targets, we employed an siRNA screening approach and determined that the epigenetic regulator and E3 ubiquitin ligase, UHRF1, is required for t(1;19) pre-B-ALL cell viability in a ROR1-dependent manner. Upon UHRF1 silencing, ROR1 protein is reduced without altering ROR1 mRNA, and ectopically expressed UHRF1 is sufficient to increase ROR1 levels. Additionally, proteasome inhibition rescues loss of ROR1 protein after UHRF1 silencing, suggesting a role for the proteasome in the UHRF1-ROR1 axis. Finally, we show that ROR1-positive cells are twice as sensitive to the UHRF1-targeting drug, naphthazarin, and undergo increased apoptosis compared to ROR1-negative cells. Naphthazarin elicits reduced expression of UHRF1 and ROR1, and combination of naphthazarin with inhibitors of pre-B cell receptor signaling results in further reduction of cell survival compared with either inhibitor alone. Therefore, our work reveals a mechanism by which UHRF1 stabilizes ROR1, suggesting a potential targeting strategy to inhibit ROR1 in t(1;19) pre-B-ALL and other malignancies.	[Chow, Marilynn; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Gao, Lina; MacManiman, Jason D.; Bicocca, Vincent T.; Chang, Bill H.; Alumkal, Joshi J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Gao, Lina; Alumkal, Joshi J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [MacManiman, Jason D.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Chang, Bill H.] Oregon Hlth & Sci Univ, Div Pediat Hematol & Oncol, Doernbecher Childrens Hosp, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA.; Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA.	tynerj@ohsu.edu		Chow-Castro, Marilynn/0000-0001-8819-4441; Bicocca, Vincent/0000-0002-5702-4586	Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) [TL1TR000129]; Hyundai Hope on Wheels; Leukemia and Lymphoma Society; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; National Cancer Institute [5R00CA151457-04, 1R01CA183947-01]; NATIONAL CANCER INSTITUTE [R00CA151457, K99CA151457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000129] Funding Source: NIH RePORTER	Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Hyundai Hope on Wheels; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The pCS2-6XMYC vector was a generous gift from Dr. Monika Davare. The authors would like to thank David K. Edwards V, Samantha L. Savage, Anna M. Reister Schultz, Dr. Haijiao Zhang, and Janet Pittsenbarger for their technical expertise and Dr. Kevin M. Watanabe-Smith for editing the manuscript. MC was supported in part by the Oregon Clinical and Translational Research Institute (OCTRI) (TL1TR000129) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). BHC is supported by the Hyundai Hope on Wheels. JWT is supported by The Leukemia and Lymphoma Society, the V Foundation for Cancer Research, Gabrielle's Angel Foundation for Cancer Research, and the National Cancer Institute (5R00CA151457-04; 1R01CA183947-01).	Abu-Alainin W, 2016, J PATHOL, V238, P423, DOI 10.1002/path.4665; Acharya BR, 2011, APOPTOSIS, V16, P924, DOI 10.1007/s10495-011-0613-1; Alhosin M, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0453-5; Alhosin M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08996; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Balakrishnan A, 2017, CLIN CANCER RES, V23, P3061, DOI 10.1158/1078-0432.CCR-16-2083; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Baskar S, 2012, MABS-AUSTIN, V4, P349, DOI 10.4161/mabs.19870; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Borcherding N, 2014, PROTEIN CELL, V5, P496, DOI 10.1007/s13238-014-0059-7; Fernandez NB, 2016, MOL CARCINOGEN, V55, P1772, DOI 10.1002/mc.22426; Broome HE, 2011, LEUKEMIA RES, V35, P1390, DOI 10.1016/j.leukres.2011.06.021; Chen DF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162638; Choi MY, 2015, CL LYMPH MYELOM LEUK, V15, pS167, DOI 10.1016/j.clml.2015.02.010; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Daskalos A, 2011, CANCER-AM CANCER SOC, V117, P1027, DOI 10.1002/cncr.25531; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Foa R, 2003, BRIT J HAEMATOL, V120, P484, DOI 10.1046/j.1365-2141.2003.04113.x; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Hunger SP, 1996, BLOOD, V87, P1211, DOI 10.1182/blood.V87.4.1211.bloodjournal8741211; Jia YH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.7; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kaucka M, 2011, ACTA PHYSIOL, V203, P351, DOI 10.1111/j.1748-1716.2011.02306.x; Kim JA, 2012, INT J ONCOL, V40, P157, DOI 10.3892/ijo.2011.1195; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kim MY, 2015, INT J ONCOL, V46, P1659, DOI 10.3892/ijo.2015.2857; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Li P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011859; Loh ML, 2012, CLIN CANCER RES, V18, P2754, DOI 10.1158/1078-0432.CCR-11-1936; Ma J, 2015, BIOCHEM BIOPH RES CO, V464, P147, DOI 10.1016/j.bbrc.2015.06.104; Mani R, 2015, LEUKEMIA, V29, P346, DOI 10.1038/leu.2014.199; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Moorman AV, 2010, BLOOD, V115, P206, DOI 10.1182/blood-2009-07-232124; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Myrianthopoulos V, 2016, EUR J MED CHEM, V114, P390, DOI 10.1016/j.ejmech.2016.02.043; Niebuhr B, 2013, BLOOD, V122, P413, DOI 10.1182/blood-2013-01-480244; Nygren MK, 2009, EXP HEMATOL, V37, P225, DOI 10.1016/j.exphem.2008.10.007; Qu XY, 2015, EPIGENETICS-US, V10, P526, DOI 10.1080/15592294.2015.1048060; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rau R, 2009, HEMATOL ONCOL, V27, P171, DOI 10.1002/hon.904; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Sanchez-Aguilera A, 2010, LEUKEMIA, V24, P97, DOI 10.1038/leu.2009.217; Sanda T, 2013, CANCER DISCOV, V3, P564, DOI 10.1158/2159-8290.CD-12-0504; Shabani M, 2008, LEUKEMIA LYMPHOMA, V49, P1360, DOI 10.1080/10428190802124000; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Tasian SK, 2017, BRIT J HAEMATOL, V176, P867, DOI 10.1111/bjh.14474; Troeger A, 2012, BLOOD, V119, P4708, DOI 10.1182/blood-2011-12-395939; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1; Widhopf GF, 2014, P NATL ACAD SCI USA, V111, P793, DOI 10.1073/pnas.1308374111; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]	60	6	6	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5221	5232		10.1038/s41388-018-0299-8	http://dx.doi.org/10.1038/s41388-018-0299-8			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29849118	Green Accepted			2022-12-26	WOS:000445093100006
J	Cheng, L; Al-Owais, M; Covarrubias, ML; Koch, WJ; Manning, DR; Peers, C; Riobo-Del Galdo, NA				Cheng, Lan; Al-Owais, Moza; Covarrubias, Manuel L.; Koch, Walter J.; Manning, David. R.; Peers, Chris; Riobo-Del Galdo, Natalia A.			Coupling of Smoothened to inhibitory G proteins reduces voltage-gated K+ currents in cardiomyocytes and prolongs cardiac action potential duration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); heart; Hedgehog signaling pathway; cardiovascular; potassium channel; ion channel; action potential; arrhythmias; noncanonical; Smoothened	HEDGEHOG PATHWAY; ACTIVATION; CHANNELS; G(I)	SMO (Smoothened), the central transducer of Hedgehog signaling, is coupled to heterotrimeric G(i) proteins in many cell types, including cardiomyocytes. In this study, we report that activation of SMO with SHH (Sonic Hedgehog) or a small agonist, purmorphamine, rapidly causes a prolongation of the action potential duration that is sensitive to a SMO inhibitor. In contrast, neither of the SMO agonists prolonged the action potential in cardiomyocytes from transgenic G(i)CT/TTA mice, in which G(i) signaling is impaired, suggesting that the effect of SMO is mediated by G(i) proteins. Investigation of the mechanism underlying the change in action potential kinetics revealed that activation of SMO selectively reduces outward voltage-gated K+ repolarizing (Kv) currents in isolated cardiomyocytes and that it induces a down-regulation of membrane levels of Kv4.3 in cardiomyocytes and intact hearts from WT but not from GiCT/TTA mice. Moreover, perfusion of intact hearts with Shh or purmorphamine increased the ventricular repolarization time (QT interval) and induced ventricular arrhythmias. Our data constitute the first report that acute, noncanonical Hh signaling mediated by G(i) proteins regulates K+ currents density in cardiomyocytes and sensitizes the heart to the development of ventricular arrhythmias.	[Cheng, Lan; Riobo-Del Galdo, Natalia A.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Covarrubias, Manuel L.] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [Al-Owais, Moza; Peers, Chris] Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Leeds LS2 9JT, W Yorkshire, England; [Riobo-Del Galdo, Natalia A.] Univ Leeds, Sch Med, Leeds Inst Canc & Pathol, Leeds LS2 9JT, W Yorkshire, England; [Koch, Walter J.] Temple Univ, Dept Pharmacol, Philadelphia, PA 19140 USA; [Koch, Walter J.] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA; [Manning, David. R.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; University of Leeds; University of Leeds; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Riobo-Del Galdo, NA (corresponding author), Sch Mol & Cellular Biol, Miall Bldg,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	n.a.riobo-delgaldo@leeds.ac.uk	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; CHENG, LAN/0000-0002-3620-3366; Covarrubias, Manuel/0000-0002-0881-4143; Al-Owais, Moza/0000-0001-9122-7873	National Institutes of Health [2RO1GM080396]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 2RO1GM080396 (to D. R. M. and N. R.- D. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Carbe CJ, 2014, AM J PHYSIOL-HEART C, V307, pH66, DOI 10.1152/ajpheart.00166.2014; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Granados-Fuentes D, 2012, J NEUROSCI, V32, P10045, DOI 10.1523/JNEUROSCI.0174-12.2012; Karczewski P, 1997, BASIC RES CARDIOL, V92, P37, DOI 10.1007/BF00794066; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lin L, 2010, MOL CELL NEUROSCI, V43, P315, DOI 10.1016/j.mcn.2009.12.005; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Martinez-Chinchilla P, 2008, METHOD ENZYMOL, V446, P189, DOI 10.1016/S0076-6879(08)01611-X; Nerbonne Jeanne M, 2016, Card Electrophysiol Clin, V8, P257, DOI 10.1016/j.ccep.2016.01.001; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Paulis L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07983; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Riobo NA, 2006, CELL CYCLE, V5, P1612, DOI 10.4161/cc.5.15.3130; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Swope David, 2012, Mol Cell Biol, V32, P1056, DOI 10.1128/MCB.06188-11; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Zhang YM, 2014, AM J PHYSIOL-HEART C, V306, pH1553, DOI 10.1152/ajpheart.00459.2013	29	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11022	11032		10.1074/jbc.RA118.001989	http://dx.doi.org/10.1074/jbc.RA118.001989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802197	Green Published, hybrid			2022-12-26	WOS:000438882800015
J	Dekhil, N; Skhairia, MA; Mhenni, B; Ben Fradj, S; Warren, R; Mardassi, H				Dekhil, Naira; Skhairia, Mohamed Amine; Mhenni, Besma; Ben Fradj, Saloua; Warren, Rob; Mardassi, Helmi			Automated IS6110-based fingerprinting of Mycobacterium tuberculosis: Reaching unprecedented discriminatory power and versatility	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; POLYMERASE-CHAIN-REACTION; LIGATION-MEDIATED PCR; COMPLEX STRAINS; OUTBREAKS; NETWORK	Background Several technical hurdles and limitations have restricted the use of IS6110 restriction fragment length polymorphism (IS6110 RFLP), the most effective typing method for detecting recent tuberculosis (TB) transmission events. This has prompted us to conceive an alternative modality, IS6110-5'3'FP, a plasmid-based cloning approach coupled to a single PCR amplification of differentially labeled 5' and 3' IS6110 polymorphic ends and their automated fractionation on a capillary sequencer. The potential of IS6110-5'3'FP to be used as an alternative to IS6110 RFLP has been previously demonstrated, yet further technical improvements are still required for optimal discriminatory power and versatility. Objectives Here we introduced critical amendments to the original IS6110-5'3'FP protocol and compared its performance to that of 24-loci multiple interspersed repetitive unit-variable number tandem repeats (MIRU-VNTR), the current standard method for TB transmission analyses. Methods IS6110-5'3'FP protocol modifications involved: (i) the generation of smaller-sized polymorphic fragments for efficient cloning and PCR amplification, (ii) omission of the plasmid amplification step in E. coli for shorter turnaround times, (iii) the use of more stable fluorophores for increased sensitivity, (iv) automated subtraction of background fluorescent signals, and (v) the automated conversion of fluorescent peaks into binary data. Results In doing so, the overall turnaround time of IS6110-5'3'FP was reduced to 4 hours. The new protocol allowed detecting almost all 5' and 3' IS6110 polymorphic fragments of any given strain, including IS6110 high-copy number Beijing strains. IS6110-5'3'FP proved much more discriminative than 24-loci MIRU-VNTR, particularly with strains of the M. tuberculosis lineage 4. Conclusions The IS6110-5'3'FP protocol described herein reached the optimal discriminatory potential of IS6110 fingerprinting and proved more accurate than 24-loci MIRU-VNTR in estimating recent TB transmission. The method, which is highly cost-effective, was rendered versatile enough to prompt its evaluation as an automatized solution for a TB integrated molecular surveillance.	[Dekhil, Naira; Skhairia, Mohamed Amine; Mhenni, Besma; Ben Fradj, Saloua; Mardassi, Helmi] Univ Tunis El Manar, Inst Pasteur Tunis, Unit Typing & Genet Mycobacteria, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Tunis, Tunisia; [Warren, Rob] Stellenbosch Univ, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, SAMRC Ctr TB Res,DST NRF Ctr Excellence Biomed TB, Cape Town, South Africa	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; National Research Foundation - South Africa; Stellenbosch University	Mardassi, H (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Unit Typing & Genet Mycobacteria, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Tunis, Tunisia.	helmi.merdassi@pasteur.rns.tn		skhairia, mohamed amine/0000-0003-2224-1596; mhenni, besma/0000-0001-6476-768X; dekhil, naira/0000-0001-7881-9348; Warren, Robin/0000-0001-5741-7358	Tunisian Ministry of Higher Education and Scientific Research [LR11IPT01]	Tunisian Ministry of Higher Education and Scientific Research	This work was supported by grants from the Tunisian Ministry of Higher Education and Scientific Research (contract LR11IPT01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Tunisian Ministry of Higher Education and Scientific Research (contract LR11IPT01).	Alito A, 1999, J CLIN MICROBIOL, V37, P788, DOI 10.1128/JCM.37.3.788-791.1999; Braden CR, 2002, EMERG INFECT DIS, V8, P1210; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; Dekhil N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153983; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Embden J.D.A.V., 1993, J CLIN MICROBIOL, V31, P406; Evans GA, 1990, CELL, V61, P17, DOI DOI 10.1016/0092-8674(90)90210-6; Gardy JL, 2013, LANCET INFECT DIS, V13, P101, DOI 10.1016/S1473-3099(12)70295-5; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gauthier M, 2015, J CLIN MICROBIOL, V53, P498, DOI 10.1128/JCM.01611-14; HAAS WH, 1993, J CLIN MICROBIOL, V31, P1293, DOI 10.1128/JCM.31.5.1293-1298.1993; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jonsson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095159; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Matsumoto T, 2013, J MICROBIOL METH, V93, P239, DOI 10.1016/j.mimet.2013.03.022; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; ProdHom G, 1997, J CLIN MICROBIOL, V35, P3331, DOI 10.1128/JCM.35.12.3331-3334.1997; Reisig F, 2005, J CLIN MICROBIOL, V43, P5622, DOI 10.1128/JCM.43.11.5622-5627.2005; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; ROSS BC, 1993, J CLIN MICROBIOL, V31, P329, DOI 10.1128/JCM.31.2.329-334.1993; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Thabet S, 2014, INT J INFECT DIS, V29, P211, DOI 10.1016/j.ijid.2014.10.004; Velji P, 2009, EMERG INFECT DIS, V15, P1609, DOI 10.3201/eid1510.090463; Walker TM, 2013, CLIN MICROBIOL INFEC, V19, P796, DOI 10.1111/1469-0691.12183; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2015, GLOB TUB REP 2015; Yang ZH, 2001, J CLIN MICROBIOL, V39, P1691, DOI 10.1128/JCM.39.5.1691-1695.2001; Yokoyama E, 2006, J MICROBIOL METH, V65, P425, DOI 10.1016/j.mimet.2005.08.014; Zheng C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/763204; Zignol M, 2016, NEW ENGL J MED, V375, P1081, DOI 10.1056/NEJMsr1512438	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197913	10.1371/journal.pone.0197913	http://dx.doi.org/10.1371/journal.pone.0197913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856789	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800051
J	Furtado, JM; Almeida, SM; Mascarenhas, P; Ferraz, ME; Ferreira, JC; Villanova, M; Monteiro, MP; Ferraz, FP				Furtado, Jose M.; Almeida, Silvia M.; Mascarenhas, Paulo; Ferraz, Maria E.; Ferreira, Jose C.; Villanova, Manuel; Monteiro, Mariana P.; Ferraz, Fernando P.			Anthropometric features as predictors of atherogenic dyslipidemia and cardiovascular risk in a large population of school-aged children	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; BODY-MASS-INDEX; TO-HEIGHT RATIO; CORONARY-HEART-DISEASE; CIRCULATING OXIDIZED LDL; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; INSULIN SENSITIVITY; CHILDHOOD OBESITY; ADOLESCENTS	Background Autopsy studies reveal that atherosclerosis lesions can be found as early as two years of age. To slow the development of this early pathology, obesity and dyslipidemia prevention should start from childhood making it urgent to explore new ways to evaluate dyslipidemia risk in children that can be applied widely, such as the non-invasive anthropometric evaluation. Objective Assess the metabolic profile of a pediatric population at a specific age to describe the association between anthropometric and biochemical cardiovascular disease risk factors; and evaluate selected anthropometric variables as potential predictors for dyslipidemic cardiovascular risk. Design and methods Anthropometric features, bioimpedance parameters and fasting clinical profile were assessed in Lisbon and the Tagus Valley region pre-pubertal nine-year-old children (n = 1.496) from 2009-2013 in a descriptive, cross-sectional study. Anthropometric variables predictive power was evaluated through regression analysis. Results At least one abnormal lipid parameter was found in 65% of "normal weight", 73% of "overweight" and 81% of "obese" children according to the International Obesity Task Force IOTF) standards. Dyslipidemia was present in 67.8% of children. Waist-hip ratio (WHR) explained 0.4% of total cholesterol (TC) variance. Waist circumference (WC) explained 2.8% of apolipoprotein (APO) A1 variance. Waist-circumference-to-height-ratio (WHtR) explained 2.7%, 2.8% and 1.9% of low-density lipoprotein cholesterol (LDL-c), APO B, and N_ HDL-c variance, respectively. Children with abnormally high WHR levels had an increase in risk of 4.49, 3.40 and 5.30 times, respectively, for developing cardiovascular disease risk factors measured as high-risk levels of TC, LDL-c and non-HDL-c (N_ HDL-c) (p<0.05). Only 29.9% of "normal weight" children had no anthropometric, bioimpedance or biochemical parameters associated with CV risk. Conclusion A large proportion of school age children have at least one lipid profile abnormality. BMI, zBMI, calf circumference (CC), hip circumference (HC), WC, and WHR are directly associated with dyslipidemia, whereas HC and calf circumference (CC) adjusted to WC, and mid-upper arm circumference (MUAC), are all inversely associated with dyslipidemia. Selected anthropometric variables are likely to help predict increased odds of having CV risk factors.	[Furtado, Jose M.; Almeida, Silvia M.; Mascarenhas, Paulo; Ferraz, Maria E.; Ferreira, Jose C.; Ferraz, Fernando P.] Ctr Genet Med & Nutr Pediat Egas Moniz, Campus Univ, Monte De Caparica, Portugal; [Furtado, Jose M.; Almeida, Silvia M.; Mascarenhas, Paulo; Ferraz, Fernando P.] Inst Univ Egas Moniz, Campus Univ, Monte De Caparica, Portugal; [Ferreira, Jose C.] Univ Med Warsaw, Dept Obstet & Gynecol, Warsaw, Poland; [Villanova, Manuel] Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; [Villanova, Manuel] Univ Porto, IBMC, Porto, Portugal; [Villanova, Manuel] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Monteiro, Mariana P.] Univ Porto, Unit Multidisciplinary Res Biomed UMIB, ICBAS, Clin & Expt Endocrinol Grp, Porto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Furtado, JM (corresponding author), Ctr Genet Med & Nutr Pediat Egas Moniz, Campus Univ, Monte De Caparica, Portugal.; Furtado, JM (corresponding author), Inst Univ Egas Moniz, Campus Univ, Monte De Caparica, Portugal.	cgmnp@egasmoniz.edu.pt	Monteiro, Mariana P./AFP-7479-2022; Ferreira, Jose Carlos P/E-3105-2016; , Paulo/ADF-8017-2022; Vilanova, Manuel/D-2127-2013	Monteiro, Mariana P./0000-0002-0662-1831; Ferreira, Jose Carlos P/0000-0003-0517-8230; , Paulo/0000-0002-6584-1199; Vilanova, Manuel/0000-0001-7007-306X; Furtado, Jose/0000-0002-7541-6305; Almeida, Silvia/0000-0001-6358-3440	Directorate General of Health - Ministry of Health; Egas Moniz Higher Education Cooperative [27-2008]; Rui Nabeiro (Nabeiro Group)	Directorate General of Health - Ministry of Health; Egas Moniz Higher Education Cooperative; Rui Nabeiro (Nabeiro Group)	This work was funded by the Directorate General of Health - Ministry of Health and, in part, by Egas Moniz Higher Education Cooperative, grant number 27-2008 (Martins dos Santos). An informatics platform was funded by Rui Nabeiro (Nabeiro Group). There was no additional external funding received for this study.	Agirbasli M, 2016, CARDIOVASC THER, V34, P30, DOI 10.1111/1755-5922.12165; Almeida SM, 2016, OBES SCI PRACT, V2, P272, DOI 10.1002/osp4.51; Bacopoulou F, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0366-z; Berenson GS, 1998, AM J CARDIOL, V82, p22T; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Chu NF, 1998, INT J OBESITY, V22, P66, DOI 10.1038/sj.ijo.0800546; Clinic Mayo, 2016, LIP LIP BLOOD PLASM; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cruz ML, 2004, J CLIN ENDOCR METAB, V89, P108, DOI 10.1210/jc.2003-031188; Dai SF, 2014, J PEDIATR-US, V164, P247, DOI 10.1016/j.jpeds.2013.08.069; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Bibiloni MD, 2016, J PEDIATR GASTR NUTR, V63, P544, DOI 10.1097/MPG.0000000000001325; Flegal KM, 2011, ADV NUTR, V2, p159S, DOI 10.3945/an.111.000307; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Graves L, 2014, PEDIATR OBES, V9, P327, DOI 10.1111/j.2047-6310.2013.00192.x; Ho RC, 2002, METABOLISM, V51, P1478, DOI 10.1053/meta.2002.35577; Holvoet P, 2007, ATHEROSCLEROSIS, V194, P245, DOI 10.1016/j.atherosclerosis.2006.08.002; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Islam S, 1999, ARCH PEDIAT ADOL MED, V153, P57; Kahn HS, 2014, J OBES, V2014, DOI 10.1155/2014/421658; Katz EG, 2011, METAB SYNDR RELAT D, V9, P55, DOI 10.1089/met.2010.0045; Kelly AS, 2010, PEDIATR DIABETES, V11, P552, DOI 10.1111/j.1399-5448.2009.00640.x; Korsten-Reck U, 2008, VASC HEALTH RISK MAN, V4, P1089; Kumar Soumitra, 2003, J Indian Med Assoc, V101, P403; Kwiterovich PO, 2008, J CLIN ENDOCR METAB, V93, P4200, DOI 10.1210/jc.2008-1270; Lee JM, 2009, PEDIATR DIABETES, V10, P336, DOI 10.1111/j.1399-5448.2008.00474.x; Mason C, 2008, OBESITY, V16, P2690, DOI 10.1038/oby.2008.438; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; McCrindle BW, 2006, THROMB RES, V118, P49, DOI 10.1016/j.thromres.2005.01.006; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; NEWMAN WP, 1991, ANN NY ACAD SCI, V623, P16, DOI 10.1111/j.1749-6632.1991.tb43715.x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Njajou OT, 2009, DIABETES-METAB RES, V25, P733, DOI 10.1002/dmrr.1011; Norris AL, 2011, OBESITY, V19, P1415, DOI 10.1038/oby.2011.21; Okosun IS, 1999, INT J OBESITY, V23, P498, DOI 10.1038/sj.ijo.0800849; Rocha PM, 2008, METABOLISM, V57, P1315, DOI 10.1016/j.metabol.2008.01.003; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Seidell JC, 2001, AM J CLIN NUTR, V74, P315; Soghier L, 2014, REFERENCE RANGE VALU, p1 ; Stefanaki C, 2016, EUR J CLIN INVEST, V46, P767, DOI 10.1111/eci.12659; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Van Guilder GP, 2006, OBESITY, V14, P2127, DOI 10.1038/oby.2006.248; Weinbrenner T, 2006, AM J CLIN NUTR, V83, P30; Wilkins E, 2017, EUROPEAN CARDIOVASCU; Wu TY, 2006, J AM COLL CARDIOL, V48, P973, DOI 10.1016/j.jacc.2006.03.057; Yan WL, 2006, DIABETES CARE, V29, P2760, DOI 10.2337/dc06-1546; Zhu YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149392	54	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197922	10.1371/journal.pone.0197922	http://dx.doi.org/10.1371/journal.pone.0197922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856786	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800052
J	Goldfine, H				Goldfine, Howard			Cytochrome c takes on plasmalogen catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							IMPAIRMENT; LEVEL	Plasmalogensphospholipids containing a characteristic vinyl ether groupare precursors of lipids important for cellular signaling such as arachidonic acid. Plasmalogen catabolism involves cleavage of the vinyl ether bond, but the identity of the corresponding enzyme that cleaves the sn-1 vinyl ether bond was unknown. New research shows that cytochrome c, with some help from another lipid, catalyzes the oxidative cleavage of this bond. This discovery, and the subsequent mechanistic dissection, provides exciting new directions for lipid signaling research.	[Goldfine, Howard] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Goldfine, H (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	goldfinh@pennmedicine.upenn.edu	Goldfine, Howard/AAB-8097-2020					CADENAS E, 1980, BIOCHEM J, V187, P131, DOI 10.1042/bj1870131; Fujino T, 2017, EBIOMEDICINE, V17, P199, DOI 10.1016/j.ebiom.2017.02.012; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629; McLeod R.S., 2016, BIOCH LIPIDS LIPOPRO, V6, P259; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]; Weisser M, 1997, CHEM PHYS LIPIDS, V90, P135, DOI 10.1016/S0009-3084(97)00089-3; Yamashita S, 2017, LIPIDS, V52, P575, DOI 10.1007/s11745-017-4260-3; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	9	1	1	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8710	8711		10.1074/jbc.H118.003072	http://dx.doi.org/10.1074/jbc.H118.003072			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29858391	Green Published, hybrid			2022-12-26	WOS:000434205700032
J	Grandhi, R; Peitz, GW; Foley, LM; Bonfield, CM; Fellows-Mayle, W; Hitchens, TK; Mooney, MP				Grandhi, Ramesh; Peitz, Geoffrey W.; Foley, Lesley M.; Bonfield, Christopher M.; Fellows-Mayle, Wendy; Hitchens, T. Kevin; Mooney, Mark P.			The influence of suturectomy on age-related changes in cerebral blood flow in rabbits with familial bicoronal suture craniosynostosis: A quantitative analysis	PLOS ONE			English	Article							SPIN-LABELED MRI; INTRACRANIAL-PRESSURE; SINGLE-SUTURE; CRANIOFACIAL GROWTH; COMPLEX CRANIOSYNOSTOSIS; CHILDREN; SYNOSTOSIS; PERFUSION; BRAIN; VOLUME	Background Coronal suture synostosis is a condition which can have deleterious physical and cognitive sequelae in humans if not corrected. A well-established animal model has previously demonstrated disruptions in intracranial pressure and developmental abnormalities in rabbits with congenital craniosynostosis compared to wild type rabbits. Objective The current study aimed to measure the cerebral blood flow (CBF) in developing rabbits with craniosynostosis who underwent suturectomy compared to those with no intervention and compared to wild type rabbits. Methods Rabbits with early onset coronal suture synostosis were assigned to have suturectomy at 10 days of age (EOCS-SU, n = 15) or no intervention (EOCS, n = 18). A subset of each group was randomly selected for measurement at 10 days of age, 25 days of age, and 42 days of age. Wild type rabbits (WT, n = 18) were also randomly assigned to measurement at each time point as controls. Cerebral blood flow at the bilateral hemispheres, cortices, thalami, and superficial cortices was measured in each group using arterial spin-labeling MRI. Results At 25 days of age, CBF at the superficial cortex was significantly higher in EOCS rabbits (192.6 +/- 10.1 mL/100 mg/min on the left and 195 +/- 9.5 mL/100 mg/min on the right) compared to WT rabbits (99.2 +/- 29.1 mL/100 mg/min on the left and 96.2 +/- 21.4 mL/100 mg/min on the right), but there was no significant difference in CBF between EOCS-SU (97.6 +/- 11.3 mL/100 mg/min on the left and 99 +/- 7.4 mL/100 mg/min on the right) and WT rabbits. By 42 days of age the CBF in EOCS rabbits was not significantly different than that of WT rabbits. Conclusion Suturectomy eliminated the abnormally increased CBF at the superficial cortex seen in EOCS rabbits at 25 days of age. This finding contributes to the evidence that suturectomy limits abnormalities of ICP and CBF associated with craniosynostosis.	[Grandhi, Ramesh; Peitz, Geoffrey W.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Foley, Lesley M.; Hitchens, T. Kevin] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Foley, Lesley M.; Hitchens, T. Kevin] Univ Pittsburgh, High Field Anim Imaging Ctr, Pittsburgh, PA USA; [Bonfield, Christopher M.] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA; [Fellows-Mayle, Wendy] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Mooney, Mark P.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA USA; [Mooney, Mark P.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Mooney, Mark P.] Univ Pittsburgh, Deparment Plast Surg, Pittsburgh, PA USA; [Mooney, Mark P.] Univ Pittsburgh, Deparment Orthodont, Pittsburgh, PA USA; [Mooney, Mark P.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA	University of Texas System; University of Texas Health San Antonio; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Grandhi, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA.	grandhi@uthscsa.edu			Walter L. Copeland Fund of The Pittsburgh Foundation; Posvar Hall Animal Care Facility, Department of Anthropology, University of Pittsburgh	Walter L. Copeland Fund of The Pittsburgh Foundation; Posvar Hall Animal Care Facility, Department of Anthropology, University of Pittsburgh	This work was funded by Walter L. Copeland Fund of The Pittsburgh Foundation (URL: pittsburghfoundation.org) and the Posvar Hall Animal Care Facility, Department of Anthropology, University of Pittsburgh (URL: www.anthropology.pitt.edu) to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Otibi M, 2007, J NEUROSURG, V107, P508, DOI 10.3171/PED-07/12/508; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; AUER LM, 1987, ACTA NEUROCHIR, V84, P124, DOI 10.1007/BF01418837; Beiner JM, 1997, COMP BIOCHEM PHYS A, V116, P245, DOI 10.1016/S0300-9629(96)00206-X; Bondar RL, 1995, CAN AERONAUTICS SPAC, V45, P3; Bonfield CM, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.2.FOCUS14849; CohenJr MM, 2000, CRANIOSYNOSTOSIS DIA, P95; Cooper GM, 1999, CLEFT PALATE-CRAN J, V36, P314, DOI 10.1597/1545-1569(1999)036<0314:BGRICR>2.3.CO;2; Cooper GM, 2006, PLAST RECONSTR SURG, V117, P1886, DOI 10.1097/01.prs.0000218845.70591.7e; David LR, 1996, J CRANIOFAC SURG, V7, P177, DOI 10.1097/00001665-199605000-00003; David LR, 1999, J CRANIOFAC SURG, V10, P38, DOI 10.1097/00001665-199901000-00008; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Enlow D.H., 1990, HDB FACIAL GROWTH; Fellows-Mayle WK, 2004, PLAST RECONSTR SURG, V113, P557, DOI 10.1097/01.PRS.0000101056.33534.F0; Fellows-Mayle WK, 2000, CLEFT PALATE-CRAN J, V37, P370, DOI 10.1597/1545-1569(2000)037<0370:ARCIIP>2.3.CO;2; Foley L, 2009, CHILD NERV SYST, V25, P861, DOI 10.1007/s00381-009-0812-z; Foley LM, 2005, MAGN RESON MED, V54, P798, DOI 10.1002/mrm.20621; GAULT DT, 1992, PLAST RECONSTR SURG, V90, P377, DOI 10.1097/00006534-199209000-00003; Gilbert J, 2016, CLEFT PALATE-CRAN J, V53, P210, DOI 10.1597/14-298; Gosain AK, 1996, PLAST RECONSTR SURG, V97, P292, DOI 10.1097/00006534-199602000-00004; HAREL S, 1972, BIOL NEONATE, V21, P381; Hayward R, 2016, J NEUROSURG-PEDIATR, V18, P242, DOI 10.3171/2015.6.PEDS15144; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Kapp-Simon KA, 2005, CLEFT PALATE-CRAN J, V42, P377, DOI 10.1597/04-044.1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Littleton-Kearney MT, 2000, AM J PHYSIOL-HEART C, V279, pH1208, DOI 10.1152/ajpheart.2000.279.3.H1208; Mathijssen I, 2017, J NEUROSURG-PEDIATR, V20, P498, DOI 10.3171/2017.3.PEDS17118; Miller J D, 1972, Prog Brain Res, V35, P411; Mitchell RL, 2003, CLEFT PALATE-CRAN J, V40, P486, DOI 10.1597/1545-1569(2003)040<0486:ENBICR>2.0.CO;2; Mooney MP, 2012, 9TH EUROPEAN CRANIOFACIAL CONGRESS, P9; Mooney MP, 2007, J CRANIOFAC SURG, V18, P336, DOI 10.1097/scs.0b013e3180336047; Mooney MP, 2004, EXPERT OPIN BIOL TH, V4, P279, DOI 10.1517/14712598.4.3.279; Mooney MP, 1998, CHILD NERV SYST, V14, P247, DOI 10.1007/s003810050220; Mooney MP, 1999, J CRANIOFAC SURG, V10, P104, DOI 10.1097/00001665-199903000-00003; MOONEY MP, 1994, CLEFT PALATE-CRAN J, V31, P8, DOI 10.1597/1545-1569(1994)031<0008:DOASOR>2.3.CO;2; Mooney MP, 1996, CLEFT PALATE-CRAN J, V33, P369, DOI 10.1597/1545-1569(1996)033<0369:CSPASP>2.3.CO;2; Mooney MP, 2002, UNDERSTANDING CRANIO, P209; Mursch K, 1999, CHILD NERV SYST, V15, P110, DOI 10.1007/s003810050344; NEHLIG A, 1989, J CEREBR BLOOD F MET, V9, P579, DOI 10.1038/jcbfm.1989.83; Panchal J, 2001, PLAST RECONSTR SURG, V108, P1492, DOI 10.1097/00006534-200111000-00007; Pennings FA, 2004, STROKE, V35, P1284, DOI 10.1161/01.STR.0000126039.91400.cb; Putz D A, 2002, Orthod Craniofac Res, V5, P90, DOI 10.1034/j.1600-0544.2002.01178.x; Renier D, 2000, CHILD NERV SYST, V16, P645, DOI 10.1007/s003810000320; Roatta S, 2000, EXP PHYSIOL, V85, P431, DOI 10.1017/S0958067000020388; Rollins N, 2000, PEDIATR NEUROSURG, V32, P308, DOI 10.1159/000028959; SAINTEROSE C, 1984, J NEUROSURG, V60, P727, DOI 10.3171/jns.1984.60.4.0727; SATOH M, 1990, Kaku Igaku, V27, P1411; SEN A, 1995, J NUCL MED, V36, P394; Shek JW., 1985, ATLAS RABBIT BRAIN S; Slater BJ, 2008, PLAST RECONSTR SURG, V121, p170E, DOI 10.1097/01.prs.0000304441.99483.97; Tamburrini G, 2005, CHILD NERV SYST, V21, P913, DOI 10.1007/s00381-004-1117-x; TUOR UI, 1991, PEDIATR RES, V29, P517, DOI 10.1203/00006450-199105010-00020; Zhang F, 2003, NEURORADIOLOGY, V45, P773, DOI 10.1007/s00234-003-1001-5; ZHANG WG, 1995, MAGNET RESON MED, V33, P370, DOI 10.1002/mrm.1910330310; ZHANG WG, 1993, MAGNET RESON MED, V29, P416, DOI 10.1002/mrm.1910290323	56	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197296	10.1371/journal.pone.0197296	http://dx.doi.org/10.1371/journal.pone.0197296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856748	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800017
J	Ituarte, S; Brola, TR; Fernandez, PE; Mu, HW; Qiu, JW; Heras, H; Dreon, MS				Ituarte, Santiago; Romina Brola, Tabata; Elena Fernandez, Patricia; Mu, Huawei; Qiu, Jian-Wen; Heras, Horacio; Sebastian Dreon, Marcos			A lectin of a non-invasive apple snail as an egg defense against predation alters the rat gut morphophysiology	PLOS ONE			English	Article							CARBOHYDRATE-BINDING; PERIVITELLINE FLUID; MOLLUSCA; PROTEIN; METABOLISM; SURFACE; PLANTS	The eggs of the freshwater Pomacea apple snails develop above the water level, exposed to varied physical and biological stressors. Their high hatching success seems to be linked to their proteins or perivitellins, which surround the developing embryo providing nutrients, sunscreens and varied defenses. The defensive mechanism has been unveiled in P. canaliculata and P. maculata eggs, where their major perivitellins are pigmented, non-digestible and provide a warning coloration while another perivitellin acts as a toxin. In P. scalaris, a species sympatric to the former, the defense strategy seems different, since no toxin was found and the major perivitellin, PsSC, while also colored and non-digestible, is a carbohydrate-binding protein. In this study we examine the structure and function of PsSC by sequencing its subunits, characterizing its carbohydrate binding profile and evaluating its effect on gut cells. Whereas cDNA sequencing and database search showed no lectin domain, glycan array carbohydrate binding profile revealed a strong specificity for glycosphingolipids and ABO group antigens. Moreover, PsSC agglutinated bacteria in a dose-dependent manner. Inspired on the defensive properties of seed lectins we evaluated the effects of PsSC on intestinal cells both in vitro (Caco-2 and IEC-6 cells) and in the gastrointestinal tract of rats. PsSC binds to Caco-2 cell membranes without reducing its viability, while a PsSC-containing diet temporarily induces large epithelium alterations and an increased absorptive surface. Based on these results, we propose that PsSC is involved in embryo defenses by altering the gut morphophysiology of potential predators, a convergent role to plant defensive lectins.	[Ituarte, Santiago; Romina Brola, Tabata; Heras, Horacio; Sebastian Dreon, Marcos] UNLP, CONICET, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina; [Elena Fernandez, Patricia] UNLP, Fac Ciencias Vet, Inst Patol B Epstein, Catedra Patol Gen Vet, La Plata, Buenos Aires, Argentina; [Mu, Huawei; Qiu, Jian-Wen] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Heras, Horacio] UNLP, Fac Ciencias Nat & Museo, Catedra Quim Biol, La Plata, Buenos Aires, Argentina; [Sebastian Dreon, Marcos] UNLP, Catedra Bioquim & Biol Mol, Fac Ciencias Med, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Hong Kong Baptist University; National University of La Plata; Museo La Plata; National University of La Plata	Dreon, MS (corresponding author), UNLP, CONICET, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	msdreon@gmail.com	; Heras, Horacio/R-9555-2018	Ituarte, Santiago/0000-0002-3670-2843; Heras, Horacio/0000-0003-3379-0216	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-0850, PICT 2015-0661]; Subsidio Institucional para Investigadores CIC [48/16]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Subsidio Institucional para Investigadores CIC	Financial support for this work is as follows: HH: Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2014-0850, http://www.agencia.mincyt.gob.ar/upload/Res.270-15-PICT-2014-Temas-abiertos-Tipo-A.pdf; MSD: Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2015-0661, http://www.agencia.mincyt.gob.ar/upload/PICT%202015%20TEMAS%20ABIERTOS%20TIPO%20D.pdf; MSD: Subsidio Institucional para Investigadores CIC (Resolucion No 48/16), http://www.cic.gba.gob.ar/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpuche J, 2010, COMP BIOCHEM PHYS B, V156, P1, DOI 10.1016/j.cbpb.2010.01.006; [Anonymous], 1996, GUIDE CARE USE LAB A; Arndt NX, 2011, J CELL BIOCHEM, V112, P2230, DOI 10.1002/jcb.23139; BARDOCZ S, 1995, GUT, V37, P353, DOI 10.1136/gut.37.3.353; Belogortseva NI, 1998, COMP BIOCHEM PHYS C, V119, P45, DOI 10.1016/S0742-8413(97)00180-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadierno MP, 2017, MALACOLOGIA; Chikalovets IV, 2016, FISH SHELLFISH IMMUN, V50, P27, DOI 10.1016/j.fsi.2016.01.020; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dreon MS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002961; Dreon MS, 2004, ARCH BIOCHEM BIOPHYS, V422, P1, DOI 10.1016/j.abb.2003.11.018; Dreon MS, 2010, PLOS ONE, P5, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Fujii Y, 2012, J BIOL CHEM, V447, P287; Gabor F, 1998, J CONTROL RELEASE, V55, P131, DOI 10.1016/S0168-3659(98)00043-1; Garin CF, 1996, J EXP ZOOL, V276, P307, DOI 10.1002/(SICI)1097-010X(19961201)276:5&lt;307::AID-JEZ1&gt;3.0.CO;2-S; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giglio ML, 2016, EGGS APPLE SNAIL POM, V785, P777; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2015, MALACOLOGIA, V58, P245, DOI 10.4002/040.058.0209; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Heras H, 1998, J EXP ZOOL, V280, P375, DOI 10.1002/(SICI)1097-010X(19980415)280:6<375::AID-JEZ1>3.3.CO;2-V; Heras H, 2008, TOXICON, V52, P481, DOI 10.1016/j.toxicon.2008.06.022; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ip JC, 2017, GIGASCIENCE UNPUB; Ituarte S, 2008, MOL REPROD DEV, V75, P1441, DOI 10.1002/mrd.20880; Ituarte S, 2010, COMP BIOCHEM PHYS B, V157, P66, DOI 10.1016/j.cbpb.2010.05.004; Ituarte S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050115; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kisielinski K, 2002, CLIN EXP MED, V2, P131, DOI 10.1007/s102380200018; Kovalchuk SN, 2013, FISH SHELLFISH IMMUN, V35, P1320, DOI 10.1016/j.fsi.2013.07.011; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000520; Malham SK, 2002, AQUAT LIVING RESOUR, V15, P187, DOI 10.1016/S0990-7440(02)01173-7; Martin Pablo R., 2002, INTERPOPULATION VARI, V4, P153; Oliveira JTA, 2004, FOOD CHEM TOXICOL, V42, P1737, DOI 10.1016/j.fct.2004.06.018; Pasquevich MY, 2014, COMP BIOCHEM PHYS B, V169, P63, DOI 10.1016/j.cbpb.2013.11.008; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Raven CP, 1972, CHEM ZOOL, P155; Ripoll C, 2003, PLANT SCI, V164, P517, DOI 10.1016/S0168-9452(02)00448-X; Dreon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063782; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Sun J, 2012, J PROTEOME RES, V11, P4240, DOI 10.1021/pr3003613; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vasta GR, 2007, ADV EXP MED BIOL, V598, P389; Pasquevich MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16185-9; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198361	10.1371/journal.pone.0198361	http://dx.doi.org/10.1371/journal.pone.0198361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856808	gold, Green Submitted, Green Published			2022-12-26	WOS:000433900800109
J	Kasica-Jarosz, N; Podlasz, P; Kaleczyc, J				Kasica-Jarosz, Natalia; Podlasz, Piotr; Kaleczyc, Jerzy			Pituitary adenylate cyclase-activating polypeptide (PACAP-38) plays an inhibitory role against inflammation induced by chemical damage to zebrafish hair cells	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; OXIDATIVE STRESS; LATERAL-LINE; GENE-EXPRESSION; INNER-EAR; IN-VITRO; TRANSCRIPTION FACTOR-3; MACROPHAGE FUNCTIONS; MULTIPLE-MYELOMA; DANIO-RERIO	Pituitary adenylate cyclase-activating polypeptide (PACAP-38) is a common neuropeptide exerting a wide spectrum of functions in many fields, including immunology. In the present study, 5-day post-fertilization (dpf) zebrafish larvae of three diverse genetic lines [transgenic lines Tg(MPX:GFP) with GFP-labelled neutrophils and Tg(pou4f3:GAP-GFP) with GFP-labelled hair cells and the wild-type Tuebingen] were used to investigate an inhibitory role of PACAP-38 in inflammation associated with damaged hair cells of the lateral line. Individuals of each genetic line were assigned to four groups: (1) control, and those consisting of larvae exposed to (2) 10 mu M CuSO4, (3) 10 mu M CuSO4+100 nM PACAP-38 and (4) 100 nM PACAP-38, respectively. Forty-minute exposure to CuSO4 solution was applied to evoke necrosis of hair cells and consequent inflammation. The inhibitory role of PACAP-38 was investigated in vivo under a confocal microscope by counting neutrophils migrating towards damaged hair cells in Tg(MPX: GFP) larvae. In CuSO4-treated individuals, the number of neutrophils associated with hair cells was dramatically increased, while PACAP-38 co-treatment resulted in its over 2-fold decrease. However, co-treatment with PACAP-38 did not prevent hair cells from extensive necrosis, which was found in Tg(pou4f3: GAP-GFP) individuals. Real-Time PCR analysis performed in wild-type larvae demonstrated differential expression pattern of stress and inflammation inducible markers. The most significant findings showed that CuSO4 exposure up-regulated the expression of IL-8, IL-1 ss, IL-6 and ATF3, while after PACAP-38 co-treatment expression levels of these genes were significantly decreased. The presence of transcripts for all PACAP receptors in neutrophils was also revealed. Adcyap1r1a and vipr1b appeared to be predominant forms. The present results suggest that PACAP-38 should be considered as a factor playing an important regulatory role in inflammatory response associated with pathological processes affecting zebrafish hair cells and it cannot be excluded that this interesting property has more universal significance.	[Kasica-Jarosz, Natalia; Kaleczyc, Jerzy] Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland; [Podlasz, Piotr] Univ Warmia & Mazury, Dept Pathophysiol Forens Vet & Adm, Fac Vet Med, Olsztyn, Poland	University of Warmia & Mazury; University of Warmia & Mazury	Kasica-Jarosz, N (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland.; Podlasz, P (corresponding author), Univ Warmia & Mazury, Dept Pathophysiol Forens Vet & Adm, Fac Vet Med, Olsztyn, Poland.	natalia_kasica@wp.pl; piotr.podlasz@uwm.edu.pl			KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food" [05-1/KNOW2/2015]	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"	Publication is supported by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015.	Abad C, 2006, CURR TOP MED CHEM, V6, P151, DOI 10.2174/156802606775270288; Ago Y, 2016, PACAP MODULATION CNS, P651; Arimura A, 2006, BLOOD, V107, P661, DOI 10.1182/blood-2005-03-1186; Arimura A, 2006, ANN NY ACAD SCI, V1070, P1, DOI 10.1196/annals.1317.093; Bik W, 2006, J NEUROIMMUNOL, V177, P76, DOI 10.1016/j.jneuroim.2006.04.013; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Bols NC, 2001, DEV COMP IMMUNOL, V25, P853, DOI 10.1016/S0145-305X(01)00040-4; Botz B, 2014, ARTHRITIS RHEUMATOL, V66, P2739, DOI 10.1002/art.38772; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; Dejda A, 2011, PEPTIDES, V32, P1207, DOI 10.1016/j.peptides.2011.04.003; Delgado M, 1999, J IMMUNOL, V162, P1707; Delgado M, 2003, ANN NY ACAD SCI, V992, P141, DOI 10.1111/j.1749-6632.2003.tb03145.x; Delgado M, 1996, PEPTIDES, V17, P1097, DOI 10.1016/S0196-9781(96)00171-4; DELGADO M, 1995, J NEUROIMMUNOL, V62, P137, DOI 10.1016/0165-5728(95)00105-6; Elekes K, 2011, PEPTIDES, V32, P1439, DOI 10.1016/j.peptides.2011.05.008; Elsaeidi F, 2014, J NEUROSCI, V34, P2632, DOI 10.1523/JNEUROSCI.3898-13.2014; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Garrido E, 1996, NEUROPEPTIDES, V30, P583, DOI 10.1016/S0143-4179(96)90042-6; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; GOTTSCHALL PE, 1994, BRAIN RES, V637, P197, DOI 10.1016/0006-8993(94)91233-5; Hannibal J, 1999, NEUROENDOCRINOLOGY, V70, P73, DOI 10.1159/000054461; Harmar AJ, 2004, ENDOCRINOLOGY, V145, P1203, DOI 10.1210/en.2003-1058; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hartig EI, 2016, BIOL OPEN, V5, P1134, DOI 10.1242/bio.020065; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hashimoto S, 2005, AUDIOL NEURO-OTOL, V10, P35, DOI 10.1159/000082306; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Horvath G, 2010, NEUROSCI LETT, V484, P148, DOI 10.1016/j.neulet.2010.08.039; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; ICHINOSE M, 1995, IMMUNOPHARMACOLOGY, V30, P217, DOI 10.1016/0162-3109(95)00025-O; Ji HF, 2013, HEPATOLOGY, V57, P1225, DOI 10.1002/hep.25802; Jiang LJ, 2014, P NATL ACAD SCI USA, V111, pE1383, DOI 10.1073/pnas.1402898111; Johan Kinhulta, 2001, PEPTIDES, V22, P2151; Jozsa R, 2005, PEPTIDES, V26, P2344, DOI 10.1016/j.peptides.2005.03.054; Kasica N, 2016, NEUROTOX RES, V30, P633, DOI 10.1007/s12640-016-9659-8; Kim Y, 2006, J IMMUNOL, V176, P2969, DOI 10.4049/jimmunol.176.5.2969; Kinhult J, 2002, PEPTIDES, V23, P1735, DOI 10.1016/S0196-9781(02)00149-3; Leceta J, 2000, ANN NY ACAD SCI, V921, P92; Li M, 2008, REGUL PEPTIDES, V145, P24, DOI 10.1016/j.regpep.2007.09.012; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lugo JM, 2010, FISH SHELLFISH IMMUN, V29, P513, DOI 10.1016/j.fsi.2010.05.004; Lush ME, 2014, DEV DYNAM, V243, P1187, DOI [10.1002/DVDY.24167, 10.1002/dvdy.24167]; Manecka DL, 2014, FEBS LETT, V588, P3008, DOI 10.1016/j.febslet.2014.06.009; Martinez C, 2005, J LEUKOCYTE BIOL, V77, P729, DOI 10.1189/jlb.0704432; MCCABE BF, 1989, AM J OTOL, V10, P196; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Michalski CW, 2008, AM J PHYSIOL-GASTR L, V294, pG50, DOI 10.1152/ajpgi.00058.2007; Monroe JD, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00131; Nowik N, 2015, POL J VET SCI, V18, P663, DOI 10.1515/pjvs-2015-0086; Ohtaki H, 2010, J MOL NEUROSCI, V42, P397, DOI 10.1007/s12031-010-9350-0; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Pirger Z, 2008, J MOL NEUROSCI, V36, P105, DOI 10.1007/s12031-008-9070-x; Podlasz P, 2012, J COMP NEUROL, V520, P3846, DOI 10.1002/cne.23131; Racz B, 2007, NEUROTOX RES, V12, P95, DOI 10.1007/BF03033918; Racz B, 2010, REGUL PEPTIDES, V160, P91, DOI 10.1016/j.regpep.2009.12.003; Satoh H, 2003, JARO, V4, P139, DOI 10.1007/s10162-002-3025-7; Tavares B, ACTA MED PORT, V26, P583; Varela M, 2012, DEV COMP IMMUNOL, V37, P97, DOI 10.1016/j.dci.2011.11.004; Vaudry D, 2005, PEPTIDES, V26, P2518, DOI 10.1016/j.peptides.2005.05.015; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; WANG ZY, 1995, NEUROSCIENCE, V69, P297, DOI 10.1016/0306-4522(95)00258-K; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Woods KV, 1998, CANCER RES, V58, P3142; Yang SX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1740-9; Yang SF, 2006, J PHARMACOL EXP THER, V319, P595, DOI 10.1124/jpet.106.102236; Yang Y, 2015, MAT TESTING TECHNOLO, P2, DOI [10.1186/s40779-014-0027-9, DOI 10.1186/S40779-014-0027-9]; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P10388, DOI 10.1073/pnas.1205210109; Zhang XY, 2005, CURR EYE RES, V30, P1105, DOI 10.1080/02713680500421444; Zuniga-Traslavina C, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6530531	75	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198180	10.1371/journal.pone.0198180	http://dx.doi.org/10.1371/journal.pone.0198180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856797	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800078
J	Olnes, J; Kielland, K; Genet, H; Juday, GP; Ruess, RW				Olnes, Justin; Kielland, Knut; Genet, Helene; Juday, Glenn P.; Ruess, Roger W.			Functional responses of white spruce to snowshoe hare herbivory at the treeline	PLOS ONE			English	Article							ALASKA; GROWTH; FLOODPLAIN; SUCCESSION; LANDSCAPE; MOOSE	Herbivores can modify the rate of shrub and treeline advance. Both direct and indirect effects of herbivory may simultaneously interact to affect the growth rates of plants at this ecotone. We investigated the effect of snowshoe hare herbivory on the height of white spruce at two treeline locations in Alaska, USA. White spruce is expanding its distribution both upwards in elevation and northward in latitude because of climate warming, and snowshoe hares are already present in areas likely to be colonized by spruce. We hypothesized that herbivory would result in browsed individuals having reduced height, suggesting herbivory is a direct, negative effect on spruce treeline advance. We found an interactive effect between browsing history and spruce age. When young (under 30 years old), individuals that were browsed tended to be taller than unbrowsed individuals. However, older seedlings (over 30 years old) that had been browsed were shorter than unbrowsed individuals of the same age. Hares suppress faster growing individuals that are initially taller by preferentially browsing them as they emerge above the winter snowpack. This reduced height, in combination with increased mortality associated with browsing, is predicted to slow the advance of both latitudinal and altitudinal treeline expansions and alter the structure of treeline forests.	[Olnes, Justin; Kielland, Knut; Ruess, Roger W.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Kielland, Knut; Genet, Helene; Ruess, Roger W.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Juday, Glenn P.] Univ Alaska Fairbanks, Sch Nat Resources & Agr Sci, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Olnes, J (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA.	jrolnes@alaska.edu			Bonanza Creek Long Term Ecological Research program - NSF [DEB-1026415]; Bonanza Creek Long Term Ecological Research program - USDA Forest Service Pacific Northwest Research Station [PNW01-JV11261952-231]; Alaska Geographic 2015 Research Fellowship	Bonanza Creek Long Term Ecological Research program - NSF; Bonanza Creek Long Term Ecological Research program - USDA Forest Service Pacific Northwest Research Station; Alaska Geographic 2015 Research Fellowship	This research was supported in part by the Bonanza Creek Long Term Ecological Research program funded jointly by NSF (DEB-1026415) and USDA Forest Service Pacific Northwest Research Station (PNW01-JV11261952-231) to KK and an Alaska Geographic 2015 Research Fellowship to JO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BNZ-LTER: http:// www.iter.uaf.edu/. Alaska Geographic: http://akgeo.org/.	Angell AC, 2009, FOREST ECOL MANAG, V258, P2475, DOI 10.1016/j.foreco.2009.08.030; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; BRYANT JP, 1987, ECOLOGY, V68, P1319, DOI 10.2307/1939216; Butler LG, 2008, J ECOL, V96, P136, DOI 10.1111/j.1365-2745.2007.01318.x; Cairns DM, 2004, J ECOL, V92, P1019, DOI 10.1111/j.1365-2745.2004.00945.x; Chapin FS, 2016, ECOLOGY, V97, P2986, DOI 10.1002/ecy.1529; Christie KS, 2015, BIOSCIENCE, V65, P1123, DOI 10.1093/biosci/biv137; DAVIDSON DW, 1993, OIKOS, V68, P23, DOI 10.2307/3545305; Grissino-Mayer HD, 2003, TREE-RING RES, V59, P63; Herrero A, 2016, J ECOL, V104, P430, DOI 10.1111/1365-2745.12527; Juday GP, 2015, FOREST ECOL MANAG, V350, P46, DOI 10.1016/j.foreco.2015.04.016; Krebs CJ, 2013, CAN J ZOOL, V91, P562, DOI 10.1139/cjz-2013-0012; Mathisen KM, 2017, BMC ECOL, V17, DOI 10.1186/s12898-017-0122-3; Mathisen Karen Marie, 2015, Alces, V51, P123; Miller AE, 2017, GLOBAL CHANGE BIOL, V23, P5509, DOI 10.1111/gcb.13814; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nicklen EF, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1507; Olnes J, 2017, ECOLOGY, V98, P2506, DOI 10.1002/ecy.1968; Olnes J, 2017, FOREST ECOL MANAG, V384, P83, DOI 10.1016/j.foreco.2016.10.039; Olnes J, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1475; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Roland CA, 2013, ECOL MONOGR, V83, P19, DOI 10.1890/11-2136.1; Sharam GJ, 2009, ECOSCIENCE, V16, P258, DOI 10.2980/16-2-3256; SMITH JNM, 1988, J ANIM ECOL, V57, P269, DOI 10.2307/4778; Tape KD, 2016, GLOBAL CHANGE BIOL, V22, P208, DOI 10.1111/gcb.13058; TELFER ES, 1974, J WILDLIFE MANAGE, V38, P944, DOI 10.2307/3800074; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Wolff JO, 1970, J WILDLIFE MANAGE, V42, P148	28	3	3	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198453	10.1371/journal.pone.0198453	http://dx.doi.org/10.1371/journal.pone.0198453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856842	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800127
J	Park, SJ; Park, YS; Jung, IS; Yoon, H; Shin, CM; Ahn, SH; Park, DJ; Kim, HH; Kim, N; Lee, DH				Park, Sung Jae; Park, Young Soo; Jung, In Sub; Yoon, Hyuk; Shin, Cheol Min; Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung Ho; Kim, Nayoung; Lee, Dong Ho			Is endoscopic surveillance necessary for patients who undergo total gastrectomy for gastric cancer?	PLOS ONE			English	Article							FOLLOW-UP; REMNANT CANCER; SURGERY; RECURRENCE; MULTICENTER; CARCINOMA; SURVIVAL; STOMACH	There have been only a few reports investigating the clinical efficacy of follow-up endoscopy for detection of recurrent gastric cancer after total gastrectomy (TG). We reviewed the records of 747 patients undergoing TG from 2003 to 2012 and enrolled 267 patients (70 with early gastric cancer (EGC) and 197 with advanced gastric cancer (AGC)), who received one or more follow-up endoscopy and contrast abdominal computed tomography (CT) scan. We found no tumor recurrence in the 70 EGC patients during the mean follow-up periods of 42.1 +/- 18 and 43.2 +/- 19 months by endoscopy and contrast abdominal CT scan. In 197 AGC patients, 59 patients (29.8%) had confirmed tumor recurrence during mean follow-up periods of 40.5 +/- 21 and 45.3 +/- 22 months. The most common pattern of tumor recurrence was distant metastasis (n = 35) followed by peritoneal metastasis (n = 11). Among the other 13 cases with loco-regional recurrence, seven cases were regional lymph node metastases, four were anastomosis site recurrences, and two were duodenal stump and jejunal loop site recurrences. Three of the four cases of anastomosis site recurrence were found by both endoscopy and contrast abdominal CT scan; one case was missed by contrast abdominal CT scan. However, the two cases with duodenal stump and jejunal loop recurrences were detected by contrast abdominal CT scan only. An annual follow-up endoscopy for gastric cancer after TG might have a limited role in the detection of tumor recurrence, especially in patients with EGC. Contrast abdominal CT scan may be sufficient as a follow-up method for recurrent gastric cancer after TG.	[Park, Sung Jae; Park, Young Soo; Jung, In Sub; Yoon, Hyuk; Shin, Cheol Min; Kim, Nayoung; Lee, Dong Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam Si, South Korea; [Park, Sung Jae] Seoul Med Ctr, Dept Internal Med, Seoul, South Korea; [Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung Ho] Seoul Natl Univ, Bundang Hosp, Dept Surg, Seongnam Si, South Korea	Seoul National University (SNU); Seoul Medical Center; Seoul National University (SNU)	Park, YS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam Si, South Korea.	dkree@snubh.org	Kim, Hyung Ho/J-5451-2012; Kim, Hyung-Ho/AAG-3720-2019; Yoon, Hyuk/AAT-4978-2020	Kim, Hyung-Ho/0000-0002-8916-0048; Yoon, Hyuk/0000-0002-2657-0349; Shin, Cheol Min/0000-0003-2265-9845	National Research Foundation of Korea (NRF) grant for the Global Core Research Center (GCRC) - Korea government (MSIP) [2011-0030001]	National Research Foundation of Korea (NRF) grant for the Global Core Research Center (GCRC) - Korea government (MSIP)	This study was supported by the National Research Foundation of Korea (NRF) grant for the Global Core Research Center (GCRC) funded by the Korea government (MSIP) (No. 2011-0030001).	An JY, 2008, AM J SURG, V196, P587, DOI 10.1016/j.amjsurg.2007.09.040; Borie F, 2003, EUR J SURG ONCOL, V29, P511, DOI 10.1016/S0748-7983(03)00094-5; Cardoso R, 2012, GASTRIC CANCER, V15, pS164, DOI 10.1007/s10120-012-0142-9; Hosokawa O, 2002, ENDOSCOPY, V34, P469, DOI 10.1055/s-2002-32007; Jang HJ, 2014, HEPATO-GASTROENTEROL, V61, P1283, DOI 10.5754/hge12106; Kikuchi S, 2004, LANGENBECK ARCH SURG, V389, P69, DOI 10.1007/s00423-004-0462-2; Kim JH, 2006, WORLD J SURG, V30, P1870, DOI 10.1007/s00268-005-0703-8; Kodera Y, 2003, ANN SURG ONCOL, V10, P898, DOI 10.1245/ASO.2003.12.009; Kunisaki C, 2006, ANN SURG ONCOL, V13, P363, DOI 10.1245/ASO.2006.03.061; Lee SY, 2005, EJSO-EUR J SURG ONC, V31, P265, DOI 10.1016/j.ejso.2004.11.018; Management of oesophageal and gastric cancer, 2006, MAN OES GASTR CANC N; Marrelli D, 2005, ANN SURG, V241, P247, DOI 10.1097/01.sla.0000152019.14741.97; Mikami K, 2007, CHIR GASTROENTEROL, V23, P392, DOI 10.1159/000109243; Namieno T, 1998, WORLD J SURG, V22, P869, DOI 10.1007/s002689900484; NCCN, 2015, NCCN CLIN PRACTICE G; Santoro R, 2014, WORLD J GASTROENTERO, V20, P13667, DOI 10.3748/wjg.v20.i38.13667; Takeda J, 1998, HEPATO-GASTROENTEROL, V45, P1907; Tanf IT, 2007, J SURG ONCOL, V96, P503, DOI 10.1002/jso.20823; Waddell T, 2013, ANN ONCOL, V24, P57, DOI 10.1093/annonc/mdt344; Wang J, 2012, SURG ONCOL, V21, P119, DOI 10.1016/j.suronc.2010.12.004; Whiting John, 2006, Gastric Cancer, V9, P74, DOI 10.1007/s10120-006-0360-0	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0196170	10.1371/journal.pone.0196170	http://dx.doi.org/10.1371/journal.pone.0196170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856747	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800005
J	Liu, WC; Yang, MC; Wu, YY; Chen, PH; Hsu, CM; Chen, LW				Liu, Wen-Chung; Yang, Ming-Chieh; Wu, Ying-Ying; Chen, Pei-Hsuan; Hsu, Ching-Mei; Chen, Lee-Wei			Lactobacillus plantarum reverse diabetes induced Fmo3 and ICAM expression in mice through enteric dysbiosis-related c-Jun NH2-terminal kinase pathways	PLOS ONE			English	Article							NITRIC-OXIDE; DYSFUNCTION; INJURY; MOUSE; MELLITUS; MODEL; GUT	Diabetes mellitus (DM) is characterized by increased fatality associated with the atherogenetic process. Circulating trimethylamine-N-oxide (TMAO) levels are closely associated with atherosclerosis. The flavin mono-oxygenase family (Fmo) members oxidize trimethylamine (TMA) to TMAO. The effect and the regulatory mechanism of intestinal microflora on diabetes-induced Fmo3 and intercellular adhesion molecule (ICAM) expression were examined in streptozotocin-induced diabetic mice (STZDM) and Akita mice (C57BL/6J-Ins2(Akita)). STZDM-JNK1(-/-) and Ins2(Akita)-MK1(-/-) mice were produced and used to study the role of pJNK in the regulatory mechanisms. Diabetic mice exhibited decreased Lactobacilli growth and reactive oxygen species (ROS) production in the intestinal mucosa; increased levels of pJNK and iNOS proteins in the intestinal mucosa; increased levels of serum nitrate, IL-1 beta, and TNF-alpha expression in Kupffer cells; increased Fmo3 expression in the liver; and increased ICAM expression in the aorta. Reversal of diabetes-induced enteric dysbiosis by prebiotic (FOS) or probiotic (dead L. plantarum) treatment decreased diabetes-induced pJNK and iNOS expression in the intestine, Fmo3 expression in the liver, IL-1(3 expression in Kupffer cells, and ICAM expression in the aorta and liver. Ins2(Akita)-JNK1(-/-) and STZDM-JNK1(-/-) mice demonstrated decreased levels of serum NO, IL-1 beta expression in Kupffer cells, Fmo3 expression in the liver, and ICAM expression in the aorta. GF mice cohoused with DM mice demonstrated an increase in ICAM expression in the liver. In conclusion, diabetes induced the expression of both Fmo3 and ICAM expression and possible vascular impairment through enteric dysbiosis. Diabetes-induced Fmo3 and ICAM expression could be reversed by pJNK inhibition or by correcting enteric dysbiosis.	[Liu, Wen-Chung; Yang, Ming-Chieh; Wu, Ying-Ying; Chen, Pei-Hsuan; Chen, Lee-Wei] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Liu, Wen-Chung; Yang, Ming-Chieh] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsu, Ching-Mei; Chen, Lee-Wei] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Chen, Lee-Wei] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; National Sun Yat Sen University; National Yang Ming Chiao Tung University	Chen, LW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan.; Chen, LW (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.; Chen, LW (corresponding author), Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.	lwchen@vghks.gov.tw	Stefanadis, Christodoulos/ABH-2232-2020; Liu, Wen-Chung/ABG-4262-2021	Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Wen-Chung/0000-0002-5788-632X; Chen, Lee-Wei/0000-0002-3583-1248	Almond Board of California [15-POLL14]; MQRES scholarship from Macquarie University	Almond Board of California; MQRES scholarship from Macquarie University	Three authors (WGM, MJC, QSM) received funding from grant no. 15-POLL14 from the Almond Board of California:~www.almonds.com/~and by an MQRES scholarship from Macquarie University for TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alican I, 1996, AM J PHYSIOL-GASTR L, V270, pG225, DOI 10.1152/ajpgi.1996.270.2.G225; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chen LW, 2006, CRIT CARE MED, V34, P142, DOI 10.1097/01.CCM.0000190621.48720.8C; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Esparza A, 2015, AM J PHYSIOL-CELL PH, V309, pC558, DOI 10.1152/ajpcell.00412.2014; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hunninghake GW, 2010, AM J RESP CRIT CARE, V182, P517, DOI 10.1164/rccm.200911-1757OC; Kampoli AM, 2011, CURR PHARM DESIGN, V17, P4147, DOI 10.2174/138161211798764825; Liu YW, 2011, INT IMMUNOPHARMACOL, V11, P2159, DOI 10.1016/j.intimp.2011.09.013; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Moro G, 2002, J PEDIATR GASTR NUTR, V34, P291, DOI 10.1097/00005176-200203000-00014; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; PARKS DA, 1983, SURGERY, V94, P415; Roy S, 2017, AM J PATHOL, V187, P9, DOI 10.1016/j.ajpath.2016.08.022; Sakai N, 2012, HEPATOLOGY, V55, P888, DOI 10.1002/hep.24756; Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P19, DOI 10.2174/157016112798829797; Unno N, 1997, GASTROENTEROLOGY, V113, P1246, DOI 10.1053/gast.1997.v113.pm9322519	23	16	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0196511	10.1371/journal.pone.0196511	http://dx.doi.org/10.1371/journal.pone.0196511			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851956	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200006
J	Sudha, D; Neriyanuri, S; Sachidanandam, R; Natarajan, SN; Gandra, M; Tharigopala, A; Sivashanmugam, M; Alameen, M; Vetrivel, U; Gopal, L; Khetan, V; Raman, R; Sen, P; Chidambaram, S; Arunachalam, JP				Sudha, Dhandayuthapani; Neriyanuri, Srividya; Sachidanandam, Ramya; Natarajan, Srikrupa N.; Gandra, Mamatha; Tharigopala, Arokiasamy; Sivashanmugam, Muthukumaran; Alameen, Mohammed; Vetrivel, Umashankar; Gopal, Lingam; Khetan, Vikas; Raman, Rajiv; Sen, Parveen; Chidambaram, Subbulakshmi; Arunachalam, Jayamuruga Pandian			Understanding variable disease severity in X-linked retinoschisis: Does RS1 secretory mechanism determine disease severity?	PLOS ONE			English	Article							JUVENILE RETINOSCHISIS; CLINICAL-FEATURES; PROTEIN; MUTATIONS; EXPRESSION; PHENOTYPE; GENE; ELECTRORETINOGRAPHY; GENOTYPE; FAMILIES	X-linked retinoschisis (XLRS) is a retinal degenerative disorder caused by mutations in RS1 gene leading to splitting of retinal layers (schisis) which impairs visual signal processing. Retinoschisin (RS1) is an adhesive protein which is secreted predominantly by the photoreceptors and bipolar cells as a double-octameric complex. In general, XLRS patients show wide clinical heterogeneity, presenting practical challenges in disease management. Though researchers have attempted various approaches to offer an explanation for clinical heterogeneity, the molecular basis has not been understood yet. Therefore, this study aims at establishing a link between the phenotype and genotype based on the molecular mechanism exerted by the mutations. Twenty seven XLRS patients were enrolled, of which seven harboured novel mutations. The mutant constructs were genetically engineered and their secretion profiles were studied by in vitro cell culture experiments. Based on the secretory profile, the patients were categorized as either secreted or non-secreted group. Various clinical parameters such as visual acuity, location of schisis, foveal thickness and ERG parameters were compared between the two groups and control. Although the two groups showed severe disease phenotype in comparison with control, there was no significant difference between the two XLRS groups. However, the secreted group exhibited relatively severe disease indications. On the other hand molecular analysis suggests that most of the RS1 mutations result in intracellular retention of retinoschisin. Hence, clinical parameters of patients with non-secreted profile were analyzed which in turn revealed wide variability even within the group. Altogether, our results indicate that disease severity is not merely dependent on secretory profile of the mutations. Thus, we hypothesize that intricate molecular detail such as the precise localization of mutant protein in the cell as well as its ability to assemble into a functionally active oligomer might largely influence disease severity among XLRS patients.	[Sudha, Dhandayuthapani; Natarajan, Srikrupa N.; Gandra, Mamatha; Tharigopala, Arokiasamy; Arunachalam, Jayamuruga Pandian] Vis Res Fdn, SN ONGC Dept Genet & Mol Biol, Madras, Tamil Nadu, India; [Sudha, Dhandayuthapani] SASTRA Univ, Sch Biotechnol, Thanjavur, India; [Neriyanuri, Srividya] Elite Sch Optometry, Madras, Tamil Nadu, India; [Neriyanuri, Srividya] Birla Inst Technol & Sci, Pilani, Rajasthan, India; [Sachidanandam, Ramya] Med Res Fdn, Dept Optometry, Madras, Tamil Nadu, India; [Sivashanmugam, Muthukumaran; Alameen, Mohammed; Vetrivel, Umashankar] Vis Res Fdn, Ctr Bioinformat, Madras, Tamil Nadu, India; [Gopal, Lingam; Khetan, Vikas; Raman, Rajiv; Sen, Parveen] Med Res Fdn, Dept Vitreoretinal Serv, Madras, Tamil Nadu, India; [Chidambaram, Subbulakshmi] Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell biol, Madras, Tamil Nadu, India; [Arunachalam, Jayamuruga Pandian] Sri Balaji Vidyapeeth Univ, CIDRF, Mahatma Gandhi Med Coll & Res Inst Campus, Pondicherry, India; [Chidambaram, Subbulakshmi] Pondicherry Univ, Dept Biochem & Mol Biol, Pondicherry, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Birla Institute of Technology & Science Pilani (BITS Pilani); Mahatma Gandhi Medical College & Research Institute; Pondicherry University	Arunachalam, JP (corresponding author), Vis Res Fdn, SN ONGC Dept Genet & Mol Biol, Madras, Tamil Nadu, India.; Arunachalam, JP (corresponding author), Sri Balaji Vidyapeeth Univ, CIDRF, Mahatma Gandhi Med Coll & Res Inst Campus, Pondicherry, India.	ajmpandian@gmail.com	Arunachalam, Jayamuruga Pandian/AAI-7158-2020; vetrivel, umashankar/AAW-7218-2020; Raman, Rajiv/A-7234-2009; Sen, Parveen/W-4707-2019	vetrivel, umashankar/0000-0003-4697-2115; Raman, Rajiv/0000-0001-5842-0233; Arunachalam, Jayamuruga Pandian/0000-0001-6318-225X; Khetan, Vikas/0000-0003-4396-9877	Department of Biotechnology, Government of India [BT/PR15111/GBD/27/322/2011]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by funding from the Department of Biotechnology, Government of India (http://www.dbtindia.nic.in/) (BT/PR15111/GBD/27/322/2011) from March 2011 to 2014. Grant recipient was Dr. AJP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEJONG PTVM, 1991, ARCH OPHTHALMOL-CHIC, V109, P1104, DOI 10.1001/archopht.1991.01080080064029; DeLano WL, 2014, PYMOL MOL GRAPH SYST; Eksandh LC, 2000, ARCH OPHTHALMOL-CHIC, V118, P1098, DOI 10.1001/archopht.118.8.1098; George NDL, 1996, ARCH OPHTHALMOL-CHIC, V114, P274, DOI 10.1001/archopht.1996.01100130270007; Iannaccone A, 2006, VISION RES, V46, P3845, DOI 10.1016/j.visres.2006.06.011; Johnson BA, 2010, GENETICS, V186, P1337, DOI 10.1534/genetics.110.120840; Kim SY, 2009, MOL VIS, V15, P833; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XX, 2007, MOL VIS, V13, P804; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Molday RS, 2007, EXP EYE RES, V84, P227, DOI 10.1016/j.exer.2005.12.013; Neriyanuri S, 2016, INDIAN J OPHTHALMOL, V64, P513, DOI 10.4103/0301-4738.190140; NOBLE KG, 1989, AM J OPHTHALMOL, V107, P211, DOI 10.1016/0002-9394(89)90302-4; PEACHEY NS, 1987, ARCH OPHTHALMOL-CHIC, V105, P513, DOI 10.1001/archopht.1987.01060040083038; Pimenides D, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029769; Ramsay EP, 2016, HUM MOL GENET, V25, P5311, DOI 10.1093/hmg/ddw345; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Sergeev YV, 2010, HUM MOL GENET, V19, P1302, DOI 10.1093/hmg/ddq006; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; Shinoda K, 2000, Ophthalmic Genet, V21, P171; Sivakumaran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025598; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Sudha D, 2017, OPHTHALMIC GENET, V38, P260, DOI 10.1080/13816810.2016.1214972; Sudha D, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9148-y; The Retinoschisis Consortium, 1998, FUNCT IMPL SPECTR MU, V7, P1185; Tolun G, 2016, P NATL ACAD SCI USA, V113, P5287, DOI 10.1073/pnas.1519048113; Vijayasarathy C, 2007, INVEST OPHTH VIS SCI, V48, P991, DOI 10.1167/iovs.06-0915; Vijayasarathy C, 2010, HUM MUTAT, V31, P1251, DOI 10.1002/humu.21350; Vijayasarathy C, 2009, INVEST OPHTH VIS SCI, V50, P5375, DOI 10.1167/iovs.09-3839; Vincent A, 2013, OPHTHALMOLOGY, V120, P1454, DOI 10.1016/j.ophtha.2012.12.008; Wang NK, 2015, MOL VIS, V21, P487; Wang T, 2006, BRIT J OPHTHALMOL, V90, P81, DOI 10.1136/bjo.2005.078048; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200	36	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198086	10.1371/journal.pone.0198086	http://dx.doi.org/10.1371/journal.pone.0198086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851975	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200030
J	Papp, AC; Azad, AK; Pietrzak, M; Williams, A; Handelman, SK; Igo, RP; Stein, CM; Hartmann, K; Schlesinger, LS; Sadee, W				Papp, Audrey C.; Azad, Abul K.; Pietrzak, Maciej; Williams, Amanda; Handelman, Samuel K.; Igo, Robert P., Jr.; Stein, Catherine M.; Hartmann, Katherine; Schlesinger, Larry S.; Sadee, Wolfgang			AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SURFACTANT PROTEIN-A; BURROWS-WHEELER TRANSFORM; INNATE IMMUNE-RESPONSE; COMPLEMENT RECEPTORS; BEHCETS-DISEASE; READ ALIGNMENT; GENE; SUSCEPTIBILITY; PHAGOCYTOSIS	Human alveolar macrophages (HAM) are primary bacterial niche and immune response cells during Mycobacterium tuberculosis (M.tb) infection, and human blood monocyte-derived macrophages (MDM) are a model for investigating M.tb-macrophage interactions. Here, we use a targeted RNA-Seq method to measure transcriptome-wide changes in RNA expression patterns of freshly obtained HAM (used within 6 h) and 6 day cultured MDM upon M.tb infection over time (2, 24 and 72 h), in both uninfected and infected cells from three donors each. The Ion AmpliSeq (TM) Transcriptome Human Gene Expression Kit (AmpliSeq) uses primers targeting 18,574 mRNAs and 2,228 non-coding RNAs (ncRNAs) for a total of 20,802 transcripts. AmpliSeq (TM) yields highly precise and reproducible gene expression profiles (R-2 > 0.99). Taking advantage of AmpliSeq's reproducibility, we establish well-defined quantitative RNA expression patterns of HAM versus MDM, including significant M.tb-inducible genes, in networks and pathways that differ in part between MDM and HAM. A similar number of expressed genes are detected at all time-points between uninfected MDM and HAM, in common pathways including inflammatory and immune functions, but canonical pathway differences also exist. In particular, at 2 h, multiple genes relevant to the immune response are preferentially expressed in either uninfected HAM or MDM, while the HAM RNA profiles approximate MDM profiles over time in culture, highlighting the unique RNA expression profile of freshly obtained HAM. MDM demonstrate a greater transcriptional response than HAM upon M.tb infection, with 2 to > 10 times more genes up- or down-regulated. The results identify key genes involved in cellular responses to M.tb in two different human macrophage types. Follow-up bioinformatics analysis indicates that approximately 30% of response genes have expression quantitative trait loci (eQTLs in GTEx), common DNA variants that can influence host gene expression susceptibility or resistance to M.tb, illustrated with the TREM1 gene cluster and IL-10.	[Papp, Audrey C.; Pietrzak, Maciej; Williams, Amanda; Hartmann, Katherine; Sadee, Wolfgang] Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Ctr Pharmacogen, Columbus, OH 43210 USA; [Azad, Abul K.; Schlesinger, Larry S.] Texas Biomed Res Inst, San Antonio, TX 78227 USA; [Handelman, Samuel K.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA; [Igo, Robert P., Jr.; Stein, Catherine M.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Stein, Catherine M.] Case Western Reserve Univ, TB Res Unit, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Hartmann, Katherine] European Org Res Treatment Canc, Brussels, Belgium	University System of Ohio; Ohio State University; Texas Biomedical Research Institute; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University; European Organisation for Research & Treatment of Cancer	Sadee, W (corresponding author), Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Ctr Pharmacogen, Columbus, OH 43210 USA.; Schlesinger, LS (corresponding author), Texas Biomed Res Inst, San Antonio, TX 78227 USA.	lschlesinger@txbiomed.org; wolfgang.sadee@osumc.edu	Pietrzak, Maciej/GNH-5768-2022; Igo, Rob/P-3438-2019; Stein, Catherine/P-9498-2019; Hartmann, Katherine/T-8874-2019	Igo, Rob/0000-0002-0024-1993; Stein, Catherine/0000-0002-9763-5023; Hartmann, Katherine/0000-0002-1465-9653; Hartmann, Katherine/0000-0002-7051-8185; Handelman, Samuel/0000-0001-6970-2172; Schlesinger, Larry/0000-0002-7177-8421; Pietrzak, Maciej/0000-0001-5768-7884	Melinda and Bill Gates Foundation; National Institute of Health [U01 GM 092655]; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092655] Funding Source: NIH RePORTER	Melinda and Bill Gates Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by the Melinda and Bill Gates Foundation to LSS and WS, and, National Institute of Health grant U01 GM 092655 to WS. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Azad AK, 2013, GENES IMMUN, V14, P99, DOI 10.1038/gene.2012.61; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Barrie ES, 2017, HUM MUTAT, V38, P112, DOI 10.1002/humu.23135; Beisiegel M, 2009, EUR J IMMUNOL, V39, P3369, DOI 10.1002/eji.200939615; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Blischak JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16882; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brouwer RWW, 2017, METHODS MOL BIOL, V1507, P199, DOI 10.1007/978-1-4939-6518-2_15; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cilfone NA, 2015, J IMMUNOL, V194, P664, DOI 10.4049/jimmunol.1400734; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Gao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127496; GAYNOR CD, 1995, J IMMUNOL, V155, P5343; Jain M., 2018, NAT BIOTECHNOL; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Leisching G., 2016, VIRULENCE, P1; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2270-1; Liang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088448; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Manry J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006952; Mboowa Gerald, 2014, Int J Evol Biol, V2014, P108291, DOI 10.1155/2014/108291; Moreira-Teixeira L, 2017, J IMMUNOL, V199, P613, DOI 10.4049/jimmunol.1601340; Nalpas NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13629; Naranbhai V, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0011-2016; Nguyen HA, 2012, AM J PHYSIOL-LUNG C, V303, pL608, DOI 10.1152/ajplung.00067.2012; Nguyen TTT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000229; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Ortega H., 2017, TUBERCULOSIS; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pietrzak M, 2016, BIOCHEM BIOPH RES CO, V479, P875, DOI 10.1016/j.bbrc.2016.09.114; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Rege M, 2017, MOL CELL, V67, P901, DOI 10.1016/j.molcel.2017.09.011; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryndak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123745; Sadee W, 2014, HUM GENET, V133, P1199, DOI 10.1007/s00439-014-1476-7; SCHLESINGER LS, 1990, J CLIN INVEST, V85, P1304, DOI 10.1172/JCI114568; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Schurr Erwin, 2011, Kekkaku, V86, P17; Seshadri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175844; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Singpiel A, 2017, IMMUNOBIOLOGY; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Stein CM, 2011, MAMM GENOME, V22, P91, DOI 10.1007/s00335-010-9301-7; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Stein CM, 2018, AM J EPIDEMIOL; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Takeuchi M, 2015, J AUTOIMMUN, V64, P137, DOI 10.1016/j.jaut.2015.08.013; Tan SM, 2015, IMMUNOL REV, V264, P233, DOI 10.1111/imr.12254; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tomlinson GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040348; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Volpe E, 2006, IMMUNOLOGY, V118, P449, DOI 10.1111/j.1365-2567.2006.02378.x; Wang JP, 2003, FEMS IMMUNOL MED MIC, V39, P163, DOI 10.1016/S0928-8244(03)00223-2	69	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198221	10.1371/journal.pone.0198221	http://dx.doi.org/10.1371/journal.pone.0198221			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847580	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800059
J	Paschke, P; Knecht, DA; Silale, A; Traynor, D; Williams, TD; Thomason, PA; Insall, RH; Chubb, JR; Kay, RR; Veltman, DM				Paschke, Peggy; Knecht, David A.; Silale, Augustinas; Traynor, David; Williams, Thomas D.; Thomason, Peter A.; Insall, Robert H.; Chubb, Jonathan R.; Kay, Robert R.; Veltman, Douwe M.			Rapid and efficient genetic engineering of both wild type and axenic strains of Dictyostelium discoideum	PLOS ONE			English	Article							SOCIAL AMEBA; CELL-MOVEMENT; MACROPINOCYTOSIS; CHEMOTAXIS; EXPRESSION; DYNAMICS; PROTEIN; TRANSFORMATION; ESTABLISHMENT; EVOLUTION	Dictyostelium has a mature technology for molecular-genetic manipulation based around transfection using several different selectable markers, marker re-cycling, homologous recombination and insertional mutagenesis, all supported by a well-annotated genome. However this technology is optimized for mutant, axenic cells that, unlike non-axenic wild type, can grow in liquid medium. There is a pressing need for methods to manipulate wild type cells and ones with defects in macropinocytosis, neither of which can grow in liquid media. Here we present a panel of molecular genetic techniques based on the selection of Dictyostelium transfectants by growth on bacteria rather than liquid media. As well as extending the range of strains that can be manipulated, these techniques are faster than conventional methods, often giving usable numbers of transfected cells within a few days. The methods and plasmids described here allow efficient transfection with extrachromosomal vectors, as well as chromosomal integration at a 'safe haven' for relatively uniform cell-to-cell expression, efficient gene knock-in and knock-out and an inducible expression system. We have thus created a complete new system for the genetic manipulation of Dictyostelium cells that no longer requires cell feeding on liquid media.	[Paschke, Peggy; Silale, Augustinas; Traynor, David; Williams, Thomas D.; Kay, Robert R.; Veltman, Douwe M.] MRC Lab Mol Biol, Cambridge, England; [Knecht, David A.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Thomason, Peter A.; Insall, Robert H.] Canc Res UK Beatson Inst Glasgow, Glasgow, Lanark, Scotland; [Chubb, Jonathan R.] UCL, MRC Lab Mol Cell Biol, London, England; [Chubb, Jonathan R.] UCL, Dept Cell & Dev Biol, London, England; [Silale, Augustinas] Univ Oxford, Dept Biochem, Oxford, England	MRC Laboratory Molecular Biology; University of Connecticut; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Oxford	Paschke, P (corresponding author), MRC Lab Mol Biol, Cambridge, England.	ppaschke@mrc-lmb.cam.ac.uk	Insall, Robert/G-5611-2011; Silale, Augustinas/AAK-9447-2021	Insall, Robert/0000-0003-4898-040X; Silale, Augustinas/0000-0003-3338-2087; Williams, Thomas/0000-0002-0479-5678; Knecht, David/0000-0001-6103-4296; Thomason, Peter/0000-0003-3104-8392; Paschke, Peggy/0000-0002-6248-5678	Medical Research Council [MC_U105115237]; BBSRC (Biotechnology and Biological Sciences Research Council) grant [BB/K009699/1]; Cancer Research UK grant [A15672]; Wellcome Trust Senior Fellowship [202867/Z/16/Z]; MRC [MC_U12266B]; BBSRC [BB/K009699/1] Funding Source: UKRI; MRC [MC_U105115237] Funding Source: UKRI; Medical Research Council [MC_U12266B, MC_CF12266] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC (Biotechnology and Biological Sciences Research Council) grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK grant(Cancer Research UK); Wellcome Trust Senior Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Medical Research Council grant MC_U105115237 to R. R. Kay, BBSRC (Biotechnology and Biological Sciences Research Council) grant BB/K009699/1 to R. R. Kay, Cancer Research UK grant A15672 to R. H. Insall, Wellcome Trust Senior Fellowship 202867/Z/16/Z to Jonathan R Chubb, and MRC funding (MC_U12266B) to the MRC LMCB University Unit at UCL.	Alibaud L, 2003, BIOTECHNIQUES, V35, P78, DOI 10.2144/03351st03; Antolovic V, 2017, CURR BIOL, V27, P1811, DOI 10.1016/j.cub.2017.05.028; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Bloomfield G, 2015, ELIFE, V4, DOI 10.7554/eLife.04940; Bloomfield G, 2010, SCIENCE, V330, P1533, DOI 10.1126/science.1197423; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; Cannon D, 2015, DEVELOPMENT, V142, P2840, DOI 10.1242/dev.120741; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Chubb JR, 2000, J CELL SCI, V113, P709; Chubb JR, 2002, CELL MOTIL CYTOSKEL, V53, P150, DOI 10.1002/cm.10064; Corrigan AM, 2016, ELIFE, V5, DOI 10.7554/eLife.13051; Corrigan AM, 2015, METHOD CELL BIOL, V125, P29, DOI 10.1016/bs.mcb.2014.11.001; Corrigan AM, 2014, CURR BIOL, V24, P205, DOI 10.1016/j.cub.2013.12.011; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Du QY, 2015, J MOL BIOL, V427, P3722, DOI 10.1016/j.jmb.2015.08.008; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fets L, 2014, CURR BIOL, V24, P415, DOI 10.1016/j.cub.2013.12.052; Gebbie L, 2004, MOL BIOL CELL, V15, P3915, DOI 10.1091/mbc.E03-12-0908; GERISCH G, 1967, Z NATURFORSCH PT B, VB 22, P109; Hacker U, 1997, J CELL SCI, V110, P105; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hedgethorne K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602937; Hirose S, 2011, SCIENCE, V333, P467, DOI 10.1126/science.1203903; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; Hsu DW, 2012, NUCLEIC ACIDS RES, V40, P7247, DOI 10.1093/nar/gks367; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; Joseph JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002654; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Liu TY, 2002, J CELL SCI, V115, P1907; LLOYD MM, 1990, DEV GENET, V11, P391, DOI 10.1002/dvg.1020110511; LOOMIS WF, 1971, EXP CELL RES, V64, P484, DOI 10.1016/0014-4827(71)90107-8; Muramoto T, 2005, MECH DEVELOP, V122, P733, DOI 10.1016/j.mod.2004.11.015; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; NELLEN W, 1985, GENE, V39, P155, DOI 10.1016/0378-1119(85)90309-9; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Pears CJ, 2014, DNA REPAIR, V17, P121, DOI 10.1016/j.dnarep.2014.01.008; Pollitt AY, 2006, EUR J CELL BIOL, V85, P1091, DOI 10.1016/j.ejcb.2006.05.014; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; SCHLATTERER C, 1992, EUR J CELL BIOL, V58, P172; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Stevense M, 2010, DEVELOPMENT, V137, P579, DOI 10.1242/dev.043836; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Veltman DM, 2016, ELIFE, V5, DOI 10.7554/eLife.20085; Veltman DM, 2014, J CELL BIOL, V204, P497, DOI 10.1083/jcb.201309081; Veltman DM, 2009, PLASMID, V61, P119, DOI 10.1016/j.plasmid.2008.11.002; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Wetterauer B, 1996, PLASMID, V36, P169, DOI 10.1006/plas.1996.0044; Williams TD, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213736; Wolf JB, 2015, CURR BIOL, V25, P1086, DOI 10.1016/j.cub.2015.02.061	57	34	34	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0196809	10.1371/journal.pone.0196809	http://dx.doi.org/10.1371/journal.pone.0196809			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847546	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000433634800011
J	Canini, F; Qin, BL; Arvy, N; Poulet, L; Batandier, C; Roussei, AM; Anderson, RA				Canini, Frederic; Qin, Bolin; Arvy, Nathalie; Poulet, Laurent; Batandier, Cecile; Roussei, Anne-Marie; Anderson, Richard A.			Stress exposure alters brain mRNA expression of the genes involved in insulin signalling, an effect modified by a high fat/high fructose diet and cinnamon supplement	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HIGH-FAT DIET; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; RESTRAINT STRESS; PSYCHOLOGICAL STRESS; METABOLIC SYNDROME; MAJOR DEPRESSION; CEREBRAL-CORTEX; RISK-FACTOR	In occidental societies, high fat and high sugar diets often coincide with episodes of stress. The association is likely to modify brain energy control. Brain insulin signalling is rarely studied in stressed individuals consuming high fat diets. Furthermore the effects of cinnamon supplement are not known in these conditions. Therefore, we exposed rats, over a 12-week period, to a control (C) or a high fat/high fructose (HF/HFr) diet that induces peripheral insulin resistance. A cinnamon supplement (C+CN and HF/HFr+CN) was added or not. After diet exposure, one group of rats was exposed to a 30-min restraint followed by a 10-min open-field test, their combination featuring a moderate stressor, the other rats staying unstressed in their home cages. The insulin signalling in hippocampus and frontal cortex was studied through the mRNA expression of the following genes: insulin receptor (Ir), insulin receptor substrate (Irs1), glucose transporters (Glut1 and Glut3), glycogen synthase (Gys1) and their modulators, Akt1 and Pten. In C rats, stress enhanced the expression of Ir, Irs1, Glut1, Gys1 and Akt1 mRNA. In C+CN rats, stress induced an increase in Pten but a decrease in Gys1 mRNA expression. In HF/HFr rats, stress was associated with an increase in Pten mRNA expression. In HF/HFr+CN rats, stress increased Pten mRNA expression but also decreased Gys1 mRNA expression. This suggests that a single moderate stress favours energy refilling mechanisms, an effect blunted by a previous HF/HFr diet and cinnamon supplement.	[Canini, Frederic] IRBA, Dept Neurosci & Contraintes Operat, Bretigny Sur Orge, France; [Canini, Frederic] Ecole Val Grace, 1 Pl Laveran, Paris, France; [Qin, Bolin] In Ingredients Com, Columbia, TN USA; [Qin, Bolin; Anderson, Richard A.] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA; [Arvy, Nathalie] INRA, Lab Nutr & Integrat Neurobiol, UMR 1286, Bordeaux, France; [Arvy, Nathalie] Univ Bordeaux, Lab Nutr & Integrat Neurobiol, UMR 1286, Bordeaux, France; [Poulet, Laurent; Batandier, Cecile; Roussei, Anne-Marie] Grenoble Alpes Univ, INSERM, LBFA 1055, Grenoble, France; [Anderson, Richard A.] PolyChrom Technol LLC, Edgewater, MD USA	United States Department of Agriculture (USDA); INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Canini, F (corresponding author), IRBA, Dept Neurosci & Contraintes Operat, Bretigny Sur Orge, France.; Canini, F (corresponding author), Ecole Val Grace, 1 Pl Laveran, Paris, France.	fredericcanini@gmail.com	Marissal-Arvy, Nathalie/AAL-6103-2021	Marissal-Arvy, Nathalie/0000-0002-3147-5741; Poulet, Laurent/0000-0003-2795-4122	USDA/ARS/USA CRADA [58-3K95-7-1184]; French National Agency for Research [PNRA 007]	USDA/ARS/USA CRADA; French National Agency for Research(French National Research Agency (ANR))	The work was funded by USDA/ARS/USA CRADA: 58-3K95-7-1184 and French National Agency for Research (PNRA 007). The funders provided support in the form of salary for one of the authors [BQ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Anderson RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083243; Andreoulakis E, 2012, HIPPOKRATIA, V16, P205; Archuleta TL, 2009, FREE RADICAL BIO MED, V47, P1486, DOI 10.1016/j.freeradbiomed.2009.08.014; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Atif F, 2008, EUR J PHARMACOL, V600, P59, DOI 10.1016/j.ejphar.2008.09.029; Bhat NR, 2013, J ALZHEIMERS DIS, V36, P781, DOI 10.3233/JAD-2012-121030; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown RC, 2016, J PEDIATR HEALTH CAR, V30, P558, DOI 10.1016/j.pedhc.2015.11.015; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; Couturier K, 2010, ARCH BIOCHEM BIOPHYS, V501, P158, DOI 10.1016/j.abb.2010.05.032; Couturier K, 2011, METABOLISM, V60, P1590, DOI 10.1016/j.metabol.2011.03.016; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Depke M, 2008, ENDOCRINOLOGY, V149, P2714, DOI 10.1210/en.2008-0038; Detka J, 2013, PHARMACOL REP, V65, P1591, DOI 10.1016/S1734-1140(13)71520-2; Devaney JM, 2011, HUM GENET, V129, P129, DOI 10.1007/s00439-010-0910-8; Drouet JB, 2015, NEUROSCIENCE, V285, P155, DOI 10.1016/j.neuroscience.2014.10.058; Duarte AI, 2008, BBA-MOL CELL RES, V1783, P994, DOI 10.1016/j.bbamcr.2008.02.016; Fachinetto R, 2005, PHARMACOL BIOCHEM BE, V81, P585, DOI 10.1016/j.pbb.2005.05.001; Falkowska A, 2015, INT J MOL SCI, V16, P25959, DOI 10.3390/ijms161125939; Fernandez AM, 2017, NEUROPHARMACOLOGY, P1; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Ghasemi R, 2013, MOL NEUROBIOL, V47, P145, DOI 10.1007/s12035-012-8339-9; Gruetter R, 2003, J NEUROSCI RES, V74, P179, DOI 10.1002/jnr.10785; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Harmon BT, 2010, HUM GENET, V128, P635, DOI 10.1007/s00439-010-0891-7; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Henriksen EJ, 2013, METHOD ENZYMOL, V528, P269, DOI 10.1016/B978-0-12-405881-1.00016-1; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Killday KB, 2011, J NAT PROD, V74, P1833, DOI 10.1021/np1007944; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lee YJ, 2006, NEUROSCI LETT, V392, P27, DOI 10.1016/j.neulet.2005.08.065; Li L, 2013, J ENDOCRINOL, V217, P175, DOI 10.1530/JOE-12-0559; Lu JM, 2010, CARCINOGENESIS, V31, P481, DOI 10.1093/carcin/bgp292; Marissal-Arvy N, 2014, BRIT J NUTR, V111, P1190, DOI 10.1017/S0007114513003577; McEwen BS, 2004, EUR J PHARMACOL, V490, P13, DOI 10.1016/j.ejphar.2004.02.041; MCGOWAN KM, 1995, PHARMACOL THERAPEUT, V66, P465, DOI 10.1016/0163-7258(95)00007-4; McIntyre Roger S, 2007, Ann Clin Psychiatry, V19, P257, DOI 10.1080/10401230701653377; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Moroz N, 2008, J ALZHEIMERS DIS, V15, P29; Munhoz CD, 2008, BRAZ J MED BIOL RES, V41, P1037, DOI 10.1590/S0100-879X2008001200001; Niraula K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-309; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Okamoto K, 2006, BRAIN RES, V1081, P19, DOI 10.1016/j.brainres.2006.01.081; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Ribeiro MCP, 2009, CELL BIOCHEM FUNCT, V27, P473, DOI 10.1002/cbf.1599; Pratchayasakul W, 2011, LIFE SCI, V88, P619, DOI 10.1016/j.lfs.2011.02.003; Preuss HG, 2006, J AM COLL NUTR, V25, P144, DOI 10.1080/07315724.2006.10719525; Ramalingam M, 2015, J RECEPT SIG TRANSD, V35, P1, DOI 10.3109/10799893.2014.922576; Reagan LP, 1999, ANN NY ACAD SCI, V893, P126, DOI 10.1111/j.1749-6632.1999.tb07822.x; Reagan LP, 2000, BRAIN RES, V862, P292, DOI 10.1016/S0006-8993(00)02212-5; Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sartorius T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092358; SORG O, 1992, J NEUROSCI, V12, P4923; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; SUN XJ, 1992, J BIOL CHEM, V267, P22662; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; WINOKUR A, 1988, AM J PSYCHIAT, V145, P325; Yan JQ, 2012, FREE RADICAL BIO MED, V52, P1648, DOI 10.1016/j.freeradbiomed.2012.01.033; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	70	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197094	10.1371/journal.pone.0197094	http://dx.doi.org/10.1371/journal.pone.0197094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813096	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800011
J	Mahroum, N; Adawi, M; Sharif, K; Waknin, R; Mahagna, H; Bisharat, B; Mahamid, M; Abu-Much, A; Amital, H; Bragazzi, NL; Watad, A				Mahroum, Naim; Adawi, Mohammad; Sharif, Kassem; Waknin, Roy; Mahagna, Hussein; Bisharat, Bishara; Mahamid, Mahmud; Abu-Much, Arsalan; Amital, Howard; Bragazzi, Nicola Luigi; Watad, Abdulla			Public reaction to Chikungunya outbreaks in Italy-Insights from an extensive novel data streams-based structural equation modeling analysis	PLOS ONE			English	Article							EBOLA-VIRUS DISEASE; HEALTH; INFORMATION; WEB; INFECTION; SEARCHES; INTERNET	The recent outbreak of Chikungunya virus in Italy represents a serious public health concern, which is attracting media coverage and generating public interest in terms of Internet searches and social media interactions. Here, we sought to assess the Chikungunya-related digital behavior and the interplay between epidemiological figures and novel data streams traffic. Reaction to the recent outbreak was analyzed in terms of Google Trends, Google News and Twitter traffic, Wikipedia visits and edits, and PubMed articles, exploiting structural modelling equations. A total of 233,678 page-views and 150 edits on the Italian Wikipedia page, 3,702 tweets, 149 scholarly articles, and 3,073 news articles were retrieved. The relationship between overall Chikungunya cases, as well as autochthonous cases, and tweets production was found to be fully mediated by Chikungunya-related web searches. However, in the allochthonous/imported cases model, tweet production was not found to be significantly mediated by epidemiological figures, with web searches still significantly mediating tweet production. Inconsistent relationships were detected in mediation models involving Wikipedia usage as a mediator variable. Similarly, the effect between news consumption and tweets production was suppressed by the Wikipedia usage. A further inconsistent mediation was found in the case of the effect between Wikipedia usage and tweets production, with web searches as a mediator variable. When adjusting for the Internet penetration index, similar findings could be obtained, with the important exception that in the adjusted model the relationship between GN and Twitter was found to be partially mediated by Wikipedia usage. Furthermore, the link between Wikipedia usage and PubMed/MEDLINE was fully mediated by GN, differently from what was found in the unadjusted model. In conclusion-a significant public reaction to the current Chikungunya outbreak was documented. Health authorities should be aware of this, recognizing the role of new technologies for collecting public concerns and replying to them, disseminating awareness and avoid misleading information.	[Mahroum, Naim; Sharif, Kassem; Mahagna, Hussein; Abu-Much, Arsalan; Amital, Howard; Watad, Abdulla] Sheba Med Ctr, Dept Med B, Tel Hashomer, Israel; [Mahroum, Naim; Sharif, Kassem; Waknin, Roy; Mahagna, Hussein; Abu-Much, Arsalan; Amital, Howard; Watad, Abdulla] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Adawi, Mohammad; Mahamid, Mahmud] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel; [Adawi, Mohammad] Padeh Med Ctr, Safed, Israel; [Adawi, Mohammad] Ziv Med Ctr, Safed, Israel; [Sharif, Kassem; Amital, Howard; Watad, Abdulla] Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Hashomer, Israel; [Bisharat, Bishara; Bragazzi, Nicola Luigi] Soc Hlth Promot Arab Community, Nazareth, Israel; [Mahamid, Mahmud] Nazareth Hosp EMMS, Endoscopy Unit, Nazareth, Israel; [Bragazzi, Nicola Luigi] Univ Genoa, Dept Hlth Sci, Sch Publ Hlth, Genoa, Italy	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Ziv Medical Center; Chaim Sheba Medical Center; University of Genoa	Watad, A (corresponding author), Sheba Med Ctr, Dept Med B, Tel Hashomer, Israel.; Watad, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Watad, A (corresponding author), Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Hashomer, Israel.	watad.abdulla@gmail.com	Waknin, Roy/U-8943-2019; Adawi, Mohammad/ABG-4428-2021; sharif, kassem/K-5663-2019; Bragazzi, Nicola Luigi/G-1672-2011	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Sharif, Kassem/0000-0003-3905-3313; Mahroum, Naim/0000-0002-7919-1326; Mahajna, Hussein/0000-0002-7409-8958				Amraoui F, 2016, CURR OPIN VIROL, V21, P146, DOI 10.1016/j.coviro.2016.09.014; Angelini R, 2007, EURO SURVEILL, V12, pE070906, DOI 10.2807/esw.12.36.03260-en; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044; Castillo-Ortiz JD, 2017, REUMATOL CLIN, V13, P139, DOI 10.1016/j.reuma.2016.04.009; Castillo-Ortiz JD, 2016, RHEUMATOL INT, V36, P1281, DOI 10.1007/s00296-016-3507-2; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Fairchild Geoffrey, 2015, Proc Int AAAI Conf Weblogs Soc Media, V2015, P26; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Geiss S, 2016, NEW MEDIA SOC, V18, P2740, DOI 10.1177/1461444815600281; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Guzzetta G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004762; Hickmann KS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004239; Kagashe I, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7393; Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Manogaran G., 2017, INNOVATIVE HEALTHCAR, P263, DOI [10.1007/978-3-319-55774-8_10, DOI 10.1007/978-3-319-55774-8_10]; Manogaran G, 2018, FUTURE GENER COMP SY, V82, P375, DOI 10.1016/j.future.2017.10.045; Manogaran G, 2018, WIRELESS PERS COMMUN, V102, P2099, DOI 10.1007/s11277-017-5044-z; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Moore RJ, 2009, TWITTER DATA ANAL IN; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rodgers S, 2007, J HEALTH COMMUN, V12, P105, DOI 10.1080/10810730601150064; Rossini G, 2016, EPIDEMIOL INFECT, V144, P1912, DOI 10.1017/S0950268815002940; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Russell J., 2017, TWITTER ADMITS IT OV; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085; Varatharajan R, 2018, MULTIMED TOOLS APPL, V77, P17573, DOI 10.1007/s11042-017-4768-9; Venturi Giulietta, 2017, Euro Surveill, V22, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646; Wong R, 2018, DISASTER MED PUBLIC, V12, P287, DOI 10.1017/dmp.2017.69	39	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197337	10.1371/journal.pone.0197337	http://dx.doi.org/10.1371/journal.pone.0197337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795578	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300038
J	Methot, J; Bennett, EM				Methot, Josee; Bennett, Elena M.			Reconsidering non-traditional export agriculture and household food security: A case study in rural Guatemala	PLOS ONE			English	Article							COMMERCIAL AGRICULTURE; AGRO-EXPORTS; DIVERSIFICATION; ADOPTION; CROPS; SMALLHOLDERS; DIFFUSION; AMERICA; IMPACTS; FARMERS	As the production of non-traditional export (NTX) crops by smallholder households in developing countries expands, there is a compelling need to understand the potential effects of this type of agricultural production on household food security and nutrition. We use two household surveys with a sample of 52 households, interviews, and focus groups to examine whether smallholder farmers who produce broccoli for export in a rural Guatemalan community have different household food security than farmers in the same community who are still growing traditional maize and bean crops. We explore and compare the food security status of broccoli farmers (adopters) and traditional farmers (non-adopters) across four dimensions of food security: availability, access, utilization, and stability. Adopters earned significantly more income (40%) than non-adopters, but higher incomes did not coincide with improvements in food availability, food access, or food utilization. Results indicate that adopters and non-adopters alike struggle with access to food, while the intensity of broccoli production may be undermining the ability of local agricultural systems to naturally control pests and regulate nutrients. More systematic approaches to food security assessment, especially those that consider all four dimensions of food security, are needed to better target interventions designed to alleviate food insecurity among rural smallholders.	[Methot, Josee] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada; McGill Univ, McGill Sch Environm, Ste Anne De Bellevue, PQ, Canada	McGill University; McGill University	Methot, J (corresponding author), McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	joseemet@gmail.com	Bennett, Elena/A-9553-2008	Bennett, Elena/0000-0003-3944-2925	Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN 327077, NSERC CGSM-389181-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	EMB received funding through a Natural Sciences and Engineering Research Council of Canada grant (NSERC RGPIN 327077). JM received funding through a Natural Sciences and Engineering Research Council of Canada grant (NSERC CGSM-389181-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CASE STUDY RES DESIG; [Anonymous], 2002, DIETARY DIVERSITY HO; Arbona SI, 1998, GEOGR REV, V88, P47, DOI 10.2307/215871; BARHAM B, 1992, LAT AM RES REV, V27, P43; BARHAM B, 1995, J DEV ECON, V46, P85, DOI 10.1016/0304-3878(94)00049-I; Beaulac J, 2007, PREV CHRONIC DIS, V6, P1; Bennett EM, 2005, ECOSYSTEMS, V8, P945, DOI 10.1007/s10021-005-0141-3; Bilinsky P., 2007, MONTHS ADEQUATE HOUS; Birthal PS., 2005, 85 INT FOOD POL RES; BOUIS H, 1990, 79 INT FOOD POL RES; Carletto C, 1999, ECON DEV CULT CHANGE, V47, P345, DOI 10.1086/452404; Carletto C, 2009, P EUR ASS AGR EC 111; Carletto C, 2011, AGR ECON-BLACKWELL, V42, P61, DOI 10.1111/j.1574-0862.2011.00552.x; Carletto C, 2010, WORLD DEV, V38, P814, DOI 10.1016/j.worlddev.2010.02.017; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Coates J, 2013, GLOB FOOD SECUR-AGR, V2, P188, DOI 10.1016/j.gfs.2013.05.002; Coates JC, 2010, FOOD SECUR, V2, P81, DOI 10.1007/s12571-010-0052-9; Collier P, 2002, AFR DEV REV, V14, P237, DOI 10.1111/1467-8268.00053; de Janvry A, 2010, WORLD DEV, V38, P1328, DOI 10.1016/j.worlddev.2010.02.008; Deitchler M, 2011, 12116 FOOD NUTR TECH; dePineres SAG, 1997, J DEV ECON, V52, P375; DEWEY KG, 1981, HUM ECOL, V9, P151, DOI 10.1007/BF00889132; Dix A.M., 1997, THESIS; FAO (Food and Agriculture Organization of the United Nations), 2008, INTR BAS CONC FOOD S; Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363; Food and Agriculture Organization of the United Nations, 2005, STAT FOOD INS WORLD; Food and Agriculture Organization of the United Nations, 2006, POL BRIEF, P2; Fradejas AA, 2006, PERSPECTIVAS AGR FAM, P58; Gentilini U, 2008, FOOD POLICY, V33, P521, DOI 10.1016/j.foodpol.2008.04.005; Govereh J, 2003, AGR ECON, V28, P39, DOI 10.1111/j.1574-0862.2003.tb00133.x; Hallam D, 2004, MARKET NONTRADITION; Hamilton S, 2003, LAT AM RES REV, V38, P82, DOI 10.1353/lar.2003.0033; Immink M, 1995, P WORKSH POV ALL INT; IMMINK MDC, 1993, ECON DEV CULT CHANGE, V41, P319, DOI 10.1086/452013; IMMINK MDC, 1991, ECOL FOOD NUTR, V25, P287, DOI 10.1080/03670244.1991.9991177; Ingram J, 2011, FOOD SECUR, V3, P417, DOI 10.1007/s12571-011-0149-9; Instituto de Nutricio A n de Centro Ame A rica y Panama A, 2006, PUBL, V105; Instituto Nacional de Estadistica (Guatemala), 2015, ENC NAC COND VID 201; International Livestock Research Institute, 1995, LIV POL AN; Isakson SR, 2014, J AGRAR CHANGE, V14, P347, DOI 10.1111/joac.12023; KATZ EG, 1995, WORLD DEV, V23, P327, DOI 10.1016/0305-750X(94)00118-I; Katz EG, 1994, FOOD NUTR B, V15; Kennedy ET, 1987, 63 INT FOOD POL RES; Kovach J., 1992, METHOD MEASURE ENV I; Kromann P., 2011, Journal of Environmental Protection, V2, P581, DOI 10.4236/jep.2011.25067; Levitan L, 1995, AGR ECOSYST ENVIRON, V55, P153, DOI 10.1016/0167-8809(95)00622-Y; Little P. D., 1994, Living under contract: contract farming and agrarian transformation in sub-Saharan Africa., P216; Lovell W., 2010, A BEAUTY THAT HURTS; MA, 2005, ECOSYSTEMS HUMAN WEL; Mannon SE, 2005, HUM ORGAN, V64, P16, DOI 10.17730/humo.64.1.m4020qqetn4pte8n; McKay A., 2000, DESIGNING HOUSEHOLD, VII, P83; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ministerio de Agricultura Ganaderia y Alimentacion, 2011, AGR CIFR DIR PLAN; Morales H., 2000, Agriculture and Human Values, V17, P49, DOI 10.1023/A:1007680726231; MURRAY DL, 1992, WORLD DEV, V20, P597, DOI 10.1016/0305-750X(92)90047-Y; Nellemann C, 2009, ENV FOOD CRISIS THE; Pangaribowo EH, 2013, 108 U BONN CTR DEV R; Ravallion M, 2009, WORLD BANK EC REV; Ruel MT, 2002, 140 INT FOOD POL RES; Salois MJ, 2012, J DEV STUD, V48, P1716, DOI 10.1080/00220388.2012.658376; Sandhu HS, 2010, ECOL COMPLEX, V7, P302, DOI 10.1016/j.ecocom.2010.04.006; Schuftan C, 1998, ECOL FOOD NUTR, V37, P101, DOI 10.1080/03670244.1998.9991540; Sillers D., 2006, NAT INT POV LIN OV; Singh B. P., 2002, Trends in new crops and new uses. Proceedings of the Fifth National Symposium, Atlanta, Georgia, USA, 10-13 November, 2001, P86; Stamoulis KG, 2003, CONCEPTUAL FRAMEWORK; Stanley DL, 2001, APPL ECON, V33, P1369, DOI 10.1080/00036840010007498; Swindale A., 2006, FHI 360FANTA; Thrupp LA, 2000, INT AFF, V76, P265, DOI 10.1111/1468-2346.00133; Timmer CP, 2000, FOOD POLICY, V25, P283, DOI 10.1016/S0306-9192(00)00007-5; U. S. Government, 2011, GUAT FEED FUT 2011 2; United States Agency for International Development, 2005, STRAT PLAN 2006 2010; von Braun J, 1989, 73 INT FOOD POL RES; Von Braun J, 1986, COMMERCIALIZATION SU; VONBRAUN J, 1989, 75 INT FOOD POL RES; WATTS MJ, 1993, PROG HUM GEOG, V17, P43, DOI 10.1177/030913259301700103; Webb Meghan Farley, 2016, BMC NUTR, V2, P1; Webb P, 2006, J NUTR, V136, P1404; Wiesmann D, 2009, VALIDATION FOOD FREQ; Wood S., 2010, FOOD SECURITY GLOBAL, P46; World Bank, 2009, 43920GT WORLD BANK; *WORLD BANK, 2007, WORLD DEV REP 2008 A; World Food Programme, 2008, FOOD CONS AN CALC US; World Food Programme, 2018, COMPREHENSIVE FOOD S; Zeller M, 2000, FOOD POLICY, V25, P143, DOI 10.1016/S0306-9192(99)00065-2	84	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198113	10.1371/journal.pone.0198113	http://dx.doi.org/10.1371/journal.pone.0198113			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795691	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300126
J	Podyma, B; Sun, H; Wilson, EA; Carlson, B; Pritikin, E; Gavrilova, O; Weinstein, LS; Chen, M				Podyma, Brandon; Sun, Hui; Wilson, Eric A.; Carlson, Bradley; Pritikin, Ethan; Gavrilova, Oksana; Weinstein, Lee S.; Chen, Min			The stimulatory G protein G(s) is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis, and glucose metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heterotrimeric G protein; energy metabolism; mouse genetics; glucose metabolism; cyclic AMP (cAMP); metabolic regulation; neuroscience; signal transduction; G protein-coupled receptor	PSEUDOHYPOPARATHYROIDISM TYPE 1A; BROWN ADIPOSE-TISSUE; G(S)ALPHA DEFICIENCY; PEPTIDE YY; TARGETED DISRUPTION; INSULIN SENSITIVITY; HUMAN OBESITY; FOOD-INTAKE; GNAS GENE; MICE	Central melanocortin 4 receptors (MC4Rs) stimulate energy expenditure and inhibit food intake. MC4Rs activate the G protein G(s), but whether G(s) mediates all MC4R actions has not been established. Individuals with Albright hereditary osteodystrophy (AHO), who have heterozygous G(s)-inactivating mutations, only develop obesity when the G(s) mutation is present on the maternal allele because of tissue-specific genomic imprinting. Furthermore, evidence in mice implicates G(s) imprinting within the central nervous system (CNS) in this disorder. In this study, we examined the effects of G(s) in MC4R-expressing cells on metabolic regulation. Mice with homozygous G(s) deficiency in MC4R-expressing cells (MC4RGsKO) developed significant obesity with increased food intake and decreased energy expenditure, along with impaired insulin sensitivity and cold-induced thermogenesis. Moreover, the ability of the MC4R agonist melanotan-II (MTII) to stimulate energy expenditure and to inhibit food intake was impaired in MC4RGsKO mice. MTII failed to stimulate the secretion of the anorexigenic hormone peptide YY (PYY) from enteroendocrine L cells, a physiological response mediated by MC4R-G(s) signaling, even though baseline PYY levels were elevated in these mice. In G(s) heterozygotes, mild obesity and reduced energy expenditure were present only in mice with a G(s) deletion on the maternal allele in MC4R-expressing cells, whereas food intake was unaffected. These results demonstrate that G(s) signaling in MC4R-expressing cells is required for controlling energy balance, thermogenesis, and peripheral glucose metabolism. They further indicate that G(s) imprinting in MC4R-expressing cells contributes to obesity in G(s) knockout mice and probably in individuals with Albright hereditary osteodystrophy as well.	[Podyma, Brandon; Sun, Hui; Wilson, Eric A.; Carlson, Bradley; Pritikin, Ethan; Weinstein, Lee S.; Chen, Min] NIDDK, Metab Dis Branch, NIH, Bldg 10,Rm 8C101,10 Ctr Dr, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA; [Podyma, Brandon] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Pritikin, Ethan] Univ Chicago, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia; University of Chicago	Weinstein, LS; Chen, M (corresponding author), NIDDK, Metab Dis Branch, NIH, Bldg 10,Rm 8C101,10 Ctr Dr, Bethesda, MD 20892 USA.	leew@mail.nih.gov; minc@niddk.nih.gov		Podyma, Brandon/0000-0002-0849-8726; Carlson, Bradley/0000-0003-3801-8890; Wilson, Eric/0000-0002-0089-2382	Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043315, ZIADK043302, ZICDK070002, ZIADK043313] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole by the Intramural Research Program of NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Sabah S, 2016, MED PRIN PRACT, V25, P15, DOI 10.1159/000433437; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berglund ED, 2014, NAT NEUROSCI, V17, P911, DOI 10.1038/nn.3737; Blevins JE, 2009, AM J PHYSIOL-REG I, V296, pR476, DOI 10.1152/ajpregu.90544.2008; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Cahill F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095235; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen M, 2017, J CLIN INVEST, V127, P500, DOI 10.1172/JCI88622; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 2007, BRAIN RES, V1179, P61, DOI 10.1016/j.brainres.2007.04.006; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Gautron L, 2010, J COMP NEUROL, V518, P6, DOI 10.1002/cne.22221; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Hayes MR, 2011, CELL METAB, V13, P320, DOI 10.1016/j.cmet.2011.02.001; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Holder JL, 2000, HUM MOL GENET, V9, P101; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Li YQ, 2016, P NATL ACAD SCI USA, V113, P446, DOI 10.1073/pnas.1517142113; Li YQ, 2016, J CLIN INVEST, V126, P40, DOI 10.1172/JCI76348; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Long DN, 2007, J CLIN ENDOCR METAB, V92, P1073, DOI 10.1210/jc.2006-1497; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Muniyappa R, 2013, J CLIN ENDOCR METAB, V98, pE1796, DOI 10.1210/jc.2013-1594; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Panaro BL, 2014, CELL METAB, V20, P1018, DOI 10.1016/j.cmet.2014.10.004; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Satoh N, 1998, NEUROSCI LETT, V249, P107, DOI 10.1016/S0304-3940(98)00401-7; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; Sohn JW, 2013, CELL, V152, P612, DOI 10.1016/j.cell.2012.12.022; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Vaughan CH, 2011, BRAIN RES, V1411, P17, DOI 10.1016/j.brainres.2011.07.003; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Williams DL, 2003, ENDOCRINOLOGY, V144, P4692, DOI 10.1210/en.2003-0440; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	46	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10993	11005		10.1074/jbc.RA118.003450	http://dx.doi.org/10.1074/jbc.RA118.003450			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794140	hybrid, Green Published			2022-12-26	WOS:000438882800013
J	Peng, KS; Su, GQ; Ji, JM; Yang, XJ; Miao, MM; Mo, PL; Li, M; Xu, JM; Li, WG; Yu, CD				Peng, Kesong; Su, Guoqiang; Ji, Jinmeng; Yang, Xiaojia; Miao, Mengmeng; Mo, Pingli; Li, Ming; Xu, Jianming; Li, Wengang; Yu, Chundong			Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/-catenin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; colorectal cancer; transcriptional coactivator; histone demethylase; Wnt signaling	HEPATOCELLULAR-CARCINOMA PROGRESSION; INDUCIBLE FACTOR 1-ALPHA; CELL-PROLIFERATION; EXPRESSION; OVEREXPRESSION; JHDM2A; TRANSCRIPTION; COACTIVATION; STATISTICS; MARKER	The histone demethylase Jumonji domain containing 1A (JMJD1A) is overexpressed in multiple tumors and promotes cancer progression. JMJD1A has been shown to promote colorectal cancer (CRC) progression, but its molecular role in CRC is unclear. Here, we report that JMJD1A is overexpressed in CRC specimens and that its expression is positively correlated with that of proliferating cell nuclear antigen (PCNA). JMJD1A knockdown decreased the expression of proliferative genes such as c-Myc, cyclin D1, and PCNA, suppressed CRC cell proliferation, arrested cell cycle progression, and reduced xenograft tumorigenesis. Furthermore, JMJD1A knockdown inhibited CRC cell migration, invasion, and lung metastasis by decreasing matrix metallopeptidase 9 (MMP9) expression and enzymatic activity. Moreover, bioinformatics analysis of GEO profile datasets revealed that JMJD1A expression in human CRC specimens is positively correlated with the expression of Wnt/-catenin target genes, including c-Myc, cyclin D1, and MMP9. Mechanistically, JMJD1A enhanced Wnt/-catenin signaling by promoting -catenin expression and interacting with -catenin to enhance its transactivation. JMJD1A removed the methyl groups of H3K9me2 at the promoters of c-Myc and MMP9 genes. In contrast, the JMJD1A(H1120Y) variant, which lacked demethylase activity, did not demethylate H3K9me2 at these promoters, failed to assist -catenin to induce the expression of Wnt/-catenin target genes, and failed to promote CRC progression. These findings suggest that JMJD1A's demethylase activity is required for Wnt/-catenin activation. Of note, high JMJD1A levels in CRC specimens predicted poor cancer outcomes. In summary, JMJD1A promotes CRC progression by enhancing Wnt/-catenin signaling, implicating JMJD1A as a potential molecular target for CRC management.	[Peng, Kesong; Ji, Jinmeng; Yang, Xiaojia; Miao, Mengmeng; Mo, Pingli; Yu, Chundong] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Su, Guoqiang] Xiamen Univ, Affiliated Hosp 1, Xiamen 361003, Fujian, Peoples R China; [Li, Ming; Li, Wengang] Xiamen Univ, Xiangan Hosp, Xiamen City Key Lab Biliary Tract Dis, Xiamen 361101, Fujian, Peoples R China; [Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Xiamen University; Xiamen University; Xiamen University; Baylor College of Medicine	Yu, CD (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.; Li, WG (corresponding author), Xiamen Univ, Xiangan Hosp, Xiamen City Key Lab Biliary Tract Dis, Xiamen 361101, Fujian, Peoples R China.	lwg11861@163.com; cdyu@xmu.edu.cn			National Basic Research Program of China 973 Program [2015CB553800]; National Natural Science Foundation of China [81772942, U1405225]; Natural Science Foundation of Fujian Province [2015J01548]; Science and Technology Planning Projects of Xiamen Science and Technology Bureau [3502Z20154008]; Science and Technology Planning Projects of Xiamen Health and Family Planning Commission Grant [3502Z20149004]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2018KF008]; National Institutes of Health [R01 CA193455]; CPRIT [RP150197]; NATIONAL CANCER INSTITUTE [R01CA193455] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Science and Technology Planning Projects of Xiamen Science and Technology Bureau; Science and Technology Planning Projects of Xiamen Health and Family Planning Commission Grant; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China 973 Program Grant 2015CB553800 (to C. Y.), National Natural Science Foundation of China Grants 81772942 (to C. Y.) and U1405225 (to C. Y.), Natural Science Foundation of Fujian Province Grant 2015J01548 (to G. S.), Science and Technology Planning Projects of Xiamen Science and Technology Bureau Grant 3502Z20154008 (to G. S.), Science and Technology Planning Projects of Xiamen Health and Family Planning Commission Grant 3502Z20149004 (to G. S.), Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2018KF008 (to G. S.), National Institutes of Health Grant R01 CA193455 (to J. X.), and CPRIT Grant RP150197 (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Birner P, 2000, CANCER RES, V60, P4693; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dimitrova E, 2015, EMBO REP, V16, P1620, DOI 10.15252/embr.201541113; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Goda S, 2013, J BIOL CHEM, V288, P36948, DOI 10.1074/jbc.M113.492595; Kaukonen R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12237; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Lee HY, 2013, CARCINOGENESIS, V34, P2706, DOI 10.1093/carcin/bgt256; Li J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15146; Liu YH, 2012, HEPATOLOGY, V56, P1015, DOI 10.1002/hep.25751; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mo P, 2015, ONCOGENE, V34, P3935, DOI 10.1038/onc.2014.324; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Padi SKR, 2013, GASTROENTEROLOGY, V145, P437, DOI 10.1053/j.gastro.2013.04.012; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Suikki HE, 2010, PROSTATE, V70, P889, DOI 10.1002/pros.21123; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tong ZW, 2015, J BIOL CHEM, V290, P18596, DOI 10.1074/jbc.M115.640490; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Wade MA, 2015, NUCLEIC ACIDS RES, V43, P196, DOI 10.1093/nar/gku1298; Wan W, 2017, ONCOGENE, V36, P3868, DOI 10.1038/onc.2017.13; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Xu Y, 2010, ONCOGENE, V29, P3386, DOI 10.1038/onc.2010.90; Yamada D, 2012, ANN SURG ONCOL, V19, pS355, DOI 10.1245/s10434-011-1797-x; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhao W, 2014, J BIOL CHEM, V289, P11219, DOI 10.1074/jbc.M113.535989; Zhong H, 1999, CANCER RES, V59, P5830	35	32	36	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10606	10619		10.1074/jbc.RA118.001730	http://dx.doi.org/10.1074/jbc.RA118.001730			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29802196	Green Published, hybrid			2022-12-26	WOS:000437828400019
J	Funderburk, L; Peterson, M; Shah, N; Morgan, M; Grandjean, P				Funderburk, LesLee; Peterson, Matthew; Shah, Nish; Morgan, Meredith; Grandjean, Peter			Serum vitamin D and body composition in adults undergoing fitness assessments: A correlation study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; 25-HYDROXYVITAMIN D; D DEFICIENCY; HEALTHY-MEN; MASS; ASSOCIATION; STRENGTH	The purpose of this descriptive study was to assess serum levels of 25(OH) vitamin D-3 (25 (OH) D) in participants who voluntarily participated in a fitness assessment and correlate this with muscular strength, weekly exercise, overall body composition, and dietary intake of vitamin D and calcium. Thirty-six participants were recruited. Anthropometric measurements and handgrip strength were taken with blood analyses completed utilizing 25-hydroxyvitamin D assay. A dietary screening survey was used to assess calcium and vitamin D intake. All data collection was completed at time of assessment appointment. Statistical analyses completed utilized Pearson's and Kendall's Tau correlation, with level of significance set at p < 0.05. Twenty-two percent of our sample were 25(OH) D deficient and 33% 25(OH) D insufficient, with 16% consuming adequate vitamin D and 5% consuming adequate calcium. Eight of the females and one male had below average DXA assessments for bone health. Vitamin D intake was significantly correlated with serum 25(OH) D levels (tau = 0.29, p< 0.01). In females there was an inverse relationship between 25(OH) D and weight (r = -0.45, p< 0.05). Thirtyone percent of participants had higher than desirable waist circumference and were 25(OH) D insufficient or deficient. This sample had a high rate of 25(OH) D insufficiency and deficiency, with most not consuming adequate amounts of calcium and vitamin D. Normalizing serum 25 (OH) D through food and supplements has the potential to positively impact several parameters of an individual's health including weight status, visceral adiposity and waist circumference, and bone health.	[Funderburk, LesLee; Peterson, Matthew; Morgan, Meredith; Grandjean, Peter] Baylor Univ, Robbins Coll Hlth & Human Sci, Waco, TX 76798 USA; [Shah, Nish] Houston Methodist, Orthoped & Sports Med, Sugar Land, TX USA	Baylor University	Funderburk, L (corresponding author), Baylor Univ, Robbins Coll Hlth & Human Sci, Waco, TX 76798 USA.	LesLee_Funderburk@baylor.edu						Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2002, PRACT GUID 2002; [Anonymous], 2016, AUT SELF ADM 24 HOUR; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bergman RN, OBESITY S, V14, p16S; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bliss RM, 2004, AGR RES, V52, P10; Brock K, 2010, J STEROID BIOCHEM, V121, P462, DOI 10.1016/j.jsbmb.2010.03.091; Ceglia L, 2009, CURR OPIN CLIN NUTR, V12, P628, DOI 10.1097/MCO.0b013e328331c707; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; CUMMINGS SR, 1987, AM J EPIDEMIOL, V126, P796, DOI 10.1093/oxfordjournals.aje.a114716; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Durazo-Arvizu RA, 2017, AM J EPIDEMIOL, V185, P720, DOI 10.1093/aje/kww244; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Grimaldi AS, 2013, MED SCI SPORT EXER, V45, P157, DOI 10.1249/MSS.0b013e31826c9a78; Guadalupe-Grau A, 2009, SPORTS MED, V39, P439, DOI 10.2165/00007256-200939060-00002; Gumieiro DN, 2015, NUTRITION, V31, P931, DOI 10.1016/j.nut.2014.12.022; Heyward Vivian H, 2006, ADV FITNESS ASSESSME, P120; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kelly TL, 2012, VISCERAL FAT EVALUAT; Maki KC, 2009, J CLIN LIPIDOL, V3, P289, DOI 10.1016/j.jacl.2009.07.003; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Rock CL, 2012, OBESITY, V20, P2296, DOI 10.1038/oby.2012.57; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; U. S. Department of Health and Human Services and U. S. Department of Agriculture, 2015, 2015 2020 DIET GUID; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; von Hurst PR, 2013, J STEROID BIOCHEM, V136, P330, DOI 10.1016/j.jsbmb.2012.11.015	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197903	10.1371/journal.pone.0197903	http://dx.doi.org/10.1371/journal.pone.0197903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856775	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800049
J	Gouelle, A; Rennie, L; Clark, DJ; Megrot, F; Balasubramanian, CK				Gouelle, Arnaud; Rennie, Linda; Clark, David J.; Megrot, Fabrice; Balasubramanian, Chitralakshmi K.			Addressing limitations of the Gait Variability Index to enhance its applicability: The enhanced GVI (EGVI)	PLOS ONE			English	Article							VALIDITY	Prior research has established the Gait Variability Index (GVI) as a composite measure of gait variability, based on spatiotemporal parameters, that is associated with functional outcomes. However, under certain circumstances the magnitude and directional specificity of the GVI is adversely affected by shortcomings in the calculation method. Here we present an enhanced gait variability index (EGVI) that addresses those shortcomings and improves the utility of the measure. The EGVI was further enhanced by removing some input spatiotemporal variables that captured overlapping/redundant information. The EGVI was used to reanalyze data from four previously published studies that used the original GVI. After removing data affected by the GVI's prior shortcomings, the association between EGVI and GVI values was stronger for the pooled dataset (r(2) = 0.95) and for the individual studies (r(2) = 0.8-0.98). The EGVI also revealed stronger associations between the index value and functional outcomes for some studies. The EGVI successfully addresses shortcomings in the GVI calculation that affected magnitude and directional specificity of the index. We have confirmed the validity of prior published work that used the original GVI, while also demonstrating even stronger results when these prior data were re-analyzed with the EGVI. We recommend that future research should use the EGVI as a composite measure of gait variability.	[Gouelle, Arnaud] ProtoKinetics, Gait & Balance Acad, Havertown, PA 19083 USA; [Gouelle, Arnaud] UFR STAPS Reims, Lab Performance Sante Metrol Soc PSMS, Reims, France; [Rennie, Linda] Sunnaas Rehabil Hosp, Res Dept, Nesodden, Norway; [Clark, David J.] North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr, Gainesville, FL USA; [Clark, David J.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Megrot, Fabrice] Ctr Med Phys & Readaptat Enfants Bois Larris, Unite Clin Anal Marche Mouvement, Lamorlaye, France; [Megrot, Fabrice] UTC, Sorbonne Univ, Biomecan & Bioingn UMR CNRS 7338, Compiegne, France; [Balasubramanian, Chitralakshmi K.] Univ North Florida, Dept Clin & Appl Movement Sci, Jacksonville, FL USA	Universite de Reims Champagne-Ardenne; State University System of Florida; University of Florida; UDICE-French Research Universities; Sorbonne Universite; State University System of Florida; University of North Florida	Gouelle, A (corresponding author), ProtoKinetics, Gait & Balance Acad, Havertown, PA 19083 USA.; Gouelle, A (corresponding author), UFR STAPS Reims, Lab Performance Sante Metrol Soc PSMS, Reims, France.	arnaud.gouelle@gmail.com	Gouelle, Arnaud/H-3030-2014; Balasubramanian, Chitra/GNH-3349-2022; MEGROT, Fabrice/B-8175-2011	Gouelle, Arnaud/0000-0002-2368-8448; MEGROT, Fabrice/0000-0002-6200-6315; Rennie, Linda/0000-0002-1168-5856	NIA NIH HHS [P30 AG028740] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balasubramanian CK, 2015, GAIT POSTURE, V41, P941, DOI 10.1016/j.gaitpost.2015.03.349; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Domholdt E., 2003, REHABILITATION RES P; Fontaine A, 2014, ANN PHYS REHABIL MED, V57, pe336, DOI [10.1016/j.rehab.2014.03.1231, DOI 10.1016/J.REHAB.2014.03.1231]; Gouelle A, 2016, HDB HUMAN MOTION, DOI [10.1007/978-3-319-30808-1_35-1, DOI 10.1007/978-3-319-30808-1_35-1]; Gouelle A, 2016, J MOTOR BEHAV, V48, P249, DOI 10.1080/00222895.2015.1084986; Gouelle A, 2013, GAIT POSTURE, V38, P461, DOI 10.1016/j.gaitpost.2013.01.013; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hordacre B., 2017, J NOV PHYSIOTHER PHY, V4, P14; Kalron M, 2017, PEDIATR NEUROL, V68, P73, DOI 10.1016/j.pediatrneurol.2016.11.004; Phadke CP, 2014, ARCH PHYS MED REHAB, V95, pe86, DOI [10.1016/j.apmr.2014.07.283, DOI 10.1016/J.APMR.2014.07.283]; Remy-Neris O, 2014, NEUROPHYSIOL CLIN, V44, P491, DOI [10.1016/j.neucli.2014.09.003, DOI 10.1016/J.NEUCLI.2014.09.003]; Rennie L, 2018, GAIT POSTURE, V62, P505, DOI 10.1016/j.gaitpost.2018.04.011; Rennie L, 2017, GAIT POSTURE, V54, P311, DOI 10.1016/j.gaitpost.2017.03.023; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Yelnik AP, 2015, ANN PHYS REHABIL MED, V58, P332, DOI 10.1016/j.rehab.2015.08.004	17	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198267	10.1371/journal.pone.0198267	http://dx.doi.org/10.1371/journal.pone.0198267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856818	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800094
J	Rajamanickam, R; Shanmugam, A; Thangavel, R; Devaraj, S; Soundararajan, K; Ponnirul, P; Ramalingam, R; Ganesan, RV; Parasuraman, P; Govindaraju, A				Rajamanickam, Ramachandran; Shanmugam, Achiraman; Thangavel, Rajagopal; Devaraj, Sankarganesh; Soundararajan, Kamalakkannan; Ponnirul, Ponmanickam; Ramalingam, Rajkumar; Ganesan, Ramya Vaideki; Parasuraman, Padmanabhan; Govindaraju, Archunan			Localization of a 2u-globulin in the acinar cells of preputial gland, and confirmation of its binding with farnesol, a putative pheromone, in field rat (Millardia meltada)	PLOS ONE			English	Article							BLACKBUCK ANTELOPE-CERVICAPRA; MAJOR URINARY PROTEINS; PREORBITAL GLAND; MOUSE; ODORANT; IDENTIFICATION; APHRODISIN; SEX; ALPHA(2U)-GLOBULIN; TERRITORIAL	Pheromones, low molecular weight chemical entities that bind to pheromone carrier proteins, are chemical signals that play an important role in the communication system in animals. This has been rather fairly well-studied in the rodents. The preputial gland, a rich source of pheromones in many rodents, contains a low molecular mass protein (18-20 kDa) that acts as one such pheromone carrier. However, the presence of this protein in the notorious rodent pest Millardia meltada has not yet been proven. Therefore, we aimed at identifying this protein, and the pheromones that are bound to it, in this rodent so as to utilize the information in the control of this pest. Twenty volatile compounds were identified in the preputial gland using GC-MS. Total protein of the gland was fractioned by both one and two-dimensional electrophoresis when we identified a low molecular mass protein (19 kDa, pI4.7). Adopting MALDI-TOF MS and LC-MS analyses, the protein was confirmed as a 2u-globulin. To identify the volatiles bound to this protein, we used column chromatography and GC-MS. We found that farnesol and 6-methyl-1-heptanol are the volatiles that would bind to the protein, which we propose to be putative pheromones. Immunohistochemical analysis confirmed localization of a 2u-globulin in the acinar cells of the preputial gland. Thus, we show that a 2u-globulin, a pheromone-carrier protein, is present in the preputial gland acinar cells of M. meltada and suggest farnesol and 6-methyl-1-heptanol to be the volatiles which would bind to it. The a 2u-globulin together with farnesol and 6-methyl-1-heptanol contribute to pheromonal communication of M. meltada.	[Rajamanickam, Ramachandran; Shanmugam, Achiraman; Devaraj, Sankarganesh] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Shanmugam, Achiraman; Thangavel, Rajagopal; Ponnirul, Ponmanickam; Ramalingam, Rajkumar; Govindaraju, Archunan] Bharathidasan Univ, Ctr Pheromone Technol, Dept Anim Sci, Tiruchirappalli, Tamil Nadu, India; [Thangavel, Rajagopal; Ganesan, Ramya Vaideki] Thiagarajar Coll Autonomous, Post Grad & Res Dept Zool & Microbiol, Madurai, Tamil Nadu, India; [Soundararajan, Kamalakkannan] Bishop Heber Coll Autonomous, Dept Zool, Tiruchirappalli, Tamil Nadu, India; [Ponnirul, Ponmanickam] Ayya Nadar Janaki Ammal Coll Autonomous, Dept Zool, Sivakasi, Tamil Nadu, India; [Ramalingam, Rajkumar] IMB, Nucl Dynam & Architecture Lab, Singapore, Singapore; [Parasuraman, Padmanabhan] Nanyang Technol Univ, Lee Kong Chian Sch Med, Translat Neurosci Lab, Singapore, Singapore	Bharathidasan University; Bharathidasan University; Thiagarajar College; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Shanmugam, A (corresponding author), Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India.; Shanmugam, A; Govindaraju, A (corresponding author), Bharathidasan Univ, Ctr Pheromone Technol, Dept Anim Sci, Tiruchirappalli, Tamil Nadu, India.; Parasuraman, P (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Translat Neurosci Lab, Singapore, Singapore.	achiramans@gmail.com; ppadmanabhan1@gmail.com; garchu56@yahoo.co.in	PADMANABHAN, PARASURAMAN/AAC-1062-2021; Rajagopal, Thangavel/ABX-4192-2022; Devaraj, Sankar Ganesh/AAD-2498-2022; Rajamanickam, Ramachandran/CAF-3767-2022; PONNIRUL, PONMANICKAM/AAI-3256-2020; GOVINDARAJU, ARCHUNAN/A-9072-2019	PADMANABHAN, PARASURAMAN/0000-0003-4112-4600; Rajagopal, Thangavel/0000-0001-7380-8092; Rajamanickam, Ramachandran/0000-0002-3817-7704; PONNIRUL, PONMANICKAM/0000-0002-3277-3919; GOVINDARAJU, ARCHUNAN/0000-0002-7094-0351; Devaraj, Sankar Ganesh/0000-0001-7200-7816	University Grants Commission [36-54/2008 (SR), F.18-1/2011(BSR)]; Department of Science and Technology-Fast Track proposal for Young Scientists [DST-Fast] [Track-SR/FT/LS-147]; Council of Scientific and Industrial Research [23 (0017/10/EMR-II)]; Council of Scientific and Industrial Research-Research Associateship [CSIR-RA-23(0017/10/EMR-II]; University Grants Commission-Research award [UGC-RA-30-47/2016(SA-II)]; Department of Science and Technology-Fund for Improvement of S&T infrastructure in universities & higher educational institutions [DST-FISTSR/FST/LSI-687/2016]; University Grants Commission-Special Assistance Programme [5-5/2016/DRS-1(SAP-II)]; UGC-SAP [F.3-9/2013(SAP-II)]; DST-FIST level 1 [SR-FST-LSI-647/2015]	University Grants Commission(University Grants Commission, India); Department of Science and Technology-Fast Track proposal for Young Scientists [DST-Fast]; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research-Research Associateship; University Grants Commission-Research award; Department of Science and Technology-Fund for Improvement of S&T infrastructure in universities & higher educational institutions; University Grants Commission-Special Assistance Programme; UGC-SAP(University Grants Commission, India); DST-FIST level 1(Department of Science & Technology (India))	AS gratefully acknowledges the funding agencies such as University Grants Commission [36-54/2008 (SR)], Department of Science and Technology-Fast Track proposal for Young Scientists [DST-Fast Track-SR/FT/LS-147, 2009], Council of Scientific and Industrial Research [23 (0017/10/EMR-II), 2010], Council of Scientific and Industrial Research-Research Associateship [CSIR-RA-23(0017/10/EMR-II], 2005) and University Grants Commission-Research award [UGC-RA-30-47/2016(SA-II)] for financial assistance and award respectively. Further, the research facility availed through Department of Science and Technology -Fund for Improvement of S&T infrastructure in universities & higher educational institutions [DST-FISTSR/FST/LSI-687/2016], and University Grants Commission-Special Assistance Programme [5-5/2016/DRS-1(SAP-II)] is acknowledged. AG acknowledges with thanks University Grants Commission for the award of UGC-Basic Science Research Faculty Fellowship [No.F.18-1/2011(BSR),2017], UGC-SAP [No.F.3-9/2013(SAP-II)] and DST-FIST level 1[SR-FST-LSI-647/2015] for the research facilities availed.	Achiraman S., 2002, Indian Journal of Experimental Biology, V40, P1077; Achiraman S, 2011, THERIOGENOLOGY, V76, P1676, DOI 10.1016/j.theriogenology.2011.06.033; Agungpriyono S, 2006, ANAT HISTOL EMBRYOL, V35, P325, DOI 10.1111/j.1439-0264.2006.00691.x; Archunan G., 2009, Journal of Experimental Zoology India, V12, P227; Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; Atoji Y, 1996, EUR J MORPHOL, V34, P87; ATOJI Y, 1989, J SUBMICR CYTOL PATH, V21, P375; BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Beynon RJ, 2004, PEPTIDES, V25, P1553, DOI 10.1016/j.peptides.2003.12.025; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Briand L, 2004, PEPTIDES, V25, P1545, DOI 10.1016/j.peptides.2003.10.026; Briand L, 2000, FEBS LETT, V476, P179, DOI 10.1016/S0014-5793(00)01719-1; Burger BV, 2008, J CHEM ECOL, V34, P659, DOI 10.1007/s10886-008-9462-y; Cavaggioni A, 1999, ARCH ITAL BIOL, V137, P193; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; COHEN M, 1976, Journal of the South African Veterinary Association, V47, P35; D'Innocenzo B, 2006, BIOCHEMISTRY-US, V45, P13418, DOI 10.1021/bi061409p; DINH BAO-LMH, 1965, J IMMUNOL, V95, P574; Dominic CJ, 1991, J SCI RES BANARAS, V41, P157; Fernald RD, 2014, CURR OPIN NEUROBIOL, V28, P1, DOI 10.1016/j.conb.2014.04.004; Flower DR, 1996, BIOCHEM J, V318, P1; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ilayaraja R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05201; Kannan S, 1998, CURR SCI INDIA, V74, P689; KUHN HJ, 1976, Z SAUGETIERKD, V41, P369; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakshmi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135507; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; MAINOYA JR, 1978, E AFR WILDL J, V16, P265; Marchese S, 1998, EUR J BIOCHEM, V252, P563, DOI 10.1046/j.1432-1327.1998.2520563.x; Mastrogiacomo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111932; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Odland GF, 1966, SKIN, P420; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; PIETRAS RJ, 1981, CHEM SENSES, V6, P391, DOI 10.1093/chemse/6.4.391; PoddarSarkar M, 1996, J LIPID MEDIAT CELL, V15, P89, DOI 10.1016/S0929-7855(96)00547-0; Ponmanickam P, 2010, GEN COMP ENDOCR, V167, P35, DOI 10.1016/j.ygcen.2010.03.001; Rajagopal T, 2015, INDIAN J EXP BIOL, V53, P771; Rajagopal T, 2011, BIOLOGIA, V66, P370, DOI 10.2478/s11756-011-0015-4; Rajkumar R, 2010, RAPID COMMUN MASS SP, V24, P3248, DOI 10.1002/rcm.4766; Rajkumar R, 2010, RAPID COMMUN MASS SP, V24, P721, DOI 10.1002/rcm.4437; Rajkumar R, 2009, INDIAN J BIOCHEM BIO, V46, P319; Rajkumar R, 2010, PROTEIN PEPTIDE LETT, V17, P449, DOI 10.2174/092986610790963573; RICHTER J, 1971, Zeitschrift fuer Saeugetierkunde, V36, P334; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; Sokolov VE, 1994, SKIN SOME ETHIOPIAN, P194; Stoddart DM., 1980, ECOLOGY VERTEBRATE O; Stopkova R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-45; Zeng CH, 1996, P NATL ACAD SCI USA, V93, P6626, DOI 10.1073/pnas.93.13.6626; Zhang JX, 2008, CHEM SENSES, V33, P611, DOI 10.1093/chemse/bjn028; Zhang JX, 2007, CHEM SENSES, V32, P293, DOI 10.1093/chemse/bjl058	52	1	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197287	10.1371/journal.pone.0197287	http://dx.doi.org/10.1371/journal.pone.0197287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856754	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800016
J	Templeton, CA; Strzalkowski, NDJ; Galvin, P; Bent, LR				Templeton, Cale A.; Strzalkowski, Nicholas D. J.; Galvin, Patti; Bent, Leah R.			Cutaneous sensitivity in unilateral trans-tibial amputees	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; UPPER-EXTREMITY AMPUTEES; TACTILE SPATIAL ACUITY; DURATION SPACE-FLIGHT; LOWER-LIMB AMPUTATION; CORTICAL REORGANIZATION; MUSCLE-ACTIVITY; STRING PLAYERS; FOOT SOLE; SENSATION	Aim To examine tactile sensitivity in the leg and foot sole of below-knee amputees (diabetic n = 3, traumatic n = 1), and healthy control subjects (n = 4), and examine the association between sensation and balance. Method Vibration perception threshold (VPT; 3, 40, 250Hz) and monofilaments (MF) were used to examine vibration and light touch sensitivity on the intact limb, residual limb, and homologous locations on controls. A functional reach test was performed to assess functional balance. Results Tactile sensitivity was lower for diabetic amputee subjects compared to age matched controls for both VPT and MF; which was expected due to presence of diabetic peripheral neuropathy. In contrast, the traumatic amputee participant showed increased sensitivity for VPT at 40Hz and 250Hz vibration in both the intact and residual limbs compared to controls. Amputees with lower tactile sensitivity had shorter reach distances compared to those with higher sensitivity. Conclusion Changes in tactile sensitivity in the residual limb of trans-tibial amputees may have implications for the interaction between the amputee and the prosthetic device. The decreased skin sensitivity observed in the residual limb of subjects with diabetes is of concern as changes in skin sensitivity may be important in 1) identification/prevention of excessive pressure and 2) for functional stability. Interestingly, we saw increased residual limb skin sensitivity in the individual with the traumatic amputation. Although not measured directly in the present study, this increase in tactile sensitivity may be related to cortical reorganisation, which is known to occur following amputation, and would support similar findings observed in upper limb amputees.	[Templeton, Cale A.; Strzalkowski, Nicholas D. J.; Bent, Leah R.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada; [Strzalkowski, Nicholas D. J.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Galvin, Patti] Wellington Ortho & Rehab, Guelph, ON, Canada	University of Guelph; University of Calgary	Bent, LR (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada.	lbent@uoguelph.ca						AFTANAS M, 1964, CAN J PSYCHOLOGY, V18, P101, DOI 10.1037/h0083286; Aimonetti JM, 2007, J PHYSIOL-LONDON, V580, P649, DOI 10.1113/jphysiol.2006.123075; Bjorkman A, 2004, EUR J NEUROSCI, V20, P2733, DOI 10.1111/j.1460-9568.2004.03742.x; Bjorkman A, 2009, EUR J NEUROSCI, V29, P837, DOI 10.1111/j.1460-9568.2009.06629.x; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; BRAUNE S, 1993, J NEUROL NEUROSUR PS, V56, P393, DOI 10.1136/jnnp.56.4.393; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CALFORD MB, 1991, SOMATOSENS MOT RES, V8, P249, DOI 10.3109/08990229109144748; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; Carrington AL, 2001, CLIN SCI, V101, P261, DOI 10.1042/CS20010018; Dahlin LB, 2008, DIABETIC MED, V25, P543, DOI 10.1111/j.1464-5491.2008.02433.x; Dillon YK, 2001, J ANAT, V199, P577, DOI 10.1046/j.1469-7580.2001.19950577.x; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; Galica AM, 2009, GAIT POSTURE, V30, P383, DOI 10.1016/j.gaitpost.2009.07.005; Gescheider GA, 2004, BEHAV BRAIN RES, V148, P35, DOI 10.1016/S0166-4328(03)00177-3; GEURTS ACH, 1992, SCAND J REHABIL MED, V24, P83; HABER WB, 1958, ANN NY ACAD SCI, V74, P14, DOI 10.1111/j.1749-6632.1958.tb39524.x; Hashimoto I, 2004, CLIN NEUROPHYSIOL, V115, P435, DOI 10.1016/S1388-2457(03)00340-7; Hohne A, 2012, EUR J APPL PHYSIOL, V112, P3829, DOI 10.1007/s00421-012-2364-2; Hohne A, 2011, J BIOMECH, V44, P2194, DOI 10.1016/j.jbiomech.2011.06.012; Inglis JT, 2002, ADV EXP MED BIOL, V508, P111; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Karl A, 2004, PAIN, V110, P90, DOI 10.1016/j.pain.2004.03.013; Kars H J J Cojanne, 2009, J Diabetes Sci Technol, V3, P931; Kavounoudias A, 2005, ARCH PHYS MED REHAB, V86, P633, DOI 10.1016/j.apmr.2004.10.030; Kosasih JB, 1998, J REHABIL RES DEV, V35, P85; Lowrey CR, 2014, J APPL PHYSIOL, V116, P683, DOI 10.1152/japplphysiol.01200.2013; Lundborg GN, 2010, DIABETIC MED, V27, P823, DOI 10.1111/j.1464-5491.2010.03014.x; Macefield VG, 2005, CLIN EXP PHARMACOL P, V32, P135, DOI 10.1111/j.1440-1681.2005.04143.x; Makin TR, 2015, BRAIN, V138, P2140, DOI 10.1093/brain/awv161; McKeon PO, 2007, SOMATOSENS MOT RES, V24, P171, DOI 10.1080/08990220701637224; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Novak P, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-9; Nurse MA, 2001, CLIN BIOMECH, V16, P719, DOI 10.1016/S0268-0033(01)00090-0; Perry SD, 2006, NEUROSCI LETT, V392, P62, DOI 10.1016/j.neulet.2005.08.060; Peters RM, 2009, J NEUROSCI, V29, P15756, DOI 10.1523/JNEUROSCI.3684-09.2009; Pratorius B, 2003, NEUROSCI LETT, V346, P173, DOI 10.1016/S0304-3940(03)00582-2; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Quai TM, 2005, CLIN REHABIL, V19, P668, DOI 10.1191/0269215505cr857oa; Rajabally YA, 2011, ACTA NEUROL SCAND, V124, P1, DOI 10.1111/j.1600-0404.2010.01425.x; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012; Strzalkowski NDJ, 2017, J NEUROPHYSIOL, V118, P1931, DOI 10.1152/jn.00647.2016; Strzalkowski NDJ, 2015, J NEUROPHYSIOL, V114, P2144, DOI 10.1152/jn.00524.2015; Strzalkowski NDJ, 2015, NEUROSCI LETT, V592, P94, DOI 10.1016/j.neulet.2015.02.046; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Trulsson M, 2001, EXP BRAIN RES, V137, P111, DOI 10.1007/s002210000649; Werhahn KJ, 2002, NAT NEUROSCI, V5, P936, DOI 10.1038/nn917	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197557	10.1371/journal.pone.0197557	http://dx.doi.org/10.1371/journal.pone.0197557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856766	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800031
J	Choi, S; Choi, JA; Kwon, JW; Park, SM; Jee, D				Choi, Seulggie; Choi, Jin A.; Kwon, Jin Woo; Park, Sang Min; Jee, Donghyun			Utility values for glaucoma patients in Korea	PLOS ONE			English	Article							QUALITY-OF-LIFE; NUTRITION EXAMINATION SURVEY; ANGLE-CLOSURE GLAUCOMA; NATIONAL-HEALTH; POPULATION; PREVALENCE; EUROQOL; EQ-5D	Objectives Although determining the quality of life among glaucoma patients has important clinical and public health implications, the utility value of glaucoma patients has not yet been determined in Korea. Methods The Korean National Health and Nutrition Examination Survey database was used to identify 833 glaucoma patients based on ophthalmologic examinations. The adjusted mean utility values, calculated by EuroQol-5D (EQ-5D-3L), of glaucoma patients according to patient demographics and measures of glaucoma severity were determined using multivariate linear regression analysis. Results The mean utility value of glaucoma patients was 0.8968. Patients aged 70 years or more had significantly lower utility value (0.86, p value 0.005) compared to those aged less than 50 years (0.96). Patients within the lowest quartile of income had a utility value of 0.87, compared to a utility value of 0.96 for those within the highest quartile (p value 0.001). Patients who were not married had lower utility value (0.87) compared to married patients (0.93). Patients within the lowest quartile of worse eye frequency doubling technology (FDT) score had lower utility value (0.88) compared to those within the highest quartile (0.94). Finally, bilateral vision loss patients had significantly lower utility value (0.83, p value 0.013) compared to patients without vision loss (0.92). Conclusion The present study assessed utility values of Korean glaucoma patients. The quality of life determined by EQ-5D-3L in Korean glaucoma patients was higher compared to those in other countries. Patient demographics as well as measures of disease severity were important factors in determining the quality of life within glaucoma patients.	[Choi, Seulggie; Park, Sang Min] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Choi, Jin A.; Kwon, Jin Woo; Jee, Donghyun] Catholic Univ Korea, Coll Med, St Vincents Hosp, Div Vitreous & Retina,Dept Ophthalmol, Suwon, South Korea; [Park, Sang Min] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Catholic University of Korea; Seoul National University (SNU); Seoul National University Hospital	Jee, D (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Div Vitreous & Retina,Dept Ophthalmol, Suwon, South Korea.	donghyunjee@catholic.ac.kr	Park, Sang Min/V-9194-2019	Kwon, Jin-woo/0000-0003-2093-4284	National Evidence-based Healthcare Collaborating Agency of Korea [HC16C2299]	National Evidence-based Healthcare Collaborating Agency of Korea	This study was funded by the National Evidence-based Healthcare Collaborating Agency of Korea (Grant title: Cost-effectiveness analysis of glaucoma screening and management, Grant number: HC16C2299, URL:http://www.neca.re.kr/eng/). The funding organization had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alsagoff Z, 2000, OPHTHALMOLOGY, V107, P2300, DOI 10.1016/S0161-6420(00)00385-7; Aspinall PA, 2008, INVEST OPHTH VIS SCI, V49, P1907, DOI 10.1167/iovs.07-0559; Bozzani FM, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-43; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brown MM, 2002, BRIT J OPHTHALMOL, V86, P8, DOI 10.1136/bjo.86.1.8; Chen PP, 2015, OPHTHALMOLOGY, V122, P1294, DOI 10.1016/j.ophtha.2015.03.021; Cheng HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163123; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gupta V, 2005, BRIT J OPHTHALMOL, V89, P1241, DOI 10.1136/bjo.2005.068858; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim YY, 2012, ARCH OPHTHALMOL-CHIC, V130, P1177, DOI 10.1001/archophthalmol.2012.1470; Kobelt G, 2006, ACTA OPHTHALMOL SCAN, V84, P363, DOI 10.1111/j.1600-0420.2005.00621.x; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; McDowell I., 2006, Measuring health: a guide to rating scales and questionnaires; Guedes RAP, 2014, CLIN OPHTHALMOL, V8, P529, DOI 10.2147/OPTH.S60105; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rim THT, 2014, ACTA OPHTHALMOL, V92, pe317, DOI 10.1111/aos.12355; Saw SM, 2005, J GLAUCOMA, V14, P455, DOI 10.1097/01.ijg.0000185434.08051.82; Seo SJ, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1690256; Thygesen J, 2008, CURR MED RES OPIN, V24, P1763, DOI 10.1185/03007990802111068; Tosh J, 2012, VALUE HEALTH, V15, P118, DOI 10.1016/j.jval.2011.08.002; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zanlonghi X, 2003, J FR OPHTALMOL, V26, pS39	26	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197581	10.1371/journal.pone.0197581	http://dx.doi.org/10.1371/journal.pone.0197581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847608	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800038
J	Harwell, KW; Boot, WR; Ericsson, KA				Harwell, Kyle W.; Boot, Walter R.; Ericsson, K. Anders			Looking behind the score: Skill structure explains sex differences in skilled video game performance	PLOS ONE			English	Article							MENTAL ROTATION; GENDER-DIFFERENCES; EXPERT PERFORMANCE; SPATIAL ABILITY; STRATEGIES; WOMEN	Some have explained large sex differences in visuospatial abilities by genetic adaptations to different roles in primitive hunter-gatherer societies and the interaction of innate biological differences and environmental factors. We explored the extent to which variations in behavior and acquired skills can provide alternative accounts for sex differences in the performance of a complex spatially-demanding video game (Space Fortress). Men and women with limited video game experience were given 30 hours of training, and latent curve analyses examined the development of their ship control performance and behavior. Men had significantly better control performance than women before and after training, but differences diminished substantially over the training period. An analysis of participants' joystick behaviors revealed that initially men and women relied on different patterns of control behaviors, but changes in these behaviors over time accounted for the reduced sex differences in performance. When we controlled for these differences in behavior, sex effects after training were no longer significant. Finally, examining the development of control performance and control behaviors of men and women categorized as initially high and low performers revealed the lower-performing women may have been controlling their ship using an approach that was very different from the men and higher-performing women. The potential problems of analyzing men and women's spatial performance as homogenous groups are discussed, as well as how these issues may account for sex differences in skilled video game performance and perhaps other domains involving spatial abilities.	[Harwell, Kyle W.; Boot, Walter R.; Ericsson, K. Anders] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Harwell, KW (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	harwell@psy.fsu.edu		Harwell, Kyle/0000-0003-3000-5104	Office of Naval Research [N00014-07-1-1913]	Office of Naval Research(Office of Naval Research)	Original data collection by W. R. B. was supported through the Office of Naval Research, grant number N00014-07-1-1913. The funders had no role in the present study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astur RS, 2016, BEHAV BRAIN RES, V308, P236, DOI 10.1016/j.bbr.2016.04.037; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boone AP, 2017, J EXP PSYCHOL LEARN, V43, P1005, DOI 10.1037/xlm0000370; Boot WR, 2017, TOP COGN SCI, V9, P413, DOI 10.1111/tops.12230; Cherney ID, 2004, PERCEPT MOTOR SKILL, V98, P1269, DOI 10.2466/PMS.98.4.1269-1282; Destefano M., 2016, P 38 ANN C COGN SCI, P668; DONCHIN E, 1989, ACTA PSYCHOL, V71, P1, DOI 10.1016/0001-6918(89)90002-4; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P683; Ericsson KA, 2014, INTELLIGENCE, V45, P81, DOI 10.1016/j.intell.2013.12.001; Estes Z, 2012, ARCH SEX BEHAV, V41, P557, DOI 10.1007/s10508-011-9875-5; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Geiser C, 2006, MULTIVAR BEHAV RES, V41, P261, DOI 10.1207/s15327906mbr4103_2; Geiser C, 2008, LEARN INDIVID DIFFER, V18, P419, DOI 10.1016/j.lindif.2007.09.001; Gray WD, 2017, TOP COGN SCI, V9, P289, DOI 10.1111/tops.12260; Gray WD, 2017, CURR DIR PSYCHOL SCI, V26, P59, DOI 10.1177/0963721416672904; Green CS, 2015, CURR OPIN BEHAV SCI, V4, P103, DOI 10.1016/j.cobeha.2015.04.012; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Heil M, 2008, Q J EXP PSYCHOL, V61, P683, DOI 10.1080/17470210701822967; Heil M, 2011, BIOL PSYCHOL, V86, P90, DOI 10.1016/j.biopsycho.2010.11.002; Hopp T, 2017, SIMULAT GAMING, V48, P338, DOI 10.1177/1046878117693397; Hyde JS, 2016, CURR OPIN NEUROBIOL, V38, P53, DOI 10.1016/j.conb.2016.02.007; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Lee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123259; Lee H, 2012, ACTA PSYCHOL, V139, P146, DOI 10.1016/j.actpsy.2011.11.003; Levine SC, 2016, WIRES COGN SCI, V7, P127, DOI 10.1002/wcs.1380; Lindstedt JK, 2015, BEHAV RES METHODS, V47, P945, DOI 10.3758/s13428-014-0547-y; Lucas K, 2004, COMMUN RES, V31, P499, DOI 10.1177/0093650204267930; Maeda Y, 2013, EDUC PSYCHOL REV, V25, P69, DOI 10.1007/s10648-012-9215-x; Miller DI, 2014, TRENDS COGN SCI, V18, P37, DOI 10.1016/j.tics.2013.10.011; Moe A, 2006, LEARN INDIVID DIFFER, V16, P369, DOI 10.1016/j.lindif.2007.01.002; Moe A, 2016, INTELLIGENCE, V59, P16, DOI 10.1016/j.intell.2016.10.004; Nowak NT, 2015, J ENVIRON PSYCHOL, V43, P136, DOI 10.1016/j.jenvp.2015.06.007; Okagaki L, 1996, INTERACTING VIDEO, V11, P115; Pletzer B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00425; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; R Core Team, 2021, R LANGUAGE ENV STAT; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; Silverman I., 1992, ADAPTED MIND EVOLUTI, P533; Silverman I, 2007, ARCH SEX BEHAV, V36, P261, DOI 10.1007/s10508-006-9168-6; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; Spence I, 2009, J EXP PSYCHOL LEARN, V35, P1097, DOI 10.1037/a0015641; Terlecki MS, 2008, APPL COGNITIVE PSYCH, V22, P996, DOI 10.1002/acp.1420; Terlecki MS, 2005, SEX ROLES, V53, P433, DOI 10.1007/s11199-005-6765-0; Towne TJ, 2016, ACTA PSYCHOL, V169, P27, DOI 10.1016/j.actpsy.2016.05.006; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; Wai J, 2009, J EDUC PSYCHOL, V101, P817, DOI 10.1037/a0016127	49	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197311	10.1371/journal.pone.0197311	http://dx.doi.org/10.1371/journal.pone.0197311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847565	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800028
J	Bekkelund, SI; Johnsen, SH				Bekkelund, Svein Ivar; Johnsen, Stein Harald			Creatine kinase is associated with reduced inflammation in a general population: The Tromso study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; SKELETAL-MUSCLE; OBESITY; INTERLEUKIN-6; EXPRESSION; EXERCISE	Background Creatine kinase (CK) has been associated with reduced inflammation in obesity while inflammation is associated with obesity-related cardiovascular diseases. We investigated the relationship between CK and high sensitive C-reactive protein (hs-CRP) in a general population. Methods CK and hs-CRP were measured in the population-based Tromso study that included entire birth cohorts and random samples of citizens between 30-87 years of age. The analyses were performed sex-stratified in 5969 men and 6827 women. Results CK correlated negatively with hs-CRP in men (r = -0.08, P < 0.001) and women (r = -0.06, P < 0.001). In univariable regression analyses, CK associated negatively with hs-CRP in men (u = -0.14, 95% CI -0.19 to -0.10, P < 0.001) and women (u = -0.13, 95% CI -0.18 to -0.08, P < 0.001). Mean CK declined from the 2. to the 4. quartiles of hs-CRP in both genders (P < 0.001 for trends). There were positive correlations between CK and body mass index (BMI) in men (r = 0.10, P < 0.001) and women (r = 0.07, P < 0.001). Multiple regression analyses showed a 0.13 unit decrease in hs-CRP (mg/dl) per unit CK increase in men (95% CI -0.35 to -0.20) and 0.29 mg/dl in women (95% CI -0.36 to -0.21) when adjusted for age, BMI, lipids, s-glucose, s-creatinine, transaminases and coronary heart disease. Conclusion CK were inversely and independently associated with hs-CRP in a general population. These data provide evidence that CK might have anti-inflammatory properties, but the mechanism and clinical implications are unclarified.	[Bekkelund, Svein Ivar; Johnsen, Stein Harald] Univ Hosp North Norway, Dept Neurol, Tromso, Norway; [Bekkelund, Svein Ivar; Johnsen, Stein Harald] Arctic Univ Norway, Dept Clin Med, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Bekkelund, SI (corresponding author), Univ Hosp North Norway, Dept Neurol, Tromso, Norway.; Bekkelund, SI (corresponding author), Arctic Univ Norway, Dept Clin Med, Tromso, Norway.	svein.ivar.bekkelund@unn.no			UiT The Arctic University of Norway	UiT The Arctic University of Norway	The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman H, 2011, AGE AGEING, V40, P469, DOI 10.1093/ageing/afr040; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Bekkelund SI, 2018, SCAND J CLIN LAB INV, V78, P43, DOI 10.1080/00365513.2017.1408140; Bekkelund SI, 2017, EUR J CLIN INVEST, V47, P803, DOI 10.1111/eci.12802; Brooks GC, 2010, AM J CARDIOL, V106, P56, DOI 10.1016/j.amjcard.2010.02.017; Catapano AL, 2017, BRIT J PHARMACOL, V174, P3973, DOI 10.1111/bph.13805; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Dagdeviren S, 2016, MOL CELL BIOL, V36, P2956, DOI 10.1128/MCB.00181-16; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Ding D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135713; Dutra MT, 2017, CLIN PHYSIOL FUNCT I, V37, P205, DOI 10.1111/cpf.12287; Eggen AE, 2013, SCAND J PUBLIC HEALT, V41, P65, DOI 10.1177/1403494812469851; Fernandez C, 2006, NEUROLOGY, V66, P1585, DOI 10.1212/01.wnl.0000216144.69630.6e; Fornari R, 2015, J ENDOCRINOL INVEST, V38, P367, DOI 10.1007/s40618-014-0189-z; George MD, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004344; Haan YC, 2017, MOL CELL ENDOCRINOL, V442, P24, DOI 10.1016/j.mce.2016.11.022; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242; Johnsen SH, 2014, J CLIN HYPERTENS, V16, P820, DOI 10.1111/jch.12422; Kennedy AP, 2009, OBESITY, V17, P2094, DOI 10.1038/oby.2009.101; Lee YH, 2000, CLIN RHEUMATOL, V19, P296, DOI 10.1007/s100670070049; Lilleng H, 2011, NEUROMUSCULAR DISORD, V21, P494, DOI 10.1016/j.nmd.2011.04.007; Muller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30030; Pedersen L, 2012, ADIPOCYTE, V1, P164, DOI 10.4161/adip.20344; Prado CM, 2015, CURR OPIN CLIN NUTR, V18, P535, DOI 10.1097/MCO.0000000000000216; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Rocha-Rodrigues S, 2016, LIFE SCI, V165, P100, DOI [10.1016/j.lfs.2016.09.023, 10.1016/j.lfs.2016.0]; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Sanmarti R, 1996, J RHEUMATOL, V23, P310; Sharabiani MTA, 2011, BIOMARKERS, V16, P243, DOI 10.3109/1354750X.2010.547948; Simental-Mendia LE, 2012, INFLAMMATION, V35, P1742, DOI 10.1007/s10753-012-9492-z; Tajra V, 2014, J SCI MED SPORT, V17, P662, DOI 10.1016/j.jsams.2013.09.012; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	37	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198133	10.1371/journal.pone.0198133	http://dx.doi.org/10.1371/journal.pone.0198133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813131	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800047
J	Rakhi, NK; Tuwani, R; Mukherjee, J; Bagler, G				Rakhi, N. K.; Tuwani, Rudraksh; Mukherjee, Jagriti; Bagler, Ganesh			Data-driven analysis of biomedical literature suggests broad-spectrum benefits of culinary herbs and spices	PLOS ONE			English	Article							DIABETES-MELLITUS; FOODS; MANAGEMENT; DISCOVERY; DISEASES; UPDATE; OIL	Spices and herbs are key dietary ingredients used across cultures worldwide. Beyond their use as flavoring and coloring agents, the popularity of these aromatic plant products in culinary preparations has been attributed to their antimicrobial properties. Last few decades have witnessed an exponential growth of biomedical literature investigating the impact of spices and herbs on health, presenting an opportunity to mine for patterns from empirical evidence. Systematic investigation of empirical evidence to enumerate the health consequences of culinary herbs and spices can provide valuable insights into their therapeutic utility. We implemented a text mining protocol to assess the health impact of spices by assimilating, both, their positive and negative effects. We conclude that spices show broad-spectrum benevolence across a range of disease categories in contrast to negative effects that are comparatively narrow-spectrum. We also implement a strategy for disease-specific culinary recommendations of spices based on their therapeutic tradeoff against adverse effects. Further by integrating spice-phytochemical-disease associations, we identify bioactive spice phytochemicals potentially involved in their therapeutic effects. Our study provides a systems perspective on health effects of culinary spices and herbs with applications for dietary recommendations as well as identification of phytochemicals potentially involved in underlying molecular mechanisms.	[Rakhi, N. K.; Tuwani, Rudraksh; Mukherjee, Jagriti; Bagler, Ganesh] Indraprastha Inst Informat Technol IIIT Delhi, Ctr Computat Biol, New Delhi, India; [Rakhi, N. K.] Indian Inst Technol Jodhpur, Dept Biosci & Bioengn, Jodhpur, Rajasthan, India	Indraprastha Institute of Information Technology Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur	Bagler, G (corresponding author), Indraprastha Inst Informat Technol IIIT Delhi, Ctr Computat Biol, New Delhi, India.	ganesh.bagler@gmail.com	Bagler, Ganesh/A-1102-2009	Bagler, Ganesh/0000-0003-1924-6070	Ministry of Human Resource Development, Government of India; Indian Institute of Technology Jodhpur	Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); Indian Institute of Technology Jodhpur	This work was supported by a senior research fellowship from the Ministry of Human Resource Development, Government of India and Indian Institute of Technology Jodhpur to NKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afendi FM, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr165; Bayan L, 2014, AVICENNA J PHYTOMEDI, V4, P1; Bi XY, 2017, FOOD CHEM, V217, P281, DOI 10.1016/j.foodchem.2016.08.111; Billing J, 1998, Q REV BIOL, V73, P3, DOI 10.1086/420058; Chiu B, 2016, P 15 WORKSH BIOM NAT, P166; Choi W, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw011; Chopan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169876; Curcumin N., 2017, CRIT REV FOOD SCI NU, V57, P2889, DOI [10.1080/10.1016/j.jff.2015.06.018, DOI 10.1080/10.1016/J.JFF.2015.06.018]; Davis AP, 2017, NUCLEIC ACIDS RES, V45, pD972, DOI 10.1093/nar/gkw838; Devarajan Agilandeswari, 2017, Pharmacogn Rev, V11, P73, DOI 10.4103/phrev.phrev_13_17; Doss HM, 2016, CHEM-BIOL INTERACT, V258, P175, DOI 10.1016/j.cbi.2016.09.003; Fonseca-Azevedo K, 2012, P NATL ACAD SCI USA, V109, P18571, DOI 10.1073/pnas.1206390109; Garg N, 2018, NUCLEIC ACIDS RES, V46, pD1210, DOI 10.1093/nar/gkx957; Heshmati J, 2015, COMPLEMENT THER MED, V23, P275, DOI 10.1016/j.ctim.2015.01.013; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Jain A., 2015, ARXIV150203815, P30; Jain A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139539; Jensen K, 2015, NUCLEIC ACIDS RES, V43, pD940, DOI 10.1093/nar/gku724; Jensen K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003432; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Jiang J, 2017, METABOLISM, V77, P58, DOI 10.1016/j.metabol.2017.08.006; JOHRI RK, 1992, J ETHNOPHARMACOL, V37, P85, DOI 10.1016/0378-8741(92)90067-2; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim Y., 2014, ARXIV14085882, DOI DOI 10.3115/V1/D14-1181; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Leaman R, 2016, BIOINFORMATICS, V32, P2839, DOI 10.1093/bioinformatics/btw343; Lee S, 2012, BMC MED INFORM DECIS, V12, DOI [10.1186/1472-6947-12-S1-S1, 10.1186/1472-6947-12-S1]; Li J, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw068; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Liu CT, 2017, ONCOTARGET, V8, P79680, DOI 10.18632/oncotarget.19094; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; McGee H, 1998, NATURE, V392, P649, DOI 10.1038/33528; Mikolov T., 2013, P ICLR WORKSH 2013, DOI DOI 10.1162/153244303322533223; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024; Nguyen TH, 2015, P 1 WORKSHOP VECTOR, P39, DOI DOI 10.3115/V1/W15-1506; Platel K, 2004, INDIAN J MED RES, V119, P167; Prasad VG, 2016, PHARMACOGN MAG, V12, pS441, DOI 10.4103/0973-1296.191454; Rahman K, 2006, J NUTR, V136, p736S, DOI 10.1093/jn/136.3.736S; Rakhi N, 2018, 273599 BIORXIV COLD, P1; Sahu S. K., 2016, P 15 WORK BIOM NAT L, P71, DOI DOI 10.18653/V1/W16-2928; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; Sherman PW, 1999, BIOSCIENCE, V49, P453, DOI 10.2307/1313553; Srinivasan K, 2005, INT J FOOD SCI NUTR, V56, P399, DOI 10.1080/09637480500512872; Srinivasan K, 2005, FOOD REV INT, V21, P167, DOI 10.1081/FRI-200051872; Srinivasan K, 2005, FOOD RES INT, V38, P77, DOI 10.1016/j.foodres.2004.09.001; Srinivasan K, 2017, CRIT REV FOOD SCI, V57, P1749, DOI 10.1080/10408398.2014.1003783; Srinivasan P, 2004, BIOINFORMATICS, V20, P290, DOI 10.1093/bioinformatics/bth914; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Suresh D, 2009, EUR FOOD RES TECHNOL, V228, P807, DOI 10.1007/s00217-008-0993-9; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Visioli F, 2000, CARDIOVASC RES, V47, P419, DOI 10.1016/S0008-6363(00)00053-5; Wang YL, 2017, NUCLEIC ACIDS RES, V45, pD955, DOI 10.1093/nar/gkw1118; Wrangham RW, 2009, CATCHING FIRE COOKIN; Wu CC, 2004, FOOD CHEM TOXICOL, V42, P1937, DOI 10.1016/j.fct.2004.07.008; Yang H, 2011, STUD COMPUT INTELL, V375, P205; YASHIN A, 2017, ANT MULT DIG PUBL I, V6, DOI DOI 10.3390/ANTIOX6030070; Zorofchian Moghadamtousi S, 2014, REV ANTIBACTERIAL AN	60	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198030	10.1371/journal.pone.0198030	http://dx.doi.org/10.1371/journal.pone.0198030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813110	Green Submitted, gold, Green Published			2022-12-26	WOS:000433521800041
J	Berteau, O				Berteau, Olivier			A missed Fe-S cluster handoff causes a metabolic shakeup	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							IRON-SULFUR PROTEINS	The general framework of pathways by which iron-sulfur (Fe-S) clusters are assembled in cells is well-known, but the cellular consequences of disruptions to that framework are not fully understood. Crooks et al. report a novel cellular system that creates an acute Fe-S cluster deficiency, using mutants of ISCU, the main scaffold protein for Fe-S cluster assembly. Surprisingly, the resultant metabolic reprogramming leads to the accumulation of lipid droplets, a situation encountered in many poorly understood pathological conditions, highlighting unanticipated links between Fe-S assembly machinery and human disease.	[Berteau, Olivier] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst,ChemSyBio, F-78350 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Berteau, O (corresponding author), INRA, Inst Micalis, UMR 1319, F-78350 Jouy En Josas, France.	Olivier.Berteau@inra.fr	Berteau, Olivier/AAF-9080-2019	Berteau, Olivier/0000-0002-3434-5168	European Research Council (ERC) [617053]	European Research Council (ERC)(European Research Council (ERC))	Supported by European Research Council (ERC) Consolidator Grant 617053.	Benjdia A, 2016, BIOCHEM SOC T, V44, P109, DOI 10.1042/BST20150191; Berteau O, 2017, PHOTOCHEM PHOTOBIOL, V93, P67, DOI 10.1111/php.12702; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Crooks DR, 2018, J BIOL CHEM, V293, P8297, DOI 10.1074/jbc.RA118.001885; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599	10	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8312	8313		10.1074/jbc.H118.002883	http://dx.doi.org/10.1074/jbc.H118.002883			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29802141	Green Published, hybrid			2022-12-26	WOS:000433224600035
J	Hernandez, MJ; dos Reis, LM; Marques, ID; Araujo, MJ; Truyts, CAM; Oliveira, IB; Barreto, FC; David-Neto, E; Custodio, MR; Moyses, RM; Bellorin-Font, E; Jorgetti, V				Hernandez, Mariel J.; dos Reis, Luciene M.; Marques, Igor D.; Araujo, Maria J.; Truyts, Cesar A. M.; Oliveira, Ivone B.; Barreto, Fellype C.; David-Neto, Elias; Custodio, Melani R.; Moyses, Rosa M.; Bellorin-Font, Ezequiel; Jorgetti, Vanda			The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MESENCHYMAL STEM-CELLS; HISTOMORPHOMETRIC ANALYSIS; ADIPOCYTE DIFFERENTIATION; MINERAL DISORDERS; TRABECULAR BONE; 3T3-L1 CELLS; DISEASE; SCLEROSTIN; ALENDRONATE	Purpose Osteoblasts and adipocytes are derived from mesenchymal stem cells. An imbalance in the differentiation of these lineages could affect the preservation of bone integrity. Several studies have suggested the importance of this imbalance in the pathogenesis of osteoporosis after kidney transplant (KT), but the role of bone marrow adiposity in this process is not well known, and if the treatment with the anti-absorptive (zoledronic acid-ZA) drugs could attenuate bone loss. Thus, our objective was compare bone marrow adiposity, osteoblasts and osteocytes before and after KT, verify an association between bone remodeling process (Turnover, Volume, and Mineralization-TMV classification), the osteocyte sclerostin expression to evaluate if there is a role of Wnt pathway, as well as the effect of ZA on these cells. Methods We studied 29 new living-adonor KT patients. One group received ZA at the time of KT plus cholecalciferol for twelve months, and the other group received only cholecalciferol. Bone biopsies were performed at baseline and after 12 months of treatment. Histomorphometric evaluation was performed in bone and bone marrow adipocytes. Sclerostin (Scl) expression in osteocytes was evaluated by immunohistochemistry. Results Some bone marrow adiposity parameters were increased before KT. After KT, some of them remained increased and they worsened with the use of ZA. In the baseline, lower bone Volume and Turnover, were associated with increased bone marrow adiposity parameters (some of them). After KT, both groups showed the same associations. Osteocyte Scl expression after KT decreased with the use of ZA. We observed also an inverse association between bone adiposity parameters and lower osteocyte sclerostin expression 12 months after KT. Conclusion In conclusion, the present study suggests that KT fails to normalize bone marrow adiposity, and it even gets worse with the use of ZA. Moreover, bone marrow adiposity is inversely associated with bone Volume and Turnover, which seems to be accentuated by the antiresorptive therapy.	[Hernandez, Mariel J.; dos Reis, Luciene M.; Marques, Igor D.; Araujo, Maria J.; Truyts, Cesar A. M.; Oliveira, Ivone B.; Custodio, Melani R.; Moyses, Rosa M.; Jorgetti, Vanda] Univ Sao Paulo, Hosp Clin HCFMUSP, LIM Lab Fisiopatol Renal 16, Fac Med, Sao Paulo, SP, Brazil; [Hernandez, Mariel J.; Bellorin-Font, Ezequiel] Univ Cent Venezuela, Hosp Univ Caracas, Serv Nefrol & Trasplante Renal, Caracas, Venezuela; [Araujo, Maria J.; David-Neto, Elias] Univ Sao Paulo, Div Urol, HCFMUSP, Hosp Clin,Fac Med, Sao Paulo, SP, Brazil; [Barreto, Fellype C.] Univ Fed Parana, Div Nefrol, Curitiba, Parana, Brazil; [Moyses, Rosa M.] Univ Nove Julho UNINOVE, Programa Posgrad Med, Sao Paulo, SP, Brazil; [Jorgetti, Vanda] Hosp Samaritano Amer Serv Med, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; University of Central Venezuela; Universidade de Sao Paulo; Universidade Federal do Parana; Universidade Nove de Julho	Jorgetti, V (corresponding author), Univ Sao Paulo, Hosp Clin HCFMUSP, LIM Lab Fisiopatol Renal 16, Fac Med, Sao Paulo, SP, Brazil.; Jorgetti, V (corresponding author), Hosp Samaritano Amer Serv Med, Sao Paulo, SP, Brazil.	vandajor@usp.br	Neto, Elias David D/O-3866-2018; dos Reis, Luciene M/C-7143-2013; Marques, Igor D B/C-7748-2012; Araújo, Maria/AHA-8107-2022; Custodio, Melani R/L-9509-2015; JORGETTI, VANDA/C-9470-2012; Moyses, Rosa M A/F-8268-2012; Barreto, Fellype C/C-6517-2012	dos Reis, Luciene M/0000-0001-8476-6780; Marques, Igor D B/0000-0003-2269-1503; JORGETTI, VANDA/0000-0002-4824-8879; Moyses, Rosa M A/0000-0002-7902-2127; Barreto, Fellype C/0000-0002-6394-9227; Ribeiro Custodio, Melani/0000-0001-6358-8727; truyts, cesar/0000-0001-5334-0496	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303899/2016-6, 304773/2013-1]; Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP) [2011/22962-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	R. Moyses and V. Jorgetti were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 303899/2016-6 and 304773/2013-1) and E. David-Neto was supported by Fundacao de Amparo a Pesquisa de Estado de Sao Paulo (FAPESP, 2011/22962-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen AD, 2014, CELL MOL LIFE SCI, V71, P493, DOI 10.1007/s00018-013-1440-z; Boivin GY, 2000, BONE, V27, P687, DOI 10.1016/S8756-3282(00)00376-8; Bonani M, 2014, KIDNEY BLOOD PRESS R, V39, P230, DOI 10.1159/000355781; Carvalho C, 2016, NEPHROLOGY, V21, P55, DOI 10.1111/nep.12570; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chavassieux PM, 2000, J BONE MINER RES, V15, P754, DOI 10.1359/jbmr.2000.15.4.754; Coco M, 2012, J AM SOC NEPHROL, V23, P1426, DOI 10.1681/ASN.2011060623; Cohen A, 2015, OSTEOPOROSIS INT, V26, P2471, DOI 10.1007/s00198-015-3161-7; Cohen A, 2012, J CLIN ENDOCR METAB, V97, P2782, DOI 10.1210/jc.2012-1477; Contador D, 2015, EXP BIOL MED, V240, P1235, DOI 10.1177/1535370214566565; Cunningham J, 2007, J AM SOC NEPHROL, V18, P223, DOI 10.1681/ASN.2006050427; de Oliveira RA, 2015, KIDNEY INT, V87, P1039, DOI 10.1038/ki.2014.372; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4; Duque G, 2011, OSTEOPOROSIS INT, V22, P1547, DOI 10.1007/s00198-010-1353-8; Duque G, 2007, J BONE MINER RES, V22, P1603, DOI 10.1359/JBMR.070701; Duque G, 2013, J BONE MINER RES, V28, P639, DOI 10.1002/jbmr.1782; Fairfield Heather, 2017, Curr Mol Biol Rep, V3, P114, DOI 10.1007/s40610-017-0057-7; Giovanini AF, 2018, ENDOCRINE, V59, P685, DOI 10.1007/s12020-017-1490-3; Gomes SA, 2008, J BONE MINER METAB, V26, P110, DOI 10.1007/s00774-007-0788-2; Graciolli FG, 2017, KIDNEY INT, V91, P1436, DOI 10.1016/j.kint.2016.12.029; Hida Y, 1998, LIFE SCI, V62, pPL205, DOI 10.1016/S0024-3205(98)00059-9; Iyer SP, 2014, J AM SOC NEPHROL, V25, P1331, DOI 10.1681/ASN.2013080851; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Li GW, 2014, ENDOCRINOLOGY, V155, P4731, DOI 10.1210/en.2014-1359; Li GW, 2013, BONE, V52, P668, DOI 10.1016/j.bone.2012.11.002; Li J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.348; Marques IDB, 2017, OSTEOPOROSIS INT, V28, P1675, DOI 10.1007/s00198-017-3956-9; MELSEN F, 1980, ACTA PATH MICRO IM A, V88, P83; MELSEN F, 1978, CALC TISS RES, V26, P99, DOI 10.1007/BF02013242; Menagh PJ, 2010, J BONE MINER RES, V25, P757, DOI 10.1359/jbmr.091015; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Molnar MZ, 2014, TRANSPLANT REV-ORLAN, V28, P56, DOI 10.1016/j.trre.2013.12.003; Moorthi RN, 2015, OSTEOPOROSIS INT, V26, P1801, DOI 10.1007/s00198-015-3064-7; Moyses RMA, 2015, INT UROL NEPHROL, V47, P847, DOI 10.1007/s11255-015-0971-7; Neves CL, 2013, TRANSPLANTATION, V96, P290, DOI 10.1097/TP.0b013e3182985468; Ohnaka K, 2005, BIOCHEM BIOPH RES CO, V329, P177, DOI 10.1016/j.bbrc.2005.01.117; Parajuli S, 2016, ADV CHRONIC KIDNEY D, V23, P287, DOI 10.1053/j.ackd.2016.09.006; Pereira RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138156; Recker RR, 2013, PRIMER METABOLIC BON, P307; Rojas E, 2003, KIDNEY INT, V63, P1915, DOI 10.1046/j.1523-1755.2003.00938.x; Ukita M, 2016, J CELL BIOCHEM, V117, P1419, DOI 10.1002/jcb.25432; Wang FS, 2008, ENDOCRINOLOGY, V149, P1793, DOI 10.1210/en.2007-0910; Watanabe R, 2010, CLIN J AM SOC NEPHRO, V5, P189, DOI 10.2215/CJN.06240909; Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x; Yamamoto S, 2013, J BONE MINER METAB, V31, P116, DOI 10.1007/s00774-012-0391-z	47	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197994	10.1371/journal.pone.0197994	http://dx.doi.org/10.1371/journal.pone.0197994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799857	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400034
J	Zappone, B; Patill, NJ; Lombardo, M; Lombardo, G				Zappone, Bruno; Patill, Navinkumar J.; Lombardo, Marco; Lombardo, Giuseppe			Transient viscous response of the human cornea probed with the Surface Force Apparatus	PLOS ONE			English	Article							CROSS-LINKING; UNCONFINED COMPRESSION; INTRAOCULAR-PRESSURE; BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; ARTICULAR-CARTILAGE; MATERIAL PARAMETERS; STRESS-RELAXATION; STROMA; INDENTATION	Knowledge of the biomechanical properties of the human cornea is crucial for understanding the development of corneal diseases and impact of surgical treatments (e.g., corneal laser surgery, corneal cross-linking). Using a Surface Force Apparatus we investigated the transient viscous response of the anterior cornea from donor human eyes compressed between macroscopic crossed cylinders. Corneal biomechanics was analyzed using linear viscoelastic theory and interpreted in the framework of a biphasic model of soft hydrated porous tissues, including a significant contribution from the pressurization and viscous flow of fluid within the corneal tissue. Time-resolved measurements of tissue deformation and careful determination of the relaxation time provided an elastic modulus in the range between 0.17 and 1.43 MPa, and fluid permeability of the order of 10(-13) m(4)/(N.s). The permeability decreased as the deformation was increased above a strain level of about 10%, indicating that the interstitial space between fibrils of the corneal stromal matrix was reduced under the effect of strong compression. This effect may play a major role in determining the observed rate-dependent non-linear stress-strain response of the anterior cornea, which underlies the shape and optical properties of the tissue.	[Zappone, Bruno] CNR, Ist Nanotecnol CNR Nanotec, Arcavacata Di Rende, CS, Italy; [Patill, Navinkumar J.] Univ Calabria, Dipartimento Fis, Arcavacata Di Rende, CS, Italy; [Lombardo, Marco] Vis Engn Italy Srl, Rome, Italy; [Lombardo, Giuseppe] CNR, Ist Proc Chim Fis CNR IPCF, Messina, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Nanotecnologia (NANOTEC-CNR); University of Calabria; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR)	Zappone, B (corresponding author), CNR, Ist Nanotecnol CNR Nanotec, Arcavacata Di Rende, CS, Italy.; Lombardo, G (corresponding author), CNR, Ist Proc Chim Fis CNR IPCF, Messina, Italy.	bruno.zappone@cnr.it; giuseppe.lombardo@cnr.it	Patil, Navinkumar Jayvant/AAD-2127-2019; Lombardo, Giuseppe/B-2656-2012	Lombardo, Giuseppe/0000-0002-9416-967X	Ministero dell'Istruzione, dell'Universita e della Ricerca (P.I. Giuseppe Lombardo) [PON 01_00110]	Ministero dell'Istruzione, dell'Universita e della Ricerca (P.I. Giuseppe Lombardo)	This work has been funded by Ministero dell'Istruzione, dell'Universita e della Ricerca (IT), PON 01_00110 (P.I. Giuseppe Lombardo). Vision Engineering Italy srl did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of salary for author Marco Lombardo. The specific roles of this author is articulated in the updated version of the 'author contributions' section.	Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9; ARMALY MF, 1963, INVEST OPHTH VISUAL, V2, P591; ARMSTRONG CG, 1984, J BIOMECH ENG-T ASME, V106, P165, DOI 10.1115/1.3138475; Bak-Nielsen S, 2014, J REFRACT SURG, V30, P408, DOI 10.3928/1081597X-20140513-02; BOLLING JP, 1985, OPHTHALMIC SURG LAS, V16, P563; Born M., 2000, PRINCIPLES OPTICS EL; Cheneler D, 2013, RHEOL ACTA, V52, P695, DOI 10.1007/s00397-013-0707-5; Cohen B, 1998, J BIOMECH ENG-T ASME, V120, P491, DOI 10.1115/1.2798019; Dias JM, 2013, EXP EYE RES, V115, P41, DOI 10.1016/j.exer.2013.06.004; Dupps WJ, 2007, J REFRACT SURG, V23, P66; Elsheikh A, 2005, J R SOC INTERFACE, V2, P177, DOI 10.1098/rsif.2005.0034; Elsheikh A, 2008, J REFRACT SURG, V24, P178, DOI 10.3928/1081597X-20080201-09; Elsheikh A, 2008, CURR EYE RES, V33, P205, DOI 10.1080/02713680701882519; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; Fessler JA, 2003, IEEE T SIGNAL PROCES, V51, P560, DOI 10.1109/TSP.2002.807005; Greene GW, 2011, P NATL ACAD SCI USA, V108, P5255, DOI 10.1073/pnas.1101002108; Hatami-Marbini H, 2013, EXP EYE RES, V116, P47, DOI 10.1016/j.exer.2013.07.016; Hatami-Marbini H, 2013, ANN BIOMED ENG, V41, P2399, DOI 10.1007/s10439-013-0842-2; Hatami-Marbini H, 2013, J BIOMECH, V46, P1752, DOI 10.1016/j.jbiomech.2013.03.013; Hjortdal JO, 1996, J BIOMECH, V29, P931, DOI 10.1016/0021-9290(95)00152-2; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P5; HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373; ISRAELACHVILI JN, 1990, J MATER RES, V5, P2223, DOI 10.1557/JMR.1990.2223; Johnson LK, 1983, CONTACT MECH; JUE B, 1986, J BIOMECH, V19, P847, DOI 10.1016/0021-9290(86)90135-1; Labate C, 2015, INVEST OPHTH VIS SCI, V56, P4053, DOI 10.1167/iovs.15-16875; Labate C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122868; Last JA, 2012, MICRON, V43, P1293, DOI 10.1016/j.micron.2012.02.014; Last JA, 2009, J STRUCT BIOL, V167, P19, DOI 10.1016/j.jsb.2009.03.012; Lewis PN, 2010, STRUCTURE, V18, P239, DOI 10.1016/j.str.2009.11.013; Lombardo G, 2014, PLOS ONE, V9; Lombardo M, 2015, J CATARACT REFR SURG, V41, P446, DOI 10.1016/j.jcrs.2014.12.013; Lombardo M, 2014, J CATARACT REFR SURG, V40, P1706, DOI 10.1016/j.jcrs.2014.04.024; Lombardo M, 2012, INVEST OPHTH VIS SCI, V53, P1050, DOI 10.1167/iovs.11-8720; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Muller LJ, 2004, EXP EYE RES, V78, P493, DOI 10.1016/S0014-4835(03)00206-9; Perone JM, 2017, CORNEA, V36, P1263, DOI 10.1097/ICO.0000000000001293; Petsche SJ, 2012, INVEST OPHTH VIS SCI, V53, P873, DOI 10.1167/iovs.11-8611; Roy AS, 2013, EXP EYE RES, V113, P92, DOI 10.1016/j.exer.2013.04.010; Scarcelli G, 2012, INVEST OPHTH VIS SCI, V53, P185, DOI 10.1167/iovs.11-8281; Seifert J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088186; Serrao S, 2013, J REFRACT SURG, V29, P418, DOI 10.3928/1081597X-20130430-01; Shin TJ, 1997, J BIOMECH, V30, P497, DOI 10.1016/S0021-9290(97)84433-8; Simonini I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130426; SMOLEK MK, 1993, INVEST OPHTH VIS SCI, V34, P2962; SMOLEK MK, 1990, INVEST OPHTH VIS SCI, V31, P1087; Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5; Srodka W, 2011, ACTA BIOENG BIOMECH, V13, P77; Swain MV, 2017, ACTA BIOMATER, V50, P312, DOI 10.1016/j.actbio.2016.12.007; Tranchina L, 2013, J GLAUCOMA, V22, P416, DOI 10.1097/IJG.0b013e31824cafc9; Wang HC, 1996, J BIOMECH, V29, P1633, DOI 10.1016/S0021-9290(96)80017-0; Winkler M, 2011, INVEST OPHTH VIS SCI, V52, P8818, DOI 10.1167/iovs.11-8070	54	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197779	10.1371/journal.pone.0197779	http://dx.doi.org/10.1371/journal.pone.0197779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799859	Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400023
J	Nacher, M; Adriouch, L; Huber, F; Vantilcke, V; Djossou, F; Elenga, N; Adenis, A; Couppie, P				Nacher, Mathieu; Adriouch, Leila; Huber, Florence; Vantilcke, Vincent; Djossou, Felix; Elenga, Narcisse; Adenis, Antoine; Couppie, Pierre			Modeling of the HIV epidemic and continuum of care in French Guiana	PLOS ONE			English	Article							RISK-FACTORS; DIAGNOSIS	Background In order to compute the continuum of care for French Guiana, it is necessary to estimate the total number of persons living with HIV. The main objective was to determine how many persons were infected with HIV and how many were unaware of it. Methods We used 2 different models to calculate the total number of persons infected with HIV: Spectrum's AIM module using CSAVR to compute incidence from case registration and vital statistics; and the ECDC model from the French Guiana HIV cohort data. Result The present results show that both models led to similar results regarding the incident number of cases (i.e. for 2016 174 versus 161) and the total HIV population (in 2016 3206 versus 3539) respectively. The ECDC modeling tool showed that the proportion of undiagnosed HIV infections declined from 50% in 1990 to 15% in 2015. This amounted to a stable or slightly increasing total number of undiagnosed patients of 520. Conclusions The estimations of the total HIV population by both models show that the HIV population is still growing. The incidence rate declined in 2000 and the decline of the number of newly acquired HIV infections, after a decline after 2003 is offset by population growth. The proportion of undiagnosed infections has declined to 15% but the number of undiagnosed infections remains stable. The HIV cascade shows that despite good results for treatment in care, reaching the 90*90*90 UNAIDS target may be difficult because a significant proportion of patients are lost to follow-up.	[Nacher, Mathieu; Adenis, Antoine] Ctr Hosp Cayenne, INSERM 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana; [Nacher, Mathieu; Adriouch, Leila; Huber, Florence] Ctr Hosp Cayenne, COREVIH Guyane Coordinat Lutte VIH, Cayenne, French Guiana; [Vantilcke, Vincent] Ctr Hosp Ouest Guyanais, Med Serv, St Laurent Du Maroni, French Guiana; [Djossou, Felix] Ctr Hosp Cayenne, Dept Infect & Trop Dis, Cayenne, French Guiana; [Elenga, Narcisse] Ctr Hosp Cayenne, Dept Pediat, Cayenne, French Guiana; [Couppie, Pierre] Ctr Hosp Cayenne, Dept Dermatol, Cayenne, French Guiana		Nacher, M (corresponding author), Ctr Hosp Cayenne, INSERM 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana.; Nacher, M (corresponding author), Ctr Hosp Cayenne, COREVIH Guyane Coordinat Lutte VIH, Cayenne, French Guiana.	mathieu.nacher66@gmail.com	ELENGA, Narcisse NE/C-2272-2015; nacher, mathieu/AAH-4796-2021; Adenis, Antoine/AAI-1059-2021; Djossou, Felix/AAM-8640-2020	ELENGA, Narcisse NE/0000-0003-0624-4180; nacher, mathieu/0000-0001-9397-3204; Adenis, Antoine/0000-0003-4000-4981; Huber, Florence/0000-0002-4340-0106				[Anonymous], 2017, RAPPORT ACTIVITE 201; Avenir Health AIM, 2017, AVENIR HLTH AIM SPEC; CEPIDC, 2017, CEPIDC INT DONN CAUS; Cuzin L, 2011, HIV CLIN TRIALS, V12, P339, DOI 10.1310/hct1206-339; ECDC, 2021, COVID 19 CHILDR ROL; Gourlay A, 2017, CLIN INFECT DIS, V64, P1644, DOI 10.1093/cid/cix212; INSEE, 2016, DEM GUY TOUJ AUSS DY; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Nacher M, 2006, AM J TROP MED HYG, V74, P915, DOI 10.4269/ajtmh.2006.74.915; Nacher M, 2005, AIDS, V19, P727, DOI 10.1097/01.aids.0000166096.69811.b7; Nacher M, 2010, INT J STD AIDS, V21, P359, DOI 10.1258/ijsa.2010.009570; Nacher M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192564; Nacher M, 2011, AM J TROP MED HYG, V84, P806, DOI 10.4269/ajtmh.2011.10-0671; Nacher M, 2011, AM J TROP MED HYG, V84, P239, DOI 10.4269/ajtmh.2011.10-0251; Sangare I, 2017, PUBLIC HEALTH, V151, P23, DOI 10.1016/j.puhe.2017.06.002; Sante publique France, 2020, B SANT PUBL VIH IST; Sante PubliqueFrance, 2013, SANTE PUBLIQUEFRANCE; Sante PubliqueFrance, 2015, SANTE PUBLIQUEFRANCE; Sidibe M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21133; Stover JB, 2017, PEERAPATANAPOKIN W U, P31; van Sighem A, 2015, EPIDEMIOLOGY, V26, P653, DOI 10.1097/EDE.0000000000000324	21	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197990	10.1371/journal.pone.0197990	http://dx.doi.org/10.1371/journal.pone.0197990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795698	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300109
J	Qiu, LH; Zhao, C; Wang, PF; Fan, SG; Yan, LL; Xie, BB; Jiang, SG; Wang, S; Lin, HZ				Qiu, Lihua; Zhao, Chao; Wang, Pengfei; Fan, Sigang; Yan, Lulu; Xie, Bobo; Jiang, Shigui; Wang, Shu; Lin, Heizhao			Genomic structure, expression, and functional characterization of checkpoint kinase 1 from Penaeus monodon	PLOS ONE			English	Article							BLACK TIGER SHRIMP; DNA-DAMAGE CHECKPOINT; RED SWAMP CRAYFISH; OVARIAN MATURATION; CELL-CYCLE; IN-VIVO; MOLECULAR CHARACTERIZATION; MARSUPENAEUS-JAPONICUS; PROCAMBARUS-CLARKII; WHITE SHRIMP	Chk1 is a cell-cycle regulator. Chk1 has been identified in organisms ranging from yeast to humans, but few researchers have studied Chk1 in shrimps. We cloned Chk1 from the black tiger shrimp (Penaeus monodon). The full-length cDNA sequence of PmChk1 had 3,334 base pairs (bp), with an open reading frame of 1,455 bp. The complete genomic sequence of PmChk1 (11,081 bp) contained 10 exons separated by nine introns. qRT-PCR showed that PmChk1 was highly expressed in the ovaries and gills of P. monodon. The lowest PmChk1 expression was noted in stage III of ovarian development in P. monodon. PmChk1 expression decreased significantly after injection of 5-hydroxytryptamine and eyestalk ablation in P. monodon ovaries. RNA interference experiments were undertaken to examine the expression of PmChk1, PmCDC2, and PmCyclin B. PmChk1 knockdown in the ovaries and hepatopancreas by dsRNA-Chk1 was successful. The localization and level of PmChk1 expression in the hepatopancreas was studied using in situ hybridization, which showed that data were in accordance with those of qRT-PCR. The Gonadosomatic Index of P. monodon after dsRNA-Chk1 injection was significantly higher than that after injection of dsRNA-GFP or phosphate-buffered saline. These data suggest that PmChk1 may have important roles in the ovarian maturation of P. monodon.	[Qiu, Lihua; Zhao, Chao; Wang, Pengfei; Fan, Sigang; Yan, Lulu; Xie, Bobo; Jiang, Shigui] Chinese Acad Fishery Sci, Minist Agr, Key Lab South China Sea Fishery Resources Exploit, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China; [Qiu, Lihua] Minist Agr, Key Lab Aquat Genom, Beijing, Peoples R China; [Jiang, Shigui] Sun Yat Sen Univ, South China Sea Resource Exploitat & Protect Coll, Guangzhou, Guangdong, Peoples R China; [Wang, Shu] Chinese Acad Fishery Sci, Beijing, Peoples R China; [Lin, Heizhao] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Shenzhen Base, Shenzhen, Peoples R China	Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Sun Yat Sen University; Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences	Jiang, SG (corresponding author), Chinese Acad Fishery Sci, Minist Agr, Key Lab South China Sea Fishery Resources Exploit, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China.; Jiang, SG (corresponding author), Sun Yat Sen Univ, South China Sea Resource Exploitat & Protect Coll, Guangzhou, Guangdong, Peoples R China.	jiangsg@21cn.com			Guangdong Provincial Science and Technology Program [2015A020209037, 2017A040405001]; Natural Science Foundation of Hainan Province, China [2017CXTD021]; Guangdong Provincial Science and Technology Foundation for Marine and Fishery Development [A201601A08]	Guangdong Provincial Science and Technology Program; Natural Science Foundation of Hainan Province, China; Guangdong Provincial Science and Technology Foundation for Marine and Fishery Development	This study was supported by The Guangdong Provincial Science and Technology Program (2015A020209037), the Natural Science Foundation of Hainan Province, China (2017CXTD021), the Guangdong Provincial Science and Technology Foundation for Marine and Fishery Development (A201601A08), the Guangdong Provincial Science and Technology Program (2017A040405001).	Babu K. N., 2013, International Journal of Pharmacy and Life Sciences (IJPLS), V4, P2785; Bai HK, 2015, GENE, V562, P22, DOI 10.1016/j.gene.2014.12.008; Barnum KJ, 2014, QELL CYCLE REGULATIO; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Benzie JAH, 1998, AQUACULTURE, V164, P23, DOI 10.1016/S0044-8486(98)00175-6; Bertoni F, 1999, GENE CHROMOSOME CANC, V26, P176, DOI 10.1002/(SICI)1098-2264(199910)26:2<176::AID-GCC11>3.3.CO;2-V; Caparelli ML, 2013, CELL CYCLE, V12, P916, DOI 10.4161/cc.23881; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Carrassa L, 2003, CELL CYCLE, V2, P604, DOI 10.4161/cc.2.6.503; Dai WT, 2016, MOL BIOL REP, V43, P549, DOI 10.1007/s11033-016-3988-9; Feijo ARG, 2016, MARINE BIOTECHNOLOGY, V18, P1; Fingerman M, 1997, INVERTEBR REPROD DEV, V31, P47, DOI 10.1080/07924259.1997.9672562; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Guo XG, 2015, GENES GENOM, V37, P797, DOI 10.1007/s13258-015-0310-5; Haruki N, 2000, CANCER RES, V60, P4689; Kalogeropoulos N, 2004, CELL CYCLE, V3, P1196; Kappas NC, 2000, MOL BIOL CELL, V11, P3101, DOI 10.1091/mbc.11.9.3101; Kosoy A, 2008, MOL BIOL CELL, V19, P4546, DOI 10.1091/mbc.E08-04-0444; KULKARNI GK, 1992, INVERTEBR REPROD DEV, V21, P231, DOI 10.1080/07924259.1992.9672242; Lee FY, 1997, COMP BIOCHEM PHYS A, V117, P433, DOI 10.1016/S0300-9629(96)00260-5; Liu De-feng, 2010, Zhonghua Nan Ke Xue, V16, P811; Liu QH, 2000, GENE DEV, V14, P1448; Nie ZW, 2017, CELL CYCLE, V16, P2220, DOI 10.1080/15384101.2017.1373221; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Phinyo M, 2014, AQUACULTURE, V432, P286, DOI 10.1016/j.aquaculture.2014.05.022; Qiu GF, 2008, ANIM REPROD SCI, V105, P209, DOI 10.1016/j.anireprosci.2007.03.005; Qiu GF, 2005, COMP BIOCHEM PHYS B, V140, P171, DOI 10.1016/j.cbpc.2004.09.027; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rodriguez-Gonzalez H, 2006, AQUACULTURE, V254, P637, DOI 10.1016/j.aquaculture.2005.10.020; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SAROJINI R, 1995, J EXP ZOOL, V271, P395, DOI 10.1002/jez.1402710509; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shi JX, 2016, CELL STRESS CHAPERON, V21, P295, DOI 10.1007/s12192-015-0660-6; Shigeishi H, 2002, INT J CANCER, V99, P58, DOI 10.1002/ijc.10272; Sun BZ, 2016, AQUACULTURE, V455, P87, DOI 10.1016/j.aquaculture.2016.01.002; Takai H, 2000, GENE DEV, V14, P1439; Tang KFJ, 2015, J INVERTEBR PATHOL, V130, P37, DOI 10.1016/j.jip.2015.06.009; Tassanakajon A, 1998, J MAR BIOTECHNOL, V6, P249; Tinikul Y, 2011, CELL TISSUE RES, V345, P103, DOI 10.1007/s00441-011-1176-8; Tomy S, 2016, AQUACULTURE, V452, P239, DOI 10.1016/j.aquaculture.2015.11.003; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Vatanavicharn T, 2009, COMP BIOCHEM PHYS B, V153, P244, DOI 10.1016/j.cbpb.2009.03.004; Visudtiphole V, 2009, COMP BIOCHEM PHYS A, V152, P535, DOI 10.1016/j.cbpa.2008.12.011; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 2000, CURR OPIN CELL BIOL, V12, P697, DOI 10.1016/S0955-0674(00)00154-X; Wang Y., 2016, GENETICS MOL RES GMR, V15, P34; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Wongprasert K, 2006, AQUACULTURE, V261, P1447, DOI 10.1016/j.aquaculture.2006.08.044; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Zhao C, 2015, GENET MOL RES, V14, P13380, DOI 10.4238/2015.October.26.36; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu L, 2015, ONCOGENE, V34, P4547, DOI 10.1038/onc.2014.399	55	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198036	10.1371/journal.pone.0198036	http://dx.doi.org/10.1371/journal.pone.0198036			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795680	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300119
J	Daneshmanesh, AH; Hojjat-Farsangi, M; Ghaderi, A; Moshfegh, A; Hansson, L; Schultz, J; Vagberg, J; Bystrom, S; Olsson, E; Olin, T; Osterborg, A; Mellstedt, H				Daneshmanesh, Amir Hossein; Hojjat-Farsangi, Mohammad; Ghaderi, Amineh; Moshfegh, Ali; Hansson, Lotta; Schultz, Johan; Vagberga, Jan; Bystrom, Styrbjorn; Olsson, Elisabeth; Olin, Thomas; Osterborg, Anders; Mellstedt, Hakan			A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GROWTH-FACTOR RECEPTOR; CANCER; GEMCITABINE; PATHWAY; MODELS; LINES	There is a great unmet medical need in pancreatic carcinoma (PC) for novel drugs with other mechanisms of action than existing. PC cells express the onco-fetal RTK ROR1, absent on most normal post-partem cells. ROR1 is involved in proliferation, survival, EMT and metastasis of tumor cells in various malignancies. A small molecule inhibitor (KAN0439834) (530 Da) targeting the TK domain of ROR1 was developed and the activity in ROR1 expressing human PC cell lines (n = 8) evaluated. The effects were compared to a murine mAb against the external part of ROR1, gemcitabine, erlotinib and ibrutinib. KAN0439834 induced significant apoptosis of the tumor cells. EC50 values for KAN0439834 varied between 250-650 nM depending on the cell line. The corresponding values for erlotinib and ibrutinib were 10-40 folds higher. KAN0439834 was much more effective in inducing tumor cell death than the ROR1 mAb although both inhibited ROR1 phosphorylation and downstream non-canonical Wnt pathway molecules. Combination of KAN0439834 with erlotinib or ibrutinib had significant additive effects on tumor cell death. A first-in-class small molecule ROR1 inhibitor (KAN0439834) showed promising in vitro activity against a number of human PC cell lines. Interesting is the additive effects of erlotinib and ibrutinib which warrants further studies as both these agents are in clinical trials for pancreatic carcinoma.	[Daneshmanesh, Amir Hossein; Hojjat-Farsangi, Mohammad; Ghaderi, Amineh; Moshfegh, Ali; Hansson, Lotta; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Immune & Gene Therapy Lab, CCK, Dept Oncol Pathol, Stockholm, Sweden; [Daneshmanesh, Amir Hossein; Hojjat-Farsangi, Mohammad; Ghaderi, Amineh; Moshfegh, Ali; Hansson, Lotta; Osterborg, Anders; Mellstedt, Hakan] Karolinska Inst, Stockholm, Sweden; [Hansson, Lotta; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden; [Schultz, Johan; Vagberga, Jan; Bystrom, Styrbjorn; Olsson, Elisabeth; Olin, Thomas] Kancera AB, Karolinska Inst Sci Pk, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Mellstedt, H (corresponding author), Karolinska Univ Hosp Solna, Immune & Gene Therapy Lab, CCK, Dept Oncol Pathol, Stockholm, Sweden.; Mellstedt, H (corresponding author), Karolinska Inst, Stockholm, Sweden.; Mellstedt, H (corresponding author), Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden.	hakan.mellstedt@sll.se	Hojjat-Farsangi, Mohammad/E-8171-2018	Hojjat-Farsangi, Mohammad/0000-0002-0589-5523	Swedish Research Council [K2013-64X-21464-04-3]; Cancer and Allergy Foundation [150 420, 150 122]; Cancer Society in Stockholm [144142, 164122, 151313]; King Gustaf V Jubilee Fund [144193]; Swedish Cancer Society [14 0395, 15 0894, 160534]; Torsten Soderbergs Foundation; AFA Insurance [130054]; Karolinska Institutet Foundation; Stockholm County Council [20150070]; Felix Mindus Foundation; Vinnova [201501219]; Kancera	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer and Allergy Foundation; Cancer Society in Stockholm; King Gustaf V Jubilee Fund; Swedish Cancer Society(Swedish Cancer Society); Torsten Soderbergs Foundation; AFA Insurance; Karolinska Institutet Foundation(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Felix Mindus Foundation; Vinnova(Vinnova); Kancera	This study was supported by grants from: the Swedish Research Council (HM, Proj nr: K2013-64X-21464-04-3), https://www/vr/se/; The Cancer and Allergy Foundation (HM, Ref No.: 150 420 and 150 122), https://cancerochallergifonden.se; The Cancer Society in Stockholm (HM, Ref No.: 144142, 164122; AO, Ref No.: 151313), www.rahfo.se; The King Gustaf V Jubilee Fund (AO, Ref nr: 144193), www.rahfo.sei/; The Swedish Cancer Society (AO, 14 0395, 15 0894, 160534), www.cancerfonden.se; The Torsten Soderbergs Foundation (HM), www.torstensoderbergssfiftelse.se; AFA Insurance (AO, Ref nr: 130054), www.afaforsaknrig.se; The Karolinska Institutet Foundation (HM, MHF, AO), www.ki.se; The Stockholm County Council (AO, Ref No.: 20150070), https://forskningsstod.vmi.se/Ansokan/start.asp; The Felix Mindus Foundation (HM), www.ki.se; Vinnova (AO, Ref nr: 201501219), www.vinnova.se. AHD, MHF, AM, JS, JV, SB, EO, TO, AO and HM are shareholders of Kancera AB. AM, JS, JV, SB, EO, and TO are employees of Kancera AB. HM has received research grants from Kancera. The specific roles of these authors are articulated in the Author Contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani P, 2015, BREAST CANCER-TARGET, V7, DOI 10.2147/BCTT.S90627; Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Avan A, 2013, CURR PHARM DESIGN, V19, P940, DOI 10.2174/138161213804547312; Balakrishnan A, 2017, CLIN CANCER RES, V23, P3061, DOI 10.1158/1078-0432.CCR-16-2083; Borcherding N, 2014, PROTEIN CELL, V5, P496, DOI 10.1007/s13238-014-0059-7; Bose P, 2016, EXPERT OPIN DRUG MET, V12, P1381, DOI 10.1080/17425255.2016.1239717; Choudhury A, 2010, BRIT J HAEMATOL, V151, P327, DOI 10.1111/j.1365-2141.2010.08362.x; Chung A, 2013, CLIN BREAST CANCER, V13, P223, DOI 10.1016/j.clbc.2013.04.001; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Daneshmanesh AH, 2015, BRIT J HAEMATOL, V169, P455, DOI 10.1111/bjh.13228; Daneshmanesh AH, 2013, LEUKEMIA LYMPHOMA, V54, P843, DOI 10.3109/10428194.2012.731599; DeFazio-Eli L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2866; Fryer RA, 2011, ANTICANCER RES, V31, P3747; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Furugaki K, 2010, ONCOL LETT, V1, P231, DOI 10.3892/ol_00000041; Gao W, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju204; Gradiz R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21648; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hojjat-Farsangi M, 2015, BLOOD AM SOC HEM 57, V126; Hojjat-Farsangi M, 2018, LEUKEMIA, P1, DOI [10.1038/leu.2017.301, DOI 10.1038/LEU.2017.301]; Hojjat-Farsangi M, 2014, SEMIN CANCER BIOL, V29, P21, DOI 10.1016/j.semcancer.2014.07.005; Kaucka M, 2011, ACTA PHYSIOL, V203, P351, DOI 10.1111/j.1748-1716.2011.02306.x; Lee JK, 2017, J CLIN ONCOL, V35, P3065, DOI 10.1200/JCO.2016.71.9096; Liu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127092; Malvezzi M, 2013, ANN ONCOL, V24, P792, DOI 10.1093/annonc/mdt010; Masso-Valles D, 2015, CANCER RES, V75, P1675, DOI 10.1158/0008-5472.CAN-14-2852; Ng SSW, 2000, CANCER RES, V60, P5451; Rauf F, 2018, ONCOGENE, V37, P2237, DOI 10.1038/s41388-017-0079-x; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Spadi R, 2016, WORLD J CLIN ONCOL, V7, P27, DOI 10.5306/wjco.v7.i1.27; Taieb J, 2017, ANN ONCOL, V28, P1473, DOI 10.1093/annonc/mdx174; Tomizawa M, 2010, WORLD J GASTROENTERO, V16, P1854, DOI 10.3748/wjg.v16.i15.1854; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu J, 2016, J CLIN INVEST, V126, P585, DOI 10.1172/JCI83535; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024; Zheng YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36447	42	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198038	10.1371/journal.pone.0198038	http://dx.doi.org/10.1371/journal.pone.0198038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856777	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800062
J	Sigalla, GN; Mushi, D; Gammeltoft, T				Sigalla, Geofrey Nimrod; Mushi, Declare; Gammeltoft, Tine			"Staying for the children": The role of natal relatives in supporting women experiencing intimate partner violence during pregnancy in northern Tanzania - A qualitative study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOCIAL SUPPORT; DOMESTIC VIOLENCE; SPOUSAL VIOLENCE; RURAL TANZANIA; MENTAL-HEALTH; MOSHI; DISCLOSURE; MOTHERHOOD; SYMPTOMS	Introduction Intimate partner violence (IPV) is a global health and human rights problem. In Tanzania, national studies have shown that half of all women experience partner violence in their lifetime, 38% reported being abused during a period of 12 months and 30% during pregnancy. Despite the benefits of social support to women victims of violence during pregnancy, a majority of women hesitate to seek help and, if they do, they mainly turn to their natal relatives for support. However, this process of help-seeking and the type of support received is not well documented and needs to be explored with a view to future interventions. This article investigates women's own perspectives on the support they receive from natal relatives when experiencing IPV during pregnancy. Materials and methods Eighteen participants who experienced physical IPV during pregnancy were purposively selected from a cohort of 1,116 pregnant women enrolled in a project that aimed at assessing the impact of intimate partner violence on reproductive health. In-depth interviews were used to explore the social support received from the natal family among women who experienced partner violence during pregnancy. All interviews were audio recorded, transcribed, coded and analyzed. Results Women who experienced severe IPV during pregnancy were more likely to seek help from natal relatives. Severe violence was defined by the women as acts that occurred frequently and/or resulted in injury. The women's natal relatives were willing to provide the support; however, they strongly encouraged women to maintain their marriage so that they could continue caring for their children jointly with their partners. Emotional support was the commonest form of support and included showing love and empathy and praying. Information provided to victims aimed mainly at advising them to maintain their marriage. Practical support included direct financial support and building their economic base to reduce dependency on their partners. When the couple was on the verge of separation, mediation was provided to save the marriage. Conclusion Women who experienced partner violence preferred to seek help from their natal relatives. The support provided by natal relatives was beneficial; however, maintaining the marriage for the care of children and family was given the highest priority, over separation. As a consequence, many women continued to live with violence. Stakeholders supporting victims of violence need to understand the priorities of victims of violence and structure intervention to address their needs.	[Sigalla, Geofrey Nimrod; Mushi, Declare] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Moshi, Tanzania; [Sigalla, Geofrey Nimrod] Evangel Lutheran Church Tanzania, Dept Hlth, Arusha, Tanzania; [Gammeltoft, Tine] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark	University of Copenhagen	Sigalla, GN (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Moshi, Tanzania.; Sigalla, GN (corresponding author), Evangel Lutheran Church Tanzania, Dept Hlth, Arusha, Tanzania.	gnimrody@yahoo.com	Mushi, Declare/H-2924-2019	Gammeltoft, Tine Mette/0000-0002-6723-2370	DANIDA (the Danish International Development Agency) [12-006KU]	DANIDA (the Danish International Development Agency)	This research was part of the PAVE Project (The Impact of Violence on Reproductive Health in Tanzania and Vietnam) funded by DANIDA (the Danish International Development Agency; project number 12-006KU). The funders had no role in the study design, data collection and analysis, manuscript preparation or decision to publish.	Abadi MNL, 2013, J NERV MENT DIS, V201, P602, DOI 10.1097/NMD.0b013e3182982b1d; Alhusen JL, 2014, J WOMENS HEALTH, V23, P920, DOI 10.1089/jwh.2014.4862; Amnesty International USA, 2015, VIOL WOM INF; Among GV, 2016, GLOB HLTH SCI PRACT, V4, P373; Beeble ML, 2009, J CONSULT CLIN PSYCH, V77, P718, DOI 10.1037/a0016140; Bosch K, 2006, J FAM VIOLENCE, V21, P311, DOI 10.1007/s10896-006-9027-1; Chin YM, 2013, J HEALTH ECON, V32, P997, DOI 10.1016/j.jhealeco.2013.07.005; Dilger H, 2008, ANTHROPOL QUART, V81, P207, DOI 10.1353/anq.2008.0009; Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432; Fanslow JL, 2010, J INTERPERS VIOLENCE, V25, P929, DOI 10.1177/0886260509336963; Finnbogadottir H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-293; Flavahan L, 2015, PREVENTING INTIMATE; Fraga Silvia, 2016, Porto Biomed J, V1, P77, DOI 10.1016/j.pbj.2016.04.005; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gharaibeh M, 2009, J NURS SCHOLARSHIP, V41, P376, DOI 10.1111/j.1547-5069.2009.01305.x; Hattori MK, 2007, POP STUD-J DEMOG, V61, P185, DOI 10.1080/00324720701331367; Hollos M, 2008, CULT HEALTH SEX, V10, P159, DOI 10.1080/13691050701656789; Iranzad Ilnaz, 2014, J Caring Sci, V3, P287, DOI 10.5681/jcs.2014.031; Katiti V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3345-x; Kazaura MR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3161-3; Kelly UA, 2009, RES NURS HEALTH, V32, P286, DOI 10.1002/nur.20327; Laisser RM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-13; Liang B, 2005, J COMMUNITY PSYCHOL, V36, P70; Liebschutz J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-229; Mahenge B, 2013, BJOG-INT J OBSTET GY, V120, P940, DOI 10.1111/1471-0528.12185; Manongi R, 2017, J INTERPERS VIOLENCE, V1, P1; McAlpine K, 2010, COMMUNITY MENT HLT J, V46, P26, DOI 10.1007/s10597-009-9196-5; McCloskey LA, 2005, INT FAM PLAN PERSPEC, V31, P124, DOI 10.1363/3112405; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) [Tanzania Mainland] Ministry of Health [Zanzibar] National Bereau of Statistics (NBS) Office of Chief Government Statistician (OCGS) ICF, TANZ DEM HLTH SURV M; Moore S., 1996, CHAGGA FACTS INFORM; National Bureau of Statistics of Tanzania ICF Macro, 2011, TANZ DEM HLTH SURV 2; Parvin K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3060-7; Porter KA, 2004, ANTHROPOS, V99, P3; Rogathi JJ, 2017, J AFFECT DISORDERS, V218, P238, DOI 10.1016/j.jad.2017.04.063; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Sigalla GN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172540; Sigalla GN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4157-3; Sylaska KM, 2014, TRAUMA VIOLENCE ABUS, V15, P3, DOI 10.1177/1524838013496335; Tenkorang EY, 2016, J FAM ISSUES, V1, P21; Hoang TN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162844; Tobergte D.R., 2013, J CHEM INF MODEL, V53, P1689, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, 2012, PAN AM HEAL ORGAN	43	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198098	10.1371/journal.pone.0198098	http://dx.doi.org/10.1371/journal.pone.0198098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856784	gold, Green Submitted, Green Published			2022-12-26	WOS:000433900800067
J	Radwan, H; Hashim, M; Obaid, RS; Hasan, H; Naja, F; Al Ghazal, H; Mohamed, HJJ; Rizk, R; Al Hilali, M; Rayess, R; Izzaldin, G				Radwan, Hadia; Hashim, Mona; Obaid, Reyad Shaker; Hasan, Hayder; Naja, Farah; Al Ghazal, Hessa; Mohamed, Hamid Jan Jan; Rizk, Rana; Al Hilali, Marwa; Rayess, Rana; Izzaldin, Ghamra			The Mother-Infant Study Cohort (MISC): Methodology, challenges, and baseline characteristics	PLOS ONE			English	Article							BREAST-FEEDING DURATION; BODY-MASS INDEX; 1ST 1,000 DAYS; RISK-FACTORS; HUMAN-MILK; DEVELOPMENTAL ORIGINS; LONGITUDINAL COHORT; ADIPONECTIN LEVELS; CHILDHOOD OBESITY; MATERNAL DIET	Background The United Arab Emirates (UAE) exhibits alarming high prevalence of Non-Communicable Diseases (NCDs) and their risk factors. Emerging evidence highlighted the role of maternal and early child nutrition in preventing later-onset NCDs. The objectives of this article are to describe the design and methodology of the first Mother and Infant Study Cohort (MISC) in UAE; present the baseline demographic characteristics of the study participants; and discuss the challenges of the cohort and their respective responding strategies. Methods The MISC is an ongoing two-year prospective cohort study which recruited Arab pregnant women in their third trimester from prenatal clinics in Dubai, Sharjah and Ajman. Participants will be interviewed six times (once during pregnancy, at delivery, and at 2, 6, 12 and 24months postpartum). Perinatal information is obtained from hospital records. Collected data include socio-demographic characteristics, lifestyle, dietary intake and anthropometry; infant feeding practices, cognitive development; along with maternal and infant blood profile and breast milk profile. Results The preliminary results reported that 256 completed baseline assessment (mean age: 30.5 +/- 6.0 years; 76.6% multiparous; about 60% were either overweight or obese before pregnancy). The prevalence of gestational diabetes was 19.2%. Upon delivery, 208 womeninfant pairs were retained (mean gestational age: 38.5 +/- 1.5 weeks; 33.3% caesarean section delivery; 5.3% low birthweight; 5.7% macrosomic deliveries). Besides participant retention,the main encountered challenges pertained to cultural complexity, underestimation the necessary start-up time, staff, and costs, and biochemical data collection. Conclusions Despite numerous methodological, logistical and sociocultural challenges, satisfactory follow-up rates are recorded. Strategies addressing challenges are documented, providing information for planning and implementing future birth cohort studies locally and internationally.	[Radwan, Hadia; Hashim, Mona; Obaid, Reyad Shaker; Hasan, Hayder; Al Hilali, Marwa; Rayess, Rana; Izzaldin, Ghamra] Univ Sharjah, RIMHS, Coll Hlth Sci, Dept Clin Nutr & Dietet, Sharjah, U Arab Emirates; [Naja, Farah] Amer Univ Beirut, Dept Nutr & Food Sci, Beirut, Lebanon; [Al Ghazal, Hessa] Family Hlth Promot Ctr, Sharjah, U Arab Emirates; [Mohamed, Hamid Jan Jan] Univ Sains Malaysia, Nutr & Dietet Program, Kelantan, Malaysia; [Rizk, Rana] Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands; [Rizk, Rana] Lebanese Univ, INSPECT, LB, Beirut, Lebanon	University of Sharjah; American University of Beirut; Universiti Sains Malaysia; Maastricht University; Lebanese University	Radwan, H (corresponding author), Univ Sharjah, RIMHS, Coll Hlth Sci, Dept Clin Nutr & Dietet, Sharjah, U Arab Emirates.	hradwan@sharjah.ac.ae	Radwan, Hadia/B-7955-2016; Shatawi, Hayder Hasan/E-8263-2019; , Sharef/AAV-8596-2021; Hasan, Hayder/J-4620-2019	Radwan, Hadia/0000-0002-3930-2554; Shatawi, Hayder Hasan/0000-0003-3971-0897; , Sharef/0000-0002-3494-4718; Hasan, Hayder/0000-0001-5580-1911; Shaker Obaid, Reyad/0000-0002-8440-8307; Naja, Farah/0000-0002-8861-3498; Rizk, Rana/0000-0002-8850-6502	Al Jalila Foundation [AJF 201510]; University of Sharjah Collaborative Grant [1501057003-P]	Al Jalila Foundation(Al Jalila Foundation (AJF)); University of Sharjah Collaborative Grant	We would like to note that The MISC research study has received funding from Al Jalila Foundation (AJF 201510) and University of Sharjah Collaborative Grant (1501057003-P). The study sponsors had no involvement in the research design, data collection, interpretation of the data, or publication.	Abu Dhabi Food Control Authority, 2014, PHOT ATL FOOD PORT E; Abu-Farha M, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0032-5; Agarwal MM, 2005, DIABETIC MED, V22, P1731, DOI 10.1111/j.1464-5491.2005.01706.x; Agarwal MM, 2010, DIABETES CARE, V33, P2018, DOI 10.2337/dc10-0572; Al Tajir GK, 2006, J HUM LACT, V22, P39, DOI 10.1177/0890334405283626; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; AlSeaidan M, 2016, PAEDIATR PERINAT EP, V30, P408, DOI 10.1111/ppe.12296; Anderson J, 2016, MATERN CHILD NUTR, V12, P790, DOI 10.1111/mcn.12216; Annemans L, 2007, REAL LIFE DATA GROWI; [Anonymous], GOOD MAT NUTR BEST S; [Anonymous], 2000, WHO TECHN REP SER; Bachir R, 2008, MATERN CHILD HLTH J, V12, P298, DOI 10.1007/s10995-007-0242-z; Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Beckhaus AA, 2015, ALLERGY, V70, P1588, DOI 10.1111/all.12729; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bener A, 2011, INT J WOMENS HEALTH, V3, P367, DOI 10.2147/IJWH.S26094; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Blake-Lamb TL, 2016, AM J PREV MED, V50, P780, DOI 10.1016/j.amepre.2015.11.010; Campbell Alasdair, 2011, J Glob Health, V1, P46; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Chivers P, 2010, INT J OBESITY, V34, P1169, DOI 10.1038/ijo.2010.61; Dashti M, 2014, NUTRIENTS, V6, P711, DOI 10.3390/nu6020711; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Eskenazi B, 2005, ENVIRON HEALTH PERSP, V113, P1419, DOI 10.1289/ehp.7670; Ferris WF, 2005, HORM METAB RES, V37, P695, DOI 10.1055/s-2005-870580; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Gaillard R, 2015, INT J OBESITY, V39, P677, DOI 10.1038/ijo.2014.175; Geng EH, 2012, AM J EPIDEMIOL, V175, P1080, DOI 10.1093/aje/kwr444; Gluckman PD, 2010, J DEV ORIG HLTH DIS, V1, P6, DOI 10.1017/S2040174409990171; Golding J, 2009, PAEDIATR PERINAT EP, V23, P1, DOI 10.1111/j.1365-3016.2008.01009.x; Gracie SK, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-87; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Horta B.L., 2013, LONG TERM EFFECTS BR; Hulver MW, 2004, METABOLISM, V53, P1, DOI 10.1016/j.metabol.2003.07.002; Innis SM, 2014, AM J CLIN NUTR, V99, p734S, DOI 10.3945/ajcn.113.072595; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Jiwani A, 2012, J MATERN-FETAL NEO M, V25, P600, DOI 10.3109/14767058.2011.587921; Khoo CM, 2011, DIABETES CARE, V34, P1120, DOI 10.2337/dc10-2097; Knox SS, 2009, J EPIDEMIOL COMMUN H, V63, pI1, DOI 10.1136/jech.2007.070813; Koletzko B, 2014, ANN NUTR METAB, V64, P187, DOI 10.1159/000365017; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Langley-Evans SC, 2006, P NUTR SOC, V65, P97, DOI 10.1079/PNS2005478; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P279, DOI 10.1136/jech.2004.025262; Lawrance M, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-31; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loy SL, 2014, HLTH ENV J, V5, P50; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Naja F, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0864-5; Nasreddine L, 2006, PUBLIC HEALTH NUTR, V9, P194, DOI 10.1079/PHN2005855; National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN PREC; Ng JWY, 2012, GENOME BIOL, V13, DOI [10.1186/gb4029, 10.1186/gb-2012-13-6-246]; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; NHLBI NIH, 2017, HIG BLOOD PRESS PREG; Pugh LC, 2002, BIRTH-ISS PERINAT C, V29, P95, DOI 10.1046/j.1523-536X.2002.00169.x; Radwan H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-171; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Savino F, 2013, CELL MOL BIOL, V59, P89, DOI 10.1170/T950; Savino F, 2012, ACTA PAEDIATR, V101, P1058, DOI 10.1111/j.1651-2227.2012.02744.x; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Squires J, 2009, AGES STAGES QUESTION; Tamim H, 2008, BJOG-INT J OBSTET GY, V115, P91, DOI 10.1111/j.1471-0528.2007.01568.x; The IPAQ Group, 2014, DOWNL QUEST INT PHYS; UAE Vision, 2017, WORLD CLASS HEALTHC; Velikonja T, 2017, CHILD CARE HLTH DEV, V43, P1, DOI 10.1111/cch.12397; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wahabi H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6878263; White E, 1998, EPIDEMIOL REV, V20, P43, DOI 10.1093/oxfordjournals.epirev.a017971; WHO, 2017, BAB FRIENDL HOSP IN; WHO Regional Office for the Eastern Mediterranean, 2011, PLAN ACT PREV CONTR; World Health Organization, 2014, NONC DIS NCD COUNTR; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2017, EXCL BREASTF; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6; World Health Organization UNICEF, 2007, PLANN GUID NAT IMPL; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR; Zeisel SH, 2009, AM J CLIN NUTR, V89, p685S, DOI 10.3945/ajcn.2008.26811F; Zhou WQ, 2016, INT J CLIN EXP MED, V9, P22931	83	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198278	10.1371/journal.pone.0198278	http://dx.doi.org/10.1371/journal.pone.0198278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851999	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200046
J	Blahed, IM; Konigsson, H; Ericsson, G; Spong, G				Blahed, Ida-Maria; Konigsson, Helena; Ericsson, Goran; Spong, Goran			Discovery of SNPs for individual identification by reduced representation sequencing of moose (Alces alces)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; PAIRWISE RELATEDNESS; INBREEDING COEFFICIENTS; MOLECULAR MARKERS; POPULATION; SOFTWARE; GENOME; CONSERVATION; SELECTIVITY; EVOLUTION	Monitoring of wild animal populations is challenging, yet reliable information about population processes is important for both management and conservation efforts. Access to molecular markers, such as SNPs, enables population monitoring through genotyping of various DNA sources. We have developed 96 high quality SNP markers for individual identification of moose (Alces alces), an economically and ecologically important top-herbivore in boreal regions. Reduced representation libraries constructed from 34 moose were high-throughput de novo sequenced, generating nearly 50 million read pairs. About 50 000 stacks of aligned reads containing one or more SNPs were discovered with the Stacks pipeline. Several quality criteria were applied on the candidate SNPs to find markers informative on the individual level and well representative for the population. An empirical validation by genotyping of sequenced individuals and additional moose, resulted in the selection of a final panel of 86 high quality autosomal SNPs. Additionally, five sex-specific SNPs and five SNPs for sympatric species diagnostics are included in the panel. The genotyping error rate was 0.002 for the total panel and probability of identities were low enough to separate individuals with high confidence. Moreover, the autosomal SNPs were highly informative also for population level analyses. The potential applications of this SNP panel are thus many including investigations of population size, sex ratios, relatedness, reproductive success and population structure. Ideally, SNP-based studies could improve today's population monitoring and increase our knowledge about moose population dynamics.	[Blahed, Ida-Maria; Konigsson, Helena; Ericsson, Goran; Spong, Goran] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden; [Spong, Goran] North Carolina State Univ, Coll Nat Resources, Dept Forestry & Environm Resources, Raleigh, NC USA	Swedish University of Agricultural Sciences; University of North Carolina; North Carolina State University	Blahed, IM (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden.	ida-maria.blahed@slu.se		Blahed, Ida-Maria/0000-0002-9977-2996; Spong, Goran/0000-0002-1246-5046	Swedish Environmental Protection Agency [802-213-05]; FORMAS [18203-331]; The EU/Interregional IIIA project Moose in Midscandinavia [429-6175-07]; Swedish University of Agricultural Sciences (SLU) project Beyond Moose [218-9314-15]; Helge Ax:son Johnsons stiftelse; Mauritz Carlgren foundation	Swedish Environmental Protection Agency; FORMAS(Swedish Research Council Formas); The EU/Interregional IIIA project Moose in Midscandinavia; Swedish University of Agricultural Sciences (SLU) project Beyond Moose; Helge Ax:son Johnsons stiftelse; Mauritz Carlgren foundation	This work was supported by Swedish Environmental Protection Agency, grant number: 802-213-05, https://www.naturvardsverket.se/; FORMAS, 2007-2009, http://www.formas.se/; Swedish Association for Hunting and Wildlife Management, grant number: 18203-331, https://jagareforbundet.se/; The EU/Interregional IIIA project Moose in Midscandinavia, grant number: 429-6175-07, https://jagareforbundet.se/vilt/vilt-vetande/viltforskning/viltforskningsprojekt/alg-i-mittskandia/; Swedish University of Agricultural Sciences (SLU) project Beyond Moose, grant number: 218-9314-15, http://www.viltforskning.se/beyond-moose.html; Helge Ax:son Johnsons stiftelse, grant number N/A, 2013, http://haxsonj.se/www/; Mauritz Carlgren foundation, grant number N/A, 2011, No URL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amish SJ, 2012, MOL ECOL RESOUR, V12, P653, DOI 10.1111/j.1755-0998.2012.03157.x; Andrews S., 2010, FASTQC QUALITY CONTR; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Calvete C, 2005, BIOL CONSERV, V121, P623, DOI 10.1016/j.biocon.2004.06.013; Carlsson J, 2013, J FISH BIOL, V82, P944, DOI 10.1111/jfb.12034; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Charlier J, 2008, J WILDLIFE MANAGE, V72, P411, DOI 10.2193/2007-122; Danell K., 2006, LARGE HERBIVORE ECOL; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Good JM, 2011, METHODS MOL BIOL, V772, P85, DOI 10.1007/978-1-61779-228-1_5; Haanes H, 2011, CONSERV GENET, V12, P1131, DOI 10.1007/s10592-011-0214-0; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Lindsay AR, 2008, CONSERV GENET, V9, P443, DOI 10.1007/s10592-007-9326-y; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Lynch M, 1999, GENETICS, V152, P1753; Mansson J, 2007, SCAND J FOREST RES, V22, P407, DOI 10.1080/02827580701515023; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Nichols RV, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9030033; Niedzialkowska M, 2016, BIOL J LINN SOC, V117, P879, DOI 10.1111/bij.12713; Norman AJ, 2015, ECOL EVOL, V5, P3056, DOI 10.1002/ece3.1588; Norman AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081012; Palsboll PJ, 1999, BIOL J LINN SOC, V68, P3, DOI 10.1111/j.1095-8312.1999.tb01155.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pew J, 2015, MOL ECOL RESOUR, V15, P557, DOI 10.1111/1755-0998.12323; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUMAN GENETICS, V81; R Core Team RFfSC, 2017, R LANG ENV STAT COMP; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rohrer GA, 2007, ANIM GENET, V38, P253, DOI 10.1111/j.1365-2052.2007.01593.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Solberg EJ, 2000, WILDLIFE BIOL, V6, P41, DOI 10.2981/wlb.2000.036; Suominen O, 1999, OIKOS, V84, P215, DOI 10.2307/3546716; Taylor SA, 2012, MAR ECOL PROG SER, V451, P285, DOI 10.3354/meps09694; von Thaden A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10647-w; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wennerstrom L, 2016, J MAMMAL, V97, P1, DOI 10.1093/jmammal/gyv146; Yang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04089	47	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197364	10.1371/journal.pone.0197364	http://dx.doi.org/10.1371/journal.pone.0197364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847564	gold, Green Published, Green Submitted			2022-12-26	WOS:000433634800031
J	Eymard-Vernain, E; Coute, Y; Adrait, A; Rabilloud, T; Sarret, G; Lelong, C				Eymard-Vernain, Elise; Coute, Yohann; Adrait, Annie; Rabilloud, Thierry; Sarret, Geraldine; Lelong, Cecile			The poly-gamma-glutamate of Bacillus subtilis interacts specifically with silver nanoparticles	PLOS ONE			English	Article							ACID PRODUCTION; ENGINEERED NANOMATERIALS; BACTERIA; TOXICITY; IMPACT; GENES; STRAINS; SYSTEMS; HAZARDS; IONS	For many years, silver nanoparticles, as with other antibacterial nanoparticles, have been extensively used in manufactured products. However, their fate in the environment is unclear and raises questions. We studied the fate of silver nanoparticles in the presence of bacteria under growth conditions that are similar to those found naturally in the environment (that is, bacteria in a stationary phase with low nutrient concentrations). We demonstrated that the viability and the metabolism of a gram-positive bacteria, Bacillus subtilis, exposed during the stationary phase is unaffected by 1 mg/L of silver nanoparticles. These results can be partly explained by a physical interaction of the poly-gamma-glutamate (PGA) secreted by Bacillus subtilis with the silver nanoparticles. The coating of the silver nanoparticles by the secreted PGA likely results in a loss of the bioavailability of nanoparticles and, consequently, a decrease of their biocidal effect.	[Eymard-Vernain, Elise; Rabilloud, Thierry; Lelong, Cecile] UMR CNRS CEA UGA, ProMD, LCBM, BIG, Grenoble, France; [Eymard-Vernain, Elise; Sarret, Geraldine] CNRS UGA, ISTerre, Grenoble, France; [Coute, Yohann; Adrait, Annie] INSERM CEA UGA, EDyP, BGE, BIG, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lelong, C (corresponding author), UMR CNRS CEA UGA, ProMD, LCBM, BIG, Grenoble, France.	cecile.lelong@univ-grenoble-alpes.fr	BM30, Beamline FAME/G-9313-2012; Couté, Yohann/G-2695-2015; Sarret, Geraldine/I-2797-2016	Couté, Yohann/0000-0003-3896-6196; Sarret, Geraldine/0000-0002-1709-3456; Adrait, Annie/0000-0002-1565-2859	CNRS, The University of Grenoble Alpes; "Investissements d'Avenir" French Government program of the French National Research Agency (ANR) through the A*MIDEX project [ANR-11-LABX-0064, ANR-11-IDEX-0001-02]	CNRS, The University of Grenoble Alpes; "Investissements d'Avenir" French Government program of the French National Research Agency (ANR) through the A*MIDEX project(French National Research Agency (ANR))	This work was funded by the CNRS, The University of Grenoble Alpes. This work is a contribution to the Labex Serenade (no ANR-11-LABX-0064) funded by the "Investissements d'Avenir" French Government program of the French National Research Agency (ANR) through the A*MIDEX project (no ANR-11-IDEX-0001-02). ISTerre is also part of Labex OSUG@2020 (ANR10 LABX56). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764, DOI 10.1007/s00253-001-0848-9; Ashiuchi M, 2006, J BIOSCI BIOENG, V102, P60, DOI 10.1263/jbb.102.60; Callaghan NI, 2017, COMP BIOCHEM PHYS C, V193, P30, DOI 10.1016/j.cbpc.2016.12.007; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Chen CL, 2006, AUST J CHEM, V59, P3, DOI 10.1071/CH05225; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Cox A, 2017, PLANT PHYSIOL BIOCH, V110, P33, DOI 10.1016/j.plaphy.2016.08.007; Dimkpa CO, 2014, J BASIC MICROB, V54, P889, DOI 10.1002/jobm.201400298; Dizaj SM, 2014, MAT SCI ENG C-MATER, V44, P278, DOI 10.1016/j.msec.2014.08.031; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; Eymard-Vernain E, 2018, ENVIRON SCI TECHNOL, V52, P71, DOI 10.1021/acs.est.7b04071; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P9004, DOI 10.1021/es901706j; Gambino M, 2015, J APPL MICROBIOL, V118, P1103, DOI 10.1111/jam.12779; Hakumai Y, 2016, BIOMETALS, V29, P527, DOI 10.1007/s10534-016-9928-2; Holden PA, 2016, ENVIRON SCI TECHNOL, V50, P6124, DOI 10.1021/acs.est.6b00608; Holden PA, 2014, CURR OPIN BIOTECH, V27, P73, DOI 10.1016/j.copbio.2013.11.008; Kaegi R, 2013, WATER RES, V47, P3866, DOI 10.1016/j.watres.2012.11.060; Kaegi R, 2011, ENVIRON SCI TECHNOL, V45, P3902, DOI 10.1021/es1041892; Khalil IR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020313; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Lei P, 2015, J AGR FOOD CHEM, V63, P10399, DOI 10.1021/acs.jafc.5b04523; Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405; Levard C, 2011, ENVIRON SCI TECHNOL, V45, P5260, DOI 10.1021/es2007758; Liu MQ, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5519-y; Luche S, 2016, J PROTEOMICS, V135, P170, DOI 10.1016/j.jprot.2015.07.018; Luo YY, 2016, DRUG DELIV, V23, P1882, DOI 10.3109/10717544.2015.1052863; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Mamberti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130810; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Martell A., 1982, CRITICAL STABILITY C, V5; Marvasi M, 2010, FEMS MICROBIOL LETT, V313, P1, DOI 10.1111/j.1574-6968.2010.02085.x; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Ogunleye A, 2015, MICROBIOL-SGM, V161, P1, DOI 10.1099/mic.0.081448-0; Ohsawa T, 2009, BIOSCI BIOTECH BIOCH, V73, P2096, DOI 10.1271/bbb.90341; Osera C, 2009, MICROBIOL-SGM, V155, P2282, DOI 10.1099/mic.0.026435-0; Pereira CL, 2012, J MATER SCI-MATER M, V23, P1583, DOI 10.1007/s10856-012-4639-x; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Scoffone V, 2013, BIOTECHNOL BIOENG, V110, P2006, DOI 10.1002/bit.24846; Shang ZY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00680; Sheng ZY, 2017, J ENVIRON MANAGE, V191, P290, DOI 10.1016/j.jenvman.2017.01.028; Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Sun TY, 2014, ENVIRON POLLUT, V185, P69, DOI 10.1016/j.envpol.2013.10.004; Urushibata Y, 2002, J BIOSCI BIOENG, V93, P252, DOI 10.1263/jbb.93.252; Wang LY, 2017, J MICROBIOL, V55, P554, DOI 10.1007/s12275-017-6589-y; Wigginton NS, 2010, ENVIRON SCI TECHNOL, V44, P2163, DOI 10.1021/es903187s; Yu DG, 2007, COLLOID SURFACE B, V59, P171, DOI 10.1016/j.colsurfb.2007.05.007; Yu YY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01811; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08; Zeng W, 2013, APPL MICROBIOL BIOT, V97, P2163, DOI 10.1007/s00253-013-4717-0; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06248-2; Zhang YW, 2008, J COLLOID INTERF SCI, V325, P371, DOI 10.1016/j.jcis.2008.05.063; Zhou KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32998	54	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197501	10.1371/journal.pone.0197501	http://dx.doi.org/10.1371/journal.pone.0197501			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813090	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800018
J	Jaggi, P; Mejias, A; Xu, ZH; Yin, H; Moore-Clingenpeel, M; Smith, B; Burns, JC; Tremoulet, AH; Jordan-Villegas, A; Chaussabel, D; Texter, K; Pascual, V; Ramilo, O				Jaggi, Preeti; Mejias, Asuncion; Xu, Zhaohui; Yin, Han; Moore-Clingenpeel, Melissa; Smith, Bennett; Burns, Jane C.; Tremoulet, Adriana H.; Jordan-Villegas, Alejandro; Chaussabel, Damien; Texter, Karen; Pascual, Virginia; Ramilo, Octavio			Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; JUVENILE IDIOPATHIC ARTHRITIS; AMERICAN-HEART-ASSOCIATION; ADENOVIRUS INFECTION; REPERTOIRE ANALYSES; IL-1 BLOCKADE; UNITED-STATES; EXPRESSION; CHILDREN; HOSPITALIZATIONS	Background Early identification of children with Kawasaki Disease (KD) is key for timely initiation of intravenous immunoglobulin (IVIG) therapy. However, the diagnosis of the disease remains challenging, especially in children with an incomplete presentation (inKD). Moreover, we currently lack objective tools for identification of non-response (NR) to IVIG. Methods Children with KD were enrolled and samples obtained before IVIG treatment and sequentially at 24 h and 4 +/- 6 weeks post-IVIG in a subset of patients. We also enrolled children with other febrile illnesses [adenovirus (AdV); group A streptococcus (GAS)] and healthy controls (HC) for comparative analyses. Blood transcriptional profiles were analyzed to define: a) the cKD and inKD biosignature, b) compare the KD signature with other febrile illnesses and, c) identify biomarkers predictive of clinical outcomes. Results We identified a cKD biosignature (n = 39; HC, n = 16) that was validated in two additional cohorts of children with cKD (n = 37; HC, n = 20) and inKD (n = 13; HC, n = 8) and was characterized by overexpression of inflammation, platelets, apoptosis and neutrophil genes, and underexpression of T and NK cell genes. Classifier genes discriminated KD from adenovirus with higher sensitivity and specificity (92% and 100%, respectively) than for GAS (75% and 87%, respectively). We identified a genomic score (MDTH) that was higher at baseline in IVIG-NR [median 12,290 vs. 5,572 in responders, p = 0.009] and independently predicted IVIG-NR. Conclusion A reproducible biosignature from KD patients was identified, and was similar in children with cKD and inKD. A genomic score allowed early identification of children at higher risk for nonresponse to IVIG.	[Jaggi, Preeti; Mejias, Asuncion; Ramilo, Octavio] Nationwide Childrens Hosp, Div Pediat Infect Dis, Columbus, OH 43205 USA; [Mejias, Asuncion; Smith, Bennett; Ramilo, Octavio] Ohio State Univ, Nationwide Childrens Hosp, Coll Med, Res Inst, Columbus, OH 43210 USA; [Xu, Zhaohui] Baylor Inst Immunol Res, Dallas, TX USA; [Yin, Han; Moore-Clingenpeel, Melissa] Nationwide Childrens Hosp, Res Inst, Ctr Biostat, Columbus, OH USA; [Burns, Jane C.; Tremoulet, Adriana H.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Burns, Jane C.; Tremoulet, Adriana H.] Rady Childrens Hosp, San Diego, CA USA; [Jordan-Villegas, Alejandro] Univ Texas Southwestern Med Ctr Dallas, Div Pediat Infect Dis, Dallas, TX 75390 USA; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar; [Texter, Karen] Nationwide Childrens Hosp, Div Pediat Cardiol, Columbus, OH USA; [Pascual, Virginia] Drukier Inst Childrens Hlth, New York, NY USA; [Pascual, Virginia] Weill Cornell Med, New York, NY USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Baylor Scott & White Health; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sidra Medical & Research Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Cornell University	Ramilo, O (corresponding author), Nationwide Childrens Hosp, Div Pediat Infect Dis, Columbus, OH 43205 USA.; Ramilo, O (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Coll Med, Res Inst, Columbus, OH 43210 USA.	Octavio.Ramilo@Nationwidechildrens.org	Pascual, Virginia/ABD-3099-2020; Chaussabel, Damien/AAX-1909-2020; Mejias, Asuncion/AAC-5998-2019; Moore-Clingenpeel, Melissa/K-7232-2019	Mejias, Asuncion/0000-0002-5983-8006; Xu, Zhaohui/0000-0003-0645-1737; Texter, Karen/0000-0002-7875-9266	American Heart Association Clinical Research Grant [11CRP5460003]; National Institutes of Health [UL1 TR001070]; Nationwide Children's Hospital intramural funds; Food and Drug Administration Orphan Diseases Program [FD 003514]	American Heart Association Clinical Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nationwide Children's Hospital intramural funds; Food and Drug Administration Orphan Diseases Program	Funded by American Heart Association Clinical Research Grant (11CRP5460003) to PJ; National Institutes of Health (UL1 TR001070) and Nationwide Children's Hospital intramural funds to PJ, AM, HY, MMC and OR; and Food and Drug Administration Orphan Diseases Program (FD 003514) to JCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Abe J, 2008, J ALLERGY CLIN IMMUN, V122, P1008, DOI 10.1016/j.jaci.2008.09.011; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Belay ED, 2003, PUBLIC HEALTH REP, V118, P464, DOI 10.1016/S0033-3549(04)50278-9; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Fury W, 2010, HUM IMMUNOL, V71, P865, DOI 10.1016/j.humimm.2010.06.008; Galeotti C, 2015, TRENDS MOL MED, V21, P145, DOI 10.1016/j.molmed.2015.01.005; Hachiya A, 2018, CLIN RHEUMATOL, V37, P1937, DOI 10.1007/s10067-017-3952-7; Herberg JA, 2016, JAMA-J AM MED ASSOC, V316, P835, DOI 10.1001/jama.2016.11236; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Jaggi P, 2013, CLIN INFECT DIS, V56, P58, DOI 10.1093/cid/cis807; Jordan-Villegas A, 2010, PEDIATR INFECT DIS J, V29, P770, DOI 10.1097/INF.0b013e3181dba70b; Kao AS, 2008, PEDIATR INFECT DIS J, V27, P981, DOI 10.1097/INF.0b013e31817acf4f; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Ling XB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-130; Mahajan P, 2016, JAMA-J AM MED ASSOC, V316, P846, DOI 10.1001/jama.2016.9207; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Popper SJ, 2009, J INFECT DIS, V200, P657, DOI 10.1086/603538; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rowley AH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2323-5; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Sleeper LA, 2011, J PEDIATR-US, V158, P831, DOI 10.1016/j.jpeds.2010.10.031; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Wang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167434; Yellen ES, 2010, PEDIATRICS, V125, pE234, DOI 10.1542/peds.2009-0606	39	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197858	10.1371/journal.pone.0197858	http://dx.doi.org/10.1371/journal.pone.0197858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813106	Green Published, gold			2022-12-26	WOS:000433521800033
J	Wasowicz, K; Winnicka, A; Kaleczyc, J; Zalecki, M; Podlasz, P; Pidsudko, Z				Wasowicz, Krzysztof; Winnicka, Anna; Kaleczyc, Jerzy; Zalecki, Michel; Podlasz, Piotr; Pidsudko, Zenon			Neuropeptides and lymphocyte populations in the porcine ileum and ileocecal lymph nodes during postnatal life	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; MUCOSAL IMMUNITY; POLYPEPTIDE; PROLIFERATION; TRANSMISSION; INFLAMMATION; ACTIVATION; EXPRESSION; APOPTOSIS; RESPONSES	The maturation-related changes in the concentrations of galanin (Gal), vasoactive intestinal polypeptide (VIP), substance P (SP) and somatostatin (Som), as well as in subpopulations of lymphocytes expressing antigens CD2 (lymphocytes T), CD4 (T helper), CD8 (T cytotoxic), CD21 (B lymphocytes), CD5-/CD8+ (NK cells) and TCRgamma/delta (gut mucosal/intraepitelial cells) were studied in the ileal Peyer's patches and ileo-cecal lymph nodes in female pigs aged 3 days, 2 weeks, 4 weeks and 4 months. As regards neuropeptide concentrations statistically significant changes in the ileum and lymph nodes were found only in case of Gal and VIP. The concentrations of neuropeptides were significantly higher only in new-born animals. As regards the changes in subpopulations of lymphocytes, statistically significant changes were noticed only in 4-months old animals and were dealing only with CD2+ and TCRgamma/delta cells in the ileum as well as CD4+, CD8+, CD21+ and TCRgamma/delta in lymph nodes. The highest number of CD8+, CD21+ and TCRgamma/ delta lymphocytes occurred in 4-months old animals.	[Wasowicz, Krzysztof; Podlasz, Piotr] Univ Warmia & Mazury, Dept Pathophysiol Forens Vet & Adm, Olsztyn, Poland; [Winnicka, Anna] Warsaw Univ Life Sci, Fac Vet Med, Dept Pathol & Vet Diagnost, Div Pathophysiol, Warsaw, Poland; [Kaleczyc, Jerzy; Zalecki, Michel; Pidsudko, Zenon] Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland	University of Warmia & Mazury; Warsaw University of Life Sciences; University of Warmia & Mazury	Pidsudko, Z (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland.	zenon.pidsudko@uwm.edu.pl		Wasowicz, Krzysztof/0000-0002-9496-3144; Winnicka, Anna/0000-0001-9918-3430	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food" [05- 1/KNOW2/2015]	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"	Publication supported by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", decision of Ministry of Science and Higher Education No. 05- 1/KNOW2/2015.	ANNIBALE B, 1990, GASTROENTEROLOGY, V98, P1693, DOI 10.1016/0016-5085(90)91109-J; Anton PA, 1998, ANN NY ACAD SCI, V840, P723, DOI 10.1111/j.1749-6632.1998.tb09611.x; Apolloni B, 2007, BRAIN RES REV, V55, P108, DOI 10.1016/j.brainresrev.2007.03.002; Balemba OB, 2001, INT J PARASITOL, V31, P1503, DOI 10.1016/S0020-7519(01)00273-9; Barrett K E, 1995, Gastroenterology, V108, P295, DOI 10.1016/0016-5085(95)90038-1; BIENENSTOCK J, 1989, IMMUNOL INVEST, V18, P69, DOI 10.3109/08820138909112228; BINNS RM, 1985, ADV EXP MED BIOL, V186, P661; Brill J, 2006, J NEUROSCI, V26, P6813, DOI 10.1523/JNEUROSCI.5320-05.2006; Carrion M, 2016, J LEUKOCYTE BIOL, V100, P1385, DOI 10.1189/jlb.3A0116-032RR; De Jonge WJ, 2005, J PEDIATR GASTR NUTR, V41, pS10, DOI 10.1097/01.scs.0000180287.58988.86; Delgado M, 1999, J IMMUNOL, V163, P3629; Delgado M, 2000, ANN NY ACAD SCI, V921, P55; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Kaleczyc J, 2010, J COMP PATHOL, V143, P248, DOI 10.1016/j.jcpa.2010.04.003; Kulkarni-Narla A, 1999, CELL TISSUE RES, V298, P275, DOI 10.1007/s004419900096; Montagne L, 2007, BRIT J NUTR, V97, P45, DOI 10.1017/S000711450720580X; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Owens L, 2002, J NUTR, V132, P2717, DOI 10.1093/jn/132.9.2717; REUSCH MK, 1988, ARCH DERMATOL RES, V280, P279, DOI 10.1007/BF00440600; STEAD RH, 1987, IMMUNOL REV, V100, P333, DOI 10.1111/j.1600-065X.1987.tb00538.x; Swindle MM, 1992, SWINE MODEL BIOMEDIC; Trejter M, 2002, INT J MOL MED, V10, P183; Vargova L, 2008, PHYSIOL RES, V57, pS89, DOI 10.33549/physiolres.931603; Wang Y, 2007, CLIN EXP IMMUNOL, V148, P178, DOI 10.1111/j.1365-2249.2007.03322.x; Wasowicz K., 2003, Polish Journal of Veterinary Sciences, V6, P147; Weinstock JV, 1996, ADV NEUROIMMUNOL, V6, P95, DOI 10.1016/S0960-5428(96)00009-5	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0196458	10.1371/journal.pone.0196458	http://dx.doi.org/10.1371/journal.pone.0196458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813072	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800006
J	Girard, M; Thanner, S; Pradervand, N; Hu, D; Ollagnier, C; Bee, G				Girard, Marion; Thanner, Sophie; Pradervand, Nicolas; Hu, Dou; Ollagnier, Catherine; Bee, Giuseppe			Hydrolysable chestnut tannins for reduction of postweaning diarrhea: Efficacy on an experimental ETEC F4 model	PLOS ONE			English	Article							POST-WEANING DIARRHEA; ESCHERICHIA-COLI STRAINS; GROWTH-PERFORMANCE; ENTEROTOXIGENIC STRAIN; PLANT-PRODUCTS; IN-VITRO; PIGLETS; PIGS; ACID; POLYPHENOLS	An experimental model for postweaning diarrhea with enterotoxigenic Escherichia coli F4 (ETEC F4) was set up in piglets, and the efficacy of 1% chestnut-tannin extract in preventing diarrhea was subsequently assessed. In a first trial (infection model), 32 Swiss Large White piglets (age: 24 days; average BW: 7.8 +/- 0.8 kg) were randomly assigned to two experimental groups (infected [INF], noninfected [NINF]). In a subsequent trial, 72 Swiss Large White piglets (age: 26 days; average BW: 7.4 +/- 1.5 kg) were blocked by BW and assigned within block to four experimental groups: NINF-CO: not infected and fed a standard control starter diet (CO); INF-CO: infected and fed the CO diet; NINF-TA: not infected and fed the CO diet supplemented with 1% chestnut extract containing 54% of hydrolysable tannins (TA); and INF-TA: infected and fed the TA diet. Both diets (TA and CO) were formulated to be isocaloric and isoproteic and to meet or surpass the nutritional requirements. In both trials, four days after weaning, piglets assigned to the INF group received an oral suspension of ETEC F4. Fecal score, ETEC shedding in feces (only in trial 2), and growth performance traits were measured for the following 14 days post infection. In both trials, more than 50% of the INF piglets developed diarrhea within six days post infection. Tannins reduced (P < 0.05) the average fecal score, the percentage of piglets in diarrhea, and the duration of diarrhea, whereas feed intake and the average daily gain were unaffected.	[Girard, Marion; Thanner, Sophie; Pradervand, Nicolas; Ollagnier, Catherine; Bee, Giuseppe] Agroscope, Inst Livestock Sci, Posieux, Switzerland; [Thanner, Sophie; Hu, Dou] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bee, G (corresponding author), Agroscope, Inst Livestock Sci, Posieux, Switzerland.	giuseppe.bee@agroscope.admin.ch	; Bee, Giuseppe/E-6139-2013	Girard, Marion/0000-0003-1819-3800; Bee, Giuseppe/0000-0002-6397-7543	internal Agroscope project called REDYMO	internal Agroscope project called REDYMO	The study was funded by seed money of an internal Agroscope project called REDYMO. No grant number is available.	Adeola O, 2011, J ANIM SCI, V89, P3189, DOI 10.2527/jas.2010-3715; Afsana K, 2004, BIOSCI BIOTECH BIOCH, V68, P584, DOI 10.1271/bbb.68.584; Agroscope, 2017, FUTTTERUNGSEMPFEHLUN; Alexa P, 2001, VET MED-CZECH, V46, P46, DOI 10.17221/7851-VETMED; Bag A, 2014, NAT PROD RES, V28, P1280, DOI 10.1080/14786419.2014.895729; Biagi G, 2006, J ANIM SCI, V84, P370, DOI 10.2527/2006.842370x; Biagi G, 2010, ARCH ANIM NUTR, V64, P121, DOI 10.1080/17450390903461584; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Bruins MJ, 2011, J ANIM PHYSIOL AN N, V95, P388, DOI 10.1111/j.1439-0396.2010.01066.x; BUTLER LG, 1992, BASIC LIFE SCI, V59, P693; Cho JH, 2011, J ANIM VET ADV, V10, P2127, DOI 10.3923/javaa.2011.2127.2134; Chung KT, 1998, FOOD CHEM TOXICOL, V36, P1053, DOI 10.1016/S0278-6915(98)00086-6; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Dubreuil JD, 2013, TOXINS, V5, P2009, DOI 10.3390/toxins5112009; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Elizondo AM, 2010, VET MICROBIOL, V145, P308, DOI 10.1016/j.vetmic.2010.04.003; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Frohner E., 1921, ARZNEIMITTELLEHRE TI; Gao Y, 2013, J ANIM SCI, V91, P5614, DOI 10.2527/jas.2013-6528; Goel G, 2005, NATURWISSENSCHAFTEN, V92, P497, DOI 10.1007/s00114-005-0040-7; Graziani R, 2006, EPC 2006, P328; Halas Veronika, 2012, Animals (Basel), V2, P261, DOI 10.3390/ani2020261; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Heo JM, 2015, ANIM SCI J, V86, P286, DOI 10.1111/asj.12275; Hu D, 2017, ETH SCHRIFTENREIHE T, V40, P157; Jass J, 2009, CAN J UROL, V16, P4901; Kim JC, 2011, ANIM FEED SCI TECH, V170, P222, DOI 10.1016/j.anifeedsci.2011.08.012; Kumar K, 2005, ADV AGRON, V87, P1, DOI 10.1016/S0065-2113(05)87001-4; LECCE JG, 1982, J CLIN MICROBIOL, V16, P715, DOI 10.1128/JCM.16.4.715-723.1982; Lee SH, 2010, LIVEST SCI, V131, P281, DOI 10.1016/j.livsci.2010.04.013; Madec F, 2000, VET MICROBIOL, V72, P295, DOI 10.1016/S0378-1135(99)00202-3; Melin L, 2004, J VET MED B, V51, P12, DOI 10.1111/j.1439-0450.2003.00723.x; Mohlatlole RP, 2013, TROP ANIM HEALTH PRO, V45, P1399, DOI 10.1007/s11250-013-0377-4; Molist F, 2010, LIVEST SCI, V133, P214, DOI 10.1016/j.livsci.2010.06.067; Morinaga N, 2005, J BIOL CHEM, V280, P23303, DOI 10.1074/JBC.M502093200; Myrie SB, 2008, J ANIM SCI, V86, P609, DOI 10.2527/jas.2006-793; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Niewold TA, 2007, VET MICROBIOL, V124, P362, DOI 10.1016/j.vetmic.2007.04.034; Osek J, 2001, J VET DIAGN INVEST, V13, P308, DOI 10.1177/104063870101300405; Rantzer D, 2010, P 21 IPVS C VANC CAN; Sarica S, 2016, EUR POULTRY SCI, V80, DOI 10.1399/eps.2016.121; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Silbergeld EK, 2008, EPIDEMIOLOGY, V19, pS15; Turner J.L., 2001, PROF ANIM SCI, V17, P217, DOI [https://doi.org/10.15232/S1080-7446(15)31633-8, DOI 10.15232/S1080-7446(15)31633-8]; Van Parys A, 2010, ZOONOSES PUBLIC HLTH, V57, P423, DOI 10.1111/j.1863-2378.2009.01242.x; Verhelst R, 2014, LIVEST SCI, V160, P138, DOI 10.1016/j.livsci.2013.11.026; Verhelst R, 2010, LIVEST SCI, V133, P101, DOI 10.1016/j.livsci.2010.06.035; World Health Organization, 2014, ANT RES GLOB REP SUR	48	28	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197878	10.1371/journal.pone.0197878	http://dx.doi.org/10.1371/journal.pone.0197878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799865	gold, Green Submitted, Green Published			2022-12-26	WOS:000433153400029
J	Bhat, DS; Gruca, LL; Bennett, CD; Katre, P; Kurpad, AV; Yajnik, CS; Kalhan, SC				Bhat, Dattatray S.; Gruca, Lourdes L.; Bennett, Carole D.; Katre, Prachi; Kurpad, Anura V.; Yajnik, Chittaranjan S.; Kalhan, Satish C.			Evaluation of tracer labelled methionine load test in vitamin B-12 deficient adolescent women	PLOS ONE			English	Article							HOMOCYSTEINE S-METHYLTRANSFERASE; MICROBIOLOGICAL ASSAY; PLASMA HOMOCYSTEINE; METABOLISM; BETAINE; FOLATE; HYPERHOMOCYSTEINEMIA; MICE	Background Methionine loading test (MLT) has been used primarily to identify defects in transsulfuration of homocysteine in cystathionine beta synthase deficiency. It may not be as useful to evaluate remethylation pathway, in vitamin B-12 and folate deficiencies. Objective We used tracer isotope labelled MLT to interrogate transsulfuration and remethylation independently in vitamin B-12 deficiency. Design We studied vitamin B-12 deficient women with a tracer labelled MLT before and eleven months after treatment with vitamin B-12. The fractional contribution of [C-13]homocysteine to breath CO2 was used as a measure of transsulfuration, and difference in the intracellular enrichment of [C-13]methionine and that of [(CH3)-H-2]methionine as a measure of remethylation of homocysteine. Combined pre- and post-treatment results were analyzed to investigate the association between plasma vitamin B-12 concentrations and measures of homocysteine metabolism. Results The subjects were 17 years old, with a BMI of 19.4 kg/m(2). Treatment with vitamin B-12, 2 mu g/day increased plasma B-12 from 93 (78.7, 106.2) [median (25th, 75th centiles)] to 161.5 (125.5, 226.2) pmol/L; 44% were below <150pmol/L after treatment. Fasting homocysteine concentration was significantly lower and that of cysteine higher in subjects with B-12 levels >150pmol/L. The tracer estimated transsulfuration of homocysteine was lower and remethylation higher with B-12 levels >150pmol/L when compared with those <150pmol/L. Conclusions The tracer labelled MLT in combination with fasting parameters is a robust way to estimate parameters of methionine metabolism and can be used in the field where prime-constant rate infusion studies cannot be done efficiently.	[Bhat, Dattatray S.; Katre, Prachi; Yajnik, Chittaranjan S.] King Edward Mem Hosp, Kamalnayan Bajaj Diabetol Res Ctr, Res Ctr, Pune, Maharashtra, India; [Gruca, Lourdes L.; Bennett, Carole D.; Kalhan, Satish C.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Gruca, Lourdes L.; Bennett, Carole D.; Kalhan, Satish C.] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Kurpad, Anura V.] St Johns Res Inst, Bangalore, Karnataka, India	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; St. John's National Academy of Health Sciences; St. John's Research Institute	Bhat, DS (corresponding author), King Edward Mem Hosp, Kamalnayan Bajaj Diabetol Res Ctr, Res Ctr, Pune, Maharashtra, India.	d.bhat@kemdiabetes.org		Bhat, Dattatray/0000-0001-9512-2366	National Institutes of Health [R21 HD 073880]; Indian Council of Medical Research, New Delhi [58/1/8/MRC-ICMR/2009/NCD-II]; Medical Research Council, UK [MR/J000094/1]; European Union-HEALTH [F2-2011-278917]; MRC [MC_UU_12011/3, MR/J000094/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union-HEALTH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institutes of Health (R21 HD 073880 to Prof Satish C Kalhan), Indian Council of Medical Research, New Delhi (58/1/8/MRC-ICMR/2009/NCD-II to Prof Chittaranjan S Yajnik), Medical Research Council, UK (MR/J000094/1 to Prof Chittaranjan S Yajnik), European Union-HEALTH (F2-2011-278917 to Prof Chittaranjan S Yajnik). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleie O, 2004, AM J CLIN NUTR, V80, P641; Cattaneo M, 1999, BLOOD, V93, P1118, DOI 10.1182/blood.V93.3.1118.403a38h_1118_1120; Cheng CH, 2008, EUR J NUTR, V47, P491, DOI 10.1007/s00394-008-0752-5; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Dasarathy J, 2010, AM J CLIN NUTR, V91, P357, DOI 10.3945/ajcn.2009.28457; Deshmukh US, 2010, EUR J CLIN NUTR, V64, P495, DOI 10.1038/ejcn.2010.15; Devoto G, 2006, CLIN CHEM, V52, P2281, DOI 10.1373/clinchem.2006.080366; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; JI AJ, 1995, CLIN CHEM, V41, P897; Kalhan SC, 2003, AM J PHYSIOL-ENDOC M, V284, pE733, DOI 10.1152/ajpendo.00167.2002; Katre P, 2016, EUR J CLIN NUTR, V70, P687, DOI 10.1038/ejcn.2015.155; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kumaran Kalyanaraman, 2017, BMC Nutr, V3, P41, DOI 10.1186/s40795-017-0143-5; MacCoss MJ, 2001, AM J PHYSIOL-ENDOC M, V280, pE947, DOI 10.1152/ajpendo.2001.280.6.E947; O'Leary F, 2010, NUTRIENTS, V2, P299, DOI 10.3390/nu2030299; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; Refsum H, 2001, AM J CLIN NUTR, V74, P233; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; STORCH KJ, 1988, AM J PHYSIOL, V255, pE322, DOI 10.1152/ajpendo.1988.255.3.E322; STORCH KJ, 1991, AM J CLIN NUTR, V54, P386, DOI 10.1093/ajcn/54.2.386; TAMURA T, 1990, CLIN CHEM, V36, P1993; Teng YW, 2012, J NUTR, V142, P1964, DOI 10.3945/jn.112.166835; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Van Der Griend R, 1998, J LAB CLIN MED, V132, P67, DOI 10.1016/S0022-2143(98)90027-0; Yajnik C S, 2006, J Assoc Physicians India, V54, P775	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196970	10.1371/journal.pone.0196970	http://dx.doi.org/10.1371/journal.pone.0196970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795596	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300019
J	Hahn-Goldberg, S; Jeffs, L; Troup, A; Kubba, R; Okrainec, K				Hahn-Goldberg, Shoshana; Jeffs, Lianne; Troup, Amy; Kubba, Rasha; Okrainec, Karen			"We are doing it together"; The integral role of caregivers in a patients' transition home from the medicine unit	PLOS ONE			English	Article							QUALITATIVE DATA-ANALYSIS; DISCHARGE INSTRUCTIONS; CARE TRANSITIONS; FAMILY-MEMBERS; HEART-FAILURE; PERSPECTIVES; EXPERIENCES; DISEASE; COMPREHENSION; INFORMATION	Background An admission to hospital for acute illness can be difficult for patients and lead to high levels of anxiety. Patients are given a lot of information throughout their hospital stay and instructions at discharge to follow when they get home. For complex medical patients, the ability to retain, understand, and adhere to these instructions is a critical marker of a successful transition. This study was undertaken to explore factors impacting the ability of patients to understand and adhere to instructions. Methods A qualitative design of interviews with patients and caregivers was used. Participants were adult patients and caregivers with congestive heart failure, chronic obstructive pulmonary disease, or community-acquired pneumonia being discharged home from three academic acute care hospitals in Ontario, Canada. Semi structured interviews were conducted with participants within one week following their discharge from hospital. Interviews were audio-taped and transcribed. Five independent researchers participated in an iterative process of coding, reviewing, and analyzing the interviews using direct content analysis. Results In total, 27 participants completed qualitative interviews. Analysis revealed the role of the caregiver to be critical in its relation to the ability of patients to understand and adhere to discharge instructions. Within the topic of caregiving, we draw on three areas of insight: The first clarified how caregivers support patients after they are discharged home from the hospital. The second highlighted how caregiver involvement impacts patient understanding and adherence to discharge instructions. The third revealed system factors that influence a caregiver's involvement when receiving discharge instructions. Conclusion Caregivers play an important role in the transition of a complex medical patient by impacting a patient's ability to understand and adhere to their discharge instructions. The themes identified in this paper highlight opportunities for healthcare providers and institutions to effectively involve caregivers during transitions from acute care hospitals to home.	[Hahn-Goldberg, Shoshana; Troup, Amy; Kubba, Rasha] Univ Hlth Network, OpenLab, Toronto, ON, Canada; [Hahn-Goldberg, Shoshana] Yok Univ, Sch Hlth Policy & Management, Toronto, ON, Canada; [Jeffs, Lianne] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Okrainec, Karen] Univ Hlth Network, Toronto, ON, Canada; [Okrainec, Karen] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Hahn-Goldberg, S (corresponding author), Univ Hlth Network, OpenLab, Toronto, ON, Canada.; Hahn-Goldberg, S (corresponding author), Yok Univ, Sch Hlth Policy & Management, Toronto, ON, Canada.	Shoshana.Hahn-Goldberg@uhn.ca	Jeffs, Lianne P/U-9147-2018; Okrainec, Karen/ABB-1447-2020	Okrainec, Karen/0000-0003-0754-1830; , Shoshana/0000-0002-7016-5295	Toronto General Hospital Foundation	Toronto General Hospital Foundation	The Donald J Mathews Fund from Toronto General Hospital Foundation provided some financial support for this work. The funding group had no role in design, conduct, or implementation of the study or manuscript.	Albrecht JS, 2014, J GEN INTERN MED, V29, P1491, DOI 10.1007/s11606-014-2956-0; ANDERSON JL, 1979, RHEUMATOL REHABIL, V18, P18, DOI 10.1093/rheumatology/18.1.18; Basit TN, 2003, EDUC RES-UK, V45, P143, DOI 10.1080/0013188032000133548; Blair J, 2014, J CARDIOVASC NURS, V29, P29, DOI 10.1097/JCN.0b013e3182784123; Bragstad LK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-331; Bull MJ, 2000, APPL NURS RES, V13, P76, DOI 10.1016/S0897-1897(00)80004-X; Chapin RK, 2014, SOC WORK HEALTH CARE, V53, P311, DOI 10.1080/00981389.2014.884037; CHPCA, 2004, VOIC HLTH POL ROL IN, P9; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Connolly M, 2009, J CLIN NURS, V18, P549, DOI 10.1111/j.1365-2702.2008.02551.x; Cowie MR, 2014, ESC HEART FAIL, V1, P110, DOI 10.1002/ehf2.12021; Dossa A, 2012, REHABIL NURS, V37, P277, DOI 10.1002/rnj.047; Dyrstad DN, 2015, J CLIN NURS, V24, P1693, DOI 10.1111/jocn.12773; Farmer SA, 2016, MAYO CLIN PROC, V91, P1056, DOI 10.1016/j.mayocp.2016.05.016; Farrell M, 2016, HSFR UPDATE FUTURE D; Ford BK, 2016, HEALTH SOC WORK, V41, P129, DOI 10.1093/hsw/hlw009; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Foust JB, 2012, WESTERN J NURS RES, V34, P194, DOI 10.1177/0193945911400448; Hahn-Goldberg S, 2016, HEALTHCARE Q, V19; Hahn-Goldberg S, 2015, J HOSP MED, V10, P804, DOI 10.1002/jhm.2444; Heng K. W. J., 2007, SMJ Singapore Medical Journal, V48, P1107; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hwang Stephen W, 2005, BMC Fam Pract, V6, P26, DOI 10.1186/1471-2296-6-26; Jack B, 2013, REENGINEERED DISCHAR; Jeffs L, 2017, WOLDVIEWS EVIDENCE B, V00, P1; Jeffs L, 2014, J INTERPROF CARE, V28, P507, DOI 10.3109/13561820.2014.923988; Jeffs L, 2012, PATIENT PREFER ADHER, V6, P711, DOI 10.2147/PPA.S36797; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Kwan JL, 2015, J HOSP MED, V10, P799, DOI 10.1002/jhm.2442; Leech NL, 2007, SCHOOL PSYCHOL QUART, V22, P557, DOI 10.1037/1045-3830.22.4.557; Mosca L, 2011, J CARDIOVASC NURS, V26, P305, DOI 10.1097/JCN.0b013e3181f34bb3; Okrainec K, 2016, IMPACT PATIENT CTR D; Okrainec K, 2017, J HOSP MED, V12, P110, DOI 10.12788/jhm.2692; Ontario Ministry of Health and Long Term Care, HLTH SYST FUND REF; Powers BJ, 2010, JAMA-J AM MED ASSOC, V304, P76, DOI 10.1001/jama.2010.896; Priest Helena, 2002, Nurse Res, V10, P30; Sharma A, 2017, INTERN EMERG MED, V12, P789, DOI 10.1007/s11739-017-1654-4; Shyu YIL, 2008, J CLIN NURS, V17, P2497, DOI 10.1111/j.1365-2702.2008.02450.x; SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6; Takemura M, 2011, INT J CHRONIC OBSTR, V6, P97, DOI 10.2147/COPD.S16173	40	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197831	10.1371/journal.pone.0197831	http://dx.doi.org/10.1371/journal.pone.0197831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795623	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300075
J	Li, TY; Ma, YC; Wu, XX; Chen, S; Xu, XF; Wang, H; Cao, YY; Xuan, YH				Li, Tian Ya; Ma, Yu Chen; Wu, Xian Xin; Chen, Si; Xu, Xiao Feng; Wang, Hao; Cao, Yuan Yin; Xuan, Yuan Hu			Race and virulence characterization of Puccinia graminis f. sp tritici in China	PLOS ONE			English	Article							F-SP TRITICI; STEM RUST; IDENTIFICATION; BERBERIS	Wheat stem rust was once the most destructive plant disease, but it has been largely controlled. However, to prevent future problems, the ongoing development of resistant wheat varieties requires knowledge of the changing virulence patterns for Pgt virulence of the fungus that causes wheat stem rust and the detection of new races. Surveys were conducted from 2013-2014 to determine the races of the Pgt present in China. Low levels of stem rust infections were found in China during this investigation and 11 Puccinia graminis f. sp. tritici (PO) samples were obtained. In addition, 22 Pgt samples collected from the alternate host (Berberis) were obtained and have been reported for the first time. Fifty-three isolates were obtained from all samples. Four race groups, including 13 physiological races, were identified. They included the most prevalent races, 34C3MTGQM and 34C6MRGQM, with 13.2% predominance, followed by 34COMRGQM at 11.3%. Six new races that were virulent against the resistance genes, Sr5 + Sr11, were found for the first time in China, namely 34COMRGQM, 34C3MTGQM, 34C3MKGQM, 34C3MKGSM, 34C6MTGSM, and 34C6MRGQM, with a predominance of 11.3, 13.2, 9.4, 9.4, 1.9, and 13.2%, respectively. Most of the genes studied were ineffective against one or more of the tested isolates, except Sr9e, Sr21, Sr26, Sr31, Sr33, Sr38, Sr47, and SrTt3. Genes Sr35, SrTmp, Sr30, Sr37, Sr17, and Sr36 were effective in 92.5, 86.8, 84.9, 84.9, 79.3, and 77.4% of the tested isolates, respectively. In contrast, all of the isolates were virulent against Sr6, Sr7b, Sr9a, Sr9b, Sr9d, Sr9g, and SrMcN. Our results indicate that remarkable differences exist among the categories of the races in this study (i.e., their known virulence gene spectra) and the Pgt races reported previously. In addition, the sexual cycle of Pgt may contribute to its diversity in China.	[Li, Tian Ya; Ma, Yu Chen; Wu, Xian Xin; Xu, Xiao Feng; Wang, Hao; Cao, Yuan Yin; Xuan, Yuan Hu] Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China; [Chen, Si] Heilongjiang Acad Agr Sci, Ind Crops Inst, Harbin, Heilongjiang, Peoples R China	Shenyang Agricultural University; Heilongjiang Academy of Agricultural Sciences	Cao, YY; Xuan, YH (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China.	caoyy66@aliyun.com; xuanyuanhu115@syau.edu.cn		Li, Tian Ya/0000-0002-1233-7845	National Natural Science Found of China [31701738]; National Key Basic Research Program of China [2013CB127701]; Technology Research Project of Education Department of Liaoning [LSNYB201614]	National Natural Science Found of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Technology Research Project of Education Department of Liaoning	This study was supported by the National Natural Science Found of China (31701738), the National Key Basic Research Program of China (2013CB127701), and the Technology Research Project of Education Department of Liaoning (LSNYB201614).	Abebe T., 2012, J PLANT PATHOL MICRO, V3, P1, DOI [10.4172/2157-7471.1000142, DOI 10.4172/2157-7471.1000142]; Bhattacharya S, 2017, NATURE, V542, P145, DOI 10.1038/nature.2017.21424; Cao Y. Y., 1996, J SHENYANG AGR U, V27, P26; Cao YuanYin, 2001, Acta Phytophylacica Sinica, V28, P294; Cao YuanYin, 1996, Acta Phytophylacica Sinica, V23, P45; Chen WanQuan, 1997, Acta Agronomica Sinica, V23, P655; de Bary A., 1866, NEUE UNTERSUCHUNGEN; FAO (Food and Agricultural Organization of the United Nations), 2017, SPREAD DAM WHEAT RUS; Goutam U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00861; [韩建东 HAN Jian-dong], 2010, [麦类作物学报, Journal of Triticeae Crops], V30, P163; Huang ZT, 1991, ACTA PHYTOPATHOL SIN, V21, P65; Huang ZT, 1988, ACTA PHYTOPATHOL SIN, V15, p29 ; Jin Y, 2010, PHYTOPATHOLOGY, V100, P432, DOI 10.1094/PHYTO-100-5-0432; Kolmer JA, 2007, AUST J AGR RES, V58, P631, DOI 10.1071/AR07057; Li TY, 2016, PLANT PROTECT SCI, V52, P242, DOI 10.17221/137/2015-PPS; Olivera P, 2015, PHYTOPATHOLOGY, V105, P917, DOI 10.1094/PHYTO-11-14-0302-FI; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Qiu Y.C., 1999, J SHENYANG AGR U, V30, P231; ROELFS AP, 1982, PLANT DIS, V66, P177, DOI 10.1094/PD-66-177; ROELFS AP, 1980, PHYTOPATHOLOGY, V70, P855, DOI 10.1094/Phyto-70-855; STAKMAN E. C., 1962, Identification of physiologic races of Puccinia graminis var. tritici.; Yao P., 1993, Acta Phytophylacica Sinica, V20, P65; Yao P, 1996, J SHENYANG AGR U, V27, P263; Yao Ping, 1998, Plant Protection, V24, P3; Zhao J, 2013, PHYTOPATHOLOGY, V103, P927, DOI 10.1094/PHYTO-09-12-0249-R	25	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197579	10.1371/journal.pone.0197579	http://dx.doi.org/10.1371/journal.pone.0197579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795612	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300050
J	Sandquist, EJ; Essner, JJ; Sakaguchi, DS				Sandquist, Elizabeth J.; Essner, Jeffrey J.; Sakaguchi, Donald S.			Xenotransplantation of adult hippocampal neural progenitors into the developing zebrafish for assessment of stem cell plasticity	PLOS ONE			English	Article							IN-VIVO; NEURONAL DIFFERENTIATION; RAT HIPPOCAMPUS; BRAIN	Adult stem cells are considered multipotent, restricted to differentiate into a few tissue-specific cell types. With the advent of technologies which can dedifferentiate and transdifferentiate cell types, assumptions about the process of cell fate determination must be reconsidered, including the role of extrinsic versus intrinsic factors. To determine the plasticity of adult neural progenitors, rat hippocampal progenitor cells were xenotransplanted into embryonic zebrafish. These animals allow for easy detection of transplanted cells due to their external development and transparency at early stages. Adult neural progenitors were observed throughout the zebrafish for the duration of the experiment (at least five days post-transplantation). While the majority of transplanted cells were observed in the central nervous system, a large percentage of cells were located in superficial tissues. However, approximately one-third of these cells retained neural morphology and expression of the neuronal marker, Class III beta-tubulin, indicating that the transplanted adult neural progenitors did not adapt alternate fates. A very small subset of cells demonstrated unique, non-neural flattened morphology, suggesting that adult neural progenitors may exhibit plasticity in this model, though at a very low rate. These findings demonstrate that the developing zebrafish may be an efficient model to explore plasticity of a variety of adult stem cell types and the role of external factors on cell fate.	[Sandquist, Elizabeth J.; Essner, Jeffrey J.; Sakaguchi, Donald S.] Iowa State Univ, Genet Dev & Cell Biol, Ames, IA 50011 USA; [Sakaguchi, Donald S.] Iowa State Univ, Neurosci Program, Ames, IA 50011 USA	Iowa State University; Iowa State University	Sandquist, EJ; Sakaguchi, DS (corresponding author), Iowa State Univ, Genet Dev & Cell Biol, Ames, IA 50011 USA.; Sakaguchi, DS (corresponding author), Iowa State Univ, Neurosci Program, Ames, IA 50011 USA.	esandq@iastate.edu; dssakagu@iastate.edu		Sakaguchi, Donald/0000-0003-4537-0972; Essner, Jeffrey/0000-0001-8816-3848	Howard Hughes Medical Institute Undergraduate Science Education Grant [U14_IASU JJE]; Stem Cell Research Fund of Iowa State University	Howard Hughes Medical Institute Undergraduate Science Education Grant; Stem Cell Research Fund of Iowa State University	This work was supported by Howard Hughes Medical Institute Undergraduate Science Education Grant to Research Universities [U14_IASU JJE, EJS), http://www.hhmi.org/ and the Stem Cell Research Fund of Iowa State University [DSS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani-Yaghoub M, 2004, DEVELOPMENT, V131, P4287, DOI 10.1242/dev.01295; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Denham M, 2006, STEM CELLS, V24, P918, DOI 10.1634/stemcells.2005-0151; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Ghotra VPS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031281; Greco B, 2004, STEM CELLS, V22, P600, DOI 10.1634/stemcells.22-4-600; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Hori Y, 2005, PLOS MED, V2, P347, DOI 10.1371/journal.pmed.0020103; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klassen H, 2003, VISION RES, V43, P947, DOI 10.1016/S0042-6989(03)00094-4; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Li J, 2015, CHEM GEOL, V406, P10, DOI 10.1016/j.chemgeo.2015.04.010; Oh JS, 2009, J BIOMED MATER RES A, V91A, P575, DOI 10.1002/jbm.a.32242; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Tat Jennifer, 2013, Drug Discov Today Technol, V10, pe83, DOI 10.1016/j.ddtec.2012.04.006; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xiao C, 2016, J MOL HISTOL, V47, P437, DOI 10.1007/s10735-016-9688-x; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198025	10.1371/journal.pone.0198025	http://dx.doi.org/10.1371/journal.pone.0198025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795671	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300115
J	Tsai, MC; Strong, C; Chen, WT; Lee, CT; Lin, CY				Tsai, Meng-Che; Strong, Carol; Chen, Wan-Ting; Lee, Chih-Ting; Lin, Chung-Ying			Longitudinal impacts of pubertal timing and weight status on adolescent Internet use: Analysis from a cohort study of Taiwanese youths	PLOS ONE			English	Article							SEXUAL ATTITUDES; PORNOGRAPHY; EXPOSURE; ONLINE; ADDICTION; BEHAVIORS; OBESITY; HEALTH; BRAIN; BOYS	Aim To investigate the longitudinal impacts of pubertal timing and weight status on Internet use in adolescents. Methods Three waves of data on a longitudinal cohort of 7th grade students (N = 2430) were retrieved from the Taiwan Youth Project. Univariate and multivariate regression models were applied using crude and adjusted odds ratios (OR) with 95% confidence intervals (CI) to examine the concomitant impacts of pubertal timing and weight status on adolescent Internet use. Results The dataset identified 210 (8.7%) students using the Internet for more than 20 hours/week, and 81 (3.3%) were viewing pornographic material online. Early maturing and thin-weight adolescents were at 35% and 46% increased risks of spending long hours on Internet use, respectively. While early puberty was associated with online pornography viewing among males (adjusted OR 1.84, 95% CI 1.04-3.28), early puberty was contrarily a protective factor against online gaming in females (adjusted OR 0.59, 95% CI 0.36-0.96). Conclusion Early puberty was found to be positively related to adolescent Internet use. Appropriate health education and guidance regarding Internet use should be provided to those with different developing needs.	[Tsai, Meng-Che] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan; [Strong, Carol] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Publ Hlth, Tainan, Taiwan; [Chen, Wan-Ting] Natl Univ Tainan, Coll Educ, Dept Counseling & Guidance, Tainan, Taiwan; [Lee, Chih-Ting] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan; [Lin, Chung-Ying] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National University Tainan; National Cheng Kung University; National Cheng Kung University Hospital; Hong Kong Polytechnic University	Tsai, MC (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan.; Lee, CT (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan.	ache93@yahoo.com.tw; christina.unicorn@gmail.com	chen, want/GRX-0662-2022; Strong, Carol/E-2127-2016; Strong, Carol/ABI-6992-2020; Tsai, Meng-Che/AAE-6715-2021; Lin, Chung-Ying/I-5434-2016	Strong, Carol/0000-0002-2934-5382; Strong, Carol/0000-0002-2934-5382; Tsai, Meng-Che/0000-0003-1057-3315; Lin, Chung-Ying/0000-0002-2129-4242	National Cheng Kung University Hospital [NCKUH-100503004]; Academia Sinica	National Cheng Kung University Hospital; Academia Sinica(Academia Sinica - Taiwan)	This study was supported by the research grant awarded to CT Lee from the National Cheng Kung University Hospital (NCKUH-100503004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Taiwan Youth Project was originally sponsored by the Academia Sinica and directed by Dr. Chin-Chun Yi. The Center for Survey Research of the Academia Sinica is responsible for the data distribution. We thank Dr. Yi and everyone else at the Academia Sinica and the Taiwan Youth Project for providing the data and all the other assistance they gave us.	Barrense-Dias Y, 2016, INT J OBESITY, V40, P45, DOI 10.1038/ijo.2015.146; Belanger RE, 2011, PEDIATRICS, V127, pE330, DOI 10.1542/peds.2010-1235; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Brown JD, 2009, COMMUN RES, V36, P129, DOI 10.1177/0093650208326465; Burke V, 2006, INT J PEDIATR OBES, V1, P248, DOI 10.1080/17477160600984975; Chen AS, 2013, SOC BEHAV PERSONAL, V41, P157, DOI 10.2224/sbp.2013.41.1.157; Chen W, 2002, Obes Rev, V3, P225, DOI 10.1046/j.1467-789X.2002.00064.x; Cheng SM, 2014, INT SOCIOL, V29, P324, DOI 10.1177/0268580914538084; De Leonibus C, 2014, PEDIATR OBES, V9, P292, DOI 10.1111/j.2047-6310.2013.00176.x; Durkee T, 2012, ADDICTION, V107, P2210, DOI 10.1111/j.1360-0443.2012.03946.x; Fortenberry JD, 2013, HORM BEHAV, V64, P280, DOI 10.1016/j.yhbeh.2013.03.007; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Kjelgaard HH, 2017, J ADOLESCENT HEALTH, V60, P460, DOI 10.1016/j.jadohealth.2016.11.016; Koehly LM, 2009, PREV CHRONIC DIS, V6; Lee CT, 2017, PEDIATR NEONATOL, V58, P313, DOI 10.1016/j.pedneo.2016.04.004; Li ML, 2014, OBESITY, V22, P482, DOI 10.1002/oby.20595; Lo V. H., 1999, ASIAN J COMMUN, V9, P50, DOI [DOI 10.1080/01292989909359614, 10.1080/01292989909359614]; Lo VH, 2005, J BROADCAST ELECTRON, V49, P221, DOI 10.1207/s15506878jobem4902_5; Luder MT, 2011, ARCH SEX BEHAV, V40, P1027, DOI 10.1007/s10508-010-9714-0; Mattebo M, 2013, J DEV BEHAV PEDIATR, V34, P460, DOI 10.1097/DBP.0b013e31829c44a2; Moreno MA, 2011, ARCH PEDIAT ADOL MED, V165, P797, DOI 10.1001/archpediatrics.2011.58; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Skoog T, 2013, INT J SEX HEALTH, V25, P281, DOI 10.1080/19317611.2013.815299; Skoog T, 2009, J RES ADOLESCENCE, V19, P1, DOI 10.1111/j.1532-7795.2009.00578.x; Strong C, 2018, J DEV BEHAV PEDIATR, V39, P318, DOI 10.1097/DBP.0000000000000553; Svedin CG, 2011, J ADOLESCENCE, V34, P779, DOI 10.1016/j.adolescence.2010.04.010; Tsai MC, 2015, J ADOLESCENCE, V42, P87, DOI 10.1016/j.adolescence.2015.03.016; Tsai MC, 2013, ARCH DIS CHILD, V98, P9, DOI 10.1136/archdischild-2012-301629; Tsitsika AK, 2016, EUR J PUBLIC HEALTH, V26, P617, DOI 10.1093/eurpub/ckw028; Valkenburg PM, 2011, J ADOLESCENT HEALTH, V48, P121, DOI 10.1016/j.jadohealth.2010.08.020; Wang HY, 2008, BRIT J EDUC TECHNOL, V39, P787, DOI 10.1111/j.1467-8535.2007.00773.x; Ybarra ML, 2005, CYBERPSYCHOL BEHAV, V8, P473, DOI 10.1089/cpb.2005.8.473; Yen CF, 2010, WORLD PSYCHIATRY, V9, P97; Yi CC, 2009, INT SOCIOL, V24, P397, DOI 10.1177/0268580909102914	34	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197860	10.1371/journal.pone.0197860	http://dx.doi.org/10.1371/journal.pone.0197860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795649	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300084
J	Petkov, S; Starodubova, E; Latanova, A; Kilpelainen, A; Latyshev, O; Svirskis, S; Wahren, B; Chiodi, F; Gordeychuk, I; Isaguliants, M				Petkov, Stefan; Starodubova, Elizaveta; Latanova, Anastasia; Kilpelainen, Athina; Latyshev, Oleg; Svirskis, Simons; Wahren, Britta; Chiodi, Francesca; Gordeychuk, Ilya; Isaguliants, Maria			DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; VACCINE DELIVERY; PLASMID DNA; T-CELLS; SKIN ELECTROPORATION; ANTIGEN-EXPRESSION; MICE; EFFICACY; EPITOPE; MOUSE	Optimization of DNA vaccine delivery improves the potency of the immune response and is crucial to clinical success. Here, we inquired how such optimization impacts the magnitude of the response, its specificity and type. BALB/c mice were DNA-immunized with two model immunogens, HIV-1 protease and reverse transcriptase by intramuscular or intradermal injections with electroporation. DNA immunogens were co-delivered with DNA encoding luciferase. Delivery and expression were monitored by in vivo bioluminescence imaging (BLI). The endpoint immune responses were assessed by IFN-gamma/IL-2 FluoroSpot, multiparametric flow cytometry and antibody ELISA. Expression and immunogenicity were compared in relation to the delivery route. Regardless of the route, protease generated mainly IFN-gamma, and reverse transcriptase, IL-2 and antibody response. BLI of mice immunized with protease- or reverse transcriptase/reporter plasmid mixtures, demonstrated significant loss of luminescence over time. The rate of decline of luminescence strongly correlated with the magnitude of immunogen-specific response, and depended on the immunogenicity profile and the immunization route. In vitro and in vivo BLI-based assays demonstrated that intradermal delivery strongly improved the immunogenicity of protease, and to a lesser extent, of reverse transcriptase. Immune response polarization and epitope hierarchy were not affected. Thus, by changing delivery/immunogen expression sites, it is possible to modulate the magnitude, but not the type or fine specificity of the induced immune response.	[Petkov, Stefan; Latanova, Anastasia; Kilpelainen, Athina; Wahren, Britta; Chiodi, Francesca; Isaguliants, Maria] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Starodubova, Elizaveta; Latanova, Anastasia] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Starodubova, Elizaveta; Latyshev, Oleg; Gordeychuk, Ilya; Isaguliants, Maria] Russian Acad Sci, Chumakov Fed Sci Ctr Res & Dev Immune & Biol Prod, Moscow, Russia; [Latanova, Anastasia; Latyshev, Oleg; Isaguliants, Maria] NF Gamaleja Res Ctr Epidemiol & Microbiol, Moscow, Russia; [Svirskis, Simons; Isaguliants, Maria] Riga Stradins Univ, Riga, Latvia; [Gordeychuk, Ilya] Sechenov First Moscow State Med Univ, Moscow, Russia	Karolinska Institutet; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Riga Stradins University; Sechenov First Moscow State Medical University	Petkov, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	stefan.petkov@ki.se	, ISSAGOULIANTIS/AAI-3148-2021; Eliseeva, Olesia/AGN-6838-2022; Gordeychuk, Ilya/AAD-6017-2022; Starodubova, Elizaveta S/Q-4439-2016; Latanova, Anastasia A/G-5714-2014; Gordeychuk, Ilya V/D-6515-2014	, ISSAGOULIANTIS/0000-0001-9382-2254; Gordeychuk, Ilya/0000-0002-4551-7535; Starodubova, Elizaveta S/0000-0003-2183-0858; Gordeychuk, Ilya V/0000-0002-4551-7535; Chiodi, Francesca/0000-0002-1385-8343; Latyshev, Oleg/0000-0002-5757-3809; Svirskis, Simons/0000-0001-6889-6390; Latanova, Anastasia/0000-0002-2260-6551	Russian Foundation of Basic Research project [15-15-30039]; EU Twinning project VACTRAIN (Horizon 2020) [692293]; PI project of the Swedish Institute [19806_2016]; VACTRAIN; BALTINFECT	Russian Foundation of Basic Research project; EU Twinning project VACTRAIN (Horizon 2020); PI project of the Swedish Institute; VACTRAIN; BALTINFECT	The study was supported by the Russian Foundation of Basic Research project #15-15-30039 (http:/www.rfbr.ru/rffi/ru/). Cross-border partner interactions were supported by the EU Twinning project VACTRAIN (Horizon 2020) #692293 (ec.europa.eu) and PI project of the Swedish Institute #19806_2016 (si.se) (MI). Participation of Petkov S, Chiodi F, and Wahren B was supported by VACTRAIN. Participation of Svirskis S was supported by BALTINFECT (ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Russian Foundation of Basic Research project No 15-15-30039. Cross-border partner interactions were supported by the EU Twinning project VACTRAIN #692293 and PI project of the Swedish Institute #19806_2016. Participation of Petkov S, Chiodi F, and Wahren B was supported by VACTRAIN. Participation of Svirskis S was supported by BALTINFECT. We would like to acknowledge Dr Kajsa Prokopec, Dr Jens Gertow, Dr Niklas Ahlborg and all the staff of the Research and Development Department of Mabtech, Nacka, Sweden, for their continuous support with FluoroSpot applications, assistance in the analysis of the data and helpful comments on the manuscript.	Alikhani M, 2004, J CELL PHYSIOL, V201, P341, DOI 10.1002/jcp.20067; Alonso Marta, 2013, Recent Pat DNA Gene Seq, V7, P62; Amante DH, 2015, HUM GENE THER METHOD, V26, P134, DOI 10.1089/hgtb.2015.020; Blanco-Heredia J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147571; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; De Panfilis G., 1998, EXPDERMATOL, V7; DEGROOT AS, 1991, J INFECT DIS, V164, P1058, DOI 10.1093/infdis/164.6.1058; Diehl MC, 2013, HUM VACC IMMUNOTHER, V9, P2246, DOI 10.4161/hv.24702; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Finak G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003806; Flingai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00354; Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112; French MA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00780; Geiben-Lynn R, 2008, BLOOD, V112, P4585, DOI 10.1182/blood-2008-06-165803; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOEBELS N, 1992, J IMMUNOL, V149, P661; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Gothelf A, 2012, WHAT YOU ALWAYS NEED; Grosenbaugh DA, 2011, AM J VET RES, V72, P1631, DOI 10.2460/ajvr.72.12.1631; Gutowska-Owsiak D, 2012, J INVEST DERMATOL, V132, P940, DOI 10.1038/jid.2011.398; HAAS G, 1991, EUR J IMMUNOL, V21, P1371, DOI 10.1002/eji.1830210607; Hahne F, 2010, CYTOM PART A, V77A, P121, DOI 10.1002/cyto.a.20823; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hallengard D, 2011, CLIN VACCINE IMMUNOL, V18, P1577, DOI 10.1128/CVI.05045-11; Hallengard D, 2011, VACCINE, V29, P839, DOI 10.1016/j.vaccine.2010.10.083; Hannaman D, 2016, VACCINE, V34, P3607, DOI 10.1016/j.vaccine.2016.04.077; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Hegde R, 2005, J VIROL, V79, P14688, DOI 10.1128/JVI.79.23.14688-14697.2005; HOSMALIN A, 1990, P NATL ACAD SCI USA, V87, P2344, DOI 10.1073/pnas.87.6.2344; Igoucheva O, 2013, GENE THER, V20, P939, DOI 10.1038/gt.2013.17; Isaguliants M, 2013, HUM VACC IMMUNOTHER, V9, P2111, DOI 10.4161/hv.25813; Isaguliants MG, 2004, VACCINE, V22, P1810, DOI 10.1016/j.vaccine.2003.10.052; Isitman G, 2011, VIROLOGY, V412, P110, DOI 10.1016/j.virol.2010.12.044; Khan AS, 2014, METHODS MOL BIOL, V1121, P279, DOI 10.1007/978-1-4614-9632-8_25; Kos S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.65; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Krotova O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062720; Kulkarni V, 2013, HUM VACC IMMUNOTHER, V9, P2081, DOI 10.4161/hv.25473; Latanova A, 2017, J IMMUNOL RES, V2017, P1, DOI [10.1155//2017/8595404, DOI 10.1155//2017/8595404]; Levin C, 2015, HUM VACC IMMUNOTHER, V11, P27, DOI 10.4161/hv.34299; Liard C, 2012, J INVEST DERMATOL, V132, P615, DOI 10.1038/jid.2011.346; Limberis MP, 2009, GENE THER, V16, P441, DOI 10.1038/gt.2008.177; Liu JY, 2008, J VIROL, V82, P5643, DOI 10.1128/JVI.02564-07; Migueles SA, 2015, NAT IMMUNOL, V16, P563, DOI 10.1038/ni.3161; Miller M, 2004, VACCINE, V22, P2517, DOI 10.1016/j.vaccine.2004.01.019; Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159; Mueller SN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00332; Muraro E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00197; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Petkov SP, 2013, HUM VACC IMMUNOTHER, V9, P2228, DOI 10.4161/hv.25561; Rochard A, 2011, HUM GENE THER, V22, P789, DOI 10.1089/hum.2011.092; Roos AK, 2006, MOL THER, V13, P320, DOI 10.1016/j.ymthe.2005.08.005; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Singh RAK, 2004, J IMMUNOL, V173, P4387, DOI 10.4049/jimmunol.173.7.4387; Smith HK, 2000, CELL TISSUE RES, V302, P235, DOI 10.1007/s004410000280; Smith TRF, 2017, VACCINE, V35, P2840, DOI 10.1016/j.vaccine.2017.04.008; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Starodubova E, 2012, MOL IMAGING, V11, P471, DOI 10.2310/7290.2012.00011; Starodubova E, 2010, VACCINE, V28, P1975, DOI 10.1016/j.vaccine.2009.10.098; Starodubova ES, 2008, VACCINE, V26, P5170, DOI 10.1016/j.vaccine.2008.03.070; Steinhoff M, 2001, CURR OPIN ALLERGY CL, V1, P469, DOI 10.1097/00130832-200110000-00014; Suschak JJ, 2017, HUMAN VACCINES IMMUN, p1 ; Todorova B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04547-2; Torresi J, 2017, HUM VACC IMMUNOTHER, V13, P1059, DOI 10.1080/21645515.2016.1261770; Venalis P, 2014, RHEUMATOLOGY, V53, P397, DOI 10.1093/rheumatology/ket279; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431	74	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197902	10.1371/journal.pone.0197902	http://dx.doi.org/10.1371/journal.pone.0197902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864114	gold, Green Submitted, Green Published			2022-12-26	WOS:000434097100012
J	Johnson, KO; Nelder, MP; Russell, C; Li, Y; Badiani, T; Sander, B; Sider, D; Patel, SN				Johnson, Karen O.; Nelder, Mark P.; Russell, Curtis; Li, Ye; Badiani, Tina; Sander, Beate; Sider, Douglas; Patel, Samir N.			Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014	PLOS ONE			English	Article							VECTOR IXODES-SCAPULARIS; BORRELIA-BURGDORFERI; RANGE EXPANSION; UNITED-STATES; KNOWLEDGE; SURVEILLANCE; DIAGNOSIS	Lyme disease (LD) is the most common vector-borne disease in Ontario, Canada. We describe the epidemiology and clinical manifestations of LD in Ontario and examine trends in the incidence of non-disseminated and disseminated LD. LD surveillance data from the integrated Public Health Information System (iPHIS) from 2005-2014 were mapped to symptoms according to syndrome groups (erythema migrans (EM), flu-like, cardiac, neurologic or arthritic) and disease stages (early localized, early disseminated or late disseminated). During the study period, 1,230 cases due to Borrelia burgdoferi were reported in Ontario with annual incidence rates ranging from 0.32 (2006) to 2.16 (2013) cases per 100,000 population. Seventy percent of cases had EM and the proportion of cases with EM increased over time. Other clinical manifestations included flu-like (75%), arthritic (42%), neurologic (41%) and cardiac (6%) symptoms. Early localized disease (n = 415) manifested with EM (87%) and flu-like (57%) symptoms; early disseminated disease (n = 216) manifested with neurologic (94%), cardiac (10%) and EM (63%) symptoms; and late disseminated disease (n = 475) manifested with EM (62%), neurologic (55%), cardiac (9%), and arthritic symptoms (i.e., arthralgia (93%) and arthritis (7%)). Early localized and early disseminated cases (88% each) occurred primarily from May through September, compared to late disseminated cases (81%). The proportion of cases reported to public health within 30 days of illness onset increased during the study period, while the proportion of cases reported within 1-3 months and > 3 months decreased. Geographical variations characterized by higher incidence of early localized disease and earlier public health notification (within 30 days of illness onset) occurred in regions with established or recently established LD risk areas, while later public health notification (> 3 months after illness onset) was reported more frequently in regions with recently established or no identified risk areas. This is the first study to describe the clinical manifestations of LD in Ontario, Canada. The observed geographical variations in the epidemiology of LD in Ontario reinforce the need for regionally focused public health strategies aimed at increasing awareness, promoting earlier recognition and reporting, and encouraging greater uptake of preventive measures.	[Johnson, Karen O.; Nelder, Mark P.; Russell, Curtis; Badiani, Tina; Sider, Douglas] Publ Hlth Ontario, Emergency Preparedness & Response, Enter Zoonot & Vector Borne Dis, Communicable Dis, Toronto, ON, Canada; [Li, Ye] Publ Hlth Ontario, Knowledge Serv, Analyt Serv, Toronto, ON, Canada; [Li, Ye] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Sander, Beate] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada; [Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Sander, Beate] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Sider, Douglas] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Patel, Samir N.] Publ Hlth Ontario, Publ Hlth Ontario Lab, Toronto, ON, Canada; [Patel, Samir N.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; McMaster University; University of Toronto	Johnson, KO (corresponding author), Publ Hlth Ontario, Emergency Preparedness & Response, Enter Zoonot & Vector Borne Dis, Communicable Dis, Toronto, ON, Canada.	karen.johnson@oahpp.ca	Sander, Beate/P-7665-2018	Sander, Beate/0000-0003-2128-9133; Johnson, Karen/0000-0001-5198-0502				Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Arvikar SL, 2015, INFECT DIS CLIN N AM, V29, P269, DOI 10.1016/j.idc.2015.02.004; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; BALMELLI T, 1995, RES MICROBIOL, V146, P329, DOI 10.1016/0923-2508(96)81056-4; Clow KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189393; Ertel SH, 2012, EMERG INFECT DIS, V18, P242, DOI 10.3201/eid1802.101219; Ferrouillet C, 2015, CAN J INFECT DIS MED, V26, P151, DOI 10.1155/2015/846963; Gasmi S, 2017, Can Commun Dis Rep, V43, P194, DOI 10.14745/ccdr.v43i10a01; GLASS GE, 1995, AM J PUBLIC HEALTH, V85, P944, DOI 10.2105/AJPH.85.7.944; Halperin JJ, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0445-6; Hatchette T F, 2014, Can Commun Dis Rep, V40, P194; Hatchette TF, 2015, EMERG INFECT DIS, V21, P1751, DOI 10.3201/eid2110.141640; Henry B, 2012, CAN FAM PHYSICIAN, V58, pE289; Hill D, 2015, J COMMUN HEALTH, V40, P339, DOI 10.1007/s10900-014-9940-9; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Magri Julie M, 2002, J Am Board Fam Pract, V15, P277; Meek J I, 1996, J Public Health Manag Pract, V2, P61; Ministry of Health and Long-Term care, 2010, LETS TARG LYM; Ministry of Health and Long-Term Care, COMB LYM DIS COLL AC; Mullegger RR, 2008, AM J CLIN DERMATOL, V9, P355, DOI 10.2165/0128071-200809060-00002; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; Nadelman RB, 2015, INFECT DIS CLIN N AM, V29, P211, DOI 10.1016/j.idc.2015.02.001; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Robinson ML, 2015, INFECT DIS CLIN N AM, V29, P255, DOI 10.1016/j.idc.2015.02.003; SPIELMAN A, 1994, ANN NY ACAD SCI, V740, P146, DOI 10.1111/j.1749-6632.1994.tb19865.x; Statistics Canada, 2017, EST POP 2011 CENS AD; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708	33	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198509	10.1371/journal.pone.0198509	http://dx.doi.org/10.1371/journal.pone.0198509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856831	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800132
J	Kim, H; Kwon, HJ; Park, SY; Park, Y; Park, E; Chung, JH				Kim, Hyojin; Kwon, Hyun Jung; Park, Soo Young; Park, Youngmi; Park, Eunhyang; Chung, Jin-Haeng			Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer	PLOS ONE			English	Article							PD-L1 EXPRESSION; PULMONARY ADENOCARCINOMA; DRIVER MUTATIONS; IMMUNOHISTOCHEMISTRY; DOCETAXEL; PEMBROLIZUMAB; METAANALYSIS; NIVOLUMAB; ANTIBODY; SAFETY	In this study, we present the clinicopathological features associated with PD-L1 protein and mRNA expression in a large Asian cohort of patients with non-small cell lung cancer (NSCLC) and assessed the prognostic implications of PD-L1 expression, particularly in early stage NSCLC. We retrospectively analyzed 687 NSCLC specimens (476 adenocarcinoma and 211 squamous cell carcinoma) using tissue microarray. PD-L1 immunohistochemistry (IHC) was performed using Dako 22C3 pharmDx assay and PDL1 mRNA was measured using RNA in situ hybridization (RISH). The overall prevalence of PD-L1 protein expression was 25.2% in tumor cells and PDL1 mRNA expression was 11.9%. There was a strong positive correlation between PD-L1 IHC and RISH results (Spearman's rho = 0.6, p<0.001). In adenocarcinoma, PD-L1 protein and mRNA expressions significantly correlated with poorly differentiated histologic subtype (p<0.001 and p = 0.002, respectively). PD-L1 expression was also associated with genetic alteration in adenocarcinoma. High PD-L1 expression level was associated with EGFR-naive and KRAS-mutant subgroup (p = 0.001 and p = 0.017, respectively). With a 1% cut-off value, PD-L1 protein expression showed a short overall survival duration in early stage adenocarcinoma with marginal significance (p = 0.05, Hazard ratio = 1.947). Our study revealed that PD-L1 expression varied with histologic subtype and genomic alteration status in lung adenocarcinoma, and activation of the PD-L1 pathway may be a poor prognostic factor especially in early stage lung adenocarcinoma. In addition, PDL1 RISH showed promising results in predicting PD-L1 protein expression in NSCLC.	[Kim, Hyojin; Kwon, Hyun Jung; Park, Soo Young; Park, Eunhyang; Chung, Jin-Haeng] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea; [Park, Youngmi] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Seongnam, South Korea; [Chung, Jin-Haeng] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chung, JH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea.; Chung, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea.	chungjh@snu.ac.kr		Park, Eunhyang/0000-0003-2658-5054; Kwon, Hyun Jung/0000-0001-8822-7899	Ministry of Health & Welfare, Republic of Korea [HI17C1290]; National Research Foundation of Korea (NRF) - Korean Government (MSIT) [2017R1A5A1015626]; National Research Foundation of Korea [NRF-2017R1C1B1011620]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) - Korean Government (MSIT)(National Research Foundation of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI17C1290) and the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIT) (No. 2017R1A5A1015626) to JHC, and the National Research Foundation of Korea (NRF-2017R1C1B1011620) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cha YJ, 2016, LUNG CANCER, V97, P73, DOI 10.1016/j.lungcan.2016.05.001; Chen N, 2015, J THORAC ONCOL, V10, P910, DOI 10.1097/JTO.0000000000000500; Dong ZY, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1356145; Edge SB, 2009, AJCC CANC STAGING HD; Erber R, 2017, ANTICANCER RES, V37, P6771, DOI 10.21873/anticanres.12137; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Ilie M, 2016, ANN ONCOL, V27, P147, DOI 10.1093/annonc/mdv489; Kim HR, 2017, ONCOTARGET, V8, P87234, DOI 10.18632/oncotarget.20254; Kim H, 2017, ONCOTARGET, V8, P8484, DOI 10.18632/oncotarget.14298; Koh J, 2015, MODERN PATHOL, V28, P1154, DOI 10.1038/modpathol.2015.63; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Miller RA, 2016, ARCH PATHOL LAB MED, V140, P739, DOI 10.5858/arpa.2016-0904-ED; Pan YJ, 2017, J THORAC DIS, V9, P2579, DOI 10.21037/jtd.2017.08.61; Pan ZK, 2015, J THORAC DIS, V7, P462, DOI 10.3978/j.issn.2072-1439.2015.02.13; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Scheel AH, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1131379; Sun JM, 2016, J THORAC ONCOL, V11, P1003, DOI 10.1016/j.jtho.2016.04.007; Takada K, 2016, J THORAC ONCOL, V11, P1879, DOI 10.1016/j.jtho.2016.06.006; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Yang LY, 2017, INT J GYNECOL CANCER, V27, P196, DOI 10.1097/IGC.0000000000000875; Yee D, 2017, J BIOL CHEM, V292, P20683, DOI 10.1074/jbc.M117.809053; Zhang MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10925-7	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198634	10.1371/journal.pone.0198634	http://dx.doi.org/10.1371/journal.pone.0198634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856861	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800144
J	Moroncini, G; Paolini, C; Orlando, F; Capelli, C; Grieco, A; Tonnini, C; Agarbati, S; Mondini, E; Saccomanno, S; Goteri, G; Baroni, SS; Provinciali, M; Introna, M; Del Papa, N; Gabrielli, A				Moroncini, Gianluca; Paolini, Chiara; Orlando, Fiorenza; Capelli, Chiara; Grieco, Antonella; Tonnini, Cecilia; Agarbati, Silvia; Mondini, Eleonora; Saccomanno, Stefania; Goteri, Gaia; Baroni, Silvia Svegliati; Provinciali, Mauro; Introna, Martino; Del Papa, Nicoletta; Gabrielli, Armando			Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice	PLOS ONE			English	Article							STEM-CELLS; PULMONARY-FIBROSIS; MACROPHAGE ACTIVATION; SYSTEMIC-SCLEROSIS; CYCLOPHOSPHAMIDE; TISSUE; INFLAMMATION; POLARIZATION; ENGRAFTMENT; CLEARANCE	Lung fibrosis is a severe condition resulting from several interstial lung diseases (ILD) with different etiologies. Current therapy of ILD, especially those associated with connective tissue diseases, is rather limited and new anti-fibrotic strategies are needed. In this study, we investigated the anti-fibrotic activity in vivo of human mesenchymal stromal cells obtained from whole umbilical cord (hUC-MSC). Adult immunocompetent C57B/6 mice (n. = 8 for each experimental condition) were injected intravenously with hUC-MSC (n. = 2.5 x 10(5)) twice, 24 hours and 7 days after endotracheal injection of bleomycin. Upon sacrifice at days 8, 14, 21, collagen content, inflammatory cytokine profile, and hUC-MSC presence in explanted lung tissue were analyzed. Systemic administration of a double dose of hUC-MSC significantly reduced bleomycin-induced lung injury (inflammation and fibrosis) in mice through a selective inhibition of the IL6-IL10-TGF beta axis involving lung M2 macrophages. Only few hUC-MSC were detected from explanted lungs, suggesting a "hit and run" mechanism of action of this cellular therapy. Our data indicate that hUC-MSC possess strong in vivo anti-fibrotic activity in a mouse model resembling an immunocompetent human subject affected by inflammatory ILD, providing proof of concept for ad-hoc clinical trials.	[Moroncini, Gianluca; Paolini, Chiara; Grieco, Antonella; Tonnini, Cecilia; Agarbati, Silvia; Baroni, Silvia Svegliati; Gabrielli, Armando] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Ancona, Italy; [Orlando, Fiorenza; Provinciali, Mauro] IRCCS INRCA, Ctr Tecnol Avanzate Invecchiamento, Ancona, Italy; [Capelli, Chiara; Introna, Martino] ASST Papa Giovanni XXIII, UOS Ctr Terapia Cellulare G Lanzani, Bergamo, Italy; [Mondini, Eleonora] Univ Politecn Marche, Dipartimento Med Sperimentale & Clin, Ancona, Italy; [Saccomanno, Stefania; Goteri, Gaia] Univ Politecn Marche, Anat Patol, Dipartimento Sci Biomed & Sanita Pubbl, Ancona, Italy; [Del Papa, Nicoletta] ASST G Pini CTO, UOC Day Hosp Reumatol, Dipartimento Reumatol, Milan, Italy	Marche Polytechnic University; IRCCS INRCA; ASST Papa Giovanni XXIII; Marche Polytechnic University; Marche Polytechnic University	Moroncini, G (corresponding author), Univ Politecn Marche, Dipartimento Sci Clin & Mol, Ancona, Italy.	g.moroncini@univpm.it	Introna, Martino/AAA-5823-2019; Orlando, Fiorenza/AAB-3441-2021; Gabrielli, Armando/AAC-3173-2019; MORONCINI, Gianluca/K-6021-2016; SVEGLIATI BARONI, SILVIA/L-2614-2016	Introna, Martino/0000-0001-6216-0892; Orlando, Fiorenza/0000-0001-7351-4430; MORONCINI, Gianluca/0000-0002-0380-0105; PAOLINI, Chiara/0000-0001-6364-7408; SVEGLIATI BARONI, SILVIA/0000-0001-6863-2600; CAPELLI, CHIARA/0000-0002-4454-1541	Ministero Italiano della Salute [RF-2011-02352331]	Ministero Italiano della Salute(Ministry of Health, Italy)	This work was supported by a grant RF-2011-02352331 from Ministero Italiano della Salute (to AG).	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Ayaub EA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13511-z; Bagnato G, 2015, EUR RESPIR REV, V24, P102, DOI 10.1183/09059180.00003214; Bharti D, 2018, CELL TISSUE RES, V372, P51, DOI 10.1007/s00441-017-2699-4; Braga TT, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00602; Capelli C, 2011, CYTOTHERAPY, V13, P786, DOI 10.3109/14653249.2011.563294; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; CIMOLAI N, 1992, MICROBIOL IMMUNOL, V36, P465, DOI 10.1111/j.1348-0421.1992.tb02045.x; Coulson-Thomas VJ, 2016, OCUL SURF, V14, P121, DOI 10.1016/j.jtos.2015.11.004; Cras A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0819-7; de Witte SFH, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00648; Ding DC, 2016, CELL TRANSPLANT, V25, P217, DOI 10.3727/096368915X688182; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Fraticelli P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4606; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Iudici M, 2015, AUTOIMMUN REV, V14, P575, DOI 10.1016/j.autrev.2015.02.002; Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349; Kowal-Bielecka O, 2017, ANN RHEUM DIS, V76, P1327, DOI 10.1136/annrheumdis-2016-209909; Lee RH, 2014, P NATL ACAD SCI USA, V111, P16766, DOI 10.1073/pnas.1416121111; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Maria ATJ, 2016, ARTHRITIS RHEUMATOL, V68, P1013, DOI 10.1002/art.39477; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Montironi R, 2008, CELL ONCOL, V30, P473, DOI 10.3233/CLO-2008-0433; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Moroncini G, 2015, ARTHRITIS RHEUMATOL, V67, P1891, DOI 10.1002/art.39125; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Najar M, 2016, CYTOTHERAPY, V18, P320, DOI 10.1016/j.jcyt.2015.11.013; New SEP, 2015, STEM CELL RES, V15, P1, DOI 10.1016/j.scr.2015.04.003; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Nystedt J, 2013, STEM CELLS, V31, P317, DOI 10.1002/stem.1271; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Prockop DJ, 2016, MATRIX BIOL, V51, P7, DOI 10.1016/j.matbio.2016.01.010; Provinciali M, 2011, CURR OPIN PULM MED, V17, pS3, DOI 10.1097/01.mcp.0000410742.90463.1f; Reddy M, 2016, INT J STEM CELLS, V9, P192, DOI 10.15283/ijsc16041; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sanchez-Alavez M, 2007, BRAIN RES, V1158, P71, DOI 10.1016/j.brainres.2007.05.010; Schmuck EG, 2016, STEM CELL TRANSL MED, V5, P1668, DOI 10.5966/sctm.2015-0379; Secunda R, 2015, CYTOTECHNOLOGY, V67, P793, DOI 10.1007/s10616-014-9718-z; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sueblinvong Viranuj, 2014, Adv Biosci Biotechnol, V5, P19; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tashkin DP, 2007, AM J RESP CRIT CARE, V176, P1026, DOI 10.1164/rccm.200702-326OC; Tyndall A, 2015, IMMUNOL LETT, V168, P201, DOI 10.1016/j.imlet.2015.05.017; Tyndall A, 2014, NAT REV RHEUMATOL, V10, P117, DOI 10.1038/nrrheum.2013.166; van Laar JM, 2014, JAMA-J AM MED ASSOC, V311, P2490, DOI 10.1001/jama.2014.6368; Wang HW, 2014, INT J MOL MED, V33, P263, DOI 10.3892/ijmm.2013.1572; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wells AU, 2009, RHEUMATOLOGY, V48, P40, DOI 10.1093/rheumatology/kep109; Zhang CY, 2017, EXP THER MED, V13, P1922, DOI 10.3892/etm.2017.4222; Zhao F, 2008, TRANSPL P, V40, P1700, DOI 10.1016/j.transproceed.2008.01.080	54	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0196048	10.1371/journal.pone.0196048	http://dx.doi.org/10.1371/journal.pone.0196048			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856737	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800004
J	Pacicco, L; Bodesmo, M; Torricelli, R; Negri, V				Pacicco, Luca; Bodesmo, Mara; Torricelli, Renzo; Negri, Valeria			A methodological approach to identify agro-biodiversity hotspots for priority in situ conservation of plant genetic resources	PLOS ONE			English	Article							CROP WILD RELATIVES; ECOSYSTEM SERVICES; SPECIES RICHNESS; HARVESTED PLANTS; DIVERSITY; LANDRACES; L.; INVENTORY; AREAS; PERSPECTIVES	Agro-biodiversity is seriously threatened worldwide and strategies to preserve it are dramatically required. We propose here a methodological approach aimed to identify areas with a high level of agro-biodiversity in which to set or enhance in situ conservation of plant genetic resources. These areas are identified using three criteria: Presence of Landrace diversity, Presence of wild species and Agro-ecosystem ecological diversity. A Restrictive and an Additive prioritization strategy has been applied on the entire Italian territory and has resulted in establishing nationwide 53 and 197 agro-biodiversity hotspots respectively. At present the strategies can easily be applied at a European level and can be helpful to develop conservation strategies everywhere.	[Pacicco, Luca; Bodesmo, Mara; Torricelli, Renzo; Negri, Valeria] Univ Perugia, DSA3, Perugia, Italy	University of Perugia	Negri, V (corresponding author), Univ Perugia, DSA3, Perugia, Italy.	valeria.negri@unipg.it		Pacicco, Ciro Luca/0000-0002-2053-0637; Negri, Valeria/0000-0003-2941-121X	European Community's Seventh Framework Programme "PGR Secure" [266394]; European Community's Horizon 2020 Framework Programme "Farmer's Pride" [774271]	European Community's Seventh Framework Programme "PGR Secure"; European Community's Horizon 2020 Framework Programme "Farmer's Pride"	The research leading to these results received funding from the European Community's Seventh Framework Programme, under the Grant Agreement no. 266394 "PGR Secure" (http://www.pgrsecure.org/), and from the European Community's Horizon 2020 Framework Programme, under the Grant Agreement no.774271 "Farmer's Pride" (http://www.farmerspride.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, INT TREAT PLANT GEN; [Anonymous], 2013, CGRFA1413 FAO; Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8; Bennett A. F, 2004, PACIFIC CONSERV BIOL; Berlingeri C, 2012, GENET RESOUR CROP EV, V59, P655, DOI 10.1007/s10722-011-9709-2; Bilz Kell, 2011, EUROPEAN RED LIST VA; Blasi C, 2011, BIOL CONSERV, V144, P220, DOI 10.1016/j.biocon.2010.08.019; Boccacci P, 2013, TREE GENET GENOMES, V9, P1465, DOI 10.1007/s11295-013-0651-7; Brehm JM, 2008, GENET RESOUR CROP EV, V55, P779, DOI 10.1007/s10722-007-9283-9; Brush SB, 1998, GENET RESOUR CROP EV, V45, P139, DOI 10.1023/A:1008650819946; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caldecott JO, 1996, BIODIVERS CONSERV, V5, P699, DOI 10.1007/BF00051782; Castroviejo S., 2010, PROYECTO FLORA IBERI, V278-279, P23; Ceccarelli S, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P103, DOI 10.1079/9781845938512.0103; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Christie M, 2012, ECOL ECON, V83, P67, DOI 10.1016/j.ecolecon.2012.08.012; Ciancaleoni S, 2014, GENET RESOUR CROP EV, V61, P451, DOI 10.1007/s10722-013-0049-2; Conti F., 2005, ANNOTATED CHECK LIST; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dawson JC, 2012, GENETICA, V140, P1, DOI 10.1007/s10709-012-9646-9; Dreisigacker S, 2005, CROP SCI, V45, P653, DOI 10.2135/cropsci2005.0653; Du Fan, 2012, Journal of West China Forestry Science, V41, P41; Duflot R, 2014, ACTA OECOL, V56, P19, DOI 10.1016/j.actao.2014.01.004; ECPGR, 2017, ECPGR CONC ON FARM C; Esquinas-Alcazar J. T., 1993, V1, P33; European Commission, NAT 2000 NETW; FAO, 1999, AGR BIOD MULT CHAR A; Farina Almo, 1995, P123; Feeley KJ, 2011, DIVERS DISTRIB, V17, P1132, DOI 10.1111/j.1472-4642.2011.00813.x; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fitzgerald H., 2013, 121 MTT; Gargano D., 2011, Informatore Botanico Italiano, V43, P455; Geoportale nazionale. Ministero dell'Ambiente e della Tutela del Territorio e del Mare, 6 EL UFF AR PROT EUA; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Istituto Superiore per la Protezione e la Ricerca Ambientale (ISPRA), 2015, INT DAY BIOL DIV; Izsak J, 2000, ECOL MODEL, V130, P151, DOI 10.1016/S0304-3800(00)00203-9; Jarvis A, 2000, AGR ECOSYST ENVIRON, V126, P13; Kell SP, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P218, DOI 10.1079/9781845938512.0218; Khoury CK, 2013, CROP SCI, V53, P1496, DOI 10.2135/cropsci2012.10.0585; Lamb EG, 2009, ECOL INDIC, V9, P432, DOI 10.1016/j.ecolind.2008.06.001; Landucci F, 2014, CROP SCI, V54, P1628, DOI 10.2135/cropsci2013.05.0355; Lanteri S, 2003, GENET RESOUR CROP EV, V50, P723, DOI 10.1023/A:1025075118200; Lengyel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149662; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; Maxted N, 2007, BIOL CONSERV, V140, P142, DOI 10.1016/j.biocon.2007.08.006; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Minelli A., SEZIONE SCI VITA, V2, P21; Montoya D, 2012, TRENDS ECOL EVOL, V27, P666, DOI 10.1016/j.tree.2012.07.004; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negri V, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P118, DOI 10.1079/9781845938512.0118; Negri V, 2003, GENET RESOUR CROP EV, V50, P871, DOI 10.1023/A:1025933613279; Negri V., 2012, DESCRIPTORS WEB ENAB; Negri V., 2013, 1 ITALIAN INVENTORY; Oliveira HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154801; Palm C, 2014, AGR ECOSYST ENVIRON, V187, P87, DOI 10.1016/j.agee.2013.10.010; Paracchini ML, 2008, HIGH NATURE VALUE FA; Parra-Quijano M., 2012, Genetic Resources and Crop Evolution, V59, P205, DOI 10.1007/s10722-011-9676-7; Parra-Quijano M, 2012, SPAN J AGRIC RES, V10, P419, DOI [10.5424/sjar/2011102-303-11, 10.5424/sjar/2012102-303-11]; Parra-Quijano M, 2012, BIODIVERS CONSERV, V21, P79, DOI 10.1007/s10531-011-0167-0; Parra-Quijano M, 2007, BOCCONEA, V21, P105; Perez-Vega A, 2012, ENVIRON MODELL SOFTW, V29, P11, DOI 10.1016/j.envsoft.2011.09.011; Pgrsecure.org, 2011, PGR SEC PROJ; Pgrsecurespain, PGR SEC PROJ SPAIN; Pimentel D, 1997, BIOSCIENCE, V47, P747, DOI 10.2307/1313097; Polegri L, 2010, GENET RESOUR CROP EV, V57, P867, DOI 10.1007/s10722-009-9526-z; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Raggi L, 2013, GENET RESOUR CROP EV, V60, P1515, DOI 10.1007/s10722-012-9939-y; Rajendra PS, 2011, LAND USE CLIMATE CHA; Benayas JMR, 2006, J ENVIRON MANAGE, V79, P279, DOI 10.1016/j.jenvman.2005.07.006; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; RubioTeso ML, 2014, NATL STRATEGY CONSER; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Schipanski ME, 2014, AGR SYST, V125, P12, DOI 10.1016/j.agsy.2013.11.004; Secretariat of the Convention on Biological Diversity, 1992, CONV BIOL DIV CBD; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Thomas K, 2012, GENET RESOUR CROP EV, V59, P1417, DOI 10.1007/s10722-011-9770-x; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Torricelli R., 2016, Enhancing crop genepool use: capturing wild relative and landrace diversity for crop improvement, P326, DOI 10.1079/9781780646138.0326; Tsianou MA, 2013, BIOL CONSERV, V166, P103, DOI 10.1016/j.biocon.2013.06.021; UNESCO, MAN BIOSPH PROGR; United Nations, 2012, P C SUST DEV 2012 JU; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; Vavilov NI, 1960, IZBRANNYE T PROBLEMY, V2; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; Vetelainen M, 2009, BIODIVERSITY TECHNIC, V15; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114; Yang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15723	95	19	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197709	10.1371/journal.pone.0197709	http://dx.doi.org/10.1371/journal.pone.0197709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856765	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800035
J	Petukhova, T; Ojkic, D; McEwen, B; Deardon, R; Poljak, Z				Petukhova, Tatiana; Ojkic, Davor; McEwen, Beverly; Deardon, Rob; Poljak, Zvonimir			Assessment of autoregressive integrated moving average (ARIMA), generalized linear autoregressive moving average (GLARMA), and random forest (RF) time series regression models for predicting influenza A virus frequency in swine in Ontario, Canada	PLOS ONE			English	Article								Influenza A virus commonly circulating in swine (IAV-S) is characterized by large genetic and antigenic diversity and, thus, improvements in different aspects of IAV-S surveillance are needed to achieve desirable goals of surveillance such as to establish the capacity to forecast with the greatest accuracy the number of influenza cases likely to arise. Advancements in modeling approaches provide the opportunity to use different models for surveillance. However, in order to make improvements in surveillance, it is necessary to assess the predictive ability of such models. This study compares the sensitivity and predictive accuracy of the autoregressive integrated moving average (ARIMA) model, the generalized linear autoregressive moving average (GLARMA) model, and the random forest (RF) model with respect to the frequency of influenza A virus (IAV) in Ontario swine. Diagnostic data on IAV submissions in Ontario swine between 2007 and 2015 were obtained from the Animal Health Laboratory (University of Guelph, Guelph, ON, Canada). Each modeling approach was examined for predictive accuracy, evaluated by the root mean square error, the normalized root mean square error, and the model's ability to anticipate increases and decreases in disease frequency. Likewise, we verified the magnitude of improvement offered by the ARIMA, GLARMA and RF models over a seasonal-naive method. Using the diagnostic submissions, the occurrence of seasonality and the long-term trend in IAV infections were also investigated. The RF model had the smallest root mean square error in the prospective analysis and tended to predict increases in the number of diagnostic submissions and positive virological submissions at weekly and monthly intervals with a higher degree of sensitivity than the ARIMA and GLARMA models. The number of weekly positive virological submissions is significantly higher in the fall calendar season compared to the summer calendar season. Positive counts at weekly and monthly intervals demonstrated a significant increasing trend. Overall, this study shows that the RF model offers enhanced prediction ability over the ARIMA and GLARMA time series models for predicting the frequency of IAV infections in diagnostic submissions.	[Petukhova, Tatiana; Poljak, Zvonimir] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Ojkic, Davor; McEwen, Beverly] Univ Guelph, Lab Serv Div, Anim Hlth Lab, Guelph, ON, Canada; [Deardon, Rob] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB 4, Canada; [Deardon, Rob] Univ Calgary, Dept Math & Stat, Calgary, AB, Canada	University of Guelph; University of Guelph; University of Calgary; University of Calgary	Petukhova, T (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.	tpetukho@uoguelph.ca			 [052166]		Grant number is 052166. The funders are Swine Innovation Porc within the Swine Cluster 2, Ontario Pork, and Agriculture and Agri-Food Canada. ZP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abente EJ, 2016, J VIROL, V90, P8266, DOI 10.1128/JVI.01002-16; Baudon E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179044; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cleveland R.B., 1990, J OFF STAT, V6, P3; Cootes TF, 2012, ROBUST ACCURATE SHAP, P278, DOI [10.1007/978-3-642-33786-4_21, DOI 10.1007/978-3-642-33786-4_21]; Davis R, 1999, STAT TXB MONOGRAPHS; Dunsmuir W, 2015, GLARMA GEN LINEAR AU; Forbes KJ, 2012, J INT ECON, V88, P235, DOI 10.1016/j.jinteco.2012.03.006; Fournie G, 2015, VET RES, V46, DOI 10.1186/s13567-015-0226-8; Gao HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143791; Moreno-Torres JG, 2012, IEEE T NEUR NET LEAR, V23, P1304, DOI 10.1109/TNNLS.2012.2199516; Greenbaum A, 2015, J INFECT DIS, V212, P1592, DOI 10.1093/infdis/jiv269; Grgic H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127840; Grgic H, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0194-z; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Kane MJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-276; Neumann E.J., 2012, DIS SWINE, V10th ed., P141; Poljak Z, 2014, INFLUENZA OTHER RESP, V8, P482, DOI 10.1111/irv.12248; R Core Team, 2021, R LANGUAGE ENV STAT; Soyiri IN, 2012, INT J GEN MED, V5, P381, DOI 10.2147/IJGM.S31079; Spackman E, 2014, ANIMAL INFLUENZA VIR, DOI [10.1186/s13567-015-0226-8, DOI 10.1186/S13567-015-0226-8]; Taylor JW, 2008, MANAGE SCI, V54, P253, DOI 10.1287/mnsc.1070.0786	22	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198313	10.1371/journal.pone.0198313	http://dx.doi.org/10.1371/journal.pone.0198313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856881	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800098
J	Xing, BP; Lin, HS; Zhang, ZL; Wang, CG; Wang, YG; Wang, JJ				Xing Bingpeng; Lin Heshan; Zhang Zhilan; Wang Chunguang; Wang Yanguo; Wang Jianjun			DNA barcoding for identification of fish species in the Taiwan Strait	PLOS ONE			English	Article								DNA barcoding based on a fragment of the cytochrome c oxidase subunit I (COI) gene in the mitochondrial genome is widely applied in species identification and biodiversity studies. The aim of this study was to establish a comprehensive barcoding reference database of fishes in the Taiwan Strait and evaluate the applicability of using the COI gene for the identification of fish at the species level. A total of 284 mitochondrial COI barcode sequences were obtained from 85 genera, 38 families and 12 orders of fishes. The mean length of the sequences was 655 base pairs. The average Kimura two parameter (K2P) distances within species, genera, families, orders and classes were 0.21%, 6.50%, 23.70% and 25.60%, respectively. The mean interspecific distance was 31-fold higher than the mean intraspecific distance. The K2P neighbor-joining trees based on the sequence generally clustered species in accordance with their taxonomic classifications. High efficiency of species identification was demonstrated in the present study by DNA barcoding, and we conclude that COI sequencing can be used to identify fish species.	[Xing Bingpeng; Lin Heshan; Zhang Zhilan; Wang Chunguang; Wang Yanguo; Wang Jianjun] Third Inst Oceanog State Ocean Adm, Lab Marine Biol & Ecol, Xiamen, Fujian, Peoples R China		Wang, JJ (corresponding author), Third Inst Oceanog State Ocean Adm, Lab Marine Biol & Ecol, Xiamen, Fujian, Peoples R China.	wangjianjun220@tio.org.cn		bingpeng, xing/0000-0002-4963-6574	Scientific Research Foundation of Third Institute of Oceanography [SOA (2015012)-ZZL]; Key Laboratory of Marine Ecology and Environmental Science and Engineering [SOA (MESE-2017-04)-XBP]; National Natural Science Foundation of China [41406216]; Marine Biological Sample Museum Upgrade And Expansion [(GASI-01-02-04)-WCG]	Scientific Research Foundation of Third Institute of Oceanography; Key Laboratory of Marine Ecology and Environmental Science and Engineering; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Marine Biological Sample Museum Upgrade And Expansion	This work was supported by: 1) Scientific Research Foundation of Third Institute of Oceanography, SOA (2015012)-ZZL; 2) Key Laboratory of Marine Ecology and Environmental Science and Engineering, SOA (MESE-2017-04)-XBP; 3) National Natural Science Foundation of China (41406216); The Marine Biological Sample Museum Upgrade And Expansion (GASI-01-02-04)-WCG; and 4) The Marine Biological Sample Museum Upgrade And Expansion (GASI-01-02-04)-WCG.	[Anonymous], MARINE FISHES SO FUJ; Ardura A, 2013, ZOOKEYS, P49, DOI 10.3897/zookeys.365.6409; Bhattacharjee MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049950; Bingpeng ZZLRX, 2017, APPL OCEANOGRAPHY, V36, P5; Chakraborty M, 2014, GENE, V537, P20, DOI 10.1016/j.gene.2013.12.047; Chang CH, 2017, MOL ECOL RESOUR, V17, DOI 10.1111/1755-0998.12601; Dona J, 2015, MOL ECOL RESOUR, V15, P1216, DOI 10.1111/1755-0998.12384; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Karahan A, 2017, J NAT CONSERV, V36, P1, DOI 10.1016/j.jnc.2017.01.004; Kenchington EL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185173; Keskin E, 2013, MOL ECOL RESOUR, V13, P788, DOI 10.1111/1755-0998.12120; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; McCusker MR, 2013, MOL ECOL RESOUR, V13, P177, DOI 10.1111/1755-0998.12043; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Nzelu CO, 2015, ACTA TROP, V145, P45, DOI 10.1016/j.actatropica.2015.02.003; Radulovici Adriana E., 2010, Diversity, V2, P450; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Shen YJ, 2016, ECOL EVOL, V6, P2702, DOI 10.1002/ece3.2060; Staffen CF, 2017, PEERJ, V5, DOI 10.7717/peerj.4006; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Triantafyllidis A, 2011, MITOCHONDR DNA, V22, P37, DOI 10.3109/19401736.2010.542242; Vartak VR, 2015, J SCI FOOD AGR, V95, P359, DOI 10.1002/jsfa.6728; Wang Shu-ying, 2014, Journal of Tropical Oceanography, V33, P57, DOI 10.3969/j.issn.1009-5470.2014.03.009; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weigt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041059; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017	33	49	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198109	10.1371/journal.pone.0198109	http://dx.doi.org/10.1371/journal.pone.0198109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856794	Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800069
J	ElHassan, NO; Bai, S; Gibson, N; Holland, G; Robbins, JM; Kaiser, JR				ElHassan, Nahed O.; Bai, Shasha; Gibson, Neal; Holland, Greg; Robbins, James M.; Kaiser, Jeffrey R.			The impact of prematurity and maternal socioeconomic status and education level on achievement-test scores up to 8th grade	PLOS ONE			English	Article							LATE-PRETERM INFANTS; LOW-BIRTH-WEIGHT; CHILDREN BORN; BRAIN-DEVELOPMENT; GESTATIONAL-AGE; NEURODEVELOPMENTAL OUTCOMES; SCHOOL PERFORMANCE; EARLY-TERM; METAANALYSIS; ASSOCIATION	Background The relative influence of prematurity vs. maternal social factors (socioeconomic status and education level) on academic performance has rarely been examined. Objective To examine the impact of prematurity and maternal social factors on academic performance from 3rd through 8th grade. Methods We conducted a retrospective cohort study of infants born in 1998 at the University of Arkansas for Medical Sciences. The study sample included 58 extremely low gestational age newborns (ELGANs, 23-<28 weeks), 171 preterm (>= 28-<34 weeks), 228 late preterm (>= 34-<37 weeks), and 967 term ((>= 37-<42 weeks) infants. Neonatal and maternal variables were collected including maternal insurance status (proxy measure for socioeconomic status) and education level. The primary outcomes were literacy and mathematics achievement-test scores from 3rd through 8th grade. Linear mixed models were used to identify significant predictors of academic performance. All two-way interactions between grade level, gestational-age (GA) groups, and social factors were tested for statistical significance. Results Prematurity, social factors, gender, race, gravidity, and Apgar score at one minute were critical determinants of academic performance. Favorable social factors were associated with a significant increase in both literacy and mathematic scores, while prematurity was associated with a significant decrease in mathematic scores. Examination of GA categories and social factors interaction suggested that the impact of social factors on test scores was similar for all GA groups. Furthermore, the impact of social factors varied from grade to grade for literacy, while the influence of either GA groups or social factors was constant across grades for mathematics. For example, an ELGAN with favorable social factors had a predicted literacy score 104.1 (P < .001), 98.2 (P < .001), and 76.4 (P < .01) points higher than an otherwise similar disadvantaged term infant at grades 3, 5, and 8, respectively. The difference in their predicted mathematic scores was 33.4 points for all grades (P < .05). Conclusion While there were significant deficits in academic performance for ELGANs compared to PT, LPT, and term infants, the deficit could be offset by higher SES and better-educated mothers. These favorable social factors were critical to a child's academic achievement. The role of socioeconomic factors should be incorporated in discussions on outcome with families of preterm infants.	[ElHassan, Nahed O.] Univ Arkansas Med Sci, Dept Pediat, Div Neonatol, Little Rock, AR 72205 USA; [Bai, Shasha] Univ Arkansas Med Sci, Dept Pediat, Div Biostat, Little Rock, AR 72205 USA; [Gibson, Neal; Holland, Greg] Univ Cent Arkansas, Arkansas Res Ctr, Conway, AR USA; [Robbins, James M.] Univ Arkansas Med Sci, Dept Pediat, Div Child Hlth Serv Res, Little Rock, AR 72205 USA; [Robbins, James M.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Kaiser, Jeffrey R.] Milton S SHershey Med Ctr, Dept Pediat, Div Neonatol, Hershey, PA USA; [Kaiser, Jeffrey R.] Milton S SHershey Med Ctr, Dept Obstet & Gynecol, Hershey, PA USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Central Arkansas; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	ElHassan, NO (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Div Neonatol, Little Rock, AR 72205 USA.	ElhassanNahed@uams.edu		Elhassan, Nahed/0000-0003-0868-8420				Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; BARKER DJP, 1989, LANCET, V2, P577; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brody GH, 2017, JAMA PEDIATR, V171, P46, DOI 10.1001/jamapediatrics.2016.2988; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chan E, 2016, CHILD CARE HLTH DEV, V42, P297, DOI 10.1111/cch.12320; Chyi LJ, 2008, J PEDIATR-US, V153, P25, DOI 10.1016/j.jpeds.2008.01.027; Doyle LW, 2015, PEDIATRICS, V136, pE1513, DOI 10.1542/peds.2015-2006; Dubow EF, 2009, MERRILL PALMER QUART, V55, P224; Finn AS, 2014, PSYCHOL SCI, V25, P736, DOI 10.1177/0956797613516008; Garfield CF, 2017, JAMA PEDIATR, V171, P764, DOI 10.1001/jamapediatrics.2017.1020; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075; Kaiser JR, 2015, JAMA PEDIATR, V169, P913, DOI 10.1001/jamapediatrics.2015.1631; Kidokoro H, 2014, PEDIATRICS, V134, pE444, DOI 10.1542/peds.2013-2336; Kirkegaard I, 2006, PEDIATRICS, V118, P1600, DOI 10.1542/peds.2005-2700; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Kovachy VN, 2015, DEV MED CHILD NEUROL, V57, P410, DOI 10.1111/dmcn.12652; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Lawrence E, 2017, SOCIOL FORUM, V32, P635, DOI 10.1111/socf.12352; Lipkind HS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.007; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Manley BJ, 2015, J PEDIATR-US, V166, P870, DOI 10.1016/j.jpeds.2014.12.016; Martin Joyce A, 2007, Natl Vital Stat Rep, V56, P1; Mathiasen R, 2010, PEDIATRICS, V126, pE1553, DOI 10.1542/peds.2009-0829; Moore GP, 2013, JAMA PEDIATR, V167, P967, DOI 10.1001/jamapediatrics.2013.2395; Morse SB, 2009, PEDIATRICS, V123, pE622, DOI 10.1542/peds.2008-1405; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Peacock PJ, 2012, ARCH DIS CHILD, V97, P118, DOI 10.1136/adc.2011.300925; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Ritchie SJ, 2013, PSYCHOL SCI, V24, P1301, DOI 10.1177/0956797612466268; Simms V, 2013, ARCH DIS CHILD-FETAL, V98, pF457, DOI 10.1136/archdischild-2013-303777; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51; Treyvaud K, 2012, J EXP CHILD PSYCHOL, V112, P326, DOI 10.1016/j.jecp.2012.02.009; Voyer D, 2014, PSYCHOL BULL, V140, P1174, DOI 10.1037/a0036620; Williams BL, 2013, PEDIATRICS, V131, P693, DOI 10.1542/peds.2012-1408; Wong HS, 2013, MATERN CHILD HLTH J, V17, P1689, DOI 10.1007/s10995-012-1183-8	43	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198083	10.1371/journal.pone.0198083	http://dx.doi.org/10.1371/journal.pone.0198083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29851971	Green Submitted, Green Published, gold			2022-12-26	WOS:000433893200028
J	Polizzotto, NR; Hill-Jarrett, T; Walker, C; Cho, RY				Polizzotto, Nicola Riccardo; Hill-Jarrett, Tanisha; Walker, Christopher; Cho, Raymond Y.			Normal development of context processing using the AXCPT paradigm	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; COGNITIVE CONTROL; WORKING-MEMORY; GAMMA-DISTRIBUTION; NEURAL MECHANISMS; YOUNG-ADULTS; TASK; SCHIZOPHRENIA; CHILDREN; PERFORMANCE	Context processing involves a flexible and continually updated representation of task relevant information and is a core aspect of cognitive control. The expectancy AX Continuous Performance Test (AXCPT) was designed to specifically measure context processing and has been widely applied to elucidate mechanisms of cognitive control and their impairments in conditions such as aging and schizophrenia. Here we present a large-sample, cross-sectional study of context processing aimed at characterizing its normal development from childhood to early adulthood (8 to 22 years old). We track the age-related changes in the standard AXCPT performance measures and also investigate their validity using detailed data-driven method. We show how critical maturational changes in context processing can be validly tracked from mid-adolescence onward with increasing reliance on preparatory, proactive strategies well into early adulthood. However, the early maturation from childhood into adolescence showed a sharp, two-fold discontinuity: while standard measures provide partially conflicting results suggesting an early worsening of proactive strategies, further analyses do not support their validity during this period. Our findings advocate the existence of multiple preparatory strategies that cannot be captured by indices that assume a simple dichotomy of proactive vs. reactive strategies. When evaluating context processing differences over development or in clinical populations, we advocate the explicit testing of the assumptions underlying standard AXCPT indices through complementary data-driven methods.	[Polizzotto, Nicola Riccardo; Walker, Christopher] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Hill-Jarrett, Tanisha] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Cho, Raymond Y.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; Baylor College of Medicine	Polizzotto, NR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	Nicola.R.Polizzotto@uth.tmc.edu		Walker, Christopher P/0000-0002-1042-075X	NIMH [P50 MH084053]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084053] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIMH P50 MH084053 (to David Lewis, Center P.I.) (https://grants.nih.gov/grants/oer.htm).	Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Barch DM, 2008, BIOL PSYCHIAT, V64, P11, DOI 10.1016/j.biopsych.2008.03.003; Barch DM, 2009, SCHIZOPHRENIA BULL, V35, P136, DOI 10.1093/schbul/sbn153; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; Cai WD, 2011, J NEUROSCI, V31, P5965, DOI 10.1523/JNEUROSCI.6292-10.2011; Chatham CH, 2009, P NATL ACAD SCI USA, V106, P5529, DOI 10.1073/pnas.0810002106; Crone EA, 2006, J NEUROSCI, V26, P11239, DOI 10.1523/JNEUROSCI.2165-06.2006; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Iselin AMR, 2009, COGNITIVE DEV, V24, P192, DOI 10.1016/j.cogdev.2008.07.001; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Krishnamoorthy K, 2008, TECHNOMETRICS, V50, P69, DOI 10.1198/004017007000000353; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; LIPSITZ SR, 1991, BIOMETRIKA, V78, P153; Lorsbach TC, 2008, J GENET PSYCHOL, V169, P34, DOI 10.3200/GNTP.169.1.34-50; Lorsbach TC, 2010, J COGN DEV, V11, P185, DOI 10.1080/15248371003699936; Luce RD, 1989, RESPONSE, V54, P542; MacDonald AW, 2008, SCHIZOPHRENIA BULL, V34, P619, DOI 10.1093/schbul/sbn038; MacDonald AW, 2005, NEUROPSYCHOLOGY, V19, P814, DOI 10.1037/0894-4105.19.6.814; MacDonald AW, 2003, ARCH GEN PSYCHIAT, V60, P57, DOI 10.1001/archpsyc.60.1.57; MCGILL WJ, 1965, J MATH PSYCHOL, V2, P1, DOI 10.1016/0022-2496(65)90014-3; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Niendam TA, 2014, PSYCHIAT RES-NEUROIM, V221, P13, DOI 10.1016/j.pscychresns.2013.09.001; NUECHTERLEIN KH, 1983, J ABNORM PSYCHOL, V92, P4, DOI 10.1037/0021-843X.92.1.4; Redick TS, 2011, Q J EXP PSYCHOL, V64, P1048, DOI 10.1080/17470218.2011.577226; Reynolds JR, 2006, NEUROCOMPUTING, V69, P1332, DOI 10.1016/j.neucom.2005.12.102; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Schneider W., 2012, PSYCHOL SOFTWARE TOO; ServanSchreiber D, 1996, ARCH GEN PSYCHIAT, V53, P1105; Silverstein SM, 2008, SCHIZOPHRENIA BULL, V34, P645, DOI 10.1093/schbul/sbn032; Wechsler D., 2011, WASI 2 WECHSLER ABBR	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197812	10.1371/journal.pone.0197812	http://dx.doi.org/10.1371/journal.pone.0197812			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29852005	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200021
J	Chiu, TCD; Arai, TJ; Campbell, J; Jiang, SB; Mason, RP; Stojadinovic, S				Chiu, Tsuicheng D.; Arai, Tatsuya J.; Campbell, James, III; Jiang, Steve B.; Mason, Ralph P.; Stojadinovic, Strahinja			MR-CBCT image-guided system for radiotherapy of orthotopic rat prostate tumors	PLOS ONE			English	Article							RADIATION RESEARCH PLATFORM; ANIMAL RADIATION; COMPUTED-TOMOGRAPHY; THERAPY; CANCER; REGISTRATION; PHANTOM; IRRADIATION; HYPOXIA; QUALITY	Multi-modality image-guided radiotherapy is the standard of care in contemporary cancer management; however, it is not common in preclinical settings due to both hardware and software limitations. Soft tissue lesions, such as orthotopic prostate tumors, are difficult to identify using cone beam computed tomography (CBCT) imaging alone. In this study, we characterized a research magnetic resonance (MR) scanner for preclinical studies and created a protocol for combined MR-CBCT image-guided small animal radiotherapy. Two in-house dual-modality, MR and CBCT compatible, phantoms were designed and manufactured using 3D printing technology. The phantoms were used for quality assurance tests and to facilitate end-to-end testing for combined preclinical MR and CBCT based treatment planning. MR and CBCT images of the phantoms were acquired utilizing a Varian 4.7 T scanner and XRad-225Cx irradiator, respectively. The geometry distortion was assessed by comparing MR images to phantom blueprints and CBCT. The corrected MR scans were co-registered with CBCT and subsequently used for treatment planning. The fidelity of 3D printed phantoms compared to the blueprint design yielded favorable agreement as verified with the CBCT measurements. The geometric distortion, which varied between -5% and 11% throughout the scanning volume, was substantially reduced to within 0.4% after correction. The distortion free MR images were co-registered with the corresponding CBCT images and imported into a commercial treatment planning software SmART Plan. The planning target volume (PTV) was on average 19% smaller when contoured on the corrected MR-CBCT images relative to raw images without distortion correction. An MR-CBCT based preclinical workflow was successfully designed and implemented for small animal radiotherapy. Combined MR-CBCT image-guided radiotherapy for preclinical research potentially delivers enhanced relevance to human radiotherapy for various disease sites. This novel protocol is wide-ranging and not limited to the orthotopic prostate tumor study presented in the study.	[Chiu, Tsuicheng D.; Jiang, Steve B.; Stojadinovic, Strahinja] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Arai, Tatsuya J.; Campbell, James, III; Mason, Ralph P.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chiu, TCD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	Tsuicheng.Chiu@UTsouthwestern.edu	Jiang, Steve/GRO-3951-2022; Stojadinovic, Strahinja/R-3818-2019; Mason, Ralph/C-8472-2012	Stojadinovic, Strahinja/0000-0002-6840-5747; Mason, Ralph/0000-0001-7517-3721	Cancer Prevention and Research Initiative of Texas (CPRIT) [RP140285]; ARRA supplement [1U24 CA126608];  [P41 EB015908];  [1P30 CA142543];  [S10 RR028011]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER	Cancer Prevention and Research Initiative of Texas (CPRIT); ARRA supplement; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by Cancer Prevention and Research Initiative of Texas (CPRIT) # RP140285. MRI was supported by P41 EB015908, 1P30 CA142543, and an ARRA supplement to 1U24 CA126608. Irradiation facilitated by Shared Instrumentation Grant (S10 RR028011).	Arai TJ, 2016, J PHYSIOL-LONDON, V594, P6333, DOI 10.1113/JP272030; Arai TJ, 2012, P ANN INT C IEEE ENG; Bourke VA, 2007, INT J RADIAT ONCOL, V67, P1179, DOI 10.1016/j.ijrobp.2006.11.037; Clarkson R, 2011, MED PHYS, V38, P845, DOI 10.1118/1.3533947; Combs SE, 2016, STRAHLENTHER ONKOL, V192, P209, DOI 10.1007/s00066-016-0944-5; Corroyer-Dulmont A, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160427; Deng H, 2007, PHYS MED BIOL, V52, P2729, DOI 10.1088/0031-9155/52/10/007; Desrosiers M, 2013, J RES NATL INST STAN, V118, DOI 10.6028/jres.118.021; Diepart C, 2012, CANCER RES, V72, P482, DOI 10.1158/0008-5472.CAN-11-1755; Du SS, 2016, INT J RADIAT ONCOL, V96, P529, DOI 10.1016/j.ijrobp.2016.07.008; Elas M, 2008, INT J RADIAT ONCOL, V71, P542, DOI 10.1016/j.ijrobp.2008.02.022; Ford E, 2017, PHYS MED BIOL, V62, P43, DOI 10.1088/1361-6560/62/1/43; Graves EE, 2007, MED PHYS, V34, P4359, DOI 10.1118/1.2789498; Gutierrez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143821; Hallac RR, 2016, BRIT J CANCER, V114, P1206, DOI 10.1038/bjc.2016.110; Hallac RR, 2014, MAGN RESON MED, V71, P1863, DOI 10.1002/mrm.24846; Horsman MR, 2012, NAT REV CLIN ONCOL, V9, P674, DOI 10.1038/nrclinonc.2012.171; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; Jensen MD, 2013, MED PHYS, V40, DOI 10.1118/1.4812422; Jermoumi M, 2015, PHYS MEDICA, V31, P529, DOI 10.1016/j.ejmp.2015.04.010; Jordan BF, 2010, CONTRAST MEDIA MOL I, V5, P323, DOI 10.1002/cmmi.397; Kersemans V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176693; Khoo VS, 2006, BRIT J RADIOL, V79, pS2, DOI 10.1259/bjr/41321492; Korsager AS, 2016, J APPL CLIN MED PHYS, V17, P294, DOI 10.1120/jacmp.v17i3.6088; Li G, 2008, J APPL CLIN MED PHYS, V9, P17, DOI 10.1120/jacmp.v9i4.2781; O'Callaghan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096568; O'Connor JPB, 2016, CANCER RES, V76, P787, DOI 10.1158/0008-5472.CAN-15-2062; Pereira GC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231090; Price RG, 2016, INT J RADIAT ONCOL, V95, P1281, DOI 10.1016/j.ijrobp.2016.03.002; Rodriguez M, 2009, PHYS MED BIOL, V54, P3727, DOI 10.1088/0031-9155/54/12/008; Song KH, 2010, PHYS MED BIOL, V55, P7345, DOI 10.1088/0031-9155/55/23/011; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; Sovik A, 2007, PHYS MED BIOL, V52, P499, DOI 10.1088/0031-9155/52/2/013; Stojadinovic S, 2007, MED PHYS, V34, P4706, DOI 10.1118/1.2799887; Tillner F, 2016, PHYS MED BIOL, V61, P3084, DOI 10.1088/0031-9155/61/8/3084; Tumati V, 2013, INT J ONCOL, V42, P1613, DOI 10.3892/ijo.2013.1858; van Hoof SJ, 2013, RADIOTHER ONCOL, V109, P361, DOI 10.1016/j.radonc.2013.10.003; Verhaegen F, 2014, Z MED PHYS, V24, P323, DOI 10.1016/j.zemedi.2014.02.004; Verhaegen F, 2011, PHYS MED BIOL, V56, pR55, DOI 10.1088/0031-9155/56/12/R01; Wang DM, 2004, MAGN RESON IMAGING, V22, P529, DOI 10.1016/j.mri.2004.01.008; Wang SG, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3595268; White DA, 2016, CANCER LETT, V380, P69, DOI 10.1016/j.canlet.2016.06.003; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025; Wu YC, 2007, J COMPUT ASSIST TOMO, V31, P984, DOI 10.1097/rct.0b013e31805152fa; Zhao DW, 2003, RADIAT RES, V159, P621, DOI 10.1667/0033-7587(2003)159[0621:COTODW]2.0.CO;2	45	7	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198065	10.1371/journal.pone.0198065	http://dx.doi.org/10.1371/journal.pone.0198065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847586	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800051
J	Lindtjorn, B; Mitike, D; Zidda, Z; Yaya, Y				Lindtjorn, Bernt; Mitike, Demissew; Zidda, Zillo; Yaya, Yaliso			Reducing stillbirths in Ethiopia: Results of an intervention programme	PLOS ONE			English	Article							SERVICE DELIVERY; RURAL ETHIOPIA; CHILD HEALTH; CARE; NEWBORN; TRENDS; MORTALITY; COVERAGE	Previous studies from South Ethiopia have shown that interventions that focus on intrapartum care substantially reduce maternal mortality and there is a need to operationalize health packages that could reduce stillbirths. The aim of this paper is to evaluate if a programme that aimed to improve maternal health, and mainly focusing on strengthening intrapartum care, also would reduce the number of stillbirths, and to estimate if there are other indicators that explains high stillbirth rates. Our study used a "continuum of care" approach and focussed on providing essential antenatal and obstetric services in communities through health extension workers, at antenatal and health facility services. In this follow up study, which includes the same 38.312 births registered by community health workers, shows that interventions focusing on improved intrapartum care can also reduce stillbirths (by 46%; from 14.5 to 7.8 per 1000 births). Other risk factors for stillbirths are mainly related to complications during delivery and illnesses during pregnancy. We show that focusing on Comprehensive Emergency Obstetric Care and antenatal services reduces stillbirths. However, the study also underlines that illnesses during pregnancy and complications during delivery still represent the main risk factors for stillbirths. This indicates that obstetric care need still to be strengthened, should include the continuum of care from home to the health facility, make care accessible to all, and reduce delays.	[Lindtjorn, Bernt; Yaya, Yaliso] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Mitike, Demissew] Gidole Hosp, Gidole, Ethiopia; [Zidda, Zillo] Arba Minch Hosp, Arba Minch, Ethiopia	University of Bergen	Lindtjorn, B (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	bernt.lindtjorn@uib.no	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984	Regional office of the Ministry of Health; Zonal office of the Ministry of Health; University of Bergen in Norway; Norwegian Lutheran Mission in Norway	Regional office of the Ministry of Health; Zonal office of the Ministry of Health; University of Bergen in Norway; Norwegian Lutheran Mission in Norway	We would like to thank the staff at each of the health institution, as well as the health extension workers, for taking part in this work. The authorities in the districts are also thanked. We are also grateful to for the support from the Regional and Zonal offices of the Ministry of Health.; The main funding came through the University of Bergen in Norway, and through the Norwegian Lutheran Mission in Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, SURG CAR DISTR HOSP; Atnafu H, 2016, INT J WOMENS HEALTH, V8, P421, DOI 10.2147/IJWH.S104160; Ballard K, 2016, INT J GYNECOL OBSTET, V133, P164, DOI 10.1016/j.ijgo.2015.09.027; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P29, DOI 10.4314/ejhs.v24i0.4S; Berhie Kidanemariam Alem, 2016, Matern Health Neonatol Perinatol, V2, P10, DOI 10.1186/s40748-016-0038-5; Bhutta ZA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002364; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Campbell OMR, 2016, LANCET, V388, P2193, DOI 10.1016/S0140-6736(16)31528-8; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Engmann C, 2012, J PERINATOL, V32, P585, DOI 10.1038/jp.2011.154; Flenady V, 2017, SEMIN FETAL NEONAT M, V22, P176, DOI 10.1016/j.siny.2017.02.009; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gaym Asheber, 2012, Ethiop Med J, V50, P209; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lindtjorn B. Project, 2008, RMM PROJ DOC RED MAT; Lindtjorn B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169304; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168743; Otolorin E, 2015, INT J GYNECOL OBSTET, V130, pS46, DOI 10.1016/j.ijgo.2015.03.007; Reinebrant HE, 2018, BJOG-INT J OBSTET GY, V125, P212, DOI 10.1111/1471-0528.14971; Sisay MM, 2014, J MIDWIFERY WOM HEAL, V59, pS110, DOI 10.1111/jmwh.12156; UNICEF, 2013, ETH FAR REACH HLTH W; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2017, STILLB; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Yaya Y., 2015, MATERNAL NEONATAL MO; Yaya Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119321; Yaya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096294	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197708	10.1371/journal.pone.0197708	http://dx.doi.org/10.1371/journal.pone.0197708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847607	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800039
J	Norris, SL; Sawin, VI; Ferri, M; Sastre, LR; Porgo, TAV				Norris, Susan L.; Sawin, Veronica Ivey; Ferri, Mauricio; Sastre, Laura Raques; Porgo, Teegwende A. V.			An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaks	PLOS ONE			English	Article								Background The production of high-quality guidelines in response to public health emergencies poses challenges for the World Health Organization (WHO). The urgent need for guidance and the paucity of structured scientific data on emerging diseases hinder the formulation of evidence-informed recommendations using standard methods and procedures. Objectives In the context of the response to recent public health emergencies, this project aimed to describe the information products produced by WHO and assess the quality and trustworthiness of a subset of these products classified as guidelines. Methods We selected four recent infectious disease emergencies: outbreaks of avian influenza A-H1N1 virus (2009) and H7N9 virus (2013), Middle East respiratory syndrome coronavirus (MERS-CoV) (2013), and Ebola virus disease (EVD) (2014 to 2016). We analyzed the development and publication processes and evaluated the quality of emergency guidelines using AGREE-II. Results We included 175 information products of which 87 were guidelines. These products demonstrated variable adherence to WHO publication requirements including the listing of external contributors, management of declarations of interest, and entry into WHO's public database of publications. For guidelines, the methods for development were incompletely reported; WHO's quality assurance process was rarely used; systematic or other evidence reviews were infrequently referenced; external peer review was not performed; and they scored poorly with AGREE II, particularly for rigour of development and editorial independence. Conclusions Our study suggests that WHO guidelines produced in the context of a public health emergency can be improved upon, helping to assure the trustworthiness and utility of WHO information products in future emergencies.	[Norris, Susan L.; Sawin, Veronica Ivey; Ferri, Mauricio] WHO, WHO Guidelines Review Comm, Geneva, Switzerland; [Sastre, Laura Raques] Natl Sch Publ Hlth, Madrid, Spain; [Porgo, Teegwende A. V.] Laval Univ, Dept Social & Preventat Med, Quebec City, PQ, Canada	World Health Organization; Laval University	Norris, SL (corresponding author), WHO, WHO Guidelines Review Comm, Geneva, Switzerland.	norriss@who.int			UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (the Knowledge Management work plan)	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (the Knowledge Management work plan)	This work was funded by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (the Knowledge Management work plan). The funders had no role in the study conception or design, in the collection, analysis or interpretation of the data, in the writing of this report or in the decision to submit the paper for publication.	Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Eikermann Michaela, 2014, BMC Res Notes, V7, P853, DOI 10.1186/1756-0500-7-853; Institute of Medicine (US), 2011, CLIN PRACTICE GUIDEL, DOI [10.17226/13058, DOI 10.17226/13058]; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; WHO, 2016, EM PREP RESP; WHO, 2014, INF PREV CONTR IPC G; WHO, 2013, EM RESP FRAM ERF; WHO, 2014, EB VIR DIS KEY QUEST; World Health Organization, FAC QUEST EB VIR DIS; World Health Organization, 2014, EB VIR DIS OCC SAF H; World Health Organization, EB VIR DIS PREP STRE; World Health Organization, 2014, WHO HDB GUID DEV, V2nd; World Health Organization, 2014, FAC PSYCH 1 AOD EB V	13	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198125	10.1371/journal.pone.0198125	http://dx.doi.org/10.1371/journal.pone.0198125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847593	gold, Green Submitted, Green Published			2022-12-26	WOS:000433634800056
J	Choi, SH; Yoon, HI; Kim, SH; Kim, SK; Shin, KH; Suh, CO				Choi, Seo Hee; Yoon, Hong In; Kim, Seung Hyun; Kim, Sang Kyum; Shin, Kyoo-Ho; Suh, Chang-Ok			Optimal radiotherapy strategy for primary or recurrent fibromatosis and long-term results	PLOS ONE			English	Article							DESMOID-TYPE FIBROMATOSIS; RADIATION-THERAPY; AGGRESSIVE FIBROMATOSIS; ADJUVANT RADIOTHERAPY; TREATMENT OPTIONS; BETA-CATENIN; MANAGEMENT; TUMORS; DIAGNOSIS; SURGERY	Purpose Although locally invasive or recurrent fibromatosis is primarily treated with surgery, radiotherapy (RT) produces local control for recurrent/unresectable tumors or those with positive surgical margins. Herein, we describe our updated institutional experience with RT to treat fibromatosis. Methods Forty-seven patients with fibromatosis received RT between 1990 and 2015, and were followed for >= 12 months. Eight patients received RT for gross tumors, and 39 received postoperative RT after single/multiple prior surgeries. A median dose of 54 Gy was prescribed for definitive RT; 48.6, 50.4, and 54 Gy were prescribed for R0, R1, and R2 resected tumors, respectively. Recurrences were classified as in-field, marginal, or out-field. Prognostic factors were also evaluated. Results Seven recurrences were noted, including 2 in-field, 4 marginal, and 1 out-field, after a median follow-up of 60 months. In-field recurrences occurred in 1 patient who received 40.5 Gy of salvage RT after postoperative recurrence and another who received 45 Gy for R1 resection after multiple prior operations. All marginal failures were due to insufficient clinical target volume (CTV) margins regardless of dose (3 with 45 Gy and 1 with 54 Gy). On multi-variate analysis, a CTV margin >= 5 cm and dose > 45 Gy were significant predictors of non-recurrence (p = 0.039 and 0.049, respectively). Subgroup analysis showed that patients with both an CTV margin >= 5 cm and a dose > 45 Gy showed a favorable outcome. Conclusions RT is a valuable option for treating aggressive fibromatosis; doses >= 45 Gy and a large field produce optimal results. For in-field control, a higher dose is more necessary for gross residual tumors than for totally excised lesions.	[Choi, Seo Hee; Yoon, Hong In; Suh, Chang-Ok] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Seung Hyun; Shin, Kyoo-Ho] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Orthoped Surg, Seoul, South Korea; [Kim, Sang Kyum] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, HI (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea.	YHI0225@yuhs.ac	Choi, Seo-hee/AFL-9783-2022; Choi, Seo-hee/AAH-1969-2022	Kim, Seung Hyun/0000-0002-3878-1944; Kim, Sang Kyum/0000-0003-0768-9923; Yoon, Hong In/0000-0002-2106-6856; Choi, Seo Hee/0000-0002-4083-6414	National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2017R1C1B2010379]	National Research Foundation of Korea (NRF) - Ministry of Science and ICT	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017R1C1B2010379).	ACKER JC, 1993, INT J RADIAT ONCOL, V26, P851, DOI 10.1016/0360-3016(93)90501-L; Ballo MT, 1998, INT J RADIAT ONCOL, V42, P1007, DOI 10.1016/S0360-3016(98)00285-5; Ballo MT, 1999, J CLIN ONCOL, V17, P158, DOI 10.1200/JCO.1999.17.1.158; Baumert BG, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-12; Bhattacharya B, 2005, AM J SURG PATHOL, V29, P653, DOI 10.1097/01.pas.0000157938.95785.da; Bonvalot S, 2012, ANN ONCOL, V23, P158, DOI 10.1093/annonc/mds298; Carlson JW, 2007, HISTOPATHOLOGY, V51, P509, DOI 10.1111/j.1365-2559.2007.02794.x; Casali PG, 2014, ANN ONCOL, V25, P102, DOI 10.1093/annonc/mdu254; CATTON CN, 1995, RADIOTHER ONCOL, V34, P17, DOI 10.1016/0167-8140(94)01483-J; Eastley NC, 2015, CLIN ONCOL-UK, V27, P362, DOI 10.1016/j.clon.2015.02.006; Ergen SA, 2016, BALK MED J, V33, P316, DOI 10.5152/balkanmedj.2016.140560; Escobar C, 2012, ANN ONCOL, V23, P562, DOI 10.1093/annonc/mdr386; Gluck I, 2011, INT J RADIAT ONCOL, V80, P787, DOI 10.1016/j.ijrobp.2010.02.053; Goy BW, 1997, INT J RADIAT ONCOL, V39, P659, DOI 10.1016/S0360-3016(97)00334-9; Grimer Robert, 2010, Sarcoma, V2010, P1, DOI 10.1155/2010/506182; Guadagnolo BA, 2008, INT J RADIAT ONCOL, V71, P441, DOI 10.1016/j.ijrobp.2007.10.013; Janssen ML, 2017, BRIT J SURG, V104, P347, DOI 10.1002/bjs.10477; Kasper B, 2015, EUR J CANCER, V51, P127, DOI 10.1016/j.ejca.2014.11.005; Kasper B, 2011, ONCOLOGIST, V16, P682, DOI 10.1634/theoncologist.2010-0281; Keus RB, 2013, ANN ONCOL, V24, P2672, DOI 10.1093/annonc/mdt254; Lewis JJ, 1999, ANN SURG, V229, P866, DOI 10.1097/00000658-199906000-00014; Melis M, 2008, J SURG ONCOL, V98, P594, DOI 10.1002/jso.21033; Nuyttens JJ, 2000, CANCER, V88, P1517, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.0.CO;2-9; Park HC, 2003, ONCOLOGY-BASEL, V64, P346, DOI 10.1159/000070292; REITAMO JJ, 1983, ARCH SURG-CHICAGO, V118, P1318; REITAMO JJ, 1986, AM J SURG, V151, P230, DOI 10.1016/0002-9610(86)90076-0; Rudiger HA, 2010, EJSO-EUR J SURG ONC, V36, P84, DOI 10.1016/j.ejso.2009.07.183; Rutenberg MS, 2011, PEDIATR BLOOD CANCER, V57, P435, DOI 10.1002/pbc.22916; Santti K, 2017, STRAHLENTHER ONKOL, V193, P269, DOI 10.1007/s00066-016-1091-8; Spear MA, 1998, INT J RADIAT ONCOL, V40, P637, DOI 10.1016/S0360-3016(97)00845-6; Wood TJ, 2013, RARE TUMORS, V5, P5, DOI 10.4081/rt.2013.e2; Yao X, 2014, CURR ONCOL, V21, pE613, DOI 10.3747/co.21.1995	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198134	10.1371/journal.pone.0198134	http://dx.doi.org/10.1371/journal.pone.0198134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813130	Green Published, gold			2022-12-26	WOS:000433521800048
J	Kamogawa-Schifter, Y; Yamaoka, Y; Uchida, T; Beer, A; Tribl, B; Schoniger-Hekele, M; Trauner, M; Dolak, W				Kamogawa-Schifter, Yumiko; Yamaoka, Yoshio; Uchida, Tomohisa; Beer, Andrea; Tribl, Barbara; Schoeniger-Hekele, Maximilian; Trauner, Michael; Dolak, Werner			Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years	PLOS ONE			English	Article							INFECTION; RISK; ERADICATION; PATHOGENESIS; GENE	Background and aims The prevalence of Helicobacter pylori (H. pylori) tends to be lower in Western countries such as central Europe compared with Asia. The virulence of H. pylori is influenced by its subtype composition, most importantly by the presence or absence of different types of cytotoxin-associated gene A(CagA). This study aimed to assess the prevalence of H. pylori and its respective CagA phenotype in a large retrospective cohort of patients with gastric cancer or duodenal ulcer at a Western tertiary referral institution. Methods H. pylori positive gastric biopsy samples from patients diagnosed with the afore mentioned diseases within the past 25 years were re-evaluated by histology for H. pylori and status of gastritis. Confirmed H. pylori positive cases were processed for immunohistochemistry (IHC) for H. pylori, CagA, and EastAsiantype CagA. Results The prevalence of H. pylori positive gastric biopsy samples decreased from 20.7% to 2.3% within the study period. Among the gastric cancer patients, the H. pylori positive rate was 16.6%, and didn't show significant changes over time (p = 0.38). Contrary, the H. pylori positive rate of duodenal ulcer decreased significantlyfrom 40% to 5% (p = 0.01). Within H. pylori positive groups ofboth diseases, CagA was highly detected at IHC (86% and 78%, respectively). Except for a few patients originating from East Asian countries, all CagA detected in this study were of Western type. Conclusion In this first Western investigation on the chronological prevalence of H. pylori and its most relevant subtypes, Western type of CagA was highly detected in two important index diseases of the pathogen. This raises further questions about the virulence of this subtype.	[Kamogawa-Schifter, Yumiko; Tribl, Barbara; Schoeniger-Hekele, Maximilian; Trauner, Michael; Dolak, Werner] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu City, Oita, Japan; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Yufu City, Oita, Japan; [Beer, Andrea] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Vienna; Oita University; Oita University; Medical University of Vienna	Dolak, W (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.	werner.dolak@meduniwien.ac.at		Trauner, Michael/0000-0002-1275-6425; Yamaoka, Yoshio/0000-0002-1222-5819	Anniversary Fund of the Oesterreichische Nationalbank (OeNB) [15171]	Anniversary Fund of the Oesterreichische Nationalbank (OeNB)	This study was supported by a research grant of the Anniversary Fund of the Oesterreichische Nationalbank (OeNB): project number 15171 to Yumiko Kamogawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Bilgilier C, 2018, CLIN MICROBIOL INFEC, V24, P267, DOI 10.1016/j.cmi.2017.06.025; BLASER MJ, 1995, CANCER RES, V55, P2111; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; CHRISTENSEN AH, 1992, SCAND J GASTROENTERO, V27, P933, DOI 10.3109/00365529209000166; de Bernard M, 2014, HELICOBACTER, V19, P11, DOI 10.1111/hel.12160; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; ElZimaity HMT, 1996, HUM PATHOL, V27, P35, DOI 10.1016/S0046-8177(96)90135-5; FORMAN D, 1993, LANCET, V341, P1359; Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, SCHIST LIV FLUK HEL, V61, P177; Kanada R, 2008, PATHOL INT, V58, P218, DOI 10.1111/j.1440-1827.2008.02214.x; Kocsmar E, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12387; Krejs GJ, 2007, ACTA MED AUSTRIACA, V27, P129; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; MARSHALL BJ, 1988, LANCET, V2, P1437; Nomura AMY, 2002, AM J EPIDEMIOL, V155, P1054, DOI 10.1093/aje/155.11.1054; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Palli D, 2007, INT J CANCER, V120, P859, DOI 10.1002/ijc.22435; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; PRISTAUTZ H, 1994, ENDOSCOPY, V26, P690, DOI 10.1055/s-2007-1009067; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vannella L, 2012, WORLD J GASTROENTERO, V18, P1279, DOI 10.3748/wjg.v18.i12.1279; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975	34	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197695	10.1371/journal.pone.0197695	http://dx.doi.org/10.1371/journal.pone.0197695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813089	gold, Green Published, Green Submitted			2022-12-26	WOS:000433521800026
J	Pasetto, L; Olivari, D; Nardo, G; Trolese, MC; Bendotti, C; Piccirillo, R; Bonetto, V				Pasetto, Laura; Olivari, Davide; Nardo, Giovanni; Trolese, Maria Chiara; Bendotti, Caterina; Piccirillo, Rosanna; Bonetto, Valentina			Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; CANCER CACHEXIA; SKELETAL-MUSCLE; IN-VIVO; ACTIVATION; SURVIVAL; WHOLE; PROGRESSION; VARIABILITY	Muscle wasting occurs during various chronic diseases and precedes death in humans as in mice. The evaluation of the degree of muscle atrophy in diseased mouse models is often overlooked since it requires the sacrifice of the animals for muscle examination or expensive instrumentation and highly qualified personnel, such as Magnetic Resonance Imaging (MRI). Very often behavioral tests for muscle strength evaluation are used as an outcome measurement in preclinical therapeutic trials. However, these tests are easy to perform serially, but not enough sensitive to detect early muscle changes during disease progression. Monitoring muscle loss in living animals could allow to perform more informative preclinical trials with a better evaluation of therapeutic benefit with respect to muscle wasting. We developed a non-invasive procedure based on micro-computed tomography (micro-CT) without contrast agents to monitor hind limb muscle wasting in mouse models of amyotrophic lateral sclerosis (ALS) and cancer cachexia: the transgenic SOD1(G93A) mouse and the colon adenocarcinoma C26-bearing mouse, respectively. We established the scanning procedure and the parameters to consider in the reconstructed images to calculate the Index of Muscle Mass (IMM). The coefficient of variance for the whole procedure was 2.2%. We performed longitudinally micro-CT scan of hind limbs in SOD1(G93)A mice at presymptomatic and symptomatic stages of the disease and calculated the IMM. We found that IMM in SOD1(G93A) mice was lower than age-matched controls even before symptom onset. We also detected a further decrease in IMM as disease progresses, most markedly just before disease onset. We performed the same analyses in the C26-based mouse model losing quickly body and muscle mass because of cancer cachexia. Overall, we found that the reduced muscle content detected by micro-CT mirrored the reduced muscle weight in both disease models. We developed a fast, precise and easy-to-conduct imaging procedure to monitor hind limb muscle mass, useful in therapeutic preclinical trials but also in proof-ofprinciple studies to identify the onset of muscle wasting. This method could be widely applied to other disease models characterized by muscle wasting, to assist drug development and search for early biomarkers of muscle atrophy. Moreover, reducing the number of mice needed for the experiments and being less distressing are in line with the 3R principle embodied in national and international directives for animal research.	[Pasetto, Laura; Olivari, Davide; Nardo, Giovanni; Trolese, Maria Chiara; Bendotti, Caterina; Piccirillo, Rosanna; Bonetto, Valentina] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Piccirillo, R; Bonetto, V (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy.	rosanna.piccirillo@marionegri.it; valentina.bonetto@marionegri.it	Pasetto, Laura/I-6911-2018; Bonetto, Valentina/ABB-6383-2020; Nardo, Giovanni/C-1406-2014; Piccirillo, Rosanna/AAQ-3653-2020; Pasetto, Laura/ABG-3421-2020; Bendotti, Caterina/AAB-2273-2020; Olivari, Davide/AAC-4733-2022; Bonetto, Valentina/I-4694-2018; Trolese, Maria Chiara/V-1174-2019; Piccirillo, Rosanna/K-6619-2016	Pasetto, Laura/0000-0003-0319-4448; Bonetto, Valentina/0000-0003-0456-2054; Nardo, Giovanni/0000-0002-1803-1484; Piccirillo, Rosanna/0000-0002-1613-9352; Pasetto, Laura/0000-0003-0319-4448; Bendotti, Caterina/0000-0003-1055-1271; Olivari, Davide/0000-0003-0802-6603; Bonetto, Valentina/0000-0003-0456-2054; Trolese, Maria Chiara/0000-0003-4471-2491; Piccirillo, Rosanna/0000-0002-1613-9352	Italian Association for Cancer Research (AIRC Start-UP) [11423]; Union under the Marie Curie International Reintegration Grant [PIRG08-GA-2010-277008]; European Community [259867]; Fondazione per la Ricerca Biomedica; Fondazione Cariplo [2014-1164]; Cariplo Foundation [2014-1164]	Italian Association for Cancer Research (AIRC Start-UP)(Fondazione AIRC per la ricerca sul cancro); Union under the Marie Curie International Reintegration Grant; European Community(European Commission); Fondazione per la Ricerca Biomedica; Fondazione Cariplo(Fondazione Cariplo); Cariplo Foundation(Fondazione Cariplo)	The Italian Association for Cancer Research (www.airc.it, AIRC Start-UP 11423 to RP), the Union under the Marie Curie International Reintegration Grant (PIRG08-GA-2010-277008 to RP), the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259867 (to VB and CB), the "Fondazione per la Ricerca Biomedica" (http:// www.frrb.regione.lombardia.it, a TRANS-ALS project to VB and CB), and the "Fondazione Cariplo" (http://www.fondazionecariplo.it, 2014-1164 to RP).; We thank Sara Previdi and Melissa Mombrini for help in the acquisition of the micro-CT images in the initial phase of the project, and Luigi Cervo for the statistical analysis. We are grateful to the Italian Association for Cancer Research (AIRC Start-UP 11423 to RP), the Union under the Marie Curie International Reintegration Grant (PIRG08-GA-2010-277008 to RP), the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259867 (to VB and CB), Cariplo Foundation (2014-1164 to RP) and to the "Fondazione per la Ricerca Biomedica" (TRANS-ALS project to VB and CB).	Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Aulino P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-363; Baracos VE, 2010, AM J CLIN NUTR, V91, p1133S, DOI 10.3945/ajcn.2010.28608C; Bonetto A, 2016, JOVE-J VIS EXP, DOI 10.3791/54893; Bonetto A, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00679; Bontempi P, 2018, MAGN RESON MED, V79, P459, DOI 10.1002/mrm.26685; Boyer JG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00356; Capitanio D, 2012, ANTIOXID REDOX SIGN, V17, P1333, DOI 10.1089/ars.2012.4524; Caron I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132159; Carri MT, 2006, TRENDS PHARMACOL SCI, V27, P267, DOI 10.1016/j.tips.2006.03.009; Cesari M, 2012, J CACHEXIA SARCOPENI, V3, P181, DOI 10.1007/s13539-012-0078-2; Clark DP, 2014, PHYS MED; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Derave W, 2003, NEUROBIOL DIS, V13, P264, DOI 10.1016/S0969-9961(03)00041-X; Dewil M, 2007, NEUROBIOL DIS, V26, P332, DOI 10.1016/j.nbd.2006.12.023; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; GRAHN D, 1958, GENETICS, V43, P835; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hardiman O, 2011, J NEUROL, V258, P359, DOI 10.1007/s00415-010-5830-y; Heier CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112477; Judex S, 2016, J MUSCULOSKEL NEURON, V16, P174; KOHN HI, 1956, SCIENCE, V124, P1078, DOI 10.1126/science.124.3231.1078; Lainscak Mitja, 2007, Curr Opin Support Palliat Care, V1, P299, DOI 10.1097/SPC.0b013e3282f31667; Li X, 2014, ADV DRUG DELIVER REV, V76, P116, DOI 10.1016/j.addr.2014.07.013; Marcuzzo S, 2011, EXP NEUROL, V231, P30, DOI 10.1016/j.expneurol.2011.05.007; Marino M, 2015, NEUROBIOL AGING, V36, P492, DOI 10.1016/j.neurobiolaging.2014.06.026; Martinelli GB, 2016, ONCOGENE, V35, P6212, DOI 10.1038/onc.2016.153; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; MOLE RH, 1957, BRIT J RADIOL, V30, P40, DOI 10.1259/0007-1285-30-349-40; Nardo G, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0732-2; Nardo G, 2016, BRAIN PATHOL, V26, P237, DOI 10.1111/bpa.12351; Pahor M, 2009, J NUTR HEALTH AGING, V13, P724, DOI 10.1007/s12603-009-0204-9; Penet Marie-France, 2011, Curr Opin Support Palliat Care, V5, P327, DOI 10.1097/SPC.0b013e32834c49ba; Peviani M, 2010, CNS NEUROL DISORD-DR, V9, P491, DOI 10.2174/187152710791556096; Piccirillo R, 2015, CELL CYCLE, V14, P939, DOI 10.1080/15384101.2015.1010979; Piccirillo R, 2014, DEV DYNAM, V243, P201, DOI 10.1002/dvdy.24036; Piccirillo R, 2012, EMBO J, V31, P3334, DOI 10.1038/emboj.2012.178; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Pretto F, 2015, ONCOTARGET, V6, P3043, DOI 10.18632/oncotarget.2812; Previdi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079101; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Roberts BM, 2013, FASEB J, V27, P2600, DOI 10.1096/fj.12-222844; Roeland EJ, 2017, SUPPORT CARE CANCER, V25, P365, DOI 10.1007/s00520-016-3402-0; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SATO F, 1981, INT J RADIAT BIOL, V39, P607, DOI 10.1080/09553008114550731; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Tian M, 2011, INT J ONCOL, V39, P1321, DOI 10.3892/ijo.2011.1150; Villars FO, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050986; von Haehling S, 2012, INT J CARDIOL, V161, P121, DOI 10.1016/j.ijcard.2012.09.213; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	58	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198089	10.1371/journal.pone.0198089	http://dx.doi.org/10.1371/journal.pone.0198089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813127	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800043
J	Corona, E; Wang, LY; Ko, D; Patel, CJ				Corona, Erik; Wang, Liuyang; Ko, Dennis; Patel, Chirag J.			Systematic detection of positive selection in the human-pathogen interactome and lasting effects on infectious disease susceptibility	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-INTERACTION DATABASE; RESPIRATORY SYNCYTIAL VIRUS; GENOME-WIDE ASSOCIATION; RESISTANCE ALLELE; HUMAN-POPULATIONS; UHRF1 EXPRESSION; EVOLUTION; HIV-1; PLAGUE	Infectious disease has shaped the natural genetic diversity of humans throughout the world. A new approach to capture positive selection driven by pathogens would provide information regarding pathogen exposure in distinct human populations and the constantly evolving arms race between host and disease-causing agents. We created a human pathogen interaction database and used the integrated haplotype score (iHS) to detect recent positive selection in genes that interact with proteins from 26 different pathogens. We used the Human Genome Diversity Panel to identify specific populations harboring pathogen-interacting genes that have undergone positive selection. We found that human genes that interact with 9 pathogen species show evidence of recent positive selection. These pathogens are Yersenia pestis, human immunodeficiency virus (HIV) 1, Zaire ebolavirus, Francisella tularensis, dengue virus, human respiratory syncytial virus, measles virus, Rubella virus, and Bacillus anthracis. For HIV-1, GWAS demonstrate that some naturally selected variants in the host-pathogen protein interaction networks continue to have functional consequences for susceptibility to these pathogens. We show that selected human genes were enriched for HIV susceptibility variants (identified through GWAS), providing further support for the hypothesis that ancient humans were exposed to lentivirus pandemics. Human genes in the Italian, Miao, and Biaka Pygmy populations that interact with Y. pestis show significant signs of selection. These results reveal some of the genetic footprints created by pathogens in the human genome that may have left lasting marks on susceptibility to infectious disease.	[Corona, Erik] RTI Int, Dept Biomed Informat, Durham, NC 27709 USA; [Corona, Erik; Patel, Chirag J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Wang, Liuyang; Ko, Dennis] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Ko, Dennis] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Research Triangle Institute; Harvard University; Harvard Medical School; Duke University; Duke University	Corona, E (corresponding author), RTI Int, Dept Biomed Informat, Durham, NC 27709 USA.; Corona, E (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.	erikcorona@gmail.com	Wang, Liuyang/A-7833-2011	Wang, Liuyang/0000-0001-9556-2361; Corona, Erik/0000-0003-3256-5295	NIH National Institute of Environmental Health sciences (NIEHS) [1K99ES023504]; Pharmaceutical Research and Manufacturers of America foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025052, R00ES023504] Funding Source: NIH RePORTER	NIH National Institute of Environmental Health sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Pharmaceutical Research and Manufacturers of America foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by the NIH National Institute of Environmental Health sciences (NIEHS) grant number 1K99ES023504 and a grant from the Pharmaceutical Research and Manufacturers of America foundation. The funding sources played no role in the study design, data collection, analysis, decision to publish, or preparation of this manuscript.	Aguileta G, 2010, MOL ECOL, V19, P292, DOI 10.1111/j.1365-294X.2009.04454.x; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bacot A W, 1914, J Hyg (Lond), V13, P423; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAIDWOOD RJ, 1960, SCI AM, V203, P130, DOI 10.1038/scientificamerican0960-130; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cann HM, 2002, SCIENCE, V296, P261; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Cohn Samuel K Jr, 2008, Med Hist Suppl, P74; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469; Evangelou E, 2011, AM J EPIDEMIOL, V173, P1336, DOI 10.1093/aje/kwr024; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kofunato Y, 2012, ONCOL REP, V28, P1997, DOI 10.3892/or.2012.2064; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Laayouni H, 2014, P NATL ACAD SCI USA, V111, P2668, DOI 10.1073/pnas.1317723111; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Li XL, 2012, ONCOL REP, V28, P375, DOI 10.3892/or.2012.1792; Limou S, 2012, J INFECT DIS, V205, P1155, DOI 10.1093/infdis/jis028; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028632; MCEVEDY C, 1988, SCI AM, V258, P118, DOI 10.1038/scientificamerican0288-118; McNamara PS, 2002, BRIT MED BULL, V61, P13, DOI 10.1093/bmb/61.1.13; Morens DM, 2008, LANCET INFECT DIS, V8, P710, DOI 10.1016/S1473-3099(08)70256-1; Mouchet J, 1995, Sante, V5, P293; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pearce-Duvet JMC, 2006, BIOL REV, V81, P369, DOI 10.1017/S1464793106007020; Pepin J, 2013, J EPIDEMIOL COMMUN H, V67, P473, DOI 10.1136/jech-2012-201423; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Pi JT, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0613-9; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pittman KJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005680; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; RAINERI I, 1992, NUCLEIC ACIDS RES, V20, P6261, DOI 10.1093/nar/20.23.6261; Raj T, 2013, AM J HUM GENET, V92, P517, DOI 10.1016/j.ajhg.2013.03.001; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tien AL, 2011, BIOCHEM J, V435, P175, DOI 10.1042/BJ20100840; Troyer JL, 2011, J INFECT DIS, V203, P1491, DOI 10.1093/infdis/jir046; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williams PD, 2014, J EVOLUTION BIOL, V27, P1271, DOI 10.1111/jeb.12379; Yang CR, 2013, MOL BIOL REP, V40, P5225, DOI 10.1007/s11033-013-2559-6; Yang GL, 2012, MED ONCOL, V29, P842, DOI 10.1007/s12032-011-9983-z; Zaffiri L, 2012, J INVEST SURG, V25, P67, DOI 10.3109/08941939.2012.664099; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	72	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0196676	10.1371/journal.pone.0196676	http://dx.doi.org/10.1371/journal.pone.0196676			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799843	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400005
J	Lin, MM; Qi, XJ; Chen, JY; Sun, LM; Zhong, YP; Fang, JB; Hu, CG				Lin, Miaomiao; Qi, Xiujuan; Chen, Jinyong; Sun, Leiming; Zhong, Yunpeng; Fang, Jinbao; Hu, Chungen			The complete chloroplast genome sequence of Actinidia arguta using the PacBio RS II platform	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; EVOLUTION; KIWIFRUIT	Actinidia arguta is the most basal species in a phylogenetically and economically important genus in the family Actinidiaceae. To better understand the molecular basis of the Actinidia arguta chloroplast (cp), we sequenced the complete cp genome from A. arguta using Illumina and PacBio RS II sequencing technologies. The cp genome from A. arguta was 157,611 bp in length and composed of a pair of 24,232 bp inverted repeats (IRs) separated by a 20,463 bp small single copy region (SSC) and an 88,684 bp large single copy region (LSC). Overall, the cp genome contained 113 unique genes. The cp genomes from A. arguta and three other Actinidia species from GenBank were subjected to a comparative analysis. Indel mutation events and high frequencies of base substitution were identified, and the accD and ycf2 genes showed a high degree of variation within Actinidia. Forty-seven simple sequence repeats (SSRs) and 155 repetitive structures were identified, further demonstrating the rapid evolution in Actinidia. The cp genome analysis and the identification of variable loci provide vital information for understanding the evolution and function of the chloroplast and for characterizing Actinidia population genetics.	[Lin, Miaomiao; Qi, Xiujuan; Chen, Jinyong; Sun, Leiming; Zhong, Yunpeng; Fang, Jinbao] Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China; [Hu, Chungen] Hua Zhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS; Huazhong Agricultural University	Fang, JB (corresponding author), Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China.; Hu, CG (corresponding author), Hua Zhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China.	fangjinbao@caas.cn; chungen@mail.hzau.edu.cn	Zhong, Yun/HCH-6868-2022		Agricultural Science and Technology Innovation Program (CAAS-ASTIP-ZFRI); Henan Agriculture Research System [S2014-11]; Basic Research Fund of ZFRI, CAAS [1610192017710]	Agricultural Science and Technology Innovation Program (CAAS-ASTIP-ZFRI); Henan Agriculture Research System; Basic Research Fund of ZFRI, CAAS	This research is supported by the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2016-ZFRI) to JF, the Henan Agriculture Research System (S2014-11) to JF, and the Basic Research Fund of ZFRI, CAAS (1610192017710) to MML.	Asaf S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00843; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chartier J, 1997, ACTA HORTIC, P149, DOI 10.17660/ActaHortic.1997.444.21; Chat J, 2004, AM J BOT, V91, P736, DOI 10.3732/ajb.91.5.736; Chat J, 1999, THEOR APPL GENET, V99, P314, DOI 10.1007/s001220051238; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; Cusimano N, 2016, NEW PHYTOL, V210, P680, DOI 10.1111/nph.13784; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Ferrarini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-670; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Katayama H, 2005, THEOR APPL GENET, V111, P1430, DOI 10.1007/s00122-005-0075-3; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Latocha P, 2011, FOOD RES INT, V44, P1946, DOI 10.1016/j.foodres.2011.01.032; Li JQ, 2002, SYST BOT, V27, P408; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13401-4; Li Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02076-6; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Liu LX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00968; Liu YF, 2017, NEW PHYTOL, V215, P877, DOI 10.1111/nph.14607; Lu RS, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02054; Ma PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11608; Miyamoto M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-699; Pauwels M, 2012, NEW PHYTOL, V193, P916, DOI 10.1111/j.1469-8137.2011.04003.x; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Soorni A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3412-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vieira LD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084792, 10.1371/journal.pone.0090618]; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang MX, 2015, PLANT MOL BIOL REP, V33, P1526, DOI 10.1007/s11105-015-0853-2; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wang WC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162324; Williams M. H., 2013, ACTA HORTIC, V610, P81; Wu ZH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0289-0; Wu ZQ, 2016, MITOCHONDRIAL DNA A, V27, P4155, DOI 10.3109/19401736.2014.1003890; Yang JK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053939, 10.1371/journal.pone.0073053]; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Zhang YJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00306	50	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197393	10.1371/journal.pone.0197393	http://dx.doi.org/10.1371/journal.pone.0197393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795601	Green Submitted, gold, Green Published			2022-12-26	WOS:000433084300040
J	Pardo, LE; Campbell, MJ; Edwards, W; Clements, GR; Laurance, WF				Pardo, Lain E.; Campbell, Mason J.; Edwards, Will; Clements, Gopalasamy Reuben; Laurance, William F.			Terrestrial mammal responses to oil palm dominated landscapes in Colombia	PLOS ONE			English	Article							LAND-USE; BIODIVERSITY CONSERVATION; MYRMECOPHAGA-TRIDACTYLA; AGRICULTURAL LANDSCAPE; HABITAT SELECTION; EXPANSION; IMPACTS; PLANTATIONS; DIVERSITY; MODEL	The rapid expansion of oil palm cultivation in the Neotropics has generated great debate around possible biodiversity impacts. Colombia, for example, is the largest producer of oil palm in the Americas, but the effects of oil palm cultivation on native fauna are poorly understood. Here, we compared how richness, abundance and composition of terrestrial mammal species differ between oil palm plantations and riparian forest in the Colombian Llanos region. Further, we determined the relationships and influence of landscape and habitat level variables on those metrics. We found that species richness and composition differed significantly between riparian forest and oil palm, with site level richness inside oil palm plantations 47% lower, on average, than in riparian forest. Within plantations, mammalian species richness was strongly negatively correlated with cattle abundance, and positively correlated with the density of undergrowth vegetation. Forest structure characteristics appeared to have weak and similar effects on determining mammal species richness and composition along riparian forest strips. Composition at the landscape level was significantly influenced by cover type, percentage of remaining forest and the distance to the nearest town, whereas within oil palm sites, understory vegetation, cattle relative abundance, and canopy cover had significant effects on community composition. Species specific abundance responses varied between land cover types, with oil palm having positive effects on mesopredators, insectivores and grazers. Our findings suggest that increasing habitat complexity, avoiding cattle and retaining native riparian forest-regardless of its structure-inside oil palm-dominated landscapes would help support higher native mammal richness and abundance at both local and landscape scales.	[Pardo, Lain E.; Campbell, Mason J.; Edwards, Will; Clements, Gopalasamy Reuben; Laurance, William F.] James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld, Australia; [Pardo, Lain E.] Univ Nacl Colombia, Grp Conservac & Manejo Vida Silvestre, Bogota, Colombia; [Clements, Gopalasamy Reuben] Sunway Univ, Dept Biol Sci, Bandar Sunway, Selangor, Malaysia; [Clements, Gopalasamy Reuben] Rimba, Casa Kiara 2, Kuala Lumpur, Malaysia	James Cook University; Universidad Nacional de Colombia; Sunway University	Pardo, LE (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld, Australia.; Pardo, LE (corresponding author), Univ Nacl Colombia, Grp Conservac & Manejo Vida Silvestre, Bogota, Colombia.	lepardov@gmail.com	Laurance, William F/B-2709-2012; Edwards, Will/M-6652-2015; Campbell, Mason/G-4651-2017; Pardo, Lain Efren/GZM-2777-2022; Edwards, Will/GRS-5509-2022	Laurance, William F/0000-0003-4430-9408; Edwards, Will/0000-0001-8981-7479; Campbell, Mason/0000-0001-6803-271X; Clements, Gopalasamy Reuben/0000-0002-9715-4385; Pardo Vargas, Lain Efren/0000-0002-2533-6577	Australian Laureate Fellowship; Administrative Department of Science, Technology and Innovation-COLCIENCIAS, Colombia	Australian Laureate Fellowship; Administrative Department of Science, Technology and Innovation-COLCIENCIAS, Colombia	Funding was provided by an Australian Laureate Fellowship awarded to William Laurance. The lead author also thanks the Administrative Department of Science, Technology and Innovation-COLCIENCIAS, Colombia, for funding his PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all companies for their valuable support and assistance during field work and for allowing us to work and stay on their lands, to the National Federation of Oil Palm Growers (FEDEPALMA) and the project "Biodiversity Conservation in the Areas of Oil Palm Plantations" (GEF/BID PPB). We also thank the field guides and research assistants, especially Angela Rojas-Rojas and Juan Albarracin. We are grateful to Mike Meredith, Diego Zarrate, Nicolas Younes, and David Warton for their comments. The lead author also thanks the Administrative Department of Science, Technology and Innovation-COLCIENCIAS, Colombia, for funding his PhD studies.	Akani GC, 2007, COMMUNITY STRUCTURE, P500; ALBESIANO SOFÍA, 2006, Caldasia, V28, P307; Quiroga VA, 2016, MAMM BIOL, V81, P274, DOI 10.1016/j.mambio.2016.03.002; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Azhar B, 2014, BIODIVERS CONSERV, V23, P1175, DOI 10.1007/s10531-014-0656-z; Baptiste B, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0102; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beca G, 2017, BIOL CONSERV, V210, P352, DOI 10.1016/j.biocon.2017.02.033; Bello C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501105; Benitez-Lopez A, 2017, SCIENCE, V356, P180, DOI 10.1126/science.aaj1891; Bhagwat SA, 2008, CONSERV BIOL, V22, P1368, DOI 10.1111/j.1523-1739.2008.01026.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; Camargo-Sanabria AA, 2016, ACTA OECOL, V73, P45, DOI 10.1016/j.actao.2016.02.005; Campbell BM, 2017, ECOL SOC, V22, DOI 10.5751/ES-09595-220408; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Chillo O, 2017, J APPL ECOL, V54, P986, DOI 10.1111/1365-2664.12775; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; Colwell R.K., 2016, ESTIMATES STAT ESTIM; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cosentino BJ, 2011, LANDSCAPE ECOL, V26, P371, DOI 10.1007/s10980-010-9563-1; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dammert JL, 2014, CAMBIO USO SUELOS AG; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Diaz-Pulido A, 2017, BIODIVERSIDAD 2016 E, P15; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dotta G, 2011, MAMMALIA, V75, P345, DOI 10.1515/MAMM.2011.049; Echeverria-Londono S, 2016, DIVERS DISTRIB, V22, P1099, DOI 10.1111/ddi.12478; Edwards DP, 2012, CONSERV LETT, V5, P20, DOI 10.1111/j.1755-263X.2011.00209.x; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Etter A., 2010, ECOSYSTEM FUNCTION S, P383; Fedepalma, 2014, AN EST 2014 AGR PALM; Ferrer A, 2009, BIOTA COLOMBIANA, V10, P179; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foster WA, 2011, PHILOS T R SOC B, V366, P3277, DOI 10.1098/rstb.2011.0041; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gatti A, 2006, J TROP ECOL, V22, P227, DOI 10.1017/S0266467405002956; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gilroy J., 2014, PALMAS, P1; Gilroy JJ, 2015, GLOBAL CHANGE BIOL, V21, P1531, DOI 10.1111/gcb.12696; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; IDEAM IGAC IAvH INVEMAR SINCHI IIAP, 2007, EC CONT COST MAR COL; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Lasso C.A., 2010, BIODIVERSIDAD CUENCA; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Lopez-Ricaurte L, 2017, BIOL CONSERV, V213, P225, DOI 10.1016/j.biocon.2017.07.009; Lynch JD, 2015, CALDASIA, V37, P169, DOI 10.15446/caldasia.v37n1.50992; Maddox T., 2007, 7 ZSL; MADR, 2006, AP EXP AGR 2006 2020; MADR, 2006, ESTR DES BIOC IMPL S; Madrinan LF, 2007, LAND DEGRAD DEV, V18, P199, DOI 10.1002/ldr.767; Magurran Anne E., 2011, P97; Mendes-Oliveira AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187650; Miranda F, 2014, MYRMECOPHAGA TRIDACT, DOI [10.2305/IUCN.UK.2014-1.RLTS.T14224A47441961.en, DOI 10.2305/IUCN.UK.2014-1.RLTS.T14224A47441961.EN]; Mourao G, 2007, J ZOOL, V271, P187, DOI 10.1111/j.1469-7998.2006.00198.x; Muhly TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064311; Nogeire TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068025; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pardo Lain E., 2017, Revista Biodiversidad Neotropical, V7, P108, DOI 10.18636/bioneotropical.v7i1.490; Vargas LEP, 2015, TROP CONSERV SCI, V8, P828, DOI 10.1177/194008291500800317; Pardo-Vargas Lain E., 2015, Biota Colombiana, V16, P54; Pereira P, 2012, ECOL RES, V27, P745, DOI 10.1007/s11284-012-0949-1; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Prescott GW, 2016, BIOL CONSERV, V197, P139, DOI 10.1016/j.biocon.2016.02.013; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Ramirez-Chaves he, 2016, MAMMAL NOTES, V3, P1; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Furumo PR, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5892; Rodriguez-Mahecha JV, 2006, CONS INT COL; Rojano Bolano Cesar, 2015, Edentata, V16, P37; Rojano C, 2015, EDENTATA, V16, P1; Roldan PA, 2006, METEOROL COLOMB, V10, P47; Romero-Ruiz MH, 2012, APPL GEOGR, V32, P766, DOI 10.1016/j.apgeog.2011.08.010; Sanabria C, 2014, APPL SOIL ECOL, V84, P24, DOI 10.1016/j.apsoil.2014.07.001; Sayer J, 2012, GLOB FOOD SECUR-AGR, V1, P114, DOI 10.1016/j.gfs.2012.10.003; TEAM Network, 2008, TERR VERT PROT IMPL; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Uribe C., 2013, PLAN CONSERVACION FE, P107; Vargas LEP, 2016, BIODIVERS CONSERV, V25, P739, DOI 10.1007/s10531-016-1089-7; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2015, METHODS ECOL EVOL, V6, P389, DOI 10.1111/2041-210X.12280; Wearn O, 2017, WWF CONSERVATION TEC; Wearn OR, 2017, BIOL CONSERV, V212, P162, DOI 10.1016/j.biocon.2017.05.007; Wearn OR, 2016, ECOL APPL, V26, P1409, DOI 10.1890/15-1363; Yaap B, 2016, TROP CONSERV SCI, V9, DOI 10.1177/1940082916683523; Yue S, 2015, ECOL APPL, V25, P2285, DOI 10.1890/14-1928.1; Zuur Alain F., 2009, P1	107	23	26	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197539	10.1371/journal.pone.0197539	http://dx.doi.org/10.1371/journal.pone.0197539			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795615	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000433084300048
J	Westveer, JJ; van der Geest, HG; van Loon, EE; Verdonschot, PFM				Westveer, Judith J.; van der Geest, Harm G.; van Loon, E. Emiel; Verdonschot, Piet F. M.			Connectivity and seasonality cause rapid taxonomic and functional trait succession within an invertebrate community after stream restoration	PLOS ONE			English	Article							RESTORED RIVER REACHES; BENTHIC INVERTEBRATES; LOTIC MACROINVERTEBRATES; HABITAT HETEROGENEITY; PLANT SUCCESSION; FLOW REFUGIA; LIFE-HISTORY; DISPERSAL; COLONIZATION; WATER	General colonization concepts consent that a slow process of microhabitat formation and subsequent niche realization occurs during early stages after new habitat is released. Subsequently, only few species are able to colonize new habitat in the early onset of succession, while species richness increases steadily over time. Although most colonization studies have been performed in terrestrial ecosystems, running water ecosystems are equally or even more prone to colonization after disturbance due to their dynamic nature. We question how invertebrate succession patterns reconcile with general colonization concepts. With this study we provide insight into the colonization process in newly created lowland stream trajectories and answer how within-stream bio- and functional diversity develops over time. Our results show a rapid influx of species, with a wide range of functional traits, during the first season after water flow commenced. During more than two years of regular monitoring, immigration rates were highest in autumn, marking the effects of seasonality on invertebrate dispersal. Biodiversity increased while abundance peaks of species alternated between seasons. Moreover, also days since start of the experiment explains a considerable part of the variability for taxa as well as traits. However, the relative trait composition remained similar throughout the entire monitoring period and only few specific traits had significantly higher proportions during specific seasons. This indicates that first phase colonization in freshwater streams can be a very rapid process that results in a high biodiversity and a large variety of species functional characteristics from the early onset of succession, contradicting general terrestrial colonization theory.	[Westveer, Judith J.; van der Geest, Harm G.; van Loon, E. Emiel; Verdonschot, Piet F. M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Verdonschot, Piet F. M.] Wageningen UR, Wageningen Environm Res, Wageningen, Netherlands	University of Amsterdam; Wageningen University & Research	Westveer, JJ (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	j.j.westveer@uva.nl		van Loon, E. Emiel/0000-0002-8895-0427	foundation for applied water research	foundation for applied water research	This study was funded by the foundation for applied water research (http://stowa.nl/foundation_for_applied_water_research_stowa/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD., 2021, STREAM ECOLOGY STRUC, DOI [DOI 10.1007/978-3-030-61286-3, 10.1007/978-3-030-61286-3]; [Anonymous], 1954, VEGETATIO; Baumgartner SD, 2017, HYDROBIOLOGIA, V784, P321, DOI 10.1007/s10750-016-2886-4; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Buffagni A, 2009, DISTRIBUTION ECOLOGI, V3; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; Clements F.E., 1916, PLANT SUCCESSION ANA; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Gallardo B, 2014, FRESHWATER BIOL, V59, P630, DOI 10.1111/fwb.12292; GORE JA, 1982, HYDROBIOLOGIA, V94, P183, DOI 10.1007/BF00010899; GORE JA, 1990, ENVIRON MANAGE, V14, P737, DOI 10.1007/BF02394722; Graf W., 2008, DISTRIBUTION ECOLOGI, V2; Gustafsson S, 2013, ECOL ENG, V61, P345, DOI 10.1016/j.ecoleng.2013.09.023; Haase P, 2013, HYDROBIOLOGIA, V704, P475, DOI 10.1007/s10750-012-1255-1; Haase P, 2006, HYDROBIOLOGIA, V566, P505, DOI 10.1007/s10750-006-0075-6; Havel JE, 2004, LIMNOL OCEANOGR, V49, P1229, DOI 10.4319/lo.2004.49.4_part_2.1229; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2013, ECOL EVOL, V3, P344, DOI 10.1002/ece3.470; HIGLER LWG, 2008, VERSPREIDINGSATLAS N; Horvath Z, 2016, ECOGRAPHY, V39, P726, DOI 10.1111/ecog.01685; Hughes JM, 2007, FRESHWATER BIOL, V52, P616, DOI 10.1111/j.1365-2427.2006.01722.x; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Hynes H. B. N., 1976, ANNU REV ENTOMOL, V15, P25; Jacobi GZ, 1996, J N AM BENTHOL SOC, V15, P690, DOI 10.2307/1467816; Jacobsen D, 2008, AQUAT ECOL-SAN DIEGO, P65, DOI 10.1016/B978-012088449-0.50006-6; Jahnig SC, 2009, AQUAT CONSERV, V19, P157, DOI 10.1002/aqc.976; Kappes H, 2012, AQUAT SCI, V74, P1, DOI 10.1007/s00027-011-0187-6; KENKEL NC, 1986, ECOLOGY, V67, P919, DOI 10.2307/1939814; Knispel S, 2003, FRESHWATER BIOL, V48, P604, DOI 10.1046/j.1365-2427.2003.01030.x; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; LANCASTER J, 1993, CAN J FISH AQUAT SCI, V50, P1663, DOI 10.1139/f93-187; LANCASTER J, 1993, J N AM BENTHOL SOC, V12, P385, DOI 10.2307/1467619; Lancaster J, 2000, J ANIM ECOL, V69, P442, DOI 10.1046/j.1365-2656.2000.00407.x; Leps M, 2016, SCI TOTAL ENVIRON, V557, P722, DOI 10.1016/j.scitotenv.2016.03.120; Li FQ, 2016, SCI TOTAL ENVIRON, V569, P1570, DOI 10.1016/j.scitotenv.2016.06.251; Lopez-Rodriguez MJ, 2009, J N AM BENTHOL SOC, V28, P611, DOI 10.1899/08-105.1; MAC ARTHUR ROBERT H., 1967; MACKAY RJ, 1992, CAN J FISH AQUAT SCI, V49, P617, DOI 10.1139/f92-071; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Miguelez D, 2008, ANN SOC ENTOMOL FR, V44, P317, DOI 10.1080/00379271.2008.10697570; Miller M.F., 2002, GSA TODAY, V12, P4, DOI [10.1130/1052-5173(2002)0122.0.co;2, DOI 10.1130/1052-5173(2002)0122.0.CO;2]; Milner AM, 2008, FRONT ECOL ENVIRON, V6, P413, DOI 10.1890/060149; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; Parkyn SM, 2011, ENVIRON MANAGE, V48, P602, DOI 10.1007/s00267-011-9694-4; PECKARSKY BL, 1986, CAN J FISH AQUAT SCI, V43, P700, DOI 10.1139/f86-085; Pulsford SA, 2016, BIOL REV, V91, P148, DOI 10.1111/brv.12163; Schmidt-Kloiber A, 2015, ECOL INDIC, V53, P271, DOI 10.1016/j.ecolind.2015.02.007; Schowalter TD, 2016, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 4TH EDITION, P1; Schultheis AS, 2002, MOL ECOL, V11, P317, DOI 10.1046/j.1365-294X.2002.01445.x; SOUTHWOOD TRE, 1979, BIOL J LINN SOC, V12, P327, DOI 10.1111/j.1095-8312.1979.tb00063.x; Sundermann A, 2011, ECOL APPL, V21, P1962, DOI 10.1890/10-0607.1; TAYLOR BW, 1954, ECOLOGY, V35, P569, DOI 10.2307/1931046; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Tonkin JD, 2014, FRESHWATER BIOL, V59, P1843, DOI 10.1111/fwb.12387; Townsend CR, 1997, J N AM BENTHOL SOC, V16, P531, DOI 10.2307/1468142; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; Usseglio-Polatera, 2010, INVERTEBRES EAU DOUC, V15; Van Leeuwen CHA, 2013, FRESHWATER BIOL, V58, P88, DOI 10.1111/fwb.12041; Verberk WCEP, 2008, FRESHWATER BIOL, V53, P1722, DOI 10.1111/j.1365-2427.2008.02035.x; Verdonschot P. F. M., 1990, ECOLOGICAL CHARACTER; Verdonschot PFM, 2012, LIMNOLOGICA, V42, P227, DOI 10.1016/j.limno.2012.01.001; WATERS THOMAS F., 1964, TRANS AMER FISH SOC, V93, P311, DOI 10.1577/1548-8659(1964)93[311:RODSBA]2.0.CO;2; Westveer JJ, 2017, FRESHW SCI, V36, P585, DOI 10.1086/692940; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007; Winking C, 2014, FRESHWATER BIOL, V59, P1932, DOI 10.1111/fwb.12397	71	6	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197182	10.1371/journal.pone.0197182	http://dx.doi.org/10.1371/journal.pone.0197182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795599	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300029
J	Luo, JJ; Bian, WP; Liu, Y; Huang, HY; Yin, Q; Yang, XJ; Pei, DS				Luo, Juan-Juan; Bian, Wan-Ping; Liu, Yi; Huang, Hai-Yang; Yin, Qian; Yang, Xiao-Jun; Pei, De-Sheng			CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy	FASEB JOURNAL			English	Article						gene editing; MMEJ; transgenesis; knock-in	ZINC-FINGER NUCLEASES; MEDIATED TARGETED INTEGRATION; TRANSGENIC ZEBRAFISH; HOMOLOGOUS RECOMBINATION; KNOCK-IN; SYSTEM; CLEAVAGE; REPAIR; GENES; TALEN	Numerous feasible methods for inserting large fragments of exogenous DNA sequences into the zebrafish genome have been developed, as has genome editing technology using programmable nucleases. However, the coding sequences of targeted endogenous genes are disrupted, and the expression patterns of inserted exogenous genes cannot completely recapitulate those of endogenous genes. Here we describe the establishment of a novel strategy for endogenous promoter-driven and microhomology-mediated end-joining-dependent integration of a donor vector using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9. We successfully integrated mCherry into the final coding sequence of targeted genes to generate seamless transgenic zebrafish lines with high efficiency. This novel seamless transgenesis technique not only maintained the integrity of the endogenous gene but also did not disrupt the function of targeted gene. Therefore, our microhomology-mediated end-joining-mediated transgenesis strategy may have broader applications in gene therapy. Moreover, this novel seamless gene-editing strategy in zebrafish provides a valuable new transgenesis technique, which was driven by endogenous promoters and in vivo animal reporter modes for translational medicine. It is expected to be a standard gene-editing technique in the field of zebrafish, leading to some important breakthroughs for studies in early embryogenesis.Luo, J.-J., Bian, W.-P., Liu, Y., Huang, H.-Y., Yin, Q., Yang, X.-J., Pei, D.-S. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.	[Luo, Juan-Juan; Yang, Xiao-Jun] Shantou Univ, Ctr Neurosci, Coll Med, 22 Xinling Rd, Shantou 515041, Peoples R China; [Luo, Juan-Juan; Bian, Wan-Ping; Liu, Yi; Huang, Hai-Yang; Yin, Qian; Pei, De-Sheng] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China; [Liu, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China	Shantou University; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, XJ (corresponding author), Shantou Univ, Ctr Neurosci, Coll Med, 22 Xinling Rd, Shantou 515041, Peoples R China.; Pei, DS (corresponding author), Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China.	yangx@stu.edu.cn; peids@cigit.ac.cn	Pei, De-Sheng/K-1466-2017	Pei, De-Sheng/0000-0001-6408-9575	Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing [CSTCCXLJRC201714]; National Natural Science Foundation of China [81572494]; Key Application and Development Program of the Chongqing Science and Technology Commission [cstc2014yykfC20004, cstc2014yykfC20002]; Natural Science Foundation of Guangdong Province [2015A030313440]; Hundred Talents Program of the Chinese Academy of Sciences	Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Application and Development Program of the Chongqing Science and Technology Commission; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing (CSTCCXLJRC201714 to D.-S.P.), the National Natural Science Foundation of China (81572494 to X.-J.Y.), the Key Application and Development Program of the Chongqing Science and Technology Commission (cstc2014yykfC20004 and cstc2014yykfC20002 to D.-S.P.), the Natural Science Foundation of Guangdong Province (2015A030313440 to X.-J.Y.), and the Hundred Talents Program of the Chinese Academy of Sciences (to D.-S.P.). The authors declare no conflicts of interest.	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bibikova M, 2002, GENETICS, V161, P1169; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Daniels RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100637; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grunwald DJ, 2013, NAT METHODS, V10, P303, DOI 10.1038/nmeth.2415; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Liu ZB, 2012, BIOCHEM BIOPH RES CO, V427, P223, DOI 10.1016/j.bbrc.2012.09.064; Lorens JB, 2004, J BIOCHEM BIOPH METH, V58, P101, DOI 10.1016/S0165-022X(03)00147-7; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nussleinvolhard C., 2001, ZEBRAFISH PRACTICAL, V18; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Thisse B, 2014, METHODS MOL BIOL, V1211, P53, DOI 10.1007/978-1-4939-1459-3_5; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JW, 2015, BIOTECHNIQUES, V58, P161, DOI 10.2144/000114261; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	50	16	17	0	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5132	5142		10.1096/fj.201800077RR	http://dx.doi.org/10.1096/fj.201800077RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29812974				2022-12-26	WOS:000443817700041
J	Laursen, KB; Gudas, LJ				Laursen, Kristian B.; Gudas, Lorraine J.			Combinatorial knockout of RAR alpha, RAR beta, and RAR gamma completely abrogates transcriptional responses to retinoic acid in murine embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATIVE GENOMICS VIEWER; ORPHAN NUCLEAR RECEPTOR; INDUCED GROWTH ARREST; F9 CELLS; INDUCED DIFFERENTIATION; CARCINOMA-CELLS; TARGETED DISRUPTION; EPIGENETIC CHANGES; GENE; EXPRESSION	All-trans-retinoic acid (RA), a potent inducer of cellular differentiation, functions as a ligand for retinoic acid receptors (RAR alpha, beta and gamma). RARs are activated by ligand binding, which induces transcription of direct genomic targets. However, whether embryonic stem cells respond to RA through routes that do not involve RARs is unknown. Here, we used CRISPR technology to introduce biallelic frameshift mutations in RAR alpha, RAR beta, and RAR gamma, thereby abrogating all RAR functions in murine embryonic stem cells. We then evaluated RA-responsiveness of the RAR-null cells using RNA-Seq transcriptome analysis. We found that the RAR-null cells display no changes in transcripts in response to RA, demonstrating that the RARs are essential for the regulation of all transcripts in murine embryonic stem cells in response to RA. Our key finding, that in embryonic stem cells the transcriptional effects of RA all depend on RARs, addresses a long-standing topic of discussion in the field of retinoic acid signaling.	[Laursen, Kristian B.; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.; Gudas, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	ljgudas@med.cornell.edu			National Institutes of Health [R01CA043796, R01DE10389]; Weill Cornell funds; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants R01CA043796 and R01DE10389 (to L. J. G.) and by Weill Cornell funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bastien J, 2006, ONCOGENE, V25, P2040, DOI 10.1038/sj.onc.1209241; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; CAMPOCHIARO PA, 1991, INVEST OPHTH VIS SCI, V32, P65; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drumea K, 2008, CURR OPIN HEMATOL, V15, P37, DOI 10.1097/MOH.0b013e3282f20a9c; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Han YH, 2009, J BIOL CHEM, V284, P18503, DOI 10.1074/jbc.M109.007708; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968; Laursen KB, 2013, NUCLEIC ACIDS RES, V41, P6430, DOI 10.1093/nar/gkt367; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Lee GS, 2004, CURR PHARM DESIGN, V10, P2657, DOI 10.2174/1381612043383728; Leung AYH, 2005, EXP HEMATOL, V33, P422, DOI 10.1016/j.exphem.2004.12.007; Li R, 2004, EXP CELL RES, V294, P290, DOI 10.1016/j.yexcr.2003.11.014; Marinelli A, 2009, LEUKEMIA, V23, P417, DOI 10.1038/leu.2008.205; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Mark M, 2004, CURR OPIN GENET DEV, V14, P591, DOI 10.1016/j.gde.2004.07.012; Martinez-Ceballos E, 2008, J NEUROSCI RES, V86, P2809, DOI 10.1002/jnr.21729; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matsuo T, 1998, ONCOGENE, V16, P3337, DOI 10.1038/sj.onc.1201830; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Phillips BW, 2003, PHARMACOL RES, V47, P263, DOI 10.1016/S1043-6618(03)00035-5; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricard MJ, 2013, J BIOL CHEM, V288, P28801, DOI 10.1074/jbc.M113.474254; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva C, 2009, MOL REPROD DEV, V76, P11, DOI 10.1002/mrd.20925; Snyder JM, 2005, PEDIATR RES, V57, P384, DOI 10.1203/01.PDR.0000151315.81106.D3; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stehlin-Gaon C, 2003, NAT STRUCT BIOL, V10, P820, DOI 10.1038/nsb979; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tighe AP, 2004, J CELL PHYSIOL, V198, P223, DOI 10.1002/jcp.10424; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Urvalek A, 2014, SUBCELL BIOCHEM, V70, P129, DOI 10.1007/978-94-017-9050-5_7; Urvalek AM, 2014, J BIOL CHEM, V289, P19519, DOI 10.1074/jbc.M114.556555; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wightman J, 2002, MOL CANCER THER, V1, P493; YANGYEN HF, 1991, NEW BIOL, V3, P1206	64	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11891	11900		10.1074/jbc.RA118.001951	http://dx.doi.org/10.1074/jbc.RA118.001951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29848550	Green Published, hybrid			2022-12-26	WOS:000440134500021
J	Stelcer, E; Kulcenty, K; Rucinski, M; Jopek, K; Richter, M; Trzeciak, T; Suchorska, WM				Stelcer, Ewelina; Kulcenty, Katarzyna; Rucinski, Marcin; Jopek, Karol; Richter, Magdalena; Trzeciak, Tomasz; Suchorska, Wiktoria Maria			Forced differentiation in vitro leads to stress-induced activation of DNA damage response in hiPSC-derived chondrocyte-like cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; ADRENAL-CORTEX; P53; GENERATION; CARTILAGE	A human induced pluripotent stem cell line (GPCCi001-A) created by our group was differentiated towards chondrocyte-like cells (ChiPS) via monolayer culturing with growth factors. ChiPS are promising because they have the potential to be used in tissue engineering to regenerate articular cartilage. However, their safety must be confirmed before they can be routinely used in regenerative medicine. Using microarray analysis, we compared the ChiPS to both GPCCi001-A cells and chondrocytes. The analysis showed that, compared to both GPCCi001-A cells and chondrocytes, the expression of genes engaged in DNA damage and in the tumor protein p53 signalling pathways was significantly higher in the ChiPS. The significant amount of DNA double strand breaks and increased DNA damage response may lead to incomplete DNA repair and the accumulation of mutations and, ultimately, to genetic instability. These findings provide evidence indicating that the differentiation process in vitro places stress on human induced pluripotent stem cells (hiPSCs). The results of this study raise doubts about the use of stem cell-derived components given the negative effects of the differentiation process in vitro on hiPSCs.	[Stelcer, Ewelina; Kulcenty, Katarzyna; Suchorska, Wiktoria Maria] Greater Poland Canc Ctr, Radiobiol Lab, Poznan, Poland; [Stelcer, Ewelina] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Stelcer, Ewelina; Kulcenty, Katarzyna; Suchorska, Wiktoria Maria] Poznan Univ Med Sci, Dept Electroradiol, Poznan, Poland; [Rucinski, Marcin; Jopek, Karol] Poznan Univ Med Sci, Dept Histol & Embryol, Poznan, Poland; [Richter, Magdalena; Trzeciak, Tomasz] Poznan Univ Med Sci, Dept Orthoped & Traumatol, Poznan, Poland	Wielkopolskie Centrum Onkologii; Medical University of Warsaw; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Stelcer, E (corresponding author), Greater Poland Canc Ctr, Radiobiol Lab, Poznan, Poland.; Stelcer, E (corresponding author), Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland.; Stelcer, E (corresponding author), Poznan Univ Med Sci, Dept Electroradiol, Poznan, Poland.	ewelina.stelcer@wco.pl	Suchorska, Wiktoria/CAG-0479-2022	Kulcenty, Katarzyna/0000-0001-8400-249X; Suchorska, Wiktoria/0000-0003-4742-2465; Rucinski, Marcin/0000-0002-2525-5777	National Science Centre [2012/07/E/NZ3/01819, 2016/23/N/NZ7/01892]; Greater Poland Cancer Centre [13/2017(156)]	National Science Centre(National Science Centre, Poland); Greater Poland Cancer Centre	The present study was supported by the National Science Centre (grant no. 2012/07/E/NZ3/01819) (recipient: WMS) and 2016/23/N/NZ7/01892) (recipient: ES) and Greater Poland Cancer Centre (grant no. 13/2017(156)) (recipient: ES).	Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; Baghbaderani BA, 2015, STEM CELL REP, V5, P647, DOI 10.1016/j.stemcr.2015.08.015; Durruthy-Durruthy J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094231; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; [Григорьева Ю.С. Grigoreva Yu. S.], 2013, [Российский физиологический журнал им. И.М. Сеченова, Neuroscience and Behavioral Physiology - Sechenov Physiology Journal, Rossiiskii fiziologicheskii zhurnal im. I.M. Sechenova], V99, P1160; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; He HB, 2016, STEM CELL REP, V7, P1087, DOI 10.1016/j.stemcr.2016.10.008; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077673; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jopek K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00026; Lach MS, 2017, STEM CELL RES, V20, P34, DOI 10.1016/j.scr.2017.02.004; Laptenko O, 2017, GENE DEV, V31, P955, DOI 10.1101/gad.302364.117; Lee HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163072; Lee J, 2015, FASEB J, V29, P3399, DOI 10.1096/fj.14-269720; Lin TX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0498-1; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Mandal PK, 2012, CELL, V148, P847, DOI 10.1016/j.cell.2012.02.011; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nejadnik H, 2015, STEM CELL REV REP, V11, P242, DOI 10.1007/s12015-014-9581-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Suchorska WM, 2017, STEM CELL REV REP, V13, P299, DOI 10.1007/s12015-016-9708-y; Svendsen CN, 2013, HUM MOL GENET, V22, pR32, DOI 10.1093/hmg/ddt379; Tani K, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.32; Trejter M, 2015, FOLIA HISTOCHEM CYTO, V53, P133, DOI 10.5603/FHC.a2015.0012; Trejter M, 2015, PEPTIDES, V63, P22, DOI 10.1016/j.peptides.2014.10.017; Trejter M, 2015, INT J MOL MED, V35, P702, DOI 10.3892/ijmm.2015.2064; Trzeciak T, 2016, INT ORTHOP, V40, P615, DOI 10.1007/s00264-015-3099-6; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0206-y; Yamashita A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01978	37	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198079	10.1371/journal.pone.0198079	http://dx.doi.org/10.1371/journal.pone.0198079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864138	gold, Green Published, Green Submitted			2022-12-26	WOS:000434097100019
J	Bartlett, HL; Lawson, BE; Goldfarb, M				Bartlett, Harrison L.; Lawson, Brian E.; Goldfarb, Michael			On the design of power gear trains: Insight regarding number of stages and their respective ratios	PLOS ONE			English	Article							OPTIMIZATION	This paper presents a formulation for selecting the stage ratios and number of stages in a multistage transmission with a given desired total transmission ratio in a manner that maximizes efficiency, maximizes acceleration, or minimizes the mass of the transmission. The formulation is used to highlight several implications for gear train design, including the fact that minimizing rotational inertia and mass are competing objectives with respect to optimal selection of stage ratios, and that both rotational inertia and mass can often be minimized by increasing the total number of stages beyond a minimum realizable number. Additionally, a multistage transmission will generally provide maximum acceleration when the stage ratios increase monotonically from the motor to the load. The transmission will have minimum mass when the stage ratios decrease monotonically. The transmission will also provide maximum efficiency when the corresponding stages employ constant stage ratios. This paper aims to use this optimization formulation to elucidate tradeoffs between various common objectives in gear train design (efficiency, acceleration, and mass).	[Bartlett, Harrison L.; Lawson, Brian E.; Goldfarb, Michael] Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA	Vanderbilt University	Bartlett, HL (corresponding author), Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA.	Harrison.l.bartlett@vanderbilt.edu			National Science Foundation Graduate Research Fellowship Program [1445197]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant Number 1445197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK T, 1979, PROD ENG, V50, P31; Burgess E, 1954, T ASME, V76, P493; Chong TH, 2002, MECH MACH THEORY, V37, P295, DOI 10.1016/S0094-114X(01)00078-7; Deb K, 1997, OPTIMIZING ENG DESIG; Freudenstein FaM M, 1982, ASME COMPUTERS ENG, P199; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P327, DOI 10.1016/j.cnsns.2012.07.017; Gibson JE, 1958, CONTROL SYSTEM COMPO; Golabi S, 2014, MECH MACH THEORY, V73, P197, DOI 10.1016/j.mechmachtheory.2013.11.002; Gologlu C, 2009, COMPUT IND ENG, V57, P1043, DOI 10.1016/j.cie.2009.04.006; Huang HZ, 2005, J MECH SCI TECHNOL, V19, P1080, DOI 10.1007/BF02984029; Kron M., 321256 JPL, VXV, P102; Peterson DP, 1954, MACH DES, V26, P161; Pettersson M, 2009, IEEE T ROBOT, V25, P1419, DOI 10.1109/TRO.2009.2028764; PRAYOONRAT S, 1988, COMPUT AIDED DESIGN, V20, P83, DOI 10.1016/0010-4485(88)90053-X; Roos F., 2007, METHODOLOGY INTEGRAT; Rosic B., 2001, FACTA U SERIES MECH, V1, P1107; Savsani V, 2010, MECH MACH THEORY, V45, P531, DOI 10.1016/j.mechmachtheory.2009.10.010; SELFRIDGE RG, 1980, MECH MACH THEORY, V15, P287, DOI 10.1016/0094-114X(80)90022-1; Shigley JE, 1986, STANDARD HDB MACHINE; Stetanovic-Marinovic J, 2011, T FAMENA, V35; Swantner A, 2012, ENG OPTIMIZ, V44, P1351, DOI 10.1080/0305215X.2011.646264; Tang XL, 2018, IEEE T VEH TECHNOL, V67, P1990, DOI 10.1109/TVT.2017.2769084; Tang XL, 2017, MECH SYST SIGNAL PR, V85, P329, DOI 10.1016/j.ymssp.2016.08.020; Thompson DF, 2000, MECH MACH THEORY, V35, P609, DOI 10.1016/S0094-114X(99)00036-1; Velex P, 2009, J MECH DESIGN, V131, DOI 10.1115/1.3179156; WANG HL, 1994, MECH MACH THEORY, V29, P1071, DOI 10.1016/0094-114X(94)90074-4; Yokota T, 1998, COMPUT IND ENG, V35, P523, DOI 10.1016/S0360-8352(98)00149-1	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198048	10.1371/journal.pone.0198048	http://dx.doi.org/10.1371/journal.pone.0198048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856863	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800064
J	Kuper, H; Mactaggart, I; White, S; Dionicio, C; Canas, R; Naber, J; Polack, S; Biran, A				Kuper, Hannah; Mactaggart, Islay; White, Sian; Dionicio, Carlos; Canas, Rafael; Naber, Jonathan; Polack, Sarah; Biran, Adam			Exploring the links between water, sanitation and hygiene and disability; Results from a case-control study in Guatemala	PLOS ONE			English	Article							RAPID ASSESSMENT; ACCESS; PREVALENCE; COUNTRIES; HEALTH; ISSUES	Objective To assess the Water, Sanitation and Hygiene (WASH) access and appropriateness of people with disabilities compared to those without, in Guatemala. Methods A case-control study was conducted, nested within a national survey. The study included 707 people with disabilities, and 465 age-and sex-matched controls without disabilities. Participants reported on WASH access at the household and individual level. A sub-set of 121 cases and 104 controls completed a newly designed, in-depth WASH questionnaire. Results Households including people with disabilities were more likely to use an improved sanitation facility compared to control households (age-sex-adjusted OR: 1.7, 95% CI 1.3 - 2.5), but otherwise there were no differences in WASH access at the household level. At the individual level, people with disabilities reported greater difficulties in relation to sanitation (mean score 26.2, SD 26.5) and hygiene access and quality (mean 30.7, SD 24.2) compared to those without disabilities (15.5, 21.7, p<0.001; 22.4, 19.1, p<0.01). There were no differences in different aspects of water collection between people with and without disabilities in this context where over 85% of participants had water piped into their dwelling. Among people with disabilities, older adults were more likely to experience difficulties in hygiene and sanitation than younger people with disabilities. Conclusions People with disabilities in Guatemala experience greater difficulties in accessing sanitation facilities and practicing hygienic behaviours than their peers without disabilities. More data collection is needed using detailed tools to detect these differences, highlight which interventions are needed, and to allow assessment of their effectiveness.	[Kuper, Hannah; Mactaggart, Islay; Polack, Sarah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England; [White, Sian; Biran, Adam] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Dionicio, Carlos; Canas, Rafael; Naber, Jonathan] Natl Council Disabil, Guatemala City, Guatemala	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Kuper, H (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.	Hannah.kuper@lshtm.ac.uk	Dionicio, Carlos/AAP-6979-2021	Mactaggart, Islay/0000-0001-6287-0384	CBM Latin America; CONADI (the National Council on Disability), Guatemala; Christoffel Blinden Mission; Australian Aid (Australian Government Department of Foreign Affairs and Trade) through the Australian Development Research Awards Scheme	CBM Latin America; CONADI (the National Council on Disability), Guatemala; Christoffel Blinden Mission; Australian Aid (Australian Government Department of Foreign Affairs and Trade) through the Australian Development Research Awards Scheme	This research has been funded by CBM Latin America and CONADI (the National Council on Disability), Guatemala and the Christoffel Blinden Mission to Sarah Polack. Additional funds for the WASH component of the study were obtained through Australian Aid (Australian Government Department of Foreign Affairs and Trade) through the Australian Development Research Awards Scheme under an award entitled 'Disability and its impact on safe hygiene and sanitation' to Adam Biran. The views expressed in this publication are those of the authors and not necessarily those of the Commonwealth of Australia. The Commonwealth of Australia accepts no responsibility for any loss, damage or injury resulting from reliance on any of the information or views contained in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks LM, 2014, EC COSTS EXCLUSION G; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Bernabe-Ortiz A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011300; Biran A, 2018, AM J TROP MED HYG, V98, P984, DOI 10.4269/ajtmh.17-0435; Danquah L, 2015, DISABIL REHABIL, V37, P1082, DOI 10.3109/09638288.2014.956186; Erhard L, 2013, GLOB PUBLIC HEALTH, V8, P1000, DOI 10.1080/17441692.2013.838284; Groce N, 2011, J WATER HEALTH, V9, P617, DOI 10.2166/wh.2011.198; Hulland KRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141883; International Centre for Evidence in Disability, 2017, GUAT NAT DIS STUD EN; International Federation of Red Cross and Red Crescent Societies, 2013, SOC ASS TOOL WAT SAN; Kuper H, OXFORD DEV STUDIES; Kuper H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144926; MacLeod M, 2014, J WATER HEALTH, V12, P885, DOI 10.2166/wh.2014.009; Mactaggart I, BMJ OPEN; Marella M, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0096-y; Marella M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2202-7; Ministerio de Salud Publica y Asistencia Social Instituto Nacional de Estadistica, 2015, ENC NAC SAL MAT INF; Plan International, 2013, INCL US STUD DIS PLA; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Trani JF, 2011, SOC SCI MED, V73, P1477, DOI 10.1016/j.socscimed.2011.08.040; UNICEF and WHO, 2017, PROGR SAN DRINK WAT; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; Washington Group, QUEST SETS WASH GROU; White S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155043; WHO, 2011, WORLD REPORT ON DISABILITY, P1	25	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197360	10.1371/journal.pone.0197360	http://dx.doi.org/10.1371/journal.pone.0197360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856770	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800021
J	Lee, SA; Noel, S; Sadasivam, M; Allaf, ME; Pierorazio, PM; Hamad, ARA; Rabb, H				Lee, Sul A.; Noel, Sanjeev; Sadasivam, Mohanraj; Allaf, Mohamad E.; Pierorazio, Phillip M.; Hamad, Abdel R. A.; Rabb, Hamid			Characterization of kidney CD45(int)CD11b(int)F4/80(+)MHCII(+)CX3CR1(+)Ly6C(-) "intermediate mononuclear phagocytic cells"	PLOS ONE			English	Article							DENDRITIC CELLS; MACROPHAGES; INJURY; IDENTIFICATION	Kidney immune cells play important roles in pathogenesis of many diseases, including ischemia-reperfusion injury (IRI) and transplant rejection. While studying murine kidney T cells, we serendipitously identified a kidney mononuclear phagocytic cell (MPC) subset characterized by intermediate surface expression of CD45 and CD11b. These CD45(int)CD11b(int) MPCs were further identified as F4/80(+)MHCII(+)CX3CR1(+)Ly6C(-) cells, comprising similar to 17% of total CD45(+) cells in normal mouse kidney(P<0.01) and virtually absent from all other organs examined except the heart. Systemic clodronate treatment had more significant depletive effect on the CD45(int)CD11 b(int) population (77.3%+/- 5.9%, P= 0.03) than on CD45(high)CD11b(+) population (14.8% +/- 16.6%, P = 0.49). In addition, CD45(int)CD11b(int) MPCs had higher phagocytic function in the normal kidney (35.6%+/- 3.3% vs. 24.1%+/- 2.2%, P= 0.04), but lower phagocytic capacity in post-ischemic kidney (54.9%+/- 1.0% vs. 67.8%+/- 1.9%, P< 0.01) compared to the CD45(high)CD11b(+) population. Moreover, the CD45(int)CD11b(int) population had higher intracellular production of the pro-inflammatory tumor necrosis factor (TNF)-alpha (58.4% +/- 5.2% vs. 27.3%+/- 0.9%, P < 0.001) after lipopolysaccharide (LPS) stimulation and lower production of the anti-inflammatory interleukin (IL) -10 (7.2%+/- 1.3% vs. 14.9%+/- 2.2%, P=0.02) following kidney IRI, suggesting a functional role under inflammatory conditions. The CD45(int)CD11b(int) cells increased early after IRI, and then abruptly decreased 48h later, whereas CD45(high)CD11b(+) cells steadily increased after IRI before declining at 72h (P= 0.03). We also identified the CD45(int)CD11b(int) MPC subtype in human kidney. We conclude that CD45(int)CD11b(int) F4/80(+)MHCII(+)CX3CR1(+)Ly6C(-)population represent a unique subset of MPCs found in both mouse and human kidneys. Future studies will further characterize their role in kidney health and disease.	[Lee, Sul A.; Noel, Sanjeev; Rabb, Hamid] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Lee, Sul A.] Yonsei Univ, Coll Med, Seoul, South Korea; [Sadasivam, Mohanraj; Hamad, Abdel R. A.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Allaf, Mohamad E.; Pierorazio, Phillip M.] Johns Hopkins Univ, Dept Urol, Baltimore, MD USA	Johns Hopkins University; Yonsei University; Yonsei University Health System; Johns Hopkins University; Johns Hopkins University	Rabb, H (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	hrabb1@jhmi.edu	Pierorazio, Phillip/DRJ-7483-2022; Sadasivam, Mohanraj/CAE-9353-2022	Pierorazio, Phillip/0000-0003-0766-9981; Sadasivam, Mohanraj/0000-0002-3132-2948; Lee, Sul A/0000-0003-2121-721X	National Institutes of Health [R01-DK111209, R01-DK104662]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111209, R01DK104662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (Grant R01-DK111209 and R01-DK104662).; This work was supported by the National Institutes of Health (Grant R01-DK111209 and R01-DK104662) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1996, J IMMUNOL METHODS, V194, P211, DOI 10.1016/0022-1759(96)00038-5; Amend SR, 2016, MURINE HIND LIMB LON, DOI [10.3791/53936, DOI 10.3791/53936]; Autengruber A, 2012, EUR J MICROBIOL IMMU, V2, P112, DOI 10.1556/EuJMI.2.2012.2.3; Bonavia A, 2018, PEDIATR NEPHROL, V33, P1629, DOI 10.1007/s00467-017-3774-5; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bryder D, 2006, AM J PATHOL, V169, P1899, DOI 10.2353/ajpath.2006.060864; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Chiba Takuto, 2015, Curr Pathobiol Rep, V3, P67; Couter CJ, 2016, ISOLATION FLOW CYTOM, DOI [10.3791/54114, DOI 10.3791/54114]; Dong XY, 2005, KIDNEY INT, V68, P1096, DOI 10.1111/j.1523-1755.2005.00502.x; Geem D, 2012, JOVE-J VIS EXP, DOI 10.3791/4040; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gottschalk C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00435; Gratz IK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00333; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huen SC, 2017, ANNU REV PHYSIOL, V79, P449, DOI 10.1146/annurev-physiol-022516-034219; Iwasaki S, 2011, CYTOM PART A, V79A, P46, DOI 10.1002/cyto.a.20984; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Kawakami T, 2013, J IMMUNOL, V191, P3358, DOI 10.4049/jimmunol.1300342; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Lever JM, 2018, LAB INVEST, V98, P391, DOI 10.1038/labinvest.2017.130; Li L, 2010, SEMIN NEPHROL, V30, P268, DOI 10.1016/j.semnephrol.2010.03.005; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Martina MN, 2014, JOVE-J VIS EXP, DOI 10.3791/51192; Monica J., 2005, INFLAMMATORY DISORDE; Rabb H, 1996, AM J PHYSIOL-RENAL, V271, pF408, DOI 10.1152/ajprenal.1996.271.2.F408; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Stamatiades EG, 2016, CELL, V166, P991, DOI 10.1016/j.cell.2016.06.058; Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Weisheit CK, 2015, CLIN J AM SOC NEPHRO, V10, P1841, DOI 10.2215/CJN.07100714; Williams TM, 2014, CYTOM PART A, V85, P256, DOI 10.1002/cyto.a.22420; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01	39	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198608	10.1371/journal.pone.0198608	http://dx.doi.org/10.1371/journal.pone.0198608			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856833	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800141
J	Ebbensgaard, A; Mordhorst, H; Overgaard, MT; Aarestrup, FM; Hansen, EB				Ebbensgaard, Anna; Mordhorst, Hanne; Overgaard, Michael Toft; Aarestrup, Frank Moller; Hansen, Egon Bech			Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; ANTIBACTERIAL ACTIVITY; PROLINE RESIDUES; RAINBOW-TROUT; PEPTIDE; RESISTANCE; HINGE	Due to the rapid emergence of resistance to classical antibiotics, novel antimicrobial compounds are needed. It is desirable to selectively kill pathogenic bacteria without targeting other beneficial bacteria in order to prevent the negative clinical consequences caused by many broad-spectrum antibiotics as well as reducing the development of antibiotic resistance. Antimicrobial peptides (AMPs) represent an alternative to classical antibiotics and it has been previously demonstrated that Cap18 has high antimicrobial activity against a broad range of bacterial species. In this study we report the design of a positional scanning library consisting of 696 Cap18 derivatives and the subsequent screening for antimicrobial activity against Y. ruckeri, A. salmonicida, S. Typhimurium and L. lactis as well as for hemolytic activity measuring the hemoglobin release of horse erythrocytes. We show that the hydrophobic face of Cap18, in particular I13, L17 and I24, is essential for its antimicrobial activity against S. Typhimurium, Y. ruckeri, A. salmonicida, E. coli, P. aeruginosa, L. lactis, L. monocytogenes and E. faecalis. In particular, Cap18 derivatives harboring a I13D, L17D, L17P, I24D or I24N substitution lost their antimicrobial activity against any of the tested bacterial strains. In addition, we were able to generate species-specific Cap18 derivatives by particular amino acid substitutions either in the hydrophobic face at positions L6, L17, I20, and I27, or in the hydrophilic face at positions K16 and K18. Finally, our data showed the proline residue at position 29 to be essential for the inherent low hemolytic activity of Cap18 and that substitution of the residues K16, K23, or G21 by any hydrophobic residues enhances the hemolytic activity. This study demonstrates the potential of generating species-specific AMPs for the selective elimination of bacterial pathogens.	[Ebbensgaard, Anna; Mordhorst, Hanne; Aarestrup, Frank Moller; Hansen, Egon Bech] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Ebbensgaard, Anna] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Overgaard, Michael Toft] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark	Technical University of Denmark; University of Copenhagen; Aalborg University	Hansen, EB (corresponding author), Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark.	egbh@food.dtu.dk	Hansen, Egon Bech/AGQ-4772-2022; Ebbensgaard, Anna/AAH-2582-2019; Overgaard, Michael Toft/E-1354-2011	Hansen, Egon Bech/0000-0002-3795-6706; Overgaard, Michael Toft/0000-0002-1423-2481; Ebbensgaard, Anna Elisabeth/0000-0003-2557-4679; Aarestrup, Frank/0000-0002-7116-2723	Danish Ministry of Food, Agriculture and Fisheries [3405-10-0124]; Innovation Fund Denmark [7045-00021B]	Danish Ministry of Food, Agriculture and Fisheries; Innovation Fund Denmark	This work was supported by Danish Ministry of Food, Agriculture and Fisheries programme supporting Green Development and Demonstration (GUDP grant nr.: 3405-10-0124) (http://mst.dk/erhverv/groen-virksomhed/groent-udviklings-og-demonstrationsprogram-gudp/). This work was also supported by Innovation Fund Denmark (https://innovationsfonden.dk/en), grant number 7045-00021B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREU D, 1985, BIOCHEMISTRY-US, V24, P1683, DOI 10.1021/bi00328a017; [Anonymous], 2009, METHODS DILUTION ANT; Ashby M, 2017, CURR TOP MED CHEM, V17, P537, DOI 10.2174/1568026616666160713125555; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chettri JK, 2017, J FISH DIS, V40, P97, DOI 10.1111/jfd.12497; DEMPSEY CE, 1991, FEBS LETT, V281, P240, DOI 10.1016/0014-5793(91)80402-O; Ebbensgaard A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144611; Ebenhan T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/867381; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Goff DA, 2011, CURR OPIN INFECT DIS, V24, pS11, DOI 10.1097/01.qco.0000393484.17894.05; Gould IM, 2010, INT J ANTIMICROB AG, V36, pS1, DOI 10.1016/S0924-8579(10)00497-8; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Huang Y, 2014, PROTEIN CELL, V5, P194, DOI 10.1007/s13238-014-0028-1; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067597; Lim SS, 2004, PROTEIN PEPTIDE LETT, V11, P35, DOI 10.2174/0929866043478383; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Rashid MU, 2012, ANAEROBE, V18, P249, DOI 10.1016/j.anaerobe.2011.11.005; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shin SY, 2001, J PEPT RES, V58, P504, DOI 10.1034/j.1399-3011.2001.00934.x; Suh JY, 1999, EUR J BIOCHEM, V266, P665, DOI 10.1046/j.1432-1327.1999.00917.x; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Tamma PD, 2011, INFECT DIS CLIN N AM, V25, P245, DOI 10.1016/j.idc.2010.11.011; Thennarasu S, 1996, PROTEIN ENG, V9, P1219, DOI 10.1093/protein/9.12.1219; Vermeer LS, 2012, J BIOL CHEM, V287, P34120, DOI 10.1074/jbc.M112.359067; Wren SM, 2005, ARCH SURG-CHICAGO, V140, P752, DOI 10.1001/archsurg.140.8.752; Wulff G, 2006, APPL ENVIRON MICROB, V72, P4313, DOI 10.1128/AEM.02288-05; Yang ST, 2006, BIOCHEMISTRY-US, V45, P1775, DOI 10.1021/bi051524k; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	46	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197742	10.1371/journal.pone.0197742	http://dx.doi.org/10.1371/journal.pone.0197742			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852015	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200020
J	Winans, GA; Allen, MB; Baker, J; Lesko, E; Shrier, F; Strobel, B; Myers, J				Winans, Gary A.; Allen, M. Brady; Baker, Jon; Lesko, Erik; Shrier, Frank; Strobel, Burke; Myers, Jim			Dam trout: Genetic variability in Oncorhynchus mykiss above and below barriers in three Columbia River systems prior to restoring migrational access	PLOS ONE			English	Article							SCALE POPULATION-STRUCTURE; RAINBOW-TROUT; LIFE-HISTORY; HABITAT FRAGMENTATION; CUTTHROAT TROUT; STEELHEAD; RECOLONIZATION; LANDSCAPE; RESIDENT; REMOVAL	Restoration of access to lost habitat for threatened and endangered fishes above currently impassable dams represents a major undertaking. Biological monitoring is critical to understand the dynamics and success of anadromous recolonization as, in the case of Oncorhynchus mykiss, anadromous steelhead populations are reconnected with their conspecific resident rainbow trout counterparts. We evaluate three river systems in the Lower Columbia River basin: the White Salmon, Sandy, and Lewis rivers that are in the process of removing and/or providing passage around existing human-made barriers in O. mykiss riverine habitat. In these instances, now isolated resident rainbow trout populations will be exposed to competition and/or genetic introgression with steelhead and vice versa. Our genetic analyses of 2,158 fish using 13 DNA microsatellite (mSAT) loci indicated that within each basin anadromous O. mykiss were genetically distinct from and significantly more diverse than their resident above-dam trout counterparts. Above long-standing natural impassable barriers, each of these watersheds also harbors unique rainbow trout gene pools with reduced levels of genetic diversity. Despite frequent releases of non-native steelhead and rainbow trout in each river, hatchery releases do not appear to have had a significant genetic effect on the population structure of O. mykiss in any of these watersheds. Simulation results suggest there is a high likelihood of identifying anadromous x resident individuals in the Lewis and White Salmon rivers, and slightly less so in the Sandy River. These genetic data are a prerequisite for informed monitoring, managing, and conserving the different life history forms during upstream recolonization when sympatry of life history forms of O. mykiss is restored.	[Winans, Gary A.; Myers, Jim] NOAA, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98112 USA; [Allen, M. Brady] Bonneville Power Adm, Portland, OR USA; [Baker, Jon] Mariner High Sch, Everett, WA USA; [Lesko, Erik; Shrier, Frank] PacifiCorp, Portland, OR USA; [Strobel, Burke] Portland Water Bur, Portland, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA	Winans, GA (corresponding author), NOAA, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98112 USA.	gary.winans@noaa.gov			Portland General Electric [NWC-391]; PacifiCorp [30000-31376]; general NOAA funding; PacifiCorp	Portland General Electric(General Electric); PacifiCorp; general NOAA funding(General Electric); PacifiCorp	Funding was received from Portland General Electric NWC-391, from PacifiCorp 30000-31376, and from general NOAA funding (to GAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Erik Lesko and Frank Shrier are employed by PacifiCorp. PacifiCorp provided support in the form of salaries for authors EL and FS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abadia-Cardoso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141775; Allen MB, 2016, FISHERIES, V41, P190, DOI 10.1080/03632415.2016.1150839; Andrews TC, 2016, N AM J FISH MANAGE, V36, P926, DOI 10.1080/02755947.2016.1165774; [Anonymous], 2005, NMFS NWFSC 66; [Anonymous], 1996, 5000 CNRS UMR; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Baker J, 2002, T AM FISH SOC, V131, P404, DOI 10.1577/1548-8659(2002)131&lt;0404:MMDCCT&gt;2.0.CO;2; Behnke RJ, 2002, TROUT SALMON N AM; Berejikian BA, 2017, CAN J FISH AQUAT SCI, V74, P273, DOI 10.1139/cjfas-2016-0175; Blankenship SM, 2011, T AM FISH SOC, V140, P665, DOI 10.1080/00028487.2011.584487; Busby PJ, 1996, NMFSNWFSC27 NOAA; Butler K, 2004, MOL ECOL, V13, P1589, DOI 10.1111/j.1365-294X.2004.02152.x; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Christie MR, 2011, MOL ECOL, V20, P1263, DOI 10.1111/j.1365-294X.2010.04994.x; Clemento AJ, 2008, CONSERVATION GENETIC; Coleman RA, 2018, HEREDITY, V120, P515, DOI 10.1038/s41437-017-0008-3; Courter II, 2013, CAN J FISH AQUAT SCI, V70, P701, DOI 10.1139/cjfas-2012-0457; Crawford B., 1979, ORIGIN HIST TROUT BR; Deiner K, 2007, CONSERV GENET, V8, P437, DOI 10.1007/s10592-006-9183-0; Doctor K, 2014, T AM FISH SOC, V143, P317, DOI 10.1080/00028487.2013.849617; Ford MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164801; Fuhrman AE, 2018, ECOL FRESHW FISH, V27, P350, DOI 10.1111/eff.12351; Gouskov A, 2016, EVOL APPL, V9, P394, DOI 10.1111/eva.12339; Hecht BC, 2015, G3-GENES GENOM GENET, V5, P873, DOI 10.1534/g3.114.016469; Howell P, 1985, STEELHEAD STOCK SUMM, VII; Huff DD, 2010, CONSERV GENET, V11, P2379, DOI 10.1007/s10592-010-0124-6; Jolley JC, 2018, RIVER RES APPL, V34, P44, DOI 10.1002/rra.3221; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Kazyak DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146295; Lahood ES, 2008, T AM FISH SOC, V137, P1104, DOI 10.1577/T07-181.1; Langella O., 2001, POPULATIONS 1 2 30 P; Leclerc E, 2008, MOL ECOL, V17, P1702, DOI 10.1111/j.1365-294X.2008.03710.x; Leitwein M, 2017, EVOL APPL, V10, P56, DOI 10.1111/eva.12416; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; Maher M.T, 2006, NMFSNWFSC73 NOAA; Martinez A, 2011, T AM FISH SOC, V140, P829, DOI 10.1080/00028487.2011.588094; Mattson CR, 1955, SANDY RIVER ITS ANAD; Morita K, 2001, FISHERIES SCI, V67, P179, DOI 10.1046/j.1444-2906.2001.00218.x; Narum SR, 2008, CAN J FISH AQUAT SCI, V65, P1013, DOI 10.1139/F08-025; Narum SR, 2004, J FISH BIOL, V65, P471, DOI 10.1111/j.0022-1112.2004.00461.x; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; ( Northwest Fisheries Science Center) NWFSC, 2015, STAT REV UPD PAC SAL; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; ODFW, 2013, HATCH GEN MAN PLAN S; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; PacifiCorp Cowlitz-PUD, 2004, LIC FIN TECHN STUD S; Pearse DE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0012; Phillis CC, 2016, J HERED, V107, P51, DOI 10.1093/jhered/esv085; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Riva-Rossi C, 2007, J FISH BIOL, V70, P1780, DOI 10.1111/j.1095-8649.2007.01449.x; Satterthwaite WH, 2009, T AM FISH SOC, V138, P532, DOI 10.1577/T08-164.1; Shrier FC, 2009, LEWIS RIVER UPSTREAM; Small MP, 2007, T AM FISH SOC, V136, P301, DOI 10.1577/T06-037.1; Smith BR, 2001, GENETICS, V158, P1329; Stephenson JJ, 2009, CONSERV GENET, V10, P1145, DOI 10.1007/s10592-008-9729-4; Sterling KA, 2012, CONSERV GENET, V13, P859, DOI 10.1007/s10592-012-0335-0; Tamkee P, 2010, CAN J FISH AQUAT SCI, V67, P919, DOI 10.1139/F10-034; Thrower FP, 2009, CONSERV GENET, V10, P1299, DOI 10.1007/s10592-008-9709-8; Van Doornik DM, 2015, T AM FISH SOC, V144, P150, DOI 10.1080/00028487.2014.982178; Van Doornik DM, 2015, ENVIRON BIOL FISH, V98, P637, DOI 10.1007/s10641-014-0301-4; Van Doornik DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079931; Van Leeuwen CHA, 2018, RIVER RES APPL, V34, P60, DOI 10.1002/rra.3226; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Warheit KI, 2014, MEASURING REPRODUCTI; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams JG, 2005, EFFECTS FEDERAL COLU, P150; Winans G. A., 2014, CONSERV GENET, V16, P301; Winans GA, 2008, NORTHWEST SCI, V82, P128, DOI 10.3955/0029-344X-82.S.I.128; Winans GA, 2017, T AM FISH SOC, V146, P160, DOI 10.1080/00028487.2016.1249293; Winans GA, 2010, N AM J FISH MANAGE, V30, P742, DOI 10.1577/M09-119.1; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Wood JLA, 2015, EVOLUTION, V69, P2303, DOI 10.1111/evo.12733; Wood JLA, 2015, ECOLOGY, V96, P1010, DOI 10.1890/14-1378.1; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zimmerman CE, 2000, CAN J FISH AQUAT SCI, V57, P2152, DOI 10.1139/cjfas-57-10-2152	77	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197571	10.1371/journal.pone.0197571	http://dx.doi.org/10.1371/journal.pone.0197571			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851979	Green Submitted, gold, Green Published			2022-12-26	WOS:000433893200018
J	Macias-Hernandez, N; Athey, K; Tonzo, V; Wangensteen, OS; Arnedo, M; Harwood, JD				Macias-Hernandez, Nuria; Athey, Kacie; Tonzo, Vanina; Wangensteen, Owen S.; Arnedo, Miquel; Harwood, James D.			Molecular gut content analysis of different spider body parts	PLOS ONE			English	Article							DNA DETECTION SUCCESS; DETECTABILITY HALF-LIFE; PREY DNA; GENUS DYSDERA; WOLF SPIDER; PHYLOGENETIC UTILITY; GENERALIST PREDATORS; APHID PREDATION; CANARY-ISLANDS; DIET ANALYSIS	Molecular gut-content analysis has revolutionized the study of food webs and feeding interactions, allowing the detection of prey DNA within the gut of many organisms. However, successful prey detection is a challenging procedure in which many factors affect every step, starting from the DNA extraction process. Spiders are liquid feeders with branched gut diverticula extending into their legs and throughout the prosoma, thus digestion takes places in different parts of the body and simple gut dissection is not possible. In this study, we investigated differences in prey detectability in DNA extracts from different parts of the spider's body: legs, prosoma and opisthosoma, using prey-specific PCR and metabarcoding approaches. We performed feeding trials with the woodlouse hunter spider Dysdera verneaui Simon, 1883 (Dysderidae) to estimate the time at which prey DNA is detectable within the predator after feeding. Although we found that all parts of the spider body are suitable for gut-content analysis when using prey-specific PCR approach, results based on metabarcoding suggested the opisthosoma is optimal for detection of predation in spiders because it contained the highest concentration of prey DNA for longer post feeding periods. Other spiders may show different results compared to D. verneaui, but given similarities in the physiology and digestion in different families, it is reasonable to assume this to be common across species and this approach having broad utility across spiders.	[Macias-Hernandez, Nuria; Athey, Kacie] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Macias-Hernandez, Nuria; Tonzo, Vanina; Arnedo, Miquel] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain; [Macias-Hernandez, Nuria; Tonzo, Vanina; Arnedo, Miquel] Univ Barcelona, Biodivers Res Inst IRBio, Barcelona, Spain; [Wangensteen, Owen S.] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway; [Harwood, James D.] Qingdao Agr Univ, Coll Plant Hlth & Med, Qingdao, Shandong, Peoples R China; [Macias-Hernandez, Nuria] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	University of Kentucky; University of Barcelona; University of Barcelona; UiT The Arctic University of Tromso; Qingdao Agricultural University; University of Helsinki	Macias-Hernandez, N (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.; Macias-Hernandez, N (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain.; Macias-Hernandez, N (corresponding author), Univ Barcelona, Biodivers Res Inst IRBio, Barcelona, Spain.; Macias-Hernandez, N (corresponding author), Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland.	nemaciash@gmail.com	Tonzo, Vanina/AAA-3201-2021; Wangensteen, Owen S./E-3559-2018; Macias-Hernandez, Nuria/AAA-8965-2020; Arnedo, Miquel/E-9086-2011	Tonzo, Vanina/0000-0002-5062-1070; Wangensteen, Owen S./0000-0001-5593-348X; Macias-Hernandez, Nuria/0000-0003-4759-3619; Arnedo, Miquel/0000-0003-1402-4727; Harwood, James/0000-0002-0018-7288	Ministry of Education, Culture and Sports of Spain (MECD-FECYT) [EX-2010-0852]; Spanish Ministry of Economy and Competitivity [CGL2012-36863, CGL2016-80651-P]; Catalan Government (MA) [2014SGR1604]	Ministry of Education, Culture and Sports of Spain (MECD-FECYT); Spanish Ministry of Economy and Competitivity(Spanish Government); Catalan Government (MA)	NMH was supported by a postdoctoral fellowship EX-2010-0852 of the Ministry of Education, Culture and Sports of Spain (MECD-FECYT). Additional funds were provided by project CGL2012-36863, CGL2016-80651-P from the Spanish Ministry of Economy and Competitivity and 2014SGR1604 from the Catalan Government (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Arnedo MA, 2001, CLADISTICS, V17, P313, DOI 10.1111/j.1096-0031.2001.tb00129.x; Arnedo MA, 2007, INVERTEBR SYST, V21, P623, DOI 10.1071/IS07015; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Boyer S., 2015, FOOD WEBS, V3, P1, DOI DOI 10.1016/J.F00WEB.2015.02.001; Brown DS, 2012, MOL ECOL RESOUR, V12, P259, DOI 10.1111/j.1755-0998.2011.03098.x; Brueseke MA, 2001, AM MIDL NAT, V146, P153, DOI 10.1674/0003-0031(2001)146[0153:LAITWS]2.0.CO;2; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; CARPENTER JM, 1992, CLADISTICS, V8, P147, DOI 10.1111/j.1096-0031.1992.tb00059.x; Chapman EG, 2010, MOL ECOL RESOUR, V10, P1023, DOI 10.1111/j.1755-0998.2010.02857.x; Chen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011963; Clare EL, 2014, EVOL APPL, V7, P1144, DOI 10.1111/eva.12225; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; COHEN AC, 1995, ANNU REV ENTOMOL, V40, P85, DOI 10.1146/annurev.en.40.010195.000505; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deeleman-Reinhold C.L., 1988, Tijdschrift voor Entomologie, V131, P141; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eitzinger B, 2014, MOL ECOL, V23, P3767, DOI 10.1111/mec.12654; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2016, MOL ECOL RESOUR, V16, P604, DOI 10.1111/1755-0998.12508; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Foelix RF, 1996, BIOL SPIDERS; Furlong MJ, 2014, ENTOMOL EXP APPL, V153, P128, DOI 10.1111/eea.12231; Gagnon AE, 2011, MOL ECOL RESOUR, V11, P1022, DOI 10.1111/j.1755-0998.2011.03047.x; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Greenstone MH, 2014, J ECON ENTOMOL, V107, P947, DOI 10.1603/EC13356; Greenstone MH, 2014, MOL ECOL, V23, P3799, DOI 10.1111/mec.12552; Greenstone MH, 2010, ENTOMOL EXP APPL, V136, P97, DOI 10.1111/j.1570-7458.2010.01006.x; GREENSTONE MH, 1993, ENTOMOL EXP APPL, V68, P1, DOI 10.1007/BF02380575; Hall T., 2011, GERF B BIOSCI, V2, P60; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Hatteland BA, 2011, B ENTOMOL RES, V101, P675, DOI 10.1017/S0007485311000034; Jelaska LS, 2014, MOL ECOL, V23, P3755, DOI 10.1111/mec.12566; Juen A, 2006, SOIL BIOL BIOCHEM, V38, P1872, DOI 10.1016/j.soilbio.2005.11.034; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kerzicnik LM, 2012, J ARACHNOL, V40, P71, DOI 10.1636/P11-76.1; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2015, B ENTOMOL RES, V105, P261, DOI 10.1017/S0007485314000935; Kobayashi T, 2011, BASIC APPL ECOL, V12, P532, DOI 10.1016/j.baae.2011.07.007; Krehenwinkel H, 2017, METHODS ECOL EVOL, V8, P126, DOI 10.1111/2041-210X.12647; Kuusk AK, 2008, BASIC APPL ECOL, V9, P718, DOI 10.1016/j.baae.2007.08.012; Kuusk AK, 2010, BIOL CONTROL, V55, P20, DOI 10.1016/j.biocontrol.2010.06.009; Leal MC, 2014, MOL ECOL, V23, P3838, DOI 10.1111/mec.12496; Leal MC, 2014, MOL ECOL, V23, P3870, DOI 10.1111/mec.12486; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Longhorn SJ, 2007, J ARACHNOL, V35, P278, DOI 10.1636/S05-62.1; Lundgren JG, 2014, MOL ECOL, V23, P3790, DOI 10.1111/mec.12700; Macias-Hernandez N, 2016, ZOOKEYS, P11, DOI 10.3897/zookeys.625.9847; Monzo C, 2010, B ENTOMOL RES, V100, P145, DOI 10.1017/S0007485309006920; Paula DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161841; Paula DP, 2015, MOL ECOL RESOUR, V15, P880, DOI 10.1111/1755-0998.12364; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Pumarino L, 2011, B ENTOMOL RES, V101, P271, DOI 10.1017/S0007485310000465; Raso L, 2014, MOL ECOL, V23, P3744, DOI 10.1111/mec.12649; Redd KS, 2014, MOL ECOL, V23, P3849, DOI 10.1111/mec.12795; Rezac M, 2008, J ZOOL, V275, P64, DOI 10.1111/j.1469-7998.2007.00408.x; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schmidt JM, 2014, MOL ECOL, V23, P3777, DOI 10.1111/mec.12734; Seeber J, 2010, SOIL BIOL BIOCHEM, V42, P1263, DOI 10.1016/j.soilbio.2010.04.008; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simonelli P, 2009, J PLANKTON RES, V31, P1465, DOI 10.1093/plankt/fbp087; Sint D, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0096-y; Sint D, 2011, MOL ECOL RESOUR, V11, P795, DOI 10.1111/j.1755-0998.2011.03018.x; Srivathsan A, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0150-4; Srivathsan A, 2015, MOL ECOL RESOUR, V15, P250, DOI 10.1111/1755-0998.12302; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Toft S, 2017, PHYSIOL ENTOMOL, V42, P191, DOI 10.1111/phen.12192; Traugott M, 2012, B ENTOMOL RES, V102, P239, DOI 10.1017/S0007485311000551; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Virant-Doberlet M, 2011, MOL ECOL, V20, P2204, DOI 10.1111/j.1365-294X.2011.05038.x; Waldner T, 2013, SOIL BIOL BIOCHEM, V63, P116, DOI 10.1016/j.soilbio.2013.03.030; Waldner T, 2012, MOL ECOL RESOUR, V12, P669, DOI 10.1111/j.1755-0998.2012.03135.x; Walker JM, 2006, MALACOLOGIA, V48, P265; Wallinger C, 2013, MOL ECOL RESOUR, V13, P75, DOI 10.1111/1755-0998.12032; Wangensteen OS, 2017, MARINE ANIMAL FOREST, P445, DOI 10.1007/978-3-319-21012-4_53; Wangensteen OS, 2018, PEERJ, V6, DOI 10.7717/peerj.4705; Weber DC, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4101; Welch KD, 2016, B ENTOMOL RES, V106, P91, DOI 10.1017/S0007485315000875; Welch KD, 2014, MOL ECOL, V23, P3814, DOI 10.1111/mec.12721; Wrinn KM, 2007, CAN J ZOOL, V85, P823, DOI 10.1139/Z07-063; Xu CCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142503; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	91	41	42	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0196589	10.1371/journal.pone.0196589	http://dx.doi.org/10.1371/journal.pone.0196589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847544	Green Submitted, Green Published, gold			2022-12-26	WOS:000433634800009
J	Liu, Y; Ma, L; Guo, JW; Dong, GF; Cong, JB; Ji, YL; Ning, J; Yang, GS; Wu, K				Liu, Ye; Ma, Lei; Guo, Junwang; Dong, Guofu; Cong, Jianbo; Ji, Yunlong; Ning, Jing; Yang, Guoshan; Wu, Ke			Study of new practical ESR dosimeter based on carbonated hydroxyapatite and its dosimetric properties	PLOS ONE			English	Article							IRRADIATED TOOTH ENAMEL; CO2-RADICALS; SYNTHETIC HYDROXYAPATITE; DOSE-RESPONSE; EPR; RESONANCE; APATITES; ENDOR; BONE	The development of new dosimeters with good dosimetric properties is important for quality control in radiation applications. A new practical electron spin resonance (ESR) dosimeter based on carbonated hydroxyapatite that simulated the composition and structure of tooth enamel was specially synthesized. The synthesized material was investigated by transmission electron microscope, X-ray diffraction, fourier transform infrared spectroscopy and Xray photo electron spectroscopy to confirm to the main composition of carbonated hydroxyapatite with CO32- successfully doped into the crystal lattice through optimizing the synthesis process of C/P molar ratio, pH value dynamical adjustment, annealing temperature and time. The dosimetric properties were systematically investigated by ESR spectroscopy. The results indicated that the radiation induced signal had a good dose response within a relatively wide dose range. The dose response was linear in the dose range of 0 +/- 400 Gy with a correlation coefficient of 0.9999 and had dose accumulative effect in the experimental dose range of 0 +/- 100 Gy. In a wider dose range up to 30 kGy, the dose response also presented linear feature in double-logarithmic coordinate system with a correlation coefficient of 0.9970. The dose detection limit was about 0.34Gy with a given probability of 95% confidence level depending upon a rigid calculation algorithm. The signal was extremely stable in the observation time of 360 days with a variation coefficient of 3.8%. The radiation sensitivity of the material showed no remarkable variation against photon energy from 662 KeV to 1.25 MeV and dose rate from 0.86 Gy/min to 12.17 Gy/min. The material showed more sensitive in lower photon energy range below 662 keV, which hint additional calibration may need when using in special photon energy condition. The preliminary results suggested that this newly developed dosimeter was potential to become a practical dosimeter that would expand the application fields of ESR dosimetry.	[Liu, Ye; Ma, Lei; Guo, Junwang; Dong, Guofu; Cong, Jianbo; Ji, Yunlong; Ning, Jing; Yang, Guoshan; Wu, Ke] Beijing Inst Radiat Med, Beijing Key Lab Radiat Biol, Beijing, Peoples R China		Yang, GS; Wu, K (corresponding author), Beijing Inst Radiat Med, Beijing Key Lab Radiat Biol, Beijing, Peoples R China.	yanggs@nic.bmi.ac.cn; wuk315@163.com			National Science Funds of China [31670862]	National Science Funds of China	This work is support by a grant from the National Science Funds of China (http://www.nsfc.gov.cn/) (No.31670862) to K.W.	Baghalzadeh B, 2013, GAMMA IRRADIATED ELE; Boulila S, 2015, TOXICOL MECH METHOD, V25, P155, DOI 10.3109/15376516.2014.1003358; CALLENS FJ, 1989, CALCIFIED TISSUE INT, V44, P114, DOI 10.1007/BF02556470; de Oliveira L, 2004, DEV EPR DOSIMETRY SY; de Oliveira LM, 1999, RADIAT PROT DOSIM, V84, P511, DOI 10.1093/oxfordjournals.rpd.a032789; de Oliveira LM, 2002, RADIAT PROT DOSIM, V101, P539, DOI 10.1093/oxfordjournals.rpd.a006044; de Oliveira LM, 2001, RADIAT PHYS CHEM, V61, P485, DOI 10.1016/S0969-806X(01)00309-7; DOI Y, 1979, CALCIFIED TISSUE INT, V28, P107, DOI 10.1007/BF02441228; El Feki H, 1999, J ALLOY COMPD, V287, P114, DOI 10.1016/S0925-8388(99)00070-5; El Feki H, 2000, J PHYS-CONDENS MAT, V12, P8331, DOI 10.1088/0953-8984/12/38/309; Fattibene P, 2011, RADIAT MEAS, V46, P765, DOI 10.1016/j.radmeas.2011.05.001; Gamelas JAF, 2015, COLLOID SURFACE A, V478, P62, DOI 10.1016/j.colsurfa.2015.03.044; Hajiloo N, 2012, RADIAT PROT DOSIM, V148, P487, DOI 10.1093/rpd/ncr204; MOENS PD, 1994, J CHEM SOC FARADAY T, V90, P2653, DOI 10.1039/ft9949002653; Oliveira LM, 2000, APPL RADIAT ISOTOPES, V52, P1093, DOI 10.1016/S0969-8043(00)00045-2; Sadlo J, 2012, J MOL STRUCT, V1022, P61, DOI 10.1016/j.molstruc.2012.04.062; Sato H, 2007, RADIAT MEAS, V42, P997, DOI 10.1016/j.radmeas.2007.05.048; Schramm DU, 2000, APPL RADIAT ISOTOPES, V52, P1085, DOI 10.1016/S0969-8043(00)00046-4; Slosarczyk A, 2005, J MOL STRUCT, V744, P657, DOI 10.1016/j.molstruc.2004.11.078; Vorona IP, 2008, PHYS SOLID STATE+, V50, P1852, DOI 10.1134/S1063783408100119; Vorona IP, 2006, RADIAT MEAS, V41, P577, DOI 10.1016/j.radmeas.2005.12.002; VUGMAN NV, 1995, APPL RADIAT ISOTOPES, V46, P311, DOI 10.1016/0969-8043(94)00154-R; Zyman Z, 2011, J EUR CERAM SOC, V31, P241, DOI 10.1016/j.jeurceramsoc.2010.09.005	23	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197953	10.1371/journal.pone.0197953	http://dx.doi.org/10.1371/journal.pone.0197953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813104	Green Submitted, gold, Green Published			2022-12-26	WOS:000433521800037
J	Alhamami, M; Cheng, WR; Lyu, YY; Allen, C; Zhang, XA; Cheng, HLM				Alhamami, Mosa; Cheng, Weiran; Lyu, Yuanyuan; Allen, Christine; Zhang, Xiao-an; Cheng, Hai-Ling Margaret			Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer	PLOS ONE			English	Article							CONTRAST AGENTS; STEM-CELLS; NUDE-MICE; TUMORS; METALLOPORPHYRINS; MECHANISM	Magnetic resonance imaging (MRI) contrast agents (CAs) are chemical compounds that can enhance image contrast on T-1- or T-2-weighted MR image. We have previously demonstrated the potential of MnCl2, a manganese-based CA, in cellular imaging of breast cancer using T-1-weighted MRI. In this work, we examined the potential of another class of manganese-based CAs, manganese porphyrins (MnPs), for sensitive cellular detection of multiple clinical subtypes of breast cancer using quantitative MRI. Using a clinical 3.0-T MRI scanner, the relaxivities of two MnPs, MnTPPS4 and MnTPPS3NH2, and conventional Gd-DTPA (control) were measured in ultrapure water and their T-1 contrast enhancement patterns were characterized in multiple clinical subtypes of breast cancer. The toxicity of the three CAs was evaluated in vitro. Compared to Gd-DTPA, both MnTPPS3 NH2 and MnTPPS4 enabled a more sensitive multi-subtype detection of four breast cell lines at doses that posed no cytotoxic effects, with MnTPPS3NH2 producing the greatest positive enhancement. The superior T-1 enhancement capabilities of MnPs over Gd-DTPA are statistically significant and are likely due to their greater cellular uptake and relaxivities. The results demonstrate that multiple clinical subtypes of breast cancer can be imaged on a 3.0-T MRI scanner using MnPs as T-1 cellular CAs.	[Alhamami, Mosa; Allen, Christine; Cheng, Hai-Ling Margaret] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada; [Alhamami, Mosa; Allen, Christine; Cheng, Hai-Ling Margaret] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Alhamami, Mosa; Cheng, Hai-Ling Margaret] Hosp Sick Children, Translat Med, Res Inst, Toronto, ON, Canada; [Cheng, Weiran; Zhang, Xiao-an] Univ Toronto, Dept Chem, Toronto, ON, Canada; [Cheng, Weiran; Lyu, Yuanyuan; Zhang, Xiao-an] Univ Toronto Scarborough, Dept Phys & Environm Sci, Toronto, ON, Canada; [Lyu, Yuanyuan] Zhejiang Univ City Coll, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Allen, Christine] Univ Hlth Network, Princess Margaret Canc Ctr, STTARR Innovat Ctr, Radiat Med Program, Toronto, ON, Canada; [Zhang, Xiao-an] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada; [Cheng, Hai-Ling Margaret] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada; [Cheng, Hai-Ling Margaret] Ted Rogers Ctr Heart Res, Translat Biol & Engn Program, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Scarborough; Zhejiang University City College; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Scarborough; University of Toronto	Cheng, HLM (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada.; Cheng, HLM (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Cheng, HLM (corresponding author), Hosp Sick Children, Translat Med, Res Inst, Toronto, ON, Canada.; Cheng, HLM (corresponding author), Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada.; Cheng, HLM (corresponding author), Ted Rogers Ctr Heart Res, Translat Biol & Engn Program, Toronto, ON, Canada.	hailing.cheng@utoronto.ca	Cheng, Hai-Ling Margaret/E-5551-2011	Cheng, Hai-Ling Margaret/0000-0002-0733-9512; Allen, Christine/0000-0002-4916-3965	Heart AMP; Stroke Foundation of Canada [000223]; Natural Sciences and Engineering Research Council of Canada [355795]; SickKids Foundation; NSERC Alexander Graham Bell Canada Graduate Scholarships; Ontario Graduate Scholarship; National Science Foundation of China [51303155]; Natural Sciences and Engineering Research Council of Canada (NSERC) [355795]; NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral (CGS-D3); National Science Foundation of China (NSFC) [51303155]	Heart AMP; Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); SickKids Foundation; NSERC Alexander Graham Bell Canada Graduate Scholarships; Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral (CGS-D3); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funded by Heart & Stroke Foundation of Canada (#000223 to HLMC) http://www.heartandstroke.ca/. Natural Sciences and Engineering Research Council of Canada (#355795 to HLMC) http//www.nserc-crsng-gc.ca/index_eng.asp. SickKids Foundation (to HLMC). NSERC Alexander Graham Bell Canada Graduate Scholarships - Doctoral (to MA). Ontario Graduate Scholarship (to MA). National Science Foundation of China (#51303155 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Financial support for this work was provided to H-LMC by the Heart & Stroke Foundation of Canada (# 000223), the Natural Sciences and Engineering Research Council of Canada (NSERC, # 355795), and SickKids Foundation. M.A. was supported by NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral (CGS-D3) and Ontario Graduate Scholarship,. Y.L. was supported by National Science Foundation of China (NSFC, # 51303155). The authors thank Professor Raymond Reilly for fruitful discussions.	Alhamami M, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00021; Alvares RDA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15732-8; BOCKHORST K, 1990, MAGN RESON IMAGING, V8, P499, DOI 10.1016/0730-725X(90)90058-A; Brant WE, 2012, FUNDAMENTALS DIAGNOS; BRAUNSCHWEIGER P G, 1986, Magnetic Resonance Imaging, V4, P335, DOI 10.1016/0730-725X(86)91043-X; Cheng HLM, 2014, J MAGN RESON IMAGING, V40, P1474, DOI 10.1002/jmri.24483; Cheng WR, 2014, J MED CHEM, V57, P516, DOI 10.1021/jm401124b; Digilio G, 2010, J MED CHEM, V53, P4877, DOI 10.1021/jm901876r; FIEL RJ, 1988, CANCER LETT, V40, P23, DOI 10.1016/0304-3835(88)90258-3; FURMANSKI P, 1988, CANCER RES, V48, P4604; Ganesh T, 2015, J MAGN RESON IMAGING, V41, P806, DOI 10.1002/jmri.24608; Giesel FL, 2006, INVEST RADIOL, V41, P868, DOI 10.1097/01.rli.0000246147.44835.4c; Haedicke IE, 2016, CHEM SCI, V7, P4308, DOI 10.1039/c5sc04252f; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; KOENIG SH, 1987, MAGNET RESON MED, V4, P252, DOI 10.1002/mrm.1910040306; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Loai S, 2016, J MAGN RESON IMAGING, V44, P1456, DOI 10.1002/jmri.25299; LYON RC, 1987, MAGNET RESON MED, V4, P24, DOI 10.1002/mrm.1910040104; MEGNIN F, 1987, BIOCHIM BIOPHYS ACTA, V929, P173, DOI 10.1016/0167-4889(87)90173-X; Mouraviev V, 2012, J ENDOUROL, V26, P1420, DOI 10.1089/end.2012.0171; Nofiele JT, 2015, J MAGN RESON IMAGING, V41, P397, DOI 10.1002/jmri.24561; Nofiele JT, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2013.00071; Okuhata Y, 1999, ADV DRUG DELIVER REV, V37, P121, DOI 10.1016/S0169-409X(98)00103-3; PLACE DA, 1990, INVEST RADIOL, V25, pS69, DOI 10.1097/00004424-199009001-00033; PLACE DA, 1992, MAGN RESON IMAGING, V10, P919, DOI 10.1016/0730-725X(92)90446-7; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Shuai HL, 2015, INT J EXP PATHOL, V96, P63, DOI 10.1111/iep.12111; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Zhang Z, 2009, BIOORG MED CHEM LETT, V19, P6675, DOI 10.1016/j.bmcl.2009.10.003	31	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196998	10.1371/journal.pone.0196998	http://dx.doi.org/10.1371/journal.pone.0196998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795583	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000433084300021
J	Cruz-Roa, A; Gilmore, H; Basavanhally, A; Feldman, M; Ganesan, S; Shih, N; Tomaszewski, J; Madabhushi, A; Gonzalez, F				Cruz-Roa, Angel; Gilmore, Hannah; Basavanhally, Ajay; Feldman, Michael; Ganesan, Shridar; Shih, Natalie; Tomaszewski, John; Madabhushi, Anant; Gonzalez, Fabio			High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection	PLOS ONE			English	Article							INFORMATICS; FRAMEWORK; GRADE	Precise detection of invasive cancer on whole-slide images (WSI) is a critical first step in digital pathology tasks of diagnosis and grading. Convolutional neural network (CNN) is the most popular representation learning method for computer vision tasks, which have been successfully applied in digital pathology, including tumor and mitosis detection. However, CNNs are typically only tenable with relatively small image sizes (200 x 200 pixels). Only recently, Fully convolutional networks (FCN) are able to deal with larger image sizes (500 x 500 pixels) for semantic segmentation. Hence, the direct application of CNNs to WSI is not computationally feasible because for a WSI, a CNN would require billions or trillions of parameters. To alleviate this issue, this paper presents a novel method, High-throughput Adaptive Sampling for whole-slide Histopathology Image analysis (HASHI), which involves: i) a new efficient adaptive sampling method based on probability gradient and quasi-Monte Carlo sampling, and, ii) a powerful representation learning classifier based on CNNs. We applied HASHI to automated detection of invasive breast cancer on WSI. HASHI was trained and validated using three different data cohorts involving near 500 cases and then independently tested on 195 studies from The Cancer Genome Atlas. The results show that (1) the adaptive sampling method is an effective strategy to deal with WSI without compromising prediction accuracy by obtaining comparative results of a dense sampling (similar to 6 million of samples in 24 hours) with far fewer samples (similar to 2,000 samples in 1 minute), and (2) on an independent test dataset, HASHI is effective and robust to data from multiple sites, scanners, and platforms, achieving an average Dice coefficient of 76%.	[Cruz-Roa, Angel] Univ Llanos, Sch Engn, Villavicencio, Meta, Colombia; [Cruz-Roa, Angel; Gonzalez, Fabio] Univ Nacl Colombia, Dept Comp Syst & Ind Engn, Bogota, Cundinamarca, Colombia; [Gilmore, Hannah] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Basavanhally, Ajay] Inspirata Inc, Tampa, FL USA; [Feldman, Michael; Shih, Natalie] Hosp Univ Penn, Philadelphia, PA USA; [Ganesan, Shridar] Canc Inst New Jersey, New Brunswick, NJ USA; [Tomaszewski, John] SUNY Buffalo, Univ Buffalo, Buffalo, NY USA; [Madabhushi, Anant] Case Western Reserve Univ, Cleveland, OH 44106 USA	Universidad Nacional de Colombia; Case Western Reserve University; Case Western Reserve University Hospital; University of Pennsylvania; Pennsylvania Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Case Western Reserve University	Cruz-Roa, A (corresponding author), Univ Llanos, Sch Engn, Villavicencio, Meta, Colombia.; Cruz-Roa, A (corresponding author), Univ Nacl Colombia, Dept Comp Syst & Ind Engn, Bogota, Cundinamarca, Colombia.	aacruz@unillanos.edu.co	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399; Basavanhally, Ajay/0000-0002-4713-815X; Cruz-Roa, Angel/0000-0003-3389-8913	Administrative Department of Science, Technology and Innovation - Colciencias [528/2011]; Universidad Nacional de Colombia from Universidad de los Llanos [C03-F02-35-2015, C05-F02-039-2016]; National Cancer Institute of the National Institutes of Health [1U24CA199374-01, R01CA202752-01A1, R01CA208236-01A1, R21CA179327-01, R21CA195152-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; National Center for Research Resources [1 C06 RR12463-01]; United States Department of Defense Prostate Cancer Synergistic Idea Development Award [PC120857]; United States Department of Defense Lung Cancer Idea Development New Investigator Award [LC130463]; United States Department of Defense Prostate Cancer Idea Development Award; United States Department of Defense Peer Reviewed Cancer Research Program [W81XWH-16-1-0329]; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; Administrative Department of Science, Technology and Innovation Colciencias [528/2011]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; DOD Peer Reviewed Cancer Research Program [W81XWH-16-1-0329]; Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA208236, R01CA220581, U24CA199374, R01CA202752, R01CA216579] Funding Source: NIH RePORTER	Administrative Department of Science, Technology and Innovation - Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad Nacional de Colombia from Universidad de los Llanos; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Defense Prostate Cancer Synergistic Idea Development Award(United States Department of Defense); United States Department of Defense Lung Cancer Idea Development New Investigator Award; United States Department of Defense Prostate Cancer Idea Development Award(United States Department of Defense); United States Department of Defense Peer Reviewed Cancer Research Program(United States Department of Defense); Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; Administrative Department of Science, Technology and Innovation Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; DOD Peer Reviewed Cancer Research Program; Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was funded by doctoral fellowship grant from the Administrative Department of Science, Technology and Innovation - Colciencias (528/2011), Universidad Nacional de Colombia, projects C03-F02-35-2015 and C05-F02-039-2016 from Universidad de los Llanos, the National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01; R01CA202752-01A1; R01CA208236-01A1; R21CA179327-01; R21CA195152-01 the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, National Center for Research Resources under award number 1 C06 RR12463-01; the United States Department of Defense Prostate Cancer Synergistic Idea Development Award (PC120857); the United States Department of Defense Lung Cancer Idea Development New Investigator Award (LC130463); the United States Department of Defense Prostate Cancer Idea Development Award; the United States Department of Defense Peer Reviewed Cancer Research Program W81XWH-16-1-0329; the Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Research reported in this publication was supported by doctoral fellowship grant from the Administrative Department of Science, Technology and Innovation Colciencias (528/2011), Universidad Nacional de Colombia, projects C03-F02-35-2015 and C05-F02-039-2016 from Universidad de los Llanos, the National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01, R01CA202752-01A1 R01CA208236-01A1 R21CA179327-01; R21CA195152-01 the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, National Center for Research Resources under award number 1 C06 RR12463-01 the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Idea Development Award; the DOD Peer Reviewed Cancer Research Program W81XWH-16-1-0329 the Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors also thank for K40 Tesla GPU donated by NVIDIA, HPC resources in the Core Facility for Advanced Research Computing at Case Western Reserve University, GITECX and AdaLab infraestructure at Universidad de los Llanos, and GridUIS at Industrial University of Santander which were used for training processes of CNN, machine learning classifiers and HASHI experiments. The results presented here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Cruz-Roa AA, 2013, LECT NOTES COMPUT SC, V8150, P403, DOI 10.1007/978-3-642-40763-5_50; Andrew Y. Ng, 2012, Arxiv, DOI arXiv:1112.6209; AREVALO JOHN, 2014, rev.fac.med, V22, P79; Arevalo J, 2015, ARTIF INTELL MED, V64, P131, DOI 10.1016/j.artmed.2015.04.004; Basavanhally Ajay, 2013, IEEE Trans Biomed Eng, V60, P2089, DOI 10.1109/TBME.2013.2245129; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bhargava R, 2016, ANNU REV BIOMED ENG, V18, P387, DOI 10.1146/annurev-bioeng-112415-114722; Caflisch R. E., 1998, Acta Numerica, V7, P1, DOI 10.1017/S0962492900002804; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Chappelow J, 2011, COMPUT MED IMAG GRAP, V35, P557, DOI 10.1016/j.compmedimag.2011.01.010; Chen H, 2016, PROC CVPR IEEE, P2487, DOI 10.1109/CVPR.2016.273; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Collobert R., 2011, BIGLEARN; Cruz-Roa A, 2015, NOTE STABILITY DISCR, V9287, DOI [10.1117/12.2085141, DOI 10.1117/12.2085141]; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; Cruz-Roa A, 2015, PROC SPIE, V9681, DOI 10.1117/12.2208825; Cruz-Roa A, 2015, PROC SPIE, V9287, DOI 10.1117/12.2073849; Cruz-Roa A, 2014, PROC SPIE, V9041, DOI 10.1117/12.2043872; Cruz-Roa Angel, 2011, J Pathol Inform, V2, pS4, DOI 10.4103/2153-3539.92031; Cruz-Roa A, 2011, ARTIF INTELL MED, V52, P91, DOI 10.1016/j.artmed.2011.04.010; Daniel C, 2011, COMPUT MED IMAG GRAP, V35, P496, DOI 10.1016/j.compmedimag.2010.12.004; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dillon D. A., 2010, DIS BREAST, P374; Donahue J, 2014, PR MACH LEARN RES, V32; Dorai C, 1997, IEEE T PATTERN ANAL, V19, P1115, DOI 10.1109/34.625113; Doyle S, 2006, LECT NOTES COMPUT SC, V4191, P504; Doyle S, 2008, I S BIOMED IMAGING, P496, DOI 10.1109/ISBI.2008.4541041; Elston C W, 2002, Histopathology, V41, P154; Giusti A, 2013, IEEE IMAGE PROC, P4034, DOI 10.1109/ICIP.2013.6738831; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; He L, 2012, COMPUT METH PROG BIO, V107, P538, DOI 10.1016/j.cmpb.2011.12.007; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Homeyer A, 2013, COMPUT MED IMAG GRAP, V37, P313, DOI 10.1016/j.compmedimag.2013.05.002; Huang CH, 2011, COMPUT MED IMAG GRAP, V35, P579, DOI 10.1016/j.compmedimag.2010.11.009; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Kothari Sonal, 2012, ACM BCB, V2012, P218, DOI 10.1145/2382936.2382964; Kothari S, 2013, J AM MED INFORM ASSN, V20, P1099, DOI 10.1136/amiajnl-2012-001540; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lee G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159088; Lewis JS, 2014, AM J SURG PATHOL, V38, P128, DOI 10.1097/PAS.0000000000000086; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Madabhushi Anant, 2009, Imaging Med, V1, P7, DOI 10.2217/IIM.09.9; Malon Christopher D, 2013, J Pathol Inform, V4, P9, DOI 10.4103/2153-3539.112694; Montavon G., 2009, THESIS; MOROKOFF WJ, 1994, SIAM J SCI COMPUT, V15, P1251, DOI 10.1137/0915077; Mueller D, 2011, COMPUT MED IMAG GRAP, V35, P542, DOI 10.1016/j.compmedimag.2011.06.006; Network SIG, 2005, NATL CLIN GUIDELINE, V84, p1 ; Ngiam J., 2010, ADV NEURAL INFORM PR, V23; Ning F, 2005, IEEE T IMAGE PROCESS, V14, P1360, DOI 10.1109/TIP.2005.852470; Nowak E, 2006, SAMPLING STRATEGIES, P490, DOI [10.1007/11744085_38, DOI 10.1007/11744085_38]; Otalora S, 2015, LECT NOTES COMPUT SC, V9349, P581, DOI 10.1007/978-3-319-24553-9_71; Romo-Bucheli D, 2017, CYTOM PART A, V91A, P566, DOI 10.1002/cyto.a.23065; Romo-Bucheli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32706; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sertel O, 2009, PATTERN RECOGN, V42, P1093, DOI 10.1016/j.patcog.2008.08.027; Sirinukunwattana K., 2016, ABS160300275 CORR, DOI [10.1016/j.media.2016.08.008, DOI 10.1016/J.MEDIA.2016.08.008]; Veta M, 2015, MED IMAGE ANAL, V20, P237, DOI 10.1016/j.media.2014.11.010; Veta M, 2014, IEEE T BIO-MED ENG, V61, P2819, DOI 10.1109/TBME.2014.2351051; Wang HB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.034003; Wang HB, 2014, PROC SPIE, V9041, DOI 10.1117/12.2043902; Xu J, 2016, NEUROCOMPUTING, V191, P214, DOI 10.1016/j.neucom.2016.01.034	62	58	60	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196828	10.1371/journal.pone.0196828	http://dx.doi.org/10.1371/journal.pone.0196828			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795581	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300014
J	Devkota, P; Danzi, MC; Wuchty, S				Devkota, Prajwal; Danzi, Matt C.; Wuchty, Stefan			Beyond degree and betweenness centrality: Alternative topological measures to predict viral targets	PLOS ONE			English	Article							VIRUS; PATHWAYS; NETWORK; SCREEN; GENES; HIV-1; WEB; MAP	The availability of large-scale screens of host-virus interaction interfaces enabled the topological analysis of viral protein targets of the host. In particular, host proteins that bind viral proteins are generally hubs and proteins with high betweenness centrality. Recently, other topological measures were introduced that a virus may tap to infect a host cell. Utilizing experimentally determined sets of human protein targets from Herpes, Hepatitis, HIV and Influenza, we pooled molecular interactions between proteins from different pathway databases. Apart from a protein's degree and betweenness centrality, we considered a protein's pathway participation, ability to topologically control a network and protein PageRank index. In particular, we found that proteins with increasing values of such measures tend to accumulate viral targets and distinguish viral targets from non-targets. Furthermore, all such topological measures strongly correlate with the occurrence of a given protein in different pathways. Building a random forest classifier that is based on such topological measures, we found that protein PageRank index had the highest impact on the classification of viral (non-)targets while proteins' ability to topologically control an interaction network played the least important role.	[Devkota, Prajwal; Wuchty, Stefan] Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA; [Danzi, Matt C.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Danzi, Matt C.; Wuchty, Stefan] Univ Miami, Ctr Computat Sci, Coral Gables, FL 33124 USA; [Wuchty, Stefan] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Wuchty, Stefan] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Wuchty, S (corresponding author), Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA.; Wuchty, S (corresponding author), Univ Miami, Ctr Computat Sci, Coral Gables, FL 33124 USA.; Wuchty, S (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.; Wuchty, S (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA.	wuchtys@cs.miami.edu						Bailer SM, 2009, CURR OPIN MICROBIOL, V12, P453, DOI 10.1016/j.mib.2009.06.004; Blasche S, 2013, J VIROL, V87, P12745, DOI 10.1128/JVI.02495-13; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Breiman L., 2001, MACH LEARN, V45, P5; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durmus S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00235; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Dyer MD, 2011, INFECT GENET EVOL, V11, P917, DOI 10.1016/j.meegid.2011.02.022; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Friedel CC, 2011, TRENDS MICROBIOL, V19, P501, DOI 10.1016/j.tim.2011.07.003; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Jupe S, 2012, J THROMB HAEMOST, V10, P2399, DOI 10.1111/j.1538-7836.2012.04930.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kshirsagar M, 2013, BIOINFORMATICS, V29, P217, DOI 10.1093/bioinformatics/btt245; Kshirsagar M, 2012, BIOINFORMATICS, V28, pI466, DOI 10.1093/bioinformatics/bts375; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Mariano R, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00030-15; Maynard ND, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001017; Meyniel-Schicklin L, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014738; Murali TM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002164; Navratil V, 2010, J PROTEOME RES, V9, P3527, DOI 10.1021/pr100326j; Nourani E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00094; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Qi YJ, 2010, BIOINFORMATICS, V26, pi645, DOI 10.1093/bioinformatics/btq394; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Tekir SD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00046; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Vignali M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-211; Vinayagam A, 2016, P NATL ACAD SCI USA, V113, P4976, DOI 10.1073/pnas.1603992113; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204; Wuchty S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009035; Wuchty S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011796	44	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197595	10.1371/journal.pone.0197595	http://dx.doi.org/10.1371/journal.pone.0197595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795705	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300054
J	Jensen, MS; Fredriksen, L; MacKenzie, AK; Pope, PB; Leiros, I; Chylenski, P; Williamson, AK; Christopeit, T; Ostby, H; Vaaje-Kolstad, G; Eijsink, VGH				Jensen, Marianne S.; Fredriksen, Lasse; MacKenzie, Alasdair K.; Pope, Phillip B.; Leiros, Ingar; Chylenski, Piotr; Williamson, Adele K.; Christopeit, Tony; Ostby, Heidi; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.			Discovery and characterization of a thermostable two-domain GH6 endoglucanase from a compost metagenome	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; CELLULOSE; ENZYME; HYDROLYSIS; SUBSTRATE; ETHANOL; DOMAIN; MODEL	Enzymatic depolymerization of recalcitrant polysaccharides plays a key role in accessing the renewable energy stored within lignocellulosic biomass, and natural biodiversities may be explored to discover microbial enzymes that have evolved to conquer this task in various environments. Here, a metagenome from a thermophilic microbial community was mined to yield a novel, thermostable cellulase, named mgCel6A, with activity on an industrial cellulosic substrate (sulfite-pulped Norway spruce) and a glucomannanase side activity. The enzyme consists of a glycoside hydrolase family 6 catalytic domain (GH6) and a family 2 carbohydrate binding module (CBM2) that are connected by a linker rich in prolines and threonines. MgCeI6A exhibited maximum activity at 85 degrees C and pH 5.0 on carboxymethyl cellulose (CMC), but in prolonged incubations with the industrial substrate, the highest yields were obtained at 60 degrees C, pH 6.0. Differential scanning calorimetry (DSC) indicated a T-m(app) of 76 degrees C. Both functional data and the crystal structure, solved at 1.88 A resolution, indicate that mgCel6A is an endoglucanase. Comparative studies with a truncated variant of the enzyme showed that the CBM increases substrate binding, while not affecting thermal stability. Importantly, at higher substrate concentrations the full-length enzyme was outperformed by the catalytic domain alone, underpinning previous suggestions that CBMs may be less useful in high-consistency bioprocessing.	[Jensen, Marianne S.; Fredriksen, Lasse; MacKenzie, Alasdair K.; Pope, Phillip B.; Chylenski, Piotr; Ostby, Heidi; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Leiros, Ingar; Williamson, Adele K.; Christopeit, Tony] UiT Arctic Univ Norway, Dept Chem, Norwegian Struct Biol Ctr, Tromso, Norway	Norwegian University of Life Sciences; UiT The Arctic University of Tromso	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway.	vincent.eijsink@nmbu.no	Leiros, Ingar/AAM-2940-2020; Pope, Phillip/AAQ-2251-2021	Pope, Phillip/0000-0002-2067-4059; Leiros, Ingar/0000-0001-9333-4541	Research Council of Norway through the NorZymeD project [221568]; European Research Council [336355-MicroDE]	Research Council of Norway through the NorZymeD project(Research Council of Norway); European Research Council(European Research Council (ERC)European Commission)	This work was funded by the Research Council of Norway through the NorZymeD project, project number 221568. PBP is supported by a European Research Council Starting Grant Fellowship (336355-MicroDE).	Albrecht S, 2009, J AGR FOOD CHEM, V57, P3867, DOI 10.1021/jf8038956; Andre G, 2003, PROTEIN ENG, V16, P125, DOI 10.1093/proeng/gzg017; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALZA RE, 1985, BIOCHEMISTRY-US, V24, P7797, DOI 10.1021/bi00347a044; Chandra RP, 2007, ADV BIOCHEM ENG BIOT, V108, P67, DOI 10.1007/10_2007_064; Chylenski P, 2017, J BIOTECHNOL, V246, P16, DOI 10.1016/j.jbiotec.2017.02.009; Cocinero EJ, 2009, J AM CHEM SOC, V131, P11117, DOI 10.1021/ja903322w; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DUCHESNE LC, 1989, BIOSCIENCE, V39, P238, DOI 10.2307/1311160; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; GHANGAS GS, 1988, APPL ENVIRON MICROB, V54, P2521, DOI 10.1128/AEM.54.10.2521-2526.1988; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Kostylev M, 2012, BIOFUELS-UK, V3, P61, DOI 10.4155/BFS.11.150; Kristensen JB, 2009, APPL BIOCHEM BIOTECH, V156, P557, DOI 10.1007/s12010-008-8375-0; Kumar R, 2016, BIOFUEL RES J, V3, P347, DOI 10.18331/brj2016.3.1.4; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; Liu G, 2016, BIOPROC BIOSYST ENG, V39, P133, DOI 10.1007/s00449-015-1497-1; Mayes HB, 2016, CHEM SCI, V7, P5955, DOI 10.1039/c6sc00571c; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Reddy A. P., 2013, PLoS ONE, V8, pe77985, DOI 10.1371/journal.pone.0077985; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodsrud G, 2012, BIOMASS BIOENERG, V46, P46, DOI 10.1016/j.biombioe.2012.03.028; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Sandgren M, 2013, J MOL BIOL, V425, P622, DOI 10.1016/j.jmb.2012.11.039; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Simmons CW, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0180-0; Sjode A., 2013, Patent EP, Patent No. [2376642, 23376642B1]; SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolfgang DE, 1999, BIOCHEMISTRY-US, V38, P9746, DOI 10.1021/bi990401v; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zhang S, 2000, EUR J BIOCHEM, V267, P244, DOI 10.1046/j.1432-1327.2000.00988.x; Zhang ZS, 2012, BIOTECHNOL ADV, V30, P913, DOI 10.1016/j.biotechadv.2012.01.020	61	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197862	10.1371/journal.pone.0197862	http://dx.doi.org/10.1371/journal.pone.0197862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795644	Green Published, gold			2022-12-26	WOS:000433084300085
J	Park, JJ; Park, MH; Oh, EH; Soung, NK; Lee, SJ; Jung, JK; Lee, OJ; Yun, SJ; Kim, WJ; Shin, EY; Kim, EG				Park, Jung-Jin; Park, Mee-Hee; Oh, Eun Hye; Soung, Nak-Kyun; Lee, Soo Jae; Jung, Jae-Kyung; Lee, Ok-Jun; Yun, Seok Joong; Kim, Wun-Jae; Shin, Eun-Young; Kim, Eung-Gook			The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer	ONCOGENE			English	Article							SLUG; SNAIL; INVASION; GROWTH; PHOSPHORYLATION; METASTASIS; EXPRESSION; REPRESSOR; OVARIAN; CELLS	Epithelial-mesenchymal transition (EMT) facilitates cancer invasion and metastasis and thus accelerates cancer progression. p21-activated kinase 4 (PAK4) is a critical regulator of prostate cancer (PC) progression. Here, we report that PAK4 activation promotes PC progression through the EMT regulator Slug. We find that phosphorylated PAK4(S474) (pPAK4) levels, an index of PAK4 activation, were tightly associated with Gleason score (p < 0.001), a clinical indicator of PC progression, but not with prostate serum antigen levels or tumor stage. Stable silencing of PAK4 in PC cells reduced their potential for EMT, cellular invasion, and metastasis in vivo. PAK4 bound and directly phosphorylated Slug at two previously unknown sites, S158 and S254, which resulted in its stabilization. The non-phosphorylatable form Slug(S158A/S254A) upregulated transcription of CDH1, which encodes E-cadherin, and thus suppressed EMT and invasion, to a greater extent than did wild-type Slug. The strong EMT inducer TGF-beta elevated pPAK4 and pSlug(S158) levels; PAK4 knockdown or introduction of a dominant-negative form of PAK4 inhibited both TGF-beta-stimulated EMT and an increase in pSlug(S158) levels. Finally, immunohistochemistry revealed a positive correlation between pPAK4 and pSlug(S158) but an inverse correlation between pSlug(S158) and E-cadherin. The results suggest that the PAK4-Slug axis represents a novel pathway that promotes PC progression.	[Park, Jung-Jin; Park, Mee-Hee; Oh, Eun Hye; Shin, Eun-Young; Kim, Eung-Gook] Chungbuk Natl Univ, Coll Med, Dept Biochem, Cheongju 28644, South Korea; [Park, Mee-Hee] KNIH, Korea Ctr Dis Control & Prevent, Div Med Sci Knowledge Management, Osong Eup 28159, Cheongju, South Korea; [Soung, Nak-Kyun] KRIBB, World Class Inst, Ochang Eup 28116, Cheongju, South Korea; [Lee, Soo Jae; Jung, Jae-Kyung] Chungbuk Natl Univ, Coll Pharm, Osong Eup 28160, Cheongju, South Korea; [Lee, Ok-Jun] Chungbuk Natl Univ, Coll Med, Dept Pathol, Cheongju 28644, South Korea; [Yun, Seok Joong; Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju 28644, South Korea	Chungbuk National University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Chungbuk National University; Chungbuk National University	Shin, EY; Kim, EG (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Biochem, Cheongju 28644, South Korea.	eyshin@chungbuk.ac.kr; egkim@chungbuk.ac.kr		Jung, Jae-Kyung/0000-0002-0490-9663	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1A2B3005714, 2015R1A2A2A04004251]; International Science and Business Belt Program through the Ministry of Science, ICT [2017K000490]; Chungbuk National University grant (2015)	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); International Science and Business Belt Program through the Ministry of Science, ICT; Chungbuk National University grant (2015)	This work was supported in part by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2017R1A2B3005714 and 2015R1A2A2A04004251), International Science and Business Belt Program through the Ministry of Science, ICT (2017K000490), and Chungbuk National University grant (2015).	Al-Azayzih A, 2015, BBA-MOL CELL RES, V1853, P1229, DOI 10.1016/j.bbamcr.2015.02.023; Baritaki S, 2009, CANCER RES, V69, P8376, DOI 10.1158/0008-5472.CAN-09-1069; Broster SA, 2015, FUTURE ONCOL, V11, P3197, DOI 10.2217/fon.15.253; Chen MQ, 2006, PROSTATE, V66, P911, DOI 10.1002/pros.20325; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Esposito S, 2015, ONCOTARGET, V6, P17121, DOI 10.18632/oncotarget.2736; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Hensel J, 2016, UROLOGY, V92, P6, DOI 10.1016/j.urology.2015.12.039; Kalikin LM, 2003, CANCER BIOL THER, V2, P656; Kao SH, 2014, ONCOGENE, V33, P3172, DOI 10.1038/onc.2013.279; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kim JY, 2012, FEBS J, V279, P2929, DOI 10.1111/j.1742-4658.2012.08674.x; Ko H, 2007, CELLS TISSUES ORGANS, V185, P66, DOI 10.1159/000101305; Kumar R, 2016, ADV CANCER RES, V130, P137, DOI 10.1016/bs.acr.2016.01.002; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mladinich M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5285892; Molina-Ortiz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036132; Naber HPH, 2013, BIOCHEM BIOPH RES CO, V435, P58, DOI 10.1016/j.bbrc.2013.04.037; Nakazawa M, 2017, J STEROID BIOCHEM, V166, P84, DOI 10.1016/j.jsbmb.2016.05.007; Nauseef JT, 2011, NAT REV UROL, V8, P428, DOI 10.1038/nrurol.2011.85; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Risolino M, 2014, P NATL ACAD SCI USA, V111, pE3775, DOI 10.1073/pnas.1407074111; Saitoh M, 2016, ONCOGENE, V35, P1049, DOI 10.1038/onc.2015.161; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Slabakova E, 2011, PROSTATE, V71, P1332, DOI 10.1002/pros.21350; Tania M, 2014, TUMOR BIOL, V35, P7335, DOI 10.1007/s13277-014-2163-y; Thakur N, 2014, CELL CYCLE, V13, P2400, DOI 10.4161/cc.29339; Virtakoivu R, 2015, CANCER RES, V75, P2349, DOI 10.1158/0008-5472.CAN-14-2842; Wang C, 2014, ONCOGENE, V33, P3473, DOI 10.1038/onc.2013.300; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang ZY, 2017, ONCOTARGET, V8, P22563, DOI 10.18632/oncotarget.15124; Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang HB, 2013, J BIOL CHEM, V288, P8737, DOI 10.1074/jbc.M113.455675; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Zhang KJ, 2011, LAB INVEST, V91, P426, DOI 10.1038/labinvest.2010.201; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	50	30	31	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5147	5159		10.1038/s41388-018-0327-8	http://dx.doi.org/10.1038/s41388-018-0327-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29849120				2022-12-26	WOS:000445093100001
J	Townsend, D; Hughes, E; Akien, G; Stewart, KL; Radford, SE; Rochester, D; Middleton, DA				Townsend, David; Hughes, Eleri; Akien, Geoffrey; Stewart, Katie L.; Radford, Sheena E.; Rochester, David; Middleton, David A.			Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; apolipoprotein; solid-state NMR; circular dichroism (CD); electron microscopy (EM); polyphenol; glycosaminoglycan; amyloid	TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; ALPHA-SYNUCLEIN; ATHEROSCLEROTIC PLAQUES; SULFATE PROTEOGLYCANS; CHONDROITIN SULFATE; ALZHEIMERS-DISEASE; BETA; EGCG; GLYCOSAMINOGLYCANS; GALLATE	Amyloid deposits of WT apolipoprotein A-I (apoA-I), the main protein component of high-density lipoprotein, accumulate in atherosclerotic plaques where they may contribute to coronary artery disease by increasing plaque burden and instability. Using CD analysis, solid-state NMR spectroscopy, and transmission EM, we report here a surprising cooperative effect of heparin and the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG), a known inhibitor and modulator of amyloid formation, on apoA-I fibrils. We found that heparin, a proxy for glycosaminoglycan (GAG) polysaccharides that co-localize ubiquitously with amyloid in vivo, accelerates the rate of apoA-I formation from monomeric protein and associates with insoluble fibrils. Mature, insoluble apoA-I fibrils bound EGCG (K-D = 30 +/- 3 mu m; B-max = 40 +/- 3 mu m), but EGCG did not alter the kinetics of apoA-I amyloid assembly from monomer in the presence or absence of heparin. EGCG selectively increased the mobility of specific backbone and side-chain sites of apoA-I fibrils formed in the absence of heparin, but the fibrils largely retained their original morphology and remained insoluble. By contrast, fibrils formed in the presence of heparin were mobilized extensively by the addition of equimolar EGCG, and the fibrils were remodeled into soluble 20-nm-diameter oligomers with a largely-helical structure that were nontoxic to human umbilical artery endothelial cells. These results argue for a protective effect of EGCG on apoA-I amyloid associated with atherosclerosis and suggest that EGCG-induced remodeling of amyloid may be tightly regulated by GAGs and other amyloid co-factors in vivo, depending on EGCG bioavailability.	[Townsend, David; Hughes, Eleri; Akien, Geoffrey; Rochester, David; Middleton, David A.] Univ Lancaster, Dept Chem, Lancaster LA1 4YB, England; [Stewart, Katie L.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Stewart, Katie L.] Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Lancaster University; University of Leeds; Emory University	Middleton, DA (corresponding author), Univ Lancaster, Dept Chem, Lancaster LA1 4YB, England.	d.middleton@lancaster.ac.uk		Radford, Sheena/0000-0002-3079-8039; Townsend, David/0000-0003-2687-6767; Hughes, Eleri/0000-0001-5123-7524; Middleton, David/0000-0002-3227-7632	British Heart Foundation [FS/13/28/30208, PG/16/97/32567]; Biotechnology and Biological Sciences Research Council [BB/K01451X/1, BB/K015958/1]; European Research Council under European Union [322408]; Wellcome Trust [089311/Z/09/Z]	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council under European Union(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by British Heart Foundation Grants FS/13/28/30208 (to E. H.) and PG/16/97/32567 (to D. T.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Biotechnology and Biological Sciences Research Council Grants BB/K01451X/1 and BB/K015958/1.r Recipient of funding from the European Research Council under European Union's Seventh Framework Programme (FP7/2007-) ERC Grant 322408 and Wellcome Trust Grant 089311/Z/09/Z.	Ahmed R, 2017, J AM CHEM SOC, V139, P13720, DOI 10.1021/jacs.7b05012; Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Attar A, 2013, TRANSL NEUROSCI, V4, P385, DOI 10.2478/s13380-013-0137-y; Bibow S, 2017, NAT STRUCT MOL BIOL, V24, P187, DOI 10.1038/nsmb.3345; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BRATZLER RL, 1977, CIRC RES, V40, P182, DOI 10.1161/01.RES.40.2.182; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Dragicevic N, 2011, J ALZHEIMERS DIS, V26, P507, DOI 10.3233/JAD-2011-101629; Eaton JD, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170209; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Elena B, 2005, J AM CHEM SOC, V127, P17296, DOI 10.1021/ja054411x; Engel MFM, 2012, J AM CHEM SOC, V134, P14781, DOI 10.1021/ja3031664; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Galzitskaya OV, 2017, J ALZHEIMERS DIS, V59, P785, DOI 10.3233/JAD-170230; GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Hussain R, 2015, J SYNCHROTRON RADIAT, V22, P465, DOI 10.1107/S1600577514028161; Hyung SJ, 2013, P NATL ACAD SCI USA, V110, P3743, DOI 10.1073/pnas.1220326110; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kisilevsky R, 2007, AMYLOID, V14, DOI 10.1080/13506120601116419; Kristen AV, 2012, CLIN RES CARDIOL, V101, P805, DOI 10.1007/s00392-012-0463-z; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Madine J, 2012, ANGEW CHEM INT EDIT, V51, P13140, DOI 10.1002/anie.201204459; Malmos KG, 2016, J BIOL CHEM, V291, P16849, DOI 10.1074/jbc.M116.715466; Mamos KG, 2017, J MOL BIOL, V429, P2755, DOI 10.1016/j.jmb.2017.07.014; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Mizooku Y, 2003, RAPID COMMUN MASS SP, V17, P1915, DOI 10.1002/rcm.1135; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Nakajima H, 2016, AMYLOID, V23, P17, DOI 10.3109/13506129.2015.1113167; Naumovski N, 2015, ANTIOXIDANTS-BASEL, V4, P373, DOI 10.3390/antiox4020373; O'Brien KD, 1998, CIRCULATION, V98, P519, DOI 10.1161/01.CIR.98.6.519; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Peter B, 2017, EUR BIOPHYS J BIOPHY, V46, P1, DOI 10.1007/s00249-016-1141-2; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Ramella NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; SMITH EB, 1980, ATHEROSCLEROSIS, V37, P579, DOI 10.1016/0021-9150(80)90065-9; Snow AD, 1996, EXP NEUROL, V138, P305, DOI 10.1006/exnr.1996.0069; SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306; SNOW AD, 1990, AM J PATHOL, V137, P1253; Stenvang M, 2016, BIOCHEMISTRY-US, V55, P2344, DOI 10.1021/acs.biochem.6b00063; Stewart KL, 2017, J MOL BIOL, V429, P2449, DOI 10.1016/j.jmb.2017.07.003; Stewart KL, 2016, J AM CHEM SOC, V138, P8328, DOI 10.1021/jacs.6b02816; Townsend D, 2017, BIOCHEMISTRY-US, V56, P1632, DOI 10.1021/acs.biochem.6b01120; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Vilasi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022076; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; Wang H, 2013, J MOL BIOL, V425, P492, DOI 10.1016/j.jmb.2012.11.003; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zhang Z, 2016, GLYCOBIOLOGY, V26, P1443; Zhao J, 2017, RSC ADV, V7, P32508, DOI 10.1039/c7ra03752j	83	11	11	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12877	12893		10.1074/jbc.RA118.002038	http://dx.doi.org/10.1074/jbc.RA118.002038			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29853648	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000442203500020
J	Ch'ng, SW; Irion, LD; Bonshek, R; Shaw, J; Papayannis, A; Pastor-Idoate, S; Stanga, PE				Ch'ng, Soon Wai; Irion, Luciane Dreher; Bonshek, Richard; Shaw, Joseph; Papayannis, Alessandro; Pastor-Idoate, Salvador; Stanga, Paulo Eduardo			Live porcine thirty days delayed recovery surgery: Qualitative findings with the hypersonic vitrectomy	PLOS ONE			English	Article							TISSUE FRAGMENTATION; PHYSICS; MICROSCOPY; ULTRASOUND; LESIONS; RETINA	Introduction Qualitatively assess the possible delayed structural, macroscopic and microscopic changes in the neuro-retina, retinal vasculature, retinal pigment epithelium (RPE) and optic nerve head (ONH) after pars plana vitrectomy (PPV) surgery using a new hypersonic vitrector (HV). Materials and methods Eight live porcine eyes underwent PPV using either the HV or a conventional pneumatic guillotine vitrector (GV). The un-operated fellow eye from each pig was used as an external control. The pigs were post-operatively kept alive for 30 days before termination and enucleation of the eyes. Prior to enucleation, all eyes underwent examination of the lens and indirect ophthalmoscopy. Enucleated eyes were fixed in formalin, examined macroscopically and processed for histological assessment. Microscopic analysis included assessment of neuro-retina, retinal vasculature, RPE and ONH, as well as observation for any morphological intraocular changes. Comparison was made between: (1) treated and untreated areas of the same eye (internal control) (2) different areas within the same eye operated on using different vitrector settings (3) eyes operated on with the HV and GV (4) eyes receiving surgery and the fellow un-operated eye (external control, same pig). Results All lenses had remained clear at 30 days into the postoperative period. On indirect ophthalmoscopy, the retina had remained attached in all eyes with no visible changes to the neuroretina, retinal vasculature, RPE or ONH. Two eyes showed localized RPE depigmentation secondary to previously documented intraoperative retinal touch. The Morphological changes in the retinal layers above depigmented RPE were no different from retinal change elsewhere. There were mild and similar microscopic changes observed in the neuro-retina, retinal vasculature, RPE or ONH associated with either the HV or GV PPVs. Preliminary histological findings revealed no significant differences between eyes operated on with the HV and those operated on the GV. Discussion At 30 days into the postoperative period, there seemed to be similar morphological changes attributable to the use of HV and GV. Therefore, the HV promises to be a new alternative to the currently commercially available GV for PPV.	[Ch'ng, Soon Wai; Bonshek, Richard; Papayannis, Alessandro; Pastor-Idoate, Salvador; Stanga, Paulo Eduardo] Manchester Univ NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Ch'ng, Soon Wai; Papayannis, Alessandro; Pastor-Idoate, Salvador; Stanga, Paulo Eduardo] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Vis Regenerat Lab, Manchester, Lancs, England; [Irion, Luciane Dreher; Bonshek, Richard; Shaw, Joseph] Manchester Univ NHS Fdn Trust, Natl Specialist Ophthalm Pathol Serv, Histopathol Dept, Manchester, Lancs, England; [Stanga, Paulo Eduardo] Univ Manchester, Div Evolut & Genom Sci, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr,Sch Biol Sci, Manchester, Lancs, England	Manchester Royal Eye Hospital; University of Manchester; University of Manchester; University of Manchester	Stanga, PE (corresponding author), Manchester Univ NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.; Stanga, PE (corresponding author), Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Vis Regenerat Lab, Manchester, Lancs, England.; Stanga, PE (corresponding author), Univ Manchester, Div Evolut & Genom Sci, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr,Sch Biol Sci, Manchester, Lancs, England.	mvr.lab@mft.nhs.uk	Papayannis, Alessandro/AAU-3035-2020; PASTOR-IDOATE, SALVADOR/G-2548-2016	Papayannis, Alessandro/0000-0002-4876-7433; PASTOR-IDOATE, SALVADOR/0000-0002-6463-4227; Ch'ng, Soon/0000-0002-7656-297X	Bausch Lomb	Bausch Lomb	Bausch & Lomb provided research funding. Paulo Stanga: Bausch & Lomb: Consultancy, Equipment, Research Funding, Lecture Fees, Travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond LJ, 1996, ULTRASOUND MED BIOL, V22, P101, DOI 10.1016/0301-5629(95)02022-5; BOPP S, 1993, GRAEF ARCH CLIN EXP, V231, P295, DOI 10.1007/BF00919108; CHAN KK, 1986, ULTRASOUND MED BIOL, V12, P279, DOI 10.1016/0301-5629(86)90337-6; Chang I., 2004, BIOMED ENG ONLINE, V3, P1; Cimino WW, 1999, CLIN PLAST SURG, V26, P447; Cimino WW, 1996, ULTRASOUND MED BIOL, V22, P89, DOI 10.1016/0301-5629(95)02021-7; de Nie KF, 2013, GRAEF ARCH CLIN EXP, V251, P1373, DOI 10.1007/s00417-012-2205-3; GIRARD LJ, 1976, T AM ACAD OPHTHALMOL, V81, pP432; JOHNSON NF, 1976, ACTA OPHTHALMOL, V54, P529; KAPLAN LJ, 1983, ANN OPHTHALMOL, V15, P1132; KARLIN DB, 1969, AM J OPHTHALMOL, V68, P84, DOI 10.1016/0002-9394(69)94937-X; MARMOR MF, 1977, INVEST OPHTH VIS SCI, V16, P660; O'Daly B, J MAT PROCESSING TEC, V200, P38; Pastor-Idoate S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173883; Stanga PE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178462; Steel DHW, 2011, OPHTHALMOLOGICA, V226, P27, DOI 10.1159/000328207	16	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197038	10.1371/journal.pone.0197038	http://dx.doi.org/10.1371/journal.pone.0197038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856756	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800009
J	Kanyangarara, M; Walker, N; Boerma, T				Kanyangarara, Mufaro; Walker, Neff; Boerma, Ties			Gaps in the implementation of antenatal syphilis detection and treatment in health facilities across sub-Saharan Africa	PLOS ONE			English	Article							CONGENITAL-SYPHILIS; MATERNAL SYPHILIS; TRANSMISSION; OUTCOMES; NEWBORN; HIV	Background Syphilis in pregnancy is an under-recognized public health problem, especially in sub-Saharan Africa which accounts for over 60% of the global burden of syphilis. If left untreated, more than half of maternal syphilis cases will result in adverse pregnancy outcomes including stillbirth and fetal loss, neonatal death, prematurity or low birth weight, and neonatal infections. Achieving universal coverage of antenatal syphilis screening and treatment has been the focus of the global campaign for the elimination of mother-to-child transmission of syphilis. However, little is known about the availability of antenatal syphilis screening and treatment across sub-Saharan Africa. The objective of this study was to estimate the 'likelihood of appropriate care' for antenatal syphilis screening and treatment by analyzing health facility surveys and household surveys conducted from 2010 to 2015 in 12 sub-Saharan African countries. Methods In this secondary data analysis, we linked indicators of health facility readiness to provide antenatal syphilis detection and treatment from Service Provision Assessments (SPAs) and Service Availability and Readiness Assessments (SARAs) to indicators of ANC use from the Demographic and Health Surveys (DHS) to compute estimates of the 'likelihood of appropriate care'. Results Based on data from 5,593 health facilities that reported offering antenatal care (ANC) services, the availability of syphilis detection and treatment in ANC facilities ranged from 2% to 83%. The availability of syphilis detection and treatment was substantially lower in ANC facilities in West Africa compared to the other sub-regions. Levels of ANC attendance were high (median 94.9%), but only 27% of ANC attendees initiated care at less than 4 months gestation. We estimated that about one in twelve pregnant women received ANC early (< 4 months) at a facility ready to provide syphilis detection and treatment (median 8%, range 7 +/- 32%). The largest implementation bottleneck identified was low health facility readiness, followed by timeliness of the first ANC visit. Conclusions While access was fairly high, the low levels of likelihood of antenatal syphilis detection and treatment identified reinforce the need to improve the availability of syphilis rapid diagnostic tests and treatment and the timeliness of antenatal care-seeking across sub-Saharan Africa.	[Kanyangarara, Mufaro; Walker, Neff] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Boerma, Ties] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Manitoba	Kanyangarara, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	mkanyan1@jhu.edu	Polyakov, Gleb V/A-3515-2014; Izokh, Andrey/O-2456-2013	Walker, Neff/0000-0003-3526-2978				Agyepong IA, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0212-x; [Anonymous], WORLD BANK OP DAT; Baker U, 2015, B WORLD HEALTH ORGAN, V93, P380, DOI 10.2471/BLT.14.141879; Baker Ulrika, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS43, DOI 10.1016/j.ijgo.2015.04.017; Berman SM, 2004, B WORLD HEALTH ORGAN, V82, P433; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Bryce J, 2013, PLOS MED, V10, P1; DHS Program, SERV PROV ASS SPA; Do M, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020501; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gust DA, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e79; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Kanyangarara M, J GLOB HLTH; Kruk ME, 2016, LANCET GLOB HEALTH, P1; Mabey DC, 2012, PUBLIC LIB SCI, V9, P1; Munos MK, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010801; Mwapasa V, 2006, AIDS, V20; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Newman Owiredu Morkor, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS27, DOI 10.1016/j.ijgo.2015.04.010; Nurse-Findlay S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002473; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Pan American Health Organization UNICEF, 2010, REG IN EL MOTH CHILD; Sexton J, 2005, SEX TRANSM DIS, V32, P351, DOI 10.1097/01.olq.0000154504.54686.d1; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; UNAIDS, 2016, GLOB AIDS MON; UNAIDS, **NON-TRADITIONAL**; United Nations Children's Fund, 2014, EL MOTH CHILD TRANSM; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Watson-Jones D., 2002, J INFECT DIS, P186; WHO, PREV MOTH CHILD TRAN; WHO, 2017, WHO GUID SYPH SCREEN; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organization, SERV AV READ ASS SAR; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2017, GLOB GUID CRIT PROC, V2nd	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198622	10.1371/journal.pone.0198622	http://dx.doi.org/10.1371/journal.pone.0198622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856849	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800142
J	Kisiel, LM; Jones-Bitton, A; Sergeant, JM; Coe, JB; Flockhart, DTT; Vargas, EJC; Greer, AL				Kisiel, Luz Maria; Jones-Bitton, Andria; Sergeant, Jan M.; Coe, Jason B.; Flockhart, D. T. Tyler; Canales Vargas, Erick J.; Greer, Amy L.			Modeling the effect of surgical sterilization on owned dog population size in Villa de Tezontepec, Hidalgo, Mexico, using an individual-based computer simulation model	PLOS ONE			English	Article							CANCER; URBAN	Surgical sterilization programs for dogs have been proposed as interventions to control dog population size. Models can be used to help identify the long-term impact of reproduction control interventions for dogs. The objective of this study was to determine the projected impact of surgical sterilization interventions on the owned dog population size in Villa de Tezontepec, Hidalgo, Mexico. A stochastic, individual-based simulation model was constructed and parameterized using a combination of empirical data collected on the demographics of owned dogs in Villa de Tezontepec and data available from the peer-reviewed literature. Model outcomes were assessed using a 20-year time horizon. The model was used to examine: the effect of surgical sterilization strategies focused on: 1) dogs of any age and sex, 2) female dogs of any age, 3) young dogs (i.e., not yet reached sexual maturity) of any sex, and 4) young, female dogs. Model outcomes suggested that as surgical capacity increases from 21 to 84 surgeries/month, (8.6% to 34.5% annual sterilization) for dogs of any age, the mean dog population size after 20 years was reduced between 14% and 79% compared to the base case scenario (i.e. in the absence of intervention). Surgical sterilization interventions focused only on young dogs of any sex yielded greater reductions (81% 90%) in the mean population size, depending on the level of surgical capacity. More focused sterilization targeted at female dogs of any age, resulted in reductions that were similar to focusing on mixed sex sterilization of only young dogs (82% - 92%). The greatest mean reduction in population size (90% - 91%) was associated with sterilization of only young, female dogs. Our model suggests that targeting sterilization to young females could enhance the efficacy of existing surgical dog population control interventions in this location, without investing extra resources.	[Kisiel, Luz Maria; Jones-Bitton, Andria; Sergeant, Jan M.; Coe, Jason B.; Greer, Amy L.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Jones-Bitton, Andria; Sergeant, Jan M.; Greer, Amy L.] Univ Guelph, Ctr Publ Hlth & Zoonoses, Guelph, ON, Canada; [Flockhart, D. T. Tyler] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Canales Vargas, Erick J.] Serv Salud Hidalgo, Rabies & Zoonoses Prevent Program, Mineral De La Reforma, Hidalgo, Mexico	University of Guelph; University of Guelph; University of Guelph	Kisiel, LM; Greer, AL (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.; Greer, AL (corresponding author), Univ Guelph, Ctr Publ Hlth & Zoonoses, Guelph, ON, Canada.	luzmaria_k@yahoo.com; agreer@uoguelph.ca			Mathematics of Information Technology and Complex Systems (MITACS) Globalinks Award [IT05893]; Canada Research Chairs Program; Health Services of the State of Hidalgo	Mathematics of Information Technology and Complex Systems (MITACS) Globalinks Award; Canada Research Chairs Program(Canada Research Chairs); Health Services of the State of Hidalgo	The authors gratefully acknowledge a Mathematics of Information Technology and Complex Systems (MITACS) Globalinks Award (IT05893) (to LMK) and the Canada Research Chairs Program (to ALG) for funding, as well as in kind funding provided by Health Services of the State of Hidalgo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaku M, 2009, REV PANAMERICANA SAL, V25; Amaku M, 2010, MATH POPUL STUD, V17, P69, DOI 10.1080/08898481003689452; [Anonymous], 2019, OIE TERRESTRIAL ANIM; BECK AM, 1975, AM J PUBLIC HEALTH, V65, P1315, DOI 10.2105/AJPH.65.12.1315; Belo VS, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0187233, 10.1371/Journal.pone.0187233]; Boitani L, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P147, DOI 10.1079/9781845931872.0147; BRENDLER CB, 1983, J CLIN INVEST, V71, P1114, DOI 10.1172/JCI110861; Di Nardo A, 2007, PREV VET MED, V82, P308, DOI 10.1016/j.prevetmed.2007.06.007; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Fielding WJ, 2010, INT J BAHAMIAN STUDI, V16, P63, DOI [10.15362/ijbs.v16i0.119, DOI 10.15362/IJBS.V16I0.119]; FISHBEIN DB, 1992, AM J TROP MED HYG, V47, P317; Gabriel Botella F, 1991, DEMOGRAFIA CANINA FE, V6; Hoffman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061082; Howe LM, 2006, THERIOGENOLOGY, V66, P500, DOI 10.1016/j.theriogenology.2006.04.005; Ibarra L, 1997, AVANCES CIENCIAS VET, V12; Instituto Nacional de Estadfstica, 2010, GEOGR INF; International Companion Animal Management Coalition, 2008, HUM DOG POP MAN GUID; Jana K, 2007, CONTRACEPTION, V75, P390, DOI 10.1016/j.contraception.2007.01.022; Kisiel LM, 2016, PREV VET MED, V135, P37, DOI 10.1016/j.prevetmed.2016.10.021; Kustritz MVR, 2014, VET CLIN N AM-SMALL, V44, P221, DOI 10.1016/j.cvsm.2013.10.002; Kutzler MA, 2003, THERIOGENOLOGY, V60, P1309, DOI 10.1016/S0093-691X(03)00146-8; Morales MA, 1979, ARCHIVO MEDICINA VET, V10, p161 ; Morales MA, 1992, CHILE AVANCES CIENCI, V7; Ortega-Pacheco A, 2007, ANTHROZOOS, V20, P261, DOI 10.2752/089279307X224809; Root Kustritz MV, 2010, CLIN CANINE FELINE R; Salamanca C. A, 2011, Rev. Med. Vet. Zoot., V58, P45; Baquero OS, 2016, PREV VET MED, V123, P121, DOI 10.1016/j.prevetmed.2015.11.009; SCHNEIDER R, 1969, JNCI-J NATL CANCER I, V43, P1249; Secretaria de Salud, 2015, LIN GEN OP INT EST Q; Totton SC, 2010, PREV VET MED, V97, P51, DOI 10.1016/j.prevetmed.2010.07.009; Vascellari M, 2016, PREV VET MED, V126, P183, DOI 10.1016/j.prevetmed.2016.02.008; Yoak AJ, 2016, ECOL MODEL, V341, P53, DOI 10.1016/j.ecolmodel.2016.09.018	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198209	10.1371/journal.pone.0198209	http://dx.doi.org/10.1371/journal.pone.0198209			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856830	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800085
J	Mawatari, S; Oda, K; Tabu, K; Ijuin, S; Kumagai, K; Fujisaki, K; Hashiguchi, M; Inada, Y; Uto, H; Hiramine, Y; Kure, T; Hori, T; Taniyama, O; Kasai, A; Tamai, T; Moriuchi, A; Ido, A				Mawatari, Seiichi; Oda, Kohei; Tabu, Kazuaki; Ijuin, Sho; Kumagai, Kotaro; Fujisaki, Kunio; Hashiguchi, Masafumi; Inada, Yukiko; Uto, Hirofumi; Hiramine, Yasunari; Kure, Takeshi; Hori, Takeshi; Taniyama, Oki; Kasai, Ai; Tamai, Tsutomu; Moriuchi, Akihiro; Ido, Akio			The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir	PLOS ONE			English	Article							INHIBITOR BMS-790052; NUCLEOTIDE INHIBITOR; VARIANTS RESISTANT; INFECTED PATIENTS; TREATMENT-NAIVE; IN-VITRO; DACLATASVIR; ASUNAPREVIR; COMBINATION; THERAPY	Objective The present study aimed to reveal the factors associated with virologic failure in sofosbuvir and ledipasvir (SOF/LDV)-treated patients, and identify baseline NS5A or NS5B resistance-associated substitutions (RASs). Methods Four hundred ninety-three patients with Hepatitis C Virus (HCV) genotype 1b infection were treated with SOF/LDV; 31 had a history of interferon (IFN)-free treatment with daclatasvir and asunaprevir. The effect of baseline RASs on the response to SOF/LDV therapy was analyzed. Results Overall, a sustained virologic response at 12 weeks (SVR12) was achieved in 476 patients (96.6%). The SVR12 rates in the patients with IFN-free treatment-naive and retreatment were 97.6% and 80.6%, respectively. HCV elimination was not achieved in 17 patients, 11 (including 5 with IFN-free retreatment) of whom had virologic failure. Eight patients had coexisting NS5A RASs of Q24, L28 and/or R30, L31, or Y93 and one patient had coexisting NS5A RASs of P32L and A92K. Interestingly, 10 and 8 patients had NS5B A218S and C316N RAS respectively. According to a multivariate analysis, coexisting NS5A RASs, NS5A P32 RAS, NS5B A218 and/or C316 RASs, and gamma-glutamyltranspeptidase were associated with virologic failure. In the naive patients, all patients without NS5B A218 and/or C316 RAS achieved an SVR12. Notably, the SVR12 rates of patients with coexisting NS5A and NS5B RASs were significantly lower (83.3%). Conclusions Although SOF/LDV therapy resulted in a high SVR12 rate, coexisting NS5A and NS5B RASs were associated with virologic failure. These results might indicate that the coexisting baseline RASs influence the therapeutic effects of SOF/LDV.	[Mawatari, Seiichi; Oda, Kohei; Tabu, Kazuaki; Ijuin, Sho; Kumagai, Kotaro; Hashiguchi, Masafumi; Uto, Hirofumi; Kure, Takeshi; Taniyama, Oki; Kasai, Ai; Tamai, Tsutomu; Moriuchi, Akihiro; Ido, Akio] Kagoshima Univ, Dept Human & Environm Sci, Digest & Lifestyle Dis, Grad Sch Med & Dent Sci, Sakuragaoka, Kagoshima, Japan; [Oda, Kohei; Ido, Akio] Kagoshima Univ, Dept HGF Tissue Repair & Regenerat Med, Grad Sch Med & Dent Sci, Sakuragaoka, Kagoshima, Japan; [Kumagai, Kotaro; Hori, Takeshi; Taniyama, Oki] Kagoshima City Hosp, Dept Gastroenterol & Hepatol, Uearata Cho, Kagoshima, Japan; [Fujisaki, Kunio; Hashiguchi, Masafumi] Kirishima Med Ctr, Dept Hepatol, Hayato Cho, Kirishima, Kagoshima, Japan; [Inada, Yukiko; Uto, Hirofumi] Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Takamatsu Cho, Miyazaki, Japan; [Hiramine, Yasunari; Kure, Takeshi] Kagoshima Kouseiren Hosp, Dept Internal Med, Tenpozan Cho, Kagoshima, Japan	Kagoshima University; Kagoshima University; Kagoshima City Hospital	Mawatari, S (corresponding author), Kagoshima Univ, Dept Human & Environm Sci, Digest & Lifestyle Dis, Grad Sch Med & Dent Sci, Sakuragaoka, Kagoshima, Japan.	mawatari@m2.kufm.kagoshima-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Eisai Co., Ltd; Minophagen Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Bristol-Myers Squibb Co., Ltd; MSD Co., Ltd.	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Eisai Co., Ltd(Eisai Co Ltd); Minophagen Pharmaceutical Co., Ltd.; Eisai Co., Ltd.(Eisai Co Ltd); Bristol-Myers Squibb Co., Ltd(Bristol-Myers Squibb); MSD Co., Ltd.	This work was supported in part by a grant-in-aid from the Ministry of Health, Labour and Welfare of Japan. There was no additional external funding received for this study. K.O. and A. I. belong to donated fund laboratory funded by Eisai Co., Ltd, and Minophagen Pharmaceutical Co., Ltd. Al. received honoraria from Bristol-Myers Squibb Co., Ltd., MSD Co., Ltd., Gilead Sciences Co., Ltd., and Abbvie Inc., and received research funding from Eisai Co., Ltd., Bristol-Myers Squibb Co., Ltd, and MSD Co., Ltd.. None of the other authors has a conflict of interest to disclose. The funders (Eisai Co., Ltd, and Minophagen Pharmaceutical Co., Ltd.) provided support in the form of salaries for authors [K.O. and but the all funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Akuta N, 2017, J MED VIROL, V89, P284, DOI 10.1002/jmv.24617; Backus LI, 2016, HEPATOLOGY, V64, P405, DOI 10.1002/hep.28625; Donaldson EF, 2015, HEPATOLOGY, V61, P56, DOI 10.1002/hep.27375; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Iio E, 2017, HEPATOL RES, V47, P1308, DOI 10.1111/hepr.12898; Iio E, 2017, J GASTROENTEROL, V52, P94, DOI 10.1007/s00535-016-1225-x; Ito J, 2016, HEPATOL RES, V46, P1294, DOI 10.1111/hepr.12685; Kai Y, 2015, J GASTROENTEROL, V50, P1145, DOI 10.1007/s00535-015-1108-6; Kawakami Y, 2018, J GASTROENTEROL, V53, P548, DOI 10.1007/s00535-017-1380-8; Kumada H, 2018, J GASTROENTEROL, V53, P566, DOI 10.1007/s00535-017-1396-0; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lusida MI, 2001, J CLIN MICROBIOL, V39, P3858, DOI 10.1128/JCM.39.11.3858-3864.2001; Mawatari S, 2017, J GASTROENTEROL, V52, P855, DOI 10.1007/s00535-016-1303-0; Mizokami M, 2016, J VIRAL HEPATITIS, V23, P780, DOI 10.1111/jvh.12549; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Ogawa E, 2017, J GASTROENTEROL, V52, P845, DOI 10.1007/s00535-016-1290-1; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826; Sarrazin C, 2016, GASTROENTEROLOGY, V151, P501, DOI 10.1053/j.gastro.2016.06.002; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Sciences G, 2015, HARVONI COMB TABL SO; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Suda G, 2017, J GASTROENTEROL, V52, P1122, DOI 10.1007/s00535-017-1328-z; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Svarovskaia ES, 2016, J INFECT DIS, V213, P1240, DOI 10.1093/infdis/jiv564; Terrault NA, 2016, GASTROENTEROLOGY, V151, P1131, DOI 10.1053/j.gastro.2016.08.004; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Uchida Y, 2016, HEPATOL RES, V46, P1234, DOI 10.1111/hepr.12673; Uemura H, 2018, HEPATOL RES, V48, P233, DOI 10.1111/hepr.12980; Xu SM, 2017, ANTIVIR THER, V22, P587, DOI 10.3851/IMP3149	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198642	10.1371/journal.pone.0198642	http://dx.doi.org/10.1371/journal.pone.0198642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856885	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800146
J	Portal, C; Gouyer, V; Leonard, R; Husson, MO; Gottrand, F; Desseyn, JL				Portal, Celine; Gouyer, Valerie; Leonard, Renaud; Husson, Marie-Odile; Gottrand, Frederic; Desseyn, Jean-Luc			Long-term dietary (n-3) polyunsaturated fatty acids show benefits to the lungs of Cftr F508del mice	PLOS ONE			English	Article							CYSTIC-FIBROSIS MICE; CFTR(-/-) MICE; PSEUDOMONAS-AERUGINOSA; INDUCED INFLAMMATION; PULMONARY-FUNCTION; MOUSE MODEL; GROWTH; DEFICIENCY; AZITHROMYCIN; EXPRESSION	Introduction The pro-inflammatory status of cystic fibrosis (CF) patients promotes pulmonary colonization with opportunist and pathogenic bacteria, which is favored by a sticky mucus. Oral supplementation with (n-3) long chain polyunsaturated fatty acids (LC-PUFA) has shown antiinflammatory effects. The aim of this study was to demonstrate the positive effects of a longterm diet enriched in (n-3) LC-PUFA on the lungs of Cftr F508del mice. Materials and methods Breeding Cftr Delta F508del/+ mice received a control diet or a diet enriched in (n-3) LC-PUFA for 5 weeks before mating, gestation and lactation. After weaning, the offspring were given the same diet as their mother until post-natal day 60. The effects of (n-3) LC-PUFA supplementation on the lungs were evaluated in homozygous Cftr F508del mice and their wild-type littermates after acute lung inflammation induced by Pseudomonas aeruginosa lipopolysaccharide (LPS) inhalation. Results (n-3) LC-PUFA enrichment of mothers contributes to enrichment of mammary milk and cell membrane of suckling pups. Cftr F508del mice exhibited growth retardation and lung damage with collapsed alveoli, hyperplasia of bronchial epithelial cells and inflammatory cell infiltration. The (n-3) LC-PUFA diet corrected the growth delay of Cftr F508del mice and decreased hyperplasia of bronchial epithelial cells. Besides decreasing metaplasia of Club cells after LPS inhalation, (n-3) LC-PUFA modulated lung inflammation and restricted lung damage. Conclusion Long-term (n-3) LC-PUFA supplementation shows moderate benefits to the lungs of Cftr F508del mice.	[Portal, Celine; Gouyer, Valerie; Husson, Marie-Odile; Gottrand, Frederic; Desseyn, Jean-Luc] Univ Lille, LIRIC UMR 995, CHU Lille, Inserm, Lille, France; [Leonard, Renaud] Univ Lille, UGSF UMR 8576, CNRS, Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Desseyn, JL (corresponding author), Univ Lille, LIRIC UMR 995, CHU Lille, Inserm, Lille, France.	jean-luc.desseyn@inserm.fr	Desseyn, Jean-Luc/M-5070-2018; Gouyer, Valérie/R-4984-2018; Portal, Celine/AAC-9407-2020; gottrand, frederic/G-7370-2015	Desseyn, Jean-Luc/0000-0001-6876-8049; Gouyer, Valérie/0000-0002-4223-7060; Portal, Celine/0000-0002-1862-0166; gottrand, frederic/0000-0002-5290-0436	French Cystic Fibrosis Association "Vaincre la Mucoviscidose"; French Foundation on Digestive Tract Diseases and Nutrition "DigestScience"; Universite Lille 2 fellowship	French Cystic Fibrosis Association "Vaincre la Mucoviscidose"; French Foundation on Digestive Tract Diseases and Nutrition "DigestScience"; Universite Lille 2 fellowship	This work was supported by the French Cystic Fibrosis Association "Vaincre la Mucoviscidose" and the French Foundation on Digestive Tract Diseases and Nutrition "DigestScience". C.P. is the recipient of a Universite Lille 2 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Turkmani MR, 2007, PROSTAG LEUKOTR ESS, V77, P309, DOI 10.1016/j.plefa.2007.10.009; Aldamiz-Echevarria L, 2009, PEDIATR RES, V66, P585, DOI 10.1203/PDR.0b013e3181b4e8d3; Bergamini G, 2009, AM J RESP CELL MOL, V41, P199, DOI 10.1165/rcmb.2008-0013OC; Bilsborough J, 2008, CLIN EXP ALLERGY, V38, P1959, DOI 10.1111/j.1365-2222.2008.03099.x; Bruscia EM, 2016, INCREASED SUSCEPTIBI, V310, pL711; BYARD PJ, 1990, ANN HUM BIOL, V17, P483, DOI 10.1080/03014469000001262; Delayre-Orthez C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-91; Dhooghe B, 2014, CLIN BIOCHEM, V47, P539, DOI 10.1016/j.clinbiochem.2013.12.020; Freedman SD, 2002, J APPL PHYSIOL, V92, P2169, DOI 10.1152/japplphysiol.00927.2001; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Giudetti AM, 2012, PROSTAG OTH LIPID M, V99, P57, DOI 10.1016/j.prostaglandins.2012.09.006; Hecker M, 2015, EXP LUNG RES, V41, P393, DOI 10.3109/01902148.2015.1046200; Husson MO, 2016, J INFECTION, V73, P523, DOI 10.1016/j.jinf.2016.10.001; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Konstan MW, 2003, J PEDIATR-US, V142, P624, DOI 10.1067/mpd.2003.152; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Lubamba B, 2012, J CYST FIBROS, V11, P266, DOI 10.1016/j.jcf.2012.03.003; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Mimoun M, 2009, J NUTR, V139, P2358, DOI 10.3945/jn.109.110999; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Oliver C, 2013, COCHRANE DB SYST REV, V11; Palomo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114884; Reynders V, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-104; Rosenberg LA, 2006, PEDIATR RES, V59, P191, DOI 10.1203/01.pdr.0000196720.25938.be; Roulet M, 1997, EUR J PEDIATR, V156, P952, DOI 10.1007/s004310050750; Sinaasappel M, 2002, J Cyst Fibros, V1, P51, DOI 10.1016/S1569-1993(02)00032-2; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Strandvik B, 2001, J PEDIATR-US, V139, P650, DOI 10.1067/mpd.2001.118890; Tetaert D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-39; Tiesset H, 2011, J NUTR, V141, P1101, DOI 10.3945/jn.110.134585; Tiesset H, 2009, J NUTR, V139, P82, DOI 10.3945/jn.108.096115; Tirkos S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-51; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Verhaeghe C, 2007, J CYST FIBROS, V6, P304, DOI 10.1016/j.jcf.2006.12.001; Viera AJ, 2005, FAM MED, V37, P360; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wouthuyzen-Bakker M, 2011, J CYST FIBROS, V10, P150, DOI 10.1016/j.jcf.2011.03.008; Wu HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093003; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; Zemel BS, 2000, J PEDIATR-US, V137, P374, DOI 10.1067/mpd.2000.107891	43	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197808	10.1371/journal.pone.0197808	http://dx.doi.org/10.1371/journal.pone.0197808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856782	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800041
J	van de Water, A; Matteson, K				van de Water, Antoinette; Matteson, Kevin			Human-elephant conflict in western Thailand: Socio-economic drivers and potential mitigation strategies	PLOS ONE			English	Article							ASIAN ELEPHANTS; PROTECTED AREA; ATTITUDES; PERCEPTIONS; WILDLIFE; CONSERVATION; INDIA; PATTERNS; MAXIMUS; KENYA	Understanding human-wildlife conflict is an important first step in the conservation of highly endangered species that can have adverse effects on human communities, such as elephants. To gain insights into variables that shape attitudes toward elephant conservation in Asia, we surveyed 410 households and 46 plantation owners in seven villages around the Salakpra Wildlife Sanctuary in western Thailand, an area of high human-elephant conflict. We sought to evaluate how past experiences with elephants (positive or negative), as well as socio-economic variables (age, income level, gender, and employment type) affect attitudes toward elephant conservation and coexistence in this area. In addition, we quantified deterrence methods currently used and identify potential mitigation strategies supported by community members. In general, less supportive attitudes toward elephant conservation and coexistence were held by individuals older than 35 years of age, those who had previously had experienced negative interactions with elephants, those with lower incomes, and those working in the agricultural sector. Conversely, those who had received benefits from living near elephants (e.g., supplemental income or feelings of pride from hosting volunteers or participating in conservation work) had more supportive views of elephant coexistence. Plantation owners reported using a variety of deterrence methods with varying success, with firecrackers being the most commonly utilized method. Community members identified several potentially beneficial mitigation strategies including forest restorations and patrol teams, adding water sources to wild elephant habitat, and education of local school and community groups. Overall, our results highlight the value of community members receiving benefits from living near elephants and suggest that special incentives may be needed for demographic groups disproportionately affected by elephants (e.g. those at lower income levels, those working in agriculture). A combination of these and other approaches will be required if human-elephant coexistence in western Thailand is to be realized.	[van de Water, Antoinette; Matteson, Kevin] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [van de Water, Antoinette] Bring Elephant Home Fdn, Chiang Mai, Thailand	University System of Ohio; Miami University	van de Water, A (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.; van de Water, A (corresponding author), Bring Elephant Home Fdn, Chiang Mai, Thailand.	vandewa@miamioh.edu	Matteson, Kevin/AAH-2333-2021	Matteson, Kevin/0000-0003-4526-9890; Van de Water, Antoinette/0000-0001-9410-5417	Ecosystem Partnership Fund (CEPF) of the International Union for Conservation of Nature and Natural Resources (IUCN); AW [77636000, CEPF-034]	Ecosystem Partnership Fund (CEPF) of the International Union for Conservation of Nature and Natural Resources (IUCN); AW	This work was supported by the Ecosystem Partnership Fund (CEPF) of the International Union for Conservation of Nature and Natural Resources (IUCN) (https://www.iucn.org/ regions/asia/our-work/regional-projects/critical-ecosystempartnership-fund-cepf) in 2015 for the Conservation Leadership Program of Bring the Elephant Home. The study conducted by AW was part of this program (Ref1 IUCN Project no: 77636000, Ref2 Grant Contract no: CEPF-034). The	Bal P, 2011, ENVIRON MANAGE, V48, P263, DOI 10.1007/s00267-011-9718-0; Barnes R.F.W., 2002, Pachyderm, V33, P96; Bauer H, 2003, ENVIRON CONSERV, V30, P175, DOI 10.1017/S037689290300016X; Chaiyarat R, 2015, ENDANGER SPECIES RES, V29, P95, DOI 10.3354/esr00706; Chen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162035; Choudhury A, 2008, IUCN RED LIST THREAT; Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601; Fernando P, 2005, BIODIVERS CONSERV, V14, P2465, DOI 10.1007/s10531-004-0216-z; Fernando Prithiviraj, 2011, Gajah, V35, P15; Gadd ME, 2005, ENVIRON CONSERV, V32, P50, DOI 10.1017/S0376892905001918; Goswami VR, 2017, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.7016.00144; Gross EM, 2016, J PEST SCI, V89, P497, DOI 10.1007/s10340-015-0699-2; Hill CM, 1998, ENVIRON CONSERV, V25, P244, DOI 10.1017/S0376892998000307; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; Jasmine Biba, 2015, Journal of Threatened Taxa, V7, P6843, DOI 10.11609/JoTT.o3914.6843-52; Karanth KK, 2013, ENVIRON MANAGE, V52, P1320, DOI 10.1007/s00267-013-0162-1; King LE, 2017, CONSERV BIOL, V31, P743, DOI 10.1111/cobi.12898; Leimgruber P, 2003, ANIM CONSERV, V6, P347, DOI 10.1017/S1367943003003421; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Nsonsi F, 2017, CONSERV SOC, V15, P59, DOI 10.4103/0972-4923.201394; Ogra MV, 2008, GEOFORUM, V39, P1408, DOI 10.1016/j.geoforum.2007.12.004; Osborn FV, 2002, J WILDLIFE MANAGE, V66, P674, DOI 10.2307/3803133; Ponnusamy Vanitha, 2016, Gajah, V45, P4; Sitati NW, 2006, ORYX, V40, P279, DOI 10.1017/S0030605306000834; Slotow R, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P91, DOI 10.1007/978-1-4614-0902-1_6; Srikrachang M., P FAVA; Sukumar R., 2006, International Zoo Yearbook, V40, P1, DOI 10.1111/j.1748-1090.2006.00001.x; Sukumar R., 1992, ASIAN ELEPHANT ECOLO; Suryawanshi KR, 2014, CONSERV BIOL, V28, P1657, DOI 10.1111/cobi.12320; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Vollrath F, 2002, NATURWISSENSCHAFTEN, V89, P508, DOI 10.1007/s00114-002-0375-2; Wilson S, 2015, ORYX, V49, P140, DOI 10.1017/S0030605313000513	32	20	21	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0194736	10.1371/journal.pone.0194736	http://dx.doi.org/10.1371/journal.pone.0194736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856740	gold, Green Published			2022-12-26	WOS:000433900800002
J	Park, YS; Koh, K; Kwon, YJ; Lee, O; Shim, JK				Park, Yang Sun; Koh, Kyung; Kwon, Yun Joon; Lee, Okjin; Shim, Jae Kun			Aging differentially affects online control and offline control in finger force production	PLOS ONE			English	Article							AGE-RELATED-CHANGES; PRODUCTION TASKS; PREHENSION SYNERGIES; OLDER-ADULTS; 3 DIMENSIONS; HAND; SUPERPOSITION; COORDINATION; VARIABILITY; PERFORMANCE	Human central nervous system (CNS) undergoes neurological changes during the aging process, leading to declines in hand and finger functions. Previous studies have shown that the CNS can independently process multi-finger force control and moment of force control. However, if both force and moment control are simultaneously imposed by motor task constraints, the CNS needs to resolve competing interests of generating negative and positive covariances between fingers, respectively, which causes "conflict of interest or COI". Here, we investigated how aging affects the CNS's abilities to solve COI through a new experimental paradigm. Both elderly and young subjects performed a constant force production task using index and middle fingers under two conditions, multi-finger pressing with no COI and with COI. We found that the elderly increased variance of a virtual finger (VF: an imagined finger producing the same mechanical effect as both fingers together) in time-to-time basis (i.e. online control), while increasing covariance between individual fingers (IF) forces in trial-to-trial basis (i.e. offline control) with COI than no COI. Aging affects the CNS's abilities to solve COI by deteriorating VF actions in online control and IF actions in offline control.	[Park, Yang Sun] Hanyang Univ, Dept Phys Educ, Seoul, South Korea; [Park, Yang Sun; Koh, Kyung] Hanyang Univ, Res Inst Sports Sci & Sports Ind, Movement Sci Ctr, Seoul, South Korea; [Koh, Kyung; Kwon, Yun Joon; Shim, Jae Kun] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA; [Kwon, Yun Joon; Shim, Jae Kun] Kyung Hee Univ, Coll Engn, Dept Mech Engn, Yongin, South Korea; [Lee, Okjin] Kwangwoon Univ, Dept Sports & Leisure Studies, Seoul, South Korea; [Koh, Kyung] Univ Maryland, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA	Hanyang University; Hanyang University; University System of Maryland; University of Maryland College Park; Kyung Hee University; Kwangwoon University; University System of Maryland; University of Maryland Baltimore	Shim, JK (corresponding author), Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA.; Shim, JK (corresponding author), Kyung Hee Univ, Coll Engn, Dept Mech Engn, Yongin, South Korea.	jkshim@umd.edu	Shim, Jae Kun/M-8248-2018	Shim, Jae Kun/0000-0001-8880-4684	Transnational Research Center for Rehabilitation Robots [NRCTR-EX17009]; National Rehabilitation Center, Ministry of Health and Welfare, Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [R1D1A1A09918167]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2012R1A6A3A04040457]	Transnational Research Center for Rehabilitation Robots; National Rehabilitation Center, Ministry of Health and Welfare, Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported in part by grants of the Transnational Research Center for Rehabilitation Robots (NRCTR-EX17009), National Rehabilitation Center, Ministry of Health and Welfare, Korea, and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (R1D1A1A09918167). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2012R1A6A3A04040457).	Arbib M.A., 1985, EXP BRAIN RES S, V10, P111, DOI DOI 10.1007/978-3-642-70105-4_; Arimoto S, 2001, ROBOTICA, V19, P21, DOI 10.1017/S0263574700002939; Baud-Bovy G, 2001, J NEUROPHYSIOL, V86, P604, DOI 10.1152/jn.2001.86.2.604; Bemben MG, 1998, SPORTS MED, V25, P259, DOI 10.2165/00007256-199825040-00004; Boatright JR, 1997, J HAND SURG-AM, V22A, P843, DOI 10.1016/S0363-5023(97)80079-2; Cole KJ, 1999, J NEUROSCI, V19, P3238; Danion F, 2003, BIOL CYBERN, V88, P91, DOI 10.1007/s00422-002-0336-z; GALGANSKI ME, 1993, J NEUROPHYSIOL, V69, P2108, DOI 10.1152/jn.1993.69.6.2108; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Hughes S, 1997, J AM GERIATR SOC, V45, P905, DOI 10.1111/j.1532-5415.1997.tb02957.x; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; KILBREATH SL, 1994, J PHYSIOL-LONDON, V479, P487, DOI 10.1113/jphysiol.1994.sp020312; Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401; Koh K, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhum.2016.00260, 10.33389/fnhum.2016.00260]; Koh K, 2015, EXP BRAIN RES, V233, P2539, DOI 10.1007/s00221-015-4325-6; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; Martin JR, 2009, EXP BRAIN RES, V192, P293, DOI 10.1007/s00221-008-1615-2; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Olafsdottir HB, 2008, J APPL PHYSIOL, V105, P1166, DOI 10.1152/japplphysiol.00054.2008; Oliveira MA, 2008, HUM MOVEMENT SCI, V27, P714, DOI 10.1016/j.humov.2008.04.005; Schieber MH, 2001, J NEUROSCI, V21, P2150, DOI 10.1523/JNEUROSCI.21-06-02150.2001; SCHIEBER MH, 1991, J NEUROPHYSIOL, V65, P1381, DOI 10.1152/jn.1991.65.6.1381; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Shim JK, 2005, J NEUROPHYSIOL, V93, P3649, DOI 10.1152/jn.01262.2004; Shim JK, 2005, J NEUROPHYSIOL, V93, P766, DOI 10.1152/jn.00764.2004; Shinohara M, 2004, EXP BRAIN RES, V156, P282, DOI 10.1007/s00221-003-1786-9; Shinohara M, 2003, J APPL PHYSIOL, V95, P1361, DOI 10.1152/japplphysiol.00070.2003; Shinohara M, 2003, J APPL PHYSIOL, V94, P259, DOI 10.1152/japplphysiol.00643.2002; Singh T, 2013, J APPL PHYSIOL, V115, P456, DOI 10.1152/japplphysiol.00375.2013; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaportzis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060265; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Winegard KJ, 1997, J GERONTOL A-BIOL, V52, pB337, DOI 10.1093/gerona/52A.6.B337; Zatsiorsky VM, 2004, ROBOTICA, V22, P231, DOI 10.1017/S0263574703005344; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261; Zatsiorsky VM., 1998, HUMAN KINETICS; Zhang W, 2008, J NEUROPHYSIOL, V99, P500, DOI 10.1152/jn.01029.2007	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198084	10.1371/journal.pone.0198084	http://dx.doi.org/10.1371/journal.pone.0198084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29851967	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200029
J	Gantner, J; Ordon, J; Ilse, T; Kretschmer, C; Gruetzner, R; Lofke, C; Dagdas, Y; Burstenbinder, K; Marillonnet, S; Stuttmann, J				Gantner, Johannes; Ordon, Jana; Ilse, Theresa; Kretschmer, Carola; Gruetzner, Ramona; Loefke, Christian; Dagdas, Yasin; Buerstenbinder, Katharina; Marillonnet, Sylvestre; Stuttmann, Johannes			Peripheral infrastructure vectors and an extended set of plant parts for the Modular Cloning system	PLOS ONE			English	Article							HYPERSENSITIVE RESPONSE; AVIRULENCE GENE; III EFFECTORS; XANTHOMONAS; PROTEINS; RECOGNITION; RESISTANCE; IDENTIFICATION; CONSTRUCTION; EXPRESSION	Standardized DNA assembly strategies facilitate the generation of multigene constructs from collections of building blocks in plant synthetic biology. A common syntax for hierarchical DNA assembly following the Golden Gate principle employing Type IIs restriction endonucleases was recently developed, and underlies the Modular Cloning and GoldenBraid systems. In these systems, transcriptional units and/or multigene constructs are assembled from libraries of standardized building blocks, also referred to as phytobricks, in several hierarchical levels and by iterative Golden Gate reactions. Here, a toolkit containing further modules for the novel DNA assembly standards was developed. Intended for use with Modular Cloning, most modules are also compatible with GoldenBraid. Firstly, a collection of approximately 80 additional phytobricks is provided, comprising e.g. modules for inducible expression systems, promoters or epitope tags. Furthermore, DNA modules were developed for connecting Modular Cloning and Gateway cloning, either for toggling between systems or for standardized Gateway destination vector assembly. Finally, first instances of a "peripheral infrastructure" around Modular Cloning are presented: While available toolkits are designed for the assembly of plant transformation constructs, vectors were created to also use coding sequence-containing phytobricks directly in yeast two hybrid interaction or bacterial infection assays. The presented material will further enhance versatility of hierarchical DNA assembly strategies.	[Gantner, Johannes; Ordon, Jana; Ilse, Theresa; Kretschmer, Carola; Stuttmann, Johannes] Martin Luther Univ Halle Seale, Inst Biol, Dept Plant Genet, Halle, Germany; [Gruetzner, Ramona; Marillonnet, Sylvestre] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany; [Loefke, Christian; Dagdas, Yasin] Austrian Acad Sci, Vienna BioCtr VBC, GMI, Vienna, Austria; [Buerstenbinder, Katharina] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Leibniz Institut fur Pflanzenbiochemie	Stuttmann, J (corresponding author), Martin Luther Univ Halle Seale, Inst Biol, Dept Plant Genet, Halle, Germany.	johannes.stuttmann@genetik.uni-halle.de		Burstenbinder, Katharina/0000-0002-3493-4800; Stuttmann, Johannes/0000-0002-6207-094X; Gantner, Johannes/0000-0003-3961-8660; Ordon, Jana/0000-0001-8764-6418	GRC [STU 642-1/1]; DFG [CRC 648]	GRC(Science Foundation Ireland); DFG(German Research Foundation (DFG))	This work was funded by GRC grant STU 642-1/1 (Deutsche Forschungsgemeinschaft, DFG) and seed funding by the CRC 648 (DFG) to Johannes Stuttmann. Ulla Bonas is acknowledged for generous support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlung N, 2017, PLANT J, V91, P430, DOI 10.1111/tpj.13578; Adlung N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01796; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Burstenbinder K, 2017, PLANT PHYSIOL, V173, P1692, DOI 10.1104/pp.16.01743; Buttner D, 2016, FEMS MICROBIOL REV, V40, P894, DOI 10.1093/femsre/fuw026; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504; Erickson JL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-127; Fabro G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002348; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Hecker A, 2015, PLANT PHYSIOL, V168, P776, DOI 10.1104/pp.15.00533; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kirchner SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071030, 10.1371/journal.pone.0076117]; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lampropoulos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083043; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Li W, 2017, MOL PLANT PATHOL, V18, P489, DOI 10.1111/mpp.12411; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Moore SJ, 2016, ACS SYNTH BIOL, V5, P1059, DOI 10.1021/acssynbio.6b00031; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ordon J, 2017, PLANT J, V89, P155, DOI 10.1111/tpj.13319; Patron N, 2015, NEW PHYTOL, V208, P13, DOI 10.1111/nph.13532; Perez-Gonzalez A, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0393-y; Picard Didier, 1993, Trends in Cell Biology, V3, P278, DOI 10.1016/0962-8924(93)90057-8; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Schlucking K, 2013, MOL PLANT, V6, P1814, DOI 10.1093/mp/sst065; Schreiber T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120214; Schultink A, 2017, PLANT J, V92, P787, DOI 10.1111/tpj.13715; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Szczesny R, 2010, NEW PHYTOL, V187, P1058, DOI 10.1111/j.1469-8137.2010.03346.x; Thomas WJ, 2009, PLANT J, V60, P919, DOI 10.1111/j.1365-313X.2009.03998.x; Vazquez-Vilar M, 2017, NUCLEIC ACIDS RES, V45, P2196, DOI 10.1093/nar/gkw1326; Wagner S, 2013, CELL HOST MICROBE, V14, P619, DOI 10.1016/j.chom.2013.11.006; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	50	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197185	10.1371/journal.pone.0197185	http://dx.doi.org/10.1371/journal.pone.0197185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847550	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800021
J	Hug, M; Uehli, K; Solbach, S; Brighenti-Zogg, S; Durr, S; Maier, S; Leuppi, JD; Miedinger, D				Hug, Michel; Uehli, Katrin; Solbach, Stig; Brighenti-Zogg, Stefanie; Duerr, Selina; Maier, Sabrina; Leuppi, Jorg Daniel; Miedinger, David			Screening for obstructive sleep apnea among hospital outpatients	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; CLINICAL-PRACTICE GUIDELINE; CHANNEL NASAL PRESSURE; RISK-FACTORS; OCCUPATIONAL ACCIDENTS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; RECORDING DEVICE; HEART-FAILURE; DIAGNOSIS	Background Obstructive sleep apnea syndrome (OSAS) is common in adults. People with OSAS have a higher risk of experiencing traffic accidents and occupational injuries (OIs). We aimed to clarify the diagnostic performance of a three-channel screening device (ApneaLink (TM)) compared with the gold standard of full-night attended polysomnography (PSG) among hospital outpatients not referred for sleep-related symptoms. Furthermore, we aimed to determine whether manual revision of the ApneaLink (TM) autoscore enhanced diagnostic performance. Methods We investigated 68 patients with OI and 44 without OI recruited from the University Hospital Basel emergency room, using a cross-sectional study design. Participating patients spent one night at home with ApneaLink (TM) and within 2 weeks slept for one night at the sleep laboratory. We reanalyzed all ApneaLink (TM) data after manual revision. Results We identified significant correlations between the ApneaLink (TM) apnea-hypopnea index (AHI) autoscore and the AHI derived by PSG (r = 0.525; p < 0.001) and between the ApneaLink (TM) oxygen desaturation index (ODI) autoscore and that derived by PSG (r = 0.722; p < 0.001). The ApneaLink (TM) autoscore showed a sensitivity and specificity of 82% when comparing AHI >= 5 with the cutoff for AHI and/or ODI >= 15 from PSG. In Bland Altman plots the mean difference between ApneaLink (TM) AHI autoscore and PSG was 2.75 with SD +/- 8.80 (beta = 0.034), and between ApneaLink (TM) AHI revised score and PSG -1.50 with SD +/- 9.28 (beta = 0.060). Conclusions The ApneaLink (TM) autoscore demonstrated good sensitivity and specificity compared with the gold standard (full-night attended PSG). However, Bland Altman plots revealed substantial fluctuations between PSG and ApneaLink (TM) AHI autoscore respectively manually revised score. This spread for the AHI from a clinical perspective is large, and therefore the results have to be interpreted with caution. Furthermore, our findings suggest that there is no clinical benefit in manually revising the ApneaLinkTM autoscore.	[Hug, Michel; Solbach, Stig; Leuppi, Jorg Daniel; Miedinger, David] Univ Basel, Fac Med, Basel, Switzerland; [Uehli, Katrin; Miedinger, David] Swiss Natl Accid Insurance Fund SUVA, Luzern, Switzerland; [Brighenti-Zogg, Stefanie; Duerr, Selina; Maier, Sabrina; Leuppi, Jorg Daniel; Miedinger, David] Cantonal Hosp Baselland, Univ Clin Med, Liestal, Switzerland	University of Basel; University of Geneva; Kantonsspital Baselland	Hug, M (corresponding author), Univ Basel, Fac Med, Basel, Switzerland.	michel.hug@unibas.ch	Leuppi, Jörg/W-6798-2019	Hug, Michel/0000-0003-1667-1717	Swiss National Accident Insurance Fund (SUVA)	Swiss National Accident Insurance Fund (SUVA)(Swiss National Science Foundation (SNSF))	This study was financially supported by an unrestricted grant of the Swiss National Accident Insurance Fund (SUVA). Grant number: not applicable. URL: http://www.suva.ch. Recipient: DM. The funder (SUVA) provided support in the form of a project grant that covered salaries for the involved personnel at the University Hospital Basel as well as expenses for infrastructure and conducting the study. However the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The participation of DM in the study was independent from the project grant and is covered by the contractual agreement between SUVA and DM that permits active participation in independently conducted research projects.	Nigro CA, 2013, SLEEP BREATH, V17, P259, DOI 10.1007/s11325-012-0684-4; Nigro CA, 2012, SLEEP BREATH, V16, P275, DOI 10.1007/s11325-011-0524-y; Allen AJH, 2016, THORAX, V71, P664, DOI 10.1136/thoraxjnl-2015-207994; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; BIXLER EO, 1979, AM J PSYCHIAT, V136, P1257; Crowley KE, 2013, J CLIN SLEEP MED, V9, P109, DOI 10.5664/jcsm.2400; de Silva S, 2012, IEEE ENG MED BIO, P6353, DOI 10.1109/EMBC.2012.6347447; Erman MK, 2007, J CLIN SLEEP MED, V3, P387; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Garbarino S, 2016, SLEEP, V39, P1211, DOI 10.5665/sleep.5834; Gauchard GC, 2003, OCCUP ENVIRON MED, V60, P330, DOI 10.1136/oem.60.5.330; Guilleminault C, 1978, CLIN OVERVIEW SLEEP, P1; Hamilton GS, 2004, INTERN MED J, V34, P420, DOI 10.1111/j.1445-5994.2004.00596.x; Heck M, 2007, REPETITORIUM ANASTHE; Hinkelbein J, 2007, RESUSCITATION, V74, P75, DOI 10.1016/j.resuscitation.2006.11.018; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; IKI M, 1994, AM J OTOLARYNG, V15, P124, DOI 10.1016/0196-0709(94)90061-2; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; JANSON C, 1994, EUR RESPIR J, V7, P845; Javaheri S, 1998, CIRCULATION, V97, P2154, DOI 10.1161/01.CIR.97.21.2154; Johnston RB, 1998, MED SCI SPORT EXER, V30, P1703, DOI 10.1097/00005768-199812000-00008; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kitamura Takuro, 2005, Nihon Jibiinkoka Gakkai Kaiho, V108, P20; Koyama RG, 2012, SLEEP MED, V13, P1028, DOI 10.1016/j.sleep.2012.06.017; Laube I, 1998, SCHWEIZ MED WSCHR, V128, P1487; Lesser DJ, 2012, J CLIN SLEEP MED, V8, P271, DOI 10.5664/jcsm.1912; Masa JF, 2014, SLEEP, V37, P1953, DOI 10.5665/sleep.4248; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; NELSON HD, 1994, JAMA-J AM MED ASSOC, V272, P1825, DOI 10.1001/jama.272.23.1825; Nigro CA, 2010, MEDICINA-BUENOS AIRE, V70, P53; Overstall P W, 1978, Age Ageing, VSuppl, P92; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pereira CB, 2001, NEUROREPORT, V12, P1223, DOI 10.1097/00001756-200105080-00033; Perrin PP, 1997, GERONTOLOGY, V43, P223; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Ramar K, 2015, J CLIN SLEEP MED, V11, P773, DOI 10.5664/jcsm.4858; Robinson GV, 2004, THORAX, V59, P1089, DOI 10.1136/thx.2003.015875; Schlesinger A, 1998, NEUROREPORT, V9, P49, DOI 10.1097/00001756-199801050-00010; Schweiz R, RESMED APNEALINKTM B; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; Stuck BA., 2013, PRAXIS SCHLAFMEDIZIN; Santos JT, 2010, ARCH BRONCONEUMOL, V46, P143, DOI 10.1016/j.arbres.2009.08.004; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Ulfberg J, 1996, CHEST, V110, P659, DOI 10.1378/chest.110.3.659; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198315	10.1371/journal.pone.0198315	http://dx.doi.org/10.1371/journal.pone.0198315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847582	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800063
J	Kigozi, E; Kasule, GW; Musisi, K; Lukoye, D; Kyobe, S; Katabazi, FA; Wampande, EM; Joloba, ML; Kateete, DP				Kigozi, Edgar; Kasule, George W.; Musisi, Kenneth; Lukoye, Deus; Kyobe, Samuel; Katabazi, Fred Ashaba; Wampande, Eddie M.; Joloba, Moses L.; Kateete, David Patrick			Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY TEST; RPOB MUTATIONS; MTBDRPLUS ASSAY; GENE; IDENTIFICATION; DIAGNOSIS; STRAINS; REGION; DNA	Background Accurate diagnosis of tuberculosis, especially by using rapid molecular assays, can reduce transmission of drug resistant tuberculosis in communities. However, the frequency of resistance conferring mutations varies with geographic location of Mycobacterium tuberculosis, and this affects the efficiency of rapid molecular assays in detecting resistance. This has created need for characterizing drug resistant isolates from different settings to investigate frequencies of resistance conferring mutations. Here, we describe the prevalence and patterns of rifampicin- and isoniazid- resistance conferring mutations in isolates from Uganda, which could be useful in the management of MDR-TB patients in Uganda and other countries in sub-Saharan Africa. Results Ninety seven M. tuberculosis isolates were characterized, of which 38 were MDR, seven rifampicin-resistant, 12 isoniazid-mono-resistant, and 40 susceptible to rifampicin and isoniazid. Sequence analysis of the rpoB rifampicin-resistance determining region (rpoB/RRDR) revealed mutations in six codons: 588, 531, 526, 516, 513, and 511, of which Ser531Leu was the most frequent (40%, 18/45). Overall, the three mutations (Ser531Leu, His526Tyr, Asp516Tyr) frequently associated with rifampicin-resistance occurred in 76% of the rifampicin resistant isolates while 18% (8/45) of the rifampicin-resistant isolates lacked mutations in rpoB/RRDR. Furthermore, sequence analysis of katG and inhA gene promoter revealed mainly the Ser315Thr (76%, 38/50) and C(-15) T (8%, 4/50) mutations, respectively. These two mutations combined, which are frequently associated with isoniazid-resistance, occurred in 88% of the isoniazid resistant isolates. However, 20% (10/50) of the isoniazid-resistant isolates lacked mutations both in katG and inhA gene promoter. The sensitivity of sequence analysis of rpoB/RRDR for rifampicin-resistance via detection of high confidence mutations (Ser531Leu, His526Tyr, Asp516Tyr) was 81%, while it was 77% for analysis of katG and inhA gene promoter to detect isoniazid-resistance via detection of high confidence mutations (Ser315Thr, C(-15)T, T(-8)C). Furthermore, considering the circulating TB genotypes in Uganda, the isoniazid-resistance conferring mutations were more frequent in M. tuberculosis lineage 4/sub-lineage Uganda, perhaps explaining why this genotype is weakly associated with MDR-TB. Conclusion Sequence analysis of rpoB/RRDR, katG and inhA gene promoter is useful in detecting rifampicin/isoniazid resistant M. tuberculosis isolates in Uganda however, about <= 20% of the resistant isolates lack known resistance-conferring mutations hence rapid molecular assays may not detect them as resistant.	[Kigozi, Edgar; Kyobe, Samuel; Katabazi, Fred Ashaba; Wampande, Eddie M.; Joloba, Moses L.; Kateete, David Patrick] Makerere Univ, Sch Biomed Sci, Dept Immunol & Mol Biol, Coll Hlth Sci, Kampala, Uganda; [Kigozi, Edgar; Katabazi, Fred Ashaba; Joloba, Moses L.; Kateete, David Patrick] Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Kasule, George W.; Musisi, Kenneth] Natl TB Reference Lab, Kampala, Uganda; [Lukoye, Deus] Minist Hlth, Natl TB Leprosy Program, Kampala, Uganda; [Wampande, Eddie M.] Makerere Univ, Coll Vet Med, Anim Resources & Biosecur, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Joloba, ML; Kateete, DP (corresponding author), Makerere Univ, Sch Biomed Sci, Dept Immunol & Mol Biol, Coll Hlth Sci, Kampala, Uganda.; Joloba, ML; Kateete, DP (corresponding author), Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda.	moses.joloba@case.edu; dkateete@chs.mak.ac.ug	Kateete, David Patrick/HCH-5603-2022	Kasule, George William/0000-0002-2123-9614; Kateete, David Patrick/0000-0001-8075-3069	"Basic HIV and HIV/AIDs-Related Diseases Science Training Program for Uganda (BHSTP) - Fogarty International Center [ID43TW009780]; DELTAS Africa Initiative [107743/Z/15/Z]; African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107743]; UK Government; FOGARTY INTERNATIONAL CENTER [D43TW009780] Funding Source: NIH RePORTER	"Basic HIV and HIV/AIDs-Related Diseases Science Training Program for Uganda (BHSTP) - Fogarty International Center; DELTAS Africa Initiative; African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome Trust); UK Government; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported in part by the "Basic HIV and HIV/AIDs-Related Diseases Science Training Program for Uganda (BHSTP) funded by Fogarty International Center (grant# ID43TW009780). The work was also supported through a DELTAS Africa Initiative [grant# 107743/Z/15/Z]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (Grant no. 107743) and the UK Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; Aubry A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095083; Bazira J, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-5; Bradley P, 2015, BIORXIV, DOI DOI 10.1038/NC0MMS10063; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Bwanga F, 2010, INT J TUBERC LUNG D, V14, P890; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chakravorty S, 2017, NEW ENGL J MED, V377, P2404; Clark TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083012; Engstrom A, 2012, J CLIN MICROBIOL, V50, P2026, DOI 10.1128/JCM.06664-11; Ezati N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0703-0; Feuerriegel S, 2014, J ANTIMICROB CHEMOTH, V69, P1205, DOI 10.1093/jac/dkt535; Hauck Y, 2009, J ANTIMICROB CHEMOTH; Herrera L, 2003, INT J ANTIMICROB AG, V21, P403, DOI 10.1016/S0924-8579(03)00036-0; Huyen MNT, 2013, ANTIMICROB AGENTS CH, V57, P3620, DOI 10.1128/AAC.00077-13; Jagielski T, 2014, J ANTIMICROB CHEMOTH; Jou R, 2005, J CLIN MICROBIOL, V43, P1390, DOI 10.1128/JCM.43.3.1390-1394.2005; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Lakshmi Rajesh, 2013, AM J INFECT DIS MICR, V1, P86; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liberty Mutual Insurance, 2019, 2019 WORKPL SAF IND; Lukoye D, 2014, ANTIMICROB AGENTS CH, V58, P3853, DOI 10.1128/AAC.02338-13; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Mani C, 2001, J CLIN MICROBIOL, V39, P2987, DOI 10.1128/JCM.39.8.2987-2990.2001; Marahatta S., 2012, KATHMANDU U MED J, V9, P19; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Matsiota-Bernard P, 1998, J CLIN MICROBIOL, V36, P20, DOI 10.1128/JCM.36.1.20-23.1998; Maurya AK, 2013, INDIAN J MED MICROBI, V31, P230, DOI 10.4103/0255-0857.115625; Mboowa G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-481; McIvor A, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx020; Muhumuza J, 2006, INT J TUBERC LUNG D, V10, P1262; Nabyonga Lydia, 2011, BMC Res Notes, V4, P280, DOI 10.1186/1756-0500-4-280; Nakiyingi L, 2013, AFR HEALTH SCI, V13, P522, DOI 10.4314/ahs.v13i2.46; Niehaus AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135003; Ohno H, 1996, ANTIMICROB AGENTS CH, V40, P1053, DOI 10.1128/AAC.40.4.1053; Pang Y, 2013, ANTIMICROB AGENTS CH, V57, P893, DOI 10.1128/AAC.01024-12; Poudel A, 2012, ANTIMICROB AGENTS CH, V56, P2831, DOI 10.1128/AAC.06418-11; Qazi O, 2014, INT J MYCOBACT, V3, P173, DOI 10.1016/j.ijmyco.2014.06.004; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2004, J MED MICROBIOL, V53, P107, DOI 10.1099/jmm.0.05343-0; Rosales-Klintz S, 2012, INT J MYCOBACT, V1, P124, DOI 10.1016/j.ijmyco.2012.08.001; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Sekadde MP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-133; Shubladze N, 2013, INT J MYCOBACT, V2, P73, DOI 10.1016/j.ijmyco.2013.02.002; Ssengooba W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107595; Stucki D, 2016, NAT GENET, V48, P1535, DOI 10.1038/ng.3704; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tekwu EM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-113; Tracevska T, 2002, J CLIN MICROBIOL, V40, P3789, DOI 10.1128/JCM.40.10.3789-3792.2002; van Helden P D, 2001, Methods Mol Med, V54, P19, DOI 10.1385/1-59259-147-7:019; Walusimbi S, 2013, INT J MYCOBACT, V2, P148, DOI 10.1016/j.ijmyco.2013.06.001; WHO, 2017, LEAD CAUS DEATH EC I; WHO, TUBERCULOSIS; Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14; Xie YL, 2017, NEW ENGL J MED, V377, P1043, DOI 10.1056/NEJMoa1614915	60	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198091	10.1371/journal.pone.0198091	http://dx.doi.org/10.1371/journal.pone.0198091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847567	Green Submitted, gold, Green Published			2022-12-26	WOS:000433634800053
J	Smith, FW; Rossit, S				Smith, Fraser W.; Rossit, Stephanie			Identifying and detecting facial expressions of emotion in peripheral vision	PLOS ONE			English	Article							CULTURAL-DIFFERENCES; OBJECT DETECTION; FACES; RECOGNITION; INFORMATION; FEAR; TRANSMISSION; JUDGMENTS	Facial expressions of emotion are signals of high biological value. Whilst recognition of facial expressions has been much studied in central vision, the ability to perceive these signals in peripheral vision has only seen limited research to date, despite the potential adaptive advantages of such perception. In the present experiment, we investigate facial expression recognition and detection performance for each of the basic emotions (plus neutral) at up to 30 degrees of eccentricity. We demonstrate, as expected, a decrease in recognition and detection performance with increasing eccentricity, with happiness and surprised being the best recognized expressions in peripheral vision. In detection however, while happiness and surprised are still well detected, fear is also a well detected expression. We show that fear is a better detected than recognized expression. Our results demonstrate that task constraints shape the perception of expression in peripheral vision and provide novel evidence that detection and recognition rely on partially separate underlying mechanisms, with the latter more dependent on the higher spatial frequency content of the face stimulus.	[Smith, Fraser W.; Rossit, Stephanie] Univ East Anglia, Sch Psychol, Norwich, Norfolk, England	University of East Anglia	Smith, FW (corresponding author), Univ East Anglia, Sch Psychol, Norwich, Norfolk, England.	Fraser.Smith@uea.ac.uk	Rossit, Stephanie/ABH-4911-2020	Rossit, Stephanie/0000-0001-6640-2289; Smith, Fraser/0000-0002-8016-5109				Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bayle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021584; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Calvo MG, 2014, PSYCHOL RES-PSYCH FO, V78, P180, DOI 10.1007/s00426-013-0492-x; Cecere R, 2013, J NEUROSCI, V33, P6469, DOI 10.1523/JNEUROSCI.3431-12.2013; Darwin C., 1872, EXPRESSION EMOTION M; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Du SC, 2011, J VISION, V11, DOI 10.1167/11.13.24; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Ekman P., 1976, PICTURES FACIAL AFFE; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Goffaux V, 2011, CEREB CORTEX, V21, P467, DOI 10.1093/cercor/bhq112; Goren D, 2006, VISION RES, V46, P1253, DOI 10.1016/j.visres.2005.10.028; Greening SG, 2018, CORTEX, V101, P31, DOI 10.1016/j.cortex.2017.11.016; HAGER JC, 1979, ETHOL SOCIOBIOL, V1, P77, DOI 10.1016/0162-3095(79)90007-4; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Johnson MH, 2015, NEUROSCI BIOBEHAV R, V50, P169, DOI 10.1016/j.neubiorev.2014.10.009; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Larson AM, 2009, J VISION, V9, DOI 10.1167/9.10.6; Lee DH, 2013, PSYCHOL SCI, V24, P957, DOI 10.1177/0956797612464500; Mack ML, 2008, PSYCHON B REV, V15, P28, DOI 10.3758/PBR.15.1.28; Mack ML, 2010, J EXP PSYCHOL HUMAN, V36, P1067, DOI 10.1037/a0020254; MATSUMOTO D, 1989, MOTIV EMOTION, V13, P143, DOI 10.1007/BF00992959; Matsumoto D, 2011, EMOTION, V11, P1223, DOI 10.1037/a0024356; McFadyen J, 2017, J NEUROSCI, V37, P3864, DOI 10.1523/JNEUROSCI.3525-16.2017; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Neta M, 2010, PSYCHOL SCI, V21, P901, DOI 10.1177/0956797610373934; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterberg G., 1935, ACTA OPTHALMOLOGIC S, V6, P101; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Rousselet GA, 2005, J VISION, V5, P755, DOI 10.1167/5.10.1; ROVAMO J, 1978, NATURE, V271, P54, DOI 10.1038/271054a0; Schmidt KL, 2001, YEARB PHYS ANTHROPOL, V44, P3, DOI 10.1002/ajpa.20001; Schyns PG, 1998, COGNITION, V67, P147, DOI 10.1016/S0010-0277(98)00016-X; Schyns PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005625; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; Smith FW, 2009, PSYCHOL SCI, V20, P1202, DOI 10.1111/j.1467-9280.2009.02427.x; Smith ML, 2014, EMOTION, V14, P478, DOI 10.1037/a0035588; Smith ML, 2012, CEREB CORTEX, V22, P1748, DOI 10.1093/cercor/bhr250; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sowden PT, 2006, TRENDS COGN SCI, V10, P538, DOI 10.1016/j.tics.2006.10.007; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Susskind JM, 2008, NAT NEUROSCI, V11, P739, DOI [10.1038/nn0708-739, DOI 10.1038/NN0708-739]; Sweeny TD, 2013, EMOTION, V13, P76, DOI 10.1037/a0029193; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	54	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197160	10.1371/journal.pone.0197160	http://dx.doi.org/10.1371/journal.pone.0197160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847562	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800019
J	Tumova, L; Tarkowska, D; Rehorova, K; Markova, H; Kocova, M; Rothova, O; Cecetka, P; Hola, D				Tumova, Lenka; Tarkowska, Danuse; Rehorova, Katerina; Markova, Hana; Kocova, Marie; Rothova, Olga; Cecetka, Petr; Hola, Dana			Drought-tolerant and drought-sensitive genotypes of maize (Zea mays L.) differ in contents of endogenous brassinosteroids and their drought-induced changes	PLOS ONE			English	Article							PLANT-GROWTH REGULATORS; INDUCED STOMATAL CLOSURE; ARABIDOPSIS-THALIANA; STRESS TOLERANCE; BIOSYNTHETIC-PATHWAY; FUNCTIONAL-ANALYSIS; ANTIOXIDANT SYSTEM; OXIDATIVE STRESS; DUAL APPLICATION; BRASSICA-NAPUS	The contents of endogenous brassinosteroids (BRs) together with various aspects of plant morphology, water management, photosynthesis and protection against cell damage were assessed in two maize genotypes that differed in their drought sensitivity. The presence of 28-norbrassinolide in rather high quantities (1-2 pg mg(-1) fresh mass) in the leaves of monocot plants is reported for the first time. The intraspecific variability in the presence/content of the individual BRs in drought-stressed plants is also described for the first time. The drought-resistant genotype was characterised by a significantly higher content of total endogenous BRs (particularly typhasterol and 28-norbrassinolide) compared with the drought-sensitive genotype. On the other hand, the drought-sensitive genotype showed higher levels of 28-norcastasterone. Both genotypes also differed in the drought-induced reduction/elevation of the levels of 28-norbrassinolide, 28-norcastasterone, 28-homocastasterone and 28-homodolichosterone. The differences observed between both genotypes in the endogenous BR content are probably correlated with their different degrees of drought sensitivity, which was demonstrated at various levels of plant morphology, physiology and biochemistry.	[Tumova, Lenka; Rehorova, Katerina; Markova, Hana; Kocova, Marie; Rothova, Olga; Cecetka, Petr; Hola, Dana] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Tarkowska, Danuse] Acad Sci Czech Republ, Vvi, Ctr Region Hana Biotechnol & Agr Res, Inst Expt Bot,Lab Growth Regulators, Olomouc, Czech Republic; [Tarkowska, Danuse] Palacky Univ, Olomouc, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc	Hola, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	danahola@natur.cuni.cz	Tarkowská, Danuše/F-8709-2011; Marková, Hana/S-7713-2017; Holá, Dana/H-9344-2016	Tarkowská, Danuše/0000-0003-1478-1904; Marková, Hana/0000-0002-8399-1051; Holá, Dana/0000-0002-2080-8774; Holasova, Katerina/0000-0002-7896-7057	Charles University Grant Agency [B/BIO/200516]; Charles University [SVV-2017-260426, UNCE 204013]; Ministry of Education, Youth and Sports of the Czech Republic through the National Program for Sustainability I [LO1204]	Charles University Grant Agency; Charles University; Ministry of Education, Youth and Sports of the Czech Republic through the National Program for Sustainability I	This work was financially supported by the grant B/BIO/200516 of the Charles University Grant Agency (https.//www.cum.cz/UKEN-65.html) held by LT. Lenka Tumova (LT) was also partly supported by the Charles University (https://www.cuni.cz/UKEN-65.html) research funding project SVV-2017-260426 and Olga Rothova (OR) by the Charles University (https.//www.cuni.cz/UKEN-65.html) research funding project UNCE 204013. Danuse Tarkowska (DT) is grateful for financial support provided by the grant LO1204 of the Ministry of Education, Youth and Sports of the Czech Republic (http.//www.msmt.cz/?lang=2) through the National Program for Sustainability I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H., 1991, Brassinosteroids. Chemistry, bioactivity and applications., P200; Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bajguz A, 2011, BRASSINOSTEROIDS: A CLASS OF PLANT HORMONE, P1, DOI 10.1007/978-94-007-0189-2_1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Belkhadir Y, 2015, NEW PHYTOL, V206, P522, DOI 10.1111/nph.13269; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Best NB, 2016, PLANT PHYSIOL, V171, P2633, DOI 10.1104/pp.16.00399; Bhardwaj R, 2012, BRASSINOSTEROIDS: PRACTICAL APPLICATIONS IN AGRICULTURE AND HUMAN HEALTH, P3; Bishop G, 2006, BIOCHEM SOC T, V34, P1199, DOI 10.1042/BST0341199; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JN, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1365212; Chen JN, 2017, PLANT CELL, V29, P1425, DOI 10.1105/tpc.17.00364; Choe S, 2006, PHYSIOL PLANTARUM, V126, P539, DOI 10.1111/j.1399-3054.2006.00681.x; Corvalan C, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0965-3; Deng XG, 2015, J EXP BOT, V66, P6219, DOI 10.1093/jxb/erv328; El-Khallal S. M., 2000, Egyptian Journal of Physiological Sciences, V24, P297; Feng Y, 2015, PLANT SCI, V234, P163, DOI 10.1016/j.plantsci.2015.02.015; Garcia A., 2005, Cultivos Tropicales, V26, P89; Grimplet J, 2009, PROTEOMICS, V9, P2503, DOI 10.1002/pmic.200800158; Gruszka D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01824; Gruszka D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040600; Ha Y, 2016, J EXP BOT, V67, P6297, DOI 10.1093/jxb/erw385; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hategan L, 2011, BRASSINOSTEROIDS: A CLASS OF PLANT HORMONE, P57, DOI 10.1007/978-94-007-0189-2_3; Haubrick LL, 2006, PHYSIOL PLANTARUM, V128, P134, DOI 10.1111/j.1399-3054.2006.00708.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hola D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176121; Horn R, 2013, J PROTEOME RES, V12, P1266, DOI 10.1021/pr300931u; HORVATH I, 1983, PHYSIOL PLANTARUM, V57, P532, DOI 10.1111/j.1399-3054.1983.tb02781.x; Inoue S, 2017, PLANT CELL PHYSIOL, V58, P1048, DOI 10.1093/pcp/pcx049; Jager CE, 2008, PHYSIOL PLANTARUM, V133, P417, DOI 10.1111/j.1399-3054.2008.01057.x; Janeczko A, 2010, J AGRON CROP SCI, V196, P311, DOI 10.1111/j.1439-037X.2009.00413.x; Janeczko A, 2010, BIOL PLANTARUM, V54, P477, DOI 10.1007/s10535-010-0084-1; Janeczko A, 2016, PLANT PHYSIOL BIOCH, V99, P126, DOI 10.1016/j.plaphy.2015.12.003; Janeczko A, 2011, ACTA PHYSIOL PLANT, V33, P1249, DOI 10.1007/s11738-010-0655-y; Jangid KK, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2373-1; Joo SH, 2015, PHYTOCHEMISTRY, V111, P84, DOI 10.1016/j.phytochem.2014.11.006; Joo SH, 2012, J EXP BOT, V63, P1823, DOI 10.1093/jxb/err354; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; Kang YY, 2011, BRASSINOSTEROIDS: A CLASS OF PLANT HORMONE, P269, DOI 10.1007/978-94-007-0189-2_9; Kim BK, 2008, BIOCHEM BIOPH RES CO, V374, P614, DOI 10.1016/j.bbrc.2008.07.073; Kim TW, 2005, PLANT CELL, V17, P2397, DOI 10.1105/tpc.105.033738; Kim TW, 2004, PLANT PHYSIOL, V135, P1231, DOI 10.1104/pp.104.043588; Kim YS, 2006, PHYSIOL PLANTARUM, V127, P28, DOI 10.1111/j.1399-3054.2006.00650.x; Kim YS, 2005, PHYTOCHEMISTRY, V66, P1000, DOI 10.1016/j.phytochem.2005.03.007; Kir G, 2015, PLANT PHYSIOL, V169, P826, DOI 10.1104/pp.15.00367; Lei L, 2015, PLANT J, V84, P1206, DOI 10.1111/tpj.13073; Li KR, 2008, NEW FOREST, V35, P255, DOI 10.1007/s11056-007-9075-2; Li KR, 2011, ACTA PHYSIOL PLANT, V33, P1293, DOI 10.1007/s11738-010-0661-0; Li L., 1998, Plant Growth Regulation, V24, P55, DOI 10.1023/A:1005954532397; Li L, 1998, S AFR J BOT, V64, P116, DOI 10.1016/S0254-6299(15)30844-9; Li L, 1998, PLANT GROWTH REGUL, V25, P81, DOI 10.1023/A:1010774725695; Liu TS, 2007, PLANT CELL REP, V26, P2091, DOI 10.1007/s00299-007-0418-4; Liu WH, 2008, J AGR FOOD CHEM, V56, P185, DOI 10.1021/jf0722708; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143128; Makarevitch I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030798; McKersie B, 2015, J EXP BOT, V66, P3435, DOI 10.1093/jxb/eru547; Miao ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06929-y; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nolan T, 2017, BIOCHEM J, V474, P2641, DOI 10.1042/BCJ20160633; Nolan TM, 2017, DEV CELL, V41, P33, DOI 10.1016/j.devcel.2017.03.013; Nomura T, 2005, J BIOL CHEM, V280, P17873, DOI 10.1074/jbc.M414592200; Oklestkova J, 2017, TALANTA, V170, P432, DOI 10.1016/j.talanta.2017.04.044; Opitz N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-741; Peremarti A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-125; Plomion C, 2006, PROTEOMICS, V6, P6509, DOI 10.1002/pmic.200600362; Pociecha E, 2016, PLANT GROWTH REGUL, V80, P127, DOI 10.1007/s10725-016-0149-z; Rittenberg D, 1940, J BIOL CHEM, V133, P737; Rothova O, 2014, STEROIDS, V85, P44, DOI 10.1016/j.steroids.2014.04.006; Sahni S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28298; SAIRAM RK, 1994, PLANT GROWTH REGUL, V14, P173, DOI 10.1007/BF00025220; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shahid MA, 2017, WATER RESOUR MANAG, V31, P793, DOI 10.1007/s11269-016-1435-2; Shakirova F, 2016, PLANT PHYSIOL BIOCH, V108, P539, DOI 10.1016/j.plaphy.2016.07.013; Shu LB, 2011, PROTEOMICS, V11, P4122, DOI 10.1002/pmic.201000485; SINGH J, 1993, INDIAN J AGR SCI, V63, P395; Skirycz A, 2011, J PROTEOME RES, V10, P1018, DOI 10.1021/pr100785n; Stelpflug SC, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0025; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; SUZUKI Y, 1986, AGR BIOL CHEM TOKYO, V50, P3133, DOI 10.1080/00021369.1986.10867873; Talaat NB, 2016, J PLANT GROWTH REGUL, V35, P518, DOI 10.1007/s00344-015-9557-y; Talaat NB, 2015, ENVIRON EXP BOT, V113, P47, DOI 10.1016/j.envexpbot.2015.01.006; Tao YZ, 2004, PLANT SCI, V167, P743, DOI 10.1016/j.plantsci.2004.05.012; Tarkowska D, 2016, ANAL BIOANAL CHEM, V408, P6799, DOI 10.1007/s00216-016-9807-2; Tarkowska D, 2014, PLANTA, V240, P55, DOI 10.1007/s00425-014-2063-9; Thatcher SR, 2016, PLANT PHYSIOL, V170, P586, DOI 10.1104/pp.15.01267; Tran L.S., 2016, DROUGHT STRESS TOLER, V1, P77, DOI DOI 10.1007/978-3-319-28899-4_4; Tripathi P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2420-0; Vardhini B. V., 2011, Journal of Phytology, V3, P38; Vardhini BV, 2003, PLANT GROWTH REGUL, V41, P25, DOI 10.1023/A:1027303518467; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Vriet C, 2015, TRENDS PLANT SCI, V20, P301, DOI 10.1016/j.tplants.2015.03.006; Vriet C, 2013, MOL PLANT, V6, P1738, DOI 10.1093/mp/sst096; Wei LJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00982; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Xia XJ, 2014, PLANT CELL ENVIRON, V37, P2036, DOI 10.1111/pce.12275; Ye HX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14573; Yokota T, 1997, PLANT CELL PHYSIOL, V38, P1291, DOI 10.1093/oxfordjournals.pcp.a029119; Yokota T, 2001, PHYTOCHEMISTRY, V58, P233, DOI 10.1016/S0031-9422(01)00237-0; Yusuf MA, 2010, BBA-BIOENERGETICS, V1797, P1428, DOI 10.1016/j.bbabio.2010.02.002; Zhang C, 2014, PLANT CELL REP, V33, P683, DOI 10.1007/s00299-014-1578-7; Zhang XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179477; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Zhou XY, 2016, CROP SCI, V56, P2675, DOI 10.2135/cropsci2016.01.0067	108	28	28	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197870	10.1371/jounal.pone.0197870	http://dx.doi.org/10.1371/jounal.pone.0197870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795656				2022-12-26	WOS:000433084300087
J	So, D; Shin, HW; Kim, J; Lee, M; Myeong, J; Chun, YS; Park, JW				So, Daeho; Shin, Hyun-Woo; Kim, Jiyoung; Lee, Mingyu; Myeong, Jongyun; Chun, Yang-Sook; Park, Jong-Wan			Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense	ONCOGENE			English	Article							EXTRACELLULAR VESICLES; CELL-DEATH; MITOCHONDRIAL DAMAGE; LONGEVITY PROTEIN; INFLAMMASOME; PYROPTOSIS; TRANSCRIPTION; DEACETYLASE; PATHWAY; MICROVESICLES	Mammalian cells are equipped with antiviral innate immunity. To survive and grow, human papilloma virus (HPV)-infected cervical cancer cells must overcome this host defense system. However, the precise mechanism whereby cervical cancer cells evade the immunity is not fully understood. We noted that Sirtuin 1 (SIRT1) is overexpressed in HPV-infected cervical cancer cells and hypothesized that SIRT1 counteracts antiviral immunity. Here, we found that cervical cancer cells undergo massive death by SIRT1 knockdown, but this effect is reversed by SIRT1 restoration. SIRT1-knocked-down cells showed representative features of pyroptosis, as well as highly expressed absent in melanoma 2 (AIM2) and its downstream genes related to the inflammasome response. Mechanistically, SIRT1 repressed the NF-kappa B-driven transcription of the AIM2 gene by destabilizing the RELB mRNA. Interestingly, pyroptotic death signaling in SIRT1-knocked-down cells was transmitted to naive cervical cancer cells, which was mediated by extracellular vesicles carrying AIM2 inflammasome proteins. Furthermore, the growth of cervical cancer xenografts was significantly inhibited by either SIRT1-targeting siRNAs or SIRT1-knockdown-derived extracellular vesicles. Immunohistochemical analyses showed that SIRT1 expression correlated with poor clinical outcomes in cervical cancer. In conclusion, SIRT1 enabled HPV-infected cervical cancer cells to continue growing by nullifying AIM2 inflammasome-mediated immunity. Without SIRT1, cervical cancer cells could no longer survive because of the derepression of the AIM2 inflammasome. SIRT1 could therefore be a target for the effective treatment of cervical cancer.	[So, Daeho; Shin, Hyun-Woo; Kim, Jiyoung; Lee, Mingyu; Chun, Yang-Sook; Park, Jong-Wan] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul 03080, South Korea; [So, Daeho; Shin, Hyun-Woo; Kim, Jiyoung; Lee, Mingyu; Park, Jong-Wan] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 03080, South Korea; [So, Daeho; Shin, Hyun-Woo; Kim, Jiyoung; Lee, Mingyu; Myeong, Jongyun; Chun, Yang-Sook; Park, Jong-Wan] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 03080, South Korea; [So, Daeho; Shin, Hyun-Woo; Kim, Jiyoung; Lee, Mingyu; Myeong, Jongyun; Chun, Yang-Sook; Park, Jong-Wan] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 03080, South Korea; [Chun, Yang-Sook] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 03080, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, JW (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul 03080, South Korea.; Park, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 03080, South Korea.; Park, JW (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 03080, South Korea.; Park, JW (corresponding author), Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 03080, South Korea.	parkjw@snu.ac.kr		SHIN, HYUN-WOO/0000-0002-4038-9992; Park, Jong-Wan/0000-0003-4676-5191	National Research Foundation of Korea [2016R1A2A1A05005082]	National Research Foundation of Korea(National Research Foundation of Korea)	We thank Dr. Ja Eun Kim (Kyung Hee University) for giving the plasmids for SIRT1 and mutants, and Dr. Woo Ho Kim (Seoul National University) for providing cervical cancer tissue arrays. This work was supported by a grant from the National Research Foundation of Korea (2016R1A2A1A05005082; to JWP).	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Allison SJ, 2009, AGING-US, V1, P316, DOI 10.18632/aging.100028; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bergsbaken T, 2011, J IMMUNOL, V187, P2748, DOI 10.4049/jimmunol.1100477; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boyer SN, 1996, CANCER RES, V56, P4620; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Chen IF, 2006, MOL CANCER THER, V5, P1, DOI 10.1158/1535-7163.MCT-05-0310; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Davidson S, 2011, CRIT REV ONCOL HEMAT, V79, P24, DOI 10.1016/j.critrevonc.2010.07.002; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gadducci A, 2010, ONCOL LETT, V1, P3, DOI 10.3892/ol_00000001; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; In HY, 2007, P NATL ACAD SCI USA, V105, P3374; Kamura T, 2013, TAIWAN J OBSTET GYNE, V52, P161, DOI 10.1016/j.tjog.2013.04.003; Koh WJ, 2013, J NATL COMPR CANC NE, V11, P320, DOI 10.6004/jnccn.2013.0043; Ma XM, 2016, ONCOTARGET, V7, P36185, DOI 10.18632/oncotarget.9154; Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Reinholz M, 2013, ARCH DERMATOL RES, V305, P723, DOI 10.1007/s00403-013-1375-0; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Singh S, 2015, TUMOR BIOL, V36, P6159, DOI 10.1007/s13277-015-3300-y; Small W, 2017, CANCER-AM CANCER SOC, V123, P2404, DOI 10.1002/cncr.30667; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Velez-Perez A, 2017, HUM PATHOL, V59, P102, DOI 10.1016/j.humpath.2016.09.019; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang J, 2016, INT J SCI, V5, P133; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhang DY, 2009, J BIOL CHEM, V284, P20917, DOI 10.1074/jbc.M109.020073; ZIMMERMAN EM, 1969, J CELL PHYSIOL, V74, P67, DOI 10.1002/jcp.1040740110	45	51	56	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5191	5204		10.1038/s41388-018-0339-4	http://dx.doi.org/10.1038/s41388-018-0339-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29844574				2022-12-26	WOS:000445093100004
J	Tufail, S; Sherwani, MA; Shoaib, S; Azmi, S; Owais, M; Islam, N				Tufail, Saba; Sherwani, Mohd. Asif; Shoaib, Shoaib; Azmi, Sarfuddin; Owais, Mohammad; Islam, Najmul			Ovalbumin self-assembles into amyloid nanosheets that elicit immune responses and facilitate sustained drug release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; albumin; nanotechnology; drug delivery; drug delivery system; antigen; antigen delivery; nanosheet; ovalbumin	PEPTIDE NANOFIBERS; SECRETORY GRANULES; ENDOTHELIAL-CELLS; THIOFLAVIN T; DELIVERY; FIBRILS; AGGREGATION; NANOTUBES; PROTEINS; GRAPHENE	Amyloids are associated with many neurodegenerative diseases, motivating investigations into their structure and function. Although not linked to a specific disease, albumins have been reported to form many structural aggregates. We were interested in investigating host immune responses to amyloid fibrils assembled from the model protein ovalbumin. Surprisingly, upon subjecting ovalbumin to standard denaturing conditions, we encountered giant protein nanosheets harboring amyloid-like features and hypothesized that these nanosheets might have potential in clinical or therapeutic applications. We found that the nanosheets, without the administration of any additional adjuvant, evoked a strong antibody response in mice that was higher than that observed for native ovalbumin. This suggests that amyloid nanosheets have a self-adjuvanting property. The nanosheet-induced immune response was helper T cell 2 (Th2) biased and negligibly inflammatory. While testing whether the nanosheets might form depots for the sustained release of precursor proteins, we did observe release of ovalbumin that mimicked the conformation of native protein. Moreover, the nanosheets could load the anticancer drug doxorubicin and release it in a slow and sustained manner. Taken together, our results suggest that amyloid nanosheets should be further investigated as either an antigen delivery vehicle or a multifunctional antigen and drug co-delivery system, with potential applications in simultaneous immunotherapy and chemotherapy.	[Tufail, Saba; Shoaib, Shoaib; Azmi, Sarfuddin; Islam, Najmul] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh 202002, Uttar Pradesh, India; [Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Tufail, Saba] Aligarh Muslim Univ, Biochem Sect, Womens Coll, Aligarh 202002, Uttar Pradesh, India; [Sherwani, Mohd. Asif] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; University of Alabama System; University of Alabama Birmingham	Tufail, S; Islam, N (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.	sabatufail12@gmail.com; nxi7@hotmail.com	Sherwani, Mohammad/AAR-6089-2021; Sherwani, Mohammad Asif/AAQ-2949-2021; Azmi, Sarfuddin/AAE-7602-2022	Sherwani, Mohammad Asif/0000-0001-5317-1557; Azmi, Sarfuddin/0000-0002-1868-3458; Mohammad, Owais/0000-0001-7377-7388	University Grants Commission, Government of India	University Grants Commission, Government of India(University Grants Commission, India)	Recipient of a postdoctoral fellowship from the University Grants Commission, Government of India.	An J, 2013, MAT SCI ENG C-MATER, V33, P2827, DOI 10.1016/j.msec.2013.03.008; Ansari Mairaj Ahmed, 2012, Int J Nanomedicine, V7, P2433, DOI 10.2147/IJN.S25875; Azmi S, 2013, J MED CHEM, V56, P924, DOI 10.1021/jm301407k; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Banoczi Z, 2008, J PEPT SCI, V14, P610, DOI 10.1002/psc.950; Bemporad F, 2006, PROTEIN SCI, V15, P862, DOI 10.1110/ps.051915806; Bolisetty S, 2012, ADV FUNCT MATER, V22, P3424, DOI 10.1002/adfm.201103054; Buttstedt A, 2013, AMYLOID, V20, P86, DOI 10.3109/13506129.2013.784962; Chen WS, 2017, ADV MATER, V29, DOI 10.1002/adma.201603864; Childers WS, 2010, ANGEW CHEM INT EDIT, V49, P4104, DOI 10.1002/anie.201000212; Dai B, 2015, P NATL ACAD SCI USA, V112, P2996, DOI 10.1073/pnas.1416690112; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Dogra P, 2017, J PHYS CHEM B, V121, P412, DOI 10.1021/acs.jpcb.6b11281; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Gulseren G, 2016, J MATER CHEM B, V4, P4605, DOI 10.1039/c6tb00795c; Guo C, 2012, ACS NANO, V6, P3907, DOI 10.1021/nn300015g; Gupta S, 2010, P NATL ACAD SCI USA, V107, P13246, DOI 10.1073/pnas.1005704107; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Hu Y, 2016, ACS NANO, V10, P880, DOI 10.1021/acsnano.5b06011; Humblet-Hua NPK, 2012, J AGR FOOD CHEM, V60, P9502, DOI 10.1021/jf3024529; Jacob RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23370; Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/NNANO.2010.26, 10.1038/nnano.2010.26]; Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106; Lakshmanan A, 2012, TRENDS BIOTECHNOL, V30, P155, DOI 10.1016/j.tibtech.2011.11.001; Lara C, 2012, BIOMACROMOLECULES, V13, P4213, DOI 10.1021/bm301481v; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li CX, 2013, NANOSCALE, V5, P6207, DOI 10.1039/c3nr01644g; Li CX, 2012, NAT NANOTECHNOL, V7, P421, DOI [10.1038/nnano.2012.62, 10.1038/NNANO.2012.62]; Li H, 2016, ACS APPL MATER INTER, V8, P1147, DOI 10.1021/acsami.5b08963; Lin YY, 2017, J AM CHEM SOC, V139, P13592, DOI 10.1021/jacs.7b06591; Liu T, 2014, ADV MATER, V26, P3433, DOI 10.1002/adma.201305256; Lu K, 2003, J AM CHEM SOC, V125, P6391, DOI 10.1021/ja0341642; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mesquida P, 2007, J MATER SCI-MATER M, V18, P1325, DOI 10.1007/s10856-006-0075-0; Min KI, 2016, ANGEW CHEM INT EDIT, V55, P6925, DOI 10.1002/anie.201601675; MINE Y, 1995, TRENDS FOOD SCI TECH, V6, P225, DOI 10.1016/S0924-2244(00)89083-4; Mitra S, 2017, J AM CHEM SOC, V139, P4513, DOI 10.1021/jacs.7b00925; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; Sanii B, 2011, J AM CHEM SOC, V133, P20808, DOI 10.1021/ja206199d; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Shojaee M, 2015, MAT SCI ENG C-MATER, V48, P158, DOI 10.1016/j.msec.2014.11.063; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; TAKAHASHI N, 1991, J BIOCHEM-TOKYO, V109, P846, DOI 10.1093/oxfordjournals.jbchem.a123469; Tufail S, 2015, J BIOL CHEM, V290, P4131, DOI 10.1074/jbc.M113.540989; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Udomprasert A, 2014, NAT NANOTECHNOL, V9, P537, DOI [10.1038/NNANO.2014.102, 10.1038/nnano.2014.102]; Vigneron Nathalie, 2013, Cancer Immun, V13, P15; Wang DH, 2016, ADV MATER, V28, P7414, DOI 10.1002/adma.201506476; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; You J, 2017, ADV MATER, V29, DOI 10.1002/adma.201606895; Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c	67	11	12	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11310	11324		10.1074/jbc.RA118.002550	http://dx.doi.org/10.1074/jbc.RA118.002550			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29853634	hybrid, Green Published			2022-12-26	WOS:000439449700005
J	Guo, ZZ; Chen, RY; Liu, X; Zhao, GZ; Zheng, Y; Gong, ML; Zhang, J				Guo, Zizheng; Chen, Ruiya; Liu, Xian; Zhao, Guozhen; Zheng, Yan; Gong, Mingliang; Zhang, Jun			The impairing effects of mental fatigue on response inhibition: An ERP study	PLOS ONE			English	Article							ANTERIOR CINGULATE FUNCTION; COGNITIVE CONTROL; DRIVER FATIGUE; P300 AMPLITUDE; POTENTIAL ERP; GO/NOGO TASK; DUAL-TASK; PERFORMANCE; N2; SENSITIVITY	Mental fatigue is one of the main reasons for the decline of response inhibition. This study aimed to explore the impairing influence of mental fatigue on a driver's response inhibition. The effects of mental fatigue on response inhibition were assessed by comparing brain activity and behavioral indices when performing a Go/NoGo task before and after a 90-min fatigue manipulation task. Participants in the driving group performed a simulated driving task, while individuals in the control group spent the same time watching movies. We found that participants in the driving group reported higher levels of mental fatigue and had a higher percentage of eye closure and larger lateral deviations from their lane positions, which indicated there was effective manipulation of mental fatigue through a prolonged simulated driving task. After manipulation of mental fatigue, we observed increased reaction time and miss rates, delayed NoGo-N2 latency and Go-P3 latency, and decreased NoGoP3 amplitude, which indicated that mental fatigue may slow down the speed of the inhibition process, delay the evaluation of visual stimuli and reduce the availability of attentional resources. These findings revealed the underlying neurological mechanisms of how mental fatigue impaired response inhibition.	[Guo, Zizheng; Zhao, Guozhen; Zheng, Yan] Inst Psychol, CAS Key Lab Behav Sci, Beijing, Peoples R China; [Guo, Zizheng; Chen, Ruiya; Liu, Xian; Zhang, Jun] Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Sichuan, Peoples R China; [Guo, Zizheng; Chen, Ruiya; Liu, Xian; Zhang, Jun] Southwest Jiaotong Univ, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Sichuan, Peoples R China; [Zhao, Guozhen; Zheng, Yan] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Gong, Mingliang] Miami Univ, Dept Psychol, Oxford, OH 45056 USA	Southwest Jiaotong University; Southwest Jiaotong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Ohio; Miami University	Zhao, GZ (corresponding author), Inst Psychol, CAS Key Lab Behav Sci, Beijing, Peoples R China.; Zhao, GZ (corresponding author), Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China.	zhaogz@psych.ac.cn		Zhao, Guozhen/0000-0003-4438-5320	National Natural Science Foundation of China [31771226, U1736220, P084131136010002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) #31771226, #U1736220, and #P084131136010002.	Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Bekker EM, 2004, CLIN NEUROPHYSIOL, V115, P2001, DOI 10.1016/j.clinph.2004.04.008; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cascio CN, 2015, J COGNITIVE NEUROSCI, V27, P83, DOI 10.1162/jocn_a_00693; Chen KM, 2002, INT J NURS STUD, V39, P619, DOI 10.1016/S0020-7489(01)00068-2; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dong GH, 2010, NEUROSCI LETT, V485, P138, DOI 10.1016/j.neulet.2010.09.002; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GRANDJEAN E, 1979, BRIT J IND MED, V36, P175; Guo W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136446; Hatfield J., 2017, ACCIDENT ANAL PREV, V103, P37, DOI [10.1016/j.aap.2017.03.019, DOI 10.1016/J.AAP.2017.03.01928384487]; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Kato Y, 2012, ERGONOMICS, V55, P1, DOI 10.1080/00140139.2011.633175; Kato Y, 2009, INT J PSYCHOPHYSIOL, V72, P204, DOI 10.1016/j.ijpsycho.2008.12.008; Khaliliardali Z, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066006; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P2616, DOI 10.1016/j.clinph.2004.06.013; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan GD, 2014, PSYCHOL REV, V121, P66, DOI 10.1037/a0035230; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Mantyla T, 2009, APPL NEUROPSYCHOL, V16, P11, DOI 10.1080/09084280802644086; NEVIN JA, 1969, J EXP ANAL BEHAV, V12, P875, DOI 10.1901/jeab.1969.12-875; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI 10.3758/CABN.10.2.270; Ou B, 2012, INT J IND ERGONOM, V42, P8, DOI 10.1016/j.ergon.2011.11.006; Phipps-Nelson J, 2011, J SLEEP RES, V20, P404, DOI 10.1111/j.1365-2869.2010.00900.x; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Ross V, 2015, APPL NEUROPSYCH-ADUL, V22, P61, DOI 10.1080/23279095.2013.838958; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Thiffault P, 2003, ACCIDENT ANAL PREV, V35, P381, DOI 10.1016/S0001-4575(02)00014-3; van der Linden D, 2006, PSYCHOL RES-PSYCH FO, V70, P395, DOI 10.1007/s00426-005-0228-7; Vander Molen M. W., 1991, HDB COGNITIVE PSYCHO, P9; Wu JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08844; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Zhang H, 2016, TRANSPORT RES F-TRAF, V43, P80, DOI 10.1016/j.trf.2016.06.017; Zhang H, 2016, TRANSPORT RES REC, P67, DOI 10.3141/2585-08; Zhao GZ, 2013, ACCIDENT ANAL PREV, V52, P19, DOI 10.1016/j.aap.2012.12.013	47	36	37	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198206	10.1371/journal.pone.0198206	http://dx.doi.org/10.1371/journal.pone.0198206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856827	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800083
J	Li, L; Cheng, Y; Emrich, S; Schorey, J				Li, Li; Cheng, Yong; Emrich, Scott; Schorey, Jeffrey			Activation of endothelial cells by extracellular vesicles derived from Mycobacterium tuberculosis infected macrophages or mice	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; VIRUS-INFECTION; EXOSOMES; BIOMARKERS; LIPOPROTEINS; INTERFERON; PROTEINS; DISEASES; BIOLOGY	Endothelial cells play an essential role in regulating an immune response through promoting leukocyte adhesion and cell migration and production of cytokines such as TNF alpha. Regulation of endothelial cell immune function is tightly regulated and recent studies suggest that extracellular vesicles (EVs) are prominently involved in this process. However, the importance of EVs in regulating endothelial activation in the context of a bacterial infection is poorly understood. To begin addressing this knowledge gap we characterized the endothelial cell response to EVs released from Mycobacterium tuberculosis (Mtb) infected macrophages. Our result showed increased macrophage migration through the monolayer when endothelial cells were pretreated with EVs isolated from Mtb-infected macrophages. Transcriptome analysis showed a significant upregulation of genes involved in cell adhesion and the inflammatory process in endothelial cells treated with EVs. These results were validated by quantitative PCR and flow cytometry. Pathway analysis of these differentially expressed genes indicated that several immune response-related pathways were up-regulated. Endothelial cells were also treated with EVs isolated from the serum of Mtb-infected mice. Interestingly, EVs isolated 14 days but not 7 or 21 days post-infection showed a similar ability to induce endothelial cell activation suggesting a change in EV function during the course of an Mtb infection. Immunofluorescence microscopy result indicated that NF-kappa B and the Type 1 interferon pathways were involved in endothelial activation by EVs. In summary, our data suggest that EVs can activate endothelial cells and thus may play an important role in modulating host immune responses during an Mtb infection.	[Li, Li; Cheng, Yong; Schorey, Jeffrey] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Emrich, Scott] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN USA	University of Notre Dame; University of Tennessee System; University of Tennessee Knoxville	Schorey, J (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	schorey.1@nd.edu			National Institute of Allergy and Infectious Diseases [Al052439]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funds for this work were provided by the grant Al052439 from the National Institute of Allergy and Infectious Diseases. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funds for this work were provided by the grant A1052439 from the National Institute of Allergy and Infectious Diseases. The authors declare no conflict of interest for the described studies. We thank Dr. Erlian Zeng in the Genomics and Bioinformatics Core Facility at Notre Dame for assistance with the pathway analysis.	Athman JJ, 2015, J IMMUNOL, V195, P1044, DOI 10.4049/jimmunol.1402894; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Bonner SM, 1998, J VIROL METHODS, V71, P159, DOI 10.1016/S0166-0934(97)00211-5; Boulanger CM, 2017, NAT REV CARDIOL, V14, P259, DOI 10.1038/nrcardio.2017.7; Cadena AM, 2017, NAT REV IMMUNOL, V17, P691, DOI 10.1038/nri.2017.69; Cines DB, 1998, BLOOD, V91, P3527; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; Danielson Kirsty M, 2014, Exosomes Microvesicles, V2, DOI 10.5772/58390; Diaz G, 2016, SCI REP-UK, V6, DOI 10.1038/srep37975; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Erdbrugger U, 2016, J AM SOC NEPHROL, V27, P12, DOI 10.1681/ASN.2015010074; Feldmann H, 1996, J VIROL, V70, P2208, DOI 10.1128/JVI.70.4.2208-2214.1996; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; FRIEDMAN HM, 1981, J INFECT DIS, V143, P266, DOI 10.1093/infdis/143.2.266; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Giugliano S, 2015, GASTROENTEROLOGY, V148, P392, DOI 10.1053/j.gastro.2014.10.040; Hargett LA, 2013, PULM CIRC, V3, P329, DOI 10.4103/2045-8932.114760; Helmke Alexandra, 2016, World J Nephrol, V5, P125, DOI 10.5527/wjn.v5.i2.125; Tong HV, 2017, TROP MED INT HEALTH, V22, P1063, DOI 10.1111/tmi.12923; Huang XK, 2014, ASIAN PAC J ALLERGY, V32, P235, DOI 10.12932/AP0432.32.3.2014; Iwanaszko M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1511-7; Joshi P, 2015, INT J MOL SCI, V16, P4800, DOI 10.3390/ijms16034800; Katsuda T, 2014, PROTEOMICS, V14, P412, DOI 10.1002/pmic.201300389; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Kruh-Garcia NA, 2015, TUBERCULOSIS, V95, P26, DOI 10.1016/j.tube.2014.10.010; Kruh-Garcia NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103811; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; Povero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113651; Raab-Traub N, 2017, NAT REV MICROBIOL, V15, P559, DOI 10.1038/nrmicro.2017.60; Rubio D, 2013, CELL HOST MICROBE, V13, P701, DOI 10.1016/j.chom.2013.04.015; Sadovska L, 2015, ANTICANCER RES, V35, P6379; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Schorey JS, 2016, J CLIN INVEST, V126, P1181, DOI 10.1172/JCI81132; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Shin J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/617809; Singh PP, 2012, J IMMUNOL, V189, P777, DOI 10.4049/jimmunol.1103638; Singh PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018564; Smith VL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43578; Taylor SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003470; Valbuena G, 2006, ANNU REV PATHOL-MECH, V1, P171, DOI 10.1146/annurev.pathol.1.110304.100031; Valbuena G, 2009, THROMB HAEMOSTASIS, V102, P1071, DOI 10.1160/TH09-03-0186; van Balkom BWM, 2013, BLOOD, V121, P3997, DOI 10.1182/blood-2013-02-478925; WOLINSKY H, 1980, CIRC RES, V47, P301, DOI 10.1161/01.RES.47.3.301; World Health Organization, GLOB TUB REP 2015; Zaborowski MP, 2015, BIOSCIENCE, V65, P783, DOI 10.1093/biosci/biv084; Zielinska KA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00592	49	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198337	10.1371/journal.pone.0198337	http://dx.doi.org/10.1371/journal.pone.0198337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851993	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200049
J	Yuasa, M; Saito, M; Molina, C; Moore-Lotridge, SN; Benvenuti, MA; Mignemi, NA; Okawa, A; Yoshii, T; Schwartz, HS; Nyman, JS; Schoenecker, JG				Yuasa, Masato; Saito, Masanori; Molina, Cesar; Moore-Lotridge, Stephanie N.; Benvenuti, Michael A.; Mignemi, Nicholas A.; Okawa, Atsushi; Yoshii, Toshitaka; Schwartz, Herbert S.; Nyman, Jeffry S.; Schoenecker, Jonathan G.			Unexpected timely fracture union in matrix metalloproteinase 9 deficient mice	PLOS ONE			English	Article							REPAIR; TIBIA	Immediately following a fracture, a fibrin laden hematoma is formed to prevent bleeding and infection. Subsequently, the organized removal of fibrin, via the protease plasmin, is essential to permit fracture repair through angiogenesis and ossification. Yet, when plasmin activity is lost, the depletion of fibrin alone is insufficient to fully restore fracture repair, suggesting the existence of additional plasmin targets important for fracture repair. Previously, activated matrix metalloproteinase 9 (MMP-9) was demonstrated to function in fracture repair by promoting angiogenesis. Given that MMP-9 is a defined plasmin target, it was hypothesized that pro-MMP-9, following plasmin activation, promotes fracture repair. This hypothesis was tested in a fixed murine femur fracture model with serial assessment of fracture healing. Contrary to previous findings, a complete loss of MMP-9 failed to affect fracture healing and union through 28 days post injury. Therefore, these results demonstrated that MMP-9 is dispensable for timely fracture union and cartilage transition to bone in fixed femur fractures. Pro-MMP-9 is therefore not a significant target of plasmin in fracture repair and future studies assessing additional plasmin targets associated with angiogenesis are warranted.	[Yuasa, Masato; Saito, Masanori; Molina, Cesar; Moore-Lotridge, Stephanie N.; Benvenuti, Michael A.; Mignemi, Nicholas A.; Schwartz, Herbert S.; Nyman, Jeffry S.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA; [Yuasa, Masato; Saito, Masanori; Okawa, Atsushi; Yoshii, Toshitaka] Tokyo Med & Dent Univ, Dept Orthopaed Surg, Tokyo, Japan; [Moore-Lotridge, Stephanie N.; Schoenecker, Jonathan G.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Mignemi, Nicholas A.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Nyman, Jeffry S.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Nyman, Jeffry S.] Vanderbilt Univ, Ctr Bone Biol, Med Ctr, Nashville, TN USA; [Nyman, Jeffry S.] Tennessee Valley Hlth Care Syst, Dept Vet Affairs, Nashville, TN USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Vanderbilt University; Tokyo Medical & Dental University (TMDU); Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	Jon.schoenecker@vanderbilt.edu	Saito, Masanori/GRR-1714-2022	Molina, Cesar Sebastian/0000-0002-2400-3906; Nyman, Jeffry/0000-0001-7403-7605; Saito, Masanori/0000-0002-4139-4013	Department of Orthopaedics and Rehabilitation-Vanderbilt University Medical Center; Caitlin Lovejoy Fund; Vanderbilt Orthopaedic Institute Research Grant; Pre-doctoral pharmacology training grant [T32 GM007628]; NCI/NIH Cancer Center Support Grant [2P30 CA068485-14]; Vanderbilt Mouse Metabolic Phenotyping Center Grant [5U24DK059637-13]; Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences from the NIH [S10RR027631]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER	Department of Orthopaedics and Rehabilitation-Vanderbilt University Medical Center; Caitlin Lovejoy Fund; Vanderbilt Orthopaedic Institute Research Grant; Pre-doctoral pharmacology training grant; NCI/NIH Cancer Center Support Grant; Vanderbilt Mouse Metabolic Phenotyping Center Grant; Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences from the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was supported by the Department of Orthopaedics and Rehabilitation-Vanderbilt University Medical Center (JGS); The Caitlin Lovejoy Fund (JGS); and by the Vanderbilt Orthopaedic Institute Research Grant (JGS). SNM was supported by T32 GM007628 Pre-doctoral pharmacology training grant. Use of the Translational Pathology Shared Resource was supported by NCI/NIH Cancer Center Support Grant (2P30 CA068485-14) and the Vanderbilt Mouse Metabolic Phenotyping Center Grant (5U24DK059637-13). Small animal imaging and analysis were supported in part by the Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences (S10RR027631) from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TJ, 2016, JBJS REV, V4, DOI 10.2106/JBJS.RVW.15.00099; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; BENVENUTI MANT, 2012, ORTHOP CLIN NORTH AM, V10, P11, DOI DOI 10.1016/J.0CL.2016.12.009; Chalidis BE, 2009, STRATEG TRAUMA LIMB, V4, P89, DOI 10.1007/s11751-009-0065-0; CLAES LE, 1998, CLIN ORTHOP RELAT R, V47; Cole HA, 2013, BONE, V52, P337, DOI 10.1016/j.bone.2012.10.011; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Gradl G, 2014, INJURY, V45, pS1, DOI 10.1016/j.injury.2013.10.046; HALLOCK GG, 1993, PLAST RECONSTR SURG, V92, P49, DOI 10.1097/00006534-199307000-00007; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; KLEIN P, 2004, J ORTHOP RES, V2, P6, DOI DOI 10.1016/J.0RTHRES.2004.02.006; LAING P, 2006, J BONE JOINT SURG BR; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Miclau T, 2007, J ORTHOP RES, V25, P1552, DOI 10.1002/jor.20435; Mohseni Mohammad Ali, 2011, Pak J Biol Sci, V14, P490; ONEILL KR, 2012, BONE, V3, P8, DOI DOI 10.1016/J.B0NE.2012.03.008; Park SH, 2003, J ORTHOP TRAUMA, V17, P2, DOI 10.1097/00005131-200301000-00002; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Tay BKB, 1998, J ORTHOP RES, V16, P636, DOI 10.1002/jor.1100160518; YUASA M, 2014, BONE, V7, P2, DOI DOI 10.1016/J.B0NE.2014.07.002; Yuasa M, 2015, J CLIN INVEST, V125, P3117, DOI 10.1172/JCI80313; ORTHOP CLIN NORTH AM, P181	23	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198088	10.1371/journal.pone.0198088	http://dx.doi.org/10.1371/journal.pone.0198088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851987	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200031
J	Wang, HW; Shi, HN; Cheng, J; Xie, F; Luo, YK; Tang, J				Wang, Hong-Wei; Shi, Hua-Ning; Cheng, Jia; Xie, Fang; Luo, Yu-Kun; Tang, Jie			Real-time shear wave elastography (SWE) assessment of short-and long-term treatment outcome in Budd-Chiari syndrome: A pilot study	PLOS ONE			English	Article							INCREASES LIVER STIFFNESS; CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; CLINICAL-USE; EFSUMB GUIDELINES; VIRUS-INFECTION; FIBROSIS; RECOMMENDATIONS; ELASTICITY; CIRRHOSIS	Purpose The first aim of this study was to analyze the relationships between liver stiffness measurement, hepatic venous pressure and liver fibrosis. The second aim was to demonstrate the utility of real-time shear wave elastography for evaluation of Budd-Chiari syndrome patients before and after balloon hepatic venous angioplasty. Materials and methods A total of 32 patients with Budd-Chiari syndrome slated for successful balloon angioplasty met the inclusion and exclusion criteria. Shear wave elastography was used to generate dynamic liver stiffness measurement 2 days before angioplasty and 2 days, 3 months, and 6 months after angioplasty. Hepatic venous pressures were measured during balloon angioplasty. Correlations among liver stiffness, hepatic venous pressure, and fibrosis were assessed. Result Mean liver stiffness was 35.17 +/- 10.60 kPa, 20.15 +/- 5.47 kPa, 15.36 +/- 4.34 kPa and 15.68 +/- 5.58 kPa at baseline and 2 days, 3 months, and 6 months after angioplasty, respectively. Liver stiffness measured at 2 days and 3 months after angioplasty was significantly decreased (P < 0.001); liver stiffness measured at 6 months after angioplasty was not significantly different from that measured at 3 months after angioplasty (P = 0.636). Analysis of liver stiffness measurement and hepatic venous pressure before balloon angioplasty yielded a coefficient of correlation r = 0.701 (P < 0.001). Before and 2d after angioplasty, liver stiffness measurement did not correlated with fibrosis (r = -0.170, P = 0.22), (r = 0.223, P = 0.220), respectively, while the LSM difference before and 2 days after angioplasty negatively correlated with stiffness severity (r = -0.502, P = 0.003). Liver stiffness measured at 2 days and 3 months after angioplasty was significantly decreased (P < 0.001), remaining stable at 3 months, though still in the cirrhotic range. Conclusions The liver stiffness of Budd-Chiari syndrome patients, measured by shear wave elastography, decreased considerably after hepatic venous recanalization, and significantly correlated with hepatic venous pressure though not with degree of fibrosis. Shear wave elastography may be effective in monitoring short-and long-term treatment outcomes in Budd-Chiari syndrome.	[Wang, Hong-Wei; Cheng, Jia; Xie, Fang; Luo, Yu-Kun; Tang, Jie] Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing, Peoples R China; [Wang, Hong-Wei] Yong Liang Hosp, Dept Ultrasound, Baoding, Peoples R China; [Shi, Hua-Ning] Chengde Med Coll, Dept Ultrasound, Affiliated Hosp, Chengde, Peoples R China	Chinese People's Liberation Army General Hospital; Chengde Medical University	Luo, YK; Tang, J (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing, Peoples R China.	lyk301@163.com; txiner@vip.sina.com		, wang/0000-0002-7052-7866	National Natural Science Foundation of China [81271588]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81271588) (YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf S, 2010, J HEPATOL, V52, pS168, DOI 10.1016/S0168-8278(10)60413-8; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Berzigotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058742; Boozari B, 2008, J HEPATOL, V49, P572, DOI 10.1016/j.jhep.2008.04.025; Bota S, 2013, DIGEST LIVER DIS, V45, P762, DOI 10.1016/j.dld.2013.02.008; Cassinotto C, 2014, J HEPATOL, V61, P550, DOI 10.1016/j.jhep.2014.04.044; Colli A, 2010, RADIOLOGY, V257, P872, DOI 10.1148/radiol.10100013; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Couinaud C., 1992, Annali Italiani di Chirurgia, V63, P693; CRAXI A, 2011, J HEPATOL, V55, P245, DOI DOI 10.1016/J.JHEP.2011.02.023; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Fisher NC, 1999, GUT, V44, P568, DOI 10.1136/gut.44.4.568; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Guido M, 2004, GUT, V53, P1878; Janssen HLA, 2003, J HEPATOL, V38, P364, DOI 10.1016/S0168-8278(02)00434-8; Jiang TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157219; Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561; Mederacke I, 2009, LIVER INT, V29, P1500, DOI 10.1111/j.1478-3231.2009.02100.x; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Poynard T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163276; Reiberger T, 2012, J GASTROENTEROL, V47, P561, DOI 10.1007/s00535-011-0517-4; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Samir AE, 2015, RADIOLOGY, V274, P888, DOI 10.1148/radiol.14140839; Suh CH, 2014, RADIOLOGY, V271, P895, DOI 10.1148/radiol.14131251; Valla D, 1997, HEPATOLOGY, V25, P814, DOI 10.1002/hep.510250405; Valla DC, 2009, J HEPATOL, V50, P195, DOI 10.1016/j.jhep.2008.10.007; Wang HK, 2012, TRANSPL P, V44, P814, DOI 10.1016/j.transproceed.2012.01.035	32	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197550	10.1371/journal.pone.0197550	http://dx.doi.org/10.1371/journal.pone.0197550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847588	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800037
J	Tran, NTT; Blizzard, CL; Luong, KN; Truong, NLV; Tran, BQ; Otahal, P; Nelson, M; Magnussen, C; Gall, S; Bui, TV; Srikanth, V; Au, TB; Hai, ST; Phung, HN; Tran, MH; Callisaya, M				Nga Thi Thu Tran; Blizzard, Christopher Leigh; Khue Ngoc Luong; Ngoc Le Van Truong; Bao Quoc Tran; Otahal, Petr; Nelson, Mark; Magnussen, Costan; Gall, Seana; Tan Van Bui; Srikanth, Velandai; Thuy Bich Au; Son Thai Hai; Hai Ngoc Phung; Mai Hoang Tran; Callisaya, Michele			The importance of waist circumference and body mass index in cross-sectional relationships with risk of cardiovascular disease in Vietnam	PLOS ONE			English	Article							TO-HEIGHT RATIO; VISCERAL FAT ACCUMULATION; METABOLIC SYNDROME; CARDIOMETABOLIC RISK; ANTHROPOMETRIC INDEXES; HIP RATIO; CONSENSUS STATEMENT; INSULIN-RESISTANCE; ABDOMINAL OBESITY; ADIPOSE-TISSUE	Background Waist circumference (WC) is an indicator of intra-abdominal adipose tissue, high levels of which confer an increased risk of cardiometabolic disease. Population data on WC should be more informative than data on body mass index (BMI), which is a general indicator of body size. This study aimed to evaluate the importance of WC relative to BMI in cross-sectional relationships with blood pressure (BP), glucose, and total cholesterol (TC) in the adult population of Vietnam. Methods The data were collected in a population-based survey conducted during 2009-10 using the "WHO STEPwise approach to surveillance of risk factors for non-communicable disease" (STEPS) methodology. The survey participants (n = 14 706 aged 25 to 64 years) were selected by multi-stage stratified cluster sampling from eight provinces representative of the eight geographical regions of Vietnam. All measurements were performed in accordance with the STEPS protocols. All analyses were performed using complex survey methods. Results The measurements of WC and BMI were highly correlated (men r = 0.80, women r = 0.77). For men, the strongest and predominant associations with BP, glucose, and TC were for WC or an index based on WC. For women, this was true for glucose but BMI was more important for BP and TC. WC or an index based on WC provided better discrimination than BMI of hypertension and elevated glucose, and of raised TC for men. Information on four new anthropometric indices did not improve model fit or subject discrimination. Conclusion For BP/hypertension, glucose/elevated glucose, and TC/raised TC, WC was more informative than BMI for Vietnamese men, but both WC and BMI were important for Vietnamese women. Both WC and BMI need to be assessed for estimation of CVD risk in Vietnam.	[Nga Thi Thu Tran; Blizzard, Christopher Leigh; Otahal, Petr; Nelson, Mark; Magnussen, Costan; Gall, Seana; Tan Van Bui; Thuy Bich Au; Hai Ngoc Phung; Mai Hoang Tran; Callisaya, Michele] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Tan Van Bui] Can Tho Univ Med & Pharm, Can Tho City, Vietnam; [Khue Ngoc Luong; Ngoc Le Van Truong; Bao Quoc Tran; Son Thai Hai] Minist Hlth Socialist Republ Vietnam, Med Serv Adm, Hanoi, Vietnam; [Srikanth, Velandai] Monash Univ, Cent Clin Sch, Peninsula Clin Sch, Dept Med, Melbourne, Vic, Australia	University of Tasmania; Menzies Institute for Medical Research; Can Tho University of Medicine & Pharmacy (CTUMP); Monash University	Blizzard, CL (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	Leigh.Blizzard@utas.edu.au	Callisaya, Michele/I-2333-2013; Magnussen, Costan/AAA-8260-2020; Tran, Nga/L-5423-2015; Bui, Tan/G-4138-2014; Magnussen, Costan/J-7177-2014	Callisaya, Michele/0000-0003-2122-1622; Otahal, Petr/0000-0003-4042-1769; Tran, Nga/0000-0001-6434-0504; Bui, Tan/0000-0001-6357-7307; Phung, Hai/0000-0003-1533-8074; Srikanth, Velandai/0000-0002-8442-8981; Magnussen, Costan/0000-0002-6238-5730	Atlantic Philanthropies Inc, United States [G0015338]; Tasmania Graduate Research Scholarship; National Health and Medical Research Council Career Development Fellowship; Atlantic Philanthropies Inc., USA	Atlantic Philanthropies Inc, United States; Tasmania Graduate Research Scholarship; National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Atlantic Philanthropies Inc., USA	This work was supported by The Atlantic Philanthropies Inc, United States (grant number G0015338). NTTT is supported by a Tasmania Graduate Research Scholarship; LB is supported by a National Health and Medical Research Council Career Development Fellowship.; We would like to thank The Atlantic Philanthropies Inc., USA for its financial support for data collection of the survey. We thank the Ministry of Health of the Socialist Republic of Vietnam and the provincial data collection teams for their contributions. We also thank Catrina Boon and Kate Butorac for their assistance with training and supervision of data collection teams.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amato MC, 2013, J ENDOCRINOL INVEST, V36, P537, DOI 10.3275/8943; [Anonymous], 1995, PHYS STAT US INT ANT; Ardern CI, 2004, OBES RES, V12, P1094, DOI 10.1038/oby.2004.137; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Balkau B, 2002, DIABETES METAB, V28, P364; Beydoun MA, 2011, PUBLIC HEALTH NUTR, V14, P77, DOI 10.1017/S1368980010002648; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Blondin DP, 2011, OBESITY, V19, pS83; Chen G, 2011, INT J CLIN PRACT, V65, P592, DOI 10.1111/j.1742-1241.2011.02653.x; Cheong KC, 2015, DIABETES METAB SYND, V9, P74, DOI 10.1016/j.dsx.2015.02.006; Consultation WHO Expert, 2008, WAIST CIRCUMFERENCE; Deng WW, 2013, AM J HYPERTENS, V26, P58, DOI 10.1093/ajh/hps001; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Freiberg MS, 2008, OBESITY, V16, P463, DOI 10.1038/oby.2007.75; Ghosh J. R., 2007, SMJ Singapore Medical Journal, V48, P232; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Guerrero-Romero F, 2003, ARCH MED RES, V34, P428, DOI 10.1016/S0188-4409(03)00073-0; Hajian-Tilaki K, 2014, J RES HEALTH SCI, V14, P276; Hojgaard B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002619; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Huxley R, 2008, J HYPERTENS, V26, P169, DOI 10.1097/HJH.0b013e3282f16ad3; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lee JW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1471-5; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Li R, 2015, ASIA-PAC J PUBLIC HE, V27, pNP457, DOI 10.1177/1010539512465306; Li WC, 2013, EUR J NUTR, V52, P57, DOI 10.1007/s00394-011-0286-0; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P287; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Miyawaki T, 2004, INTERNAL MED, V43, P1138, DOI 10.2169/internalmedicine.43.1138; Mohammadifard N, 2013, J HEALTH POPUL NUTR, V31, P388; MUELLER WH, 1991, AM J EPIDEMIOL, V133, P858, DOI 10.1093/oxfordjournals.aje.a115966; NAKAMURA T, 1994, ATHEROSCLEROSIS, V107, P239, DOI 10.1016/0021-9150(94)90025-6; Norgan NG, 1997, INT J OBESITY, V21, P738, DOI 10.1038/sj.ijo.0800473; Ostchega Y, 2012, AM J HYPERTENS, V25, P1271, DOI 10.1038/ajh.2012.120; Pepe MS, 2009, STATA J, V9, P1; Roka R, 2015, HIGH BLOOD PRESS CAR, V22, P265, DOI 10.1007/s40292-015-0106-3; Sakurai M, 2006, HYPERTENS RES, V29, P75, DOI 10.1291/hypres.29.75; Schooling CM, 2010, DIABETOLOGIA, V53, P393, DOI 10.1007/s00125-009-1613-3; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Soreide K, 2009, J CLIN PATHOL, V62, P1, DOI 10.1136/jcp.2008.061010; Staiano AE, 2012, INT J OBESITY, V36, P1450, DOI 10.1038/ijo.2011.268; StataCorp, STAT C; Tulloch-Reid MK, 2003, DIABETES CARE, V26, P2556, DOI 10.2337/diacare.26.9.2556; VALDEZ R, 1993, INT J OBESITY, V17, P77; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2008, WHO STEPS SURV MAN W; Zazai R, 2014, OBES SURG, V24, P777, DOI 10.1007/s11695-013-1141-6; Zhou ZQ, 2009, PUBLIC HEALTH NUTR, V12, P1061, DOI 10.1017/S1368980008003601; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	55	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198202	10.1371/journal.pone.0198202	http://dx.doi.org/10.1371/journal.pone.0198202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813112	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000433521800056
J	Cade, WT; Bohnert, KL; Reeds, DN; Peterson, LR; Bittel, AJ; Bashir, A; Byrne, BJ; Taylor, CL				Cade, William Todd; Bohnert, Kathryn L.; Reeds, Dominic N.; Peterson, Linda R.; Bittel, Adam J.; Bashir, Adil; Byrne, Barry J.; Taylor, Carolyn L.			Peak oxygen uptake (VO2peak) across childhood, adolescence and young adulthood in Barth syndrome: Data from cross-sectional and longitudinal studies	PLOS ONE			English	Article							UPRIGHT CYCLE ERGOMETRY; ALL-CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; PHYSIOLOGICAL-RESPONSES; CARDIOVASCULAR EVENTS; MUSCULAR EXERCISE; SKELETAL-MUSCLE; LACTIC-ACID; HEALTHY-MEN; DISEASE	Barth syndrome (BTHS) is an ultra-rare, X-linked recessive disorder characterized by cardio-skeletal myopathy, exercise intolerance, and growth delay. Oxygen uptake during peak exercise (VO2peak) has been shown to be severely limited in individuals with BTHS however; the trajectory of VO2peak from childhood to young adulthood is unknown. The objective of this study was to describe VO2peak from childhood through young adulthood in BTHS. Methods and Materials: VO2peak over time was presented through cross-sectional (n = 33 participants) and a longitudinal analyses (n = 12 participants). Retrospective data were obtained through maximal exercise testing on a cycle ergometer from individuals with BTHS who were or are currently enrolled in a research study during July 2006-September 2017. Participants included in the cross-sectional analysis were divided into 3 groups for analysis: 1) children (n = 13), 2) adolescents (n = 8), and 3) young adults (n = 12). Participants in the longitudinal analysis had at least two exercise tests over a span of 2-9 years. Results: VO(2peak )relative to body weight (ml/kgBW/min), fat-free mass (FFM) and by percent of predicted VO2peak obtained were not significantly different between children, adolescents and young adults. VO2peak did not longitudinally change over a mean time of similar to 5 years in late adolescent and young adult participants with repeated tests. A model including both cardiac and skeletal muscle variables best predicted VO2peak . Conclusions: In conclusion, VO2peak relative to body weight and fat-free mass demonstrates short- and long-term stability from childhood to young adulthood in BTHS with some variability among individuals.	[Cade, William Todd; Bohnert, Kathryn L.; Bittel, Adam J.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63130 USA; [Cade, William Todd; Reeds, Dominic N.; Peterson, Linda R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Bashir, Adil] Auburn Univ, Dept Elect & Comp Engn, Auburn, AL 36849 USA; [Byrne, Barry J.] Univ Florida, Dept Pediat, Gainesville, FL USA; [Taylor, Carolyn L.] Med Univ South Carolina, Dept Pediat, Charleston, SC USA	Washington University (WUSTL); Washington University (WUSTL); Auburn University System; Auburn University; State University System of Florida; University of Florida; Medical University of South Carolina	Cade, WT (corresponding author), Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63130 USA.; Cade, WT (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	tcade@wustl.edu	Peterson, Linda R/ABH-2815-2021	Cade, William/0000-0002-2329-7623; Byrne, Barry J./0000-0002-7302-1756; Peterson, Linda/0000-0001-8766-4552	National Institutes of Health [R01HL107406-01, UL1TR000448]; Barth Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007434] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health R01HL107406-01 and UL1TR000448 and from the Barth Syndrome Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2000, ACSMS GUID EX TEST P; Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; Armstrong N, 1994, Exerc Sport Sci Rev, V22, P435; Armstrong N, 1998, MED SCI SPORT EXER, V30, P165, DOI 10.1097/00005768-199801000-00023; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bashir A, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13130; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BONZHEIM SC, 1992, AM J CARDIOL, V69, P40, DOI 10.1016/0002-9149(92)90673-M; Cade WT, 2017, JIMD REP, V32, P15, DOI 10.1007/8904_2016_553; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Foundation BS, 2018, BARTH SYNDR FREQ ASK; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Hill AV, 1924, P R SOC LOND B-CONTA, V97, P155, DOI 10.1098/rspb.1924.0048; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 1996, ICH HARM TRIP GUID S; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 2018, ICH HARM TRIP GUID S; Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594; Kang SL, 2016, PEDIATR CARDIOL, V37, P167, DOI 10.1007/s00246-015-1260-z; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Krahenbuhl G S, 1985, Exerc Sport Sci Rev, V13, P503; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; Malina RM, 1997, ANN HUM BIOL, V24, P19, DOI 10.1080/03014469700004742; Malina RM, 1991, GROWTH MATURATION PH; Pivarnik JM, 1996, RES Q EXERCISE SPORT, V67, P345, DOI 10.1080/02701367.1996.10607962; QUINN TJ, 1995, ARCH PHYS MED REHAB, V76, P257, DOI 10.1016/S0003-9993(95)80612-1; Roberts AE, 2012, AM J MED GENET A, V158A, P2726, DOI 10.1002/ajmg.a.35609; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Ross RM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-31; Rowland T.W., 2005, CHILDRENS EXERCISE P; Spencer CT, 2011, AM J PHYSIOL-HEART C, V301, pH2122, DOI 10.1152/ajpheart.00479.2010; Storch EA, 2009, CHILD HEALTH CARE, V38, P137, DOI 10.1080/02739610902813344; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028; Thompson WR, 2016, GENET MED, V18, P1001, DOI 10.1038/gim.2015.204; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wasserman K., 1999, PRINCIPLES EXERCISE; WHIPP BJ, 1990, MED SCI SPORT EXER, V22, P62; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	42	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197776	10.1371/journal.pone.0197776	http://dx.doi.org/10.1371/journal.pone.0197776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795646	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300073
J	Ghazal, F; Theobald, H; Rosenqvist, M; Al-Khalili, F				Ghazal, Faris; Theobald, Holger; Rosenqvist, Marten; Al-Khalili, Faris			Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; STROKE; PROGRESSION; DIAGNOSIS; DEMENTIA; REGISTRY; ECG	Background Atrial fibrillation (AF) is a major risk factor for ischemic stroke unless treated with an anticoagulant. Detecting AF can be difficult because AF is often paroxysmal and asymptomatic. The aims of this study were to develop a screening model to detect AF in a primary healthcare setting and to initiate oral anticoagulant therapy in high-risk patients to prevent stroke. Methods This was a cross-sectional study. All 70-to 74-year-old individuals registered at a single primary healthcare center in Stockholm were invited to participate in AF screening upon visiting the center during a ten-month period. Those who did not have contact with the center during this period were invited to participate by letter. Thirty-second intermittent ECG recordings were made twice a day using a handheld Zenicor device over a 2-week period in participants without AF. Oral anticoagulant therapy was offered to patients with newly detected AF. Findings Of the 415 eligible individuals, a total of 324 (78.1%) patients participated in the study. The mean age of the participants was 72 years, 52.2% were female, and the median CHA2DS2-VASc score of the participants was 3. In the target population, 34 (8.2%) individuals had previously diagnosed AF. Among participants without previously known AF, 16 (5.5%) cases of AF were detected. The final AF prevalence in the target population was 12%. Oral anticoagulant therapy was successfully initiated in 88% of these patients with newly detected AF. Conclusions The AF screening project exhibited a high participation rate and resulted in a high rate of newly discovered AF; of these newly diagnosed patients, 88% could be treated with an oral anticoagulant.	[Ghazal, Faris; Rosenqvist, Marten; Al-Khalili, Faris] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Cardiol Unit, Stockholm, Sweden; [Theobald, Holger] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Karolinska Institutet	Ghazal, F (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Cardiol Unit, Stockholm, Sweden.	faris.ghazal@ki.se		Ghazal, Faris/0000-0001-5529-4243; , Faris/0000-0003-4891-0639	Bayer Health Care [2015/PO4501400356]; Pfizer Foundation [2015/N3587463]; Capio primary care [2014/2602]	Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Pfizer Foundation; Capio primary care	This project has received following funders: 1-Bayer Health Care,2015/PO4501400356, https://www.bayer.com; 2-Pfizer Foundation 2015/N3587463, https://www.pfizer.com; 3-Capio primary care, 2014/2602, https://capio.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bury G, 2015, INT J CARDIOL, V178, P247, DOI 10.1016/j.ijcard.2014.10.037; Cacciatore F, 2012, DEMENT GERIATR COGN, V34, P143, DOI 10.1159/000342195; Cadby G, 2015, CHEST, V148, P945, DOI 10.1378/chest.15-0229; Chan NY, 2017, HEART, V103, P24, DOI 10.1136/heartjnl-2016-309993; Disertori M, 2011, AM HEART J, V162, P382, DOI 10.1016/j.ahj.2011.05.008; Doliwa PS, 2009, SCAND CARDIOVASC J, V43, P163, DOI 10.1080/14017430802593435; Engdahl J, 2013, CIRCULATION, V127, P930, DOI 10.1161/CIRCULATIONAHA.112.126656; Farmakis D, 2013, HELL J CARDIOL, V54, P368; Friberg L, 2018, EUR HEART J, V39, P453, DOI 10.1093/eurheartj/ehx579; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Kerr CR, 2005, AM HEART J, V149, P489, DOI 10.1016/j.ahj.2004.09.053; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Konecny T, 2014, AM J CARDIOL, V114, P272, DOI 10.1016/j.amjcard.2014.04.030; Lee SS, 2017, EUR HEART J, V38, P2599, DOI 10.1093/eurheartj/ehx316; Poulsen MB, 2017, INT J STROKE, V12, P192, DOI 10.1177/1747493016669883; Rizos T, 2011, CEREBROVASC DIS, V32, P276, DOI 10.1159/000330348; Sandhu RK, 2011, AM HEART J, V161, P986, DOI 10.1016/j.ahj.2011.02.001; Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X; Steg PG, 2012, HEART, V98, P195, DOI 10.1136/heartjnl-2011-300550; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Xiong QM, 2015, INT J CARDIOL, V191, P172, DOI 10.1016/j.ijcard.2015.05.011	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198069	10.1371/journal.pone.0198069	http://dx.doi.org/10.1371/journal.pone.0198069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795689	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300124
J	Joseph, PV; Wang, YP; Fourie, NH; Henderson, WA				Joseph, Paule V.; Wang, Yupeng; Fourie, Nicolaas H.; Henderson, Wendy A.			A computational framework for predicting obesity risk based on optimizing and integrating genetic risk score and gene expression profiles	PLOS ONE			English	Article							ASSOCIATION; NORMALIZATION; LOCI	Recent large-scale genome-wide association studies have identified tens of genetic loci robustly associated with Body Mass Index (BMI). Gene expression profiles were also found to be associated with BMI. However, accurate prediction of obesity risk utilizing genetic data remains challenging. In a cohort of 75 individuals, we integrated 27 BMI-associated SNPs and obesity-associated gene expression profiles. Genetic risk score was computed by adding BMI-increasing alleles. The genetic risk score was significantly correlated with BMI when an optimization algorithm was used that excluded some SNPs. Linear regression and support vector machine models were built to predict obesity risk using gene expression profiles and the genetic risk score. An adjusted R-2 of 0.556 and accuracy of 76% was achieved for the linear regression and support vector machine models, respectively. In this paper, we report a new mathematical method to predict obesity genetic risk. We constructed obesity prediction models based on genetic information for a small cohort. Our computational framework serves as an example for using genetic information to predict obesity risk for specific cohorts.	[Joseph, Paule V.; Fourie, Nicolaas H.; Henderson, Wendy A.] NIH, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [Wang, Yupeng] Phronetik Inc, Plano, TX USA	National Institutes of Health (NIH) - USA	Henderson, WA (corresponding author), NIH, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA.	hendersw@mail.nih.gov	Joseph, Paule/N-2701-2013; Henderson, Wendy A./F-1171-2018	Joseph, Paule/0000-0002-1198-9622; Henderson, Wendy A./0000-0003-3924-7118	National Institute of Nursing Research [1ZIANR000018-01-07]; Office of Workforce Diversity; NIH; Rockefeller University Heilbrunn Scholar; Phronetik Inc.; NATIONAL INSTITUTE OF NURSING RESEARCH [ZIANR000018, ZIANR000035] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Office of Workforce Diversity; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Heilbrunn Scholar; Phronetik Inc.; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Support provided by the National Institute of Nursing Research (to WAH, 1ZIANR000018-01-07 and Intramural Research Training Award to PVJ); Office of Workforce Diversity, NIH to PVJ; Rockefeller University Heilbrunn Scholar to PVJ. Phronetik Inc. provided support in the form of salaries for author YW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; GIANT consortium, 2011, GIANT GEN INV ANTHRO; Horne BD, 2005, ANN HUM GENET, V69, P176, DOI 10.1046/j.1529-8817.2005.00155.x; Hurt Ryan T, 2010, Gastroenterol Hepatol (N Y), V6, P780; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Orkunoglu-Suer FE, 2011, OBESITY, V19, P662, DOI 10.1038/oby.2010.180; Peterson V.L., 2012, OPEN OBES J, V4, P18; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stack CB, 2011, GENET MED, V13, P131, DOI 10.1097/GIM.0b013e318201164c; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Zhu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091442	27	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197843	10.1371/journal.pone.0197843	http://dx.doi.org/10.1371/journal.pone.0197843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795655	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300079
J	Santana, CP; Medeiros, FD; Correia, LP; Diniz, PHGD; Veras, G; Medeiros, ACD				Santana, Cleildo P.; Medeiros, Francinalva D.; Correia, Lidiane P.; Diniz, Paulo Henrique G. D.; Veras, Germano; Medeiros, Ana Claudia D.			Dissolution and uniformity of content of tablets developed with extract of Ximenia americana L.	PLOS ONE			English	Article								Herbal medicines currently represent an important part of the world pharmaceutical market, which shows growing interest in the use of herbal medicines. However, the production of such medicines involves a complex series of steps, which determine the production viability and the quality of the final product. Ximenia americana L. is a plant occurring in several regions of the world, with well-known and applied medicinal properties. Thus, the aim of this work was to develop and evaluate the physical and physical-chemical quality of tablets produced with X americana L. extract. The extract was spray-dried from a hydroethanolic extractive solution and characterized as to its phytochemical composition. The chemical marker was determined and quantified using validated chromatographic methods. These methods indicated the presence of gallic acid at a concentration of 1.61 mg g(-1). Formulations were proposed and analyzed for their flow and compaction properties. The best formulation was used to obtain a batch of tablets, which was evaluated for its quality characteristics and showed to be within the pharmacopoeial specifications for average weight, hardness, friability, and disintegration time. The dissolution profile of the tablets produced was obtained, showing the release of about 70% of the vegetable extract content within 30 minutes. Results showed that it was possible to obtain herbal tablets containing a high content of vegetal extract by direct compression, developing a rapid process of formulation and production and guaranteeing the quality characteristics of the final product.	[Santana, Cleildo P.; Medeiros, Francinalva D.; Medeiros, Ana Claudia D.] Univ Estadual Paraiba, Ctr Ciencias Biol & Saude, Lab Desenvolvimento & Ensaios Medicamentos, Campina Grande, Paraiba, Brazil; [Correia, Lidiane P.; Medeiros, Ana Claudia D.] Univ Estadual Paraiba, Ctr Ciencias Biol & Saude, Dept Farm, Campina Grande, Paraiba, Brazil; [Diniz, Paulo Henrique G. D.; Veras, Germano] Univ Estadual Paraiba, Lab Quim Analit & Quimiometria, Campina Grande, Paraiba, Brazil	Universidade Estadual da Paraiba; Universidade Estadual da Paraiba; Universidade Estadual da Paraiba	Medeiros, ACD (corresponding author), Univ Estadual Paraiba, Ctr Ciencias Biol & Saude, Lab Desenvolvimento & Ensaios Medicamentos, Campina Grande, Paraiba, Brazil.; Medeiros, ACD (corresponding author), Univ Estadual Paraiba, Ctr Ciencias Biol & Saude, Dept Farm, Campina Grande, Paraiba, Brazil.	anaclaudia@uepb.edu.br	Diniz, Paulo/F-2724-2012; Neto, Jose Germano Veras/E-3751-2013; de Medeiros, Ana Cláudia Dantas/E-3387-2013; Veras, Germano/AAN-7721-2020	Diniz, Paulo/0000-0002-8652-5478; Neto, Jose Germano Veras/0000-0003-0173-3778; de Medeiros, Ana Cláudia Dantas/0000-0002-8682-0178; Veras, Germano/0000-0003-0173-3778; Santana, Cleildo/0000-0002-8097-7633				Abu-Diak OA, 2011, MOL PHARMACEUT, V8, P1362, DOI 10.1021/mp200157b; Afifi SA, 2012, LIFE SCI J, V9, P4260; Bernatoniene J, 2010, J MED PLANTS RES, V4, P925; Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003; Chaves TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155532; da Silva KMA, 2015, B LATINOAM CARIBE PL, V14, P92; Fereja TH, 2015, J PHARM PHARMACOL, V2, P1; Fernandes FHA, 2016, J THERM ANAL CALORIM, V123, P2531, DOI 10.1007/s10973-016-5241-0; Fernandes HA, 2017, J THERM ANAL CALORIM, DOI 10.1007/s10973-017-6437-7; Gallo L., 2013, INT J RES PHARM BIOM, V4, P1360; Guideline ICH, 2005, GUIDELINE ICH VALIDA, V1, P5; Gupta R, 2013, INDO AM J PHARM RES, V3, P4366; Kartini K., 2012, ASIAN J PHARM CLIN R, V5, P191; Kumar N, 2011, AFR J PHARM PHARMACO, V5, P2335, DOI 10.5897/AJPP11.694; MAKKAR HPS, 1993, J CHEM ECOL, V19, P613, DOI 10.1007/BF00984996; Medeiros ACD, 2007, J THERM ANAL CALORIM, V88, P311, DOI 10.1007/s10973-006-8005-4; Qian F, 2012, PHARM RES-DORDR, V29, P2766, DOI 10.1007/s11095-012-0695-7; Rasheed NMA, 2012, ANN PHYTOMEDICINE, V1, P1; Santana CP, 2018, J THERM ANAL CALORIM, V133, P603, DOI 10.1007/s10973-017-6764-8; Silva MSP, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/681207; The United States Pharmacopeia, 2013, NAT FORM 25; van Drooge DJ, 2004, J CONTROL RELEASE, V97, P441, DOI 10.1016/j.jconrel.2004.03.018	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197323	10.1371/journal.pone.0197323	http://dx.doi.org/10.1371/journal.pone.0197323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795592	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300037
J	Wang, WW; He, JY; Pan, DD; Wu, Z; Guo, YX; Zeng, XQ; Lian, LW				Wang, Wenwen; He, Jiayi; Pan, Daodong; Wu, Zhen; Guo, Yuxing; Zeng, Xiaoqun; Lian, Liwei			Metabolomics analysis of Lactobacillus plantarum ATCC 14917 adhesion activity under initial acid and alkali stress	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; PROBIOTIC PROPERTIES; CARBON METABOLISM; S-LAYER; PH; RESPONSES; BACTERIA; CHEESE; MEMBRANE; GENES	The adhesion ability of Lactobacillus plantarum affects retention time in the human gastrointestinal tract, as well as influencing the interaction with their host. In this study, the relationship between the adhesion activity of, and metabolic changes in, L. plantarum ATCC 14917 under initial acid and alkali stress was evaluated by analyzing auto-aggregation, protein adhesion and cell adhesion in vitro. Based on scanning electron microscope (SEM) and transmission electron microscope (TEM) analysis, the morphology of the bacteria became thickset and the thickness of their cell walls decreased under initial alkali stress. The fold changes of auto-aggregation, adhere to mucin and HT-29 cell lines of L. plantarum ATCC 14917 in the acid group were increased by 1.141, 1.125 and 1.156, respectively. But decreased significantly in the alkali group (fold changes with 0.842, 0.728 and 0.667). Adhesion-related protein increased in the acid group but declined in the alkali group at the mRNA expression level according to real time polymerase chain reaction (RT-PCR) analysis. The changes in the metabolite profiles of L. plantarum ATCC 14917 were characterized using Ultra-Performance Liquid Chromatography-Electrospray ionization-Quadrupole-Time of Flight-mass spectrometry (UPLS-ESI-Q-TOF-MS). In the alkali group, the content of a lot of substances involved in the energy and amino acid metabolism decreased, but the content of some substances involved in the energy metabolism was slightly increased in the acid group. These findings demonstrate that energy metabolism is positively correlated with the adhesion ability of L. plantarum ATCC 14917. The amino-acids metabolism, especially the amino acids related to pH-homeostasis mechanisms (lysine, aspartic acid, arginine, proline and glutamic acid), showed an obvious effect on the adhesion ability of L. plantarum ATCC 14917. This investigation provides a better understanding of L. plantarum's adhesion mechanisms under initial pH stress.	[Wang, Wenwen; He, Jiayi; Pan, Daodong; Wu, Zhen; Zeng, Xiaoqun] Ningbo Univ, Marine Sci Sch, Key Lab Anim Prot Deep Proc Technol Zhejiang, Ningbo, Zhejiang, Peoples R China; [Pan, Daodong; Guo, Yuxing] Nanjing Normal Univ, Ginling Coll, Dept Food Sci & Nutr, Nanjing, Jiangsu, Peoples R China; [Lian, Liwei] Ningbo Dairy Grp, Ningbo, Zhejiang, Peoples R China	Ningbo University; Nanjing Normal University	Pan, DD; Wu, Z (corresponding author), Ningbo Univ, Marine Sci Sch, Key Lab Anim Prot Deep Proc Technol Zhejiang, Ningbo, Zhejiang, Peoples R China.; Pan, DD (corresponding author), Nanjing Normal Univ, Ginling Coll, Dept Food Sci & Nutr, Nanjing, Jiangsu, Peoples R China.	daodongpan@163.com; woodsen@163.com	Wu, Zhen/AFN-8777-2022; , ZhenWu/AEC-6724-2022	Wu, Zhen/0000-0002-3607-6440; Pan, Daodong/0000-0003-2935-9781	Natural Science Funding of China [31601487, 31671869, 31471598]; Natural Science Funding of Zhejiang [LQ16C200002]; Science and Technology Department of Ningbo [2016C10022]; Open Funding of the Key Laboratory of Animal Protein Deep Processing Technology of Zhejiang [ZX2015000928]; K. C. Wong Magna Fund in Ningbo University; Ningbo Dairy Group	Natural Science Funding of China; Natural Science Funding of Zhejiang; Science and Technology Department of Ningbo; Open Funding of the Key Laboratory of Animal Protein Deep Processing Technology of Zhejiang; K. C. Wong Magna Fund in Ningbo University; Ningbo Dairy Group	This work was supported by the Natural Science Funding of China (31601487, 31671869, 31471598), the Natural Science Funding of Zhejiang (LQ16C200002), the Science and Technology Department of Ningbo (2016C10022), Open Funding of the Key Laboratory of Animal Protein Deep Processing Technology of Zhejiang (ZX2015000928) and the K. C. Wong Magna Fund in Ningbo University. The Ningbo Dairy Group provided support in the form of salaries for author LL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by the Natural Science Funding of China (31601487, 31671869, 31471598), the Science and Technology Bureau of Ningbo (2016C10022), and the K. C. Wong Magna Fund in Ningbo University.	Abo-Amer Aly E., 2007, ScienceAsia, V33, P313, DOI 10.2306/scienceasia1513-1874.2007.33.313; Antikainen J, 2002, MOL MICROBIOL, V46, P381, DOI 10.1046/j.1365-2958.2002.03180.x; Ardhana MM, 2003, INT J FOOD MICROBIOL, V86, P87, DOI 10.1016/S0168-1605(03)00081-3; Beal C, 2001, J DAIRY SCI, V84, P2347, DOI 10.3168/jds.S0022-0302(01)74683-8; Bond DR, 1996, APPL ENVIRON MICROB, V62, P2095, DOI 10.1128/AEM.62.6.2095-2099.1996; Buck BL, 2009, J APPL MICROBIOL, V107, P269, DOI 10.1111/j.1365-2672.2009.04204.x; Choi EA, 2015, LWT-FOOD SCI TECHNOL, V62, P210, DOI 10.1016/j.lwt.2015.01.019; Cocolin L, 2000, LETT APPL MICROBIOL, V30, P126, DOI 10.1046/j.1472-765X.2000.00682.x; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Ercolini D, 2003, APPL ENVIRON MICROB, V69, P3540, DOI 10.1128/AEM.69.6.3540-3548.2003; Even S, 2002, MOL MICROBIOL, V45, P1143, DOI 10.1046/j.1365-2958.2002.03086.x; Fallingborg J, 1999, DAN MED BULL, V46, P183; Ferchichi M, 2005, J BIOTECHNOL, V120, P402, DOI 10.1016/j.jbiotec.2005.05.017; Gale E. F., 2006, ADV ENZYMOLOGY RELAT, V6, P1; Gevers D, 2003, APPL ENVIRON MICROB, V69, P1270, DOI 10.1128/AEM.69.2.1270-1275.2003; GIRAUD E, 1991, APPL MICROBIOL BIOT, V36, P96, DOI 10.1007/BF00164706; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Higuchi T, 1997, J BACTERIOL, V179, P3362, DOI 10.1128/JB.179.10.3362-3364.1997; Ivanisevic J, 2013, ANAL CHEM, V85, P6876, DOI 10.1021/ac401140h; Jiang ML, 2016, J DAIRY SCI, V99, P1736, DOI 10.3168/jds.2015-10434; Kajfasz JK, 2011, FOOD MICROBIOL FOOD, P23, DOI 10.1007/978-0-387-92771-8_2; Kleerebezem M, 2000, ENZYME MICROB TECH, V26, P840, DOI 10.1016/S0141-0229(00)00180-0; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; KOBAYASHI H, 1985, J BIOL CHEM, V260, P72; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Li SJ, 2014, J DAIRY SCI, V97, P7334, DOI 10.3168/jds.2014-7912; Manolopoulou E, 2003, INT J FOOD MICROBIOL, V82, P153, DOI 10.1016/S0168-1605(02)00258-1; METERISSIAN SH, 1995, CANCER LETT, V89, P145, DOI 10.1016/0304-3835(94)03659-7; Mira D. O. R., 2001, APPL ENVIRON MICROB, V67, P1657, DOI DOI 10.1128/AEM.67.4.1657-1662.2001; Molin G, 2001, AM J CLIN NUTR, V73, p380S, DOI 10.1093/ajcn/73.2.380s; Nyanga-Koumou AP, 2012, CRIT REV MICROBIOL, V38, P185, DOI 10.3109/1040841X.2011.640978; Pilone GJ, 1998, ARGININE METABOLISM, P79; Raccach M, 1985, US, Patent No. [US4514424[P], 4514424]; Randazzo CL, 2004, INT J FOOD MICROBIOL, V90, P9, DOI 10.1016/S0168-1605(03)00159-4; Rochfort S, 2005, J NAT PROD, V68, P1813, DOI 10.1021/np050255w; ROZES N, 1993, LETT APPL MICROBIOL, V17, P126, DOI 10.1111/j.1472-765X.1993.tb01440.x; Sanders JW, 1999, FEMS MICROBIOL REV, V23, P483, DOI 10.1111/j.1574-6976.1999.tb00409.x; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Spano G, 2004, J APPL MICROBIOL, V96, P185, DOI 10.1046/j.1365-2672.2003.02132.x; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Streit F, 2008, J APPL MICROBIOL, V105, P1071, DOI 10.1111/j.1365-2672.2008.03848.x; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; Uroic K, 2016, LWT-FOOD SCI TECHNOL, V69, P623, DOI 10.1016/j.lwt.2016.02.013; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Wang LQ, 2010, WORLD J MICROB BIOT, V26, P1999, DOI 10.1007/s11274-010-0384-9; Wang Y, 2005, CRYOBIOLOGY, V50, P294, DOI 10.1016/j.cryobiol.2005.03.001; Xu DY, 2012, BLOOD TRANSFUS-ITALY, V10, P321, DOI 10.2450/2012.0076-11	49	30	30	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196231	10.1371/journal.pone.0196231	http://dx.doi.org/10.1371/journal.pone.0196231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795550	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300006
J	Kokkonen, P; Bednar, D; Dockalova, V; Prokop, Z; Damborsky, J				Kokkonen, Piia; Bednar, David; Dockalova, Veronika; Prokop, Zbynek; Damborsky, Jiri			Conformational changes allow processing of bulky substrates by a haloalkane dehalogenase with a small and buried active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; protein conformation; molecular dynamics; molecular evolution; active site; conformational change; enzyme catalysis; haloalkane dehalogenase; dichloroethane degradation; ethylene dichloride; organic halogen; organohalogen	MOLECULAR-DYNAMICS SIMULATIONS; X-RAY-STRUCTURE; HALIDE-BINDING; SPECIFICITY; TIME; MECHANISM; BOND; MUTATIONS; EVOLUTION; GEOMETRY	Haloalkane dehalogenases catalyze the hydrolysis of halogen-carbon bonds in organic halogenated compounds and as such are of great utility as biocatalysts. The crystal structures of the haloalkane dehalogenase DhlA from the bacterium from Xanthobacter autotrophicus GJ10, specifically adapted for the conversion of the small 1,2-dichloroethane (DCE) molecule, display the smallest catalytic site (110 angstrom(3)) within this enzyme family. However, during a substrate-specificity screening, we noted that DhlA can catalyze the conversion of far bulkier substrates, such as the 4-(bromomethyl)-6,7-dimethoxy-coumarin (220 angstrom(3)). This large substrate cannot bind to DhlA without conformational alterations. These conformational changes have been previously inferred from kinetic analysis, but their structural basis has not been understood. Using molecular dynamic simulations, we demonstrate here the intrinsic flexibility of part of the cap domain that allows DhlA to accommodate bulky substrates. The simulations displayed two routes for transport of substrates to the active site, one of which requires the conformational change and is likely the route for bulky substrates. These results provide insights into the structure-dynamics function relationships in enzymes with deeply buried active sites. Moreover, understanding the structural basis for the molecular adaptation of DhlA to 1,2-dichloroethane introduced into the biosphere during the industrial revolution provides a valuable lesson in enzyme design by nature.	[Kokkonen, Piia; Bednar, David; Dockalova, Veronika; Prokop, Zbynek; Damborsky, Jiri] Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Dept Expt Biol, Loschmidt Labs, Kamenice 5-A13, Brno 62500, Czech Republic; [Kokkonen, Piia; Bednar, David; Dockalova, Veronika; Prokop, Zbynek; Damborsky, Jiri] St Annes Univ Hosp, Int Ctr Clin Res, Pekarska 53, Brno 65691, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Prokop, Z; Damborsky, J (corresponding author), Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Dept Expt Biol, Loschmidt Labs, Kamenice 5-A13, Brno 62500, Czech Republic.; Prokop, Z; Damborsky, J (corresponding author), St Annes Univ Hosp, Int Ctr Clin Res, Pekarska 53, Brno 65691, Czech Republic.	zbynek@chemi.muni.cz; jiri@chemi.muni.cz	Damborsky, Jiri/H-3799-2012; Bednar, David/ABF-5943-2020; Prokop, Zbynek/H-5707-2012	Damborsky, Jiri/0000-0002-7848-8216; Bednar, David/0000-0002-6803-0340; Prokop, Zbynek/0000-0001-9358-4081; Brumovska, Veronika/0000-0002-6606-2058; Bartos, Piia/0000-0001-6002-1856	Ministry of Education, Youth and Sports of the Czech Republic under the Project CESNET [LM2015042]; Ministry of Education, Youth and Sports of the Czech Republic under the Project CERIT-Scientific Cloud [LM2015085]	Ministry of Education, Youth and Sports of the Czech Republic under the Project CESNET; Ministry of Education, Youth and Sports of the Czech Republic under the Project CERIT-Scientific Cloud	Computational resources were supplied by the Ministry of Education, Youth and Sports of the Czech Republic under the Projects CESNET (Project No. LM2015042) and CERIT-Scientific Cloud (Project No. LM2015085).	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; [Anonymous], PYMOL MOL GRAPH SYST; Blaha-Nelson D, 2017, J AM CHEM SOC, V139, P1155, DOI 10.1021/jacs.6b10801; Boehr DD, 2018, PROTEIN SCI, V27, P825, DOI 10.1002/pro.3379; Bohac M, 2002, BIOCHEMISTRY-US, V41, P14272, DOI 10.1021/bi026427v; Brezovsky J, 2016, ACS CATAL, V6, P7597, DOI 10.1021/acscatal.6b02081; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case D., 2015, AMBER, V14; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Damborsky J, 1999, PROTEIN ENG, V12, P989, DOI 10.1093/protein/12.11.989; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doerr S, 2016, J CHEM THEORY COMPUT, V12, P1845, DOI 10.1021/acs.jctc.6b00049; Doerr S, 2014, J CHEM THEORY COMPUT, V10, P2064, DOI 10.1021/ct400919u; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P2371, DOI 10.1021/ct900275y; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Holloway P, 1998, BIOTECHNOL BIOENG, V59, P520, DOI 10.1002/(SICI)1097-0290(19980820)59:4<520::AID-BIT16>3.0.CO;2-D; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KENNES C, 1995, EUR J BIOCHEM, V228, P403; Koudelakova T, 2013, BIOTECHNOL J, V8, P32, DOI 10.1002/biot.201100486; Koudelakova T, 2011, BIOCHEM J, V435, P345, DOI 10.1042/BJ20101405; Krooshof GH, 1998, BIOCHEMISTRY-US, V37, P15013, DOI 10.1021/bi9815187; Krooshof GH, 1999, PROTEIN SCI, V8, P355; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liu XY, 2007, ACTA CRYSTALLOGR D, V63, P1000, DOI 10.1107/S0907444907037705; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Markwick PRL, 2011, PHYS CHEM CHEM PHYS, V13, P20053, DOI 10.1039/c1cp22100k; Marques SM, 2016, UNDERSTANDING ENZYMES: FUNCTION, DESIGN, ENGINEERING, AND ANALYSIS, P421; Nagata Y, 2015, APPL MICROBIOL BIOT, V99, P9865, DOI 10.1007/s00253-015-6954-x; Narayanan C, 2016, CATALYSTS, V6, DOI 10.3390/catal6060081; Naritomi Y, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554380; Otyepka M, 2002, PROTEIN SCI, V11, P1206, DOI 10.1110/ps.ps3830102; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Piccirillo E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196918; Pikkemaat MG, 1999, BIOCHEMISTRY-US, V38, P12052, DOI 10.1021/bi990849w; Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185; Pikkemaat MG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.8.e35; PRIES F, 1994, J BIOL CHEM, V269, P17490; Rogne P, 2018, P NATL ACAD SCI USA, V115, P3012, DOI 10.1073/pnas.1721508115; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; ROZEBOOM HJ, 1988, J MOL BIOL, V200, P611, DOI 10.1016/0022-2836(88)90548-7; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schanstra JP, 1996, J BIOL CHEM, V271, P14747, DOI 10.1074/jbc.271.25.14747; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P5624, DOI 10.1021/bi952904g; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P13186, DOI 10.1021/bi961151a; Sharir-Ivry A, 2015, CHEM-EUR J, V21, P7159, DOI 10.1002/chem.201406236; Shek R, 2017, BIOCHEMISTRY-US, V56, P6734, DOI 10.1021/acs.biochem.7b00982; STUCKI G, 1995, ENVIRON SCI TECHNOL, V29, P2339, DOI 10.1021/es00009a028; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	60	6	7	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11505	11512		10.1074/jbc.RA117.000328	http://dx.doi.org/10.1074/jbc.RA117.000328			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858243	Green Published, hybrid			2022-12-26	WOS:000439449700020
J	Bhattacharyya, S; Feferman, L; Han, XR; Ouyang, YL; Zhang, FM; Linhardt, RJ; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.; Tobacman, Joanne K.			Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); c-Fos; c-Jun transcription factor; chondroitin sulfate; epidermal growth factor receptor (EGFR); Src homology 2 domain (SH2 domain); phosphoprotein phosphatase; arylsulfatase B; N-acetylgalactosamine-4-sulfatase; transcription factor AP-1; PTPN11; prostate; stem cells	EPIDERMAL-GROWTH-FACTOR; MUCOPOLYSACCHARIDOSIS TYPE-VI; FACTOR RECEPTOR; CHONDROITIN SULFATE; SEQUENTIAL DEGRADATION; MELANOMA-CELLS; CANCER; N-ACETYLGALACTOSAMINE-4-SULFATASE; VERSICAN; TISSUE	Epidermal growth factor receptor (EGFR) has a crucial role in cell differentiation and proliferation and cancer, and its expression appears to be up-regulated when arylsulfatase B (ARSB or GalNAc-4-sulfatase) is reduced. ARSB removes 4-sulfate groups from the nonreducing end of dermatan sulfate and chondroitin 4-sulfate (C4S), and its decreased expression has previously been reported to inhibit the activity of the ubiquitous protein-tyrosine phosphatase, nonreceptor type 11 (SHP2 or PTPN11). However, the mechanism by which decline in ARSB leads to decline in SHP2 activity is unclear. Here, we show that SHP2 binds preferentially C4S, rather than chondroitin 6-sulfate, and confirm that SHP2 activity declines when ARSB is silenced. The reduction in ARSB activity, and the resultant increase in C4S, increased the expression of EGFR (Her1/ErbB1) in human prostate stem and epithelial cells. The increased expression of EGFR occurred after 1) the decline in SHP2 activity, 2) enhanced c-Jun N-terminal kinase (JNK) activity, 3) increased nuclear DNA binding by c-Jun and c-Fos, and 4) EGFR promoter activation. In response to exogenous EGF, there was increased bromodeoxyuridine incorporation, consistent with enhanced cell proliferation. These findings indicated that ARSB and chondroitin 4-sulfation affect the activation of an important dual phosphorylation threonine-tyrosine kinase and the mRNA expression of a critical tyrosine kinase receptor in prostate cells. Restoration of ARSB activity with the associated reduction in C4S may provide a new therapeutic approach for managing malignancies in which EGFR-mediated tyrosine kinase signaling pathways are active.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, 840 S Wood St,CSN 440,M-C 718, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol & Biomed Engn, Troy, NY 12180 USA; [Han, Xiaorui; Ouyang, Yilan; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,CSN 440,M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu			University of Illinois Cancer Center	University of Illinois Cancer Center	This work was supported by the University of Illinois Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article.	ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S., 2017, ONCOTARGET, V8; Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2017, ONCOTARGET, V8, P4169, DOI 10.18632/oncotarget.13751; Bhattacharyya S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153463; Bhattacharyya S, 2014, J BIOL CHEM, V289, P17564, DOI 10.1074/jbc.M114.561589; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bunda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9859; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; CHING KZ, 1993, MOL CELL BIOCHEM, V126, P151, DOI 10.1007/BF00925693; Crawley A, 2004, PEDIATR RES, V55, P585, DOI 10.1203/01.PDR.0000113789.30640.5C; DESOUSA JF, 1990, J BIOL CHEM, V265, P20150; Di Lorenzo G, 2004, TUMORI J, V90, P163, DOI 10.1177/030089160409000201; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Feferman L, 2018, CANCER BIOMARK, V21, P229, DOI 10.3233/CBM-170680; Foulcer SJ, 2015, METHODS MOL BIOL, V1229, P587, DOI 10.1007/978-1-4939-1714-3_46; GLASER JH, 1979, J BIOL CHEM, V254, P2316; Grindel B, 2016, ONCOTARGET, V7, P10433, DOI 10.18632/oncotarget.7197; Gross Mitchell E, 2004, Clin Adv Hematol Oncol, V2, P53; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Guerin O, 2010, PHARMACEUTICALS, V3, P2238, DOI 10.3390/ph3072238; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hernandez D, 2011, J BIOL CHEM, V286, P1475, DOI 10.1074/jbc.M110.127522; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; INGMAR B, 1979, BIOCHEM J, V179, P7, DOI 10.1042/bj1790007; Jathal Maitreyee K., 2011, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V11, P131; Jiang CY, 2012, J CANCER RES CLIN, V138, P637, DOI 10.1007/s00432-011-1143-5; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Kotlo K, 2013, GLYCOCONJUGATE J, V30, P667, DOI 10.1007/s10719-013-9468-8; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; LaRochelle JR, 2016, BIOCHEMISTRY-US, V55, P2269, DOI 10.1021/acs.biochem.5b01287; Liu ZL, 2010, BIOCHEMISTRY-US, V49, P9839, DOI 10.1021/bi101305b; Luo XL, 2016, CELL REP, V17, P2979, DOI 10.1016/j.celrep.2016.11.048; Manole S, 2016, CANCER RES, V76, P5219, DOI 10.1158/0008-5472.CAN-16-0123; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Qi C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010134; Reyes N, 2016, CANCER BIOMARK, V16, P191, DOI 10.3233/CBM-150555; Rivera-Colon Y, 2012, J MOL BIOL, V423, P736, DOI 10.1016/j.jmb.2012.08.020; Rogerson SJ, 1997, PARASITOL TODAY, V13, P70, DOI 10.1016/S0169-4758(96)10081-8; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Seth D, 1999, BRIT J CANCER, V80, P657, DOI 10.1038/sj.bjc.6690407; Sharpe B, 2017, PROSTATE, V77, P1312, DOI 10.1002/pros.23391; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; SHERWOOD ER, 1995, WORLD J UROL, V13, P290; Solit DB, 2007, J CLIN ONCOL, V25, P241, DOI 10.1200/JCO.2006.08.8187; Suhovskih Anastasia V, 2013, ISRN Oncol, V2013, P680136, DOI 10.1155/2013/680136; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Wang QW, 2016, CANCER INVEST, V34, P255, DOI 10.1080/07357907.2016.1193745; Wight TN, 2018, MATRIX BIOL, V71-72, P396, DOI 10.1016/j.matbio.2018.02.019; Xu W, 2015, GENE THER, V22, P247, DOI 10.1038/gt.2014.110; Zhang XL, 2014, GLIA, V62, P259, DOI 10.1002/glia.22604	62	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11076	11087		10.1074/jbc.RA117.001244	http://dx.doi.org/10.1074/jbc.RA117.001244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794138	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000438882800020
J	Barlow, P				Barlow, Paul			Grasping the nettle: A bacterial invasin that targets immunoglobulin variable domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								In a new paper, the protein InvD from Yersinia pseudotuberculosis, a zoonotic pathogen, is shown to assist late-stage invasion of intestinal epithelia. Remarkably, InvD acts by binding the Fab region of IgG or IgA. It straddles adjacent light-chain and heavy-chain variable domains, but its binding is different from that of antigens in that complementarity-determining regions do not participate. Structure determination revealed that its Fab-interacting domain adopts an immunoglobulin-like fold, fused to the preceding immunoglobulin-like domain and carried on a long stalk anchored to the bacterial outer membrane. Possible roles of this unusual host-pathogen interaction include avoidance of clearance from the intestine by secretory IgA.	[Barlow, Paul] Univ Edinburgh, Sch Chem, Edinburgh EH9 3FJ, Midlothian, Scotland; [Barlow, Paul] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3FJ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Barlow, P (corresponding author), Univ Edinburgh, Sch Chem, Edinburgh EH9 3FJ, Midlothian, Scotland.; Barlow, P (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3FJ, Midlothian, Scotland.							Beckingham JA, 1999, BIOCHEM J, V340, P193, DOI 10.1042/0264-6021:3400193; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Marone G., 2004, Clinical and Experimental Allergy Reviews, V4, P64, DOI 10.1111/j.1472-9725.2004.00036.x; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Sadana P, 2018, J BIOL CHEM, V293, P8672, DOI 10.1074/jbc.RA117.001068; Townsley-Fuchs J, 1997, Int Rev Immunol, V14, P325, DOI 10.3109/08830189709116523	6	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8691	8692		10.1074/jbc.H118.002949	http://dx.doi.org/10.1074/jbc.H118.002949			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29858390	Green Published, hybrid			2022-12-26	WOS:000434205700030
J	Boncompagni, E; Orozco-Arroyo, G; Cominelli, E; Gangashetty, PI; Grando, S; Zu, TTK; Daminati, MG; Nielsen, E; Sparvoli, F				Boncompagni, Eleonora; Orozco-Arroyo, Gregorio; Cominelli, Eleonora; Gangashetty, Prakash Irappa; Grando, Stefania; Zu, Theophilus Tenutse Kwaku; Daminati, Maria Gloria; Nielsen, Erik; Sparvoli, Francesca			Antinutritional factors in pearl millet grains: Phytate and goitrogens content variability and molecular characterization of genes involved in their pathways	PLOS ONE			English	Article							PHYTIC ACID CONTENT; ZINC CONTENT; IN-VITRO; IRON STATUS; IDENTIFICATION; FLAVONOIDS; GOITER; GLUCOSYLTRANSFERASE; IODINE; CROPS	Pearl millet [Pennisetum glaucum (L.) R. Br.] is an important "orphan" cereal and the most widely grown of all the millet species worldwide. It is also the sixth most important cereal in the world after wheat, rice, maize, barley, and sorghum, being largely grown and used in West Africa as well as in India and Pakistan. The present study was carried out in the frame of a program designed to increase benefits and reduce potential health problems deriving from the consumption of pearl millet. The specific goal was to provide a database of information on the variability existing in pearl millet germplasm as to the amounts of phytate, the most relevant antinutrient compound, and the goitrogenic compounds C-glycosylflavones (C-GFs) accumulated in the grain. Results we obtained clearly show that, as indicated by the range in values, a substantial variability subsists across the investigated pearl millet inbred lines as regards the grain level of phytic acid phosphate, while the amount of C-GFs shows a very high variation. Suitable potential parents to be used in breeding programs can be therefore chosen from the surveyed material in order to create new germplasm with increased nutritional quality and food safety. Moreover, we report novel molecular data showing which genes are more relevant for phytic acid biosynthesis in the seeds as well as a preliminary analysis of a pearl millet orthologous gene for C-GFs biosynthesis. These results open the way to dissect the genetic determinants controlling key seed nutritional phenotypes and to the characterization of their impact on grain nutritional value in pearl millet.	[Boncompagni, Eleonora; Zu, Theophilus Tenutse Kwaku; Nielsen, Erik] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy; [Orozco-Arroyo, Gregorio; Cominelli, Eleonora; Daminati, Maria Gloria; Sparvoli, Francesca] CNR, Inst Agr Biol & Biotechnol, Milan, Italy; [Gangashetty, Prakash Irappa] Int Crops Res Inst Semi Arid Trop, ICRISAT Sahelian Ctr, Niamey, Niger; [Grando, Stefania] Int Crops Res Inst Semi Arid Trop, ICRISAT Patancheru, Hyderabad, Andhra Prades, India	University of Pavia; Consiglio Nazionale delle Ricerche (CNR); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Sparvoli, F (corresponding author), CNR, Inst Agr Biol & Biotechnol, Milan, Italy.	sparvoli@ibba.cnr.it	Cominelli, Eleonora/O-6381-2015; Orozco-Arroyo, Gregorio/AAF-2447-2020; Sparvoli, Francesca/G-8372-2015	Cominelli, Eleonora/0000-0002-3612-3323; Orozco-Arroyo, Gregorio/0000-0001-7509-6244; NIELSEN, ERIK/0000-0003-0730-6566; Sparvoli, Francesca/0000-0002-3304-7548	NewPearl grant [AF 1301-015]; Fondazione Cariplo [FC 2013-0891]	NewPearl grant; Fondazione Cariplo(Fondazione Cariplo)	This work was funded by the NewPearl grant funded in the frame of the CERES joint initiative by Agropolis Fondation (No AF 1301-015) and by Fondazione Cariplo (No FC 2013-0891 to FS and EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All India Coordinated Research Project on Pearl Millet (AICRP-Pearl millet) (Indian Council of Agricultural Research ICAR), 2013, PEARL MILL BIOL; ANDREWS DJ, 1992, ADV AGRON, V48, P89, DOI 10.1016/S0065-2113(08)60936-0; BIRZER DM, 1987, NUTR REP INT, V36, P131; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Brazier-Hicks M, 2013, METAB ENG, V16, P11, DOI 10.1016/j.ymben.2012.11.004; Brazier-Hicks M, 2009, J BIOL CHEM, V284, P17926, DOI 10.1074/jbc.M109.009258; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Du YG, 2010, PLANT PHYSIOL, V154, P324, DOI 10.1104/pp.110.161042; Elhage ME, 2002, J FOOD CHEM, V77, P193; ELTOM M, 1984, ACTA MED SCAND, V215, P467; Elyas SHA, 2002, FOOD CHEM, V78, P75, DOI 10.1016/S0308-8146(01)00386-7; Ferreyra MLF, 2013, J BIOL CHEM, V288, P31678, DOI 10.1074/jbc.M113.510040; FAO, 1995, FOOD NUTR SER, V27; FAO, 2016, FAOSTAT DAT; FAO (Food and Agricultural Organization of the United Nations), 2014, FAOSTAT DAT; Fileppi M, 2010, MOL BREEDING, V25, P453, DOI 10.1007/s11032-009-9344-1; Finkelstein JL, 2017, CURR OPIN BIOTECH, V44, P138, DOI 10.1016/j.copbio.2017.01.003; GAITAN E, 1995, J CLIN ENDOCR METAB, V80, P1144, DOI 10.1210/jc.80.4.1144; GAITAN E, 1990, ANNU REV NUTR, V10, P21, DOI [10.1146/annurev.nu.10.070190.000321, 10.1146/annurev.nutr.10.1.21]; GAITAN E, 1989, J CLIN ENDOCR METAB, V68, P707, DOI 10.1210/jcem-68-4-707; Goncalves CEL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061247; Govindaraj M, 2013, CROP SCI, V53, P507, DOI 10.2135/cropsci2012.08.0477; Gupta S. K., 2009, Crop Improvement, V36, P4; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hirade Y, 2015, FEBS LETT, V589, P1778, DOI 10.1016/j.febslet.2015.05.010; Ito T, 2017, PLANT J, V91, P187, DOI 10.1111/tpj.13555; Kim SI, 2011, MOL GENET GENOMICS, V286, P119, DOI 10.1007/s00438-011-0631-2; Klopfenstein CF, SORGHUM MILLETS CHEM, P125; Kulthe A.A., 2016, ADV LIFE SCI, V5, P4672; Lestienne I, 2005, J AGR FOOD CHEM, V53, P8342, DOI 10.1021/jf050741p; Manwaring HR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01944; Middleton E, 2000, PHARMACOL REV, V52, P673; Muthamilarasan M, 2016, PLANT SCI, V242, P89, DOI 10.1016/j.plantsci.2015.08.023; Nagatomo Y, 2014, PLANT J, V80, P437, DOI 10.1111/tpj.12645; Nourbakhsh A, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00725; OSMAN AK, 1981, J HUM NUTR, V35, P302; OSMAN AK, 1981, ECOL FOOD NUTR, V11, P121, DOI 10.1080/03670244.1981.9990666; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Panzeri D, 2011, NEW PHYTOL, V191, P70, DOI 10.1111/j.1469-8137.2011.03666.x; Pilu R, 2003, THEOR APPL GENET, V107, P980, DOI 10.1007/s00122-003-1316-y; RABOY V, 1993, CROP SCI, V33, P1300, DOI 10.2135/cropsci1993.0011183X003300060036x; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; RABOY V, 1985, PLANT PHYSIOL, V79, P323, DOI 10.1104/pp.79.1.323; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Rai KN, 2015, PLANT GENET RESOUR-C, V13, P75, DOI 10.1017/S1479262114000665; Rai K.N., 2013, J SAT AGR RES, V11, P1; Reddy PS., 2015, PLANT GENE, V1, P35, DOI [DOI 10.1016/J.PLGENE.2015.02.001, 10.1016/j.plgene.2015.02.001]; REICHERT RD, 1979, CEREAL CHEM, V56, P291; Reichert RD, 1980, POLYPHENOLS CEREAL L, P50; Saleh ASM, 2013, COMPR REV FOOD SCI F, V12, P281, DOI 10.1111/1541-4337.12012; Sasaki N, 2015, FEBS LETT, V589, P182, DOI 10.1016/j.febslet.2014.11.045; SATIJA DR, 1985, THEOR APPL GENET, V70, P693, DOI 10.1007/BF00252299; Sato Y, 2011, J PLANT RES, V124, P385, DOI 10.1007/s10265-010-0381-y; SIMWEMBA CG, 1984, J AGR FOOD CHEM, V32, P31, DOI 10.1021/jf00121a008; Souci SW., 2000, FOOD COMPOSITION NUT; Sparvoli Francesca, 2015, Plants-Basel, V4, P728, DOI 10.3390/plants4040728; Sparvoli F, 2014, SIGNAL COMMUN PLANTS, P19, DOI 10.1007/978-3-319-06511-3_2; Stevenson-Paulik J, 2002, J BIOL CHEM, V277, P42711, DOI 10.1074/jbc.M209112200; Upadhyaya HD, 2017, PLANT GENET RESOUR-C, V15, P438, DOI 10.1017/S1479262116000113; Varshney RK, 2017, NAT BIOTECHNOL, V35, P969, DOI 10.1038/nbt.3943; Velu G., 2008, Crop Improvement, V35, P186; Velu G, 2007, PLANT BREEDING, V126, P182, DOI 10.1111/j.1439-0523.2007.01322.x; Velu G, 2011, EUPHYTICA, V180, P251, DOI 10.1007/s10681-011-0387-0; Vinoth A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00029; Wang J, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/205101; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; Yadav H. P., 2016, BROADENING GENETIC B, P205, DOI [10.1007/978-81-322-3613-9_8, DOI 10.1007/978-81-322-3613-9_8]; Zimmermann MB, 2006, ANNU REV NUTR, V26, P367, DOI 10.1146/annurev.nutr.26.061505.111236	72	19	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198394	10.1371/journal.pone.0198394	http://dx.doi.org/10.1371/journal.pone.0198394			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856884	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800114
J	Chen, XY; Liu, YY; Yang, Y; Feng, J; Liu, PW; Sui, C; Wei, JH				Chen, Xuyu; Liu, Yangyang; Yang, Yun; Feng, Jian; Liu, Peiwei; Sui, Chun; Wei, Jianhe			Trunk surface agarwood-inducing technique with Rigidoporus vinctus: An efficient novel method for agarwood production	PLOS ONE			English	Article							AQUILARIA-SINENSIS; IDENTIFICATION; FUNGI	Only when Aquilaria spp. or Gyrinops spp. trees are wounded, due to insect attack, or microbial invasion, agarwood can be successfully induced. In the present study, a fungus which can induce agarwood formation efficiently was isolated and a suitable method for its application to induce agarwood formation was developed. Rigidoporus vinctus was isolated from the inner layers from infectious A. sinensis trees. When the fermentation liquid of fungi inoculated back to A. sinensis tree, agarwood was found to be induced. In addition, a novel method called trunk surface agarwood-inducing technique (Agar-Sit) was developed to produce agarwood with R. vinctus. The alcohol soluble extract content of the agarwood, up to 38.9%, far higher than the requirement (10%) in Chinese Pharmacopoeia and the six characteristic compounds of agarwood used as Chinese Medicinal Materials were all detected. Their relative percentages of the sesquiterpenes in the essential oil were 22.76%. This is the first report of the Agar-Sit and also the application of R. vinctus in agarwood induction. According to the results, when the combination of Agar-Sit and R. vinctus is used agarwood can be induced with high yield and good quality.	[Chen, Xuyu; Liu, Yangyang; Yang, Yun; Liu, Peiwei; Sui, Chun; Wei, Jianhe] Chinese Acad Med Sci, Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ, Inst Med Plant Dev, Beijing, Peoples R China; [Chen, Xuyu; Liu, Yangyang; Yang, Yun; Liu, Peiwei; Sui, Chun; Wei, Jianhe] Chinese Acad Med Sci, Natl Engn Lab Breeding Endangered Med Mat, Inst Med Plant Dev, Beijing, Peoples R China; [Chen, Xuyu; Liu, Yangyang; Yang, Yun; Liu, Peiwei; Sui, Chun; Wei, Jianhe] Peking Union Med Coll, Beijing, Peoples R China; [Chen, Xuyu; Liu, Yangyang; Yang, Yun; Feng, Jian; Liu, Peiwei; Wei, Jianhe] Chinese Acad Med Sci, Hainan Prov Key Lab Resources Conservat & Dev Sou, Hainan Branch, Inst Med Plant Dev, Haikou, Hainan, Peoples R China; [Chen, Xuyu; Liu, Yangyang; Yang, Yun; Feng, Jian; Liu, Peiwei; Wei, Jianhe] Peking Union Med Coll, Haikou, Hainan, Peoples R China; [Wei, Jianhe] Chinese Acad Med Sci, Key Lab State Adm Tradit Chinese Med Agarwood Sus, Hainan Branch, Inst Med Plant Dev, Haikou, Hainan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Wei, JH (corresponding author), Chinese Acad Med Sci, Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ, Inst Med Plant Dev, Beijing, Peoples R China.; Wei, JH (corresponding author), Chinese Acad Med Sci, Natl Engn Lab Breeding Endangered Med Mat, Inst Med Plant Dev, Beijing, Peoples R China.; Wei, JH (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Wei, JH (corresponding author), Chinese Acad Med Sci, Hainan Prov Key Lab Resources Conservat & Dev Sou, Hainan Branch, Inst Med Plant Dev, Haikou, Hainan, Peoples R China.; Wei, JH (corresponding author), Peking Union Med Coll, Haikou, Hainan, Peoples R China.; Wei, JH (corresponding author), Chinese Acad Med Sci, Key Lab State Adm Tradit Chinese Med Agarwood Sus, Hainan Branch, Inst Med Plant Dev, Haikou, Hainan, Peoples R China.	csui@implad.ac.cn; wjianh@263.net	liu, yang/HHY-8583-2022		National Natural Science Foundation of China [81673549, 81303312, 81403055]; Major Science And Technology Plan Project of Hainan Province [ZDKJ2016004]; Medical and Health Science and Technology Innovation Project (Major Collaborative Innovation Project) [2016-I2M-2-003]; Science & Technology Program of Hainan Province [ZDXM2015059]; "Ten Thousand Plan" -National High Level Talents Special Support Plan [99950534]; Natural Science Foundation of Hainan province [20168369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science And Technology Plan Project of Hainan Province; Medical and Health Science and Technology Innovation Project (Major Collaborative Innovation Project); Science & Technology Program of Hainan Province; "Ten Thousand Plan" -National High Level Talents Special Support Plan; Natural Science Foundation of Hainan province	This study was funded by the National Natural Science Foundation of China (grant numbers 81673549, 81303312 and 81403055) (http://www.nsfc.gov.cn/); Major Science And Technology Plan Project of Hainan Province (grant number ZDKJ2016004) (http://dost.hainan.gov.cn/); Medical and Health Science and Technology Innovation Project (Major Collaborative Innovation Project) (grant number 2016-I2M-2-003); Science & Technology Program of Hainan Province (grant number ZDXM2015059). "Ten Thousand Plan" -National High Level Talents Special Support Plan (grant number 99950534) and Natural Science Foundation of Hainan province (grant number 20168369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Science Foundation of China (grant numbers. 81673549, 81303312 and 81403055); Major Science And Technology Plan Project of Hainan Province (grant number ZDKJ2016004); Medical and Health Science and Technology Innovation Project (Major Collaborative Innovation Project) (grant number 2016-I2M-2-003); Science & Technology Program of Hainan Province (grant number ZDXM2015059); "Ten Thousand Plan" -National High Level Talents Special Support Plan (grant number 99950534) and Natural Science Foundation of Hainan province (grant number 20168369).	BHATTARCHARYYA B., 1952, SCI AND CULTURE, V18, P240; Blanchette R., 2009, Patent No. [US7638145B2, 7638145, No 7638145]; Burkill IH., 1935, SCI CULT-UK, P240; Chen XY, 2011, WORLD J MICROB BIOT, V27, P495, DOI 10.1007/s11274-010-0480-x; Chen XuYu, 2017, Acta Agriculturae Jiangxi, V29, P95; Chen XY, 2017, CURR MICROBIOL, V74, P460, DOI 10.1007/s00284-016-1193-7; CITES, 2004, P 13 M C PART INT BA; Commission of Chinese Pharmacopoeia, 2010, CHINESE PHARMACOPOEI, P185; Faizal A, 2017, TREES-STRUCT FUNCT, V31, P189, DOI 10.1007/s00468-016-1471-9; Gao ZH, 2012, GENE, V505, P167, DOI 10.1016/j.gene.2012.03.072; Guangdong Institute of Botany, 1976, ACTA BOT SIN, V18, P287; Guo SX, 2013, China patent, Patent No. [CN102649939 A, 102649939]; Huang H, 2013, China patent, Patent No. [CN102499264 A, 102499264]; Ito Michiho, 2005, Natural Medicines, V59, P104; Liu YY, 2013, MOLECULES, V18, P3086, DOI 10.3390/molecules18033086; Mohamed R, 2013, SAINS MALAYS, V42, P1365; Naef R, 2011, FLAVOUR FRAG J, V26, P73, DOI 10.1002/ffj.2034; Norhaslida R, 2014, BIOMASS BIOENERG, V61, P206, DOI 10.1016/j.biombioe.2013.12.015; Persoon GA, 2008, ADV AGROFOR, V5, P245; Qi S.Y., 1998, CHIN J BIOTECH, V14, P464; Subehan, 2005, Journal of Traditional Medicines, V22, P244; Wei J. H., 2010, Patent No. [CN101755629B, 101755629]; Xu W., 2011, THESIS; Yagura T, 2005, TETRAHEDRON LETT, V46, P4395, DOI 10.1016/j.tetlet.2005.04.072; [张倩 Zhang Qian], 2015, [中国药学杂志, Chinese Pharmaceutical Journal], V50, P213; [张争 ZHANG Zheng], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P156	26	12	13	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198111	10.1371/journal.pone.0198111	http://dx.doi.org/10.1371/journal.pone.0198111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856792	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800070
J	Hagenaars, SP; Radakovic, R; Crockford, C; Fawns-Ritchie, C; Harris, SE; Gale, CR; Deary, IJ				Hagenaars, Saskia P.; Radakovic, Ratko; Crockford, Christopher; Fawns-Ritchie, Chloe; Harris, Sarah E.; Gale, Catharine R.; Deary, Ian J.		Int Ftd-Genomics Consortium	Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; POLYGENIC RISK; ALZHEIMERS-DISEASE; IMPAIRMENT; ASSOCIATION; DYSFUNCTION; PATTERNS; CARRIERS; REPEAT; COMMON	Neurodegenerative disorders are associated with impaired cognitive function and worse physical health outcomes. This study aims to test whether polygenic risk for Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), or frontotemporal dementia (FTD) is associated with cognitive function and physical health in the UK Biobank, a cohort of healthy individuals. Group-based analyses were then performed to compare the top and bottom 10% for the three neurodegenerative polygenic risk scores; these groups were compared on the cognitive and physical health variables. Higher polygenic risk for AD, ALS, and FTD was associated with lower cognitive performance. Higher polygenic risk for FTD was also associated with increased forced expiratory volume in is and peak expiratory flow. A significant group difference was observed on the symbol digit substitution task between individuals with high polygenic risk for FTD and high polygenic risk for ALS. The results suggest some overlap between polygenic risk for neurodegenerative disorders, cognitive function and physical health.	[Hagenaars, Saskia P.; Radakovic, Ratko; Fawns-Ritchie, Chloe; Harris, Sarah E.; Gale, Catharine R.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Hagenaars, Saskia P.; Radakovic, Ratko; Crockford, Christopher; Fawns-Ritchie, Chloe; Gale, Catharine R.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Hagenaars, Saskia P.] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, Denmark Hill, London, England; [Radakovic, Ratko] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Radakovic, Ratko] Univ Edinburgh, Anne Rowling Regenerat Neurol Clin, Edinburgh, Midlothian, Scotland; [Radakovic, Ratko; Crockford, Christopher] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Radakovic, Ratko] Univ East Anglia, Fac Med & Hlth Sci, Norwich Res Pk, Norwich, Norfolk, England; [Harris, Sarah E.] Univ Edinburgh, Ctr Genom & Expt Med, Med Genet Sect, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.] Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Gale, Catharine R.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Edinburgh; University of Edinburgh; University of London; King's College London; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of East Anglia; University of Edinburgh; University of Edinburgh; University of Southampton	Deary, IJ (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.; Deary, IJ (corresponding author), Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.	ian.deary@ed.ac.uk	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X; Gale, Catharine/0000-0002-3361-8638; Fawns-Ritchie, Chloe/0000-0002-7493-2228; Hagenaars, Saskia/0000-0001-9697-8596	University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative [MR/K026992/1]; BBSRC; Medical Research Council (MRC); National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust and King's College London; Euan MacDonald Centre for Motor Neurone Disease Research; Dementias Platform UK (DPUK) through the MRC [MR/L023784/2]; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MC_U147585819, G0400491, MR/S015132/1, MC_U147585827, MC_UU_12011/2, MR/L023784/2] Funding Source: UKRI	University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust and King's College London; Euan MacDonald Centre for Motor Neurone Disease Research; Dementias Platform UK (DPUK) through the MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was undertaken in The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1); funding from the BBSRC and Medical Research Council (MRC) is gratefully acknowledged. This report represents independent research part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. CC is supported by the Euan MacDonald Centre for Motor Neurone Disease Research. CF-R is supported by Dementias Platform UK (DPUK), funded through the MRC (MR/L023784/2).	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Vilatela MEA, 2012, ARCH MED RES, V43, P622, DOI 10.1016/j.arcmed.2012.10.017; Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Brenner D, 2016, BRAIN, V139, pCP14, DOI 10.1093/brain/aww033; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Caselli RJ, 2014, ALZHEIMERS DEMENT, V10, P84, DOI 10.1016/j.jalz.2013.01.004; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Clarke TK, 2016, MOL PSYCHIATR, V21, P419, DOI 10.1038/mp.2015.12; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1; Geschwind DH, 2001, ANN NEUROL, V50, P741, DOI 10.1002/ana.10024; Hagenaars SP, 2018, MOL PSYCHIATR, V23, P1575, DOI 10.1038/mp.2017.189; Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jiskoot LC, 2016, NEUROLOGY, V87, P384, DOI 10.1212/WNL.0000000000002895; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; MacPherson SE, 2015, J ALZHEIMERS DIS, V44, P481, DOI 10.3233/JAD-140990; MacPherson SE, 2012, J INT NEUROPSYCH SOC, V18, P234, DOI 10.1017/S1355617711001561; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McIntosh AM, 2013, BIOL PSYCHIAT, V73, P938, DOI 10.1016/j.biopsych.2013.01.011; Prince M., 2014, DEMENTIA UK UPDATE; R Core Team, 2021, R LANGUAGE ENV STAT; Rascovsky K, 2002, NEUROLOGY, V58, P1801, DOI 10.1212/WNL.58.12.1801; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rohrer JD, 2015, LANCET NEUROL, V14, P253, DOI 10.1016/S1474-4422(14)70324-2; Sabuncu MR, 2012, CEREB CORTEX, V22, P2653, DOI 10.1093/cercor/bhr348; Silveri MC, 2003, DEMENT GERIATR COGN, V16, P296, DOI 10.1159/000072816; Smith A., 1991, LEARN DISORD, p83 ; Stokholm J, 2013, J NEUROL NEUROSUR PS, V84, P170, DOI 10.1136/jnnp-2012-303813; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tang SS, 2016, J ALZHEIMERS DIS, V52, P1157, DOI 10.3233/JAD-160236; Taylor LJ, 2013, J NEUROL NEUROSUR PS, V84, P494, DOI 10.1136/jnnp-2012-303526; Thai C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139082; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; van Blitterswijk M, 2012, CURR OPIN NEUROL, V25, P689, DOI 10.1097/WCO.0b013e32835a3efb; Van Cauwenberghe C, 2016, GENET MED, V18, P421, DOI 10.1038/gim.2015.117; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009; Vieira Renata Teles, 2013, Clin Pract Epidemiol Ment Health, V9, P88, DOI 10.2174/1745017901309010088; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Walton E, 2014, SCHIZOPHRENIA BULL, V40, P1263, DOI 10.1093/schbul/sbt174	50	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198187	10.1371/journal.pone.0198187	http://dx.doi.org/10.1371/journal.pone.0198187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856801	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000433900800081
J	Hosny, KM; Rizg, WY				Hosny, Khaled Mohamed; Rizg, Waleed Yousof			Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; RELEASE; VITRO; DEGRADATION; BISPHOSPHONATES; MICROSPHERES; COPOLYMER; SAFETY	There are many challenges facing the use of alendronate sodium for the treatment of osteoporosis such as low bioavailability of 0.6% and oesophageal ulceration with bleeding. Due to the aforementioned limitation, the main objective of this research is to utilize a statistical experimental design in the formulation and optimization of alendronate in the form of controlled release biodegradable intramuscular in-situ gel. A Box - Behnken experimental design employing Statgraphics (R) software was used to develop an optimized in-situ gel formulation and to estimate the effects of Poly-DL-lactide-coglycolide as a primary polymer, the copolymer polycaprolactone, and lipid surfactant capryol 90. Every system was evaluated for gellation character, and in vitro release. As a novel technique for evaluation of the in-situ gel, in-vivo biodegradability rate was estimated in rats. Pharmacokinetic parameters were assessed in rabbits. The results indicated a significant effect of the copolymer and lipid surfactant on initial burst, and a significant effect of the primary and copolymer on drug percentage released. The optimum formulation showed a 5% initial burst, an in-vivo biodegradability rate estimated at 8% every seven days in rats, and the pharmacokinetic evaluation revealed that alendronate sodium mean residence time extended to 102 days in rabbits. In conclusion, the optimum biodegradable intramuscular in-situ gel formulations is a promising approach for providing higher bioavailability, extended release for more than three months, with elimination of esophageal side effects.	[Hosny, Khaled Mohamed; Rizg, Waleed Yousof] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Jeddah, Saudi Arabia; [Hosny, Khaled Mohamed] Beni Suef Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Bani Suwayf, Egypt; [Rizg, Waleed Yousof] Univ Nottingham, Sch Pharm, Boots Sci Bldg, Nottingham, England	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Beni Suef University; University of Nottingham	Hosny, KM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Jeddah, Saudi Arabia.; Hosny, KM (corresponding author), Beni Suef Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Bani Suwayf, Egypt.	Elswaify2000@yahoo.com	Hosny, Khaled M/H-9793-2012; rizg, waleed/AAS-5132-2021; Hosny, Khaled/GWC-2586-2022	Hosny, Khaled/0000-0002-4904-1378	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, [D-002-166-1438]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah,	This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (D-002-166-1438).	Ahmed TA, 2016, DRUG DES DEV THER, V10, P405, DOI 10.2147/DDDT.S98078; Al Deeb SK, 2004, TALANTA, V64, P695, DOI 10.1016/j.talanta.2004.03.044; Balakrishnan P, 2009, EUR J PHARM BIOPHARM, V72, P539, DOI 10.1016/j.ejpb.2009.03.001; Bauer DC, 2000, ARCH INTERN MED, V160, P517, DOI 10.1001/archinte.160.4.517; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Che X, 2014, INT J PHARMACEUT, V469, P23, DOI 10.1016/j.ijpharm.2014.04.044; Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI [10.1089/ten.tea.2009.0229, 10.1089/ten.TEA.2009.0229]; Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2; Goldenstein J, 2010, ANN BIOMED ENG, V38, P235, DOI 10.1007/s10439-009-9850-7; Hosny KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154926; Hosny KM, 2013, EXPERT OPIN DRUG DEL, V10, P741, DOI 10.1517/17425247.2013.799136; Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060991u; Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098; Kempe S, 2012, J CONTROL RELEASE, V161, P668, DOI 10.1016/j.jconrel.2012.04.016; Khajeh M, 2011, J SUPERCRIT FLUID, V55, P944, DOI 10.1016/j.supflu.2010.10.017; Kranz H, 2001, INT J PHARM, V212, P11, DOI 10.1016/S0378-5173(00)00568-8; Lee JY, 2010, INT J PHARMACEUT, V392, P51, DOI 10.1016/j.ijpharm.2010.03.033; Loh XJ, 2010, J CONTROL RELEASE, V143, P175, DOI 10.1016/j.jconrel.2009.12.030; Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8; Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F; Luurila S, 1999, PHARMACOL TOXICOL, V84, P24, DOI 10.1111/j.1600-0773.1999.tb02106.x; Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/j.ejpb.2004.03.003; Papathanasiou KE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04956-3; PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X; Patel RB, 2010, J BIOMED MATER RES A, V94A, P476, DOI 10.1002/jbm.a.32724; Peters ML, 2001, CLEV CLIN J MED, V68, P945, DOI 10.3949/ccjm.68.11.945; Schnitzer T, 2000, AGING CLIN EXP RES, V12, P1; Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044; Song Z., 2017, ENERG FUEL, V32, P352; Tadrous M, 2014, OSTEOPOROSIS INT, V25, P2671, DOI 10.1007/s00198-014-2789-z; Tan LP, 2004, INT J PHARMACEUT, V283, P89, DOI 10.1016/j.ijpharm.2004.06.022; Vibha B., 2014, INT J PHARM SCI, V4, P577; Yang Q, 2000, DRUG DEV IND PHARM, V26, P61, DOI 10.1081/DDC-100100328	33	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197540	10.1371/journal.pone.0197540	http://dx.doi.org/10.1371/journal.pone.0197540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856752	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800030
J	Kobayashi, Y; Inagawa, H; Kohchi, C; Kazumura, K; Tsuchiya, H; Miwa, T; Okazaki, K; Soma, GI				Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Kazumura, Kimiko; Tsuchiya, Hiroshi; Miwa, Toshiyuki; Okazaki, Katsuichiro; Soma, Gen-Ichiro			Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer's disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet	PLOS ONE			English	Article							SHOCK-PROTEIN 65; JUZEN-TAIHO-TO; ACTIVATED MACROPHAGE; OXIDATIVE STRESS; AMYLOID-BETA; WHEAT-FLOUR; BIOLOGICAL-ACTIVITIES; PHAGOCYTIC-ACTIVITY; MICROGLIAL CELLS; TRANSGENIC MICE	The pathogenesis of Alzheimer's disease (AD) remains unclear, but an imbalance between the production and clearance of amyloid-beta (A beta) peptides is known to play a critical role in AD progression. A promising preventative approach is to enhance the normal A beta clearance activity of brain phagocytes such as microglia. In mice, the intraperitoneal injection of Toll-like receptor 4 agonist was shown to enhance A beta clearance and exhibit a preventative effect on AD-related pathology. Our previous clinical study demonstrated that orally administered Pantoea agglomerans-derived lipopolysaccharide (LPSp) exhibited an LDL (low-density lipoprotein)-lowering effect in human volunteers with hyperlipidemia, a known risk factor for AD. In vitro studies have shown that LPSp treatment increases A beta phagocytosis by microglial cells; however it is still unclear whether orally administered LPSp exhibits a preventive effect on AD progression. We show here that in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet, oral administration of LPSp at 0.3 or 1 mg/kg body weight.day for 18 weeks significantly improved glucose metabolism and lipid profiles. The LPSp treatment also reduced pro-inflammatory cytokine expression and oxidative-burst activity in the peripheral blood. Moreover, LPSp significantly reduced brain A beta burden and memory impairment as seen in the water maze test, although we could not confirm a significant enhancement of A beta phagocytosis in microglia isolated from the brains after treatment. Taken together, our results show that LPSp holds promise as a preventative therapy for AD or AD-related diseases induced by impairment of metabolic functions.	[Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Kagawa Univ, Fac Med, Dept Integrated, Takamatsu, Kagawa, Japan; [Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Kagawa Univ, Fac Med, Dept Holist Immunol, Takamatsu, Kagawa, Japan; [Inagawa, Hiroyuki; Soma, Gen-Ichiro] Technol Res Assoc, Control Innate Immun, Takamatsu, Kagawa, Japan; [Inagawa, Hiroyuki; Soma, Gen-Ichiro] Niigata Univ Pharm & Appl Life Sci, Res Inst Hlth Living, Niigata, Japan; [Kohchi, Chie] Macrophi Inc, Takamatsu, Kagawa, Japan; [Kazumura, Kimiko; Tsuchiya, Hiroshi; Miwa, Toshiyuki] Hamamatsu Photon KK, Cent Res Lab, Shizuoka, Japan; [Okazaki, Katsuichiro] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Takamatsu, Kagawa, Japan	Kagawa University; Kagawa University; Niigata University; Hamamatsu Photonics; Kagawa University	Kobayashi, Y (corresponding author), Kagawa Univ, Fac Med, Dept Integrated, Takamatsu, Kagawa, Japan.; Kobayashi, Y (corresponding author), Kagawa Univ, Fac Med, Dept Holist Immunol, Takamatsu, Kagawa, Japan.	kobayashi@shizenmeneki.org		Kobayashi, Yutaro/0000-0003-0253-077X	Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); 'Technologies for creating next generation agriculture, forestry and fisheries' (Bio-oriented Technology Research Advancement Institution, NARO)	Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); 'Technologies for creating next generation agriculture, forestry and fisheries' (Bio-oriented Technology Research Advancement Institution, NARO)	This work was supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP) and'Technologies for creating next generation agriculture, forestry and fisheries' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CK is employed by Macrophi Inc. The funder provided support in the form of salaries for author [CK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KK, HT and TM are employed by Hamamatsu Photonics K.K. The funder provided support in the form of salaries for authors [KK, HT and TM],but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andreeva TV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P122, DOI 10.1134/S0006297917020043; Baek H, 2016, ONCOTARGET, V7, P69347, DOI 10.18632/oncotarget.12469; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Cheng XR, 2014, AGEING RES REV, V13, P13, DOI 10.1016/j.arr.2013.10.002; Drummond E, 2017, ACTA NEUROPATHOL, V133, P155, DOI 10.1007/s00401-016-1662-x; Forstl H, 2010, BR J DIABETES VASC D, V10, P115, DOI [DOI 10.1177/1474651410368408, 10.1177/1474651410368408]; Fukasaka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126849; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Godyn J, 2016, PHARMACOL REP, V68, P127, DOI 10.1016/j.pharep.2015.07.006; Grundtman C, 2015, ATHEROSCLEROSIS, V242, P303, DOI 10.1016/j.atherosclerosis.2015.06.044; Gulhane M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28990; Gulyas M, 2016, NEUROINFORMATICS, V14, P479, DOI 10.1007/s12021-016-9303-z; Hara H, 2010, J ALZHEIMERS DIS, V20, P427, DOI 10.3233/JAD-2010-1381; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hutter JC, 2014, TOXICOL IND HEALTH, V30, P442, DOI 10.1177/0748233712458140; IGUCHI M, 1992, CHEM PHARM BULL, V40, P1004, DOI 10.1248/cpb.40.1004; Inagawa H, 2016, IN VIVO, V30, P205; Inagawa H, 2011, ANTICANCER RES, V31, P2431; Kadowaki T, 2011, ANTICANCER RES, V31, P2467; Kobayashi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195008; Kobayashi Y, 2017, ANTICANCER RES, V37, P3917, DOI 10.21873/anticanres.11774; Kobayashi Y, 2016, ANTICANCER RES, V36, P3693; Kohchi C, 2006, J BIOSCI BIOENG, V102, P485, DOI 10.1263/jbb.102.485; Liu KF, 2016, IMMUNOL LETT, V174, P28, DOI 10.1016/j.imlet.2016.04.008; Liu Y, 2014, BEHAV BRAIN RES, V267, P178, DOI 10.1016/j.bbr.2014.02.040; Loffler T, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00232; Lofgren L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27688; Mancuso G, 2005, INFECT IMMUN, V73, P5620, DOI 10.1128/IAI.73.9.5620-5627.2005; Matsuyama N, 2001, J MED MICROBIOL, V50, P865, DOI 10.1099/0022-1317-50-10-865; Mehla J, 2014, J ALZHEIMERS DIS, V39, P145, DOI 10.3233/JAD-131238; Michaud JP, 2013, P NATL ACAD SCI USA, V110, P1941, DOI 10.1073/pnas.1215165110; Montenegro D, 2015, BIOORG MED CHEM LETT, V25, P466, DOI 10.1016/j.bmcl.2014.12.036; Morley JE, 2012, BBA-MOL BASIS DIS, V1822, P650, DOI 10.1016/j.bbadis.2011.11.015; Murphy EA, 2015, CURR OPIN CLIN NUTR, V18, P515, DOI 10.1097/MCO.0000000000000209; Nakata K, 2011, NUTR RES PRACT, V5, P435, DOI 10.4162/nrp.2011.5.5.435; Neves AL, 2013, J MOL ENDOCRINOL, V51, pR51, DOI 10.1530/JME-13-0079; NISHIZAWA T, 1992, CHEM PHARM BULL, V40, P479, DOI 10.1248/cpb.40.479; OKUTOMI T, 1992, CHEM PHARM BULL, V40, P1268; Palomera-Avalos V, 2017, MOL NEUROBIOL, V54, P1661, DOI 10.1007/s12035-016-9770-0; Paul G, 2012, EUR J CLIN INVEST, V42, P95, DOI 10.1111/j.1365-2362.2011.02552.x; Peluso Ilaria, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P351; Qin YR, 2016, J IMMUNOL, V197, P3281, DOI 10.4049/jimmunol.1600873; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rezvani-Kamran A, 2017, PHARM BIOL, V55, DOI 10.1080/13880209.2017.1362010; Schrag M, 2013, NEUROBIOL DIS, V59, P100, DOI 10.1016/j.nbd.2013.07.005; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; Vonghia L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/239623; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wakame K, 2015, ANTICANCER RES, V35, P4501; Walker JM, 2017, NEUROBIOL DIS, V100, P87, DOI 10.1016/j.nbd.2017.01.004; Xian YF, 2015, EUR J PHARMACOL, V760, P88, DOI 10.1016/j.ejphar.2015.04.013; Zhao YT, 2015, J AGR FOOD CHEM, V63, P4843, DOI 10.1021/acs.jafc.5b01246	54	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198493	10.1371/journal.pone.0198493	http://dx.doi.org/10.1371/journal.pone.0198493			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856882	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800130
J	Lin, MY; Cheng, LJ; Chiu, YW; Hsieh, HM; Wu, PH; Lin, YT; Wang, SL; Jian, FX; Hsu, CC; Yang, SA; Lee, HL; Hwang, SJ				Lin, Ming-Yen; Cheng, Li-Jen; Chiu, Yi-Wen; Hsieh, Hui-Min; Wu, Ping-Hsun; Lin, Yi-Ting; Wang, Shu-Li; Jian, Feng-Xuan; Hsu, Chih Cheng; Yang, Shu-An; Lee, Huei-Lan; Hwang, Shang-Jyh			Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; MULTIDISCIPLINARY CARE; PERFORMANCE; REPLACEMENT; OUTCOMES; QUALITY; PEOPLE; TAIWAN; PAY	Inadequate care of chronic kidney disease (CKD) is common and may be associated with adverse outcomes after dialysis. The nationwide pre-end-stage renal disease pay for performance program (P4P) has been implemented in Taiwan to improve quality of CKD care. However, the effectiveness of the P4P program in improving the outcomes of pre-dialysis care and dialysis is uncertain. We conducted a longitudinal cohort study. Patients who newly underwent long-term dialysis (>= 3 mo) between 2007 and 2009 were identified from the Taiwan National Health Insurance Research Database. Based on the patient enrolment of the P4P program, they were categorized into P4P or non-P4P groups. We analysed pre-dialysis care, healthcare expenditures, and mortality between two groups. Among the 26 588 patients, 25.5% participated in the P4P program. The P4P group received significantly better quality of care, including a higher frequency of glomerular filtration rate measurement and CKD complications survey, a higher rate of vascular access preparation, and more frequent use of arteriovenous fistulas than the non-P4P group did. The P4P group had a 68.4% reduction of the 4-year total healthcare expenditure (excluding dialysis fee), which is equivalent to US$345.7 million, and a significant 22% reduction in three-year mortality after dialysis (hazard ratio 0.78, 95% confidence interval: 0.75-0.82, P < 0.001) compared with the non-P4P group. P4P program improves quality of pre-dialysis CKD care, and provide survival benefit and a long-term cost saving for dialysis patients.	[Lin, Ming-Yen; Cheng, Li-Jen; Chiu, Yi-Wen; Wu, Ping-Hsun; Jian, Feng-Xuan; Yang, Shu-An; Lee, Huei-Lan; Hwang, Shang-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Hsieh, Hui-Min] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Wu, Ping-Hsun; Lin, Yi-Ting; Hwang, Shang-Jyh] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Lin, Yi-Ting] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wang, Shu-Li] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Hsu, Chih Cheng; Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Hsu, Chih Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih Cheng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University	Hwang, SJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.; Hwang, SJ (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan.; Hwang, SJ (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Hwang, SJ (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.	sjhwang@kmu.edu.tw	Wu, Ping-Hsun/S-8746-2017; Lin, Ming Yen/A-8637-2010	Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming Yen/0000-0002-8194-4833	National Health Insurance Administration, Ministry of Health and Welfare [M0HW103-NH-1001]; Kaohsiung Medical University Hospital [KMUH103-3R10]	National Health Insurance Administration, Ministry of Health and Welfare; Kaohsiung Medical University Hospital	This project was funded by National Health Insurance Administration, Ministry of Health and Welfare (M0HW103-NH-1001) and Kaohsiung Medical University Hospital (KMUH103-3R10) to SJH. The sponsors had no role in the study design, data collection and analysis, publication decision, and interpretation of data; writing the report; and the decision to submit the report for publication.	[Anonymous], 2001, AM J KIDNEY DIS, V37, pS137, DOI [DOI 10.1016/S0272-6386(01)70007-8, 10.1016/s0272-6386(01)70007-8]; Bayliss EA, 2011, CLIN J AM SOC NEPHRO, V6, P704, DOI 10.2215/CJN.06610810; Bello AK, 2015, AM J KIDNEY DIS, V65, P15, DOI 10.1053/j.ajkd.2014.07.033; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Chen PM, 2015, AM J MED, V128, P68, DOI 10.1016/j.amjmed.2014.07.042; Chen Y-R, 2012, NEPHROL DIAL TRANSPL, V28, P671; Chen YR, 2014, NEPHROLOGY, V19, P699, DOI 10.1111/nep.12316; Cheng C-L, 2015, INT J CARDIOLOGY; Desai AA, 2007, CLIN J AM SOC NEPHRO, V2, P1087, DOI 10.2215/CJN.00510107; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fishbane S, 2012, KIDNEY INT, V81, P1167, DOI 10.1038/ki.2012.138; Garcia-Garcia G, 2013, KIDNEY INT SUPPL, V3, P178, DOI 10.1038/kisup.2013.9; Gilmore J, 2006, NEPHROL NURS J, V33, P487; Hao H, 2015, KIDNEY INT; Hemmelgarn BR, 2007, J AM SOC NEPHROL, V18, P993, DOI 10.1681/ASN.2006080860; Hsieh HM, 2016, NEPHROL DIAL TRANSPL, V32, P1184; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Jones SM, 2011, AM J KIDNEY DIS, V57, P449, DOI 10.1053/j.ajkd.2010.10.053; Karunaratne K, 2013, NEPHROL DIAL TRANSPL, V28, P2107, DOI 10.1093/ndt/gft093; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; McCulloch CE, 2011, STAT SCI, V26, P388, DOI 10.1214/11-STS361; Neuhaus JM, 2013, STAT MED, V32, P2419, DOI 10.1002/sim.5682; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; Rayner HC, 2014, NEPHROL DIAL TRANSPL, V29, P644, DOI 10.1093/ndt/gft486; Singhal R, 2014, KIDNEY INT, V86, P399, DOI 10.1038/ki.2014.16; So Y, 2014, SAS GLOBAL FORUM; Wei SY, 2010, NEPHROLOGY, V15, P108, DOI 10.1111/j.1440-1797.2009.01154.x; Yu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112820	31	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198387	10.1371/journal.pone.0198387	http://dx.doi.org/10.1371/journal.pone.0198387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856821	Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800110
J	Maldonato, NM; Sperandeo, R; Caiazzo, G; Cioffi, V; Cozzolino, P; De Santo, RM; Fusco, ML; Lorio, VS; Gigante, E; Marone, P; Nascivera, N; Scognamiglio, C				Maldonato, Nelson Mauro; Sperandeo, Raffaele; Caiazzo, Giovanni; Cioffi, Valeria; Cozzolino, Pasquale; De Santo, Rosa Maria; Fusco, Maria Luigia; Lorio, Vittoria Silviana; Gigante, Elena; Marone, Patrizia; Nascivera, Nicole; Scognamiglio, Chiara			Keep moving without hurting: The interaction between physical activity and pain in determining cognitive function at the population level	PLOS ONE			English	Article							OLDER MEN; ALZHEIMERS-DISEASE; MESSENGER-RNA; IMPAIRMENT; EXERCISE; PERFORMANCE; PREDICTORS; MACARTHUR; MORTALITY; MORPHINE	Background A number of studies have evaluated the association between cognitive function, pain, and physical activity. To our knowledge, however, no previous studies have evaluated these factors at the population level. Aims To evaluate the association between cognitive function in the elderly with pain, physical activity, and the interaction between these variables. Estimates are generated for the United States population. Methods We made use of the NHANES database (1999-2002), making adjustments so that our results represent the United States population. Cognitive function was evaluated through the Digit Symbol Substitution Test. Our main predictors were (1) pain, defined as soreness of either the shoulder, neck, lower back and joint, or a severe headache (2) physical activity, measured as the performance while performing tasks at home, physical activity intensity, walking, bicycle riding, and muscle strengthening. Results Most individual pain sites were not significantly associated with cognitive function, while all physical activity factors were associated with an increase in cognitive function. When evaluating the sample subset of those with cognitive scores lower than the median, a combination of more pain and less physical activity was consistently associated with lower cognitive scores when compared to those performing more physical activity with or without pain.When evaluating individuals with cognitive scores above the median, a similar association pattern was perceived. Conclusions Among the population of individuals above the age of 60, higher cognitive levels are associated with more physical activity and less with pain, although both factors might impact cognition. Public policy resources should be commensurate with these findings when targeting cognitive function among the aging population.	[Maldonato, Nelson Mauro] Univ Naples Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy; [Sperandeo, Raffaele] Univ Basilicata, Dept Human Sci, Potenza, Italy; [Caiazzo, Giovanni; Cioffi, Valeria; Cozzolino, Pasquale; De Santo, Rosa Maria; Fusco, Maria Luigia; Lorio, Vittoria Silviana; Gigante, Elena; Marone, Patrizia; Nascivera, Nicole; Scognamiglio, Chiara] SiPGI, Sch Specializat Integrated Gestalt Psychotherapy, Naples, Italy	University of Naples Federico II; University of Basilicata	Maldonato, NM (corresponding author), Univ Naples Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy.	nelsonmauro.maldonato@unina.it	MALDONATO, NELSON MAURO/AAG-3791-2021	MALDONATO, NELSON MAURO/0000-0002-6401-2305; Sperandeo, Raffaele/0000-0002-8892-179X; Cioffi, Valeria/0000-0003-2889-9292				Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; Antepohl W, 2003, NEUROREHABILITATION, V18, P307; Bennett D. A., 2002, Neurology, V59, P198; BERKMAN LF, 1993, J CLIN EPIDEMIOL, V46, P1129, DOI 10.1016/0895-4356(93)90112-E; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BLUMENTHAL JA, 1991, J GERONTOL, V46, pP352, DOI 10.1093/geronj/46.6.P352; Boyette-Davis JA, 2008, NEUROSCIENCE, V151, P558, DOI 10.1016/j.neuroscience.2007.10.032; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Centers for Disease Control and Prevention (CDC), NAT CTR HLTH STAT NA; Chodzko-Zajko W J, 1994, Exerc Sport Sci Rev, V22, P195; CLARKSONSMITH L, 1990, PSYCHOL AGING, V5, P437; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Grace GM, 1999, J CLIN EXP NEUROPSYC, V21, P477, DOI 10.1076/jcen.21.4.477.876; HULTSCH DF, 1993, J GERONTOL, V48, pP1, DOI 10.1093/geronj/48.1.P1; Karp JF, 2006, PAIN MED, V7, P444, DOI 10.1111/j.1526-4637.2006.00212.x; Kaufman AS, 1999, ESSENTIALS WAIS 3 AS; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lee DM, 2010, PAIN, V151, P30, DOI 10.1016/j.pain.2010.04.024; Lee PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06085; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; Maihofner C, 2007, EUR J PAIN, V11, P903, DOI 10.1016/j.ejpain.2007.03.006; Maldonato M., 2011, WORLD FUTURES, V67, P569, DOI DOI 10.1080/02604027.2011.615591; Maldonato M, 2018, SMART INNOV SYST TEC, V69, P369, DOI 10.1007/978-3-319-56904-8_35; Maldonato NM, 2017, WORLD FUTURES, P1; Mersky H, 1994, TASK FORCE TAXONOMY; Millecamps M, 2004, PAIN, V109, P214, DOI 10.1016/j.pain.2003.12.028; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Newman AB, 2009, J GERONTOL A-BIOL, V64, P1251, DOI 10.1093/gerona/glp127; NHANES, 1999, COGN FUNCT DAT DOC C; Oosterman JM, 2011, CLIN J PAIN, V27, P70, DOI 10.1097/AJP.0b013e3181f15cf5; Proust-Lima C, 2007, AM J EPIDEMIOL, V165, P344, DOI 10.1093/aje/kwk017; RCore Team, 2020, R LANG ENV STAT COMP; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Sperandeo R, 2016, COGNITIVE INFOCOMMUN; Sperandeo R, 2017, 2017 8 INT IEEE INT; Swindell WR, 2012, REJUV RES, V15, P405, DOI 10.1089/rej.2011.1297; Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896; Tassain V, 2003, PAIN, V104, P389, DOI 10.1016/S0304-3959(03)00047-2; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Welmerink DB, 2010, J GERONTOL A-BIOL, V65, P1242, DOI 10.1093/gerona/glq115; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Williams P, 1997, AUST NZ J PUBL HEAL, V21, P45, DOI 10.1111/j.1467-842X.1997.tb01653.x	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197745	10.1371/journal.pone.0197745	http://dx.doi.org/10.1371/journal.pone.0197745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856761	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800038
J	Nakano, T; Moriya, K; Koike, K; Horie, T				Nakano, Takafumi; Moriya, Kyoji; Koike, Kazuhiko; Horie, Toshiharu			Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells	PLOS ONE			English	Article							CUTANEA-TARDA; 5-AMINOLEVULINATE SYNTHASE; URINARY PORPHYRINS; OXIDATIVE STRESS; HEME; IRON; INFECTION; PROTOPORPHYRIN; IDENTIFICATION; DEGRADATION	Porphyria cutanea tarda (PCT), the most common of the human porphyrias, arises from a deficiency of uroporphyrinogen decarboxylase. Studies have shown a high prevalence of hepatitis C virus (HCV) infection in patients with PCT. While these observations implicate HCV infection as a risk factor for PCT pathogenesis, the mechanism of interaction between the virus and porphyrin metabolism is unknown. This study aimed to assess the effect of HCV core protein on intracellular porphyrin metabolism to elucidate the link between HCV infection and PCT. The accumulation and excretion of porphyrins after treatment with 5-aminolevulinic acid, a porphyrin precursor, were compared between cells stably expressing HCV core protein and controls. Cells expressing HCV core protein had lower amounts of intracellular protoporphyrin IX and heme and had higher amounts of excreted coproporphyrin III, the oxidized form of coproporphyrinogen III, compared with controls. These observations suggest that HCV core protein affects porphyrin metabolism and facilitates the export of excess coproporphyrinogen III and/or coproporphyrin III, possibly via porphyrin transporters. Real-time PCR analysis revealed that the presence of HCV core protein increased the mRNA expression of porphyrin exporters ABCG2 and FLVCR1. Western blot analysis showed a higher expression level of FLVCR1, but not ABCG2, as well as a higher expression level of mature ALAS1, which is the rate-limiting enzyme in the heme synthesis pathway, in HCV core protein-expressing cells compared with controls. The data indicate that HCV core protein induced abnormal intracellular porphyrin metabolism, with an over-excretion of coproporphyrin III. These findings may partially account for the susceptibility of HCV-infected individuals to PCT development.	[Nakano, Takafumi; Horie, Toshiharu] Teikyo Heisei Univ, Fac Pharmaceut Sci, Biopharmaceut & Mol Toxicol Unit, Nakano Ku, Tokyo, Japan; [Moriya, Kyoji; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Nakano, T (corresponding author), Teikyo Heisei Univ, Fac Pharmaceut Sci, Biopharmaceut & Mol Toxicol Unit, Nakano Ku, Tokyo, Japan.	t.nakano@thu.ac.jp			Japan Society for Promotion of Science [15K21346, 16K08377]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI Grant Number 15K21346 (TN) and 16K08377 (TH) from Japan Society for Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; Brudieux E, 2001, J VIRAL HEPATITIS, V8, P41, DOI 10.1046/j.1365-2893.2001.00266.x; Cribier B, 1996, ARCH DERMATOL, V132, P1448, DOI 10.1001/archderm.132.12.1448; Dailey TA, 2005, BIOCHEM J, V386, P381, DOI 10.1042/BJ20040570; Dedania B, 2015, J CLIN TRANSL HEPATO, V3, P127, DOI 10.14218/JCTH.2015.00010; Esmat S, 2014, LIVER INT, V34, P1033, DOI 10.1111/liv.12513; FELSHER BF, 1973, JAMA-J AM MED ASSOC, V226, P663, DOI 10.1001/jama.226.6.663; Gisbert JP, 2003, J HEPATOL, V39, P620, DOI 10.1016/S0168-8278(03)00346-5; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; Hindmarsh JT, 1999, CLIN CHEM, V45, P1070; Jackson JM, 2002, DERMATOL CLIN, V20, P449, DOI 10.1016/S0733-8635(02)00013-X; Jalil S, 2010, CLIN GASTROENTEROL H, V8, P297, DOI 10.1016/j.cgh.2009.11.017; Jonker JW, 2007, AM J PHYSIOL-CELL PH, V292, pC2204, DOI 10.1152/ajpcell.00359.2006; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kubitz R, 2004, GASTROENTEROLOGY, V126, P541, DOI 10.1053/j.gastro.2003.11.003; Kubota Y, 2016, J BIOL CHEM, V291, P20516, DOI 10.1074/jbc.M116.719161; Lau JYN, 1998, SEMIN LIVER DIS, V18, P169, DOI 10.1055/s-2007-1007152; Martinelli ALC, 1999, J CLIN GASTROENTEROL, V29, P327, DOI 10.1097/00004836-199912000-00006; MORAN MJ, 1995, INT J BIOCHEM CELL B, V27, P585, DOI 10.1016/1357-2725(95)00017-J; Moriya K, 2001, CANCER RES, V61, P4365; Moriya K, 2009, AM J PATHOL, V175, P1515, DOI 10.2353/ajpath.2009.090102; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Phillips JD, 2007, P NATL ACAD SCI USA, V104, P5079, DOI 10.1073/pnas.0700547104; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Ruggieri A, 2004, ARCH VIROL, V149, P61, DOI 10.1007/s00705-003-0202-x; Ruggieri A, 1997, VIROLOGY, V229, P68, DOI 10.1006/viro.1996.8420; Ryan C F, 2012, LIVER INT, V32, P880, DOI [DOI 10.1111/j.1478-3231.2012.02794.x, 10.1111/j.1478-3231.2012.02794.x, DOI 10.1111/J.1478-3231.2012.02794.X]; Sekine S, 2015, TOXICOL APPL PHARM, V282, P237, DOI 10.1016/j.taap.2014.12.004; Strosberg AD, 2010, VIRUSES-BASEL, V2, P1734, DOI 10.3390/v2081734; van Ijzendoorn SCD, 2004, MOL BIOL CELL, V15, P4115, DOI 10.1091/mbc.E04-04-0290; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; Yoshino K, 2007, J BIOCHEM, V142, P453, DOI 10.1093/jb/mvm159; Zheng JY, 2008, MOL CELL BIOCHEM, V319, P153, DOI 10.1007/s11010-008-9888-0	36	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198345	10.1371/journal.pone.0198345	http://dx.doi.org/10.1371/journal.pone.0198345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856826	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800106
J	Surles-Zeigler, MC; Li, YG; Distel, TJ; Omotayo, H; Ge, SK; Ford, BD				Surles-Zeigler, Monique C.; Li, Yonggang; Distel, Timothy J.; Omotayo, Hakeem; Ge, Shaokui; Ford, Byron D.			Transcriptomic analysis of neuregulin-1 regulated genes following ischemic stroke by computational identification of promoter binding sites: A role for the ETS-1 transcription factor	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; RECOMBINANT HUMAN NEUREGULIN-1; CHRONIC HEART-FAILURE; RAT MODEL; NERVOUS-SYSTEM; BRAIN ISCHEMIA; SCHWANN-CELLS; PHOSPHORYLATION; INFLAMMATION; NEUROPROTECTION	Ischemic stroke is a major cause of mortality in the United States. We previously showed that neuregulin-1 (NRG1) was neuroprotective in rat models of ischemic stroke. We used gene expression profiling to understand the early cellular and molecular mechanisms of NRG1's effects after the induction of ischemia. Ischemic stroke was induced by middle cerebral artery occlusion (MCAO). Rats were allocated to 3 groups: (1) control, (2) MCAO and (3) MCAO + NRG1. Cortical brain tissues were collected three hours following MCAO and NRG1 treatment and subjected to microarray analysis. Data and statistical analyses were performed using R/Bioconductor platform alongside Genesis, Ingenuity Pathway Analysis and Enrichr software packages. There were 2693 genes differentially regulated following ischemia and NRG1 treatment. These genes were organized by expression patterns into clusters using a K-means clustering algorithm. We further analyzed genes in clusters where ischemia altered gene expression, which was reversed by NRG1 (clusters 4 and 10). NRG1, IRS1, OPA3, and POU6F1 were central linking (node) genes in cluster 4. Conserved Transcription Factor Binding Site Finder (CONFAC) identified ETS-1 as a potential transcriptional regulator of NRG1 suppressed genes following ischemia. A transcription factor activity array showed that ETS-1 activity was increased 2-fold, 3 hours following ischemia and this activity was attenuated by NRG1. These findings reveal key early transcriptional mechanisms associated with neuroprotection by NRG1 in the ischemic penumbra.	[Surles-Zeigler, Monique C.] Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA; [Li, Yonggang; Distel, Timothy J.; Omotayo, Hakeem; Ge, Shaokui; Ford, Byron D.] Univ Calif Riverside, Sch Med, Dept Biomed Sci, Riverside, CA 92521 USA; [Li, Yonggang] ICF, Atlanta, GA USA	Morehouse School of Medicine; University of California System; University of California Riverside	Ford, BD (corresponding author), Univ Calif Riverside, Sch Med, Dept Biomed Sci, Riverside, CA 92521 USA.	byron.ford@medsch.ucr.edu		Surles-Zeigler, Monique/0000-0002-2308-8813; Ford, Byron/0000-0002-6636-1461	National Institutes of Health [NS060659, RR026137, RR003034, MD000101]; Morehouse School of Medicine; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morehouse School of Medicine; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by the National Institutes of Health (NS060659, RR026137, RR003034, MD000101) and Morehouse School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Bacci S, 2013, ATHEROSCLEROSIS, V226, P140, DOI 10.1016/j.atherosclerosis.2012.10.035; BEDERSON JB, 1986, J NEUROSURG, V64, P795, DOI 10.3171/jns.1986.64.5.0795; Benedek A, 2006, BRAIN RES, V1116, P159, DOI 10.1016/j.brainres.2006.07.123; Buller B, 2012, GLIA, V60, P1906, DOI 10.1002/glia.22406; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cowley DO, 2000, GENE DEV, V14, P366; Dang J, 2012, J MOL NEUROSCI, V46, P578, DOI 10.1007/s12031-011-9645-9; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; Guo WP, 2006, BRAIN RES, V1087, P180, DOI 10.1016/j.brainres.2006.03.007; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; Hemi R, 2002, J BIOL CHEM, V277, P8961, DOI 10.1074/jbc.M109391200; HO WH, 1995, J BIOL CHEM, V270, P26722; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Hossmann KA, 2012, J CEREBR BLOOD F MET, V32, P1310, DOI 10.1038/jcbfm.2011.186; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isotalo K, 2012, BRAIN PATHOL, V22, P765, DOI 10.1111/j.1750-3639.2012.00586.x; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; Karanam S, 2004, NUCLEIC ACIDS RES, V32, pW475, DOI 10.1093/nar/gkh353; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Li Q, 2009, J MOL NEUROSCI, V37, P67, DOI 10.1007/s12031-008-9121-3; Li YG, 2007, BRAIN RES, V1184, P277, DOI 10.1016/j.brainres.2007.09.037; Li YG, 2011, TOXICOL APPL PHARM, V253, P261, DOI 10.1016/j.taap.2011.03.026; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Pulliam JVK, 2013, BRAIN RES, V1495, P76, DOI 10.1016/j.brainres.2012.11.052; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Ridder DA, 2009, BRAIN RES, V1272, P3, DOI 10.1016/j.brainres.2009.03.046; Shneider NA, 2009, J NEUROSCI, V29, P4719, DOI 10.1523/JNEUROSCI.5790-08.2009; Shyu WC, 2004, NEUROBIOL AGING, V25, P935, DOI 10.1016/j.neurobiolaging.2003.10.012; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Suzuki S, 2001, EXP NEUROL, V170, P63, DOI 10.1006/exnr.2001.7701; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Takagi Y, 2002, J CEREBR BLOOD F MET, V22, P1311, DOI 10.1097/01.WCB.0000034148.72481.F4; Touzani O, 2001, CURR OPIN NEUROL, V14, P83, DOI 10.1097/00019052-200102000-00013; Walton M, 1998, MOL BRAIN RES, V61, P11, DOI 10.1016/S0169-328X(98)00169-7; Wang SL, 2015, J NEUROL SCI, V357, P28, DOI 10.1016/j.jns.2015.06.055; Wang YY, 2013, MOL CELL ENDOCRINOL, V367, P50, DOI 10.1016/j.mce.2012.12.016; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Wu R, 2001, MOL CELL NEUROSCI, V17, P683, DOI 10.1006/mcne.2000.0957; Xu Y, 2007, CELL DEATH DIFFER, V14, P79, DOI 10.1038/sj.cdd.4401928; Xu ZF, 2006, J CEREBR BLOOD F MET, V26, P527, DOI 10.1038/sj.jcbfm.9600212; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	68	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197092	10.1371/journal.pone.0197092	http://dx.doi.org/10.1371/journal.pone.0197092			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856744	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800010
J	Zavodovskaya, R; Stover, SM; Murphy, BG; Katzman, S; Durbin-Johnson, B; Britton, M; Finno, CJ				Zavodovskaya, Regina; Stover, Susan M.; Murphy, Brian G.; Katzman, Scott; Durbin-Johnson, Blythe; Britton, Monica; Finno, Carrie J.			Bone formation transcripts dominate the differential gene expression profile in an equine osteoporotic condition associated with pulmonary silicosis	PLOS ONE			English	Article							DENTIN MATRIX PROTEIN-1; MESENCHYMAL STEM-CELLS; LONG PENTRAXIN PTX3; OSTEOBLAST DIFFERENTIATION; SKELETAL DEVELOPMENT; COLLAGEN-XXIV; TRPV4 CAUSE; RECEPTOR; DISEASE; SIALOPROTEIN	Osteoporosis has been associated with pulmonary silicosis in California horses exposed to soils rich in cytotoxic silica dioxide crystals, a syndrome termed silicate associated osteoporosis (SAO). The causal mechanism for the development of osteoporosis is unknown. Osteoporotic lesions are primarily located in bone marrow-rich sites such as ribs, scapula and pelvis. Gene transcription patterns within bone marrow and pulmonary lymph nodes of affected horses may offer clues to disease pathobiology. Bone marrow core and tracheobronchial lymph node tissue samples harvested postmortem from affected and unaffected horses were examined histologically and subjected to RNA sequencing (RNA-seq). Sequenced data were analyzed for differential gene expression and gene ontology. Meta-transcriptomic and metagenomic assays evaluated samples for infectious agents. Thirteen of 17 differentially expressed transcripts in bone marrow were linked to bone and cartilage formation such as integrin binding bone sialoprotein (log(2)FC = 3.39, P-FDR = 0.013) and chondroadherin (log(2)FC = 4.48, P-FDR = 0.031). Equus caballus solute carrier family 9, subfamily A2 (log(2)FC = 3.77, P-FDR = 0.0034) was one of the four differentially expressed transcripts linked to osteoclast activity. Osteoblasts were hyperplastic and hypertrophic in bone marrow from affected horses. Biological pathways associated with skeletal morphogenesis were significantly enriched in affected horses. The 30 differentially expressed genes in affected lymph nodes were associated with inflammatory responses. Evidence of infectious agents was not found. The SAO affected bone marrow molecular signature demonstrated increased transcription and heightened activation of osteoblasts. Increased osteoblastic activity could be part of the pathological mechanism for osteoporosis or a compensatory response to the accelerated osteolysis. Transcriptome data offer gene targets for inquiries into the role of osteocytes and osteoblasts in SAO pathogenesis. Viral or bacterial infectious etiology in SAO is less likely based on metatranscriptomic and metagenomic data but cannot be completely ruled out.	[Zavodovskaya, Regina; Stover, Susan M.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, UC Davis Sch Vet Med, Davis, CA 95616 USA; [Murphy, Brian G.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, UC Davis Sch Vet Med, Davis, CA 95616 USA; [Katzman, Scott] Univ Calif Davis, Dept Surg & Radiol Sci, UC Davis Sch Vet Med, Davis, CA 95616 USA; [Durbin-Johnson, Blythe] Univ Calif Davis, Dept Publ Hlth Sci, UC Davis Sch Vet Med, Davis, CA 95616 USA; [Britton, Monica] Univ Calif Davis, UC Davis Genome Ctr, Bioinformat Core Facil, Davis, CA 95616 USA; [Finno, Carrie J.] Univ Calif Davis, Dept Populat Hlth & Reprod, UC Davis Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Zavodovskaya, R (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, UC Davis Sch Vet Med, Davis, CA 95616 USA.	rzav@ucdavis.edu	Finno, Carrie J/W-4701-2019		Beijing Genomics Institute at UC Davis Signature Research in Genomics Grant Program [SRGESAO 69240]; Center for Equine Health UC Davis [V431U81]; State of California satellite wagering fund; National Institutes of Health (NIH), National Center for Research Resources as a Ruth L. Kirschstein National Research Service (NRSA) Award: Comparative Medical Science Training Program [T32 OD 011147]; NIH: National Institute of Neurological Disorders and Stroke [1K010D015134-01A1, L40 TR001136]	Beijing Genomics Institute at UC Davis Signature Research in Genomics Grant Program; Center for Equine Health UC Davis; State of California satellite wagering fund; National Institutes of Health (NIH), National Center for Research Resources as a Ruth L. Kirschstein National Research Service (NRSA) Award: Comparative Medical Science Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH: National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was financially supported by the Beijing Genomics Institute at UC Davis Signature Research in Genomics Grant Program (SRGESAO 69240 to SMS); the Center for Equine Health UC Davis (V431U81 to RZ) with funds provided by the State of California satellite wagering fund and contributions by private donors; National Institutes of Health (NIH), National Center for Research Resources as a Ruth L. Kirschstein National Research Service (NRSA) Award: Comparative Medical Science Training Program: T32 OD 011147 to RZ. Support for C.J.F. provided by the NIH: National Institute of Neurological Disorders and Stroke (1K010D015134-01A1 and L40 TR001136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani A, 2014, PANMINERVA MED, V56, P145; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anderson JDC, 2008, JAVMA-J AM VET MED A, V232, P1694, DOI 10.2460/javma.232.11.1694; Arens AM, 2011, VET PATHOL, V48, P593, DOI 10.1177/0300985810385151; BALGAIRIES E, 1957, J Radiol Electrol Arch Electr Medicale, V38, P1112; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; Battaglino RA, 2008, BONE, V42, P180, DOI 10.1016/j.bone.2007.09.046; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; Chaplet M, 2003, J BONE MINER RES, V18, P1506, DOI 10.1359/jbmr.2003.18.8.1506; Choi SJ, 2009, DEV BIOL, V325, P129, DOI 10.1016/j.ydbio.2008.10.014; David A., 2015, ACM C BIOINF COMP BI; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Durham MAC, 2006, P 52 ANN CONV AM ASS; Finno CJ, 2016, FREE RADICAL BIO MED, V101, P261, DOI 10.1016/j.freeradbiomed.2016.10.009; FISHER LW, 1983, J BIOL CHEM, V258, P2723; Gao YG, 2004, GENE, V341, P101, DOI 10.1016/j.gene.2004.05.026; Garcia-Carrasco M, 2009, ISR MED ASSOC J, V11, P486; Geering B, 2014, J LEUKOCYTE BIOL, V95, P293, DOI 10.1189/jlb.0813462; Guilak F, 2010, ANN NY ACAD SCI, V1192, P404, DOI 10.1111/j.1749-6632.2010.05389.x; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; INGRAM RT, 1993, J BONE MINER RES, V8, P1019; Jazayeri M, 2015, MOL CELL BIOMECH, V12, P197; Jorgensen NR, 2007, RESP MED, V101, P177, DOI 10.1016/j.rmed.2006.03.029; Khavandgar Z, 2015, CELL MOL LIFE SCI, V72, P959, DOI 10.1007/s00018-014-1778-x; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lamande SR, 2011, NAT GENET, V43, P1142, DOI 10.1038/ng.945; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Li JJ, 2016, MOL CELL BIOL, V36, P2282, DOI 10.1128/MCB.01077-15; Li X, 2009, TOXICOL MECH METHOD, V19, P51, DOI 10.1080/15376510802354201; Liao KM, 2016, QJM-INT J MED, V109, P69, DOI 10.1093/qjmed/hcv062; Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104; Lui VCH, 1996, GENOMICS, V32, P401, DOI 10.1006/geno.1996.0135; LuuThe V, 1995, J STEROID BIOCHEM, V55, P581, DOI 10.1016/0960-0760(95)00209-X; MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Matsuo N, 2008, CONNECT TISSUE RES, V49, P68, DOI 10.1080/03008200801913502; McIlwraith CW, 2018, J ORTHOP RES, V36, P823, DOI 10.1002/jor.23738; McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134; Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Valenzuela EN, 2017, WIEN MED WOCHENSCHR, V167, P2, DOI 10.1007/s10354-016-0496-4; Ninomiya K, 2007, BIOCHEM BIOPH RES CO, V362, P460, DOI 10.1016/j.bbrc.2007.07.193; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451; Perkins TN, 2015, HUM MOL GENET, V24, P1374, DOI 10.1093/hmg/ddu551; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Schwartz L W, 1981, Chest, V80, P82; Seitz S, 2009, J BONE MINER RES, V24, P62, DOI 10.1359/JBMR.080907; Semik E, 2017, VET COMP ONCOL, V15, P1370, DOI 10.1111/vco.12279; Sheikh S, 2015, J BONE MINER METAB, V33, P180, DOI 10.1007/s00774-014-0572-z; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Streett DP KR, 2015, P 6 ACM C BIOINF COM; Takayanagi H, 2010, ANN NY ACAD SCI, V1192, P117, DOI 10.1111/j.1749-6632.2009.05303.x; Tallmadge RL, 2015, CLIN IMMUNOL, V160, P261, DOI 10.1016/j.clim.2015.05.005; Tashima T, 2015, BIOCHEM BIOPH RES CO, V463, P292, DOI 10.1016/j.bbrc.2015.05.053; Terasawa M, 2004, J BONE MINER METAB, V22, P430, DOI 10.1007/s00774-004-0504-4; Tessier L, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4107-6; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Vincent K, 2013, J MOL GRAPH MODEL, V39, P108, DOI 10.1016/j.jmgm.2012.10.007; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yildizgoren MT, 2016, ENVIRON HEALTH PREV, V21, P149, DOI 10.1007/s12199-016-0509-3; Yildizgoren MT, 2014, TUBERK TORAK, V62, P98, DOI 10.5578/tt.5721; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	79	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197459	10.1371/journal.pone.0197459	http://dx.doi.org/10.1371/journal.pone.0197459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856822	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800024
J	Butovskaya, ML; Windhager, S; Karelin, D; Mezentseva, A; Schaefer, K; Fink, B				Butovskaya, Marina L.; Windhager, Sonja; Karelin, Dimitri; Mezentseva, Anna; Schaefer, Katrin; Fink, Bernhard			Associations of physical strength with facial shape in an African pastoralist society, the Maasai of Northern Tanzania	PLOS ONE			English	Article							GRIP STRENGTH; DIGIT RATIO; REPRODUCTIVE SUCCESS; HANDGRIP STRENGTH; MUSCLE STRENGTH; TESTOSTERONE; DOMINANCE; BODY; ATTRACTIVENESS; MEN	Objectives Previous research has documented associations of physical strength and facial morphology predominantly in men of Western societies. Faces of strong men tend to be more robust, are rounder and have a prominent jawline compared with faces of weak men. Here, we investigate whether the morphometric patterns of strength-face relationships reported for members of industrialized societies can also be found in members of an African pastoralist society, the Maasai of Northern Tanzania. Materials and methods Handgrip strength (HGS) measures and facial photographs were collected from a sample of 185 men and 120 women of the Maasai in the Ngorongoro Conservation Area. In youngadults (20-29 years; n = 95) and mid-adults (30-50 years; n = 114), we digitized 71 somatometric landmarks and semilandmarks to capture variation in facial morphology and performed shape regressions of landmark coordinates upon HGS. Results were visualized in the form of thin-plate plate spline deformation grids and geometric morphometric morphs. Results Individuals with higher HGS tended to have wider faces with a lower and broader forehead, a wider distance between the medial canthi of the eyes, a wider nose, fuller lips, and a larger, squarer lower facial outline compared with weaker individuals of the same age-sex group. In mid-adult men, these associations were weaker than in the other age-sex groups. Discussion We conclude that the patterns of HGS relationships with face shape in the Maasai are similar to those reported from related investigations in samples of industrialized societies. We discuss differences between the present and related studies with regard to knowledge about the causes for age- and sex-related facial shape variation and physical strength associations.	[Butovskaya, Marina L.] Russian Acad Sci, Inst Ethnol & Anthropol, Moscow, Russia; [Butovskaya, Marina L.] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Butovskaya, Marina L.; Mezentseva, Anna] Russian State Univ Humanities, Social Anthropol Res & Educ Ctr, Moscow, Russia; [Windhager, Sonja] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Karelin, Dimitri] Moscow MV Lomonosov State Univ, Moscow, Russia; [Karelin, Dimitri] Russian Acad Sci, Inst Geog, Moscow, Russia; [Schaefer, Katrin] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Fink, Bernhard] Univ Gottingen, Dept Behav Ecol, Gottingen, Germany; [Fink, Bernhard] Leibniz ScienceCampus Primate Cognit, Gottingen, Germany; [Fink, Bernhard] Inst Adv Study, Hanse Wissensch Kolleg, Delmenhorst, Germany	Russian Academy of Sciences; N.N. Miklukho-Maklai Institute of Ethnology & Anthropology; HSE University (National Research University Higher School of Economics); Russian State University for the Humanities; University of Vienna; Lomonosov Moscow State University; Institute of Geography, Russian Academy of Sciences; Russian Academy of Sciences; University of Vienna; University of Gottingen	Windhager, S (corresponding author), Univ Vienna, Dept Theoret Biol, Vienna, Austria.	sonja.windhager@univie.ac.at	Karelin, Dmitry/AAK-9470-2020; Butovskaya, Marina/E-2368-2016; Mezentseva, Anna Александровна/AAD-4735-2020; Karelin, Dmitriy/AAE-5169-2019; Mezentseva, Anna/GZA-7080-2022; Windhager, Sonja/K-7618-2013; Fink, Bernhard/G-7312-2011; Schaefer, Katrin/G-8632-2011	Karelin, Dmitry/0000-0001-5778-3163; Butovskaya, Marina/0000-0002-5528-0519; Mezentseva, Anna Александровна/0000-0001-6149-8971; Windhager, Sonja/0000-0003-1809-8678; Fink, Bernhard/0000-0003-2739-5236; Schaefer, Katrin/0000-0002-0173-3092	Russian Foundation of Basic Research [16-06-00-223]; Faculty of Life Sciences, University of Vienna [IP 547012]; Austrian Science Fund, FWF [P29397]; German Science Foundation, DFG [FI1450/7-2]; Leibniz ScienceCampus Primate Cognition; University of Vienna; Austrian Science Fund (FWF) [P 29397] Funding Source: researchfish	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Faculty of Life Sciences, University of Vienna; Austrian Science Fund, FWF(Austrian Science Fund (FWF)); German Science Foundation, DFG(German Research Foundation (DFG)); Leibniz ScienceCampus Primate Cognition; University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Russian Foundation of Basic Research, 16-06-00-223 (MLB and DK); Faculty of Life Sciences, University of Vienna, IP 547012 (KS); Austrian Science Fund, FWF, P29397 (SW); German Science Foundation, DFG, FI1450/7-2 and Leibniz ScienceCampus Primate Cognition (BF). Open access funding provided by the University of Vienna.	Bhasin S, 2001, J ENDOCRINOL, V170, P27, DOI 10.1677/joe.0.1700027; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Boothroyd LG, 2013, EVOL PSYCHOL-US, V11, P1044, DOI 10.1177/147470491301100508; Butovskaya ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136208; Butovskaya ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep03148; Butovskaya ML, 2017, SIBERIAN HIST RES, V3, P221, DOI DOI 10.17223/; Coast E, 2006, J COMP FAM STUD, V37, P399, DOI 10.3138/jcfs.37.3.399; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DEWSBURY DA, 1982, Q REV BIOL, V57, P135, DOI 10.1086/412672; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; Enlow DH, 1996, ESSENTIALS FACIAL GR; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Farkas L.G., 1981, ANTHROPOMETRY HEAD F; Farkas LG, 1994, ANTHROPOMETRY HEAD F, P3; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Frederiksen H, 2002, GENET EPIDEMIOL, V23, P110, DOI 10.1002/gepi.1127; Geniole SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132726; Good P, 2000, PERMUTATION TESTS PR; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; Hoffman T, 1979, Am J Sports Med, V7, P265; Holzleitner IJ, 2016, EVOL HUM BEHAV, V37, P217, DOI 10.1016/j.evolhumbehav.2015.11.004; Homewood K, 1991, MAASAI AND ECOLOGY; Isen J, 2014, AM J PHYS ANTHROPOL, V154, P189, DOI 10.1002/ajpa.22492; Jacobs A., 1965, THESIS; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Josephs RA, 2003, PSYCHOL SCI, V14, P158, DOI 10.1111/1467-9280.t01-1-01435; KOMI PV, 1978, ACTA PHYSIOL SCAND, V103, P210, DOI 10.1111/j.1748-1716.1978.tb06208.x; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mareckova K, 2011, HORM BEHAV, V60, P681, DOI 10.1016/j.yhbeh.2011.09.004; Melita A. W., 2013, Journal of Service Science and Management, V6, P117, DOI 10.4236/jssm.2013.61012; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Mitteroecker P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118374; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Montalcini T, 2013, ENDOCRINE, V43, P342, DOI 10.1007/s12020-012-9733-9; MUELLER U, 1993, NATURE, V363, P490, DOI 10.1038/363490a0; Nicolay CW, 2005, INT J IND ERGONOM, V35, P605, DOI 10.1016/j.ergon.2005.01.007; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Roney JR, 2003, EVOL HUM BEHAV, V24, P365, DOI 10.1016/S1090-5138(03)00053-9; Schaefer Katrin, 2009, Biology Theory, V4, P98, DOI 10.1162/biot.2009.4.1.98; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Soler C, 2014, J EVOLUTION BIOL, V27, P1930, DOI 10.1111/jeb.12446; Spencer Paul, 1988, MAASAI MATAPATO STUD; Vaara JP, 2012, J STRENGTH COND RES, V26, P2078, DOI 10.1519/JSC.0b013e31823b06ff; van der Meij L, 2012, P ROY SOC B-BIOL SCI, V279, P202, DOI 10.1098/rspb.2011.0764; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Whitehouse AJO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1351; Wind AE, 2010, EUR J PEDIATR, V169, P281, DOI 10.1007/s00431-009-1010-4; Windhager S, 2013, AM J HUM BIOL, V25, P847, DOI 10.1002/ajhb.22444; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219	58	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197738	10.1371/journal.pone.0197738	http://dx.doi.org/10.1371/journal.pone.0197738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29852024	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200019
J	Cuetos-Bueno, J; Hernandez-Ortiz, D; Graham, C; Houk, P				Cuetos-Bueno, Javier; Hernandez-Ortiz, Dalia; Graham, Curtis; Houk, Peter			Human and environmental gradients predict catch, effort, and species composition in a large Micronesian coral-reef fishery	PLOS ONE			English	Article							LENGTH-WEIGHT RELATIONSHIPS; MARINE FOOD WEBS; AMERICAN-SAMOA; POPULATIONS; SUSTAINABILITY; VULNERABILITY; FLUCTUATIONS; EXPLOITATION; MANAGEMENT; ABUNDANCE	The consistent supply of fresh fish to commercial markets may mask growing fishing footprints and localized depletions, as fishing expands to deeper/further reefs, smaller fish, and more resilient species. To test this hypothesis, species-based records and fisher interviews were gathered over one year within a large, demand-driven coral-reef fishery in Chuuk, Micronesia. We first assessed catch statistics with respect to high windspeeds and moon phases that are known to constrain both catch and effort. While lower daily catch success was predicted by higher windspeeds and greater lunar illumination, total daily landings fluctuated less than fishing success across environmental gradients. Instead, daily landings were mainly driven by the number of flights from Chuuk to Guam (i.e., international demand). Given that demand masked local drivers of overall catch volume, we further evaluated species-based indicators of fisheries exploitation. Most target species (75%) had either a positively skewed size distribution or proportional contributions that were dependent upon favorable conditions (i.e. season and moon phases). Skewed size distributions indicated truncated growth associated with fishing mortality, and in turn, suggested that size-based management policies may be most effective for these species. In contrast, environmentally-constrained catch success indicated species that may be more susceptible to growing fishing footprints and may respond better to gear/quota/area policies compared to size policies. Species-based responses offered a simplified means to combine species into fisheries management units. Finally, a comparison of commercial and subsistence landings showed higher vulnerability to fishing among species preferentially targeted by commercial fisheries, offering new insights into how commercial harvesting can disproportionately impact resources, despite having lower annual catch volumes.	[Cuetos-Bueno, Javier; Hernandez-Ortiz, Dalia; Houk, Peter] Univ Guam, Marine Lab, Mangilao, GU 96923 USA; [Graham, Curtis] Chuuk Dept Marine Resources, Chuuk, Micronesia	University of Guam	Cuetos-Bueno, J (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	javiercuetos@gmail.com			Margaret A. Cargill Foundation	Margaret A. Cargill Foundation	This study was funded by Margaret A. Cargill Foundation small grants program administered by the Micronesia Conservation Trust (JCB, PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130800; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Bhathal B, 2008, FISH RES, V91, P26, DOI 10.1016/j.fishres.2007.10.022; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; Birkeland C, 2017, CORAL REEFS, V36, P1, DOI 10.1007/s00338-016-1535-8; Bos AR, 2012, J FISH BIOL, V81, P2074, DOI 10.1111/j.1095-8649.2012.03454.x; Brewer TD, 2009, BIOL CONSERV, V142, P1797, DOI 10.1016/j.biocon.2009.03.021; Cesar H., 2003, EC WORLDWIDE CORAL R; Chavarro SB, 2014, ANIM CONSERV, V17, P133, DOI 10.1111/acv.12066; Cheung W, 2005, FUZZY LOGIC EXPERT S, DOI [10.1016/j.biocon.2005.01.017, DOI 10.1016/J.BIOCON.2005.01.017]; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Craig P, 2008, FISH RES, V89, P230, DOI 10.1016/j.fishres.2007.08.018; Craig PC, 1997, FISH B-NOAA, V95, P680; Crona BI, 2016, FISH FISH, V17, P1175, DOI 10.1111/faf.12109; Cuetos-Bueno J, 2017, J APPL ICHTHYOL, V33, P645, DOI 10.1111/jai.13339; Cuetos-Bueno J, 2015, SUPPORTING COMMUNITY; Cuetos-Bueno J., 2012, ADV MICRONESIA CHALL; Cuetos-Bueno J, 2018, FISH RES, V199, P263, DOI 10.1016/j.fishres.2017.10.010; Cuetos-Bueno J, 2015, REV FISH BIOL FISHER, V25, P179, DOI 10.1007/s11160-014-9358-6; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Franca AR, 2015, BRAZ J OCEANOGR, V63, P289, DOI 10.1590/S1679-87592015087506303; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; FROESE R., 2022, US; Froese R, 2016, FISH FISH, V17, P785, DOI 10.1111/faf.12146; FSMDS, 2010, SUMM AN KEY IND FSM; Gillett R., 2016, FISHERIES EC PACIFIC; Godoy N, 2010, ECOL APPL, V20, P1504, DOI 10.1890/09-1806.1; Graham T., 1994, BIOL ANAL NEARSHORE; Harper S, 2012, FISHERIES CATCH RE 2; Houk P, 2018, ECOL MONOGR, V88, P109, DOI 10.1002/ecm.1278; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; Houk P, 2016, STATUS MANAGEMENT CO; Houk P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23971-6; Houk P, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1727; Houk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130823; Houk P, 2013, MAR ECOL PROG SER, V488, P23, DOI 10.3354/meps10410; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Jenks G.F., 1963, INT YB CARTOGR, V3, P119; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Kaunda-Arara Boaz, 2003, Western Indian Ocean Journal of Marine Science, V2, P105; Kulbicki M, 2005, CYBIUM, V29, P235; Kuparinen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22245; Lassi F., 2009, FEDERATED STATES MIC; Lindfield S. J., 2015, THESIS; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Maire E, 2016, ECOL LETT, V19, P351, DOI 10.1111/ele.12577; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClenachan L, 2013, FISH FISH, V14, P239, DOI 10.1111/j.1467-2979.2012.00465.x; McLean M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166319; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Nadon MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133960; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2014, CURR OPIN ENV SUST, V7, P44, DOI 10.1016/j.cosust.2013.11.027; Prince J, 2015, FISH RES, V171, P42, DOI 10.1016/j.fishres.2015.06.008; Rhodes KL, 2008, CORAL REEFS, V27, P443, DOI 10.1007/s00338-007-0331-x; Rhodes K. L., 2011, MARKET FORCES NEARSH; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Rooney N, 2008, ECOL LETT, V11, P867, DOI 10.1111/j.1461-0248.2008.01193.x; Rouyer T, 2012, ECOL LETT, V15, P658, DOI 10.1111/j.1461-0248.2012.01781.x; Sabater M, 2014, INTERRELATIONS CORAL, P195; Sadovy de Mitcheson Yvonne, 2015, P166; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Silverman B.W., 1986, DENSITY ESTIMATION S; Smith R.O., 1947, SURVEY FISHERIES FOR; Taylor BM, 2017, MAR FRESHWATER RES, V68, P1088, DOI 10.1071/MF16169; Taylor BM, 2014, CORAL REEFS, V33, P869, DOI 10.1007/s00338-014-1187-5; Trebilco R, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0816; Weijerman M, 2016, FISH B-NOAA, V114, P237, DOI 10.7755/FB.114.2.9; Zeller D, 2005, RECONSTRUCTION CORAL; Zgliczynski BJ, 2017, ECOL INDIC, V73, P411, DOI 10.1016/j.ecolind.2016.09.045	76	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198068	10.1371/journal.pone.0198068	http://dx.doi.org/10.1371/journal.pone.0198068			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852023	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200025
J	Chen, JW; Liao, PW; Hsieh, CJ; Chen, CC; Chiou, SJ				Chen, Jeng-Wen; Liao, Po-Wu; Hsieh, Chi-Jeng; Chen, Chu-Chieh; Chiou, Shang-Jyh			Factors associated with changing indications for adenotonsillectomy: A population-based longitudinal study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; HEALTH-INSURANCE; TONSILLECTOMY; CHILDREN; MANAGEMENT; TAIWAN; RATES; OTOLARYNGOLOGISTS; ADENOIDECTOMY; DATABASE	Objective Adenotonsillectomy (AT) is one of the most common surgical procedures performed in children and adults. We aim to assess the factors associated with changes in the incidence of and indications for AT using population-level data. Study design This retrospective cohort study investigated patients who underwent AT between 1997 and 2010 by using data from the Taiwan National Health Insurance Research Database. We examined surgical rates and indications by the calendar year as well as age, sex, hospital level, and insured residence areas for the correlating factors. Results The average annual incidence rate of AT was 14.7 per 100,000 individuals during 1997 - 2010. Pediatric (< 18 years) patients represented 48.2% of the total AT population. More than 99% of the patients underwent the AT procedures as an inpatient intervention. Longitudinal data demonstrated an increasing trend in the pediatric AT rates from 1997 (4.3/100,000) to 2010 (5.7/100,000) (p = 0.029). In the adult subgroup, a decreasing prevalence of infectious indications (p = 0.014) coincided with an increasing neoplastic indications (p = 0.001). In the pediatric subgroup, the prevalence of obstructive indications increased (p = 0.002). The logistic regression analyses indicated that the significant factors associated with the changing surgical indications for AT were the age in the adult subgroup and hospital level in the pediatric subgroup. Conclusions This study revealed a low AT rate in Taiwan than that in other countries. Pediatric AT incidence increased during 1997 - 2010. Although a rising prevalence of obstructive and neoplastic indications was noted, infection remained the most common indications for AT. Age in the adult subgroup and hospital level in the pediatric subgroup were factors associated with the changing indications for AT.	[Chen, Jeng-Wen] Fu Jen Catholic Univ, Catholic Cardinal Tien Hosp, Dept Otolaryngol Head & Neck Surg, New Taipei, Taiwan; [Chen, Jeng-Wen] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Chen, Jeng-Wen] Natl Taiwan Univ Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Liao, Po-Wu] Catholic Yonghe Cardinal Tien Hosp, Dept Otolaryngol, New Taipei, Taiwan; [Hsieh, Chi-Jeng] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei, Taiwan; [Chen, Chu-Chieh; Chiou, Shang-Jyh] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	Fu Jen Catholic University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; Asia Eastern University of Science & Technology; National Taipei University of Nursing & Health Science (NTUNHS)	Chiou, SJ (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.	shangjyh@ntunhs.edu.tw	Chen, Jeng-Wen/N-3906-2016	Chen, Jeng-Wen/0000-0003-3635-4815; Hsieh, Chi-Jeng/0000-0001-8491-2223; Chiou, Shang-Jyh/0000-0003-4966-9533	Catholic Cardinal Tien Hospital [CTH-104-1-2D03, CTH-106A-2A22, CTH-107-MF-02]; National Taipei University of Nursing and Health Sciences	Catholic Cardinal Tien Hospital; National Taipei University of Nursing and Health Sciences	This work was supported by research grants (CTH-104-1-2D03, CTH-106A-2A22 and CTH-107-MF-02) from Catholic Cardinal Tien Hospital in cooperation with National Taipei University of Nursing and Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora RN, 2010, SLEEP, V33, P1408, DOI 10.1093/sleep/33.10.1408; Bhattacharyya N, 2010, OTOLARYNG HEAD NECK, V143, P680, DOI 10.1016/j.otohns.2010.06.918; Capper R, 2001, CLIN OTOLARYNGOL, V26, P371, DOI 10.1046/j.1365-2273.2001.00485.x; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiu HF, 2013, J EPIDEMIOL, V23, P205, DOI 10.2188/jea.JE20120155; Choi HG, 2014, EUR ARCH OTO-RHINO-L, V271, P2293, DOI 10.1007/s00405-013-2759-7; Cielo CM, 2016, CURR PROB PEDIATR AD, V46, P27, DOI 10.1016/j.cppeds.2015.10.006; Clement WA, 2013, J LARYNGOL OTOL, V127, P392, DOI 10.1017/S0022215113000108; Clement WA, 2004, J LARYNGOL OTOL, V118, P357, DOI 10.1258/002221504323086543; Darrow DH, 2002, LARYNGOSCOPE, V112, P6; Erickson BK, 2009, OTOLARYNG HEAD NECK, V140, P894, DOI 10.1016/j.otohns.2009.01.044; Faramarzi A, 2010, INT J PEDIATR OTORHI, V74, P133, DOI 10.1016/j.ijporl.2009.10.024; Fedeli U, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-25; Glover JA, 2008, INT J EPIDEMIOL, V37, P9, DOI 10.1093/ije/dym258; Goodman DC, 2012, J PEDIATR-US, V160, P716, DOI 10.1016/j.jpeds.2012.01.033; Hoddeson EK, 2009, OTOLARYNG HEAD NECK, V140, P19, DOI 10.1016/j.otohns.2008.09.023; Hultcrantz E, 2013, ORL J OTO-RHINO-LARY, V75, P184, DOI 10.1159/000342322; Juul ML, 2018, CLIN OTOLARYNGOL, V43, P274, DOI 10.1111/coa.12959; Koshy E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103600; Lee CWS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013761; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; Mcleod R, 2017, CLIN OTOLARYNGOL, V42, P573, DOI 10.1111/coa.12773; McNeill R A, 1960, Ulster Med J, V29, P59; Paradise JL, 2002, PEDIATRICS, V110; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; Parker NP, 2011, INT J PEDIATR OTORHI, V75, P282, DOI 10.1016/j.ijporl.2010.11.019; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Tsou YA, 2013, INT J PEDIATR OTORHI, V77, P677, DOI 10.1016/j.ijporl.2013.01.011; van den Akker EH, 2004, CLIN OTOLARYNGOL, V29, P161, DOI 10.1111/j.0307-7772.2004.00771.x; van Kempen MJP, 2000, INT ARCH ALLERGY IMM, V122, P8, DOI 10.1159/000024354; Vestergaard H, 2007, PEDIATR INFECT DIS J, V26, P1117, DOI 10.1097/INF.0b013e31814536ba; Waltonen JD, 2009, LARYNGOSCOPE, V119, P102, DOI 10.1002/lary.20017; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0193317	10.1371/journal.pone.0193317	http://dx.doi.org/10.1371/journal.pone.0193317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29843158	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800001
J	Hagio, K; Obata, H; Nakazawa, K				Hagio, Kohtaroh; Obata, Hiroki; Nakazawa, Kimitaka			Effects of breathing movement on the reduction of postural sway during postural-cognitive dual tasking	PLOS ONE			English	Article							CENTER-OF-MASS; UPRIGHT STANCE; BODY SWAY; ATTENTION; BALANCE; STABILIZATION; PERFORMANCE; RESPIRATION	An execution of cognitive processing interferes with postural sway during quiet standing. It reduces sway variability in young adults, but the mechanism is not clear. To elucidate the mechanisms, we focused on breathing in the present study. The purpose of this study was to clarify whether a decrease in postural sway amplitude during a postural-cognitive task is related to the change in breathing movement. The center of pressure (COP) was recorded via a force plate and the motion of leg joints (ankle, knee, and hip), and breathing movements were measured with a 3D motion capture system in quiet standing and standing with cognitive (mental arithmetic) task conditions. The change ratios of each variable from the quiet standing condition to the cognitive task were also calculated. It was shown that the MASt condition produced a significantly smaller RMS of COP displacement as compared to the QSt condition (p < 0.01). The results revealed that the breathing rate was faster and the amplitude of breathing movement smaller when subjects performed the cognitive task. A significant positive correlation (r = 0.75, p < 0.01) was found between the change ratio of breathing amplitude and the COP amplitude. The present results suggest that reduced standing postural sway during a cognitive task is related, at least in part, to a decrease in breathing amplitude.	[Hagio, Kohtaroh; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Sports Sci Lab, Tokyo, Japan; [Obata, Hiroki] Kyushu Inst Technol, Inst Liberal Arts, Dept Humanities & Social Sci, Fukuoka, Japan; [Hagio, Kohtaroh] Nakamura Gakuen Univ Jr Coll, Div Early Childhood Care & Educ, Jyonan Ku, Fukuoka, Fukuoka, Japan	University of Tokyo; Kyushu Institute of Technology	Nakazawa, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Sports Sci Lab, Tokyo, Japan.	nakazawa@idaten.c.u.tokyo.ac.jp						ALLEN MT, 1989, PSYCHOPHYSIOLOGY, V26, P603, DOI 10.1111/j.1469-8986.1989.tb00718.x; Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; BOUISSET S, 1994, NEUROREPORT, V5, P957, DOI 10.1097/00001756-199404000-00026; Boulanger M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173678; CALLISTER R, 1992, J PHYSIOL-LONDON, V454, P373, DOI 10.1113/jphysiol.1992.sp019269; Caron O, 2004, NEUROSCI LETT, V366, P6, DOI 10.1016/j.neulet.2004.04.085; Hodges PW, 2002, EXP BRAIN RES, V144, P293, DOI 10.1007/s00221-002-1040-x; HUFSCHMIDT A, 1980, ARCH PSYCHIAT NERVEN, V228, P135, DOI 10.1007/BF00365601; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Kuznetsov NA, 2012, J MOTOR BEHAV, V44, P241, DOI 10.1080/00222895.2012.688894; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Little CE, 2014, EXP BRAIN RES, V232, P2049, DOI 10.1007/s00221-014-3894-0; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; MULDER G, 1981, PSYCHOPHYSIOLOGY, V18, P392, DOI 10.1111/j.1469-8986.1981.tb02470.x; Norrie RG, 2002, EXP BRAIN RES, V146, P315, DOI 10.1007/s00221-002-1172-z; PORGES SW, 1992, BIOL PSYCHOL, V34, P93, DOI 10.1016/0301-0511(92)90012-J; Riley MA, 2003, BRAIN RES BULL, V62, P191, DOI 10.1016/j.brainresbull.2003.09.012; Stins JF, 2011, HUM MOVEMENT SCI, V30, P190, DOI 10.1016/j.humov.2010.05.013; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Stoffregen TA, 2006, ECOL PSYCHOL, V18, P191, DOI 10.1207/s15326969eco1803_3; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Ueta K, 2014, J MOTOR BEHAV, V47, P37; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yamamoto A, 2015, GAIT POSTURE, V41, P291, DOI 10.1016/j.gaitpost.2014.08.016	24	5	5	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197385	10.1371/journal.pone.0197385	http://dx.doi.org/10.1371/journal.pone.0197385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813100	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800015
J	Prosser, C; Meyer, W; Ellis, J; Lee, R				Prosser, Christiane; Meyer, Wieland; Ellis, John; Lee, Rogan			Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia ( 2010 to 2016)	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; K13-PROPELLER POLYMORPHISMS; GENETIC DIVERSITY; DRUG-RESISTANCE; SPREAD; COMBINATION; MUTATIONS; PARASITES	Background The World Health Organization currently recommends artemisinin (along with a partner drug) as the global frontline treatment for Plasmodium falciparum malaria. Artemisinin resistant P. falciparum are now found throughout the greater Mekong subregion of South East Asia. Several polymorphisms in the parasite's kelch gene have been demonstrated to confer artemisinin resistance. While genotypes within the greater Mekong subregion are thoroughly examined in the literature, P. falciparum populations within several areas that do not (yet) have endemic resistance are underrepresented. Results This investigation characterised the Pfkelch13 propeller domains from 153 blood samples of 140 imported cases of P. falciparum malaria in New South Wales from 2010 to 2016. A low level of propeller domain diversity was observed, including the C580 (Y) under bar coding mutation most strongly associated with artemisinin resistance in South East Asia. The resistance genotype was found in a sample originating in Papua New Guinea, where this mutation, or artemisinin treatment failure, have not been previously reported. Sequencing a panel of geographically informative polymorphisms within the organellar genomes identified the C580 (Y) under bar parasite as having Oceanic origins. Patient data analysis revealed that New South Wales, Australia, P. falciparum malaria cases often originated from regions with limited drug resistance screening. Conclusions The C580 (Y) under bar finding from outside of the greater Mekong subregion supports the consensus to upscale molecular surveillance of artemisinin resistance outside of South East Asia. The genetic screening results identify a risk of importing resistant falciparum malaria to Australia, supporting an ongoing surveillance protocol to pre-empt treatment failure and contribute to global data gathering.	[Prosser, Christiane; Meyer, Wieland] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Westmead Clin Sch,Fac Med & Hlt, Sydney, NSW, Australia; [Prosser, Christiane; Ellis, John] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia; [Prosser, Christiane; Meyer, Wieland] Westmead Inst Med Res, Westmead, NSW, Australia; [Prosser, Christiane; Lee, Rogan] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR, Westmead, NSW, Australia	University of Sydney; University of Technology Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Lee, R (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR, Westmead, NSW, Australia.	Rogan.Lee@health.nsw.gov.au	Ellis, John T/L-6988-2016	Ellis, John T/0000-0001-7328-4831; Prosser, Christiane/0000-0002-4657-9949				Abdulla S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0445-x; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Anderson TJC, 2017, MOL BIOL EVOL, V34, P131, DOI 10.1093/molbev/msw228; Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; [Anonymous], 2001, ANT DRUG COMB THER R; [Anonymous], 2017, WWARN K13 MOL SURV; ARIE S, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5127; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Cerqueira GC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1204-4; Denis MB, 2006, TROP MED INT HEALTH, V11, P1360, DOI 10.1111/j.1365-3156.2006.01690.x; Desai MM, 2013, GENETICS, V193, P565, DOI 10.1534/genetics.112.147157; Digaleh H, 2013, CELL MOL LIFE SCI, V70, P4681, DOI 10.1007/s00018-013-1409-y; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Franco-Paredes C, 2006, LANCET INFECT DIS, V6, P139, DOI 10.1016/S1473-3099(06)70410-8; Ghansah A, 2014, SCIENCE, V345, P1297, DOI 10.1126/science.1259423; Hunja CW, 2013, INT J PARASITOL, V43, P885, DOI 10.1016/j.ijpara.2013.07.001; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Malaria GENPfCP, 2016, ELIFE, V5; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Mita T, 2016, ANTIMICROB AGENTS CH, V60, P3340, DOI 10.1128/AAC.02370-15; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Robert A, 2005, P NATL ACAD SCI USA, V102, P13676, DOI 10.1073/pnas.0500972102; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Schlagenhauf P, 2010, CLIN INFECT DIS, V50, P826, DOI 10.1086/650575; Sibley CH, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0316-5; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197369	10.1371/journal.pone.0197369	http://dx.doi.org/10.1371/journal.pone.0197369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813085	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800014
J	Grempler, R; Wolff, M; Simon, E; Schmid, R; Eisele, C; Rieber, K; Fischer, E; Mettel, S; Gabrielyan, O; Delic, D; Luippold, G; Redeman, N				Grempler, Rolf; Wolff, Michael; Simon, Eric; Schmid, Ramona; Eisele, Claudia; Rieber, Kathrin; Fischer, Elke; Mettel, Sonja; Gabrielyan, Ogsen; Delic, Denis; Luippold, Gerd; Redeman, Norbert			Discovery and translation of a target engagement marker for AMP-activated protein kinase (AMPK)	PLOS ONE			English	Article							OSTEOACTIVIN; METFORMIN; AICAR; EXPRESSION; CLONING; GPNMB; CELLS; LIVER	Background Activation of the AMP-activated protein kinase (AMPK) is an attractive approach for the treatment of type 2 diabetes. AMPK activation reduces glucose levels in animal models of type 2 diabetes by increasing glucose uptake in skeletal muscles and reducing hepatic glucose production. Furthermore, AMPK activation ameliorates hepatic steatosis in animal models. For the clinical development of AMPK activators it is essential to have a reliable target engagement marker for appropriate dose finding and to support proof of clinical principle. While the activation of AMPK by quantification of the phosphorylation of AMPK at Thr(172) in target tissues can be assessed pre-clinically, this is not feasible in clinical studies. Therefore, we attempted to identify and translate a peripheral target engagement biomarker downstream of AMPK activation for clinical use in blood samples. Methods For pharmacological activation of AMPK, two AMPK activators were synthesized (compound 1 and 2). A compound with structural similarities but no pharmacological effect on AMPK phosphorylation was synthesized as negative control (compound 3). Whole blood from healthy volunteers was incubated with an AMPK activator for up to 6 hours and mRNA sequencing was performed. Additionally, human PBMCs were isolated to evaluate Thr(172)-phosphorylation of AMPK in Western blots. In order to enable identification of translatable biomarker candidates, blood samples from HanWistar rats treated for two weeks with an AMPK activator were also subjected to mRNA sequencing. Furthermore, concentration response curves for four biomarker candidates were recorded in human blood samples using Nanostring nCounter technology. Finally, ZDF rats were treated with increasing doses of compound 2 for five weeks to investigate the glucose-lowering efficacy. To investigate changes of mRNA expression of two selected biomarker candidates in this ZDF rat study, qRT-PCR was performed. Results Pharmacological activation of AMPK in human PBMCs revealed an increase in Thr(172)-phosphorylation of AMPK, confirming target engagement in these blood cells. RNA sequencing of human blood samples identified 608 deregulated genes after AMPK activation. Additionally, AMPK activation led to deregulation of 367 genes in whole blood from HanWistar rats which mapped to the respective human genes. 22 genes out of the intersection of genes deregulated in both species are proposed as potential translatable target engagement biomarker candidates. The most prominent genes were transmembrane glycoprotein NMB (GPNMB, osteoactivin), calcium-binding protein A9 (S100A9), peptidoglycan recognition protein (PGLYRP1) and Ras homolog gene family, member B (RHOB). Specificity for AMPK was shown by testing inactive compound 3 in HanWistar rats. The exposure-effect relationship for GPNMB was investigated in a subchronic study in diabetic ZDF rats. GPNMB showed a dose-dependent up-regulation both acutely and after subchronic dosing. GPNMB up-regulation correlated with an increased Thr(172)-phosphorylation of AMPK in liver and quadriceps muscle in rats. Conclusion GPNMB has been identified as a translatable target engagement biomarker for use in clinical studies.	[Grempler, Rolf; Wolff, Michael; Schmid, Ramona; Eisele, Claudia; Rieber, Kathrin; Mettel, Sonja; Gabrielyan, Ogsen; Delic, Denis] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Translat Med & Clin Pharmacol, Biberach, Germany; [Simon, Eric] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Target Discovery Res, Biberach, Germany; [Fischer, Elke; Luippold, Gerd; Redeman, Norbert] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Cardio Metab Dis Res, Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Grempler, R (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Dept Translat Med & Clin Pharmacol, Biberach, Germany.	rolf.grempler@boehringer-ingelheim.com						Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Auciello FR, 2014, FEBS LETT, V588, P3361, DOI 10.1016/j.febslet.2014.07.025; Boon H, 2008, DIABETOLOGIA, V51, P1893, DOI 10.1007/s00125-008-1108-7; Col NF, 2012, BREAST CANCER RES TR, V135, P639, DOI 10.1007/s10549-012-2170-x; Haralanova-Ilieva B, 2005, J HEPATOL, V42, P565, DOI 10.1016/j.jhep.2004.12.021; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Inc N. T, NCOUNTER EXPR DAT AN; Katayama A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16920; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kumagai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143413; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Perdikari A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf5357; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	24	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197849	10.1371/journal.pone.0197849	http://dx.doi.org/10.1371/journal.pone.0197849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799853	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400026
J	Jager, M; Lee, MJ; Li, CD; Farmer, SR; Fried, SK; Layne, MD				Jager, Mike; Lee, Mi-Jeong; Li, Chendi; Farmer, Stephen R.; Fried, Susan K.; Layne, Matthew D.			Aortic carboxypeptidase-like protein enhances adipose tissue stromal progenitor differentiation into myofibroblasts and is upregulated in fibrotic white adipose tissue	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MUSCLE-CELL DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; IN-VIVO; EMBRYONIC-DEVELOPMENT; HUMAN PREADIPOCYTES; CONNECTIVE-TISSUE; BINDING PROTEIN; STEM-CELLS; FIBROSIS	White adipose tissue expands through both adipocyte hypertrophy and hyperplasia and it is hypothesized that fibrosis or excess accumulation of extracellular matrix within adipose tissue may limit tissue expansion contributing to metabolic dysfunction. The pathways that control adipose tissue remodeling are only partially understood, however it is likely that adipose tissue stromal and perivascular progenitors participate in fibrotic remodeling and also serve as adipocyte progenitors. The goal of this study was to investigate the role of the secreted extracellular matrix protein aortic carboxypeptidase-like protein (ACLP) on adipose progenitor differentiation in the context of adipose tissue fibrosis. Treatment of 10T1/2 mouse cells with recombinant ACLP suppressed adipogenesis and enhanced myofibroblast differentiation, which was dependent on transforming growth factor-beta receptor kinase activity. Mice fed a chronic high fat diet exhibited white adipose tissue fibrosis with elevated ACLP expression and cellular fractionation of these depots revealed that ACLP was coexpressed with collagens primarily in the inflammatory cell depleted stromal-vascular fraction (SVF). SVF cells isolated from mice fed a high fat diet secreted increased amounts of ACLP compared to low fat diet control SVF. These cells also exhibited reduced adipogenic differentiation capacity in vitro. Importantly, differentiation studies in primary human adipose stromal cells revealed that mature adipocytes do not express ACLP and exogenous ACLP administration blunted their differentiation potential while upregulating myofibroblastic markers. Collectively, these studies identify ACLP as a stromal derived mediator of adipose progenitor differentiation that may limit adipocyte expansion during white adipose tissue fibrosis.	[Jager, Mike; Li, Chendi; Farmer, Stephen R.; Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Lee, Mi-Jeong; Fried, Susan K.] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Lee, Mi-Jeong; Fried, Susan K.] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Li, Chendi] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Li, Chendi] Harvard Med Sch, Boston, MA USA	Boston University; Boston University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Layne, MD (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	mlayne@bu.edu	Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Farmer, Stephen/0000-0003-2483-2795	Boston University School of Medicine Metabolism, Endocrinology and Obesity Training Program [2T32DK007201]; Boston Nutrition Obesity Research Center (NIH/NIDDK) [P30DK046200, R01DK080448]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	Boston University School of Medicine Metabolism, Endocrinology and Obesity Training Program; Boston Nutrition Obesity Research Center (NIH/NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by Boston University School of Medicine Metabolism, Endocrinology and Obesity Training Program (2T32DK007201), a pilot and feasibility grant from the Boston Nutrition Obesity Research Center (NIH/NIDDK P30DK046200), and R01DK080448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI 10.1016/j.yexcr.2003.10.020; Alazami AM, 2016, HUM GENET, V135, P525, DOI 10.1007/s00439-016-1660-z; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; Bourlier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031274; Cai QK, 2004, AM J PHYSIOL-CELL PH, V287, pC707, DOI 10.1152/ajpcell.00170.2004; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Didangelos A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008128; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Gagnon A, 2005, EXP CELL RES, V308, P265, DOI 10.1016/j.yexcr.2005.04.031; Gagnon A, 2002, ENDOCRINOLOGY, V143, P2478, DOI 10.1210/en.143.7.2478; Ghosh S, 2010, EXP CELL RES, V316, P2087, DOI 10.1016/j.yexcr.2010.04.015; Guglielmi V, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.22; Gusinjac A, 2011, METABOLISM, V60, P782, DOI 10.1016/j.metabol.2010.07.028; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; HAUNER H, 1991, INT J OBESITY, V15, P121; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Ith B, 2005, GENE EXPR PATTERNS, V5, P533, DOI 10.1016/j.modgep.2004.11.002; Iwayama T, 2015, GENE DEV, V29, P1106, DOI 10.1101/gad.260554.115; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Jiang YW, 2014, CELL REP, V9, P1007, DOI 10.1016/j.celrep.2014.09.049; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim YH, 2016, FASEB J, V30, P2528, DOI 10.1096/fj.201500107R; Lackey DE, 2014, AM J PHYSIOL-ENDOC M, V306, pE233, DOI 10.1152/ajpendo.00476.2013; Layne MD, 2002, CIRC RES, V90, P728, DOI 10.1161/01.RES.0000013289.97650.C8; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lin YF, 2005, J CELL MOL MED, V9, P929, DOI 10.1111/j.1582-4934.2005.tb00389.x; Marcelin G, 2017, CELL METAB, V25, P673, DOI 10.1016/j.cmet.2017.01.010; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pellegrinelli V, 2014, J PATHOL, V233, P183, DOI 10.1002/path.4347; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Ro HS, 2001, GENE, V280, P123, DOI 10.1016/S0378-1119(01)00771-5; Ro HS, 2007, OBESITY, V15, P288, DOI 10.1038/oby.2007.569; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5980; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wei J, 2005, CIRC RES, V97, P1323, DOI 10.1161/01.RES.0000194331.76925.5c; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zheng C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.54	65	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197777	10.1371/journal.pone.0197777	http://dx.doi.org/10.1371/journal.pone.0197777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799877	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400022
J	Bae, SH; Kim, J; Kim, AY; Lee, JY; Choi, MY; Lim, KH; Choi, DG				Bae, Seok Hyun; Kim, Jisoo; Kim, Ah Young; Lee, Joo Yeon; Choi, Mi Young; Lim, Key Hwan; Choi, Dong Gyu			Effect of combining inferior oblique muscle weakening procedures with exotropia surgery on the surgical correction of exotropia	PLOS ONE			English	Article							DISSOCIATED VERTICAL DEVIATION; INTERMITTENT EXOTROPIA; PRIMARY POSITION; V-PATTERN; OVERACTION; TRANSPOSITION; MYECTOMY; ANTERIOR	Purpose To determine whether the inferior oblique (IO) muscle weakening procedure combined with exotropia surgery affects the surgical correction of exotropia. Design Institutional, retrospective study. Methods We retrospectively reviewed the medical records of 310 patients who had undergone exotropia-correcting surgery combined with IO weakening (group A, 64 patients) or without IO weakening (group B, 246) with a postoperative follow-up of 6 months or more. The main outcome measures were the postoperative mean angle of horizontal deviation, the success rate, and the overcorrection rate. Surgical success was defined as an alignment between 10 prism diopters (PD) of exodeviation and 5 PD of esodeviation. Results The postoperative mean angles of exodeviation, throughout the follow-up period, did not significantly differ between the groups. Although the surgical success rate was higher in group B at postoperative 1 month (p = 0.035), there was no statistical difference between the 2 groups from postoperative 6 months.: The final success rates were 56.3 and 51.6% (p = 0.509). The overcorrection rate was significantly higher in group A at postoperative 1, 6 and 24 months (p = 0.017, p = 0.028, p = 0.030, respectively); however, at the final follow-up, there was no overcorrection in either group. Conclusion The overcorrection rate was higher in group A until postoperative 2 years, even though the mean angles of exodeviation and the success rates did not significantly differ between the 2 groups. Surgeons should be mindful of overcorrection when planning exotropia surgery combined with the IO weakening procedure.	[Bae, Seok Hyun; Choi, Dong Gyu] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Jisoo; Choi, Mi Young] Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Dept Ophthalmol, Cheongju, South Korea; [Kim, Ah Young; Lim, Key Hwan] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Ophthalmol, Seoul, South Korea; [Lee, Joo Yeon] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Ophthalmol, Anyang, South Korea	Hallym University; Chungbuk National University; Chungbuk National University Hospital; Ewha Womans University; Hallym University	Choi, DG (corresponding author), Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea.	eyechoi@hallym.or.kr						Duane A, 1934, ARCH OPHTHALMOL-CHIC, V11, P394, DOI 10.1001/archopht.1934.00830100016002; Duane A, 1919, ARCH OPHTHALMOL-CHIC, V48, P1; Duane A, 1896, ANN OPHTHALMOL OTOLA, V5, P969; Ela-Dalman N, 2007, J AAPOS, V11, P17, DOI 10.1016/j.jaapos.2006.06.009; Fard MA, 2010, J AAPOS, V14, P35, DOI 10.1016/j.jaapos.2009.11.011; Goldchmit M, 2003, J AAPOS, V7, P241, DOI 10.1016/S1091-8531(03)00114-9; GUZZINATI G C, 1955, Ann Ottalmol Clin Ocul, V81, P447; Kumar K, 2008, J AAPOS, V12, P401, DOI 10.1016/j.jaapos.2008.01.015; Lim HT, 2008, J AAPOS, V12, P390, DOI 10.1016/j.jaapos.2007.11.019; Minguini Nilza, 2005, Binocul Vis Strabismus Q, V20, P21; Sekeroglu HT, 2014, EYE, V28, P553, DOI 10.1038/eye.2014.16; Sekeroglu HT, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/813085; Squirrell DM, 2007, J AAPOS, V11, P48, DOI 10.1016/j.jaapos.2006.09.018; Stager DR, 2004, J AAPOS, V8, P462, DOI 10.1016/j.jaapos.2004.07.004; STAGER DR, 1973, ARCH OPHTHALMOL-CHIC, V90, P15, DOI 10.1001/archopht.1973.01000050017003; URIST MJ, 1952, AMA ARCH OPHTHALMOL, V47, P220; WILSON ME, 1989, OPHTHALMOLOGY, V96, P950	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198002	10.1371/journal.pone.0198002	http://dx.doi.org/10.1371/journal.pone.0198002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795692	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300112
J	Valley-Omar, Z; Iyengar, P; von Mollendorf, C; Tempia, S; Moerdyk, A; Hellferscee, O; Martinson, N; McMorrow, M; Variava, E; Masonoke, K; Cohen, AL; Cohen, C; Treurnicht, FK				Valley-Omar, Ziyaad; Iyengar, Preetha; von Mollendorf, Claire; Tempia, Stefano; Moerdyk, Alexandra; Hellferscee, Orienka; Martinson, Neil; McMorrow, Meredith; Variava, Ebrahim; Masonoke, Katlego; Cohen, Adam L.; Cohen, Cheryl; Treurnicht, Florette K.			Intra-host and intra-household diversity of influenza A viruses during household transmissions in the 2013 season in 2 periurban communities of South Africa	PLOS ONE			English	Article							HEMAGGLUTININ; MUTATIONS; INFECTION; VARIANTS; FAMILIES; REVEALS; DEEP	Limited information is available on influenza virus sequence drift between transmission events. In countries with high HIV burdens, like South Africa, the direct and indirect effect of HIV on influenza sequence drift between transmission events may be of public health concern. To this end, we measured hemagglutinin sequence diversity between influenza transmission events using data and specimens from a study investigating household transmission dynamics of seasonal influenza viruses in 2 peri-urban communities in South Africa during the 2013 influenza season. Thirty index cases and 107 of 110 eligible household contacts were enrolled into the study, 47% (14/30) demonstrating intra-household laboratory-confirmed influenza transmission. In this study 35 partial hemagglutinin gene sequences were obtained by Sanger sequencing from 11 index cases (sampled at enrolment only) and 16 secondary cases (8 cases sampled at 1 and 8 cases sampled at 2 time-points). Viral sequence identities confirmed matched influenza transmission pairs within the 11 households with corresponding sequenced index and secondary cases. Phylogenetic analysis revealed 10 different influenza viral lineages in the 14 households. Influenza A(H1N1) pdm09 strains were shown to be genetically distinct between the 2 communities (from distinct geographic regions), which was not observed for the influenza A(H3N2) strains. Intrahost/intra-household influenza A(H3N2) sequence drift was identified in 2 households. The first was a synonymous mutation between the index case and a household contact, and the second a non-synonymous mutation between 2 serial samples taken at days 0 and 4 post enrolment from an HIV-infected secondary case. Limited inter-household sequence diversity was observed as highlighted by sharing of the same influenza strain between different households within each community. The limited intra-household sequence drift is in line with previous studies also using Sanger sequencing, corroborating the presence of strict selective bottlenecks that limit sequence variance. We were not able to directly ascertain the effect of HIV on influenza sequence drift between transmission events.	[Valley-Omar, Ziyaad; von Mollendorf, Claire; Moerdyk, Alexandra; Hellferscee, Orienka; Cohen, Cheryl; Treurnicht, Florette K.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Valley-Omar, Ziyaad] Univ Cape Town, Div Med Virol, Dept Pathol, Cape Town, South Africa; [Iyengar, Preetha] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Tempia, Stefano; McMorrow, Meredith] Ctr Dis Control & Prevent, Influenza Program, Pretoria, South Africa; [Tempia, Stefano; McMorrow, Meredith; Cohen, Adam L.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Tempia, Stefano; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Hellferscee, Orienka] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Martinson, Neil; Masonoke, Katlego] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa; [Cohen, Adam L.] WHO, Dept Immunizat Vaccines & Biol, Global Immunizat Monitoring & Surveillance, Expanded Programme Immunizat, Geneva, Switzerland	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Cape Town; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; World Health Organization	Valley-Omar, Z; Treurnicht, FK (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.; Valley-Omar, Z (corresponding author), Univ Cape Town, Div Med Virol, Dept Pathol, Cape Town, South Africa.	z.valley-omar@uct.ac.za; florettet@nicd.ac.za	McMorrow, Meredith/M-1274-2019; Hellferscee, Orienka/AAN-6202-2020; Variava, Ebrahim/AAO-5717-2020	Hellferscee, Orienka/0000-0001-9246-8927; Variava, Ebrahim/0000-0003-2888-789X; Cohen, Cheryl/0000-0003-0376-2302; McMorrow, Meredith/0000-0001-6363-4033; Valley-Omar, Ziyaad/0000-0003-4804-3774	United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [5U19GH000622, 5U51IP000528]; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by funds from the United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia; cooperative agreements 5U19GH000622 and 5U51IP000528. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadom TR, 2016, VACCINE, V34, P5649, DOI 10.1016/j.vaccine.2016.09.011; [Anonymous], 2010, CDC REAL TIM RT PCR, p1 ; Bearden A, 2012, INFLUENZA OTHER RESP, V6, P374, DOI 10.1111/j.1750-2659.2011.00322.x; Budgell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120226; Cushing A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16178; diseases NIfc, 2014, RESP VIR SURV REP; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghedin E, 2012, J INFECT DIS, V206, P1504, DOI 10.1093/infdis/jis571; Gubareva LV, 2002, J INFECT DIS, V186, P1575, DOI 10.1086/345372; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Iyengar P, 2015, J INFECTION, V71, P578, DOI 10.1016/j.jinf.2015.09.001; Leonard AS, 2016, J VIROL, V90, P11247, DOI 10.1128/JVI.01657-16; Mohamed S, 2014, AIDS, V28, P1315, DOI 10.1097/QAD.0000000000000267; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Oguma T, 2011, INFECT CONT HOSP EP, V32, P267, DOI 10.1086/658671; Organisation WH, 2011, WHO WEEKLY EPIDEMIOL, V86, P7; Poon LLM, 2016, NAT GENET, V48, P195, DOI 10.1038/ng.3479; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Riley S, 2013, Hong Kong Med J, V19 Suppl 4, P6; Shisana O, 2012, AFRICAN NATL HIV P; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Teo SSS, 2007, PEDIATR INFECT DIS J, V26, P645, DOI 10.1097/INF.0b013e3180616cfb; World Health Organization (WHO), WHO INF MOL DIAGN IN; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	26	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198101	10.1371/journal.pone.0198101	http://dx.doi.org/10.1371/journal.pone.0198101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795677	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300125
J	Volhard, T; Jessen, F; Kleineidam, L; Wolfsgruber, S; Lanzerath, D; Wagner, M; Maier, W				Volhard, Theresia; Jessen, Frank; Kleineidam, Luca; Wolfsgruber, Steffen; Lanzerath, Dirk; Wagner, Michael; Maier, Wolfgang			Advance directives for future dementia can be modified by a brief video presentation on dementia care: An experimental study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OF-LIFE; PEOPLE; AUTONOMY	Objectives To investigate whether life-sustaining measures in medical emergency situations are less accepted for an anticipated own future of living with dementia, and to test whether a resource-oriented, in contrast to a deficit-oriented video about the same demented person, would increase the acceptance of such life-saving measures. Design Experimental study conducted between September 2012 and February 2013. Setting Community dwelling female volunteers living in the region of Bonn, Germany. Participants 278 women aged 19 to 89 (mean age 53.4 years). Intervention Presentation of a video on dementia care focusing either on the deficits of a demented woman (negative framing), or focusing on the remaining resources (positive framing) of the same patient. Main outcome measures Approval of life-sustaining treatments in five critical medical scenarios under the assumption of having comorbid dementia, before and after the presentation of the brief videos on care. Results At baseline, the acceptance of life-sustaining measures in critical medical situations was significantly lower in subjects anticipating their own future life with dementia. Participants watching the resource-oriented film on living with dementia had significantly higher post-film acceptance rates compared to those watching the deficit-oriented negatively framed film. This effect particularly emerges if brief and efficient life-saving interventions with a high likelihood of physical recovery are available (eg, antibiotic treatment for pneumonia). Conclusions Anticipated decisions regarding life-sustaining measures are negatively influenced by the subjective imagination of living with dementia, which might be shaped by common, unquestioned stereotypes. This bias can be reduced by providing audio-visual information on living with dementia which is not only centred around cognitive and functional losses but also focuses on remaining resources and the apparent quality of life. This is particularly true if the medical threat can be treated efficiently. These findings have implications for the practice of formulating, revising, and supporting advance directives.	[Volhard, Theresia; Lanzerath, Dirk] German Reference Ctr Eth Life Sci DRZE, Bonn, Germany; [Jessen, Frank] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Jessen, Frank; Wolfsgruber, Steffen; Wagner, Michael; Maier, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Kleineidam, Luca; Wolfsgruber, Steffen; Wagner, Michael; Maier, Wolfgang] Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany	University of Cologne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Wagner, M; Maier, W (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.; Wagner, M; Maier, W (corresponding author), Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany.	Michael.Wagner@ukbonn.de; Wolfgang.Maier@ukbonn.de	Wagner, Michael/E-2325-2011; Jessen, Frank/AAK-6170-2020	Wagner, Michael/0000-0003-2589-6440; Lanzerath, Dirk/0000-0003-0652-8829	German Federal Ministry of Education and Research in Germany [01GP1002D]	German Federal Ministry of Education and Research in Germany	The study was funded by the German Federal Ministry of Education and Research in Germany (https://www.bmbf.de). Grant number 01GP1002D. Recipient: WM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer Europe, 2006, ALZH EUR REP US ADV; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; [Anonymous], 2006, CONV RIGHTS PERS DIS; Bronner Katharina, 2016, BMC Res Notes, V9, P149, DOI 10.1186/s13104-016-1960-3; Buller T, 2015, J MED ETHICS, V41, P701, DOI 10.1136/medethics-2014-102024; Davis JK, 2002, BIOETHICS, V16, P114, DOI 10.1111/1467-8519.00274; de Boer ME, 2010, INT PSYCHOGERIATR, V22, P201, DOI 10.1017/S1041610209990706; Dening KH, 2011, INT PSYCHOGERIATR, V23, P1535, DOI 10.1017/S1041610211001608; Dickinson C, 2013, INT PSYCHOGERIATR, V25, P2011, DOI 10.1017/S1041610213001531; Ditto PH, 2006, MED DECIS MAKING, V26, P313, DOI 10.1177/0272989X06290494; Dresser R, 2015, J MED ETHICS, V41, P975, DOI 10.1136/medethics-2014-102237; Dworkin R. M., 1994, LIFES DOMINION ARGUM; Handels RLH, 2017, ALZHEIMERS DEMENT, V13, P903, DOI 10.1016/j.jalz.2016.12.015; Hartog CS, 2014, J CRIT CARE, V29, P128, DOI 10.1016/j.jcrc.2013.08.024; Jongsma KR, 2016, J MED ETHICS, V42, P597, DOI 10.1136/medethics-2015-102889; Jox RJ, 2014, INT LIBR ETH LAW NEW, V54, P73, DOI 10.1007/978-94-007-7377-6_5; Lehrl S., 2005, MEHRFACH WORTSCHATZ; Lemmens C, 2012, EUR J HEALTH LAW, V19, P177, DOI 10.1163/157180912X629117; Marson DC, 2001, INT J LAW PSYCHIAT, V24, P267, DOI 10.1016/S0160-2527(01)00064-4; Novak P, 2017, LANCET NEUROL, V16, P123, DOI [10.1016/s1474-4422(16)30331-3, 10.1016/S1474-4422(16)30331-3]; Palmer BW, 2016, ARCH CLIN NEUROPSYCH, V31, P530, DOI 10.1093/arclin/acw051; Schoene-Seifert B, 2016, J AM MED DIR ASSOC, V17, P294, DOI 10.1016/j.jamda.2016.01.014; Swaffer K, 2014, DEMENTIA-LONDON, V13, P709, DOI 10.1177/1471301214548143; TEDESCHI JT, 1971, AM PSYCHOL, V26, P685, DOI 10.1037/h0032110; Thiel MJ, 2014, INT LIBR ETH LAW NEW, V54, P17, DOI 10.1007/978-94-007-7377-6_2; Triplett P, 2008, J AGING HEALTH, V20, P583, DOI 10.1177/0898264308317822; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; Vogelstein E, 2016, J MED PHILOS, V41, P500, DOI 10.1093/jmp/jhw019; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Williams N, 2007, INT J GERIATR PSYCH, V22, P1229, DOI 10.1002/gps.1819; Yates E, 2015, J PAIN SYMPTOM MANAG, V50, P806, DOI 10.1016/j.jpainsymman.2015.06.011	31	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197229	10.1371/journal.pone.0197229	http://dx.doi.org/10.1371/journal.pone.0197229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795605	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300031
J	Wulsin, AC; Franco-Villanueva, A; Romancheck, C; Morano, RL; Smith, BL; Packard, BA; Danzer, SC; Herman, JP				Wulsin, Aynara C.; Franco-Villanueva, Ana; Romancheck, Christian; Morano, Rachel L.; Smith, Brittany L.; Packard, Benjamin A.; Danzer, Steve C.; Herman, James P.			Functional disruption of stress modulatory circuits in a model of temporal lobe epilepsy	PLOS ONE			English	Article							C-FOS EXPRESSION; INDUCED STATUS-EPILEPTICUS; PITUITARY-ADRENOCORTICAL AXIS; TRAUMATIC BRAIN-INJURY; MESSENGER-RNA LEVELS; PILOCARPINE MODEL; RESTRAINT STRESS; TIME-COURSE; RAT-BRAIN; SPONTANEOUS SEIZURES	Clinical data suggest that the neuroendocrine stress response is chronically dysregulated in a subset of patients with temporal lobe epilepsy (TLE), potentially contributing to both disease progression and the development of psychiatric comorbidities such as anxiety and depression. Whether neuroendocrine dysregulation and psychiatric comorbidities reflect direct effects of epilepsy-related pathologies, or secondary effects of disease burden particular to humans with epilepsy (i.e. social estrangement, employment changes) is not clear. Animal models provide an opportunity to dissociate these factors. Therefore, we queried whether epileptic mice would reproduce neuroendocrine and behavioral changes associated with human epilepsy. Male FVB mice were exposed to pilocarpine to induce status epilepticus (SE) and the subsequent development of spontaneous recurrent seizures. Morning baseline corticosterone levels were elevated in pilocarpine treated mice at 1, 7 and 10 weeks post-SE relative to controls. Similarly, epileptic mice had increased adrenal weight when compared to control mice. Exposure to acute restraint stress resulted in hypersecretion of corticosterone 30 min after the onset of the challenge. Anatomical analyses revealed reduced Fos expression in infralimbic and prelimbic prefrontal cortex, ventral subiculum and basal amygdala following restraint. No differences in Fos immunoreactivity were found in the paraventricular nucleus of the hypothalamus, hippocampal subfields or central amygdala. In order to assess emotional behavior, a second cohort of mice underwent a battery of behavioral tests, including sucrose preference, open field, elevated plus maze, 24h home-cage monitoring and forced swim. Epileptic mice showed increased anhedonic behavior, hyperactivity and anxiety-like behaviors. Together these data demonstrate that epileptic mice develop HPA axis hyperactivity and exhibit behavioral dysfunction. Endocrine and behavioral changes are associated with impaired recruitment of forebrain circuits regulating stress inhibition and emotional reactivity. Loss of forebrain control may underlie pronounced endocrine dysfunction and comorbid psychopathologies seen in temporal lobe epilepsy.	[Wulsin, Aynara C.; Franco-Villanueva, Ana; Romancheck, Christian; Morano, Rachel L.; Smith, Brittany L.; Packard, Benjamin A.; Herman, James P.] Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA; [Wulsin, Aynara C.; Danzer, Steve C.] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Herman, JP (corresponding author), Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA.	james.herman@uc.edu	Franco-Villanueva, Ana/X-9013-2019	Franco-Villanueva, Ana/0000-0003-4971-0591; Wulsin, Aynara/0000-0002-4501-6845	University of Cincinnati Retention;  [R01-NS-062806];  [R01-NS-065020];  [T32-GM063483];  [F30-NS-095578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS095578, R01NS065020, R01NS062806] Funding Source: NIH RePORTER	University of Cincinnati Retention; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by University of Cincinnati Retention Grant to James Herman, R01-NS-062806 and R01-NS-065020 to SCD, T32-GM063483 and F30-NS-095578 to ACW. The University of Cincinnati nor NIH had further role in the study design; data collection, analysis and interpretation; writing of the report nor in the decision to submit for publication.	Allendorfer JB, 2014, EPILEPSY BEHAV, V36, P115, DOI 10.1016/j.yebeh.2014.05.003; Barros VN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00072; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Buckmaster PS, 2012, EPILEPSY RES, V102, P153, DOI 10.1016/j.eplepsyres.2012.05.012; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; CHEN X, 1995, NEUROSCIENCE, V64, P675, DOI 10.1016/0306-4522(94)00532-A; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; De Kloet ER, 2016, COPING FORCED SWIM S, P2016; de Oliveira CV, 2015, PHYSIOL BEHAV, V143, P142, DOI 10.1016/j.physbeh.2015.03.004; do Nascimento AL, 2012, BRAIN RES, V1470, P98, DOI 10.1016/j.brainres.2012.06.008; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; FELDMAN RG, 1976, J NERV MENT DIS, V162, P345, DOI 10.1097/00005053-197605000-00005; Figueiredo HF, 2003, EUR J NEUROSCI, V18, P2357, DOI 10.1046/j.1460-9568.2003.02932.x; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Giordano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141221; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Herman JP, 2006, BEHAV BRAIN RES, V174, P215, DOI 10.1016/j.bbr.2006.05.035; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hester MS, 2016, EXP NEUROL, V280, P1, DOI 10.1016/j.expneurol.2016.03.015; Hester MS, 2014, EPILEPSY BEHAV, P2, DOI [10.1016/j.yebeh.2013.12.022, DOI 10.1016/J.YEBEH.2013.12.022]; Hosford B, 2016, J NEUROSCI; Howell K, 2002, EXP PHYSIOL, V87, P747, DOI 10.1113/eph8702477; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Klein S, 2015, EXP NEUROL, V263, P263, DOI 10.1016/j.expneurol.2014.09.004; Kling MA, 2009, DEPRESS ANXIETY, V26, P641, DOI 10.1002/da.20546; Kondziella D, 2007, J NEUROCHEM, V103, P2136, DOI 10.1111/j.1471-4159.2007.04926.x; Lopes MW, 2016, EPILEPSY BEHAV, V55, P92, DOI 10.1016/j.yebeh.2015.12.001; Maccotta L, 2013, NEUROIMAGE-CLIN, V2, P862, DOI 10.1016/j.nicl.2013.06.011; Mahbod P, 2018, ENDOCRINOLOGY, V159, P388, DOI 10.1210/en.2017-00540; Marques AH, 2009, ANN NY ACAD SCI, V1179, P1, DOI 10.1111/j.1749-6632.2009.04987.x; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; McCullers DL, 2001, J NEUROSCI RES, V64, P277; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McKlveen JM, 2015, J NEUROENDOCRINOL, V27, P446, DOI 10.1111/jne.12272; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Mustafa T, 2015, STRESS, V18, P408, DOI 10.3109/10253890.2015.1025044; Myers B, 2012, CELL MOL NEUROBIOL, V32, P683, DOI 10.1007/s10571-012-9801-y; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; O'Toole KK, 2014, EPILEPSY RES, V108, P29, DOI 10.1016/j.eplepsyres.2013.10.013; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sarkisova K, 2011, PROG NEURO-PSYCHOPH, V35, P854, DOI 10.1016/j.pnpbp.2010.11.010; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Singewald N, 2007, NEUROSCI BIOBEHAV R, V31, P18, DOI 10.1016/j.neubiorev.2006.02.003; Solomon MB, 2010, J NEUROENDOCRINOL, V22, P13, DOI 10.1111/j.1365-2826.2009.01933.x; Soussi R, 2015, BRAIN STRUCT FUNCT, V220, P2449, DOI 10.1007/s00429-014-0800-2; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Steimer T, 2002, DIALOGUES CLIN NEURO, P4; Stewart LS, 2003, EPILEPSY BEHAV, V4, P153, DOI 10.1016/S1525-5050(03)00006-4; Suleymanova EM, 2016, NEUROSCIENCE, V315, P79, DOI 10.1016/j.neuroscience.2015.11.061; Tsukiyama N, 2011, STRESS, V14, P368, DOI 10.3109/10253890.2010.544345; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Umeoka EHL, 2011, BRAIN RES, V1381, P141, DOI 10.1016/j.brainres.2011.01.042; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Varga D, 2015, FRONT BEHAV NEUROSCI, V9, P14, DOI 10.3389/fnbeh.2015.00157; Vollmer LL, 2016, BIOL PSYCHIAT, V80, P541, DOI 10.1016/j.biopsych.2016.04.022; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Webb NE, 2014, NEUROREHABILITATION, V34, P625, DOI 10.3233/NRE-141074; Weinberg MS, 2007, NEUROSCIENCE, V150, P478, DOI 10.1016/j.neuroscience.2007.09.013; Wieser HG, 2004, EPILEPSIA, V45, P32; Wulsin AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00214; Wulsin AC, 2016, PHYSIOL BEHAV, V166, P22, DOI 10.1016/j.physbeh.2016.05.015; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	82	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197955	10.1371/journal.pone.0197955	http://dx.doi.org/10.1371/journal.pone.0197955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795651	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300103
J	Kanda, M; Tanaka, H; Shimizu, D; Miwa, T; Umeda, S; Tanaka, C; Kobayashi, D; Hattori, N; Suenaga, M; Hayashi, M; Iwata, N; Yamada, S; Fujiwara, M; Kodera, Y				Kanda, Mitsuro; Tanaka, Haruyoshi; Shimizu, Dai; Miwa, Takashi; Umeda, Shinichi; Tanaka, Chie; Kobayashi, Daisuke; Hattori, Norifumi; Suenaga, Masaya; Hayashi, Masamichi; Iwata, Naoki; Yamada, Suguru; Fujiwara, Michitaka; Kodera, Yasuhiro			SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PERITONEAL METASTASIS; MALIGNANT PHENOTYPE; SYNAPTOTAGMIN 7; TRIAL; CHEMOTHERAPY; GUIDELINES; BIOMARKER; SENSOR; EMT	Liver metastasis remains a serious problem in the management of gastric cancer (GC). Our aims were to identify through transcriptome analysis a molecule that mediates hepatic metastasis in GC, and to evaluate its potential as a diagnostic marker and a therapeutic target. The effects of knocking out a relevant molecule using genome editing were evaluated in vitro experiments and in mouse xenograft models. Expression levels of candidate molecule in 300 pairs of gastric tissues were determined to assess whether differentially expressed genes predicted hepatic recurrence, metastasis, or both. Transcriptome data identified the overexpression of synaptotagmin VII (SYT7) in GC tissues with hepatic metastasis. Its expression in the GC cell lines was high, particularly in those that exhibited a differentiated phenotype, and positively correlated with the expression of SNAI1 and TGFB3, and inversely with RGS2. SYT7 knockout inhibited the proliferation of GC cells, indicated by increased apoptosis with activated caspase and loss of mitochondria membrane potential, G2/M cell-cycle arrest and attenuated cell migration, invasion, and adhesion. The tumorigenicity of SYT7-knockout cells was moderately reduced in a mouse model of subcutaneous metastasis in which the levels of BCL2 and HIF1A were decreased and was more strikingly attenuated in a model of hepatic metastasis. The SYT7 levels in the primary GC tissues were significantly associated with hepatic recurrence, metastasis, and adverse prognosis. SYT7 represents a tool for prediction and monitoring of hepatic metastasis from GC as well as being a promising therapeutic target.	[Kanda, Mitsuro; Tanaka, Haruyoshi; Shimizu, Dai; Miwa, Takashi; Umeda, Shinichi; Tanaka, Chie; Kobayashi, Daisuke; Hattori, Norifumi; Suenaga, Masaya; Hayashi, Masamichi; Iwata, Naoki; Yamada, Suguru; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol Surg 2, Nagoya, Aichi, Japan	Nagoya University	Kanda, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol Surg 2, Nagoya, Aichi, Japan.	m-kanda@med.nagoya-u.ac.jp	Kanda, Mitsuro/M-4891-2014; Fujiwara, Michitaka/AAV-9715-2021	Kanda, Mitsuro/0000-0001-5464-3819; Kodera, Yasuhiro/0000-0002-6173-7474	JSS Young Researcher Award 2014;  [16K19889]	JSS Young Researcher Award 2014; 	This work was supported by a Grant-in-Aid for Encouragement of Young Scientists (B, 16K19889, Japan) and JSS Young Researcher Award 2014.	Acikgoz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141090; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Chen XY, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0070-6; Cheng CH, 2016, MOL MED REP, V13, P1495, DOI 10.3892/mmr.2015.4717; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Gao JF, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0072-1; Goodman KA, 2015, J CLIN ONCOL, V33, P3082, DOI 10.1200/JCO.2014.59.1941; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Kanda M, 2018, ANN SURG, V267, P495, DOI 10.1097/SLA.0000000000002096; Kanda M, 2016, INT J CANCER, V139, P2290, DOI 10.1002/ijc.30286; Kanda M, 2016, ANN SURG ONCOL, V23, P532, DOI 10.1245/s10434-016-5375-0; Kanda M, 2016, INT J ONCOL, V49, P1195, DOI 10.3892/ijo.2016.3584; Kanda M, 2016, ONCOTARGET, V7, P13667, DOI 10.18632/oncotarget.7269; Kanda M, 2016, INT J CANCER, V138, P721, DOI 10.1002/ijc.29803; Kanda M, 2015, EXPERT REV GASTROENT, V9, P1549, DOI 10.1586/17474124.2015.1094373; Kanda M, 2016, ANN SURG ONCOL, V23, P214, DOI 10.1245/s10434-015-4457-8; Kanda M, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0066-9; Kodera Y, 2014, GASTRIC CANCER, V17, P206, DOI 10.1007/s10120-013-0299-x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liu H, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-7; Liu XD, 2010, INT J MOL SCI, V11, P2267, DOI 10.3390/ijms11062267; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Miwa T, 2017, ANN SURG ONCOL, V24, P3771, DOI 10.1245/s10434-017-5882-7; Nie Hui, 2017, J Cell Signal, V2; Oki E, 2016, GASTRIC CANCER, V19, P968, DOI 10.1007/s10120-015-0530-z; Okines A, 2010, ANN ONCOL, V21, pv50, DOI 10.1093/annonc/mdq164; Poli G, 2013, ENDOCR-RELAT CANCER, V20, P537, DOI 10.1530/ERC-13-0150; Qi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132743; Razzak M, 2014, NAT REV CLIN ONCOL, V11, P689, DOI [10.1038/nrclinonc.2014.176, 10.1038/nrclinonc.2013.235, 10.1038/nrclinonc.2013.201]; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; Samykutty A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/287358; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904; Segovia M, 2010, P NATL ACAD SCI USA, V107, P19032, DOI 10.1073/pnas.1014070107; Shih AM, 2016, J CELL BIOCHEM, V117, P1446, DOI 10.1002/jcb.25436; Shimizu D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42089; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wadhwa R, 2013, NAT REV CLIN ONCOL, V10, P643, DOI 10.1038/nrclinonc.2013.170; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Weber JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114033; Wolff DW, 2012, INT J CANCER, V130, P1521, DOI 10.1002/ijc.26138; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088913; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364	47	43	44	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5355	5366		10.1038/s41388-018-0335-8	http://dx.doi.org/10.1038/s41388-018-0335-8			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29858600				2022-12-26	WOS:000445759700008
J	Akduman, N; Rodelsperger, C; Sommer, RJ				Akduman, Nermin; Roedelsperger, Christian; Sommer, Ralf J.			Culture-based analysis of Pristionchus-associated microbiota from beetles and figs for studying nematode-bacterial interactions	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS DB27; CAENORHABDITIS-ELEGANS; C. ELEGANS; PACIFICUS; EVOLUTION; BEHAVIOR; PLASTICITY; ISLAND; MODEL; DIET	The interplay with bacteria is of crucial importance for the interaction of multicellular organisms with their environments. Studying the associations between the nematode model organisms Caenorhabditis elegans and Pristionchus pacificus with bacteria constitutes a powerful system to investigate these interactions at a mechanistic level. P. pacificus is found in association with scarab beetles in nature and recent studies revealed the succession and dynamics of this nematode and its microbiome during the decomposition of one particular host species, the rhinoceros beetle Oryctes borbonicus on La Reunion Island. However, these studies were performed using culture-free methods, with no attempt made to establish bacterial cultures from the beetle-nematode ecosystem and to investigate the effects of these microbes on life history traits in P. pacificus. Here, we establish and characterize a collection of 136 bacterial strains that have been isolated from scarab beetles and figs, another Pristionchus-associated environment, as a resource for studying their effect on various nematode traits. Classification based on 16S sequencing identified members of four bacterial phyla with the class of Gammaproteobacteria representing the majority with 81 strains. Assessing the survival of P. pacificus on individual bacteria allowed us to propose candidate groups of pathogens such as Bacillaceae, Actinobacteria, and Serratia. In combination with chemoattraction data, it was revealed that P. pacificus is able to recognize and avoid certain groups of pathogens, but not others. Our collection of bacterial strains forms a natural resource to study the effects of bacterial diet on development and other traits. Furthermore, these results will form the basis of future studies to elucidate the molecular mechanisms of recognition and pathogenicity.	[Akduman, Nermin; Roedelsperger, Christian; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Max Planck Ring 5, Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Max Planck Ring 5, Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	, roedelsberg/Q-3831-2019	, roedelsberg/0000-0002-7905-9675; Sommer, Ralf/0000-0003-1503-7749	Deutsche Forschungsgemeinschaft (DFG) [GRK 1708]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) Graduiertenkolleg "Molecular principles of bacterial survival strategies" (GRK 1708) to R.J.S.	Althani AA, 2016, J CELL PHYSIOL, V231, P1688, DOI 10.1002/jcp.25284; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Hong RL, 2006, CURR BIOL, V16, P2359, DOI 10.1016/j.cub.2006.10.031; Iatsenko I, 2014, APPL ENVIRON MICROB, V80, P3266, DOI 10.1128/AEM.00464-14; Iatsenko I, 2013, INFECT IMMUN, V81, P3942, DOI 10.1128/IAI.00700-13; Lightfoot James W., 2016, BMC Research Notes, V9, P142, DOI 10.1186/s13104-016-1886-9; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; McGaughran A, 2016, MOL BIOL EVOL, V33, P2257, DOI 10.1093/molbev/msw093; Meyer JM, 2017, ENVIRON MICROBIOL, V19, P1476, DOI 10.1111/1462-2920.13697; Moreno E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2263; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rae R, 2012, INT J PARASITOL, V42, P747, DOI 10.1016/j.ijpara.2012.05.005; Ragsdale E J, NEMATODE MODEL COMP; Ragsdale EJ, 2013, CELL, V155, P922, DOI 10.1016/j.cell.2013.09.054; Rodelsperger C, 2017, CELL REP, V21, P834, DOI 10.1016/j.celrep.2017.09.077; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanghvi GV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164881; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sinha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044255; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Stiernagle Theresa, 2006, WormBook, P1; Susoy V, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501031; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Weitekamp CA, 2017, ANNU REV GENET, V51, P219, DOI 10.1146/annurev-genet-120116-024515; Werner MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07455-7; Wilecki M, 2015, J EXP BIOL, V218, P1306, DOI 10.1242/jeb.118620; Yilmaz LS, 2014, TRENDS GENET, V30, P496, DOI 10.1016/j.tig.2014.07.010; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	32	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198018	10.1371/journal.pone.0198018	http://dx.doi.org/10.1371/journal.pone.0198018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864131	Green Submitted, gold, Green Published			2022-12-26	WOS:000434097100016
J	Ferreira, G; Costa, C; Bassaizteguy, V; Santos, M; Cardozo, R; Montes, J; Settineri, R; Nicolson, GL				Ferreira, Gonzalo; Costa, Carlos; Bassaizteguy, Veronica; Santos, Marcelo; Cardozo, Romina; Montes, Jose; Settineri, Robert; Nicolson, Garth L.			Incubation of human sperm with micelles made from glycerophospholipid mixtures increases sperm motility and resistance to oxidative stress	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LIPID REPLACEMENT THERAPY; PLASMA-MEMBRANE; MITOCHONDRIAL FUNCTIONALITY; MOLECULAR REPLACEMENT; CYTOPLASMIC DROPLETS; CELLULAR MEMBRANES; QUALITY PARAMETERS; HYDROGEN-PEROXIDE; HUMAN SPERMATOZOA	Membrane integrity is essential in maintaining sperm viability, signaling, and motility, which are essential for fertilization. Sperm are highly susceptible to oxidative stress, as they are rich in sensitive polyunsaturated fatty acids (PUFA), and are unable to synthesize and repair many essential membrane constituents. Because of this, sperm cellular membranes are important targets of this process. Membrane Lipid Replacement (MLR) with glycerophospholipid mixtures (GPL) has been shown to ameliorate oxidative stress in cells, restore their cellular membranes, and prevent loss of function. Therefore, we tested the effects of MLR on sperm by tracking and monitoring GPL incorporation into their membrane systems and studying their effects on sperm motility and viability under different experimental conditions. Incubation of sperm with mixtures of exogenous, unoxidized GPL results in their incorporation into sperm membranes, as shown by the use of fluorescent dyes attached to GPL. The percent overall (total) sperm motility was increased from 52 +/- 2.5% to 68 +/- 1.34% after adding GPL to the incubation media, and overall sperm motility was recovered from 7 +/- 2% after H2O2 treatment to 58 +/- 2.5%)(n = 8, p<0.01) by the incorporation of GPL into sperm membranes. When sperm were exposed to H2O2, the mitochondrial inner membrane potential (MIMP), monitored using the MIMP tracker dye JC-1 in flow cytometry, diminished, whereas the addition of GPL prevented the decrease in MIMP. Confocal microscopy with Rhodamine-123 and JC-1 confirmed the mitochondrial localization of the dyes. We conclude that incubation of human sperm with glycerolphospholipids into the membranes of sperm improves sperm viability, motility, and resistance to oxidizing agents like H2O2. This suggests that human sperm might be useful to test innovative new treatments like MLR, since such treatments could improve fertility when it is adversely affected by increased oxidative stress.	[Ferreira, Gonzalo; Costa, Carlos; Bassaizteguy, Veronica; Santos, Marcelo; Cardozo, Romina] Univ Republica, Dept Biofis, Lab Canales Ion & Senalizac Celular, Fac Med, Montevideo, Uruguay; [Montes, Jose] Fertilab, Montevideo, Uruguay; [Settineri, Robert] Sierra Prod Res LLC, Irvine, CA USA; [Nicolson, Garth L.] Inst Mol Med, Dept Mol Pathol, Huntington Beach, CA USA	Universidad de la Republica, Uruguay	Ferreira, G (corresponding author), Univ Republica, Dept Biofis, Lab Canales Ion & Senalizac Celular, Fac Med, Montevideo, Uruguay.	ferreira@fmed.edu.uy	Ferreira, Gonzalo/AAF-5749-2019	Ferreira, Gonzalo/0000-0002-4518-8698; Santos Vives, Marcelo/0000-0003-0804-4983	CSIC; Universidad de la Republica, Uruguay; Universidad de la Republica, Montevideo, Uruguay; Universidad de la Republica	CSIC; Universidad de la Republica, Uruguay; Universidad de la Republica, Montevideo, Uruguay; Universidad de la Republica	The authors declare that the Robert Settineri and Jose Montes are members of the following commercial companies: Sierra Productions Research, LLC and Fertilab respectively. Neither company participated in the study design, data collection and analysis, decision to publish, and only provided financial support in the form of authors' salaries and/or research materials. Robert Settineri participated in this paper in its writing, editing and reviewing of the manuscript. Jose Montes participated in this study by performing the swim-up procedures of the human sperm samples and also helped performing research and validating the results obtained in the lab. The funders provided support in the form of salaries for authors [CSIC and Universidad de la Republica, Uruguay for Gonzalo Ferreira, Carlos Costa, Veronica Bassaizteguy, Romina Cardozo and Marcelo Santos, IMM and Allergy Research Group for Garth L. Nicolson. Each funding organization did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are stated in the 'author contributions' section. In addition, CSIC is a national agency from the Universidad de la Republica, Montevideo, Uruguay, that provides grants for funding research in Uruguay, helping research groups to get the materials and equipment used during their research, as they did in this study (p944, p146, p91 to GF). Its purpose is mostly to improve human knowledge. Universidad de la Republica also paid the salaries of many of the authors of this paper. The Institute for Molecular Medicine is a non-profit organization directed by Dr. Prof. Emeritus Garth L. Nicolson dedicated to biomedical research. The Allergy Research Group is an organization dedicated to producing and marketing hypoallergenic nutritional supplements and has supported this research by donating equipment and purifying and making the lipid mixture used throughout many of the experiments in this paper in collaboration with Dr. Garth L. Nicolson and Dr. Gonzalo Ferreira.	Abreu MSC, 2004, BIOPHYS J, V87, P353, DOI [10.1529/biophysj.104.040576, 10.1529/biophysi.104.040576]; Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z; Agadjanyan M, 2003, J CHRONIC FATIGUE SY, V11, P23, DOI [DOI 10.1300/J092V11N03_03, 10.1300/J092v11n03_03]; Agmon E, 2017, CURR OPIN CHEM BIOL, V39, P83, DOI 10.1016/j.cbpa.2017.06.002; Agnihotri SK, 2016, IN VITRO CELL DEV-AN, V52, P953, DOI 10.1007/s11626-016-0061-x; Aitken RJ, 2012, J ANDROL, V33, P1096, DOI 10.2164/jandrol.112.016535; Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; AITKEN RJ, 1989, BIOL REPROD, V41, P183, DOI 10.1095/biolreprod41.1.183; Aitken RJ, 2017, MOL REPROD DEV, V84, P1039, DOI 10.1002/mrd.22871; Aitken RJ, 2014, ASIAN J ANDROL, V16, P31, DOI 10.4103/1008-682X.122203; Aitken RJ, 2016, REPROD FERT DEVELOP, V28, P1, DOI 10.1071/RD15325; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Amaral S, 2016, CURR MED CHEM, V23, P3575, DOI 10.2174/0929867323666160425113518; Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5; Barroso G, 2006, FERTIL STERIL, V85, P149, DOI 10.1016/j.fertnstert.2005.06.046; Bell M., 1992, Advances in Contraceptive Delivery Systems, V8, P144; Ben Abdallah F, 2012, ANDROLOGIA, V44, P272, DOI 10.1111/j.1439-0272.2011.01177.x; Biswas S, 2011, J DRUG TARGET, V19, P552, DOI 10.3109/1061186X.2010.536983; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; BRODNITZ MH, 1968, J AGR FOOD CHEM, V16, P994, DOI 10.1021/jf60160a001; Byrne RD, 2005, BIOCHEM J, V387, P393, DOI 10.1042/BJ20040947; Martinez-Soto JC, 2016, SYST BIOL REPROD MED, V62, P387, DOI 10.1080/19396368.2016.1246623; CARLSON JC, 1983, ENDOCRINOLOGY, V113, P190, DOI 10.1210/endo-113-1-190; CAROTHERS Z B, 1972, Journal of Cell Biology, V52, P273, DOI 10.1083/jcb.52.2.273; Chaki SP, 2002, CONTRACEPTION, V66, P187, DOI 10.1016/S0010-7824(02)00349-9; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chen CS, 1997, BIOCHEM MOL BIOL INT, V43, P291; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Chen SJ, 2013, ARCH GYNECOL OBSTET, V288, P191, DOI 10.1007/s00404-013-2801-4; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Cohen R, 2016, ADV ANAT EMBRYOL CEL, V220, P107, DOI 10.1007/978-3-319-30567-7_6; Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555; Cooper TG, 2004, HUM REPROD, V19, P2283, DOI 10.1093/humrep/deh410; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Costa TG C., 2015, FUNCTIONAL MED FOODS, V18, P202; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; De Biasi S., 2015, CURR PROTOC CYTOM, V72, P1; du Plessis SS, 2010, ANDROLOGIA, V42, P206, DOI 10.1111/j.1439-0272.2009.00980.x; Engel S, 1999, ANDROLOGIA, V31, P17, DOI 10.1046/j.1439-0272.1999.00230.x; EVENSON DP, 1982, J HISTOCHEM CYTOCHEM, V30, P279, DOI 10.1177/30.3.6174566; Flis VV, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013235; Franken LE, 2017, ADV SCI, V4, DOI 10.1002/advs.201600476; Gadella BM, 2014, THERIOGENOLOGY, V81, P74, DOI 10.1016/j.theriogenology.2013.09.005; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Graves JE, 2005, J ASSIST REPROD GEN, V22, P219, DOI 10.1007/s10815-005-4925-3; Guthrie HD, 2012, THERIOGENOLOGY, V78, P1700, DOI 10.1016/j.theriogenology.2012.05.002; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; HARTREE EF, 1959, BIOCHEM J, V71, P423, DOI 10.1042/bj0710423; HELFRICH P, 1990, BIOPHYS J, V57, P1075, DOI 10.1016/S0006-3495(90)82625-4; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; HONG CY, 1994, ANDROLOGIA, V26, P61; Iwasawa T, 2007, TETRAHEDRON, V63, P6506, DOI 10.1016/j.tet.2007.03.075; JONES R, 1976, PROC R SOC SER B-BIO, V193, P317, DOI 10.1098/rspb.1976.0050; JONES R, 1973, PROC R SOC SER B-BIO, V184, P103, DOI 10.1098/rspb.1973.0035; Kan FWK, 1996, J HISTOCHEM CYTOCHEM, V44, P687, DOI 10.1177/44.7.8675990; Kasai T, 2002, ASIAN J ANDROL, V4, P97; Kasimanickam VR, 2016, REPROD DOMEST ANIM, V51, P461, DOI 10.1111/rda.12702; Khosrowbeygi A, 2007, PROSTAG LEUKOTR ESS, V77, P117, DOI 10.1016/j.plefa.2007.08.003; Ko EY, 2014, FERTIL STERIL, V102, P1518, DOI 10.1016/j.fertnstert.2014.10.020; Kodama H, 1996, J ANDROL, V17, P151; Kumaresan A, 2009, ANIM REPROD SCI, V110, P162, DOI 10.1016/j.anireprosci.2008.01.006; Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; Lenzi A, 2000, FRONT BIOSCI-LANDMRK, V5, pE1, DOI 10.2741/Lenzi; Li J, 2015, ASIAN J PHARM SCI, V10, P81, DOI 10.1016/j.ajps.2014.09.004; LIN DS, 1993, J LIPID RES, V34, P491; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Liu TY, 2009, ADV FUNCT MATER, V19, P616, DOI 10.1002/adfm.200801304; Losano JDA, 2017, REPROD DOMEST ANIM, V52, P289, DOI 10.1111/rda.12901; Lucio CF, 2017, REPROD DOMEST ANIM, V52, P208, DOI 10.1111/rda.12860; Malvezzi H, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-121; Misro MM, 2004, INT J ANDROL, V27, P82, DOI 10.1046/j.0105-6263.2003.00451.x; Morris G, 2018, MOL NEUROBIOL, V55, P5767, DOI 10.1007/s12035-017-0793-y; Mylonas C, 1999, IN VIVO, V13, P295; NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015; Nekoonam S, 2016, CRYOBIOLOGY, V72, P106, DOI 10.1016/j.cryobiol.2016.02.008; Nicolson G.L., 2016, INT J CLIN MED, V7, P133, DOI [10.4236/ijcm.2016.72015, DOI 10.4236/IJCM.2016.72015]; Nicolson G.L., 2006, J CHRONIC FATIGUE SY, V13, P57, DOI [10.1300/J092v13n01_06, DOI 10.1300/J092V13N01_06]; Nicolson GL, 2008, CLIN EXP METASTAS, V25, P161, DOI 10.1007/s10585-007-9129-z; Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247; Nicolson Garth L, 2016, Discoveries (Craiova), V4, pe54, DOI 10.15190/d.2016.1; Nicolson GL, 2017, BBA-BIOMEMBRANES, V1859, P1704, DOI 10.1016/j.bbamem.2017.04.013; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1657, DOI 10.1016/j.bbamem.2013.11.010; Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18; Nicolson GL, 2010, CANCER METAST REV, V29, P543, DOI 10.1007/s10555-010-9245-0; Nicolson GL, 2005, PATHOL ONCOL RES, V11, P139, DOI 10.1007/BF02893390; NICOLSON GL, 1974, SCIENCE, V184, P1294, DOI 10.1126/science.184.4143.1294; Ogden D, 1994, MICROELECTRODE TECHN; Oresti GM, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131201; Oresti GM, 2011, LIPIDS, V46, P1081, DOI 10.1007/s11745-011-3601-x; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Orta G, 2012, J PHYSIOL-LONDON, V590, P2659, DOI 10.1113/jphysiol.2011.224485; Pangas SA, 2014, KNOBIL NEILLS PHYSL; Paoli D, 2011, FERTIL STERIL, V95, P2315, DOI 10.1016/j.fertnstert.2011.03.059; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Piomboni P, 2012, INT J ANDROL, V35, P109, DOI 10.1111/j.1365-2605.2011.01218.x; Davila MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138777; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Publicover SJ, 2008, FRONT BIOSCI, V13, P5623; QUINN PJ, 1980, J REPROD FERTIL, V60, P403, DOI 10.1530/jrf.0.0600403; Ragni G, 1998, HUM REPROD, V13, P1859, DOI 10.1093/humrep/13.7.1859; Rajashri M, 2016, COEFFICIENT VARIATIO; Rao KS, 2006, ANAL CHIM ACTA, V576, P177, DOI 10.1016/j.aca.2006.06.019; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Reyes N, 2001, BIOPHYSICAL J; Sabeti P, 2016, INT J REPROD BIOMED, V14, P231; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Scharwey M, 2013, J CELL SCI, V126, P5317, DOI 10.1242/jcs.134130; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Sikka SC, 2001, CURR MED CHEM, V8, P851, DOI 10.2174/0929867013373039; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Storey BT, 1997, MOL HUM REPROD, V3, P203, DOI 10.1093/molehr/3.3.203; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Suleiman SA, 1996, J ANDROL, V17, P530; Surai PF, 2000, THERIOGENOLOGY, V53, P1025, DOI 10.1016/S0093-691X(00)00249-1; Suzuki-Toyota F, 2010, CELL TISSUE RES, V341, P429, DOI 10.1007/s00441-010-1012-6; Tapia JA, 2012, REPROD DOMEST ANIM, V47, P65, DOI 10.1111/j.1439-0531.2012.02046.x; Tavilani H, 2006, ANDROLOGIA, V38, P173, DOI 10.1111/j.1439-0272.2006.00735.x; Tavilani H, 2007, PROSTAG LEUKOTR ESS, V77, P45, DOI 10.1016/j.plefa.2007.07.001; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; TOSIC J, 1946, NATURE, V158, P485, DOI 10.1038/158485a0; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Uribe P, 2015, MOL HUM REPROD, V21, P237, DOI 10.1093/molehr/gau107; Uribe P., 2017, ANDROLOGIA, V49; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Venkatesh S, 2009, INDIAN J MED RES, V129, P127; Verma A, 1998, ANDROLOGIA, V30, P325; Vireque AA, 2016, FERTIL STERIL, V106, P273, DOI 10.1016/j.fertnstert.2016.03.044; Volpe S, 2009, REPROD DOMEST ANIM, V44, P275, DOI 10.1111/j.1439-0531.2009.01457.x; Wade MA, 2003, REPRODUCTION, V125, P175, DOI 10.1530/reprod/125.2.175; Wang LG, 2015, SCI CHINA LIFE SCI, V58, P66, DOI 10.1007/s11427-014-4769-0; Wennemuth G, 1998, ANDROLOGIA, V30, P141; Witte TS, 2007, ANIM REPROD SCI, V102, P181, DOI 10.1016/j.anireprosci.2007.07.007; Wolfe CA, 1998, BIOL REPROD, V59, P1506, DOI 10.1095/biolreprod59.6.1506; Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Xu H, 2013, ASIAN J ANDROL, V15, P799, DOI 10.1038/aja.2013.69; Yamanaka M, 2016, J REPROD DEVELOP, V62, P599, DOI 10.1262/jrd.2016-112; Yeung CH, 1997, FERTIL STERIL, V67, P1156, DOI 10.1016/S0015-0282(97)81455-0; Zabludovsky N, 1999, ANDROLOGIA, V31, P91, DOI 10.1046/j.1439-0272.1999.00254.x; Zalata AA, 1998, MOL HUM REPROD, V4, P111, DOI 10.1093/molehr/4.2.111; Zanetti SR, 2010, BIOCHIMIE, V92, P1886, DOI 10.1016/j.biochi.2010.08.015; Zaniboni L, 2009, ANIM REPROD SCI, V112, P51, DOI 10.1016/j.anireprosci.2008.04.002; Zhang TP, 2015, INT J NANOMED, V10, P6175, DOI 10.2147/IJN.S91348; Zhao H, 2010, CYTOM PART A, V77A, P399, DOI 10.1002/cyto.a.20867; Zhao JP, 2009, MACROMOL CHEM PHYS, V210, P1026, DOI 10.1002/macp.200900161; Zhu LH, 2011, MOL REPROD DEV, V78, P920, DOI 10.1002/mrd.21382; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	155	22	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197897	10.1371/journal.pone.0197897	http://dx.doi.org/10.1371/journal.pone.0197897			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856778	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800048
J	Hellmuth, C; Uhl, O; Demmelmair, H; Grunewald, M; Auricchio, R; Castillejo, G; Korponay-Szabo, IR; Polanco, I; Roca, M; Vriezinga, SL; Werkstetter, KJ; Koletzko, B; Mearin, ML; Kirchberg, FF				Hellmuth, Christian; Uhl, Olaf; Demmelmair, Hans; Grunewald, Maria; Auricchio, Renata; Castillejo, Gemma; Korponay-Szabo, Ilma R.; Polanco, Isabel; Roca, Maria; Vriezinga, Sabine L.; Werkstetter, Katharine J.; Koletzko, Berthold; Mearin, M. Luisa; Kirchberg, Franca F.			The impact of human breast milk components on the infant metabolism	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; LYSOPHOSPHATIDIC ACID; LIPID-METABOLISM; DIETARY-PROTEIN; ADIPOSE-TISSUE; DOCOSAHEXAENOIC ACID; CHILDHOOD OBESITY; SKELETAL-MUSCLE; GENE-EXPRESSION	Background & aims Breastfeeding is beneficial for mothers and infants. Underlying mechanisms and biochemical mediators thus need to be investigated to develop and support improved infant nutrition practices promoting the child health. We analysed the relation between maternal breast milk composition and infant metabolism. Methods 196 pairs of mothers and infants from a European research project (PreventCD) were studied. Maternal milk samples collected at month 1 and month 4 after birth were analysed for macronutrient classes, hormone, and fatty acid (FA) content. Phospholipids, acylcarnitines, and amino acids were measured in serum samples of 4-month old infants. Associations between milk components and infant metabolites were analysed with spearman correlation and linear mixed effect models (LME). P-values were corrected for multiple testing (P-LME). Results Month 1 milk protein content was strongly associated with infant serum lyso-phosphatidylcholine (LPC) 14: 0 (P-LME = 0.009). Month 1 milk insulin was associated to infant acetylcarnitine (P-LME = 0.01). There were no associations between milk protein content and serum amino acids and milk total fat content and serum polar lipids. Middle- and odd-chain FA% in breast milk at both ages were significantly related to serum LPC and sphingomyelins (SM) species in infant serum (all P-LME < 0.05), while FA% 20: 5n(-3) and 22: 6n(-3) percentages were significantly associated to serum LPC 22:6 (P-LME = 1.91x10(-4)/7.93x10(-5)) in milk only at month 4. Other polyunsaturated fatty acids and hormones in milk showed only weak associations with infant serum metabolites. Conclusions Infant serum LPC are influenced by breast milk FA composition and, intriguingly, milk protein content in early but not late lactation. LPC 14:0, previously found positively associated with obesity risk, was the serum metabolite which was the most strongly associated to milk protein content. Thus, LPC 14:0 might be a key metabolite not only reflecting milk protein intake in infants, but also relating high protein content in milk or infant formula to childhood obesity risk.	[Hellmuth, Christian; Uhl, Olaf; Demmelmair, Hans; Grunewald, Maria; Werkstetter, Katharine J.; Koletzko, Berthold; Kirchberg, Franca F.] Univ Munich, Ludwig Maximilians Univ Munchen, Div Metab & Nutr Med, Med Ctr,Dr von Hauner Childrens Hosp, Munich, Germany; [Auricchio, Renata] Univ Federico II, Dept Med Translat Sci, Naples, Italy; [Auricchio, Renata] Univ Federico II, European Lab Invest Food Induced Dis, Naples, Italy; [Castillejo, Gemma] Hosp Univ St Joan Reus, Dept Pediat Gastroenterol Unit, URV, IIPV, Reus, Spain; [Korponay-Szabo, Ilma R.] Heim Pal Natl Pediat Inst, Celiac Dis Ctr, Budapest, Hungary; [Korponay-Szabo, Ilma R.] Univ Debrecen, Dept Pediat, Debrecen, Hungary; [Polanco, Isabel] La Paz Univ Hosp, Dept Pediat Gastroenterol & Nutr, Madrid, Spain; [Roca, Maria] Inst Invest Sanitaria La Fe, U Enfermedad Celiaca & Inmunopatol Digest, Valencia, Spain; [Vriezinga, Sabine L.; Mearin, M. Luisa] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands	University of Munich; University of Naples Federico II; University of Naples Federico II; Universitat Rovira i Virgili; University of Debrecen; Hospital Universitario La Paz; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Koletzko, B (corresponding author), Univ Munich, Ludwig Maximilians Univ Munchen, Div Metab & Nutr Med, Med Ctr,Dr von Hauner Childrens Hosp, Munich, Germany.	office.koletzko@med.lmu.de	AURICCHIO, RENATA/AAC-7718-2022; Korponay-Szabó, Ilma/AFK-1690-2022; Roca, Maria/AGD-5148-2022; Korponay-Szabó, Ilma/AAF-9048-2022; Llorens, María Roca/AAD-4676-2020	Roca, Maria/0000-0001-8157-2446; Uhl, Olaf/0000-0001-8064-7717; Kirchberg, Franca Fabiana/0000-0001-6863-1202	Commission of the European Communities, the 6th Framework Programme [FP6-2005-FOOD-4B-36383-PREVENTCD]; Commission of the European Communities,the 7th Framework Programme [FP7-289346-EARLY NUTRITION]; European Research Council Advanced Grant ERC-2012-AdG [322605 META-GROWTH]; Azrieli Foundation; Deutsche Zoliakie Gesellschaft; Eurospital; Fondazione Celiachia; Fria Brod; Institute de Salud Carlos III; Spanish Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Komitet Badan Naukowych [1715/B/P01/2008/34]; Fundacja Nutricia [1W44/FNUT3/2013]; Hungarian Scientific Research Funds [OTKA101788, NKFI120392, TAMOP 2.2.11/1/KONV-2012-0023]; Stichting Coeliakie Onderzoek Nederland; Thermo Fisher Scientific; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition	Commission of the European Communities, the 6th Framework Programme; Commission of the European Communities,the 7th Framework Programme; European Research Council Advanced Grant ERC-2012-AdG; Azrieli Foundation; Deutsche Zoliakie Gesellschaft; Eurospital; Fondazione Celiachia; Fria Brod; Institute de Salud Carlos III(Instituto de Salud Carlos III); Spanish Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Komitet Badan Naukowych; Fundacja Nutricia(Danone Nutricia); Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Stichting Coeliakie Onderzoek Nederland; Thermo Fisher Scientific; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition	This work was financially supported by the Commission of the European Communities, the 6th Framework Programme, contract FP6-2005-FOOD-4B-36383-PREVENTCD, the 7th Framework Programme, contract FP7-289346-EARLY NUTRITION, the European Research Council Advanced Grant ERC-2012-AdG - no.322605 META-GROWTH, the Azrieli Foundation, Deutsche Zoliakie Gesellschaft, Eurospital, Fondazione Celiachia, Fria Brod, Institute de Salud Carlos III, Spanish Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Komitet Badan Naukowych (1715/B/P01/2008/34), Fundacja Nutricia (1W44/FNUT3/2013), Hungarian Scientific Research Funds (OTKA101788, NKFI120392 and TAMOP 2.2.11/1/KONV-2012-0023), Stichting Coeliakie Onderzoek Nederland, Thermo Fisher Scientific, and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare to have no conflict of interest.	Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bank S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26789; Benaicheta N, 2016, BRIT J NUTR, V115, P6, DOI 10.1017/S0007114515004195; Binns C, 2016, ASIA-PAC J PUBLIC HE, V28, P7, DOI 10.1177/1010539515624964; Bourlieu C, 2014, CRIT REV FOOD SCI, V54, P1427, DOI 10.1080/10408398.2011.640757; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; Casadio YS, 2010, J HUM LACT, V26, P376, DOI 10.1177/0890334410376948; DESCHRIJVER R, 1990, J NUTR, V120, P1624, DOI 10.1093/jn/120.12.1624; Esch CEH, 2010, EUR J GASTROEN HEPAT, V22, P1424, DOI 10.1097/MEG.0b013e32833fe9ae; Fiamoncini J, 2015, MOL NUTR FOOD RES, V59, P1573, DOI 10.1002/mnfr.201400743; Fields DA, 2012, PEDIATR OBES, V7, P304, DOI 10.1111/j.2047-6310.2012.00059.x; Fox MK, 2006, J AM DIET ASSOC, V106, pS77, DOI 10.1016/j.jada.2005.09.039; Gauster M, 2005, J LIPID RES, V46, P1517, DOI 10.1194/jlr.M500054-JLR200; Gibson RA, 1997, EUR J CLIN NUTR, V51, P578, DOI 10.1038/sj.ejcn.1600446; Grote V, 2016, EUR J CLIN NUTR, V70, P250, DOI 10.1038/ejcn.2015.162; Guebre-Egziabher F, 2008, EUR J CLIN NUTR, V62, P1287, DOI 10.1038/sj.ejcn.1602857; Helland IB, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e82; Hellmuth C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2108909; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hoffman DR, 2006, J PEDIATR GASTR NUTR, V42, P287, DOI 10.1097/01.mpg.0000189366.91792.64; Hurtado JA, 2015, J PEDIATR GASTR NUTR, V61, P472, DOI 10.1097/MPG.0000000000000864; Innis SM, 1999, AM J CLIN NUTR, V70, P383; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Jonsson K, 2016, ACTA PAEDIATR, V105, P1462, DOI 10.1111/apa.13592; Kankaanpaa P, 2001, ALLERGY, V56, P633, DOI 10.1034/j.1398-9995.2001.00965.x; Kirchberg FF, 2016, J AUTOIMMUN, V72, P95, DOI 10.1016/j.jaut.2016.05.006; Kirchberg FF, 2015, J CLIN ENDOCR METAB, V100, P149, DOI 10.1210/jc.2014-3157; Kuang YL, 2012, BRIT J NUTR, V108, P1351, DOI 10.1017/S0007114511006854; Labonte ED, 2010, FASEB J, V24, P2516, DOI 10.1096/fj.09-144436; Laitinen K, 2006, PEDIATR RES, V59, P723, DOI 10.1203/01.pdr.0000203158.31452.9e; Lamri MY, 1995, NUTRITION, V11, P444; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Liu YY, 2015, BRIT J NUTR, V113, P1069, DOI 10.1017/S0007114514004310; Madani S, 2004, NUTRITION, V20, P554, DOI 10.1016/j.nut.2004.03.010; Madeira MS, 2014, BRIT J NUTR, V111, P1521, DOI 10.1017/S0007114513004029; Mastrangelo A, 2016, INT J OBESITY, V40, P1494, DOI 10.1038/ijo.2016.92; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mitoulas LR, 2003, BRIT J NUTR, V90, P979, DOI 10.1079/BJN2003979; Molto-Puigmarti C, 2011, CLIN NUTR, V30, P116, DOI 10.1016/j.clnu.2010.07.013; Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010; Moriyama T, 2004, BIOSCI BIOTECH BIOCH, V68, P352, DOI 10.1271/bbb.68.352; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Oddy WH, 2006, PEDIAT ALLERG IMM-UK, V17, P4, DOI 10.1111/j.1399-3038.2005.00340.x; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; POLBERGER S, 1993, J PEDIATR GASTR NUTR, V17, P283, DOI 10.1097/00005176-199310000-00009; Prell C, 2016, DTSCH ARZTEBL INT, V113, P435, DOI 10.3238/arztebl.2016.0435; Ramirez M, 2001, EARLY HUM DEV, V65, pS95, DOI 10.1016/S0378-3782(01)00211-0; Rancoule C, 2013, DIABETOLOGIA, V56, P1394, DOI 10.1007/s00125-013-2891-3; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Rauschert S, 2017, ANN NUTR METAB, V70, P201, DOI 10.1159/000459635; Rudolph MC, 2016, BMI INT J OBES, DOI [10.1038/ijo.2016.211, DOI 10.1038/IJO.2016.211]; Rzehak P, 2014, ANN NUTR METAB, V64, P294, DOI 10.1159/000365037; Saarela T, 2005, ACTA PAEDIATR, V94, P1176, DOI 10.1080/08035250510036499; Scholtens S, 2009, BRIT J NUTR, V101, P116, DOI 10.1017/S0007114508993521; SEKAS G, 1985, J LAB CLIN MED, V105, P190; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shamir R, 2016, NESTLE NUTR WORKS SE, V86, P67, DOI 10.1159/000442724; Stimming M, 2014, J AGR FOOD CHEM, V62, P10153, DOI 10.1021/jf502469b; SUBBAIAH PV, 1992, BIOCHIM BIOPHYS ACTA, V1128, P83, DOI 10.1016/0005-2760(92)90261-S; Uhl O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162040; van Elten TM, 2015, ALLERGY, V70, P1468, DOI 10.1111/all.12703; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Vriezinga SL, 2014, NEW ENGL J MED, V371, P1304, DOI 10.1056/NEJMoa1404172; Wahl S, 2012, OBESITY FACTS, V5, P660, DOI 10.1159/000343204; Wang Q, 2016, PEDIATR NEUROL, V59, P54, DOI 10.1016/j.pediatrneurol.2016.02.017; YASHIRO M, 1980, J NUTR SCI VITAMINOL, V26, P59, DOI 10.3177/jnsv.26.59; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhang L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040237; Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6	71	25	27	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197713	10.1371/journal.pone.0197713	http://dx.doi.org/10.1371/journal.pone.0197713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856767	Green Published, gold			2022-12-26	WOS:000433900800036
J	Thomenius, MJ; Totman, J; Harvey, D; Mitchell, LH; Riera, TV; Cosmopoulos, K; Grassian, AR; Klaus, C; Foley, M; Admirand, EA; Jahic, H; Majer, C; Wigle, T; Jacques, SL; Gureasko, J; Brach, D; Lingaraj, T; West, K; Smith, S; Rioux, N; Waters, NJ; Tang, CY; Raimondi, A; Munchhof, M; Mills, JE; Ribich, S; Scott, MP; Kuntz, KW; Janzen, WP; Moyer, M; Smith, JJ; Chesworth, R; Copeland, RA; Boriack-Sjodin, PA				Thomenius, Michael J.; Totman, Jennifer; Harvey, Darren; Mitchell, Lorna H.; Riera, Thomas, V; Cosmopoulos, Kat; Grassian, Alexandra R.; Klaus, Christine; Foley, Megan; Admirand, Elizabeth A.; Jahic, Haris; Majer, Christina; Wigle, Tim; Jacques, Suzanne L.; Gureasko, Jodi; Brach, Dorothy; Lingaraj, Trupti; West, Kip; Smith, Sherri; Rioux, Nathalie; Waters, Nigel J.; Tang, Cuyue; Raimondi, Alejandra; Munchhof, Michael; Mills, James E.; Ribich, Scott; Scott, Margaret Porter; Kuntz, Kevin W.; Janzen, William P.; Moyer, Mikel; Smith, Jesse J.; Chesworth, Richard; Copeland, Robert A.; Boriack-Sjodin, P. Ann			Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation	PLOS ONE			English	Article							LYSINE METHYLTRANSFERASE SMYD2; SELECTIVE INHIBITOR; GASTRIC-CANCER; UP-REGULATION; IN-VITRO; METHYLATION; MIGRATION; CARCINOMA; EXPRESSION; INVASION	A key challenge in the development of precision medicine is defining the phenotypic consequences of pharmacological modulation of specific target macromolecules. To address this issue, a variety of genetic, molecular and chemical tools can be used. All of these approaches can produce misleading results if the specificity of the tools is not well understood and the proper controls are not performed. In this paper we illustrate these general themes by providing detailed studies of small molecule inhibitors of the enzymatic activity of two members of the SMYD branch of the protein lysine methyltransferases, SMYD2 and SMYD3. We show that tool compounds as well as CRISPR/Cas9 fail to reproduce many of the cell proliferation findings associated with SMYD2 and SMYD3 inhibition previously obtained with RNAi based approaches and with early stage chemical probes.	[Thomenius, Michael J.; Totman, Jennifer; Harvey, Darren; Mitchell, Lorna H.; Riera, Thomas, V; Cosmopoulos, Kat; Grassian, Alexandra R.; Klaus, Christine; Foley, Megan; Admirand, Elizabeth A.; Jahic, Haris; Majer, Christina; Wigle, Tim; Jacques, Suzanne L.; Gureasko, Jodi; Brach, Dorothy; Lingaraj, Trupti; West, Kip; Smith, Sherri; Rioux, Nathalie; Waters, Nigel J.; Tang, Cuyue; Raimondi, Alejandra; Munchhof, Michael; Mills, James E.; Ribich, Scott; Scott, Margaret Porter; Kuntz, Kevin W.; Janzen, William P.; Moyer, Mikel; Smith, Jesse J.; Chesworth, Richard; Copeland, Robert A.; Boriack-Sjodin, P. Ann] Epizyme Inc, Cambridge, MA 02139 USA		Thomenius, MJ (corresponding author), Epizyme Inc, Cambridge, MA 02139 USA.	mthomenius@epizyme.com		Waters, Nigel/0000-0002-5063-295X	Epizyme Inc.	Epizyme Inc.	All work described in this manuscript was funded by Epizyme Inc. (www.epizyme.com) who provided support in the form of salaries for all authors and played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Bagislar S, 2016, ONCOTARGET, V7, P66398, DOI 10.18632/oncotarget.12012; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Chan-Penebre E, 2017, MOL CANCER THER, V16, P850, DOI 10.1158/1535-7163.MCT-16-0678; Chen LB, 2007, WORLD J GASTROENTERO, V13, P5718, DOI 10.3748/wjg.v13.i43.5718; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Cock-Rada AM, 2012, CANCER RES, V72, P810, DOI 10.1158/0008-5472.CAN-11-1052; Dong SW, 2014, ONCOL REP, V32, P1064, DOI 10.3892/or.2014.3307; Eggert E, 2016, J MED CHEM, V59, P4578, DOI 10.1021/acs.jmedchem.5b01890; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Fu ZQ, 2005, ACTA CRYSTALLOGR D, V61, P1643, DOI 10.1107/S0907444905033494; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Jiang YY, 2014, J MOL BIOL, V426, P3413, DOI 10.1016/j.jmb.2014.02.019; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Komatsu S, 2015, BRIT J CANCER, V112, P357, DOI 10.1038/bjc.2014.543; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Leinhart K, 2011, GENES-BASEL, V2, P210, DOI 10.3390/genes2010210; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Luo XG, 2007, J BIOSCI BIOENG, V103, P444, DOI 10.1263/jbb.103.444; Luo XG, 2010, IUBMB LIFE, V62, P194, DOI 10.1002/iub.288; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mitchell LH, 2016, ACS MED CHEM LETT, V7, P134, DOI 10.1021/acsmedchemlett.5b00272; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata DED, 2015, MUCOSAL IMMUNOL, V8, P1131, DOI 10.1038/mi.2015.4; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Olsen JB, 2016, MOL CELL PROTEOMICS, V15, P892, DOI 10.1074/mcp.M115.053280; Peserico A, 2015, J CELL PHYSIOL, V230, P2447, DOI 10.1002/jcp.24975; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Reynoird N, 2016, GENE DEV, V30, P772, DOI 10.1101/gad.275529.115; Sarris ME, 2016, CANCER CELL, V29, P354, DOI 10.1016/j.ccell.2016.01.013; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Skawran B, 2008, MODERN PATHOL, V21, P505, DOI 10.1038/modpathol.3800998; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; Sweis RF, 2015, ACS MED CHEM LETT, V6, P695, DOI 10.1021/acsmedchemlett.5b00124; Sakamoto LHT, 2014, LEUKEMIA RES, V38, P496, DOI 10.1016/j.leukres.2014.01.013; Van Aller GS, 2016, STRUCTURE, V24, P774, DOI 10.1016/j.str.2016.03.010; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Wang L, 2017, J GASTRIC CANCER, V17, P295, DOI 10.5230/jgc.2017.17.e33; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Wang SZ, 2008, BMB REP, V41, P294, DOI 10.5483/BMBRep.2008.41.4.294; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Xu GL, 2015, J BIOL CHEM, V290, P5414, DOI 10.1074/jbc.M114.610345; Zhu Y, 2016, HUM PATHOL, V52, P153, DOI 10.1016/j.humpath.2016.01.012; Zou JN, 2009, CANCER LETT, V280, P78, DOI 10.1016/j.canlet.2009.02.015	48	40	40	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197372	10.1371/journal.pone.0197372	http://dx.doi.org/10.1371/journal.pone.0197372			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856759	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800022
J	Yudkina, AV; Dvornikova, AP; Zharkov, DO				Yudkina, Anna, V; Dvornikova, Antonina P.; Zharkov, Dmitry O.			Variable termination sites of DNA polymerases encountering a DNA-protein cross-link	PLOS ONE			English	Article							BASE EXCISION-REPAIR; STRAND-DISPLACEMENT; GENOMIC INSTABILITY; REPLICATION BYPASS; ESCHERICHIA-COLI; LESION-BYPASS; MAJOR GROOVE; MECHANISM; BETA; PEPTIDE	DNA-protein cross-links (DPCs) are important DNA lesions induced by endogenous crosslinking agents such as formaldehyde or acetaldehyde, as well as ionizing radiation, cancer chemotherapeutic drugs, and abortive action of some enzymes. Due to their very bulky nature, they are expected to interfere with DNA and RNA synthesis and DNA repair. DPCs are highly genotoxic and the ability of cells to deal with them is relevant for many chemotherapeutic interventions. However, interactions of DNA polymerases with DPCs have been poorly studied due to the lack of a convenient experimental model. We have used NaBH4-induced trapping of E. coli formamidopyrimidine-DNA glycosylase with DNA to construct model DNA polymerase substrates containing a DPC in single-stranded template, or in the template strand of double-stranded DNA, or in the non-template (displaced) strand of double- stranded DNA. Nine DNA polymerases belonging to families A, B, X, and Y were studied with respect to their behavior upon encountering a DPC: Klenow fragment of E. coli DNA polymerase I, Thermus aquaticus DNA polymerase I, Pyrococcus furiosus DNA polymerase, Sulfolobus solfataricus DNA polymerase IV, human DNA polymerases beta, kappa and lambda, and DNA polymerases from bacteriophages T4 and RB69. Although none were able to fully bypass DPCs in any context, Family B DNA polymerases (T4, RB69) and Family Y DNA polymerase IV were able to elongate the primer up to the site of the cross-link if a DPC was located in single-stranded template or in the displaced strand. In other cases, DNA synthesis stopped 4-5 nucleotides before the site of the cross-link in single-stranded template or in double-stranded DNA if the polymerases could displace the downstream strand. We suggest that termination of DNA polymerases on a DPC is mostly due to the unrelieved conformational strain experienced by the enzyme when pressing against the cross-linked protein molecule.	[Yudkina, Anna, V; Dvornikova, Antonina P.; Zharkov, Dmitry O.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Lab Genome & Prot Engn, Novosibirsk, Russia; [Yudkina, Anna, V; Zharkov, Dmitry O.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University	Zharkov, DO (corresponding author), Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Lab Genome & Prot Engn, Novosibirsk, Russia.; Zharkov, DO (corresponding author), Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia.	dzharkov@niboch.nsc.ru	Zharkov, Dmitry/K-2158-2012; Yudkina, Anna/ABA-5710-2020	Zharkov, Dmitry/0000-0001-5013-0194; Yudkina, Anna/0000-0003-3682-3431; Dvornikova, Antonina/0000-0002-8863-9786	Russian Science Foundation [17-14-01190]; Russian State funded 2013-2020 budget project [VI.62.1.5, 0309-2016-0003]; Russian Ministry of Science and Education [6.5773.2017NU]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian State funded 2013-2020 budget project; Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation)	This research was supported by Russian Science Foundation (17-14-01190). Partial salary support from the Russian State funded 2013-2020 budget project (VI.62.1.5, 0309-2016-0003) and Russian Ministry of Science and Education (6.5773.2017NU) is acknowledged. The funders had no involvement in any part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J BIOL CHEM, V280, P3665, DOI [10.1074/jbc.M412922200, DOI 10.1074/JBC.M412922200]; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Belousova EA, 2015, DNA REPAIR, V29, P112, DOI 10.1016/j.dnarep.2015.02.001; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Ceska TA, 1998, TRENDS BIOCHEM SCI, V23, P331, DOI 10.1016/S0968-0004(98)01259-6; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Dorjsuren D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp641; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Garcia-Diaz M, 2005, DNA REPAIR, V4, P1358, DOI 10.1016/j.dnarep.2005.09.001; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Ishchenko AA, 2002, BIOCHEMISTRY-US, V41, P7540, DOI 10.1021/bi0121297; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Komori K, 2000, PROTEIN ENG, V13, P41, DOI 10.1093/protein/13.1.41; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Maskey RS, 2017, NUCLEIC ACIDS RES, V45, P4564, DOI 10.1093/nar/gkx107; Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; OLINSKI R, 1992, ARCH BIOCHEM BIOPHYS, V297, P139, DOI 10.1016/0003-9861(92)90651-C; Pata JD, 2010, BBA-PROTEINS PROTEOM, V1804, P1124, DOI 10.1016/j.bbapap.2010.01.020; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; PazElizur T, 1997, BIOCHEMISTRY-US, V36, P1766, DOI 10.1021/bi9621324; Podlutsky AJ, 2001, BIOCHEMISTRY-US, V40, P809, DOI 10.1021/bi002064s; Pomerantz RT, 2013, NAT STRUCT MOL BIOL, V20, P748, DOI 10.1038/nsmb.2573; PRASAD R, 1994, J BIOL CHEM, V269, P18096; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Ringquist S, 1998, METH MOL B, V77, P283; Rodriguez I, 2005, P NATL ACAD SCI USA, V102, P6407, DOI 10.1073/pnas.0500597102; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shibata Y, 2014, CURR BIOL, V24, pR463, DOI 10.1016/j.cub.2014.03.033; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Steitz TA, 2004, PHILOS T R SOC B, V359, P17, DOI 10.1098/rstb.2003.1374; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Stingele J, 2015, NAT REV MOL CELL BIO, V16, P455, DOI 10.1038/nrm4015; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; SUN B, 1995, J BIOL CHEM, V270, P19501, DOI 10.1074/jbc.270.33.19501; Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032; Villani G, 2011, J BIOL CHEM, V286, P32094, DOI 10.1074/jbc.M111.246611; Wickramaratne S, 2016, J BIOL CHEM, V291, P23589, DOI 10.1074/jbc.M116.745257; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Xia SL, 2014, BIOCHEMISTRY-US, V53, P2752, DOI 10.1021/bi4014215; Xu XY, 2008, J AM CHEM SOC, V130, P703, DOI 10.1021/ja077102a; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807	63	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198480	10.1371/journal.pone.0198480	http://dx.doi.org/10.1371/journal.pone.0198480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856874	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800128
J	Herstad, KMV; Moen, AEF; Gaby, JC; Moe, L; Skancke, E				Herstad, Kristin Marie Valand; Moen, Aina Elisabeth Fossum; Gaby, John Christian; Moe, Lars; Skancke, Ellen			Characterization of the fecal and mucosa-associated microbiota in dogs with colorectal epithelial tumors	PLOS ONE			English	Article							INVASIVE ESCHERICHIA-COLI; HUMAN GUT MICROBIOME; RIBOSOMAL-RNA; GRANULOMATOUS COLITIS; HEALTHY DOGS; CANINE; BACTERIAL; CANCER; COMMUNITIES; DISEASE	Colorectal epithelial tumors occur spontaneously in dogs, and the pathogenesis seems to parallel that of humans. The development of human colorectal tumorigenesis has been linked to alterations in the composition of the intestinal microbiota. This study characterized the fecal- and mucosa-associated microbiota in dogs with colorectal epithelial tumors (n = 10). The fecal microbiota was characterized by 16S rDNA analysis and compared with that of control dogs (n = 13). We also determined the mucosa-associated microbiota composition in colonic tumor tissue (n = 8) and in adjacent non-tumor tissue (n = 5) by 16S rDNA-and rRNA profiling. The fecal microbial community structure in dogs with tumors was different from that of control samples and was distinguished by oligotypes affiliated with Enterobacteriaceae, Bacteroides, Helicobacter, Porphyromonas, Peptostreptococcus and Streptococcus, and lower abundance of Ruminococcaceae, Slackia, Clostridium XI and Faecalibacterium. The overall community structure and populations of mucosal bacteria were not different based on either the 16S rDNA or the 16S rRNA profile in tumor tissue vs. adjacent non-tumor tissue. However, the proportion of live, potentially active bacteria appeared to be higher in non-tumor tissue compared with tumor tissue and included Slackia, Roseburia, unclass. Ruminococcaeceae, unclass. Lachnospiraceae and Oscillibacter. Colorectal tumors are rarely diagnosed in dogs, but despite this limitation, we were able to show that dogs with colorectal tumors have distinct fecal microbiota profiles. These initial results support the need for future case-control studies that are adequately powered, as well as age-matched and breed-matched, in order to evaluate the influence of bacteria on colorectal cancer etiopathogenesis and to determine whether the bacteria may have potential as biomarkers in clinical settings.	[Herstad, Kristin Marie Valand; Moe, Lars; Skancke, Ellen] Norwegian Univ Life Sci NMBU, Fac Vet Med, Dept Compan Anim Clin Sci, Oslo, Norway; [Moen, Aina Elisabeth Fossum] Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, Lorenskog, Norway; [Moen, Aina Elisabeth Fossum] Univ Oslo, Oslo, Norway; [Gaby, John Christian] Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, As, Norway	Norwegian University of Life Sciences; University of Oslo; University of Oslo; Norwegian University of Life Sciences	Herstad, KMV (corresponding author), Norwegian Univ Life Sci NMBU, Fac Vet Med, Dept Compan Anim Clin Sci, Oslo, Norway.	kristin.herstad@nmbu.no	Gaby, John/AAA-1219-2020; Moen, Aina/M-5209-2019	Gaby, John/0000-0003-2980-729X; Moen, Aina/0000-0002-1892-846X	Astri and Birger Torsted Foundation (KMVH); Pasteur Foundation	Astri and Birger Torsted Foundation (KMVH); Pasteur Foundation	The Astri and Birger Torsted Foundation (KMVH), httpl/www.legatsiden no/innhold/visettlegat.php?d=2298, the Norwegian research foundation for canine cancer, http//www.krefthoshund.no/ (KMVH) and the Pasteur Foundation, http://legeforeningen.no/Emner/Andre-emner/Fond-og-legater/Andre-legateri Pasteurlegatet/ (KMVH) provided financial support. Grant numbers were not available from these organisations.	Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Allen-Vercoe E, 2014, IMMUNOL LETT, V162, P54, DOI 10.1016/j.imlet.2014.05.014; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baxter NT, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0205-y; Beloshapka AN, 2013, FEMS MICROBIOL ECOL, V84, P532, DOI 10.1111/1574-6941.12081; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cassmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147321; Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607; CHEN Q, 2012, PLOS ONE, V7; Clarke KR, 2015, PRIMER V7 USER MANUA; Craven M, 2004, J SMALL ANIM PRACT, V45, P336, DOI 10.1111/j.1748-5827.2004.tb00245.x; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; DRESSMAN JB, 1986, PHARMACEUT RES, V3, P123, DOI 10.1023/A:1016353705970; Eaton KA, 1996, J CLIN MICROBIOL, V34, P3165, DOI 10.1128/JCM.34.12.3165-3170.1996; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595; Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501; Garcia-Mazcorro JF, 2017, PEERJ, V5, DOI 10.7717/peerj.3184; Gorbach SL, 1996, MED MICROBIOLOGY; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Gronvold AMR, 2010, FEMS MICROBIOL ECOL, V71, P313, DOI 10.1111/j.1574-6941.2009.00808.x; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hang I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-90; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Hassler S, 2008, EUR J EPIDEMIOL, V23, P273, DOI 10.1007/s10654-008-9232-8; Head K.W., 2003, HISTOLOGICAL CLASSIF; Herstad KMV, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1073-9; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Johnson RL, 2013, CANCER METAST REV, V32, P39, DOI 10.1007/s10555-012-9404-6; Jones Mary, 2007, World J Surg Oncol, V5, P51, DOI 10.1186/1477-7819-5-51; Kasiraj AC, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw085; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kozich J, 2013, MMISEQ WET LAB SOP; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Li QH, 2017, MBIO, V8, DOI [10.1128/mbio.01703-16, 10.1128/mBio.01703-16]; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Manchester AC, 2013, J VET INTERN MED, V27, P56, DOI 10.1111/jvim.12020; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; McEntee MF, 1999, VET PATHOL, V36, P228, DOI 10.1354/vp.36-3-228; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Moen Aina E F, 2016, BMC Res Notes, V9, P328, DOI 10.1186/s13104-016-2110-7; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727; Neiger R, 2000, J VET INTERN MED, V14, P125, DOI 10.1892/0891-6640(2000)014&lt;0125:IIDACF&gt;2.3.CO;2; Oh C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131468; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olson E, 2015, J VET INTERN MED J V; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Pericleous M, 2013, J GASTROINTEST ONCOL, V4, P409, DOI 10.3978/j.issn.2078-6891.2013.003; SCHAFFER E, 1968, J SMALL ANIM PRACT, V9, P491, DOI 10.1111/j.1748-5827.1968.tb04634.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2013, MISEQ SOP; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Tang J, 2010, GENOME RES, V20, P341, DOI 10.1101/gr.092726.109; Team RC, 2014, COMP RFFS; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Valerius KD, 1997, J AM ANIM HOSP ASSOC, V33, P156, DOI 10.5326/15473317-33-2-156; VANDERGAAG I, 1988, CAN J VET RES, V52, P75; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilke C.O., 2017, cowplot: Streamlined plot theme and plot annotations for ``ggplot2''. R package version 0.8.0; Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9; Youmans L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050813; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	92	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198342	10.1371/journal.pone.0198342	http://dx.doi.org/10.1371/journal.pone.0198342			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852000	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000433893200050
J	Milali, MP; Sikulu-Lord, MT; Kiware, SS; Dowell, FE; Povinelli, RJ; Corliss, GF				Milali, Masabho P.; Sikulu-Lord, Maggy T.; Kiware, Samson S.; Dowell, Floyd E.; Povinelli, Richard J.; Corliss, George F.			Do NIR spectra collected from laboratory-reared mosquitoes differ from those collected from wild mosquitoes?	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CLUSTERING-TECHNIQUES; AGE; MODELS; INSECTS; COMPLEX	Background Near infrared spectroscopy (NIRS) is a high throughput technique that measures absorbance of specific wavelengths of light by biological samples and uses this information to classify the age of lab-reared mosquitoes as younger or older than seven days with an average accuracy greater than 80%. For NIRS to estimate ages of wild mosquitoes, a sample of wild mosquitoes with known age in days would be required to train and test the model. Mark-release-recapture is the most reliable method to produce wild-caught mosquitoes of known age in days. However, it is logistically demanding, time inefficient, subject to low recapture rates, and raises ethical issues due to the release of mosquitoes. Using labels from Detinova dissection results in a mathematical model with poor accuracy. Alternatively, a model trained on spectra from laboratory-reared mosquitoes where age in days is known can be applied to estimate the age of wild mosquitoes, but this would be appropriate only if spectra collected from laboratory-reared and wild mosquitoes are similar. Methods and findings We performed k-means (k = 2) cluster analysis on a mixture of spectra collected from lab-reared and wild Anopheles arabiensis to determine if there is any significant difference between these two groups. While controlling the numbers of mosquitoes included in the model at each age, we found two clusters with no significant difference in distribution of spectra collected from lab-reared and wild mosquitoes (p = 0.25). We repeated the analysis using hierarchical clustering, and similarly, no significant difference was observed (p = 0.13). Conclusion We find no difference between spectra collected from laboratory-reared and wild mosquitoes of the same age and species. The results strengthen and support the on-going practice of applying the model trained on spectra collected from laboratory-reared mosquitoes, especially first-generation laboratory-reared mosquitoes.	[Milali, Masabho P.; Kiware, Samson S.] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Milali, Masabho P.; Kiware, Samson S.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Sikulu-Lord, Maggy T.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Dowell, Floyd E.] ARS, USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Povinelli, Richard J.; Corliss, George F.] Marquette Univ, Dept Elect & Comp Engn, Milwaukee, WI 53233 USA	Marquette University; Ifakara Health Institute; University of Queensland; United States Department of Agriculture (USDA); Marquette University	Milali, MP (corresponding author), Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA.; Milali, MP (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.	pmasabho@ihi.or.tz		Povinelli, Richard/0000-0001-8439-0146; Kiware, Samson/0000-0001-7252-520X	Grand Challenges Canada Stars for Global Health - government of Canada [043901]; Marquette University Graduate School	Grand Challenges Canada Stars for Global Health - government of Canada; Marquette University Graduate School	This study was funded by Grand Challenges Canada Stars for Global Health funded by the government of Canada grant 043901 awarded to MTSL and Marquette University Graduate School, for studentship awarded to MPM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich BT, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1801; ANIEDU I, 1989, J APPL ENTOMOL, V107, P387, DOI 10.1111/j.1439-0418.1989.tb00273.x; [Anonymous], J STAT SOFTWARE; Arthur D., 2007, P 18 ANN ACM SIAM S; Beklemishev W. N., 1959, Bulletin of the World Health Organization, V21, P223; Bokobza L, 1998, JOURNAL OF NEAR INFRARED SPECTROSCOPY, VOL 6 1998, P3, DOI 10.1255/jnirs.116; BRAZY JE, 1991, CLIN PERINATOL, V18, P519, DOI 10.1016/S0095-5108(18)30510-4; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Chen MH, 2008, J STAT PLAN INFER, V138, P387, DOI 10.1016/j.jspi.2007.06.007; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; DETINOVA TS, 1968, ANNU REV ENTOMOL, V13, P427, DOI 10.1146/annurev.en.13.010168.002235; Detinova TS, 1945, MED PARASITOLOGY, V14, P49; Dowell FE, 1999, J ECON ENTOMOL, V92, P165, DOI 10.1093/jee/92.1.165; Frahling G, 2008, INT J COMPUT GEOM AP, V18, P605, DOI 10.1142/S0218195908002787; Gomathi B, 2014, INT J ADV RES COMPUT, V5; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jong MCM de, 1995, MATH MODELLING VET E, P25; Kaufman L., 2009, FINDING GROUPS DATA; Kinable J, 2011, J COMPUT VIROL HACKI, V7, P233, DOI 10.1007/s11416-011-0151-y; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Krajacich BJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2501-1; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; Macdonald G., 1957, EPIDEMIOLOGY CONTROL, P201; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; Milali MP, 2016, THESIS, P377; Ng'habi KRN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-356; Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298; Parmigiani G, J ROYAL STAT SOC; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Perez-Mendoza J, 2004, J ECON ENTOMOL, V97, P1159, DOI 10.1603/0022-0493(2004)097[1159:CAOTSO]2.0.CO;2; Perez-Mendoza J, 2002, J MED ENTOMOL, V39, P499, DOI 10.1603/0022-2585-39.3.499; Poeter E, 2007, GROUND WATER, V45, P390, DOI 10.1111/j.1745-6584.2007.00350.x; Punitha SC, 2012, PROCEDIA ENGINEER, V30, P100, DOI 10.1016/j.proeng.2012.01.839; Reeves WK, 2010, MED VET ENTOMOL, V24, P32, DOI 10.1111/j.1365-2915.2009.00843.x; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sander J, 1998, DATA MIN KNOWL DISC, V2, P169, DOI 10.1023/A:1009745219419; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005040; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759; Soul JS, 1999, SEMINARS PEDIAT NEUR; Steinbach M., 2000, COMP DOCUMENT CLUSTE; Sterman JD, 2002, SYST DYNAM REV, V18, P501, DOI 10.1002/sdr.261; Struyf A, 1997, COMPUT STAT DATA AN, V26, P17, DOI 10.1016/S0167-9473(97)00020-0; SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126; Tan P., 2006, INTRO DATA MINING; Uttah E, 2013, INT J SCI RES PUBLIC, V3; Wagstaff K., 2001, CONSTRAINED K MEANS; Wit E, 2012, STAT NEERL, V66, P217, DOI 10.1111/j.1467-9574.2012.00530.x; Zhang Z., 2006, 18 INT C PATT REC IC; Zhu Y, 2014, INTERNATIONAL CONFERENCE ON ENERGY AND POWER ENGINEERING (EPE 2014), P1	53	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198245	10.1371/journal.pone.0198245	http://dx.doi.org/10.1371/journal.pone.0198245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851994	Green Submitted, gold, Green Published			2022-12-26	WOS:000433893200042
J	Wilson, L; Turkistani, FA; Huang, W; Tran, DM; Lin, TK				Wilson, Leslie; Turkistani, Fatema A.; Huang, Wei; Tran, Dang M.; Lin, Tracy Kuo			The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing	PLOS ONE			English	Article								Introduction California's Workers' Compensation System (CAWCS) Department of Industrial Relations questioned the adequacy of the current Medi-Cal fee-schedule pricing and requested analysis of alternatives that maximize price availability and maintain budget neutrality. Objectives To compare CAWCS pharmacy-dispensed (PD) drug prices under alternative fee schedules, and identify combinations of alternative benchmarks that have prices available for the largest percentage of PD drugs and that best reach budget neutrality. Methods Claims transaction-level data (2011-2013) from CAWCS were used to estimate total annual PD pharmaceutical payments. Medi-Cal pricing data was from the Workman's Compensation Insurance System (WCIS). Average Wholesale Prices (AWP), Wholesale Acquisition Costs (WAC), Direct Prices (DP), Federal Upper Limit (FUL) prices, and National Average Drug Acquisition Costs (NADAC) were from Medi-Span. We matched National Drug Codes (NDCs), pricing dates, and drug quantity for comparisons. We report pharmacy-dispensed (PD) claims frequency, reimbursement matching rate, and paid costs by CAWCS as the reference price against all alternative price benchmarks. Results Of 12,529,977 CAWCS claims for pharmaceutical products 11.6% (1,462,814) were for PD drugs. Prescription drug cost for CAWCS was over $152M; $63.9M, $47.9M, and $40.6M in 2011-2013. Ninety seven percent of these CAWCS PD claims had a Medi-Cal price. Alternative mechanisms provided a price for fewer claims; NADAC 94.23%, AWP 90.94%, FUL 73.11%, WAC 66.98%, and DP 14.33%. Among CAWCS drugs with no Medi-Cal price in PD claims, AWP, WAC, NADAC, DP, and FUL provided prices for 96.7%, 63.14%, 24.82%, 20.83%, and 15.08% of claims. Overall CAWCS paid 100.52% of Medi-Cal, 60% of AWP, 97% of WAC, 309.53% of FUL, 103.83% of DP, and 136.27% of NADAC. Conclusions CAWCS current Medi-Cal fee-schedule price list for PD drugs is more complete than all alternative fee-schedules. However, all reimbursement approaches would require combinations of pricing benchmarks. We suggest keeping primary reimbursement at 100% of Medi-Cal and for drugs without a primary Medi-Cal price calculating the maximum fee as 60% of AWP and then 97% of WAC. Alternatively, we suggest using NADAC as a primary fee schedule followed by either 60% AWP and 97% WAC or AWP-40% for drugs with no NADAC price. Fee-schedules may not offer the best price and a formulary approach may provide more flexibility.	[Wilson, Leslie; Turkistani, Fatema A.; Huang, Wei; Tran, Dang M.; Lin, Tracy Kuo] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Turkistani, Fatema A.] Taibah Univ, Coll Pharm, Dept Clin & Hosp Pharm, Al Madinah, Saudi Arabia; [Lin, Tracy Kuo] London Sch Econ & Polit Sci, Dept Social Policy, London, England	University of California System; University of California San Francisco; Taibah University; University of London; London School Economics & Political Science	Wilson, L (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.	Leslie.Wilson@ucsf.edu			California Department of Industrial Relations, Division of Workers' Compensation; California Division of Workers' Compensation	California Department of Industrial Relations, Division of Workers' Compensation; California Division of Workers' Compensation	Funded by California Department of Industrial Relations, Division of Workers' Compensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a contract with the California Division of Workers' Compensation and with data from CWCI. We thank Duyen-Anh Pham and Osama A. Shoair for their major contributions.	[Anonymous], 2004, MEDICAID MEDICARE DR; [Anonymous], MED US SPEND US REV; California Health Care Foundation, HLTH CAR WORKS ALL C; Center for Evidence-based Policy Medicaid Evidence-based Decisions Project (MED), 2016, MED SPEC DRUGS CURR; Center for Medicare and Medicaid Services, 2016, FED UPP LIM; Center for Medicare & Meddicaid Services, STAT PRESCR DRUG RES; Center for Medicare & Medicaid Services, SURV RET PRIC; Center of Medicare and Medicaid Services (CMS), 2013, METH CALC NAT AV DRU; Danzon P. M., 2014, ENCY HLTH EC, V3, P127; Division of Workers' Compensation, 2011, DIV WORK COMP EMPL I; Division of Workers' Compensation State of California, DIV WORK COMP INJ WO; Express Scripts, 2015, DRUG TREND REP; Fein AJ, NADAC MOMENTUM CALIF; Gencarelli DM, 2002, NAT HLTH POL FOR JUN; Hartman M, 2018, HEALTH AFFAIR, V37, P150, DOI 10.1377/hlthaff.2017.1299; Healthcare Solutions, 2014, WORKCOMPWIRE; Kuschner Beth, 2006, Case Manager, V17, P63, DOI 10.1016/j.casemgr.2006.07.003; Levinson DR, 2013, MEDICAID DRUG PRICIN; Messer M., 2012, ANAL DRUG PRICING ME; Microsoft Office, EXC 2013 QUICK START; Millman Inc, 2015, MILLM MED IND RES RE; System CW, 2015, C CHRONICLES; Tag H, 2013, AMCP GUIDE PHARM PAY; Victor RA, 2006, COST USE PHARM WORKE; Wei A, 2014, CHSWC 2014 ANN REPOR; Wilson L, 2005, AM J IND MED, V48, P239, DOI 10.1002/ajim.20208; Wolters Kluwer, MED SPAN PRIC RX; Workers' Compensation Insurance Rating Bureau of California, 2016, WCIRB REP STAT CAL W; Wynn BO, 2016, IMPLEMENTING DRUG FO	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197449	10.1371/journal.pone.0197449	http://dx.doi.org/10.1371/journal.pone.0197449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799850	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400011
J	Chen, X; Li, LY; Jiang, JL; Li, K; Su, ZB; Zhang, FQ; Zhang, WJ; Zhao, GQ				Chen, Xi; Li, Long-Yun; Jiang, Jin-Lan; Li, Kai; Su, Zhen-Bo; Zhang, Fu-Qiang; Zhang, Wen-Jing; Zhao, Guo-Qing			Propofol elicits autophagy via endoplasmic reticulum stress and calcium exchange in C2C12 myoblast cell line	PLOS ONE			English	Article							OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; IN-VITRO; RATS; PROLIFERATION; ANTIOXIDANTS; DYSFUNCTION; ANESTHETICS; INHIBITION; INDUCTION	In this study, we investigated the relationship between propofol and autophagy and examined whether this relationship depends on ER stress, production of ROS (reactive oxygen species), and disruption of calcium (Ca2+) homeostasis. To this end, we measured C2C12 cell apoptosis in vitro, along with Ca2+ levels; ROS production; and expression of proteins and genes associated with autophagy, Ca(2+ )homeostasis, and ER stress, including LC3 (microtubule-associate protein 1 light chain 3), p62, AMPK (adenosine 5'-monophosphate (AMP)-activated protein kinase), phosphorylated AMPK, mTOR (the mammalian target of rapamycin), phosphorylated mTOR, CHOP (C/BEP homologous protein), and Grp78/Bip (78 kDa glucose-regulated protein). We found that propofol treatment induced autophagy, ER stress, and Ca2+ release. The ratio of phosphorylated AMPK to AMPK increased, whereas the ratio of phosphorylated mTOR to mTOR decreased. Collectively, the data suggested that propofol induced autophagy in vitro through ER stress, resulting in elevated ROS and Ca2+. Additionally, co-administration of an ER stress inhibitor blunted the effect of propofol.	[Chen, Xi; Li, Long-Yun; Li, Kai; Su, Zhen-Bo; Zhang, Wen-Jing; Zhao, Guo-Qing] Jilin Univ, China Japan Union Hosp, Dept Anesthesiol, Changchun, Jilin, Peoples R China; [Jiang, Jin-Lan; Zhang, Fu-Qiang] Jilin Univ, China Japan Union Hosp, Dept Res Ctr, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Zhao, GQ (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Anesthesiol, Changchun, Jilin, Peoples R China.	guoqingzhao1965@163.com			Jilin Province for Creative Veterinary Science Research	Jilin Province for Creative Veterinary Science Research	Jilin Province for Creative Veterinary Science Research to GQZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Balyasnikova IV, 2005, ANESTH ANALG, V100, P929, DOI 10.1213/01.ANE.0000147707.49192.88; Basu S, 2001, RESUSCITATION, V50, P341, DOI 10.1016/S0300-9572(01)00351-3; Cali T, 2013, BBA-MOL BASIS DIS, V1832, P495, DOI 10.1016/j.bbadis.2013.01.004; Chang CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028323; Chen RM, 2003, ANESTHESIOLOGY, V98, P1178, DOI 10.1097/00000542-200305000-00021; Cui WY, 2011, CLIN EXP PHARMACOL P, V38, P747, DOI 10.1111/j.1440-1681.2011.05584.x; Culley DJ, 2013, BRIT J ANAESTH, V110, P19, DOI 10.1093/bja/aet169; Culley DJ, 2007, CURR OPIN ANESTHESIO, V20, P408, DOI 10.1097/ACO.0b013e3282efd18b; Decuypere JP, 2011, AUTOPHAGY, V7, P1472, DOI 10.4161/auto.7.12.17909; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Frohlich D, 2006, EUR J ANAESTH, V23, P948, DOI 10.1017/S0265021506000822; Gao J, 2006, INFLAMM RES, V55, P385, DOI 10.1007/s00011-006-5116-0; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Jawan B, 2008, TOXICOL APPL PHARM, V229, P362, DOI 10.1016/j.taap.2008.01.044; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karashima Y, 2002, BRIT J PHARMACOL, V137, P683, DOI 10.1038/sj.bjp.0704912; Kashiwagi A, 2015, ANESTHESIOLOGY, V122, P1075, DOI 10.1097/ALN.0000000000000561; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Leitzke AS, 2013, STROKE, V44, P3587, DOI 10.1161/STROKEAHA.113.001988; Li Y, 2013, ACTA ANAESTH SCAND, V57, P380, DOI 10.1111/aas.12018; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Meng QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033053; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Noh HS, 2010, MOL CELLS, V30, P455, DOI 10.1007/s10059-010-0130-z; Ou X, 2014, STEM CELLS, V32, P1183, DOI 10.1002/stem.1641; Panzhinskiy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077228; Peropadre A, 2011, CHEM RES TOXICOL, V24, P185, DOI 10.1021/tx100262c; Ren GY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11607-0; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Shiomi M, 2014, J ANESTH, V28, P593, DOI 10.1007/s00540-013-1755-9; Simpson RS, 2013, ANAESTH INTENS CARE, V41, P805; van Vliet AR, 2014, BBA-MOL CELL RES, V1843, P2253, DOI 10.1016/j.bbamcr.2014.03.009; Volti GL, 2008, CLIN TER, V159, P463; Wang DT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/684965; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Wu QC, 2018, CAN J PHYSIOL PHARM, V96, DOI 10.1139/cjpp-2017-0243; Xie J, 2009, CANCER LETT, V282, P35, DOI 10.1016/j.canlet.2009.02.055; Young C, 2000, CRIT CARE MED, V28, P854, DOI 10.1097/00003246-200003000-00041; Yu KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131208; Zhou J, 2012, AUTOPHAGY, V8, P338, DOI 10.4161/auto.18721	48	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197934	10.1371/journal.pone.0197934	http://dx.doi.org/10.1371/journal.pone.0197934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795639	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300099
J	Fragkakis, EM; El-Jawhari, JJ; Dunsmuir, RA; Millner, PA; Rao, AS; Henshaw, KT; Pountos, I; Jones, E; Giannoudis, PV				Fragkakis, Evangelos M.; El-Jawhari, Jehan Jomaa; Dunsmuir, Robert A.; Millner, Peter A.; Rao, Abhay S.; Henshaw, Karen T.; Pountos, Ippokratis; Jones, Elena; Giannoudis, Peter V.			Vertebral body versus iliac crest bone marrow as a source of multipotential stromal cells: Comparison of processing techniques, tri-lineage differentiation and application on a scaffold for spine fusion	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PHENOTYPIC CHARACTERIZATION; OSTEOPROGENITOR CELLS; CULTURE-CONDITIONS; PROGENITOR CELLS; LUMBAR; AUTOGRAFT; TISSUE; PROLIFERATION; OPTIMIZATION	The potential use of bone progenitors, multipotential stromal cells (MSCs) helping spine fusion is increasing, but convenient MSC sources and effective processing methods are critical factors yet to be optimised. The aim of this study was to test the effect of bone marrow processing on the MSC abundance and to compare the differentiation capabilities of vertebral body-bone marrow (VB-BM) MSCs versus iliac crest-bone marrow (IC-BM) MSCs. We assessed the effect of the red blood cell lysis (ammonium chloride, AC) and density-gradient centrifugation (Lymphoprep (TM) LMP), on the extracted VB-BM and IC-BM MSC numbers. The MSC abundance (indicated by colony counts and CD45(low)CD271(high) cell numbers), phenotype, proliferation and tri-lineage differentiation of VB-BM MSCs were compared with donor-matched IC-BM MSCs. Importantly, the MSC attachment and osteogenesis were examined when VB-BM and IC-BM samples were loaded on a beta-tricalcium phosphate scaffold. In contrast to LMP, using AC yielded more colonies from IC-BM and VB-BM aspirates (p = 0.0019 & p = 0.0201 respectively). For IC-BM and VB-BM, the colony counts and CD45(low)CD271(high) cell numbers were comparable (p = 0.5186, p = 0.2640 respectively). Furthermore, cultured VB-BM MSCs exhibited the same phenotype, proliferative and adipogenic potential, but a higher osteogenic and chondrogenic capabilities than IC-BM MSCs (p = 0.0010 and p = 0.0005 for calcium and glycosaminoglycan (GAG) levels, respectively). The gene expression data confirmed higher chondrogenesis for VB-BM MSCs than IC-BM MSCs, but osteogenic gene expression levels were comparable. When loaded on Vitoss (TM) both MSCs showed a similar degree of attachment and survival, but a better osteogenic ability was detected for VB-BM MSCs as measured by alkaline phosphatase activity (p = 0.0386). Collectively, the BM processing using AC had more MSC yield than using LMP. VB-BM MSCs have a comparable phenotype and proliferative capacity, but higher chondrogenesis and osteogenesis with or without using scaffold than donor-matched IC-BM MSCs. Given better accessibility, VB-BM could be an ideal MSC source for spinal bone fusion.	[Fragkakis, Evangelos M.; El-Jawhari, Jehan Jomaa; Henshaw, Karen T.; Jones, Elena; Giannoudis, Peter V.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Fragkakis, Evangelos M.; Dunsmuir, Robert A.; Millner, Peter A.; Rao, Abhay S.] Leeds Teaching Hosp NHS Trust, Leeds Dept Neurosci, Leeds, W Yorkshire, England; [El-Jawhari, Jehan Jomaa] Mansoura Univ, Fac Med, Dept Clin Pathol, Mansoura, Egypt; [Pountos, Ippokratis; Giannoudis, Peter V.] Leeds Teaching Hosp NHS Trust, Acad Unit Trauma & Orthopaed Surg, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; Egyptian Knowledge Bank (EKB); Mansoura University; University of Leeds	Giannoudis, PV (corresponding author), Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.; Giannoudis, PV (corresponding author), Leeds Teaching Hosp NHS Trust, Acad Unit Trauma & Orthopaed Surg, Leeds, W Yorkshire, England.	P.Giannoudis@leeds.ac.uk	Pountos, Ippokratis/AAB-5697-2019; Giannoudis, Peter/AAA-3617-2020; El-Jawhari, Jehan/C-6880-2017; Jones, Elena/AAL-2818-2021	Pountos, Ippokratis/0000-0002-0050-5151; Giannoudis, Peter/0000-0002-5205-7696; El-Jawhari, Jehan/0000-0002-0580-4492; Jones, Elena/0000-0001-9365-2283	Italian Society of Trauma and Orthopaedics, SIOT; Yorkshire Children's Spine Foundation	Italian Society of Trauma and Orthopaedics, SIOT; Yorkshire Children's Spine Foundation	This study was funded by the Italian Society of Trauma and Orthopaedics, SIOT, (second-level scholarship grant) and by the Yorkshire Children's Spine Foundation, covering mainly laboratory bench fees and reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbah SA, 2011, SPINE, V36, P1752, DOI 10.1097/BRS.0b013e31822576a4; Ahrens N, 2004, TRANSPLANTATION, V78, P925, DOI 10.1097/01.tp.0000133305.81823.2a; Baboola TG, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4574; Brodano GB, 2012, EUR SPINE J, V21, pS3, DOI 10.1007/s00586-012-2233-z; Brodano GB, 2013, EUR SPINE J, V22, pS979, DOI 10.1007/s00586-013-3028-6; Carrancio S, 2008, EXP HEMATOL, V36, P1014, DOI 10.1016/j.exphem.2008.03.012; Churchman SM, 2012, ARTHRITIS RHEUM-US, V64, P2632, DOI 10.1002/art.34434; Cox G, 2012, BONE, V50, P510, DOI 10.1016/j.bone.2011.07.016; Cuthbert R, 2012, CYTOTHERAPY, V14, P431, DOI 10.3109/14653249.2011.651533; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Dai LY, 2008, SPINE, V33, P1299, DOI 10.1097/BRS.0b013e3181732a8e; Dal Pozzo S, 2010, CYTOTHERAPY, V12, P579, DOI 10.3109/14653241003709660; de Almeida DC, 2016, STEM CELL REP, V6, P168, DOI 10.1016/j.stemcr.2016.01.003; Defino HLA, 2009, SPINE, V34, P1549, DOI 10.1097/BRS.0b013e3181a9c087; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; El-Jawhari JJ, 2017, J BONE JOINT SURG AM, V99, P1305, DOI 10.2106/JBJS.16.01138; El-Jawhari JJ, 2016, J ORTHOP RES, V34, P597, DOI 10.1002/jor.23070; Epstein NE, 2008, SPINE J, V8, P882, DOI 10.1016/j.spinee.2007.11.005; Espagnolle N, 2014, J CELL MOL MED, V18, P104, DOI 10.1111/jcmm.12168; Faundez Antonio A, 2006, Eur Spine J, V15 Suppl 5, P630, DOI 10.1007/s00586-006-0162-4; Fogel Guy R, 2006, Spine J, V6, P421, DOI 10.1016/j.spinee.2005.09.011; Fontes CRP.A., 1994, METHODS CELL TRANS H; Gao Chunyang, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P115; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hernigou P, 2013, INT ORTHOP, V37, P2279, DOI 10.1007/s00264-013-2017-z; Horn P, 2011, METHODS MOL BIOL, V698, P23, DOI 10.1007/978-1-60761-999-4_3; Jager Marcus, 2010, Orthop Rev (Pavia), V2, pe20, DOI 10.4081/or.2010.e20; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; Kang J, 2012, SPINE, V37, P1083, DOI 10.1097/BRS.0b013e31823ed817; Khashan M, 2013, SPINE, V38, P1885, DOI 10.1097/BRS.0b013e3182a3d7dc; Kouroupis D, 2013, J ORTHOP RES, V31, P1950, DOI 10.1002/jor.22438; Kruyt MC, 2004, BIOMATERIALS, V25, P1463, DOI 10.1016/S0142-9612(03)00490-3; Le Huec J C, 1997, Acta Orthop Belg, V63, P202; Lotfy Ahmed, 2014, International Journal of Stem Cells, V7, P135, DOI 10.15283/ijsc.2014.7.2.135; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Mansilla E., 2013, J TRANSPLANT TECHNOL, V3, P118, DOI [DOI 10.4172/2161-0991.1000118, 10.4172/2161-0991.1000118]; McLain RF, 2005, J BONE JOINT SURG AM, V87A, P2655, DOI 10.2106/JBJS.E.00230; McLain RF, 2009, SPINE J, V9, P995, DOI 10.1016/j.spinee.2009.08.455; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Min WK, 2010, EUR SPINE J, V19, P1753, DOI 10.1007/s00586-010-1424-8; Nakai T, 2016, J ORTHOP RES, V34, P1361, DOI 10.1002/jor.23326; Niu CC, 2009, SPINE, V34, P2715, DOI 10.1097/BRS.0b013e3181b47232; Risbud MV, 2006, SPINE, V31, P83, DOI 10.1097/01.brs.0000193891.71672.e4; Romih M, 2005, EUR SPINE J, V14, P645, DOI 10.1007/s00586-004-0827-9; Rosset P, 2014, ORTHOP TRAUMATOL-SUR, V100, pS107, DOI 10.1016/j.otsr.2013.11.010; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Shim EK, 2016, CELL TRANSPLANTATION; Shriver MF, 2015, SPINE J, V15, P2016, DOI 10.1016/j.spinee.2015.05.010; Steib JP, 2000, REV CHIR ORTHOP, V86, P127; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x; Watkins R, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000275; Yoshikawa T, 2010, SPINE, V35, pE475, DOI 10.1097/BRS.0b013e3181cd2cf4	56	18	18	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197969	10.1371/journal.pone.0197969	http://dx.doi.org/10.1371/journal.pone.0197969			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795650	Green Published, gold			2022-12-26	WOS:000433084300107
J	Silagi, ML; Radanovic, M; Conforto, AB; Mendonca, LIZ; Mansur, LL				Silagi, Marcela Lima; Radanovic, Marcia; Conforto, Adriana Bastos; Zanotto Mendonca, Lucia Iracema; Mansur, Leticia Lessa			Inference comprehension in text reading: Performance of individuals with right- versus left-hemisphere lesions and the influence of cognitive functions	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; MINI-MENTAL-STATE; DISCOURSE; MECHANISMS; GENERATION; DAMAGE	Background Right-hemisphere lesions (RHL) may impair inference comprehension. However, comparative studies between left-hemisphere lesions (LHL) and RHL are rare, especially regarding reading comprehension. Moreover, further knowledge of the influence of cognition on inferential processing in this task is needed. Objectives To compare the performance of patients with RHL and LHL on an inference reading comprehension task. We also aimed to analyze the effects of lesion site and to verify correlations between cognitive functions and performance on the task. Methods Seventy-five subjects were equally divided into the groups RHL, LHL, and control group (CG). The Implicit Management Test was used to evaluate inference comprehension. In this test, subjects read short written passages and subsequently answer five types of questions (explicit, logical, distractor, pragmatic, and other), which require different types of inferential reasoning. The cognitive functional domains of attention, memory, executive functions, language, and visuospatial abilities were assessed using the Cognitive Linguistic Quick Test (CLQT). Results The LHL and RHL groups presented difficulties in inferential comprehension in comparison with the CG. However, the RHL group presented lower scores than the LHL group on logical, pragmatic and otherquestions. A covariance analysis did not show any effect of lesion site within the hemispheres. Overall, all cognitive domains were correlated with all the types of questions from the inference test (especially logical, pragmatic, and other). Attention and visuospatial abilities affected the scores of both the RHL and LHL groups, and only memory influenced the performance of the RHL group. Conclusions Lesions in either hemisphere may cause difficulties in making inferences during reading. However, processing more complex inferences was more difficult for patients with RHL than for those with LHL, which suggests that the right hemisphere plays an important role in tasks with higher comprehension demands. Cognition influences inferential processing during reading in brain-injured subjects.	[Silagi, Marcela Lima; Mansur, Leticia Lessa] Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Audiol, Sao Paulo, Brazil; [Radanovic, Marcia] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Conforto, Adriana Bastos; Zanotto Mendonca, Lucia Iracema] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Silagi, ML (corresponding author), Univ Sao Paulo, Sch Med, Dept Phys Therapy Speech Language Pathol & Audiol, Sao Paulo, Brazil.	marcela_silagi@hotmail.com	Radanovic, Marcia/F-9325-2012; Silagi, Marcela/D-6650-2019; Conforto, Adriana Bastos/C-9371-2014	Radanovic, Marcia/0000-0002-3256-6397; Conforto, Adriana Bastos/0000-0001-7869-3490				Bailey HR, 2017, MEM COGNITION, V45, P940, DOI 10.3758/s13421-017-0707-2; BEEMAN M, 1993, BRAIN LANG, V44, P80, DOI 10.1006/brln.1993.1006; Blake ML, 2009, J SPEECH LANG HEAR R, V52, P373, DOI 10.1044/1092-4388(2009/07-0172); BROWNELL HH, 1986, BRAIN LANG, V27, P310, DOI 10.1016/0093-934X(86)90022-2; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Carriedo N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150289; Casarin F.S., 2014, BATERIA MONTREAL AVA; Duchene May-Carle A., 2000, GESTION LIMPLICITE; Federmeier KD, 2008, LANG LINGUIST COMPAS, V2, P1, DOI 10.1111/j.1749-818x.2007.00042.x; FERSTL EC, 2007, HIGHER LEVEL LANGUAG; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friese U, 2008, J COGNITIVE NEUROSCI, V20, P2110, DOI 10.1162/jocn.2008.20141; Goel V, 2007, CEREB CORTEX, V17, P2245, DOI 10.1093/cercor/bhl132; Goodglass H, 2001, ASSESSMENT APHASIA R, V3rd; Gouldthorp B, 2015, LATERALITY, V20, P348, DOI 10.1080/1357650X.2014.979194; Gutierrez- Calvo M., 1999, PSICOLINGUISTICA ESP; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harvey H, 2017, J EXP PSYCHOL HUMAN, V43, P518, DOI 10.1037/xhp0000329; Helm Estabrooks N, 2001, COGNITIVE LINGUISTIC; Hielscher M, 2004, FOLIA PHONIATR LOGO, V56, P14, DOI 10.1159/000075325; Jang G, 2013, NEUROIMAGE, V81, P61, DOI 10.1016/j.neuroimage.2013.05.027; Jin H, 2009, INT J PSYCHOPHYSIOL, V71, P142, DOI 10.1016/j.ijpsycho.2008.08.009; Marini A, 2012, SEMIN SPEECH LANG, V33, P68, DOI 10.1055/s-0031-1301164; Mason RA, 2004, PSYCHOL SCI, V15, P1, DOI 10.1111/j.0963-7214.2004.01501001.x; McDonald S, 2000, BRAIN LANG, V75, P82, DOI 10.1006/brln.2000.2342; Moreno R.A, 1998, REV PSIQ CLIN, V25, P50; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olkoniemi H, 2016, J EXP PSYCHOL LEARN, V42, P433, DOI 10.1037/xlm0000176; Barreyro JP, 2012, SPAN J PSYCHOL, V15, P471, DOI 10.5209/rev_SJOP.2012.v15.n2.38857; Perfetti CA, 2008, HDB NEUROSCIENCE LAN; Powers C, 2012, NEUROPSYCHOLOGIA, V50, P2577, DOI 10.1016/j.neuropsychologia.2012.07.008; Saldert C, 2007, CLIN LINGUIST PHONET, V21, P637, DOI 10.1080/02699200701431056; Sarter M, 1996, AM PSYCHOL, V51, P13, DOI 10.1037/0003-066X.51.1.13; Silagi ML, 2014, CODAS, V26, P407, DOI 10.1590/2317-1782/20142013058; Smith GE, 2003, MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER'S DISEASE, P63; Sperber Dan, 1986, RELEVANCE COMMUNICAT, V142; Sundermeier BA, 2005, BRAIN LANG, V95, P402, DOI 10.1016/j.bandl.2005.03.005; Tompkins CA, 2001, J SPEECH LANG HEAR R, V44, P400, DOI 10.1044/1092-4388(2001/033); van Dijk T., 1983, STRATEGIES DISCOURSE; Virtue S, 2005, BRAIN LANG, V93, P327, DOI 10.1016/j.bandl.2004.10.012; Virtue S, 2008, J COGNITIVE NEUROSCI, V20, P2274, DOI 10.1162/jocn.2008.20160; Virtue S, 2006, MEM COGNITION, V34, P1341, DOI 10.3758/BF03193276; Virtue S, 2006, BRAIN RES, V1084, P104, DOI 10.1016/j.brainres.2006.02.053; Virtue S, 2012, LATERALITY, V17, P549, DOI 10.1080/1357650X.2011.586781; Westby C, 2004, FOLIA PHONIATR LOGO, V56, P254, DOI 10.1159/000078345; Yeari M, 2015, MEMORY, V23, P1193, DOI 10.1080/09658211.2014.968169	47	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197195	10.1371/journal.pone.0197195	http://dx.doi.org/10.1371/journal.pone.0197195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795602	Green Submitted, gold, Green Published			2022-12-26	WOS:000433084300030
J	Vallino Costassa, E; D'Angelo, A; Mazza, M; Meloni, D; Baioni, E; Maurella, C; Colussi, S; Martinelli, N; Lo Faro, M; Berrone, E; Favole, A; Crociara, P; Grifoni, S; Gallo, M; Lombardi, G; Iulini, B; Casalone, C; Corona, C				Vallino Costassa, Elena; D'Angelo, Antonio; Mazza, Maria; Meloni, Daniela; Baioni, Elisa; Maurella, Cristiana; Colussi, Silvia; Martinelli, Nicola; Lo Faro, Monica; Berrone, Elena; Favole, Alessandra; Crociara, Paola; Grifoni, Silvia; Gallo, Marina; Lombardi, Guerino; Iulini, Barbara; Casalone, Cristina; Corona, Cristiano			Clinical, pathological, and molecular features of classical and L-type atypical-BSE in goats	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; ABNORMAL PRION PROTEIN; EXPERIMENTAL TRANSMISSION; NATURAL SCRAPIE; SHEEP SCRAPIE; ACCUMULATION; PHENOTYPES; INFECTION; PRP; IDENTIFICATION	Monitoring of small ruminants for transmissible spongiform encephalopathies (TSEs) has recently become more relevant after two natural scrapie suspected cases of goats were found to be positive for classical BSE (C-BSE). C-BSE probably established itself in this species unrecognized, undermining disease control measures. This opens the possibility that TSEs in goats may remain an animal source for human prion diseases. Currently, there are no data regarding the natural presence of the atypical BSE in caprines. Here we report that C-BSE and L-type atypical BSE (L-BSE) isolates from bovine species are intracerebrally transmissible to goats, with a 100% attack rate and a significantly shorter incubation period and survival time after C-BSE than after L-BSE experimental infection, suggesting a lower species barrier for classical agentin goat. All animals showed nearly the same clinical features of disease characterized by skin lesions, including broken hair and alopecia, and abnormal mental status. Histology and immunohistochemistry showed several differences between C-BSE and L-BSE infection, allowing discrimination between the two different strains. The lymphoreticular involvement we observed in the C-BSE positive goats argues in favour of a peripheral distribution of PrPSc similar to classical scrapie. Western blot and other currently approved screening tests detected both strains in the goats and were able to classify negative control animals. These data demonstrate that active surveillance of small ruminants, as applied to fallen stock and/or healthy slaughter populations in European countries, is able to correctly identify and classify classical and L-BSE and ultimately protect public health.	[Vallino Costassa, Elena; Mazza, Maria; Meloni, Daniela; Baioni, Elisa; Maurella, Cristiana; Colussi, Silvia; Lo Faro, Monica; Berrone, Elena; Favole, Alessandra; Crociara, Paola; Grifoni, Silvia; Gallo, Marina; Iulini, Barbara; Casalone, Cristina; Corona, Cristiano] CEA, Ctr Anim Encephalopathies, Ist Zooprofilatt Sperimentale Piemonte Liguria, Turin, Italy; [D'Angelo, Antonio] Univ Turin, Sez Clin Med, Dipartimento Sci Vet, Grugliasco, Turin, Italy; [Martinelli, Nicola; Lombardi, Guerino] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy	IZS Piemonte Liguria e Valle D'aosta; University of Turin; IZS Lombardia e Emilia	Corona, C (corresponding author), CEA, Ctr Anim Encephalopathies, Ist Zooprofilatt Sperimentale Piemonte Liguria, Turin, Italy.	cristiano.corona@izsto.it	Crociara, Paola/N-4862-2019; Favole, Alessandra/I-4775-2018; Costassa, Elena Vallino/N-7639-2019; Berrone, Elena/N-4826-2019	Crociara, Paola/0000-0001-7446-1609; Favole, Alessandra/0000-0003-4110-4327; Costassa, Elena Vallino/0000-0001-8582-1294; Berrone, Elena/0000-0002-1731-4810; Lombardi, Guerino/0000-0003-0977-5761; D'ANGELO, Antonio/0000-0002-5924-8882; maurella, cristiana/0000-0003-3481-8380	Italian Ministry of Health [IZSPLV04/13RC, RF-2013-02354884]	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by Italian Ministry of Health grants IZSPLV04/13RC to Dr. C. Corona and RF-2013-02354884 to Dr. C. Casalone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acutis PL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-8; Acutis PL, 2004, J GEN VIROL, V85, P3165, DOI 10.1099/vir.0.80053-0; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Braun U, 1997, SCHWEIZ ARCH TIERH, V139, P35; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; D'Angelo A, 2007, VET J, V174, P106, DOI 10.1016/j.tvjl.2006.04.007; Dustan BH, 2008, VET PATHOL, V45, P443, DOI 10.1354/vp.45-4-443; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; Goldmann W, 1996, NATURE, V382, P32, DOI 10.1038/382032b0; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; HADLOW W. J., 1961, RES VET SCI, V2, P289; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hardt M, 2000, J COMP PATHOL, V122, P43, DOI 10.1053/jcpa.1999.0343; Heggebo R, 2002, J GEN VIROL, V83, P479, DOI 10.1099/0022-1317-83-2-479; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Jeffrey M, 2006, J COMP PATHOL, V134, P171, DOI 10.1016/j.jcpa.2005.10.003; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Konold T, 2007, VET REC, V161, P395, DOI 10.1136/vr.161.11.395-d; Konold T, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-13; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-16; Ligios C, 2002, J COMP PATHOL, V127, P45, DOI 10.1053/jcpa.2002.0589; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; Matsuura Y, 2013, J COMP PATHOL, V149, P113, DOI 10.1016/j.jcpa.2012.11.231; Meloni D, 2017, J VET DIAGN INVEST, V29, P232, DOI 10.1177/1040638716688045; Meloni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043133; Nicot S, 2014, J INFECT DIS, V209, P950, DOI 10.1093/infdis/jit596; Nonno R, 2008, ABSTR PRION C; Schreuder BEC, 1996, NATURE, V381, P563, DOI 10.1038/381563a0; Simmons MM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0394-1; Spiropoulos J, 2011, EMERG INFECT DIS, V17, P2253, DOI 10.3201/eid1712.110333; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; van Keulen LJM, 2002, APMIS, V110, P23, DOI 10.1034/j.1600-0463.2002.100104.x; Wells GAH, 1991, BRAIN PATHOL, V1, P69, DOI 10.1111/j.1750-3639.1991.tb00642.x	46	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198037	10.1371/journal.pone.0198037	http://dx.doi.org/10.1371/journal.pone.0198037			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795663	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300120
J	Zhang, P; Zeng, D; Yi, YL; Tang, YY; Zou, W; Yang, XF; Wang, CY; Tang, XQ				Zhang, Ping; Zeng, Dan; Yi, Yi-Li; Tang, Yi-Yun; Zou, Wei; Yang, Xue-Feng; Wang, Chun-Yan; Tang, Xiao-Qing			beta 2-microglobulin induces depressive- and anxiety-like behaviors in rat	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; CHRONIC ANTIDEPRESSANT TREATMENT; TAIL SUSPENSION TEST; ANIMAL-MODEL; ANTIGEN PRESENTATION; T-CELLS; MICE; DISORDERS; BIOMARKERS; DEFICIENT	beta 2-microglobulin (B2M), the light chain of major histocompatibility complex class I (MHC I) molecules, has been found to impair hippocampal neurogenesis. Based on the crucial role of hippocampal neurogenesis disturbance in the process of depression and anxiety, the aim of the present study is to investigate whether B2M leads to depressive-and anxiety-like behaviors. We found that 6 days after intracerebroventricular injection with B2M (0.3 mu g), the immobility times of rats in the tail suspension test and the forced swimming test were increased, the swimming and climbing time in the forced swimming test was decreased, and the latency to feed in the novelty-suppressed feeding test was increased, indicating that B2M induces depressive-like behaviors. In addition, in the elevated plus maze test, B2M-treated rats displayed obvious decline in the number of entries into and the proportion of time spent in the open arm, while the number of total arm entries was no change, which indicated that B2M induces anxiety-like behaviors. Our present findings suggest that target B2M might represent a novel approach for treatment of depression and anxiety.	[Zhang, Ping; Zeng, Dan; Yi, Yi-Li; Zou, Wei] Univ South China, Affiliated Nanhua Hosp, Dept Neurol, Hengyang, Hunan, Peoples R China; [Zhang, Ping; Zeng, Dan; Yi, Yi-Li; Tang, Yi-Yun; Zou, Wei; Wang, Chun-Yan; Tang, Xiao-Qing] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Inst Neurosci, Hengyang, Hunan, Peoples R China; [Tang, Yi-Yun; Tang, Xiao-Qing] Univ South China, Med Coll, Dept Physiol, Hengyang, Hunan, Peoples R China; [Yang, Xue-Feng] Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang, Hunan, Peoples R China; [Wang, Chun-Yan] Univ South China, Med Coll, Dept Pathophysiol, Hengyang, Hunan, Peoples R China	University of South China; University of South China; University of South China; University of South China; University of South China	Tang, XQ (corresponding author), Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Inst Neurosci, Hengyang, Hunan, Peoples R China.; Tang, XQ (corresponding author), Univ South China, Med Coll, Dept Physiol, Hengyang, Hunan, Peoples R China.; Yang, XF (corresponding author), Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang, Hunan, Peoples R China.	yxf9988@126.com; tangxq-usc@qq.com			Natural Science Foundation of China [81471310, 81771178]; Major Research Topics of the Health and Family Planning Commission of Hunan province [A2017020]; Key Projects of the Education Department of Hunan province [17A187]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Topics of the Health and Family Planning Commission of Hunan province; Key Projects of the Education Department of Hunan province	Zhang Ping received the funding of Natural Science Foundation of China (http://www.nstc.gov.cn/publish/portal1/, 81471310, 81771178), Zou Wei received the funding of the the Major Research Topics of the Health and Family Planning Commission of Hunan province (http://wjw.hunan.gov.cn.; A2017020) and the Key Projects of the Education Department of Hunan province (http://gov.hnedu.cn/; 17A187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Natural Science Foundation of China (81471310, 81771178), the Major Research Topics of the Health and Family Planning Commission of Hunan province (A2017020), and the Key Projects of the Education Department of Hunan province (17A187). We thank Dr. Xiangping Chu for his critical reading.	Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BIJLMAKERS MJ, 1993, CURR OPIN IMMUNOL, V5, P21, DOI 10.1016/0952-7915(93)90076-5; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Choi YH, 2003, PHYSIOL BEHAV, V79, P795, DOI 10.1016/S0031-9384(03)00205-1; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Corlin DB, 2005, CLIN CHEM, V51, P1177, DOI 10.1373/clinchem.2005.049544; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Fitzsimons CP, 2013, MOL PSYCHIATR, V18, P993, DOI 10.1038/mp.2012.123; Fuss J, 2015, PLOS ONE, V5, P12769, DOI [10.1371/journal.pone.0012769.g001, DOI 10.1371/JOURNAL.PONE.0012769.G001]; Haller J, 2012, CURR OPIN PSYCHIATR, V25, P59, DOI 10.1097/YCO.0b013e32834de34f; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Jessberger S, 2014, TRENDS CELL BIOL, V24, P558, DOI 10.1016/j.tcb.2014.07.003; Kang EC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019026; Kastenschmidt EK, 2011, MT SINAI J MED, V78, P527, DOI 10.1002/msj.20266; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Lamers F, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.115; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MCARTHUR JC, 1992, NEUROLOGY, V42, P1707, DOI 10.1212/WNL.42.9.1707; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; NEEFJES JJ, 1993, CURR OPIN IMMUNOL, V5, P27, DOI 10.1016/0952-7915(93)90077-6; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Pinheiro SH, 2007, AN ACAD BRAS CIENC, V79, P71, DOI 10.1590/S0001-37652007000100010; Ramsey JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156624; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schoenfeld TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P113, DOI 10.1038/npp.2014.230; Siopi E, 2016, J NEUROSCI, V36, P518, DOI 10.1523/JNEUROSCI.2817-15.2016; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Tang MM, 2016, PHYSIOL BEHAV, V161, P166, DOI 10.1016/j.physbeh.2016.04.034; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Verhoof E, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-12; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048367; Xie J, 2003, BLOOD, V101, P4005, DOI 10.1182/blood-2002-11-3368; Yun S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147256; Zhang J, 2008, AM J CLIN PATHOL, V129, P526, DOI 10.1309/W01Y0B808EMEH12L; Zheng P, 2013, MOL CELL PROTEOMICS, V12, P207, DOI 10.1074/mcp.M112.021816; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198027	10.1371/journal.pone.0198027	http://dx.doi.org/10.1371/journal.pone.0198027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795686	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300116
J	Dong, PX; Xiong, Y; Yu, JH; Chen, L; Tao, T; Yi, S; Hanley, SJB; Yue, JM; Watari, H; Sakuragi, N				Dong, Peixin; Xiong, Ying; Yu, Jiehai; Chen, Lin; Tao, Tang; Yi, Song; Hanley, Sharon J. B.; Yue, Junming; Watari, Hidemichi; Sakuragi, Noriaki			Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer	ONCOGENE			English	Article							CELL-PROLIFERATION; MESENCHYMAL TRANSITION; BETA-CATENIN; IFN-GAMMA; INVASION; B7-H1; PROGRESSION; METASTASIS; REVERSES; TARGET	PD-L1, a key inhibitory immune receptor, has crucial functions in cancer immune evasion, but whether PD-L1 promotes the malignant properties of cervical cancer (CC) cells and the mechanism by which PD-L1 is regulated in CC remains unclear. We report that PD-L1 is overexpressed in CC, and shRNA-mediated PD-L1 depletion suppresses the proliferation, invasion, and tumorigenesis of CC cells. Loss of miR-140/142/340/383 contributes to PD-L1 upregulation. miR-18a enhances PD-L1 levels by targeting PTEN, WNK2 (ERK1/2 pathway inhibitor), and SOX6 (Wnt/beta-catenin pathway inhibitor and p53 pathway activator) to activate the PI3K/AKT, MEK/ERK, and Wnt/beta-catenin pathways and inhibit the p53 pathway, and miR-18a also directly suppresses the expression of the tumor suppressors BTG3 and RBSP3 (CTDSPL). miR-18a overexpression in CC cells is triggered by OCT4 overexpression. Our data implicate PD-L1 as a novel oncoprotein and indicate that miR-140/142/340/383 and miR-18a are key upstream regulators of PD-L1 and potential targets for CC treatment.	[Dong, Peixin; Hanley, Sharon J. B.; Sakuragi, Noriaki] Hokkaido Univ, Dept Womens Hlth Educ Syst, Sch Med, Sapporo, Hokkaido 0608638, Japan; [Dong, Peixin; Watari, Hidemichi] Hokkaido Univ, Dept Obstet & Gynecol, Sch Med, Sapporo, Hokkaido 0608638, Japan; [Xiong, Ying; Yu, Jiehai; Chen, Lin] Sun Yat Sen Univ, Dept Gynecol, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China; [Tao, Tang; Yi, Song] Chinese Univ Hong Kong, Fac Med, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA	Hokkaido University; Hokkaido University; State Key Lab Oncology South China; Sun Yat Sen University; Chinese University of Hong Kong; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Dong, PX (corresponding author), Hokkaido Univ, Dept Womens Hlth Educ Syst, Sch Med, Sapporo, Hokkaido 0608638, Japan.; Dong, PX; Watari, H (corresponding author), Hokkaido Univ, Dept Obstet & Gynecol, Sch Med, Sapporo, Hokkaido 0608638, Japan.; Yue, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.; Yue, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA.	dpx1cn@gmail.com; jyue@uthsc.edu; watarih@med.hokudai.ac.jp	Dong, Peixin/M-5592-2015	Dong, Peixin/0000-0002-2335-1394	Department of Women's Health Educational System; JSPS [15K10697, 16K11123]; Science and Technology Planning Project of Guangdong Province, China [2014A020212124]	Department of Women's Health Educational System; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science and Technology Planning Project of Guangdong Province, China	This research was supported by a grant from the Department of Women's Health Educational System, JSPS Grant-in-Aid for Scientific Research (C) (15K10697 and 16K11123) and the Science and Technology Planning Project of Guangdong Province, China (2014A020212124). We thank Dr. Zhujie Xu for experimental assistance.	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Anand M, 2011, HAEMATOL-HEMATOL J, V96, P253, DOI 10.3324/haematol.2010.027086; Cai YH, 2014, CELL SIGNAL, V26, P1204, DOI 10.1016/j.cellsig.2014.02.013; Chen J, 2016, ANN ONCOL, V27, P409, DOI 10.1093/annonc/mdv615; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen LJ, 2017, CELL PHYSIOL BIOCHEM, V42, P2267, DOI 10.1159/000480000; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Deng JH, 2017, MOL MED REP, V15, P1654, DOI 10.3892/mmr.2017.6180; Dong PX, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0415-y; Dong PX, 2016, ONCOTARGET, V7, P20260, DOI 10.18632/oncotarget.7754; Fang F, 2014, INT J CLIN EXP PATHO, V7, P6447; Fujita Y, 2015, MOL THER, V23, P717, DOI 10.1038/mt.2015.10; Gong AY, 2009, J IMMUNOL, V182, P1325, DOI 10.4049/jimmunol.182.3.1325; Guo W, 2015, TUMOR BIOL, V36, P9049, DOI 10.1007/s13277-015-3644-3; He J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10019; Heong V, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e20; Huo WY, 2017, J CANCER, V8, P57, DOI 10.7150/jca.16723; Ihira K, 2017, ONCOTARGET, V8, P13509, DOI 10.18632/oncotarget.14586; Jiang DQ, 2017, ONCOTARGET, V8, P4001, DOI 10.18632/oncotarget.13136; Konno Y, 2014, ONCOTARGET, V5, P6049, DOI 10.18632/oncotarget.2157; Kramer HB, 2016, NUCLEIC ACIDS RES, V44, P582, DOI 10.1093/nar/gkv948; Li CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12574; Li J, 2017, CELL PHYSIOL BIOCHEM, V41, P907, DOI [10.1159/00460504, 10.1159/000460504]; Liang XJ, 2014, J LEUKOCYTE BIOL, V95, P179, DOI 10.1189/jlb.0613330; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mezache L, 2015, MODERN PATHOL, V28, P1594, DOI 10.1038/modpathol.2015.108; Mitra S, 2010, GENE CHROMOSOME CANC, V49, P155, DOI 10.1002/gcc.20726; Moniz S, 2007, ONCOGENE, V26, P6071, DOI 10.1038/sj.onc.1210706; Munoz-Fontela C, 2016, NAT REV IMMUNOL, V16, P741, DOI 10.1038/nri.2016.99; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Ribeiro J, 2014, MOL BIOL REP, V41, P1525, DOI 10.1007/s11033-013-2998-0; Ryan BC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1057-y; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Song X, 2014, ONCOL REP, V31, P1191, DOI 10.3892/or.2013.2955; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Su YL, 2016, ONCOTARGET, V7, P68397, DOI 10.18632/oncotarget.11722; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Wang J, 2016, ONCOGENE, V35, P1692, DOI 10.1038/onc.2015.234; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Wang YH, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/687535; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Xiong Y, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0520-6; Xu SH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11406; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035; Zheng Z, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.211	49	77	81	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5257	5268		10.1038/s41388-018-0347-4	http://dx.doi.org/10.1038/s41388-018-0347-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29855617	hybrid, Green Published			2022-12-26	WOS:000445759700001
J	Bechard, ME; Word, AE; Tran, AV; Liu, XJ; Locasale, JW; McDonald, OG				Bechard, Matthew E.; Word, Anna E.; Tran, Amanda V.; Liu, Xiaojing; Locasale, Jason W.; McDonald, Oliver G.			Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases	ONCOGENE			English	Article							ANABOLIC GLUCOSE-METABOLISM; RAS-TRANSFORMED CELLS; PROMOTE TUMOR-GROWTH; 6-PHOSPHOGLUCONATE DEHYDROGENASE; DUCTAL ADENOCARCINOMA; PHOSPHATE PATHWAY; KRAS; PATTERNS; PROTEIN; BIOSYNTHESIS	Pancreatic ductal adenocarcinoma (PDAC) adopts several unique metabolic strategies to support primary tumor growth. Whether additional metabolic strategies are adopted to support metastatic tumorigenesis is less clear. This could be particularly relevant for distant metastasis, which often follows a rapidly progressive clinical course. Here we report that PDAC distant metastases evolve a unique series of metabolic reactions to maintain activation of the anabolic glucose enzyme phosphogluconate dehydrogenase (PGD). PGD catalytic activity was recurrently elevated across distant metastases, and modulating PGD activity levels dictated tumorigenic capacity. Metabolomics data raised the possibility that distant metastases evolved a core pentose conversion pathway (PCP) that converted glucose-derived metabolites into PGD substrate, thereby hyperactivating the enzyme. Consistent with this, each individual metabolite in the PCP stimulated PGD catalysis in distant metastases, and knockdown of each individual PCP enzyme selectively impaired tumorigenesis. We propose that the PCP manufactures PGD substrate outside of the rate-limiting oxidative pentose phosphate pathway (oxPPP). This enables PGD-dependent tumorigenesis by providing adequate substrate to fuel high catalytic activity, and raises the possibility that PDAC distant metastases adopt their own unique metabolic strategies to support tumor growth.	[Bechard, Matthew E.; Word, Anna E.; Tran, Amanda V.; McDonald, Oliver G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Word, Anna E.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Liu, Xiaojing; Locasale, Jason W.] Duke Univ, Sch Med, Duke Canc Inst, Durham, NC USA; [Liu, Xiaojing; Locasale, Jason W.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Liu, Xiaojing; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [McDonald, Oliver G.] Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [McDonald, Oliver G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Duke University; Duke University; Duke University; Vanderbilt University; Vanderbilt University	McDonald, OG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.; McDonald, OG (corresponding author), Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.; McDonald, OG (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	oliver.g.mcdonald@vanderbilt.edu	Locasale, Jason W/ABE-6505-2020	Locasale, Jason W/0000-0002-7766-3502; Word, Anna/0000-0002-6088-1781; Liu, Xiaojing/0000-0002-4231-6017	AACR Pancreatic Cancer Action Network Pathway to Leadership grant; Vanderbilt GI SPORE; Vanderbilt Digestive Diseases Research Center; NATIONAL CANCER INSTITUTE [R01CA222594] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021630, S10OD018164] Funding Source: NIH RePORTER	AACR Pancreatic Cancer Action Network Pathway to Leadership grant; Vanderbilt GI SPORE; Vanderbilt Digestive Diseases Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the AACR Pancreatic Cancer Action Network Pathway to Leadership grant (OGM), the Vanderbilt GI SPORE (OGM), and the Vanderbilt Digestive Diseases Research Center (OGM).	Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter H, 2010, CANCER BIOL THER, V10, P582, DOI 10.4161/cbt.10.6.12537; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Davidson SM, 2017, NAT MED, V23, P235, DOI 10.1038/nm.4256; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DYSON JED, 1971, BIOCHEM BIOPH RES CO, V43, P183, DOI 10.1016/S0006-291X(71)80104-3; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Habrook CJ, 2017, CANCER CELL, V31, P5, DOI 10.1016/j.ccell.2016.12.006; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hanau S, 2013, BBA-PROTEINS PROTEOM, V1834, P2647, DOI 10.1016/j.bbapap.2013.09.018; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; KOHLER E, 1970, FEBS LETT, V6, P225, DOI 10.1016/0014-5793(70)80063-1; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Makohon-Moore A, 2016, NAT REV CANCER, V16, P553, DOI 10.1038/nrc.2016.66; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Mueller S, 2018, NATURE, V554, P62, DOI 10.1038/nature25459; Murphy SJ, 2016, CANCER RES, V76, P749, DOI 10.1158/0008-5472.CAN-15-2198; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Qiu WL, 2011, ONCOTARGET, V2, P862; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Rippa M, 1998, BBA-PROTEIN STRUCT M, V1429, P83, DOI 10.1016/S0167-4838(98)00222-2; Rohatgi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098760; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shan CL, 2014, MOL CELL, V55, P552, DOI 10.1016/j.molcel.2014.06.020; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yao PB, 2017, J BIOL CHEM, V292, P17113, DOI 10.1074/jbc.M117.810309; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhong Y, 2017, CLIN CANCER RES, V23, P1607, DOI 10.1158/1078-0432.CCR-15-1615	54	15	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 20	2018	37	38					5248	5256		10.1038/s41388-018-0346-5	http://dx.doi.org/10.1038/s41388-018-0346-5			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU2IP	29849117	Green Accepted			2022-12-26	WOS:000445093100008
J	Balogh, KN; Templeton, DJ; Cross, JV				Balogh, Kristen N.; Templeton, Dennis J.; Cross, Janet, V			Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses	PLOS ONE			English	Article							FACTOR MIF; GASTRIC-CANCER; TUMOR-GROWTH; MOUSE MODEL; EXPRESSION; INDUCTION; ADENOCARCINOMA; ANGIOGENESIS; TOLERANCE; PROGNOSIS	The Macrophage Migration Inhibitory Factor (MIF) is an inflammatory cytokine that is overexpressed in a number of cancer types, with increased MIF expression often correlating with tumor aggressiveness and poor patient outcomes. In this study, we aimed to better understand the link between primary tumor expression of MIF and increased tumor growth. Using the MMTV-PyMT murine model of breast cancer, we observed that elevated MIF expression promoted tumor appearance and growth. Supporting this, we confirmed our previous observation that higher MIF expression supported tumor growth in the 4T1 murine model of breast cancer. We subsequently discovered that loss of MIF expression in 4T1 cells led to decreased cell numbers and increased apoptosis in vitro under reduced serum culture conditions. We hypothesized that this increase in cell death would promote detection by the host immune system in vivo, which could explain the observed impairment in tumor growth. Supporting this, we demonstrated that loss of MIF expression in the primary tumor led to an increased abundance of intra-tumoral IFNgamma-producing CD4+ and CD8+ T cells, and that depletion of T cells from mice bearing MIF-deficient tumors restored growth to the level of MIF-expressing tumors. Furthermore, we found that MIF depletion from the tumor cells resulted in greater numbers of activated intra-tumoral dendritic cells (DCs). Lastly, we demonstrated that loss of MIF expression led to a robust induction of a specialized form of cell death, immunogenic cell death (ICD), in vitro. Together, our data suggests a model in which MIF expression in the primary tumor dampens the anti-tumor immune response, promoting tumor growth.	[Balogh, Kristen N.; Templeton, Dennis J.; Cross, Janet, V] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Cross, JV (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	cross@virginia.edu		Balogh, Kristen/0000-0002-8746-745X	University of Virginia Institutional training grant from the National Cancer Institute [T32 CA009109]; University of Virginia Cancer Center Support Grant from the National Cancer Institute [P30 CA44579]; Farrow Fellowship; Women's 4-miler Breast Cancer Research Fund from the University of Virginia Cancer Center; Department of Pathology, University of Virginia School of Medicine; NATIONAL CANCER INSTITUTE [T32CA009109, P30CA044579] Funding Source: NIH RePORTER	University of Virginia Institutional training grant from the National Cancer Institute; University of Virginia Cancer Center Support Grant from the National Cancer Institute; Farrow Fellowship; Women's 4-miler Breast Cancer Research Fund from the University of Virginia Cancer Center; Department of Pathology, University of Virginia School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the University of Virginia Institutional training grant T32 CA009109 from the National Cancer Institute (KNB); University of Virginia Cancer Center Support Grant P30 CA44579 from the National Cancer Institute (KNB); Farrow Fellowship (KNB); University of Virginia Cancer Center Support Grant P30 CA44579 from the National Cancer Institute (JVC); Women's 4-miler Breast Cancer Research Fund from the University of Virginia Cancer Center (JVC); and Department of Pathology, University of Virginia School of Medicine (JVC).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; Bini L, 1997, ELECTROPHORESIS, V18, P2832, DOI 10.1002/elps.1150181519; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Conine SJ, 2014, OBESITY, V22, P418, DOI 10.1002/oby.20555; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Dickerhof N, 2015, FREE RADICAL BIO MED, V89, P498, DOI 10.1016/j.freeradbiomed.2015.09.009; Dudek AM, 2013, CYTOKINE GROWTH F R, V24, P319, DOI 10.1016/j.cytogfr.2013.01.005; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Guo P, 2015, TUMOR BIOL, V36, P5095, DOI 10.1007/s13277-015-3161-4; Guo YB, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-28; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; He XX, 2006, GUT, V55, P797, DOI 10.1136/gut.2005.078113; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Ichiyama H, 2004, CYTOKINE, V26, P187, DOI 10.1016/j.cyto.2004.02.007; Johler SM, 2016, CANCER IMMUNOL IMMUN, V65, P1465, DOI 10.1007/s00262-016-1896-4; Kamimura A, 2000, CANCER, V89, P334, DOI 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Matsushita H, 2015, CANCER IMMUNOL RES, V3, P26, DOI 10.1158/2326-6066.CIR-14-0098; Meyer-Siegler K, 1998, DIAGN MOL PATHOL, V7, P44, DOI 10.1097/00019606-199802000-00008; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Nakajima C, 2001, CANCER RES, P3399; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ouertatani- Sakouhi Hajer, 2009, BIOCHEMISTRY-US, V70, P646; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Schreiber RD, 1983, FORUM DIMMUNOLOGIE, P203; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Ullrich E, 2008, CELL DEATH DIFFER, V15, P21, DOI 10.1038/sj.cdd.4402266; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Xu SG, 2016, INT J ONCOL, V49, P2105, DOI 10.3892/ijo.2016.3704; Yaddanapudi K, 2015, CANCER IMMUNOL RES, P1, DOI [10.1158/2326-6066.CIR-14-0209, DOI 10.1158/2326-6066.CIR-14-0209]; Yan XC, 2006, CYTOKINE, V33, P188, DOI 10.1016/j.cyto.2006.01.006; Zhou Q, 2008, J IMMUNOL, V181, P1877, DOI 10.4049/jimmunol.181.3.1877	47	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197702	10.1371/journal.pone.0197702	http://dx.doi.org/10.1371/journal.pone.0197702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864117	Green Submitted, Green Published, gold			2022-12-26	WOS:000434097100007
J	Hollenbach, J; Jung, K; Noelke, J; Gasse, H; Pfeffer, C; Koy, M; Brehm, R				Hollenbach, Julia; Jung, Klaus; Noelke, Joanna; Gasse, Hagen; Pfeffer, Christiane; Koy, Mirja; Brehm, Ralph			Loss of connexin43 in murine Sertoli cells and its effect on blood-testis barrier formation and dynamics	PLOS ONE			English	Article							TIGHT JUNCTION STRANDS; CARCINOMA-IN-SITU; NF-KAPPA-B; SEMINIFEROUS EPITHELIUM; POSTNATAL-DEVELOPMENT; ANDROGEN RECEPTOR; GENE-EXPRESSION; GAP-JUNCTION; MOUSE TESTIS; OCCLUDIN EXPRESSION	Connexin43 (Cx43) is the predominant testicular gap junction protein and in cases of impaired spermatogenesis, Cx43 expression has been shown to be altered in several mammals. Amongst other functions, Cx43 is supposed to regulate junction formation of the blood-testis barrier (BTB). The aim of the present study was to investigate the expression pattern of different tight junction (TJ) proteins of the murine BTB using SC-specific Cx43 knockout mice (SCCx43KO). Adult homozygous male SCCx43KO mice (SCCx43KO(-/-)) predominantly show an arrest of spermatogenesis and SC-only tubules that might have been caused by an altered BTB assembly, composition or regulation. TJ molecules claudin-3, -5 and -11 were examined in adult wild type (WT) and SCCx43KO(-/-) mice using immunohistochemistry (IHC) and quantitative real-time PCR (qRT-PCR). In this context, investigation of single tubules with residual spermatogenesis in SCCx43KO(-/-) mice was particularly interesting to identify a potential Cx43-independent influence of germ cells (GC) on BTB composition and dynamics. In tubules without residual spermatogenesis, a diffuse cytoplasmic distribution pattern for claudin-11 protein could be demonstrated in mutant mice. Nevertheless, claudin-11 seems to form functional TJ. Claudin-3 and -5 could not be detected immunohistochemically in the seminiferous epithelium of those tubules. Correspondingly, claudin-3 and -5 mRNA expression was decreased, providing evidence of generally impaired BTB dynamics in adult KO mice. Observations of tubules with residual spermatogenesis suggested a Cx43-independent regulation of TJ proteins by GC populations. To determine initial BTB formation in peripubertal SCCx43KO(-/-) mice, immunohistochemical staining and qRT-PCR of claudin-11 were carried out in adolescent SCCx43KO(-/-) and WT mice. Additionally, BTB integrity was functionally analysed using a hypertonic glucose fixative. These analyses revealed that SCCx43KO(-/-) mice formed an intact BTB during puberty in the same time period as WT mice, which however seemed to be accelerated.	[Hollenbach, Julia; Noelke, Joanna; Gasse, Hagen; Pfeffer, Christiane; Brehm, Ralph] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Jung, Klaus] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Koy, Mirja] Univ Vet Med Hannover, Inst Immunol, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Brehm, R (corresponding author), Univ Vet Med Hannover, Inst Anat, Hannover, Germany.	ralph.brehm@tiho-hannover.de		Jung, Klaus/0000-0001-9955-748X; Brehm, Ralph/0000-0002-0489-7594				Ahmed A.H., 2005, THESIS; Batias C, 2000, J HISTOCHEM CYTOCHEM, V48, P793, DOI 10.1177/002215540004800608; BERGMANN M, 1987, ADV ANAT EMBRYOL CEL, V105, P1; Brehm R, 2006, ANAT EMBRYOL, V211, P223, DOI 10.1007/s00429-005-0075-8; Brehm R, 2002, J PATHOL, V197, P647, DOI 10.1002/path.1140; Brehm R, 2007, AM J PATHOL, V171, P19, DOI 10.2353/ajpath.2007.061171; Brehm R, 2006, NEOPLASIA, V8, P499, DOI 10.1593/neo.05847; Carette D, 2010, DEV BIOL, V346, P54, DOI 10.1016/j.ydbio.2010.07.014; Chakraborty P, 2014, MOL ENDOCRINOL, V28, P1055, DOI 10.1210/me.2013-1134; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Chihara M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107847; Chihara M, 2010, MOL REPROD DEV, V77, P630, DOI 10.1002/mrd.21200; Chojnacka K, 2012, REPROD BIOL, V12, P341, DOI 10.1016/j.repbio.2012.10.007; Cyr DG, 1999, ENDOCRINOLOGY, V140, P3815, DOI 10.1210/en.140.8.3815; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Defamie N, 2003, LAB INVEST, V83, P449, DOI 10.1097/01.LAB.0000059928.82702.6D; Delfino FJ, 2003, MOL CELL ENDOCRINOL, V201, P1, DOI 10.1016/S0303-7207(03)00005-4; Derangeon M, 2009, BBA-BIOMEMBRANES, V1788, P768, DOI 10.1016/j.bbamem.2008.10.023; Duffy HS, 2000, J NEUROSCI, V20; Dym M, 1970, Biology Reprod., V3, P308; Florin A, 2005, ENDOCRINOLOGY, V146, P1532, DOI 10.1210/en.2004-0834; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Gerber J, 2016, REPRODUCTION, V151, pR15, DOI 10.1530/REP-15-0366; Gerber J, 2014, HISTOL HISTOPATHOL, V29, P935, DOI 10.14670/HH-29.935; Giese S, 2012, DIS MODEL MECH, V5, P895, DOI 10.1242/dmm.008649; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Gye MC, 2003, ARCH ANDROLOGY, V49, P271, DOI [10.1080/713828170, 10.1080/01485010390204913]; Hejmej A, 2007, EQUINE VET J, V39, P122, DOI 10.2746/042516407X169393; Hejmej Anna, 2008, Endokrynol Pol, V59, P112; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; JEGOU B, 1993, ENDOCRINOLOGY, V132, P2557, DOI 10.1210/en.132.6.2557; Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011; Kim B, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134965; Kojima T, 2007, J MEMBRANE BIOL, V217, P13, DOI 10.1007/s00232-007-9021-4; Komljenovic D, 2009, CELL TISSUE RES, V337, P281, DOI 10.1007/s00441-009-0809-7; Kopera I, 2010, EUR J HISTOCHEM, V54, P67, DOI 10.4081/ejh.2010.e15; Korhonen HM, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131938; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lee NPY, 2007, FRONT BIOSCI-LANDMRK, V12, P1552, DOI 10.2741/2168; Li MWM, 2010, P NATL ACAD SCI USA, V107, P17998, DOI 10.1073/pnas.1007047107; Li MWM, 2009, P NATL ACAD SCI USA, V106, P10213, DOI 10.1073/pnas.0901700106; Li N, 2016, FASEB J, V30, P1436, DOI 10.1096/fj.15-276527; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mazaud-Guittot S, 2010, BIOL REPROD, V82, P202, DOI 10.1095/biolreprod.109.078907; McCabe MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.094318; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Moroi S, 1998, AM J PHYSIOL-CELL PH, V274, pC1708, DOI 10.1152/ajpcell.1998.274.6.C1708; Morrow CMK, 2010, PHILOS T R SOC B, V365, P1679, DOI 10.1098/rstb.2010.0025; Morrow CMK, 2009, BIOL REPROD, V81, P871, DOI 10.1095/biolreprod.109.077040; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; NAGANO T, 1976, ANAT RECORD, V185, P403, DOI 10.1002/ar.1091850403; Noelke J, 2015, CELL TISSUE RES, V361, P633, DOI 10.1007/s00441-015-2126-7; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; PELLETIER RM, 1995, J ANDROL, V16, P400; PELLETIER RM, 1992, MICROSC RES TECHNIQ, V20, P3, DOI 10.1002/jemt.1070200104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pointis G, 2005, TRENDS ENDOCRIN MET, V16, P300, DOI 10.1016/j.tem.2005.07.001; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rios-Rojas C, 2015, REPRODUCTION, V149, pR181, DOI 10.1530/REP-14-0663; RISLEY MS, 1992, J CELL SCI, V103, P81; Risley MS, 2002, BIOL REPROD, V67, P945, DOI 10.1095/biolreprod67.3.945; Rode K, 2015, THERIOGENOLOGY, V84, P763, DOI 10.1016/j.theriogenology.2015.05.009; Rondanino C, 2017, MOL HUM REPROD, V23, P304, DOI 10.1093/molehr/gax017; Ruettinger C, 2008, HISTOCHEM CELL BIOL, V130, P537, DOI 10.1007/s00418-008-0432-9; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Smith L, 2011, REPRODUCTION, V141, P151, DOI 10.1530/REP-10-0404; Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212; Stanton PG, 2016, SEMIN CELL DEV BIOL, V59, P166, DOI 10.1016/j.semcdb.2016.06.018; Steger K, 1999, HISTOCHEM CELL BIOL, V112, P215, DOI 10.1007/s004180050409; SU L, 2014, SPERMATOGENESIS, V3, DOI DOI 10.4161/SPMG.26460; Tarulli GA, 2006, BIOL REPROD, V74, P798, DOI 10.1095/biolreprod.105.050450; Tarulli GA, 2008, REPRODUCTION, V135, P867, DOI 10.1530/REP-07-0572; VITALE R, 1973, ANAT REC, V176, P333, DOI 10.1002/ar.1091760309; Wang LN, 2014, NEUROCHEM RES, V39, P97, DOI 10.1007/s11064-013-1194-x; Weider K, 2011, DIFFERENTIATION, V82, P38, DOI 10.1016/j.diff.2011.03.001; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168; Yao PL, 2010, BIOL REPROD, V82, P516, DOI 10.1095/biolreprod.109.080374	85	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198100	10.1371/journal.pone.0198100	http://dx.doi.org/10.1371/journal.pone.0198100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856785	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800068
J	Hu, C; Li, YJ; Zhao, ZW; Wei, SQ; Zhao, ZX; Chen, HL; Wu, PL				Hu, Chao; Li, Yujun; Zhao, Ziwen; Wei, Shuquan; Zhao, Zhuxiang; Chen, Huiling; Wu, Peilian			In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; CARBAPENEM RESISTANCE; MECHANISMS; EMERGENCE; SURVEILLANCE; COMBINATION; HOSPITALS; AMERICA; SYSTEM; STRAIN	Introduction Multidrug-resistant Acinetobacter baumannii (A. baumannii) has become one of the greatest threats worldwide to the therapeutic management of infections. Our previous research confirmed an in vitro synergistic effect of amlodipine and imipenem against A. baumannii, and this study is designed to understand its mechanism. Methods Sixty-four non-duplicate A. baumannii isolates were collected and tested for antimicrobial susceptibility by the disk diffusion method. PCR amplification and sequencing were used to identify the presence of the adeB, adeE, adeH, adeJ, abeM and abeS efflux pump genes. The minimal inhibitory concentrations of imipenem, imipenem+amlodipine and imipenem +carbonyl cyanide m-chlorophenyl-hydrazone against these isolates were also determined by the broth microdilution method before and after siRNA silencing of the expression of the adeABC efflux pump. Results In this study, the combination of amlodipine with imipenem showed synergistic antimicrobial activity against sixty-four A. baumannii isolates when compared with the activity of imipenem alone (p<0.025). In the multidrug-resistant group, AML was more effective than carbonyl cyanide m-chlorophenyl-hydrazone (p<0.001). The efflux pump genes adeB, adeE, adeH, adeJ, abeM and abeS were detected in 100% (4/64), 75% (48/64), 0% (0/64), 100% (64/64), 96.9% (62/64) and 96.9% (62/64) of the sixty-four A. baumannii isolates, respectively. The expression of the adeABC efflux pump genes in the multidrug-resistant group (5.05 +/- 19.25) is clearly higher than in the non-multidrug-resistant group (0.17 +/- 0.20), (p = 0.01). A gene silencing test verified that the mRNA expression levels of adeABC were decreased at 12 h and increased at 24 h, while the reversal of imipenem resistance by amlodipine disappeared at 12 h and reappeared at 24 h. Conclusions The combination of amlodipine with imipenem exhibits an in vitro synergistic antimicrobial effect on multidrug-resistant A. baumannii, which may be due to the inhibition of the AdeABC efflux pump.	[Hu, Chao; Li, Yujun; Zhao, Ziwen; Wei, Shuquan; Zhao, Zhuxiang; Wu, Peilian] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Chen, Huiling] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Zhao, ZW (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	zhaozw2016@163.com	chen, hui/HDO-2955-2022		Natural Science Foundation of Guangdong Province [10151006001000015]; Guangzhou Medical and Health Science and Technology Project; Guangzhou Medical and Health Science and Technology Project, Guangzhou City Health Bureau [201102A212019, 20151A011004, 20151A011005]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou Medical and Health Science and Technology Project; Guangzhou Medical and Health Science and Technology Project, Guangzhou City Health Bureau	This project was supported by the Natural Science Foundation of Guangdong Province (Grant No. 10151006001000015) (ZZ) and Guangzhou Medical and Health Science and Technology Project, Guangzhou City Health Bureau, Grant No. 201102A212019 (ZZ), Grant No. 20151A011004 (YL), Grant No. 20151A011005. I had describe all sources of funding that supported our work, including grant numbers. The URLs list below: http://www.gdstc.gov.cn/, http://kjgl.gzmed.gov.cn/.	Bonnin RA, 2013, EXPERT REV ANTI-INFE, V11, P571, DOI [10.1586/ERI.13.38, 10.1586/eri.13.38]; Bou G, 2000, J CLIN MICROBIOL, V38, P3299, DOI 10.1128/JCM.38.9.3299-3305.2000; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Chau SL, 2004, ANTIMICROB AGENTS CH, V48, P4054, DOI 10.1128/AAC.48.10.4054-4055.2004; Cheng XW, 2014, CANCER BIOL THER, V15, P1068, DOI 10.4161/cbt.29185; Clinical and Laboratory Standard Institute, 2012, M100 S22 CLSI; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Deng M, 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10.1128/AAC.01727-13; El-Shazly S, 2015, INT J INFECT DIS, V41, P42, DOI 10.1016/j.ijid.2015.10.016; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Hasan B, 2014, J MED MICROBIOL, V63, P50, DOI 10.1099/jmm.0.063925-0; Hou PF, 2012, CHEMOTHERAPY, V58, P152, DOI 10.1159/000335599; Hu FP, 2016, CLIN MICROBIOL INFEC, V22, pS9, DOI 10.1016/j.cmi.2016.01.001; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Lamberton JS, 2003, MOL BIOTECHNOL, V24, P111, DOI 10.1385/MB:24:2:111; Li YJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-548; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Mazumdar K, 2010, INT J ANTIMICROB AG, V36, P295, DOI 10.1016/j.ijantimicag.2010.05.003; Neonakis IK, 2011, INT J ANTIMICROB AG, V37, P102, DOI 10.1016/j.ijantimicag.2010.10.014; Peleg AY, 2007, ANTIMICROB AGENTS CH, V51, P2065, DOI 10.1128/AAC.01198-06; Pereira MR, 2011, ANTIMICROB AGENTS CH, V55, P3115, DOI 10.1128/AAC.01566-10; Pletz MW, 2013, INT J MED MICROBIOL, V303, P176, DOI 10.1016/j.ijmm.2013.02.014; Quale J, 2003, CLIN INFECT DIS, V37, P214, DOI 10.1086/375821; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Theodorou MC, 2012, EUR J PHARM SCI, V47, P84, DOI 10.1016/j.ejps.2012.05.004; Yanagihara K, 2006, J ANTIMICROB CHEMOTH, V57, P122, DOI 10.1093/jac/dki416; Yu QL, 2013, INT J ANTIMICROB AG, V41, P179, DOI 10.1016/j.ijantimicag.2012.10.009; Zarrilli Raffaele, 2009, J Infect Dev Ctries, V3, P335, DOI 10.3855/jidc.240	31	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198061	10.1371/journal.pone.0198061	http://dx.doi.org/10.1371/journal.pone.0198061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856791	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800065
J	Yamamiya, D; Mizukoshi, E; Kaji, K; Terashima, T; Kitahara, M; Yamashita, T; Arai, K; Fushimi, K; Honda, M; Kaneko, S				Yamamiya, Daisuke; Mizukoshi, Eishiro; Kaji, Kiichiro; Terashima, Takeshi; Kitahara, Masaaki; Yamashita, Tatsuya; Arai, Kuniaki; Fushimi, Kazumi; Honda, Masao; Kaneko, Shuichi			Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides	PLOS ONE			English	Article; Proceedings Paper	68th Annual Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)	OCT 20-24, 2017	Washington, DC	Amer Assoc Study Liver Dis			HLA-A2-RESTRICTED EPITOPE; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2A; LAMIVUDINE THERAPY; VIRAL CLEARANCE; CTL EPITOPES; IDENTIFICATION; INFECTION; CELLS; ANTIGEN	Background & aims Many individuals are infected with hepatitis B virus (HBV) worldwide, and this virus is commonly controlled by treatments with interferon (IFN)-alpha and nucleoside analogues (NA). However, the complete elimination of HBV by these treatments is difficult and, thus, the development of new treatments is needed. Host immune responses are closely involved in the elimination of HBV, suggesting the usefulness of immunotherapy. In the present study, we attempted to identify novel cytotoxic T-lymphocyte (CTL) epitopes that are useful for immunotherapy against HBV. Methods CTL epitopes were predicted using computer software. Immune responses to each peptide were evaluated by IFN-gamma ELISPOT and cytotoxic assays. The relationships between the immune responses to these newly identified CTL epitopes and the clinical backgrounds of patients and administration of NA were analyzed. Peptides were administered to mice as vaccines and peptide-specific T-cell induction was measured in vivo. Results Positive reactions to 10 synthesized peptides were detected in 3 or more patients using the IFN-gamma ELISPOT assay, and concentration-dependent cytotoxicity against 2 of these peptides was observed in the cytotoxic assay. Some peptides that correlated with serum ALT, HBsAg, and HBV core-related antigen (HBcrAg) levels were identified. Immune reactions against some peptides were enhanced by the administration of NA. Regarding their effects as a vaccine, peptide-specific T-cells were induced by four peptides in vivo. Conclusions Novel HBV epitopes that correlated with HBsAg and HBcrAg levels were identified. These newly identified epitopes may be useful in the analysis of immune responses to HBV and development of immunotherapy against HBV.	[Yamamiya, Daisuke; Mizukoshi, Eishiro; Kaji, Kiichiro; Terashima, Takeshi; Kitahara, Masaaki; Yamashita, Tatsuya; Arai, Kuniaki; Fushimi, Kazumi; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	Kanazawa University	Mizukoshi, E (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.	eishirom8848@m-kanazawa.jp	Yamashita, Tatsuya/K-8648-2015; Terashima, Takeshi/AHC-9917-2022	Yamashita, Tatsuya/0000-0002-3602-8086; Fushimi, Kazumi/0000-0002-1158-4211; Yamamiya, Daisuke/0000-0001-8934-6240	Health Labour Sciences Research Grant	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Health Labour Sciences Research Grant "Research project on hepatitis B drug discovery practical use etc." http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h26/gaiyo/21.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoletti A, 2003, ANTIVIR RES, V60, P61, DOI 10.1016/j.antiviral.2003.08.012; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Comber JD, 2014, HEPAT RES TREAT, V2014, DOI [DOI 10.1155/2014/860562, 10.1155/2014/860562]; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Ikeda-Moore Y, 1997, J IMMUNOL, V159, P6242; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Kimura T, 2002, J CLIN MICROBIOL, V40, P439, DOI 10.1128/JCM.40.2.439-445.2002; Kondo Y, 2004, J MED VIROL, V74, P425, DOI 10.1002/jmv.20194; Kusumoto S, 2015, CLIN INFECT DIS, V61, P719, DOI 10.1093/cid/civ344; Kuzushima K, 2001, BLOOD, V98, P1872, DOI 10.1182/blood.V98.6.1872; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Mashima E, 2015, ONCOTARGETS THER, V8, P2045, DOI 10.2147/OTT.S62102; Mizukoshi E, 2006, INT J CANCER, V118, P1194, DOI 10.1002/ijc.21468; Mizukoshi E, 2004, J IMMUNOL, V173, P5863, DOI 10.4049/jimmunol.173.9.5863; Mizukoshi E, 2006, HEPATOLOGY, V43, P1284, DOI 10.1002/hep.21203; Nakamura Erina, 2011, Rinsho Byori, V59, P838; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; Ono A, 2012, J HEPATOL, V57, P508, DOI 10.1016/j.jhep.2012.04.037; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Shinkai N, 2006, HEPATOL RES, V36, P272, DOI 10.1016/j.hepres.2006.08.005; Sobao Y, 2002, J HEPATOL, V36, P105, DOI 10.1016/S0168-8278(01)00264-1; Sobao Y, 2001, J HEPATOL, V34, P922, DOI 10.1016/S0168-8278(01)00048-4; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Sun L, 2014, PROTEIN CELL, V5, P317, DOI 10.1007/s13238-014-0041-4; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003	31	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198264	10.1371/journal.pone.0198264	http://dx.doi.org/10.1371/journal.pone.0198264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Science & Technology - Other Topics	GH8ES	29856876	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800092
J	Ziraba, A; Orindi, B; Muuo, S; Floyd, S; Birdthistle, IJ; Mumah, J; Osindo, J; Njoroge, P; Kabiru, CW				Ziraba, Abdhalah; Orindi, Benedict; Muuo, Sheru; Floyd, Sian; Birdthistle, Isolde J.; Mumah, Joyce; Osindo, Jane; Njoroge, Pauline; Kabiru, Caroline W.			Understanding HIV risks among adolescent girls and young women in informal settlements of Nairobi, Kenya: Lessons for DREAMS	PLOS ONE			English	Article							SEXUAL PARTNERSHIPS; AGE-DISPARATE; INFECTION; BEHAVIOR; SLUM; TRANSITION; MEN	Introduction High incidence of HIV infection among adolescent girls and young women (AGYW) has been attributed to the numerous and often layered vulnerabilities that they encounter including violence against women, unfavourable power relations that are worsened by age-disparate sexual relations, and limited access to sexual and reproductive health information and services. For AGYW living in urban informal settlements (slums), these vulnerabilities are compounded by pervasive poverty, fragmented social networks, and limited access to social services including health and education. In this paper, we assess sexual risk behaviours and their correlates among AGYW in two slum settlements in Nairobi, Kenya, prior to the implementation of interventions under the Determined Resilient Empowered AIDS-free Mentored and Safe (DREAMS) Partnership. Methods We drew on secondary data from the Transition to Adulthood study, the most recent representative study on adolescent sexual behaviour in the two settlements. The study was nested within the Nairobi Urban Health and Demographic Surveillance System (NUHDSS). Data were collected in 2009 from 1,390 AGYW aged 12-23 years. We estimated the proportions of AGYW reporting ever tested for HIV, condom use, multiple sexual partners and age-disparate sex by socio-demographic characteristics. "High risk" sexual behaviour was defined as a composite of these four variables and age at first sex. Multivariable regression analyses were performed to identify factors associated with risk behaviours. Results Fifty-one percent of AGYW reported that they had ever tested for HIV and received results of their last test, with the proportion rising steeply by age (from 15% to 84% among those <15 years and 20-23 years, respectively). Of 578 AGYW who were sexually active in the 12 months preceding the survey, 26% reported using a condom at last sex, 4% had more than one sexual partner, and 26% had sex with men who were at least 5 years older or younger. All girls aged below 15 years who had sex (n = 9) had not used condoms at last sex. The likelihood of engaging in "high risk" sexual risk behaviour was higher among older AGYW (19-23 years), those in marital unions, of Luo ethnicity, out of school, living alone or with a friend (versus parents), living with spouse (versus parents), and those whose friends engaged in risky/anti-social behaviours. In contrast, Muslim faith, co-residence with both parents, and belonging to an organised social group were associated with lower odds of risky sexual behaviours. Conclusion Our study findings suggest that multifaceted approaches addressing the educational and social mediators of AGYW's vulnerability and that also reach the people with whom AGYW live and interact, are needed to reduce the rapid onset of sexual risk during the adolescent years. There is a particular need to reach the youngest adolescent girls in poor urban settings, among whom condom use and awareness of HIV status is rare.	[Ziraba, Abdhalah; Orindi, Benedict; Muuo, Sheru; Mumah, Joyce; Osindo, Jane; Njoroge, Pauline] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Orindi, Benedict] Katholieke Univ Leuven, Kapucijnenvoer 35, Leuven, Belgium; [Floyd, Sian; Birdthistle, Isolde J.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Kabiru, Caroline W.] Univ Witwatersrand, Sch Publ Hlth, Parktown, South Africa; [Kabiru, Caroline W.] Populat Council, Nairobi, Kenya	African Population & Health Research Centre; KU Leuven; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Birdthistle, IJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	Isolde.Birdthistle@lshtm.ac.uk	Ziraba, Abdhalah/T-3707-2019	Orindi, Benedict/0000-0002-4601-7890; Birdthistle, Isolde/0000-0001-5742-6588; Kabiru, Caroline/0000-0002-0735-9839; Ziraba, Abdhalah/0000-0002-3417-6536	Wellcome Trust [GR 07830M]; Bill and Melinda Gates Foundation [OPP1136774]; APHRC	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); APHRC	The Transition to Adulthood study was part of a larger project, the Urbanization and Poverty Health Dynamics project, funded by the Wellcome Trust (Grant No. GR 07830M). Analysis and writing time was supported with funding from the Bill and Melinda Gates Foundation (Grant Number OPP1136774) as well as general support from APHRC. This project was nested in the Nairobi Urban Health and Demographic Surveillance System, which is part of the INDEPTH Network. The funders had no role in the decision to publish or in the preparation of the manuscript.	Achia TNO, AFR J PRIM HLTH CARE, V5, P547; APHRC, 2017, KENYA UPHD TRANS AD; Beguy D, 2015, INT J EPIDEMIOL, V44, P462, DOI 10.1093/ije/dyu251; Bengesai AV, 2018, J BIOSOC SCI, V50, P124, DOI 10.1017/S0021932017000104; Brodish PH, 2013, J BIOSOC SCI, V45, P853, DOI 10.1017/S002193201200082X; Case KK, 2012, B WORLD HEALTH ORGAN, V90, P831, DOI 10.2471/BLT.12.102574; Clark S, 2011, INT PERSPECT SEX R H, V37, P181, DOI 10.1363/3718111; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Ettarh RR, 2012, AJAR-AFR J AIDS RES, V11, P337, DOI 10.2989/16085906.2012.754833; Evans M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21310; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Gelmon L, 2009, KENYA HIV PREVENTION; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; HUNTER DJ, 1994, AIDS, V8, P93, DOI 10.1097/00002030-199401000-00014; Kabiru CW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-685; Kabiru CW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-412; Kabiru CW, 2010, J YOUTH STUD, V13, P453, DOI 10.1080/13676261003801754; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Marston M, 2013, INT PERSPECT SEX R H, V39, P22, DOI 10.1363/3902213; Maughan-Brown B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159162; Mensch BS, 1998, STUD FAMILY PLANN, V29, P167, DOI 10.2307/172157; Ministry of Health National AIDS and STI Control Programme, 2016, KEN HIV EST 2015; NACC, 2016, KEN AIDS RESP PROGR; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Okigbo CC, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0069-9; Onsomu Elijah O, 2013, Afr J Reprod Health, V17, P46; PEPFAR, 2017, WORK TOG AIDS FREE F; Pilgrim Nanlesta A, 2015, Int J Adolesc Med Health, V27, P319, DOI 10.1515/ijamh-2014-0032; Rositch AF, 2012, INT J STD AIDS, V23, P468, DOI 10.1258/ijsa.2012.011361; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; UNAIDS, 2016, GLOB AIDS UPD; UNAIDS, 2014, THE GAP REP; Ziraba AK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-663; Zulu EM, 2002, POP STUD-J DEMOG, V56, P311, DOI 10.1080/00324720215933	38	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197479	10.1371/journal.pone.0197479	http://dx.doi.org/10.1371/journal.pone.0197479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29851988	Green Published, gold, Green Accepted			2022-12-26	WOS:000433893200015
J	Von Hoermann, C; Jauch, D; Kubotsch, C; Reichel-Jung, K; Steiger, S; Ayasse, M				Von Hoermann, Christian; Jauch, Dennis; Kubotsch, Carolin; Reichel-Jung, Kirsten; Steiger, Sandra; Ayasse, Manfred			Effects of abiotic environmental factors and land use on the diversity of carrion-visiting silphid beetles (Coleoptera: Silphidae): A large scale carrion study	PLOS ONE			English	Article							HETEROTROPHIC SUCCESSION; FOREST MANAGEMENT; ARTHROPOD ASSEMBLAGES; SAPROXYLIC BEETLES; INSECT SUCCESSION; BURYING BEETLES; NICROPHORUS F; BODY-MASS; DECOMPOSITION; DYNAMICS	Anthropogenic land use causes global declines in biodiversity. Despite the knowledge that animal carrion is the most nutrient-rich form of dead organic matter, studies on landscape and local scales determining whether and the means by which land use intensity influences the diversity of the carrion-associated insect fauna are globally scarce. We investigated the effects of land use intensity and abiotic and biotic environmental factors on the abundance, species richness, and diversity of the important ecosystem-service-providing silphid beetle taxon (carrion beetles) in three regions of Germany. In 61 forest stands distributed over three geographically distinct regions in Central Europe, we trapped silphid beetles on exposed piglet cadavers during late summer. In all three regions, higher ambient temperatures and higher fine sand contents were associated with the abundance of the silphid beetle taxa. The carrion community silphid diversity was negatively affected by an increase in mean ambient temperature in all three regions. Although management intensity in forests did not affect the overall abundance of Silphidae, the abundance of Nicrophorus humator decreased significantly with higher forest management intensity across all three regions. Unmanaged and age-class forests showed a higher abundance of N. humator compared with extensively managed forest stands. These findings indicate that N. humator has potential as an indicator species for anthropogenic disturbances in forests. Overall, the direct responses of the silphid beetle community to diverse soil characteristics underline soil as an important factor determining the abundance and diversity of necrophagous carrion beetles in Central Europe. To protect these valuable ecosystem-service providers, forest-management-induced soil modifications need to be paid close attention.	[Von Hoermann, Christian; Jauch, Dennis; Kubotsch, Carolin; Reichel-Jung, Kirsten; Steiger, Sandra; Ayasse, Manfred] Univ Ulm, Inst Evolutionary Ecol & Conservat Gen, Ulm, Germany; [Von Hoermann, Christian] Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany	Ulm University	Von Hoermann, C (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Gen, Ulm, Germany.; Von Hoermann, C (corresponding author), Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany.	Christian.vonHoerman@npv-bw.bayern.de			German Research Foundation (DFG) [AY 12/9-1, STE 1874/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work has been (partly) funded by the German Research Foundation (DFG) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (AY 12/9-1, STE 1874/4-1 to Dr. Christian von Hoermann, http://www.biodiversity-exploratories.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Amuchastegui N, 2007, FOREST ECOL MANAG, V253, P56, DOI 10.1016/j.foreco.2007.07.004; Arnold JM., 2015, STATUS ENTWICKLUNG A; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Barton PS, 2017, J MED ENTOMOL, V54, P964, DOI 10.1093/jme/tjw242; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Barton PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053961; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Benbow M.E., 2016, CARRION ECOLOGY EVOL; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; BOULTON AJ, 1988, OECOLOGIA, V76, P477, DOI 10.1007/BF00377047; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Charabidze D, 2016, INT J LEGAL MED, V130, P273, DOI 10.1007/s00414-015-1253-8; Chauvet Bernard, 2008, Entomologiste (Paris), V64, P15; Ciesla B, 2011, JAGD MACHT GESCH JAG; Creighton JC, 1998, BIOL CONSERV, V86, P281, DOI 10.1016/S0006-3207(98)00035-4; Dekeirsschieter J, 2011, BIOTECHNOL AGRON SOC, V15, P435; Dekeirsschieter J, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7301; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Dobler S, 2000, MOL PHYLOGENET EVOL, V15, P390, DOI 10.1006/mpev.1999.0765; Eggert Anne-Katrin, 1997, P216; Ehnstrom B, 1993, RODLISTADE EVERTEBRA; Farwig N, 2014, OECOLOGIA, V175, P1291, DOI 10.1007/s00442-014-2974-y; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Freude H., 1971, K FER MITTELEUROPAS; Fujita A, 2008, ENTOMOL SCI, V11, P39, DOI 10.1111/j.1479-8298.2007.00243.x; Gossner MM, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00177.1; Gossner MM, 2013, CONSERV BIOL, V27, P605, DOI 10.1111/cobi.12023; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Haelewaters D, 2015, B SOC ROYALE BELGE E, V151, P37; HANNAH L, 1995, BIODIVERS CONSERV, V4, P128, DOI 10.1007/BF00137781; Hastir Pierre, 2001, Notes Fauniques de Gembloux, V44, P13; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Holloway AK, 1997, BIOL CONSERV, V81, P145, DOI 10.1016/S0006-3207(96)00158-9; Ikeda H, 2008, EVOLUTION, V62, P2065, DOI 10.1111/j.1558-5646.2008.00432.x; Jakubec P, 2015, EUR J ENTOMOL, V112, P747, DOI 10.14411/eje.2015.071; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Knapp M, 2016, ENVIRON ENTOMOL, V45, P1022, DOI 10.1093/ee/nvw047; Lachat T, 2012, ECOL INDIC, V23, P323, DOI 10.1016/j.ecolind.2012.04.013; Lange M, 2014, FOREST ECOL MANAG, V329, P166, DOI 10.1016/j.foreco.2014.06.012; Lange M, 2011, BIODIVERS CONSERV, V20, P2133, DOI 10.1007/s10531-011-0078-0; LAWRENCE JF, 1982, ANNU REV ECOL SYST, V13, P261, DOI 10.1146/annurev.es.13.110182.001401; LOMOLINO MV, 1995, CONSERV BIOL, V9, P605, DOI 10.1046/j.1523-1739.1995.09030605.x; Loranger J, 2012, ECOLOGY, V93, P2674, DOI 10.1890/12-0328.1; Magurran A.E, 2004, MEASURING BIOL DIVER; Matuszewski S, 2008, FORENSIC SCI INT, V180, P61, DOI 10.1016/j.forsciint.2008.06.015; Matuszewski S, 2016, INT J LEGAL MED, V130, P221, DOI 10.1007/s00414-015-1145-y; Matuszewski S, 2014, INT J LEGAL MED, V128, P1039, DOI 10.1007/s00414-014-0965-5; Matuszewski S, 2011, FORENSIC SCI INT, V207, P150, DOI 10.1016/j.forsciint.2010.09.022; Matuszewski S, 2010, FORENSIC SCI INT, V195, P42, DOI 10.1016/j.forsciint.2009.11.007; Matuszewski S, 2010, FORENSIC SCI INT, V194, P85, DOI 10.1016/j.forsciint.2009.10.016; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Michaud JP, 2010, FORENSIC SCI INT, V202, P64, DOI 10.1016/j.forsciint.2010.04.028; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; MLUV, 2005, STECKBR BRAND BOD NO; Mondor E.B., 2012, NAT ED KNOWL, V3, P21; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Moura AO, 2005, BRAZ ARCH BIOL TECHN, V48, P477, DOI 10.1590/S1516-89132005000300018; MUTHS EL, 1991, J KANSAS ENTOMOL SOC, V64, P447; Nadeau P, 2015, BEETLES BIODIVERSITY, P125; Niemela J, 2007, J INSECT CONSERV, V11, P5, DOI 10.1007/s10841-006-9014-0; Novak B., 1961, ACTA U PALACKI OLOMU, V6, P45; Novak B., 1962, ACTA U PALACKI OLOMU, V11, P263; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Payne LX, 2006, OIKOS, V115, P69; Peck S.B., 1990, P1113; Peck SB, 1993, CATALOG COLEOPTERAN; Poggio L, 2015, INT J APPL EARTH OBS, V34, P122, DOI 10.1016/j.jag.2014.08.005; PUKOWSKI ERNA, 1933, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V27, P518, DOI 10.1007/BF00403155; R Core Team, 2021, R LANGUAGE ENV STAT; Ratcliffe B.C., 1996, B U NEBRASKA STATE M, V13; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; SCHOENLY K, 1987, OECOLOGIA, V73, P192, DOI 10.1007/BF00377507; SCHOENLY KG, 1989, OECOLOGIA, V79, P140, DOI 10.1007/BF00378252; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SIKES DS, 2008, ENCY ENTOMOLOGY, P749; Sikes DS., 1807, HDB ZOOLOGY ARTHROPO, P288; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sippola AL, 2004, SCAND J FOREST RES, V19, P152, DOI 10.1080/02827580410026294; Speight MCD, 1989, NATURE ENV SERIES, V42, P1; Storaunet KO, 2005, SILVA FENN, V39, P429, DOI 10.14214/sf.479; Sugiura S, 2013, BIOL CONSERV, V159, P206, DOI 10.1016/j.biocon.2012.11.003; Swift M. J., 1979, Decomposition in terrestrial ecosystems.; Tompalski P, 2015, FOREST SCI, V61, P861, DOI 10.5849/forsci.14-175; Trumbo ST, 2000, J INSECT CONSERV, V4, P245, DOI 10.1023/A:1011390215088; Tumer AR, 2013, LEGAL MED-TOKYO, V15, P149, DOI 10.1016/j.legalmed.2012.11.003; Urbanski A, 2015, J ENTOMOL RES SOC, V17, P1; Urbanski A, 2015, COLEOPTS BULL, V69, P283, DOI 10.1649/0010-065X-69.2.283; von Hoermann C, 2016, J CHEM ECOL, V42, P756, DOI 10.1007/s10886-016-0719-6; von Hoermann C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-18; Wolf Jordan N., 2004, Urban Ecosystems, V7, P371, DOI 10.1007/s11252-005-6836-6; Zenner EK, 2006, FOREST ECOL MANAG, V222, P326, DOI 10.1016/j.foreco.2005.10.027	97	14	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0196839	10.1371/journal.pone.0196839	http://dx.doi.org/10.1371/journal.pone.0196839			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847551	gold, Green Published, Green Submitted			2022-12-26	WOS:000433634800012
J	Wright, T; Jowsey, T; Stanton, J; Elder, H; Stevens, S; Wouldes, TA				Wright, Tanya; Jowsey, Tanisha; Stanton, Josephine; Elder, Hinemoa; Stevens, Suzanne; Wouldes, Trecia A.			Patient experience of a psychiatric Mother Baby Unit	PLOS ONE			English	Article							MENTAL-HEALTH; WOMEN; ILLNESS; DISORDERS; FRAMEWORK; RECOVERY; FATHERS	Background Mothers with severe mental illness are vulnerable and engage with services cautiously due to fears of stigma and custody loss. To develop best practice standards and patient-centred services, the subjective experience of those who use it must inform service improvement and policy. Method This study utilised exploratory concurrent mixed methods design with primarily qualitative data. Women admitted between April 2015 and December 2016 to a newly developed psychiatric Mother Baby Unit (MBU) in New Zealand were invited to participate in this study. Qualitative data were collected in three ways: (i) semi-structured interviews incorporating Maori concepts of health and wellness by research assistants near discharge; (ii) invitation to provide anonymous feedback in writing using an open format; (iii) unsolicited verbal feedback provided during a home visit three months after discharge. Thematic analysis was undertaken. Demographic and clinical information was collected prospectively for mother-infant pairs during the course of admission and three months post-discharge. Results Forty-five people participated in the study. High rates of satisfaction were described. Strengths of the service-as perceived by mothers-included co-admission of mother and infant, staff warmth and availability, transparent practice, inclusion of families, and having a comfortable environment. Mothers described intense distress and confusion, as well as negative self-perceptions when acutely unwell. Infant co-admission and the inclusion of partners and other family members alleviated mothers' distress. Personal attributes of staff, practical support with caregiving, a range of therapeutic approaches and holistic care were all valued. Feedback collected three months after discharge was the most reflective. Significant inter-ethnic differences were not apparent. Conclusions The experience of inpatient care can have lasting influence on recovery and wellbeing. Employing a Maori model of health broadened the holistic nature of enquiry. The approach and timing taken in seeking the views of participants' yielded different information, all of which is of value to service evaluation and refinement. The findings suggest that keeping mothers and infants together during health service utilisation such as MBUs should be a priority for policy makers and service designers. This approach is consistent with Maori values, combining the importance of whanau relationships (kinship), wairua (spiritual connectivity), hinengaro (the mind) and tinana (physical health). These findings suggest that 'holistic care'-in this case following a Maori holistic health model-is important in mental health settings.	[Wright, Tanya; Stevens, Suzanne; Wouldes, Trecia A.] Univ Auckland, Dept Psychol Med, Fac Med & Hlth Sci, Auckland, New Zealand; [Wright, Tanya; Stanton, Josephine] Auckland Dist Hlth Board, Starship Hosp, Child & Family Unit, Auckland, New Zealand; [Jowsey, Tanisha] Univ Auckland, Fac Med & Hlth Sci, Ctr Med & Hlth Serv Educ, Auckland, New Zealand; [Elder, Hinemoa] Te Whare Wananga Anuiarangi, Whakatane, New Zealand	University of Auckland; Auckland District Health Board; Starship Children's Hospital; University of Auckland	Wright, T (corresponding author), Univ Auckland, Dept Psychol Med, Fac Med & Hlth Sci, Auckland, New Zealand.; Wright, T (corresponding author), Auckland Dist Hlth Board, Starship Hosp, Child & Family Unit, Auckland, New Zealand.	tanya@adhb.govt.nz			A+ Trust, Auckland District Health Board [6429]	A+ Trust, Auckland District Health Board	The research on which this paper is based was funded by A+ Trust, Auckland District Health Board, Grant no 6429.	Abel S, 2001, SOC SCI MED, V53, P1135, DOI 10.1016/S0277-9536(00)00408-1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Antonysamy A, 2009, ARCH WOMEN MENT HLTH, V12, P359, DOI 10.1007/s00737-009-0085-2; Austin M P, 2017, MENTAL HLTH CARE PER; Bassett J.L., 1999, J MENTAL HLTH, V8, P597, DOI DOI 10.1080/09638239917067; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Connellan K, 2017, ARCH WOMEN MENT HLTH, P1; Connerty TJ, 2015, COMMUNITY MENT HLTH, P1; Crowe M, 2015, AUST NZ J PSYCHIAT, V49, P616, DOI 10.1177/0004867415582053; Dolman C, 2013, ARCH WOMEN MENT HLTH, V16, P173, DOI 10.1007/s00737-013-0336-0; Drake RE, 2014, CAN J PSYCHIAT, V59, P236, DOI 10.1177/070674371405900502; Durie M, 2004, INT J EPIDEMIOL, V33, P1138, DOI 10.1093/ije/dyh250; Durie M., 1994, WHAIORA MAORI DEV; Durie MH, 1996, AUSTRALAS PSYCHIATRY, V4, P189; Elder H, 2013, BRAIN IMPAIR, V14, P415, DOI 10.1017/BrImp.2013.29; Geertz C, 1966, INTERPRETATION CULTU, P360; Gillham R, 2015, INT J WOMENS HEALTH, V7, P459, DOI 10.2147/IJWH.S69472; Howard L, 2003, SOC PSYCH PSYCH EPID, V38, P450, DOI 10.1007/s00127-003-0663-y; Howden-Chapman P, 2000, SOCIAL INEQUALITIES, P76; Johannsen BMW, 2016, AM J PSYCHIAT, V173, P635, DOI 10.1176/appi.ajp.2015.14121510; Johansson H, 2003, SCAND J CARING SCI, V17, P339, DOI 10.1046/j.0283-9318.2003.00233.x; Jones CP, 2000, AM J PUBLIC HEALTH, V90, P1212, DOI 10.2105/AJPH.90.8.1212; Leamy M, 2011, BRIT J PSYCHIAT, V199, P445, DOI 10.1192/bjp.bp.110.083733; Marrs J, 2014, J REPROD INFANT PSYC, V32, P340, DOI 10.1080/02646838.2014.920951; Ministry of Health, 2017, REP MAT 2015; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Nair R, 2010, AUSTRALAS PSYCHIATRY, V18, P573, DOI 10.3109/10398562.2010.499946; Neil S, 2006, ARCH WOMEN MENT HLTH, V9, P109, DOI 10.1007/s00737-005-0116-6; New Zealand Ministry of Health, 2013, 7 ANN REV PER MAT MO; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P233, DOI 10.1007/s11135-006-9000-3; Patton M. Q., 2005, QUALITATIVE RES; Reid H, 2017, CLIN PSYCHOL PSYCHOT, V24, P919, DOI 10.1002/cpp.2056; Rothbauer P., 2008, SAGE ENCY QUALITATIV, P892, DOI DOI 10.4135/9781412963909.N468; Sacristan JA, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-6; SCAMBLER G, 1986, SOCIOL HEALTH ILL, V8, P26, DOI 10.1111/1467-9566.ep11346455; Smylie J, 2006, LANCET, V367, P2029, DOI 10.1016/S0140-6736(06)68893-4; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Tamasese K, 2005, AUST NZ J PSYCHIAT, V39, P300, DOI 10.1111/j.1440-1614.2005.01572.x; Turbott J, 1996, AUST NZ J PSYCHIAT, V30, P720, DOI 10.3109/00048679609065037; UK National Institute for Health and Care Excellence, 2014, ANT POSTN MENT HLTH; Wan MW, 2008, GEN HOSP PSYCHIAT, V30, P177, DOI 10.1016/j.genhosppsych.2007.12.001; WINNICOTT DW, 1960, INT J PSYCHOANAL, V41, P585	42	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198241	10.1371/journal.pone.0198241	http://dx.doi.org/10.1371/journal.pone.0198241			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847584	gold, Green Submitted, Green Published			2022-12-26	WOS:000433634800060
J	Anand, U; Yiangou, Y; Akbar, A; Quick, T; MacQuillan, A; Fox, M; Sinisi, M; Korchev, YE; Jones, B; Bloom, SR; Anand, P				Anand, Uma; Yiangou, Yiangos; Akbar, Ayesha; Quick, Tom; MacQuillan, Anthony; Fox, Mike; Sinisi, Marco; Korchev, Yuri E.; Jones, Ben; Bloom, Steve R.; Anand, Praveen			Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons	PLOS ONE			English	Article							CAPSAICIN RESPONSES; INSULIN-SECRETION; FOOD-INTAKE; IN-VIVO; CELLS; LOCALIZATION; POLYPEPTIDE; CONTRIBUTE; EXENDIN-4; INCRETIN	Introduction Glucagon like-peptide 1 receptor (GLP-1R) agonists diminish appetite and may contribute to the weight loss in inflammatory bowel disease (IBD). Objectives The aim of this study was to determine, for the first time, the expression of GLP-1R by colon nerve fibres in patients with IBD, and functional effects of its agonists in cultured rat and human sensory neurons. Methods GLP-1R and other nerve markers were studied by immunohistochemistry in colon biopsies from patients with IBD (n = 16) and controls (n = 8), human dorsal root ganglia (DRG) tissue, and in GLP-1R transfected HEK293 cells. The morphological effects of incretin hormones oxyntomodulin, exendin-4 and glucagon were studied on neurite extension in cultured DRG neurons, and their functional effects on capsaicin and ATP signalling, using calcium imaging. Results Significantly increased numbers of colonic mucosal nerve fibres were observed in IBD biopsies expressing GLP-1R (p = 0.0013), the pan-neuronal marker PGP9.5 (p = 0.0008), and sensory neuropeptide CGRP (p = 0.0014). An increase of GLP-1R positive nerve fibres in IBD colon was confirmed with a different antibody to GLP-1R (p = 0.016). GLP-1R immunostaining was intensely positive in small and medium-sized neurons in human DRG, and in human and rat DRG cultured neurons. Co-localization of GLP-1R expression with neuronal markers in colon and DRG confirmed the neural expression of GLP-1R, and antibody specificity was confirmed in HEK293 cells transfected with the GLP-1R. Treatment with oxyntomodulin, exendin-4 and GLP-1 increased neurite length in cultured neurons compared with controls, but did not stimulate calcium influx directly, or affect capsaicin responses. However, exendin-4 significantly enhanced ATP responses in human DRG neurons. Conclusion Our results show that increased GLP-1R innervation in IBD bowel could mediate enhanced visceral afferent signalling, and provide a peripheral target for therapeutic intervention. The differential effect of GLP-1R agonists on capsaicin and ATP responses in neurons suggest they may not affect pain mechanisms mediated by the capsaicin receptor TRPV1, but may enhance the effects of purinergic agonists.	[Anand, Uma; Yiangou, Yiangos; Akbar, Ayesha; Quick, Tom; MacQuillan, Anthony; Fox, Mike; Sinisi, Marco; Korchev, Yuri E.; Anand, Praveen] Imperial Coll London, Hammersmith Hosp, Dept Med, Peripheral Neuropathy Unit,Ctr Clin Translat, London, England; [Anand, Uma] Imperial Coll London, Hammersmith Hosp, Dept Med, Nanomed Res Lab, London, England; [Quick, Tom; MacQuillan, Anthony; Fox, Mike; Sinisi, Marco] Royal Natl Orthopaed Hosp, Peripheral Nerve Injury Unit, Stanmore, Middx, England; [Jones, Ben; Bloom, Steve R.] Imperial Coll London, Hammersmith Hosp, Dept Med, Div Diabet Endocrinol & Metab, London, England	Imperial College London; Imperial College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Imperial College London	Anand, P (corresponding author), Imperial Coll London, Hammersmith Hosp, Dept Med, Peripheral Neuropathy Unit,Ctr Clin Translat, London, England.	p.anand@imperial.ac.uk	Jones, Ben/GXG-7037-2022	quick, tom/0000-0002-5342-1509; Anand, Uma/0000-0002-3704-4600	MRC [MR/R010676/1] Funding Source: UKRI; Medical Research Council [MR/R010676/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acosta A, 2014, GUT, V63, P687, DOI 10.1136/gutjnl-2013-306235; Ahren B, 2004, AM J PHYSIOL-REG I, V286, pR269, DOI 10.1152/ajpregu.00423.2003; Akbar A, 2008, GUT, V57, P923, DOI 10.1136/gut.2007.138982; Akbar A, 2010, GUT, V59, P767, DOI 10.1136/gut.2009.194449; Amato A, 2010, NEUROGASTROENT MOTIL, V22, P664, DOI 10.1111/j.1365-2982.2010.01476.x; Amato A, 2014, J ENDOCRINOL, V221, P29, DOI 10.1530/JOE-13-0525; Anand U, 2006, NEUROSCI LETT, V399, P51, DOI 10.1016/j.neulet.2006.01.046; Anand U, 2013, EUR J PAIN, V17, P1012, DOI 10.1002/j.1532-2149.2012.00269.x; Bang-Berthelsen CH, 2016, INFLAMM BOWEL DIS, V22, P2078, DOI 10.1097/MIB.0000000000000847; Brookes SJH, 2013, NAT REV GASTRO HEPAT, V10, P286, DOI 10.1038/nrgastro.2013.29; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG120, DOI 10.1152/ajpgi.00076.2012; Dakin CL, 2001, ENDOCRINOLOGY, V142, P4244, DOI 10.1210/en.142.10.4244; Delgado-Aros S, 2002, AM J PHYSIOL-GASTR L, V282, pG424; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Elsherif Y, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/762191; Fischer AJ, 2005, J NEUROSCI, V25, P10157, DOI 10.1523/JNEUROSCI.3247-05.2005; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164, DOI 10.1210/endo-126-4-2164; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; Himeno T, 2011, DIABETES, V60, P2397, DOI 10.2337/db10-1462; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huypens P, 2000, DIABETOLOGIA, V43, P1012, DOI 10.1007/s001250051484; Kanoski SE, 2011, ENDOCRINOLOGY, V152, P3103, DOI 10.1210/en.2011-0174; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Keller J, 2015, EUR J CLIN INVEST, V45, P1234, DOI 10.1111/eci.12542; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; KREYMANN B, 1987, LANCET, V2, P1300; LU M, 1993, ENDOCRINOLOGY, V132, P94, DOI 10.1210/en.132.1.94; Moran GW, 2012, REGUL PEPTIDES, V177, P40, DOI 10.1016/j.regpep.2012.04.006; Nakamura E, 2011, DIGESTION, V83, P13, DOI 10.1159/000323399; Naslund E, 1999, AM J PHYSIOL-REG I, V277, pR910, DOI 10.1152/ajpregu.1999.277.3.R910; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Plamboeck A, 2013, EUR J ENDOCRINOL, V169, P187, DOI 10.1530/EJE-13-0264; Puddu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/975032; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Quinson N, 2013, CAN J PHYSIOL PHARM, V91, P941, DOI 10.1139/cjpp-2013-0025; Reid TS., 2013, CLIN DIABETES, V31, P148, DOI DOI 10.2337/DIACLIN.31.4.148; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Rogers GJ, 2011, J PHYSIOL-LONDON, V589, P1081, DOI 10.1113/jphysiol.2010.198069; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Wynne K, 2006, INT J OBESITY, V30, P1729, DOI 10.1038/sj.ijo.0803344; Yiangou Y, 2001, NEUROGASTROENT MOTIL, V13, P365, DOI 10.1046/j.1365-2982.2001.00276.x; Yiangou Yiangos, 2011, J Pain Res, V4, P347, DOI 10.2147/JPR.S25189; Zhang Y, 2011, INVEST OPHTH VIS SCI, V52, P278, DOI 10.1167/iovs.09-4727; Zietek T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00154	48	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198024	10.1371/journal.pone.0198024	http://dx.doi.org/10.1371/journal.pone.0198024			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813107	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800040
J	Campmans, Z; van Rhijn, A; Dull, RM; Santen-Reestman, J; Taxis, K; Borgsteede, SD				Campmans, Zizi; van Rhijn, Arianne; Dull, Rene M.; Santen-Reestman, Jacqueline; Taxis, Katja; Borgsteede, Sander D.			Preventing dispensing errors by alerting for drug confusions in the pharmacy information system-A survey of users	PLOS ONE			English	Article							SOUND-ALIKE; LOOK-ALIKE; RESPONSE RATES; NAMES; MEDICINES; ONLINE; SAFETY	Introduction Drug confusion is thought to be the most common type of dispensing error. Several strategies can be implemented to reduce the risk of medication errors. One of these are alerts in the pharmacy information system. Objective To evaluate the experiences of pharmacists and pharmacy technicians with alerts for drug name and strength confusion. Methods In May 2017, a cross-sectional survey of pharmacists and pharmacy technicians was performed in community pharmacies in the Netherlands using an online questionnaire. Results Of the 269 respondents, 86% (n=230) had noticed the alert for drug name confusion, and 26% (n=67) for drug strength confusion. Of those 230, 9% (n=20) had experienced that the alert had prevented dispensing the wrong drug. For drug strength confusion, this proportion was 12% (n=8). Respondents preferred to have an alert for drug name and strength confusion in the pharmacy information system. 'Alert fatigue' was an important issue, so alerts should only be introduced for frequent confusions or confusions with serious consequences. Conclusion Pharmacists and pharmacy technicians were positive about having alerts for drug confusions in their pharmacy information system and experienced that alerts contributed to the prevention of dispensing errors. To prevent alert fatigue, it was considered important not to include all possible confusions as a new alert: the potential contribution to the prevention of drug confusion should be weighed against the risk of alert fatigue.	[Campmans, Zizi; Borgsteede, Sander D.] Hlth Base Fdn, Dept Clin Decis Support, Houten, Netherlands; [Campmans, Zizi; Taxis, Katja] Univ Groningen, Dept PharmacoTherapy Epidemiol & Econ PTEE, Groningen, Netherlands; [van Rhijn, Arianne; Santen-Reestman, Jacqueline] Cent Medicat Incidents Registrat, Portal Patient Safety, Utrecht, Netherlands; [Dull, Rene M.] SAL Pharm Schuytgraaf, Arnhem, Netherlands; [Borgsteede, Sander D.] Erasmus Univ, Med Ctr, Dept Hosp Pharm, Rotterdam, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC	Borgsteede, SD (corresponding author), Hlth Base Fdn, Dept Clin Decis Support, Houten, Netherlands.; Borgsteede, SD (corresponding author), Erasmus Univ, Med Ctr, Dept Hosp Pharm, Rotterdam, Netherlands.	sander.borgsteede@healthbase.nl	Taxis, Katja/ABE-2637-2021; Borgsteede, Sander Diederik/AAA-6553-2022	Taxis, Katja/0000-0001-8539-2004; 	SAL pharmacy Schuytgraaf	SAL pharmacy Schuytgraaf	The authors received no specific funding for this work. RMD is employed as pharmacist at SAL pharmacy Schuytgraaf. SAL pharmacy Schuytgraaf provided support in the form of salary for RMD, but did not have any additional role in the study design, data collection, analysis, decision to publish or preparation of the manuscript. The specific roles of the author is articulated in the 'author contributions' section.	Aerny-Perreten N, 2015, J EVAL CLIN PRACT, V21, P688, DOI 10.1111/jep.12367; Ancker JS, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0430-8; [Anonymous], NAT TALL MAN LETT LI; Anto Berko, 2011, Int J Pharm Pract, V19, P51, DOI 10.1111/j.2042-7174.2010.00072.x; Borgsteede S, 2016, PHARM WEEKBLAD, V151, P14; Cheung KC, 2014, J AM MED INFORM ASSN, V21, pE63, DOI 10.1136/amiajnl-2013-001818; Cheung KC, 2009, BRIT J CLIN PHARMACO, V67, P676, DOI 10.1111/j.1365-2125.2009.03428.x; Ciociano N, 2014, INT J CLIN PHARM-NET, V36, P233, DOI 10.1007/s11096-013-9885-6; DeHenau C, 2016, APPL ERGON, V52, P77, DOI 10.1016/j.apergo.2015.06.009; Eimermann V, 2014, PHARM WEEKBLAD, V149, P22; Emmerton LM, 2012, INT J CLIN PHARM-NET, V34, P4, DOI 10.1007/s11096-011-9595-x; Filik R, 2006, HUM FACTORS, V48, P39, DOI 10.1518/001872006776412199; Flynn Elizabeth Allan, 2003, J Am Pharm Assoc (Wash), V43, P191; Galanter WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101977; Health Quality & Safety Commission New Zealand (HQSC), 2013, TALL MAN LETT LIST R, P1; Institute for Safe Medication Practices (ISMP), 2016, SOC SCI MED, P6; James K Lynette, 2009, Int J Pharm Pract, V17, P9; KNMP, 2013, KNMP RICHTL TER HAND; Lambert BL, 2016, BMJ QUAL SAF, V25, P213, DOI 10.1136/bmjqs-2015-004929; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Or CKL, 2014, DRUG SAFETY, V37, P351, DOI 10.1007/s40264-014-0156-9; Ostini Remo, 2012, Int J Pharm Pract, V20, P349, DOI 10.1111/j.2042-7174.2012.00210.x; Peterson GM, 1999, J CLIN PHARM THER, V24, P57, DOI 10.1046/j.1365-2710.1999.00199.x; Pharmacy Board of Australia, 2015, GUID DISP MED, P16; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Stichting Farmaceutische Kengetallen, 2016, PHARM WEEKBL; The pharmacy Guild of Australia, 2013, DISP YOUR PRESCR MED, P2; Thompson CA, 2008, AM J HEALTH-SYST PH, V65, P386, DOI 10.2146/news080020; Tuohy N, 2005, J EMERG NURS, V31, P569, DOI 10.1016/j.jen.2005.07.012; Zhong WJ, 2016, BMJ QUAL SAF, V25, P233, DOI 10.1136/bmjqs-2015-004562	30	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197469	10.1371/journal.pone.0197469	http://dx.doi.org/10.1371/journal.pone.0197469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813099	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800016
J	Ghosh, A; Sarkar, S; Banerjee, S; Behbod, F; Tawfik, O; McGregor, D; Graff, S; Banerjee, SK				Ghosh, Arnab; Sarkar, Sandipto; Banerjee, Snigdha; Behbod, Fariba; Tawfik, Ossama; McGregor, Douglas; Graff, Stephanie; Banerjee, Sushanta K.			MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis	PLOS ONE			English	Article							MYOEPITHELIAL CELL; MESENCHYMAL TRANSITION; MAMMARY-TUMORS; MOUSE MODELS; EXPRESSION; RECEPTOR; MARKERS; MICROENVIRONMENT; MORPHOGENESIS; STATISTICS	Mouse models of breast cancer with specific molecular subtypes (e.g., ER or HER2 positive) in an immunocompetent or an immunocompromised environment significantly contribute to our understanding of cancer biology, despite some limitations, and they give insight into targeted therapies. However, an ideal triple-negative breast cancer (TNBC) mouse model is lacking. What has been missing in the TNBC mouse model is a sequential progression of the disease in an essential native microenvironment. This notion inspired us to develop a TNBC-model in syngeneic mice using a mammary intraductal (MIND) method. To achieve this goal, Mvt-1and 4T1 TNBC mouse cell lines were injected into the mammary ducts via nipples of FVB/N mice and BALB/c wild-type immunocompetent mice, respectively. We established that the TNBC-MIND model in syngeneic mice could epitomize all breast cancer progression stages and metastasis into the lungs via lymphatic or hematogenous dissemination within four weeks. Collectively, the syngeneic mouse-TNBC-MIND model may serve as a unique platform for further investigation of the underlying mechanisms of TNBC growth and therapies.	[Ghosh, Arnab; Sarkar, Sandipto; Banerjee, Snigdha; McGregor, Douglas; Graff, Stephanie; Banerjee, Sushanta K.] VA Med Ctr, Canc Res Unit, Kansas City, KS USA; [Ghosh, Arnab; Sarkar, Sandipto; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Banerjee, Snigdha; Behbod, Fariba; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Tawfik, Ossama] St Lukes Hosp Kansas City, Kansas City, MO USA; [McGregor, Douglas] VA Med Ctr, Dept Pathol, Kansas City, MO USA; [Graff, Stephanie] HCA Midwest Hlth, Sarah Cannon Canc Ctr, Overland Pk, KS USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Saint Luke's Hospital - Missouri; Sarah Cannon Research Institute	Banerjee, SK (corresponding author), VA Med Ctr, Canc Res Unit, Kansas City, KS USA.; Banerjee, SK (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.; Banerjee, SK (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	sbanerjee2@kumc.edu	Ghosh, Arnab/ABE-6292-2020; Banerjee, Sushanta/AAG-6534-2021	Banerjee, Sushanta/0000-0002-7698-0717; Ghosh, Arnab/0000-0003-0355-7763	Kansas City Area Life Science grant award; Department of Veterans Affairs [5I01BX001989-04, I01BX001002-05]; Grace Hortense Greenley Trust; Veterans Affairs [I01BX001002] Funding Source: NIH RePORTER	Kansas City Area Life Science grant award; Department of Veterans Affairs(US Department of Veterans Affairs); Grace Hortense Greenley Trust; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Kansas City Area Life Science grant award (Sushanta K. Banerjee), Merit review grant from Department of Veterans Affairs (Sushanta K. Banerjee, 5I01BX001989-04 and Snigdha Banerjee, I01BX001002-05), and Grace Hortense Greenley Trust, directed by The Research Foundation in memory of Eva Lee Caldwell (SKB and SG).	Adriance MC, 2005, BREAST CANCER RES, V7, P190, DOI 10.1186/bcr1286; American cancer Society, 2015, CANC FACTS FIG; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Aprelikova O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155262; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bailey-Downs LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098624; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Braber S, 2010, AM J PHYSIOL-LUNG C, V299, pL843, DOI 10.1152/ajplung.00192.2010; DeRose Yoko S, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1423s60; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Deugnier MA, 2002, BREAST CANCER RES, V4, P224, DOI 10.1186/bcr459; Dewar R, 2011, ARCH PATHOL LAB MED, V135, P422, DOI 10.1043/2010-0336-CP.1; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hamperl H, 1970, Curr Top Pathol, V53, P161; Heerboth S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0048-3; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Jonkers J, 2007, J MAMMARY GLAND BIOL, V12, P191, DOI 10.1007/s10911-007-9050-8; Kau P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-120; Khamis ZI, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/574025; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Kim JB, 2004, BREAST CANCER RES, V6, P22, DOI 10.1186/bcr645; Kittrell F., 2016, BIOPROTOCOL, V6; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Lakhani SR, 2001, BREAST CANCER RES, V3, P1, DOI 10.1186/bcr260; Lan Y, 2007, GENESIS, V45, P618, DOI 10.1002/dvg.20334; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Lu XM, 2004, STEM CELLS DEV, V13, P521, DOI 10.1089/scd.2004.13.521; Maity G, 2018, J BIOL CHEM, V293, P4334, DOI 10.1074/jbc.RA117.000333; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; Manning HC, 2016, J NUCL MED, V57, p60S, DOI 10.2967/jnumed.115.157917; McClatchey AI, 1999, ONCOGENE, V18, P5334, DOI 10.1038/sj.onc.1203086; Noblitt LW, 2005, CANCER GENE THER, V12, P46, DOI 10.1038/sj.cgt.7700763; NUNNERLEY HB, 1972, BRIT J RADIOL, V45, P717, DOI 10.1259/0007-1285-45-538-717; Pandey PR, 2010, FRONT BIOSCI-LANDMRK, V15, P226, DOI 10.2741/3617; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Plante Isabelle, 2011, J Vis Exp, DOI 10.3791/2828; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Rashid OM, 2013, J THORAC DIS, V5, P385, DOI 10.3978/j.issn.2072-1439.2013.06.17; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Rostoker R, 2015, GENOM DATA, V5, P399, DOI 10.1016/j.gdata.2015.06.032; Rostoker R, 2015, ENDOCR-RELAT CANCER, V22, P145, DOI 10.1530/ERC-14-0490; Sarkar S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.43; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Tordai A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2088; Tsai Ming-Ju, 2014, ISRN Biochem, V2014, P351959, DOI 10.1155/2014/351959; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valdez KE, 2011, J PATHOL, V225, P565, DOI 10.1002/path.2969; VANDENBRENK HAS, 1975, BRIT J CANCER, V31, P46, DOI 10.1038/bjc.1975.6; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P499, DOI 10.1111/j.1440-1681.2007.04601.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang Y, 2017, ONCOTARGET, V8, P30621, DOI 10.18632/oncotarget.15695; Ye Yumei, 2004, Breast Dis, V19, P69; Zelenko Z, 2017, ONCOGENE, V36, P1394, DOI 10.1038/onc.2016.305; Zhang XC, 2008, INT J BIOL SCI, V4, P259	75	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198143	10.1371/journal.pone.0198143	http://dx.doi.org/10.1371/journal.pone.0198143			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813119	Green Submitted, gold, Green Published			2022-12-26	WOS:000433521800050
J	Cai, JH; Kumar, P; Chopin, J; Miklavcic, SJ				Cai, Jinhai; Kumar, Pankaj; Chopin, Joshua; Miklavcic, Stanley J.			Land-based crop phenotyping by image analysis: Accurate estimation of canopy height distributions using stereo images	PLOS ONE			English	Article							SURFACE MODELS; PLANT; BIOMASS; YIELD	In this paper we report on an automated procedure to capture and characterize the detailed structure of a crop canopy by means of stereo imaging. We focus attention specifically on the detailed characteristic of canopy height distribution-canopy shoot area as a function of height-which can provide an elaborate picture of canopy growth and health under a given set of conditions. We apply the method to a wheat field trial involving ten Australian wheat varieties that were subjected to two different fertilizer treatments. A novel camera self-calibration approach is proposed which allows the determination of quantitative plant canopy height data (as well as other valuable phenotypic information) by stereo matching. Utilizing the canopy height distribution to provide a measure of canopy height, the results compare favourably with manual measurements of canopy height (resulting in an R-2 value of 0.92), and are indeed shown to be more consistent. By comparing canopy height distributions of different varieties and different treatments, the methodology shows that different varieties subjected to the same treatment, and the same variety subjected to different treatments can respond in much more distinctive and quantifiable ways within their respective canopies than can be captured by a simple trait measure such as overall canopy height.	[Cai, Jinhai; Kumar, Pankaj; Chopin, Joshua; Miklavcic, Stanley J.] Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5095, Australia	University of South Australia	Cai, JH; Miklavcic, SJ (corresponding author), Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5095, Australia.	Jinhai.cai@unisa.edu.au; Stan.Miklavcic@unisa.edu.au		Miklavcic, Stanley/0000-0002-2361-246X; Chopin, Joshua/0000-0002-5012-5827; Cai, Jinhai/0000-0002-7298-1579	Australian Research Council [LP140100347]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council: Linkage Program LP140100347. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Bendig J, 2015, INT J APPL EARTH OBS, V39, P79, DOI 10.1016/j.jag.2015.02.012; Bendig J, 2014, REMOTE SENS-BASEL, V6, P10395, DOI 10.3390/rs61110395; Cai J, 2012, IET IMAGE PROCESS, V6, P687, DOI 10.1049/iet-ipr.2011.0281; Cai JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157102; Cai JH, 2015, J EXP BOT, V66, P6551, DOI 10.1093/jxb/erv359; CHEN JM, 1991, AGR FOREST METEOROL, V57, P1, DOI 10.1016/0168-1923(91)90074-Z; Deery D, 2014, AGRONOMY-BASEL, V4, P349, DOI 10.3390/agronomy4030349; Fernandez MGS, 2017, PLANT PHYSIOL, V174, P2008, DOI 10.1104/pp.17.00707; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Furbank R. T., 2009, FUNCT PLANT BIOL, V36, P5; Harris BN, 2010, PLANT SOIL, V336, P377, DOI 10.1007/s11104-010-0489-9; Hartley RI, 1999, INT J COMPUT VISION, V35, P115, DOI 10.1023/A:1008115206617; Hirschmuller H, 2008, IEEE T PATTERN ANAL, V30, P328, DOI 10.1109/TPAMl.2007.1166; Holman FH, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8121031; Jin J, 2009, J FIELD ROBOT, V26, P591, DOI 10.1002/rob.20293; Kovalchuk N, 2017, FUNCT PLANT BIOL, V44, P290, DOI [10.1071/FP16202, 10.1071/fp16202]; Kumar P., 2012, P 27 C IM VIS COMP N, P301; Kumar P, 2014, I C CONT AUTOMAT ROB, P211, DOI 10.1109/ICARCV.2014.7064306; Kumar P, 2014, PLANT SOIL, V380, P193, DOI 10.1007/s11104-014-2071-3; Li B, 2013, IEEE INT C INT ROBOT, P1301, DOI 10.1109/IROS.2013.6696517; Li QY, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0231-1; Madec S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02002; Murakami T, 2012, COMPUT ELECTRON AGR, V89, P70, DOI 10.1016/j.compag.2012.08.003; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Sankaran S, 2015, EUR J AGRON, V70, P112, DOI 10.1016/j.eja.2015.07.004; Szeliski R., COMPUTER VISION ALGO; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Virlet N, 2017, FUNCT PLANT BIOL, V44, P143, DOI 10.1071/FP16163; Watanabe K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00421; Xiong X, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0157-7	31	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196671	10.1371/journal.pone.0196671	http://dx.doi.org/10.1371/journal.pone.0196671			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795568	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000433084300011
J	Heussler, CD; Walter, A; Oberkofler, H; Insam, H; Arthofer, W; Schlick-Steiner, BC; Steiner, FM				Heussler, Carina D.; Walter, Andreas; Oberkofler, Hannes; Insam, Heribert; Arthofer, Wolfgang; Schlick-Steiner, Birgit C.; Steiner, Florian M.			Influence of three artificial light sources on oviposition and half-life of the Black Soldier Fly, Hermetia illucens (Diptera: Stratiomyidae): Improving small-scale indoor rearing	PLOS ONE			English	Article							ESCHERICHIA-COLI; FLIES DIPTERA; LARVAE; REDUCTION; CHICKEN; WASTE	Hermetia illucens (L.), the Black Soldier Fly, has received increased scientific attention for its potential in circular waste management where larvae can serve as feedstuff for livestock and for biodiesel production. The flies occur naturally in (sub)-tropical and warm-temperate climates, and their mating depends on space and sunlight. Small-scale indoor rearing of Black Soldier Flies has been challenging because they react sensitive to artificial light sources and cage sizes, but recent studies have shown that small-scale rearing under artificial light is feasible. Here, we test the influence of three artificial light sources (light-emitting diodes, fluorescent lamps, and halogen lamps) on small-scale indoor rearing. Three experiments were conducted to compare oviposition traits (pre-oviposition period, total oviposition-period, and egg mass per female) and half-life among the three light sources. Oviposition did not differ among the three light sources, but male and female half-life did. Based on the performance of the light-emitting diodes and their outstanding energy efficiency, we recommend this light source for small-scale indoor rearing of Black Soldier Flies.	[Heussler, Carina D.; Oberkofler, Hannes; Arthofer, Wolfgang; Schlick-Steiner, Birgit C.; Steiner, Florian M.] Univ Innsbruck, Dept Ecol, Innsbruck, Austria; [Heussler, Carina D.; Walter, Andreas; Insam, Heribert] Univ Innsbruck, Dept Microbiol, Innsbruck, Austria; [Walter, Andreas] Management Ctr Innsbruck, Dept Biotechnol & Food Engn, Innsbruck, Austria	University of Innsbruck; University of Innsbruck	Heussler, CD (corresponding author), Univ Innsbruck, Dept Ecol, Innsbruck, Austria.; Heussler, CD (corresponding author), Univ Innsbruck, Dept Microbiol, Innsbruck, Austria.	Carina.Heussler@uibk.ac.at	Walter, Andreas/C-5286-2019; Insam, Heribert/B-4649-2013; Insam, Heribert/AAM-4543-2021	Insam, Heribert/0000-0002-5136-2752; Walter, Andreas/0000-0002-0018-8379; Steiner, Florian M./0000-0003-2414-4650; Schlick-Steiner, Birgit/0000-0003-4026-5778; Heussler, Carina Desiree/0000-0002-4716-2280	Austrian Science Fund (FWF) [P 26444-B22]; Austrian Study Grant Authority	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Study Grant Authority	This work was funded by the Austrian Science Fund (FWF) (P 26444-B22) and the corresponding author was funded by the Austrian Study Grant Authority.	Aldana J, 2016, U.S. Patent, Patent No. [WO2013166590 A1, 2013166590]; Banks IJ, 2014, TROP MED INT HEALTH, V19, P14, DOI 10.1111/tmi.12228; BOOTH DC, 1984, ENVIRON ENTOMOL, V13, P421, DOI 10.1093/ee/13.2.421; CALLAN E M, 1974, Entomologist's Monthly Magazine, V109, P232; Diener S, 2001, P WAST SAF 2 INT C S; Erickson MC, 2004, J FOOD PROTECT, V67, P685, DOI 10.4315/0362-028X-67.4.685; FURMAN DP, 1959, J ECON ENTOMOL, V52, P917, DOI 10.1093/jee/52.5.917; JAMES MAURICE T., 1935, BULL BROOKLYN ENT SOC, V30, P165; Ju RT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0116; Lalander C, 2013, SCI TOTAL ENVIRON, V458, P312, DOI 10.1016/j.scitotenv.2013.04.033; Li Q, 2011, FUEL, V90, P1545, DOI 10.1016/j.fuel.2010.11.016; Liu QL, 2008, ENVIRON ENTOMOL, V37, P1525, DOI 10.1603/0046-225X-37.6.1525; Manurung Robert, 2016, Journal of Entomology and Zoology Studies, V4, P1036; Nakamura S, 2016, APPL ENTOMOL ZOOL, V51, P161, DOI 10.1007/s13355-015-0376-1; Newton GL, 2005, S STAT SCI AN MAN WA; Nguyen TTX, 2015, ENVIRON ENTOMOL, V44, P406, DOI 10.1093/ee/nvv002; Oonincx DGAB, 2016, J INSECT PHYSIOL, V95, P133, DOI 10.1016/j.jinsphys.2016.10.006; Oonincx DGAB, 2015, J INSECTS FOOD FEED, V1, P131, DOI 10.3920/JIFF2014.0023; Rana K.S., 2015, INT J FISH AQUAC, V5, P41; Sheppard DC, 2002, J MED ENTOMOL, V39, P695, DOI 10.1603/0022-2585-39.4.695; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P309, DOI 10.1111/j.1749-7345.2007.00101.x; Taguchi T, 2008, IEEJ T ELECTR ELECTR, V3, P21, DOI 10.1002/tee.20228; TINGLE F C, 1975, Journal of the Georgia Entomological Society, V10, P179; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; Tomberlin JK, 2002, J ENTOMOL SCI, V37, P345, DOI 10.18474/0749-8004-37.4.345; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; Tomberlin JK, 2001, FLA ENTOMOL, V84, P729, DOI 10.2307/3496413; Zhang JB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20201; Zheng LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02563; Zheng LY, 2012, RENEW ENERG, V41, P75, DOI 10.1016/j.renene.2011.10.004; Zhou F, 2013, J MED ENTOMOL, V50, P1224, DOI 10.1603/ME13021	31	29	30	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197896	10.1371/journal.pone.0197896	http://dx.doi.org/10.1371/journal.pone.0197896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795660	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300092
J	Li, CX; Ke, Q; Yao, CG; Mi, Y; Liu, HM; Lv, YP; Yao, C				Li, Chengxiang; Ke, Qiang; Yao, Chenguo; Mi, Yan; Liu, Hongmei; Lv, Yanpeng; Yao, Cheng			Cell electrofusion based on nanosecond/microsecond pulsed electricl fields	PLOS ONE			English	Article							MEMBRANE PERMEABILIZATION; MODELING ELECTROPORATION; MAMMALIAN-CELLS; SINGLE; FUSION; LYMPHOCYTES; ULTRASHORT	Traditionally, microsecond pulsed electric field was widely used in cell electrofusion technology. However, it was difficult to fuse the cells with different sizes. Because the effect of electroporation based on microsecond pulses was greatly influenced by cell sizes. It had been reported that the differences between cell sizes can be ignored when cells were exposed to nanosecond pulses. However, pores induced by those short nanosecond pulses tended to be very small (0.9 nm) and the pores were more easy to recover. In this work, a finite element method was used to simulate the distribution, radius and density of the pores. The innovative idea of "cell electrofusion based on nanosecond/microsecond pulses" was proposed in order to combine the advantages of nanosecond pulses and microsecond pulses. The model consisted of two contact cells with different sizes. Three kinds of pulsed electric fields were made up of two 100-ns, 10-kV/cm pulses; two 10-mu s, 1-kV/cm pulses; and a sequence of a 100-ns, 10-kV/cm pulse, followed by a 10-mu s, 1-kV/cm pulse. Some obvious advantageous can be found when nanosecond/microsecond pulses were considered. The pore radius was large enough (70nm) and density was high (5x10(13)m(-2)) in the cell junction area. Moreover, pores in the non-contact area of the cell membrane were small (1-10 nm) and sparse (10(9)-10(12)m(-2)). Areas where the transmembrane voltage was higher than 1V were only concentrated in the cell junction. The transmembrane voltage of other areas were at most 0.6V when we tested the rest of the cell membrane. Cell fusion efficiency can be improved remarkably because electroporation was concentrated in the cell contact area.	[Li, Chengxiang; Ke, Qiang; Yao, Chenguo; Mi, Yan; Liu, Hongmei; Lv, Yanpeng; Yao, Cheng] Chongqing Univ, Sch Elect Engn, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China	Chongqing University	Li, CX (corresponding author), Chongqing Univ, Sch Elect Engn, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China.	lichengxiang@cqu.edu.cn	liu, hongmei/AAG-6494-2019	liu, hongmei/0000-0001-5193-9462; Yao, Chenguo/0000-0002-1781-2756	National Natural Science Foundation of China [51677017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the reviewers of this work for their valuable contributions. Financial Support: Project supported by the National Natural Science Foundation of China (51677017).	ASAMI K, 1989, BIOCHIM BIOPHYS ACTA, V1010, P49, DOI 10.1016/0167-4889(89)90183-3; Chang D. C, 1992, PLANT PHYSIOL, V99, p365 ; Chopinet L, 2013, J MEMBRANE BIOL, V246, P851, DOI 10.1007/s00232-013-9579-y; DeBruin KA, 1999, BIOPHYS J, V77, P1213, DOI 10.1016/S0006-3495(99)76973-0; Delemotte L, 2012, J MEMBRANE BIOL, V245, P531, DOI 10.1007/s00232-012-9434-6; Deminsky M, 2013, J MEMBRANE BIOL, V246, P821, DOI 10.1007/s00232-013-9552-9; Esser AT, 2009, TECHNOL CANCER RES T, V8, P289, DOI 10.1177/153303460900800406; FUKUDA T, 1987, BLOOD, V70, P612; Garner AL, 2007, BIOCHEM BIOPH RES CO, V362, P139, DOI 10.1016/j.bbrc.2007.07.159; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V341, P1266, DOI 10.1016/j.bbrc.2006.01.094; Gowrishankar TR, 2003, P NATL ACAD SCI USA, V100, P3203, DOI 10.1073/pnas.0636434100; Guo SQ, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.43; Hu Q, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031914; Joshi RP, 2004, IEEE T PLASMA SCI, V32, P1677, DOI 10.1109/TPS.2004.830971; Katja T, 2010, JOVE-J VIS EXP, pe1991 ; Kato M, 2011, J IMMUNOL METHODS, V373, P102, DOI 10.1016/j.jim.2011.08.008; Kiesel M, 2006, BIOPHYS J, V90, P4720, DOI 10.1529/biophysj.105.078725; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Lamberti P, 2013, IEEE T DIELECT EL IN, V20, P1231, DOI 10.1109/TDEI.2013.6571439; Liu LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158739; Luo LX., 2003, CELL FUSION TECHNOLO; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Napotnik TB, 2012, BIOELECTROMAGNETICS, V33, P257, DOI 10.1002/bem.20707; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2015, BBA-BIOMEMBRANES, V1848, P958, DOI 10.1016/j.bbamem.2014.12.026; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pucihar G, 2009, IEEE T BIO-MED ENG, V56, P1491, DOI 10.1109/TBME.2009.2014244; Rems L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03382; Scarlett SS, 2009, BBA-BIOMEMBRANES, V1788, P1168, DOI 10.1016/j.bbamem.2009.02.006; SCHNETTLER R, 1985, FEMS MICROBIOL LETT, V27, P195, DOI 10.1111/j.1574-6968.1985.tb00666.x; Silve A, 2012, BIOELECTROCHEMISTRY, V87, P260, DOI 10.1016/j.bioelechem.2011.10.002; SIXOU S, 1990, BIOCHIM BIOPHYS ACTA, V1028, P154, DOI 10.1016/0005-2736(90)90149-I; Sukhorukov VL, 2006, BIOCHEM BIOPH RES CO, V346, P829, DOI 10.1016/j.bbrc.2006.05.193; TEISSIE J, 1986, BIOCHEM BIOPH RES CO, V140, P258, DOI 10.1016/0006-291X(86)91084-3; Trontelj Katja, 2010, THESIS; Usaj M, 2010, J MEMBRANE BIOL, V236, P107, DOI 10.1007/s00232-010-9272-3; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Weaver JC, 2002, BIOELECTROCHEMISTRY, V56, P207, DOI 10.1016/S1567-5394(02)00038-5; Yao C, 2017, IEEE T BIOMEDICAL EN, V9294, P1, DOI DOI 10.1109/DASC.2017.8102101; Yao CG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173181; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Zgalin MK, 2012, J MEMBRANE BIOL, V245, P643, DOI 10.1007/s00232-012-9481-z; ZIMMERMANN U, 1984, CIBA F SYMP, V103, P60; Zimmermann U, 1984, CHARGE FIELD EFFECTS, p293 ; Zimmermann V, 1981, PLANTA, V151, P26, DOI [10.1007/BF00384233, DOI 10.1007/BF00384233]	47	5	6	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197167	10.1371/journal.pone.0197167	http://dx.doi.org/10.1371/journal.pone.0197167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795594	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300028
J	Heinicke, U; Haydn, T; Kehr, S; Vogler, M; Fulda, S				Heinicke, Ulrike; Haydn, Tinka; Kehr, Sarah; Vogler, Meike; Fulda, Simone			BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis	ONCOGENE			English	Article							MITOCHONDRIAL PATHWAY; ANTITUMOR-ACTIVITY; CANCER-THERAPY; MCL-1; JNJ-26481585; DISCOVERIES; RESISTANCE; CHILDREN; LEUKEMIA; OVERCOME	BH3 mimetics are emerging novel anticancer therapeutics that potently and specifically inhibit antiapoptotic BCL-2 proteins and thereby induce cell death in many cancer entities. Previously, we demonstrated that JNJ-26481585 (JNJ), a second-generation histone deacetylase inhibitor (HDACI), engages mitochondrial apoptosis via upregulation of several BH3-only proteins. In the present study, we describe synergistic interactions of JNJ with BH3 mimetics (i.e. ABT-737, ABT-199) in rhabdomyosarcoma (RMS) cells. Importantly, JNJ synergizes with ABT-199 to trigger apoptosis in primary-derived RMS cells isolated from tumor samples, underlining the translational importance of combining these compounds and their potential to improve cancer therapy. Importantly, JNJ/ABT-199 cotreatment also significantly inhibits long-term survival of RMS cells. Mechanistically, JNJ increases expression levels of the BH3-only protein BIM, while exposure to ABT-199 displaces BIM from BCL-2 and shuttles BIM to MCL-1, which also constitutively sequesters NOXA. Both BIM and NOXA contribute to JNJ/ABT-199-mediated cell death, as individual knockdown of NOXA or BIM significantly prevents cell death. Further, JNJ and ABT-199 act in concert to activate BAK and BAX, resulting in loss of the mitochondrial membrane potential (MMP) and caspase activation. These events are required for JNJ/ABT-199-mediated apoptosis, since BAK or BAX silencing or inhibition of caspases significantly protects from JNJ/ABT-199-induced cell death. Rescue experiments demonstrate that overexpression of MCL-1, but not overexpression of BCL-2, blocks JNJ/ABT-199-induced apoptosis. In conclusion, this study provides the first demonstration of ABT-199-induced priming, which sensitizes RMS cells to HDACI, such as JNJ, by engaging mitochondrial apoptosis, highlighting that BH3 mimetics show great promise for the treatment of RMS.	[Heinicke, Ulrike; Haydn, Tinka; Kehr, Sarah; Vogler, Meike; Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Germany; [Haydn, Tinka; Fulda, Simone] German Canc Consortium DKTK Partner Site, Frankfurt, Germany; [Haydn, Tinka; Fulda, Simone] German Canc Res Ctr, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ)	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Germany.; Fulda, S (corresponding author), German Canc Consortium DKTK Partner Site, Frankfurt, Germany.; Fulda, S (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	simone.fulda@kgu.de		Vogler, Meike/0000-0003-2650-586X; Fulda, Simone/0000-0002-0459-6417	BMBF; Deutsche Krebshilfe; Deutsche Kinderkrebsstiftung; Medical Faculty, Goethe-University Frankfurt	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Kinderkrebsstiftung; Medical Faculty, Goethe-University Frankfurt	We thank D. Bruecher for expert technical assistance and C. Hugenberg for excellent secretarial assistance. This work has been partially supported by grants from the BMBF, the Deutsche Krebshilfe and the Deutsche Kinderkrebsstiftung (to SF) and a grant from the Medical Faculty, Goethe-University Frankfurt (to MV).	Arts J, 2009, CLIN CANCER RES, V15, P6841, DOI 10.1158/1078-0432.CCR-09-0547; Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Carol H, 2014, PEDIATR BLOOD CANCER, V61, P245, DOI 10.1002/pbc.24724; Carter BZ, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.512.512; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Choudhary GS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.525; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dagher R, 1999, Oncologist, V4, P34; Dantonello TM, 2009, J CLIN ONCOL, V27, P1446, DOI 10.1200/JCO.2007.15.0466; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson Grant, 2015, Cold Spring Harb Protoc, V2015, P481, DOI 10.1101/pdb.prot086470; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Heinicke U, 2016, ONCOGENE, V35, P3729, DOI 10.1038/onc.2015.440; Heinicke U, 2015, ONCOTARGET, V6, P37836, DOI 10.18632/oncotarget.6097; Heinicke U, 2014, CANCER LETT, V351, P50, DOI 10.1016/j.canlet.2014.04.021; Hugle M, 2015, CELL DEATH DIFFER, V22, P1946, DOI 10.1038/cdd.2015.59; Khaw SL, 2014, LEUKEMIA, V28, P1207, DOI 10.1038/leu.2014.1; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Matthews GM, 2012, ADV CANCER RES, V116, P165, DOI 10.1016/B978-0-12-394387-3.00005-7; Michels J, 2014, BIOCHEM PHARMACOL, V92, P55, DOI 10.1016/j.bcp.2014.07.029; MILLER RW, 1995, CANCER, V75, P395, DOI 10.1002/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W; Niu XJ, 2016, CLIN CANCER RES, V22, P4440, DOI 10.1158/1078-0432.CCR-15-3057; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pazzaglia L, 2009, HISTOL HISTOPATHOL, V24, P61, DOI 10.14670/HH-24.61; Peirs S, 2014, BLOOD, V124, P3738, DOI 10.1182/blood-2014-05-574566; Phillips DC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.88; Portell CA, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.509.509; Preuss E, 2013, J BIOL CHEM, V288, P35287, DOI 10.1074/jbc.M113.495986; Sarosiek KA, 2016, FEBS J, V283, P3523, DOI 10.1111/febs.13714; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tong JS, 2017, CANCER RES, V77, P2512, DOI 10.1158/0008-5472.CAN-16-3242	39	22	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5325	5339		10.1038/s41388-018-0212-5	http://dx.doi.org/10.1038/s41388-018-0212-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29858601				2022-12-26	WOS:000445759700006
J	Cui, LG; Zhang, YJ; Deng, J; Xu, MZ				Cui, Ligang; Zhang, Yajun; Deng, Jie; Xu, Maozeng			A novel multi-item joint replenishment problem considering multiple type discounts	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION ALGORITHM; DETERMINING ORDER QUANTITIES; SUPPLIER SELECTION PROBLEM; INVENTORY SYSTEMS; UNCERTAIN DEMAND; DELIVERY PROBLEM; VOLUME DISCOUNT; MODEL; ENVIRONMENTS; IMPROVEMENT	In business replenishment, discount offers of multi-item may either provide different discount schedules with a single discount type, or provide schedules with multiple discount types. The paper investigates the joint effects of multiple discount schemes on the decisions of multi-item joint replenishment. In this paper, a joint replenishment problem (JRP) model, considering three discount (all-unit discount, incremental discount, total volume discount) offers simultaneously, is constructed to determine the basic cycle time and joint replenishment frequencies of multi-item. To solve the proposed problem, a heuristic algorithm is proposed to find the optimal solutions and the corresponding total cost of the JRP model. Numerical experiment is performed to test the algorithm and the computational results of JRPs under different discount combinations show different significance in the replenishment cost reduction.	[Cui, Ligang; Xu, Maozeng] Chongqing Jiaotong Univ, Sch Econ & Management, Chongqing 400074, Peoples R China; [Zhang, Yajun] Guizhou Univ Finance & Econ, Sch Business Adm, Guiyang 550025, Guizhou, Peoples R China; [Deng, Jie] Chongqing Univ Technol, Intellectual Property Inst Chongqing, Chongqing 400054, Peoples R China	Chongqing Jiaotong University; Guizhou University of Finance & Economics; Chongqing University of Technology	Zhang, YJ (corresponding author), Guizhou Univ Finance & Econ, Sch Business Adm, Guiyang 550025, Guizhou, Peoples R China.	zhangyajun99@163.com	Zhang, Yajun/HIR-1478-2022	XU, Maozeng/0000-0003-2231-4222; Cui, Ligang/0000-0001-6579-9958	National Natural Science Foundation of China [71602015, 71371080, 71471024]; Humanities and Social Sciences Foundation of the Chinese Ministry of Education [16YJC630014]; Social Science Planning Project of Chongqing [2015YBGL117]; Science and Technology Research Program of Chongqing Municipal Education Commission [KJ1500523, KJ1709208]; Fundamental and Frontier Research Project of Chongqing [cstc2016jcyjA0530]; Social Science Key Laboratory Program of Chongqing Municipal Education Commission [17SKJ033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Sciences Foundation of the Chinese Ministry of Education; Social Science Planning Project of Chongqing; Science and Technology Research Program of Chongqing Municipal Education Commission; Fundamental and Frontier Research Project of Chongqing; Social Science Key Laboratory Program of Chongqing Municipal Education Commission	This work was supported by National Natural Science Foundation of China (71602015 to LC; 71371080; 71471024 to MX), Humanities and Social Sciences Foundation of the Chinese Ministry of Education (16YJC630014) to LC, Social Science Planning Project of Chongqing (2015YBGL117) to LC, Science and Technology Research Program of Chongqing Municipal Education Commission (KJ1500523 to LC; KJ1709208 to JD), and Fundamental and Frontier Research Project of Chongqing (cstc2016jcyjA0530) to LC, Social Science Key Laboratory Program of Chongqing Municipal Education Commission (17SKJ033) to LC. Social Science Key Laboratory Program of Chongqing Municipal Education Commission 17SKJ033 Dr. Ligang Cui. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKIN E, 1989, OPER RES LETT, V8, P61, DOI 10.1016/0167-6377(89)90001-1; Ayhan MB, 2015, COMPUT IND ENG, V85, P1, DOI 10.1016/j.cie.2015.02.026; Cha BC, 2005, OR SPECTRUM, V27, P569, DOI 10.1007/s00291-005-0196-8; Chao XL, 2008, EUR J OPER RES, V191, P142, DOI 10.1016/j.ejor.2007.08.012; Cui LG, 2017, J CLEAN PROD, V142, P2028, DOI 10.1016/j.jclepro.2016.11.081; Cui LG, 2014, EXPERT SYST APPL, V41, P1792, DOI 10.1016/j.eswa.2013.08.078; Ebrahim RM, 2009, ADV ENG SOFTW, V40, P766, DOI 10.1016/j.advengsoft.2009.02.003; Eynan A, 1998, IIE TRANS, V30, P1025, DOI 10.1023/A:1007503629054; GOYAL SK, 1974, MANAGE SCI B-APPL, V21, P436, DOI 10.1287/mnsc.21.4.436; Haksever C, 2008, EUR J OPER RES, V184, P930, DOI 10.1016/j.ejor.2006.12.019; KASPI M, 1983, IIE TRANS, V15, P264, DOI 10.1080/05695558308974644; Khouja M, 2008, EUR J OPER RES, V186, P1, DOI 10.1016/j.ejor.2007.03.007; Lee AHI, 2013, APPL MATH MODEL, V37, P4733, DOI 10.1016/j.apm.2012.09.056; Lee FC, 2003, COMPUT OPER RES, V30, P1319, DOI 10.1016/S0305-0548(02)00073-4; Liu S, 2017, EUR J OPER RES, V260, P1115, DOI 10.1016/j.ejor.2017.01.020; Liu S, 2015, J OPER MANAG, V36, P46, DOI 10.1016/j.jom.2015.03.003; Lv SX, 2018, INT J MACH LEARN CYB, V9, P1623, DOI 10.1007/s13042-017-0669-5; Manerba D, 2012, EUR J OPER RES, V222, P287, DOI 10.1016/j.ejor.2012.04.028; Mansini R, 2012, OMEGA-INT J MANAGE S, V40, P445, DOI 10.1016/j.omega.2011.09.001; Moon IK, 2008, INT J SYST SCI, V39, P629, DOI 10.1080/00207720701832614; Munson CL, 2010, EUR J OPER RES, V201, P581, DOI 10.1016/j.ejor.2009.03.043; Munson C. L., 1998, Production and Operations Management, V7, P352, DOI 10.1111/j.1937-5956.1998.tb00129.x; Nilsson A, 2008, J OPER RES SOC, V59, P1415, DOI 10.1057/palgrave.jors.2602446; Nilsson A, 2007, INT J PROD ECON, V108, P399, DOI 10.1016/j.ijpe.2006.12.022; Paul S, 2014, COMPUT IND ENG, V74, P179, DOI 10.1016/j.cie.2014.05.015; Qin H, 2012, OMEGA-INT J MANAGE S, V40, P415, DOI 10.1016/j.omega.2011.05.005; Razmi J, 2010, INT J ADV MANUF TECH, V49, P379, DOI 10.1007/s00170-009-2392-1; Shi JM, 2010, INT J PROD ECON, V128, P322, DOI 10.1016/j.ijpe.2010.07.033; SHU FT, 1971, MANAGE SCI B-APPL, V17, pB406; SILVER EA, 1976, MANAGE SCI, V22, P1351, DOI 10.1287/mnsc.22.12.1351; Toptal A, 2009, EUR J OPER RES, V198, P504, DOI 10.1016/j.ejor.2008.09.037; VANEIJS MJG, 1992, EUR J OPER RES, V59, P405, DOI 10.1016/0377-2217(92)90197-H; Wang G, 2004, INT J PROD ECON, V91, P1, DOI 10.1016/S0925-5273(03)00221-4; Wang L., 2012, P IEEE INN SMART GRI, P1, DOI [DOI 10.1109/TGRS.2012.2225841, 10.1109/ISGT-Asia.2012.6303109, DOI 10.1109/ISGT-ASIA.2012.6303109]; Wang L, 2015, EXPERT SYST APPL, V42, P4310, DOI 10.1016/j.eswa.2015.01.048; Wang L, 2012, KNOWL-BASED SYST, V36, P104, DOI 10.1016/j.knosys.2012.06.007; Wildeman RE, 2006, EUR J OPER RES, V174, P1595, DOI [10.1016/j.ejor.2005.02.056, DOI 10.1016/J.EJOR.2005.02.056]; Xia WJ, 2007, OMEGA-INT J MANAGE S, V35, P494, DOI 10.1016/j.omega.2005.09.002; Xu JF, 2000, ANN OPER RES, V96, P317, DOI 10.1023/A:1018999418377; Yang W, 2012, EXPERT SYST APPL, V39, P3081, DOI 10.1016/j.eswa.2011.08.171; Zeng YR, 2016, INT J COMPUT INT SYS, V9, P1001, DOI 10.1080/18756891.2016.1256567; Zhang GQ, 2010, EUR J OPER RES, V206, P350, DOI 10.1016/j.ejor.2010.02.038; Zhang JL, 2013, COMPUT OPER RES, V40, P2703, DOI 10.1016/j.cor.2013.05.016; Zhang X, 2018, INFORM MANAGE-AMSTER, V55, P482, DOI 10.1016/j.im.2017.11.003	44	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0194738	10.1371/journal.pone.0194738	http://dx.doi.org/10.1371/journal.pone.0194738			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856746	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800003
J	Diamond-Smith, N; Rudolph, K				Diamond-Smith, Nadia; Rudolph, Kara			The association between uneven sex ratios and violence: Evidence from 6 Asian countries	PLOS ONE			English	Article							GENDER PREFERENCES; SON PREFERENCE; INDIA; CHINA; MEN; CHILDREN; CRIME; LESS; CARE	It has been hypothesized that uneven sex ratios in the population could lead to increased violence. The objective of this analysis is to explore the relationship between uneven sex ratios in the population and violence. This analysis uses data collected from men in six Asian countries about their experiences and perpetration of violence. We combine this with region-and age specific sex ratios calculated from Census data to explore the relationship between sex ratios and violence using multilevel models. We find that men from region-age brackets with higher ratios of men to women are significantly more likely to report ever having raped a woman, having perpetrated intimate partner violence, or having used a weapon. We find no evidence for an association between sex ratios and reports of ever having raped a man.	[Diamond-Smith, Nadia] Univ Calif San Francisco, Dept Epidemiol & Biostat & Global Hlth Sci, San Francisco, CA 94143 USA; [Rudolph, Kara] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Diamond-Smith, N (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat & Global Hlth Sci, San Francisco, CA 94143 USA.	Nadia.diamond-smith@ucsf.edu		Diamond-Smith, Nadia/0000-0002-8711-3029	Robert Wood Johnson Foundation Health and Society Scholars Program	Robert Wood Johnson Foundation Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF))	KR was supported by the Robert Wood Johnson Foundation Health and Society Scholars Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeykoon A T, 1995, Asia Pac Popul J, V10, P5; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Barcellos S, 2012, CHILD GENDER PARENTA; Bongaarts J, 2015, POPUL DEV REV, V41, P241, DOI 10.1111/j.1728-4457.2015.00046.x; Bose S, 2013, EC POLITICAL WEEKLY; BunRong K, 2012, EUBIOS J ASIAN INT B, V22; Canudas-Romo V., 2015, Asia-Pacific Population Journal, V30, P1; Cavanaugh MM, 2012, J HUM BEHAV SOC ENVI, V22, P607, DOI 10.1080/10911359.2011.598757; Chiapa C, 2012, MIGRATION SEX RATIOS; Choucri Nazli, 1974, POPULATION DYNAMICS; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; De Boeck P, 2011, J STAT SOFTWARE, V39; Diamond-Smith N, 2015, DEMOGRAPHY, V52, P641, DOI 10.1007/s13524-014-0356-z; Dobash R.E., 1979, VIOLENCE WIVES CASE; Edlund L, 2007, MORE MEN MORE CRIME; Edlund L, 2013, REV ECON STAT, V95, P1520, DOI 10.1162/REST_a_00356; Fulu E, 2013, QUANTITATIVE FINDING; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Fuse K, 2010, DEMOGR RES, V23, P1031, DOI 10.4054/DemRes.2010.23.36; Guilmoto CZ, 2015, POP STUD-J DEMOG, V69, P299, DOI 10.1080/00324728.2015.1091603; Guilmoto CZ, 2012, DEMOGRAPHY, V49, P77, DOI 10.1007/s13524-011-0083-7; Guilmoto CZ, 2009, POPUL DEV REV, V35, P519, DOI 10.1111/j.1728-4457.2009.00295.x; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hesketh T, 2011, EARLY HUM DEV, V87, P759, DOI 10.1016/j.earlhumdev.2011.08.016; HOSSAIN MM, 1988, AM J PUBLIC HEALTH, V78, P1349, DOI 10.2105/AJPH.78.10.1349; Hudson VM, 2002, INT SECURITY, V26, P5, DOI 10.1162/016228802753696753; KABEER N., 2013, FEMINIST EC, V20, P138; Khan MA, 2000, ASIA PAC POPULAT J, V15, P43; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Park CB, 1995, POPULATION DEV REV, V21; Raj A, 2014, LANCET, V383, P865, DOI 10.1016/S0140-6736(14)60435-9; Schacht R, 2016, HUM NATURE-INT BIOS, V27, P489, DOI 10.1007/s12110-016-9271-x; Schacht R, 2014, TRENDS ECOL EVOL, V29, P214, DOI 10.1016/j.tree.2014.02.001; South SJ, 2014, DEMOGRAPHY, V51, P1019, DOI 10.1007/s13524-014-0289-6; Tracer DP, 2009, AM J HUM BIOL, V21, P635, DOI 10.1002/ajhb.20928; Trent K, 2012, J MARRIAGE FAM, V74, P201, DOI 10.1111/j.1741-3737.2011.00875.x; Zimmer Z, 2001, J Cross Cult Gerontol, V16, P353, DOI 10.1023/A:1014582603718	37	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197516	10.1371/journal.pone.0197516	http://dx.doi.org/10.1371/journal.pone.0197516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856763	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800028
J	Hou, Y; Yao, Q; Zhang, GN; Ding, LX; Huang, H				Hou, Yu; Yao, Qi; Zhang, Genai; Ding, Lixiang; Huang, Hui			Polymethylmethacrylate distribution is associated with recompression after vertebroplasty or kyphoplasty for osteoporotic vertebral compression fractures: A retrospective study	PLOS ONE			English	Article							PERCUTANEOUS VERTEBROPLASTY; STRUCTURAL-PROPERTIES; CEMENT AUGMENTATION; BALLOON KYPHOPLASTY; VOLUME; BODY; RESTORATION; BEHAVIOR; DENSITY; LEVEL	Background Osteoporotic vertebral compression fracture, always accompanied with pain and height loss of vertebral body, has a significant negative impact on life quality of patients. Vertebroplasty or kyphoplasty is minimal invasive techniques to reconstruct the vertebral height and prevent further collapse of the fractured vertebrae by injecting polymethylmethacrylate into vertebral body. However, recompression of polymethylmethacrylate augmented vertebrae with significant vertebral height loss and aggressive local kyphotic was observed frequently after VP or KP. The purpose of this study was to investigate the effect of polymethylmethacrylate distribution on recompression of the vertebral body after vertebroplasty or kyphoplasty surgery for osteoporotic vertebral compression fracture. Methods A total of 281 patients who were diagnosed with vertebral compression fracture (T5-L5) from June 2014 to June 2016 and underwent vertebroplasty or kyphoplasty by polymethylmethacrylate were retrospectively analyzed. The X-ray films at 1 day and 12 months after surgery were compared to evaluate the recompression of operated vertebral body. Patients were divided into those without recompression (non-recompression group) and those with recompression (recompression group). Polymethylmethacrylate distribution pattern, including location and relationship to endplates, was compared between the two groups by lateral X-ray film. Multivariate logistic regression analysis was performed to assess the potential risk factors associated with polymethylmethacrylate distribution for recompression. Results One hundred and six (37.7%) patients experienced recompression after surgery during the follow-up period. The polymethylmethacrylate distributed in the middle of vertebral body showed significant differences between two groups. In non-recompression group, the polymethylmethacrylate in the middle portion of vertebral body were closer to endplates than that in the recompression group (upper: t = 31.41, p< 0.001; lower: t = 12.19, p< 0.001). The higher percentage of the height of polymethylmethacrylate in the middle portion of vertebral body indicates the lower risk of recompression (odds ratio [OR]< 0.01, p< 0.001). The recompression group and non- recompression group showed significant difference in "contacted" polymethylmethacrylate distribution pattern (polymethylmethacrylate contacted to the both upper/ lower endplates) (chi(2) = 66.23, p< 0.001). The vertebra with a "contacted" polymethylmethacrylate distribution pattern has lower risk of recompression (OR = 0.09, p< 0.001). Conclusions Either more polymethylmethacrylate in the middle portion of vertebral body or "contacted" polymethylmethacrylate distribution pattern had a significantly less incidence of recompression. The findings indicated that the control of polymethylmethacrylate distribution during surgery may reduce the risks of recompression after vertebroplasty or kyphoplasty.	[Hou, Yu; Yao, Qi; Zhang, Genai; Ding, Lixiang; Huang, Hui] Capital Med Univ, Beijing Shijitan Hosp, Dept Orthoped, Beijing, Peoples R China	Capital Medical University	Hou, Y; Ding, LX (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Dept Orthoped, Beijing, Peoples R China.	13810276769@163.com; dinglx@163.com			Beijing Municipal Administration of Hospitals' Youth Programme [QML20150702]; Beijing Natural Science Foundation [7172107]; Basic and Clinical Joint Foundation of Capital Medical University [16JL53]; Beijing Municipal Commission of Science and Technology Fund [Z151100003915094]	Beijing Municipal Administration of Hospitals' Youth Programme; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Basic and Clinical Joint Foundation of Capital Medical University; Beijing Municipal Commission of Science and Technology Fund	This work received support from the Beijing Municipal Administration of Hospitals' Youth Programme (no. QML20150702), http.//www.bjah.gov.cn/; the Beijing Natural Science Foundation (no. 7172107), http//bjnsf.bjkw.gov.cn/; the Basic and Clinical Joint Foundation of Capital Medical University (no. 16JL53), http://www.ccmu.edu.cn/; and Beijing Municipal Commission of Science and Technology Fund (no. Z151100003915094), http://www.bjkw.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz G, 2017, EUR SPINE J; Buchbinder R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006349.pub2; Grant JP, 2001, SPINE, V26, P889, DOI 10.1097/00007632-200104150-00012; Ha KY, 2013, OSTEOPOROSIS INT, V24, P1207, DOI 10.1007/s00198-012-2065-z; Heo DH, 2009, OSTEOPOROSIS INT, V20, P473, DOI 10.1007/s00198-008-0682-3; Hou Y, 2009, SPINE, V34, pE427, DOI 10.1097/BRS.0b013e3181a2ea0a; Jansen LE, 2015, J MECH BEHAV BIOMED, V50, P299, DOI 10.1016/j.jmbbm.2015.06.023; Kim DJ, 2010, J KOREAN NEUROSURG S, V48, P125, DOI 10.3340/jkns.2010.48.2.125; Kim MJ, 2006, SPINE, V31, P2079, DOI 10.1097/01.brs.0000231714.15876.76; Kim YY, 2010, EUR SPINE J, V19, P1907, DOI 10.1007/s00586-010-1479-6; Lador R, 2010, SPINE J, V10, P1128, DOI 10.1016/j.spinee.2010.09.025; Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009; Lowe TG, 2004, SPINE, V29, P2389, DOI 10.1097/01.brs.0000143623.18098.e5; McKiernan F, 2003, SPINE, V28, P2517, DOI 10.1097/01.BRS.0000092424.29886.C9; Molloy S, 2003, SPINE, V28, P1549, DOI 10.1097/00007632-200307150-00014; Molloy S, 2005, AM J NEURORADIOL, V26, P401; Niu JJ, 2015, ACTA RADIOL, V56, P1380, DOI 10.1177/0284185114556016; Rohlmann A, 2006, EUR SPINE J, V15, P1255, DOI 10.1007/s00586-005-0018-3; Tan Eelin, 2016, J Spine Surg, V2, P111, DOI 10.21037/jss.2016.06.05; Weng DHH, 2015, SPINE, V40, P1903, DOI 10.1097/BRS.0000000000001066; Wilke HJ, 2006, SPINE, V31, P2934, DOI 10.1097/01.brs.0000248423.28511.44; Zhang L, 2017, CLIN INTERV AGING, V12, P431, DOI 10.2147/CIA.S113240	22	12	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198407	10.1371/journal.pone.0198407	http://dx.doi.org/10.1371/journal.pone.0198407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856859	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800117
J	Morales-Cordovilia, JA; Sanchez, V; Ratajczak, M				Morales-Cordovilia, Juan A.; Sanchez, Victoria; Ratajczak, Martin			Protein alignment based on higher order conditional random fields for template-based modeling	PLOS ONE			English	Article							PREDICTION; SEARCH; SERVER	The query-template alignment of proteins is one of the most critical steps of template-based modeling methods used to predict the 3D structure of a query protein. This alignment can be interpreted as a temporal classification or structured prediction task and first order Conditional Random Fields have been proposed for protein alignment and proven to be rather successful. Some other popular structured prediction problems, such as speech or image classification, have gained from the use of higher order Conditional Random Fields due to the well known higher order correlations that exist between their labels and features. In this paper, we propose and describe the use of higher order Conditional Random Fields for query-template protein alignment. The experiments carried out on different public datasets validate our proposal, especially on distantly-related protein pairs which are the most difficult to align.	[Morales-Cordovilia, Juan A.; Sanchez, Victoria] Univ Granada, Dept Teoria Senal Telemat & Comunicac, Granada, Spain; [Ratajczak, Martin] Graz Univ Technol, Signal Proc & Speech Commun Lab, Graz, Austria	University of Granada; Graz University of Technology	Morales-Cordovilia, JA (corresponding author), Univ Granada, Dept Teoria Senal Telemat & Comunicac, Granada, Spain.	jamc@ugr.es		Sanchez Calle, Victoria Eugenia/0000-0003-1546-9728	Consejeria de Economia, Innovacion y Ciencia (Junta de Andalucia) [P12.TIC.1485]; Spanish MINECO/FEDER Project [TEC2016-80141-P]	Consejeria de Economia, Innovacion y Ciencia (Junta de Andalucia)(Junta de Andalucia); Spanish MINECO/FEDER Project	This research was supported by Project P12.TIC.1485 funded by Consejeria de Economia, Innovacion y Ciencia (Junta de Andalucia) and Spanish MINECO/FEDER Project TEC2016-80141-P.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arnab A, 2016, LECT NOTES COMPUT SC, V9906, P524, DOI 10.1007/978-3-319-46475-6_33; Bernardes Juliana S, 2013, Recent Pat Biotechnol, V7, P122; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Cheng Jianlin, 2008, IEEE Rev Biomed Eng, V1, P41, DOI 10.1109/RBME.2008.2008239; Clares JD, 2017, IEEE INT C TEL SIGN; Do CB, 2006, LECT NOTES COMPUTER, P3909; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jo T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17573; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Lackner P, 2000, PROTEIN ENG, V13, P745, DOI 10.1093/protein/13.11.745; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Lindahl E, 2000, J MOL BIOL, V295, P613, DOI 10.1006/jmbi.1999.3377; Ma J., 2015, PROTEIN STRUCTURE PR; Ma JZ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003500; Ma JZ, 2012, BIOINFORMATICS, V28, pI59, DOI 10.1093/bioinformatics/bts213; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Peng JA, 2010, BIOINFORMATICS, V26, pi294, DOI 10.1093/bioinformatics/btq192; Peng J, 2009, LECT NOTES COMPUT SC, V5541, P31, DOI 10.1007/978-3-642-02008-7_3; Qian Xian, 2009, ICML; Ratajczak M, 2016, INTERSPEECH, P2756, DOI 10.21437/Interspeech.2016-832; Ratajczak M, 2017, INTERSPEECH, P1318, DOI 10.21437/Interspeech.2017-1064; Ratajczak M, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P2137; Ratajczak M, 2015, LECT NOTES ARTIF INT, V9284, P168, DOI 10.1007/978-3-319-23528-8_11; Service R. F., 2016, SCIENCE; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Wang C, 2016, BIOINFORMATICS, V32, P462, DOI 10.1093/bioinformatics/btv581; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01448; Wang Sheng, 2008, Journal of Bioinformatics and Computational Biology, V6, P347, DOI 10.1142/S0219720008003461; Wang ZY, 2011, PROTEOMICS, V11, P3786, DOI 10.1002/pmic.201100196; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Ye N., 2013, PROBABILISTIC LEARNI; Ye Nan, 2009, ADV NEURAL INFORM PR, P2196; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	42	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197912	10.1371/journal.pone.0197912	http://dx.doi.org/10.1371/journal.pone.0197912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856860	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800050
J	Vij, R; Lin, ZH; Schneider, K; Seshasayee, D; Koerber, JT				Vij, Rajesh; Lin, Zhonghua; Schneider, Kellen; Seshasayee, Dhaya; Koerber, James T.			Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization	PLOS ONE			English	Article							INFLUENZA-VIRUS CHALLENGE; DNA VACCINE POTENCY; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; EPICUTANEOUS IMMUNIZATION; TRANSGENE EXPRESSION; TOPICAL APPLICATION; MEMBRANE-PROTEINS; IMMUNE-RESPONSES; UBIQUITIN-C	Monoclonal antibodies (mAbs) have enabled numerous basic research discoveries and therapeutic approaches for many protein classes. However, there still exist a number of target classes, such as multi-pass membrane proteins, for which antibody discovery is difficult, due in part to lack of high quality, recombinant protein. Here we describe the impact of several parameters on antigen expression and the development of mAbs against human claudin 4 (CLDN4), a potential multi-indication cancer target. Using gene gun-based DNA delivery and bioluminescence imaging, we optimize promoter type by comparing expression profiles of four robust in vivo promoters. In addition, we observe that most vectors rapidly lose expression, ultimately reaching almost background levels by three days post-delivery. Recognizing this limitation, we next explored skin pretreatment strategies as an orthogonal method to further boost the efficiency of mAb generation. We show that SDS pretreatment can boost antigen expression, but fails to significantly increase mAb discovery efficiency. In contrast, we find that sandpaper pretreatment yields 5-fold more FACS(+) anti-CLDN4 hybridomas, without impacting antigen expression. Our findings coupled with other strategies to improve DNA immunizations should improve the success of mAb discovery against other challenging targets and enable the generation of critical research tools and therapeutic candidates.	[Vij, Rajesh; Lin, Zhonghua; Schneider, Kellen; Seshasayee, Dhaya; Koerber, James T.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Koerber, JT (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	koerber.james@gene.com						Bates MK, 2006, BIOTECHNIQUES, V40, P199, DOI 10.2144/000112088; Chambers RS, 2003, NAT BIOTECHNOL, V21, P1088, DOI 10.1038/nbt858; Chen HM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-42; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cheng JK, 2016, ACS SYNTH BIOL, V5, P1455, DOI 10.1021/acssynbio.6b00075; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Cooper AR, 2015, NUCLEIC ACIDS RES, V43, P682, DOI 10.1093/nar/gku1312; De Benedetto A, 2012, J INVEST DERMATOL, V132, P949, DOI 10.1038/jid.2011.435; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Douthwaite JA, 2015, MABS-AUSTIN, V7, P152, DOI 10.4161/19420862.2014.985158; England E, 2015, J BIOMOL SCREEN, V20, P536, DOI 10.1177/1087057114557776; Frerichs DM, 2008, VACCINE, V26, P2782, DOI 10.1016/j.vaccine.2008.02.070; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Hansen DT, 2016, SCI REP-UK, V6, DOI 10.1038/srep21925; Hazen M, 2014, MABS-AUSTIN, V6, P95, DOI 10.4161/mabs.26761; Hensley SE, 2007, MOL THER, V15, P393, DOI 10.1038/sj.mt.6300024; Hotzel I, 2011, PROTEIN ENG DES SEL, V24, P679, DOI 10.1093/protein/gzr039; Hornsby M, 2015, MOL CELL PROTEOMICS, V14, P2833, DOI 10.1074/mcp.O115.052209; Hough CD, 2000, CANCER RES, V60, P6281; Huang CM, 2006, MOL CELL PROTEOMICS, V5, P523, DOI 10.1074/mcp.M500259-MCP200; Hutchings CJ, 2017, NAT REV DRUG DISCOV, V16, P661, DOI 10.1038/nrd.2017.173; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kahlon R, 2003, VACCINE, V21, P2890, DOI 10.1016/S0264-410X(03)00141-5; Kato-Nakano M, 2010, ANTICANCER RES, V30, P4555; Kim DJ, 2007, HUM GENE THER, V18, P1129, DOI 10.1089/hum.2007.090; Kim TW, 2003, J CLIN INVEST, V112, P109, DOI 10.1172/JCI200317293; Kissenpfennig A, 2006, TRENDS IMMUNOL, V27, P132, DOI 10.1016/j.it.2006.01.003; Lauterbach H, 2006, J IMMUNOL, V176, P4600, DOI 10.4049/jimmunol.176.8.4600; Lee KJ, 2014, J PHARMACOL EXP THER, V350, P223, DOI 10.1124/jpet.114.215574; Liu LJ, 2001, VACCINE, V20, P42, DOI 10.1016/S0264-410X(01)00324-3; Liu SY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.27; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Morita A, 2001, GENE THER, V8, P1729, DOI 10.1038/sj.gt.3301580; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Neesse A, 2012, ARCH BIOCHEM BIOPHYS, V524, P64, DOI 10.1016/j.abb.2012.01.009; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Raju PA, 2006, VACCINE, V24, P4644, DOI 10.1016/j.vaccine.2005.08.067; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Sasaki S, 2002, GENE THER, V9, P828, DOI 10.1038/sj.gt.3301696; Schlabach MR, 2010, P NATL ACAD SCI USA, V107, P2538, DOI 10.1073/pnas.0914803107; Sellins K, 2005, MOL THER, V12, P451, DOI 10.1016/j.ymthe.2005.04.008; Shinoda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30442; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Sung RS, 2001, MOL THER, V3, P757, DOI 10.1006/mthe.2001.0318; Suschak JJ, 2015, J IMMUNOL, V194, P630, DOI 10.4049/jimmunol.1402530; Suzuki M, 2009, CANCER SCI, V100, P1623, DOI 10.1111/j.1349-7006.2009.01239.x; Takeda H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11333; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Torres CAT, 1997, J IMMUNOL, V158, P4529; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang SX, 2006, VACCINE, V24, P4531, DOI 10.1016/j.vaccine.2005.08.023; Watabe S, 2001, VACCINE, V19, P4434, DOI 10.1016/S0264-410X(01)00194-3; Wilkinson TCI, 2015, J BIOMOL SCREEN, V20, P454, DOI 10.1177/1087057114560698; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671	58	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197962	10.1371/journal.pone.0197962	http://dx.doi.org/10.1371/journal.pone.0197962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856790	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800055
J	Diiro, GM; Seymour, G; Kassie, M; Muricho, G; Muriithi, BW				Diiro, Gracious M.; Seymour, Greg; Kassie, Menale; Muricho, Geoffrey; Muriithi, Beatrice Wambui			Women's empowerment in agriculture and agricultural productivity: Evidence from rural maize farmer households in western Kenya	PLOS ONE			English	Article							FRACTIONAL RESPONSE VARIABLES; GENDER DIFFERENTIALS; FOOD SECURITY; ALLOCATION; EFFICIENCY; DECISIONS; NUTRITION; AFRICA; HEALTH	This paper documents a positive relationship between maize productivity in western Kenya and women's empowerment in agriculture, measured using indicators derived from the abbreviated version of the Women's Empowerment in Agriculture Index. Applying a cross-sectional instrumental-variable regression method to a data set of 707 maize farm house-holds from western Kenya, we find that women's empowerment in agriculture significantly increases maize productivity. Although all indicators of women's empowerment significantly increase productivity, there is no significant association between the women's workload (amount of time spent working) and maize productivity. Furthermore, the results show heterogenous effects with respect to women's empowerment on maize productivity for farm plots managed jointly by a male and female and plots managed individually by only a male or female. More specifically, the results suggest that female-and male-managed plots experience significant improvements in productivity when the women who tend them are empowered. These findings provide evidence that women's empowerment contributes not only to reducing the gender gap in agricultural productivity, but also to improving, specifically, productivity from farms managed by women. Thus, rural development interventions in Kenya that aim to increase agricultural productivity-and, by extension, improve food security and reduce poverty-could achieve greater impact by integrating women's empowerment into existing and future projects.	[Diiro, Gracious M.; Kassie, Menale; Muricho, Geoffrey; Muriithi, Beatrice Wambui] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Seymour, Greg] Int Food Policy Res Inst, CGIAR Res Program Policies Inst & Markets, Washington, DC 20036 USA	International Centre of Insect Physiology & Ecology (ICIPE); CGIAR; International Food Policy Research Institute (IFPRI)	Diiro, GM (corresponding author), Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.	gdiiro@icipe.org	Muriithi, Beatrice/ABA-9991-2020; Kassie, Menale/ADT-2906-2022	Muriithi, Beatrice/0000-0001-7946-8949; Seymour, Greg/0000-0002-2213-0450; , Menale Kassie/0000-0002-6754-2432; Diiro, Gracious/0000-0002-7345-4244	UK's Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); German Federal Ministry for Economic Cooperation and Development (BMZ); Kenyan Government; European Union; Biovision Foundation; UK Government's Department for International Development (DFID)	UK's Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); German Federal Ministry for Economic Cooperation and Development (BMZ); Kenyan Government; European Union(European Commission); Biovision Foundation; UK Government's Department for International Development (DFID)	We acknowledge core funding to the International Centre of Insect Physiology and Ecology (icipe) provided by UK's Department for International Development (DFID), the Swedish International Development Cooperation Agency (Sida), the Swiss Agency for Development and Cooperation (SDC), the German Federal Ministry for Economic Cooperation and Development (BMZ), and the Kenyan Government. The work on push-pull technology is funded primarily by the European Union, with additional support from the Biovision Foundation and the UK Government's Department for International Development (DFID). We also thank Emily Kimathi for producing study area map and Sandie Fitchat for language editing. The views expressed herein do not necessarily reflect the official opinion of the donors or icipe.	Adato M., 2000, IMPACT PROGRESA WOME; Aguilar A, 2015, AGR ECON-BLACKWELL, V46, P311, DOI 10.1111/agec.12167; Ahearn MC, 2010, 3 GLOB C AGR RUR HOU; Akpan NS, 2015, SOCIAL SCI, V4, P110; Alene AD, 2008, WORLD DEV, V36, P1247, DOI 10.1016/j.worlddev.2007.06.015; Alkire S, 2013, WORLD DEV, V52, P71, DOI 10.1016/j.worlddev.2013.06.007; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; Browning M, 1998, ECONOMETRICA, V66, P1241, DOI 10.2307/2999616; Doss C, 2006, J AFR ECON, V15, P149, DOI 10.1093/jae/eji025; Doss C., 1996, STAFF PAPER SERIES U, V96-11; Doss C, 2002, AGR EC, V25, P27; Doss C., 2013, J AFRICAN EC, V23, pi62; DUFLO E., 2004, NATL BUREAU EC RES W, V10498, P37; Ellis A.M., 2005, GENDER EC GROWTH UGA; Ending Rural Hunger, 2016 DAT; FAO, 2018, FOOD SEC STAT; Farnworth C.R., 2015, J GENDER AGR FOOD SE, V1, P20, DOI [https://doi.org/10.22004/ag.econ.246040, DOI 10.22004/AG.ECON.246040]; FIDA/Federation of Women Lawyers Kenya, 2009, WOM LAND PROP RIGHT; Fischer E, 2012, FOOD SECUR, V4, P441, DOI 10.1007/s12571-012-0199-7; Folbre N., 2013, J AFRICAN EC, V23, pi128; Food and Agriculture Organization (FAO), 2011, STAT FOOD AGR 2010 2; Gilbert G. A., 2002, AFRICAN STUDIES Q, V6, P223; Heyer A., 2006, REV AFRICAN POLITICA, V107, P67; HODDINOTT J, 1995, OXFORD B ECON STAT, V57, P77, DOI 10.1111/j.1468-0084.1995.tb00028.x; Houston J. E., 2014, Journal of Food Distribution Research, V45, P35; JACOBY HG, 1995, J POLIT ECON, V103, P938, DOI 10.1086/262009; Kameri-Mbote P., 2006, Development (London), V49, P43, DOI 10.1057/palgrave.development.1100274; Kameri-Mbote P, 2005, 20059 IELRC; Karamba RW, 2015, AGR ECON-BLACKWELL, V46, P357, DOI 10.1111/agec.12169; Kassie M, 2015, FOOD SECUR, V7, P1299, DOI 10.1007/s12571-015-0517-y; Kassie M, 2014, WORLD DEV, V56, P153, DOI 10.1016/j.worlddev.2013.10.025; Khan ZR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0284; Kilic T, 2015, WORLD DEV, V70, P416, DOI 10.1016/j.worlddev.2014.06.017; Malapit H.J., 2017, 1647 IFPRI; Malapit HJL, 2015, J DEV STUD, V51, P1097, DOI 10.1080/00220388.2015.1018904; Malapit HJL, 2015, FOOD POLICY, V52, P54, DOI 10.1016/j.foodpol.2015.02.003; Manda DK, 2014, J AFR ECON, V23, pI4, DOI 10.1093/jae/ejt021; MCELROY MB, 1981, INT ECON REV, V22, P333, DOI 10.2307/2526280; McPeak JG, 2006, AM J AGR ECON, V88, P525, DOI 10.1111/j.1467-8276.2006.00877.x; Odeny M., 2013, AFR ANN WORLD BANK C; Oseni G, 2015, AGR ECON-BLACKWELL, V46, P285, DOI 10.1111/agec.12166; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Papke LE, 2008, J ECONOMETRICS, V145, P121, DOI 10.1016/j.jeconom.2008.05.009; Peterman A, 2010, 1111 ESA FAO; QUISUMBING AR, 1994, J DEV ECON, V43, P167, DOI 10.1016/0304-3878(94)90003-5; Quisumbing AR, 2003, OXFORD B ECON STAT, V65, P283, DOI 10.1111/1468-0084.t01-1-00052; Quisumbing AR, 1996, WORLD DEV, V24, P1579, DOI 10.1016/0305-750X(96)00059-9; Quisumbing AR., 2014, CLOSING KNOWLEDGE GA, P3, DOI [10.1007/978-94-017-8616-4, DOI 10.1007/978-94-017-8616-4]; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Ross KL, 2015, INT FOOD AGRIBUS MAN, V18, P127; Seebens H., 2011, 1110 ESA FAO UN AGR; Seguino S, 2013, J AFRICAN EC, V23, pi18; Seymour G., 2017, AGR EC; Slavchevska V, 2015, AGR ECON-BLACKWELL, V46, P335, DOI 10.1111/agec.12168; Smith L.C., 2003, 3 IFPRI; Sproule K., 2017, 1647 IFPRI; Sraboni E, 2014, WORLD DEV, V61, P11, DOI 10.1016/j.worlddev.2014.03.025; THOMAS D, 1990, J HUM RESOUR, V25, P635, DOI 10.2307/145670; Thomas D, 1997, CHILD HLTH DISTRIBUT; Tiruneh A., 2001, GENDER DIFFERENTIALS; UDRY C, 1995, FOOD POLICY, V20, P407, DOI 10.1016/0306-9192(95)00035-D; Wekwete NN, 2013, J AFRICAN EC, V23, pi87; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Bank, 2014, LEV FIELD IMPR OPP W; Zereyesus YA, 2017, J INT DEV, V29, P899, DOI 10.1002/jid.3307	65	50	52	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197995	10.1371/journal.pone.0197995	http://dx.doi.org/10.1371/journal.pone.0197995			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29852008	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200023
J	Nyitrai, G; Spisak, T; Spisak, Z; Gajari, D; Dioszegi, P; Kincses, TZ; Czurko, A				Nyitrai, Gabriella; Spisak, Tamas; Spisak, Zsofia; Gajari, David; Dioszegi, Palma; Kincses, Tamas Zsigmond; Czurko, Andras			Stepwise occlusion of the carotid arteries of the rat: MRI assessment of the effect of donepezil and hypoperfusion-induced brain atrophy and white matter microstructural changes	PLOS ONE			English	Article							CHRONIC CEREBRAL HYPOPERFUSION; VOXEL-BASED MORPHOMETRY; VASCULAR COGNITIVE IMPAIRMENT; BLOOD-FLOW; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; MICROGLIAL ACTIVATION; HIPPOCAMPAL DAMAGE; SPATIAL STATISTICS; OXIDATIVE STRESS	Bilateral common carotid artery occlusion (BCCAo) in the rat is a widely used animal model of vascular dementia and a valuable tool for preclinical pharmacological drug testing, although the varying degrees of acute focal ischemic lesions it induces could interfere with its translational value. Recently, a modification to the BCCAo model, the stepwise occlusion of the two carotid arteries, has been introduced. To acquire objective translatable measures, we used longitudinal multimodal magnetic resonance imaging (MRI) to assess the effects of semi-chronic (8 days) donepezil treatment in this model, with half of the Wistar rats receiving the treatment one week after the stepwise BCCAo. With an ultrahigh field MRI, we measured high-resolution anatomy, diffusion tensor imaging, cerebral blood flow measurements and functional MRI in response to whisker stimulation, to evaluate both the structural and functional effects of the donepezil treatment and stepwise BCCAo up to 5 weeks post-occlusion. While no large ischemic lesions were detected, atrophy in the striatum and in the neocortex, along with widespread white matter microstructural changes, were found. Donepezil ameliorated the transient drop in the somatosensory BOLD response in distant cortical areas, as detected 2 weeks after the occlusion but the drug had no effect on the long term structural changes. Our results demonstrate a measurable functional MRI effect of the donepezil treatment and the importance of diffusion MRI and voxel based morphometry (VBM) analysis in the translational evaluation of the rat BCCAo model.	[Nyitrai, Gabriella; Spisak, Tamas; Spisak, Zsofia; Gajari, David; Dioszegi, Palma; Kincses, Tamas Zsigmond; Czurko, Andras] Gedeon Richter Plc, Preclin Imaging Ctr, Pharmacol & Drug Safety Res, Budapest, Hungary; [Kincses, Tamas Zsigmond] Univ Szeged, Albert Szent Gyorgyi Clin Ctr, Dept Neurol, Szeged, Hungary	Gedeon Richter Chemistry Works; Szeged University	Nyitrai, G (corresponding author), Gedeon Richter Plc, Preclin Imaging Ctr, Pharmacol & Drug Safety Res, Budapest, Hungary.	nyitraige@richter.hu	Spisak, Tamas/GWQ-9005-2022; Czurkó, András/H-5500-2019	Czurko, Andras/0000-0002-1985-7296	Gedeon Richter Plc.; Hungarian National Research, Development and Innovation Office [KMOP-1.1.5-08-2009-0001, KTIA_NAP_13-1-2013-0001]; National Brain Research Program [KTIA_13_NAP-A-11/20, KTIA 13 NAP-A-II/3]; EU-Hungarian grant [EFOP-3.6.1-16-2016-00008]	Gedeon Richter Plc.; Hungarian National Research, Development and Innovation Office; National Brain Research Program; EU-Hungarian grant	The study was supported by Gedeon Richter Plc., the Hungarian National Research, Development and Innovation Office (KMOP-1.1.5-08-2009-0001, KTIA_NAP_13-1-2013-0001), the National Brain Research Program (Grant No. KTIA_13_NAP-A-11/20. and KTIA 13 NAP-A-II/3) and an EU-funded Hungarian grant EFOP-3.6.1-16-2016-00008. The funders provided support in the form of salaries for authors [G.Ny, AC, T.S, Zs.S, D.G, P.D], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Amat-Foraster M, 2017, NEUROPHARMACOLOGY, V113, P45, DOI 10.1016/j.neuropharm.2016.09.017; An HD, 2015, NEUROL RES, V37, P502, DOI 10.1179/1743132815Y.0000000004; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Avelar WM, 2015, INT J STROKE, V10, P1197, DOI 10.1111/ijs.12574; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; Cechetti F, 2012, LIFE SCI, V91, P29, DOI 10.1016/j.lfs.2012.05.013; Cechetti F, 2012, NEUROBIOL LEARN MEM, V97, P90, DOI 10.1016/j.nlm.2011.09.008; Cechetti F, 2012, BRAIN RES BULL, V87, P109, DOI 10.1016/j.brainresbull.2011.10.006; Chida Y, 2011, BRAIN RES, V1414, P22, DOI 10.1016/j.brainres.2011.07.026; Choy M, 2006, J CEREBR BLOOD F MET, V26, P1066, DOI 10.1038/sj.jcbfm.9600259; Czurko A, 1997, P NATL ACAD SCI USA, V94, P2766, DOI 10.1073/pnas.94.6.2766; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Du SQ, 2017, MOL NEUROBIOL, V54, P3670, DOI 10.1007/s12035-016-9915-1; Elzhov T., 2013, MINPACK LM R INTERFA, V1, P1; Farkas E, 2005, NEUROSCI LETT, V387, P168, DOI 10.1016/j.neulet.2005.06.036; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Ganzella M, 2012, NEUROL SCI, V33, P985, DOI 10.1007/s10072-011-0872-1; Gill Sudeep S, 2004, ACP J Club, V141, P39; Girouard H, 2006, ARTERIOSCL THROM VAS, V26, P826, DOI 10.1161/01.ATV.0000205849.22807.6e; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gorelick PB, 2016, BBA-MOL BASIS DIS, V1862, P860, DOI 10.1016/j.bbadis.2015.12.015; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hamzei F, 2003, NEUROIMAGE, V20, P1393, DOI 10.1016/S1053-8119(03)00384-7; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jing Z, 2015, J CEREBR BLOOD F MET, V35, P1249, DOI 10.1038/jcbfm.2015.55; Jiwa NS, 2010, J NEUROCHEM, V115, P814, DOI 10.1111/j.1471-4159.2010.06958.x; Kanaya K, 2012, PSYCHOGERIATRICS, V12, P172, DOI 10.1111/j.1479-8301.2011.00399.x; Kincses ZT, 2015, J ALZHEIMERS DIS, V47, P277, DOI 10.3233/JAD-143195; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kwon KJ, 2014, J NEUROL SCI, V347, P66, DOI 10.1016/j.jns.2014.09.021; Lee JH, 2007, BRAIN RES, V1185, P246, DOI 10.1016/j.brainres.2007.09.016; Li CX, 2017, BRAIN CONNECT, V7, P98, DOI 10.1089/brain.2016.0445; Li WJ, 2012, NEUROIMAGE, V60, P1083, DOI 10.1016/j.neuroimage.2011.12.077; Lin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085441; Maillard P, 2012, NEUROLOGY, V79, P442, DOI 10.1212/WNL.0b013e3182617136; Malouf R, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004395.pub2, DOI 10.1002/14651858.CD004395.PUB2]; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Muller M, 2011, ANN NEUROL, V70, P237, DOI 10.1002/ana.22392; Nakahata K, 2008, ANESTHESIOLOGY, V109, P124, DOI 10.1097/ALN.0b013e31817c0316; NI JW, 1995, BRAIN RES, V673, P290, DOI 10.1016/0006-8993(94)01436-L; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ohta H, 1997, NEUROSCIENCE, V79, P1039, DOI 10.1016/S0306-4522(97)00037-7; Ouchi Y, 1998, J NUCL MED, V39, P198; Pallares V, 2015, COMPUT METH PROG BIO, V121, P66, DOI [10.1016/j.cmpb.7015.05.011, 10.1016/j.cmpb.2015.05.011]; Pappas BA, 1996, BRAIN RES, V708, P50, DOI 10.1016/0006-8993(95)01267-2; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Provenzano FA, 2013, JAMA NEUROL, V70, P455, DOI 10.1001/jamaneurol.2013.1321; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245; ROSEN BR, 1991, MAGNET RESON MED, V19, P285, DOI 10.1002/mrm.1910190216; Sakr HF, 2014, J PHYSIOL PHARMACOL, V65, P41; Sambeth A, 2007, EUR J PHARMACOL, V572, P151, DOI 10.1016/j.ejphar.2007.06.018; Sarti C, 2002, BEHAV BRAIN RES, V136, P13, DOI 10.1016/S0166-4328(02)00090-6; Sato Y, 2013, NEUROSURGERY, V73, P592, DOI 10.1227/NEU.0000000000000013; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soria G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074631; Spisak T, 2017, NEUROSCIENCE, V344, P133, DOI 10.1016/j.neuroscience.2016.12.018; Sumiyoshi A, 2014, NEUROIMAGE, V98, P82, DOI 10.1016/j.neuroimage.2014.04.075; Suzuki H, 2013, NEUROIMAGE, V77, P215, DOI 10.1016/j.neuroimage.2013.03.042; Sztriha LK, 2009, J NEUROL SCI, V283, P36, DOI 10.1016/j.jns.2009.02.307; Tambalo S, 2015, J NEUROSCI, V35, P10088, DOI 10.1523/JNEUROSCI.0540-15.2015; Tanaka K, 1996, BRAIN RES, V729, P55, DOI 10.1016/S0006-8993(96)00400-3; Tomimoto H, 2003, ACTA NEUROPATHOL, V106, P527, DOI 10.1007/s00401-003-0749-3; van der Zwaag W, 2009, J MAGN RESON IMAGING, V30, P1171, DOI 10.1002/jmri.21951; Volgyi K, 2018, MOL NEUROBIOL, V55, P4253, DOI 10.1007/s12035-017-0641-0; Wakita H, 2002, BRAIN RES, V924, P63, DOI 10.1016/S0006-8993(01)03223-1; Wang XX, 2015, MAGN RESON IMAGING, V33, P551, DOI 10.1016/j.mri.2015.02.010; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Wu H, 2016, NEUROSCIENCE, V322, P221, DOI 10.1016/j.neuroscience.2016.02.043; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou C, 2008, J CEREBR BLOOD F MET, V28, P1275, DOI 10.1038/jcbfm.2008.21	86	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198265	10.1371/journal.pone.0198265	http://dx.doi.org/10.1371/journal.pone.0198265			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851990	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000433893200044
J	Zhou, S; Zhang, JS; Ma, FY; Tang, CH; Tang, QJ; Zhang, XY				Zhou, Shuai; Zhang, Jingsong; Ma, Fuying; Tang, Chuanhong; Tang, Qingjiu; Zhang, Xiaoyu			Investigation of lignocellulolytic enzymes during different growth phases of Ganoderma lucidum strain G0119 using genomic, transcriptomic and secretomic analyses	PLOS ONE			English	Article							FRUITING BODY DEVELOPMENT; CELL-WALL INTEGRITY; SCHIZOPHYLLUM-COMMUNE; PLEUROTUS-OSTREATUS; FUNCTIONAL-ANALYSIS; ACID BIOSYNTHESIS; AGARICUS-BISPORUS; FUNGAL GROWTH; WHEAT-STRAW; MUSHROOM	Ganoderma lucidum is a medicinal mushroom that is well known for its ability to enhance human health, and products made from this fungus have been highly profitable. The substrate-degrading ability of G. lucidum could be related to its growth. CAZy proteins were more abundant in its genome than in the other white rot fungi models. Among these CAZy proteins, changes in lignocellulolytic enzymes during growth have not been well studied. Using genomic, transcriptomic and secretomic analyses, this study focuses on the lignocellulolytic enzymes of G. lucidum strain G0119 to determine which of these degradative enzymes contribute to its growth. From the genome sequencing data, genes belonging to CAZy protein families, especially genes involved in lignocellulose degradation, were investigated. The gene expression, protein abundance and enzymatic activity of lignocellulolytic enzymes in mycelia over a growth cycle were analysed. The overall expression cellulase was higher than that of hemicellulase and lignin-modifying enzymes, particularly during the development of fruiting bodies. The cellulase and hemicellulase abundances and activities increased after the fruiting bodies matured, when basidiospores were produced in massive quantities till the end of the growth cycle. Additionally, the protein abundances of the lignin-modifying enzymes and the expression of their corresponding genes, including laccases and lignin-degrading heme peroxidases, were highest when the mycelia fully spread in the compost bag. Type I cellobiohydrolase was observed to be the most abundant extracellular lignocellulolytic enzyme produced by the G. lucidum strain G0119. The AA2 family haem peroxidases were the dominant lignin-modifying enzyme expressed during the mycelial growth phase, and several laccases might play roles during the formation of the primordium. This study provides insight into the changes in the lignocellulose degradation ability of G. lucidum during its growth and will facilitate the discovery of new approaches to accelerate the growth of G. lucidum in culture.	[Zhou, Shuai; Ma, Fuying; Zhang, Xiaoyu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Biophys MOE, Wuhan, Hubei, Peoples R China; [Zhou, Shuai; Zhang, Jingsong; Tang, Chuanhong; Tang, Qingjiu] Shanghai Acad Agr Sci, Natl Engn Res Ctr Edible Fungi, Inst Edible Fungi, Minist Agr,Key Lab Appl Mycol Resources & Utilisa, Shanghai, Peoples R China	Huazhong University of Science & Technology; Ministry of Agriculture & Rural Affairs; Shanghai Academy of Agricultural Sciences	Zhang, XY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Biophys MOE, Wuhan, Hubei, Peoples R China.	zhangxiaoyuhust@163.com	Zhang, Jing/GWZ-7332-2022; Zhang, xiaoyu/GXA-3206-2022		National Nature Science Foundation of China [31401933]; National Basic Research Program of China [2014CB138301]; Shanghai Agriculture Scientific Development Program [G2014070107]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Agriculture Scientific Development Program	Funded by 1. National Nature Science Foundation of China(grant no. 31401933). http://www.nsfc.gov.cn/english/site_1/index.html. Funder Tang Chuanhong provides the resource of strain G0119 and the Genomic analysis data. 2. National Basic Research Program of China (grant no. 2014CB138301). Funder Zhang Xiaoyu provides the idea of this study and manuscript revising. http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm. 3. Shanghai Agriculture Scientific Development Program (grant no. G2014070107). Funder Tang Chuanhong provides the resource of strain G0119 and the Genomic analysis data.	Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; BONNEN AM, 1994, APPL ENVIRON MICROB, V60, P960, DOI 10.1128/AEM.60.3.960-965.1994; BOURBONNAIS R, 1990, FEBS LETT, V267, P99, DOI 10.1016/0014-5793(90)80298-W; Chen S, 2004, EUR J BIOCHEM, V271, P318, DOI 10.1046/j.1432-1033.2003.03930.x; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elisashvili V, 2008, ACTA MICROBIOL IMM H, V55, P157, DOI 10.1556/AMicr.55.2008.2.7; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gong Ming, 2016, Acta Edulis Fungi, V23, P1; Hakkinen M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-134; Hu YR, 2018, APPL MICROBIOL BIOT, V102, P1911, DOI 10.1007/s00253-017-8730-6; Janusz G, 2013, ENZYME MICROB TECH, V52, P1, DOI 10.1016/j.enzmictec.2012.10.003; JI JX, 1993, MYCOL RES, V97, P283, DOI 10.1016/S0953-7562(09)81121-0; JONG SC, 1992, ADV APPL MICROBIOL, V37, P101, DOI 10.1016/S0065-2164(08)70253-3; Kitamoto Yukata, 2001, Mycoscience, V42, P143, DOI 10.1007/BF02464130; Kubicek CP., 2013, FUNGI LIGNOCELLULOSI; Lechner BE, 2006, PROCESS BIOCHEM, V41, P594, DOI 10.1016/j.procbio.2005.08.004; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin ZB, 2015, MODERN STUDY GANODER; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Madhavan S, 2014, MYCOL PROG, V13, P1199, DOI 10.1007/s11557-014-1009-8; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; McCleary BV, 2014, CARBOHYD RES, V385, P9, DOI 10.1016/j.carres.2013.12.001; Ohga S, 2001, FEMS MICROBIOL LETT, V201, P111, DOI 10.1111/j.1574-6968.2001.tb10741.x; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Patyshakuliyeva A, 2015, ENVIRON MICROBIOL, V17, P3098, DOI 10.1111/1462-2920.12967; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pontes MVA, 2017, FUNGAL GENET BIOL, P68, DOI [10.1556/AMICR.55.2008.2.7, DOI 10.1556/AMICR.55.2008.2.7]; Salmen L, 1998, J PULP PAP SCI, V24, P99; Shao L, 1983, FUNGAL TAXONOMY; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Suguimoto HH, 2001, FEMS MICROBIOL LETT, V194, P235, DOI 10.1111/j.1574-6968.2001.tb09475.x; Thiellement H, 2007, METHODS MOL BIOL; Ulziijargal E, 2011, INT J MED MUSHROOMS, V13, P343, DOI 10.1615/IntJMedMushr.v13.i4.40; Vetrovsky T, 2011, BIODEGRADATION, V22, P709, DOI 10.1007/s10532-010-9390-8; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yu GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119439; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhang G, 2018, MICROBIOL RES, V207, P280, DOI 10.1016/j.micres.2017.12.015; Zhang G, 2017, FUNGAL GENET BIOL, V104, P6, DOI 10.1016/j.fgb.2017.04.004; Zhang JJ, 2015, MICROBIOL RES, V179, P54, DOI 10.1016/j.micres.2015.06.005; Zhou XW, 2013, CRIT REV MICROBIOL, V39, P416, DOI 10.3109/1040841X.2012.722606	49	21	21	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198404	10.1371/journal.pone.0198404	http://dx.doi.org/10.1371/journal.pone.0198404			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852018	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200053
J	Oniciu, DC; Hashiguchi, T; Shibazaki, Y; Bisgaier, CL				Oniciu, Daniela Carmen; Hashiguchi, Taishi; Shibazaki, Yuichiro; Bisgaier, Charles L.			Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM (TM) model of NASH	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; INDUCED HEPATIC STEATOSIS; HIGH-DENSITY-LIPOPROTEIN; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; STATIN THERAPY; ANIMAL-MODELS; FIBROSIS; PLACEBO; CONFERS	Background and aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) can advance, if untreated, to liver fibrosis, cirrhosis, hepatocellular carcinoma, liver failure and liver-related death. In the United States, NASH affects approximately 2-5% of the population and an additional 10-30% have NAFLD. The number of drugs in development for NASH is growing steadily, along with nonclinical models to support prediction of clinical success. Here we evaluate gemcabene, a first-in-class clinical candidate for dyslipidemia, for its potential utility, based on its combined lipid-lowering and anti-inflammatory efficacy in clinical trials, in a preclinical model of NASH. Methods Gemcabene was evaluated in the STAM (TM) murine model of NASH. Gemcabene intervention in mice made diabetic with streptozotocin and fed a high fat high-caloric diet was assessed for changes in plasma, and hepatic histological and mRNA markers of lipid metabolism and inflammation. Results Gemcabene significantly downregulated hepatic mRNA markers of inflammation (TNF-alpha, MCP-1, MIP-1 beta, CCR5, CCR2, NF-kappa B), lipogenesis and lipid modulation (ApoC-III, ACC1, ADH-4, Sulf-2), and fibrosis (TIMP-1 and MMP-2). These effects are important for the prevention of steatosis, inflammation, and hepatocyte ballooning (i.e., the components of the NAFLD Activity Score or NAS), and inhibition of fibrosis progression, and were observed following treatment with gemcabene. Conclusions These non-clinical findings corroborate with existing clinical data to support the clinical evaluation of gemcabene as a potential new treatment for NASH.	[Oniciu, Daniela Carmen; Bisgaier, Charles L.] Gemphire Therapeut Inc, Livonia, MI USA; [Hashiguchi, Taishi; Shibazaki, Yuichiro] SMC Labs Inc, 2-16-1 Minami Kamata, Ota City, Tokyo, Japan		Oniciu, DC (corresponding author), Gemphire Therapeut Inc, Livonia, MI USA.	doniciu@gemphire.com			Gemphire Therapeutics	Gemphire Therapeutics	The research was funded by Gemphire Therapeutics. Daniela Carmen Oniciu and Charles L. Bisgaier are employed by Gemphire Therapeutics Inc. The funder (Gemphire Therapeutics Inc.) provided support in the form of salaries for authors CB and DO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Taishi Hashiguchi and Yuichiro Shibazaki are employed by SMC Laboratories, Inc. SMC Laboratories, Inc. provided support in the form of salaries for authors TH and YS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the'author contributions' section.	AaltoSetala K, 1996, J LIPID RES, V37, P1802; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Bays HE, 2003, AM J CARDIOL, V92, P538, DOI 10.1016/S0002-9149(03)00721-5; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Bisgaier CL, 2015, CIRCULATION, V132; Bisgaier CL, 1998, J LIPID RES, V39, P17; Bonapace S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088371; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515; Degrace P, 2007, J BIOL CHEM, V282, P20816, DOI 10.1074/jbc.M611391200; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fujii H, 2009, J ATHEROSCLER THROMB, V16, P893; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Hassing HC, 2012, HEPATOLOGY, V55, P1746, DOI 10.1002/hep.25580; Hirata T, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/587140; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Jarvis LM, 2016, CHEM ENG NEWS, V94, P46; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohli R, 2011, J HEPATOL, V55, P941, DOI 10.1016/j.jhep.2011.04.010; Kowala M., 2005, United States application publication, Patent No. [US 2005/0004196, 20050004196]; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Lefebvre E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158156; Li MR, 2014, WORLD J GASTROENTERO, V20, P14010, DOI 10.3748/wjg.v20.i38.14010; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Motamed N, 2017, CLIN RES HEPATOL GAS, V41, P31, DOI 10.1016/j.clinre.2016.07.005; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888; Ratziu V, 2013, NAT REV GASTRO HEPAT, V10, P676, DOI 10.1038/nrgastro.2013.193; Ridker PM, 2007, AM J CARDIOL, V100, P1659, DOI 10.1016/j.amjcard.2007.09.072; Saito K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12466; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Scherer A, 2016, DIGEST DIS, V34, P27, DOI 10.1159/000447278; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; SIRTORI CR, 1993, EUR J CLIN INVEST, V23, P686, DOI 10.1111/j.1365-2362.1993.tb01286.x; Srivastava RAK, 2016, ARTERIOSCLER THROMB, V36, DOI DOI 10.1016/J.JACL.2016.08.002; Stein E, 2016, J CLIN LIPIDOL, V10, P1212, DOI 10.1016/j.jacl.2016.08.002; Stein LL, 2009, ADV THER, V26, P893, DOI 10.1007/s12325-009-0072-z; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Williams KJ, 2010, CURR OPIN LIPIDOL, V21, P218, DOI 10.1097/MOL.0b013e328338cabc; WINDLER E, 1985, J LIPID RES, V26, P556; Xu ZJ, 2016, ADV THER, V33, P2069, DOI 10.1007/s12325-016-0416-4; Yu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002159	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0194568	10.1371/journal.pone.0194568	http://dx.doi.org/10.1371/journal.pone.0194568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847555	Green Submitted, gold, Green Published			2022-12-26	WOS:000433634800003
J	Khosravi, A; Sharifi, I; Tavakkoli, H; Derakhshanfar, A; Keyhani, AR; Salari, Z; Mosallanejad, SS; Bamorovat, M				Khosravi, Ahmad; Sharifi, Iraj; Tavakkoli, Hadi; Derakhshanfar, Amin; Keyhani, Ali Reza; Salari, Zohreh; Mosallanejad, Seyedeh Saedeh; Bamorovat, Mehdi			Embryonic toxico-pathological effects of meglumine antimoniate using a chick embryo model	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; SODIUM STIBOGLUCONATE; ANGIOGENESIS; EXPRESSION; QUANTIFICATION; STRESS; RAT	Leishmaniasis is one of the diverse and neglected tropical diseases. Embryo-toxicity of drugs has always been a major concern. Chick embryo is a preclinical model relevant in the assessment of adverse effects of drugs. The current study aimed to assess embryonic histopathological disorders and amniotic fluid biochemical changes following meglumine antimoniate treatment. The alteration of vascular branching pattern in the chick's extra-embryonic membrane and exploration of molecular cues to early embryonic vasculogenesis and angiogenesis were also quantified. Embryonated chicken eggs were treated with 75 or 150 mg/kg of meglumine antimoniate. Embryo malformations, growth retardation and haemorrhages on the external body surfaces were accompanied by histopathological lesions in the brain, kidney, liver and heart in a dose-dependent manner. Significant rise occurred in the biochemical indices of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase and amylase in the amniotic fluid. Quantification of the extra-embryonic membrane vasculature showed that the anti-angiogenic and anti-vasculogenic effects of the drug were revealed by a significant decrease in fractal dimension value and mean capillary area. The relative expression levels of vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 mRNA also significantly reduced. Concerns of a probable teratogenicity of meglumine antimoniate were established by data presented in this study. It is concluded that tissue lesions, amniotic fluid disturbance, altered early extra-embryonic vascular development and gene expression as well as the consecutive cascade of events, might eventually lead to developmental defects in embryo following meglumine antimoniate treatment. Therefore, the use of meglumine antimoniate during pregnancy should be considered as potentially embryo-toxic. Hence, physicians should be aware of such teratogenic effects and limit the use of this drug during the growing period of the fetus, particularly in rural communities. Further pharmaceutical investigations are crucial for planning future strategies.	[Khosravi, Ahmad; Sharifi, Iraj; Keyhani, Ali Reza; Mosallanejad, Seyedeh Saedeh; Bamorovat, Mehdi] Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran; [Tavakkoli, Hadi] Shahid Bahonar Univ Kerman, Sch Vet Med, Dept Clin Sci, Kerman, Iran; [Derakhshanfar, Amin] Shiraz Univ Med Sci, Ctr Comparat & Expt Med, Shiraz, Iran; [Salari, Zohreh] Kerman Univ Med Sci, Afzalipour Sch Med, Obstet & Gynecol Ctr, Kerman, Iran	Kerman University of Medical Sciences; Shahid Bahonar University of Kerman (SBUK); Shiraz University of Medical Science; Kerman University of Medical Sciences	Sharifi, I (corresponding author), Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran.; Tavakkoli, H (corresponding author), Shahid Bahonar Univ Kerman, Sch Vet Med, Dept Clin Sci, Kerman, Iran.	iraj.sharifi@yahoo.com; Tavakkoli@uk.ac.ir	Derakhshanfar, Amin/O-3712-2017; Sharifi, Iraj/AAY-8267-2020; Bamorovat, Mehdi/AAD-3051-2021; Khosravi, Ahmad/AAA-5264-2019; Salari, Zohreh/M-6589-2019	Derakhshanfar, Amin/0000-0002-8007-9446; Bamorovat, Mehdi/0000-0002-4900-4278; Sharifi, Iraj/0000-0002-6894-6834	Kerman University of Medical Sciences [94/588]	Kerman University of Medical Sciences	This work was supported by a grant (No. 94/588) from the Kerman University of Medical Sciences to IS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alkhawajah AM, 1996, J APPL ANIM RES, V10, P15, DOI 10.1080/09712119.1996.9706126; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Berger BA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005459; Bulant CA, 2017, MICROVASC RES, V112, P53, DOI 10.1016/j.mvr.2017.03.004; Campbell KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181484; Cantanhede LF, 2015, DRUG CHEM TOXICOL, V38, P312, DOI 10.3109/01480545.2014.963599; CHULAY JD, 1988, T ROY SOC TROP MED H, V82, P69, DOI 10.1016/0035-9203(88)90267-2; Delgado G, 2011, BIOMED PHARMACOTHER, V65, P569, DOI 10.1016/j.biopha.2010.12.016; dos Santos MR, 2008, REV ASSOC MED BRAS, V54, P13; Feng Y, 2017, J MATERN-FETAL NEO M, V30, P1874, DOI 10.1080/14767058.2016.1228061; Silva JSFE, 2013, REV SOC BRAS MED TRO, V46, P669, DOI 10.1590/0037-8682-0104-2013; Frezard F, 2001, ANTIMICROB AGENTS CH, V45, P913, DOI 10.1128/AAC.45.3.913-916.2001; Gheorghescu AK, 2015, TOXICOL APPL PHARM, V289, P79, DOI 10.1016/j.taap.2015.09.004; Groenendijk BCW, 2005, CIRC RES, V96, P1291, DOI 10.1161/01.RES.0000171901.40952.0d; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Haselgrubler R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182788; HERWALDT BL, 1992, AM J TROP MED HYG, V46, P296, DOI 10.4269/ajtmh.1992.46.296; Huang WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175595; Jacobsen Ilse D, 2012, Methods Mol Biol, V845, P487, DOI 10.1007/978-1-61779-539-8_34; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136698; Kirchner LM, 1996, MICROVASC RES, V51, P2, DOI 10.1006/mvre.1996.0002; Kishore RK, 2009, INDIAN J BIOCHEM BIO, V46, P106; Kutwin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178277; Mansouri, 2015, ASJ, V12, P83; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Miranda ES, 2006, REPROD TOXICOL, V21, P292, DOI 10.1016/j.reprotox.2005.09.010; Oosterbaan AM, 2012, MICROVASC RES, V83, P98, DOI 10.1016/j.mvr.2011.11.001; OZSOYLU S, 1992, AM J DIS CHILD, V146, P1021; Paumgartten FJR, 2001, REPROD TOXICOL, V15, P327, DOI 10.1016/S0890-6238(01)00127-7; Resnick N, 2003, ENDOTHELIUM-J ENDOTH, V10, P197, DOI 10.1080/713715231; Seidlitz E, 2004, MICROVASC RES, V67, P105, DOI 10.1016/j.mvr.2003.12.005; Sharifi I, 2015, IRAN J PUBLIC HEALTH, V44, P299; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Lima MIS, 2010, ARCH TOXICOL, V84, P227, DOI 10.1007/s00204-009-0485-0; Tavakkoli H., 2016, Iranian Journal of Veterinary Surgery, V11, P17; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; WHO, 2010, CONTR LEISHM M WHO E	38	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0196424	10.1371/journal.pone.0196424	http://dx.doi.org/10.1371/journal.pone.0196424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799841	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400004
J	Mahmoud, SS; Ibrahim, IH; Sallam, ASM; Gareeb, WA				Mahmoud, Sherif S.; Ibrahim, Ibrahim H.; Sallam, Abdel Sattar M.; Gareeb, Wafaa A.			Paradox response of cornea to different color intensities of visible light: An experimental study	PLOS ONE			English	Article							SPECTROSCOPY	The technological development is associated with human daily life and had an impact on its social life. Due to the difficulty of estimating the daily exposure to light; research is needed to determine how much natural and man-made lights could affect the cornea. Visible light radiation could have damaging effect on the human eye; the type and degree of damage are related to the duration and the cumulative exposure as well as to the intensity of the rays. There are noticeable increases in using electronic devices and colored lamps in decoration and toys as well, without any specific regulation. We studied the effect of such human activity on the corneal structure and the vibrational characteristics of corneal tissue by Fourier transform infrared spectroscopy. To achieve these goals, Chinchilla rabbits were exposed to two different lux of blue, green or red color lamps. The results indicate that the corneal tissue responds non-specifically to each lux and accordingly the color. The detected changes are including corneal protein secondary structure as well as lipids, in particular phospholipids. This was concomitant with more ordered membrane bilayer and changes in the corneal membrane phase organization. No lux/color-response relationship was established.	[Mahmoud, Sherif S.] Res Inst Ophthalmol, Biophys & Laser Sci Unit, Giza, Egypt; [Ibrahim, Ibrahim H.; Sallam, Abdel Sattar M.; Gareeb, Wafaa A.] Ain Shams Univ, Fac Sci, Dept Phys, Abbasiya Sq, Cairo, Egypt	Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Research Institute of Ophthalmology (RIO); Egyptian Knowledge Bank (EKB); Ain Shams University	Mahmoud, SS (corresponding author), Res Inst Ophthalmol, Biophys & Laser Sci Unit, Giza, Egypt.	sheri_sm@yahoo.com	Mahmoud, Sherif Siddick/AAJ-7442-2020	Mahmoud, Sherif Siddick/0000-0002-6826-6011; Sallam, Abdelsattar Mohamed/0000-0002-9081-4192				Allinger NL, 1972, ORGANIC CHEM, P105, DOI 10.1002/bmb.1973.5690010303; BORCHMAN D, 1991, INVEST OPHTH VIS SCI, V32, P2404; BURKE MJ, 1972, BIOCHEMISTRY-US, V11, P2435, DOI 10.1021/bi00763a008; CAMERON DG, 1980, BIOCHIM BIOPHYS ACTA, V596, P463, DOI 10.1016/0005-2736(80)90135-2; Hayasaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015599; JORDAN DR, 1986, CAN J OPHTHALMOL, V21, P216; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Nussbaumer B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011269.pub2; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1986, METHOD ENZYMOL, V130, P290; van Norren D, 2016, EYE, V30, P169, DOI 10.1038/eye.2015.218; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; ZAGORSKI MG, 1992, BIOCHEMISTRY-US, V31, P5621, DOI 10.1021/bi00139a028	13	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0196827	10.1371/journal.pone.0196827	http://dx.doi.org/10.1371/journal.pone.0196827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799834	gold, Green Submitted, Green Published			2022-12-26	WOS:000433153400007
J	Soler, C; Goossens, T; Bermejo, A; Migura-Garcia, L; Cusco, A; Francino, O; Fraile, L				Soler, Cassandra; Goossens, Tim; Bermejo, Alvaro; Migura-Garcia, Lourdes; Cusco, Anna; Francino, Olga; Fraile, Lorenzo			Digestive microbiota is different in pigs receiving antimicrobials or a feed additive during the nursery period	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; VETERINARY-MEDICINE; GROWTH-PERFORMANCE; SODIUM-BUTYRATE; ANTIBIOTICS; BACTERIA; SWINE; COMMUNITIES; RESISTANCE; PIGLETS	Antimicrobials have been used in a prophylactic way to decrease the incidence of digestive disorders during the piglet post-weaning period. Nowadays, it is urgent to reduce their consumption in livestock to address the problem of antimicrobial resistance. In this study, the effect of a product on piglet microbiota has been investigated as an alternative to antimicrobials. Three groups of ten post-weaning pigs were sampled at 0, 15 and 30 days one week post-weaning; the control, antibiotic and feed additive group received a standard post-weaning diet without antibiotics or additives, the same diet as the control group but with amoxicillin and colistin sulphate and the same diet as the control group but with a feed additive (Sanacore-EN, Nutriad International N.V.), respectively. The total DNA extracted from faeces was used to amplify the 16S RNA gene for massive sequencing under manufacturer's conditions. Sequencing data was quality filtered and analyzed using QIIME software and suitable statistical methods. In general terms, age modifies significantly the microbiota of the piglets. Thus, the oldest the animal, the highest bacterial diversity observed for the control and the feed additive groups. However, this diversity was very similar in the antibiotic group throughout the trial. Interestingly, a clear increase in abundance of Bacillus and Lactobacillus spp was detected within the feed additive group versus the antibiotic and control groups. In conclusion, the feed additive group had a positive effect in the endogenous micro biota of post-weaning pigs increasing both, the diversity of bacterial families and the abundance of lactic acid bacteria during the post-weaning period.	[Soler, Cassandra; Fraile, Lorenzo] Univ Lleida, ETSEA, Dept Ciencia Anim, Lleida, Spain; [Goossens, Tim; Bermejo, Alvaro] Nutriad Int NV, Dendermonde, Belgium; [Migura-Garcia, Lourdes] UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Cusco, Anna; Francino, Olga] Fac Vet, Serv Vet Genet Mol, Campus Univ Autonoma Barcelona, Bellaterra, Spain	Universitat de Lleida; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Fraile, L (corresponding author), Univ Lleida, ETSEA, Dept Ciencia Anim, Lleida, Spain.	lorenzo.fraile@ca.udl.cat	Francino, Olga/K-5683-2017; Migura-Garcia, Lourdes/E-3560-2016; Fraile, Lorenzo/AGE-2172-2022; Fraile, Lorenzo/A-1142-2009; Cusco, Anna/GRY-5131-2022; Fraile, Lorenzo/GQQ-8989-2022; Cusco, Anna/F-6262-2019	Francino, Olga/0000-0002-9022-3835; Migura-Garcia, Lourdes/0000-0003-2935-928X; Fraile, Lorenzo/0000-0002-8980-5862; Fraile, Lorenzo/0000-0002-8980-5862; Cusco, Anna/0000-0002-9574-5755; Fraile, Lorenzo/0000-0002-8980-5862; Goossens, Tim/0000-0003-1105-8315	University of Lleida; Nutriad International N.V.	University of Lleida; Nutriad International N.V.	This work was supported by a research contract of the University of Lleida with Nutriad International N.V. The funder provided support in the form of salaries for authors [Tim Goosens and Alvaro Bermejo], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Burow E, 2014, PREV VET MED, V113, P364, DOI 10.1016/j.prevetmed.2013.12.007; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Garcia-Migura L, 2014, VET MICROBIOL, V170, P1, DOI 10.1016/j.vetmic.2014.01.013; Guardabassi L, 2013, VET REC, V173, P599, DOI 10.1136/vr.f7276; Hanczakowska E, 2011, ANN ANIM SCI, V11, P115; Holman DB, 2014, FEMS MICROBIOL ECOL, V90, P599, DOI 10.1111/1574-6941.12419; Huang C, 2015, J NUTR, V145, P2774, DOI 10.3945/jn.115.217406; Jiang RH, 2000, J NUTR, V130, P21; Karlsson F, 2013, VET MICROBIOL, V165, P402, DOI 10.1016/j.vetmic.2013.03.031; KATZ E, 1977, BACTERIOL REV, V41, P449, DOI 10.1128/MMBR.41.2.449-474.1977; Keesing F, 2015, SCIENCE, V349, P235, DOI 10.1126/science.aac7892; Kraatz M, 2008, INT J SYST EVOL MICR, V58, P2755, DOI 10.1099/ijs.0.2008/001032-0; Lan R, 2017, J SCI FOOD AGR, V97, P1335, DOI 10.1002/jsfa.7871; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2016, NAT REV GASTRO HEPAT, V13, P69, DOI 10.1038/nrgastro.2016.4; Liebler-Tenorio EM, 1999, DIS SWINE, P821; Liu YL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0040-1; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Looft T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00276; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lynch H, 2017, PREV VET MED, V139, P50, DOI 10.1016/j.prevetmed.2017.02.008; Malmuthuge N, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00036; McCracken BA, 1999, J NUTR, V129, P613, DOI 10.1093/jn/129.3.613; Michiels J, 2010, ARCH ANIM NUTR, V64, P136, DOI 10.1080/17450390903499915; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Nisbet D, 2002, ANTON LEEUW INT J G, V81, P481, DOI 10.1023/A:1020541603877; Pluske JR, 2002, NUTR RES REV, V15, P333, DOI 10.1079/NRR200242; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Roto SM, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00028; Salcedo J, 2016, J DAIRY SCI, V99, P7733, DOI 10.3168/jds.2016-10966; Schmidt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028284; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Unno T, 2015, J MICROBIOL BIOTECHN, V25, P431, DOI 10.4014/jmb.1408.08063; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; Walia K, 2016, PREV VET MED, V131, P79, DOI 10.1016/j.prevetmed.2016.07.009; Wang M, 2013, J NUTR, V143, P795, DOI 10.3945/jn.112.173096; Weber TE, 2014, J ANIM SCI, V92, P4172, DOI 10.2527/jas.2013-7402; Wu H, 2015, TRENDS ENDOCRIN MET, V26, P758, DOI 10.1016/j.tem.2015.09.011; Xiong HT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27070; Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127	52	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197353	10.1371/journal.pone.0197353	http://dx.doi.org/10.1371/journal.pone.0197353			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799833	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400009
J	Ludwig, JM; Zhang, YL; Chamulitrat, W; Stremmel, W; Pathil, A				Ludwig, Johannes Maximilian; Zhang, Yuling; Chamulitrat, Walee; Stremmel, Wolfgang; Pathil, Anita			Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; KUPFFER CELLS; FATTY LIVER; TNF-ALPHA; TGF-BETA; DISEASE; ROLES; MICE; LIPOPOLYSACCHARIDE; PATHOGENESIS	Aim Endotoxin-mediated liver inflammation is a key component of many acute and chronic liver diseases contributing to liver damage, fibrosis and eventually organ failure. Here, we investigated ursodeoxycholyl lysophosphatidylethanolamide (UDCA-LPE), a synthetic bile acid-phospholipid conjugate regarding its anti-inflammatory and anti-fibrogenic properties. Methods Anti-inflammatory properties of UDCA-LPE were evaluated in a mouse model of D-galactosamine/lipopolysaccharide (GaIN/LPS)-induced acute liver injury, LPS treated RAW264.7 macrophages and murine primary Kupffer cells. Furthermore, anti-inflammatory and anti-fibrotic effects of UDCA-LPE were studied on primary hepatic stellate cells (HSC) incubated with supernatant from LPS +/- UDCA-LPE treated RAW264.7 cells. Results UDCA-LPE ameliorated LPS-induced increase of IL-6, TNF-alpha, TGF-beta, NOX-2 in the GaIN/ LPS model by up to 80.2% for IL-6. Similarly, UDCA-LPE markedly decreased the expression of inflammatory cytokines IL-6, TNF-alpha and TGF-beta as well as the chemokines MCP1 and RANTES in LPS-stimulated RAW 264.7 cells. Anti-inflammatory effects were also observed in primary murine Kupffer cells. Mechanistic evaluation revealed a reversion of LPS-activated pro-inflammatory TLR4 pathway by UDCA-LPE. Moreover, UDCA-LPE inhibited iNOS and NOX-2 expression while activating eNOS via phosphorylation of AKT and pERK1/2 in RAW264.7 cells. HSC treated with conditioned medium from LPS +/- UDCALPE RAW264.7 cells showed lower fibrogenic activation due to less SMAD2/3 phosphorylation, reduced expression of profibrogenic CTGF and reduced pro-inflammatory chemokine expression. Conclusion In the setting of endotoxin-mediated liver inflammation, UDCA-LPE exerts profound antiinflammatory and anti-fibrotic effect implying a promising potential for the drug candidate as an experimental approach for the treatment of acute and chronic liver diseases.	[Ludwig, Johannes Maximilian; Zhang, Yuling; Chamulitrat, Walee; Stremmel, Wolfgang; Pathil, Anita] Heidelberg Univ, Dept Internal Med Gastroenterol & Hepatol 4, Heidelberg, Germany; [Ludwig, Johannes Maximilian] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	Ruprecht Karls University Heidelberg; University of Duisburg Essen	Pathil, A (corresponding author), Heidelberg Univ, Dept Internal Med Gastroenterol & Hepatol 4, Heidelberg, Germany.	anita.pathil-warth@med.uni-heidelberg.de		Zhang, Yuling/0000-0001-8956-2808; Stremmel, Wolfgang/0000-0002-8545-1753	German Research Foundation [PA 2365/1-1]; Olympia Morata Postdoctoral Fellowship of the Medical Faculty of University of Heidelberg; Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	German Research Foundation(German Research Foundation (DFG)); Olympia Morata Postdoctoral Fellowship of the Medical Faculty of University of Heidelberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	This study was supported by the German Research Foundation (PA 2365/1-1). AP was funded by the Olympia Morata Postdoctoral Fellowship of the Medical Faculty of University of Heidelberg. We acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg. WS has a patent on UDCA-LPE (no industrial funding).	Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Booth AJ, 2010, AM J TRANSPLANT, V10, P220, DOI 10.1111/j.1600-6143.2009.02826.x; Cao Q, 2002, BIOCHEM BIOPH RES CO, V294, P849, DOI 10.1016/S0006-291X(02)00586-7; Carter-Kent C, 2008, AM J GASTROENTEROL, V103, P1036, DOI 10.1111/j.1572-0241.2007.01709.x; Chamulitrat W, 2009, HEPATOLOGY, V50, P143, DOI 10.1002/hep.22955; Colletti LM, 1996, HEPATOLOGY, V23, P506; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fujiyoshi M, 2011, J HEPATO-BIL-PAN SCI, V18, P13, DOI 10.1007/s00534-010-0304-2; GOLDIN RD, 1995, INT J EXP PATHOL, V76, P353; Gressner OA, 2008, LIVER INT, V28, P1207, DOI 10.1111/j.1478-3231.2008.01729.x; Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21; Jung YY, 2013, KOREAN J PHYSIOL PHA, V17, P209, DOI 10.4196/kjpp.2013.17.3.209; Katsuyama M, 2012, J CLIN BIOCHEM NUTR, V50, P9, DOI 10.3164/jcbn.11-06SR; Kuhla A, 2009, AM J PHYSIOL-GASTR L, V296, pG1069, DOI 10.1152/ajpgi.90689.2008; Leifeld L, 2003, J PATHOL, V199, P335, DOI 10.1002/path.1298; LEIST M, 1995, AM J PATHOL, V146, P1220; Li JR, 1999, AM J PHYSIOL-GASTR L, V276, pG1069, DOI 10.1152/ajpgi.1999.276.5.G1069; Liu SL, 2013, AM J PHYSIOL-GASTR L, V305, pG163, DOI 10.1152/ajpgi.00003.2013; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Morikawa A, 1996, INFECT IMMUN, V64, P734, DOI 10.1128/IAI.64.3.734-738.1996; Nellen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036614; Oneta CM, 1999, J LAB CLIN MED, V134, P466, DOI 10.1016/S0022-2143(99)90167-1; Pathil A, 2014, BRIT J PHARMACOL, V171, P5113, DOI 10.1111/bph.12837; Pathil A, 2012, HEPATOLOGY, V55, P1369, DOI 10.1002/hep.25531; Pathil A, 2012, EUR J CLIN INVEST, V42, P130, DOI 10.1111/j.1365-2362.2011.02563.x; Pathil A, 2011, J HEPATOL, V54, P674, DOI 10.1016/j.jhep.2010.07.028; Poniachik J, 1999, J LAB CLIN MED, V133, P342, DOI 10.1016/S0022-2143(99)90064-1; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Singh RP, 2012, CHEM RES TOXICOL, V25, P2127, DOI 10.1021/tx300228d; SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509; Son G, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/453563; Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Uemura M, 2005, MOL BIOL CELL, V16, P4214, DOI 10.1091/mbc.E05-02-0149; Varela-Rey M, 2007, CYTOKINE, V37, P212, DOI 10.1016/j.cyto.2007.03.013; Wang JL, 2015, SHOCK, V43, P379, DOI 10.1097/SHK.0000000000000312; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Yi HS, 2013, J GASTROEN HEPATOL, V28, P99, DOI 10.1111/jgh.12017	47	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197836	10.1371/journal.pone.0197836	http://dx.doi.org/10.1371/journal.pone.0197836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795632	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300077
J	Novoselova, EG; Lunin, SM; Glushkova, OV; Khrenov, MO; Parfenyuk, SB; Zakharova, NM; Fesenko, EE				Novoselova, Elena G.; Lunin, Sergey M.; Glushkova, Olga V.; Khrenov, Maxim O.; Parfenyuk, Svetlana B.; Zakharova, Nadezhda M.; Fesenko, Evgeny E.			Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; HEAT-SHOCK; IMMUNE-RESPONSE; CYTOKINE STORM; SEPSIS; ANTIOXIDANT; SEROTONIN; MELATONIN; IMMUNOTHERAPY	In the present work, we aimed to study the effects of free and polybutylcyanoacrylate nanoparticle-bound thymulin on immune cell activity in mice with chronic inflammation. NF-KB, MAPK, and PKC-8 signaling pathway activity was assessed, alongside Hsp72, Hsp90-alpha, and TLR4 expression and levels of apoptosis. In addition, plasma cytokines and blood and brain melatonin and serotonin levels were measured. In mice treated with gradually raised doses of lipopolysaccharide, significant increases in the activity of the signaling pathways tested, heat-shock protein and TLR4 expression, lymphocyte apoptosis, and plasma proinflammatory cytokine levels were noted. Moreover, we observed significantly heightened serotonin concentrations in the plasma and especially the brains of mice with inflammation. In contrast, melatonin levels were reduced in the tissues examined, particularly so in the brain. Treatment of these mice with thymulin alleviated fever, reduced apoptosis, increased splenic cell number, and decreased cytokine production, Hsp72, Hsp90, and TLR4 expression, and the activity of the signaling pathways examined. In addition, thymulin partially restored brain and blood serotonin and melatonin levels. Thus, thymulin suppressed the proinflammatory response in LPS-treated mice, indicating the potential of thymulin co-therapy in the treatment of sepsis. Nanoparticle-bound thymulin was more effective in several respects.	[Novoselova, Elena G.; Lunin, Sergey M.; Glushkova, Olga V.; Khrenov, Maxim O.; Parfenyuk, Svetlana B.; Zakharova, Nadezhda M.; Fesenko, Evgeny E.] Inst Cell Biophys, Pushchino, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Novoselova, EG (corresponding author), Inst Cell Biophys, Pushchino, Moscow Region, Russia.	elenanov_06@mail.ru	Lunin, Sergey/ACX-5729-2022; Glushckova, Olga V/C-6352-2015; Zakharova, Nadezhda M/C-7081-2015; Novoselova, Elena/C-6523-2015	Lunin, Sergey/0000-0002-9537-9935; Glushckova, Olga V/0000-0002-0257-6439; Zakharova, Nadezhda M/0000-0002-9905-8100; Novoselova, Elena/0000-0002-5097-3797	Program of Russian Academy of Sciences 1.18 "Molecular and Cellular Biology and post-genomic technologies"; Russian Foundation for Basic Research [17-44-500047, 18-04-00091]	Program of Russian Academy of Sciences 1.18 "Molecular and Cellular Biology and post-genomic technologies"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work was supported by Program of Russian Academy of Sciences 1.18 "Molecular and Cellular Biology and post-genomic technologies" to EEF and by Russian Foundation for Basic Research, grants No 17-44-500047 to SML, 18-04-00091 to EGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Borken F, 2017, J IMMUNOL, V198, P4781, DOI 10.4049/jimmunol.1700142; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Crowley LC., 2016, COLD SPRING HARB PRO, V2016, P958, DOI DOI 10.1101/PDB.PROT087312; DARDENNE M, 1982, P NATL ACAD SCI-BIOL, V79, P5370, DOI 10.1073/pnas.79.17.5370; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Dwarkasing JT, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0260-0; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Franks Z, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0073-4; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He WL, 2008, J PHARM SCI-US, V97, P2250, DOI 10.1002/jps.21148; Henriques-Coelho T, 2008, ENDOCRINOLOGY, V149, P4367, DOI 10.1210/en.2008-0018; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Huber-Lang M, 2014, J IMMUNOL, V192, P5324, DOI 10.4049/jimmunol.1400341; Jara EL, 2017, IMMUNOL LETT, V184, P76, DOI 10.1016/j.imlet.2017.02.010; KANTE B, 1982, J PHARM SCI, V71, P786, DOI 10.1002/jps.2600710716; Kema IP, 2000, J CHROMATOGR B, V747, P33, DOI 10.1016/S0378-4347(00)00341-8; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Li YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22747; Lunin SM, 2008, IMMUNOL INVEST, V37, P858, DOI 10.1080/08820130802447629; Lunin SM, 2017, INT J IMMUNOPATH PH, V30, P58, DOI 10.1177/0394632017694625; Lunin SM, 2011, EXPERT OPIN THER TAR, V15, P1337, DOI 10.1517/14728222.2011.641952; Lunin SM, 2010, EXPERT OPIN THER TAR, V14, P775, DOI 10.1517/14728222.2010.499127; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mercer Becky A, 2006, Int J Chron Obstruct Pulmon Dis, V1, P137, DOI 10.2147/copd.2006.1.2.137; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Novoselova EG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/724838; Novoselova E G, 2009, Dokl Biol Sci, V428, P484; Novoselova EG, 2006, BIOCHEMISTRY-MOSCOW+, V71, P376, DOI 10.1134/S0006297906040055; Novoselova EG, 2009, EUR J PHARMACOL, V615, P234, DOI 10.1016/j.ejphar.2009.05.004; Opal SM, 2011, SEMIN RESP CRIT CARE, V32, P569, DOI 10.1055/s-0031-1287865; Otto GP, 2013, CRIT CARE, V17, DOI 10.1186/cc12540; Patil NK, 2016, PHARMACOL RES, V111, P688, DOI 10.1016/j.phrs.2016.07.019; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; Pfeifhofer-Obermair C, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0137-y; Pinsky MR, 2001, CONTRIB NEPHROL, V132, P354; PLEAU JM, 1980, P NATL ACAD SCI-BIOL, V77, P2861, DOI 10.1073/pnas.77.5.2861; Prauchner CA, 2017, BURNS, V43, P471, DOI 10.1016/j.burns.2016.09.023; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Rinaldi S, 2009, CURR DRUG TARGETS, V10, P872, DOI 10.2174/138945009789108774; Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Unsinger J, 2009, J LEUKOCYTE BIOL, V86, P219, DOI 10.1189/jlb.1008615; Wall DM, 2014, CELL MICROBIOL, V16, P1746, DOI 10.1111/cmi.12368; Wang HL, 2008, AM J EMERG MED, V26, P711, DOI 10.1016/j.ajem.2007.10.031	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197601	10.1371/journal.pone.0197601	http://dx.doi.org/10.1371/journal.pone.0197601			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795607	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300056
J	Tan, NYQ; Chew, M; Tham, YC; Nguyen, QD; Yasuda, M; Cheng, CY; Wong, TY; Sabanayagam, C				Tan, Nicholas Y. Q.; Chew, Merwyn; Tham, Yih-Chung; Quang Duc Nguyen; Yasuda, Masayuki; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi			Associations between sleep duration, sleep quality and diabetic retinopathy	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; RISK-FACTORS; APNEA; PREVALENCE; METAANALYSIS; RESTRICTION; SEVERITY; ADULTS; INDEX	Background Abnormal durations of sleep have been associated with risk of diabetes. However, it is not clear if sleep duration is associated with diabetic retinopathy (DR). Methods In a cross-sectional study, we included 1,231 (Malay, n = 395; Indian, n= 836) adults (mean age 64.4 +/- 9.0 years, 50.4% female) with diabetes from the second visit of two independent population-based cohort studies (2011-15) in Singapore. Self-reported habitual sleep duration was categorized as short (<6 h), normal (6 <= h <8), and long (>= 8 h). Questionnaires were administered to detect risk of obstructive sleep apnea (OSA), excessive daytime sleepiness, and insomnia, all of which may indicate poor quality of sleep. The associations between sleep-related characteristics with moderate DR and vision-threatening DR (VTDR) were analysed using logistic regression models adjusted for potential confounders. Results Prevalence of moderate DR and VTDR in the study population were 10.5% and 6.3% respectively. The mean duration of sleep was 6.4 +/- 1.5 h. Compared to normal sleep duration, both short and long sleep durations were associated with moderate DR with multivariable odds ratio (95% confidence interval) of 1.73 (1.03-2.89) and 2.17 (1.28-3.66) respectively. Long sleep duration (2.37 [1.16-4.89]), high risk of OSA (2.24 [1.09-4.75]), and excessive daytime sleepiness (3.27 [1.02-10.30]) were separately associated with VTDR. Conclusion Sleep duration had a U-shaped association with moderate DR; long sleep duration, excessive daytime sleepiness and high risk of OSA were positively associated with VTDR.	[Tan, Nicholas Y. Q.; Chew, Merwyn; Tham, Yih-Chung; Quang Duc Nguyen; Yasuda, Masayuki; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Singapore Eye Res Inst, Singapore, Singapore; [Tan, Nicholas Y. Q.; Chew, Merwyn; Tham, Yih-Chung; Quang Duc Nguyen; Yasuda, Masayuki; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Singapore Natl Eye Ctr, Singapore, Singapore; [Tan, Nicholas Y. Q.; Chew, Merwyn] Natl Univ Singapore Hosp, Dept Ophthalmol, Singapore, Singapore; [Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Cheng, Ching-Yu; Wong, Tien Yin] Natl Univ Singapore, Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore	Sabanayagam, C (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Sabanayagam, C (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Sabanayagam, C (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.	charumathi.sabanayagam@seri.com.sg	Wong, Tien Yin/AAC-9724-2020; Sabanayagam, Charumathi/C-1294-2011; Chung, Yih/AIF-2414-2022; Cheng, Ching-Yu/Y-2229-2019	Wong, Tien Yin/0000-0002-8448-1264; Sabanayagam, Charumathi/0000-0002-4042-4719; Chung, Yih/0000-0002-6752-797X; Cheng, Ching-Yu/0000-0003-0655-885X; Chew, Merwyn/0000-0002-3136-4769	National Medical Research Council, Singapore [NMRC CIRG/1371/2013, NMRC/STaR/016/2013]; SingHealth Foundation Research [SHF/FG563S/2012]	National Medical Research Council, Singapore(National Medical Research Council, Singapore); SingHealth Foundation Research(SingHealth)	This study was supported by the National Medical Research Council (NMRC CIRG/1371/2013 and NMRC/STaR/016/2013), Singapore and SingHealth Foundation Research, SHF/FG563S/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf Q, 2013, DIABETIC MED, V30, pE5, DOI 10.1111/dme.12090_12; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Banerjee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079521; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bromley LE, 2012, SLEEP, V35, P977, DOI 10.5665/sleep.1964; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chasens ER, 2013, DIABETES EDUCATOR, V39, P74, DOI 10.1177/0145721712467683; Cheung CMG, 2017, OPHTHALMOLOGY, V124, P1305, DOI 10.1016/j.ophtha.2017.03.056; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Grandner MA, 2013, NAT SCI SLEEP, V5, P93, DOI 10.2147/NSS.S31063; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hikichi T, 2011, CLIN OPHTHALMOL, V5, P655, DOI 10.2147/OPTH.S19559; Jee D, 2017, ACTA OPHTHALMOL, V95, P41, DOI 10.1111/aos.13169; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lavie L, 2002, AM J RESP CRIT CARE, V165, P1624, DOI 10.1164/rccm.20110-040OC; Lee S., 2016, MOB INF SYST, V2016, P1, DOI DOI 10.1016/J.SMRV.2016.02.001; Leong WB, 2016, DIABETIC MED, V33, P158, DOI 10.1111/dme.12817; LINSENMEIER RA, 1986, J GEN PHYSIOL, V88, P521, DOI 10.1085/jgp.88.4.521; Meng LL, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0195-8; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Narkiewicz K, 1997, J HYPERTENS, V15, P1613, DOI 10.1097/00004872-199715120-00062; Obara EA, 2017, INVEST OPHTH VIS SCI, V58, P2187, DOI 10.1167/iovs.16-21168; Ong TH, 2010, SLEEP BREATH, V14, P371, DOI 10.1007/s11325-010-0350-7; Raman R, 2012, ACTA DIABETOL, V49, P255, DOI 10.1007/s00592-010-0240-2; Roth T, 1996, CLIN THER, V18, P562, DOI 10.1016/S0149-2918(96)80207-4; Rudrappa S, 2012, BRIT J OPHTHALMOL, V96, P1535, DOI 10.1136/bjophthalmol-2012-301991; Sabanayagam C, 2017, CLIN EXP OPHTHALMOL, V45, P779, DOI 10.1111/ceo.12974; Seneviratne U, 2004, SLEEP MED, V5, P339, DOI 10.1016/j.sleep.2004.01.021; Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073; Shiba T, 2010, AM J OPHTHALMOL, V149, P959, DOI 10.1016/j.ajo.2010.01.006; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tahrani AA, 2012, AM J RESP CRIT CARE, V186, P434, DOI 10.1164/rccm.201112-2135OC; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Unver YB, 2009, OPEN SLEEP J, V2, P11, DOI DOI 10.2174/1874620900902010011; Wang X, 2013, RESPIROLOGY, V18, P140, DOI 10.1111/j.1440-1843.2012.02267.x; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu T, 1998, ARCH OPHTHALMOL-CHIC, V116, P83, DOI 10.1001/archopht.116.1.83	43	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196399	10.1371/journal.pone.0196399	http://dx.doi.org/10.1371/journal.pone.0196399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795569	Green Published, gold			2022-12-26	WOS:000433084300007
J	Bennici, S; Cases, GL; Distefano, G; Di Guardo, M; Continella, A; Ferlito, F; Gentile, A; La Malfa, S				Bennici, Stefania; Cases, Giuseppina Las; Distefano, Gaetano; Di Guardo, Mario; Continella, Alberto; Ferlito, Filippo; Gentile, Alessandra; La Malfa, Stefano			Elucidating the contribution of wild related species on autochthonous pear germplasm: A case study from Mount Etna	PLOS ONE			English	Article							GENETIC DIVERSITY; CHLOROPLAST DNA; MICROSATELLITE MARKERS; HYPERVARIABLE REGIONS; PHYLOGENETIC ANALYSIS; L. CULTIVARS; ASIAN PEARS; FRUIT SIZE; SSR; APPLE	The pear (genus Pyrus) is one of the most ancient and widely cultivated tree fruit crops in temperate climates. The Mount Etna area claims a large number of pear varieties differentiated due to a long history of cultivation and environmental variability, making this area particularly suitable for genetic studies. Ninety-five pear individuals were genotyped using the simple sequence repeat (SSR) methodology interrogating both the nuclear (nDNA) and chloroplast DNA (cpDNA) to combine an investigation of maternal inheritance of chloroplast SSRs (cpSSRs) with the high informativity of nuclear SSRs (nSSRs). The germplasm was selected ad hoc to include wild genotypes, local varieties, and national and international cultivated varieties. The objectives of this study were as follows: (i) estimate the level of differentiation within local varieties; (ii) elucidate the phylogenetic relationships between the cultivated genotypes and wild accessions; and (iii) estimate the potential genetic flow and the relationship among the germplasms in our analysis. Eight nSSRs detected a total of 136 alleles with an average minor allelic frequency and observed heterozygosity of 0.29 and 0.65, respectively, whereas cpSSRs allowed identification of eight haplotypes (S4 Table). These results shed light on the genetic relatedness between Italian varieties and wild genotypes. Among the wild species, compared with P. amygdaliformis, few P. pyraster genotypes exhibited higher genetic similarity to local pear varieties. Our analysis revealed the presence of genetic stratification with a 'wild' subpopulation characterizing the genetic makeup of wild species and the international cultivated varieties exhibiting the predominance of the 'cultivated' subpopulation.	[Bennici, Stefania; Cases, Giuseppina Las; Distefano, Gaetano; Di Guardo, Mario; Continella, Alberto; Gentile, Alessandra; La Malfa, Stefano] Univ Catania, Dipartimento Agr Alimentaz & Ambiente, Catania, Italy; [Cases, Giuseppina Las; Ferlito, Filippo] Ctr Ric Olivicoltura Frutticoltura & Agrumicoltur, Consiglio Ric Agr & Anal Econ Agr, Acireale, Italy	University of Catania; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Distefano, G (corresponding author), Univ Catania, Dipartimento Agr Alimentaz & Ambiente, Catania, Italy.	distefag@unict.it	Continella, Alberto/B-5756-2014; Ferlito, Filippo/GRF-4754-2022; Di Guardo, Mario/AAA-7498-2021	Continella, Alberto/0000-0002-7734-9927; La Malfa, Stefano/0000-0001-5869-0348; Di Guardo, Mario/0000-0003-3339-2007; Ferlito, Filippo/0000-0003-0797-5620; , Giuseppina Las Casas/0000-0003-2632-3820; Bennici, Stefania/0000-0001-6887-8256; Distefano, Gaetano/0000-0002-6080-6466	Department of Agriculture, Food and Environment of Catania University, Catania, Italy	Department of Agriculture, Food and Environment of Catania University, Catania, Italy	The authors declare the study was supported by internal funding of Department of Agriculture, Food and Environment of Catania University, Catania, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, AFR J BIOTECHNOL, V9, P8323; Allard A, 2016, J EXP BOT, V67, P2875, DOI 10.1093/jxb/erw130; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bao L, 2008, SCI HORTIC-AMSTERDAM, V116, P374, DOI 10.1016/j.scienta.2008.02.008; Bao L, 2007, GENET RESOUR CROP EV, V54, P959, DOI 10.1007/s10722-006-9152-y; Bassil N, 2009, GENET RESOUR CROP EV, V56, P339, DOI 10.1007/s10722-008-9369-z; Brini W, 2008, SCI HORTIC-AMSTERDAM, V115, P337, DOI 10.1016/j.scienta.2007.10.012; Campbell CS, 2007, PLANT SYST EVOL, V266, P119, DOI 10.1007/s00606-007-0545-y; Continella G., 2006, Italus Hortus, V13, P210; Damigella P, 1991, 39 QUADERNI RICERCA; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Erfani J, 2012, PLANT MOL BIOL REP, V30, P1065, DOI 10.1007/s11105-012-0421-y; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans RC, 2002, AM J BOT, V89, P1478, DOI 10.3732/ajb.89.9.1478; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandez-Fernandez F, 2006, MOL ECOL NOTES, V6, P1039, DOI 10.1111/j.1471-8286.2006.01422.x; Ferradini N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00751; Fresnedo-Ramirez J, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0985-z; Gasi F, 2013, SCI HORTIC-AMSTERDAM, V157, P74, DOI 10.1016/j.scienta.2013.04.017; Iketani H, 1998, GENET RESOUR CROP EV, V45, P533, DOI 10.1023/A:1008646016181; Katayama H, 2003, THEOR APPL GENET, V106, P303, DOI 10.1007/s00122-002-1003-4; Katayama H, 2007, GENET RESOUR CROP EV, V54, P1573, DOI 10.1007/s10722-006-9170-9; Katayama H, 2012, TREE GENET GENOMES, V8, P313, DOI 10.1007/s11295-011-0442-y; Kimura T, 2002, BREEDING SCI, V52, P115, DOI 10.1270/jsbbs.52.115; Korotkova N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112998; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Liu J, 2013, TREE GENET GENOMES, V9, P433, DOI 10.1007/s11295-012-0564-x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Miranda C, 2010, J AM SOC HORTIC SCI, V135, P428, DOI 10.21273/JASHS.135.5.428; Monte-Corvo L, 2001, J AM SOC HORTIC SCI, V126, P517, DOI 10.21273/JASHS.126.5.517; Monte-Corvo L, 2000, GENET RESOUR CROP EV, V47, P257, DOI 10.1023/A:1008794809807; Nishitani C, 2009, BREEDING SCI, V59, P391, DOI 10.1270/jsbbs.59.391; Oliveira CM, 1999, SCI HORTIC-AMSTERDAM, V79, P163, DOI 10.1016/S0304-4238(98)00205-2; Paganova V, 2003, EKOL BRATISLAVA, V22, P225; Pereira-Lorenzo S, 2010, TREE GENET GENOMES, V6, P701, DOI 10.1007/s11295-010-0285-y; Pleines T, 2009, PLANT SYST EVOL, V282, P281, DOI 10.1007/s00606-008-0036-9; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Rana JC, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0821-2; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reim S, 2017, GENET RESOUR CROP EV, V64, P1075, DOI 10.1007/s10722-016-0426-8; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosyara UR, 2013, MOL BREEDING, V32, P875, DOI 10.1007/s11032-013-9916-y; Saba MK, 2017, INT J FRUIT SCI, V17, P82, DOI 10.1080/15538362.2016.1220343; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sehic J, 2012, SCI HORTIC-AMSTERDAM, V145, P39, DOI 10.1016/j.scienta.2012.07.023; Sisko M, 2009, J AM SOC HORTIC SCI, V134, P97, DOI 10.21273/JASHS.134.1.97; Teng YW, 2002, J AM SOC HORTIC SCI, V127, P262, DOI 10.21273/JASHS.127.2.262; Teng YW, 2001, J HORTIC SCI BIOTECH, V76, P771; Terakami S, 2012, TREE GENET GENOMES, V8, P841, DOI 10.1007/s11295-012-0469-8; Urbanovich OY, 2011, RUSS J GENET+, V47, P305, DOI 10.1134/S1022795411030173; Urrestarazu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138417; Urrestarazu J, 2012, TREE GENET GENOMES, V8, P1163, DOI 10.1007/s11295-012-0502-y; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Wunsch A, 2007, SCI HORTIC-AMSTERDAM, V113, P37, DOI 10.1016/j.scienta.2007.02.002; Wuyun T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133686; Wuyun T, 2013, TREE GENET GENOMES, V9, P167, DOI 10.1007/s11295-012-0544-1; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Xuan H, 2008, ACTA HORTIC, P439, DOI 10.17660/ActaHortic.2008.800.55; Yakovin NA, 2011, RUSS J GENET+, V47, P564, DOI 10.1134/S1022795411040156; Yamamoto T, 2002, MOL ECOL NOTES, V2, P14, DOI 10.1046/j.1471-8286.2002.00128.x; Yamamoto T, 2004, BREEDING SCI, V54, P239, DOI 10.1270/jsbbs.54.239; Yamamoto T, 2002, EUPHYTICA, V124, P129, DOI 10.1023/A:1015677505602; Yamamoto T, 2001, THEOR APPL GENET, V102, P865, DOI 10.1007/s001220000524; Zarei A, 2017, BIOTECHNOL BIOTEC EQ, V31, P289, DOI 10.1080/13102818.2016.1276414; Zheng XY, 2014, MOL PHYLOGENET EVOL, V80, P54, DOI 10.1016/j.ympev.2014.07.009	67	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198512	10.1371/journal.pone.0198512	http://dx.doi.org/10.1371/journal.pone.0198512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856850	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800133
J	Chong, KH; Zhang, XM; Zheng, J				Chong, Ket Hing; Zhang, Xiaomeng; Zheng, Jie			Dynamical analysis of cellular ageing by modeling of gene regulatory network based attractor landscape	PLOS ONE			English	Article							P53 TUMOR SUPPRESSION; DNA-DAMAGE; CYCLE CHECKPOINTS; CELLS; DIFFERENTIATION; SENESCENCE; PROTEIN; KINASE; ATM; TRANSCRIPTION	Ageing is a natural phenomenon that is inherently complex and remains a mystery. Conceptual model of cellular ageing landscape was proposed for computational studies of ageing. However, there is a lack of quantitative model of cellular ageing landscape. This study aims to investigate the mechanism of cellular ageing in a theoretical model using the framework of Waddington's epigenetic landscape. We construct an ageing gene regulatory network (GRN) consisting of the core cell cycle regulatory genes (including p53). A model parameter (activation rate) is used as a measure of the accumulation of DNA damage. Using the bifurcation diagrams to estimate the parameter values that lead to multi-stability, we obtained a conceptual model for capturing three distinct stable steady states (or attractors) corresponding to homeostasis, cell cycle arrest, and senescence or apoptosis. In addition, we applied a Monte Carlo computational method to quantify the potential landscape, which displays: I) one homeostasis attractor for low accumulation of DNA damage; II) two attractors for cell cycle arrest and senescence (or apoptosis) in response to high accumulation of DNA damage. Using the Waddington's epigenetic landscape framework, the process of ageing can be characterized by state transitions from landscape I to II. By in silico perturbations, we identified the potential landscape of a perturbed network (inactivation of p53), and thereby demonstrated the emergence of a cancer attractor. The simulated dynamics of the perturbed network displays a landscape with four basins of attraction: homeostasis, cell cycle arrest, senescence (or apoptosis) and cancer. Our analysis also showed that for the same perturbed network with low DNA damage, the landscape displays only the homeostasis attractor. The mechanistic model offers theoretical insights that can facilitate discovery of potential strategies for network medicine of ageing-related diseases such as cancer.	[Chong, Ket Hing; Zhang, Xiaomeng; Zheng, Jie] Nanyang Technol Univ, Sch Comp Sci & Engn, Biomed Informat Lab, Singapore 639798, Singapore; [Zheng, Jie] Nanyang Technol Univ, Complex Inst, Singapore 637723, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zheng, J (corresponding author), Nanyang Technol Univ, Sch Comp Sci & Engn, Biomed Informat Lab, Singapore 639798, Singapore.; Zheng, J (corresponding author), Nanyang Technol Univ, Complex Inst, Singapore 637723, Singapore.	zhengjie@ntu.edu.sg	Zheng, Jie/AAX-1454-2021; Zheng, Jie/C-1356-2011	Zheng, Jie/0000-0001-6774-9786; Chong, Ket Hing/0000-0002-2914-2358	MOE AcRF Tier 1 Seed Grant on Complexity Ministry of Education, Singapore [RGC2/13, M4011101.020]; MOE AcRF Tier 1 Grant Ministry of Education, Singapore [2015-T1-002-094]	MOE AcRF Tier 1 Seed Grant on Complexity Ministry of Education, Singapore; MOE AcRF Tier 1 Grant Ministry of Education, Singapore(Ministry of Education, Singapore)	This project is supported by the MOE AcRF Tier 1 Seed Grant on Complexity (RGC2/13, M4011101.020), and MOE AcRF Tier 1 Grant (2015-T1-002-094) Ministry of Education, Singapore.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Cheng Q, 2010, CELL CYCLE, V9, P472, DOI 10.4161/cc.9.3.10556; Chong KH, 2015, MATH BIOSCI, V259, P27, DOI 10.1016/j.mbs.2014.10.010; Conrad E., OSCILL8 SUITE TOOLS; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Davies PCW, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-30; Davila-Velderrain J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00160; DEFFIE A, 1993, MOL CELL BIOL, V13, P3415, DOI 10.1128/MCB.13.6.3415; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Edelstein-Keshet L, 2001, J THEOR BIOL, V213, P509, DOI 10.1006/jtbi.2001.2429; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2013, SEMIN CANCER BIOL, V23, P270, DOI 10.1016/j.semcancer.2013.06.003; Huang S, 2012, BIOESSAYS, V34, P149, DOI 10.1002/bies.201100031; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; KAUFFMAN S, 1971, J THEOR BIOL, V31, P429, DOI 10.1016/0022-5193(71)90020-8; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Kirkwood TBL, 2011, PHILOS T R SOC B, V366, P64, DOI 10.1098/rstb.2010.0275; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kriete A, 2014, COMPUTATIONAL SYSTEM, P407; Lai PBS, 2007, APOPTOSIS, V12, P387, DOI 10.1007/s10495-006-0571-1; Lavaf A., 2009, J CANC MOL, V5, P9; Li CH, 2015, CANCER RES, V75, P2607, DOI 10.1158/0008-5472.CAN-15-0079; Li CH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0774; Li CH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003165; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nelson P, 2017, P NATL ACAD SCI USA, V114, P12982, DOI 10.1073/pnas.1618854114; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Sun TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027882; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Waddington C H, 1957, STRATEGY GENES DISCU; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang X, 2018, BIORXIV, DOI [10.1101/310771, DOI 10.1101/310771]; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	61	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197838	10.1371/journal.pone.0197838	http://dx.doi.org/10.1371/journal.pone.0197838			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856751	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800045
J	Della Bella, C; Spinicci, M; Grassi, A; Bartalesi, F; Benagiano, M; Truthmann, K; Tapinassi, S; Troilo, A; D'Elios, S; Alnwaisri, H; Shuralev, E; Singh, M; Bartoloni, A; D'Elios, MM				Della Bella, Chiara; Spinicci, Michele; Grassi, Alessia; Bartalesi, Filippo; Benagiano, Marisa; Truthmann, Katja; Tapinassi, Simona; Troilo, Arianna; D'Elios, Sofia; Alnwaisri, Heba; Shuralev, Eduard; Singh, Mahavir; Bartoloni, Alessandro; D'Elios, Mario Milco			Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ALANINE DEHYDROGENASE; DIAGNOSIS; GAMMA; RESPONSES; ANTIGENS; RECOMBINANT; EXPRESSION; PREVENTION; BIOMARKERS	Background Tuberculosis (TB) still is a major worldwide health problem, with 10.4 million new cases in 2016. Only 5-15% of people infected with M. tuberculosis develop TB disease while others remain latently infected (LTBI) during their lifetime. Thus, the absence of tests able to distinguish between latent infection and active tuberculosis is one of the major limits of currently available diagnostic tools. Methods A total of 215 patients were included in the study as active TB cases (n = 73), LTBI subjects (n = 88) and healthy persons (n = 54). Peripheral blood mononuclear cells (PBMCs) were isolated from each patient and the LIOSpot (R) TB anti-human IL-2 ELISpot assay was performed to test their proliferative response to M. tuberculosis antigens ESAT-6, CFP-10 and Ala-DH. Statistical analysis was performed to define the sensitivity and the specificity of the LIOSpot (R) TB kit for each antigen used and to set the best cut off value that enables discrimination between subjects with active TB or latent TB infection. Results Comparing the LIOSpot (R) TB results for each tested antigen between uninfected and infected subjects and between people with latent infection and active TB disease, the differences were significant for each antigen (p<0.0001) but the ROC analysis demonstrated a high accuracy for the Ala-DH test only, with a cut off value of 12.5 SFC per million PBMCs and the Ala-DH ROC curve conferred a 96% sensitivity and 100% specificity to the test. For the ESAT-6 antigen, with a best cut off value of 71.25 SFC per million PBMCs, a sensitivity of 86% and specificity of 36% was obtained. Finally, the best cut off value for CFP-10 was 231.25 SFC per million PBMCs, with a sensitivity of 80% and a specificity of 54%. Thus, as for IGRA assays such as Quantiferon and T-Spot TB tests, ESAT-6 and CFP-10 are unable to distinguish LTBI from active TB when IL-2 is measured. On the contrary, the IL-2 production induced by Ala-DH, measured by LIOSpot (R) TB kit, shows high sensitivity and specificity for active TB disease. Conclusions This study demonstrates that the LIOSpot (R) TB test is a highly useful diagnostic tool to discriminate between latent TB infection and active tuberculosis in adults patients.	[Della Bella, Chiara; Spinicci, Michele; Grassi, Alessia; Benagiano, Marisa; Tapinassi, Simona; Troilo, Arianna; Alnwaisri, Heba; D'Elios, Mario Milco] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Bartalesi, Filippo; Bartoloni, Alessandro] Florence Careggi Univ Hosp, Infect & Trop Dis Unit, Florence, Italy; [Truthmann, Katja; Singh, Mahavir] LIONEX Diagnost & Therapeut GmbH, Braunschweig, Germany; [D'Elios, Sofia] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Shuralev, Eduard] Kazan Fed Univ, Inst Environm Sci, Kazan, Tatarstan, Russia; [Shuralev, Eduard] Kazan State Med Acad, Cent Res Lab, Kazan, Tatarstan, Russia; [Shuralev, Eduard] Fed Ctr Toxicol Radiat & Biol Safety, Kazan, Tatarstan, Russia	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; Lionex Diagnostics & Therapeutics GmbH; University of Pisa; Kazan Federal University; Kazan State Medical Academy	D'Elios, MM (corresponding author), Univ Florence, Dept Expt & Clin Med, Florence, Italy.; Bartoloni, A (corresponding author), Florence Careggi Univ Hosp, Infect & Trop Dis Unit, Florence, Italy.	alessandro.bartoloni@unifi.it; mariomilco.delios@unifi.it	Benagiano, Marisa/AAD-6443-2019; Tapinassi, Simona/AAD-3472-2019; delios, sofia/GRT-0149-2022; Spinicci, MIchele/AAC-6187-2022; Shuralev, Eduard/M-1147-2013; DELLA BELLA, CHIARA/K-1432-2018; D'Elios, Mario Milco/Y-9573-2019	Benagiano, Marisa/0000-0003-0792-2326; Tapinassi, Simona/0000-0001-6425-5190; Shuralev, Eduard/0000-0003-0650-3090; DELLA BELLA, CHIARA/0000-0002-2565-6220; D'Elios, Mario Milco/0000-0001-9160-0930; SPINICCI, MICHELE/0000-0002-5377-7118	EU-FP7-SME-project Demonstration of NOPERSIST (DEM NOPERSIST grant) [606577]; LIONEX Diagnostics and Therapeutics GmbH	EU-FP7-SME-project Demonstration of NOPERSIST (DEM NOPERSIST grant); LIONEX Diagnostics and Therapeutics GmbH	The authors thank the EU-FP7-SME-project Demonstration of NOPERSIST results leading tonovel, validated diagnostic tests for active human and bovine tuberculosis (DEM NOPERSIST grant no: 606577). LIONEX Diagnostics and Therapeutics GmbH. provided support in the form of salaries for authors KT and MS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Agren D, 2008, J MOL BIOL, V377, P1161, DOI 10.1016/j.jmb.2008.01.091; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Centers for Disease Control and Prevention, 2010, MMWR, V59; Centers for Disease Control and Prevention, 2013, LAT TUB INF GUID PRI; Chiappini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046041; Dhanasekaran S, 2013, GENES IMMUN, V14, P356, DOI 10.1038/gene.2013.26; Dutta NK, 2014, MICROBIOL MOL BIOL R, V78, P343, DOI 10.1128/MMBR.00010-14; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Giffin MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155522; Giffin MM, 2012, J BACTERIOL, V194, P1045, DOI 10.1128/JB.05914-11; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Hoppe LE, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6747; Hutter B, 1998, GENE, V212, P21, DOI 10.1016/S0378-1119(98)00134-6; Hutter B, 1999, BIOCHEM J, V343, P669, DOI 10.1042/0264-6021:3430669; Kahwati LC, 2016, 1405212EF1 US PREV S; Kamakia R, 2017, INT J TUBERC LUNG D, V21, P278, DOI 10.5588/ijtld.16.0176; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, P111, DOI 10.1093/cid/ciw778; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Mahmoudi S, 2017, EUR CYTOKINE NETW, V28, P36, DOI 10.1684/ecn.2017.0391; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Movahedi B, 2017, IRAN J MED SCI, V42, P275; National Institute for Health and Care Excellence, 2016, NICE GUID; National Tuberculosis Controllers Association, NSTC 2016 ANN M; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Schluger NW, 2017, AM J RESP CRIT CARE, V195, P1112, DOI 10.1164/rccm.201703-0446ED; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Sun Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166501; Suzukawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152483; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Won EJ, 2017, J INFECTION, V74, P281, DOI 10.1016/j.jinf.2016.11.010; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, GLOB TUB REP 2017; Wu J, 2017, TUBERCULOSIS, V102, P68, DOI 10.1016/j.tube.2016.06.001; Zhou B, 2017, ACS APPL MATER INTER, V9, P18493, DOI 10.1021/acsami.7b03211	40	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197825	10.1371/journal.pone.0197825	http://dx.doi.org/10.1371/journal.pone.0197825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856871	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800043
J	Depre, F; Aboud, N; Mayer, B; Salama, A				Depre, Fabian; Aboud, Nasra; Mayer, Beate; Salama, Abdulgabar			Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice	PLOS ONE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; AUTOIMMUNE THROMBOCYTOPENIA; ANTI-D; TREATMENT OPTIONS; MEDICAL THERAPY; ADULT PATIENTS; PURPURA; MANAGEMENT; ROMIPLOSTIM; SAFETY	Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and tolerability of the drugs used in practice. Material and methods We retrospectively reviewed the results of therapy of 400 patients with chronic ITP. All Patients were treated at our institution between 1996-2016 under consideration of guidelines, general recommendations, and individual aspects, including gender, age, weight, comorbidity, patient's medical history and bleeding risk. Results Treatment was not required in 25% of patients (n = 100) during observation. In treated patients (n = 300), the rate of patients that responded and tolerated treatment with prednisolone was 59% (52/88), with azathioprine 32% (29/90), with eltrombopag 49% (31/63), with romiplostim 59% 27/45, with IVIG (intravenous immunoglobulines) 75% (94/126), with anti-D 37% (19/52) and with dexamethasone 60% (25/42) patients. Eighteen treated patients (6%) entered sustained remission after treatment with various drugs. Twenty-six patients underwent splenectomy (Splx) resulting in sustained remission in 15 cases (60%). Only two patients remained refractory to Splx and to all used drugs. Discussion None of the currently available drugs used in the treatment of ITP are invariably safe and effective. Responses, the duration of response, intolerability, and the course of disease are unpredictable. Although the treatment of ITP has considerably improved in the recent years, the currently available drugs may rarely cure affected patients. The need for safe and effective therapy in ITP is evident. Optimal treatment decisions for each patient remains a challenge in many cases.	[Depre, Fabian; Aboud, Nasra; Mayer, Beate; Salama, Abdulgabar] Charite, Inst Transfus Med, Berlin, Germany; [Depre, Fabian] Charite, Dept Cardiol, Campus Benjamin Franklin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Salama, A (corresponding author), Charite, Inst Transfus Med, Berlin, Germany.	abdulgabar.salama@charite.de		Mayer, Beate/0000-0002-6238-8405				Aboud N, 2017, TRANSFUS MED HEMOTH, V44, P23, DOI 10.1159/000449038; Burns CM, 2016, RHEUM DIS CLIN N AM, V42, P1, DOI 10.1016/j.rdc.2015.08.001; Bussel JB, 2011, BLOOD, V118, P28, DOI 10.1182/blood-2010-10-313908; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Choi PYI, 2012, INTERN MED J, V42, P841, DOI 10.1111/j.1445-5994.2012.02740.x; Chouhan JD, 2010, PHARMACOTHERAPY, V30, P666, DOI 10.1592/phco.30.7.666; Cuker A, 2016, BLOOD, V128, P1547, DOI 10.1182/blood-2016-03-603365; Cuker A, 2015, SEMIN THROMB HEMOST, V41, P395, DOI 10.1055/s-0034-1544001; Depre F, 2018, BLOOD TRANSFUS-ITALY, V16, P307, DOI 10.2450/2017.0258-16; Depre F, 2016, TRANSFUS MED HEMOTH, V43, P375, DOI 10.1159/000446195; George JN, 2006, J THROMB HAEMOST, V4, P1664, DOI 10.1111/j.1538-7836.2006.02013.x; Ghanima W, 2012, BLOOD, V120, P960, DOI 10.1182/blood-2011-12-309153; Godeau B, 2007, CURR OPIN HEMATOL, V14, P535, DOI 10.1097/MOH.0b013e3282b9748f; Heng LL, 2011, INT J HEMATOL, V94, P142, DOI 10.1007/s12185-011-0894-8; IMBACH P, 1981, LANCET, V1, P1228; IMBACH P, 1981, HELV PAEDIATR ACTA, V36, P81; Khellaf M, 2011, BLOOD, V118, P4338, DOI 10.1182/blood-2011-03-340166; Kjaersgaard M, 2009, PEDIATR BLOOD CANCER, V53, P1315, DOI 10.1002/pbc.22248; Kuhne T, 2000, PEDIATR RES, V48, P374; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2013, BRIT J HAEMATOL, V161, P411, DOI 10.1111/bjh.12260; Kuter DJ, 2010, NEW ENGL J MED, V363, P1889, DOI 10.1056/NEJMoa1002625; Lozano ML, 2016, ANN HEMATOL, V95, P1089, DOI 10.1007/s00277-016-2665-3; Mahevas M, 2016, BLOOD, V128, P1625, DOI 10.1182/blood-2016-03-704734; Matzdorff A, 2014, ONCOL RES TREAT, V37, P6, DOI 10.1159/000356910; Matzdorff AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027350; Mayer B, 2017, VOX SANG, V112, P64, DOI 10.1111/vox.12467; McMillan R, 1997, ANN INTERN MED, V126, P307, DOI 10.7326/0003-4819-126-4-199702150-00007; Meyer O, 2006, PEDIATR BLOOD CANCER, V47, P721, DOI 10.1002/pbc.21006; Meyer O, 2004, EUR J HAEMATOL, V73, P71, DOI 10.1111/j.1600-0609.2004.00244.x; Michel M, 2015, BRIT J HAEMATOL, V170, P218, DOI 10.1111/bjh.13415; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Norgaard M, 2011, BLOOD, V117, P3514, DOI 10.1182/blood-2010-10-312819; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2015, ADV THER, V32, P875, DOI 10.1007/s12325-015-0251-z; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Psaila B, 2008, BRIT J HAEMATOL, V143, P16, DOI 10.1111/j.1365-2141.2008.07275.x; Rodeghiero F, 2010, EUR J HAEMATOL, V84, P160, DOI 10.1111/j.1600-0609.2009.01361.x; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; SALAMA A, 1983, LANCET, V2, P193; Salama A, 2017, EXPERT OPIN EMERG DR, V22, P27, DOI 10.1080/14728214.2017.1294158; Salama A, 2011, EXPERT REV HEMATOL, V4, P107, DOI [10.1586/ehm.10.76, 10.1586/EHM.10.76]; Saleh MN, 2013, BLOOD, V121, P537, DOI 10.1182/blood-2012-04-425512; Saleh MN, 2000, SEMIN ONCOL, V27, P99; Scaradavou A, 1997, BLOOD, V89, P2689, DOI 10.1182/blood.V89.8.2689; STASI R, 1995, AM J MED, V98, P436, DOI 10.1016/S0002-9343(99)80342-8; Vesely SK, 2004, ANN INTERN MED, V140, P112, DOI 10.7326/0003-4819-140-3-200402030-00012; Vianelli N, 2013, HAEMATOLOGICA, V98, P875, DOI 10.3324/haematol.2012.075648; Weide R, 2016, ONCOL RES TREAT, V39, P41, DOI 10.1159/000442769; Whipple A.O., 1926, SURG GYNECOL OBSTET, V42, P329; WINTROBE MM, 1951, ARCH INTERN MED, V88, P310, DOI 10.1001/archinte.1951.03810090041004; Witmer CM, 2016, PEDIATR BLOOD CANCER, V63, P1227, DOI 10.1002/pbc.25961	52	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198184	10.1371/journal.pone.0198184	http://dx.doi.org/10.1371/journal.pone.0198184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856800	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800079
J	Eckersley, CP; White, TR; Cutcliffe, HC; Shridharani, JK; Wood, GW; Bass, CR				Eckersley, Christopher P.; White, Terrance R.; Cutcliffe, Hattie C.; Shridharani, Jay K.; Wood, Garrett W.; Bass, Cameron R.			Foul tip impact attenuation of baseball catcher masks using head impact metrics	PLOS ONE			English	Article							CONCUSSION; SEVERITY	Currently, no scientific consensus exists on the relative safety of catcher mask styles and materials. Due to differences in mass and material properties, the style and material of a catcher mask influences the impact metrics observed during simulated foul ball impacts. The catcher surrogate was a Hybrid III head and neck equipped with a six degree of freedom sensor package to obtain linear accelerations and angular rates. Four mask styles were impacted using an air cannon for six 30 m/s and six 35 m/s impacts to the nasion. To quantify impact severity, the metrics peak linear acceleration, peak angular acceleration, Head Injury Criterion, Head Impact Power, and Gadd Severity Index were used. An Analysis of Covariance and a Tukey's HSD Test were conducted to compare the least squares mean between masks for each head injury metric. For each injury metric a P-Value less than 0.05 was found indicating a significant difference in mask performance. Tukey's HSD test found for each metric, the traditional style titanium mask fell in the lowest performance category while the hockey style mask was in the highest performance category. Limitations of this study prevented a direct correlation from mask testing performance to mild traumatic brain injury.	[Eckersley, Christopher P.; White, Terrance R.; Cutcliffe, Hattie C.; Shridharani, Jay K.; Wood, Garrett W.; Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Eckersley, CP (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	christopher.eckersley@duke.edu		Eckersley, Christopher/0000-0001-5467-0358; Cutcliffe, Hattie/0000-0001-8456-1996; Wood, Garrett/0000-0002-5619-5527	Duke Undergraduate Research Support Office with an Undergraduate Research Support Creative Arts Grant	Duke Undergraduate Research Support Office with an Undergraduate Research Support Creative Arts Grant	Funding for catcher masks and air cannon materials was provided by the Duke Undergraduate Research Support Office with an Undergraduate Research Support Creative Arts Grant provided to CE. The Duke Undergraduate Research Support Office website can be found at https://undergraduateresearch.duke.edu/opportunities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, P INT RES COUNC BIOM; [Anonymous], 2017, BASEBALL T; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Engineers SoA, 2014, SURF VEH REC PRACT 1; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Gadd C.W., 1966, SAE TECHNICAL PAPER; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heald J, 1994, BALL STANDARDS RELEV; Horwitz NH, 1999, NEUROSURGERY, V45, P944, DOI 10.1097/00006123-199910000-00050; Laudner K.G., 2014, J ATHLETIC ENHANCEME, V3, P1; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Newman J, 1999, INT IRCOBI C BIOM IM; Newman JA, 1980, SAE TECHNICAL PAPER; NHTSA, 2011, OCC CRASH PROT 571 2; NOCSAE, 2015, 024 NOCSAE; Schwizer P, 2016, PROCEDIA ENGINEER, V147, P228, DOI 10.1016/j.proeng.2016.06.218; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Siu J, 2016, INT J EXERCISE SCI, V9, P3; Theye Fred, 2004, Clin Med Res, V2, P165; Versace J., 1971, 710881 SAE, DOI DOI 10.4271/710881	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198316	10.1371/journal.pone.0198316	http://dx.doi.org/10.1371/journal.pone.0198316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856814	gold, Green Published, Green Submitted			2022-12-26	WOS:000433900800099
J	Glazunova, OA; Shakhova, NV; Psurtseva, NV; Moiseenko, KV; Kleimenov, SY; Fedorova, TV				Glazunova, Olga A.; Shakhova, Natalia, V; Psurtseva, Nadezhda, V; Moiseenko, Konstantin, V; Kleimenov, Sergei Y.; Fedorova, Tatiana, V			White-rot basidiomycetes Junghuhnia nitida and Steccherinum bourdotii: Oxidative potential and laccase properties in comparison with Trametes hirsuta and Coriolopsis caperata	PLOS ONE			English	Article							LIGNIN MODEL-COMPOUND; FUNGAL LACCASES; PYCNOPORUS-SANGUINEUS; REDOX POTENTIALS; COPPER IONS; PURIFICATION; ENZYME; WOOD; POLYPORALES; REACTIVITY	White-rot basidiomycetes from the poorly studied residual polyporoid clade of Polyporales order Junghuhnia nitida (Pers.) Ryvarden and Steccherinum bourdotii Saliba & A. David grow as secondary xylotrohps on well decomposed woody materials. The main objective of the current study was to compare oxidative potential, growth, production of oxidative enzymes and laccase properties of J. nitida and S. bourdotii with that of typical primary xylotrohps Trametes hirsuta (Wulfen) Lloyd and Coriolopsis caperata (Berk.) Murrill, belonging to the core polyporoid clade. For the first time we report species J. nitida and S. bourdotii as active laccase producers. New laccases from J. nitida and S. bourdotii were purified and characterized. They had an identical molecular weight of 63 kDa and isoelectric points of 3.4 and 3.1, respectively. However, the redox potential of the T1 copper site for both J. nitida (610 mV) and S. bourdotii (640 mV) laccases was lower than those for T. hirsuta and C. caperata laccases. The new laccases showed higher temperature optima and better thermal stability than T. hirsuta and C. caperata laccases. Their half-lives were more than 40 min at 70 degrees C. The laccases from J. nitida and S. bourdotii showed higher affinity to syringyltype phenolic compounds than T. hirsuta and C. caperata laccases. The oxidative potential of studied fungi as well as the properties of their laccases are discussed in terms of the fungal life-style.	[Glazunova, Olga A.; Moiseenko, Konstantin, V; Kleimenov, Sergei Y.; Fedorova, Tatiana, V] Russian Acad Sci, AN Bach Inst Biochem, Res Ctr Biotechnol, Moscow, Russia; [Shakhova, Natalia, V; Psurtseva, Nadezhda, V] Russian Acad Sci, Komarov Bot Inst, St Petersburg, Russia; [Kleimenov, Sergei Y.] Russian Acad Sci, Koltzov Inst Dev Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Glazunova, OA (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Res Ctr Biotechnol, Moscow, Russia.	helga758@yandex.ru	Shakhova, Natalia Vitalievna/H-5513-2013; Glazunova, Olga/S-8267-2016; Moiseenko, Konstantin V/F-9802-2015; Kleymenov, Sergey/R-1195-2018	Shakhova, Natalia Vitalievna/0000-0002-8733-2168; Glazunova, Olga/0000-0002-9001-4072; Kleymenov, Sergey/0000-0001-5085-0327	Russian Foundation for Basic Research [16-04-01184]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/ru/), grant no 16-04-01184 to TVF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaes T, 2017, APPL ECOL ENV RES, V15, P207, DOI 10.15666/aeer/1501_207224; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Barrasa JM, 2014, FUNGAL GENET BIOL, V72, P106, DOI 10.1016/j.fgb.2014.03.007; Bertrand G., 1896, CR HEBD SEANCES ACAD, V123, P463; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Chernykh A, 2008, J APPL MICROBIOL, V105, P2065, DOI 10.1111/j.1365-2672.2008.03924.x; Cottyn B, 2015, PHYTOCHEM LETT, V13, P280, DOI 10.1016/j.phytol.2015.07.002; Dantan-Gonzalez E, 2008, INT MICROBIOL, V11, P163, DOI 10.2436/20.1501.01.56; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eichlerova I, 2015, FUNGAL ECOL, V13, P10, DOI 10.1016/j.funeco.2014.08.002; Farnet AM, 2004, ENZYME MICROB TECH, V34, P549, DOI 10.1016/j.enzmictec.2003.11.021; Farver O, 2011, FEBS J, V278, P3463, DOI 10.1111/j.1742-4658.2011.08268.x; Fedorova TV, 2013, APPL BIOCHEM MICRO+, V49, P570, DOI 10.1134/S0003683813060082; Frasconi M, 2010, BBA-PROTEINS PROTEOM, V1804, P899, DOI 10.1016/j.bbapap.2009.12.018; Galli C, 2011, APPL MICROBIOL BIOT, V91, P123, DOI 10.1007/s00253-011-3240-4; Giardina P, 2015, CELL MOL LIFE SCI, V72, P855, DOI 10.1007/s00018-014-1821-y; Gibertoni TB, 2007, FUNGAL DIVERS, V25, P49; Glazunova OA, 2013, FEBS J, V280, P124; Glazunova OA, 2018, CATALYSTS, V8, DOI 10.3390/catal8040152; Glazunova OA, 2015, ACTA CRYSTALLOGR D, V71, P854, DOI 10.1107/S1399004715001595; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatakka A, 2010, MYCOTA, V10, P319; Hattori T, 2005, FUNGAL DIVERS, V18, P73; Hilden K, 2007, APPL MICROBIOL BIOT, V77, P301, DOI 10.1007/s00253-007-1155-x; Hilden K, 2009, BIOTECHNOL LETT, V31, P1117, DOI 10.1007/s10529-009-9998-0; Iakovlev A, 2000, MICROB ECOL, V39, P236; JOVANOVIC SV, 1991, J PHYS CHEM-US, V95, P10824, DOI 10.1021/j100179a054; Kiiskinen LL, 2004, MICROBIOL-SGM, V150, P3065, DOI 10.1099/mic.0.27147-0; Koroleva OV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P618, DOI 10.1023/A:1010299012591; Koroljova-Skorobogat'ko OV, 1998, BIOTECHNOL APPL BIOC, V28, P47; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahtinen M, 2009, J MOL CATAL B-ENZYM, V57, P204, DOI 10.1016/j.molcatb.2008.09.004; Li KC, 1999, APPL ENVIRON MICROB, V65, P2654; Liers C, 2007, ENZYME MICROB TECH, V41, P785, DOI 10.1016/j.enzmictec.2007.07.002; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez MJ, 1996, EUR J BIOCHEM, V237, P424, DOI 10.1111/j.1432-1033.1996.0424k.x; Mate D, 2010, CHEM BIOL, V17, P1030, DOI 10.1016/j.chembiol.2010.07.010; Mukhin V. A., 1993, FUNGI EUROPE INVESTI, P139; Myasoedova NM, 2008, APPL BIOCHEM MICRO+, V44, P73, DOI 10.1134/S0003683808010122; Orlikowska M, 2018, INT J BIOL MACROMOL, V107, P1629, DOI 10.1016/j.ijbiomac.2017.10.024; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Spirin W, 2007, ANN BOT FENN, V44, P298; STALPERS J A, 1978, Studies in Mycology, V16, P1; SUATONI JC, 1961, ANAL CHEM, V33, P1894, DOI 10.1021/ac50154a032; Subramanian Janakiraman, 2014, INT J PHARM BIOL ARC, V5, P8; Tadesse MA, 2008, ORG BIOMOL CHEM, V6, P868, DOI 10.1039/b716002j; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; TIEN M, 1988, METHOD ENZYMOL, V161, P238; Ullrich R, 2005, APPL MICROBIOL BIOT, V67, P357, DOI 10.1007/s00253-004-1861-6; Vares T, 1997, CAN J BOT, V75, P61, DOI 10.1139/b97-007; Vasina DV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173813; Vasina DV, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0729-0; Vasina DV, 2015, BIOCHIMIE, V116, P154, DOI 10.1016/j.biochi.2015.07.015; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Xu F, 2001, APPL BIOCHEM BIOTECH, V95, P125, DOI 10.1385/ABAB:95:2:125; Yakovleva KE, 2007, APPL BIOCHEM MICRO+, V43, P661, DOI 10.1134/S0003683807060166	59	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197667	10.1371/journal.pone.0197667	http://dx.doi.org/10.1371/journal.pone.0197667			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856762	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800033
J	Tordesillas-Gutierrez, D; Ayesa-Arriola, R; Delgado-Alvarado, M; Robinson, JL; Lopez-Morinigo, J; Pujol, J; Dominguez-Ballesteros, ME; David, AS; Crespo-Facorro, B				Tordesillas-Gutierrez, Diana; Ayesa-Arriola, Rosa; Delgado-Alvarado, Manuel; Robinson, Jennifer L.; Lopez-Morinigo, Javier; Pujol, Jesus; Encarnacion Dominguez-Ballesteros, M.; David, Anthony S.; Crespo-Facorro, Benedicto			The right occipital lobe and poor insight in first-episode psychosis	PLOS ONE			English	Article							NONAFFECTIVE PSYCHOSIS; GREY-MATTER; CHRONIC-SCHIZOPHRENIA; PREFRONTAL CORTEX; MENTAL-DISORDER; GRAY-MATTER; AWARENESS; BRAIN; ANOSOGNOSIA; UNAWARENESS	Lack of insight is a core feature of non-affective psychosis and has been associated with poorer outcomes. Brain abnormalities underlying lack of insight have been suggested, mostly in the frontal lobe, although previous research showed mixed results. We used a voxel-based morphometry (VBM) analysis in 108 first-episode non-affective psychosis patients to investigate the pattern of brain structural abnormalities related to lack of insight. In addition, 77 healthy volunteers were compared with the patients classified as having poor and good insight. The shortened version of the Scale to Assess Unawareness of Mental Disorder was used to evaluate insight. Patients with poor insight (n = 68) compared with patients with good insight (n = 40) showed a single significant cluster (k(c) = 5834; PcFWE = 0.001) of reduced grey matter volume (GMV) in the right occipital lobe extending to its lateral and medial surfaces, the cuneus, and the middle temporal gyrus. In addition, GMV at this cluster showed a negative correlation with the score of the SUMD (r = -0.305; p = 0.001). When comparing patients with poor insight with healthy subjects overall reductions of GMV were found, mainly in frontal and occipital lobes. Hence, poor insight in non-affective psychosis seems to be associated with specific brain abnormalities in the right occipital and temporal cortical regions. Dysfunction in any combination of these areas may contribute to lack of insight in non-affective psychosis. Specifically, the ` right' hemisphere dysfunction underlying impaired insight in our sample is consistent with previously reported similarities between lack of insight in psychosis and anosognosia in neurological disorders.	[Tordesillas-Gutierrez, Diana; Delgado-Alvarado, Manuel] Valdecilla Biomed Res Inst IDIVAL, Neuroimaging Unit, Technol Facil, Santander, Cantabria, Spain; [Tordesillas-Gutierrez, Diana; Ayesa-Arriola, Rosa; Pujol, Jesus; Crespo-Facorro, Benedicto] Ctr Invest Biomed Red Salud Mental, CIBERSAM, Santander, Spain; [Ayesa-Arriola, Rosa; Crespo-Facorro, Benedicto] Univ Cantabria, Univ Hosp Marques de Valdecilla, Sch Med, Dept Psychiat,IDIVAL, Santander, Spain; [Robinson, Jennifer L.] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Robinson, Jennifer L.] Auburn Univ, Dept Elect & Comp Engn, Resonance Imaging Res Ctr, Auburn, AL 36849 USA; [Robinson, Jennifer L.] Auburn Univ, Dept Kinesiol, Auburn, AL 36849 USA; [Lopez-Morinigo, Javier; David, Anthony S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England; [Pujol, Jesus] Hosp del Mar, MRI Res Unit, Barcelona, Spain; [Encarnacion Dominguez-Ballesteros, M.] Hosp Virgen Macarena, UGC Psychiat, Seville, Spain	Hospital Universitario Marques de Valdecilla (HUMV); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; University of London; King's College London; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario Virgen Macarena	Tordesillas-Gutierrez, D (corresponding author), Valdecilla Biomed Res Inst IDIVAL, Neuroimaging Unit, Technol Facil, Santander, Cantabria, Spain.; Tordesillas-Gutierrez, D (corresponding author), Ctr Invest Biomed Red Salud Mental, CIBERSAM, Santander, Spain.	diana.tordesillas@idival.org	Ayesa-Arriola, Rosa/AFS-1408-2022; David, Anthony/O-1750-2019; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Tordesillas-Gutierrez, Diana/H-6893-2015; Crespo-Facorro, BENEDICTO/AAY-2238-2021	Ayesa-Arriola, Rosa/0000-0003-0570-5352; David, Anthony/0000-0003-0967-774X; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Tordesillas-Gutierrez, Diana/0000-0003-1458-3932; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132	Institute de Salud Carlos III [PI020499, PI050427, PI060507, PI14/00639, PI14/00918]; Fundacion Institute de Investigacion Marques de Valdecilla [NCT0235832, NCT02534363, API07/011]	Institute de Salud Carlos III(Instituto de Salud Carlos III); Fundacion Institute de Investigacion Marques de Valdecilla	This work was supported by the Institute de Salud Carlos III (PI020499, PI050427, PI060507, PI14/00639 and PI14/00918) and Fundacion Institute de Investigacion Marques de Valdecilla (NCT0235832, NCT02534363, and API07/011). No pharmaceutical industry has participated in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH MS, 1987, ANN NEUROL, V21, P149, DOI 10.1002/ana.410210207; Aleman A, 2006, BRIT J PSYCHIAT, V189, P204, DOI 10.1192/bjp.189.3.204; AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826; Andreasen N.C., 1983, SCALE ASSESMENT NEGA; Andreasen N.C., 1984, SCALE ASSESMENT POSI; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Antonius D, 2011, SCHIZOPHR RES, V128, P76, DOI 10.1016/j.schres.2011.02.020; Arango C, 2011, SCHIZOPHRENIA BULL, V37, P27, DOI 10.1093/schbul/sbq143; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ayesa-Arriola R, 2014, SCHIZOPHR RES, V157, P271, DOI 10.1016/j.schres.2014.05.011; Ayesa-Arriola R, 2011, EARLY INTERV PSYCHIA, V5, P140, DOI 10.1111/j.1751-7893.2010.00249.x; Bassitt DP, 2007, EUR ARCH PSY CLIN N, V257, P58, DOI 10.1007/s00406-006-0685-z; Bedford NJ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-106; Berge D, 2011, ACTA PSYCHIAT SCAND, V123, P431, DOI 10.1111/j.1600-0447.2010.01635.x; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Besharati S, 2014, CORTEX, V61, P127, DOI 10.1016/j.cortex.2014.08.016; BRAFF DL, 1991, ARCH GEN PSYCHIAT, V48, P891; Buchy L, 2011, J PSYCHIATR RES, V45, P781, DOI 10.1016/j.jpsychires.2010.10.016; Buckley PF, 2007, CNS DRUGS, V21, P129, DOI 10.2165/00023210-200721020-00004; Celesia GG, 1997, NEUROLOGY, V49, P88, DOI 10.1212/WNL.49.1.88; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cocchini G, 2009, NEUROPSYCHOLOGY, V23, P223, DOI 10.1037/a0014266; Cooke MA, 2008, SCHIZOPHR RES, V103, P40, DOI 10.1016/j.schres.2008.04.022; Crumlish N, 2005, ACTA PSYCHIAT SCAND, V112, P449, DOI 10.1111/j.1600-0447.2005.00620.x; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; David A. S, 2004, INSIGHT PSYCHOSIS AW; Drake RJ, 2003, SCHIZOPHR RES, V62, P165, DOI 10.1016/S0920-9964(02)00382-1; Fan JE, 2017, J AFFECT DISORDERS, V207, P203, DOI 10.1016/j.jad.2016.08.027; First MB, 2001, STRUCTURED CLIN INTE; Flashman LA, 2001, J NEUROPSYCH CLIN N, V13, P255, DOI 10.1176/appi.neuropsych.13.2.255; Gilleen J, 2011, SCHIZOPHRENIA BULL, V37, P61, DOI 10.1093/schbul/sbq100; Ha TH, 2004, PSYCHIAT RES-NEUROIM, V132, P251, DOI 10.1016/j.pscychresns.2004.05.001; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Kim JJ, 2012, J PSYCHIATR RES, V46, P1318, DOI 10.1016/j.jpsychires.2012.06.012; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Kumar A, 2014, PSYCHOPATHOLOGY, V47, P32, DOI 10.1159/000348486; Laroi F, 2000, PSYCHIAT RES-NEUROIM, V100, P49, DOI 10.1016/S0925-4927(00)00063-9; Liemburg EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042707; Lincoln TM, 2007, SCHIZOPHRENIA BULL, V33, P1324, DOI 10.1093/schbul/sbm002; LYSAKER P, 1995, J NERV MENT DIS, V183, P103, DOI 10.1097/00005053-199502000-00007; Maier F, 2016, CORTEX, V82, P35, DOI 10.1016/j.cortex.2016.05.019; McFarland J, 2013, EUR ARCH PSY CLIN N, V263, P133, DOI 10.1007/s00406-012-0333-8; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Michel P, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-229; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Morgan KD, 2010, BRIT J PSYCHIAT, V197, P141, DOI 10.1192/bjp.bp.109.070888; Moro V, 2016, CORTEX, V83, P62, DOI 10.1016/j.cortex.2016.07.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orfei MD, 2013, SOC COGN AFFECT NEUR, V8, P418, DOI 10.1093/scan/nss016; Osatuke K, 2008, COMPR PSYCHIAT, V49, P70, DOI 10.1016/j.comppsych.2007.08.001; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pelayo-Teran JM, 2008, EARLY INTERV PSYCHIA, V2, P178, DOI 10.1111/j.1751-7893.2008.00074.x; Raij TT, 2012, SCHIZOPHR RES, V139, P27, DOI 10.1016/j.schres.2012.05.011; Ruiz AI, 2008, ACTAS ESP PSIQUIATRI, V36, P111; Saeedi H, 2007, SCHIZOPHR RES, V89, P123, DOI 10.1016/j.schres.2006.09.018; Sapara A, 2007, SCHIZOPHR RES, V89, P22, DOI 10.1016/j.schres.2006.09.016; Sapara A, 2016, WORLD J PSYCHIATR, V6, P311, DOI 10.5498/wjp.v6.i3.311; Shad MU, 2004, NEUROIMAGE, V22, P1315, DOI 10.1016/j.neuroimage.2004.03.016; Tordesillas-Gutierrez D, 2015, SCHIZOPHR RES, V164, P74, DOI 10.1016/j.schres.2015.01.032; Trevisi M, 2012, PSYCHOPATHOLOGY, V45, P235, DOI 10.1159/000329998; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Meer L, 2013, SCHIZOPHRENIA BULL, V39, P1352, DOI 10.1093/schbul/sbs122; Yue Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147204	65	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197715	10.1371/journal.pone.0197715	http://dx.doi.org/10.1371/journal.pone.0197715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8ES	29856773	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800037
J	Lv, JM; Wang, MY				Lv, Jian-Min; Wang, Ming-Yu			In vitro generation and bioactivity evaluation of C-reactive protein intermediate	PLOS ONE			English	Article							ACTIVATED PLATELETS; INFLAMMATION; DISSOCIATION; IDENTIFICATION; REARRANGEMENT; LOCALIZES; FORM; CRP	The conformational conversion of pentameric C-reactive protein (pCRP) to monomeric CRP (mCRP) has been shown to play important roles in the action of CRP in inflammation regulation. In vivo studies revealed the origin of mCRP and provided insights into how pCRP dissociation affected its functions. However, the interplay and exact bioactivities of CRP isoforms still remain uncertain due to the rapid conformational conversion and complex milieu in vivo. Herein, we have used surface-immobilization of pCRP to generate a preservable intermediate with dual antigenicity expression of both pCRP and mCRP. The intermediate has been further shown to exhibit modified bioactivities, such as a high affinity with solution-phase pCRP and an enhanced capacity of complement interaction. These results thus not only provide the conformational conversion details of CRP, but also propose a simple way in vitro to study how the functions of CRP are tuned by distinct isoforms.	[Lv, Jian-Min; Wang, Ming-Yu] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Gansu, Peoples R China	Lanzhou University	Wang, MY (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou, Gansu, Peoples R China.	wangmy@lzu.edu.cn		Wang, Ming-Yu/0000-0002-6622-5996	National Natural Science Foundation of China [31401101]; Fundamental Research Funds for the Central Universities [lzujbky-2016-83, lzujbky-2016-222]; NSFC [31401101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NSFC(National Natural Science Foundation of China (NSFC))	Ming-Yu Wang received National Natural Science Foundation of China,grant number 31401101, and Fundamental Research Funds for the Central Universities, grant number lzujbky-2016-83. Jian-MinLv received Fundamental Research Funds for the Central Universities, grant number lzujbky-2016-222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr. Yi Wu for his constructive advices in data analysis. This work was supported by grants from the NSFC (31401101) and the Fundamental Research Funds for the Central Universities (lzujbky-2016-83, lzujbky-2016-222).	Agrawal A, 2001, J IMMUNOL, V166, P3998, DOI 10.4049/jimmunol.166.6.3998; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Diehl EE, 2000, AM J MED SCI, V319, P79, DOI 10.1097/00000441-200002000-00002; Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Khreiss T, 2002, J BIOL CHEM, V277, P40775, DOI 10.1074/jbc.M205378200; Kresl JJ, 1998, INT J BIOCHEM CELL B, V30, P1415, DOI 10.1016/S1357-2725(98)00078-8; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Liu Dongsheng, 2016, Biophys Rep, V2, P33; Liu Zheng, 2016, Biophys Rep, V2, P21; Lv JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20014-y; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Molins B, 2011, CARDIOVASC RES, V92, P328, DOI 10.1093/cvr/cvr226; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Park SY, 2012, J BIOL CHEM, V287, P11261, DOI 10.1074/jbc.M111.310953; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Shi P, 2014, ACTA BIOL HUNG, V65, P265, DOI 10.1556/ABiol.65.2014.3.3; Shrivastava AK, 2015, EGYPT HEART J, V67, P89, DOI 10.1016/j.ehj.2014.11.005; Slevin M, 2009, HISTOL HISTOPATHOL, V24, P1473, DOI 10.14670/HH-24.1473; Thiele JR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/372432; Thiele JR, 2014, CIRCULATION, V130, P35, DOI 10.1161/CIRCULATIONAHA.113.007124; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Udvarnoki K, 2007, CLIN VACCINE IMMUNOL, V14, P335, DOI 10.1128/CVI.00155-06; Verma S, 2004, CIRCULATION, V109, P1914, DOI 10.1161/01.CIR.0000127085.32999.64; Wang HW, 2001, BIOCHEM BIOPH RES CO, V288, P75, DOI 10.1006/bbrc.2001.5733; Wang Shengliu, 2017, Biophys Rep, V3, P8, DOI 10.1007/s41048-017-0035-x; Wu Y, 2015, BIOL CHEM, V396, P1181, DOI 10.1515/hsz-2015-0149; YING SC, 1989, J IMMUNOL, V143, P221; Zhang LL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01087	36	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198375	10.1371/journal.pone.0198375	http://dx.doi.org/10.1371/journal.pone.0198375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851992	Green Submitted, gold, Green Published			2022-12-26	WOS:000433893200051
J	He, JY; Beck, NK; Kossik, AL; Zhang, JW; Seto, E; Meschke, JS; Novosselov, I				He, Jiayang; Beck, Nicola K.; Kossik, Alexandra L.; Zhang, Jiawei; Seto, Edmund; Meschke, John Scott; Novosselov, Igor			Evaluation of micro-well collector for capture and analysis of aerosolized Bacillus subtilis spores	PLOS ONE			English	Article							FIBEROPTIC CHEMICAL SENSORS; ENHANCED RAMAN-SPECTROSCOPY; INDOOR AIR-QUALITY; ATMOSPHERIC-PRESSURE; ELECTROSTATIC PRECIPITATION; SAMPLING TIME; SYSTEM; FLUORESCENCE; PARTICLES; BIOAEROSOLS	Bioaerosol sampling and identification are vital for the assessment and control of airborne pathogens, allergens, and toxins. In-situ analysis of chemical and biological particulate matter can significantly reduce the costs associated with sample preservation, transport, and analysis. The analysis of conventional filters is challenging, due to dilute samples in large collection regions. A low-cost cartridge for collection and analysis of aerosols is developed for use in epidemiological studies and personal exposure assessments. The cartridge collects aerosol samples in a micro-well which reduces particles losses due to the bounce and does not require any coating. The confined particle collection area (d(well)similar to 1.4 mm) allows reducing the elution volume for subsequent analysis. The performance of the cartridge is validated in laboratory studies using aerosolized bacterial spores (Bacillus subtilis). Colony forming unit analysis is used for bacterial spore enumeration. Cartridge collection efficiency is evaluated by comparison with the reference filters and found to be consistent with tested flow rates. Sample recovery for the pipette elution is similar to 80%. Due to the high density of the collected sample, the cartridge is compatible with in-situ spectroscopic analysis and sample elution into the 10-20 mu l liquid volume providing a significant increase in sample concentration for subsequent analysis.	[He, Jiayang; Zhang, Jiawei; Novosselov, Igor] Univ Washington, Mech Engn, Seattle, WA 98195 USA; [Beck, Nicola K.; Kossik, Alexandra L.; Seto, Edmund; Meschke, John Scott; Novosselov, Igor] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Novosselov, I (corresponding author), Univ Washington, Mech Engn, Seattle, WA 98195 USA.; Novosselov, I (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	ivn@uw.edu	Novosselov, Igor/ABA-1810-2020	Novosselov, Igor/0000-0002-6347-7450; He, Jiayang/0000-0002-9740-791X	National Institute of Environmental Health Sciences [1R21ES024715, 1R33ES024715]; National Institute of Biomedical Imaging and Bioengineering [U01 EB021923]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021923] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was partially funded by a grant from the National Institute of Environmental Health Sciences (grant numbers 1R21ES024715 and 1R33ES024715 to Edmund Seto); and by a grant from the National Institute of Biomedical Imaging and Bioengineering (grant number U01 EB021923 to Edmund Seto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranovski IE, 2005, J AEROSOL SCI, V36, P609, DOI 10.1016/j.jaerosci.2004.11.014; Ariessohn PC, 2011, US Patent, Patent No. 7875095; Austin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137789; Cai J, 2014, AEROSOL AIR QUAL RES, V14, P1, DOI 10.4209/aaqr.2013.03.0088; Campbell SD, 2005, OPTICALLY BASED MAT; Chartier R, 2017, INDOOR AIR, V27, P147, DOI 10.1111/ina.12281; Dacunto PJ, 2015, ENVIRON SCI-PROC IMP, V17, P1959, DOI [10.1039/c5em00365b, 10.1039/C5EM00365B]; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; Damit B, 2017, AEROSOL SCI TECH, V51, P488, DOI 10.1080/02786826.2016.1275515; Deng RS, 2008, AEROSOL SCI TECH, V42, P899, DOI 10.1080/02786820802360674; Development OoR, LIT REV PROT PROC SO; Dippel B., 1999, J AEROSOL SCI, V30, pS907, DOI DOI 10.1016/S0021-8502(99)80464-9; Dons E, 2017, ENVIRON SCI TECHNOL, V51, P1859, DOI 10.1021/acs.est.6b05782; Eversole JD, 2001, FIELD ANAL CHEM TECH, V5, P205, DOI 10.1002/fact.1022; Farquharson S, 2004, J RAMAN SPECTROSC, V35, P82, DOI 10.1002/jrs.1111; Foat TG, 2016, J AEROSOL SCI, V95, P43, DOI 10.1016/j.jaerosci.2016.01.007; Gao ML, 2015, ENVIRON POLLUT, V199, P56, DOI 10.1016/j.envpol.2015.01.013; Godwin C, 2007, INDOOR AIR, V17, P109, DOI 10.1111/j.1600-0668.2006.00459.x; Goo J, 2002, J AEROSOL SCI, V33, P1493, DOI 10.1016/S0021-8502(02)00109-X; Grinshpun SA, 2016, MANUAL ENV MICROBIOL; Han TT, 2017, AEROSOL SCI TECH, V51, P903, DOI 10.1080/02786826.2017.1329516; He J, 2017, AEROSOL SCI TECHNOLO; Heutte N, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-016-5751-z; Huffman J.A., 2017, MICROBIOLOGY AEROSOL, DOI [10.1002/9781119132318.ch1d, DOI 10.1002/9781119132318.CH1D, DOI 10.1002/9781119132318]; Johnson KK, 2016, ATMOS MEAS TECH DISC, DOI [10.5194/amt-2015-331, DOI 10.5194/AMT-2015-331]; Kesavan J, 2015, ENVIRON SCI-PROC IMP, V17, P638, DOI 10.1039/c4em00510d; Koehler Kirsten A, 2015, Curr Environ Health Rep, V2, P399, DOI 10.1007/s40572-015-0070-z; Kudelski A, 2008, TALANTA, V76, P1, DOI 10.1016/j.talanta.2008.02.042; Lin XJ, 1997, AM IND HYG ASSOC J, V58, P480, DOI 10.1080/15428119791012577; LRe Al, 2004, EMERG INFECT DIS, V10, DOI [10.3201/eid1006.030716, DOI 10.3201/EID1006.030716]; MARPLE VA, 1980, ENVIRON SCI TECHNOL, V14, P976, DOI 10.1021/es60168a019; Marquardt BJ, 2001, RAMAN SPECTROSCOPY L; Nazaroff WW, 2016, INDOOR AIR, V26, P61, DOI 10.1111/ina.12174; Njalsson T, 2018, J AEROSOL SCI; Novosselov IV, 2014, AEROSOL SCI TECH, V48, P822, DOI 10.1080/02786826.2014.932895; Novosselov IV, 2014, AEROSOL SCI TECH, V48, P163, DOI 10.1080/02786826.2013.865832; O'Hara RE, 2005, J ENVIRON HEALTH, V68, P24; Pan YL, 2015, J QUANT SPECTROSC RA, V150, P12, DOI 10.1016/j.jqsrt.2014.06.007; PAYET S, 1992, J AEROSOL SCI, V23, P723, DOI 10.1016/0021-8502(92)90039-X; Petrov GI, 2005, OPT EXPRESS, V13, P9537, DOI 10.1364/OPEX.13.009537; Pospisilova M, 2015, SENSORS-BASEL, V15, P25208, DOI 10.3390/s151025208; Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x; Reponen T., 2017, EXPOSURE MICROBIOLOG, P85, DOI DOI 10.1007/978-3-319-61688-9_4; Roux JM, 2016, ENVIRON SCI POLLUT R, V23, P8175, DOI 10.1007/s11356-015-5522-3; Sengupta A, 2005, J AEROSOL SCI, V36, P651, DOI 10.1016/j.jaerosci.2004.11.001; Seto E., 2014, INT ENV MODELLING SO; Sivaprakasam V, 2004, OPT EXPRESS, V12, P4457, DOI 10.1364/OPEX.12.004457; Stiles PL, 2008, ANNU REV ANAL CHEM, V1, P601, DOI 10.1146/annurev.anchem.1.031207.112814; Triado-Margarit X, 2017, INDOOR AIR, V27, P564, DOI 10.1111/ina.12343; Volckens J, 2017, INDOOR AIR, V27, P409, DOI 10.1111/ina.12318; Wang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120308; Wang Z, 2001, J AEROSOL SCI, V32, P661, DOI 10.1016/S0021-8502(00)00108-7; Willeke K, 1998, AEROSOL SCI TECH, V28, P439, DOI 10.1080/02786829808965536; Wolfbeis OS, 2008, ANAL CHEM, V80, P4269, DOI 10.1021/ac800473b; Zhang XF, 2002, AEROSOL SCI TECH, V36, P617, DOI 10.1080/02786820252883856	55	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197783	10.1371/journal.pone.0197783	http://dx.doi.org/10.1371/journal.pone.0197783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847559	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800041
J	Noonan, SHC; Kluibenschedl, A; Fabricius, KE				Noonan, Sam H. C.; Kluibenschedl, Anna; Fabricius, Katharina E.			Ocean acidification alters early successional coral reef communities and their rates of community metabolism	PLOS ONE			English	Article							CALCIFICATION RATE; PARTIAL-PRESSURE; CLIMATE-CHANGE; CO2; ORGANISMS; RESPONSES; ALGAE; DECALCIFICATION; DISSOLUTION; RESILIENCE	Ocean acidification is expected to alter community composition on coral reefs, but its effects on reef community metabolism are poorly understood. Here we document how early successional benthic coral reef communities change in situ along gradients of carbon dioxide (CO2), and the consequences of these changes on rates of community photosynthesis, respiration, and light and dark calcification. Ninety standardised benthic communities were grown on PVC tiles deployed at two shallow-water volcanic CO2 seeps and two adjacent control sites in Papua New Guinea. Along the CO2 gradient, both the upward facing phototrophic and the downward facing cryptic communities changed in their composition. Under ambient CO2, both communities were dominated by calcifying algae, but with increasing CO2 they were gradually replaced by non-calcifying algae (predominantly green filamentous algae, cyanobacteria and macroalgae, which increased from similar to 30% to similar to 80% cover). Responses were weaker in the invertebrate communities, however ascidians and tube-forming polychaetes declined with increasing CO2. Differences in the carbonate chemistry explained a far greater amount of change in communities than differences between the two reefs and successional changes from five to 13 months, suggesting community successions are established early and are under strong chemical control. As pH declined from 8.0 to 7.8, rates of gross photosynthesis and dark respiration of the 13-month old reef communities (upper and cryptic surfaces combined) significantly increased by 10% and 20%, respectively, in response to altered community composition. As a consequence, net production remained constant. Light and dark calcification rates both gradually declined by 20%, and low or negative daily net calcification rates were observed at an aragonite saturation state of <2.3. The study demonstrates that ocean acidification as predicted for the end of this century will strongly alter reef communities, and will significantly change rates of community metabolism.	[Noonan, Sam H. C.; Kluibenschedl, Anna; Fabricius, Katharina E.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Kluibenschedl, Anna] Univ Otago, Dept Marine Sci, Dunedin, New Zealand	Australian Institute of Marine Science; University of Otago	Noonan, SHC (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	s.noonan@aims.gov.au	Fabricius, Katharina/F-1759-2010	Fabricius, Katharina/0000-0001-7671-4358; Noonan, Sam/0000-0002-0392-6197	Australian Institute of Marine Science; National Geographic Society Committee for Research and Exploration	Australian Institute of Marine Science; National Geographic Society Committee for Research and Exploration(National Geographic Society)	This study was funded by the Australian Institute of Marine Science and a grant by the National Geographic Society Committee for Research and Exploration to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Albright R, 2018, NATURE, V555, P516, DOI 10.1038/nature25968; Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Andersson AJ, 2014, NAT CLIM CHANGE, V4, P56, DOI 10.1038/NCLIMATE2050; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Barkley HC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500328; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Comeau S, 2015, BIOGEOSCIENCES, V12, P365, DOI 10.5194/bg-12-365-2015; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2374; Comeau S, 2016, GLOBAL CHANGE BIOL, V22, P1225, DOI 10.1111/gcb.13023; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; Crook ED, 2012, CORAL REEFS, V31, P239, DOI 10.1007/s00338-011-0839-y; Cyronak T, 2013, GEOPHYS RES LETT, V40, P4876, DOI 10.1002/grl.50948; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; Edmunds PJ, 2016, BIOSCIENCE, V66, P350, DOI 10.1093/biosci/biw023; Enochs IC, 2015, NAT CLIM CHANGE, V5, P1083, DOI 10.1038/NCLIMATE2758; Enochs IC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1742; Eyre BD, 2014, NAT CLIM CHANGE, V4, P969, DOI 10.1038/NCLIMATE2380; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1536; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Gattuso JP, 1999, P NATL ACAD SCI USA, V96, P13017, DOI 10.1073/pnas.96.23.13017; Gazeau F, 2015, MAR ECOL PROG SER, V527, P1, DOI 10.3354/meps11287; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Kennedy EV, 2017, MAR ECOL PROG SER, V569, P129, DOI 10.3354/meps12076; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Lane AC, 2013, MAR BIOL, V160, P1983, DOI 10.1007/s00227-012-2056-9; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Leclercq N, 2002, LIMNOL OCEANOGR, V47, P558, DOI 10.4319/lo.2002.47.2.0558; Lewis E., 1998, PROGRAM DEV CO2 SYST; Linares C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0587; Lombardi C, 2011, MAR ECOL-EVOL PERSP, V32, P211, DOI 10.1111/j.1439-0485.2010.00426.x; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; MEESE RJ, 1992, J EXP MAR BIOL ECOL, V165, P59, DOI 10.1016/0022-0981(92)90289-M; Morrow KM, 2015, ISME J, V9, P894, DOI 10.1038/ismej.2014.188; Munday PL, 2014, NAT CLIM CHANGE, V4, P487, DOI [10.1038/nclimate2195, 10.1038/NCLIMATE2195]; Noonan SHC, 2016, ICES J MAR SCI, V73, P715, DOI 10.1093/icesjms/fsv127; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; R Development Core Team, 2017, LANG ENV STAT COMP; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Ricke KL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034003; Rivest EB, 2017, CURR CLIM CHANGE REP, V3, P271, DOI 10.1007/s40641-017-0082-x; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Solomon S., 2014, CLIMATE CHANGE 2013; Suggett DJ, 2012, GLOBAL CHANGE BIOL, V18, P3015, DOI 10.1111/j.1365-2486.2012.02767.x; Vogel N, 2014, LIMNOL OCEANOGR, V60, P263, DOI [10.1002/lno.10021, DOI 10.1002/ING.10021]	69	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197130	10.1371/journal.pone.0197130	http://dx.doi.org/10.1371/journal.pone.0197130			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847575	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000433634800018
J	Oteng-Pabi, SK; Clouthier, CM; Keillor, JW				Oteng-Pabi, Samuel K.; Clouthier, Christopher M.; Keillor, Jeffrey W.			Design of a glutamine substrate tag enabling protein labelling mediated by Bacillus subtilis transglutaminase	PLOS ONE			English	Article							STREPTOMYCES-MOBARAENSIS TRANSGLUTAMINASE; MICROBIAL TRANSGLUTAMINASE; PEPTIDE; ENZYME; ASSAY; PURIFICATION; ANTIBODIES	Transglutaminases (TGases) are enzymes that catalyse protein cross-linking through a transamidation reaction between the side chain of a glutamine residue on one protein and the side chain of a lysine residue on another. Generally, TGases show low substrate specificity with respect to their amine substrate, such that a wide variety of primary amines can participate in the modification of specific glutamine residue. Although a number of different TGases have been used to mediate these bioconjugation reactions, the TGase from Bacillus subtilis (bTG) may be particularly suited to this application. It is smaller than most TGases, can be expressed in a soluble active form, and lacks the calcium dependence of its mammalian counterparts. However, little is known regarding this enzyme and its glutamine substrate specificity, limiting the scope of its application. In this work, we designed a FRET-based ligation assay to monitor the bTG-mediated conjugation of the fluorescent proteins Clover and mRuby2. This assay allowed us to screen a library of random heptapeptide glutamine sequences for their reactivity with recombinant bTG in bacterial cells, using fluorescence assisted cell sorting. From this library, several reactive sequences were identified and kinetically characterized, with the most reactive sequence (YAHQAHY) having a k(cat)/K-M value of 19 +/- 3 mu M-1 min(-1). This sequence was then genetically appended onto a test protein as a reactive 'Q-tag' and fluorescently labelled with dansyl-cadaverine, in the first demonstration of protein labelling mediated by bTG.	[Oteng-Pabi, Samuel K.; Clouthier, Christopher M.; Keillor, Jeffrey W.] Univ Ottawa, Dept Chem & Biomol Sci, Ctr Catalysis & Res Innovat, 30 Marie Curie, Ottawa, ON, Canada	University of Ottawa	Keillor, JW (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ctr Catalysis & Res Innovat, 30 Marie Curie, Ottawa, ON, Canada.	jkeillor@uottawa.ca			Natural Sciences and Engineering Research Council of Canada [184034]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Grant Number 184034. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Natural Sciences and Engineering Research Council of Canada (NSERC) for financial support of this work.	Agyare KK, 2010, J AGR FOOD CHEM, V58, P1946, DOI 10.1021/jf903530d; Caja S, 2011, CELL MOL IMMUNOL, V8, P103, DOI 10.1038/cmi.2010.65; Day N, 1999, ANAL BIOCHEM, V274, P141, DOI 10.1006/abio.1999.4255; Dean KM, 2014, NAT CHEM BIOL, V10, P512, DOI [10.1038/NCHEMBIO.1556, 10.1038/nchembio.1556]; Fisher ML, 2015, MOL CANCER RES, V13, P1083, DOI 10.1158/1541-7786.MCR-14-0685-T; Gillet SMFG, 2005, ANAL BIOCHEM, V347, P221, DOI 10.1016/j.ab.2005.09.035; Gundersen MT, 2014, APPL MICROBIOL BIOT, V98, P219, DOI 10.1007/s00253-013-4886-x; Halim D, 2007, BIOORG MED CHEM LETT, V17, P305, DOI 10.1016/j.bmcl.2006.10.061; Hitomi K, 2009, AMINO ACIDS, V36, P619, DOI 10.1007/s00726-008-0126-6; Javitt G, 2017, BMC BIOTECHNOL, V17, P1, DOI [10.1186/s12896-016-0323-4, DOI 10.1186/S12896-016-0323-4]; Jeger S, 2010, ANGEW CHEM INT EDIT, V49, P9995, DOI 10.1002/anie.201004243; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; Keillor JW, 2015, TRENDS PHARMACOL SCI, V36, P32, DOI 10.1016/j.tips.2014.10.014; Kerr C, 2017, ONCOGENE, V36, P2981, DOI 10.1038/onc.2016.452; Kieliszek M, 2014, FOLIA MICROBIOL, V59, P241, DOI 10.1007/s12223-013-0287-x; Kumazawa Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1086, DOI 10.1271/bbb.61.1086; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lee JH, 2013, BIOTECHNOL BIOENG, V110, P2865, DOI 10.1002/bit.24970; Lee JH, 2013, BIOTECHNOL BIOENG, V110, P353, DOI 10.1002/bit.24622; Liu S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-112; Liu YH, 2014, J IND MICROBIOL BIOT, V41, P1227, DOI 10.1007/s10295-014-1468-6; McPherson DC, 2005, J BACTERIOL, V187, P8278, DOI 10.1128/JB.187.24.8278-8290.2005; Mirzaei M, 2011, FOOD ENG, V9, P2000; Noda S, 2013, BIOCHEM ENG J, V74, P76, DOI 10.1016/j.bej.2013.02.011; Oteng-Pabi SK, 2014, CHEM COMMUN, V50, P6604, DOI 10.1039/c4cc00994k; Oteng-Pabi SK, 2013, ANAL BIOCHEM, V441, P169, DOI 10.1016/j.ab.2013.07.014; Placido D, 2008, PROTEIN EXPRES PURIF, V59, P1, DOI 10.1016/j.pep.2007.12.004; Ragkousi K, 2004, J BACTERIOL, V186, P5567, DOI 10.1128/JB.186.17.5567-5575.2004; Rashidian M, 2013, BIOCONJUGATE CHEM, V24, P1277, DOI 10.1021/bc400102w; Salis B, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0202-4; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Steffen W, 2017, J BIOL CHEM, V292, P15622, DOI 10.1074/jbc.M117.797811; Strop P, 2014, BIOCONJUGATE CHEM, V25, P855, DOI 10.1021/bc500099v; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Szardenings M, 2003, J RECEPT SIG TRANSD, V23, P307, DOI 10.1081/RRS-120026973; Tsai CY, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0283-y; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5; Yurimoto H, 2004, BIOSCI BIOTECH BIOCH, V68, P2058, DOI 10.1271/bbb.68.2058; Zhang DX, 2010, BIOTECHNOL GENET ENG, V26, P205; Zhu Y, 2008, TRENDS BIOTECHNOL, V26, P559, DOI 10.1016/j.tibtech.2008.06.006	41	8	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197956	10.1371/journal.pone.0197956	http://dx.doi.org/10.1371/journal.pone.0197956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847605	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800045
J	Saleh, AA; El-Far, AH; Abdel-Latif, MA; Emam, MA; Ghanem, R; Abd El-Hamid, HS				Saleh, Ahmed A.; El-Far, Ali H.; Abdel-Latif, Mervat A.; Emam, Mohamed A.; Ghanem, Rania; Abd El-Hamid, Hatem S.			Exogenous dietary enzyme formulations improve growth performance of broiler chickens fed a low-energy diet targeting the intestinal nutrient transporter genes	PLOS ONE			English	Article							XYLANASE SUPPLEMENTATION; CLOSTRIDIUM-PERFRINGENS; NONSTARCH POLYSACCHARIDES; ACID-TRANSPORT; EXPRESSION; PROTEASE; DIGESTIBILITY; HEALTH; COMBINATION; NUTRITION	Diminishing the cost of broiler chicken diet is a critical issue in the poultry industry. Numerous studies were performed to achieve this pivotal objective by diet supplementation with alternative feed additives. In the current study, low-energy broiler rations were supplemented with different commercial multienzyme formulations to minimize the cost, and increase the digestibility and absorption of the digested macronutrients. Cobb Avian 48 broiler chicks (mixed sex, 1-d-old, n = 3120) were randomly allocated into six groups, and each group was subdivided into four replicates (130 birds per replicate). The birds were randomly allocated into a control group fed basal diet (CB); control group fed low-energy diet (CL); and birds fed low-energy diets supplemented with different enzyme formulations. The enzyme formulations used were Xylam 500 (R) (CLX group), Hemicell (R) (CLH group), Avizyme (R) (CLA group), and Megazyme (R) (CLM group,) following the doses recommended by the manufacturers. The growth performance of CLA and CLH group birds was significantly improved when compared with CL. In comparison with CB, Avizyme (R) significantly (p < 0.001) increased the intestinal PEPT1, GLUT2, ACC, and IL-2 expression; PEPT1 facilitates the absorption of micronutrients. In conclusion, exogenous multienzyme complexes may be included in the low-energy diet to enhance the performance of broiler chickens (Avizyme (R) > Hemicell (R) > Megazyme (R)), and reduce the diet cost by up-regulating the expression of intestinal nutrient transporter genes, and improving the immunity and serum biochemical parameters of broiler chickens.	[Saleh, Ahmed A.] Kafrelsheikh Univ, Dept Poultry Prod, Fac Agr, Kafrelsheikh, Egypt; [El-Far, Ali H.] Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour, El Beheira, Egypt; [Abdel-Latif, Mervat A.] Damanhour Univ, Fac Vet Med, Dept Nutr & Vet Clin Nutr, Damanhour, El Beheira, Egypt; [Emam, Mohamed A.] Damanhour Univ, Fac Vet Med, Dept Nutr & Vet Clin Nutr, Damanhour, El Beheira, Egypt; [Ghanem, Rania] Mansoura Lab, Anim Hlth Res Inst, Mansoura, Egypt; [Abd El-Hamid, Hatem S.] Damanhour Univ, Fac Vet Med, Dept Poultry Dis, Damanhour, El Beheira, Egypt	Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Damanhour University; Animal Health Research Institute (AHRI); Egyptian Knowledge Bank (EKB); Damanhour University	El-Far, AH (corresponding author), Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour, El Beheira, Egypt.; Abdel-Latif, MA (corresponding author), Damanhour Univ, Fac Vet Med, Dept Nutr & Vet Clin Nutr, Damanhour, El Beheira, Egypt.	ali.elfar@damanhour.edu.eg; mervat.abdellatif@vetmed.dmu.edu.eg	Saleh, Ahmed/J-4965-2019; El-Far, Prof Dr/Ali H./L-7946-2017; Saleh, Ahmed Ali/H-7928-2014; Abdel-Latif, Mervat/ABG-8943-2021; Abdel-Latif, Mervat A./AAC-5685-2019	Saleh, Ahmed/0000-0002-2052-5248; El-Far, Prof Dr/Ali H./0000-0001-9721-4360; Saleh, Ahmed Ali/0000-0002-2052-5248; Abdel-Latif, Mervat/0000-0002-7996-0121; 				Abdalla M. O., 1999, Malaysian Applied Biology, V28, P73; Abdel-Latif MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185153; Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Ahmad Z, 2013, PAK VET J, V33, P388; ALLAN WH, 1974, VET REC, V95, P120, DOI 10.1136/vr.95.6.120; ALMIRALL M, 1995, J NUTR, V125, P947; Amerah AM, 2017, POULTRY SCI, V96, P807, DOI 10.3382/ps/pew297; AOAC, 2005, OFFICIAL METHODS ANA; Bedford MR, 1996, WORLD POULTRY SCI J, V52, P61, DOI 10.1079/WPS19960007; Bedford MR, 2000, ANIM FEED SCI TECH, V86, P1, DOI 10.1016/S0377-8401(00)00155-3; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Cafe MB, 2002, J APPL POULTRY RES, V11, P29, DOI 10.1093/japr/11.1.29; Choct M, 1996, BRIT POULTRY SCI, V37, P609, DOI 10.1080/00071669608417891; Coles E.H., 1986, VET CLIN PATH; Deng YX, 2011, BIOL TRACE ELEM RES, V144, P647, DOI 10.1007/s12011-011-9018-9; Dignass AU, 1996, EXP CELL RES, V225, P422, DOI 10.1006/excr.1996.0193; Donohue M, 2009, J APPL POULTRY RES, V18, P325, DOI 10.3382/japr.2008-00134; Ebrahimi R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/149745; Field CJ, 2000, MED SCI SPORT EXER, V32, pS377, DOI 10.1097/00005768-200007001-00002; Flores C, 2016, J APPL POULTRY RES, V25, P328, DOI 10.3382/japr/pfw016; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Freitas DM, 2011, J APPL POULTRY RES, V20, P322, DOI 10.3382/japr.2010-00295; Gilbert ER, 2008, J ANIM SCI, V86, P2135, DOI 10.2527/jas.2007-0826; Guo SS, 2014, POULTRY SCI, V93, P94, DOI 10.3382/ps.2013-03188; Horvatovic MP, 2015, BRAZ J POULTRY SCI, V17, P25, DOI 10.1590/1516-635x170125-30; Hosseini SM, 2017, J POULT SCI, V54, P149, DOI 10.2141/jpsa.0160099; Iji PA, 2004, J SCI FOOD AGR, V84, P1451, DOI 10.1002/jsfa.1816; JIN G, 2001, ASIAN POULT, V5, P26; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217; Kalmendal R, 2012, POULTRY SCI, V91, P1387, DOI 10.3382/ps.2011-02064; Lana GRQ, 2015, RURAL, V45, P111, DOI [10.1590/0103-8478cr20131544, DOI 10.1590/0103-8478CR20131544]; Lee CY, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.11; Lee S.A., 2017, J WORLDS POULTRY RES, V7, P35; Lu H, 2016, J ANIM SCI S5, V94, P447, DOI [10.2527/jam2016-0928, DOI 10.2527/JAM2016-0928]; Marcu A., 2013, ANIM SCI BIOTECHNOL, V46, P339; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nian F, 2011, ASIAN AUSTRAL J ANIM, V24, P1282, DOI 10.5713/ajas.2011.10441; Olukosi OA, 2015, POULTRY SCI, V94, P2662, DOI 10.3382/ps/pev260; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Prandini F, 2008, ZOOTECH INT, V9, P25; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Ravindran R., 2005, POULTRY 2010; Romero LF, 2014, POULTRY SCI, V93, P2501, DOI 10.3382/ps.2013-03789; Ruhnke I, 2015, J ANIM PHYSIOL AN N, V99, P29, DOI 10.1111/jpn.12313; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Williams MP, 2014, J APPL POULTRY RES, V23, P188, DOI 10.3382/japr.2013-00856; Yuan JM, 2007, ASIAN AUSTRAL J ANIM, V20, P1222, DOI 10.5713/ajas.2007.1222; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhou MJ, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0219-2	51	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198085	10.1371/journal.pone.0198085	http://dx.doi.org/10.1371/journal.pone.0198085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847558	Green Submitted, Green Published, gold			2022-12-26	WOS:000433634800052
J	Bouassa, RSM; Simaleko, MM; Camengo, SP; Mossoro-Kpinde, CD; Veyer, D; Matta, M; Robin, L; Longo, JD; Gresenguet, G; Pere, H; Meye, JF; Belec, L				Bouassa, Ralph-Sydney Mboumba; Simaleko, Marcel Mbeko; Camengo, Serge Police; Mossoro-Kpinde, Christian Diamant; Veyer, David; Matta, Mathieu; Robin, Leman; Longo, Jean De Dieu; Gresenguet, Gerard; Pere, Helene; Meye, Jean-Francois; Belec, Laurent			Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic	PLOS ONE			English	Article							ANYPLEX II HPV28; SUB-SAHARAN AFRICA; PERFORMANCE EVALUATION; CERVICAL-CANCER; HIGH PREVALENCE; UNINFECTED MEN; POSITIVE MEN; HIV; INFECTION; TRANSMISSION	Background High-risk (HR) human papillomavirus (HPV) infection remains a great concern in relation to African men who have sex with men (MSM), especially those infected with HIV. The prevalence of HR-HPV and associated risk factors was estimated in a cross-sectional observational study covering MSM living in Bangui, Central African Republic. Methods MSM receiving care at the Centre National de Reference des Infections Sexuellement Transmissibles et de la Therapie Antiretrovirale, Bangui, were included. HIV serostatus and socio-demographic and behavioral characteristics were collected. HPV DNA was detected and genotyped on anal swabs using Anyplex (TM) II HPV28 test (Seegene, South Korea), and HSV DNA by in-house real-time PCR. Logistic regression analyses were used to determine risk factors associated with HPV outcomes. Results 42 MSM (mean age, 23.2 years; range, 14-39) including 69.1% HIV-1-positive and 30.9% HIV-negative were prospectively enrolled. The prevalence of anal HPV was 69.1%, including 82.7% of HR-HPV which were multiple in 52.0%. The most prevalent genotypes were HPV-35, HPV-58, HPV-59 and HPV-31. While, HPV-16 and HPV-18 were present in a minority of samples. Multiple HR-HPV infection was more frequent in HIV-positive MSM (41.4%) with 2.7 genotypes per anal samples than in HIV-negative (7.7%) with 1.5 genotypes per anal samples. HPV types included in the prophylactic Gardasil-9 (R) vaccine were detected in 68.9% of specimens and HPV-58 was the most frequently detected. MSM infected by HPV-16 and HPV-18 were all infected by HIV-1. Few anal swabs (11.9%) contained HSV-2 DNA without relationship with HPV detection. Condomless receptive anal intercourse was the main risk factor to being infected with any type of HPV and condomless insertive anal intercourse was significantly less associated with HPV contamination than receptive anal intercourse (Odd ratio = 0.02). Conclusion MSM in Bangui are at-risk of HIV and HR-HPV anal infections. The unusual distribution of HPV-35 as predominant HPV suggests possible geographic specificities in the molecular epidemiology of HR-HPV in sub-Saharan Africa. Scaling up prevention strategies against HPV infection and related cancers adapted for MSM in Africa should be prioritized. Innovative interventions should be conceived for the MSM population living in Bangui.	[Bouassa, Ralph-Sydney Mboumba] Ecole Doctorale Reg Infectiol Trop Franceville, Franceville, Gabon; [Bouassa, Ralph-Sydney Mboumba] Paris Descartes, BioSPC, Ecole Doctorale Bio Sorbonne Paris Cite, Paris, France; [Simaleko, Marcel Mbeko; Longo, Jean De Dieu; Gresenguet, Gerard] Ctr Natl Reference Infect Sexuellement Transmissi, Bangui, Cent Afr Republ; [Camengo, Serge Police] Hop Amitie, Serv Gastro Enterol, Bangui, Cent Afr Republ; [Camengo, Serge Police; Mossoro-Kpinde, Christian Diamant; Longo, Jean De Dieu; Gresenguet, Gerard] Fac Sci Sante Bangui, Bangui, Cent Afr Republ; [Mossoro-Kpinde, Christian Diamant] Labo Natl Biol Clin & Sante Publ, Bangui, Cent Afr Republ; [Veyer, David; Matta, Mathieu; Robin, Leman; Pere, Helene; Belec, Laurent] Hop Europe Georges Pompidou, Lab Virol, Paris, France; [Veyer, David; Matta, Mathieu; Robin, Leman; Pere, Helene; Belec, Laurent] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Longo, Jean De Dieu; Gresenguet, Gerard] Fac Sci Sante Bangui, Dept Sante Publ, Unite Recherches & Intervent Malad Sexuellement T, Bangui, Cent Afr Republ; [Meye, Jean-Francois] Univ Sci Sante, Libreville & Fac Med Libreville, Ctr Hosp Univ Angondje, Serv Gynecol Obstet, Libreville, Gabon	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Mossoro-Kpinde, CD (corresponding author), Fac Sci Sante Bangui, Bangui, Cent Afr Republ.; Mossoro-Kpinde, CD (corresponding author), Labo Natl Biol Clin & Sante Publ, Bangui, Cent Afr Republ.	mossoro_kpinde@yahoo.fr			Gabonese Government	Gabonese Government	We thank Mr Dionke Fofana and Dr Alexis Naissem, from Ensemble pour une Solidarite Therapeutique en Reseau (GIP-ESTHER) and Expertise France, Paris, for contributions and relevant discussions. A native English-speaking colleague, Mrs WANJIRU Jackline, Graduate Institute of International and Development Studies, LL.M in International Law, Geneva, Switzerland, edited the manuscript. Ralph-Sydney Mboumba Bouassa is a PhD student from the Ecole Doctorale d'Infectiologie Tropicale, Franceville, Gabon, benefiting from a scholarship of the Gabonese Government and is holder of merit from the Agence Universitaire de la Francophonie. We thank Dr Frederic Bois, Chief of the Models for Ecotoxicology and Toxicology Unit, Institut National de l'Environnement Industriel et des Risques (INERIS), Verneuil en Halatte, France, for helping us in statistical analyses.	Akarolo-Anthony SN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-656; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Beyrer C, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8726-9; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Bouassa RSM, 2017, MED SANTE TROP, V27, P16, DOI [10.1684/mst.2017.0648, 10.1684/mst.2016.0648]; Bouassa RSM, 2017, EXPERT REV ANTI-INFE, V15, P613, DOI 10.1080/14787210.2017.1322902; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruisten Sylvia M, 2003, Curr Womens Health Rep, V3, P288; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089959; Cranston RD, 2012, INT J STD AIDS, V23, P195, DOI 10.1258/ijsa.2011.011169; Cranston RD, 2015, SEX TRANSM DIS, V42, P671, DOI 10.1097/OLQ.0000000000000372; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; Del Amo J, 2013, J INFECT DIS, V207, P1235, DOI 10.1093/infdis/jit028; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Dosekun O, 2010, CURR OPIN HIV AIDS, V5, P291, DOI 10.1097/COH.0b013e32833a88a3; Eaton LA, 2017, SEX TRANSM INFECT; Espy MJ, 2000, J CLIN MICROBIOL, V38, P795, DOI 10.1128/JCM.38.2.795-799.2000; Estrade C, 2014, J CLIN MICROBIOL, V52, P607, DOI 10.1128/JCM.02749-13; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garbuglia AR, 2015, J CLIN VIROL, V72, P49, DOI 10.1016/j.jcv.2015.09.001; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Herbst JH, 2016, MMWR-MORBID MORTAL W, V65, P42, DOI 10.15585/mmwr.su6501a7; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Keglovitz K, 2017, LGBT HEALTH, V4, P72, DOI 10.1089/lgbt.2016.0049; Keshinro B, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21270; Kwon MJ, 2014, J CLIN VIROL, V59, P246, DOI 10.1016/j.jcv.2014.01.015; Larsson GL, 2015, J MOL DIAGN, V17, P293, DOI 10.1016/j.jmoldx.2014.12.004; Latsuzbaia A, 2016, DIAGN MICR INFEC DIS, V85, P318, DOI 10.1016/j.diagmicrobio.2016.04.011; Lee CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161460; LeGoff J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-83; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Marcuccilli F, 2015, J VIROL METHODS, V217, P8, DOI 10.1016/j.jviromet.2015.02.018; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Mbeko Simaleko M, 2016, ALLIANCE FRANCOPHONE; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; Menard D, 2003, J VIROL METHODS, V111, P129, DOI 10.1016/S0166-0934(03)00169-1; Mendez-Martinez R, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0671-4; Mmbaga EJ, 2017, SEX TRANSM INFECT; Moller LM, 2015, AIDS, V29, pS211, DOI 10.1097/QAD.0000000000000890; Muller EE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1706-9; Nowak RG, 2016, SEX TRANSM DIS, V43, P243, DOI 10.1097/OLQ.0000000000000431; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Okolo Clement, 2010, Infect Agent Cancer, V5, P24, DOI 10.1186/1750-9378-5-24; Ong JJ, 2016, SEX TRANSM INFECT, V92, P368, DOI 10.1136/sextrans-2015-052121; Ong JJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-557; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Park JN, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18752; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pasquier C, 2017, DIAGN MICR INFEC DIS, V87, P25, DOI 10.1016/j.diagmicrobio.2016.08.022; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Ren XQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2641259; Rhodes SD, 2017, AM J PUBLIC HEALTH, V107, P969, DOI 10.2105/AJPH.2017.303814; Rindskopf D, 2002, J EDUC BEHAV STAT, V27, P147, DOI 10.3102/10769986027002147; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Saraiya M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv086; Scheurer ME, 2005, INT J GYNECOL CANCER, V15, P727, DOI 10.1111/j.1525-1438.2005.00246.x; Skeate JG, 2016, J GEN VIROL, V97, P422, DOI 10.1099/jgv.0.000341; Supindham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124499; Taylor S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1633-9; Tebit DM, 2012, CURR HIV RES, V10, P3, DOI 10.2174/157016212799304689; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276; Weiss H, 2004, HERPES S, V11, p24A; Wirtz AL, 2017, LANCET HIV; World Health Organization, 2016, CONS GUID US ANT DRU	70	18	19	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197845	10.1371/journal.pone.0197845	http://dx.doi.org/10.1371/journal.pone.0197845			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795661	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300081
J	Razuk, M; Barela, JA; Peyre, H; Gerard, CL; Bucci, MP				Razuk, Milena; Barela, Jose Angelo; Peyre, Hugo; Gerard, Christophe Loic; Bucci, Maria Pia			Eye movements and postural control in dyslexic children performing different visual tasks	PLOS ONE			English	Article							ATTENTION	The aim of this study was to examine eye movements and postural control performance among dyslexic children while reading a text and performing the Landolt reading task. Fifteen dyslexic and 15 non-dyslexic children were asked to stand upright while performing two experimental visual tasks: text reading and Landolt reading. In the text reading task, children were asked to silently read a text displayed on a monitor, while in the Landolt reading task, the letters in the text were replaced by closed circles and Landolt rings, and children were asked to scan each circle/ring in a reading-like fashion, from left to right, and to count the number of Landolt rings. Eye movements (Mobile T2 (R), SuriCog) and center of pressure excursions (Framiral (R), Grasse, France) were recorded. Visual performance variables were total reading time, mean duration of fixation, number of pro- and retro-saccades, and amplitude of pro-saccades. Postural performance variable was the center of pressure area. The results showed that dyslexic children spent more time reading the text and had a longer duration of fixation than non-dyslexic children. However, no difference was observed between dyslexic and non-dyslexic children in the Landolt reading task. Dyslexic children performed a higher number of pro- and retro-saccades than non-dyslexic children in both text reading and Landolt reading tasks. Dyslexic children had smaller pro-saccade amplitude than non-dyslexic children in the text reading task. Finally, postural performance was poorer in dyslexic children than in non-dyslexic children. Reading difficulties in dyslexic children are related to eye movement strategies required to scan and obtain lexical and semantic meaning. However, postural control performance, which was poor in dyslexic children, is not related to lexical and semantic reading requirements and might not also be related to different eye movement behavior.	[Razuk, Milena; Peyre, Hugo; Bucci, Maria Pia] Paris Diderot Univ, Robert Debre Hosp, INSERM, UMR 1141, Paris, France; [Razuk, Milena; Barela, Jose Angelo] Cruzeiro Univ, Inst Phys Act & Sport Sci, Sao Paulo, SP, Brazil; [Barela, Jose Angelo] Sao Paulo State Univ, Inst Biosci, Rio Claro, SP, Brazil; [Peyre, Hugo; Gerard, Christophe Loic] Robert Debre Hosp, Child & Adolescent Psychiat Dept, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Cruzeiro do Sul; Universidade Estadual Paulista; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Razuk, M (corresponding author), Paris Diderot Univ, Robert Debre Hosp, INSERM, UMR 1141, Paris, France.; Razuk, M (corresponding author), Cruzeiro Univ, Inst Phys Act & Sport Sci, Sao Paulo, SP, Brazil.	milena.razuk@gmail.com	Barela, José A/F-4284-2012	Barela, José A/0000-0003-0951-254X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/05602-7]; FAPESP [2013/25653-7, 2015/26637-0]; Sao Paulo State Research Foundation (FAPESP) [FAPESP-BEPE: 2016/05602-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through a scholarship to Milena Razuk (grant number 2016/05602-7), FAPESP doctorate scholarship: 2013/25653-7, and FAPESP Grant: 2015/26637-0. The funder has analyzed and approved the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the children who participated in this study and to their parents and thankful to the Sao Paulo State Research Foundation (FAPESP) for financial support FAPESP-BEPE: 2016/05602-7; FAPESP doctorate scholarship: 2013/25653-7; FAPESP Grant: 2015/26637-0.	Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Benfatto MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165508; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bucci MP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00981; Bucci MP, 2014, RES DEV DISABIL, V35, P1292, DOI 10.1016/j.ridd.2014.03.029; Bucci MP, 2013, RES DEV DISABIL, V34, P3727, DOI 10.1016/j.ridd.2013.07.032; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Chevrie-Muller C, 1977, BATTERIE LANGAGE ORA; Gouleme N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130196; Hatzidaki A, 2011, DYSLEXIA, V17, P85, DOI 10.1002/dys.416; Henderson JM, 2018, Q J EXP PSYCHOL, V71, P314, DOI 10.1080/17470218.2017.1329322; Hillen R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00384; Legrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035301; Lukasova K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00987; Pozzo T, 2006, NEUROSCI LETT, V403, P211, DOI 10.1016/j.neulet.2006.03.049; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; Razuk M, 2014, RES DEV DISABIL, V35, P1988, DOI 10.1016/j.ridd.2014.03.045; Seassau M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00085; Starr MS, 2001, TRENDS COGN SCI, V5, P156, DOI 10.1016/S1364-6613(00)01619-3; Tiadi A, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhurn.2010.00058, 10.3389/fnhum.2016.00058]; Trauzettel-Klosinski S, 2010, ACTA OPHTHALMOL, V88, P681, DOI 10.1111/j.1755-3768.2009.01523.x; Vagge A, 2015, ANN DYSLEXIA, V65, P24, DOI 10.1007/s11881-015-0098-7; Viana AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072719	23	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198001	10.1371/journal.pone.0198001	http://dx.doi.org/10.1371/journal.pone.0198001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795687	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300111
J	Seo, DH; Kim, MJ; Kim, KH; Park, J; Shin, DW; Kim, H; Jeon, W; Kim, H; Park, JM				Seo, Dong Hyun; Kim, Min Joung; Kim, Kyung Hwan; Park, Junseok; Shin, Dong Wun; Kim, Hoon; Jeon, Woochan; Kim, Hyunjong; Park, Joon Min			The characteristics of pediatric emergency department visits in Korea: An observational study analyzing Korea Health Panel data	PLOS ONE			English	Article							PROFILE	Objective We investigated the characteristics of pediatric emergency department (ED) patients in Korea and determined factors associated with hospital admission after ED treatment. Methods Korea Health Panel data from 2008 through 2013 were analyzed retrospectively; we included patients under 18 years old who visited the ED at least once. We collected patient and household epidemiologic data such as sex, age group, region of residence, disability, chronic disease, household income quintile, national health insurance type, use of private insurance, and annual frequency of ED visits. We also examined data related to each ED visit, such as reason for visit, medical service provided, and hospital size/ownership. We then investigated which factors were correlated with case disposition (discharge home or hospital admission) after ED treatment. Results In total, 3,160 pediatric ED visits occurred during the six-year period. Males (57.5%) and children aged 0-5 years (47.7%) made more visits than females and older children, respectively. The proportion of ED visits for disease (67.7%) was much higher than for injury or poisoning (32.2%), and 452 cases (14.3%) required hospital admission. For hospital admission, the odds ratio (OR) of females was 0.73 compared to males, and the OR of children aged 6-11 was 0.68 compared to children aged 0-5. The OR of capital residents was 0.69 compared to province residents, and the OR of the highest income quintile was 0.51 compared to the lowest quintile. The OR of children with private insurance coverage was 0.49 compared to those lacking private insurance, and the OR of ED visits due to disease was 1.82 compared to visits due to injury/poisoning. Conclusion This analysis of clinical and demographic characteristics of pediatric ED visits and hospital admissions can serve as the foundation of future prospective studies required for establishing appropriate policies for the Korean pediatric emergency medical system.	[Seo, Dong Hyun; Kim, Kyung Hwan; Park, Junseok; Shin, Dong Wun; Kim, Hoon; Jeon, Woochan; Kim, Hyunjong; Park, Joon Min] Inje Univ, Ilsan Paik Hosp, Dept Emergency Med, Goyang, South Korea; [Kim, Min Joung] Yonsei Univ, Coll Med, Dept Emergency Med, Seoul, South Korea	Inje University; Yonsei University; Yonsei University Health System	Park, JM (corresponding author), Inje Univ, Ilsan Paik Hosp, Dept Emergency Med, Goyang, South Korea.	aero7@outlook.kr		Kim, Min Joung/0000-0003-1634-5209; Jeon, woochan/0000-0003-2674-3593; gim, gyeonghwan/0000-0002-1915-3643; Park, Joon Min/0000-0001-7258-8892; Kim, Hyunjong/0000-0001-6473-9646				Ben-Isaac E, 2010, PEDIATRICS, V125, P454, DOI 10.1542/peds.2009-0544; Billings J, 2000, Issue Brief (Commonw Fund), P1; Boyle A, 2016, EMERG MED J, V33, P307, DOI 10.1136/emermed-2014-203616; Boyle A, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/838610; Branche C., 2008, WORLD REPORT CHILD I; Falik M, 2001, MED CARE, V39, P551, DOI 10.1097/00005650-200106000-00004; Fong C, 1999, ACAD EMERG MED, V6, P744, DOI 10.1111/j.1553-2712.1999.tb00446.x; HADDY RI, 1987, J FAM PRACTICE, V24, P389; Kubicek K, 2012, PEDIATR EMERG CARE, V28, P977, DOI 10.1097/PEC.0b013e31826c9aab; Kwak YH, 2012, J KOREAN MED SCI, V27, P1222, DOI 10.3346/jkms.2012.27.10.1222; Nawar Eric W, 2007, Adv Data, P1; Niska Richard, 2010, Natl Health Stat Report, P1; Salami O, 2012, PEDIATR EMERG CARE, V28, P43, DOI 10.1097/PEC.0b013e31823f2412; Thompson C, 2010, EMERG MED J, V27, P22, DOI 10.1136/emj.2008.068817; 유재욱, 2010, Clinical and Experimental Pediatrics, V53, P314	15	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197929	10.1371/journal.pone.0197929	http://dx.doi.org/10.1371/journal.pone.0197929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795653	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300098
J	Zhang, L; Spencer, TJ; Biederman, J; Bhide, PG				Zhang, Lin; Spencer, Thomas J.; Biederman, Joseph; Bhide, Pradeep G.			Attention and working memory deficits in a perinatal nicotine exposure mouse model	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR EXPRESSION; ENVIRONMENTAL TOBACCO-SMOKE; ORIGIN ALLELIC EXPRESSION; DIFFERENT TIME-WINDOWS; DEFICIT/HYPERACTIVITY DISORDER; IN-UTERO; BRAIN-DEVELOPMENT; DNA METHYLATION; CIGARETTE-SMOKE; SEX-DIFFERENCES	Background Cigarette smoking by pregnant women is associated with a significant increase in the risk for cognitive disorders in their children. Preclinical models confirm this risk by showing that exposure of the developing brain to nicotine produces adverse behavioral outcomes. Here we describe behavioral phenotypes resulting from perinatal nicotine exposure in a mouse model, and discuss our findings in the context of findings from previously published studies using preclinical models of developmental nicotine exposure. Methodology/Principal findings Female C57BI/6 mice received drinking water containing nicotine (100pg/ml) + saccharin (2%) starting 3 weeks prior to breeding and continuing throughout pregnancy, and until 3 weeks postpartum. Over the same period, female mice in two control groups received drinking water containing saccharin (2%) or plain drinking water. Offspring from each group were weaned at 3-weeks of age and subjected to behavioral analyses at 3 months of age. We examined spontaneous locomotor activity, anxiety-like behavior, spatial working memory, object based attention, recognition memory and impulsive-like behavior. We found significant deficits in attention and working memory only in male mice, and no significant changes in the other behavioral phenotypes in male or female mice. Exposure to saccharin alone did not produce significant changes in either sex. Conclusion/Significance The perinatal nicotine exposure produced significant deficits in attention and working memory in a sex-dependent manner in that the male but not female offspring displayed these behaviors. These behavioral phenotypes are associated with attention deficit hyperactivity disorder (ADHD) and have been reported in other studies that used pre-or perinatal nicotine exposure. Therefore, we suggest that preclinical models of developmental nicotine exposure could be useful tools for modeling ADHD and related disorders.	[Zhang, Lin; Bhide, Pradeep G.] Florida State Univ, Coll Med, Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA; [Spencer, Thomas J.; Biederman, Joseph] Harvard Med Sch, Pediat Psychopharmacol, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA USA	State University System of Florida; Florida State University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bhide, PG (corresponding author), Florida State Univ, Coll Med, Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA.	pradeep.bhide@med.fsu.edu		Bhide, Pradeep/0000-0003-4236-9415	Jimand Betty Ann Rodgers Chair at Florida State University College of Medicine; Jim and Betty Ann Rodgers Chair fund at Florida State University College of Medicine	Jimand Betty Ann Rodgers Chair at Florida State University College of Medicine; Jim and Betty Ann Rodgers Chair fund at Florida State University College of Medicine	This work was supported by funds from the Jimand Betty Ann Rodgers Chair at Florida State University College of Medicine.; This work was supported by the Jim and Betty Ann Rodgers Chair fund at Florida State University College of Medicine. We thank our colleagues Deirdre McCarthy, Melissa Martin and Samantha Pavlock for their valuable input on the experimental design and data interpretation, and for critical reading of earlier versions of this manuscript. We are grateful to the staff of the Florida State University Laboratory Animal Resources for assistance with mouse colony management.	Ajarem JS, 1998, PHARMACOL BIOCHEM BE, V59, P313, DOI 10.1016/S0091-3057(97)00408-5; Alderson RM, 2013, NEUROPSYCHOLOGY, V27, P287, DOI 10.1037/a0032371; Alkam T, 2013, PSYCHOPHARMACOLOGY, V230, P451, DOI 10.1007/s00213-013-3175-9; Alkam T, 2013, BEHAV BRAIN RES, V239, P80, DOI 10.1016/j.bbr.2012.10.058; Alkam T, 2011, BEHAV BRAIN RES, V220, P185, DOI 10.1016/j.bbr.2011.01.039; Amos-Kroohs RM, 2013, NEUROTOXICOL TERATOL, V35, P34, DOI 10.1016/j.ntt.2013.01.001; Andersen SL, 2000, NEUROSCI BIOBEHAV R, V24, P137, DOI 10.1016/S0149-7634(99)00044-5; Atluri P, 2001, DEV BIOL, V240, P143, DOI 10.1006/dbio.2001.0453; Balsevich G, 2014, BEHAV BRAIN RES, V266, P7, DOI 10.1016/j.bbr.2014.02.038; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Biederman J, 2004, BIOL PSYCHIAT, V55, P692, DOI 10.1016/j.biopsych.2003.12.003; Biederman J, 2012, WORLD J BIOL PSYCHIA, V13, P60, DOI 10.3109/15622975.2011.562243; BREESE CR, 1993, J PHARMACOL EXP THER, V264, P448; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Brown A, 2012, J PSYCHIATR RES, V46, P476, DOI 10.1016/j.jpsychires.2012.01.008; Bryden DW, 2016, NEUROPSYCHOPHARMACOL, V41, P716, DOI 10.1038/npp.2015.197; Chistyakov V, 2010, EUR J PHARMACOL, V640, P87, DOI 10.1016/j.ejphar.2010.04.044; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Eppolito AK, 2010, NEUROTOXICOL TERATOL, V32, P336, DOI 10.1016/j.ntt.2009.12.009; Fried R, 2016, J CLIN EXP NEUROPSYC, V38, P487, DOI 10.1080/13803395.2015.1127896; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guerrero-Preston R, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12378; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Hall BJ, 2016, TOXICOL SCI, V151, P236, DOI 10.1093/toxsci/kfw042; Heath CJ, 2010, PHYSIOL BEHAV, V101, P764, DOI 10.1016/j.physbeh.2010.08.021; Ivorra C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0384-5; Jamal A, 2016, 44 CTR DIS CONTR; Klein LC, 2004, PHARMACOL BIOCHEM BE, V78, P13, DOI 10.1016/j.pbb.2004.01.005; Klein LC, 2003, NICOTINE TOB RES, V5, P117, DOI 10.1080/1462220021000060446; Ladd-Acosta C, 2016, ENVIRON RES, V144, P139, DOI 10.1016/j.envres.2015.11.014; Lee H, 2016, TOX RESEARCH, V32, P275, DOI 10.5487/TR.2016.32.4.275; Linnet KM, 2005, PEDIATRICS, V116, P462, DOI 10.1542/peds.2004-2054; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; Mattfeld AT, 2016, NEUROIMAGE-CLIN, V10, P274, DOI 10.1016/j.nicl.2015.12.003; Milberger S, 1996, AM J PSYCHIAT, V153, P1138; Pagani LS, 2014, NEUROSCI BIOBEHAV R, V44, P195, DOI 10.1016/j.neubiorev.2013.03.008; Pauly JR, 2008, FRONT BIOSCI-LANDMRK, V13, P505, DOI 10.2741/2696; Pauly JR, 2004, INT J DEV NEUROSCI, V22, P329, DOI 10.1016/j.ijdevneu.2004.05.009; Paz R, 2007, NEUROPSYCHOPHARMACOL, V32, P693, DOI 10.1038/sj.npp.1301066; Popke EJ, 1997, PHARMACOL BIOCHEM BE, V58, P843, DOI 10.1016/S0091-3057(97)98985-1; Report USSGs, 2016, REP USSGS; Romero RD, 2004, PHARMACOL BIOCHEM BE, V78, P675, DOI 10.1016/j.pbb.2004.04.033; Santiago SE, 2014, NEUROSCI RES, V79, P41, DOI 10.1016/j.neures.2013.10.006; Schneider AS, 2002, ANN NY ACAD SCI, V971, P135, DOI 10.1111/j.1749-6632.2002.tb04447.x; Schneider T, 2011, NEUROPSYCHOPHARMACOL, V36, P1114, DOI 10.1038/npp.2010.249; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shacka JJ, 1997, NEUROTOXICOL TERATOL, V19, P467, DOI 10.1016/S0892-0362(97)00063-9; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Smith D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137953; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Thompson BL, 2005, BEHAV BRAIN RES, V164, P107, DOI 10.1016/j.bbr.2005.06.010; Torres OV, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.04.005; Tribollet E, 2004, NEUROSCIENCE, V124, P405, DOI 10.1016/j.neuroscience.2003.09.028; Vaglenova J, 2008, NEUROBIOL LEARN MEM, V90, P527, DOI 10.1016/j.nlm.2008.06.009; Vaglenova J, 2004, BEHAV BRAIN RES, V150, P159, DOI 10.1016/j.bbr.2003.07.005; Valera EM, 2005, BIOL PSYCHIAT, V57, P439, DOI 10.1016/j.biopsych.2004.11.034; Wilens TE, 2008, J PEDIATR-US, V153, P414, DOI 10.1016/j.jpeds.2008.04.030; Wilhelm-Benartzi CS, 2012, ENVIRON HEALTH PERSP, V120, P296, DOI 10.1289/ehp.1103927; Yamashita M, 2013, PSYCHOPHARMACOLOGY, V227, P741, DOI 10.1007/s00213-013-3009-9; Yochum C, 2014, EXP NEUROL, V254, P145, DOI 10.1016/j.expneurol.2014.01.016; Zhu JM, 2017, INT J DEV NEUROSCI, V58, P26, DOI 10.1016/j.ijdevneu.2017.01.014; Zhu JM, 2014, J NEUROSCI, V34, P2768, DOI 10.1523/JNEUROSCI.4402-13.2014; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	68	29	30	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198064	10.1371/journal.pone.0198064	http://dx.doi.org/10.1371/journal.pone.0198064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795664	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300123
J	Itoh, K; Adachi, Y; Yamada, T; Suzuki, TL; Otomo, T; McBride, HM; Yoshimori, T; Iijima, M; Sesaki, H				Itoh, Kie; Adachi, Yoshihiro; Yamada, Tatsuya; Suzuki, Takamichi L.; Otomo, Takanobu; McBride, Heidi M.; Yoshimori, Tamotsu; Iijima, Miho; Sesaki, Hiromi			A brain-enriched Drp1 isoform associates with lysosomes, late endosomes, and the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED PROTEIN-1; MITOCHONDRIAL FISSION FACTOR; PHOSPHATIDIC-ACID; DIVISION; FUSION; FORM; MACHINERY; MAINTAINS; AUTOPHAGY; QUALITY	Dynamin-related protein 1 (Drp1) constricts mitochondria as a mechanochemical GTPase during mitochondrial division. The Drp1 gene contains several alternative exons and produces multiple isoforms through RNA splicing. Here we performed a systematic analysis of Drp1 transcripts in different mouse tissues and identified a previously uncharacterized isoform that is highly enriched in the brain. This Drp1 isoform is termed Drp1(ABCD) because it contains four alterative exons: A, B, C, and D. Remarkably, Drp1(ABCD) is located at lysosomes, late endosomes, and the plasma membrane in addition to mitochondria. Furthermore, Drp1(ABCD) is concentrated at the interorganelle interface between mitochondria and lysosomes/late endosomes. The localizations of Drp1(ABCD) at lysosomes, late endosomes, and the plasma membrane require two exons, A and B, that are present in the GTPase domain. Drp1(ABCD) assembles onto these membranes in a manner that is regulated by its oligomerization and GTP hydrolysis. Experiments using lysosomal inhibitors show that the association of Drp1(ABCD) with lysosomes/late endosomes depends on lysosomal pH but not their protease activities. Thus, Drp1 may connect mitochondria to endosomal-lysosomal pathways in addition to mitochondrial division.	[Itoh, Kie; Adachi, Yoshihiro; Yamada, Tatsuya; Suzuki, Takamichi L.; Iijima, Miho; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Otomo, Takanobu; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; [McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 0G4, Canada	Johns Hopkins University; Osaka University	Sesaki, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	hsesaki@jhmi.edu	Otomo, Takanobu/AAD-3586-2019; McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280; Yamada, Tatsuya/0000-0002-6906-9861	NIGMS, National Institutes of Health [GM084015, GM123266]; Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University-University of Maryland Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123266, R01GM084015] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University-University of Maryland Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants GM084015 (to M. I.) and GM123266 (to H. S.), the Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center, and the Johns Hopkins University-University of Maryland Diabetes Research Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Yoshihiro, 2018, Small GTPases, V9, P472, DOI 10.1080/21541248.2017.1321614; Adachi Y, 2016, MOL CELL, V63, P1034, DOI 10.1016/j.molcel.2016.08.013; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Francy CA, 2015, J BIOL CHEM, V290, P11692, DOI 10.1074/jbc.M114.610881; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gajendiran P, 2018, J CELL MOL MED, V22, P2210, DOI 10.1111/jcmm.13501; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Merrill RA, 2014, INT J BIOCHEM CELL B, V48, P92, DOI 10.1016/j.biocel.2013.12.012; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shields LY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.94; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yamada T, 2016, AM J PATHOL, V186, P2798, DOI 10.1016/j.ajpath.2016.06.025; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	35	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11809	11822		10.1074/jbc.RA117.001253	http://dx.doi.org/10.1074/jbc.RA117.001253			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29853636	Green Published, hybrid			2022-12-26	WOS:000440134500015
J	Shaw, JA; Henard, CA; Liu, L; Dieckman, LM; Vazquez-Torres, A; Bourret, TJ				Shaw, Jeff A.; Henard, Calvin A.; Liu, Lin; Dieckman, Lynne M.; Vazquez-Torres, Andres; Bourret, Travis J.			Salmonella enterica serovar Typhimurium has three transketolase enzymes contributing to the pentose phosphate pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pentose phosphate pathway (PPP); Salmonella enterica; bacterial metabolism; enzyme kinetics; enzyme purification; oxidation-reduction (redox); Transketolase	ESCHERICHIA-COLI-RPOS; SIGMA(S)-DEPENDENT GENES; STATIONARY-PHASE; CROSS-PROTECTION; IDENTIFICATION; EXPRESSION; PURIFICATION; STARVATION; RESISTANCE; PROTEINS	The genus Salmonella is responsible for many illnesses in humans and other vertebrate animals. We report here that Salmonella enterica serovar Typhimurium harbors three transketolases that support the non-oxidative branch of the pentose phosphate pathway. BLAST analysis identified two genes, STM14_2885 and STM14_2886, that together encode a putative transketolase (TktC) with 46-47% similarity to the known TktA and TktB isoforms. Assessing the mRNA and protein expression for each of the three transketolases, we determined that all are expressed in WT cells and regulated to varying extents by the alternative sigma factor RpoS. Enzyme assays with lysates from WT and transketolase-knockout strains established that TktA is responsible for >88% of the transketolase activity in WT cells. We purified recombinant forms of each isoenzyme to assess the kinetics for canonical transketolase reactions. TktA and TktB had comparable values for V-max (539-1362 m NADH consumed/s), K-m (80-739 m), and catalytic efficiency (1.02 x 10(8)-1.06 x 10(9) m(-1)/s) for each substrate tested. The recombinant form of TktC had lower K-m values (23-120 m), whereas the V-max (7.8-16 m NADH consumed/s) and catalytic efficiency (5.58 x 10(6) to 6.07 x 10(8) m(-1)/s) were 10-100-fold lower. Using a murine model of Salmonella infection, we showed that a strain lacking all three transketolases is avirulent in C57BL/6 mice. These data provide evidence that S. Typhimurium possesses three transketolases that contribute to pathogenesis.	[Shaw, Jeff A.; Bourret, Travis J.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Henard, Calvin A.; Liu, Lin; Vazquez-Torres, Andres] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80011 USA; [Dieckman, Lynne M.] Creighton Univ, Dept Chem, Omaha, NE 68178 USA; [Vazquez-Torres, Andres] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [Henard, Calvin A.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA	Creighton University; University of Colorado System; University of Colorado Anschutz Medical Campus; Creighton University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Bourret, TJ (corresponding author), Creighton Univ, Dept Med Microbiol & Immunol, 2500 Calif Plaza, Omaha, NE 68178 USA.	TravisBourret@creighton.edu	Bourret, Travis/J-4673-2019	Shaw, Jeff/0000-0001-6064-6012; Bourret, Travis/0000-0002-4154-929X	Veterans Affairs Merit Grant [BX0002073]; National Institutes of Health (NIH) Project [AI54959]; NIH Institutional Training Grant [AI052066]; NIGMS, NIH [GM103427]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054959, T32AI052066, R01AI136520, R01AI054959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002073] Funding Source: NIH RePORTER	Veterans Affairs Merit Grant(US Department of Veterans Affairs); National Institutes of Health (NIH) Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Grant BX0002073, National Institutes of Health (NIH) Project AI54959, NIH Institutional Training Grant AI052066, and NIGMS, NIH, Grant GM103427. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Cheville AM, 1996, APPL ENVIRON MICROB, V62, P1822, DOI 10.1128/AEM.62.5.1822-1824.1996; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DATTA AG, 1961, J BIOL CHEM, V236, P617; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; Eisenstark A, 1996, FREE RADICAL BIO MED, V21, P975, DOI 10.1016/S0891-5849(96)00154-2; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Frankel D. G., 1987, ESCHERICHIA COLI SAL; GIVSKOV M, 1994, J BACTERIOL, V176, P7, DOI 10.1128/JB.176.1.7-14.1994; Henard C. A., 2013, REGULATION BACTERIAL, P425; Henard CA, 2010, J BIOL CHEM, V285, P36785, DOI 10.1074/jbc.M110.160960; Holzmeister C, 2011, PROTEOMICS, V11, P1664, DOI 10.1002/pmic.201000652; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; IIDA A, 1993, J BACTERIOL, V175, P5375, DOI 10.1128/JB.175.17.5375-5383.1993; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; JENKINS DE, 1990, J BACTERIOL, V172, P2779, DOI 10.1128/jb.172.5.2779-2781.1990; JOSEPHSON BL, 1969, J BACTERIOL, V100, P1289, DOI 10.1128/JB.100.3.1289-1295.1969; Jung IL, 2005, CURR MICROBIOL, V50, P314, DOI 10.1007/s00284-005-4501-1; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Leekitcharoenphon P, 2016, APPL ENVIRON MICROB, V82, P2516, DOI 10.1128/AEM.03821-15; Lin E. C. C., 1996, ESCHERICHIA COLI SAL, V1, P307; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; Lozano-Juste J, 2011, J EXP BOT, V62, P3501, DOI 10.1093/jxb/err042; Lundberg BE, 1999, INFECT IMMUN, V67, P436, DOI 10.1128/IAI.67.1.436-438.1999; Maeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144697; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markert B, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-7; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Saint-Ruf C, 2004, GENETICS, V168, P541, DOI 10.1534/genetics.104.028704; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Singh V., 2013, J VET SCI ANIM HUSB, V1, P301, DOI [DOI 10.15744/2348-9790.1.301, 10.15744/2348-9790.1.301]; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Sprenger GA, 1995, ARCH MICROBIOL, V164, P324, DOI 10.1007/BF02529978; SPRENGER GA, 1995, EUR J BIOCHEM, V230, P525; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; TAKEUCHI T, 1986, BIOCHIM BIOPHYS ACTA, V872, P24, DOI 10.1016/0167-4838(86)90143-3; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; WOOD T, 1986, CELL BIOCHEM FUNCT, V4, P241, DOI 10.1002/cbf.290040403; ZHAO GS, 1994, J BACTERIOL, V176, P6134, DOI 10.1128/jb.176.19.6134-6138.1994	57	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11271	11282		10.1074/jbc.RA118.003661	http://dx.doi.org/10.1074/jbc.RA118.003661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29848552	hybrid, Green Published			2022-12-26	WOS:000439449700002
J	Mesfin, EA; Beyene, D; Tesfaye, A; Admasu, A; Addise, D; Amare, M; Dagne, B; Yaregal, Z; Tesfaye, E; Tessema, B				Mesfin, Eyob Abera; Beyene, Dereje; Tesfaye, Abreham; Admasu, Addisu; Addise, Desalegn; Amare, Miskir; Dagne, Biniyam; Yaregal, Zelalem; Tesfaye, Ephrem; Tessema, Belay			Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVALENCE; PYRAZINAMIDE; ASSAY	Background Multidrug drug-resistant tuberculosis (MDR-TB) is a major health problem and seriously threatens TB control and prevention efforts globally. Ethiopia is among the 30th highest TB burden countries for MDR-TB with 14% prevalence among previously treated cases. The focus of this study was on determining drug resistance patterns of Mycobacterium tuberculosis among MDR-TB suspected cases and associated risk factors. Methods A cross-sectional study was conducted in Addis Ababa from June 2015 to December 2016. Sputum samples and socio-demographic data were collected from 358 MDR-TB suspected cases. Samples were analyzed using Ziehl-Neelsen technique, GeneXpert MTB/RIF assay, and culture using Lowenstein-Jensen and Mycobacterial growth indicator tube. Data were analyzed using SPSS version 23. Results A total of 226 the study participants were culture positive for Mycobacterium tuberculosis, among them, 133 (58.8%) participants were males. Moreover, 162 (71.7%) had been previously treated for tuberculosis, while 128 (56.6%) were TB/HIV co-infected. A majority [122 (54%)] of the isolates were resistant to any first-line anti-TB drugs. Among the resistant isolates, 110 (48.7%) were determined to be resistant to isoniazid, 94 (41.6%) to streptomycin, 89 (39.4%) to rifampicin, 72 (31.9%) to ethambutol, and 70 (30.9%) to pyrazinamide. The prevalence of MDR-TB was 89 (39.4%), of which 52/89 (58.4%) isolates were resistance to all five first-line drugs. Risk factors such as TB/HIV co-infection (AOR = 5.59, p = 0.00), cigarette smoking (AOR = 3.52, p = 0.045), alcohol drinking (AOR = 5.14, p = 0.001) hospital admission (AOR = 3.49, p = 0.005) and visiting (AOR = 3.34, p = 0.044) were significantly associated with MDR-TB. Conclusions The prevalence of MDR-TB in the study population was of a significantly high level among previously treated patients and age group of 25-34. TB/HIV co-infection, smoking of cigarette, alcohol drinking, hospital admission and health facility visiting were identified as risk factors for developing MDR-TB. Therefore, effective strategies should be designed considering the identified risk factors for control of MDR-TB.	[Mesfin, Eyob Abera; Beyene, Dereje] Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Mesfin, Eyob Abera; Addise, Desalegn; Amare, Miskir; Dagne, Biniyam; Yaregal, Zelalem; Tesfaye, Ephrem] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Tesfaye, Abreham] Addis Ababa City Adm Hlth Bur, Hlth Res & Lab Serv, Addis Ababa, Ethiopia; [Admasu, Addisu] St Peter Hosp, Addis Ababa, Ethiopia; [Tessema, Belay] Univ Gondar, Coll Med & Hlth Sci, Dept Med Microbiol, Gondar, Ethiopia	Addis Ababa University; University of Gondar	Mesfin, EA (corresponding author), Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.; Mesfin, EA (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	eyob2001@gmail.com	Tes, Bel/L-3858-2019	Dagne, Biniyam/0000-0002-5930-2690	Addis Ababa University; College of Natural Science Department of Microbial Cellular and Molecular Biology; Ethiopian Public Health Institute (EPHI)	Addis Ababa University; College of Natural Science Department of Microbial Cellular and Molecular Biology; Ethiopian Public Health Institute (EPHI)	Financial and material supports required for sample collection, laboratory analysis were obtained from Addis Ababa University, College of Natural Science Department of Microbial Cellular and Molecular Biology, and Ethiopian Public Health Institute (EPHI).	Abate Dereje, 2012, BMC Res Notes, V5, P462, DOI 10.1186/1756-0500-5-462; Abdella K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1955-3; Adane K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1933-9; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Barroso Elizabeth Clara, 2003, J. Pneumologia, V29, P89, DOI 10.1590/S0102-35862003000200008; Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Berhan A, 2013, ETHIOP J HEALTH SCI, V23, P271, DOI 10.4314/ejhs.v23i3.10; Demissie M., 2014, OPEN ACCESS LIB J, V1, P1, DOI DOI 10.4236/OALIB.1100489; Deribew A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018614; Falzon D., 2011, WHO GUIDELINES PROGR; Fauci AS, 2008, J INFECT DIS, V197, P1493, DOI 10.1086/587904; Federal Ministry of Health of Ethiopia (FMOH), 2009, GUID PROGR CLIN MAN; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Hanif M, 2009, INT J TUBERC LUNG D, V13, P74; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Hoek KGP, 2009, SAMJ S AFR MED J, V99, P785; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Kent PT, 1985, GUIDE LEVEL 3 LAB; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Mekonnen F, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1202-7; Meskel Dawit Wolde, 2008, Ethiop Med J, V46, P219; Migliori GB, 2010, TROP MED INT HEALTH, V15, P1052, DOI 10.1111/j.1365-3156.2010.02581.x; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Mulu Wondemagegn, 2017, BMC Res Notes, V10, P8, DOI 10.1186/s13104-016-2328-4; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Sharma SK, 2011, INDIAN J MED RES, V133, P312; Shen GH, 2009, INT J TUBERC LUNG D, V13, P371; Shi WL, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.61; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; Sosa AD, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P447, DOI 10.1007/978-0-387-89370-9_25; Tessema B, 2012, INT J TUBERC LUNG D, V16, P805, DOI 10.5588/ijtld.11.0522; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; WHO, 1998, LAB SERV TUB CONTR 2; WHO, 2017, GLOB TUB REP 2017; WHO, 2011, TECHN OP PRACT CONS; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization (WHO), 2015, WHO ETH UPDATE SHEET; Yohanes A, 2012, AFR HEALTH SCI, V12, P325, DOI 10.4314/ahs.v12i3.12	40	28	28	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197737	10.1371/journal.pone.0197737	http://dx.doi.org/10.1371/journal.pone.0197737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864118	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100008
J	Han, YQ; Wu, C; Yang, L; Zhang, DY; Xiao, YT				Han, Yongqiang; Wu, Chao; Yang, Lang; Zhang, Deyong; Xiao, Yutao			Resistance to Nilaparvata lugens in rice lines introgressed with the resistance genes Bph14 and Bph15 and related resistance types	PLOS ONE			English	Article							BROWN PLANTHOPPER RESISTANCE; NEAR-ISOGENIC LINES; ORYZA-SATIVA L.; IDENTIFICATION; DELPHACIDAE; MECHANISM; HEMIPTERA; HYBRIDS; ASIA	Crop resistance is a cost-effective and environmentally friendly strategy for pest management. The brown planthopper (BPH, Nilaparvata lugens) is a devastating rice insect pest due to its ability to rapidly overcome plant resistance and the lack of sufficient resistance resources. BR4831 (a rice breeding line derived from the pyramiding of two BPH resistance genes, Bph14 and Bph15, into the elite rice variety Huang-Hua-Zhan, HHZ) and two single-gene introgression lines (HF106, carrying Bph14, and C602, carrying Bph15, in the elite rice cultivar 9311) were evaluated for their resistance to BPH using a standard seed box screening test coupled with field tests. The related resistance types were determined using laboratory assays. The seed box test and laboratory biological assays showed that BR4831 exhibited strong antibiotic resistance, and the behavioral assay showed that this line also exhibited strong antixenotic resistance, while both HF106 and C602 exhibited only weak antibiosis and no antixenotic resistance. Field tests showed significantly improved resistance in BR4831 compared to that of its recipient parent HHZ and slightly increased resistance in HF106 and C602 in comparison with their recipient parent 9311. These results demonstrate that the rice line BR4831, with pyramided resistance genes, exhibits higher resistance than the monogenic lines HF106 and C602 and highlight the benefits of combining the seed box seedling test, field tests and laboratory assays to thoroughly analyze plant resistance types.	[Han, Yongqiang; Wu, Chao; Yang, Lang; Xiao, Yutao] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China; [Han, Yongqiang; Zhang, Deyong] Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Hunan Academy of Agricultural Sciences	Xiao, YT (corresponding author), Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China.	xiao20020757@163.com		Wu, Chao/0000-0003-4163-5179	National Natural Science Foundation of China [31601646]; Special Funds for Industrial Development of Dapeng New District, Shenzhen City [JCYJ20170303154440838]; Science and Technology Program of Shenzhen [KY20160103]; National Key Research and Development Program [2016YFD0200809]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds for Industrial Development of Dapeng New District, Shenzhen City; Science and Technology Program of Shenzhen; National Key Research and Development Program	This work was supported by National Natural Science Foundation of China (CN) in a grant awarded to YX (Award Number: 31601646); Special Funds for Industrial Development of Dapeng New District, Shenzhen City to YX (Award Number: JCYJ20170303154440838); Science and Technology Program of Shenzhen in a grant to YX (Award Number: KY20160103) and National Key Research and Development Program in a grant to DZ (Award Number: 2016YFD0200809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Fan FF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00986; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Horgan F., 2009, PLANTHOPPERS NEW THR, P281; Horgan FG, 2015, CROP PROT, V78, P222, DOI 10.1016/j.cropro.2015.09.014; Hu J, 2013, PEST MANAG SCI, V69, P802, DOI 10.1002/ps.3437; Hu J, 2012, MOL BREEDING, V29, P61, DOI 10.1007/s11032-010-9526-x; Hu W, 2016, PLANT BREEDING, V135, P291, DOI 10.1111/pbr.12364; Huang Z, 2001, THEOR APPL GENET, V102, P929, DOI 10.1007/s001220000455; Jena KK, 2017, THEOR APPL GENET, V130, P2345, DOI 10.1007/s00122-017-2963-8; Jena KK, 2010, RICE, V3, P161, DOI 10.1007/s12284-010-9050-y; Li J, 2011, PEST MANAG SCI, V67, P528, DOI 10.1002/ps.2089; Li JinBo, 2006, Scientia Agricultura Sinica, V39, P2132; Liu YL, 2016, RICE, V9, DOI 10.1186/s12284-016-0096-3; Lv WT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-674; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; PATHAK PK, 1982, J ECON ENTOMOL, V75, P194, DOI 10.1093/jee/75.2.194; Qiu YF, 2013, GENET MOL RES, V12, P3201, DOI [10.4238/2013.August.29.4, 10.4238]; Ren JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep37645; Rola A. C., 1993, PESTICIDES RICE PROD; Wang HB, 2016, RICE, V9, DOI 10.1186/s12284-016-0126-1; Wang HY, 2008, CROP PROT, V27, P514, DOI 10.1016/j.cropro.2007.08.004; Xiao C, 2016, SCI REP-UK, V6, DOI 10.1038/srep38159; Xiao YL, 2016, FIELD CROP RES, V186, P47, DOI 10.1016/j.fcr.2015.11.009; Yang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01060-4; Zhang F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1329-3	28	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198630	10.1371/journal.pone.0198630	http://dx.doi.org/10.1371/journal.pone.0198630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856853	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800143
J	Bevet, S; Niles, MT; Pope, L				Bevet, Samuel; Niles, Meredith T.; Pope, Lizzy			You can't "nudge" nuggets: An investigation of college late-night dining with behavioral economics interventions	PLOS ONE			English	Article							WEIGHT; FOOD; CONSUMPTION; DECREASE; FRUIT	A mixed-methods approach was used to evaluate and improve the "late-night dining" options in a university dining hall. Surveys assessed student desires for late-night offerings, and evaluated students' habits and motivations during late-night dining. Two interventions were implemented to see if students could be "nudged" into different choice patterns. In the first, a "veggie-heavy" entree was added at the beginning of the entree line, so that students would substitute an entree containing vegetables for the alternatives. In the second, a snack-food bar was set up to cater to students who didn't want to stand in the long entree line, and preferred a snack. Data on food choice was collected during the interventions. Survey responses showed significant differences in the reasons females and males utilized late-night dining (p<0.001). We also found that students at late-night dining had a lower emphasis on health than the general student population. Even students at late-night who reported being health-conscious showed no difference in food selections from students who said health was not important (p = 0.883). Veggie-heavy entrees had mild success in increasing vegetable selection. However, veggie-heavy entrees were largely ignored when the other option was chicken nuggets. The snack bar was very popular. Entree placement and convenience lines may have mild impacts on food selection in a late-night dining environment.	[Bevet, Samuel] Univ Vermont, Dept Food Syst, Burlington, VT USA; [Niles, Meredith T.; Pope, Lizzy] Univ Vermont, Dept Nutr & Food Sci, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Pope, L (corresponding author), Univ Vermont, Dept Nutr & Food Sci, Burlington, VT 05405 USA.	efpope@uvm.edu			University of Vermont Dean of Student's Office	University of Vermont Dean of Student's Office	The study was funded by the University of Vermont Dean of Student's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bertoia ML, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001878; Brunner TA, 2013, APPETITE, V71, P89, DOI 10.1016/j.appet.2013.07.014; 전예숙, 2015, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V44, P216; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; COUNIHAN CM, 1992, ANTHROPOL QUART, V65, P55, DOI 10.2307/3318134; DeBate RD, 2001, ADOLESCENCE, V36, P819; Djuric Z, 2002, NUTR CANCER, V43, P141, DOI 10.1207/S15327914NC432_4; Driskell JA, 2005, J AM DIET ASSOC, V105, P798, DOI 10.1016/j.jada.2005.02.004; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; JACCARD J, 1984, PSYCHOL BULL, V96, P589, DOI 10.1037/0033-2909.96.3.589; Just D. R., 2009, Choices. The Magazine of Food, Farm, and Resources Issues, V24, punpaginated; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Levitsky DA, 2004, INT J OBESITY, V28, P1435, DOI 10.1038/sj.ijo.0802776; Liu PJ, 2014, APPL ECON PERSPECT P, V36, P6, DOI 10.1093/aepp/ppt027; Loewenstein G, 2003, Q J ECON, V118, P1209, DOI 10.1162/003355303322552784; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Nelson MC, 2009, J NUTR EDUC BEHAV, V41, P287, DOI 10.1016/j.jneb.2008.05.005; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Pope L, 2016, J NUTR EDUC BEHAV, P1; Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1-17, 10.1301/nr.2004.jan.1&ndash;17, 10.1111/j.1753-4887.2004.tb00001.x]; Rozin P, 2011, JUDGM DECIS MAK, V6, P323; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Thaler R.H., 2021, NUDGE FINAL EDITION; Thorndike AN, 2012, AM J PUBLIC HEALTH, V102, P527, DOI 10.2105/AJPH.2011.300391; Wansink B, 2013, PLOS ONE, V8, P1; Wichianson JR, 2009, STRESS HEALTH, V25, P235, DOI 10.1002/smi.1242; World Health Organisation, 2003, DIET NUTR PREV CHRON	30	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198162	10.1371/journal.pone.0198162	http://dx.doi.org/10.1371/journal.pone.0198162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29851972	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200038
J	Hasan, M; Sutradhar, I; Akter, T; Das Gupta, R; Joshi, H; Haider, MR; Sarker, M				Hasan, Mehedi; Sutradhar, Ipsita; Akter, Tahmina; Das Gupta, Rajat; Joshi, Hemraj; Haider, Mohammad Rifat; Sarker, Malabika			Prevalence and determinants of hypertension among adult population in Nepal: Data from Nepal Demographic and Health Survey 2016	PLOS ONE			English	Article							CARDIOVASCULAR RISK; AWARENESS; COMMUNITIES; BANGLADESH; OBESITY; NAIROBI; BURDEN; COHORT; MIDDLE; KENYA	Like other developing countries, Nepal is currently going through epidemiological transition along with rising burden of Non-communicable Diseases. However, since 2013, no study investigated the prevalence and determinants of hypertension in Nepal involving nationally representative sample. Therefore, this study aimed to find out the current prevalence of hypertension in Nepal and its determinants using the latest nationally representative data obtained from Nepal Demographic and Health Survey (NDHS) 2016. The NDHS 2016 collected data on hypertension from 13,304 men and women aged 18 years and above from 5,520 urban and 5,970 rural households covering seven administrative provinces and three ecological zones. Participants were considered as hypertensive when their systolic blood pressure was >= 140 mmHg and/or diastolic blood pressure was >= 90 mmHg and/or they reported taking antihypertensive medication. A total of 19.9% study participants were diagnosed as hypertensive of which majority were male (male-24.3%, female-16.9%), ever married (ever married-21.7%, unmarried-6.1%) and residents of urban area (urban-20.9%, rural-18.3%). Hypertension prevalence has shown growing trend with the increase of age. This prevalence was also higher among rich and overweight/obese individuals. In multivariable logistic regression analysis, older age, male gender, better education, residence at urban area and province 4 and 5 and being overweight/obese were found positive association with having hypertension. When the determinants of hypertension were stratified by sex of the participants, difference was observed in case of age group, education and place of residence. As one out of every five individuals in Nepal are hypertensive, public health initiatives are immediately required for prevention and control of hypertension to reduce mortality and morbidity associated with this progressive disease.	[Hasan, Mehedi; Sutradhar, Ipsita; Das Gupta, Rajat; Sarker, Malabika] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Akter, Tahmina] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh; [Joshi, Hemraj] Child Hlth Program Off, Lifeline Nepal, Kathmandu, Nepal; [Haider, Mohammad Rifat] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC USA	Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Dhaka; University of South Carolina System; University of South Carolina Columbia	Hasan, M (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	Mehedihasan6376@gmail.com	Gupta, Rajat Das/E-5545-2018; Hasan, Mehedi/J-8056-2019; Hasan, Mehedi/HHC-4236-2022; Sutradhar, Ipsita/AAW-6456-2021; Haider, Mohammad Rifat/N-9987-2016	Gupta, Rajat Das/0000-0002-7680-676X; Hasan, Mehedi/0000-0003-2153-4979; Sutradhar, Ipsita/0000-0003-4747-7693; Haider, Mohammad Rifat/0000-0002-0690-8242; Sarker, Malabika/0000-0001-7293-8805				Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Bernabe-Ortiz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035127; Black HR, 1997, ARCH INTERN MED, V157, P2413; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Chataut J., 2012, KATHMANDU U MED J, V9, P13, DOI DOI 10.3126/KUMJ.V9I1.6255; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; Dhital S. M., 2013, Regional Health Forum, V17, P44; Engelgau MM, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8724-5; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Ghosh S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010085; Giles Thomas D, 2005, J Clin Hypertens (Greenwich), V7, P505, DOI 10.1111/j.1524-6175.2005.04769.x; Government of Nepal, 2014, MULT ACT PLAN PREV C; Griffiths P, 2005, EUR J CLIN NUTR, V59, P1217, DOI 10.1038/sj.ejcn.1602228; Hodgson TA, 2001, MED CARE, V39, P599, DOI 10.1097/00005650-200106000-00008; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Irazola VE, 2016, GLOB HEART, V11, P47, DOI 10.1016/j.gheart.2015.12.008; Islam MZ, 2004, ASIA PAC J CLIN NUTR, V13, P61; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Karki KB, 2008, WHO STEPS SURVEILLAN; Krishnan A, 2013, HYPERTENSION S E ASI; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lee SH, 2005, J KOREAN MED SCI, V20, P188, DOI 10.3346/jkms.2005.20.2.188; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lionakis N, 2012, WORLD J CARDIOL, V4, P135, DOI 10.4330/wjc.v4.i5.135; Malekzadeh MM, 2013, J HYPERTENS, V31, P1364, DOI 10.1097/HJH.0b013e3283613053; Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Mehta KD, 2011, SE ASIAN J TROP MED, V42, P197; Mishra SR, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0119-7; Misra A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1420; MOHP New ERA ICF International., 2017, NEP DEM HLTH SURV 20; National Planning Commission, 2017, DEM CHANG NEP TRENDS; Rahman MM, 2015, J HYPERTENS, V33, P465, DOI 10.1097/HJH.0000000000000421; Schmieder RE, 2010, DTSCH ARZTEBL INT, V107, P866, DOI 10.3238/arztebl.2010.0866; Sharma SK, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/821971; Shihab HM, 2012, CIRCULATION, V126, P2983, DOI 10.1161/CIRCULATIONAHA.112.117333; Shrestha UK, 2006, DIABETIC MED, V23, P1130, DOI 10.1111/j.1464-5491.2006.01953.x; Vaidya Abhinav, 2012, Indian Heart J, V64, P128, DOI 10.1016/S0019-4832(12)60045-5; Vaidya A, 2010, INT J ENV RES PUB HE, V7, P2726, DOI 10.3390/ijerph7062726; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56	43	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198028	10.1371/journal.pone.0198028	http://dx.doi.org/10.1371/journal.pone.0198028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852006	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200024
J	Sharma, V; Siedenburg, G; Birke, J; Mobeen, F; Jendrossek, D; Prakash, T				Sharma, Vikas; Siedenburg, Gabriele; Birke, Jakob; Mobeen, Fauzul; Jendrossek, Dieter; Prakash, Tulika			Metabolic and taxonomic insights into the Gram-negative natural rubber degrading bacterium Steroidobacter cummioxidans sp nov., strain 35Y	PLOS ONE			English	Article							CLEARING PROTEIN LCP; DNA-DNA HYBRIDIZATION; MICROBIAL-DEGRADATION; GEN. NOV.; PHOSPHOENOLPYRUVATE CARBOXYKINASE; GENOME SEQUENCE; OXYGENASE ROXA; GUTTA-PERCHA; LATEX; CLEAVAGE	The pathway of rubber (poly [cis-1,4-isoprene]) catabolism is well documented for Gram-positive rubber degraders but only little information exists for Gram-negative species. The first documented potent rubber degrading Gram-negative strain is Xanthomonas sp. strain 35Y that uses extracellular rubber oxygenases for the initial cleavage of the polyisoprene molecule. However, neither the exact phylogenetic position of Xanthomonas sp. strain 35Y nor the catabolic pathway of the primary polyisoprene cleavage products have been investigated. In this contribution, we started to address both these issues by a comprehensive taxonomic characterization and by the analysis of the draft genome sequence of strain 35Y. Evaluation of the 16S rRNA gene sequence pointed to a borderline taxonomic position of strain 35Y as a novel species of the genus Steroidobacter. Further, substantial differences in the genotypic properties of strain 35Y and the members of the genus Steroidobacter, including average nucleotide identity (ANI) and in silico DNA-DNA hybridization (DDH), resolved the taxonomic position of strain 35Y and suggested its positioning as a novel species of the genus Steroidobacter. This was further confirmed by comparative analysis of physiological and biochemical features of strain 35Y with other members of the genus Steroidobacter. Thus, we conclude that strain 35Y represents a novel species of the genus Steroidobacter, for which we propose the designation Steroidobacter cummioxidans sp. nov., strain 35Y(T). A comprehensive analysis of the draft genome of S. cummioxidans strain 35Y revealed similarities but also substantial differences to rubber degrading Gram-positive counterparts. In particular, the putative transporters for the uptake of polyisoprene cleavage products differ from Gram-positive rubber degrading species. The draft genome sequence of S. cummioxidans strain 35Y will be useful for researchers to experimentally verify the predicted similarities and differences in the pathways of polyisoprene catabolism in Gram-positive and Gram-negative rubber degrading species.	[Sharma, Vikas; Mobeen, Fauzul; Prakash, Tulika] Indian Inst Technol IIT Mandi, Sch Basic Sci, Mandi, India; [Siedenburg, Gabriele; Birke, Jakob; Jendrossek, Dieter] Univ Stuttgart, Inst Microbiol, Stuttgart, Germany; [Siedenburg, Gabriele] Univ Duisburg Essen, Essen, Germany	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; University of Stuttgart; University of Duisburg Essen	Prakash, T (corresponding author), Indian Inst Technol IIT Mandi, Sch Basic Sci, Mandi, India.	tulika@iitmandi.ac.in	Sharma, Vikas/B-6627-2013	Sharma, Vikas/0000-0002-1095-4030	funding agency "Deutsche Forschungsgemeinschaft" [Je 152/17-1]; Ministry of Human Resource Development (MHRD), India	funding agency "Deutsche Forschungsgemeinschaft"(German Research Foundation (DFG)); Ministry of Human Resource Development (MHRD), India	This work was supported by the Dieter Jendrossek recieved the grant with reference number, Je 152/17-1 from the funding agency "Deutsche Forschungsgemeinschaft (http://www.dfg.de/.)" and Vikas Sharma is recipient of research fellowship from Ministry of Human Resource Development (MHRD), India (http://mhrd.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birke J, 2017, APPL ENV MICROBIOL; Birke J, 2015, APPL ENVIRON MICROB, V81, P3793, DOI 10.1128/AEM.00275-15; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Bode HB, 2000, APPL ENVIRON MICROB, V66, P3680, DOI 10.1128/AEM.66.9.3680-3685.2000; Braaz R, 2004, APPL ENVIRON MICROB, V70, P7388, DOI 10.1128/AEM.70.12.7388-7395.2004; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; Brigham CJ, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-26; Chevreux B., 1999, COMPUTER SCI BIOL P, P45; Fahrbach M, 2008, INT J SYST EVOL MICR, V58, P2215, DOI 10.1099/ijs.0.65342-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gong ZL, 2016, ANTON LEEUW INT J G, V109, P1073, DOI 10.1007/s10482-016-0706-5; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hiessl S, 2012, APPL ENVIRON MICROB, V78, P2874, DOI 10.1128/AEM.07969-11; Hyeon JE, 2012, J BACTERIOL, V194, P2181, DOI 10.1128/JB.06562-11; Ilcu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05268-2; Imai S, 2013, J GEN APPL MICROBIOL, V59, P199, DOI 10.2323/jgam.59.199; Jendrossek D, 2003, FEMS MICROBIOL LETT, V224, P61, DOI 10.1016/S0378-1097(03)00424-5; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Jendrossek D, 1997, FEMS MICROBIOL LETT, V150, P179, DOI 10.1111/j.1574-6968.1997.tb10368.x; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Jyothsna TSS, 2016, INT J SYST EVOL MICR, V66, P1268, DOI 10.1099/ijsem.0.000874; Kasai D, 2017, BIOSCI BIOTECH BIOCH, V81, P614, DOI 10.1080/09168451.2016.1263147; Kerkhoff K., 2000, THESIS; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Luo Q, 2014, APPL ENVIRON MICROB, V80, P3895, DOI 10.1128/AEM.00473-14; Luo Q, 2013, APPL ENVIRON MICROB, V79, P1140, DOI 10.1128/AEM.03016-12; Malaysian Rubber Board, LEMB GET MAL; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Cardenas JP, 2015, INT J SYST EVOL MICR, V65, P3641, DOI 10.1099/ijsem.0.000468; Ranta PM, 2004, CLIN INFECT DIS, V38, P252, DOI 10.1086/380789; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Riedel C, 2001, J MOL MICROB BIOTECH, V3, P573; Rother W, 2016, APPL ENVIRON MICROB, V82, P6593, DOI 10.1128/AEM.02176-16; Rose K, 2005, APPL ENVIRON MICROB, V71, P2803, DOI 10.1128/AEM.71.6.2803-2812.2005; Rose K, 2005, BIOMACROMOLECULES, V6, P180, DOI 10.1021/bm0496110; Sakai M, 2014, MICROBES ENVIRON, V29, P89, DOI 10.1264/jsme2.ME13169; Schmitt G, 2010, MICROBIOL-SGM, V156, P2537, DOI 10.1099/mic.0.038992-0; Schoner TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090922; Seidel J, 2013, P NATL ACAD SCI USA, V110, P13833, DOI 10.1073/pnas.1305560110; Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; STEINBUCHEL A, 1995, CAN J MICROBIOL, V41, P94, DOI 10.1139/m95-175; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TIJSSEN JPF, 1982, BIOCHIM BIOPHYS ACTA, V721, P394, DOI 10.1016/0167-4889(82)90094-5; TSUCHII A, 1990, APPL ENVIRON MICROB, V56, P269, DOI 10.1128/AEM.56.1.269-274.1990; Watcharakul S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0703-x; Wiener MC, 2011, P NATL ACAD SCI USA, V108, P10929, DOI 10.1073/pnas.1106927108; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yikmis M, 2012, MICROBIOLOGYOPEN, V1, P13, DOI 10.1002/mbo3.3; Yoshida K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-290	53	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197448	10.1371/journal.pone.0197448	http://dx.doi.org/10.1371/journal.pone.0197448			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851965	Green Submitted, Green Published, gold			2022-12-26	WOS:000433893200014
J	Silva, N; Bullinger, M; Moreira, H; Canavarro, MC; Carona, C				Silva, Neuza; Bullinger, Monika; Moreira, Helena; Canavarro, Maria Cristina; Carona, Carlos			Establishing priorities for psychological interventions in pediatric settings: A decision-tree approach using the DISABKIDS-10 Index as a screening instrument	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; PRIMARY-CARE; DIFFICULTIES QUESTIONNAIRE; CHRONIC ILLNESS; CHILDREN; ADOLESCENTS; VALIDITY; DISORDERS; STRENGTHS	Most children and adolescents with chronic health conditions have impaired health-related quality of life and are at high risk of internalizing and externalizing problems. However, few patients present clinically significant symptoms. Using a decision-tree approach, this study aimed to identify risk profiles for psychological problems based on measures that can be easily scored and interpreted by healthcare professionals in pediatric settings. The participants were 736 children and adolescents between 8-18 years of age with asthma, epilepsy, cerebral palsy, type-1diabetes or obesity. The children and adolescents completed self-report measures of health-related quality of life (DISABKIDS-10) and psychological problems (Strengths and Difficulties Questionnaire). Sociodemographic and clinical data were collected from their parents/physicians. Children and adolescents were classified into the normal (78.5%) or borderline/clinical range (21.5%) according to the Strengths and Difficulties Questionnaire cut-off values for psychological problems. The overall accuracy of the decision-tree model was 78.1% (sensitivity = 71.5%; specificity = 79.9%), with 4 profiles predicting 71.5% of borderline/clinical cases. The strongest predictor of psychological problems was ahealth-related quality of life standardized score below the threshold of 57.5 for patients with cerebral palsy, epilepsy or obesity and below 70.0 for patients with asthma or diabetes. Other significant predictors were low socio-economic status, single-parent household, medication intake and younger age. The model showed adequate validity (risk = .28, SE = .02) and accuracy (area under the Receiver Operating Characteristic curve = .84; CI = .80/.87). The identification of pediatric patients at high risk for psychological problems may contribute to a more efficient allocation of health resources, particularly with regard to their referral to specialized psychological assessment and intervention.	[Silva, Neuza; Moreira, Helena; Canavarro, Maria Cristina; Carona, Carlos] Univ Coimbra, Fac Psychol & Educ Sci, Cognit & Behav Ctr Res & Intervent, Coimbra, Portugal; [Silva, Neuza; Bullinger, Monika] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Carona, Carlos] Cerebral Palsy Assoc Coimbra, Federat Portuguese Cerebral Palsy Assoc, Coimbra, Portugal	Universidade de Coimbra; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bullinger, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	bullinger@uke.de	da Silva, Neuza/A-9883-2013; Canavarro, Maria Cristina/A-9893-2013; Carona, Carlos/B-1097-2013	da Silva, Neuza/0000-0003-4110-9961; Bullinger, Monika/0000-0001-8876-0159; Canavarro, Maria Cristina/0000-0002-5083-7322; Carona, Carlos/0000-0002-3605-3513	Portuguese Foundation for Science and Technology [SFRH/BD/69885/2010, SFRH/BPD/70063/2010]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This study was conducted within the Relationships, Development & Health research group of the R&D Unit Cognitive-Behavioral Centre for Research and Intervention of the University of Coimbra, Portugal (PEst-OE/PSI/UI0730/2014) and the Department of Medical Psychology of the University Medical Center Hamburg-Eppendorf, Germany. NS and HM were supported by Doctoral (SFRH/BD/69885/2010) and Postdoctoral (SFRH/BPD/70063/2010) Grants from the Portuguese Foundation for Science and Technology, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; AUSTIN JK, 1994, EPILEPSIA, V35, P608, DOI 10.1111/j.1528-1157.1994.tb02481.x; Barlow JH, 2006, CHILD CARE HLTH DEV, V32, P19, DOI 10.1111/j.1365-2214.2006.00591.x; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Briggs-Gowan MJ, 2000, J AM ACAD CHILD PSY, V39, P841, DOI 10.1097/00004583-200007000-00012; BRODY DS, 1980, ARCH INTERN MED, V140, P1286, DOI 10.1001/archinte.140.10.1286; Bullinger M, 2006, J PUBLIC HEALTH-HEID, V14, P343, DOI 10.1007/s10389-006-0066-0; CALKINS DR, 1991, ANN INTERN MED, V114, P451, DOI 10.7326/0003-4819-114-6-451; Carona C, 2015, J CHILD HEALTH CARE, V19, P466, DOI 10.1177/1367493514522867; COSTELLO EJ, 1988, ARCH GEN PSYCHIAT, V45, P1107; Delen D, 2013, EXPERT SYST APPL, V40, P3970, DOI 10.1016/j.eswa.2013.01.012; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Eisman EJ, 2000, PROF PSYCHOL-RES PR, V31, P131, DOI 10.1037/0735-7028.31.2.131; Fleitlich B., 2005, QUESTIONARIO CAPACID; Forthofer MS, 2000, AM J HEALTH BEHAV, V24, P36, DOI 10.5993/AJHB.24.1.6; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 2003, INT REV PSYCHIATR, V15, P173, DOI 10.1080/0954026021000046137; Greenhalgh J, 1999, J EVAL CLIN PRACT, V5, P401, DOI 10.1046/j.1365-2753.1999.00209.x; HARPER DC, 1991, J PEDIATR PSYCHOL, V16, P533, DOI 10.1093/jpepsy/16.5.533; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; Holden EW, 1997, J PEDIATR PSYCHOL, V22, P15; Kass GV, 1980, J R STAT SOC C-APPL, P119; Kuczmarski RJ, 2000, Adv Data, P1; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Ludemann L, 2006, ACTA RADIOL, V47, P303, DOI 10.1080/02841850500539033; Mazonson P D, 1996, J Am Board Fam Pract, V9, P336; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Moreira H, 2013, J PEDIATR-US, V163, P1471, DOI 10.1016/j.jpeds.2013.06.028; Muhlan H, 2008, CLIN PSYCHOL PSYCHOT, V15, P142, DOI 10.1002/cpp.573; NELSON E, 1983, JAMA-J AM MED ASSOC, V249, P3331, DOI 10.1001/jama.249.24.3331; Newacheck PW, 1998, PEDIATRICS, V102, P117, DOI 10.1542/peds.102.1.117; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Pinquart M, 2011, J PEDIATR PSYCHOL, V36, P1003, DOI 10.1093/jpepsy/jsr042; Quitmann JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153953; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Rush KS, 2004, BEHAV MODIF, V28, P621, DOI 10.1177/0145445503259830; Sawyer MG, 2004, QUAL LIFE RES, V13, P1309, DOI 10.1023/B:QURE.0000037489.41344.b2; Silva N, 2015, CHILD CARE HLTH DEV, V41, P112, DOI 10.1111/cch.12147; Simoes M., 1994, THESIS; Smedje H, 1999, EUR CHILD ADOLES PSY, V8, P63, DOI 10.1007/s007870050086; Speechley KN, 2008, EPILEPSY BEHAV, V13, P337, DOI 10.1016/j.yebeh.2008.05.001; Spieth LE, 1996, J PEDIATR PSYCHOL, V21, P175, DOI 10.1093/jpepsy/21.2.175; STEIN REK, 1982, PUBLIC HEALTH REP, V97, P354; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; The DISABKIDS Group Europe, 2006, DISABKIDS QUEST QUAL; Tremolada M, 2016, PSYCHO-ONCOLOGY, V25, P1408, DOI 10.1002/pon.4072; Tremolada M, 2015, HEALTH SOC WORK, V40, pE148, DOI 10.1093/hsw/hlv067; Varni James W, 2005, Health Qual Life Outcomes, V3, P34, DOI 10.1186/1477-7525-3-34; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43; Vila G, 2003, PSYCHOSOMATICS, V44, P319, DOI 10.1176/appi.psy.44.4.319; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1111/1469-7610.00302; WEILAND SK, 1992, PEDIATRICS, V89, P445; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; Woerner W, 2002, Z KINDER JUG-PSYCH, V30, P105, DOI 10.1024//1422-4917.30.2.105; World Health Organization, 1993, MEAS QUAL LIF CHILDR; Zeller MH, 2006, PEDIATRICS, V117, P1155, DOI 10.1542/peds.2005-1141	58	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198402	10.1371/journal.pone.0198402	http://dx.doi.org/10.1371/journal.pone.0198402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH8CD	29852026	Green Submitted, gold, Green Published			2022-12-26	WOS:000433893200052
J	Merlhiot, G; Mermillod, M; Le Pennec, JL; Dutheil, F; Mondillon, L				Merlhiot, Gaetan; Mermillod, Martial; Le Pennec, Jean-Luc; Dutheil, Frederic; Mondillon, Laurie			Influence of uncertainty on framed decision-making with moral dilemma	PLOS ONE			English	Article							TEMPORAL UNPREDICTABILITY; EMOTION REGULATION; GENDER-DIFFERENCES; STIMULUS SEQUENCE; COGNITIVE LOAD; NEURAL BASES; JUDGMENT; STRESS; RISK; DISSOCIATION	In cases of impending natural disasters, most events are uncertain and emotionally relevant, both critical factors for decision-making. Moreover, for exposed individuals, the sensitivity to the framing of the consequences (gain or loss) and the moral judgments they have to perform (e.g., evacuate or help an injured person) constitute two central effects that have never been examined in the same context of decision-making. In a framed decision-making task with moral dilemma, we investigated whether uncertainty (i.e., unpredictably of events) and a threatening context would influence the framing effect (actions framed in loss are avoided in comparison to the ones framed in gain) and the personal intention effect (unintentional actions are more morally acceptable in comparison to intentional actions) on the perceived moral acceptability of taking action. Considering the impact of uncertainty and fear on the processes underlying these effects, we assumed that these emotions would lead to the negation of the two effects. Our results indicate that the exposure to uncertain events leads to the negation of the framing effect, but does not influence the moral acceptability and the effect of personal intention. We discuss our results in the light of dual-process models (i.e. systematic vs. heuristic), appraisal theories, and neurocognitive aspects. These elements highlight the importance of providing solutions to cope with uncertainty, both for scientists and local populations exposed to natural hazards.	[Merlhiot, Gaetan; Mondillon, Laurie] Univ Clermont Auvergne, CNRS, LAPSCO, Physiol & Psychosocial Stress,LABEX ClerVolc, Clermont Ferrand, France; [Mermillod, Martial] Univ Grenoble Alpes, LPNC, Grenoble, France; [Mermillod, Martial] CNRS, UMR LPNC 5105, Grenoble, France; [Mermillod, Martial] Univ Grenoble Alpes, LJK, Grenoble, France; [Mermillod, Martial] CNRS, UMR LJK 5524, Grenoble, France; [Le Pennec, Jean-Luc] Univ Clermont Auvergne, CNRS, IRD, OPGC,Lab Magmas & Volcans,LABEX ClerVolc, Clermont Ferrand, France; [Dutheil, Frederic] Univ Clermont Auvergne, CNRS, LAPSCO Stress Physiol & Psychosocial,WittyFit, CHU Clermont Ferrand,Sante Travail Environm, Clermont Ferrand, France; [Dutheil, Frederic] Australian Catholic Univ, Fac Hlth, Melbourne, Vic, Australia	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Australian Catholic University	Merlhiot, G (corresponding author), Univ Clermont Auvergne, CNRS, LAPSCO, Physiol & Psychosocial Stress,LABEX ClerVolc, Clermont Ferrand, France.	gaetan.merlhiot@gmail.com	Dutheil, Frederic/O-9707-2014	Dutheil, Frederic/0000-0002-1468-6029	Clermont-Ferrand Center for Volcano Research (ClerVolc Excellence Laboratory) - French Government Laboratory of Excellence initiative [ANR-10-LABX-0006]; Region Auvergne; European Regional Development Fund	Clermont-Ferrand Center for Volcano Research (ClerVolc Excellence Laboratory) - French Government Laboratory of Excellence initiative; Region Auvergne(Region Auvergne-Rhone-Alpes); European Regional Development Fund(European Commission)	This work was supported by the Clermont-Ferrand Center for Volcano Research (ClerVolc Excellence Laboratory, http://clervolc.univ-bpclermont.fr/) financed by the French Government Laboratory of Excellence initiative (noANR-10-LABX-0006), the Region Auvergne, and the European Regional Development Fund. This is Laboratory of Excellence ClerVolc contribution number 268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adolphs R, 2013, CURR BIOL, V23, pR79, DOI 10.1016/j.cub.2012.11.055; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Banerjee K, 2010, J COGN CULT, V10, P253, DOI 10.1163/156853710X531186; Barclay J, 2008, GEOL SOC SPEC PUBL, V305, P163, DOI 10.1144/SP305.14; Bollon T, 2013, COGNITION EMOTION, V27, P376, DOI 10.1080/02699931.2012.712947; Bradley M. M., 2007, B3 U FLOR; Bruchon-Schweitzer ML, 1993, MANUEL INVENTAIRE AN; Carvajal F, 2013, EXP BRAIN RES, V228, P467, DOI 10.1007/s00221-013-3578-1; Cassotti M, 2012, EMOTION, V12, P926, DOI 10.1037/a0026788; Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007; Cushman F, 2012, SOC NEUROSCI-UK, V7, P269, DOI 10.1080/17470919.2011.614000; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; De Martino B, 2010, P NATL ACAD SCI USA, V107, P3788, DOI 10.1073/pnas.0910230107; Donovan A, 2014, J APPL VOLCANOL, V3, P15, DOI [10.1186/s13617-014-0015-5, DOI 10.1186/S13617-014-0015-5]; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Friesdorf R, 2015, PERS SOC PSYCHOL B, V41, P696, DOI 10.1177/0146167215575731; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Greco V, 2003, PERS INDIV DIFFER, V34, P1057, DOI 10.1016/S0191-8869(02)00091-0; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2007, TRENDS COGN SCI, V11, P322, DOI 10.1016/j.tics.2007.06.004; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2005, CAMBRIDGE HDB THINKI, P267, DOI DOI 10.1111/COGS.12119; Kahneman D, 2007, TRENDS COGN SCI, V11, P45, DOI 10.1016/j.tics.2006.11.007; Kliegl R, 2010, VIS COGN, V18, P655, DOI 10.1080/13506280902986058; Koppe G, 2015, NEUROIMAGE, V120, P214, DOI 10.1016/j.neuroimage.2015.06.081; Koppe G, 2014, NEUROIMAGE, V101, P236, DOI 10.1016/j.neuroimage.2014.07.008; Kuhberger A, 1998, ORGAN BEHAV HUM DEC, V75, P23, DOI 10.1006/obhd.1998.2781; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Mata R, 2011, ANN NY ACAD SCI, V1235, P18, DOI 10.1111/j.1749-6632.2011.06200.x; MONAT A, 1972, J PERS SOC PSYCHOL, V24, P237, DOI 10.1037/h0033297; Otto B, 2014, COGN AFFECT BEHAV NE, V14, P923, DOI 10.3758/s13415-013-0240-0; Pabst S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00142; Pabst S, 2013, BEHAV BRAIN RES, V250, P39, DOI 10.1016/j.bbr.2013.04.046; Pastotter B, 2013, COGNITION, V126, P373, DOI 10.1016/j.cognition.2012.11.003; Paxton JM, 2010, TOP COGN SCI, V2, P511, DOI 10.1111/j.1756-8765.2010.01096.x; Petrinovich L, 1996, ETHOL SOCIOBIOL, V17, P145, DOI 10.1016/0162-3095(96)00041-6; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phelps EA, 2014, ANNU REV NEUROSCI, V37, P263, DOI 10.1146/annurev-neuro-071013-014119; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sokol-Hessner P, 2013, SOC COGN AFFECT NEUR, V8, P341, DOI 10.1093/scan/nss002; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Strohminger N, 2011, COGNITION, V119, P295, DOI 10.1016/j.cognition.2010.12.012; THOMSON JJ, 1985, YALE LAW J, V94, P1395, DOI 10.2307/796133; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Waldmann MR, 2007, PSYCHOL SCI, V18, P247, DOI 10.1111/j.1467-9280.2007.01884.x; Whalen PJ, 2007, TRENDS COGN SCI, V11, P499, DOI 10.1016/j.tics.2007.08.016; Whitney P, 2008, PSYCHON B REV, V15, P1179, DOI 10.3758/PBR.15.6.1179; ZAKOWSKI SG, 1995, PSYCHOL HEALTH, V10, P409, DOI 10.1080/08870449508401960	69	3	4	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197923	10.1371/journal.pone.0197923	http://dx.doi.org/10.1371/journal.pone.0197923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847589	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800044
J	Almatarneh, S; Gamallo, P				Almatarneh, Sattam; Gamallo, Pablo			A lexicon based method to search for extreme opinions	PLOS ONE			English	Article							SENTIMENT ANALYSIS; REVIEWS; PATTERNS	Studies in sentiment analysis and opinion mining have been focused on many aspects related to opinions, namely polarity classification by making use of positive, negative or neutral values. However, most studies have overlooked the identification of extreme opinions (most negative and most positive opinions) in spite of their vast significance in many applications. We use an unsupervised approach to search for extreme opinions, which is based on the automatic construction of a new lexicon containing the most negative and most positive words.	[Almatarneh, Sattam; Gamallo, Pablo] Univ Santiago de Compostela, Ctr Singular Invest Tecnol Informac CITIUS, Santiago De Compostela, A Coruna, Spain	Universidade de Santiago de Compostela	Almatarneh, S (corresponding author), Univ Santiago de Compostela, Ctr Singular Invest Tecnol Informac CITIUS, Santiago De Compostela, A Coruna, Spain.	sattam.almatarneh@usc.es	gamallo, pablo/A-6985-2009; Almatarneh, Sattam/O-9163-2016	gamallo, pablo/0000-0002-5819-2469; Almatarneh, Sattam/0000-0002-6970-4888				Almatarneh S, 2017, SEARCHING MOST NEGAT, P14, DOI [10.1007/978-3-319-69548-8_2, DOI 10.1007/978-3-319-69548-8_2]; Asghar MZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171649; Asghar MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140204; Benamara Farah, 2007, ICWSM; Blitzer J., 2007, ANN M ASS COMP LING, P440, DOI DOI 10.1109/IRPS.2011.5784441; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Cambria E., 2014, 28 AAAI C ART INT; Cambria E., 2016, P COLING 2016 26 INT, P2666, DOI DOI 10.1007/978-3-319-55209-5_5; Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31; Cambria E, 2013, IEEE INTELL SYST, V28, P15, DOI 10.1109/MIS.2013.30; Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345; DAndrea Alessia, 2015, INT J COMPUTER APPL, DOI [10.5120/ijca2015905866, DOI 10.5120/IJCA2015905866]; Denecke K, 2009, TOPIC RELATED SENTIM; Ding X., 2008, P 2008 INT C WEB SEA, P231, DOI DOI 10.1145/1341531.1341561; Du W, 2010, COMPUTER INFORM SCI, V3, P52, DOI [10.5539/cis.v3n1p52, DOI 10.5539/CIS.V3N1P52]; Esuli A., 2006, LREC, P417, DOI DOI 10.1155/2015/715730; Guerini M, 2015, IEEE T AFFECT COMPUT, P99; Hatzivassiloglou V, 1997, 35TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 8TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P174, DOI 10.3115/976909.979640; Hutto C.J., 2014, PROC INT AAAI C WEB; Kamps Jaap, 2004, P 4 INT C LANG RES E, P1115; Lee J, 2008, ELECTRON COMMER R A, V7, P341, DOI 10.1016/j.elerap.2007.05.004; Lee Y, 2009, LECT NOTES ARTIF INT, V5459, P201, DOI 10.1007/978-3-642-00831-3_19; Lin Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079294; Liu B, 2010, CH CRC MACH LEARN PA, P627; Luca M, 2016, MANAGE SCI, V62, P3412, DOI 10.1287/mnsc.2015.2304; Maas A. L., 2011, P 49 ANN M ASS COMP, P142; Mohammad SM, 2013, COMPUT INTELL-US, V29, P436, DOI 10.1111/j.1467-8640.2012.00460.x; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Pang Bo, 2005, CS0506075 ARXIV, P115, DOI DOI 10.3115/1219840.1219855; Poria S., 2015, P 2015 C EMP METH NA, P2539; Poria S, 2015, IEEE COMPUT INTELL M, V10, P26, DOI 10.1109/MCI.2015.2471215; Poria S, 2014, KNOWL-BASED SYST, V69, P45, DOI 10.1016/j.knosys.2014.05.005; Potts C., 2011, NSF WORKSH RESTR AD; Potts Christopher, 2010, P SEMANTICS LINGUIST, V20, P636; Severyn A, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P959, DOI 10.1145/2766462.2767830; Sokolova M, 2009, RANLP, P421; Taboada M, 2011, COMPUT LINGUIST, V37, P267, DOI 10.1162/COLI_a_00049; Takamura H., 2007, HLT NAACL, V2007, P292; Tang D., 2014, P 8 INT WORKSH SEM E; Tripathy A, 2016, EXPERT SYST APPL, V57, P117, DOI 10.1016/j.eswa.2016.03.028; Zhang Lei, 2011, P 49 ANN M ASS COMPU, P575; Zhang Z, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P542	45	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197816	10.1371/journal.pone.0197816	http://dx.doi.org/10.1371/journal.pone.0197816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799867	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400024
J	Rodgers, CD; Meyer, AM; Rosenberg, NC; Lukowski, ZL; Schaefer, JL; Martorana, GM; Levine, MA; Meyers, CA; Sherwood, MB				Rodgers, Cooper D.; Meyer, Alissa M.; Rosenberg, Nicole C.; Lukowski, Zachary L.; Schaefer, Jamie L.; Martorana, Gina M.; Levine, Monica A.; Meyers, Craig A.; Sherwood, Mark B.			The impact of conjunctival flap method and drainage cannula diameter on bleb survival in the rabbit model	PLOS ONE			English	Article							GLAUCOMA FILTRATION SURGERY; CHAMBER TUBE SHUNT; MITOMYCIN-C; NEOVASCULAR GLAUCOMA; FILTERING SURGERY; ENCIRCLING BAND; ANIMAL-MODEL; TRABECULECTOMY; COMPLICATIONS; PREVALENCE	Purpose To examine the effect of cannula diameter and conjunctival flap method on bleb survival in rabbits undergoing cannula-based glaucoma filtration surgery (GFS). Methods Twelve New Zealand White rabbits underwent GFS in both eyes. The twenty-four eyes were divided into four groups. Two of the four groups (N = 12) received limbus-based conjunctival flaps (LBCF), and the other two (N = 12) received fornix-based conjunctival flaps (FBCF). Six FBCF rabbit eyes were implanted with 22-gauge drainage tubes, and the other six were implanted with 26-gauge tubes. Likewise, six LBCF rabbits received 22-gauge drainage tubes and six received 26-gauge tubes. Filtration blebs were evaluated every three days by a masked observer. Bleb failure was defined as the primary endpoint in this study and was recorded after two consecutive flat bleb evaluations. Results Group 1 (LBCF, 22- gauge cannula) had a mean bleb survival time (Mean +/- SD) of 18.7 +/- 2.9 days. Group 2 (LBCF, 26-gauge cannula) also had a mean bleb survival time of 18.7 +/- 2.9 days. Group 3 (FBCF, 22-gauge cannula) had a mean bleb survival time of 19.2 +/- 3.8 days. Group 4 (FBCF, 26-gauge cannula) had a mean bleb survival time of 19.7 +/- 4.1 days. A 2-way analysis of variance showed that neither surgical approach nor cannula gauge made a statistically significant difference in bleb survival time (P = 0.634 and P= 0.874). Additionally, there was no significant interaction between cannula gauge and conjunctival flap approach (P = 0.874), suggesting that there was not a combination of drainage gauge and conjunctival flap method that produced superior bleb survival. Conclusion Limbus and fornix-based conjunctival flaps are equally effective in promoting bleb survival using both 22 and 26-gauge cannulas in the rabbit model. The 26-gauge drainage tube may be preferred because its smaller size facilitates the implantation process, reducing the risk of corneal contact.	[Rodgers, Cooper D.; Meyer, Alissa M.; Rosenberg, Nicole C.; Lukowski, Zachary L.; Schaefer, Jamie L.; Martorana, Gina M.; Levine, Monica A.; Meyers, Craig A.; Sherwood, Mark B.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32611 USA; [Rodgers, Cooper D.] Univ Kansas, Sch Med, Kansas City, KS USA; [Lukowski, Zachary L.] Georgia Augusta Univ, Med Coll, Augusta, GA USA; [Schaefer, Jamie L.] West Virginia Univ, Dept Ophthalmol, Morgantown, WV USA; [Martorana, Gina M.] Univ Florida, Dept Dermatol, Gainesville, FL USA	State University System of Florida; University of Florida; University of Kansas; University of Kansas Medical Center; University System of Georgia; Augusta University; West Virginia University; State University System of Florida; University of Florida	Sherwood, MB (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL 32611 USA.	sherwood@ufl.edu		Rodgers, Cooper/0000-0001-6885-1731; Schaefer, Jamie/0000-0003-3044-2152	Research to Prevent Blindness (New York, NY)	Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB))	This study was supported in part by an unrestricted grant from Research to Prevent Blindness (New York, NY), to the Department of Ophthalmology, University of Florida. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad CE, 2017, AM J OPHTHALMOL, V174, P33, DOI 10.1016/j.ajo.2016.10.006; Berestka JS, 1997, OPHTHALMOLOGY, V104, P187, DOI 10.1016/S0161-6420(97)30335-2; Bettin P, 2012, GLAUCOMA SURG; Bourne RRA, 2003, BRIT J OPHTHALMOL, V87, P1069, DOI 10.1136/bjo.87.9.1069; Christakis PG, 2011, OPHTHALMOLOGY, V118, P2180, DOI 10.1016/j.ophtha.2011.05.004; Cordeiro MF, 1997, INVEST OPHTH VIS SCI, V38, P1639; Gagnon MM, 1997, CORNEA, V16, P314; Gedde SJ, 2012, AM J OPHTHALMOL, V153; Gedde SJ F W, 2017, PRIMARY TUB IN PRESS; Gedde SJ, 2007, AM J OPHTHALMOL, V143, P23, DOI 10.1016/j.ajo.2006.07.022; GRESSEL MG, 1984, OPHTHALMOLOGY, V91, P378; Gwon A., RABBIT CATARACT SURG; Gwon A, 2008, RABBIT CATARACT SURG; Hau S, 2009, CURR OPIN OPHTHALMOL, V20, P131, DOI 10.1097/ICU.0b013e328325a54b; He MG, 2006, INVEST OPHTH VIS SCI, V47, P4772, DOI 10.1167/iovs.06-0309; Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006; Jones Emma, 2005, Curr Opin Ophthalmol, V16, P107, DOI 10.1097/01.icu.0000156138.05323.6f; KHAW PT, 1993, OPHTHALMOLOGY, V100, P367; Lukowski ZL, 2013, J GLAUCOMA, V22, P145, DOI 10.1097/IJG.0b013e31822e8c83; Martorana GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138054; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; MILLER MH, 1989, OPHTHALMIC SURG LAS, V20, P350; Min J, 2012, INVEST OPHTH VIS SCI, V53, P7625, DOI 10.1167/iovs.12-10120; Min J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035627; Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031; MOLTENO ACB, 1976, S AFR MED J, V50, P1062; Nguyen N, 1996, OPHTHALMOLOGY, V103, P1426, DOI 10.1016/S0161-6420(96)30488-0; SCHOCKET SS, 1985, OPHTHALMOLOGY, V92, P553; SCHOCKET SS, 1982, OPHTHALMOLOGY, V89, P1188; Sherwood Mark Brian, 2006, Trans Am Ophthalmol Soc, V104, P478; Suhr AW, 2012, J GLAUCOMA, V21, P523, DOI 10.1097/IJG.0b013e318227a565; Tezel G, 1997, OPHTHALMIC SURG LAS, V28, P551; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083656; Wells AP, 2003, OPHTHALMOLOGY, V110, P2192, DOI 10.1016/S0161-6420(03)00800-5	35	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196968	10.1371/journal.pone.0196968	http://dx.doi.org/10.1371/journal.pone.0196968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795580	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300018
J	Rojas, JC; Kolomiets, MV; Bernal, JS				Rojas, Julio C.; Kolomiets, Michael V.; Bernal, Julio S.			Nonsensical choices? Fall armyworm moths choose seemingly best or worst hosts for their larvae, but neonate larvae make their own choices	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; SCIRPOPHAGA-INCERTULAS LEPIDOPTERA; CHILO-SUPPRESSALIS LEPIDOPTERA; INTEGRATED PEST-MANAGEMENT; INDUCED PLANT ODORS; CORN-BORER; OVIPOSITION PREFERENCE; POPULATION-DYNAMICS; CUTICULAR LIPIDS; BALSAS TEOSINTE	Selecting optimal host plants is critical for herbivorous insects, such as fall armyworm (Spodoptera frugiperda), an important maize pest in the Americas and Africa. Fall armyworm larvae are presumed to have limited mobility, hence female moths are presumed to be largely responsible for selecting hosts. We addressed host selection by fall armyworm moths and neonate and older (3 rd -instar) larvae, as mediated by resistance and herbivory in maize plants. Thus, we compared discrimination among three maize cultivars with varying degrees of resistance to fall armyworm, and between plants subjected or not to two types of herbivory. The cultivars were: (i) susceptible, and deficient in jasmonic acid (JA) production and green leaf volatiles (GLV) emissions (inbred line B73-lox10); (ii) modestly resistant (B73), and; (iii) highly resistant (Mp708). The herbivory types were: (i) ongoing (= fall armyworm larvae present), and; (ii) future (= fall armyworm eggs present). In choice tests, moths laid more eggs on the highly resistant cultivar, and least on the susceptible cultivar, though on those cultivars larvae performed poorest and best, respectively. In the context of herbivory, moths laid more eggs: (i) on plants subject to versus free of future herbivory, regardless of whether plants were deficient or not in JA and GLV production; (ii) on plants subject versus free of ongoing herbivory, and; (iii) on plants not deficient in compared to deficient in JA and GLV production. Neonate larvae dispersed aerially from host plants (i.e. ballooned), and most larvae colonized the modestly resistant cultivar, and fewest the highly resistant cultivar, suggesting quasi-directional, directed aerial descent. Finally, dispersing older larvae did not discriminate among the three maize cultivars, nor between maize plants and (plastic) model maize plants, suggesting random, visually-oriented dispersal. Our results were used to assemble a model of host selection by fall armyworm moths and larvae, including recommendations for future research.	[Rojas, Julio C.; Bernal, Julio S.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Kolomiets, Michael V.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Rojas, Julio C.] Colegio Frontera Sur, Grp Ecol Artropodos & Manejo Plagas, Dept Agr Soc & Ambiente, Tapachula, Chiapas, Mexico	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; El Colegio de la Frontera Sur (ECOSUR)	Bernal, JS (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	juliobernal@tamu.edu	Rojas, Julio C/A-8798-2013; Bernal, Julio S./N-1290-2013	Rojas, Julio C/0000-0002-5730-5388; Bernal, Julio S./0000-0003-4615-2213	Consejo Nacional de Ciencia y Tecnologia (CONACyT) (Mexico) [231944]; NSF [IOS-0925561]; NSF-DEB [0818240]; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries and the Office of the Vice President for Research	Consejo Nacional de Ciencia y Tecnologia (CONACyT) (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF)); NSF-DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries and the Office of the Vice President for Research	JCR thanks Consejo Nacional de Ciencia y Tecnologia (CONACyT) (Mexico) for sabbatical scholarship support at Texas A&M University (#231944). Development of the lox10 knock-out mutants was supported by NSF grant IOS-0925561 to MVK. Additional, partial support for this research was provided by NSF-DEB (0818240) to JSB. The open access publishing fees for this article were paid by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate T, 2000, ANNU REV ENTOMOL, V45, P631, DOI 10.1146/annurev.ento.45.1.631; ALI A, 1990, ANN ENTOMOL SOC AM, V83, P725, DOI 10.1093/aesa/83.4.725; ALTIERI MA, 1987, HUM ECOL, V15, P189, DOI 10.1007/BF00888380; ANDREWS KL, 1980, FLA ENTOMOL, V63, P456, DOI 10.2307/3494530; Ankala A, 2013, PLANT SCI, V199, P103, DOI 10.1016/j.plantsci.2012.09.017; Bandoly M, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1114198; BARFIELD CS, 1987, FLA ENTOMOL, V70, P110, DOI 10.2307/3495097; Bellota E, 2018, NEOTROP ENTOMOL, V47, P171, DOI 10.1007/s13744-017-0516-0; Bernal JS, 2015, ENTOMOL EXP APPL, V155, P206, DOI 10.1111/eea.12299; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Blanco CA, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14006; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; BUNTIN GD, 1986, FLA ENTOMOL, V69, P549, DOI 10.2307/3495389; CABI-Centre For Agriculture and Biosciences International, 2017, DAT SPOD FRUG FALL A; Capinera J.L., 2000, FALL ARMYWORM SPODOP; Carroll MJ, 2008, J CHEM ECOL, V34, P291, DOI 10.1007/s10886-007-9414-y; Carroll MJ, 2006, J CHEM ECOL, V32, P1911, DOI 10.1007/s10886-006-9117-9; Casmuz Augusto, 2010, Rev. Soc. Entomol. Argent., V69, P209; CHANG NT, 1985, FLA ENTOMOL, V68, P296, DOI 10.2307/3494364; Chapman JW, 1999, BEHAV ECOL, V10, P298, DOI 10.1093/beheco/10.3.298; Chen YG, 2008, ENTOMOL EXP APPL, V126, P244, DOI 10.1111/j.1570-7458.2007.00662.x; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Chuang WP, 2014, MOL PLANT MICROBE IN, V27, P461, DOI 10.1094/MPMI-07-13-0193-R; Coapio GG, 2016, J ECON ENTOMOL, V109, P2364, DOI 10.1093/jee/tow198; Cohen MB, 2000, ENVIRON ENTOMOL, V29, P958, DOI 10.1603/0046-225X-29.5.958; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Craig TP, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P20; De La Rosa-Cancino W, 2016, ENVIRON ENTOMOL, V45, P384, DOI 10.1093/ee/nvv229; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dirie AM, 2000, ENVIRON ENTOMOL, V29, P972, DOI 10.1603/0046-225X-29.5.972; Felton GW, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P19; Penaflor MFGV, 2011, PLANTA, V234, P207, DOI 10.1007/s00425-011-1409-9; GILBERT C, 1994, ANNU REV ENTOMOL, V39, P323, DOI 10.1146/annurev.en.39.010194.001543; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hardke JT, 2015, J INTEGR PEST MANAG, V6, DOI 10.1093/jipm/pmv009; Hassanali A, 2008, PHILOS T R SOC B, V363, P611, DOI 10.1098/rstb.2007.2173; Hilker M, 2015, ANNU REV ENTOMOL, V60, P493, DOI 10.1146/annurev-ento-010814-020620; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; Horikoshi RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34864; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Howe Gregg A., 2008, P7, DOI 10.1007/978-1-4020-8182-8_1; Hrabar H, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00173.1; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Jakka SRK, 2016, APPL ENVIRON MICROB, V82, P1023, DOI 10.1128/AEM.02871-15; KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x; Khan Z, 2016, J CHEM ECOL, V42, P689, DOI 10.1007/s10886-016-0730-y; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037420; Lopez C, 2013, ENTOMOL EXP APPL, V149, P256, DOI 10.1111/eea.12131; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Louis J, 2013, NEW PHYTOL, V199, P66, DOI 10.1111/nph.12308; LUGINBILL P, 1928, USDA TECH B, V34; Luthe DS, 2011, PLANT SIGNAL BEHAV, V6, P126, DOI 10.4161/psb.6.1.14255; Maag D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135722; Meagher RL, 2011, J INSECT BEHAV, V24, P337, DOI 10.1007/s10905-011-9259-7; Midega CAO, 2018, CROP PROT, V105, P10, DOI 10.1016/j.cropro.2017.11.003; MITCHELL ER, 1981, J ENVIRON SCI HEAL A, V16, P387, DOI 10.1080/10934528109374991; Moore RG, 2004, ECOL ENTOMOL, V29, P327, DOI 10.1111/j.0307-6946.2004.00611.x; Morales H., 2000, Agriculture and Human Values, V17, P49, DOI 10.1023/A:1007680726231; Morales H, 2001, AGR ECOSYST ENVIRON, V84, P145, DOI 10.1016/S0167-8809(00)00200-0; MORRILL W L, 1973, Environmental Entomology, V2, P415, DOI 10.1093/ee/2.3.415; MORRILL W L, 1973, Environmental Entomology, V2, P195, DOI 10.1093/ee/2.2.195; Murúa Gabriela, 2004, Acta Zool. Mex, V20, P199; Murua MG, 2008, ANN ENTOMOL SOC AM, V101, P639, DOI 10.1603/0013-8746(2008)101[639:FAMCOS]2.0.CO;2; NG SS, 1990, J ECON ENTOMOL, V83, P1575, DOI 10.1093/jee/83.4.1575; Pannuti LER, 2016, J ECON ENTOMOL, V109, P1125, DOI 10.1093/jee/tow042; Pannuti LER, 2016, ENVIRON ENTOMOL, V45, P192, DOI 10.1093/ee/nvv159; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899; Perovic DJ, 2008, AUST J ENTOMOL, V47, P289, DOI 10.1111/j.1440-6055.2008.00660.x; Petzold-Maxwell JL, 2012, ANN APPL BIOL, V160, P43, DOI 10.1111/j.1744-7348.2011.00515.x; PITRE HN, 1983, J ECON ENTOMOL, V76, P463, DOI 10.1093/jee/76.3.463; Pogue M.G, 2002, WORLD REVISION GENUS, V43, P1; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Prado PIKL, 1999, ECOL ENTOMOL, V24, P80, DOI 10.1046/j.1365-2311.1999.00173.x; Raitanen J, 2014, BEHAV ECOL, V25, P110, DOI 10.1093/beheco/art092; Ramalho FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111588; RAULSTON JR, 1986, FLA ENTOMOL, V69, P455, DOI 10.2307/3495379; Refsnider JM, 2010, ANNU REV ECOL EVOL S, V41, P39, DOI 10.1146/annurev-ecolsys-102209-144712; Rharrabe K, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00005; Robert CAM, 2013, PLANT BIOTECHNOL J, V11, P628, DOI 10.1111/pbi.12053; Roitberg BD, 1999, ENTOMOL EXP APPL, V91, P187, DOI 10.1023/A:1003622703384; Rojas JC, 2003, ENVIRON ENTOMOL, V32, P1386, DOI 10.1603/0046-225X-32.6.1386; SAS Institute Inc, 2016, JMP VERS 13 1 0 1989; Schoonhoven L. M., 2005, Insect-plant biology; Signoretti AGC, 2012, NEOTROP ENTOMOL, V41, P22, DOI 10.1007/s13744-011-0003-y; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Stokstad E, 2017, SCIENCE, V356, P473, DOI 10.1126/science.356.6337.473; Takahashi CG, 2012, ENTOMOL EXP APPL, V145, P191, DOI 10.1111/eea.12004; Tamiru A, 2015, CURR OPIN INSECT SCI, V9, P51, DOI 10.1016/j.cois.2015.02.011; Tamiru A, 2012, J CHEM ECOL, V38, P231, DOI 10.1007/s10886-012-0082-1; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Tellez-Rodriguez P, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-48; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; TRUJILLOARRIAGA J, 1990, AGR ECOSYST ENVIRON, V31, P337, DOI 10.1016/0167-8809(90)90232-3; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010; van Huis A., 1981, MEDEDELINGEN LANDBOUWHOGESCHOOL WAGENINGEN, V81, P1; Varella AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130437; Vickery R.A., 1929, TECHNICAL BULLETIN O, V138, P1; Walla TR, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.10601; Wyckhuys KAG, 2006, CROP PROT, V25, P1180, DOI 10.1016/j.cropro.2006.03.003; Yamazaki K, 2010, OIKOS, V119, P796, DOI 10.1111/j.1600-0706.2009.18300.x; YANG G, 1993, J CHEM ECOL, V19, P2055, DOI 10.1007/BF00983808; YANG G, 1993, FLA ENTOMOL, V76, P302, DOI 10.2307/3495730; YANG G, 1993, ENVIRON ENTOMOL, V22, P547, DOI 10.1093/ee/22.3.547; Yanoviak SP, 2005, NATURE, V433, P624, DOI 10.1038/nature03254; Yanoviak SP, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0534; Yanoviak SP, 2009, BIOL LETTERS, V5, P510, DOI 10.1098/rsbl.2009.0029; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220	115	21	21	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197628	10.1371/journal.pone.0197628	http://dx.doi.org/10.1371/journal.pone.0197628			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795622	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300058
J	Li, D; Musante, V; Zhou, WL; Picciotto, MR; Nairn, AC				Li, Daniel; Musante, Veronica; Zhou, Wenliang; Picciotto, Marina R.; Nairn, Angus C.			Striatin-1 is a B subunit of protein phosphatase PP2A that regulates dendritic arborization and spine development in striatal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING; AXONAL-TRANSPORT; ACTIN; 2A; PHOSPHORYLATION; DYNAMICS; BRAIN; DEPHOSPHORYLATION; MICROTUBULES; PLASTICITY	Striatin-1, a subunit of the serine/threonine phosphatase PP2A, is preferentially expressed in neurons in the striatum. As a member of the striatin family of B subunits, striatin-1 is a core component together with PP2A of a multiprotein complex called STRIPAK, the striatin-interacting phosphatase and kinase complex. Little is known about the function of striatin-1 or the STRIPAK complex in the mammalian striatum. Here, we identify a selective role for striatin-1 in striatal neuron maturation. Using a small hairpin RNA (shRNA) knockdown approach in primary striatal neuronal cultures, we determined that reduced expression of striatin-1 results in increased dendritic complexity and an increased density of dendritic spines, classified as stubby spines. The dendritic phenotype was rescued by co-expression of a striatin-1 mutant construct insensitive to the knockdown shRNA but was not rescued by co-expression of PP2A- or Mob3-binding deficient striatin-1 constructs. Reduction of striatin-1 did not result in deficits in neuronal connectivity in this knockdown model, as we observed no abnormalities in synapse formation or in spontaneous excitatory postsynaptic currents. Thus, this study suggests that striatin-1 is a regulator of neuronal development in striatal neurons.	[Li, Daniel; Musante, Veronica; Zhou, Wenliang; Picciotto, Marina R.; Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Nairn, AC (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06520 USA.	angus.nairn@yale.edu	Picciotto, Marina/F-8747-2012	Picciotto, Marina/0000-0002-4404-1280; Nairn, Angus/0000-0002-7075-0195; Zhou, Wenliang/0000-0001-7792-1201	National Institutes of Health Grant [DA14241]; Yale/National Institutes of Health Neuroproteomics Center from NIDA [DA018343]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044, R37DA014241, R01DA014241, P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale/National Institutes of Health Neuroproteomics Center from NIDA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Becky Carlyle and Rivka Schwarcz for their assistance with experimental procedures, Rashaun Wilson for help in data analysis, and Darren Wilson and Rich Trinko for assistance in virus production. We thank Drs. Sreeganga Chandra, Anthony Koleske, and Paul Lombroso for guidance. We thank Drs. Wang Min, Anne-Claude Gingras, and Paul Greengard for constructs and antibodies. We also thank Dr. Jean Kanyo of the Yale/NIDA Neuroproteomics Center for proteomics analysis. Electrophysiology work was supported by National Institutes of Health Grant DA14241. Proteomics analysis was supported by Yale/National Institutes of Health Neuroproteomics Center Grant DA018343 from NIDA.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Andrade EC, 2017, J NEUROSCI, V37, P2709, DOI 10.1523/JNEUROSCI.4559-15.2017; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Berry KP, 2017, NEURON, V96, P43, DOI 10.1016/j.neuron.2017.08.008; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Chen HW, 2002, MOL CELL BIOL, V22, P1792, DOI 10.1128/MCB.22.6.1792-1803.2002; Chen YK, 2012, MOL BIOL CELL, V23, P4383, DOI 10.1091/mbc.E12-05-0365; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Falk T, 2006, J COMP NEUROL, V494, P275, DOI 10.1002/cne.20819; Fan QW, 2001, J NEUROCHEM, V76, P391, DOI 10.1046/j.1471-4159.2001.00063.x; Farah CA, 2008, CELL MOTIL CYTOSKEL, V65, P515, DOI 10.1002/cm.20284; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hiraga A, 2000, BIOCHEM J, V346, P433, DOI 10.1042/0264-6021:3460433; Hoffman A, 2017, MOL CELL NEUROSCI, V84, P119, DOI 10.1016/j.mcn.2017.01.005; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; Khazaei MR, 2011, J NEUROCHEM, V117, P29, DOI 10.1111/j.1471-4159.2010.06971.x; Kilian P, 2008, ENDOCRINOLOGY, V149, P2923, DOI 10.1210/en.2007-0313; Lin LF, 2017, J BIOL CHEM, V292, P9451, DOI 10.1074/jbc.M116.772442; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Musante V, 2017, ELIFE, V6, DOI 10.7554/eLife.24998; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Nishi A, 2017, J BIOL CHEM, V292, P1462, DOI 10.1074/jbc.M116.752402; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Penrod RD, 2011, J NEUROSCI METH, V200, P1, DOI 10.1016/j.jneumeth.2011.05.029; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; SAITO T, 1995, BIOCHEMISTRY-US, V34, P7376, DOI 10.1021/bi00022a010; Sakuma C, 2016, CELL REP, V16, P2289, DOI 10.1016/j.celrep.2016.07.066; Sakuma C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17769; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schulte J, 2010, J NEUROSCI, V30, P5189, DOI 10.1523/JNEUROSCI.5823-09.2010; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Xiang QJ, 2002, GENETICS, V160, P169; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	61	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11179	11194		10.1074/jbc.RA117.001519	http://dx.doi.org/10.1074/jbc.RA117.001519			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802198	Green Published, hybrid			2022-12-26	WOS:000438882800029
J	Castillo, A; Grogan, TR; Wegrzyn, GH; Ly, KV; Walker, VP; Calkins, KL				Castillo, Adrian; Grogan, Tristan R.; Wegrzyn, Grace H.; Ly, Karrie, V; Walker, Valencia P.; Calkins, Kara L.			Umbilical cord blood bilirubins, gestational age, and maternal race predict neonatal hyperbilirubinemia	PLOS ONE			English	Article							DISCHARGE; JAUNDICE; NEWBORN	Objective No validated biomarker at birth exists to predict which newborns will develop severe hyperbilirubinemia. This study's primary aim was to build and validate a prediction model for severe hyperbilirubinemia using umbilical cord blood bilirubins (CBB) and risk factors at birth in neonates at risk for maternalfetal blood group incompatibility. This study's secondary aim was to compare the accuracy of CBB to the direct antigen titer. Methods Inclusion criteria for this prospective cohort study included: >= 35 weeks gestational age, mother with blood type O and/or Rh negative or positive antibody screen, and <24 hours of age. The primary outcome was severe hyperbilirubinemia, defined as phototherapy during the initial hospital stay. Secondary outcomes were a total serum bilirubin concentration > 95 th and > 75 th percentile during the initial hospital stay. The predictive performance and accuracy of the two tests (CBB and direct antigen titer) for each outcome was assessed using area under a receiveroperating characteristic curve (AUC), sensitivity, and specificity. Results When compared to neonates who did not receive phototherapy (n = 463), neonates who received phototherapy (n = 36) had a greater mean CBB +/- standard deviation (2.5 +/- 0.7 vs. 1.6 +/- 0.4 mg/dL, p< 0.001). For every 0.3 mg/dL increase in CBB, a neonate was 3.20 (95% confidence interval, 2.31 +/- 4.45), 2.10 (1.63 +/- 2.70), and 3.12 (2.44 +/- 3.99) times more likely to receive phototherapy or have a total serum bilirubin concentration > 95 th and > 75 th percentile, respectively. The AUC +/- standard error (95% confidence interval) for CBB for phototherapyand a total serum bilirubin concentration > 95 th and > 75 th percentile was 0.89 +/- 0.03 (0.82-0.95), 0.81 +/- 0.04 (0.73-0.90), and 0.84 +/- 0.02 (0.80-0.89), respectively. However, the AUC for gestational age and maternal Asian race for these outcomes was only 0.55 +/- 0.05 (0.45-0.66),0.66 +/- 0.05 (0.56-0.76), and 0.57 +/- 0.04 (0.0-0.64), respectively. When the CBB was combined with gestational age and maternal Asian race, the AUC for a total serum bilirubin concentration > 95 th percentile improved to 0.87 +/- 0.03 (0.81-0.92) (p = 0.034 vs. the model with CBB only and p< 0.001 vs. the model with clinical risk factors only). In a sub-group of subjects (n = 189), the AUC for the direct antigen titer for phototherapy was 0.64 +/- 0.06 (0.52-0.77) with a 52% sensitivity and 77% specificity. In contrast, a CBB cut-point of 1.85 mg/dL was 92% sensitive and 70% specific for phototherapy with an AUC of 0.87 +/- 0.04 (0.80-0.95). Conclusion CBB, in combination with gestational age and maternal race, may be a useful, non-invasive test to predict shortly after birth which neonates will develop severe hyperbilirubinemia.	[Castillo, Adrian] Stanford Univ, Med Ctr, Dept Med, Palo Alto, CA 94304 USA; [Castillo, Adrian] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Grogan, Tristan R.] Univ Calif Los Angeles, Dept Med, Stat Core, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wegrzyn, Grace H.] Loyola Univ, Stritch Sch Med, Chicago, IL 60611 USA; [Wegrzyn, Grace H.; Ly, Karrie, V; Walker, Valencia P.; Calkins, Kara L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, Dept Pediat,UCLA Mattel Childrens Hosp, Los Angeles, CA 90095 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Loyola University Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Calkins, KL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, Dept Pediat,UCLA Mattel Childrens Hosp, Los Angeles, CA 90095 USA.	Kcalkins@mednet.ucla.edu		Calkins, Kara/0000-0001-6658-7981	Gerber Foundation [3881]	Gerber Foundation	KLC received funding from the Gerber Foundation (http://www.gerberfoundation.org/) grant number 3881. The funder did not have any any role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bernaldo Adélia Jeha Nasser, 2004, Sao Paulo Med. J., V122, P99, DOI 10.1590/S1516-31802004000300005; BERNSTEIN RB, 1969, J CLIN INVEST, V48, P1678, DOI 10.1172/JCI106133; Bhutani VK, 2016, J PERINATOL, V36, P853, DOI 10.1038/jp.2016.106; Bhutani VK, 2009, J PERINATOL, V29, pS5, DOI 10.1038/jp.2008.210; Bhutani VK, 2013, J PEDIATR-US, V162, P477, DOI 10.1016/j.jpeds.2012.08.022; BROUWERS HAA, 1988, LANCET, V2, P641; Calkins K, 2015, J Neonatal Perinatal Med, V8, P243, DOI 10.3233/NPM-15814111; Darling EK, 2014, PEDIATRICS, V134, pE1017, DOI 10.1542/peds.2014-1146; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinesh D, 2005, J PAEDIATR CHILD H, V41, P504, DOI 10.1111/j.1440-1754.2005.00692.x; Farhat R, 2011, N AM J MED SCI, V3, P146, DOI 10.4297/najms.2011.3146; IBM Corp, IBM SPSS STAT WIND V; Ipek IO, 2012, J MATERN-FETAL NEO M, V25, P1375, DOI 10.3109/14767058.2011.636089; KNUDSEN A, 1989, ACTA PAEDIATR SCAND, V78, P217, DOI 10.1111/j.1651-2227.1989.tb11059.x; Knupfer M, 2005, ACTA PAEDIATR, V94, P581, DOI 10.1080/08035250410023881; Lee HC, 2014, PEDIATR EMERG CARE, V30, P315, DOI 10.1097/PEC.0000000000000120; Mah MP, 2010, PEDIATRICS, V125, pE1143, DOI 10.1542/peds.2009-1412; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maruo Y, 2014, J PEDIATR-US, V165, P36, DOI 10.1016/j.jpeds.2014.01.060; Peeters B, 2016, EUR J PEDIATR, V175, P651, DOI 10.1007/s00431-016-2690-1; RISEMBERG HM, 1977, ARCH DIS CHILD, V52, P219, DOI 10.1136/adc.52.3.219; ROSENFELD J, 1986, J FAM PRACTICE, V23, P556; Shahid R, 2012, J PERINATOL, V32, P966, DOI 10.1038/jp.2012.26; Wu XJ, 2015, PEDIATR RES, V78, P585, DOI 10.1038/pr.2015.134; Yaseen Hakam, 2005, J Perinatol, V25, P590, DOI 10.1038/sj.jp.7211356	26	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197888	10.1371/journal.pone.0197888	http://dx.doi.org/10.1371/journal.pone.0197888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856776	Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800047
J	Fan, YF; Chen, JX; Cheng, YJ; Raza, MA; Wu, XL; Wan, ZL; Liu, QL; Wang, R; Wan, XC; Yong, TW; Liu, WG; Liu, J; Du, JB; Shu, K; Yang, WY; Yang, F				Fan, Yuanfang; Chen, Junxu; Cheng, Yajiao; Raza, Muhammad Ali; Wu, Xiaoling; Wan, Zhonglin; Liu, Qinlin; Wang, Rui; Wan, Xiaochun; Yong, Taiwen; Liu, Weiguo; Liu, Jiang; Du, Junbo; Shu, Kai; Yang, Wenyu; Yang, Feng			Effect of shading and light recovery on the growth, leaf structure, and photosynthetic performance of soybean in a maize-soybean relay-strip intercropping system	PLOS ONE			English	Article							SEEDLINGS; YIELD; TOLERANCE; RESPONSES; PATTERNS	Intercropping is an important agronomic practice adopted to increase crop production and resource efficiency in areas with intensive agricultural production. Two sequential field trials were conducted in 2015 +/- 2016 to investigate the effect of shading on the morphological features, leaf structure, and photosynthetic characteristics of soybean in a maize-soybean relay-strip intercropping system. Three treatments were designed on the basis of different row configurations A1 ("50 cm + 50 cm" one row of maize and one row of soybean with a 50 cm spacing between the rows), A2 ("160 cm + 40 cm" two rows of maize by wide-narrow row planting, where two rows of soybean were planted in the wide rows with a width of 40 cm, and with 60 cm row spacing was used between the maize and soybean rows), and CK (sole cropping of soybean, with 70 cm rows spacing). Results showed that the photosynthetically active radiation transmittances of soybean canopy at V5 stage under A2 treatment (31.1%) were considerably higher than those under A1 (8.7%) treatment, and the red-to-far-red ratio was reduced significantly under A1 (0.7) and A2 (1.0) treatments compared with those under CK (1.2). By contrast with CK, stem diameter, total aboveground biomass, chlorophyll content and net photosynthetic rate decreased significantly except plant height under A1 and A2. The thickness of palisade tissue and spongy tissue of soybean leaf under A1 and A2 were significantly reduced at V5 stage compared with CK. The leaf thicknesses under A1 and A2 were lower than those in CK by 39.5% and 18.2%, respectively. At the R1 stage of soybean (after maize harvest), the soybean plant height, stem biomass, leaf biomass and petiole biomass under A1 and A2 treatments were still significantly lower than those under CK, but no significant differences were observed in Chl a/b, P-n, epidermis thickness and spongy tissue thickness of soybean leaves in A2 compared with CK. In addition, the soybean yields (g plant(-1)) under A1 and A2 were 54.69% and 16.83% lower than those in CK, respectively. These findings suggested that soybean plants can regulate its morphological characteristics and leaf anatomical structures under different light environments.	[Fan, Yuanfang; Chen, Junxu; Cheng, Yajiao; Raza, Muhammad Ali; Wu, Xiaoling; Wan, Zhonglin; Liu, Qinlin; Wang, Rui; Wan, Xiaochun; Yong, Taiwen; Liu, Weiguo; Liu, Jiang; Du, Junbo; Shu, Kai; Yang, Wenyu; Yang, Feng] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Fan, Yuanfang; Chen, Junxu; Cheng, Yajiao; Raza, Muhammad Ali; Wu, Xiaoling; Wan, Zhonglin; Liu, Qinlin; Wang, Rui; Wan, Xiaochun; Yong, Taiwen; Liu, Weiguo; Liu, Jiang; Du, Junbo; Shu, Kai; Yang, Wenyu; Yang, Feng] Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Sichuan, Peoples R China; [Fan, Yuanfang; Yang, Wenyu; Yang, Feng] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs	Yang, WY; Yang, F (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.; Yang, WY; Yang, F (corresponding author), Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Sichuan, Peoples R China.; Yang, WY; Yang, F (corresponding author), Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Sichuan, Peoples R China.	mssiyangwy@sicau.edu.cn; f.yang@sicau.edu.cn	Wang, Zhonglin/ADF-8684-2022; Cheng, Yajiao/AHA-7227-2022; Raza, Muhammad Ali/R-8597-2019; Wang, Zhonglin/GVT-8943-2022	Raza, Muhammad Ali/0000-0003-3817-6848; Wang, Zhonglin/0000-0001-6355-9651	National Nature Science Foundation [31601328, 31571615]; National Key Research and Development Program of China [2016YFD0300602, 2016YFD0300209]; Program on Industrial Technology System of National Soybean [CARS-04-P519]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Program on Industrial Technology System of National Soybean	The research was supported by the National Nature Science Foundation (grant number 31601328, 31571615) to FY and X. Wu, the National Key Research and Development Program of China (grant numbers 2016YFD0300602, 2016YFD0300209) to WY, and Program on Industrial Technology System of National Soybean (grant number CARS-04-P519) to WY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MK, 2004, PLANT SOIL, V266, P273; Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; Chen Y, 2011, J ANHUI AGR SCI, V6, P3726; Contin DR, 2014, TREES-STRUCT FUNCT, V28, P1705, DOI 10.1007/s00468-014-1079-x; Cui Liang, 2015, Yingyong Shengtai Xuebao, V26, P2414; Deng YM, 2012, PLANT PHYSIOL BIOCH, V55, P93, DOI 10.1016/j.plaphy.2012.03.006; [杜宁 Du Ning], 2011, [生态学报, Acta Ecologica Sinica], V31, P6049; Gao R, 2015, SCIENCE, P34; Giller KE, 2011, FIELD CROP RES, V124, P468, DOI 10.1016/j.fcr.2011.04.010; Gong WZ, 2015, PHOTOSYNTHETICA, V53, P259, DOI 10.1007/s11099-015-0103-8; Gou F, 2017, FIELD CROP RES, V200, P122, DOI 10.1016/j.fcr.2016.09.015; Huang CD, 2017, FIELD CROP RES, V201, P41, DOI 10.1016/j.fcr.2016.10.021; Jiang CD, 2011, PLANT PHYSIOL, V155, P1416, DOI 10.1104/pp.111.172213; Kalve S, 2014, J EXP BOT, V65, P6385, DOI 10.1093/jxb/eru358; Kermah M, 2017, FIELD CROP RES, V213, P38, DOI 10.1016/j.fcr.2017.07.008; Li Rui, 2014, Acta Prataculturae Sinica, V23, P198; Li T, 2014, J PHOTOCH PHOTOBIO B, V137, P31, DOI 10.1016/j.jphotobiol.2014.04.022; Liang ZhenLin, 2000, Soybean Science, V19, P35; Liu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169218; Oguchi R, 2003, PLANT CELL ENVIRON, V26, P505, DOI 10.1046/j.1365-3040.2003.00981.x; Pierik R, 2014, PLANT PHYSIOL, V166, P5, DOI 10.1104/pp.114.239160; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rahman T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178332; RAO MR, 1980, EXP AGR, V16, P105, DOI 10.1017/S0014479700010796; Rodriguez N., 2011, THESIS; Sarrantonio M., 2003, Journal of Crop Production, V8, P53, DOI 10.1300/J144v08n01_04; Shi XD, 2006, J ANHUI AGR SCI; Su BY, 2014, PHOTOSYNTHETICA, V52, P332, DOI 10.1007/s11099-014-0036-7; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; Wan P, 2016, J SW U; [王锐 Wang Rui], 2015, [核农学报, Journal of Nuclear Agricultural Sciences], V29, P1182; Wang Yi, 2013, Acta Agronomica Sinica, V39, P1871, DOI 10.3724/SP.J.1006.2013.01871; Wang Zhu, 2007, Acta Agronomica Sinica, V33, P1502; Wittmann C, 2001, BASIC APPL ECOL, V2, P145, DOI 10.1078/1439-1791-00047; [吴其林 WU Qilin], 2007, [大豆科学, Soybean Science], V26, P868; [吴涛 Wu Tao], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P1586; Wu YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10026-5; Wu YS, 2016, PLANT PROD SCI, V19, P206, DOI 10.1080/1343943X.2015.1128095; Yang F, 2015, AGRON J, V107, P296, DOI 10.2134/agronj14.0263; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; Yao Y, 2007, SCI AGR SINICA, DOI [10.1104/PP.111.172213, DOI 10.1104/PP.111.172213]	41	68	73	15	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198159	10.1371/journal.pone.0198159	http://dx.doi.org/10.1371/journal.pone.0198159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851989	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200037
J	Kahramanoglu, I; Aktas, M; Gunduz, S				Kahramanoglu, Ibrahim; Aktas, Mehmet; Gunduz, Serife			Effects of fludioxonil, propolis and black seed oil application on the postharvest quality of "Wonderful" pomegranate	PLOS ONE			English	Article							PUNICA-GRANATUM L.; VITAMIN-C; ANTIOXIDANT ACTIVITY; STORAGE-TEMPERATURE; FRUIT; LIFE	Pomegranate fruit consumption has increased rapidly throughout the world, mainly because of its medical and nutritive attributes. Thus, considerable commercial and scientific interest exists in prolonging its postharvest life with non-chemical applications as much as possible to meet the year-round demand for this fruit. The present work aimed to study the effects of black seed oil (0.1% and 0.5%), propolis (0.01% and 0.1%) and fludioxonil (0.06%), with and without modified atmosphere packaging (MAP), on the postharvest quality of pomegranate cv. Wonderful. Treated fruits were stored at 6.5 +/- 1 degrees C and 90 +/- 95% relative humidity for 150 days. The results indicated that both black seed oil and propolis treatments significantly influenced the maintenance of fruit weight and quality. At 150 days after storage, the fruit weight loss of the samples treated with MAP + 0.5% black seed oil, MAP + 0.1% propolis and MAP alone were found to be 5.5%, 6.3%, and 9.1%, respectively, whereas the weight loss of the untreated control fruits was 19.8%. Application of either 0.5% black seed oil or 0.1% propolis, especially when combined with MAP, was also effective in controlling gray mold development and slowing the occurrence of chilling injury.	[Kahramanoglu, Ibrahim; Aktas, Mehmet] European Univ Lefke, Fac Agr Sci & Technol, Dept Hort Prod & Mkt, Via Mersin, Lefke, Northern Cyprus, Turkey; [Gunduz, Serife] Near East Univ, Inst Educ, Via Mersin, Lefkosa, Northern Cyprus, Turkey; [Kahramanoglu, Ibrahim] Alnar Narcilik Ltd, Via Mersin, Guzelyurt, Cyprus, Turkey	Lefke Avrupa University; Near East University	Kahramanoglu, I (corresponding author), European Univ Lefke, Fac Agr Sci & Technol, Dept Hort Prod & Mkt, Via Mersin, Lefke, Northern Cyprus, Turkey.; Kahramanoglu, I (corresponding author), Alnar Narcilik Ltd, Via Mersin, Guzelyurt, Cyprus, Turkey.	ibrahimcy84@yahoo.com	Kahramanoglu, Ibrahim/A-8628-2014	Kahramanoglu, Ibrahim/0000-0002-6074-6395				Abd-Elghany N. A., 2012, J HORT SCI ORNAMENT, V4, P07; Al-Mughrabi M.A., 1995, J KING SAUDI U, V7, P239, DOI [110.1016/j.indcrop.2013.03.028, DOI 10.1016/J.INDCROP.2013.03.028]; Ali A, 2014, INT J AGRIC BIOL, V16, P1117; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Arendse E, 2014, CYTA-J FOOD, V12, P389, DOI 10.1080/19476337.2014.900114; Artes F, 1998, Z LEBENSM UNTERS F A, V207, P316, DOI 10.1007/s002170050339; Artes F, 2000, J FOOD SCI, V65, P1112, DOI 10.1111/j.1365-2621.2000.tb10248.x; Silva IMBR, 2015, SEMIN-CIENC AGRAR, V36, P2555, DOI 10.5433/1679-0359.2015v36n4p2555; Caleb OJ, 2012, FOOD BIOPROCESS TECH, V5, P15, DOI 10.1007/s11947-011-0525-7; CBI, CBI PROD FACT SHEET; Coleman MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042768; El- Badawy H. E., 2012, RES J AGR BIOL SCI, V8, P420; ELYATEM SM, 1984, SCI HORTIC-AMSTERDAM, V24, P287, DOI 10.1016/0304-4238(84)90113-4; Fawole OA, 2013, IND CROP PROD, V47, P300, DOI 10.1016/j.indcrop.2013.03.028; Fawole OA, 2012, BRIT FOOD J, V114, P1518, DOI 10.1108/00070701211273009; Fischer UA, 2011, FOOD CHEM, V127, P807, DOI 10.1016/j.foodchem.2010.12.156; FULEKI T, 1968, J FOOD SCI, V33, P78, DOI 10.1111/j.1365-2621.1968.tb00888.x; Gil G. I., 1996, J EUROPEAN FOOD RES, V202, P481, DOI DOI 10.1007/BF01197269; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Jurenka J, 2008, ALTERN MED REV, V13, P128; Kader A. A., 1984, CALIF AGR, V38, P4; Kader AA, 1995, ACTA HORTIC, P59, DOI 10.17660/ActaHortic.1995.398.6; Kahramanoglu I., 2006, POMEGRANATE PRODUCTI; Klimczak I, 2007, J FOOD COMPOS ANAL, V20, P313, DOI 10.1016/j.jfca.2006.02.012; Krell R., 1996, FAO AGR SERVICES B N, V124; Kulkarni AP, 2005, FOOD CHEM, V93, P319, DOI 10.1016/j.foodchem.2004.09.029; Lee HS, 1999, FOOD CHEM, V65, P165, DOI 10.1016/S0308-8146(98)00180-0; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Maclean D, 2011, 997 U GEORG COOP; Miguel GA, 2004, J BIOMED BIOTECHNOL, P338, DOI 10.1155/S1110724304403076; Miguel MG, 2010, J MED PLANTS RES, V4, P2836; Nanda S, 2001, POSTHARVEST BIOL TEC, V22, P61, DOI 10.1016/S0925-5214(00)00181-2; Nerya O, 2006, ACTA HORTIC, P655, DOI 10.17660/ActaHortic.2006.712.81; Ozdemir AE, 2010, TURK J AGRIC FOR, V34, P155, DOI 10.3906/tar-0902-50; Palou L, 2007, POSTHARVEST BIOL TEC, V43, P133, DOI 10.1016/j.postharvbio.2006.08.013; Selcuk N, 2016, TURK J AGRIC FOR, V40, P475, DOI 10.3906/tar-1509-57; Sridevi P, 2017, INT J CURRENT MICROB, V6, P1778, DOI [10.20546/ijcmas.2017.612.201, DOI 10.20546/IJCMAS.2017.612.201]; Tedford E.C., 2005, IMPACT SCHOLAR NEW P; Viuda-Martos M, 2010, COMPR REV FOOD SCI F, V9, P635, DOI 10.1111/j.1541-4337.2010.00131.x; Zarei M, 2011, FRUITS, V66, P121, DOI 10.1051/fruits/2011021	40	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198411	10.1371/journal.pone.0198411	http://dx.doi.org/10.1371/journal.pone.0198411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852011	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200054
J	Martinez-Eixarch, M; Alcaraz, C; Vinas, M; Noguerol, J; Aranda, X; Prenafeta-Boldu, FX; Saldana-De la Vega, JA; Catala, MD; Ibanez, C				Martinez-Eixarch, Maite; Alcaraz, Carles; Vinas, Marc; Noguerol, Joan; Aranda, Xavier; Xavier Prenafeta-Boldu, Francesc; Antonio Saldana-De la Vega, Jesus; del Mar Catala, Maria; Ibanez, Carles			Neglecting the fallow season can significantly underestimate annual methane emissions in Mediterranean rice fields	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; AIR CO2 ENRICHMENT; CH4 EMISSIONS; FLOODED RICE; CALIFORNIA RICE; NITROUS-OXIDE; PADDY FIELD; PHOTOSYNTHETIC CHARACTERISTICS; STRAW INCORPORATION; SOIL-TEMPERATURE	Paddy rice fields are one of the most important sources of anthropogenic methane. Improving the accuracy in the CH4 budget is fundamental to identify strategies to mitigate climate change. Such improvement requires a mechanistic understanding of the complex interactions between environmental and agronomic factors determining CH4 emissions, and also the characterization of the annual temporal CH4 emissions pattern in the whole crop cycle. Hence, both the growing and fallow seasons must be included. However, most of the previous research has been based on single-factor analyses that are focused on the growing season. In order to fill this gap, a study was conducted in a Mediterranean rice agrosystem (Ebre Delta, Catalonia) following a farm-to-farm approach with the purpose of 1) evaluating the cumulative and temporal pattern of CH4 emission, and 2) conducting a multi-variate analyses to assess the associative pattern, relative contribution and temporal variation of the main explanatory variables concerning the observed CH4 emissions. Measurements of CH4 emissions and agronomic and environmental parameters in 15 commercial rice fields were monitored monthly, during a whole crop field cycle. The temporal pattern of CH4 emission followed a bi-modal distribution peaking in August and October. The cumulative annual CH4 emissions from rice fields amounted 314 kg CH4 kg ha(-1), of which ca. 70% were emitted during the fallow season. The main controlling factors of the CH4 emission rate in the growing season were positive related to water level and plant cover, while soil redox was negatively related. The main controlling factors in the fallow season were water level (negatively related, conversely to the growing season), as well as straw incorporation and soil temperature (positively related). The results of this study highlight the importance of the often neglected fallow season in the accurate estimation of CH4 emissions and, thus, the necessity of measurement programs that cover the whole crop field cycle. This information is the first step for setting effective mitigation strategies based on straw and water management.	[Martinez-Eixarch, Maite; Alcaraz, Carles; Antonio Saldana-De la Vega, Jesus; Ibanez, Carles] IRTA Inst Agrifood Res & Technol, Aquat Ecosyst, San Carlos de la Rapita, Spain; [Vinas, Marc; Noguerol, Joan] IRTA Inst Agrifood Res & Technol, GIRO, Torre Marimon, Caldes De Montb, Spain; [Aranda, Xavier; Xavier Prenafeta-Boldu, Francesc] IRTA Inst Agrifood Res & Technol, Fruticulture, Torre Marimon, Caldes De Montb, Spain; [del Mar Catala, Maria] IRTA Inst Agrifood Res & Technol, Extens Crops, Amposta, Spain	IRTA; IRTA; IRTA; IRTA	Martinez-Eixarch, M (corresponding author), IRTA Inst Agrifood Res & Technol, Aquat Ecosyst, San Carlos de la Rapita, Spain.	teresa.martinezeixarch@irta.cat	Ibanez, Carles/D-2777-2009; Prenafeta-Boldú, Francesc Xavier/B-5295-2014; Martí, Carles Ibáñez/AAV-6637-2021; Martinez-Eixarch, Maite/AAY-9399-2020; Aranda, Xavier/A-6529-2013; Alcaraz, Carles/D-1930-2009; Martinez-Eixarch, Maite/A-9813-2011; Viñas, Marc/A-2502-2014; catala, maria del mar/M-5091-2018	Ibanez, Carles/0000-0002-7091-5527; Prenafeta-Boldú, Francesc Xavier/0000-0001-9514-7029; Martinez-Eixarch, Maite/0000-0002-7352-8522; Aranda, Xavier/0000-0001-5335-613X; Alcaraz, Carles/0000-0002-2147-4796; Martinez-Eixarch, Maite/0000-0002-7352-8522; Viñas, Marc/0000-0002-4124-3602; catala, maria del mar/0000-0002-1026-7097	European Union Life + Environmental Policy and Governance [Life13 ENV/ES/001182]; CERCA Programme / Generalitat de Catalunya	European Union Life + Environmental Policy and Governance; CERCA Programme / Generalitat de Catalunya	This work was supported by the European Union Life + Environmental Policy and Governance; project entitled "Pilot project for adaptation and mitigation measures for Climate Change in Ebre Delta" (Life13 ENV/ES/001182). The support of the CERCA Programme / Generalitat de Catalunya is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto MCR, 2015, FIELD CROP RES, V184, P162, DOI 10.1016/j.fcr.2015.10.004; Altor AE, 2008, WETLANDS, V28, P423, DOI 10.1672/07-98.1; Banger K, 2012, GLOBAL CHANGE BIOL, V18, P3259, DOI 10.1111/j.1365-2486.2012.02762.x; Bhattacharyya P, 2014, AGR ECOSYST ENVIRON, V189, P127, DOI 10.1016/j.agee.2014.03.013; Bhattacharyya P, 2012, SOIL TILL RES, V124, P119, DOI 10.1016/j.still.2012.05.015; Brye KR, 2016, GEODERMA REG, V7, P223, DOI 10.1016/j.geodrs.2016.04.005; Brye KR, 2013, SOIL SCI, V178, P519, DOI 10.1097/SS.0000000000000020; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chaudhary S, 2017, SOIL TILL RES, V166, P59, DOI 10.1016/j.still.2016.10.005; CICERONE RJ, 1983, J GEOPHYS RES-OCEANS, V88, P1022, DOI 10.1029/JC088iC15p11022; Conen F, 2000, EUR J SOIL SCI, V51, P111, DOI 10.1046/j.1365-2389.2000.00292.x; Das K, 2008, ACTA PHYSIOL PLANT, V30, P569, DOI 10.1007/s11738-008-0156-4; Davidson EA, 2002, AGR FOREST METEOROL, V113, P21, DOI 10.1016/S0168-1923(02)00100-4; Devevre OC, 2000, SOIL BIOL BIOCHEM, V32, P1773, DOI 10.1016/S0038-0717(00)00096-1; Eggleston H.S., 2006, 2019 REF 2006 IPCC G; Figueiredo N, 2015, PADDY WATER ENVIRON, V13, P313, DOI 10.1007/s10333-014-0447-x; Fitzgerald GJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P767, DOI 10.1029/2000GB001259; Guo GJ, 2013, J PHYS CHEM B, V117, P6498, DOI 10.1021/jp3117215; Hatala JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051303; HOLZAPFELPSCHORN A, 1986, J GEOPHYS RES-ATMOS, V91, P1803, DOI 10.1029/JD091iD11p11803; Hou PF, 2013, J ENVIRON SCI, V25, P1874, DOI 10.1016/S1001-0742(12)60273-3; Ji XH, 2012, J SCI FOOD AGR, V92, P1038, DOI 10.1002/jsfa.5550; Kataki S, 2017, J ENVIRON MANAGE, V196, P201, DOI 10.1016/j.jenvman.2017.02.058; Katayanagi N, 2016, SCI TOTAL ENVIRON, V547, P429, DOI 10.1016/j.scitotenv.2015.12.149; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Knox SH, 2016, J GEOPHYS RES-BIOGEO, V121, P978, DOI 10.1002/2015JG003247; Kraehmer H, 2017, RICE PRODUCTION WORL, P93, DOI 10.1007/978-3-319-47516-5_4; Kudo Y, 2014, AGR ECOSYST ENVIRON, V186, P77, DOI 10.1016/j.agee.2014.01.015; Kutzbach L, 2007, BIOGEOSCIENCES, V4, P1005, DOI 10.5194/bg-4-1005-2007; Lagomarsino A, 2016, PEDOSPHERE, V26, P533, DOI 10.1016/S1002-0160(15)60063-7; LeMer J, 1996, EUR J SOIL BIOL, V32, P71; Li XM, 2016, SOIL BIOL BIOCHEM, V94, P70, DOI 10.1016/j.soilbio.2015.11.013; Linquist BA, 2015, GLOBAL CHANGE BIOL, V21, P407, DOI 10.1111/gcb.12701; Liu C, 2014, GLOBAL CHANGE BIOL, V20, P1366, DOI 10.1111/gcb.12517; Livingston G., 1995, BIOGENIC TRACE GASES, P14; Lu YH, 2002, BIOL FERT SOILS, V36, P136, DOI 10.1007/s00374-002-0504-2; Ma J, 2008, SOIL SCI PLANT NUTR, V54, P638, DOI 10.1111/j.1747-0765.2008.00278.x; Maggini R, 2006, J BIOGEOGR, V33, P1729, DOI 10.1111/j.1365-2699.2006.01465.x; Meijide A, 2017, AGR ECOSYST ENVIRON, V238, P168, DOI 10.1016/j.agee.2016.08.017; Meijide A, 2011, BIOGEOSCIENCES, V8, P3809, DOI 10.5194/bg-8-3809-2011; Minamikawa K., 2012, GREENHOUSE GAS MEAS, V2, P118, DOI DOI 10.1080/20430779.2012.729988; Minamikawa K, 2007, SOIL SCI PLANT NUTR, V53, P657, DOI 10.1111/j.1747-0765.2007.00172.x; Mishra S, 1997, BIOL FERT SOILS, V24, P399, DOI 10.1007/s003740050264; Mussoline W, 2013, BIORESOURCE TECHNOL, V148, P135, DOI 10.1016/j.biortech.2013.08.107; Neue H. U., 1994, CLIMATE BIOSPHERE IN, P65; Neue HU, 1996, ATMOS ENVIRON, V30, P1751, DOI 10.1016/1352-2310(95)00375-4; Nguyen DH, 2016, BIOL FERT SOILS, V52, P261, DOI 10.1007/s00374-015-1074-4; Parkin T., 2010, GRACENET SAMPLING PR, V3, P1, DOI DOI 10.2134/JEQ2009.0231; Pathak H, 2006, PADDY WATER ENVIRON, V4, P111, DOI 10.1007/s10333-006-0038-6; Pedersen AR, 2010, EUR J SOIL SCI, V61, P888, DOI 10.1111/j.1365-2389.2010.01291.x; Pereira J, 2013, ATMOS ENVIRON, V80, P464, DOI 10.1016/j.atmosenv.2013.08.045; Peyron M, 2016, AGR ECOSYST ENVIRON, V232, P17, DOI 10.1016/j.agee.2016.07.021; Pihlatie MK, 2013, AGR FOREST METEOROL, V171, P124, DOI 10.1016/j.agrformet.2012.11.008; Pittelkow CM, 2014, AGRON J, V106, P968, DOI 10.2134/agronj13.0491; Pittelkow CM, 2014, GLOBAL CHANGE BIOL, V20, P1382, DOI 10.1111/gcb.12413; Pittelkow CM, 2013, AGR ECOSYST ENVIRON, V177, P10, DOI 10.1016/j.agee.2013.05.011; Ponnamperuma F. N., 1972, Advances in Agronomy, V24, P29, DOI 10.1016/S0065-2113(08)60633-1; Sahrawat KL, 2005, CURR SCI INDIA, V88, P735; Sanchis E., 2012, ENVIRON ENG SCI, V29, P12; Sander BO, 2014, GEODERMA, V235, P355, DOI 10.1016/j.geoderma.2014.07.020; SASS RL, 1994, GLOBAL BIOGEOCHEM CY, V8, P135, DOI 10.1029/94GB00588; Saunois M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/120207; SCHUTZ H, 1990, BIOGEOCHEMISTRY, V11, P77; SCHUTZ H, 1989, BIOGEOCHEMISTRY, V7, P33, DOI 10.1007/BF00000896; SEILER W, 1984, J ATMOS CHEM, V1, P241; Suryavanshi P, 2013, PADDY WATER ENVIRON, V11, P321, DOI 10.1007/s10333-012-0323-5; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tokida T, 2010, BIOGEOSCIENCES, V7, P2639, DOI 10.5194/bg-7-2639-2010; Tokida T, 2011, GLOBAL CHANGE BIOL, V17, P3327, DOI 10.1111/j.1365-2486.2011.02475.x; TYLER SC, 1994, GLOBAL BIOGEOCHEM CY, V8, P1, DOI 10.1029/93GB03123; van Bodegom P, 2001, APPL ENVIRON MICROB, V67, P3586, DOI 10.1128/AEM.67.8.3586-3597.2001; van Bodegom PM, 2000, NUTR CYCL AGROECOSYS, V58, P231, DOI 10.1023/A:1009854905333; van der Gon HACD, 2002, P NATL ACAD SCI USA, V99, P12021, DOI 10.1073/pnas.192276599; vanderGon HAC, 1996, GLOBAL BIOGEOCHEM CY, V10, P1, DOI 10.1029/95GB03460; Vizza C, 2017, BIOGEOSCIENCES, V14, P431, DOI 10.5194/bg-14-431-2017; Wang MX, 2002, NUTR CYCL AGROECOSYS, V64, P43, DOI 10.1023/A:1021183706235; Wang WQ, 2015, FIELD CROP RES, V181, P42, DOI 10.1016/j.fcr.2015.07.007; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382, DOI 10.2136/sssaj1993.03615995005700020016x; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wu YP, 2015, SOIL RES, V53, P298, DOI 10.1071/SR14261; Xie BH, 2010, PLANT SOIL, V326, P393, DOI 10.1007/s11104-009-0020-3; Yan Xiong-fei, 2008, Forestry Studies in China, V10, P23, DOI 10.1007/s11632-008-0013-y; ZEIKUS JG, 1976, APPL ENVIRON MICROB, V31, P99, DOI 10.1128/AEM.31.1.99-107.1976; Zhang BW, 2016, GLOBAL BIOGEOCHEM CY, V30, P1246, DOI 10.1002/2016GB005381; Zhang Y, 2011, BIOGEOSCIENCES, V8, P1225, DOI 10.5194/bg-8-1225-2011; Zhang YH, 2011, AQUAT BOT, V95, P262, DOI 10.1016/j.aquabot.2011.08.005; Zhang Z.J., 2015, J SENSORS, V2015, P10, DOI DOI 10.1109/LED.2015.2483760; Zheng XH, 2006, GLOBAL CHANGE BIOL, V12, P1717, DOI 10.1111/j.1365-2486.2006.01199.x	89	11	12	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198081	10.1371/journal.pone.0198081	http://dx.doi.org/10.1371/journal.pone.0198081			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29852016	gold, Green Published, Green Submitted			2022-12-26	WOS:000433893200027
J	Chopra, R; Bushart, DD; Shakkottai, VG				Chopra, Ravi; Bushart, David D.; Shakkottai, Vikram G.			Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; SCA1 TRANSGENIC MICE; MITOCHONDRIAL OXIDANT STRESS; MOUSE MODEL; ALZHEIMERS-DISEASE; PYRAMIDAL NEURONS; ACTION-POTENTIALS; CALCIUM SPIKES; K+ CHANNELS; LOCALIZATION	Purkinje neuron dendritic degeneration precedes cell loss in cerebellar ataxia, but the basis for dendritic vulnerability in ataxia remains poorly understood. Recent work has suggested that potassium (K+) channel dysfunction and consequent spiking abnormalities contribute to Purkinje neuron degeneration, but little attention has been paid to how K+ channel dysfunction impacts dendritic excitability and the role this may play in the degenerative process. We examined the relationship between K+ channel dysfunction, dendritic excitability and dendritic degeneration in spinocerebellar ataxia type 1 (SCA1). Examination of published RNA sequencing data from SCA1 mice revealed reduced expression of several K+ channels that are important regulators of excitability in Purkinje neuron dendrites. Patch clamp recordings in Purkinje neurons from SCA1 mice identified increased dendritic excitability in the form of enhanced back-propagation of action potentials and an increased propensity to produce dendritic calcium spikes. Dendritic excitability could be rescued by restoring expression of large-conductance calcium-activated potassium (BK) channels and activating other K+ channels with baclofen. Importantly, this treatment combination improves motor performance and mitigates dendritic degeneration in SCA1 mice. These results suggest that reduced expression of K+ channels results in persistently increased dendritic excitability at all stages of disease in SCA1, which in turn may contribute to the dendritic degeneration that precedes cell loss.	[Chopra, Ravi] Univ Michigan, Sch Med, Med Scientist Training Program, Ann Arbor, MI USA; [Chopra, Ravi] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Bushart, David D.; Shakkottai, Vikram G.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Shakkottai, Vikram G.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shakkottai, VG (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Shakkottai, VG (corresponding author), Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA.	vikramsh@med.umich.edu		Bushart, David/0000-0002-3852-127X	NIH [R01NS085054, T32GM007863]; National Ataxia Foundation Research Post-Doctoral Fellowship Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085054] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation Research Post-Doctoral Fellowship Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH R01NS085054 (V.G.S.), the NIH T32GM007863 (R.C.), and the National Ataxia Foundation Research Post-Doctoral Fellowship Award (R.C.).	Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5904, DOI 10.1111/bph.13349; Alvina K, 2010, J NEUROSCI, V30, P7249, DOI 10.1523/JNEUROSCI.6341-09.2010; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Bushart DD, 2018, ANN CLIN TRANSL NEUR, V5, P297, DOI 10.1002/acn3.527; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chen XW, 2010, P NATL ACAD SCI USA, V107, P12323, DOI 10.1073/pnas.1001745107; Chopra R, 2014, FUTUR NEUROL, V9, P187, DOI 10.2217/FNL.14.6; Clark HB, 1997, J NEUROSCI, V17, P7385; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; Dell'Orco JM, 2017, HUM MOL GENET, V26, P3935, DOI 10.1093/hmg/ddx281; Dell'Orco JM, 2015, J NEUROSCI, V35, P11292, DOI 10.1523/JNEUROSCI.1357-15.2015; Duarri A, 2015, CELL MOL LIFE SCI, V72, P3387, DOI 10.1007/s00018-015-1894-2; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Egorova PA, 2016, J NEUROPHYSIOL, V115, P2840, DOI 10.1152/jn.00913.2015; Fernandez-Alacid L, 2009, J NEUROCHEM, V110, P1363, DOI 10.1111/j.1471-4159.2009.06229.x; FERRER I, 1994, NEUROPATH APPL NEURO, V20, P38, DOI 10.1111/j.1365-2990.1994.tb00955.x; Gao ZY, 2012, J NEUROSCI, V32, P15533, DOI 10.1523/JNEUROSCI.2454-12.2012; Goldberg JA, 2012, NAT NEUROSCI, V15, P1414, DOI 10.1038/nn.3209; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Hansen ST, 2013, HUM MOL GENET, V22, P271, DOI 10.1093/hmg/dds427; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holmes WT, 1992, ELECT MODELS NEURONA, P7; Hourez R, 2011, J NEUROSCI, V31, P11795, DOI 10.1523/JNEUROSCI.0905-11.2011; Hurlock EC, 2008, J NEUROSCI, V28, P4640, DOI 10.1523/JNEUROSCI.5486-07.2008; Indriati DW, 2013, J NEUROSCI, V33, P3668, DOI 10.1523/JNEUROSCI.2921-12.2013; Ingram M, 2016, NEURON, V89, P1194, DOI 10.1016/j.neuron.2016.02.011; Inoue T, 2001, J NEUROPHYSIOL, V85, P1750, DOI 10.1152/jn.2001.85.4.1750; Jayabal S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29489; Kasumu AW, 2012, CHEM BIOL, V19, P1340, DOI 10.1016/j.chembiol.2012.07.013; Keiser MS, 2016, ANN NEUROL, V80, P754, DOI 10.1002/ana.24789; Kim JE, 2007, INTEST RES, V5, P26; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2520, DOI 10.1073/pnas.73.7.2520; Mark MD, 2015, J NEUROSCI, V35, P8882, DOI 10.1523/JNEUROSCI.0891-15.2015; Martina M, 2003, J NEUROSCI, V23, P5698; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Ohtsuki G, 2012, NEURON, V75, P108, DOI 10.1016/j.neuron.2012.05.025; Otsu Y, 2014, NEURON, V84, P137, DOI 10.1016/j.neuron.2014.08.035; Raman IM, 1999, J NEUROSCI, V19, P1663; Rancz EA, 2010, P NATL ACAD SCI USA, V107, P22284, DOI 10.1073/pnas.1008605107; Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Sanchez-Padilla J, 2014, NAT NEUROSCI, V17, P832, DOI 10.1038/nn.3717; Shakkottai VG, 2011, J NEUROSCI, V31, P13002, DOI 10.1523/JNEUROSCI.2789-11.2011; Shuvaev AN, 2017, J PHYSIOL-LONDON, V595, P141, DOI 10.1113/JP272950; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Telgkamp P, 2002, J NEUROSCI, V22, P8447; Unno T, 2012, P NATL ACAD SCI USA, V109, P17693, DOI 10.1073/pnas.1212786109; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Zagha E, 2010, J NEUROPHYSIOL, V103, P3516, DOI 10.1152/jn.00982.2009	61	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198040	10.1371/journal.pone.0198040	http://dx.doi.org/10.1371/journal.pone.0198040			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847609	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800049
J	Millings, EJ; De Rosa, MC; Fleet, S; Watanabe, K; Rausch, R; Egli, D; Li, G; Leduc, CA; Zhang, YY; Fischer, SG; Leibel, RL				Millings, Elizabeth J.; De Rosa, Maria Caterina; Fleet, Sarah; Watanabe, Kazuhisa; Rausch, Richard; Egli, Dieter; Li, Gen; Leduc, Charles A.; Zhang, Yiying; Fischer, Stuart G.; Leibel, Rudolph L.			ILDR2 has a negligible role in hepatic steatosis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ADENOVIRAL VECTOR; LIPID-METABOLISM; KUPFFER CELLS; GENE; MUTATIONS; KNOCKOUT; INJURY; SEQUESTRATION; TRANSDUCTION	We have previously reported that Ildr2 knockdown via adenovirally-delivered shRNA causes hepatic steatosis in mice. In the present study we investigated hepatic biochemical and anatomic phenotypes of Cre-mediated Ildr2 knock-out mice. Liver-specific Ildr2 knock-out mice were generated in C57BL/6J mice segregating for a floxed (exon 1) allele of Ildr2, using congenital and acute (10-13-week-old male mice) Cre expression. In addition, Ildr2 shRNA was administered to Ildr2 knock-out mice to test the effects of Ildr2 shRNA, per se, in the absence of Ildr2 expression. RNA sequencing was performed on livers of these knockdown and knockout mice. Congenital and acute liver-specific and hepatocyte-specific knockout mice did not develop hepatic steatosis. However, administration of Ildr2 shRNA to Ildr2 knock-out mice did cause hepatic steatosis, indicating that the Ildr2 shRNA had apparent "off-target" effects on gene(s) other than Ildr2. RNA sequencing and BLAST sequence alignment revealed Dgka as a candidate gene mediating these "off-target" effects. Ildr2 shRNA is 63% homologous to the Dgka gene, and Dgka expression decreased only in mice displaying hepatic steatosis. Dgka encodes diacylglycerol kinase (DGK) alpha, one of a family of DGKs which convert diacylglycerides to phosphatidic acid for second messenger signaling. Dgka knockdown mice would be expected to accumulate diacylglyceride, contributing to the observed hepatic steatosis. We conclude that ILDR2 plays a negligible role in hepatic steatosis. Rather, hepatic steatosis observed previously in Ildr2 knockdown mice was likely due to shRNA targeting of Dgka and/or other "off-target" genes. We propose that the gene candidates identified in this follow-up study may lead to identification of novel regulators of hepatic lipid metabolism.	[Millings, Elizabeth J.; De Rosa, Maria Caterina; Fleet, Sarah; Watanabe, Kazuhisa; Rausch, Richard; Egli, Dieter; Leduc, Charles A.; Zhang, Yiying; Fischer, Stuart G.; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, Naomi Berrie Diabet Ctr, New York, NY 10027 USA; [Millings, Elizabeth J.; De Rosa, Maria Caterina; Fleet, Sarah; Watanabe, Kazuhisa; Rausch, Richard; Egli, Dieter; Leduc, Charles A.; Zhang, Yiying; Fischer, Stuart G.; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, Div Mol Genet, New York, NY 10027 USA; [Li, Gen] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Millings, Elizabeth J.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Fleet, Sarah] Boston Childrens Hosp, Ctr Nutr, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Watanabe, Kazuhisa] Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi, Japan	Columbia University; Columbia University; Columbia University; Emory University; Harvard University; Boston Children's Hospital; Jichi Medical University	Leibel, RL (corresponding author), Columbia Univ, Dept Pediat, Naomi Berrie Diabet Ctr, New York, NY 10027 USA.; Leibel, RL (corresponding author), Columbia Univ, Dept Pediat, Div Mol Genet, New York, NY 10027 USA.	rl232@cumc.columbia.edu	Watanabe, Kazuhisa/ABY-2241-2022	LeDuc, Charles/0000-0002-2073-5050; Millings, Elizabeth/0000-0002-2077-9985; Watanabe, Kazuhisa/0000-0002-5640-0818	United States National Institutes of Health [RO1-DK 066518, P30 DK63608-09, P30 DK26687-31]; National Science Foundation Graduate Research Fellowship Program [DGE 11-44155]; United Negro College Fund / Merck Graduate Dissertation Fellowship; Italian Ministry of Education and University, University of Salerno, Italy; Russell Berrie Foundation; United States National Institutes of Health; Japan Society for the Promotion of Science; Manpei Suzuki Diabetes Foundation; New York Stem Cell Foundation Robertson Prize; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK066518] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); United Negro College Fund / Merck Graduate Dissertation Fellowship; Italian Ministry of Education and University, University of Salerno, Italy; Russell Berrie Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Manpei Suzuki Diabetes Foundation; New York Stem Cell Foundation Robertson Prize; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the United States National Institutes of Health (http://www.nih.gov/): RO1-DK 066518, P30 DK63608-09 (http://derc.cumc.columbia.edu/) and P30 DK26687-31 (http://www.nyorc.org/) to RLL; the National Science Foundation Graduate Research Fellowship Program (http://www.nsfgrfp.org/): DGE 11-44155 and the United Negro College Fund / Merck Graduate Dissertation Fellowship (www.uncf.org) to EJM; the Italian Ministry of Education and University, University of Salerno, Italy (http://www.unisa.it/) and the Russell Berrie Foundation (http://www.russellberriefoundation.org/home.php) to MCDR; the United States National Institutes of Health (http://www.nih.gov/) Pediatric Scientist Development Program to SF; the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/), the Manpei Suzuki Diabetes Foundation (http://www.suzuki-manpei-df.or.jp/english/) and the Russell Berrie Foundation (http://www.russellberriefoundation.org/home.php) to KW; and the New York Stem Cell Foundation Robertson Prize (https://nyscf.org/) to DE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beatty MS, 2012, ADV CANCER RES, V115, P39, DOI [10.1016/B978-0-12-3983,12-8.00002-1, 10.1016/B978-0-12-398342-8.00002-1]; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Carpino G, 2013, INT J MOL SCI, V14, P20112, DOI 10.3390/ijms141020112; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; De Souza AT, 2006, NUCLEIC ACIDS RES, V34, P4486, DOI 10.1093/nar/gkl609; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519; Dokmanovic-Chouinard M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000137; Fan X, 2013, CELL BIOL INT, V37, P284, DOI 10.1002/cbin.10035; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuse M, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28960; Ganz M, 2013, HEPATOL INT, V7, pS771, DOI 10.1007/s12072-013-9468-6; Gao HZ, 2003, HUM MUTAT, V22, P24, DOI 10.1002/humu.10230; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775; Hagelkruys A, 2014, DEVELOPMENT, V141, P604, DOI 10.1242/dev.100487; Halldorsdottir Solveig, 2009, Int J Body Compos Res, V7, P147; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iacobas DA, 2008, CELL COMMUN ADHES, V15, P195, DOI 10.1080/15419060802014222; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Krajden M, 1999, J CLIN MICROBIOL, V37, P1683, DOI 10.1128/JCM.37.6.1683-1686.1999; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Magee N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5170402; Manneras-Holm L, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12372; MEEHAN RR, 1984, EMBO J, V3, P1881, DOI 10.1002/j.1460-2075.1984.tb02062.x; Milne SB, 2008, BIOCHEMISTRY-US, V47, P9372, DOI 10.1021/bi800492c; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Smart N, 2013, CIRC RES, V112, pE29, DOI 10.1161/CIRCRESAHA.112.300555; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ugai H, 2002, JPN J CANCER RES, V93, P598, DOI 10.1111/j.1349-7006.2002.tb01296.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Washington K, 2000, HUM PATHOL, V31, P822, DOI 10.1053/hupa.2000.8440; Watanabe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067234; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Wood M, 1999, CANCER GENE THER, V6, P367, DOI 10.1038/sj.cgt.7700090; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Xie S., 2015, CELL LOGIST, V5, DOI [10.1080/21592799.2015.1078431, DOI 10.1080/21592799.2015.1078431]; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	59	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197548	10.1371/journal.pone.0197548	http://dx.doi.org/10.1371/journal.pone.0197548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847571	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800036
J	Vinson, CC; Mota, APZ; Oliveira, TN; Guimaraes, LA; Leal-Bertioli, SCM; Williams, TCR; Nepomuceno, AL; Saraiva, MAP; Araujo, ACG; Guimaraes, PM; Brasileiro, ACM				Vinson, Christina Cleo; Zotta Mota, Ana Paula; Oliveira, Thais Nicolini; Guimaraes, Larissa Arrais; Macedo Leal-Bertioli, Soraya Cristina; Williams, Thomas Christopher Rhys; Nepomuceno, Alexandre Lima; Passos Saraiva, Mario Alfredo; Guerra Araujo, Ana Claudia; Guimaraes, Patricia Messenberg; Brasileiro, Ana C. M.			Early responses to dehydration in contrasting wild Arachis species	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; IMPROVES DROUGHT TOLERANCE; STRESS RESPONSES; ABSCISIC-ACID; ASPARAGINE SYNTHETASE; GENE-EXPRESSION; PEANUT; ARABIDOPSIS; GENOME; PROTEINS	Wild peanut relatives (Arachis spp.) are genetically diverse and were selected throughout evolution to a range of environments constituting, therefore, an important source of allelic diversity for abiotic stress tolerance. In particular, A. duranensis and A. stenosperma, the parents of the reference Arachis A-genome genetic map, show contrasting transpiration behavior under limited water conditions. This study aimed to build a comprehensive gene expression profile of these two wild species under dehydration stress caused by the withdrawal of hydroponic nutrient solution. For this purpose, roots of both genotypes were collected at seven time-points during the early stages of dehydration and used to construct cDNA paired-end libraries. Physiological analyses indicated initial differences in gas exchange parameters between the drought-tolerant genotype of A. duranensis and the drought-sensitive genotype of A. stenosperma. High-quality Illumina reads were mapped against the A. duranensis reference genome and resulted in the identification of 1,235 and 799 Differentially Expressed Genes (DEGs) that responded to the stress treatment in roots of A. duranensis and A. stenosperma, respectively. Further analysis, including functional annotation and identification of biological pathways represented by these DEGs confirmed the distinct gene expression behavior of the two contrasting Arachis species genotypes under dehydration stress. Some species-exclusive and common DEGs were then selected for qRT-PCR analysis, which corroborated the in silico expression profiling. These included genes coding for regulators and effectors involved in drought tolerance responses, such as activation of osmosensing molecular cascades, control of hormone and osmolyte content, and protection of macromolecules. This dataset of transcripts induced during the dehydration process in two wild Arachis genotypes constitute new tools for the understanding of the distinct gene regulation processes in these closely related species but with contrasting drought responsiveness. In addition, our findings provide insights into the nature of drought tolerance in wild germoplasm, which might be explored as novel sources of diversity and useful wild alleles to develop climate-resilient crop varieties.	[Vinson, Christina Cleo; Zotta Mota, Ana Paula; Oliveira, Thais Nicolini; Guimaraes, Larissa Arrais; Macedo Leal-Bertioli, Soraya Cristina; Passos Saraiva, Mario Alfredo; Guerra Araujo, Ana Claudia; Guimaraes, Patricia Messenberg; Brasileiro, Ana C. M.] Embrapa Recursos Genet & Biotecnol, CP, Parque Estacao Biol,Final W5 Norte, Brasilia, DF, Brazil; [Vinson, Christina Cleo] Univ Brasilia, Campus Darcy Ribeiro, Brasilia, DF, Brazil; [Zotta Mota, Ana Paula; Oliveira, Thais Nicolini; Williams, Thomas Christopher Rhys] Univ Fed Rio Grande do Sul, Campus Vale, Porto Alegre, RS, Brazil; [Nepomuceno, Alexandre Lima] Embrapa Soja, CP, Londrina, PR USA; [Guimaraes, Larissa Arrais] Univ Georgia, Dept Hort, Tifton, GA USA; [Guimaraes, Larissa Arrais] Univ Georgia, Inst Plant Breeding, Tifton, GA USA; [Macedo Leal-Bertioli, Soraya Cristina] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Federal do Rio Grande do Sul; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Brasileiro, ACM (corresponding author), Embrapa Recursos Genet & Biotecnol, CP, Parque Estacao Biol,Final W5 Norte, Brasilia, DF, Brazil.	ana.brasileiro@embrapa.br	Brasileiro, Ana Cristina Miranda/AAN-2187-2021; Guimaraes, Patricia messenberg/G-1824-2012	Brasileiro, Ana Cristina Miranda/0000-0003-0530-062X; Vinson, Christina/0000-0001-8779-8075; Guimaraes, patricia/0000-0001-9799-3042; Zotta Mota, Ana Paula/0000-0003-3251-1406; BERTIOLI, SORAYA/0000-0002-9683-5357; Williams, Thomas/0000-0003-1954-2961	Embrapa - Brazilian Agricultural Research Corporation; CNPq- Brazilian National Council for Scientific and Technological Development; CAPES- Coordination for the Improvement of Higher Education Personnel; FAP-DF- Distrito Federal Research Foundation	Embrapa - Brazilian Agricultural Research Corporation; CNPq- Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES- Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAP-DF- Distrito Federal Research Foundation	This work was financially supported by grants from Embrapa - Brazilian Agricultural Research Corporation; CNPq- Brazilian National Council for Scientific and Technological Development; CAPES- Coordination for the Improvement of Higher Education Personnel and FAP-DF- Distrito Federal Research Foundation. Each of the funding bodies granted the funds based on a research proposal. They had no influence over the experimental design, data analysis or interpretation, or writing the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Ariz I, 2013, PHYSIOL PLANTARUM, V148, P522, DOI 10.1111/j.1399-3054.2012.01712.x; Neto ADA, 2010, J PLANT INTERACT, V5, P1, DOI 10.1080/17429140902999243; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Banerjee A, 2016, PLANT GROWTH REGUL, V79, P1, DOI 10.1007/s10725-015-0113-3; Bedada G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-995; Bemer M, 2017, TRENDS PLANT SCI, V22, P66, DOI 10.1016/j.tplants.2016.10.007; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Botha AM, 2017, PLANT CELL ENVIRON, V40, P1679, DOI 10.1111/pce.12998; Brasileiro ACM, 2014, INT J PLANT BIOL RES, V2, P1017; Brasileiro ACM, 2015, PLANT MOL BIOL REP, V33, P1876, DOI 10.1007/s11105-015-0882-x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen W, 2013, PLANT MOL BIOL, V83, P219, DOI 10.1007/s11103-013-0084-6; Chen XP, 2016, P NATL ACAD SCI USA, V113, P6785, DOI 10.1073/pnas.1600899113; Clevenger J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01446; Drame KN, 2007, PLANT PHYSIOL BIOCH, V45, P236, DOI 10.1016/j.plaphy.2007.02.002; Du H, 2014, PLANT J, V78, P834, DOI 10.1111/tpj.12508; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Ferguson ME, 2005, BIODIVERS CONSERV, V14, P1777, DOI 10.1007/s10531-004-0699-7; Foyer CH, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.112, 10.1038/nplants.2016.112]; Gaufichon L, 2010, PLANT SCI, V179, P141, DOI 10.1016/j.plantsci.2010.04.010; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Selvaraj MG, 2017, PLANT BIOTECHNOL J, V15, P1465, DOI 10.1111/pbi.12731; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Guerra D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00057; Guimaraes LA, 2017, PLANT MOL BIOL, V94, P79, DOI 10.1007/s11103-017-0594-8; Guimaraes LA, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0176-4; Guimaraes P. M., 2010, Tropical Plant Biology, V3, P183, DOI 10.1007/s12042-010-9056-z; Guimaraes PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140937; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Haswell ES, 2015, J GEN PHYSIOL, V145, P389, DOI 10.1085/jgp.201411295; Himuro Y, 2014, J PLANT PHYSIOL, V171, P1127, DOI 10.1016/j.jplph.2014.04.007; Huda KMK, 2013, J EXP BOT, V64, P3099, DOI 10.1093/jxb/ert182; Janila P, 2016, FRONT PLANT SCI, P7; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lawrence D, 2015, NAT CLIM CHANGE, V5, P27, DOI [10.1038/nclimate2430, 10.1038/NCLIMATE2430]; Leal-Bertioli SCM, 2015, ANN BOT-LONDON, V115, P237, DOI 10.1093/aob/mcu237; Leal-Bertioli SCM, 2012, ENVIRON EXP BOT, V84, P17, DOI 10.1016/j.envexpbot.2012.04.005; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Martins PK, 2008, GENET MOL BIOL, V31, P512, DOI 10.1590/S1415-47572008000300019; Maurel C, 2015, PHYSIOL REV, V95, P1321, DOI 10.1152/physrev.00008.2015; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Morgante CV, 2013, FUNCT PLANT BIOL, V40, P1298, DOI 10.1071/FP13096; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; PEOPLES MB, 1986, PLANT PHYSIOL, V82, P946, DOI 10.1104/pp.82.4.946; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Rabara RC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1575-4; Roberts WR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3623-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Singh D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3596-7; Stalker HT, 2017, CROP SCI, V57, P1102, DOI 10.2135/cropsci2016.09.0824; Stolf-Moreira R, 2011, PLANT MOL BIOL REP, V29, P19, DOI 10.1007/s11105-010-0203-3; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swain S, 2017, BBA-GENE REGUL MECH, V1860, P636, DOI 10.1016/j.bbagrm.2016.10.012; Tian XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131455; Todaka D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00084; Tripathi P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2420-0; Wan XR, 2006, BIOCHEM BIOPH RES CO, V347, P1030, DOI 10.1016/j.bbrc.2006.07.026; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Zandalinas SI, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0791-7; Zargar SM, 2017, J PROTEOMICS, V169, P233, DOI 10.1016/j.jprot.2017.04.010; Zhao PC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00954; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	77	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198191	10.1371/journal.pone.0198191	http://dx.doi.org/10.1371/journal.pone.0198191			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847587	Green Submitted, gold, Green Published			2022-12-26	WOS:000433634800058
J	Cops, J; Mullens, W; Verbrugge, FH; Swennen, Q; Reynders, C; Penders, J; Rigo, JM; Hansen, D				Cops, Jirka; Mullens, Wilfried; Verbrugge, Frederik H.; Swennen, Quirine; Reynders, Carmen; Penders, Joris; Rigo, Jean-Michel; Hansen, Dominique			Selective abdominal venous congestion to investigate cardiorenal interactions in a rat model	PLOS ONE			English	Article							INFERIOR VENA-CAVA; SYSTOLIC HEART-FAILURE; INTRAABDOMINAL PRESSURE; ENDOCRINE FUNCTION; VOLUME EXPANSION; RENAL-FUNCTION; KIDNEY INJURY; LIGATION; ANGIOTENSIN; DYSFUNCTION	Abdominal congestion may play an important role in the cardiorenal syndrome and has been demonstrated to drive disease progression. An animal model for abdominal congestion, without other culprit mechanisms that are often present in patients such as low cardiac output or chronic kidney disease, might be interesting to allow a better study of the pathophysiology of the cardiorenal syndrome. The objective of this study was to develop a clinically relevant and valid rat model with abdominal venous congestion and without preexisting heart and/or kidney dysfunction. To do so, a permanent surgical constriction (20 Gauge) of the thoracic inferior vena cava (IVC) was applied in male Sprague Dawley rats (IVCc, n = 7), which were compared to sham-operated rats (SHAM, n = 6). Twelve weeks after surgery, abdominal venous pressure (mean: 13.8 vs 4.9 mmHg, p < 0.01), plasma creatinine (p < 0.05), plasma cystatin c (p < 0.01), urinary albumin (p < 0.05), glomerular surface area (p < 0.01) and width of Bowman's space (p < 0.05) of the IVCc group were significantly increased compared to the SHAM group for a comparable absolute body weight between groups (559 vs 530g, respectively, p = 0.73). Conventional cardiac echocardio-graphic and hemodynamic parameters did not differ significantly between both groups, indicating that cardiac function was not compromised by the surgery. In conclusion, we demonstrate that constriction of the thoracic IVC in adult rats is feasible and significantly increases the abdominal venous pressure to a clinically relevant level, thereby inducing abdominal venous congestion.	[Cops, Jirka; Mullens, Wilfried; Swennen, Quirine; Penders, Joris; Rigo, Jean-Michel; Hansen, Dominique] Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Cops, Jirka] Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium; [Mullens, Wilfried; Verbrugge, Frederik H.] Ziekenhuis Oost Limburg, Dept Cardiol, Genk, Belgium; [Reynders, Carmen; Penders, Joris] Ziekenhuis Oost Limburg, Clin Lab, Genk, Belgium; [Hansen, Dominique] Jessa Hosp, Heart Ctr Hasselt, Hasselt, Belgium	Hasselt University; Hasselt University; East Limburg Hospital; East Limburg Hospital	Cops, J (corresponding author), Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, BIOMED Biomed Res Inst, Diepenbeek, Belgium.; Cops, J (corresponding author), Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium.	jirka.cops@uhasselt.be	Rigo, Jean-Michel/E-3456-2010; Verbrugge, Frederik Hendrik/AAC-4134-2019; Hansen, Dominique/AAH-5883-2021	Rigo, Jean-Michel/0000-0002-0031-526X; Verbrugge, Frederik Hendrik/0000-0003-0599-9290; Hansen, Dominique/0000-0003-3074-2737; Penders, Joris/0000-0003-1877-6125; Cops, Jirka/0000-0002-1749-7119	BOF funding from UHasselt/BIOMED	BOF funding from UHasselt/BIOMED	J.C. is supported by BOF funding from UHasselt/BIOMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Afsar B, 2016, CLIN KIDNEY J, V9, P39, DOI 10.1093/ckj/sfv124; Barbuto N, 2004, J CELL MOL MED, V8, P102, DOI 10.1111/j.1582-4934.2004.tb00264.x; Castrop H, 2017, ACTA PHYSIOL, V219, P544, DOI 10.1111/apha.12760; CIRKSENA WJ, 1966, J CLIN INVEST, V45, P179, DOI 10.1172/JCI105330; CLAVELL AL, 1993, AM J PHYSIOL, V265, pR1416, DOI 10.1152/ajpregu.1993.265.6.R1416; Constantinides Christakis, 2011, ILAR J, V52, pe21; Damman K, 2011, J AM COLL CARDIOL, V57, P2233, DOI 10.1016/j.jacc.2010.10.065; Damman K, 2010, EUR J HEART FAIL, V12, P974, DOI 10.1093/eurjhf/hfq118; de Vries WB, 2010, PEDIATR RES, V67, P72, DOI 10.1203/PDR.0b013e3181bf570d; Dupont Matthias, 2011, Curr Heart Fail Rep, V8, P233, DOI 10.1007/s11897-011-0071-7; DURIETZ B, 1979, UROL RES, V7, P253; Erdem A, 2000, NEPHROL DIAL TRANSPL, V15, P1175, DOI 10.1093/ndt/15.8.1175; FITZSIMONS JT, 1982, AM J PHYSIOL, V243, pR558, DOI 10.1152/ajpregu.1982.243.5.R558; Golub RM, 1992, CLIN ANAT, V5, P441, DOI DOI 10.1002/CA.980050604; Harjola VP, 2017, EUR J HEART FAIL, V19, P821, DOI 10.1002/ejhf.872; Huebert RC, 2011, AM J PATHOL, V179, P1851, DOI 10.1016/j.ajpath.2011.06.045; Ichinose F, 2004, AM J PHYSIOL-HEART C, V286, pH1070, DOI 10.1152/ajpheart.00940.2003; Kanzaki G, 2013, PATHOL INT, V63, P169, DOI 10.1111/pin.12044; KAWAMURA J, 1979, INVEST UROL, V16, P463; Legrand M, 2014, CRIT CARE MED, V42, P2109, DOI 10.1097/CCM.0000000000000404; LEVY M, 1972, J CLIN INVEST, V51, P922, DOI 10.1172/JCI106887; Lisy O, 2005, AM J PHYSIOL-REG I, V288, pR158, DOI 10.1152/ajpregu.00444.2004; Lisy O, 2000, CIRCULATION, V102, P338; MANN JFE, 1981, PHARMACOL BIOCHEM BE, V15, P337, DOI 10.1016/0091-3057(81)90259-8; Mullens W, 2008, J CARD FAIL, V14, P508, DOI 10.1016/j.cardfail.2008.02.010; Mullens W, 2008, J AM COLL CARDIOL, V51, P300, DOI 10.1016/j.jacc.2007.09.043; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Murakami M, 2014, BIOL PHARM BULL, V37, P834, DOI 10.1248/bpb.b14-00012; Nijst Petra, 2014, Curr Heart Fail Rep, V11, P453, DOI 10.1007/s11897-014-0218-4; Ostermann M, 2017, BEST PRACT RES-CLIN, V31, P305, DOI 10.1016/j.bpa.2017.09.001; PAGANELLI WC, 1988, CIRC RES, V62, P279, DOI 10.1161/01.RES.62.2.279; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; Redfors B, 2014, LAB ANIM-UK, V48, P6, DOI 10.1177/0023677213502015; REINHARDT WO, 1951, P SOC EXP BIOL MED, V77, P809; Ronco C, 2008, INTENS CARE MED, V34, P957, DOI 10.1007/s00134-008-1017-8; Ross EA, 2012, J CARD FAIL, V18, P930, DOI 10.1016/j.cardfail.2012.10.010; Ruxanda F, 2014, B UASVM VET MED, V71, DOI [10.1177/0023677213502015, DOI 10.1177/0023677213502015]; SCHRIER RW, 1971, CIRC RES, V29, P490, DOI 10.1161/01.RES.29.5.490; Shaqura M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184161; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Simonetto DA, 2015, HEPATOLOGY, V61, P648, DOI 10.1002/hep.27387; SRAER JD, 1989, J CARDIOVASC PHARM, V14, pS21, DOI 10.1097/00005344-198906144-00006; Tang WHW, 2010, HEART, V96, P255, DOI 10.1136/hrt.2009.166256; Testani JM, 2013, EUR J HEART FAIL, V15, P599, DOI 10.1093/eurjhf/hft060; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Viswanathan G, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/283137; WATKINS L, 1976, J CLIN INVEST, V57, P1606, DOI 10.1172/JCI108431; Watts SW, 2012, PHARMACOL REV, V64, P359, DOI 10.1124/pr.111.004697; Wei CM, 1997, AM J PHYSIOL-REG I, V273, pR838, DOI 10.1152/ajpregu.1997.273.2.R838; Wiedmeyer CE, 2010, COMPARATIVE MED, V60, P448; Yang CF, 2014, TZU CHI MED J, V26, P119, DOI 10.1016/j.tcmj.2014.07.005; Zheng Zhao, 2016, Mathematical Problems in Engineering, V2016, DOI 10.1155/2016/8927169; Zhou J, 2009, ARTERIOSCL THROM VAS, V29, P863, DOI 10.1161/ATVBAHA.109.185678	54	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197687	10.1371/journal.pone.0197687	http://dx.doi.org/10.1371/journal.pone.0197687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813081	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800024
J	Niimi, T; Nakamura, T				Niimi, Touko; Nakamura, Taro			The fission yeast SPB component Dms1 is required to initiate forespore membrane formation and maintain meiotic SPB components	PLOS ONE			English	Article							SPINDLE POLE BODY; NUCLEOTIDE EXCHANGE FACTOR; SPORE PLASMA-MEMBRANE; SCHIZOSACCHAROMYCES-POMBE; NUCLEAR-ENVELOPE; SPORULATION; MEIOSIS; GENE; PROTEIN; CONJUGATION	The spindle pole body (SPB) plays a central role in spore plasma membrane formation in addition to its recognized role in microtubule organization. During meiosis, a biomembrane called the forespore membrane (FSM) is newly formed at the SPB. Although several SPB proteins essential for the initiation of FSM formation (meiotic SPB components) have been identified, the molecular mechanism is still unknown. Here, we report the isolation and functional characterization of Dms1 as a component of the SPB. We show that FSM formation does not initiate in dms1. cells. Dms1 protein is constitutively expressed throughout the life cycle and localizes to the SPB and the nuclear envelope. The predicted Dms1 protein has a transmembrane domain, which is required for correct localization at the SPB. Dms1 is essential for the proper localization of three meiotic SPB components, Spo15, Spo2, and Spo13, but these components do not affect localization of Dms1. Collectively, these results suggest that Dms1 anchors these meiotic SPB components to the SPB, thereby facilitating the initiation of FSM formation.	[Niimi, Touko; Nakamura, Taro] Osaka City Univ, Grad Sch Sci, Dept Biol, Sumiyoshi Ku, Osaka, Japan	Osaka Metropolitan University	Nakamura, T (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol, Sumiyoshi Ku, Osaka, Japan.	taronaka@sci.osaka-cu.ac.jp		Nakamura, Taro/0000-0002-3343-7765	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K07057, 18K06225]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. Nakamura (#15K07057 and #18K06225) (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-1507057/, https://kaken.nii.au.jp/ja/grant/KAKENHI-PROJECT-18K06225/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blyth J, 2018, GENETICS, V208, P589, DOI 10.1534/genetics.117.300527; BRESCH C, 1968, MOL GEN GENET, V102, P301, DOI 10.1007/BF00433721; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; EGEL R, 1971, PLANTA, V98, P89, DOI 10.1007/BF00387025; EGEL R, 1974, EXP CELL RES, V88, P127, DOI 10.1016/0014-4827(74)90626-0; Feng SS, 2012, J BIOL CHEM, V287, P15602, DOI 10.1074/jbc.M111.333245; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Hagan I., 2004, MOL BIOL SCHIZOSACCH, P207; HIRATA A, 1982, J GEN APPL MICROBIOL, V28, P263, DOI 10.2323/jgam.28.263; IINO Y, 1995, GENETICS, V140, P1235; Ikemoto S, 2000, J CELL SCI, V113, P545; Imada Kazuki, 2020, Small GTPases, V11, P146, DOI 10.1080/21541248.2017.1356425; Imada K, 2016, MOL BIOL CELL, V27, P3317, DOI 10.1091/mbc.E16-03-0162; Itadani A, 2010, EUKARYOT CELL, V9, P1925, DOI 10.1128/EC.00022-10; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; KISHIDA M, 1986, CURR GENET, V10, P443, DOI 10.1007/BF00419871; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Loprieno N, 1974, HDB GENETICS, P395; Martin-Castellanos C, 2005, CURR BIOL, V15, P2056, DOI 10.1016/j.cub.2005.10.038; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nakamura-Kubo M, 2003, MOL BIOL CELL, V14, P1109, DOI 10.1091/mbc.E02-08-0504; Nakamura-Kubo M, 2011, MOL BIOL CELL, V22, P3442, DOI 10.1091/mbc.E11-02-0125; Nakase Y, 2004, GENES CELLS, V9, P1275, DOI 10.1111/j.1365-2443.2004.00806.x; Nakase Y, 2008, MOL BIOL CELL, V19, P2476, DOI 10.1091/mbc.E08-02-0118; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; NIELSEN O, 1989, EMBO J, V8, P269, DOI 10.1002/j.1460-2075.1989.tb03373.x; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Shimoda C, 2004, J CELL SCI, V117, P389, DOI 10.1242/jcs.00980; Shimoda C, 2004, MOL BIOL SCHIZOSACCH, P311; TANAKA K, 1982, J CELL SCI, V56, P263; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; TANAKA K, 1986, J CELL SCI, V80, P253; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Ucisik-Akkaya E, 2014, G3-GENES GENOM GENET, V4, P1173, DOI 10.1534/g3.114.011049; Uzawa S, 2004, MOL BIOL CELL, V15, P5219, DOI 10.1091/mbc.E04-03-0255; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; WOODS A, 1989, J CELL SCI, V93, P491; Yamamoto M., 1997, MATING SPORULATION S, P1037; Yang HJ, 2010, MOL BIOL CELL, V21, P1272, DOI 10.1091/mbc.E09-10-0842; YOO BY, 1973, ARCH MIKROBIOL, V91, P1, DOI 10.1007/BF00409533; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047	46	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197879	10.1371/journal.pone.0197879	http://dx.doi.org/10.1371/journal.pone.0197879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813128	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800034
J	Mo, SS; Urdahl, AM; Madslien, K; Sunde, M; Nesse, LL; Slettemeas, JS; Norstrom, M				Mo, Solveig Solverod; Urdahl, Anne Margrete; Madslien, Knut; Sunde, Marianne; Nesse, Live L.; Slettemeas, Jannice Schau; Norstrom, Madeleine			What does the fox say? Monitoring antimicrobial resistance in the environment using wild red foxes as an indicator	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; BETA-LACTAMASES; MOLECULAR CHARACTERIZATION; FECAL SAMPLES; RESERVOIR; MAMMALS; GENES	The objective of this study was to estimate and compare the occurrence of AMR in wild red foxes in relation to human population densities. Samples from wild red foxes (n = 528) included in the Norwegian monitoring programme on antimicrobial resistance in bacteria from food, feed and animals were included. All samples were divided into three different groups based on population density in the municipality where the foxes were hunted. Of the 528 samples included, 108 (20.5%), 328 (62.1%) and 92 (17.4%) originated from areas with low, medium and high population density, respectively. A single faecal swab was collected from each fox. All samples were plated out on a selective medium for Enterobacteriaceae for culturing followed by inclusion and susceptibility testing of one randomly selected Escherichia colt to assess the overall occurrence of AMR in the Gram-negative bacterial population. Furthermore, the samples were subjected to selective screening for detection of E. colt displaying resistance towards extended-spectrum cephalosporins and fluoroquinolones. In addition, a subset of samples (n = 387) were subjected to selective culturing to detect E. colt resistant to carbapenems and colistin, and enterococci resistant to vancomycin. Of these, 98 (25.3%), 200 (51.7%) and 89 (23.0%) originated from areas with low, medium and high population density, respectively. Overall, the occurrence of AMR in indicator E. colt from wild red foxes originating from areas with different human population densities in Norway was low to moderate (8.8%). The total occurrence of AMR was significantly higher; chi(2) (1,N = 336) = 6.53,p = 0.01 in areas with high population density compared to areas with medium population density. Similarly, the occurrence of fluoroquinolone resistant E. colt isolated using selective detection methods was low in areas with low population density and more common in areas with medium or high population density. In conclusion, we found indications that occurrence of AMR in wild red foxes in Norway is associated with human population density. Foxes living in urban areas are more likely to be exposed to AMR bacteria and resistance drivers from food waste, garbage, sewage, waste water and consumption of contaminated prey compared to foxes living in remote areas. The homerange of red fox has been shown to be limited thereby the red fox constitutes a good sentinel for monitoring antimicrobial resistance in the environment. Continuous monitoring on the occurrence of AMR in different wild species, ecological niches and geographical areas can facilitate an increased understanding of the environmental burden of AMR in the environment. Such information is needed to further assess the impact for humans, and enables implementation of possible control measures for AMR in humans, animals and the environment in a true "One Health" approach.	[Mo, Solveig Solverod; Urdahl, Anne Margrete; Madslien, Knut; Sunde, Marianne; Nesse, Live L.; Slettemeas, Jannice Schau; Norstrom, Madeleine] Norwegian Vet Inst, Oslo, Norway	Norwegian Veterinary Institute	Norstrom, M (corresponding author), Norwegian Vet Inst, Oslo, Norway.	madelaine.norstrom@vetinst.no		Slettemeas, Jannice Schau/0000-0003-2542-6991; Urdahl, Anne Margrete/0000-0002-6149-2825; Mo, Solveig Solverod/0000-0003-4532-9857; Sunde, Marianne/0000-0002-2326-4338; Norstrom, Madelaine/0000-0002-9073-1397	Norwegian Research Council [255383, 250212/E50]; Norwegian Environment Agency [M-764vertical bar2017]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Environment Agency	This study was supported by the Norwegian Research Council (255383) to Anne Margrete Urdahl, The Norwegian Environment Agency (M-764 broken vertical bar 2017) to Anne Margrete Urdahl, and Norwegian Research Council (250212/E50) to Live Nesse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso Y, 2012, J ANTIMICROB CHEMOTH, V67, P582, DOI 10.1093/jac/dkr507; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.141r; [Anonymous], 2021, LANG ENV STAT COMP; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Brinas L, 2003, ANTIMICROB AGENTS CH, V47, P2056, DOI 10.1128/AAC.47.6.2056-2058.2003; Carson M, 2012, VECTOR-BORNE ZOONOT, V12, P583, DOI 10.1089/vbz.2011.0825; Dziekan G, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P92; European Food Safety Authority, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4380; European Food Safety Authority (EFSA), 2014, EFSA J, V12, P33; European Medicines Agency, 2016, SAL VET ANT AG 29 EU; Goncalves A, 2012, LETT APPL MICROBIOL, V54, P73, DOI 10.1111/j.1472-765X.2011.03173.x; Goncalves A, 2012, MICROB DRUG RESIST, V18, P215, DOI 10.1089/mdr.2011.0145; Grobbel M, 2012, COL ENV 3 ASM C AMR; Guardabassi L., 2006, ANTIMICROBIAL RESIST, P1; Guardabassi L., 2008, GUIDE ANTIMICROBIAL, P1; Guenther S, 2010, SCI TOTAL ENVIRON, V408, P3519, DOI 10.1016/j.scitotenv.2010.05.005; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Madslien K, 2017, SURVEILLANCE PROGRAM; Mo SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154019; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Nordmann P, 2016, J CLIN MICROBIOL, V54, P1395, DOI 10.1128/JCM.00446-16; NORM/NORM-VET, 2016, NORM NORM VET 2015 U; NORM/NORM-VET. NORM/NORM-VET, 2010, NORM NORM VET 2010 U; NORM/NORM-VET. NORM/NORM-VET, 2014, NORM NORM VET 2014 U; NORM/NORM-VET.NORM/NORM-VET, 2016, NORM NORM VET 2016 U; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Prescott JF, 2014, VET MICROBIOL, V171, P273, DOI 10.1016/j.vetmic.2014.02.035; Radhouani H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00023; Radhouani H, 2013, ARCH MICROBIOL, V195, P141, DOI 10.1007/s00203-012-0853-7; Radhouani H, 2011, J ENVIRON MONITOR, V13, P2227, DOI 10.1039/c0em00682c; Radhouani H, 2011, J WILDLIFE DIS, V47, P769, DOI 10.7589/0090-3558-47.3.769; Robinson TP, 2016, T ROY SOC TROP MED H, V110, P377, DOI 10.1093/trstmh/trw048; Schmidt GV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131672; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Ulstad CR, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0156-x; Walton Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175291; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Xavier BB, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.27.30280	43	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0198019	10.1371/journal.pone.0198019	http://dx.doi.org/10.1371/journal.pone.0198019			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799852	Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400036
J	Pang, Z; Junkins, RD; Raudonis, R; MacNeil, AJ; McCormick, C; Cheng, ZY; Lin, TJ				Pang, Zheng; Junkins, Robert D.; Raudonis, Renee; MacNeil, Adam J.; McCormick, Craig; Cheng, Zhenyu; Lin, Tong-Jun			Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways	PLOS ONE			English	Article							NF-KAPPA-B; AERUGINOSA LUNG INFECTION; TOLL-LIKE RECEPTORS; SYNDROME CRITICAL REGION; PSEUDOMONAS-AERUGINOSA; DOWN-SYNDROME; DENDRITIC CELLS; HOST RESPONSE; IFN-BETA; TRANSCRIPTION FACTORS	Toll-like receptors (TLRs) recognize the conserved molecular patterns in microorganisms and trigger myeloid differentiation primary response 88 (MyD88) and/or TIR-domain-containing adapter-inducing interferon-beta (TRIF) pathways that are critical for host defense against microbial infection. However, the molecular mechanisms that govern TLR signaling remain incompletely understood. Regulator of calcineurin-1 (RCAN1), a small evolutionarily conserved protein that inhibits calcineurin phosphatase activity, suppresses inflammation during Pseudomonas aeruginosa infection. Here, we define the roles for RCAN1 in P. aeruginosa lipopolysaccharide (LPS)-activated TLR4 signaling. We compared the effects of P. aeruginosa LPS challenge on bone marrow-derived macrophages from both wild-type and RCAN1-deficient mice and found that RCAN1 deficiency increased the MyD88-NF-kB-mediated cytokine production (IL-6, TNF and MIP-2), whereas TRIF-interferon-stimulated response elements (ISRE)-mediated cytokine production (IFN beta, RANTES and IP-10) was suppressed. RCAN1 deficiency caused increased IkB alpha phosphorylation and NF-kB activity in the MyD88-dependent pathway, but impaired ISRE activation and reduced IRF7 expression in the TRIF-dependent pathway. Complementary studies of a mouse model of P. aeruginosa LPS-induced acute pneumonia confirmed that RCAN1-deficient mice displayed greatly enhanced NF-kB activity and MyD88-NF-kB-mediated cytokine production, which correlated with enhanced pulmonary infiltration of neutrophils. By contrast, RCAN1 deficiency had little effect on the TRIF pathway in vivo. These findings demonstrate a novel regulatory role of RCAN1 in TLR signaling, which differentially regulates MyD88 and TRIF pathways.	[Junkins, Robert D.; Raudonis, Renee; MacNeil, Adam J.; McCormick, Craig; Cheng, Zhenyu; Lin, Tong-Jun] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Junkins, Robert D.; Raudonis, Renee; MacNeil, Adam J.; McCormick, Craig; Cheng, Zhenyu; Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [McCormick, Craig; Lin, Tong-Jun] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada; [Lin, Tong-Jun] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Junkins, Robert D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [MacNeil, Adam J.] Brock Univ, Dept Hlth Sci, St Catharines, ON, Canada	Dalhousie University; Dalhousie University; Dalhousie University; University of North Carolina; University of North Carolina Chapel Hill; Brock University	Lin, TJ (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.; Lin, TJ (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.; Lin, TJ (corresponding author), Beatrice Hunter Canc Res Inst, Halifax, NS, Canada.; Lin, TJ (corresponding author), IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada.	tong-jun.lin@dal.ca	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722; Raudonis, Renee/0000-0001-6267-8747; Cheng, Zhenyu/0000-0002-7240-9126; Pang, Zheng/0000-0001-7800-1124	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from Natural Sciences and Engineering Research Council of Canada and Canadian Institutes of Health Research.; This work is funded by Natural Sciences and Engineering Research Council of Canada and Canadian Institutes of Health Research.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alzuherri H, 2003, CELL SIGNAL, V15, P471, DOI 10.1016/S0898-6568(02)00120-1; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Cai SS, 2009, J IMMUNOL, V183, P6629, DOI 10.4049/jimmunol.0901033; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Carrigan SO, 2010, J IMMUNOL, V185, P3602, DOI 10.4049/jimmunol.0903429; Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117; Chen B, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.81; Cheung DOY, 2000, INFECT IMMUN, V68, P4585, DOI 10.1128/IAI.68.8.4585-4592.2000; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Dorner BG, 2004, J IMMUNOL, V172, P3119, DOI 10.4049/jimmunol.172.5.3119; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Fukui A, 2013, MICROBIOL IMMUNOL, V57, P198, DOI 10.1111/1348-0421.12022; HESS CB, 1987, J IMMUNOL, V138, P3949; Holmes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011435; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Junkins RD, 2013, J IMMUNOL, V190, P5178, DOI 10.4049/jimmunol.1203196; Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kim SS, 2011, J BIOL CHEM, V286, P37841, DOI 10.1074/jbc.M111.232165; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; KLIMPEL GR, 1990, CELL IMMUNOL, V128, P603, DOI 10.1016/0008-8749(90)90052-S; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Li B, 2006, BLOOD, V107, P2814, DOI 10.1182/blood-2005-09-3610; Li MC, 2009, CURR MOL MED, V9, P365, DOI 10.2174/156652409787847137; Lin TJ, 2002, J IMMUNOL, V169, P4522, DOI 10.4049/jimmunol.169.8.4522; Liu C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.260; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; Moles A, 2014, J HEPATOL, V60, P782, DOI 10.1016/j.jhep.2013.12.005; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Pang Z, 2017, J LEUKOCYTE BIOL, V102, P1461, DOI 10.1189/jlb.4A0517-197R; Pinna F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00610; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Power MR, 2004, J BIOL CHEM, V279, P49315, DOI 10.1074/jbc.M402111200; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ruiz J, 2016, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00105; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Schroder K, 2007, J IMMUNOL, V179, P3495, DOI 10.4049/jimmunol.179.6.3495; Shin SY, 2011, J CELL SCI, V124, P82, DOI 10.1242/jcs.076034; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Sobrado M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-48; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Sundstrom JB, 2001, J VIROL, V75, P6070, DOI 10.1128/JVI.75.13.6070-6085.2001; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Ullah MO, 2016, J LEUKOCYTE BIOL, V100, P27, DOI 10.1189/jlb.2RI1115-531R; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Wu ZL, 2013, J IMMUNOL, V191, P5885, DOI 10.4049/jimmunol.1301271; Xaus J, 2000, BLOOD, V95, P3823; Yang YJ, 2009, J EXP MED, V206, P195, DOI 10.1084/jem.20081140; Yue L, 2016, AM J PATHOL, V186, P1234, DOI 10.1016/j.ajpath.2016.01.005; Zhao W, 2011, J BIOL CHEM, V286, P5519, DOI 10.1074/jbc.M110.149823	86	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197491	10.1371/journal.pone.0197491	http://dx.doi.org/10.1371/journal.pone.0197491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799862	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400013
J	Judge, JL; Nagel, DJ; Owens, KM; Rackow, A; Phipps, RP; Sime, PJ; Kottmann, RM				Judge, Jennifer L.; Nagel, David J.; Owens, Kristina M.; Rackow, Ashley; Phipps, Richard P.; Sime, Patricia J.; Kottmann, R. M.			Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol	PLOS ONE			English	Article							MYOFIBROBLAST DIFFERENTIATION; ACID; ACTIVATION; TARGET; PH	Pulmonary fibrosis is a chronic and irreversible scarring disease in the lung with poor prognosis. Few therapies are available; therefore it is critical to identify new therapeutic targets. Our lab has previously identified the enzyme lactate dehydrogenase-A (LDHA) as a potential therapeutic target in pulmonary fibrosis. We found increases in LDHA protein and its metabolic product, lactate, in patients with idiopathic pulmonary fibrosis (IPF). Importantly, we described lactate as a novel pro-fibrotic mediator by acidifying the extracellular space, and activating latent transforming growth factor beta (TGF-beta 1) in a pH-dependent manner. We propose a pro-fibrotic feed-forward loop by which LDHA produces lactate, lactate decreases pH in the extracellular space and activates TGF-beta 1 which can further perpetuate fibrotic signaling. Our previous work also demonstrates that the LDHA inhibitor gossypol inhibits TGF-beta 1-induced myofibroblast differentiation and collagen production in vitro. Here, we employed a mouse model of bleomycin-induced pulmonary fibrosis to test whether gossypol inhibits pulmonary fibrosis in vivo. We found that gossypol dose-dependently inhibits bleomycin-induced collagen accumulation and TGF-beta 1 activation in mouse lungs when treatment is started on the same day as bleomycin administration. Importantly, gossypol was also effective at treating collagen accumulation when delayed 7 days following bleomycin. Our results demonstrate that inhibition of LDHA with the inhibitor gossypol is effective at both preventing and treating bleomycin-induced pulmonary fibrosis, and suggests that LDHA may be a potential therapeutic target for pulmonary fibrosis.	[Judge, Jennifer L.; Rackow, Ashley; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Environm Med, Rochester, NY 14627 USA; [Judge, Jennifer L.; Nagel, David J.; Owens, Kristina M.; Rackow, Ashley; Phipps, Richard P.; Sime, Patricia J.; Kottmann, R. M.] Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14627 USA; [Nagel, David J.; Owens, Kristina M.; Phipps, Richard P.; Sime, Patricia J.; Kottmann, R. M.] Univ Rochester, Dept Med Pulm & Crit Care Med, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester	Kottmann, RM (corresponding author), Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14627 USA.; Kottmann, RM (corresponding author), Univ Rochester, Dept Med Pulm & Crit Care Med, Rochester, NY 14627 USA.	matt_kottmann@urmc.rochester.edu		Nagel, David/0000-0002-0626-8118	National Institutes of Health [RO1HL127001, RO1HL133761, T32HL066988, F31HL132453]; Parker B. Francis fellowship; Greg Chandler and Guy Solimano Pulmonary Fibrosis Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127001, F31HL132453, T32HL066988, R01HL133761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis fellowship; Greg Chandler and Guy Solimano Pulmonary Fibrosis Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health, RO1HL127001 (PJS), RO1HL133761 (PJS), T32HL066988 (PJS), F31HL132453 (JLJ); Parker B. Francis fellowship (RMK); Greg Chandler and Guy Solimano Pulmonary Fibrosis Research Fund (MK, PJS). The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.16; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; BAUR PS, 1983, J TRAUMA, V23, P853, DOI 10.1097/00005373-198310000-00001; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Deng SJ, 2013, J VET SCI, V14, P281, DOI 10.4142/jvs.2013.14.3.281; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; GUPTA GS, 1988, BIOCHEM INT, V17, P25; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsiao W, 2012, MOL VIS, P2033; IKEDA M, 1990, ANDROLOGIA, V22, P409; Jones KM, 2015, MOL IMAGING BIOL, V17, P177, DOI 10.1007/s11307-014-0784-6; Judge JL, 2015, AM J PHYSIOL-LUNG C, V309, pL879, DOI 10.1152/ajplung.00153.2015; Judge JL, 2017, RAD RES; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Kottmann RM, 2015, AM J PHYSIOL-LUNG C, V309, pL1305, DOI 10.1152/ajplung.00058.2015; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Kottmann RM, 2009, RESPIROLOGY, V14, P917, DOI 10.1111/j.1440-1843.2009.01624.x; Koukourakis MI, BR J CANC, V89, P877, DOI 10; Kulkarni AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063798; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; LEE CYG, 1982, MOL CELL BIOCHEM, V47, P65; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Li H, 2011, PHARM RES-DORDR, V28, P3256, DOI 10.1007/s11095-011-0498-2; Lin J, 2013, ONCOL REP, V30, P731, DOI 10.3892/or.2013.2489; Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985; Lu RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074853; McMahon G, 1996, BIOCHEM J, P343; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Olsen KC, 2014, AM J RESP CELL MOL, V50, P737, DOI 10.1165/rcmb.2013-0092OC; Poobalarahi F, 2006, AM J PHYSIOL-HEART C, V291, pH2924, DOI 10.1152/ajpheart.00153.2006; Ready N, 2011, J THORAC ONCOL, V6, P781, DOI 10.1097/JTO.0b013e31820a0ea6; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Schelman WR, 2014, INVEST NEW DRUG, V32, P295, DOI 10.1007/s10637-013-9999-7; SCHON R, 1965, ANAL BIOCHEM, V12, P413, DOI 10.1016/0003-2697(65)90208-3; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sonpavde G, 2012, ONCOL REP, P1803; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Van Poznak C, 2001, BREAST CANCER RES TR, V66, P239, DOI 10.1023/A:1010686204736; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Zhuang LQ, 2010, MODERN PATHOL, V23, P45, DOI 10.1038/modpathol.2009.129	46	22	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197936	10.1371/journal.pone.0197936	http://dx.doi.org/10.1371/journal.pone.0197936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795645	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300100
J	Pedler, A; McMahon, K; Galloway, G; Durbridge, G; Sterling, M				Pedler, Ashley; McMahon, Katie; Galloway, Graham; Durbridge, Gail; Sterling, Michele			Intramuscular fat is present in cervical multifidus but not soleus in patients with chronic whiplash associated disorders	PLOS ONE			English	Article							NECK-DISABILITY-INDEX; EXTENSOR MUSCLES; CHRONIC PAIN; INJURY; VALIDATION; WAD	The presence of intramuscular fat (IMF) in the cervical spine muscles of patients with whiplash associated disorders (WAD) has been consistently found. The mechanisms underlying IMF are not clear but preliminary evidence implicates a relationship with stress system responses. We hypothesised that if systemic stress system responses do play a role then IMF would be present in muscles remote to the cervical spine. We aimed to investigate if IMF are present in muscle tissue remote (soleus) to the cervical spine in people with chronic WAD. A secondary aim was to investigate associations between IMF and posttraumatic stress symptom levels. Forty-three people with chronic WAD (25 female) and 16 asymptomatic control participants (11 female) participated. Measures of pain, disability and posttraumatic stress symptoms were collected from the WAD participants. Both groups underwent MRI measures of IMF in cervical multifidus and the right soleus muscle. There was significantly greater IMF in cervical multifidus in patients with WAD and moderate/severe disability compared to controls (p = 0.009). There was no difference in multifidus IMF between the mild and moderate/severe disability WAD groups (p = 0.64), or the control and mild WAD groups (p = 0.21). IMF in the right soleus was not different between the groups (p = 0.47). In the WAD group, we found no correlation between PDS symptoms and cervical multifidus IMF or between PDS symptoms and soleus IMF. Global differences in IMF are not a feature of chronic WAD, with differences in IMF limited to the cervical spine musculature. While the mechanisms for the development of IMF in the cervical spine following whiplash injury remain unclear, our data indicate that local factors more likely contribute to these differences.	[Pedler, Ashley; Sterling, Michele] Univ Queensland, NHMRC Ctr Res Excellence Recovery Following Rd Tr, Recover Injury Res Ctr, Brisbane, Qld, Australia; [Pedler, Ashley; Sterling, Michele] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia; [McMahon, Katie; Galloway, Graham; Durbridge, Gail] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Galloway, Graham] Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland; University of Queensland	Sterling, M (corresponding author), Univ Queensland, NHMRC Ctr Res Excellence Recovery Following Rd Tr, Recover Injury Res Ctr, Brisbane, Qld, Australia.; Sterling, M (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia.	m.sterling@uq.edu.au	Sterling, Michele/F-1679-2010; Galloway, Graham/D-2009-2011; McMahon, Katie L/C-6440-2009	Sterling, Michele/0000-0003-1772-2248; Galloway, Graham/0000-0002-0805-2775; McMahon, Katie L/0000-0002-6357-615X				Abbott R, 2015, J ORTHOP SPORT PHYS, V45, P281, DOI 10.2519/jospt.2015.5719; Ahmadi N, 2011, AM J CARDIOL, V108, P29, DOI 10.1016/j.amjcard.2011.02.340; Akerblom S, 2017, INT J BEHAV MED, V24, P249, DOI 10.1007/s12529-017-9641-8; Anderson SE, 2012, RADIOLOGY, V262, P567, DOI 10.1148/radiol.11102115; Elliott J, 2008, CLIN RADIOL, V63, P681, DOI 10.1016/j.crad.2007.11.011; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021194; Elliott J, 2009, EUR SPINE J, V18, P1371, DOI 10.1007/s00586-009-1130-6; Elliott JM, 2015, SPINE, V40, pE694, DOI 10.1097/BRS.0000000000000891; Elliott JM, 2014, PAIN MED, V15, P1938, DOI 10.1111/pme.12518; Elliott JM, 2014, SPINE, V39, P39, DOI 10.1097/BRS.0000000000000033; Elliott JM, 2010, SPINE, V35, P948, DOI 10.1097/BRS.0b013e3181bb0e55; Ferrari R, 2005, ANN RHEUM DIS, V64, P1337, DOI 10.1136/ard.2004.034447; Foa E.B., 1995, PDS POSTTRAUMATIC ST; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Hertzum-Larsen R, 2014, EUR SPINE J, V23, P1673, DOI 10.1007/s00586-014-3362-3; Jergovic M, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00049; Koenig J, 2016, PAIN PRACT, V16, P1048, DOI 10.1111/papr.12399; Li Q, 2013, EUR SPINE J, V22, P14, DOI 10.1007/s00586-012-2490-x; Linnman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019182; Londhe P, 2015, BONE, V80, P131, DOI 10.1016/j.bone.2015.03.015; Meisingset I, 2016, MANUAL THER, V22, P94, DOI 10.1016/j.math.2015.10.013; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Sterling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077903; Sterling M, 2012, PAIN, V153, P1727, DOI 10.1016/j.pain.2012.05.004; Sterling M, 2011, PAIN, V152, P1272, DOI 10.1016/j.pain.2011.01.056; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Walton DM, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/876871; Ware J., 1993, SF 36 HLTH SURVEY MA	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197438	10.1371/journal.pone.0197438	http://dx.doi.org/10.1371/journal.pone.0197438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795590	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300042
J	Wang, Y; Eans, SO; Stacy, HM; Narayanapillai, SC; Sharma, A; Fujioka, N; Haddad, L; McLaughlin, J; Avery, BA; Xing, CG				Wang, Yi; Eans, Shainnel O.; Stacy, Heather M.; Narayanapillai, Sreekanth C.; Sharma, Abhisheak; Fujioka, Naomi; Haddad, Linda; McLaughlin, Jay; Avery, Bonnie A.; Xing, Chengguo			A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications	PLOS ONE			English	Article							KAVA PIPER-METHYSTICUM; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE-INDUCED LUNG TUMORIGENESIS; A/J MICE; LABORATORY-ANIMALS; QUALITY-CONTROL; DRY EXTRACTS; HERBAL DRUG; CHROMATOGRAPHY; DIHYDROMETHYSTICIN; IONIZATION	Kava is regaining its popularity with detailed characterizations warranted. We developed an ultraperformance liquid chromatography high-resolution tandem mass spectrometry (UPLC-MS/MS) method for major kavalactones (kavain, dihydrokavain, methysticin, dihydromethysticin and desmethoxyyangonin) with excellent selectivity and specificity. The method has been validated for different matrices following the Food and Drug Administration guidance of analytical procedures and methods validation. The scope of this method has been demonstrated by quantifying these kavalactones in two kava products, characterizing their tissue distribution and pharmacokinetics in mice, and detecting their presence in human urines and plasmas upon kava intake. As expected, the abundances of these kavalactones differed significantly in kava products. All of them exhibited a large volume of distribution with extensive tissue affinity and adequate mean residence time (MRT) in mice. This method also successfully quantified these kavalactones in human body fluids upon kava consumption at the recommended human dose. This UPLC-MS/MS method therefore can be used to characterize kava products and its pharmacokinetics in animals and in humans.	[Wang, Yi; Narayanapillai, Sreekanth C.; Xing, Chengguo] Univ Florida, Dept Med Chem, Gainesville, FL 32611 USA; [Eans, Shainnel O.; Stacy, Heather M.; McLaughlin, Jay] Univ Florida, Dept Pharmacodynam, Gainesville, FL 32610 USA; [Narayanapillai, Sreekanth C.; Xing, Chengguo] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Sharma, Abhisheak; Avery, Bonnie A.] Univ Florida, Dept Pharmaceut, Gainesville, FL USA; [Fujioka, Naomi] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Haddad, Linda] Univ Florida, Dept Family Community & Hlth Syst Sci, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida	Xing, CG (corresponding author), Univ Florida, Dept Med Chem, Gainesville, FL 32611 USA.; Xing, CG (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	chengguoxing@cop.ufl.edu	Narayanapillai, Sreekanth Chanickal/AAQ-4442-2020; Sharma, Abhisheak/H-9327-2019; Sharma, Abhisheak/V-8401-2017	Sharma, Abhisheak/0000-0003-0553-4039	National Institute of Health [R01CA193278]; Masonic Cancer Center University of Minnesota; University of Florida College of Pharmacy and Department of Medicinal Chemistry; COP PROSPER Award; NATIONAL CANCER INSTITUTE [R01CA193278] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Masonic Cancer Center University of Minnesota(University of Minnesota System); University of Florida College of Pharmacy and Department of Medicinal Chemistry; COP PROSPER Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was partially provided by the National Institute of Health R01CA193278 (CX), Masonic Cancer Center University of Minnesota (NF and CX), the Start-up fund from University of Florida College of Pharmacy and Department of Medicinal Chemistry (JPM and CX), and the COP PROSPER Award (CX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anke J, 2004, J ETHNOPHARMACOL, V93, P153, DOI 10.1016/j.jep.2004.04.009; [Anonymous], 2005, VAL AN PROC TEXT MET; Baum SS, 1998, PROG NEURO-PSYCHOPH, V22, P1105, DOI 10.1016/S0278-5846(98)00062-1; Bilia AR, 2002, J AGR FOOD CHEM, V50, P5016, DOI 10.1021/jf020049j; Bobeldijk I, 2005, J CHROMATOGR A, V1067, P107, DOI 10.1016/j.chroma.2005.01.013; Clouatre DL, 2004, TOXICOL LETT, V150, P85, DOI 10.1016/j.toxlet.2003.07.005; Dams R, 2003, J AM SOC MASS SPECTR, V14, P1290, DOI 10.1016/S1044-0305(03)00574-9; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Fan H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009419; Feltenstein MW, 2003, PHYTOTHER RES, V17, P210, DOI 10.1002/ptr.1107; Food Administration D, 2001, FED REGISTER, V66, P28526; Gaub M, 2004, J PHARMACEUT BIOMED, V36, P859, DOI 10.1016/j.jpba.2004.06.030; Geier FP, 2004, PHYTOTHER RES, V18, P297, DOI 10.1002/ptr.1422; Guo JS, 2015, ANAL CHEM, V87, P5872, DOI 10.1021/acs.analchem.5b01129; He XG, 1997, PLANTA MED, V63, P70, DOI 10.1055/s-2006-957608; JAMIESON DD, 1990, CLIN EXP PHARMACOL P, V17, P495, DOI 10.1111/j.1440-1681.1990.tb01349.x; KELEDJIAN J, 1988, J PHARM SCI, V77, P1003, DOI 10.1002/jps.2600771203; King R, 2000, J AM SOC MASS SPECTR, V11, P942, DOI 10.1016/S1044-0305(00)00163-X; Kuchta K, 2015, PLANTA MED, V81, P1647, DOI 10.1055/s-0035-1558295; Lasme P, 2008, J AGR FOOD CHEM, V56, P4976, DOI 10.1021/jf800439g; Lebot V, 2014, FOOD CHEM, V151, P554, DOI 10.1016/j.foodchem.2013.11.120; Lechtenberg M, 1999, J CHROMATOGR A, V848, P457, DOI 10.1016/S0021-9673(99)00425-2; LEHMANN E, 1989, PHARMACOPSYCHIATRY, V22, P258, DOI 10.1055/s-2007-1014611; Leitzman P, 2014, CANCER PREV RES, V7, P86, DOI 10.1158/1940-6207.CAPR-13-0301; Martin AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111572; Mathews JM, 2005, DRUG METAB DISPOS, V33, P1555, DOI 10.1124/dmd.105.004317; Mathews JM, 2002, DRUG METAB DISPOS, V30, P1153, DOI 10.1124/dmd.30.11.1153; Murauer A, 2017, PLANTA MED, V83, P1053, DOI 10.1055/s-0043-100632; Narayanapillai SC, 2016, DRUG METAB DISPOS, V44, P422, DOI 10.1124/dmd.115.068387; Narayanapillai SC, 2014, CHEM RES TOXICOL, V27, P1871, DOI 10.1021/tx5003194; Narayanapillai SC, 2014, CARCINOGENESIS, V35, P2365, DOI 10.1093/carcin/bgu149; Pittler MH., 2003, COCHRANE DB SYST REV, pCD003383, DOI [10.1002/14651858.CD003383, DOI 10.1002/14651858.CD003383]; RASMUSSEN AK, 1979, XENOBIOTICA, V9, P1; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Russmann S, 2003, EUR J GASTROEN HEPAT, V15, P1033, DOI 10.1097/00042737-200309000-00015; Savage KM, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0986-5; Shaik AA, 2012, ARKIVOC, P137, DOI 10.3998/ark.5550190.0013.813; Shaik AA, 2009, BIOORG MED CHEM LETT, V19, P5732, DOI 10.1016/j.bmcl.2009.08.003; Shao Y, 1998, J CHROMATOGR A, V825, P1, DOI 10.1016/S0021-9673(98)00699-2; Smith KK, 2001, PSYCHOPHARMACOLOGY, V155, P86, DOI 10.1007/s002130100686; Stevinson C, 2002, DRUG SAFETY, V25, P251, DOI 10.2165/00002018-200225040-00003; Stokvis E, 2005, RAPID COMMUN MASS SP, V19, P401, DOI 10.1002/rcm.1790; Tarbah F, 2003, J CHROMATOGR B, V789, P115, DOI 10.1016/S1570-0232(03)00046-1; Tarbah F, 2013, ANN TOXICOL ANAL, V25, P109; Teschke R, 2013, PHYTOTHER RES, V27, P472, DOI 10.1002/ptr.4729; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Wang Y, 2017, CHEM RES TOXICOL, V30, P705, DOI 10.1021/acs.chemrestox.6b00426; *WHO, 2007, ASS RISK HEP KAV PRO; WHO, 2016, KAV REV SAF TRAD REC, V1, P1	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197940	10.1371/journal.pone.0197940	http://dx.doi.org/10.1371/journal.pone.0197940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795658	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300101
J	Lu, L; Dong, JL; Wang, LL; Xia, Q; Zhang, D; Kim, HJ; Yin, T; Fan, SJ; Shen, Q				Lu, Lu; Dong, Jiali; Wang, Lili; Xia, Qing; Zhang, Dan; Kim, Hyejin; Yin, Tao; Fan, Saijun; Shen, Qiang			Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide	ONCOGENE			English	Article							HUMAN TUMOR-CELLS; ACQUIRED RADIORESISTANCE; LUNG-CANCER; STEM-CELLS; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; CARCINOMA-CELLS; PATHWAY; GENERATION; MICE	Radiotherapy significantly improves the therapeutic outcomes and survival of breast cancer patients. However, the acquired resistance to this therapeutic modality is a major clinical challenge. Here we show that ionizing irradiation (IR)-induced phosphorylation of signal transducer and activator of transcription 3 (STAT3) at the Tyr705 residue and the induction of reactive oxygen species (ROS) in wild-type and radioresistant MDA-MB-231 and MDA-MB-468 triple-negative breast cancer (TNBC) cell lines. Comparing with radiosensitive parental TNBC cells, significantly low levels of ROS and higher protein levels of phospho-STAT3 and Bcl-2 were observed in TNBC cells with acquired radioresistance. Moreover, knockdown of STAT3 by shRNA sensitized the TNBC cells to IR. Niclosamide, a potent inhibitor of STAT3, overcame the radioresistance in TNBC cells via inhibition of STAT3 and Bcl-2 and induction of ROS. In combination with radiation, niclosamide treatment resulted in significant increase of ROS generation and induction of apoptosis in parental and radioresistant TNBC cells in vitro and TNBC xenograft tumors in vivo. These findings demonstrate that activation of STAT3 and Bcl-2 and reduction of ROS contribute to the development of radioresistance in TNBC, and niclosamide acts as a potent radiosensitizer via inhibiting STAT3 and Bcl-2 and increasing ROS generation in TNBC cells and xenograft tumors. Our findings suggest that niclosamide in combination with irradiation may offer an effective alternative approach for restoring the sensitivity of radioresistant TNBC cells to IR for improved therapeutic efficacy and outcomes.	[Lu, Lu; Dong, Jiali; Fan, Saijun] Chinese Acad Med Sci, Inst Radiat Med, Tianjin 300192, Peoples R China; [Lu, Lu; Dong, Jiali; Fan, Saijun] Peking Union Med Coll, Tianjin Key Lab Radiat Med & Mol Nucl Med, Tianjin 300192, Peoples R China; [Wang, Lili] Soochow Univ, Dept Radiat Oncol, Affiliated Hosp 1, Suzhou 215006, Jiangshu, Peoples R China; [Wang, Lili; Xia, Qing; Zhang, Dan; Kim, Hyejin; Yin, Tao; Shen, Qiang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Xia, Qing] Shanghai Jiao Tong Univ, Dept Oncol, Affiliated Renji Hosp, Sch Med,Pancreat Canc Ctr, Shanghai 200127, Peoples R China; [Zhang, Dan] Shandong Univ Tradit Chinese Med, Coll Basic Med Sci, Jinan 250355, Shandong, Peoples R China; [Yin, Tao] Huazhong Univ Sci & Technol, Pancreat Dis Inst, Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Soochow University - China; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; Shandong University of Traditional Chinese Medicine; Huazhong University of Science & Technology	Fan, SJ (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Tianjin 300192, Peoples R China.; Fan, SJ (corresponding author), Peking Union Med Coll, Tianjin Key Lab Radiat Med & Mol Nucl Med, Tianjin 300192, Peoples R China.; Shen, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA.	fansaijun@irm-cams.ac.cn; qshen@mdanderson.org	wang, lili/HDL-7210-2022	Shen, Qiang/0000-0002-1491-5434	National Natural Science Foundation of China [81472495, 81572969, 81172127, 81703169, 81730086]; Technology and Development and Research Projects for Research Institutes, Chinese Ministry of Science and Technology [2014EG150134]; Tianjin Science and Technology Support Plan Project [14ZCZDSY00001]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-017]; University of Texas M. D. Anderson Cancer Center; Prevent Cancer Foundation Holden Family Research Grant in Breast Cancer Prevention; Duncan Family Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology and Development and Research Projects for Research Institutes, Chinese Ministry of Science and Technology; Tianjin Science and Technology Support Plan Project; CAMS Innovation Fund for Medical Sciences (CIFMS); University of Texas M. D. Anderson Cancer Center; Prevent Cancer Foundation Holden Family Research Grant in Breast Cancer Prevention; Duncan Family Institute	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81472495, 81572969, 81172127, 81703169, and 81730086); the Technology and Development and Research Projects for Research Institutes, Chinese Ministry of Science and Technology (2014EG150134); the Tianjin Science and Technology Support Plan Project (14ZCZDSY00001); the CAMS Innovation Fund for Medical Sciences (CIFMS, No. 2016-I2M-1-017); in part by startup funds from The University of Texas M. D. Anderson Cancer Center (to QS); Prevent Cancer Foundation Holden Family Research Grant in Breast Cancer Prevention (to QS); and Seed Funding Research Program of Duncan Family Institute (to QS). We also thank Amy Ninetto, PhD, ELS, Department of Scientific Publications, The University of Texas MD Anderson Cancer Center, for her editing of the manuscript.	Al-Hadiya Badraddin M H, 2005, Profiles Drug Subst Excip Relat Methodol, V32, P67, DOI 10.1016/S0099-5428(05)32002-8; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Arend RC, 2016, ONCOTARGET, V7, P86803, DOI 10.18632/oncotarget.13466; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Desai S, 2018, BBA-MOL CELL RES, V1865, P196, DOI 10.1016/j.bbamcr.2017.10.006; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dumont FJ, 2012, CURR CANCER DRUG TAR, V12, P899; Fan SJ, 2013, P NATL ACAD SCI USA, V110, P18650, DOI 10.1073/pnas.1308206110; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Han TJ, 2016, J NEURO-ONCOL, V130, P89, DOI 10.1007/s11060-016-2231-9; Hernandez-Aya LF, 2011, J CLIN ONCOL, V29, P2628, DOI 10.1200/JCO.2010.32.1877; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Jin YY, 2018, EXP CELL RES, V362, P362, DOI 10.1016/j.yexcr.2017.11.037; Kim EJ, 2013, J CELL BIOCHEM, V114, P1248, DOI 10.1002/jcb.24465; Kim JS, 2016, ONCOTARGET, V7, P7055, DOI 10.18632/oncotarget.6855; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Li XX, 2017, BIOMED PHARMACOTHER, V96, P434, DOI 10.1016/j.biopha.2017.09.149; Liu H, 2015, ONCOTARGETS THER, V8, P509, DOI 10.2147/OTT.S76958; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Liu XY, 2012, BIOCHEM PHARMACOL, V83, P1456, DOI 10.1016/j.bcp.2012.02.010; Londono-Joshi AI, 2014, MOL CANCER THER, V13, P800, DOI 10.1158/1535-7163.MCT-13-0555; Lu L, 2016, FREE RADICAL BIO MED, V99, P463, DOI 10.1016/j.freeradbiomed.2016.09.007; Marmol I, 2017, J INORG BIOCHEM, V176, P123, DOI 10.1016/j.jinorgbio.2017.08.020; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Peter B, 2018, LEUKEMIA, V32, P1016, DOI 10.1038/leu.2017.338; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Sato K, 2017, CANCER SCI, V108, P2004, DOI 10.1111/cas.13323; Shimura T, 2010, ONCOGENE, V29, P4826, DOI 10.1038/onc.2010.238; Shimura T, 2014, RADIOTHER ONCOL, V112, P302, DOI 10.1016/j.radonc.2014.07.015; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tinoco G, 2013, J CANCER, V4, P117, DOI 10.7150/jca.4925; Turaga K, 2010, CANCER CONTROL, V17, P177, DOI 10.1177/107327481001700306; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Wang LL, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-P6-12-04; Wang TL, 2005, CANCER RES, V65, P10338, DOI 10.1158/0008-5472.CAN-04-4614; Wang X, 2018, CLIN CANCER RES, V24, P858, DOI 10.1158/1078-0432.CCR-17-0345; Wang Y, 2018, CANCER LETT, V415, P117, DOI 10.1016/j.canlet.2017.12.003; Wang Y, 2017, MOL CANCER THER, V16, P578, DOI 10.1158/1535-7163.MCT-16-0606; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074538; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Ye TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085887; Yeh Jennifer E, 2013, JAKSTAT, V2, pe24635, DOI 10.4161/jkst.24635; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Zhang YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14329	55	90	91	5	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 27	2018	37	39					5292	5304		10.1038/s41388-018-0340-y	http://dx.doi.org/10.1038/s41388-018-0340-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV0NW	29855616				2022-12-26	WOS:000445759700004
J	AlAbdi, L; He, M; Yang, QY; Norvil, AB; Gowher, H				AlAbdi, Lama; He, Ming; Yang, Qianyi; Norvil, Allison B.; Gowher, Humaira			The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; endothelial cell; cell differentiation; E1A-binding protein p300 (P300); gene regulation; chromatin immunoprecipitation (ChiP); DNA methylation; histone acetylation; vascular endothelial growth factor (VEGF); angiogenesis; Cited2; H3K27 acetylation; Vezf1	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; EMBRYONIC STEM-CELLS; GROWTH-FACTOR; NEGATIVE REGULATOR; DOWNSTREAM TARGET; HEART DEVELOPMENT; DNA METHYLATION; GENE-EXPRESSION; FACTOR-I; DIFFERENTIATION	Formation of the vasculature by angiogenesis is critical for proper development, but angiogenesis also contributes to the pathogenesis of various disorders, including cancer and cardiovascular diseases. Vascular endothelial zinc finger 1 (Vezf1), is a Kruppel-like zinc finger protein that plays a vital role in vascular development. However, the mechanism by which Vezf1 regulates this process is not fully understood. Here, we show that Vezf1(-/-) mouse embryonic stem cells (ESC) have significantly increased expression of a stem cell factor, Cbp/p300-interacting transactivator 2 (Cited2). Compared with WT ESCs, Vezf1(-/-) ESCs inefficiently differentiated into endothelial cells (ECs), which exhibited defects in the tube-formation assay. These defects were due to reduced activation of EC-specific genes concomitant with lower enrichment of histone 3 acetylation at Lys(27) (H3K27) at their promoters. We hypothesized that overexpression of Cited2 in Vezf1(-/-) cells sequesters P300/CBP away from the promoters of proangiogenic genes and thereby contributes to defective angiogenesis in these cells. This idea was supported by the observation that shRNA-mediated depletion of Cited2 significantly reduces the angiogenic defects in the Vezf1(-/-) ECs. In contrast to previous studies that have focused on the role of Vezf1 as a transcriptional activator of proangiogenic genes, our findings have revealed a role for Vezf1 in modulating the expression of the antiangiogenic factor Cited2. Vezf1 previously has been characterized as an insulator protein, and our results now provide insights into the mechanism, indicating that Vezf1 can block inappropriate, nonspecific interactions of promoters with cis-located enhancers, preventing aberrant promoter activation.	[AlAbdi, Lama; He, Ming; Yang, Qianyi; Norvil, Allison B.; Gowher, Humaira] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Gowher, Humaira] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Yang, Qianyi] Washington Univ, Sch Med, Dept Anesthesiol, 660 S Euclid Ave, St Louis, MO 63110 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Washington University (WUSTL)	Gowher, H (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Gowher, H (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	hgowher@purdue.edu	Yang, Qianyi/AAW-6730-2021; Gowher, Humaira/AAG-7112-2019	Norvil, Allison/0000-0001-8551-0269; Gowher, Humaira/0000-0002-1250-9571	American Heart Association (AHA) Scientist Development Award [17SDG33700153]; King Saud University (KSU); NCI, National Institutes of Health [P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118654] Funding Source: NIH RePORTER	American Heart Association (AHA) Scientist Development Award(American Heart Association); King Saud University (KSU)(King Saud University); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association (AHA) Scientist Development Award 17SDG33700153 (to H.G.) a Graduate Student Fellowship from the King Saud University (KSU) (to L.A.) and NCI, National Institutes of Health Grant P30 CA023168. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Bruderer M, 2013, J VASC RES, V50, P265, DOI 10.1159/000353287; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; CLARK SP, 1990, NUCLEIC ACIDS RES, V18, P5119, DOI 10.1093/nar/18.17.5119; Deudero JJP, 2008, J BIOL CHEM, V283, P11435, DOI 10.1074/jbc.M703875200; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Du JW, 2013, CURR OPIN HEMATOL, V20, P301, DOI 10.1097/MOH.0b013e3283606022; Du JW, 2012, CELL CYCLE, V11, P2413, DOI 10.4161/cc.20803; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Fox SB, 2004, CANCER RES, V64, P6075, DOI 10.1158/0008-5472.CAN-04-0708; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Gerald D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3824; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Gowher H, 2012, P NATL ACAD SCI USA, V109, P2370, DOI 10.1073/pnas.1121538109; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Imanirad P, 2013, BLOOD CELL MOL DIS, V51, P256, DOI 10.1016/j.bcmd.2013.08.005; KOYANONAKAGAWA N, 1994, MOL CELL BIOL, V14, P5099, DOI 10.1128/MCB.14.8.5099; Kranc KR, 2015, STEM CELLS, V33, P699, DOI 10.1002/stem.1889; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kuhnert F, 2005, DEV BIOL, V283, P140, DOI 10.1016/j.ydbio.2005.04.003; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lebowitz PF, 1998, CELL ADHES COMMUN, V6, P277, DOI 10.3109/15419069809010787; Lee JY, 2009, BIOCHEM BIOPH RES CO, V387, P641, DOI 10.1016/j.bbrc.2009.07.029; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Miyashita H, 2005, ENDOTHELIUM-J ENDOTH, V12, P163, DOI 10.1080/10623320500227101; Miyashita H, 2004, ARTERIOSCL THROM VAS, V24, P878, DOI 10.1161/01.ATV.0000126373.52450.32; Pacheco-Leyva I, 2016, STEM CELL REP, V7, P1037, DOI 10.1016/j.stemcr.2016.10.002; Petell CJ, 2016, NUCLEIC ACIDS RES, V44, P7605, DOI 10.1093/nar/gkw426; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Xiong JW, 1999, DEV BIOL, V206, P123, DOI 10.1006/dbio.1998.9144; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yang SY, 2001, ARTERIOSCL THROM VAS, V21, P1934, DOI 10.1161/hq1201.099432; Yang Z, 2008, LIFE SCI, V82, P512, DOI 10.1016/j.lfs.2007.12.005; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zou ZM, 2010, ARTERIOSCL THROM VAS, V30, P1378, DOI 10.1161/ATVBAHA.109.200428	47	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11109	11118		10.1074/jbc.RA118.002911	http://dx.doi.org/10.1074/jbc.RA118.002911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794136	hybrid, Green Published			2022-12-26	WOS:000438882800023
J	Bishof, I; Dammer, EB; Duong, DM; Kundinger, SR; Gearing, M; Lah, JJ; Levey, AI; Seyfried, NT				Bishof, Isaac; Dammer, Eric B.; Duong, Duc M.; Kundinger, Sean R.; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.			RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; protein aggregation; systems biology; Tau protein (Tau); neurodegeneration; mass spectrometry (MS); proteomics; RNA-binding protein; intrinsically disordered protein; RNA processing	FRONTOTEMPORAL LOBAR DEGENERATION; PRION-LIKE DOMAINS; AMYOTROPHIC-LATERAL-SCLEROSIS; INSOLUBLE BRAIN PROTEOME; LOW-COMPLEXITY DOMAINS; NEURODEGENERATIVE DISEASES; MESSENGER-RNA; NUCLEAR-LOCALIZATION; NETWORK APPROACH; TAU	The U1 small nuclear ribonucleoprotein 70 kDa (U1-70K) and other RNA-binding proteins (RBPs) are mislocalized to cytoplasmic neurofibrillary Tau aggregates in Alzheimer's disease (AD), yet the co-aggregation mechanisms are incompletely understood. U1-70K harbors two disordered low-complexity domains (LC1 and LC2) that are necessary for aggregation in AD brain extracts. The LC1 domain contains highly repetitive basic (Arg/Lys) and acidic (Asp/Glu) residues, referred to as a basic-acidic dipeptide (BAD) domain. We report here that this domain shares many of the properties of the Gln/Asn-rich LC domains in RBPs that also aggregate in neurodegenerative disease. These properties included self-assembly into oligomers and localization to nuclear granules. Co-immunoprecipitations of recombinant U1-70K and deletions lacking the LC domain(s) followed by quantitative proteomic analyses were used to resolve functional classes of U1-70K-interacting proteins that depend on the BAD domain for their interaction. Within this interaction network, we identified a class of RBPs with BAD domains nearly identical to that found in U1-70K. Two members of this class, LUC7L3 and RBM25, required their respective BAD domains for reciprocal interactions with U1-70K and nuclear granule localization. Strikingly, a significant proportion of RBPs with BAD domains had elevated insolubility in the AD brain proteome. Furthermore, we show that the BAD domain of U1-70K can interact with Tau from AD brains but not from other tauopathies. These findings highlight a mechanistic role for BAD domains in stabilizing RBP interactions and in potentially mediating co-aggregation with the pathological AD-specific Tau isoforms.	[Bishof, Isaac; Dammer, Eric B.; Duong, Duc M.; Kundinger, Sean R.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA; [Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Bishof, Isaac; Dammer, Eric B.; Duong, Duc M.; Kundinger, Sean R.; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Seyfried, NT (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	nseyfri@emory.edu	Levey, Allan/F-2104-2011; Dammer, Eric B/V-8652-2019	Levey, Allan/0000-0002-3153-502X; Dammer, Eric B/0000-0003-2947-7606; Duong, Duc/0000-0001-5880-1888	National Institutes of Health, NINDS [P30NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007480, P30NS055077, F31NS093859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, U01AG046161, R01AG053960, R21AG054206] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge Drs. Anita Corbett (Emory Department of Biology) and Daniel Reines (Emory Department of Biochemistry) for providing helpful comments to the manuscript. We also thank Dr. Measho Abreha for technical advice on brain homogenization and immunoprecipitation conditions. Finally, we acknowledge David S. Sanders who on Twitter created the Basic-Acidic Dipeptide (BAD) domain acronym after reading our paper on bioRxiv (https://www.biorxiv.org/). Research reported in this publication was supported in part by the Emory Neuroscience NINDS Core Facilities (Grant P30NS055077) from the National Institutes of Health, NINDS.	Allen M, 2018, ALZHEIMERS DEMENT, V14, P352, DOI 10.1016/j.jalz.2017.09.012; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cherry JD, 2018, J NEUROPATH EXP NEUR, V77, P40, DOI 10.1093/jnen/nlx100; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Diner I, 2014, J BIOL CHEM, V289, P35296, DOI 10.1074/jbc.M114.562959; Egloff S, 2017, EMBO J, V36, P934, DOI 10.15252/embj.201695740; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Falkenberg CV, 2017, BIOPHYS J, V113, P235, DOI 10.1016/j.bpj.2017.01.031; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Freibaum BD, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00035; Hales CM, 2016, PROTEOMICS, V16, P3042, DOI 10.1002/pmic.201600057; Hales CM, 2014, BRAIN PATHOL, V24, P344, DOI 10.1111/bpa.12133; Hales CM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-15; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Howell VM, 2007, HUM MOL GENET, V16, P2506, DOI 10.1093/hmg/ddm206; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; Karpievitch YV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S5; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36741; Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Maziuk B, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00089; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Raj T, 2017, BIORXIV, DOI [10.1101/174565, DOI 10.1101/174565]; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; ROMAC JMJ, 1995, GENE DEV, V9, P1400, DOI 10.1101/gad.9.11.1400; ROMAC JMJ, 1994, MOL CELL BIOL, V14, P4662, DOI 10.1128/MCB.14.7.4662; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Shaw DJ, 2010, J BIOCHEM, V147, P885, DOI 10.1093/jb/mvq025; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stejskalova E, 2014, J CELL SCI, V127, P3909, DOI 10.1242/jcs.155838; Umoh ME, 2018, EMBO MOL MED, V10, P48, DOI 10.15252/emmm.201708202; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vance C, 2013, HUM MOL GENET, V22, P2676, DOI 10.1093/hmg/ddt117; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Webb CHT, 2014, METHODS MOL BIOL, V1126, P117, DOI 10.1007/978-1-62703-980-2_8; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wolozin B, 2015, ADV EXP MED BIOL, V822, P11, DOI 10.1007/978-3-319-08927-0_3; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	79	33	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11047	11066		10.1074/jbc.RA118.001747	http://dx.doi.org/10.1074/jbc.RA118.001747			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29802200	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000438882800018
J	O'Leary, EI; Jiang, ZP; Strub, MP; Lee, JC				O'Leary, Emma I.; Jiang, Zhiping; Strub, Marie-Paule; Lee, Jennifer C.			Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated -synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; NEUTRON REFLECTOMETRY; AMPHIPATHIC HELIX; LIPID VESICLES; PHASE-BEHAVIOR; A-SYNUCLEIN; HUMAN BRAIN; IN-VITRO; BINDING	Membrane association of -synuclein (-syn), a neuronal protein associated with Parkinson's disease (PD), is involved in -syn function and pathology. Most previous studies on -syn-membrane interactions have not used the physiologically relevant N-terminally acetylated (N-acetyl) -syn form nor the most naturally abundant cellular lipid, i.e. phosphatidylcholine (PC). Here, we report on how PC membrane fluidity affects the conformation and aggregation propensity of N-acetyl -syn. It is well established that upon membrane binding, -syn adopts an -helical structure. Using CD spectroscopy, we show that N-acetyl -syn transitions from -helical to disordered at the lipid melting temperature (T-m). We found that this fluidity sensing is a robust characteristic, unaffected by acyl chain length (T-m = 34-55 degrees C) and preserved in its homologs - and -syn. Interestingly, both N-acetyl -syn membrane binding and amyloid formation trended with lipid order (1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) > 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)/sphingomyelin/cholesterol (2:2:1) DOPC), with gel-phase vesicles shortening aggregation kinetics and promoting fibril formation compared to fluid membranes. Furthermore, we found that acetylation enhances binding to PC micelles and small unilamellar vesicles with high curvature (r approximate to 16-20 nm) and that DPPC binding is reduced in the presence of cholesterol. These results confirmed that the exposure of hydrocarbon chains (i.e. packing defects) is essential for binding to zwitterionic gel membranes. Collectively, our in vitro results suggest that N-acetyl -syn localizes to highly curved, ordered membranes inside a cell. We propose that age-related changes in membrane fluidity can promote the formation of amyloid fibrils, insoluble materials associated with PD.	[O'Leary, Emma I.; Jiang, Zhiping; Lee, Jennifer C.] NHLBI, Lab Prot Conformat & Dynam, NIH, Bldg 10, Bethesda, MD 20892 USA; [Strub, Marie-Paule] NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lee, JC (corresponding author), NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA.	leej4@mail.nih.gov	O'Leary, Emma/P-9387-2019	O'Leary, Emma/0000-0002-6437-3848	Intramural Research Program at the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001055] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Brisbois CA, 2016, BIOCHEMISTRY-US, V55, P4939, DOI 10.1021/acs.biochem.6b00599; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Chong SSY, 2014, BIOCHEMISTRY-US, V53, P450, DOI 10.1021/bi401457r; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Galvagnion C, 2017, J PARKINSON DIS, V7, P433, DOI 10.3233/JPD-171103; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jiang ZP, 2017, J PHYS CHEM LETT, V8, P29, DOI 10.1021/acs.jpclett.6b02304; Jiang ZP, 2015, J PHYS CHEM B, V119, P4812, DOI 10.1021/jp512499r; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Kranenburg M, 2005, J PHYS CHEM B, V109, P6553, DOI 10.1021/jp0457646; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Leftin A, 2013, J MOL BIOL, V425, P2973, DOI 10.1016/j.jmb.2013.04.002; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Levi M, 1997, MECH AGEING DEV, V97, P109, DOI 10.1016/S0047-6374(97)00047-X; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; McGlinchey RP, 2017, BIOCHEMISTRY-US, V56, P3881, DOI 10.1021/acs.biochem.7b00360; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Pirc K, 2015, BBA-BIOMEMBRANES, V1848, P2002, DOI 10.1016/j.bbamem.2015.06.021; Quinn PJ, 2009, BBA-BIOMEMBRANES, V1788, P33, DOI 10.1016/j.bbamem.2008.08.005; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Vargas KJ, 2017, CELL REP, V18, P161, DOI 10.1016/j.celrep.2016.12.023; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Xu LJ, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/1720621; Yap TL, 2015, J BIOL CHEM, V290, P744, DOI 10.1074/jbc.M114.610584; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010	68	52	52	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11195	11205		10.1074/jbc.RA118.002780	http://dx.doi.org/10.1074/jbc.RA118.002780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29853639	Green Published, hybrid			2022-12-26	WOS:000438882800030
J	Cao, D; Liu, YL; Ma, LL; Jin, XF; Guo, GY; Tan, RR; Liu, Z; Zheng, L; Ye, F; Liu, W				Cao, Dan; Liu, Yanli; Ma, Linlong; Jin, Xiaofang; Guo, Guiyi; Tan, Rongrong; Liu, Zheng; Zheng, Lin; Ye, Fei; Liu, Wei			Transcriptome analysis of differentially expressed genes involved in selenium accumulation in tea plant (Camellia sinensis)	PLOS ONE			English	Article							GREEN TEA; PHOSPHATE TRANSPORTER; OXIDATIVE STRESS; HORMONAL-CONTROL; SULFATE UPTAKE; SELENATE; BIOFORTIFICATION; RICE; TRANSLOCATION; PEROXIDASE	Tea plant (Camellia sinensis) has strong enrichment ability for selenium (Se). Selenite is the main form of Se absorbed and utilized by tea plant. However, the mechanism of selenite absorption and accumulation in tea plant is still unknown. In this study, RNA sequencing (RNA-seq) was used to perform transcriptomic analysis on the molecular mechanism of selenite absorption and accumulation in tea plant. 397.98 million high-quality reads were obtained and assembled into 168,212 unigenes, 89,605 of which were extensively annotated. There were 60,582 and 1,362 differentially expressed genes (DEGs) in roots and leaves, respectively. RNA-seq results were further validated by quantitative RT-PCR. Based on GO terms, the unigenes were mainly involved in cell, binding and metabolic process. KEGG pathway enrichment analysis showed that predominant pathways included ribosome and protein processing in endoplasmic reticulum. Further analysis revealed that sulfur metabolism, glutathione metabolism, selenocompound metabolism and plant hormone signal transduction responded to selenite in tea plant. Additionally, a large number of genes of higher expressions associated with phosphate transporters, sulfur assimilation, antioxidant enzymes, antioxidant substances and responses to ethylene and jasmonic acid were identified. Stress-related plant hormones might play a signaling role in promoting sulfate/selenite uptake and assimilation in tea plant. Moreover, some other Se accumulation mechanisms of tea plant were found. Our study provides a possibility for controlling Se accumulation in tea plant through bio-technologies and will be helpful for breeding new tea cultivars.	[Cao, Dan; Liu, Yanli; Ma, Linlong; Jin, Xiaofang; Tan, Rongrong; Liu, Zheng; Zheng, Lin; Ye, Fei] Hubei Acad Agr Sci, Fruit & Tea Res Inst, Wuhan, Hubei, Peoples R China; [Guo, Guiyi; Liu, Wei] Xinyang Agr & Forestry Univ, Henan Key Lab Tea Comprehens Utilizat South Henan, Xinyang, Henan, Peoples R China	Hubei Academy of Agricultural Sciences; Xinyang Agriculture & Forestry University	Jin, XF (corresponding author), Hubei Acad Agr Sci, Fruit & Tea Res Inst, Wuhan, Hubei, Peoples R China.; Guo, GY (corresponding author), Xinyang Agr & Forestry Univ, Henan Key Lab Tea Comprehens Utilizat South Henan, Xinyang, Henan, Peoples R China.	xfjin@126.com; ggy6363@aliyun.com		, Dan/0000-0002-4219-5593	Innovation Center Fund for Agricultural Science and Technology in Hubei Province of China [2016-620-000-001-032]; Fund of Hubei Academy of Agricultural Science [2018NKYJJ12]; Open Fund of Henan Key Laboratory of Tea Comprehensive Utilization in South Henan of China [HNKLTOF2017002]	Innovation Center Fund for Agricultural Science and Technology in Hubei Province of China; Fund of Hubei Academy of Agricultural Science; Open Fund of Henan Key Laboratory of Tea Comprehensive Utilization in South Henan of China	The work was supported by the Innovation Center Fund for Agricultural Science and Technology in Hubei Province of China (2016-620-000-001-032), the Fund of Hubei Academy of Agricultural Science (2018NKYJJ12) and the Open Fund of Henan Key Laboratory of Tea Comprehensive Utilization in South Henan of China (HNKLTOF2017002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Arpat AB, 2012, PLANT J, V71, P479, DOI 10.1111/j.1365-313X.2012.05004.x; Bhatt I, 2011, BIOTECHNOL ADV, V29, P850, DOI 10.1016/j.biotechadv.2011.07.002; Bork C, 1998, GENE, V212, P147, DOI 10.1016/S0378-1119(98)00155-3; Cabannes E, 2011, PLANT PHYSIOL, V157, P2227, DOI 10.1104/pp.111.183897; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Cakir O, 2016, PLANT BIOTECHNOL J, V14, P543, DOI 10.1111/pbi.12397; Cakir O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135677; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chen LC, 2002, J AGR FOOD CHEM, V50, P5128, DOI 10.1021/jf0201374; Chen Si-yang, 2011, Huanjing Kexue, V32, P284; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; El Kassis E, 2007, PLANT PHYSIOL, V143, P1231, DOI 10.1104/pp.106.091462; Elberse IAM, 2003, J ECOL, V91, P371, DOI 10.1046/j.1365-2745.2003.00776.x; ELRASHIDI MA, 1987, SOIL SCI, V144, P141, DOI 10.1097/00010694-198708000-00008; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Freeman JL, 2010, PLANT PHYSIOL, V153, P1630, DOI [10.1104/pp.110.156570, 10.1186/1472-6785-10-19]; Fu LH, 2002, J BIOL CHEM, V277, P25983, DOI 10.1074/jbc.M202912200; Gomes-Junior RA, 2007, FUNCT PLANT BIOL, V34, P449, DOI 10.1071/FP07010; Gong XZ, 1996, NATURAL PRODUCTS RES, P59; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harinasut Poontariga, 2003, ScienceAsia, V29, P109, DOI 10.2306/scienceasia1513-1874.2003.29.109; Hatzfeld Y, 2000, GENE, V248, P51, DOI 10.1016/S0378-1119(00)00132-3; Hernandez-Castro E, 2015, J SOIL SCI PLANT NUT, V15, P694; Hopkins L, 2004, PLANT BIOLOGY, V6, P408, DOI 10.1055/s-2004-820872; [胡玉荣 Hu Yurong], 2015, [园艺学报, Acta Horticulturae Sinica], V42, P2306; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Huang J., 2014, EFFECTS SELENIUM TEA; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Johnson R, 2012, MATURITAS, V73, P280, DOI 10.1016/j.maturitas.2012.08.008; Keskinen R, 2010, PLANT SOIL, V333, P301, DOI 10.1007/s11104-010-0345-y; Koprivova A, 2016, PLANT MOL BIOL, V91, P617, DOI 10.1007/s11103-016-0438-y; Lehotai N, 2016, PLANT CELL REP, V35, P1, DOI [10.1007/s00213-016-4382-y, DOI 10.1007/S00213-016-4382-Y]; Li CY, 2015, FUNGAL GENET BIOL, V82, P168, DOI 10.1016/j.fgb.2015.07.008; Liu XW, 2016, PLANT SOIL, V399, P295, DOI 10.1007/s11104-015-2699-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lyons GH, 2004, NUTR REV, V62, P247, DOI 10.1301/nr2004.jun247-252; Mimmo T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01887; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Perumalla AVS, 2011, FOOD RES INT, V44, P827, DOI 10.1016/j.foodres.2011.01.022; Pilon-Smits E.A.H., 2015, PROGR BOT, V76, P93; Pilon-Smits EA, 2017, SELENIUM IN PLANTS; Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006; Rajkumar AP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1767-y; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; Schiavon M, 2013, J AGR FOOD CHEM, V61, P10542, DOI 10.1021/jf4031822; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; SHRIFT A, 1969, PLANT PHYSIOL, V44, P893, DOI 10.1104/pp.44.6.893; Song ZP, 2017, ENVIRON EXP BOT, V137, P158, DOI 10.1016/j.envexpbot.2017.02.011; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Tamaoki M, 2008, PLANT PHYSIOL, V146, P1219, DOI 10.1104/pp.107.110742; Thavarajah D, 2008, J AGR FOOD CHEM, V56, P10747, DOI 10.1021/jf802307h; Van Hoewyk D, 2008, PHYSIOL PLANTARUM, V132, P236, DOI 10.1111/j.1399-3054.2007.01002.x; Wang XiaoFang, 2016, Journal of Agricultural Resources and Environment, V33, P334; [温立香 Wen Lixiang], 2013, [热带作物学报, Chinese Journal of Tropical Crops], V34, P201; White PJ, 2016, ANN BOT-LONDON, V117, P217, DOI 10.1093/aob/mcv180; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; Winkel LHE, 2012, ENVIRON SCI TECHNOL, V46, P571, DOI 10.1021/es203434d; [向昌国 Xiang Changguo], 2012, [天然产物研究与开发, Natural Product R & D], V24, P1084; Xie JuanPing, 2016, Food Research and Development, V37, P156; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang LH, 2006, PEDOSPHERE, V16, P646, DOI 10.1016/S1002-0160(06)60098-2; Zhang LH, 2015, J PLANT NUTR, V38, P768, DOI 10.1080/01904167.2014.939287; Zhang LH, 2014, NEW PHYTOL, V201, P1183, DOI 10.1111/nph.12596; Zhao HT, 2015, J CO2 UTIL, V11, P10, DOI 10.1016/j.jcou.2014.11.004; Zhao XQ, 2010, PLANT PHYSIOL, V153, P1871, DOI 10.1104/pp.110.157867; Zhou W., 2012, J MOUNTAIN AGR BIOL, V31, P514; Zhu JM, 2010, NAT S MED GEOGR; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006	76	24	29	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197506	10.1371/journal.pone.0197506	http://dx.doi.org/10.1371/journal.pone.0197506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856771	Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800027
J	Ilyinskii, PO; Kovalev, GI; O'Neil, CP; Roy, CJ; Michaud, AM; Drefs, NM; Pechenkin, MA; Fu, FN; Johnston, LPM; Ovchinnikov, DA; Kishimoto, TK				Ilyinskii, Petr O.; Kovalev, Grigoriy, I; O'Neil, Conlin P.; Roy, Christopher J.; Michaud, Alicia M.; Drefs, Natalia M.; Pechenkin, Mikhail A.; Fu, Fen-ni; Johnston, Lloyd P. M.; Ovchinnikov, Dmitry A.; Kishimoto, Takashi Kei			Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS 16; ESTABLISHED TUMORS; PEPTIDE VACCINATION; THERAPEUTIC VACCINE; IMMUNE-RESPONSE; CANCER; NANOPARTICLES; ANTIGEN; CELLS; WOMEN	We previously reported that synthetic vaccine particles (SVP) encapsulating antigens and TLR agonists resulted in augmentation of immune responses with minimal production of systemic inflammatory cytokines. Here we evaluated two different polymer formulations of SVP-encapsulated antigens and tested their ability to induce cytolytic T lymphocytes (CTL) in combination with SVP-encapsulated adjuvants. One formulation led to efficient antigen processing and cross-presentation, rapid and sustained CTL activity, and expansion of CD8(+) T cell effector memory cells locally and centrally, which persisted for at least 1-2 years after a single immunization. SVP therapeutic dosing resulted in suppression of tumor growth and a substantial delay in mortality in several syngeneic mouse cancer models. Treatment with checkpoint inhibitors and/or cytotoxic drugs, while suboptimal on their own, showed considerable synergy with SVP immunization. SVP encapsulation of endosomal TLR agonists provided superior CTL induction, therapeutic benefit and/or improved safety profile compared to free adjuvants. SVP vaccines encapsulating mutated HPV-16 E7 and E6/E7 recombinant proteins led to induction of broad CTL activity and strong inhibition of TC-1 tumor growth, even when administered therapeutically 13-14 days after tumor inoculation in animals bearing palpable tumors. A pilot study in non-human primates showed that SVP-encapsulated E7/E6 adjuvanted with SVP-encapsulated poly(I:C) led to robust induction of antigen-specific T and B cell responses.	[Ilyinskii, Petr O.; O'Neil, Conlin P.; Roy, Christopher J.; Michaud, Alicia M.; Fu, Fen-ni; Johnston, Lloyd P. M.; Kishimoto, Takashi Kei] Selecta Biosci, Watertown, MA 02472 USA; [Kovalev, Grigoriy, I; Drefs, Natalia M.; Pechenkin, Mikhail A.; Ovchinnikov, Dmitry A.] SelectaRUS, Chimki, Moskovskaya Obl, Russia		Kishimoto, TK (corresponding author), Selecta Biosci, Watertown, MA 02472 USA.	kkishimoto@selectabio.com	Kovalev, Grigoriy/V-8768-2018	Kovalev, Grigoriy/0000-0003-4346-3585; Roy, Chad/0000-0002-1710-6974	Selecta Biosciences; SelectaRUS; Skolkovo foundation [G49/14]	Selecta Biosciences; SelectaRUS; Skolkovo foundation	Selecta Biosciences provided support in the form of salaries for authors POI, CPO, CJR, AMM, FF, LPMJ, TKK, and SelectaRUS provided support in the form of salaries for authors GIK, NMD, MAP, and DAO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Grigoriy Kovalev, Natalia Drefs, Mikhail Pechenkin and Dmitry Ovchinnikov were supported in part by the grant from the Skolkovo foundation #G49/14 from December 10, 2014. Skolkovo Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322; Bae SH, 2007, CLIN CANCER RES, V13, P341, DOI 10.1158/1078-0432.CCR-06-1838; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Bartkowiak T, 2015, P NATL ACAD SCI USA, V112, pE5290, DOI 10.1073/pnas.1514418112; Benne N, 2016, J CONTROL RELEASE, V234, P124, DOI 10.1016/j.jconrel.2016.05.033; Berraondo P, 2007, CANCER RES, V67, P8847, DOI 10.1158/0008-5472.CAN-07-0321; Chaoul N, 2015, CANCER RES, V75, P3279, DOI 10.1158/0008-5472.CAN-15-0454; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Daayana S, 2010, BRIT J CANCER, V102, P1129, DOI 10.1038/sj.bjc.6605611; Fraser CC, 2014, VACCINE, V32, P2896, DOI 10.1016/j.vaccine.2014.02.024; Frazer IH, 2004, VACCINE, V23, P172, DOI 10.1016/j.vaccine.2004.05.013; Guo CQ, 2013, ADV CANCER RES, V119, P421, DOI 10.1016/B978-0-12-407190-2.00007-1; Gutjahr A, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040034; Heidenreich R, 2015, INT J CANCER, V137, P372, DOI 10.1002/ijc.29402; Hemont C, 2013, J LEUKOCYTE BIOL, V93, P599, DOI 10.1189/jlb.0912452; Ilyinskii PO, 2014, VACCINE, V32, P2882, DOI 10.1016/j.vaccine.2014.02.027; Ilyinskii PO, 2015, BIOL TREAT SUBSTANCE, P249; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kirkwood JM, 2012, CA-CANCER J CLIN, V62, P309, DOI 10.3322/caac.20132; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lin KY, 1996, CANCER RES, V56, P21; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Peng SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116389; Petit RG, 2014, J IMMUNOTHERAPY C S3, V2, P92; Preville X, 2005, CANCER RES, V65, P641; Rietscher R, 2016, EUR J PHARM BIOPHARM, V102, P20, DOI 10.1016/j.ejpb.2016.02.014; Rivera-Gil P, 2009, NANO LETT, V9, P4398, DOI 10.1021/nl902697j; Sacco JJ, 2016, HUM VACC IMMUNOTHER, V12, P1085, DOI 10.1080/21645515.2015.1121338; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Schlom J, 2014, ADV CANCER RES, V121, P67, DOI 10.1016/B978-0-12-800249-0.00002-0; SEEDORF K, 1987, EMBO J, V6, P139, DOI 10.1002/j.1460-2075.1987.tb04731.x; Serda RE, 2013, INT J NANOMED, V8, P1683, DOI 10.2147/IJN.S31756; Seth A, 2015, NANOMEDICINE-UK, V10, P959, DOI [10.2217/NNM.14.200, 10.2217/nnm.14.200]; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Silva AL, 2015, VACCINE, V33, P847, DOI 10.1016/j.vaccine.2014.12.059; Silva JM, 2013, J CONTROL RELEASE, V168, P179, DOI 10.1016/j.jconrel.2013.03.010; Song C, 2016, INT J NANOMED, V11, P3753, DOI 10.2147/IJN.S110796; Sun YY, 2016, CLIN CANCER RES, V22, P657, DOI 10.1158/1078-0432.CCR-15-0234; Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1; Van Damme P, 2016, CLIN CANCER RES, V22, P3238, DOI 10.1158/1078-0432.CCR-16-0085; van Steenwijk PJD, 2014, CANCER IMMUNOL IMMUN, V63, P147, DOI 10.1007/s00262-013-1499-2; van Steenwijk PJD, 2012, CANCER IMMUNOL IMMUN, V61, P1485, DOI 10.1007/s00262-012-1292-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Welters MJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8307; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Wong KK, 2016, ADV IMMUNOL, V130, P191, DOI 10.1016/bs.ai.2015.12.001; Yan J, 2009, VACCINE, V27, P431, DOI 10.1016/j.vaccine.2008.10.078; Yan J, 2008, VACCINE, V26, P5210, DOI 10.1016/j.vaccine.2008.03.069; Yang A, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0293-9	56	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197694	10.1371/journal.pone.0197694	http://dx.doi.org/10.1371/journal.pone.0197694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856772	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800034
J	Martinez, O; Reyes-Valdes, MH				Martinez, Octavio; Humberto Reyes-Valdes, M.			On an algorithmic definition for the components of the minimal cell	PLOS ONE			English	Article							ESSENTIAL GENES; TRANSCRIPTION FACTOR; METABOLIC PATHWAYS; MUTATIONS CAUSE; RNA-POLYMERASE; GENOME; NETWORK; MODEL; LIFE; ESSENTIALITY	Living cells are highly complex systems comprising a multitude of elements that are engaged in the many convoluted processes observed during the cell cycle. However, not all elements and processes are essential for cell survival and reproduction under steady-state environmental conditions. To distinguish between essential from expendable cell components and thus define the 'minimal cell' and the corresponding 'minimal genome', we postulate that the synthesis of all cell elements can be represented as a finite set of binary operators, and within this framework we show that cell elements that depend on their previous existence to be synthesized are those that are essential for cell survival. An algorithm to distinguish essential cell elements is presented and demonstrated within an interactome. Data and functions implementing the algorithm are given as supporting information. We expect that this algorithmic approach will lead to the determination of the complete interactome of the minimal cell, which could then be experimentally validated. The assumptions behind this hypothesis as well as its consequences for experimental and theoretical biology are discussed.	[Martinez, Octavio] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad LANGEBIO, Unidad Genom Avanzada, Guanajuato, Mexico; [Humberto Reyes-Valdes, M.] Univ Autonoma Agr Antonio Narro, Grad Program Plant Genet Resources Arid Lands, Saltillo, Coahuila, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Martinez, O (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad LANGEBIO, Unidad Genom Avanzada, Guanajuato, Mexico.	octavio.martinez@cinvestav.mx	Martinez, Octavio/F-3951-2014	Martinez, Octavio/0000-0002-7590-0041				Abner K, 2014, J THEOR BIOL, V341, P78, DOI 10.1016/j.jtbi.2013.09.035; Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bach-Pages M, 2017, TRENDS PLANT SCI, V22, P449, DOI 10.1016/j.tplants.2017.04.006; Bang-Jensen J, 2009, SPRINGER MONOGR MATH, P1, DOI 10.1007/978-1-84800-998-1_1; Bedau M, 2010, NATURE, V465, P422, DOI 10.1038/465422a; Bender EA., 2012, INTRO MATH MODELING; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Bhowmik D, 2017, BIOPHYS J, V88, P8958; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; Bunner AE, 2010, J MOL BIOL, V398, P1, DOI 10.1016/j.jmb.2010.02.036; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Champion L, 2017, TRENDS CELL BIOL, V27, P26, DOI 10.1016/j.tcb.2016.07.004; CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524; Cirilli M, 2017, BBA-GEN SUBJECTS, V1861, P467, DOI 10.1016/j.bbagen.2016.10.002; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Diestel R., 2000, GRAD TEXT M, V173; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Fu H., 2004, PROTEIN PROTEIN INTE, V261; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gibson DG, 2014, NATURE, V509, P168, DOI 10.1038/509168a; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gunji YP, 2008, J THEOR BIOL, V253, P659, DOI 10.1016/j.jtbi.2008.04.017; Guven-Maiorov E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005579; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hall EA, 2017, AM J HUM GENET, V100, P706, DOI 10.1016/j.ajhg.2017.03.008; Hartmann T, 1996, ENTOMOL EXP APPL, V80, P177, DOI 10.1007/BF00194753; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; HUANG RP, 1993, DNA CELL BIOL, V12, P265, DOI 10.1089/dna.1993.12.265; Huang X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3239; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Ideker T, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005771; ITAYA M, 1995, FEBS LETT, V362, P257, DOI 10.1016/0014-5793(95)00233-Y; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Junker B. H., 2011, ANAL BIOL NETWORKS; Kannan K, 2017, SCIENCE, V355, P1024, DOI 10.1126/science.aam9739; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Li X, 2017, NAT BIOTECHNOL, V35, P940, DOI 10.1038/nbt.3968; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Mercy G, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4597; Meyer MJ, 2018, NAT METHODS, V15, P107, DOI 10.1038/nmeth.4540; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Mincheva M, 2007, J MATH BIOL, V55, P61, DOI 10.1007/s00285-007-0099-1; Mistry D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187091; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Muetze Tanja, 2017, Curr Protoc Bioinformatics, V59, DOI 10.1002/cpbi.35; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Najmanovich RJ, 2017, CURR OPIN STRUC BIOL, V45, P85, DOI 10.1016/j.sbi.2016.11.024; OBERHOLZER T, 1995, BIOCHEM BIOPH RES CO, V207, P250, DOI 10.1006/bbrc.1995.1180; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Piazza I, 2018, CELL, V172, P358, DOI 10.1016/j.cell.2017.12.006; Porcar Manuel, 2011, Syst Synth Biol, V5, P1, DOI 10.1007/s11693-011-9084-5; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; RCore Team, 2020, R LANG ENV STAT COMP; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Rosanova A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07761-0; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89; Schatz A, 1944, P SOC EXP BIOL MED, V55, P66, DOI 10.3181/00379727-55-14461; Seitz H., 2007, ANAL PROTEIN DNA INT; Selkov E, 1996, NUCLEIC ACIDS RES, V24, P26, DOI 10.1093/nar/24.1.26; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Tang Q, 2019, BRIEF BIOINFORM, V20, P1322, DOI 10.1093/bib/bbx173; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Vickers CE, 2010, NAT CHEM BIOL, V6, P875, DOI 10.1038/nchembio.484; Virchow R, 1858, CELLULARPATHOLOGIE I; Wade N., 2010, NY TIMES, V20, P1; Wang B, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005621; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Xavier JC, 2014, MICROBIOL MOL BIOL R, V78, P487, DOI 10.1128/MMBR.00050-13; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Xu J., 2012, J INTERDISCIPLINARY, V1, P50, DOI [10.5455/jihp.20121209033242, DOI 10.5455/JIHP.20121209033242]; Yuh Chiou-Hwa, 2001, P73; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	98	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198222	10.1371/journal.pone.0198222	http://dx.doi.org/10.1371/journal.pone.0198222			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856803	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800090
J	Park, KA; Choi, DD; Oh, SY				Park, Kyung-Ah; Choi, Daye Diana; Oh, Sei Yeul			Macular choroidal thickness and peripapillary retinal nerve fiber layer thickness in normal adults and patients with optic atrophy due to acute idiopathic demyelinating optic neuritis	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY; NEUROPATHY; GLAUCOMA	Purpose To evaluate the association between macular choroidal thickness and peripapillary RNFL thickness in patients with optic atrophy due to acute idiopathic demyelinating optic neuritis and in normal controls using spectral domain optical coherence tomography (SD-OCT). Methods We performed SD-OCT peripapillary RNFL circular scan centered on the optic disc with horizontal and vertical crosshair scans through the fovea using the enhanced depth technique in 62 eyes with optic atrophy due to acute idiopathic demyelinating optic neuritis and 86 eyes of normal controls. The association between RNFL thickness and macular choroidal thickness measurements was assessed. Results The mean age was 43 +/- 14 years (mean +/- SD) in patients with optic atrophy and 45 +/- 16 years in healthy controls (p = 0.791). There was a significant association between nasal peripapillary RNFL thickness and choroidal thickness at 3.0 mm nasal to the foveal center in patients with optic atrophy in multivariate analysis (estimate = 1.398, p = 0.011). In controls, there were significant associations between global average, superior, and inferior peripapillary RNFL thickness and choroidal thickness at 3.0 mm superior to the foveal center (estimate = -60.112, p = 0.044, estimate = 15.821, p = 7.312, and estimate = 15.203, p = 7.222, respectively). Conclusions Our SD-OCT data revealed that there was a significant association between peripapillary RNFL thickness and macular choroidal thickness in patients with optic atrophy due to acute idiopathic demyelinating optic neuritis and in controls, although the mechanism remained unclear. The difference in the pattern of association between patients with optic atrophy and controls suggests that optic atrophy caused by acute idiopathic demyelinating optic neuritis could affect the pattern of association between peripapillary RNFL thickness and macular choroidal thickness.	[Park, Kyung-Ah; Choi, Daye Diana; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu			Samsung Medical Center [SMX1180041]	Samsung Medical Center(Samsung)	This work was supported by the Samsung Medical Center, SMX1180041, to M.D. Kyung-Ah Park supported this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Deng JJ, 2018, INVEST OPHTH VIS SCI, V59, P1577, DOI 10.1167/iovs.17-22748; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Garcia-Basterra I, 2016, Arch Soc Esp Oftalmol, V91, P223, DOI 10.1016/j.oftal.2015.12.019; Garcia-Basterra I, 2016, BRIT J OPHTHALMOL, V100, P891, DOI 10.1136/bjophthalmol-2015-307526; Gonul S, 2015, AM J OPHTHALMOL, V159, P994, DOI 10.1016/j.ajo.2015.01.036; Gupta P, 2016, AM J OPHTHALMOL, V161, P4, DOI 10.1016/j.ajo.2015.09.018; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Jones AL, 2001, BRIT J OPHTHALMOL, V85, P673, DOI 10.1136/bjo.85.6.673; Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2; Karahan E, 2017, SEMIN OPHTHALMOL, V32, P602, DOI 10.3109/08820538.2016.1139736; Kucukevcilioglu M, 2017, CURR EYE RES, V42, P302, DOI 10.3109/02713683.2016.1170856; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Medeiros FA, 2003, AM J OPHTHALMOL, V135, P406, DOI 10.1016/S0002-9394(02)02049-4; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Wang XG, 2014, BRIT J OPHTHALMOL, V98, P1368, DOI 10.1136/bjophthalmol-2013-304547	17	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198340	10.1371/journal.pone.0198340	http://dx.doi.org/10.1371/journal.pone.0198340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856811	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800104
J	Taneja, S; Rongsen-Chandola, T; Mohan, SB; Mazumder, S; Bhandari, N; Kaur, J; Arya, N; Chowdhury, R; Martines, JC; Bahl, R; Bhan, MK				Taneja, Sunita; Rongsen-Chandola, Temsunaro; Mohan, Sanjana Brahmawar; Mazumder, Sarmila; Bhandari, Nita; Kaur, Jasmine; Arya, Nikita; Chowdhury, Ranadip; Martines, Jose Carlos; Bahl, Rajiv; Bhan, M. K.			Mid upper arm circumference as a predictor of risk of mortality in children in a low resource setting in India	PLOS ONE			English	Article							WEIGHT-FOR-HEIGHT; ANTHROPOMETRIC INDICATORS; HOSPITALIZED CHILDREN; Z-SCORE; MALNUTRITION; PROGRAMS; AGE	Objective In this secondary analysis of data from an intervention trial, we assessed the performance of Mid Upper Arm Circumference (MUAC) as a predictor of mortality in children aged 6- 59 months from Delhi, India, one year after their initial MUAC measurements were taken. Additionally, we assessed MUAC as an absolute value and MUAC z-scores as predictors of risk of mortality. Methods In the trial, children were screened using MUAC prior to referral to the study clinic. These children were revisited a year later to ascertain their vital status. Baseline MUAC and MUAC z-scores were used to categorize children as severely (MUAC < 115 mm, MUAC z-score <-3SD) or moderately (MUAC 115 to < 125 mm, MUAC z-score <-2SD) malnourished. The proportion of malnutrition, risk of mortality, relative risk estimates, positive predictive value and area under the curve (AUC) by MUAC and MUAC z-scores were calculated. Results In the resurvey, the first 36159 children of the 48635 in the initial survey were contacted. Of these, vital status of 34060 (94.2%) was available. The proportion of severe malnutrition by MUAC (< 115 mm) was 0.5% with an associated mortality of 4.7% over a one year period and an attributable mortality of 13% while the proportion of the severe malnutrition by MUAC z-score (<-3SDwas 0.9% with an associated mortality of 2.2%. Conclusions MUAC is a significant predictor of subsequent mortality in under-five children. In settings where height measurement is not feasible, MUAC can be used as a screening tool for identifying severely malnourished children for management.	[Taneja, Sunita; Rongsen-Chandola, Temsunaro; Mohan, Sanjana Brahmawar; Mazumder, Sarmila; Bhandari, Nita; Kaur, Jasmine; Arya, Nikita; Chowdhury, Ranadip] Ctr Hlth Res & Dev Soc Appl Studies, New Delhi, India; [Martines, Jose Carlos] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Bhan, M. K.] Indian Inst Technol, New Delhi, India	University of Bergen; World Health Organization; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Bhan, MK (corresponding author), Indian Inst Technol, New Delhi, India.	rajkbhan@gmail.com	Martines, Jose Carlos/ABE-4082-2020; Chowdhury, Ranadip/P-2416-2019; Mazumder, Sarmila/AAD-8952-2020	Chowdhury, Ranadip/0000-0002-0055-6653; Mazumder, Sarmila/0000-0003-4200-6112	Department of Maternal, Newborn, Child and Adolescent Health, World Health Organisation, Geneva (WHO Collaborating Centre) [IND-096]; Centre for Intervention Science in Maternal and Child Health (CISMAC) [250216, 223269]; Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway; Knowledge Integration and Technology Platform (KnIT); Grand Challenges Initiative of the Biotechnology Industry Research Assistance Council (BIRAC) of the Government of India; Bill & Melinda Gates Foundation (USA); Grand Challenges Initiative of the Department of Biotechnology of the Government of India	Department of Maternal, Newborn, Child and Adolescent Health, World Health Organisation, Geneva (WHO Collaborating Centre); Centre for Intervention Science in Maternal and Child Health (CISMAC); Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway; Knowledge Integration and Technology Platform (KnIT); Grand Challenges Initiative of the Biotechnology Industry Research Assistance Council (BIRAC) of the Government of India; Bill & Melinda Gates Foundation (USA)(Bill & Melinda Gates Foundation); Grand Challenges Initiative of the Department of Biotechnology of the Government of India	The Society for Applied Studies acknowledges the core support provided by the Department of Maternal, Newborn, Child and Adolescent Health, World Health Organisation, Geneva (WHO Collaborating Centre IND-096) and the Centre for Intervention Science in Maternal and Child Health (CISMAC grants 250216) (CISMAC; project number 223269), which is funded by the Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway. We also acknowledge the support extended by the Knowledge Integration and Technology Platform (KnIT), a Grand Challenges Initiative of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) of the Government of India and Bill & Melinda Gates Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo VM, 2015, PUBLIC HEALTH NUTR, V18, P3244, DOI 10.1017/S1368980015000543; ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; [Anonymous], 1999, WHO MAN SEV MALN; BAIRAGI R, 1981, AM J CLIN NUTR, V34, P2592, DOI 10.1093/ajcn/34.11.2592; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Bhandari N, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000144; BRIEND A, 1989, EUR J CLIN NUTR, V43, P715; Briend A., 2016, BMC NUTR, V2, P63, DOI [10.1186/s40795-016-0101-7, DOI 10.1186/S40795-016-0101-7, 10.1186/s40795-016, DOI 10.1186/S40795-016]; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Dasgupta R, 2013, INDIAN PEDIATR, V50, P154, DOI 10.1007/s13312-013-0032-1; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Grellety E, 2016, BMC NUTR, V2, P10, DOI [10.1186/s40795-016-0049-7, DOI 10.1186/S40795-016-0049-7]; Jayachandran S., 2013, ECON POLIT WEEKLY, V48, P77; Jayachandran S, 2015, WHY ARE INDIAN CHILD, P1; Laillou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101159; Maust A, 2015, J NUTR, V145, P2604, DOI 10.3945/jn.115.214957; Myatt M, 2007, WFH MUAC ESTIMATING; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; PELLETIER DL, 1994, J NUTR, V124, pS2047; Rasmussen J, 2012, EUR J CLIN NUTR, V66, P998, DOI 10.1038/ejcn.2012.95; Sachdeva S, 2016, PUBLIC HEALTH NUTR, V19, P2513, DOI 10.1017/S1368980016000719; VELLA V, 1994, EUR J CLIN NUTR, V48, P189; World Health Organization, 2013, WHO GUID UPD MAN SEV; World Health Organization Expert Committee on Physical Status, 1995, TECHNICAL REPORT SER, V854	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197832	10.1371/journal.pone.0197832	http://dx.doi.org/10.1371/journal.pone.0197832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856757	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800044
J	Mohammed, F; Elshafey, A; Al-Balool, H; Alaboud, H; Al Ben Ali, M; Baqer, A; Bastaki, L				Mohammed, Fawziah; Elshafey, Alaa; Al-balool, Haya; Alaboud, Hayat; Al Ben Ali, Mohammed; Baqer, Adel; Bastaki, Laila			Mutation spectrum analysis of Duchenne/Becker muscular dystrophy in 68 families in Kuwait: The era of personalized medicine	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; REAL-TIME PCR; GENE DELETIONS; DMD GENE; NONSENSE MUTATION; CHINESE PATIENTS; MULTIPLEX PCR; DYSTROPHINOPATHY; DIAGNOSIS; DATABASE	Duchenne and Becker muscular dystrophies (DMD/BMD) are X-linked recessive neuromuscular disorders characterized by progressive irreversible muscle weakness and atrophy that affect both skeletal and cardiac muscles. DMD/BMD is caused by mutations in the Dystrophin gene on the X chromosome, leading to the absence of the essential muscle protein Dystrophin in DMD. In BMD, Dystrophin is partially functioning with a shorter protein product. Recent advances in molecular therapies for DMD require precise genetic diagnoses because most therapeutic strategies are mutation-specific. Hence, early diagnosis is crucial to allow appropriate planning for patient care and treatment. In this study, data from DMD/BMD patients who attended the Kuwait Medical Genetic Center during the last 20 years was retrieved from a Kuwait neuromuscular registry and analyzed. We combined multiplex PCR and multiplex ligation-dependent probe amplification (MLPA) with Sanger sequencing to detect Dystrophin gene mutations. A total of 35 different large rearrangements, 2 deletioninsertions (Indels) and 4 substitution mutations were identified in the 68 unrelated families. The deletion and duplication rates were 66.2% and 4.4%, respectively. The analyzed data from our registry revealed that 11 (16%) of the DMD families will benefit from newly introduced therapies (Ataluren and exon 51 skipping). At the time of submitting this paper, two cases have already enrolled in Ataluren (Tranlsarna T) therapy, and one case has been enrolled in exon 51 skipping therapy.	[Mohammed, Fawziah] Kuwait Univ, Fac Allied Hlth Sci, Med Lab Sci, Jabriah, Kuwait; [Elshafey, Alaa; Al-balool, Haya; Alaboud, Hayat; Al Ben Ali, Mohammed; Baqer, Adel; Bastaki, Laila] Minist Hlth, Kuwait Med Genet Ctr, Shouaikh, Kuwait	Kuwait University	Mohammed, F (corresponding author), Kuwait Univ, Fac Allied Hlth Sci, Med Lab Sci, Jabriah, Kuwait.	fawziahmam@hsc.edu.kw						Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2016, J MED GENET, V53, P145, DOI 10.1136/jmedgenet-2015-103387; Aartsma-Rus Annemieke, 2014, J Neuromuscul Dis, V1, P41; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; ABBS S, 1991, J MED GENET, V28, P304, DOI 10.1136/jmg.28.5.304; Abbs Stephen, 2010, Neuromuscul Disord, V20, P422, DOI 10.1016/j.nmd.2010.04.005; Al-Jumah M, 2002, SAUDI MED J, V23, P1478; Aoki Y, 2012, P NATL ACAD SCI USA, V109, P13763, DOI 10.1073/pnas.1204638109; Basak J, 2006, NEUROL INDIA, V54, P310, DOI 10.4103/0028-3886.27164; Baskin B, 2014, MOL GENET GENOM MED, V2, P539, DOI 10.1002/mgg3.108; BEGGS AH, 1990, HUM GENET, V86, P45; Bellayou H, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/325210; Bello Luca, 2016, Acta Myol, V35, P122; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Chen WJ, 2013, CLIN CHIM ACTA, V423, P35, DOI 10.1016/j.cca.2013.04.006; Echigoya Y, 2017, P NATL ACAD SCI USA, V114, P4213, DOI 10.1073/pnas.1613203114; Echigoya Y, 2014, NUCLEIC ACID THER, V24, P57, DOI 10.1089/nat.2013.0451; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Finkel RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081302; Flanigan KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/humu.21426; Guo RL, 2015, J HUM GENET, V60, P435, DOI 10.1038/jhg.2015.43; Haas M, 2015, NEUROMUSCULAR DISORD, V25, P5, DOI 10.1016/j.nmd.2014.11.011; Hwa HL, 2007, J FORMOS MED ASSOC, V106, P339, DOI 10.1016/S0929-6646(09)60318-1; Ishmukhametova A, 2012, EUR J HUM GENET, V20, P1096, DOI 10.1038/ejhg.2012.51; Juan-Mateu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135189; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Laing Nigel G, 2011, Clin Biochem Rev, V32, P129; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Lee BL, 2012, J KOREAN MED SCI, V27, P274, DOI 10.3346/jkms.2012.27.3.274; Lim KRQ, 2017, DRUG DES DEV THER, V11, P533, DOI 10.2147/DDDT.S97635; Liu YG, 1999, LIFE SCI, V65, P863, DOI 10.1016/S0024-3205(99)00316-1; Manjunath M, 2015, NEUROL INDIA, V63, P58, DOI 10.4103/0028-3886.152635; Matsuo M, 2016, BRAIN DEV-JPN, V38, P4, DOI 10.1016/j.braindev.2015.05.014; Nosaeid MH, 2009, CLIN BIOCHEM, V42, P1291, DOI 10.1016/j.clinbiochem.2009.04.016; Prior TW, 2005, J MOL DIAGN, V7, P317, DOI 10.1016/S1525-1578(10)60560-0; Reinig AM, 2017, PHARMACOTHERAPY, V37, P492, DOI 10.1002/phar.1909; Shawky R.M., 2014, EGYPT J MED HUM GENE, V15, P235, DOI [10.1016/j.ejmhg.2014.03.004, DOI 10.1016/J.EJMHG.2014.03.004]; Singh V, 1997, HUM GENET, V99, P206, DOI 10.1007/s004390050340; Takeshima Y, 2001, BRAIN DEV-JPN, V23, P788, DOI 10.1016/S0387-7604(01)00326-6; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Todorova A, 2008, NEUROMUSCULAR DISORD, V18, P667, DOI 10.1016/j.nmd.2008.06.369; Toh ZYC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145620; Traverso M, 2006, BIOCHEM BIOPH RES CO, V339, P145, DOI 10.1016/j.bbrc.2005.11.006; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Vengalil S, 2017, J CLIN NEUROL, V13, P91, DOI 10.3988/jcn.2017.13.1.91; Wang Y, 2014, MOL GENET GENOMICS, V289, P1013, DOI 10.1007/s00438-014-0847-z; Wein N, 2014, NAT MED, V20, P992, DOI 10.1038/nm.3628; Wu BB, 2017, MOL CYTOGENET, V10, DOI 10.1186/s13039-017-0301-0; Yiu EM, 2015, J PAEDIATR CHILD H, V51, P759, DOI 10.1111/jpc.12868; Zhang T, 2013, CLIN CHIM ACTA, V424, P33, DOI 10.1016/j.cca.2013.05.006	51	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197205	10.1371/journal.pone.0197205	http://dx.doi.org/10.1371/journal.pone.0197205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847600	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800023
J	Overbosch, FW; van Gool, T; Matser, A; Sonder, GJB				Overbosch, Femke W.; van Gool, Tom; Matser, Amy; Sonder, Gerard J. B.			Low incidence of helminth infections (schistosomiasis, strongyloidiasis, filariasis, toxocariasis) among Dutch long-term travelers: A prospective study, 2008-2011	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; RETURNING TRAVELERS; TROPICAL COUNTRIES; DISEASE RISKS; EOSINOPHILIA; SERODIAGNOSIS; MIGRANTS; MALARIA	Background Despite the considerable burden of helminth infections in developing countries and increasing international travel, little is known about the risks of infection for travelers. Objective We studied the attack and incidence rate of serology confirmed strongyloidiasis, filariasis, and toxocariasis among long-term travelers and associated factors. A second objective was to evaluate eosinophilia as a positive/negative predictive value (PPV/NPV) for a recent helminth infection. Methods From 2008 to 2011, clients of the Public Health Service travel clinic planning travel to (sub) tropical countries for 12 +/- 52 weeks were invited to participate in a prospective study. Participants kept a weekly diary, recording itinerary, symptoms, and physician visits during travel and completed a post-travel questionnaire. Pre-and post-travel blood samples were serologically tested for the presence of IgG antibodies against Schistosoma species, Strongyloides stercoralis, filarial species, and Toxacara species and were used for a blood cell count. Factors associated with recent infection were analyzed using Poisson regression. Differences among groups of travelers were studied using chi square tests. Results For the 604 participants, median age was 25 years (interquartile range [IQR]: 23 +/- 29), 36% were male, median travel duration was 20 weeks (IQR: 15 +/- 25), and travel purpose was predominantly tourism (62%). Destinations were Asia (45%), Africa (18%), and the Americas (37%). Evidence of previous infection was found in 13/604 participants: antibodies against Schistosoma spp. in 5 (0.8%), against S.stercoralis in 3 (0.5%), against filarial species in 4 (0.7%), and against Toxocara spp. in 1 (0.2%). Ten recent infections were found in 9 participants (3, 1, 6, 0 cases, in the above order), making the attack rates 0.61, 0.17, 1.1 and 0, and the incidence rates per 1000 person-months 1.5, 0.34, 2.6 and 0. The overall PPV and NPV of eosinophila for recent infection were 0 and 98%, respectively. Conclusions The risk of the helminth infections under study in this cohort of long-term travelers was low. Routine screening for eosinophilia appeared not to be of diagnostic value.	[Overbosch, Femke W.; Sonder, Gerard J. B.] Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands; [Overbosch, Femke W.; Sonder, Gerard J. B.] Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands; [van Gool, Tom; Sonder, Gerard J. B.] Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, Amsterdam, Netherlands; [van Gool, Tom] Acad Med Ctr, Parasitol Sect, Dept Med Microbiol, Amsterdam, Netherlands; [Matser, Amy] Publ Hlth Serv GGD, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Overbosch, FW (corresponding author), Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.; Overbosch, FW (corresponding author), Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands.	foverbosch@ggd.amsterdam.nl		Matser, Amy/0000-0003-4291-1905	Netherlands Organization for Health Research and Development (ZonMW) [12501 0001]; Department of Research and Development of the Public Health Service Amsterdam	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Department of Research and Development of the Public Health Service Amsterdam	This study was conducted within the Amsterdam Academic Collaborative Center on Public Health: a collaboration between the Public Health Service of Amsterdam and the Academic Medical Center of the University of Amsterdam, the Netherlands. The Amsterdam Academic Collaborative Center on Public Health is financially supported by the Netherlands Organization for Health Research and Development (ZonMW; grant number 12501 0001). The study was also financially supported by the Department of Research and Development of the Public Health Service Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, GLOBAL INFECT DISEAS; Baaten GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-84; Centers for Disease Control and Prevention, DPDX D LAB IND PAR D; Centers for Disease Control and Prevention (CDC), PAR LOIAS; Chen LH, 2006, JAMA-J AM MED ASSOC, V296, P2234, DOI 10.1001/jama.296.18.2234; FEGAN D, 1993, OCCUP MED-OXFORD, V43, P135, DOI 10.1093/occmed/43.3.135; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Field V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-330; Houze S, 2003, EVALUATION REACTIF E; JACQUIER P, 1991, J CLIN MICROBIOL, V29, P1831, DOI 10.1128/JCM.29.9.1831-1835.1991; Landelijk Coordinatiecentrum Reizigersadvisering. National Coordination Centre for Traveler' Health Advice, 2008, NAT GUID TRAV HLTH A; LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353; Lingscheid T, 2017, AM J TROP MED HYG, V97, P567, DOI 10.4269/ajtmh.17-0034; Lipner EM, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000088; Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582; Meltzer E, 2008, AM J TROP MED HYG, V78, P702, DOI 10.4269/ajtmh.2008.78.702; Overbosch FW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192193; Salzer HJF, 2017, TRAVEL MED INFECT DI, V20, P49, DOI 10.1016/j.tmaid.2017.09.001; Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Soonawala D, 2014, AM J TROP MED HYG, V90, P835, DOI 10.4269/ajtmh.13-0594; The Carter Center, ONCH EL PROGR AM OEP; Toovey S, 2007, J TRAVEL MED, V14, P50, DOI 10.1111/j.1708-8305.2006.00092.x; Toovey S, 2007, J TRAVEL MED, V14, P42, DOI 10.1111/j.1708-8305.2006.00091.x; UNWTO, 2016, TOURISM HIGHLIGHTS, DOI [10.18111/9789284418145, DOI 10.18111/9789284418145]; Van Den Broucke S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003559; van Doorn HR, 2007, DIAGN MICR INFEC DIS, V57, P409, DOI 10.1016/j.diagmicrobio.2006.10.002; van Doorn HR, 2007, J CLIN MICROBIOL, V45, P438, DOI 10.1128/JCM.01735-06; van Gool T, 2002, J CLIN MICROBIOL, V40, P3432, DOI 10.1128/JCM.40.9.3432-3437.2002; Whelan J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1502-6; WHO, 2017, GLOB PROGR EL LYMPH, P441; World Health Assembly, WHA27 52 INT RES TRO; World Health Organisation, 2016, SCH SOIL TRANSM HELM, P585; World Health Organization, PREV BLINDN VIS IMP; World Health Organization, 2016, GLOB HLTH EST 2015 S; World Health Organization, INT WORMS STRONG	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197770	10.1371/journal.pone.0197770	http://dx.doi.org/10.1371/journal.pone.0197770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847574	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800040
J	Cavalcante, MG; Bastos, CEMC; Nagamachi, CY; Pieczarka, JC; Vicari, MR; Noronha, RCR				Cavalcante, Manoella Gemaque; Matos Carvalho Bastos, Carlos Eduardo; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar; Vicari, Marcelo Ricardo; Rodrigues Noronha, Renata Coelho			Physical mapping of repetitive DNA suggests 2n reduction in Amazon turtles Podocnemis (Testudines: Podocnemididae)	PLOS ONE			English	Article							INTERSTITIAL TELOMERIC SEQUENCES; HISTONE H3 GENES; 5S RIBOSOMAL-RNA; CONSERVED SYNTENY; CHROMOSOME; EVOLUTION; RDNA; MECHANISMS; UNIFILIS; INSIGHTS	Cytogenetic studies show that there is great karyotypic diversity in order Testudines (2n=26-68), and that this may be mainly attributed to the presence/absence of micro-chromosomes. Members of the Podocnemididae family have the smallest diploid numbers of this order (2n=26-28), which may be a derived condition of the group. Diverse studies suggest that repetitive-DNA-rich sites generally act as hotspots for doublestrand breaks and chromosomal reorganization. In this context, we used fluorescent in situ hybridization (FISH) to map telomeric sequences (TTAGGG)n, 45S rDNA, and the genes encoding histones H1 and H3 in two species of genus Podocnemis. We also observed conservation of the 45S rDNA and H1 histone sequences (probable case of conserved synteny), but multiple conserved and non-conserved clusters of H3 genes, which colocalized with the interstitial telomeric sequences in the Podocnemis genome. Our results suggest that fusions have occurred between macro and microchromosomes or between microchromosomes, leading to the observed reduction in diploid number in the family Podocnemididae.	[Cavalcante, Manoella Gemaque; Matos Carvalho Bastos, Carlos Eduardo; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar; Rodrigues Noronha, Renata Coelho] Univ Fed Para, Inst Ciencias Biol, Lab Citogenet, Ctr Estudos Avancados Biodiversidade, Belem, Para, Brazil; [Vicari, Marcelo Ricardo] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, Parana, Brazil	Universidade Federal do Para; Universidade Estadual de Ponta Grossa	Noronha, RCR (corresponding author), Univ Fed Para, Inst Ciencias Biol, Lab Citogenet, Ctr Estudos Avancados Biodiversidade, Belem, Para, Brazil.	renatarcm@gmail.com	Nagamachi, Cleusa/AAV-8985-2021; Noronha, Renata Coelho Rodrgues/K-8619-2012; Noronha, Renata Coelho Coelho Rodrigues/B-6376-2018; Vicari, Marcelo Ricardo/I-2299-2015; Pieczarka, Julio C/E-7585-2016	Noronha, Renata Coelho Rodrgues/0000-0001-8815-2399; Noronha, Renata Coelho Coelho Rodrigues/0000-0001-9150-8544; Vicari, Marcelo Ricardo/0000-0003-3913-9889; Pieczarka, Julio C/0000-0003-2951-8877; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through the Edital Universal [475013/2012-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [047/2012 PRO -AMAZONIA]; FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX) [TO 011/2008]; Banco Nacional de Desenvolvimento Economico e Social-BNDES [Operacao 2.318.698.0001]; CNPq [308428/2013-7, 308401/2013-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through the Edital Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Banco Nacional de Desenvolvimento Economico e Social-BNDES; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through the Edital Universal (Proc. 475013/2012-3) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through the Edital 047/2012 PRO -AMAZONIA: Biodiversidade e Sustentabilidade on a project coordinated by CYN; by FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX, TO 011/2008) and Banco Nacional de Desenvolvimento Economico e Social-BNDES (Operacao 2.318.698.0001) on a project coordinated by JCP. CYN (308428/2013-7) and JCP (308401/2013-1) are grateful to CNPq for Productivity Grants.	Aksenova AY, 2013, P NATL ACAD SCI USA, V110, P19866, DOI 10.1073/pnas.1319313110; AYRES M, 1969, CYTOGENETICS, V8, P401, DOI 10.1159/000130051; Barros AV, 2017, GENE, V608, P20, DOI 10.1016/j.gene.2017.01.013; BICKHAM JW, 1981, SCIENCE, V212, P1291, DOI 10.1126/science.212.4500.1291; BICKHAM JW, 1983, COPEIA, P918, DOI 10.2307/1445093; Bolzan AD, 2017, MUTAT RES-REV MUTAT, V773, P51, DOI 10.1016/j.mrrev.2017.04.002; Bolzan AD, 2012, MUTAGENESIS, V27, P1, DOI 10.1093/mutage/ger052; Bruschi DP, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-22; Noleto RB, 2006, GENET MOL BIOL, V29, P263, DOI 10.1590/S1415-47572006000200011; BULL JJ, 1980, CAN J ZOOL, V58, P828, DOI 10.1139/z80-115; Cabral-De-Mello DC, 2011, CYTOGENET GENOME RES, V134, P127, DOI 10.1159/000326803; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Carvalho A, 2011, J GENET, V90, P95, DOI 10.1007/s12041-011-0033-6; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; Costa GWWF, 2014, CYTOGENET GENOME RES, V144, P62, DOI 10.1159/000366301; Lopez MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010654; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Eirin-Lopez JM, 2009, EVOLUTIONARY BIOLOGY: CONCEPT, MODELING, AND APPLICATION, P139, DOI 10.1007/978-3-642-00952-5_8; Fantin C, 2014, CARYOLOGIA, V61, P253, DOI [10.1080/00087114.2008.10589637, DOI 10.1080/00087114.2008.10589637]; Fantin C, 2011, CARYOLOGIA, V64, P154, DOI 10.1080/00087114.2002.10589777; Farre M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027239; de Araujo REF, 2016, GENETICA, V144, P407, DOI 10.1007/s10709-016-9909-y; Ferri V., 2002, TURTLES TORTOISES FI; Georgiev O., 2012, Genetics and Plant Physiology, V2, P145; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gunski RJ, 2013, GENET MOL BIOL, V36, P353, DOI [10.1590/S1415-47572013005000029, 10.1590/s1415-47572013005000029]; Hashimoto DT, 2011, CYTOGENET GENOME RES, V134, P64, DOI 10.1159/000323512; HUANG CC, 1969, CHROMOSOMA, V26, P245, DOI 10.1007/BF00326519; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; KILLEBREW F C, 1975, Journal of Herpetology, V9, P281, DOI 10.2307/1563192; Kirk IK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179112; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Longo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-334; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; Montiel EE, 2016, CYTOGENET GENOME RES, V148, P292, DOI 10.1159/000447478; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Noronha RCR, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0281-5; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Porto FE, 2014, ZEBRAFISH, V11, P318, DOI 10.1089/zeb.2014.0996; Primo CC, 2017, ZEBRAFISH, V14, P161, DOI 10.1089/zeb.2016.1386; Pucci MB, 2018, GENET MOL BIOL, V41, P585, DOI [10.1590/1678-4685-gmb-2017-0121, 10.1590/1678-4685-GMB-2017-0121]; de Almeida BRR, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0494-6; da Costa MJR, 2016, CYTOGENET GENOME RES, V148, P199, DOI 10.1159/000446562; Rosa KO, 2012, REV FISH BIOL FISHER, V22, P739, DOI 10.1007/s11160-011-9250-6; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scacchetti PC, 2011, COMP CYTOGENET, V5, P223, DOI 10.3897/CompCytogen.v5i3.1375; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; Schmid M, 2016, CYTOGENET GENOME RES, V148, P211, DOI 10.1159/000446298; SHAMPAY J, 1995, CHROMOSOMA, V104, P29, DOI 10.1007/BF00352223; Slijepcevic P, 1998, CHROMOSOMA, V106, P413; Srikulnath K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134829; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suarez P, 2013, CYTOGENET GENOME RES, V141, P295, DOI 10.1159/000354997; Tsipouri V, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r155; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; Ventura K, 2014, GENET MOL BIOL, V37, P61, DOI 10.1590/S1415-47572014000100011; Viana PF, 2016, NUCLEUS CALCUTTA, V59, P191, DOI 10.1007/s13237-016-0174-3	66	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197536	10.1371/journal.pone.0197536	http://dx.doi.org/10.1371/journal.pone.0197536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813087	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800020
J	Yugander, A; Sundaram, RM; Singh, K; Ladhalakshmi, D; Rao, LVS; Madhav, MS; Badri, J; Prasad, MS; Laha, GS				Yugander, Arra; Sundaram, Raman M.; Singh, Kuldeep; Ladhalakshmi, Duraisamy; Rao, Lella V. Subba; Madhav, Maganti Sheshu; Badri, Jyothi; Prasad, Madamsetty Srinivas; Laha, Gouri Sankar			Incorporation of the novel bacterial blight resistance gene Xa38 into the genetic background of elite rice variety Improved Samba Mahsuri	PLOS ONE			English	Article							RESTORER LINE; IDENTIFICATION; SELECTION; DISEASE	Bacterial blight (BB) in rice caused by Xanthomonas oryzae pv. oryzae (Xoo) is a major global production constraint, particularly in irrigated and rain-fed lowland areas. Improved Samba Mahsuri (ISM) is an elite, high-yielding, fine-grain type, BB-resistant rice variety possessing three BB-resistant genes (Xa21, xa13 and xa5) and is highly popular in the southern parts of India. As the BB pathogen is highly dynamic and the evolution of pathogen virulence against the deployed resistance genes is common, we added a novel BB-resistant gene, Xa38, into ISM through marker-assisted backcross breeding (MABB) to increase the spectrum and durability of BB resistance. The breeding line PR 114 (Xa38) was used as the donor for Xa38, whereas ISM was used as the recurrent parent. Foreground selection was conducted using PCR-based gene-specific markers for the target genes, whereas background selection was conducted using a set of polymorphic SSR markers between the parents and backcrossing that continued until the third generation. Eighteen homozygous BC3F2 plants possessing all four BB-resistant genes in the homozygous state and with a recurrent parent genome (RPG) recovery of more than 92% were identified and advanced to the BC3F6 generation. These 18 backcross-derived lines (BDLs) exhibited very high level of resistance against multiple Xoo strains and displayed agro-morphological traits, grain qualities and yield levels similar to or better than those of the recurrent parent ISM.	[Yugander, Arra; Sundaram, Raman M.; Ladhalakshmi, Duraisamy; Rao, Lella V. Subba; Madhav, Maganti Sheshu; Badri, Jyothi; Prasad, Madamsetty Srinivas; Laha, Gouri Sankar] ICAR Indian Inst Rice Res, Hyderabad, Telangana, India; [Singh, Kuldeep] ICAR Natl Bur Plant Genet Resources, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Laha, GS (corresponding author), ICAR Indian Inst Rice Res, Hyderabad, Telangana, India.	lahags@yahoo.co.in	Sundaram, Raman/L-5294-2019	Singh, Kuldeep/0000-0001-5239-6586; Arra, Yugander/0000-0001-6778-4258				[Anonymous], 2014, STAND EV SYST RIC, V5th; [Anonymous], 2015, VISION 2050 ICAR IND; Beachell HM, 1963, INT RICE COMM NEWSL, V17, P1364; Bhasin H, 2012, MOL BREEDING, V30, P607, DOI 10.1007/s11032-011-9646-y; Bosque PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062301; Cheema KK, 2008, GENET RES, V90, P397, DOI 10.1017/S0016672308009786; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen S, 2000, CROP SCI, V40, P239, DOI 10.2135/cropsci2000.401239x; Devadath S., 1992, Plant diseases of international importance. Volume I. Diseases of cereals and pulses., P158; Dokku P, 2013, EUPHYTICA, V192, P87, DOI 10.1007/s10681-013-0878-2; Ellur RK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29188; Gnanamanickam SS, 1999, CURR SCI INDIA, V77, P1435; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; Gopalakrishnan S, 2008, PLANT BREEDING, V127, P131, DOI 10.1111/j.1439-0523.2007.01458.x; Guvvala L. D., 2013, Journal of Crop Science and Biotechnology, V16, P111, DOI 10.1007/s12892-013-0009-6; Hajira S, 2014, PROGR RES, V9, P1224; Hari Y, 2013, PLANT BREEDING, V132, P586, DOI 10.1111/pbr.12056; Hospital F, 1997, THEOR APPL GENET, V95, P1181, DOI 10.1007/s001220050679; Hossian M, 2004, FAO C RIC GLOB MARK; Hunjan M. S., 2014, Indian Phytopathology, V67, P20; ICAR-Indian Institute of Rice Research, 2012, ALL IND COORD RIC IM; Joseph M, 2004, MOL BREEDING, V13, P377, DOI 10.1023/B:MOLB.0000034093.63593.4c; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khush G. S., 1989, BACTERIAL BLIGHT RIC, P207; Kim SM, 2015, THEOR APPL GENET, V128, P1933, DOI 10.1007/s00122-015-2557-2; Kumar PN, 2012, PHYTOPATHOLOGY, V102, P222, DOI 10.1094/PHYTO-03-11-0075; Kumar VA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01195; Laha G.S., 2016, USDA TECHNICAL B, V91; Laha GS, 2009, DRR TECHNICAL B, V41; LITTLE RR, 1958, CEREAL CHEM, V35, P111; MEW TW, 1993, PLANT DIS, V77, P5, DOI 10.1094/PD-77-0005; Mondal KK, 2014, PHYSIOL MOL PLANT P, V86, P98, DOI 10.1016/j.pmpp.2014.03.005; Pandey MK, 2013, MOL BREEDING, V31, P239, DOI 10.1007/s11032-012-9779-7; Pradhan SK, 2015, RICE, V8, DOI 10.1186/s12284-015-0051-8; Prasad G. S. V., 2008, USDA TECHNICAL B, V33; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Stoskopf N, 1993, PLANT BREEDING THEOR; Suh JP, 2013, RICE, V6, DOI 10.1186/1939-8433-6-5; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Sundaram RM, 2014, RICE, V7, DOI 10.1186/s12284-014-0012-7; Sundaram Raman M., 2009, Biotechnology Journal, V4, P400, DOI 10.1002/biot.200800310; Sundaram RM, 2011, GENOMICS CROP IMPROV; van Berloo R, 1999, J HERED, V90, P328, DOI 10.1093/jhered/90.2.328; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yugander A, 2017, EUR J PLANT PATHOL, V149, P171, DOI 10.1007/s10658-017-1176-y; Yugander A., 2014, INDIAN J PLANT PROTE, V42, P149; Zheng K., 1995, IRRI DISCUSSION PAPE	48	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198260	10.1371/journal.pone.0198260	http://dx.doi.org/10.1371/journal.pone.0198260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813124	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800061
J	Rasche, P; Mertens, A; Miron-Shatz, T; Berzon, C; Schlick, CM; Jahn, M; Becker, S				Rasche, Peter; Mertens, Alexander; Miron-Shatz, Talya; Berzon, Corinne; Schlick, Christopher M.; Jahn, Michael; Becker, Stefan			Seamless recording of glucometer measurements among older experienced diabetic patients - A study of perception and usability	PLOS ONE			English	Article							BLOOD-GLUCOSE; EFFICACY; PAPER	Self-measurement and documentation of blood-glucose are critical elements of diabetes management, particularly in regimes including insulin. In this study, we analyze the usability of iBG-STAR, the first blood glucose meter connectable to a smartphone. This technology records glucometer measurements, removing the burden of documentation from diabetic patients. This study assesses the potential for implementation of iBG-STAR in routine care. Twelve long-term diabetic patients (4 males; median age of 66.5 years) were enrolled in the study. N = 4/12 reported diabetic polyneuropathy. Reported subjective mental workload for all tasks related to iBG-STAR was on average lower than 12 points, corresponding to the verbal code 'nearly no effort needed'. A "Post Study System Usability Questionnaire", evaluated the glucometer at an average value of 2.06 (SD = 1.02) on a 7-Likert-scale (1 = 'I fully agree' to 7 = 'I completely disagree') for usability. These results represent a positive user experience. Patients with polyneuropathy may experience physical difficulties in completing the tasks, thereby affecting usability. Technologically savvy patients (n = 6) with a positive outlook on diabetes assessed the product as a suitable tool for themselves and would recommend to other diabetic patients. The main barrier to regular use was treating physicians' inability to retrieve digitally recorded data. This barrier was due to a shortcoming in interoperability of mobile devices and medical information systems.	[Rasche, Peter; Mertens, Alexander; Schlick, Christopher M.] Rhein Westfal TH Aachen, Inst Ind Engn & Ergon, Aachen, Germany; [Miron-Shatz, Talya; Berzon, Corinne] Ono Acad Coll, Sch Business, Ctr Med Decis Making, Kiryat Ono, Israel; [Miron-Shatz, Talya] Ctr Med Publ Interest, New York, NY USA; [Jahn, Michael; Becker, Stefan] Univ Duisburg Essen, Dept Nephrol, Essen, Germany	RWTH Aachen University; University of Duisburg Essen	Becker, S (corresponding author), Univ Duisburg Essen, Dept Nephrol, Essen, Germany.	stefan.becker@uk-essen.de	Rasche, Peter/J-9388-2019	Rasche, Peter/0000-0001-7974-8668	Federal Ministry of Education and Research [FKZ: 16SV7111]; Federal Ministry of Education and Research (Germany)	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF))	The study was conducted within the project Tech4Age (www.tech4age.de), which is funded by the Federal Ministry of Education and Research (FKZ: 16SV7111). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was conducted within the project Tech4Age (www.tech4age.de), which is funded by the Federal Ministry of Education and Research (Germany) (FKZ: 16SV7111).	Becker S, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3328; Bonoto BC, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6309; Cho JH, 2009, J TELEMED TELECARE, V15, P77, DOI 10.1258/jtt.2008.080412; Dale O, 2007, J CLIN EPIDEMIOL, V60, P8, DOI 10.1016/j.jclinepi.2006.04.005; FDA and U.S. Department of Health and Human Services, 2016, APPL HUM FACT US ENG; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; HLS-EU CONSORTIUM, 2012, COMP REP HLTH LIT 8; International Standards Organization, 2008, EAS OP EV PROD 1; JAY GM, 1992, J GERONTOL, V47, pP250, DOI 10.1093/geronj/47.4.P250; Joshi R, 2017, PATIENT PREFER ADHER, V11, P271, DOI 10.2147/PPA.S122490; Kim HS, 2014, DIABETES METAB J, V38, P204, DOI 10.4093/dmj.2014.38.3.204; Li Ying, 2016, JMIR Diabetes, V1, pe2, DOI 10.2196/diabetes.4475; Lindberg Inger, 2017, JMIR Diabetes, V2, pe10, DOI 10.2196/diabetes.6884; Lithgow Kirstie, 2017, JMIR Diabetes, V2, pe2, DOI 10.2196/diabetes.6643; Luger TM, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2924; Martinez Mark, 2017, JMIR Diabetes, V2, pe12, DOI 10.2196/diabetes.6468; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendiola MF, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4283; Mertens A, USE INFORM COMMUNICA, V16; Mertens A, 2017, INITIAL RESULT UNPUB; Mertens A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004446; O'Hara L, 2013, PSYCHOL HEALTH, V28, P1227, DOI 10.1080/08870446.2013.800516; O'Kane MJ, 2008, BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE; Osborn Chandra Y, 2017, JMIR Diabetes, V2, pe21, DOI 10.2196/diabetes.8039; Ose D, 2017, JMIR RES PROTOC, V6, P60, DOI 10.2196/resprot.6314; Otto T, 2014, SOC COGN AFFECT NEUR, V9, P307, DOI 10.1093/scan/nss136; Parkin Christopher G, 2009, J Diabetes Sci Technol, V3, P500; Pfutzner A, 2012, CURR MED RES OPIN, V28, P525, DOI 10.1185/03007995.2012.673479; Piwek L, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001953; Renard E, 2005, AM J MED, V118, p12S, DOI 10.1016/j.amjmed.2005.07.052; Ronda MCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129403; Rothlin F., GESUNDHEITSKOMPETENZ; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Scheibe Madlen, 2015, Med 2 0, V4, pe1, DOI 10.2196/med20.3912; Stone AA, 2003, CONTROL CLIN TRIALS, V24, P182, DOI 10.1016/S0197-2456(02)00320-3; Van Someren M.W., 1994, THINK ALOUD METHOD P; Zhang SY, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2183; Zijlstra F. R. H., 1993, THESIS	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197455	10.1371/journal.pone.0197455	http://dx.doi.org/10.1371/journal.pone.0197455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799861	Green Submitted, gold, Green Published			2022-12-26	WOS:000433153400012
J	Zhang, XT; Jian, LB; Xu, MF				Zhang, Xuetao; Jian, Libo; Xu, Meifeng			Robust 3D point cloud registration based on bidirectional Maximum Correntropy Criterion	PLOS ONE			English	Article								This paper presents a robust 3D point cloud registration algorithm based on bidirectional Maximum Correntropy Criterion (MCC). Comparing with traditional registration algorithm based on the mean square error (MSE), using the MCC is superior in dealing with complex registration problem with non-Gaussian noise and large outliers. Since the MCC is considered as a probability measure which weights the corresponding points for registration, the noisy points are penalized. Moreover, we propose to use bidirectional measures which can maximum the overlapping parts and avoid the registration result being trapped into a local minimum. Both of these strategies can better apply the information theory method to the point cloud registration problem, making the algorithm more robust. In the process of implementation, we integrate the fixed-point optimization technique based on the iterative closest point algorithm, resulting in the correspondence and transformation parameters that are solved iteratively. The comparison experiments under noisy conditions with related algorithms have demonstrated good performance of the proposed algorithm.	[Zhang, Xuetao; Jian, Libo] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian 710049, Peoples R China; [Xu, Meifeng] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xu, MF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China.	xumf96@163.com		Xu, Meifeng/0000-0002-2779-5267	National Natural Science Foundation of China [61305096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (61305096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was in part supported by the National Natural Science Foundation of China (61305096).	Ajmal M, 2006, INT J COMPUT VISION, V66, P19, DOI [10.1007/s11263-005-3221-0, DOI 10.1007/S11263-005-3221-0]; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chen B, 2013, ELSEV INSIGHT, P1; Chen BD, 2017, AUTOMATICA, V76, P70, DOI 10.1016/j.automatica.2016.10.004; Chen BD, 2016, IEEE T SIGNAL PROCES, V64, P3376, DOI 10.1109/TSP.2016.2539127; Chetverikov D, 2005, IMAGE VISION COMPUT, V23, P299, DOI 10.1016/j.imavis.2004.05.007; Du SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188039; Gao Y, 2015, ACM T INTEL SYST TEC, V6, DOI 10.1145/2735959; Godin G., 2005, P SPIE VIDEOMATRICS, P279; Hasanbelliu E, 2014, IEEE T PATTERN ANAL, V36, P2436, DOI 10.1109/TPAMI.2014.2324585; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Liu WF, 2007, IEEE T SIGNAL PROCES, V55, P5286, DOI 10.1109/TSP.2007.896065; Liu YH, 2006, IMAGE VISION COMPUT, V24, P762, DOI 10.1016/j.imavis.2006.01.009; Lu K, 2016, NEUROCOMPUTING, V215, P1, DOI 10.1016/j.neucom.2016.06.010; Mian AS, 2006, IEEE T PATTERN ANAL, V28, P1584, DOI 10.1109/TPAMI.2006.213; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Peng L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148483; Petricek T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187943; Phillips JM, 2007, 3DIM 2007: SIXTH INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P427; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Shiratori T, 2015, 2015 INTERNATIONAL CONFERENCE ON 3D VISION, P232, DOI 10.1109/3DV.2015.33; Xu A, 2016, IEEE INT JOINT C NEU, P24; Yang Y, 2017, IEEE SYS MAN CYBERN, P1898; Yuan X., 2009, P 26 ANN INT C MACH, P1193; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zhou ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112918	28	10	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197542	10.1371/journal.pone.0197542	http://dx.doi.org/10.1371/journal.pone.0197542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799864	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400016
J	Liu, D; Huang, YM; Yan, H; Jiang, YL; Zhao, T; An, SS				Liu, Dong; Huang, Yimei; Yan, Hao; Jiang, Yueli; Zhao, Tong; An, Shaoshan			Dynamics of soil nitrogen fractions and their relationship with soil microbial communities in two forest species of northern China	PLOS ONE			English	Article							LITTER DECOMPOSITION; TERRESTRIAL ECOSYSTEMS; LOESS PLATEAU; ORGANIC NITROGEN; N MINERALIZATION; CROP RESIDUES; BIOMASS; TEMPERATURE; GRASSLAND; AVAILABILITY	Microbially-mediated soil N mineralization and transformation are crucial to plant growth. However, changes in soil microbial groups and various N components are not clearly understood. To explore the relationship between soil N components and microbial communities, we conducted an in-situ experiment on two typically planted forest species, namely, Sibirica Apricot (SA) and Prunus davidiana Franch (PdF) by using closed-top polyvinyl chloride tubes. Changes in soil inorganic N, organic N (ON) fractions, and levels of microbial phospholipid fatty acids (PLFAs) were measured bimonthly from April 2012 to April 2013. Microbial PLFAs and the concentrations of easily-available microbial biomass N (MBN; similar to 60 mg kg(-1)), soluble ON (SON; similar to 20 mg kg(-1)), and inorganic N were similar between the two soils whereas the ON (similar to 900 mg kg(-1)) and its major part total acid-hydrolyzable N (HTN; similar to 500 mg kg(-1)), were significantly different (p < 0.05) in most months (5/6 and 4/6; respectively). The canonical correlation analysis of soil N fractions and microbial parameters indicated that the relationship between total PLFAs (total biomass of living cells) and NH4+-N was the most representative. The relative contributions (indicated by the absolute value of canonical coefficient) of NH4+-N were the largest, followed by NO3-N and MBN. For the HTN component, the relative percentage of hydrolyzable amino acid N and ammonium N decreased markedly in the first half of the year. Canonical variation mainly reflected the relationship between ammonium N and bacterial PLFAs, which were the most sensitive indicators related to soil N changes. The relative contributions of HTN components to the link between soil microbial groups and HTN components were ammonium N > amino acid N > amino sugar N. Observations from our study indicate the sensitivity of soil N mineralization indicators in relation to the temporal variation of soil microbial groups and N fractions.	[Liu, Dong; Huang, Yimei; Yan, Hao; Jiang, Yueli; Zhao, Tong] Northwest A&F Univ, Coll Resource & Environm Sci, Minist Agr, Key Lab Plant Nutr & Agri Environm Northwest Chin, Yangling, Shaanxi, Peoples R China; [Liu, Dong; An, Shaoshan] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Huang, YM (corresponding author), Northwest A&F Univ, Coll Resource & Environm Sci, Minist Agr, Key Lab Plant Nutr & Agri Environm Northwest Chin, Yangling, Shaanxi, Peoples R China.	ymhuang1971@nwsuaf.edu.cn			National Natural Science Foundation of China [41101254]; International Partnership Program of Chinese Academy of Sciences [161461KYSB20170013]; China Postdoctoral Science Foundation [2017M623266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Partnership Program of Chinese Academy of Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We would like to thank the National Natural Science Foundation of China (41101254), the International Partnership Program of Chinese Academy of Sciences, Grant No. 161461KYSB20170013, and China Postdoctoral Science Foundation (2017M623266) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Sciences Foundation of China (41101254) and supported by the International Partnership Program of Chinese Academy of Sciences, Grant No. 161461KYSB20170013, and China Postdoctoral Science Foundation (2017M623266).	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Amelung W, 2001, SOIL BIOL BIOCHEM, V33, P553, DOI 10.1016/S0038-0717(00)00195-4; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; BAATH E, 1995, SOIL BIOL BIOCHEM, V27, P229, DOI 10.1016/0038-0717(94)00140-V; Baggs EM, 2000, SOIL USE MANAGE, V16, P82, DOI 10.1111/j.1475-2743.2000.tb00179.x; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Balser TC, 2000, LINKING MICROBIAL CO; Bao S., 2007, SOIL AGR CHEM ANAL, V3; Bell C, 2008, MICROB ECOL, V56, P153, DOI 10.1007/s00248-007-9333-z; Bending GD, 1999, BIOL FERT SOILS, V29, P319, DOI 10.1007/s003740050559; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Brant JB, 2006, OECOLOGIA, V148, P650, DOI 10.1007/s00442-006-0402-7; Bremner JM., 1965, METHODS SOIL ANAL; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P831, DOI 10.1016/0038-0717(85)90143-9; Buckeridge KM, 2010, PLANT SOIL, V330, P407, DOI 10.1007/s11104-009-0214-8; Burton J, 2010, J SOIL SEDIMENT, V10, P1267, DOI 10.1007/s11368-010-0238-y; Cabrera ML, 2005, J ENVIRON QUAL, V34, P75, DOI 10.2134/jeq2005.0075; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Chu HY, 2010, PLANT SOIL, V329, P411, DOI 10.1007/s11104-009-0167-y; Creamer CA, 2015, SOIL BIOL BIOCHEM, V80, P175, DOI 10.1016/j.soilbio.2014.10.008; De Santo AV, 2009, PLANT SOIL, V318, P217, DOI 10.1007/s11104-008-9831-x; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; Dijkstra FA, 2005, PLANT SOIL, V272, P41, DOI 10.1007/s11104-004-3848-6; Edwards KA, 2013, SOIL BIOL BIOCHEM, V57, P83, DOI 10.1016/j.soilbio.2012.07.018; Fabio ES, 2009, CAN J FOREST RES, V39, P330, DOI 10.1139/X08-182; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Grayston SJ, 2005, SOIL BIOL BIOCHEM, V37, P1157, DOI 10.1016/j.soilbio.2004.11.014; Grayston SJ, 2001, SOIL BIOL BIOCHEM, V33, P533, DOI 10.1016/S0038-0717(00)00194-2; Hackl E, 2004, FOREST ECOL MANAG, V188, P101, DOI 10.1016/j.foreco.2003.07.014; Hartge Blake, 1986, METHODS SOIL ANAL 1; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Ibell PT, 2010, J SOIL SEDIMENT, V10, P1027, DOI 10.1007/s11368-010-0222-6; IUSS Working Group WRB, 2015, WORLD REF BAS SOIL R, V106, DOI 10.1017/S0014479706394902; Jones DL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003250; Kelley KR, 1995, FERT RES, V42, P1, DOI 10.1007/BF00750495; Kimura R, 2005, J ARID ENVIRON, V63, P439, DOI 10.1016/j.jaridenv.2005.03.030; Krivtsov V, 2011, PEDOSPHERE, V21, P26, DOI 10.1016/S1002-0160(10)60075-6; Larsen KS, 2007, ARCT ANTARCT ALP RES, V39, P268, DOI 10.1657/1523-0430(2007)39[268:RAMDIT]2.0.CO;2; Leckie SE, 2005, FOREST ECOL MANAG, V220, P88, DOI 10.1016/j.foreco.2005.08.007; Leinweber P, 2000, J PLANT NUTR SOIL SC, V163, P433; Lipson DA, 1999, ECOLOGY, V80, P1623; Liu D, 2016, GEODERMA, V272, P93, DOI 10.1016/j.geoderma.2016.03.005; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Macdonald LM, 2004, SOIL BIOL BIOCHEM, V36, P489, DOI 10.1016/j.soilbio.2003.11.001; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; MAZZARINO MJ, 1991, PLANT SOIL, V138, P85, DOI 10.1007/BF00011811; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Nannipieri P, 2009, SOIL BIOL BIOCHEM, V41, P2357, DOI 10.1016/j.soilbio.2009.07.013; Nu R.K., 1999, SOIL AGR CHEM ANAL; Oquist MG, 2009, GLOBAL CHANGE BIOL, V15, P2715, DOI 10.1111/j.1365-2486.2009.01898.x; Pansu M, 2003, SOIL BIOL BIOCHEM, V35, P37, DOI 10.1016/S0038-0717(02)00234-1; Potthoff M, 2006, SOIL BIOL BIOCHEM, V38, P1851, DOI 10.1016/j.soilbio.2005.12.009; Prescott CE, 1996, SOIL BIOL BIOCHEM, V28, P1319, DOI 10.1016/S0038-0717(96)00132-0; PRESCOTT CE, 1994, CAN J FOREST RES, V24, P2424, DOI 10.1139/x94-313; RAISON RJ, 1987, SOIL BIOL BIOCHEM, V19, P521, DOI 10.1016/0038-0717(87)90094-0; Ren Wen, 2011, Journal of Forestry Research (Harbin), V22, P569, DOI 10.1007/s11676-011-0200-x; Rich JJ, 2004, SOIL BIOL BIOCHEM, V36, P1431, DOI 10.1016/j.soilbio.2004.03.008; Ros GH, 2011, SOIL BIOL BIOCHEM, V43, P1714, DOI 10.1016/j.soilbio.2011.04.017; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schmidt BHM, 2011, SOIL BIOL BIOCHEM, V43, P1742, DOI 10.1016/j.soilbio.2011.04.021; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Schulten H.-R., 1998, Biology and Fertility of Soils, V26, P1, DOI 10.1007/s003740050335; Shen WS, 2010, PLANT SOIL, V337, P137, DOI 10.1007/s11104-010-0511-2; Siira-Pietikainen A, 2003, BIOL FERT SOILS, V37, P163, DOI 10.1007/s00374-002-0571-4; Smithwick EAH, 2005, BIOGEOCHEMISTRY, V76, P517, DOI 10.1007/s10533-005-0031-y; Subke JA, 2004, OECOLOGIA, V139, P551, DOI 10.1007/s00442-004-1540-4; Tahovska K, 2013, SOIL BIOL BIOCHEM, V59, P58, DOI 10.1016/j.soilbio.2012.12.015; Thomas KD, 2000, CAN J FOREST RES, V30, P1698, DOI 10.1139/cjfr-30-11-1698; Treonis AM, 2007, BIOL FERT SOILS, V43, P541, DOI 10.1007/s00374-006-0133-2; Waldrop MP, 2004, BIOGEOCHEMISTRY, V67, P235, DOI 10.1023/B:BIOG.0000015321.51462.41; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Wang CH, 2011, PLANT SOIL, V340, P397, DOI 10.1007/s11104-010-0611-z; Wang L, 2006, ENVIRON SCI POLICY, V9, P675, DOI 10.1016/j.envsci.2006.08.003; Wang ZJ, 2014, CATENA, V115, P159, DOI 10.1016/j.catena.2013.11.012; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Xu YQ, 2007, PLANT SOIL, V300, P289, DOI 10.1007/s11104-007-9416-0; Yan ER, 2008, BIOGEOCHEMISTRY, V89, P239, DOI 10.1007/s10533-008-9216-5; Zhu TB, 2013, BIOL FERT SOILS, V49, P323, DOI 10.1007/s00374-012-0725-y; ZOU XM, 1992, PLANT SOIL, V139, P275, DOI 10.1007/BF00009319	81	15	15	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196567	10.1371/journal.pone.0196567	http://dx.doi.org/10.1371/journal.pone.0196567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795562	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300009
J	Wu, W; Xiao, ZB; An, WY; Dong, YY; Zhang, BK				Wu, Wei; Xiao, Zhibin; An, Wenyi; Dong, Yuanyang; Zhang, Bingkun			Dietary sodium butyrate improves intestinal development and function by modulating the microbial community in broilers	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; OXIDATIVE STRESS; GROWTH-PERFORMANCE; GUT MICROBIOTA; GASTROINTESTINAL-TRACT; CORTICOSTERONE EXPOSURE; IMMUNE-RESPONSE; FEED ADDITIVES; DNA-DAMAGE; MORPHOLOGY	This study investigated the effects of dietary sodium butyrate (SB) supplementation, provided as a specially coated product, on growth performance, intestinal development, morphological structure and function in broilers. In total, 720 one-day-old Arbor Acres male broilers were randomly allocated into six treatment groups with six replicates each and then fed basal diets (control) supplemented with 0, 200, 400, 800 or 1000 mg/kg of SB or with antibiotics (100 mg/kg aureomycin and 20 mg/kg colistin sulfate). The growth trial lasted for 42 days. No differences (P>0.05) in growth performance were detected between groups during the grower period (1-21 d) or over the total (1-42 d) trial period, whereas the addition of SB improved the intestinal structure by stimulating (P<0.05) goblet cells on jejunal and ileal villi accompanied by a trend towards increased (P-diets<0.10) ileal villus height. In addition, more inerratic leaf-shaped villi and mucus secretion and significantly fewer erosions were demonstrated by scanning electron microscopy. Apart from decreased (P<0.05) malondialdehyde (MDA) in the ileal mucosa at 21 d of age, supplemental SB at higher doses (800 mg/kg) led to greater (P<0.05) total antioxidant capacity and depressed (P<0.05) MDA concentrations in the jejunal mucosa. Birds fed with 400 mg/kg and 800 mg/kg SB had higher (P<0.05) acetic acid concentrations at 42 d and higher butyric acid at 21 d in the jejunum chyme. Morever, chicks fed SB diet were found to have higher concentrations of butyric acid (P<0.05) in the ileal chyme. SB additions at 400 mg/kg displayed higher Firmicutes and Proteobacteria levels, while a higher (P<0.05) relative abundance of Bacteroidetes was observed at 800 mg/kg. Furthermore, we found a striking decrease in Enterobacteriaceae and increases in Lachnospiraceae and Rikenellaceae in the cecal lumen of birds fed 800 mg/kg SB as well as a higher proportion of Ruminococcaceae and a noticeable reduction (P<0.05) of Lactobacillaceae in birds treated with 400 mg/kg SB. Taken together, our results support the importance of SB in improving the intestinal development, morphological structure and biological functions of broilers through modulation of the microbial community, which seems to be optimized for gut health at higher doses (800 mg/kg) of SB.	[Wu, Wei; Xiao, Zhibin; An, Wenyi; Dong, Yuanyang; Zhang, Bingkun] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	China Agricultural University	Zhang, BK (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	bingkunzhang@126.com		Wu, Wei/0000-0001-8160-4030	Chinese Universities Scientific Fund [15057001]	Chinese Universities Scientific Fund	This research was financially supported by Chinese Universities Scientific Fund (No. 15057001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse SL, 1999, CARCINOGENESIS, V20, P629, DOI 10.1093/carcin/20.4.629; Adil Sheikh, 2010, Vet Med Int, V2010, P479485, DOI 10.4061/2010/479485; Aguilar EC, 2016, J NUTR BIOCHEM, V34, P99, DOI 10.1016/j.jnutbio.2016.05.002; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cerisuelo A, 2014, POULTRY SCI, V93, P599, DOI 10.3382/ps.2013-03528; Chamba F., 2014, International Journal of Poultry Science, V13, P390; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; CLAUSEN MR, 1995, GUT, V37, P684, DOI 10.1136/gut.37.5.684; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Czerwinski J, 2012, ARCH ANIM NUTR, V66, P102, DOI 10.1080/1745039X.2012.663668; De Boever P, 2000, APPL MICROBIOL BIOT, V53, P709, DOI 10.1007/s002530000330; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fernandez-Rubio C, 2009, POULTRY SCI, V88, P943, DOI 10.3382/ps.2008-00484; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; GALFI P, 1990, ACTA VET HUNG, V38, P3; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hu ZH, 2007, ANIM FEED SCI TECH, V132, P240, DOI 10.1016/j.anifeedsci.2006.03.017; Huang C, 2015, J NUTR, V145, P2774, DOI 10.3945/jn.115.217406; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jiang Y, 2015, ANIM PROD SCI, V55, P587, DOI 10.1071/AN13348; Jin L, 2014, J INTEGR AGR, V13, P2731, DOI 10.1016/S2095-3119(13)60729-7; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; KRIPKE SA, 1989, JPEN-PARENTER ENTER, V13, P109, DOI 10.1177/0148607189013002109; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leeson S, 2005, POULTRY SCI, V84, P1418, DOI 10.1093/ps/84.9.1418; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Mahdavi R, 2009, J ANIM VET ADV, V8, P1702; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Moquet PCA, 2016, WORLD POULTRY SCI J, V72, P61, DOI 10.1017/S004393391500269X; MORTENSEN FV, 1990, GUT, V31, P1391, DOI 10.1136/gut.31.12.1391; Olukosi OA, 2014, J ANIM SCI, V92, P3945, DOI 10.2527/jas.2013-6368; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Rigsbee L, 2012, AM J GASTROENTEROL, V107, P1740, DOI 10.1038/ajg.2012.287; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V507, P819, DOI 10.1111/j.1469-7793.1998.819bs.x; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rosignoli P, 2001, CARCINOGENESIS, V22, P1675, DOI 10.1093/carcin/22.10.1675; Sauer J, 2007, J NUTR BIOCHEM, V18, P736, DOI 10.1016/j.jnutbio.2006.12.012; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shankar V, 2015, ISME J, V9, P1899, DOI 10.1038/ismej.2014.258; Sikandar A, 2017, ASIAN AUSTRAL J ANIM, V30, P690, DOI 10.5713/ajas.16.0824; Smulikowska S, 2009, J ANIM FEED SCI, V18, P478, DOI 10.22358/jafs/66422/2009; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van Deun K, 2008, AVIAN PATHOL, V37, P379, DOI 10.1080/03079450802216603; Wu YA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154410; Xu JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162461; Yang Y, 2009, WORLD POULTRY SCI J, V65, P97, DOI 10.1017/S0043933909000008; Zhang WH, 2011, POULTRY SCI, V90, P2592, DOI 10.3382/ps.2011-01446; Zhang WH, 2011, BRIT POULTRY SCI, V52, P292, DOI 10.1080/00071668.2011.578121; Zhou D, 2017, WORLD J GASTROENTERO, V23, P60, DOI 10.3748/wjg.v23.i1.60	58	61	70	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197762	10.1371/journal.pone.0197762	http://dx.doi.org/10.1371/journal.pone.0197762			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795613	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300071
J	Chen, HL; Yuan, CY; Cheng, HH; Chang, TC; Huang, SK; Kuo, CC; Wu, KK				Chen, Hua-Ling; Yuan, Chao-Yun; Cheng, Huei-Hsuan; Chang, Tzu-Ching; Huang, Shau-Ku; Kuo, Cheng-Chin; Wu, Kenneth K.			Restoration of hydroxyindole O-methyltransferase levels in human cancer cells induces a tryptophan-metabolic switch and attenuates cancer progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell metabolism; enzyme; metastasis; tryptophan; 5-methoxytryptophan; HIOMT; hydroxyindole O-methyltransferase; melatonin	AMINO-ACID DECARBOXYLASE; CYCLOOXYGENASE-2 PROMOTER ACTIVATION; MESSENGER-RNA; EXPRESSION; SEROTONIN; MELATONIN; 5-METHOXYTRYPTOPHAN; P300; GENE	5-Methoxytryptophan (5-MTP) is a tryptophan metabolite with recently discovered anti-inflammatory and tumor-suppressing activities. Its synthesis is catalyzed by a hydroxyindole O-methyltransferase (HIOMT)-like enzyme. However, the exact identity of this HIOMT in human cells remains unclear. Human HIOMT exists in several alternatively spliced isoforms, and we hypothesized that 5-MTP-producing HIOMT is a distinct isoform. Here, we show that human fibroblasts and cancer cells express the HIOMT298 isoform as contrasted with the expression of the HIOMT345 isoform in pineal cells. Sequencing analysis of the cloned isoforms revealed that HIOMT298 is identical to the sequence of a previously reported truncated HIOMT isoform. Of note, HIOMT298 expression was reduced in cancer cells and tissues. Stable transfection of A549 cancer cells with HIOMT298 restored HIOMT expression to normal levels, accompanied by 5-MTP production. Furthermore, HIOMT298 transfection caused a tryptophan-metabolic switch from serotonin to 5-MTP production. To determine the in vivo relevance of this alteration, we compared growth and lung metastasis of HIOMT298-transfected A549 cells with those of vector- or untransfected A549 cells as controls in a murine xenograft model. Of note, the HIOMT298-transfected A549 cells exhibited slower growth and lower metastasis than the controls. Our findings provide insight into the crucial role of HIOMT298 in 5-MTP production in cells and in inhibiting cancer progression and highlight the potential therapeutic value of 5-MTP for managing cancer.	[Chen, Hua-Ling; Yuan, Chao-Yun; Kuo, Cheng-Chin; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli 35053, Taiwan; [Chen, Hua-Ling; Huang, Shau-Ku] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli 35053, Taiwan; [Yuan, Chao-Yun; Cheng, Huei-Hsuan; Chang, Tzu-Ching; Wu, Kenneth K.] China Med Univ Hosp, Metabol Med Res Ctr, Taichung 40402, Taiwan; [Cheng, Huei-Hsuan; Chang, Tzu-Ching; Wu, Kenneth K.] China Med Univ, Grad Inst Biomed Sci, Taichung 40402, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Coll Life Sci, Dept Med Sci, Hsinchu 30013, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Coll Life Sci, Inst Biotechnol, Hsinchu 30013, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Tsing Hua University; National Tsing Hua University	Kuo, CC; Wu, KK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	kuocc@nhri.org.tw; kkgo@nhri.org.tw			Ministry of Science and Technology Excellent Research Team Program [MOST-104-2811-B-039-010]	Ministry of Science and Technology Excellent Research Team Program	This work was supported by Ministry of Science and Technology Excellent Research Team Program MOST-104-2811-B-039-010 (to K.K.W. and C.-C.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguanno A, 1996, J BIOL CHEM, V271, P4528; Avgeris M, 2008, CLIN BIOCHEM, V41, P1140, DOI 10.1016/j.clinbiochem.2008.04.026; Botros HG, 2013, J PINEAL RES, V54, P46, DOI 10.1111/j.1600-079X.2012.01020.x; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; Cheng HH, 2016, ONCOTARGET, V7, P31243, DOI 10.18632/oncotarget.9111; Cheng HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088507; Cheng HH, 2012, P NATL ACAD SCI USA, V109, P13231, DOI 10.1073/pnas.1209919109; Chu LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152166; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; DONOHUE SJ, 1993, DNA CELL BIOL, V12, P715, DOI 10.1089/dna.1993.12.715; DONOHUE SJ, 1992, J BIOL CHEM, V267, P5184; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Jung B, 2006, CANCER RES, V66, P9789, DOI 10.1158/0008-5472.CAN-06-1776; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; Mediavilla MD, 2010, CURR MED CHEM, V17, P4462, DOI 10.2174/092986710794183015; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; RODRIGUEZ IR, 1994, J BIOL CHEM, V269, P31969; Sarrouilhe D, 2015, CURR MOL MED, V15, P62, DOI 10.2174/1566524015666150114113411; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Vachtenheim J, 1997, EUR J CANCER, V33, P2411, DOI 10.1016/S0959-8049(97)00302-X; Vijayalaxmi, 2002, J CLIN ONCOL, V20, P2575, DOI 10.1200/JCO.2002.11.004; Wang YF, 2016, CIRC RES, V119, P222, DOI 10.1161/CIRCRESAHA.116.308559	24	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11131	11142		10.1074/jbc.RA117.000597	http://dx.doi.org/10.1074/jbc.RA117.000597			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794137	Green Published, hybrid			2022-12-26	WOS:000438882800025
J	Hohnadel, M; Maumy, M; Chollet, R				Hohnadel, Marisa; Maumy, Myriam; Chollet, Renaud			Development of a micromanipulation method for single cell isolation of prokaryotes and its application in food safety	PLOS ONE			English	Article							FOODBORNE PATHOGENS	For nearly a century, conventional microbiological methods have been standard practice for detecting and identifying pathogens in food. Nevertheless, the microbiological safety of food has improved and various rapid methods have been developed to overcome the limitations of conventional methods. Alternative methods are expected to detect low cell numbers, since the presence in food of even a single cell of a pathogenic organism may be infectious. With respect to low population levels, the performance of a detection method is assessed by producing serial dilutions of a pure bacterial suspension to inoculate representative food matrices with highly diluted bacterial cells (fewer than 10 CFU/ml). The accuracy of data obtained by multiple dilution techniques is not certain and does not exclude some colonies arising from clumps of cells. Micromanipulation techniques to capture and isolate single cells from environmental samples were introduced more than 40 years ago. The main limitation of the current micromanipulation technique is still the low recovery rate for the growth of a single cell in culture medium. In this study, we describe a new single cell isolation method and demonstrate that it can be used successfully to grow various types of microorganism from picked individual cells. Tests with Gram-positive and Gram-negative organisms, including cocci, rods, aerobes, anaerobes, yeasts and molds showed growth recovery rates from 60% to 100% after micromanipulation. We also highlight the use of our method to evaluate and challenge the detection limits of standard detection methods in food samples contaminated by a single cell of Salmonella enterica.	[Hohnadel, Marisa; Chollet, Renaud] Merck, Life Sci Appl Solut, Biomonitoring R&D, Molsheim, France; [Maumy, Myriam] Univ Strasbourg, Inst Rech Math Avancee, UMR7501, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hohnadel, M (corresponding author), Merck, Life Sci Appl Solut, Biomonitoring R&D, Molsheim, France.	marisa.hohnadel@merckgroup.com		Hohnadel, Marisa/0000-0003-3751-0226	Merck	Merck(Merck & Company)	Merck provided support in the form of salaries for authors [MH, MM, RC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashida N, 2010, APPL MICROBIOL BIOT, V85, P1211, DOI 10.1007/s00253-009-2330-z; Frohlich J, 2000, FEMS MICROBIOL REV, V24, P567; Frohlich J, 1999, SYST APPL MICROBIOL, V22, P249, DOI 10.1016/S0723-2020(99)80072-1; International Organization for Standardization, 67852001E ISO; Ishey T, 2006, APPL MICROBIOL BIOT, V69, P510, DOI 10.1007/s00253-005-0014-x; ISO 6579:2002(E), 65792002E ISO; Oliver SP, 2005, FOODBORNE PATHOG DIS, V2, P115, DOI 10.1089/fpd.2005.2.115; Roeder B, 2010, APPL ENVIRON MICROB, V76, P2600, DOI 10.1128/AEM.01506-09; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SLY LI, 1987, J MICROBIOL METH, V6, P177, DOI 10.1016/0167-7012(87)90013-3; VANSOESTBERGEN AA, 1969, APPL MICROBIOL, V18, P1092, DOI 10.1128/AEM.18.6.1092-1093.1969; Zhao X, 2014, J MICROBIOL BIOTECHN, V24, P297, DOI 10.4014/jmb.1310.10013	12	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0198208	10.1371/journal.pone.0198208	http://dx.doi.org/10.1371/journal.pone.0198208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851964	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200041
J	Keskitalo, A; Munukka, E; Toivonen, R; Hollmen, M; Kainulainen, H; Huovinen, P; Jalkanen, S; Pekkala, S				Keskitalo, Anniina; Munukka, Eveliina; Toivonen, Raine; Hollmen, Maija; Kainulainen, Heikki; Huovinen, Pentti; Jalkanen, Sirpa; Pekkala, Satu			Enterobacter cloacae administration induces hepatic damage and subcutaneous fat accumulation in high-fat diet fed mice	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; ADIPOSE-TISSUE; GUT MICROBIOTA; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; ACTIVATION; GLUCOSE; STRESS	Accumulating evidence indicates that gut microbiota plays a significant role in obesity, insulin resistance and associated liver disorders. Family Enterobacteriaceae and especially Enterobacter cloacae strain B29 have been previously linked to obesity and hepatic damage. The underlying mechanisms, however, remain unclear. Therefore, we comprehensively examined the effects of E. cloacae subsp. cloacae (ATCC (R) 13047 (TM)) administration on host metabolism of mice fed with high-fat diet (HFD). C57BL/6N mice were randomly divided into HFD control, chow control, and E. cloacae treatment groups. The E. cloacae treatment group received live bacterial cells in PBS intragastrically twice a week, every other week for 13 weeks. Both control groups received PBS intragastrically. After the 13-week treatment period, the mice were sacrificed for gene and protein expression and functional analyses. Our results show that E. cloacae administration increased subcutaneous fat mass and the relative proportion of hypertrophic adipocytes. Both subcutaneous and visceral fat had signs of decreased insulin signaling and elevated lipolysis that was reflected in higher serum glycerol levels. In addition, E. cloacae -treated mice had significantly higher hepatic AST and AST/ALT ratio, and their liver histology indicated fibrosis, demonstrating that E. cloacae subsp. cloacae administration promotes hepatic damage in HFD fed mice.	[Keskitalo, Anniina; Toivonen, Raine; Hollmen, Maija; Huovinen, Pentti; Jalkanen, Sirpa] Univ Turku, Inst Biomed, Turku, Finland; [Keskitalo, Anniina; Munukka, Eveliina] Turku Univ Hosp, Dept Clin Microbiol, Turku, Finland; [Hollmen, Maija; Jalkanen, Sirpa] Univ Turku, Medicity Res Lab, Turku, Finland; [Kainulainen, Heikki; Pekkala, Satu] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland	University of Turku; University of Turku; University of Turku; University of Jyvaskyla	Keskitalo, A (corresponding author), Univ Turku, Inst Biomed, Turku, Finland.; Keskitalo, A (corresponding author), Turku Univ Hosp, Dept Clin Microbiol, Turku, Finland.; Pekkala, S (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.	anniina.keskitalo@utu.fi; satu.p.pekkala@jyu.fi	Munukka, Eveliina/GQP-6540-2022; Hollmén, Maija/B-5831-2017; Huovinen, Pentti/C-9121-2019	Hollmén, Maija/0000-0002-3250-7653; Huovinen, Pentti/0000-0003-0003-1539; Keskitalo, Anniina/0000-0002-3342-4358; Pekkala, Satu/0000-0003-3107-0813	The Academy of Finland [267719, 285503]; Finnish Diabetes Research Foundation; Finnish Cultural Foundation (Central and Southwest Finland funds); Emil Aaltonen Foundation; Instrumentarium Research foundation; Diabetes Wellness foundation; Turku University Foundation	The Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Cultural Foundation (Central and Southwest Finland funds); Emil Aaltonen Foundation; Instrumentarium Research foundation; Diabetes Wellness foundation; Turku University Foundation	This work was financially supported by The Academy of Finland professorship (SJ) and postdoctoral fellowships (SP, grant ID 267719 and RT, grant ID 285503), the Finnish Diabetes Research Foundation (SP), the Finnish Cultural Foundation (Central and Southwest Finland funds; SP and EM), Emil Aaltonen Foundation (EM), Instrumentarium Research foundation (SP), Diabetes Wellness foundation (SP), and Turku University Foundation (AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2013, BRIEF FUNCT GENOMICS, V12, P381, DOI 10.1093/bfgp/elt014; Caselli C, 2014, MOL GENET METAB, V113, P155, DOI 10.1016/j.ymgme.2014.09.003; Catalan V, 2012, J CLIN ENDOCR METAB, V97, pE1880, DOI 10.1210/jc.2012-1670; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Fernandes P, 2014, J IMMUNOL, V193, P6103, DOI 10.4049/jimmunol.1303083; Giordano A, 2013, J LIPID RES, V54, P2423, DOI 10.1194/jlr.M038638; Hargett SR, 2016, AM J PHYSIOL-ENDOC M, V310, pE276, DOI 10.1152/ajpendo.00342.2015; Harmon DB, 2016, ARTERIOSCL THROM VAS, V36, P682, DOI 10.1161/ATVBAHA.116.307166; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim S, 2015, J IMMUNOL, V194, P4498, DOI 10.4049/jimmunol.1401399; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Lee SO, 2002, EUR J CLIN MICROBIOL, V21, P577, DOI 10.1007/s10096-002-0772-7; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; LINDBERG AA, 1990, REV INFECT DIS, V12, pS133; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Makki K, 2013, ISRN INFLAMMATION, V2013; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Munukka E, 2017, ISME J; Munukka E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152786; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Nyblom H, 2006, LIVER INT, V26, P840, DOI 10.1111/j.1478-3231.2006.01304.x; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pekkala S, 2015, OBESITY, V23, P581, DOI 10.1002/oby.20993; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Saponaro C, 2015, NUTRIENTS, V7, P9453, DOI 10.3390/nu7115475; Taira R, 2015, J CLIN BIOCHEM NUTR, V56, P149, DOI 10.3164/jcbn.14-74; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Washington K, 2000, HUM PATHOL, V31, P822, DOI 10.1053/hupa.2000.8440; World Health Organization, OB OV FACT SHEET 201; Yan HY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01786; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093; Zlotnikov-Klionsky Y, 2015, IMMUNITY, V43, P776, DOI 10.1016/j.immuni.2015.08.015	52	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0198262	10.1371/journal.pone.0198262	http://dx.doi.org/10.1371/journal.pone.0198262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847581	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800061
J	Opell, BD; Clouse, ME; Andrews, SF				Opell, Brent D.; Clouse, Mary E.; Andrews, Sheree F.			Elastic modulus and toughness of orb spider glycoprotein glue	PLOS ONE			English	Article							VISCOUS CAPTURE THREADS; STICKY DROPLETS; WEAVING SPIDERS; SILK FIBERS; WEB; EVOLUTION; ADHESION; ARANEAE; SPUN; POLYMERIZATION	An orb web's prey capture thread features tiny glue droplets, each formed of an adhesive glycoprotein core surrounded by an aqueous layer. Small molecules in the aqueous layer confer droplet hygroscopicity and maintain glycoprotein viscoelasticity, causing droplet volume and glycoprotein performance to track changes in environmental humidity. Droplet extension combines with that of a thread's supporting flagelliform fibers to sum the adhesive forces of multiple droplets, creating an effective adhesive system. We combined measurements of the force on an extending droplet, as gauged by the deflection of its support line, with measurements of glycoprotein volume and droplet extension to determine the Young's modulus (E) and toughness of three species' glycoproteins. We did this at five relative humidities between 20 - 90% to assess the effect of humidity on these properties. When droplets of a thread span extend, their extensions are constrained and their glycoprotein filaments remain covered by aqueous material. This was also the case during the first extension phase of the individual droplets that we examined. However, as extension progressed, the aqueous layer was progresses disrupted, exposing the glycoprotein. During the first extension phase E ranged from 0.00003 GPa, a value similar to that of fibronectin, a glycoprotein that anchors cells in the extracellular matrix, to 0.00292 GPa, a value similar to that of resilin in insect ligaments. Second phase E increased 4.7 - 19.4-fold. When compared at the same humidity the E of each species' glycoprotein was less than 5% of the value reported for its flagelliform fibers. This difference may facilitate the coordinated extension of these two capture thread components that is responsible for summing the thread's adhesive forces.	[Opell, Brent D.; Clouse, Mary E.; Andrews, Sheree F.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Opell, BD (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA USA.	bopell@vt.edu		Opell, Brent/0000-0002-1830-0752	National Science Foundation grant [IOS-1257719]	National Science Foundation grant(National Science Foundation (NSF))	National Science Foundation grant IOS-1257719 (BO) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2009, J EXP BIOL, V212, P1989, DOI 10.1242/jeb.028282; Amarpuri G, 2015, ACS NANO, V9, P11472, DOI 10.1021/acsnano.5b05658; [Anonymous], 2017, WORLD SPID CAT V18 5; [Anonymous], 2001, SILICONE RUBBER; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Chacon P., 1980, Bulletin of the British Arachnological Society, V5, P29; Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w; CODDINGTON JA, 1989, J ARACHNOL, V17, P71; Collin MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21589; Craig C.L., 2003, SPIDER WEBS SILK TRA; Dickinson GH, 2009, J EXP BIOL, V212, P3499, DOI 10.1242/jeb.029884; Dimitrov D, 2017, CLADISTICS, V33, P221, DOI 10.1111/cla.12165; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055; Foelix R. F, 2011, BIOL SPIDERS; Garb JE., 2013, SPIDER RES 21 CENTUR; Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4; Hormiga G, 2014, ANNU REV ENTOMOL, V59, P487, DOI 10.1146/annurev-ento-011613-162046; Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106; Liao CP, 2015, J ARACHNOL, V43, P97, DOI 10.1636/M14-50.1; Lucas JM, 2002, J EXP BIOL, V205, P1807; Mead-Hunter R, 2012, LANGMUIR, V28, P6731, DOI 10.1021/la300622h; NALDRETT MJ, 1993, J MAR BIOL ASSOC UK, V73, P689, DOI 10.1017/S0025315400033221; Opell BD, 2007, J EXP BIOL, V210, P2352, DOI 10.1242/jeb.004952; Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682; Opell BD, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.161539; Opell BD, 2013, J EXP BIOL, V216, P3023, DOI 10.1242/jeb.084822; Opell BD, 2011, J EXP BIOL, V214, P2988, DOI 10.1242/jeb.055996; Opell BD, 2009, J EXP BIOL, V212, P3026, DOI 10.1242/jeb.030064; Penalver E, 2006, SCIENCE, V312, P1761, DOI 10.1126/science.1126628; Piorkowski D, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1489-x; Rasband W., 2006, IMAGEJ; ROE RJ, 1975, J COLLOID INTERF SCI, V50, P70, DOI 10.1016/0021-9797(75)90255-6; Sahni V, 2014, BIOMACROMOLECULES, V15, P1225, DOI 10.1021/bm401800y; Sahni V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00041; Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019; Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x; Sensenig AT, 2013, J EXP BIOL, V216, P3388, DOI 10.1242/jeb.085571; Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851; So CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36219; Stellwagen SD, 2016, J ARACHNOL, V44, P401, DOI 10.1636/M15-78.1; Stellwagen SD, 2015, ANN M P ADH SOC, V2015, P1; Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147; TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203; Townley Mark A., 2013, P283; Townley MA, 2012, CHEM BIODIVERS, V9, P2159, DOI 10.1002/cbdv.201200077; Vasanthavada K, 2012, J BIOL CHEM, V287, P35986, DOI 10.1074/jbc.M112.399816; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Waite JH, 2017, J EXP BIOL, V220, P517, DOI 10.1242/jeb.134056; Wolff JO, 2015, SOFT MATTER, V11, P2394, DOI 10.1039/c4sm02130d; WORK RW, 1982, TEXT RES J, V52, P349, DOI 10.1177/004051758205200508; WORK RW, 1981, J ARACHNOL, V9, P299	58	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0196972	10.1371/journal.pone.0196972	http://dx.doi.org/10.1371/journal.pone.0196972			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847578	Green Published, gold, Green Submitted			2022-12-26	WOS:000433634800014
J	Han, SF; Proctor, AR; Ren, JX; Benoit, DSW; Choe, R				Han, Songfeng; Proctor, Ashley R.; Ren, Jingxuan; Benoit, Danielle S. W.; Choe, Regine			Temporal blood flow changes measured by diffuse correlation tomography predict murine femoral graft healing	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TISSUE ENGINEERED PERIOSTEUM; BONE; RAT; SPECTROSCOPY; SUBSTITUTES; HYDROGELS	Blood flow changes during bone graft healing have the potential to provide important information about graft success, as the nutrients, oxygen, circulating cells and growth factors essential for integration are delivered by blood. However, longitudinal monitoring of blood flow changes during graft healing has been a challenge due to limitations in current techniques. To this end, non-invasive diffuse correlation tomography (DCT) was investigated to enable longitudinal monitoring of three-dimensional blood flow changes in deep tissue. Specific to this study, longitudinal blood flow changes were utilized to predict healing outcomes of common interventions for massive bone defects using a common mouse femoral defect model. Weekly blood flow changes were non-invasively measured using a diffuse correlation tomography system for 9 weeks in three types of grafts: autografts (N = 7), allografts (N = 6) and tissue-engineered allografts (N = 6). Healing outcomes were quantified using an established torsion testing method 9 weeks after transplantation. Analysis of the spatial and temporal blood flow reveals that major differences among the three groups were captured in weeks 1 - 5 after graft transplantation. A multivariate model to predict maximum torque by relative blood flow changes over 5 weeks after graft transplantation was built using partial least squares regression. The results reveal lower bone strength correlates with greater cumulative blood flow over an extended period of time (i.e., 1 - 5 weeks). The current research demonstrates that DCT-measured blood flow changes after graft transplantation can be utilized to predict long-term healing outcomes in a mouse femoral graft model.	[Han, Songfeng] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Proctor, Ashley R.; Ren, Jingxuan; Benoit, Danielle S. W.; Choe, Regine] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Benoit, Danielle S. W.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA; [Benoit, Danielle S. W.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Benoit, Danielle S. W.] Univ Rochester, Dept Chem Engn, Rochester, NY 14627 USA; [Benoit, Danielle S. W.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Choe, Regine] Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Choe, R (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.; Choe, R (corresponding author), Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA.	Regine_Choe@urmc.rochester.edu	Han, Songfeng/J-3682-2019	Benoit, Danielle/0000-0001-7137-8164; Ren, Jingxuan/0000-0002-0020-1211; Choe, Regine/0000-0001-5851-4504	National Institutes of Health [R01 AR071363, R01 AR064200]; National Science Foundation [CBET 1507384]; Div Of Chem, Bioeng, Env, & Transp Sys [1507384] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064200, R01AR071363, P30AR069655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health, R01 AR071363 (RC) and R01 AR064200 (DB) (https://www.nih.gov/); and the National Science Foundation, CBET 1507384 (RC) (https://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarachantachote N., 2014, INT J PURE APPL MATH, V94, P307, DOI [10.12732/ijpam.v94i3.2, DOI 10.12732/IJPAM.V94I3.2]; Benoit DSW, 2007, J BIOMED MATER RES A, V81A, P259, DOI 10.1002/jbm.a.31292; Bishop C. M, 2006, PATTERN RECOGNITION; Choe R, 2012, IEEE J SEL TOP QUANT, V18, P1367, DOI 10.1109/JSTQE.2011.2177963; Culver JP, 2003, J CEREBR BLOOD F MET, V23, P911, DOI 10.1097/01.WCB.0000076703.71231.BB; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Han SF, 2016, BIOMED OPT EXPRESS, V7, P3262, DOI 10.1364/BOE.7.003262; Han SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143891; Han SF, 2015, BIOMED OPT EXPRESS, V6, P2695, DOI 10.1364/BOE.6.002695; He L, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.8.086003; Hoffman MD, 2015, J TISSUE ENG REGENER, V9; Hoffman MD, 2015, BIOMATERIALS, V52, P426, DOI 10.1016/j.biomaterials.2015.02.064; Hoffman MD, 2014, ACTA BIOMATER, V10, P3431, DOI 10.1016/j.actbio.2014.04.012; Hoffman MD, 2013, BIOMATERIALS, V34, P8887, DOI 10.1016/j.biomaterials.2013.08.005; Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978; Institute S, 2017, JMP 13 MULTIVARIATE; Jermyn M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086007; Lin Y, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869469; Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777; Loi F, 2016, BONE, V86, P199, DOI [10.1016/j.bone.2016.020, DOI 10.1016/J.BONE.2016.020]; Mankin HJ, 2005, CLIN ORTHOP RELAT R, P210, DOI 10.1097/01.blo.0000150371.77314.52; Muratore M, 2013, ANAL CHIM ACTA, V793, P1, DOI 10.1016/j.aca.2013.06.012; Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004; Reynolds DG, 2007, J BIOMECH, V40, P3178, DOI 10.1016/j.jbiomech.2007.04.004; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Xie C, 2007, TISSUE ENG, V13, P435, DOI 10.1089/ten.2006.0182; Zhou C, 2006, OPT EXPRESS, V14, P1125, DOI 10.1364/OE.14.001125	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197031	10.1371/journal.pone.0197031	http://dx.doi.org/10.1371/journal.pone.0197031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813078	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800009
J	Adedipe, OE; Jacot, TA; Thurman, AR; Doncel, GF; Clark, MR				Adedipe, Oluwatosin E.; Jacot, Terry A.; Thurman, Andrea R.; Doncel, Gustavo F.; Clark, Meredith R.			Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques	PLOS ONE			English	Article							DRIED BLOOD SPOTS; PREEXPOSURE PROPHYLAXIS; MICROBICIDE TRIALS; HUMAN TISSUE; PREVENTION; SIMULANT; SCIENCE; STATE; CELLS	Background The topical HIV prevention (microbicides) field is in acute need of a method to rapidly and objectively measure adherence to product use in clinical trials. Infrared (IR) spectroscopy has been used in many pharmaceutical and forensic applications but has yet to be applied to adherence monitoring. In this study, we report on efforts to test the feasibility of using IR spectroscopy as a means to measure residual active or placebo vaginal product, semen exposure and vaginal insertion from a single swab. Methods A portable IR spectrometer equipped with diamond attenuated total reflectance (ATR) was used to capture spectra of unused vs. vaginally-used swabs, vaginal swabs containing semen, and vaginal swabs to which either tenofovir-containing or matching placebo products (vaginal gel or insert) were added. Spectral data obtained from swabs placed directly on the spectrometer were divided into calibration and testing sets for developing and validating discriminant models set up to provide yes/no predictions of: vaginal vs. non-vaginal use, presence vs. no presence of each test product, and presence vs. no presence of semen. Further validation of models was performed using vaginal swabs collected from a clinical study evaluating vaginally administered placebo insert formulations. Results For each discriminant model developed to predict vaginal vs. non-vaginal use, presence vs. no presence of each test product, and presence vs. no presence of semen, classified validation samples not included in the model development were correctly identified into their respective classes with minimal prediction error. Clinically obtained vaginal swabs collected 15-60 minutes after placebo insert use were also correctly identified, further validating the models. Conclusion Our findings demonstrate the proof of concept that IR spectroscopy can be a method for rapid detection and characterization of microbicide products and biological fluids present in vaginal swabs. This novel method has potential to support real-time, on-site adherence monitoring in clinical or field settings.	[Adedipe, Oluwatosin E.; Jacot, Terry A.; Thurman, Andrea R.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA; [Doncel, Gustavo F.; Clark, Meredith R.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Arlington, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Adedipe, OE (corresponding author), Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA.	AdedipOE@evms.edu		Clark, Meredith/0000-0002-4476-8287; Adedipe, Oluwatosin/0000-0001-5742-9949	United States Agency for International Development (USAID) [AID-OAA-14-00005, AID-OAA-A-14-00010]; Bill & Melinda Gates Foundation [OPP1114939]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by United States Agency for International Development (USAID) under Cooperative Agreements (AID-OAA-14-00005 and AID-OAA-A-14-00010) awarded to CONRAD, www.usaid.gov; Bill & Melinda Gates Foundation, #OPP1114939 awarded to CONRAD, www.gatesfoundation.org.	Barcot O, 2007, APPL SPECTROSC, V61, P309, DOI 10.1366/000370207780220804; Boyd P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125682; Camo, SIMC SOFT IND MOD CL; Castillo-Mancilla J, 2016, ANTIMICROB AGENTS CH, V60, P6692, DOI 10.1128/AAC.01017-16; Chiriboga L, 1998, BIOSPECTROSCOPY, V4, P55, DOI 10.1002/(SICI)1520-6343(1998)4:1<55::AID-BSPY6>3.0.CO;2-R; Chiriboga L, 1998, BIOSPECTROSCOPY, V4, P47, DOI 10.1002/(SICI)1520-6343(1998)4:1<47::AID-BSPY5>3.0.CO;2-P; DIEM M, 2008, VIBRATIONAL SPECTROS; Elkins KM, 2011, J FORENSIC SCI, V56, P1580, DOI 10.1111/j.1556-4029.2011.01870.x; Esbensen K.H, 2004, MULTIVARIATE DATA AN; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Huck CW, 2017, MOLECULES, V22; Katzenstein D A, 1997, J Assoc Nurses AIDS Care, V8 Suppl, P46, DOI 10.1016/S1055-3290(97)80008-8; Kettaneh-Wold N, 2006, MULTI MEGAVARIATE 2; Krafft C, 2006, SPECTROSC-INT J, V20, P195, DOI 10.1155/2006/738186; Kumar VS, 2016, CLIN CHEM, V62, P1041, DOI 10.1373/clinchem.2015.253179; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Lorber A., 1987, J CHEMOM, V1, P19, DOI DOI 10.1002/CEM.1180010105; Masse BR, 2009, EMERG THEMES EPIDEMI, V6, DOI 10.1186/1742-7622-6-5; McCormack SM, 2014, CLIN INFECT DIS, V59, pS41, DOI 10.1093/cid/ciu297; Muchomba FM, 2012, JAIDS-J ACQ IMM DEF, V61, P490, DOI 10.1097/QAI.0b013e31826f9962; Naumann D., 2008, BIOMEDICAL VIBRATION, P1, DOI DOI 10.1002/9780470283172.CH1; Orphanou CM, 2015, FORENSIC SCI INT, V252, pE10, DOI 10.1016/j.forsciint.2015.04.020; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011600; Shaw A, 2008, BIOMEDICAL VIBRATION, P79; Stalter RM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20746; Thurman AR, 2014, SEX TRANSM DIS, V41, P739, DOI 10.1097/OLQ.0000000000000209; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Tolley EE, 2010, AIDS BEHAV, V14, P1124, DOI 10.1007/s10461-009-9635-x; Turner AN, 2009, J CLIN EPIDEMIOL, V62, P759, DOI 10.1016/j.jclinepi.2008.07.011; United Nations Programme on HIV/ AIDS (UN), 2017, UN PROGR HIV AIDS 90; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; VANDEGINSTE BGM, 1998, HDB CHEMOMETRICS; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Williams AB, 2013, AIDS BEHAV, V17, P284, DOI 10.1007/s10461-012-0172-7; Wold S., 1987, J CHEMOMETR, V1, P41, DOI DOI 10.1002/CEM.1180010107; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]; Zapata F., 2015, J FORENSIC MED, V1; Zidan AS, 2010, AAPS J, V12, P202, DOI 10.1208/s12248-010-9177-1	40	1	1	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197906	10.1371/journal.pone.0197906	http://dx.doi.org/10.1371/journal.pone.0197906			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799875	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400031
J	Pujol, JL; Roch, B; Roth, C; Merel, JP				Pujol, Jean-Louis; Roch, Benoit; Roth, Caroline; Merel, Jean-Pierre			Qualitative study of patients' decision-making when accepting second-line treatment after failure of first-line chemotherapy	PLOS ONE			English	Article							CELL LUNG-CANCER; LIFE; END; THERAPY; CARE	Objective Treatment failures in advanced lung cancer are frequent events affecting patients during or after first-line chemotherapy. International guidelines recommend second-line chemotherapy. However, around one half of patients who experience disease progression enter a systemic second-line therapy. In the herein qualitative study, we investigated patients' thoughts and attitudes determining the decision to undergo a second-line chemotherapy. Methods Thirty-three purposively selected patients who recently accepted second-line or palliative chemotherapy were invited to participate in this survey consisting of semi-structured in-depth interviews. Grounded theory was applied to investigate participants' perceptions of the context that have surrounded their decision to undergo palliative chemotherapy. Results For most patients, tumor burden and reduced quality of life in relation with lung cancer itself were major drivers of the decision-making process. There was a balance between two different attitudes: making a decision to undergo a new line of chemotherapy or starting a psychological process in order to accept end of life. Choosing between these two attitudes allowed the patient to keep the matter of palliative care at a distance. Even in case of low chance of success, many patients who worried about their life partner's future would accept a new chemotherapy line. Some patients experienced ambivalent thoughts regarding social network, particularly about their family as daily function impairment required an increased need for relative's support. The initial "Worrying about others" thoughts left place to in an increasing self-need of care as those provided by relatives; this phenomenon might increase patients' self-perception of being a burden for others. Confidence previously established with formal caregiver support was another major decision driver: some patients with sustained confidence in their medical staff may have privileged this formal support rather than family support when the latter was perceived as weak, insufficient or intrusive. Conclusion This study identified three domains involved into a complex interplay for lung cancer patients' decision regarding second-line palliative chemotherapy: (i) perception of the definitive loss of health, (ii) interactions between idiosyncrasy (hope, disease burden) and environment (healthcare and social network support), and (iii) patient's subjective evaluation of chemotherapy benefit risk.	[Pujol, Jean-Louis; Roch, Benoit; Roth, Caroline; Merel, Jean-Pierre] Hop Univ Arnaud de Villeneuve, Thorac Oncol Unit, Montpellier, France; [Pujol, Jean-Louis] Univ Montpellier 3, EA 4556, Epsylon Interdisciplinary Properties & Property D, Rue Pr Henri Serre, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite Paul-Valery	Pujol, JL (corresponding author), Hop Univ Arnaud de Villeneuve, Thorac Oncol Unit, Montpellier, France.; Pujol, JL (corresponding author), Univ Montpellier 3, EA 4556, Epsylon Interdisciplinary Properties & Property D, Rue Pr Henri Serre, Montpellier, France.	jl-pujol@chu-montpellier.fr		ROCH, Benoit/0000-0002-4064-7621	fond de dotation Henri Pujol; Roche	fond de dotation Henri Pujol; Roche(Roche Holding)	This study has been supported by the "fond de dotation Henri Pujol" and by Roche.	Barlesi F, 2006, LUNG CANCER, V51, P159, DOI 10.1016/j.lungcan.2005.08.017; Buiting HM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1933; Burt RS, 2005, BROKERAGE CLOSURE IN; Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x; Choi Y-S, 2014, SHOCK VIB, V2014, P10, DOI DOI 10.1016/J.MEE.2014.12.007; Chouaid C, 2013, J THORAC ONCOL, V8, P997, DOI 10.1097/JTO.0b013e318299243b; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Earle CC, 2010, J CLIN ONCOL, V28, P3205, DOI 10.1200/JCO.2010.30.8601; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Folkman S, 2010, PSYCHO-ONCOLOGY, V19, P901, DOI 10.1002/pon.1836; Gralla RJ, 2004, LUNG CANCER-J IASLC, V46, pS41, DOI 10.1016/S0169-5002(04)80040-0; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Karanth S, 2018, J THORACIC ONCOLOGY; Keating NL, 2006, JNCI-J NATL CANCER I, V98, P1053, DOI 10.1093/jnci/djj298; Kobayakawa M, 2016, PSYCHO-ONCOLOGY, V25, P641, DOI 10.1002/pon.3982; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; Oeki M, 2012, EUR J ONCOL NURS, V16, P145, DOI 10.1016/j.ejon.2011.04.010; Ortmann O, 2016, J CANCER RES CLIN, V142, P1, DOI 10.1007/s00432-014-1906-x; Pujol JL, 2017, PSYCHO-ONCOLOGY, V26, P793, DOI 10.1002/pon.4231; Schulz MS, 2016, PSYCHOONCOLOGY, P20; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soo RA, J THORAC ONCOL; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197605	10.1371/journal.pone.0197605	http://dx.doi.org/10.1371/journal.pone.0197605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH1HI	29799879	Green Published, gold, Green Submitted			2022-12-26	WOS:000433153400018
J	Go, H; Momoi, N; Kashiwabara, N; Haneda, K; Chishiki, M; Imamura, T; Sato, M; Goto, A; Kawasaki, Y; Hosoya, M				Go, Hayato; Momoi, Nobuo; Kashiwabara, Nozomi; Haneda, Kentaro; Chishiki, Mina; Imamura, Takashi; Sato, Maki; Goto, Aya; Kawasaki, Yukihiko; Hosoya, Mitsuaki			Neonatal and maternal serum creatinine levels during the early postnatal period in preterm and term infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; RENAL-FUNCTION; PLASMA CREATININE; AGE; GROWTH; LIFE; GLOMERULOSCLEROSIS; EXTRAUTERINE; CLEARANCE; NEWBORN	We investigated the relationship of neonatal and maternal serum creatinine (nSCr and mSCr, respectively) with various maternal/infant characteristics at different gestational ages (GA). We reviewed medical records of neonates admitted to NICU. We collected data on birth weight, GA, Apgar scores, medications, etc. Spearman's test was used to analyze the correlation between serum creatinine and continuous variables, and the Mann-Whitney U and Kruskal-Wallis tests for continuous variables between groups. The changes in nSCr, mSCr, and nSCr/mSCr ratio because of gestational age and the points in gestational changes in trends were estimated using joinpoint trend analysis. From 614 neonate and mother pairs, we found that nSCr was significantly correlated with GA. However, mSCr at >28 wks decreased with GA. The nSCr/mSCr ratio was correlated with GA. In infants born <29 weeks, pregnancy-induced hypertension (PIH) (p = 0.000, beta = 0.20) and mSCr (p = 0.000, beta = 0.73) were significantly associated with nSCr. In term infants, maternal magnesium administration (p = 0.000, beta = 0.25), respiratory distress syndrome (p = 0.013, beta = 0.16), PIH (p = 0.005, beta = 0.19), and mSCr (p = 0.000, beta = 0.33) were significantly associated with nSCr. nSCr reflected mSCr at all gestational ages. The correlation between nSCr and mSCr in preterm infants (p = 0.000, beta = 0.74) was stronger than in term infants (p = 0.000, beta = 0.34).	[Go, Hayato; Momoi, Nobuo; Kashiwabara, Nozomi; Haneda, Kentaro; Chishiki, Mina; Imamura, Takashi; Sato, Maki; Kawasaki, Yukihiko; Hosoya, Mitsuaki] Fukushima Med Univ, Sch Med, Dept Pediat, Fukushima, Japan; [Goto, Aya] Fukushima Med Univ, Ctr Integrated Sci & Humanities, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Go, H (corresponding author), Fukushima Med Univ, Sch Med, Dept Pediat, Fukushima, Japan.	gohayato2525@gmail.com						Aggarwal A, 2005, J TROP PEDIATRICS, V51, P295, DOI 10.1093/tropej/fmi017; Agras PI, 2004, REN FAIL, V26, P112; Auron A, 2006, J PERINATOL, V26, P755, DOI 10.1038/sj.jp.7211604; Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201; Bateman DA, 2015, PEDIATR RES, V77, P696, DOI 10.1038/pr.2015.25; FAWER CL, 1979, HELV PAEDIATR ACTA, V34, P11; FELDMAN H, 1982, ARCH DIS CHILD, V57, P123, DOI 10.1136/adc.57.2.123; Filler G, 2016, CURR OPIN PEDIATR, V28, P173, DOI 10.1097/MOP.0000000000000318; Gallini F, 2000, PEDIATR NEPHROL, V15, P119, DOI 10.1007/s004670000356; Giapros V, 2011, PEDIATR NEPHROL, V26, P1873, DOI 10.1007/s00467-011-1895-9; GORDJANI N, 1988, EUR J PEDIATR, V148, P143, DOI 10.1007/BF00445923; Guignard JP, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e49; Hahn WH, 2014, PEDIATR NEPHROL, V29, P311, DOI 10.1007/s00467-013-2632-3; Iacobelli S, 2009, J PERINATOL, V29, P232, DOI 10.1038/jp.2008.203; Kandasamy Y, 2013, PEDIATR NEPHROL, V28, P1791, DOI 10.1007/s00467-013-2462-3; Kwiatkowski S, 2016, J MATERN-FETAL NEO M, V29, P1566, DOI 10.3109/14767058.2015.1053865; LAO TT, 1989, GYNECOL OBSTET INVES, V28, P70, DOI 10.1159/000293517; Miall LS, 1999, PEDIATRICS, V104, pE761, DOI 10.1542/peds.104.6.e76; Miles RR, 2004, CLIN CHEM, V50, P1704, DOI 10.1373/clinchem.2004.036533; NDUKA N, 1986, TROP GEOGR MED, V38, P386; Plank C, 2010, AM J NEPHROL, V32, P287, DOI 10.1159/000319045; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Ricci Z, 2013, NEPHROL DIAL TRANSPL, V28, P2211, DOI 10.1093/ndt/gft074; Schlackow I, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001279; Sonntag J, 1996, EUR J PEDIATR, V155, P815, DOI 10.1007/BF02002914; STONESTREET BS, 1978, PEDIATRICS, V61, P788; Thayyil S, 2008, J PERINATOL, V28, P226, DOI 10.1038/sj.jp.7211905; ZACCHELLO G, 1982, ARCH DIS CHILD, V57, P297, DOI 10.1136/adc.57.4.297	28	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0196721	10.1371/journal.pone.0196721	http://dx.doi.org/10.1371/journal.pone.0196721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795567	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300012
J	Kuchenbecker, U; Chase, D; Reichert, A; Schiffner-Rohe, J; Atwood, M				Kuchenbecker, Ulrike; Chase, Daniela; Reichert, Anika; Schiffner-Rohe, Julia; Atwood, Mark			Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; ECONOMIC-IMPACT; PUBLIC-HEALTH; DISEASE; OLDER; POPULATION; AGE; STRATEGIES	Introduction In Germany, a 23-valent polysaccharide pneumococcal vaccine (PPSV23) is recommended for elderly (60+) and patients 16+ with chronic diseases not associated with immune suppression. For all other patients at risk, sequential immunization with a 13-valent pneumococcal conjugate vaccine (PCV13) first, followed by PPSV23 is recommended. Repeated vaccination with PPSV23 is recommended every 6 years after individual assessment by the physician. This was adopted into the vaccination directive with binding reimbursement and funding. However, additional voluntary services allow statutory health insurances to differentiate from each other. Aim of this study is to estimate the cost-effectiveness of voluntary service scenarios compared to the strategy in place to support informed decision making. Methods A microsimulation framework with Markov-type process of a population susceptible to pneumococcal disease over a lifetime horizon was developed to compare effectiveness and cost-effectiveness of different vaccination strategies. We simulated 1,000 iterations for seven scenarios. Assumptions were derived from published literature and probabilistic sensitivity analysis was run to show the robustness of the model. Results Our study indicates that all voluntary service strategies could prevent further clinical cases compared to the existing policy. Depending on the scenario, 48-142 invasive pneumococcal disease (IPD), 24,000-45,000 hospitalized all-cause nonbacteremic pneumonia (NBP), 15,000-45,000 outpatient NBP cases, and 4,000-8,000 deaths could be avoided on average. This refers to potential savings of (sic)115 Mio. -(sic)187 Mio. for medical and non-medical costs. Additional costs per patient for the payer are (sic)2.48 to (sic)7.13 and for the society (sic)2.20 to (sic)6.85. The ICER per LYG ranged from (sic)3,662 to (sic)23,061 (payer) and (sic)3,258 to (sic)29,617 societal). All but one scenario was cost-effective in >= 60% of the generated 1,000 simulations. Conclusion Compared to the vaccination strategy in place, the different hypothetical scenarios can be considered cost-effective and suitable as additional voluntary services.	[Kuchenbecker, Ulrike] Xcenda GmbH, Hannover, Germany; [Chase, Daniela; Reichert, Anika] INAV GmbH, Berlin, Germany; [Schiffner-Rohe, Julia] Pfizer GmbH, Berlin, Germany; [Atwood, Mark] PAI, Boston, MA USA	Pfizer; Policy Analysis Inc	Kuchenbecker, U (corresponding author), Xcenda GmbH, Hannover, Germany.	ulrike.kuchenbecker@xcenda.de			Pfizer Deutschland GmbH; Pfizer Inc.	Pfizer Deutschland GmbH; Pfizer Inc.(Pfizer)	This study was supported by an unrestricted research grant from Pfizer Deutschland GmbH and Pfizer Inc. The funder provided support in the form of salaries for authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author's Contributions section.	Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; Barbieri M, 2005, VALUE HEALTH, V8, P10, DOI 10.1111/j.1524-4733.2005.03070.x; Black S, 2013, VACCINE, V31, P6046, DOI 10.1016/j.vaccine.2013.08.008; Boccalini S, 2013, HUM VACC IMMUNOTHER, V9, P699, DOI 10.4161/hv.23268; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Briggs A, 2000, BRIT MED J, V320, P246, DOI 10.1136/bmj.320.7229.246; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; Chen QS, 2017, MED DECIS MAKING, V37, P243, DOI 10.1177/0272989X16670605; Cho BH, 2013, VACCINE, V31, P6011, DOI 10.1016/j.vaccine.2013.10.024; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Ethgen O, 2012, PHARMACOECONOMICS, V30, P171, DOI 10.2165/11593050-000000000-00000; Evers SMAA, 2007, EUR J CLIN MICROBIOL, V26, P531, DOI 10.1007/s10096-007-0327-z; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Falkenhorst G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169368; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Fry AM, 2002, VACCINE, V21, P303, DOI 10.1016/S0264-410X(02)00451-6; Gesundheitsberichterstattung dB, 2017, KEY FIGURES NATL ACC; Gesundheitsberichterstattung dB, 2017, INABILITY WORK DAYS; GmbH A-I, QUAL REP 2012; Goedeme T., 2013, INT J MICROSIMULATIO, V6, P50; Grijalva CG, 2007, LANCET, V2007; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hoffken G, 2009, Pneumologie, V63, pe1, DOI 10.1055/s-0029-1215037; Huber MB, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040426; Institut fdEiK, DRG BROWS 2013; Institut fQuTiG, QUAL 2015 2016; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2017, ALLG METH; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jackson LA, 2013, VACCINES; Jackson LA, 2013, VACCINE, V31, P3577, DOI 10.1016/j.vaccine.2013.04.085; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Jiang YL, 2012, EXPERT REV PHARM OUT, V12, P645, DOI [10.1586/erp.12.54, 10.1586/ERP.12.54]; Johnstone J, 2007, ARCH INTERN MED, V167, P1938, DOI 10.1001/archinte.167.18.1938; Kassenarztliche B, UNIFORM VALUE SCALE; Kassenarztliche Vereinigung B, VACCINATION AGREEMEN; Kim SY, 2008, PHARMACOECONOMICS, V26, P191, DOI 10.2165/00019053-200826030-00004; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kolditz M, 2016, RESP MED, V121, P32, DOI 10.1016/j.rmed.2016.10.015; Kraicer-Melamed H, 2016, VACCINE, V34, P4083, DOI 10.1016/j.vaccine.2016.06.045; Kraicer-Melamed H, 2016, VACCINE, V34, P1540, DOI 10.1016/j.vaccine.2016.02.024; Kuhlmann A, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-4; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Mangen MJJ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2302-3; McNeil SA, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/3605834; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; Patterson S., 2016, Trials in Vaccinology, V5, P92, DOI 10.1016/j.trivac.2016.04.004; Pelton SI, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1162-y; Pfizer, 2016, GLYSET; Pletz M W, 2012, Pneumologie, V66, P470; Pletz MW, 2016, VACCINE, V34, P2342, DOI 10.1016/j.vaccine.2016.03.052; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P845, DOI 10.1007/s00103-013-1693-6; Reinert RR, 2005, CLIN MICROBIOL INFEC, V11, P985, DOI 10.1111/j.1469-0691.2005.01282.x; Robert K-I, PNEUMOKOKKENERKRANKU; Robert K-I, 2017, PNEUMOWEB LABORSENEL; Robert K-I, 2017, WEB BASIERTE ABFRAGE; Robert Koch-Institut, 2016, EPIDEMIOLOGISCHES B, V37, P385; Robert Koch-Institut, 2016, EPIDEMIOLOGISCHES B, V36, P351; Rote L, DRUG PRICES 2013; Rubin JL, 2010, VACCINE, V28, P7634, DOI 10.1016/j.vaccine.2010.09.049; Schmedt N, 2017, COMMUNICATION; Schnoor M, 2007, J INFECTION, V55, P233, DOI 10.1016/j.jinf.2007.04.355; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; SIMBERKOFF MS, 1986, NEW ENGL J MED, V315, P1318, DOI 10.1056/NEJM198611203152104; Sisk JE, 2003, ANN INTERN MED, V138, P960, DOI 10.7326/0003-4819-138-12-200306170-00007; Smith KJ, 2008, VACCINE, V26, P1420, DOI 10.1016/j.vaccine.2008.01.007; Smith KJ, 2013, AM J PREV MED, V44, P373, DOI 10.1016/j.amepre.2012.11.035; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Theidel U, 2013, DTSCH ARZTEBL INT, V110, P743, DOI 10.3238/arztebl.2013.0743; Ultsch B, 2016, PHARMACOECONOMICS, V34, P227, DOI 10.1007/s40273-015-0335-2; Van der Linden M, 2017, COMMUNICATION; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Weycker D, 2012, VACCINE, V30, P5437, DOI 10.1016/j.vaccine.2012.05.076; World HO, 2008, WEEKLY EPIDEMIOLOGIC, V42	75	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e019790r	10.1371/journal.pone.0197905	http://dx.doi.org/10.1371/journal.pone.0197905			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795647	Green Published, Green Submitted, gold			2022-12-26	WOS:000433084300093
J	Lahr, EC; Dunn, RR; Frank, SD				Lahr, Eleanor C.; Dunn, Robert R.; Frank, Steven D.			Variation in photosynthesis and stomatal conductance among red maple (Acer rubrum) urban planted cultivars and wildtype trees in the southeastern United States	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; CLIMATE-CHANGE; LEAF SURFACES; TEMPERATURE; GROWTH; ACCLIMATION; CONSEQUENCES; RESPONSES; PATTERNS; NORTHERN	Photosynthesis is a fundamental process that trees perform over fluctuating environmental conditions. This study of red maple (Acer rubrum L.) characterizes photosynthesis, stomatal conductance, and water use efficiency in planted cultivars relative to wildtype trees. Red maple is common in cities, yet there is little understanding of how physiological processes affect the long-term growth, condition, and ecosystem services provided by urban trees. In the first year of our study, we measured leaf-level gas exchange and performed short-term temperature curves on urban planted cultivars and on suburban and rural wildtype trees. In the second year, we compared urban planted cultivars and urban wildtype trees. In the first year, urban planted trees had higher maximum rates of photosynthesis and higher overall rates of photosynthesis and stomatal conductance throughout the summer, relative to suburban or rural wildtype trees. Urban planted trees again had higher maximum rates of photosynthesis in the second year. However, urban wildtype trees had higher water use efficiency as air temperatures increased and similar overall rates of photosynthesis, relative to cultivars, in mid and late summer. Our results show that physiological differences between cultivars and wildtype trees may relate to differences in their genetic background and their responses to local environmental conditions, contingent on the identity of the horticultural variety. Overall, our results suggest that wildtype trees should be considered for some urban locations, and our study is valuable in demonstrating how site type and tree type can inform tree planting strategies and improve long-term urban forest sustainability.	[Lahr, Eleanor C.; Frank, Steven D.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Lahr, Eleanor C.; Dunn, Robert R.] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Lahr, EC (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Lahr, EC (corresponding author), North Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA.	eclahr@ncsu.edu	Bell, E/M-9188-2018	Bell, E/0000-0003-4896-3327; Dunn, Robert/0000-0002-6030-4837	United States Geological Survey [G11AC20471, G13AC00405, G15AP00153]; National Institute of Food and Agriculture, U.S. Department of Agriculture [2013-02476]	United States Geological Survey(United States Geological Survey); National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This project was supported by Cooperative Agreement No. G11AC20471, G13AC00405 and G15AP00153 from the United States Geological Survey. The National Institute of Food and Agriculture, U.S. Department of Agriculture also supported this research under award number 2013-02476 to SDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; ADKINS CR, 2012, IPM SELECT DECIDUOUS; Anderson PD, 1998, NEW PHYTOL, V140, P477, DOI 10.1111/j.1469-8137.1998.00296.x; [Anonymous], 2021, LANG ENV STAT COMP; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bauerle WL, 2011, HORTSCIENCE, V46, P163, DOI 10.21273/HORTSCI.46.2.163; Bauerle WL, 2003, TREE PHYSIOL, V23, P841, DOI 10.1093/treephys/23.12.841; Bodnaruk EW, 2017, LANDSCAPE URBAN PLAN, V157, P457, DOI 10.1016/j.landurbplan.2016.08.016; Caillon R, 2014, FUNCT ECOL, V28, P1449, DOI 10.1111/1365-2435.12288; Chen LX, 2011, J HYDROL, V402, P388, DOI 10.1016/j.jhydrol.2011.03.034; Chung H, 2013, J PLANT RES, V126, P447, DOI 10.1007/s10265-013-0565-3; Crous KY, 2011, GLOBAL CHANGE BIOL, V17, P1560, DOI 10.1111/j.1365-2486.2010.02325.x; Dale AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173844; Dale Adam G., 2016, Arboriculture & Urban Forestry, V42, P181; Dale AG, 2014, ECOL APPL, V24, P1596, DOI 10.1890/13-1961.1; Dale AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102996; Dale AG, 2015, THESIS; Damour G, 2010, PLANT CELL ENVIRON, V33, P1419, DOI 10.1111/j.1365-3040.2010.02181.x; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Facey SL, 2014, CURR OPIN INSECT SCI, V5, P66, DOI 10.1016/j.cois.2014.09.015; Frank SD, 2013, J INTEGR PEST MANAG, V4, DOI 10.1603/IPM12007; George K, 2007, ATMOS ENVIRON, V41, P7654, DOI 10.1016/j.atmosenv.2007.08.018; Gerten D, 2008, GLOBAL CHANGE BIOL, V14, P2365, DOI 10.1111/j.1365-2486.2008.01651.x; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Gunderson CA, 2000, TREE PHYSIOL, V20, P87; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; Halekoh U, 2014, J STAT SOFTW, V59, P1; Krause GH, 2013, J PLANT PHYSIOL, V170, P822, DOI 10.1016/j.jplph.2013.01.005; Hikosaka K, 2007, TREE PHYSIOL, V27, P1035, DOI 10.1093/treephys/27.7.1035; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Johnson DM, 2011, TREE PHYSIOL, V31, P659, DOI 10.1093/treephys/tpr050; Kondo MC, 2017, LANDSCAPE URBAN PLAN, V157, P193, DOI 10.1016/j.landurbplan.2016.07.003; Lahr EC, 2015, GLOBAL CHANGE BIOL, V21, P4221, DOI 10.1111/gcb.13010; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lewis JD, 2001, PLANT CELL ENVIRON, V24, P539, DOI 10.1046/j.1365-3040.2001.00700.x; McPherson E. Gregory, 2012, Arboriculture & Urban Forestry, V38, P172; Meineke EK, 2017, J URB ECOL, V3, P1; Meineke E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1574; Meineke EK, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0586; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; Pincebourde S, 2016, INTEGR COMP BIOL, V56, P45, DOI 10.1093/icb/icw016; Pincebourde S, 2012, FUNCT ECOL, V26, P844, DOI 10.1111/j.1365-2435.2012.02013.x; Raupp Michael J., 2006, Arboriculture & Urban Forestry, V32, P297; Roy S, 2012, URBAN FOR URBAN GREE, V11, P351, DOI 10.1016/j.ufug.2012.06.006; Savi T, 2015, NEW PHYTOL, V205, P1106, DOI 10.1111/nph.13112; Searle SY, 2012, TREE PHYSIOL, V32, P389, DOI 10.1093/treephys/tps027; Sendall KM, 2015, GLOBAL CHANGE BIOL, V21, P1342, DOI 10.1111/gcb.12781; Shanahan DF, 2017, LANDSCAPE URBAN PLAN, V157, P231, DOI 10.1016/j.landurbplan.2016.07.004; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Tooker JF, 2012, J APPL ECOL, V49, P974, DOI 10.1111/j.1365-2664.2012.02173.x; Townsend A. M., 1998, Journal of Environmental Horticulture, V16, P189; TOWNSEND AM, 1979, SILVAE GENET, V28, P33; Walters R.S., 1990, USDA HDB, V2, P654; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Youngsteadt E, 2015, GLOBAL CHANGE BIOL, V21, P97, DOI 10.1111/gcb.12692; Ziska LH, 2004, OECOLOGIA, V139, P454, DOI 10.1007/s00442-004-1526-2; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	58	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197866	10.1371/journal.pone.0197866	http://dx.doi.org/10.1371/journal.pone.0197866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0HY	29795659	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300086
J	Wu, T; Huang, YN; Chen, YJ; Zhang, M				Wu, Tao; Huang, Yina; Chen, Yijun; Zhang, Min			Antibacterial Effect of (2E,2E)-4,4-Trisulfanediylbis(but-2-enoic acid) against Staphylococcus aureus	PLOS ONE			English	Article							MACERATED GARLIC EXTRACT; ANTIMICROBIAL ACTIVITY; CEDRUS-DEODARA; ESSENTIAL OILS; PINE NEEDLES; ALLICIN; DISRUPTION; CELLS	A new highly active molecule, (2E, 2E)-4,4-trisulfanediylbis(but-2-enoic acid) (TSDB), was designed and synthesized through comparative molecular field analysis with the diallyl trisulfide structure of garlic. TSDB exerted a strong inhibitory effect against Staphylococcus aureus, with minimal inhibitory and minimal bactericidal concentrations of 16 and 128 mu g/mL, respectively. TSDB destructed the integrity of the S. aureus cell membrane but weakly damaged the bacterial cell wall. TSDB also increased the conductivity and protein expression in microbial broth but minimally influenced the level of extracellular alkaline phosphatase. TSDB could be a novel food preservative.	[Wu, Tao; Huang, Yina; Chen, Yijun; Zhang, Min] Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Tianjin, Peoples R China; [Wu, Tao; Huang, Yina; Chen, Yijun; Zhang, Min] Minist Educ, Key Lab Food Nutr & Safety, Tianjin, Peoples R China; [Wu, Tao; Huang, Yina; Chen, Yijun; Zhang, Min] Tianjin Univ Sci & Technol, Inst New Rural Dev, Tianjin, Peoples R China; [Wu, Tao; Huang, Yina; Chen, Yijun; Zhang, Min] Minist Educ, Engn Res Ctr Food Biotechnol, Tianjin, Peoples R China	Tianjin University Science & Technology; Tianjin University Science & Technology	Wu, T; Zhang, M (corresponding author), Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Tianjin, Peoples R China.; Wu, T; Zhang, M (corresponding author), Minist Educ, Key Lab Food Nutr & Safety, Tianjin, Peoples R China.; Wu, T; Zhang, M (corresponding author), Tianjin Univ Sci & Technol, Inst New Rural Dev, Tianjin, Peoples R China.; Wu, T; Zhang, M (corresponding author), Minist Educ, Engn Res Ctr Food Biotechnol, Tianjin, Peoples R China.	wutaoxx@gmail.com; zm0102@sina.com	Wu, Tao/E-7769-2011	Wu, Tao/0000-0002-0629-8421	Fundamental Research Funds for the Tianjin Universities [2017KDZD02]; Innovation of modern Agricultural Project [F17RO2]; National Key Research and Development Program of China [2017YFD0400106]	Fundamental Research Funds for the Tianjin Universities; Innovation of modern Agricultural Project; National Key Research and Development Program of China	This work was supported by Fundamental Research Funds for the Tianjin Universities, 2017KDZD02, to PhD Tao Wu; Innovation of modern Agricultural Project, F17RO2, Pro Min Zhang; National Key Research and Development Program of China, 2017YFD0400106, Pro Min Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fundamental Research Funds for the Tianjin Universities [2017KDZD02], National Key Research and Development Program of China [2017YFD0400106], and Innovation of modern Agricultural Project [F17RO2] are gratefully acknowledged.	Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Avato P, 2000, PHYTOMEDICINE, V7, P239, DOI 10.1016/S0944-7113(00)80010-0; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Bakri IM, 2005, ARCH ORAL BIOL, V50, P645, DOI 10.1016/j.archoralbio.2004.12.002; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; Gruhlke MCH, 2010, FREE RADICAL BIO MED, V49, P1916, DOI 10.1016/j.freeradbiomed.2010.09.019; Kadariya J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/827965; Kim JW, 2004, FOOD SCI BIOTECHNOL, V13, P235; Kyung KH, 2002, J FOOD SCI, V67, P780, DOI 10.1111/j.1365-2621.2002.tb10676.x; LAUGHTON C, 1984, ANAL BIOCHEM, V140, P417, DOI 10.1016/0003-2697(84)90187-8; Lee HJ, 1998, J AGR FOOD CHEM, V46, P737, DOI 10.1021/jf970501c; Leng BF, 2011, MOLECULES, V16, P7958, DOI 10.3390/molecules16097958; Lu XN, 2011, FOOD MICROBIOL, V28, P537, DOI 10.1016/j.fm.2010.11.002; Millet COM, 2011, EXP PARASITOL, V127, P490, DOI 10.1016/j.exppara.2010.10.001; Ren FK, 2009, B KOREAN CHEM SOC, V30, P687; Su HL, 2009, BIOMATERIALS, V30, P5979, DOI 10.1016/j.biomaterials.2009.07.030; TIETZ NW, 1983, J CLIN CHEM CLIN BIO, V21, P731; Tsao SM, 2001, J MED MICROBIOL, V50, P646, DOI 10.1099/0022-1317-50-7-646; Wallock-Richards D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112726; Wang SH, 2012, EMERG INFECT DIS, V18, P1557, DOI 10.3201/eid1810.120468; Wu YP, 2017, FOOD CHEM, V218, P463, DOI 10.1016/j.foodchem.2016.07.090; Yoshida H, 1999, BIOSCI BIOTECH BIOCH, V63, P591, DOI 10.1271/bbb.63.591; Yoshida H, 1998, BIOSCI BIOTECH BIOCH, V62, P1014, DOI 10.1271/bbb.62.1014; Zeng WC, 2012, INT J FOOD MICROBIOL, V153, P78, DOI 10.1016/j.ijfoodmicro.2011.10.019	24	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197348	10.1371/journal.pone.0197348	http://dx.doi.org/10.1371/journal.pone.0197348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795597	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300039
J	Zhou, H; Xu, QZ; Zhang, R; Zhuang, ZX; Ma, YQ; Wang, W; Ma, TY; Sui, Y; Liu, Y; Cao, XJ				Zhou, He; Xu, Qi-Zheng; Zhang, Rui; Zhuang, Zi-Xin; Ma, Yin-Qiang; Wang, Wei; Ma, Tian-Yu; Sui, Yi; Liu, Yang; Cao, Xiaojuan			Gonadal transcriptome analysis of hybrid triploid loaches (Misgurnus anguillicaudatus) and their diploid and tetraploid parents	PLOS ONE			English	Article							PROGENY; CHINA; TELEOSTEI; COBITIDAE; PLOIDY; SALMON; EGGS; FISH	Hybrid triploid loaches (Misgurnus anguillicaudatus) were generated from natural tetraploid and diploid loaches. We studied the gonads of parents and offspring from direct and reciprocal crosses through histological and transcriptome analyses. The triploid offspring had inferior ability to form sperm and egg cells compared with diploid forms. After sequencing the transcriptomes, 655,109,158 clean reads were obtained, and 62,821 unigenes and 178,962 transcripts were assembled. Of these unigenes, 23,189 were annotated in the GO database, 18,525 in the KEGG database and 24,661 in the KOG database. 36 fertility-related genes were found to be differentially expressed between the direct cross (2n x 4n) progenies and their parents, while 53 fertility-related genes between the reciprocal cross (4n x 2n) progenies and their parents. Following protein-protein interaction network analyses, 54 differentially expressed genes, including PLCB4, cyp17a1 and Pla2g4d, were mined, yielding candidate genes involved in the poor fertility of hybrid triploid loaches. This is the first report of transcriptomes of gonads of hybrid triploid loaches and their parents, offering a substantial contribution to sequence resources for this species and providing a deep insight into the molecular mechanism controlling the fertility of hybrid triploid fish.	[Zhou, He; Xu, Qi-Zheng; Zhang, Rui; Zhuang, Zi-Xin; Wang, Wei; Ma, Tian-Yu; Liu, Yang] Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China; [Ma, Yin-Qiang] Dalian Med Univ, Dalian, Peoples R China; [Sui, Yi] Maanshan Municipal Agr Commiss, Maanshan, Anhui, Peoples R China; [Cao, Xiaojuan] Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ,Key Lab Freshwater Anim Breeding,Mini, Wuhan, Hubei, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Dalian Medical University; Huazhong Agricultural University	Cao, XJ (corresponding author), Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ,Key Lab Freshwater Anim Breeding,Mini, Wuhan, Hubei, Peoples R China.	caoxiaojuan@mail.hzau.edu.cn			Natural Science Foundation of China [31272650]; Fundamental Research Funds for the Central Universities of China [2662015PY033]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by Natural Science Foundation of China (Project Number: 31272650) and Fundamental Research Funds for the Central Universities of China (Project Number: 2662015PY033).	[Anonymous], 2012, YELLOW RIVER; Aoki T., 1997, DNA MOL GENETICS FIS, P38; Arai K, 2003, FOLIA BIOL-KRAKOW, V51, P107; Arai K, 2008, NIPPON SUISAN GAKK, V57, P2167; Audic S, 1997, SIGNIFICANCE DIGITAL; Carrasco LAP, 1998, J REPROD FERTIL, V113, P197, DOI 10.1530/jrf.0.1130197; COPPE A, 2010, BIOMED CENTRAL GENOM, V11, DOI DOI 10.1186/1471-2164-11-635; Gao Qi, 2005, Acta Genetica Sinica, V32, P1045; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Itono M, 2006, J EXP ZOOL PART A, V305A, P513, DOI 10.1002/jez.a.283; Jia MM, 2017, OXIDATIVE STRESS REL; Jiang HB, 2015, PROTEOME TRANSCRIPTO; Li W., 2012, THESIS; Li YJ, 2012, J APPL ICHTHYOL, V28, P900, DOI 10.1111/jai.12057; Li Y.W., 2010, METALL MATER TRANS A, V41, P2010, DOI DOI 10.3791/2011; Li YJ, 2008, NIPPON SUISAN GAKK, V74, P177, DOI 10.2331/suisan.74.177; Li YJ, 2016, GENETICA, V144, P601, DOI 10.1007/s10709-016-9928-8; Li YJ, 2015, GENETICA, V143, P555, DOI 10.1007/s10709-015-9853-2; Li YJ, 2013, AQUACULT INT, V21, P759, DOI 10.1007/s10499-012-9551-3; Li YJ, 2011, GENETICA, V139, P805, DOI 10.1007/s10709-011-9585-x; Li YJ, 2010, ICHTHYOL RES, V57, P358, DOI 10.1007/s10228-010-0168-0; Li Ya-juan, 2009, Dalian Shuichan Xueyuan Xuebao, V24, P236; [李雅娟 Li Yajuan], 2015, [东北农业大学学报, Journal of Northeast Agricultural University], V46, P83; Liu Hong-Liang, 2013, Yichuan, V35, P955, DOI 10.3724/SP.J.1005.2013.00955; Luo WW, 2015, INT J MOL SCI, V16, P16017, DOI 10.3390/ijms160716017; MATSUBARA K, 1995, AQUACULTURE, V131, P37, DOI 10.1016/0044-8486(94)00339-P; Morishima K, 2002, ZOOL SCI, V19, P565, DOI 10.2108/zsj.19.565; NAKAMURA M, 1993, ZOOL SCI, V10, P117; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Pereiro P, 2012, PLOS ONE; PIFERRER F, 1994, J FISH BIOL, V45, P541, DOI 10.1111/j.1095-8649.1994.tb00923.x; PIFERRER F, 2007, GENETICA GENOMICA AC, P401; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suzuki R, 2008, B J SOC SCI FISH, V51, P889; Tiwary BK, 2000, J FISH BIOL, V57, P1343, DOI 10.1111/j.1095-8649.2000.tb00493.x; Tiwary BK, 2004, REV FISH BIOL FISHER, V14, P391, DOI 10.1007/s11160-004-8361-8; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058274; Yang H, 2016, ANIM REPROD SCI, V175, P18, DOI 10.1016/j.anireprosci.2016.10.004; Yin Hong-bin, 2000, Oceanologia et Limnologia Sinica, V31, P123; Yin Jie, 2005, Acta Hydrobiologica Sinica, V29, P469; Yoshikawa H, 2008, J APPL ICHTHYOL, V24, P410, DOI 10.1111/j.1439-0426.2008.01129.x; Yuan J.F., 2013, THESIS; Zhang QQ, 1998, J EXP ZOOL, V281, P608, DOI 10.1002/(SICI)1097-010X(19980815)281:6&lt;608::AID-JEZ9&gt;3.0.CO;2-R; Zhang QQ, 1999, ICHTHYOL RES, V46, P153, DOI 10.1007/BF02675433; Zhang QQ, 1996, FISHERIES SCI, V62, P870, DOI 10.2331/fishsci.62.870; Zhang YJ, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-169; Zhao Wen, 2014, Journal of Fisheries of China, V38, P1255; Zhou H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081299; Zhou Li, 2017, Aquaculture and Fisheries, V2, P103, DOI 10.1016/j.aaf.2017.04.003; Zhou X, 2009, THESIS	51	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198179	10.1371/journal.pone.0198179	http://dx.doi.org/10.1371/journal.pone.0198179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795681	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300133
J	Veyel, D; Sokolowska, EM; Moreno, JC; Kierszniowska, S; Cichon, J; Wojciechowska, I; Luzarowski, M; Kosmacz, M; Szlachetko, J; Gorka, M; Meret, M; Graf, A; Meyer, EH; Willmitzer, L; Skirycz, A				Veyel, Daniel; Sokolowska, Ewelina M.; Moreno, Juan C.; Kierszniowska, Sylwia; Cichon, Justyna; Wojciechowska, Izabela; Luzarowski, Marcin; Kosmacz, Monika; Szlachetko, Jagoda; Gorka, Michal; Meret, Michael; Graf, Alexander; Meyer, Etienne H.; Willmitzer, Lothar; Skirycz, Aleksandra			PROMIS, global analysis of PROtein-metabolite interactions using size separation in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolomics; protein-protein interaction; proteomics; systems biology; chromatography; ligand-binding protein; protein-small molecule interactions; size-exclusion chromatography	MASS-SPECTROMETRY; POLYAMINE BIOSYNTHESIS; AFFINITY PURIFICATION; CRYSTAL-STRUCTURE; COMPLEXES; IDENTIFICATION; PLANTS; DRUG; PROTEASOME; KINASES	Small molecules not only represent cellular building blocks and metabolic intermediates, but also regulatory ligands and signaling molecules that interact with proteins. Although these interactions affect cellular metabolism, growth, and development, they have been largely understudied. Herein, we describe a method, which we named PROtein-Metabolite Interactions using Size separation (PROMIS), that allows simultaneous, global analysis of endogenous protein-small molecule and of protein-protein complexes. To this end, a cell-free native lysate from Arabidopsis thaliana cell cultures was fractionated by size-exclusion chromatography, followed by quantitative metabolomic and proteomic analyses. Proteins and small molecules showing similar elution behavior, across protein-containing fractions, constituted putative interactors. Applying PROMIS to an A. thaliana extract, we ascertained known protein-protein (PPIs) and protein-metabolite (PMIs) interactions and reproduced binding between small-molecule protease inhibitors and their respective proteases. More importantly, we present examples of two experimental strategies that exploit the PROMIS dataset to identify novel PMIs. By looking for similar elution behavior of metabolites and enzymes belonging to the same biochemical pathways, we identified putative feedback and feed-forward regulations in pantothenate biosynthesis and the methionine salvage cycle, respectively. By combining PROMIS with an orthogonal affinity purification approach, we identified an interaction between the dipeptide Tyr-Asp and the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. In summary, we present proof of concept for a powerful experimental tool that enables system-wide analysis of PMIs and PPIs across all biological systems. The dataset obtained here comprises nearly 140 metabolites and 5000 proteins, which can be mined for putative interactors.	[Veyel, Daniel; Sokolowska, Ewelina M.; Moreno, Juan C.; Cichon, Justyna; Wojciechowska, Izabela; Luzarowski, Marcin; Kosmacz, Monika; Szlachetko, Jagoda; Gorka, Michal; Graf, Alexander; Meyer, Etienne H.; Willmitzer, Lothar; Skirycz, Aleksandra] Max Planck Inst Mol Plant Physiol, Dept Willmitzer, D-14476 Potsdam, Germany; [Kierszniowska, Sylwia; Meret, Michael] MetaSysX GmbH, D-14476 Potsdam, Germany	Max Planck Society	Skirycz, A (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Willmitzer, D-14476 Potsdam, Germany.	skirycz@mpimp-golm.mpg.de	Meyer, Etienne H/C-1952-2008; Skirycz, Aleksandra/AAM-7911-2021	Meyer, Etienne H/0000-0003-4712-9824; Kierszniowska, Sylwia/0000-0002-4736-9222; Moreno Beltran, Juan Camilo/0000-0001-9722-5262; Skirycz, Aleksandra/0000-0002-7627-7925; Graf, Alexander/0000-0002-6696-5206				Aryal UK, 2014, PLANT CELL, V26, P3867, DOI 10.1105/tpc.114.127563; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; Han BW, 2011, PROTEINS, V79, P3236, DOI 10.1002/prot.23153; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Henderson B, 2014, BIOCHEM SOC T, V42, P1671, DOI 10.1042/BST20140273; Hooper CM, 2017, NUCLEIC ACIDS RES, V45, pD1064, DOI 10.1093/nar/gkw1041; Huber KVM, 2015, NAT METHODS, V12, P1055, DOI [10.1038/NMETH.3590, 10.1038/nmeth.3590]; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kosmacz M, 2018, PLANT PHYSIOL, V177, P411, DOI 10.1104/pp.18.00285; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Krueger S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017806; Li XY, 2011, BIOESSAYS, V33, P485, DOI 10.1002/bies.201100026; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Luzarowski M, 2017, J EXP BOT, V68, P3487, DOI 10.1093/jxb/erx183; Maeda K, 2014, NAT PROTOC, V9, P2256, DOI 10.1038/nprot.2014.148; Mooney S, 2010, PHYTOCHEMISTRY, V71, P495, DOI 10.1016/j.phytochem.2009.12.015; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Naka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9039; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Ottenhof HH, 2004, PLANT J, V37, P61, DOI 10.1046/j.1365-313X.2003.01940.x; Pommerrenig B, 2011, PLANT CELL, V23, P1904, DOI 10.1105/tpc.110.079657; POWERS SG, 1976, J BIOL CHEM, V251, P3786; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Sauter M, 2013, BIOCHEM J, V451, P145, DOI 10.1042/BJ20121744; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tholl D, 2014, PLANT J, V79, P541, DOI 10.1111/tpj.12635; Tilton GB, 2006, PLANT MOL BIOL, V61, P629, DOI 10.1007/s11103-006-0037-4; Van Leene J, 2015, NAT PROTOC, V10, P169, DOI 10.1038/nprot.2014.199; Veyel D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42387; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Waduwara-Jayabahu I, 2012, PLANT PHYSIOL, V158, P1728, DOI 10.1104/pp.111.191072; Watanabe N, 2007, J MOL BIOL, V371, P685, DOI 10.1016/j.jmb.2007.05.061; Yang GX, 2012, METHODS, V57, P459, DOI 10.1016/j.ymeth.2012.06.013; Zierer W, 2016, PLANT PHYSIOL, V170, P790, DOI 10.1104/pp.15.00786	43	29	29	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12440	12453		10.1074/jbc.RA118.003351	http://dx.doi.org/10.1074/jbc.RA118.003351			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29853640	Green Published, hybrid			2022-12-26	WOS:000441408500011
J	Wang, ZY; Fang, LF; Zhou, ZS; Pacheco, S; Gomez, I; Song, FP; Soberon, M; Zhang, J; Bravo, A				Wang, Zeyu; Fang, Longfa; Zhou, Zishan; Pacheco, Sabino; Gomez, Isabel; Song, Fuping; Soberon, Mario; Zhang, Jie; Bravo, Alejandra			Specific binding between Bacillus thuringiensis Cry9Aa and Vip3Aa toxins synergizes their toxicity against Asiatic rice borer (Chilo suppressalis)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; toxin; Bacillus; insect; epitope mapping; pesticide; synergism; synergistic activity	BORDER MEMBRANE-VESICLES; VEGETATIVE INSECTICIDAL PROTEIN; SPODOPTERA-FRUGIPERDA MIDGUT; CRY11AA TOXIN; CRYSTAL PROTEIN; RECEPTOR; LEPIDOPTERA; DIFFERS; SITES; GENE	The bacterium Bacillus thuringiensis produces several insecticidal proteins, such as the crystal proteins (Cry) and the vegetative insecticidal proteins (Vip). In this work, we report that a specific interaction between two B. thuringiensis toxins creates insecticidal synergism and unravel the molecular basis of this interaction. When applied together, the three-domain Cry toxin Cry9Aa and the Vip Vip3Aa exhibited high insecticidal activity against an important insect pest, the Asiatic rice borer (Chilo suppressalis). We found that these two proteins bind specifically to brush border membrane vesicles of C. suppressalis and that they do not share binding sites because no binding competition was observed between them. Binding assays revealed that the Cry9Aa and Vip3Aa proteins interacted with high affinity. We mapped their specific interacting regions by analyzing binding of Cry9Aa to overlapping fragments of Vip3Aa and by analyzing binding of Vip3Aa to individual domains of Cry9Aa. Binding to peptide arrays helped narrow the binding sites to domain II loop-3 of Cry9Aa and to (TKKMKTL434)-T-428 in Vip3Aa. Site-directed mutagenesis confirmed that these binding regions participate in binding that directly correlates with the synergism between the two proteins. In summary, we show that the B. thuringiensis Cry9Aa and Vip3Aa toxins display potent synergy based on a specific interaction between them. Our results further our understanding of the complex synergistic activities among B. thuringiensis toxins and are highly relevant to the development of toxin combinations for effective insect control and for delaying development of insect resistance.	[Wang, Zeyu; Fang, Longfa; Zhou, Zishan; Song, Fuping; Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Wang, Zeyu; Pacheco, Sabino; Gomez, Isabel; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Universidad Nacional Autonoma de Mexico	Zhang, J (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.; Bravo, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Av Univ 2001 Ap Postal 510-3, Cuernavaca 62210, Morelos, Mexico.	jzhang@ippcaas.cn; bravo@ibt.unam.mx	Pacheco, Sabino/AFJ-9017-2022; de la Parra, Maria Alejandra Bravo/R-6740-2017	Pacheco, Sabino/0000-0002-0208-0046; Wang, Zeyu/0000-0003-0087-8123	National Key Research and Development Program of China [2017YFD0200400]; Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia) [008]	National Key Research and Development Program of China; Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia)	This work was supported by National Key Research and Development Program of China Grant 2017YFD0200400 and the Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia 008). The authors declare that they have no conflicts of interest with the contents of this article.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bel Y, 2017, TOXINS, V9, DOI 10.3390/toxins9040131; Ben Hamadou-Charfi D, 2013, J INVERTEBR PATHOL, V114, P139, DOI 10.1016/j.jip.2013.07.003; Bergamasco VB, 2013, J INVERTEBR PATHOL, V112, P152, DOI 10.1016/j.jip.2012.11.011; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carriere Y, 2016, TRENDS BIOTECHNOL, V34, P291, DOI 10.1016/j.tibtech.2015.12.011; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Chakroun M, 2016, MICROBIOL MOL BIOL R, V80, P329, DOI 10.1128/MMBR.00060-15; Chakroun M, 2014, APPL ENVIRON MICROB, V80, P6258, DOI 10.1128/AEM.01521-14; CRICKMORE N., 2018, BACILLUS THURINGIENS; Fang LF, 2016, ELECTRON J BIOTECHN, V21, P54, DOI 10.1016/j.ejbt.2016.02.005; Fernandez LE, 2005, FEBS LETT, V579, P3508, DOI 10.1016/j.febslet.2005.05.032; FINNEY D J, 1971, P333; Gayen S, 2012, J PLANT BIOCHEM BIOT, V21, pS128, DOI 10.1007/s13562-012-0148-8; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Hernandez-Martinez P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16406-1; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Jansens S, 1997, CROP SCI, V37, P1616, DOI 10.2135/cropsci1997.0011183X003700050035x; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang K, 2016, TOXICON, V120, P49, DOI 10.1016/j.toxicon.2016.07.019; Jiao YY, 2016, J INVERTEBR PATHOL, V136, P95, DOI 10.1016/j.jip.2016.03.010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kramer A, 1998, METH MOL B, V87, P25; Kunthic T, 2017, EUR BIOPHYS J BIOPHY, V46, P257, DOI 10.1007/s00249-016-1162-x; Kuvshinov V, 2001, PLANT SCI, V160, P341, DOI 10.1016/S0168-9452(00)00398-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert B, 1996, APPL ENVIRON MICROB, V62, P80, DOI 10.1128/AEM.62.1.80-86.1996; Lee MK, 2006, BIOCHEM BIOPH RES CO, V339, P1043, DOI 10.1016/j.bbrc.2005.11.112; Lee MK, 2003, APPL ENVIRON MICROB, V69, P4648, DOI 10.1128/AEM.69.8.4648-4657.2003; Liu JG, 2011, J INVERTEBR PATHOL, V108, P92, DOI 10.1016/j.jip.2011.07.007; Lorence A, 1997, FEBS LETT, V414, P303, DOI 10.1016/S0014-5793(97)01014-4; Lu MX, 2013, SCI REP-UK, V3, DOI 10.1038/srep03211; Marchetti E, 2009, BIOCONTROL SCI TECHN, V19, P463, DOI 10.1080/09583150902807535; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meng FX, 2003, J ECON ENTOMOL, V96, P1838, DOI 10.1603/0022-0493-96.6.1838; Naimov S, 2014, J INVERTEBR PATHOL, V115, P99, DOI 10.1016/j.jip.2013.11.003; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Palma L, 2017, TOXINS, V9, DOI 10.3390/toxins9050165; Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102; Perez C, 2007, CELL MICROBIOL, V9, P2931, DOI 10.1111/j.1462-5822.2007.01007.x; de Escudero IR, 2007, APPL ENVIRON MICROB, V73, P337, DOI 10.1128/AEM.01511-06; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; SMULEVITCH SV, 1991, FEBS LETT, V293, P25, DOI 10.1016/0014-5793(91)81144-W; Song R, 2008, APPL MICROBIOL BIOT, V80, P647, DOI 10.1007/s00253-008-1613-0; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; vanFrankenhuyzen K, 1997, APPL ENVIRON MICROB, V63, P4132, DOI 10.1128/AEM.63.10.4132-4134.1997; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Zack MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11702-2	57	21	22	4	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11447	11458		10.1074/jbc.RA118.003490	http://dx.doi.org/10.1074/jbc.RA118.003490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29858245	Green Published, hybrid			2022-12-26	WOS:000439449700015
J	Woll, KA; Guzik-Lendrum, S; Bensel, BM; Bhanu, NV; Dailey, WP; Garcia, BA; Gilbert, SP; Eckenhoff, RG				Woll, Kellie A.; Guzik-Lendrum, Stephanie; Bensel, Brandon M.; Bhanu, Natarajan V.; Dailey, William P.; Garcia, Benjamin A.; Gilbert, Susan P.; Eckenhoff, Roderic G.			An allosteric propofol-binding site in kinesin disrupts kinesin-mediated processive movement on microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; kinesin; anesthesia; single-molecule biophysics; photoaffinity labeling; molecular motor; tubulin; propofol; single molecule motility	HAND-OVER-HAND; AXONAL-TRANSPORT; SUPERFAMILY PROTEIN; ORGANELLE TRANSPORT; CRYSTAL-STRUCTURE; MOTOR PROTEIN; MOTILITY; MECHANISMS; VESICLES; NEURONS	Microtubule-based molecular motors mediate transport of intracellular cargo to subdomains in neurons. Previous evidence has suggested that the anesthetic propofol decreases the average run-length potential of the major anterograde transporters kinesin-1 and kinesin-2 without altering their velocity. This effect on kinesin has not been observed with other inhibitors, stimulating considerable interest in the underlying mechanism. Here, we used a photoactive derivative of propofol, meta-azipropofol (AziPm), to search for potential propofol-binding sites in kinesin. Single-molecule motility assays confirmed that AziPm and propofol similarly inhibit kinesin-1 and kinesin-2. We then applied AziPm in semiquantitative radiolabeling and MS microsequencing assays to identify propofol-binding sites within microtubule-kinesin complexes. The radiolabeling experiments suggested preferential AziPm binding to the ATP-bound microtubule-kinesin complex. The photolabeled residues were contained within the kinesin motor domain rather than at the motor domain--tubulin interface. No residues within the P-loop of kinesin were photolabeled, indicating an inhibitory mechanism that does not directly affect ATPase activity and has an effect on run length without changing velocity. Our results also indicated that when the kinesin motor interacts with the microtubule during its processive run, a site forms in kinesin to which propofol can then bind and allosterically disrupt the kinesin-microtubule interaction, resulting in kinesin detachment and run termination. The discovery of the propofol-binding allosteric site in kinesin may improve our understanding of the strict coordination of the motor heads during the processive run. We hypothesize that propofol's potent effect on intracellular transport contributes to various components of its anesthetic action.	[Woll, Kellie A.; Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Bhanu, Natarajan V.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guzik-Lendrum, Stephanie; Bensel, Brandon M.; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Guzik-Lendrum, Stephanie; Bensel, Brandon M.; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Dailey, William P.] Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Pennsylvania	Eckenhoff, RG (corresponding author), 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu			National Institutes of Health [R37-GM054141, P01-GM55876, GM110174, AI118891]; National Science Foundation [DGE-1321851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, R37GM054141, R01GM110174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R37-GM054141 (to S.P.G.), P01-GM55876 (to R.G.E.), and GM110174 and AI118891 (to B.A.G.), and National Science Foundation Graduate Research Fellowship Program Grant DGE-1321851 (to K.A.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bayley H., 1983, PHOTOGENERATED REAGE, DOI [10.1016/S0075-7535(08)70436-4, DOI 10.1016/S0075-7535(08)70436-4]; Bensel BM, 2017, P NATL ACAD SCI USA, V114, pE4281, DOI 10.1073/pnas.1701482114; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; LASEK RJ, 1984, J CELL BIOL, V99, pS212, DOI 10.1083/jcb.99.1.212s; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; Leite LF, 2011, ACTA PHARMACOL SIN, V32, P31, DOI 10.1038/aps.2010.175; Liu DF, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.24490; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Minoura I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10058; Mintz CD, 2012, J NEUROSURG ANESTH, V24, P368, DOI 10.1097/ANA.0b013e31826a03a6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Niwa S, 2013, EMBO J, V32, P1352, DOI 10.1038/emboj.2013.59; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Shang ZG, 2014, ELIFE, V3, DOI 10.7554/eLife.04686; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ulaganathan V, 2013, J AM CHEM SOC, V135, P2263, DOI 10.1021/ja310377d; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; VIANCOUR TA, 1993, BRAIN RES, V628, P209, DOI 10.1016/0006-8993(93)90957-O; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Woll KA, 2017, ACS CHEM BIOL, V12, P1353, DOI 10.1021/acschembio.7b00222; Woll KA, 2016, ANESTH ANALG, V123, P1253, DOI 10.1213/ANE.0000000000001365; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	63	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11283	11295		10.1074/jbc.RA118.002182	http://dx.doi.org/10.1074/jbc.RA118.002182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29844014	Green Published, hybrid			2022-12-26	WOS:000439449700003
J	Yeow, J; Tan, KW; Holdbrook, DA; Chong, ZS; Marzinek, JK; Bond, PJ; Chng, SS				Yeow, Jiang; Tan, Kang Wei; Holdbrook, Daniel A.; Chong, Zhi-Soon; Marzinek, Jan K.; Bond, Peter J.; Chng, Shu-Sin			The architecture of the OmpC-MlaA complex sheds light on the maintenance of outer membrane lipid asymmetry in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						outer membrane; lipid transport; phospholipid; membrane protein; protein complex; lipid asymmetry; membrane channel; MlaA; OmpC; osmoporin	GRAM-NEGATIVE BACTERIA; SALMONELLA-TYPHIMURIUM; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; LIPOPOLYSACCHARIDE TRANSPORT; BIOLOGICAL FUNCTION; OSMOPORIN OMPC; PROTEIN; INSERTION; BARREL	A distinctive feature of the Gram-negative bacterial cell envelope is the asymmetric outer membrane (OM), where lipopolysaccharides and phospholipids (PLs) reside in the outer and inner leaflets, respectively. This unique lipid asymmetry renders the OM impermeable to external insults, including antibiotics and bile salts. In Escherichia coli, the complex comprising osmoporin OmpC and the OM lipoprotein MlaA is believed to maintain lipid asymmetry by removing mislocalized PLs from the outer leaflet of the OM. How this complex performs this function is unknown. Here, we defined the molecular architecture of the OmpC-MlaA complex to gain insights into its role in PL transport. Using in vivo photo-cross-linking and molecular dynamics simulations, we established that MlaA interacts extensively with OmpC and is located entirely within the lipid bilayer. In addition, MlaA forms a hydrophilic channel, likely enabling PL translocation across the OM. We further showed that flexibility in a hairpin loop adjacent to the channel is critical in modulating MlaA activity. Finally, we demonstrated that OmpC plays a functional role in maintaining OM lipid asymmetry together with MlaA. Our work offers glimpses into how the OmpC-MlaA complex transports PLs across the OM and has important implications for future antibacterial drug development.	[Yeow, Jiang; Tan, Kang Wei; Chong, Zhi-Soon; Chng, Shu-Sin] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Yeow, Jiang] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Holdbrook, Daniel A.; Marzinek, Jan K.; Bond, Peter J.] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Marzinek, Jan K.; Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Chng, Shu-Sin] Natl Univ Singapore, Singapore Ctr Environm Life Sci Engn, Singapore 117456, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Chng, SS (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.; Bond, PJ (corresponding author), ASTAR, Bioinformat Inst, Singapore 138671, Singapore.	peterjb@bii.a-star.edu.sg; chmchngs@nus.edu.sg	; Chng, Shu Sin/B-1759-2018	Marzinek, Jan/0000-0002-5493-8753; Yeow, Jiang/0000-0001-5384-7211; Bond, Peter/0000-0003-2900-098X; Chng, Shu Sin/0000-0001-5466-7183	National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship; Singapore Ministry of Education Academic Research Fund Tier 3 Grant [MOE2012-T3-1-008]; National University of Singapore start-up funding; Singapore Ministry of Education Academic Research Fund Tier 1 Grant [MOE2013-T2-1-148]; Singapore Ministry of Education Academic Research Fund Tier 2 Grant [MOE2013-T2-1-148]	National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship(National University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 3 Grant(Ministry of Education, Singapore); National University of Singapore start-up funding(National University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 1 Grant(Ministry of Education, Singapore); Singapore Ministry of Education Academic Research Fund Tier 2 Grant(Ministry of Education, Singapore)	This work was supported by funds from the National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship (to J.Y.). Computational work was supported in part by the Singapore Ministry of Education Academic Research Fund Tier 3 Grant MOE2012-T3-1-008 (to J.K.M. and P.J.B.). All experimental work was supported by the National University of Singapore start-up funding and the Singapore Ministry of Education Academic Research Fund Tier 1 Grant and Tier 2 Grant MOE2013-T2-1-148 (to S.-S.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abellon-Ruiz J, 2017, NAT MICROBIOL, V2, P1616, DOI 10.1038/s41564-017-0046-x; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Chong ZS, 2015, MOL MICROBIOL, V98, P1133, DOI 10.1111/mmi.13202; Dalebroux ZD, 2014, P NATL ACAD SCI USA, V111, P1963, DOI 10.1073/pnas.1316901111; Dekker N, 2000, MOL MICROBIOL, V35, P711, DOI 10.1046/j.1365-2958.2000.01775.x; DeLano W. L., 2012, PYMOL MOL GRAPH SYST; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Ekiert DC, 2017, CELL, V169, P273, DOI 10.1016/j.cell.2017.03.019; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FUNAHARA Y, 1980, J BACTERIOL, V141, P1463, DOI 10.1128/JB.141.3.1463-1465.1980; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang YMM, 2016, PROTEIN SCI, V25, P1430, DOI 10.1002/pro.2939; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; Khetrapal V, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv248; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leo JC, 2015, METHODS MOL BIOL, V1329, P157, DOI 10.1007/978-1-4939-2871-2_12; Liu NZ, 1998, PROTEIN ENG, V11, P797, DOI 10.1093/protein/11.9.797; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; Naveed H, 2012, J MOL BIOL, V419, P89, DOI 10.1016/j.jmb.2012.02.043; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Paramo T, 2014, J CHEM THEORY COMPUT, V10, P2151, DOI 10.1021/ct401098b; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sherman DJ, 2014, P NATL ACAD SCI USA, V111, P4982, DOI 10.1073/pnas.1323516111; Shrivastava R, 2017, MOL MICROBIOL, V106, P395, DOI 10.1111/mmi.13772; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sutterlin HA, 2016, P NATL ACAD SCI USA, V113, pE1565, DOI 10.1073/pnas.1601375113; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Thong S, 2016, ELIFE, V5, DOI 10.7554/eLife.19042; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503	56	38	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11325	11340		10.1074/jbc.RA118.002441	http://dx.doi.org/10.1074/jbc.RA118.002441			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29848551	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000439449700006
J	Ambrose, RL; Liu, YC; Adams, TE; Bean, AGD; Stewart, CR				Ambrose, Rebecca L.; Liu, Yu Chih; Adams, Timothy E.; Bean, Andrew G. D.; Stewart, Cameron R.			C6orf106 is a novel inhibitor of the interferon-regulatory factor 3-dependent innate antiviral response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon-regulatory factor (IRF); innate immunity; cytokine; interferon; NF-B	NF-KAPPA-B; DOUBLE-STRANDED-RNA; RIG-I; TRANSCRIPTION FACTORS; CELL-FUNCTION; CANCER-CELLS; PROTEIN; DEGRADATION; IRF3; RECOGNITION	Host recognition of intracellular viral RNA and subsequent induction of cytokine signaling are tightly regulated at the cellular level and are a target for manipulation by viruses and therapeutics alike. Here, we characterize chromosome 6 ORF 106 (C6orf106) as an evolutionarily conserved inhibitor of the innate antiviral response. C6orf106 suppresses the synthesis of interferon (IFN)-/ and proinflammatory tumor necrosis factor (TNF) in response to the dsRNA mimic poly(I:C) and to Sendai virus infection. Unlike canonical inhibitors of antiviral signaling, C6orf106 blocks interferon-regulatory factor 3 (IRF3) and, to a lesser extent, NF-B activity without modulating their activation, nuclear translocation, cellular expression, or degradation. Instead, C6orf106 interacts with IRF3 and inhibits IRF3 recruitment to type I IFN promoter sequences while also reducing the nuclear levels of the coactivator proteins p300 and CREB-binding protein (CBP). In summary, we have defined C6orf106 as a negative regulator of antiviral immunity that blocks IRF3-dependent cytokine production via a noncanonical and poorly defined mechanism. This work presents intriguing implications for antiviral immunity, autoimmune disorders, and cancer.	[Ambrose, Rebecca L.; Bean, Andrew G. D.; Stewart, Cameron R.] Commonwealth Sci & Ind Res Org CSIRO Hlth & Biose, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Liu, Yu Chih; Adams, Timothy E.] CSIRO Mfg, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Stewart, CR (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Hlth & Biose, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia.	Cameron.Stewart@csiro.au	Adams, Timothy E/I-6231-2012; Stewart, Cameron R/E-6823-2011; Rootes, Christina/H-4905-2013	Adams, Timothy E/0000-0003-3436-0066; Stewart, Cameron/0000-0002-3395-7859; Rootes, Christina/0000-0002-7448-8307	CSIRO; CSIRO Office of the Chief Executive postdoctoral fellowships	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Office of the Chief Executive postdoctoral fellowships	This work was supported by the CSIRO and CSIRO Office of the Chief Executive postdoctoral fellowships (to R. L. A. and Y. C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bae Y, 2010, FEBS LETT, V584, P4505, DOI 10.1016/j.febslet.2010.10.016; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Deffrasnes C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005478; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Francois S, 2016, J VIROL, V90, P8686, DOI 10.1128/JVI.00920-16; Gates LT, 2016, J IMMUNOL, V197, P923, DOI 10.4049/jimmunol.1502611; Gates-Tanzer LT, 2018, J BIOL CHEM, V293, P1745, DOI 10.1074/jbc.RA117.000541; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Jeong MJ, 2013, FEBS LETT, V587, P1373, DOI 10.1016/j.febslet.2013.03.010; Jiang GY, 2015, TUMOR BIOL, V36, P7881, DOI 10.1007/s13277-015-3500-5; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lei CQ, 2013, J BIOL CHEM, V288, P12596, DOI 10.1074/jbc.M112.444794; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Monson EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190597; Mulhern O, 2009, ADV EXP MED BIOL, V666, P49; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Oksayan S, 2012, J BIOL CHEM, V287, P28112, DOI 10.1074/jbc.M112.374694; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Satterfield BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8483; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Song S, 2016, MOL CELL BIOL, V36, P1136, DOI 10.1128/MCB.00744-15; Suhara W, 2002, J BIOL CHEM, V277, P22304, DOI 10.1074/jbc.M200192200; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; Triantafilou K, 2012, J CELL SCI, V125, P4761, DOI 10.1242/jcs.103887; Wang L, 2000, P NATL ACAD SCI USA, V97, P430, DOI 10.1073/pnas.97.1.430; Wang P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004726; Wang SA, 2014, BBA-MOL CELL RES, V1843, P1135, DOI 10.1016/j.bbamcr.2014.02.001; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang XP, 2015, TUMOR BIOL, V36, P5979, DOI 10.1007/s13277-015-3274-9; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049	48	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10561	10573		10.1074/jbc.RA117.001491	http://dx.doi.org/10.1074/jbc.RA117.001491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29802199	Green Published, hybrid			2022-12-26	WOS:000437828400016
J	Burgess, KA; Workman, VL; Elsawy, MA; Miller, AF; Oceandy, D; Saiani, A				Burgess, Kyle A.; Workman, Victoria L.; Elsawy, Mohamed A.; Miller, Aline F.; Oceandy, Delvac; Saiani, Alberto			RNA extraction from self-assembling peptide hydrogels to allow qPCR analysis of encapsulated cells	PLOS ONE			English	Article							HIGH-QUALITY RNA; COMPLEMENTARY OLIGOPEPTIDE; IN-VITRO; CULTURE; SCAFFOLDS; EAK16-II; SEQUENCE	Self-assembling peptide hydrogels offer a novel 3-dimensional platform for many applications in cell culture and tissue engineering but are not compatible with current methods of RNA isolation; owing to interactions between RNA and the biomaterial. This study investigates the use of two techniques based on two different basic extraction principles: solution-based extraction and direct solid-state binding of RNA respectively, to extract RNA from cells encapsulated in four beta-sheet forming self-assembling peptide hydrogels with varying net positive charge. RNA-peptide fibril interactions, rather than RNA-peptide molecular complexing, were found to interfere with the extraction process resulting in low yields. A column-based approach relying on RNA-specific binding was shown to be more suited to extracting RNA with higher purity from these peptide hydrogels owing to its reliance on strong specific RNA binding interactions which compete directly with RNA-peptide fibril interactions. In order to reduce the amount of fibrils present and improve RNA yields a broad spectrum enzyme solution-pronase-was used to partially digest the hydrogels before RNA extraction. This pre-treatment was shown to significantly increase the yield of RNA extracted, allowing downstream RT-qPCR to be performed.	[Burgess, Kyle A.; Workman, Victoria L.; Elsawy, Mohamed A.; Saiani, Alberto] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Burgess, Kyle A.; Workman, Victoria L.; Elsawy, Mohamed A.; Miller, Aline F.; Saiani, Alberto] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Miller, Aline F.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England; [Oceandy, Delvac] Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England; [Elsawy, Mohamed A.] Univ Cent Lancashire, Sch Pharm & Biomed Sci, Preston, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Central Lancashire	Saiani, A (corresponding author), Univ Manchester, Sch Mat, Manchester, Lancs, England.; Saiani, A (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	a.saiani@manchester.ac.uk	Workman, Victoria/N-1836-2019; Workman, Victoria L/C-5065-2011; Saiani, Alberto/D-9714-2011; Burgess, Kyle/O-5885-2019	Workman, Victoria/0000-0002-9135-8993; Workman, Victoria L/0000-0002-9135-8993; Saiani, Alberto/0000-0002-5504-8306; Burgess, Kyle/0000-0002-0605-2173; Elsawy, Mohamed/0000-0003-3964-2150	EPSRC [EP/K016210/1]; MRC through Manchester's Centre of Doctoral Training (CDT) in Regenerative Medicine	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC through Manchester's Centre of Doctoral Training (CDT) in Regenerative Medicine	The authors acknowledge the EPSRC (https://www.epsrc.ac.uk/) for funding this research (Grant no: EP/K016210/1) to AS and again jointly with the MRC (https://www.mrc.ac.uk/) for funding a PhD scholarship through Manchester's Centre of Doctoral Training (CDT) in Regenerative Medicine to KAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Rehana Sung and Dr Andrew Smith of MIB, University of Manchester for help with HPLC, as well as the Genomic Technologies Core Facility at the University of Manchester for use of their equipment. The authors acknowledge the EPSRC for funding this research (Grant no: EP/K016210/1) and again jointly with the MRC for funding a PhD scholarship through Manchester's Centre of Doctoral Training (CDT) in Regenerative Medicine. All research data supporting this work are directly available within this publication.	Arosio P, 2012, BIOPHYS J, V102, P1617, DOI 10.1016/j.bpj.2012.03.012; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Caliari SR, 2016, NAT METHODS, V13, P405, DOI 10.1038/nmeth.3839; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Diaz LAC, 2014, J TISSUE ENG REGEN M, V8, P159; Du EY, 2017, AUST J CHEM, V70, P1, DOI 10.1071/CH16241; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1; Gasparian A, 2015, ANAL BIOCHEM, V484, P1, DOI 10.1016/j.ab.2015.05.002; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Guilbaud JB, 2010, LANGMUIR, V26, P11297, DOI 10.1021/la100623y; Hong Y, 2005, COLLOID SURFACE B, V46, P152, DOI 10.1016/j.colsurfb.2005.11.004; Hong YS, 2004, J ADHESION, V80, P913, DOI 10.1080/00218460490508616; Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374; Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Koster N, 2016, TISSUE ENG PART C-ME, V22, P552, DOI [10.1089/ten.tec.2015.0362, 10.1089/ten.TEC.2015.0362]; Koutsopoulos S, 2016, J BIOMED MATER RES A, V104, P1002, DOI 10.1002/jbm.a.35638; Kumar D, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201702424; Lee NR, 2013, BIOMACROMOLECULES, V14, P3267, DOI 10.1021/bm400876s; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g; Mujeeb A, 2013, ACTA BIOMATER, V9, P4609, DOI 10.1016/j.actbio.2012.08.044; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Swain JF, 2001, J BIOL CHEM, V276, P12222, DOI 10.1074/jbc.M011128200; Szkolar L, 2014, J PEPT SCI, V20, P578, DOI 10.1002/psc.2666; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; Tang C, 2014, INT J PHARMACEUT, V465, P427, DOI 10.1016/j.ijpharm.2014.02.039; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Wan S, 2016, ACTA BIOMATER, V46, P29, DOI 10.1016/j.actbio.2016.09.033; Wang CM, 2008, ANAL BIOCHEM, V380, P333, DOI 10.1016/j.ab.2008.06.005; Wang LM, 2010, BIOMATERIALS, V31, P1612, DOI 10.1016/j.biomaterials.2009.11.024; Xu HL, 2013, INT J MOL SCI, V14, P14185, DOI 10.3390/ijms140714185; Yu C, 2013, TISSUE ENG PART C-ME, V19, P829, DOI [10.1089/ten.tec.2012.0693, 10.1089/ten.TEC.2012.0693]; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334	36	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197517	10.1371/journal.pone.0197517	http://dx.doi.org/10.1371/journal.pone.0197517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864116	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000434097100006
J	Liu, W; Li, Q; Li, H; Li, J; Wang, HJ; Li, B				Liu, Wei; Li, Qin; Li, Hui; Li, Jia; Wang, Hai-Jun; Li, Bin			20-year trends in prevalence of overweight and obesity among children aged 0-6 in Harbin, China: A multiple cross-sectional study	PLOS ONE			English	Article							5TH NATIONAL-SURVEY; CHILDHOOD OVERWEIGHT; PHYSICAL-ACTIVITY; ADOLESCENTS; ADIPOSITY; CONSEQUENCES; WORLDWIDE; EPIDEMIC; GROWTH; ADULTS	To examine the 20-year trends in the combined prevalence of overweight and obesity among children aged 0-6 years between 1995 and 2015 in Harbin, China, we selected altogether 49,553 children aged 0-6 years old by using a multistage stratified cluster sampling methods in Harbin, one provincial capital city in northeast China in 1995, 2005 and 2015. Height and weight information of the children were collected. We used the child growth standards of World Health Organization to calculate the Z-scores for body mass index (BMI). Cut-offs recommended by World Health Organization and International Obesity Task Force were used to define overweight and obesity for each children. We found there is no difference between boys' BMI and girls' among newborns in each survey point (p>0.05), but in older age groups, the BMI of boys was higher than that of girls (p<0.05). From 1995 to 2015, the average BMI was increasing continuously among boys older than 42 months and girls older than 48 months (p<0.01 for linear trend across year) in Harbin. The combined prevalence of overweight and obesity increased from 2.6% in 1995 to 7.6% in 2015. For every 10-year the risk of combined overweight and obesity in children aged 0-6 years increased by 167% (95%CI: 146%, 188%, p<0.01). The combined prevalence of overweight and obesity in most age subgroups showed an increasing trend over time (p<0.01 for trend test across survey year). The age when the combined prevalence of overweight and obesity dramatically increased was earlier in 2015 than that in 2005 and 1995. In conclusion, there was an increasing trend of the combined prevalence of overweight and obesity during the past 20 years in Harbin and the age when the prevalence dramatically increased became earlier. Comprehensive intervention should be undertaken among younger children to prevent and control children's overweight and obesity.	[Liu, Wei; Li, Bin] Harbin Med Univ, Sch Publ Hlth, Dept Social Med, Harbin, Heilongjiang, Peoples R China; [Li, Qin; Wang, Hai-Jun] Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China; [Li, Hui] Capital Inst Pediat, Dept Growth & Dev, Beijing, Peoples R China; [Li, Jia] Harbin Maternal & Child Hlth Care Hosp, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Peking University; Capital Institute of Pediatrics (CIP)	Li, B (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Social Med, Harbin, Heilongjiang, Peoples R China.	libin63lb@163.com	Li, Qin/AAS-9349-2021; Wang, Haijun/AAD-1302-2021; Li, Qin/M-1155-2018	Li, Qin/0000-0002-8633-8859; Wang, Haijun/0000-0003-0849-2903; Li, Qin/0000-0002-8633-8859	National Health and Family Planning Commission of the People's Republic of China; Beingmate Women and Children Development Research Foundation; National Health and Family Planning Commission of PRC; Harbin Health and Family Planning Commission	National Health and Family Planning Commission of the People's Republic of China; Beingmate Women and Children Development Research Foundation; National Health and Family Planning Commission of PRC; Harbin Health and Family Planning Commission	The study was funded by The National Health and Family Planning Commission of the People's Republic of China and Beingmate Women and Children Development Research Foundation to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2014, OBES REV, V15, P49, DOI 10.1111/obr.12123; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Chen J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111104; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Farley TA, 2012, AM J PREV MED, V43, pS93, DOI 10.1016/j.amepre.2012.06.003; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Gamit S. S., 2015, International Journal of Medical Science and Public Health, V4, P42; Hernandez-Cordero S, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2016.52; Hughes AR, 2014, PEDIATRICS, V134, pE1354, DOI 10.1542/peds.2014-1908; Hui L, 2009, CHIN J PEDIAT, V47, P493; Kowal M, 2015, AM J HUM BIOL, V27, P646, DOI 10.1002/ajhb.22704; Lissner L, 2010, OBES REV, V11, P553, DOI 10.1111/j.1467-789X.2009.00696.x; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Olds TS, 2010, INT J OBESITY, V34, P57, DOI 10.1038/ijo.2009.211; Romon M, 2009, PUBLIC HEALTH NUTR, V12, P1735, DOI 10.1017/S1368980008004278; Skouteris H, 2010, OBES REV, V11, P757, DOI 10.1111/j.1467-789X.2010.00806.x; Song Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011904; Song Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010518; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Tambalis KD, 2010, OBESITY, V18, P161, DOI 10.1038/oby.2009.188; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; WHO, 2006, WHO CHILD GROWTH STA; Xiao YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134466; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhang YQ, 2017, AM J PHYS ANTHROPOL, V163, P497, DOI 10.1002/ajpa.23224; Zhang YX, 2011, ANN HUM BIOL, V38, P485, DOI 10.3109/03014460.2011.555415; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942; Zong XN, 2017, ANN HUM BIOL, V44, P636, DOI 10.1080/03014460.2017.1358394	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0198032	10.1371/journal.pone.0198032	http://dx.doi.org/10.1371/journal.pone.0198032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864123	Green Published, Green Submitted, gold			2022-12-26	WOS:000434097100017
J	Yang, L; Koyanagi, A; Smith, L; Hu, L; Colditz, GA; Toriola, AT; Sanchez, GFL; Vancampfort, D; Hamer, M; Stubbs, B; Waldhor, T				Yang, Lin; Koyanagi, Ai; Smith, Lee; Hu, Liang; Colditz, Graham A.; Toriola, Adetunji T.; Lopez Sanchez, Guillermo Felipe; Vancampfort, Davy; Hamer, Mark; Stubbs, Brendon; Waldhoer, Thomas			Hand grip strength and cognitive function among elderly cancer survivors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MUSCLE; ASSOCIATION; DYSFUNCTION; POPULATION; IMPAIRMENT; PREVALENCE; DEPRESSION; MORTALITY; DEMENTIA	Background We evaluated the associations of handgrip strength and cognitive function in cancer survivors >= 60 years old using data from the National Health and Nutrition Examination Survey (NHANES). Methods Data in two waves of NHANES (2011-2014) were aggregated. Handgrip strength in kilo-gram (kg) was defined as the maximum value achieved using either hand. Two cognitive function tests were conducted among adults 60 years and older. The Animal Fluency Test (AFT) examines categorical verbal fluency (a component of executive function), and the Digital Symbol Substitution test (DSST) assesses processing speed, sustained attention, and working memory. Survey analysis procedures were used to account for the complex sampling design of the NHANES. Multiple linear regression models were used to estimate associations of handgrip strength with cognitive test scores, adjusting for confounders (age, gender, race/ethnicity, education, marital status, smoking status, depressive symptoms and leisure time physical activity). Results Among 383 cancer survivors (58.5% women, mean age = 70.9 years, mean BMI = 29.3 kg/m(2)), prevalent cancer types were breast (22.9%), prostate (16.4%), colon (6.9%) and cervix (6.2%). In women, each increase in kg of handgrip strength was associated with 0.20 (95% CI: 0.08 to 0.33) higher score on AFT and 0.83 (95% CI: 0.30 to 1.35) higher score on DSST. In men, we observed an inverted U-shape association where cognitive function peaked at handgrip strength of 40-42 kg. Conclusions Handgrip strength, a modifiable factor, appears to be associated with aspects of cognitive functions in cancer survivors. Prospective studies are needed to address their causal relationship.	[Yang, Lin; Waldhoer, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria; [Koyanagi, Ai] Univ Barcelona, Res & Dev Unit, Fundacio St Joan Deu, Parc Sanitari St Joan Deu, Barcelona, Spain; [Koyanagi, Ai] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain; [Smith, Lee] Anglia Ruskin Univ, Cambridge Ctr Sports & Exercise Sci, Cambridge, England; [Hu, Liang] Zhejiang Univ, Dept Sport Sci, Hangzhou, Zhejiang, Peoples R China; [Colditz, Graham A.; Toriola, Adetunji T.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Lopez Sanchez, Guillermo Felipe] Univ Murcia, Fac Sports Sci, Murcia, Spain; [Vancampfort, Davy] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium; [Hamer, Mark] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, London, England; [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England; [Stubbs, Brendon] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, Essex, England	Medical University of Vienna; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Anglia Ruskin University; Zhejiang University; Washington University (WUSTL); University of Murcia; KU Leuven; Loughborough University; South London & Maudsley NHS Trust; University of London; King's College London; Anglia Ruskin University	Yang, L (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria.	lin.yang@muv.ac.at	Sánchez, Guillermo Felipe López/K-8703-2015; Colditz, Graham/A-3963-2009; Yang, Lin/AAE-4979-2020; Vancampfort, Davy/AAD-1987-2019; Koyanagi, Ai/D-3833-2018; Stubbs, Brendon/X-1904-2018; Hamer, Mark/C-1602-2008; Hamer, Mark/AAJ-6814-2021	Sánchez, Guillermo Felipe López/0000-0002-9897-5273; Colditz, Graham/0000-0002-7307-0291; Yang, Lin/0000-0002-1698-6666; Koyanagi, Ai/0000-0002-9565-5004; Stubbs, Brendon/0000-0001-7387-3791; Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Toriola, Adetunji/0000-0003-1079-2606	Miguel Servet contract [CP13/00150, PI15/00862]; Institute de Salud Carlos III (ISCIII) - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER)	Miguel Servet contract; Institute de Salud Carlos III (ISCIII) - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER)(European Commission)	Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the Institute de Salud Carlos III (ISCIII) - General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER).; Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII General Branch Evaluation and Promotion of Health Research and the European Regional Development Fund (ERDF-FEDER).	Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Bonsang E, 2017, PSYCHOL SCI, V28, P1201, DOI 10.1177/0956797617708634; Brandimonte MA, 2006, PSYCHOL CONCEPTS INT, V1st; Burden ST, 2010, J HUM NUTR DIET, V23, P402, DOI 10.1111/j.1365-277X.2010.01070.x; Castel H, 2017, FRONT PHARMACOL, V8, DOI [10.3389/frhar2017.00138, 10.3389/fphar.2017.00138]; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chen CH, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-98; Chen SP, 2017, JAMA OPHTHALMOL, V135, P963, DOI 10.1001/jamaophthalmol.2017.2838; Christensen JF, 2014, ANN ONCOL, V25, P947, DOI 10.1093/annonc/mdt551; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fritz NE, 2017, AGEING RES REV, V35, P112, DOI 10.1016/j.arr.2017.01.004; Haidar SG, 2004, J HAND SURG-BRIT EUR, V29B, P82, DOI 10.1016/j.jhsb.2003.09.012; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harrington S, 2011, J CANCER SURVIV, V5, P167, DOI 10.1007/s11764-010-0168-0; Janelsins MC, 2014, INT REV PSYCHIATR, V26, P102, DOI 10.3109/09540261.2013.864260; Janelsins MC, 2011, SEMIN ONCOL, V38, P431, DOI 10.1053/j.seminoncol.2011.03.014; Jang JY, 2015, J PHYS THER SCI, V27, P3911, DOI 10.1589/jpts.27.3911; Jehn CF, 2015, J NEUROIMMUNOL, V287, P88, DOI 10.1016/j.jneuroim.2015.08.012; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Moore HCF, 2014, ONCOLOGY-NY, V28, P797; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Ng T, 2016, NEURO-ONCOLOGY, V18, P244, DOI 10.1093/neuonc/nov162; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Proust-Lima C, 2007, AM J EPIDEMIOL, V165, P344, DOI 10.1093/aje/kwk017; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rock CL, 2012, OBESITY, V20, P2296, DOI 10.1038/oby.2012.57; Soyupek F, 2008, UROL ONCOL-SEMIN ORI, V26, P141, DOI 10.1016/j.urolonc.2006.12.014; Steiber N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163917; Tsai SW, 2015, J DIABETES COMPLICAT, V29, P367, DOI 10.1016/j.jdiacomp.2015.01.014; Tuokko H, 2017, CLIN NEUROPSYCHOL, V31, P233, DOI 10.1080/13854046.2016.1254279; Veronese N, 2017, J GERONTOL A-BIOL, V72, P362, DOI 10.1093/gerona/glw139; Veronese N, 2016, EXP GERONTOL, V81, P110, DOI 10.1016/j.exger.2016.05.008; Zhao GX, 2014, BRIT J SPORT MED, V48, P244, DOI 10.1136/bjsports-2013-092731; Zimmer P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1820954	40	22	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197909	10.1371/journal.pone.0197909	http://dx.doi.org/10.1371/journal.pone.0197909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI0YU	29864112	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000434097100013
J	Liu, MF; Huang, M; Shui, Y; Biville, F; Zhu, DK; Wang, MS; Jia, RY; Chen, S; Sun, KF; Zhao, XX; Yang, Q; Wu, Y; Chen, XY; Cheng, AC				Liu, MaFeng; Huang, Mi; Shui, Yun; Biville, Francis; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Sun, KunFeng; Zhao, XinXin; Yang, Qiao; Wu, Ying; Chen, XiaoYue; Cheng, AnChun			Roles of B739_1343 in iron acquisition and pathogenesis in Riemerella anatipestifer CH-1 and evaluation of the RA-CH-1 Delta B739_1343 mutant as an attenuated vaccine	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; VIRULENCE; RECEPTOR; PROTEIN; SEROTYPES; DUCKS; PATHOGENICITY; INFECTION; TRANSPORT; BINDING	Iron is one of the most important elements for bacterial survival and pathogenicity. The iron uptake mechanism of Riemerella anatipestifer (R. anatipestifer, RA), a major pathogen that causes septicemia and polyserositis in ducks, is largely unknown. Here, the functions of the putative TonB-dependent iron transporter of RA-CH-1, B739_1343, in iron utilization and pathogenicity were investigated. Under iron-starved conditions, the mutant strain RA-CH-1 Delta B739_1343 exhibited more seriously impaired growth than the wild-type strain RA-CH-1, and the expression of B739_1343 in the mutant strain restored growth. qRT-PCR results showed that the transcription of B739_1343 was not regulated by iron conditions. In an animal model, the median lethal dose (LD50) of the mutant strain RA-CH-1 Delta B739_1343 increased more than 10(4)-fold (1.6x10(12) CFU) compared to that of the wildtype strain RA-CH-1 (1.43x10(8) CFU). In a duck co-infection model, the mutant strain RA-CH-1 Delta B739_1343 was outcompeted by the wild-type RA-CH-1 in the blood, liver and brain of infected ducks, indicating that B739_1343 is a virulence factor of RA-CH-1. Finally, immunization with live bacteria of the mutant strain RA-CH-1 Delta B739_1343 protected 83.33% of ducks against a high-dose (100-fold LD50) challenge with the wild-type strain RA-CH-1, suggesting that the mutant strain RA-CH-1 Delta B739_1343 could be further developed as a potential live attenuated vaccine candidate for the duck industry.	[Liu, MaFeng; Huang, Mi; Shui, Yun; Wang, MingShu; Jia, RenYong; Chen, Shun; Sun, KunFeng; Zhao, XinXin; Yang, Qiao; Wu, Ying; Cheng, AnChun] Sichuan Agr Univ, Inst Prevent Vet Med, Coll Vet Med, Chengdu, Sichuan, Peoples R China; [Liu, MaFeng; Huang, Mi; Shui, Yun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Sun, KunFeng; Zhao, XinXin; Yang, Qiao; Wu, Ying; Chen, XiaoYue; Cheng, AnChun] Sichuan Agr Univ, Coll Vet Med, Res Ctr Avian Dis, Chengdu, Sichuan, Peoples R China; [Liu, MaFeng; Huang, Mi; Shui, Yun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Sun, KunFeng; Zhao, XinXin; Yang, Qiao; Wu, Ying; Chen, XiaoYue; Cheng, AnChun] Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Biville, Francis] Inst Pasteur, Dept Infect & Epidemiol, Unite Infect Bacteriennes Invas, Paris, France	Sichuan Agricultural University; Sichuan Agricultural University; Key Laboratory of Animal Disease & Human Health of Sichuan Province; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Liu, MF; Cheng, AC (corresponding author), Sichuan Agr Univ, Inst Prevent Vet Med, Coll Vet Med, Chengdu, Sichuan, Peoples R China.; Liu, MF; Cheng, AC (corresponding author), Sichuan Agr Univ, Coll Vet Med, Res Ctr Avian Dis, Chengdu, Sichuan, Peoples R China.; Liu, MF; Cheng, AC (corresponding author), Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China.	liumafengra@163.com; chenganchun@vip.163.com	huang, mi wei/GVT-4152-2022; Zhu, Dekang/A-2292-2014	Zhu, Dekang/0000-0002-7314-1088	National Natural Science Foundation of China [31772772]; International S&T Cooperation Program of Sichuan Province [2016HH0052]; China Agricultural Research System [CARS-42-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of Sichuan Province; China Agricultural Research System	This work was supported by the National Natural Science Foundation of China (Grant No. 31772772, http://www.nsfc.gov.crii, Recipient: M.L.), International S&T Cooperation Program of Sichuan Province (Grant No. 2016HH0052, https//www.scst gov.cn, Recipient: M.L.), and the China Agricultural Research System (CARS-42-17, http://www.moa.gov.cn, Recipient: A.C.). The funders (M.L. and A.G.) had a role in study design, decision to publish and perparation of the manuscript.	Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; [Anonymous], 2013, DIS POULTRY; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cherayil BJ, 2011, IMMUNOL RES, V50, P1, DOI 10.1007/s12026-010-8199-1; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Datta S, 2012, BIOMETALS, V25, P275, DOI 10.1007/s10534-011-9501-y; Fetherston JD, 2012, INFECT IMMUN, V80, P3880, DOI 10.1128/IAI.00086-12; Fusco WG, 2013, J BACTERIOL, V195, P3115, DOI 10.1128/JB.00199-13; Guo YQ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00382; Hagan EC, 2009, MOL MICROBIOL, V71, P79, DOI 10.1111/j.1365-2958.2008.06509.x; HANCOCK REW, 1976, J BACTERIOL, V127, P1370, DOI 10.1128/JB.127.3.1370-1375.1976; HANCOCK REW, 1977, ARCH MICROBIOL, V114, P231, DOI 10.1007/BF00446867; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JW, 2010, VACCINE, V28, P7956, DOI 10.1016/j.vaccine.2010.09.072; Liu MF, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8682057; Liu MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37159; LOH H, 1992, AVIAN PATHOL, V21, P453, DOI 10.1080/03079459208418863; Lu FY, 2013, VET MICROBIOL, V167, P713, DOI 10.1016/j.vetmic.2013.08.020; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; PATHANASOPHON P, 1995, AVIAN PATHOL, V24, P195, DOI 10.1080/03079459508419059; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porcheron G, 2015, VET MICROBIOL, V179, P2, DOI 10.1016/j.vetmic.2015.03.024; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; SANDHU T, 1979, AVIAN DIS, V23, P662, DOI 10.2307/1589742; SANDHU TS, 1991, AVIAN PATHOL, V20, P233, DOI 10.1080/03079459108418760; SEGERS P, 1993, INT J SYST BACTERIOL, V43, P768, DOI 10.1099/00207713-43-4-768; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tu J, 2014, VET MICROBIOL, V168, P395, DOI 10.1016/j.vetmic.2013.11.027; Wang MY, 2017, VET MICROBIOL, V201, P162, DOI 10.1016/j.vetmic.2017.01.027; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Yang JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128251; Zheng FY, 2011, MOL CELL PROBE, V25, P65, DOI 10.1016/j.mcp.2010.10.004; Zou JC, 2015, VET MICROBIOL, V177, P193, DOI 10.1016/j.vetmic.2015.03.003	39	9	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197310	10.1371/journal.pone.0197310	http://dx.doi.org/10.1371/journal.pone.0197310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847566	gold, Green Published, Green Submitted			2022-12-26	WOS:000433634800027
J	Saeui, CT; Nairn, AV; Galizzi, M; Douville, C; Gowda, P; Park, M; Dharmarha, V; Shah, SR; Clarke, A; Austin, M; Moremen, KW; Yarema, KJ				Saeui, Christopher T.; Nairn, Alison V.; Galizzi, Melina; Douville, Christopher; Gowda, Prateek; Park, Marian; Dharmarha, Vrinda; Shah, Sagar R.; Clarke, Amelia; Austin, Melissa; Moremen, Kelley W.; Yarema, Kevin J.			Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes	PLOS ONE			English	Article							PANCREATIC-CANCER CELLS; ACYL SIDE-CHAIN; POLYSIALIC ACID; MANNAC ANALOGS; EXPRESSION; SIALYLATION; BIOSYNTHESIS; FLUX; NUTRIENT; IDENTIFICATION	In this report we use 'high-flux' tributanoyl- modified N-acetylmannosamine (ManNAc) analogs with natural N-acetyl as well as non-natural azido-and alkyne N-acyl groups (specifically, 1,3,4-O-Bu(3)ManNAc, 1,3,4-O-Bu(3)ManNAz, and 1,3,4-O-Bu(3)ManNAl respectively) to probe intracellular sialic acid metabolism in the near-normal MCF10A human breast cell line in comparison with earlier stage T-47D and more advanced stage MDA-MB-231 breast cancer lines. An integrated view of sialic acid metabolism was gained by measuring intracellular sialic acid production in tandem with transcriptional profiling of genes linked to sialic acid metabolism. The transcriptional profiling showed several differences between the three lines in the absence of ManNAc analog supplementation that helps explain the different sialoglycan profiles naturally associated with cancer. Only minor changes in mRNA transcript levels occurred upon exposure to the compounds confirming that metabolic flux alone can be a key determinant of sialoglycoconjugate display in breast cancer cells; this result complements the well-established role of genetic control (e.g., the transcription of STs) of sialylation abnormalities ubiquitously associated with cancer. A notable result was that the different cell lines produced significantly different levels of sialic acid upon exogenous ManNAc supplementation, indicating that feedback inhibition of UDP-GlcNAc2-epimerase/ManNAc kinase (GNE) D generally regarded as the 'gatekeeper' enzyme for titering flux into sialic acid biosynthesis D is not the only regulatory mechanism that limits production of this sugar. A notable aspect of our metabolic glycoengineering approach is its ability to discriminate cell subtype based on intracellular metabolism by illuminating otherwise hidden cell type-specific features. We believe that this strategy combined with multi-dimensional analysis of sialic acid metabolism will ultimately provide novel insights into breast cancer subtypes and provide a foundation for new methods of diagnosis.	[Saeui, Christopher T.; Douville, Christopher; Gowda, Prateek; Park, Marian; Dharmarha, Vrinda; Shah, Sagar R.; Clarke, Amelia; Austin, Melissa; Yarema, Kevin J.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Saeui, Christopher T.; Douville, Christopher; Gowda, Prateek; Park, Marian; Dharmarha, Vrinda; Shah, Sagar R.; Clarke, Amelia; Austin, Melissa; Yarema, Kevin J.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Baltimore, MD USA; [Nairn, Alison V.; Galizzi, Melina; Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Moremen, Kelley W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Johns Hopkins University; Johns Hopkins University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Yarema, KJ (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA.; Yarema, KJ (corresponding author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Baltimore, MD USA.	kyarema1@jhu.edu	Moremen, Kelley/AAD-4661-2019	Austin, Melissa/0000-0001-7876-3962; Nairn, Alison/0000-0002-4453-7593; Clarke, Amelia/0000-0003-0009-1216; Park, Marian/0000-0002-1458-3548	Willowcroft Foundation; Sol Goldman Pancreatic Cancer Research Center Fund (JHM I); National Institutes of Health [R01CA112314, P41GM103490]; NATIONAL CANCER INSTITUTE [R01CA112314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	Willowcroft Foundation; Sol Goldman Pancreatic Cancer Research Center Fund (JHM I); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Willowcroft Foundation, the Sol Goldman Pancreatic Cancer Research Center Fund (JHM I), and the National Institutes of Health (R01CA112314 (to KJY) and P41GM103490 (to KWM)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by the Willowcroft Foundation, the Sol Goldman Pancreatic Cancer Research Center Fund (JHMI), and the National Institutes of Health (R01CA112314 (to KJY) and P41GM103490 (to KWM)).	Aich U, 2008, ACS CHEM BIOL, V3, P230, DOI 10.1021/cb7002708; Almaraz RT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017558; Almaraz RT, 2012, ANN BIOMED ENG, V40, P806, DOI 10.1007/s10439-011-0450-y; Almaraz RT, 2012, BIOTECHNOL BIOENG, V109, P992, DOI 10.1002/bit.24363; Badr HA, 2017, BIOMATERIALS, V116, P158, DOI 10.1016/j.biomaterials.2016.11.044; Badr HA, 2015, DATA BRIEF, V5, P481, DOI 10.1016/j.dib.2015.09.043; Badr HA, 2015, BIOMATERIALS, V70, P23, DOI 10.1016/j.biomaterials.2015.08.020; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Bonay P, 1996, J BIOL CHEM, V271, P13292; Bork K, 2017, GENE EXPR PATTERNS, V23-24, P52, DOI 10.1016/j.gep.2017.03.003; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bull C, 2016, TRENDS BIOCHEM SCI, V41, P519, DOI 10.1016/j.tibs.2016.03.007; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Campbell CT, 2007, MOL BIOSYST, V3, P187, DOI 10.1039/b614939c; Campbell CT, 2008, J MED CHEM, V51, P8135, DOI 10.1021/jm800873k; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Codelli JA, 2008, J AM CHEM SOC, V130, P11486, DOI 10.1021/ja803086r; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; CULLING CFA, 1976, J HISTOCHEM CYTOCHEM, V24, P1225, DOI 10.1177/24.12.187689; DENNIS JW, 1987, CANCER METAST REV, V5, P185, DOI 10.1007/BF00046998; Drolez A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081309; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Dube DH, 2003, CURR OPIN CHEM BIOL, V7, P616, DOI 10.1016/j.cbpa.2003.08.006; Elmouelhi N, 2009, J MED CHEM, V52, P2515, DOI 10.1021/jm801661m; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Finke JM, 2017, BBA-GEN SUBJECTS, V1861, P2228, DOI 10.1016/j.bbagen.2017.06.008; Fraschilla I, 2017, IMMUNOL REV, V276, P178, DOI 10.1111/imr.12526; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; HADFIELD AF, 1983, J PHARM SCI, V72, P748, DOI 10.1002/jps.2600720709; Hein JE, 2010, CHEM SOC REV, V39, P1302, DOI 10.1039/b904091a; Hinderlich S, 2015, TOP CURR CHEM, V366, P97, DOI 10.1007/128_2013_464; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Ikegami K, 2014, CELL REP, V9, P801, DOI 10.1016/j.celrep.2014.10.006; Jacobs CL, 2001, BIOCHEMISTRY-US, V40, P12864, DOI 10.1021/bi010862s; James AD, 2015, J BIOL CHEM, V290, P24760, DOI 10.1074/jbc.M115.668707; Johnson SM, 2016, BLOOD, V128, P453, DOI 10.1182/blood-2015-12-688051; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KAYSER H, 1992, J BIOL CHEM, V267, P16934; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Killer MC, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0553-y; Kim EJ, 2004, BIOTECHNOL PROGR, V20, P1674, DOI 10.1021/bp049841q; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Krentsis IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021389; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lemieux GA, 1999, J AM CHEM SOC, V121, P4278, DOI 10.1021/ja984228m; Lundblad A, 2015, UPSALA J MED SCI, V120, P104, DOI 10.3109/03009734.2015.1027429; Ma XL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.427; Macauley MS, 2014, NAT CHEM BIOL, V10, P7, DOI 10.1038/nchembio.1415; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Mathew MP, 2017, CHEMBIOCHEM, V18, P1204, DOI 10.1002/cbic.201600698; Mathew MP, 2016, ONCOTARGET, V7, P66491, DOI 10.18632/oncotarget.11582; Mathew MP, 2015, BIOORG MED CHEM LETT, V25, P1223, DOI 10.1016/j.bmcl.2015.01.060; Mathew MP, 2012, BIOORG MED CHEM LETT, V22, P6929, DOI 10.1016/j.bmcl.2012.09.017; Nagler RH, 2017, MED CARE, V55, P879, DOI 10.1097/MLR.0000000000000798; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; Naso MF, 2010, MABS-AUSTIN, V2, P519, DOI 10.4161/mabs.2.5.13078; Pearce OMT, 2016, GLYCOBIOLOGY, V26, P111, DOI 10.1093/glycob/cwv097; Perez LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123397; PETERS BP, 1976, CARBOHYD RES, V47, P345, DOI 10.1016/S0008-6215(00)84204-4; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saeui CT, 2018, MOL PHARMACEUT, V15, P705, DOI 10.1021/acs.molpharmaceut.7b00525; Saleh A, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-45; Sampathkumar SG, 2006, NAT PROTOC, V1, P2377, DOI 10.1038/nprot.2006.319; Sampathkumar SG, 2006, CHEM BIOL, V13, P1265, DOI 10.1016/j.chembiol.2006.09.016; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; SCHWARTZ EL, 1983, BIOCHIM BIOPHYS ACTA, V762, P489, DOI 10.1016/0167-4889(83)90051-4; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Song YK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180988; Tian Y, 2015, CLIN PROTEOM, V12, DOI [10.1186/s12014-12015-19083-12018, DOI 10.1186/S12014-12015-19083-12018]; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Vojta A, 2016, BBA-GEN SUBJECTS, V1860, P1776, DOI 10.1016/j.bbagen.2016.01.002; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; Wang ZY, 2009, CURR OPIN CHEM BIOL, V13, P565, DOI 10.1016/j.cbpa.2009.08.001; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; WEISS P, 1989, J BIOL CHEM, V264, P17635; Wide L, 2009, J CLIN ENDOCR METAB, V94, P958, DOI 10.1210/jc.2008-2070; Winer LSP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109916; Wratil PR, 2016, ANGEW CHEM INT EDIT, V55, P9482, DOI 10.1002/anie.201601123; Yarema KJ, 2001, NAT BIOTECHNOL, V19, P553, DOI 10.1038/89305; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401	88	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0195812	10.1371/journal.pone.0195812	http://dx.doi.org/10.1371/journal.pone.0195812			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847599	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800007
J	Nandy, K; Collinson, DW; Scheftic, CM; Brinson, LC				Nandy, Krishanu; Collinson, David W.; Scheftic, Charlie M.; Brinson, L. Catherine			Open-source micro-tensile testers via additive manufacturing for the mechanical characterization of thin films and papers	PLOS ONE			English	Article							GRAPHENE OXIDE; MICROSTRUCTURE CHARACTERIZATION; RECONSTRUCTION; METHODOLOGY; DESIGN	The cost of specialized scientific equipment can be high and with limited funding resources, researchers and students are often unable to access or purchase the ideal equipment for their projects. In the fields of materials science and mechanical engineering, fundamental equipment such as tensile testing devices can cost tens to hundreds of thousands of dollars. While a research lab often has access to a large-scale testing machine suitable for conventional samples, loading devices for meso-and micro-scale samples for in-situ testing with the myriad of microscopy tools are often hard to source and cost prohibitive. Open-source software has allowed for great strides in the reduction of costs associated with software development and open-source hardware and additive manufacturing have the potential to similarly reduce the costs of scientific equipment and increase the accessibility of scientific research. To investigate the feasibility of open-source hardware, a micro-tensile tester was designed with a freely accessible computer-aided design package and manufactured with a desktop 3D-printer and off-the-shelf components. To our knowledge this is one of the first demonstrations of a tensile tester with additively manufactured components for scientific research. The capabilities of the tensile tester were demonstrated by investigating the mechanical properties of Graphene Oxide (GO) paper and thin films. A 3D printed tensile tester was successfully used in conjunction with an atomic force microscope to provide one of the first quantitative measurements of GO thin film buckling under compression. The tensile tester was also used in conjunction with an atomic force microscope to observe the change in surface topology of a GO paper in response to increasing tensile strain. No significant change in surface topology was observed in contrast to prior hypotheses from the literature. Based on this result obtained with the new open source tensile stage we propose an alternative hypothesis we term 'superlamellae consolidation' to explain the initial deformation of GO paper. The additively manufactured tensile tester tested represents cost savings of > 99% compared to commercial solutions in its class and offers simple customization. However, continued development is needed for the tensile tester presented here to approach the technical specifications achievable with commercial solutions.	[Nandy, Krishanu; Collinson, David W.; Scheftic, Charlie M.; Brinson, L. Catherine] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Brinson, L. Catherine] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Brinson, L. Catherine] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA	Northwestern University; Northwestern University; Duke University	Brinson, LC (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.; Brinson, LC (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Brinson, LC (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA.	cate.brinson@duke.edu	Brinson, L. Catherine/B-6678-2009		National Science Foundation [NSF CMMI-1235355]; Airforce Office of Scientific Research [AFOSR FA9550-14-1-0032-P00003]; National Institute for Standards and Technology Center for Hierarchical Materials Design (NIST CHI MAD) [70NANB14H012 Amd 5]; Ryan Fellowship; International Institute for Nanotechnology at Northwestern University; John R Templin Fellowship; Goodyear Rubber and Tire Company [4510883960]; Fulbright Program grant - Bureau of Educational and Cultural Affairs of the United States Department of State; National Science Foundation under NSF [EEC-1359004]; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource [NSF NNCI-1542205]; MRSEC program at the Materials Research Center [NSF DMR-1121262]; International Institute for Nanotechnology (IIN); Keck Foundation; State of Illinois, through the IIN; Goodyear Rubber and Tire Company	National Science Foundation(National Science Foundation (NSF)); Airforce Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institute for Standards and Technology Center for Hierarchical Materials Design (NIST CHI MAD); Ryan Fellowship; International Institute for Nanotechnology at Northwestern University; John R Templin Fellowship; Goodyear Rubber and Tire Company; Fulbright Program grant - Bureau of Educational and Cultural Affairs of the United States Department of State; National Science Foundation under NSF(National Science Foundation (NSF)); Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource; MRSEC program at the Materials Research Center; International Institute for Nanotechnology (IIN); Keck Foundation(W.M. Keck Foundation); State of Illinois, through the IIN; Goodyear Rubber and Tire Company	The authors gratefully acknowledge support from the National Science Foundation (NSF CMMI-1235355), Airforce Office of Scientific Research (AFOSR FA9550-14-1-0032-P00003) and the National Institute for Standards and Technology Center for Hierarchical Materials Design (NIST CHI MAD (70NANB14H012 Amd 5)). D.W.C. had support from the Ryan Fellowship and the International Institute for Nanotechnology at Northwestern University, the John R Templin Fellowship (maytemplintrustco.nz) and Goodyear Rubber and Tire Company (PO#4510883960 // Agreement 12 - 3/31/15, www.goodyear.com). D.W.C. was supported by a Fulbright Program grant sponsored by the Bureau of Educational and Cultural Affairs of the United States Department of State and administered by the Institute of International Education (https:// www.iie.org). C.M.S. was supported primarily by the National Science Foundation under NSF Award Number EEC-1359004. This work made use of the EPIC, Keck-II, and/or SPID facility(ies) of Northwestern University's NUANCE Center, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF NNCI-1542205); the MRSEC program (NSF DMR-1121262) at the Materials Research Center; the International Institute for Nanotechnology (IIN); the Keck Foundation; and the State of Illinois, through the IIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare that the work was partially funded by Goodyear Rubber and Tire Company. Goodyear (or other funding sources) were not involved in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication.	Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Bhamla MS, 2016, BIORXIV; Bostanabad R, 2016, J MICROSC-OXFORD, V264, P282, DOI 10.1111/jmi.12441; Bostanabad R, 2016, ACTA MATER, V103, P89, DOI 10.1016/j.actamat.2015.09.044; Chasiotis I, 2002, EXP MECH, V42, P51, DOI 10.1007/BF02411051; Collinson DW, 2016, AFM OPTICAL TENSILE; Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934; Santos EC, 2006, INT J MACH TOOL MANU, V46, P1459, DOI 10.1016/j.ijmachtools.2005.09.005; Cram DD, 2016, COMPOSITE PLA ELECT; Dewberry CT, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4922852; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Hwang SH, 2014, ACS NANO, V8, P6739, DOI 10.1021/nn500504s; Ivanova O, 2013, RAPID PROTOTYPING J, V19, P353, DOI 10.1108/RPJ-12-2011-0127; Jiang HQ, 2007, P NATL ACAD SCI USA, V104, P15607, DOI 10.1073/pnas.0702927104; Kammers AD, 2013, EXP MECH, V53, P1743, DOI 10.1007/s11340-013-9782-x; Kim JB, 2012, NAT PHOTONICS, V6, P327, DOI [10.1038/NPHOTON.2012.70, 10.1038/nphoton.2012.70]; Kim P, 2013, ADV OPT MATER, V1, P381, DOI 10.1002/adom.201300034; Koo WH, 2010, NAT PHOTONICS, V4, P222, DOI [10.1038/NPHOTON.2010.7, 10.1038/nphoton.2010.7]; Kuhner F, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2751099; Lee SG, 2010, ADV MATER, V22, P5013, DOI 10.1002/adma.201002320; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Liu Y, 2013, COMPUT AIDED DESIGN, V45, P65, DOI 10.1016/j.cad.2012.03.007; Medhekar NV, 2010, ACS NANO, V4, P2300, DOI 10.1021/nn901934u; Nandy K, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201500666; Thomas AV, 2015, ADV MATER, V27, P3256, DOI 10.1002/adma.201405821; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216; Wood CD, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4024177; Xu HY, 2014, COMP MATER SCI, V85, P206, DOI 10.1016/j.commatsci.2013.12.046; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840	29	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197999	10.1371/journal.pone.0197999	http://dx.doi.org/10.1371/journal.pone.0197999			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813103	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800038
J	Petersen, DR; Saba, LM; Sayin, VI; Papagiannakopoulos, T; Schmidt, EE; Merrill, GF; Orlicky, DJ; Shearn, CT				Petersen, Dennis R.; Saba, Laura M.; Sayin, Volkan I.; Papagiannakopoulos, Thales; Schmidt, Edward E.; Merrill, Gary F.; Orlicky, David J.; Shearn, Colin T.			Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; REACTIVE ALDEHYDES; LIPID-PEROXIDATION; HEPATIC STEATOSIS; TUMOR-SUPPRESSOR; HEME OXYGENASE-1; DEFICIENT MICE; MURINE MODEL	Objective In the liver, a contributing factor in the pathogenesis of non-alcoholic fatty liver disease (NASH) is oxidative stress, which leads to the accumulation of highly reactive electrophilic a/I3 unsaturated aldehydes. The objective of this study was to determine the impact of NASH on protein carbonylation and antioxidant responses in a murine model. Methods Liver-specific phosphatase and tensin homolog (PTEN)-deletion mice (PTENLKO) or control littermates were fed a standard chow diet for 45-55 weeks followed by analysis for liver injury, oxidative stress and inflammation. Results Histology and Picrosirius red-staining of collagen deposition within the extracellular matrix revealed extensive steatosis and fibrosis in the PTENLKO mice but no steatosis or fibrosis in controls. Increased steatosis and fibrosis corresponded with significant increases in inflammation. PTEN-deficient livers showed significantly increased cell-specific oxidative damage, as detected by 4-hydroxy-2-nonenal (4-HNE) and acrolein staining. Elevated staining correlated with an increase in nuclear DNA repair foci (yH2A.X) and cellular proliferation index (Ki67) within zones 1 and 3, indicating oxidative damage was zonally restricted and was associated with increased DNA damage and cell proliferation. Immunoblots showed that total levels of antioxidant response proteins induced by nuclear factor erythroid-2-like-2 (Nrf2), including GST mu, GSTrr and CBR1/3, but not HO-1, were elevated in PTENLKO as compared to controls, and IHC showed this response also occurred only in zones 1 and 3. Furthermore, an analysis of autophagy markers revealed significant elevation of p62 and LC3II expression. Mass spectrometric (MS) analysis identified significantly more carbonylated proteins in whole cell extracts prepared from PTENLKO mice (966) as compared to controls (809). Pathway analyses of identified proteins did not uncover specific pathways that were preferentially carbonylated in PTENLKO livers but, did reveal specific strongly increased carbonylation of thioredoxin reductase and of glutathione-S-transferases (GST) M6, O1, and O2. Conclusions Results show that disruption of PTEN resulted in steatohepatitis, fibrosis and caused hepatic induction of the Nrf2-dependent antioxidant system at least in part due to elevation of p62. This response was both cell-type and zone specific. However, these responses were insufficient to mitigate the accumulation of products of lipid peroxidation.	[Petersen, Dennis R.; Saba, Laura M.; Shearn, Colin T.] Univ Colorado, Sch Pharm, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA; [Sayin, Volkan I.; Papagiannakopoulos, Thales] NYU, Sch Med, Dept Pathol, New York, NY USA; [Sayin, Volkan I.; Papagiannakopoulos, Thales] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY USA; [Schmidt, Edward E.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Merrill, Gary F.] Oregon State Univ, Dept Biochem & Biophys, Corvalis, OR USA; [Orlicky, David J.] Univ Colorado, Sch Med, Dept Pathol, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; New York University; New York University; Montana State University System; Montana State University Bozeman; Oregon State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Shearn, CT (corresponding author), Univ Colorado, Sch Pharm, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	colin.shearn@ucdenver.edu	Saba, Laura/R-9533-2018	Saba, Laura/0000-0001-9649-1294; Shearn, Colin/0000-0002-9618-9885; Orlicky, David/0000-0002-0417-1400	National Institutes of Health Institute of Alcohol Abuse and Alcoholism (NIAAA) [5R37 AA009300-22, F32 AA018613-03]; National Cancer Institute [R01CA154986-01, R01CA215784]; National Institute of Aging [R21AG055022]; NATIONAL CANCER INSTITUTE [R01CA154986, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG055022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018613] Funding Source: NIH RePORTER	National Institutes of Health Institute of Alcohol Abuse and Alcoholism (NIAAA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded by a grant from the National Institutes of Health Institute of Alcohol Abuse and Alcoholism (NIAAA) 5R37 AA009300-22 (To D.R.P.), F32 AA018613-03 (To C.T.S), National Cancer Institute R01CA154986-01 (To B. L.S.), R01CA215784 (To E.E.S.), and National Institute of Aging R21AG055022 (To E.E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; Alexander KJ, 2018, CHEM-EUR J, V24, P3013, DOI 10.1002/chem.201705541; Aroor AR, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-29; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakhautdin B, 2014, J HEPATOL, V61, P1029, DOI 10.1016/j.jhep.2014.06.007; Bankoglu EE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166956; Bartolini D, 2018, TRANSL RES, V193, P54, DOI 10.1016/j.trsl.2017.11.007; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cebula M, 2015, ANTIOXID REDOX SIGN, V23, P823, DOI 10.1089/ars.2015.6378; Chang J, 2013, AM J PHYSIOL-RENAL, V304, pF348, DOI 10.1152/ajprenal.00568.2012; Chen WY, 2016, CELL MOL GASTROENTER, V2, P685, DOI 10.1016/j.jcmgh.2016.05.010; Doorn JA, 2004, BIOCHEMISTRY-US, V43, DOI [10.1021/bi049136q, DOI 10.1021/BIO49136Q]; Doycheva I, 2018, J CLIN GASTROENTEROL, V52, P339, DOI 10.1097/MCG.0000000000000925; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ebert B, 2010, BIOCHEMISTRY-US, V49, P8499, DOI 10.1021/bi100814d; Eckl PM, 2017, FREE RADICAL BIO MED, V111, P244, DOI 10.1016/j.freeradbiomed.2017.02.002; Eckl Peter M., 2003, Molecular Aspects of Medicine, V24, P161, DOI 10.1016/S0098-2997(03)00010-4; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; Galligan JJ, 2012, CHEM RES TOXICOL, V25, P1012, DOI 10.1021/tx300002q; Hashemi M, 2012, DNA CELL BIOL, V31, P672, DOI 10.1089/dna.2011.1343; He LN, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0045-1; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; Jeon S, 2014, MOL NUTR FOOD RES, V58, P830, DOI 10.1002/mnfr.201300112; Kanehisa M, 2017, METHODS MOL BIOL, V1611, P135, DOI 10.1007/978-1-4939-7015-5_11; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee HW, 2015, ONCOTARGET, V6, P33226, DOI 10.18632/oncotarget.5429; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; Li B, 2016, IRISH J MED SCI, V185, P93, DOI 10.1007/s11845-014-1226-9; Liu B, 2015, INT J CLIN EXP MED, V8, P19867; Liu L, 2017, ONCOTARGET, V8, P57707, DOI 10.18632/oncotarget.17202; Liu L, 2015, ENVIRON TOXICOL PHAR, V39, P229, DOI 10.1016/j.etap.2014.11.029; Luo ZL, 2014, J GASTROEN HEPATOL, V29, P215, DOI 10.1111/jgh.12389; Macdonald GA, 2001, J GASTROEN HEPATOL, V16, P599, DOI 10.1046/j.1440-1746.2001.02445.x; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Malaguarnera L, 2005, J HEPATOL, V42, P585, DOI 10.1016/j.jhep.2004.11.040; Martina HJ, 2011, CHEM-BIOL INTERACT, V191, P48, DOI 10.1016/j.cbi.2010.12.006; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Niu YN, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4313204; Nobili V, 2010, INT J MOL MED, V26, P471, DOI 10.3892/ijmm_00000487; Osna NA, 2016, WORLD J GASTROENTERO, V22, P6192, DOI 10.3748/wjg.v22.i27.6192; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ramadori P, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3420286; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P2498, DOI 10.1089/ars.2014.5843; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Saba LM, 2015, FEBS J, V282, P3556, DOI 10.1111/febs.13358; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Schaupp CM, 2015, CHEM-BIOL INTERACT, V234, P154, DOI 10.1016/j.cbi.2014.11.010; Shearn CT, 2015, FREE RADICAL BIO MED, V89, P1144, DOI 10.1016/j.freeradbiomed.2015.10.420; Shearn CT, 2013, FREE RADICAL BIO MED, V65, P680, DOI 10.1016/j.freeradbiomed.2013.07.011; Shearn CT, 2011, BIOCHEMISTRY-US, V50, P3984, DOI 10.1021/bi200029w; Shearn CT, 2017, FREE RADICAL BIO MED, V113, P280, DOI 10.1016/j.freeradbiomed.2017.10.004; Shearn CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154152; Shearn CT, 2016, REDOX BIOL, V7, P68, DOI 10.1016/j.redox.2015.11.013; Shearn CT, 2014, J BIOL CHEM, V289, P15449, DOI 10.1074/jbc.M113.543942; Shearn CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096553; Shearn CT, 2013, J NUTR BIOCHEM, V24, P1436, DOI 10.1016/j.jnutbio.2012.12.002; Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P519, DOI 10.1089/ars.2016.6776; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Origassa CST, 2013, WORLD J HEPATOL, V5, P541, DOI 10.4254/wjh.v5.i10.541; Taguchi K, 2014, MOL CELL BIOL, V34, P900, DOI 10.1128/MCB.01384-13; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Valle A, 2012, LIVER INT, V32, P951, DOI 10.1111/j.1478-3231.2012.02765.x; Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026; Watanabe S, 2007, J GASTROEN HEPATOL, V22, pS96, DOI 10.1111/j.1440-1746.2006.04665.x	75	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0198139	10.1371/journal.pone.0198139	http://dx.doi.org/10.1371/journal.pone.0198139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799837	gold, Green Submitted, Green Published			2022-12-26	WOS:000433153400039
J	Bargali, HS; Ahmed, T				Bargali, Harendra Singh; Ahmed, Tanveer			Patterns of livestock depredation by tiger (Panthera tigris) and leopard (Panthera pardus) in and around Corbett Tiger Reserve, Uttarakhand, India	PLOS ONE			English	Article							PROTECTED AREAS; PREY SELECTION; NATIONAL-PARK; CONSERVATION; MANAGEMENT; CONFLICT; BIODIVERSITY; PERSPECTIVES; PERCEPTIONS; CARNIVORES	India with estimated more than 2000 tigers (across 18 states) accounts for more than half of the remaining tigers across its range countries. Long-term conservation requires measures to protect the large carnivores and its prey base beyond the Protect Areas. The Corbett Tiger Reserve (CTR) and adjoining forest divisions with high density of tigers play a crucial role in conservation of tiger in Uttarakhand state as well as the Terai-Arc Landscape. However, CTR is surrounded with multiple-use forest (forest divisions), agriculture land, human habitation, townships and developmental projects. The movement of large carnivores and other wildlife through such habitats adds to the chances of human-wildlife conflict. The aim of the current study was to understand the patterns of livestock depredation by tigers and leopards in and around CTR. We examined a total of 8365 incidents of livestock depredation between 2006 and 2015 with tigers killing more livestock in a year (573.3 +/- 41.2) than leopards (263.2 +/- 9.9). Geographically, in north zone of CTR leopards were the major livestock predator (166.6 +/- 1 1), whereas tigers (547.7 +/- 40.1) in south zone. Examination of livestock kills indicated cows (75%) as the main victim, followed by buffaloes and other species. Analysis revealed that the livestock depredation by tigers varied significantly among seasons in south zone but not in north zone. However, such an explicit seasonal variation was not observed for leopards in north and south zone of CTR. Hotspots of livestock predation were identified around CTR. Addressing a conflict situation in a time-bound manner, timely disbursement of ex-gratia payment, involving locals at various tourism related activities and consistent rapport building initiatives are required to mitigate the human-wildlife conflict.	[Bargali, Harendra Singh; Ahmed, Tanveer] Corbett Fdn, Ramnagar, Uttarakhand, India; [Ahmed, Tanveer] Aligarh Muslim Univ, Dept Wildlife Sci, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Bargali, HS (corresponding author), Corbett Fdn, Ramnagar, Uttarakhand, India.	hsbargali@gmail.com	Ahmed, Tanveer/AFK-1392-2022	Ahmed, Tanveer/0000-0002-7690-4300	Corbett Foundation; WWF-India	Corbett Foundation; WWF-India	The information on livestock depredation was collected under a collaborative project jointly funded by The Corbett Foundation and WWF-India.	Ahmed Rahim Ali, 2012, World Journal of Zoology, V7, P158; [Anonymous], 2008, CONS AR SER ZOOL SUR, V35, P1; Bagchi S, 2003, J ZOOL, V260, P285, DOI 10.1017/S0952836903003765; Bargali H. S., 2014, Indian Forester, V140, P224; Barua M, 2013, BIOL CONSERV, V157, P309, DOI 10.1016/j.biocon.2012.07.014; Biswas S, 2002, J ZOOL, V256, P411, DOI 10.1017/S0952836902000456; Bruyere B, 2009, ENVIRON MANAGE, V43, P49, DOI 10.1007/s00267-008-9190-7; Champion H. G., 1968, REVISED SURVEY FORES, P404; Chan KMA, 2007, CONSERV BIOL, V21, P59, DOI 10.1111/j.1523-1739.2006.00570.x; Chhatre A, 2005, CONSERV BIOL, V19, P310, DOI 10.1111/j.1523-1739.2005.00012.x; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Dinerstein E, 2006, SETTING PRIORITIES C; Dinerstein E, 1997, FRAMEWORK IDENTIFY 1; Government of India, 2014, STAT DENS CHANG FOR; Hayward MW, 2012, J ZOOL, V286, P221, DOI 10.1111/j.1469-7998.2011.00871.x; Hemmer H., 1987, P28; Herrington S.J., 1987, P51; Hussain A, 2016, ENVIRON DEV SUSTAIN, V18, P57, DOI 10.1007/s10668-015-9621-6; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jhala Y.V., 2011, STATUS TIGERS COPRED, P302; Jhala Y. V., 2014, STATUS TIGERS COPRED; Johnsingh AJT, 2006, AMBIO, V35, P135, DOI 10.1579/0044-7447(2006)35[135:SACOTT]2.0.CO;2; Karanth K.U., 2005, ECON POLIT WEEKLY, V40, P4803; Karanth KK, 2008, BIOL CONSERV, V141, P2357, DOI 10.1016/j.biocon.2008.06.027; Karanth KK, 2010, BIOL CONSERV, V143, P2865, DOI 10.1016/j.biocon.2010.05.002; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Kitchener AC, 2000, ANIM CONSERV, V3, P113, DOI 10.1111/j.1469-1795.2000.tb00236.x; Kumaraguru A, 2011, EUR J WILDLIFE RES, V57, P627, DOI 10.1007/s10344-010-0473-y; Kutty R., 2001, PROTECTED AREAS INDI; Lamichhane Saneer, 2015, Journal of Threatened Taxa, V7, P8081; Ludwig D, 2001, ANNU REV ECOL SYST, V32, P481, DOI 10.1146/annurev.ecolsys.32.081501.114116; Macdonald David W., 2010, P3; Madhusudan MD, 2003, ENVIRON MANAGE, V31, P466, DOI 10.1007/s00267-002-2790-8; Maikhuri RK, 2000, ENVIRON CONSERV, V27, P43, DOI 10.1017/S0376892900000060; MAZAK V, 1981, Mammalian Species, P1, DOI 10.2307/3504004; Miller TR, 2011, BIOL CONSERV, V144, P948, DOI 10.1016/j.biocon.2010.04.001; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; MUHAMMED N., 2007, J SOCIAL RES DEV, V4, P86; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Negi CS, 2003, INT J SUST DEV WORLD, V10, P169, DOI 10.1080/13504500309469795; Nyhus PJ, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P125, DOI 10.1016/B978-0-8155-1570-8.00008-6; Patterson BD, 2004, BIOL CONSERV, V119, P507, DOI 10.1016/j.biocon.2004.01.013; Rastogi A, 2014, SOC NATUR RESOUR, V27, P1271, DOI 10.1080/08941920.2014.917753; Rastogi A, 2014, ENVIRON MANAGE, V53, P913, DOI 10.1007/s00267-014-0248-4; Rastogi A, 2013, BIOL CONSERV, V161, P182, DOI 10.1016/j.biocon.2013.03.013; Rastogi A, 2012, J ENVIRON MANAGE, V113, P328, DOI 10.1016/j.jenvman.2012.10.003; Rastogi A, 2010, BIOL CONSERV, V143, P2956, DOI 10.1016/j.biocon.2010.04.039; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Sanderson E., 2006, SETTING PRIORITIES C; Shahabuddin G., 2007, MAKING CONSERVATION; Swanepoel LH, 2015, ORYX, V49, P595, DOI 10.1017/S0030605313001282; Terborgh J, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P307; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; TTF, 2005, PROJECT TIGER; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; WWF, 2000, WWF GLOB TIG CONS ST	58	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0195612	10.1371/journal.pone.0195612	http://dx.doi.org/10.1371/journal.pone.0195612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795557	Green Submitted, gold, Green Published			2022-12-26	WOS:000433084300002
J	Hurtado, A; Real, FM; Palomino, R; Carmona, FD; Burgos, M; Jimenez, R; Barrionuevo, FJ				Hurtado, Alicia; Real, Francisca M.; Palomino, Rogelio; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.			Sertoli cell-specific ablation of miR-17-92 cluster significantly alters whole testis transcriptome without apparent phenotypic effects	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; STEM-CELLS; DELETION	MicroRNAs are frequently organized into polycistronic clusters whose transcription is controlled by a single promoter. The miR-17-92 cluster is expressed in most embryonic and postnatal organs. It is a potent oncogene associated to several types of cancer and it is involved in several important developmental processes. In the testis, expression of the miR-17-92 cluster in the germ cells is necessary to maintain normal spermatogenesis. This cluster is also expressed in Sertoli cells (the somatic cells of the seminiferous tubules), which require miRNAs for correct cell development and survival. To study the possible role of miR-17-92 in Sertoli cell development and function and, in order to overcome the postnatal lethality of miR-17-92(-/) mice, we conditionally deleted it in embryonic Sertoli cells shortly after the sex determination stage using an Amh-Cre allele. Mutant mice developed apparently normal testes and were fertile, but their testis transcriptomes contained hundreds of moderately deregulated genes, indicating that testis homeostasis is tightly controlled in mammals and that miR-17-92 expression in Sertoli cells contribute to maintain normal gene expression levels, but is unnecessary for testis development and function. Our results show that significant deregulation of hundreds of genes might have no functional consequences.	[Hurtado, Alicia; Real, Francisca M.; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.] Univ Granada, Dept Genet, Granada, Spain; [Hurtado, Alicia; Real, Francisca M.; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.] Univ Granada, Ctr Invest Biomed, Inst Biotecnol, Granada, Spain; [Palomino, Rogelio] Univ Granada, Dept Bioquim & Biol Mol 1, Granada, Spain; [Palomino, Rogelio] Univ Granada, Ctr Invest Biomed, Inst Invest Biosanitaria Granada, Granada, Spain; [Real, Francisca M.] Max Planck Inst Mol Genet, Berlin, Germany	University of Granada; University of Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Max Planck Society	Jimenez, R; Barrionuevo, FJ (corresponding author), Univ Granada, Dept Genet, Granada, Spain.; Jimenez, R; Barrionuevo, FJ (corresponding author), Univ Granada, Ctr Invest Biomed, Inst Biotecnol, Granada, Spain.	rjimenez@ugr.es; fjbarrio@ugr.es	Real, Francisca Martinez/AAT-5849-2020; Barrionuevo, Francisco/AAA-7639-2019; Jiménez, Rafael/J-4103-2012; Jiménez, Rafael/AAQ-3775-2021; Carmona, F. David/F-9953-2016; Palomino-Morales, Rogelio J/L-5720-2014; Burgos, Miguel/L-3709-2014	Barrionuevo, Francisco/0000-0003-2651-1530; Jiménez, Rafael/0000-0003-4103-8219; Jiménez, Rafael/0000-0003-4103-8219; Carmona, F. David/0000-0002-1427-7639; Palomino-Morales, Rogelio J/0000-0003-3507-343X; Burgos, Miguel/0000-0003-4446-9313; Martinez Real, Francisca/0000-0003-0692-2260	Andalusian Government, Junta de Andalucia from the Spanish Ministry of Science and Innovation [B10-109, P11-CVI-7291, CGL2011-23368, CGL2015-67108-P]; Spanish Ministry of Science and Innovation [RYC-2014-16458]; Spanish Ministry of Science and Innovation	Andalusian Government, Junta de Andalucia from the Spanish Ministry of Science and Innovation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Andalusian Government, Junta de Andalucia, BIO-109 to R. Jimenez and P11-CVI-7291 to M. Burgos and grants from the Spanish Ministry of Science and Innovation (CGL2011-23368 and CGL2015-67108-P) to R. Jimenez and F.J. Barrionuevo. The authors would like to thank the Spanish Ministry of Science and Innovation for the "Ramon y Cajal" fellowship granted to F.D. Carmona (RYC-2014-16458) and the "FPU" PhD fellowship granted to A. Hurtado.	Barrionuevo FJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15635; Bian S, 2013, CELL REP, V3, P1398, DOI 10.1016/j.celrep.2013.03.037; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Cui Y, 2016, BIOINFORMATICS, V32, P1740, DOI 10.1093/bioinformatics/btw041; Dadhich RK, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106708; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Han YC, 2015, NAT GENET, V47, P766, DOI 10.1038/ng.3321; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; KOPERA IA, 2010, BIOL SCI, V365, P1593, DOI DOI 10.1098/RSTB.2009.0251; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Ortogero N, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.102269; Panneerdoss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041146; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; RICHARDSON LL, 1995, BIOL REPROD, V52, P320, DOI 10.1095/biolreprod52.2.320; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sekido R, 2013, SEX DEV, V7, P21, DOI 10.1159/000342221; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vogl AW, 2008, MOL MECH SPERMATOGEN, VXVII; Wang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003785; Wang X, 2013, TRANSPORT RES REC, P10, DOI 10.3141/2382-02; Xie RY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002713; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zhou YJ, 2016, J CELL MOL MED, V20, P939, DOI 10.1111/jcmm.12782	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197685	10.1371/journal.pone.0197685	http://dx.doi.org/10.1371/journal.pone.0197685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795630	gold, Green Published, Green Submitted			2022-12-26	WOS:000433084300060
J	Iwama, H; Kato, K; Imachi, H; Murao, K; Masaki, T				Iwama, Hisakazu; Kato, Kiyohito; Imachi, Hitomi; Murao, Koji; Masaki, Tsutomu			Human microRNAs preferentially target genes with intermediate levels of expression and its formation by mammalian evolution	PLOS ONE			English	Article							ANIMAL MICRORNAS; RECOGNITION; IMPACT; ATLAS; BIRTH	MicroRNAs (miRNAs) are short, endogenous RNAs that post-transcriptionally repress mRNAs. Over the course of evolution, many new miRNAs are known to have emerged and added to the existing miRNA repertoires of drosophilids and vertebrates. Despite the large number of miRNAs in existence, the complementary pairing of only similar to 7 bases between miRNAs and mRNAs is sufficient to induce repression. Thus, miRNA targeting is so widespread that genes coexpressed with a miRNA have evolved to avoid sites that are targeted by the miRNA. Besides this avoidance, little is known about the preferential modes of miRNA targeting. Therefore, to elucidate miRNA targeting preference and avoidance, we evaluated the bias of the number of miRNA targeting occurrences in relation to expression intensities of miRNAs and their coexpressed target mRNAs by surveying transcriptome data from human organs. We found that miRNAs preferentially target genes with intermediate levels of expression, while avoiding highly expressed ones, and that older miRNAs have greater targeting specificity, suggesting that specificity increases during the course of evolution.	[Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa, Japan; [Kato, Kiyohito; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Miki, Kagawa, Japan; [Imachi, Hitomi; Murao, Koji] Kagawa Univ, Dept Endocrinol & Metab, Fac Med, Miki, Kagawa, Japan	Kagawa University; Kagawa University; Kagawa University	Iwama, H (corresponding author), Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa, Japan.	iwama@med.kagawa-u.ac.jp		Murao, Koji/0000-0002-7335-7196	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS) [26440197]	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (grant number: 26440197) from the Japan Society for the Promotion of Science (JSPS) to H. Iwama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI (grant number: 26440197) from the Japan Society for the Promotion of Science (JSPS).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Iwama H, 2013, MOL BIOL EVOL, V30, P613, DOI 10.1093/molbev/mss262; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; McJunkin K, 2017, GENE DEV, V31, P422, DOI 10.1101/gad.290155.116; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198142	10.1371/journal.pone.0198142	http://dx.doi.org/10.1371/journal.pone.0198142			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795674	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300129
J	Kotkowiak, W; Czapik, T; Pasternak, A				Kotkowiak, Weronika; Czapik, Tomasz; Pasternak, Anna			Novel isoguanine derivative of unlocked nucleic acid-Investigations of thermodynamics and biological potential of modified thrombin binding aptamer	PLOS ONE			English	Article							DNA APTAMER; RNA DUPLEXES; 4-THIOURIDINE; SPECTRA	Thrombin binding aptamer (TBA), is a short DNA 15-mer that forms G-quadruplex structure and possesses anticoagulant properties. Some chemical modifications, including unlocked nucleic acids (UNA), 2'-deoxy-isoguanosine and 2'-deoxy-4-thiouridine were previously found to enhance the biological activity of TBA. In this paper, we present thermodynamic and biological characteristics of TBA variants that have been modified with novel isoguanine derivative of UNA as well as isoguanosine. Additionally, UNA-4-thiouracil and 4-thiouridine were also introduced simultaneously with isoguanine derivatives. Thermodynamic analysis indicates that the presence of isoguanosine in UNA or RNA series significantly decreases the stability of G-quadruplex structure. The highest destabilization is observed for substitution at one of the G-tetrad position. Addition of 4-thiouridine in UNA or RNA series usually decreases the unfavorable energetic cost of the presence of UNA or RNA isoguanine. Circular dichroism and thermal denaturation spectra in connection with thrombin time assay indicate that the introduction of UNA-isoguanine or isoguanosine into TBA negatively affects G-quadruplex folding and TBA anticoagulant properties. These findings demonstrate that the highly-ordered structure of TBA is essential for inhibition of thrombin activity.	[Kotkowiak, Weronika; Pasternak, Anna] Polish Acad Sci, Inst Bioorgan Chem, Dept Nucle Acids Bioengn, Poznan, Poland; [Czapik, Tomasz] Polish Acad Sci, Inst Bioorgan Chem, Dept Struct Chem & Biol Nucle Acids, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Pasternak, A (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Dept Nucle Acids Bioengn, Poznan, Poland.	apa@ibch.poznan.pl	Pasternak, Anna/H-9411-2013; Czapik, Tomasz/GVU-2363-2022; Czapik, Tomasz/AAM-7961-2020	Czapik, Tomasz/0000-0002-8124-1003; Czapik, Tomasz/0000-0002-8124-1003; Pasternak, Anna/0000-0002-9666-4148; Kotkowiak, Weronika/0000-0002-9776-0924	Polish Ministry of Science and Higher Education under the KNOW program; Polish National Science Center [UMO-2013/10/E/NZ1/00741, UMO-2017/25/B/NZ7/00127, UMO-2015/19/N/NZ5/02246]	Polish Ministry of Science and Higher Education under the KNOW program(Ministry of Science and Higher Education, Poland); Polish National Science Center	This publication was supported by the Polish Ministry of Science and Higher Education, under the KNOW program and by Polish National Science Center grant UMO-2013/10/E/NZ1/00741 and UMO-2017/25/B/NZ7/00127 to AP and UMO-2015/19/N/NZ5/02246 to WK. The funders had no role in study design, data collection and analysis,	Ahrens I, 2012, DISCOV MED, V13, P445; Amin A, 2013, CLIN INTERV AGING, V8, P75, DOI 10.2147/CIA.S37818; Avino A, 2014, FEBS J, V281, P1085, DOI 10.1111/febs.12670; Avino A, 2012, CURR PHARM DESIGN, V18, P2036, DOI 10.2174/138161212799958387; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Borer P. N., 1975, CRC HDB BIOCH MOL BI, V1, P589; Collins ML, 1997, NUCLEIC ACIDS RES, V25, P2979, DOI 10.1093/nar/25.15.2979; Fareed J, 2008, SEMIN THROMB HEMOST, V34, P58, DOI 10.1055/s-2008-1066025; Herrera S, 2011, TECH VASC INTERV RAD, V14, P58, DOI 10.1053/j.tvir.2011.01.002; Hirao I, 2006, CURR OPIN CHEM BIOL, V10, P622, DOI 10.1016/j.cbpa.2006.09.021; Kotkowiak W, 2018, MOL THER-NUCL ACIDS, V10, P304, DOI 10.1016/j.omtn.2017.12.013; Kotkowiak W, 2014, BIOCHEM J, V464, P203, DOI 10.1042/BJ20141023; KRAWCZYK SH, 1995, NUCLEOS NUCLEOT NUCL, V14, P1109, DOI 10.1080/15257779508012546; Langkjaer N, 2009, BIOORGAN MED CHEM, V17, P5420, DOI 10.1016/j.bmc.2009.06.045; Liu YC, 2012, J BIOL CHEM, V287, P36683, DOI 10.1074/jbc.M112.405688; Lopez-Gomollon S, 2013, METHOD ENZYMOL, V529, P65, DOI 10.1016/B978-0-12-418687-3.00006-9; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; MCBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245, DOI 10.1016/S0040-4039(00)81376-3; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Nagatoishi S, 2011, BIOCHIMIE, V93, P1231, DOI 10.1016/j.biochi.2011.03.013; Nallagatla SR, 2009, J COMB CHEM, V11, P364, DOI 10.1021/cc800178m; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Pasternak A, 2011, NUCLEIC ACIDS RES, V39, P1155, DOI 10.1093/nar/gkq823; Pasternak A, 2010, NUCLEIC ACIDS RES, V38, P6697, DOI 10.1093/nar/gkq561; Raviv SM, 2008, J THROMB HAEMOST, V6, P1764, DOI 10.1111/j.1538-7836.2008.03106.x; Roberts C, 1997, CHEM BIOL, V4, P899, DOI 10.1016/S1074-5521(97)90298-2; Roberts C, 1997, J AM CHEM SOC, V119, P4640, DOI 10.1021/ja970123s; Russo Krauss I, 2012, NUCLEIC ACIDS RES, V40, P8119, DOI 10.1093/nar/gks512; SantaLucia J., 2000, SPECTROPHOTOMETRY SP, P329; Schmid K, 2017, BIOCONJUGATE CHEM, V28, P1123, DOI 10.1021/acs.bioconjchem.7b00035; Tatarinova O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089383; Testa SM, 1999, BIOCHEMISTRY-US, V38, P16655, DOI 10.1021/bi991187d; Tothova P, 2014, BIOCHEMISTRY-US, V53, P7013, DOI 10.1021/bi500773c; Tsvetkov V, 2015, SCI REPORTS, V5, p1 ; Virgilio A, 2015, NUCLEIC ACIDS RES, V43, P10602, DOI 10.1093/nar/gkv1224; Zavyalova E, 2016, NUCLEIC ACID THER, V26, P299, DOI 10.1089/nat.2016.0606; Zeng XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24065	38	8	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197835	10.1371/journal.pone.0197835	http://dx.doi.org/10.1371/journal.pone.0197835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795635	gold, Green Submitted, Green Published			2022-12-26	WOS:000433084300076
J	Moran, A; Soriano, MC				Moran, Alejandro; Soriano, Miguel C.			Improving the quality of a collective signal in a consumer EEG headset	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; NEURAL SYNCHRONY; BRAIN; MAGNETOENCEPHALOGRAPHY; ATTENTION; COMPONENTS	This work focuses on the experimental data analysis of electroencephalography (EEG) data, in which multiple sensors are recording oscillatory voltage time series. The EEG data analyzed in this manuscript has been acquired using a low-cost commercial headset, the Emotiv EPOC+. Our goal is to compare different techniques for the optimal estimation of collective rhythms from EEG data. To this end, a traditional method such as the principal component analysis (PCA) is compared to more recent approaches to extract a collective rhythm from phase-synchronized data. Here, we extend the work by Schwabedal and Kantz (PRL 116, 104101 (2016)) evaluating the performance of the Kosambi-Hilbert torsion (KHT) method to extract a collective rhythm from multivariate oscillatory time series and compare it to results obtained from PCA. The KHT method takes advantage of the singular value decomposition algorithm and accounts for possible phase lags among different time series and allows to focus the analysis on a specific spectral band, optimally amplifying the signal-to-noise ratio of a common rhythm. We evaluate the performance of these methods for two particular sets of data: EEG data recorded with closed eyes and EEG data recorded while observing a screen flickering at 15 Hz. We found an improvement in the signal-to-noise ratio of the collective signal for the KHT over the PCA, particularly when random temporal shifts are added to the channels.	[Moran, Alejandro; Soriano, Miguel C.] UIB, IFISC, CSIC, Campus Univ Illes Balears, Palma De Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Soriano, MC (corresponding author), UIB, IFISC, CSIC, Campus Univ Illes Balears, Palma De Mallorca, Spain.	miguel@ifisc.uib-csic.es	Soriano, Miguel C./D-8480-2011; Costoya, Alejandro Morán/ABH-2443-2020	Soriano, Miguel C./0000-0002-6140-8451; Costoya, Alejandro Morán/0000-0001-7628-0019	Spanish Ministerio de Economia, Industria y Competitividad through a Ramon y Cajal Fellowship [RYC-2015-18140, TEC2016-80063-C3]	Spanish Ministerio de Economia, Industria y Competitividad through a Ramon y Cajal Fellowship	This work has been supported by the Spanish Ministerio de Economia, Industria y Competitividad through a Ramon y Cajal Fellowship (RYC-2015-18140 to Miguel C. Soriano and TEC2016-80063-C3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, PHASER IMPLEMENTATIO; [Anonymous], 2016, KHT IMPLEMENTATION; [Anonymous], 2005, BASIC PRINC CLIN APP; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Baillet S, 2017, NAT NEUROSCI, V20, P327, DOI 10.1038/nn.4504; Bobrov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020674; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Crocker L, 1986, INTRO CLASSICAL MODE; Curran EA, 2003, BRAIN COGNITION, V51, P326, DOI 10.1016/S0278-2626(03)00036-8; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; de Tommaso M, 2005, INT J PSYCHOPHYSIOL, V57, P203, DOI 10.1016/j.ijpsycho.2005.02.002; Duvinage M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-56; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Harmony T, 1999, NEUROSCI LETT, V266, P25, DOI 10.1016/S0304-3940(99)00244-X; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hyvarinen A, 2004, INDEPENDENT COMPONEN, V46; KLEMA VC, 1980, IEEE T AUTOMAT CONTR, V25, P164, DOI 10.1109/TAC.1980.1102314; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kralemann B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.055201; Kralemann B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066205; Li GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154492; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lugger K, 1998, MED BIOL ENG COMPUT, V36, P309, DOI 10.1007/BF02522476; Martinez-Leon JA, 2016, EXPERT SYST APPL, V49, P136, DOI 10.1016/j.eswa.2015.11.015; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Picinbono B, 1997, IEEE T SIGNAL PROCES, V45, P552, DOI 10.1109/78.558469; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pouryazdian S., 2009, 11th International Congress of the IUPESM. Medical Physics and Biomedical Engineering. World Congress 2009. Neuroengineering, Neural Systems, Rehabilitation and Prosthetics, P480, DOI 10.1007/978-3-642-03889-1_128; Prause N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165646; Ramaswamy R. D. D., 2017, KOSAMBI SELECTED WOR; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Revzen S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051907; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schwabedar JTC, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.104101; Shlens J., 2005, TUTORIAL PRINCIPAL C; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Stam CJ, 2003, HUM BRAIN MAPP, V19, P63, DOI 10.1002/hbm.10106; Stopczynski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086733; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tatum WO, 2007, SPRINGER DEMOS MEDIC; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550	47	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197597	10.1371/journal.pone.0197597	http://dx.doi.org/10.1371/journal.pone.0197597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795611	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300055
J	Hanisch, FG; Hansman, GS; Morozov, V; Kunz, C; Schroten, H				Hanisch, Franz-Georg; Hansman, Grant S.; Morozov, Vasily; Kunz, Clemens; Schroten, Horst			Avidity of alpha-fucose on human milk oligosaccharides and blood group-unrelated oligo/polyfucoses is essential for potent norovirus-binding targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus; carbohydrate-binding protein; glycobiology; oligosaccharide; innate immunity; anti-viral protection; food additive; human blood group antigen; milk oligosaccharide; norovirus	GROUP ANTIGENS; HELICOBACTER-PYLORI; INFECTION; GASTROENTERITIS; NOMENCLATURE; INHIBITION; DISCOVERY	There is agreement with respect to norovirus infection routes in humans regarding binding of the pathogen to gastrointestinal epithelia via recognition of blood group-active mucin-typeO-glycans as the initiating and essential event. Among food additives playing a potential role in applications to protect newborns, human milk oligosaccharides (HMOs) as competitors are of major importance. By focusing on fractions of high-molecular mass HMOs with high fucose contents, we attempted to identify the structural elements required for norovirus GII.4 (Sydney 2012, JX459908) capsid binding in neoglycolipid-based arrays. We provide evidence that HMO fractions with the strongest binding capacities contained hepta- to decasaccharides expressing branches with terminal blood group H1 or Lewis-b antigen. H2 antigen, as recognized by UEA-I lectin, is apparently not expressed in high-mass HMOs. Beyond affinity, sterical and valency effects contribute more to virus-like particle binding, as revealed for oligovalent fucose conjugates of alpha-cyclodextrin and oligofucoses from fucoidan. Accordingly, high-mass HMOs with oligovalent fucose can exhibit stronger binding capacities compared with monovalent fucose HMOs. The above features were revealed for the most clinically relevant and prevalent GII.4 strain and are distinct from other strains, like GII.10 (Vietnam 026, AF504671), which showed a preference for blood group Lewis-a positive glycans.	[Hanisch, Franz-Georg] Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany; [Hansman, Grant S.; Morozov, Vasily] Heidelberg Univ, Schaller Res Grp, Neuenheimer Feld 242, D-69120 Heidelberg, Germany; [Hansman, Grant S.; Morozov, Vasily] DKFZ, Neuenheimer Feld 242, D-69120 Heidelberg, Germany; [Hansman, Grant S.; Morozov, Vasily] Heidelberg Univ, Dept Infect Dis, Virol, Neuenheimer Feld 242, D-69120 Heidelberg, Germany; [Morozov, Vasily; Schroten, Horst] Univ Childrens Hosp Mannheim, Pediat Infect Dis Unit, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Kunz, Clemens] Univ Giessen, Inst Nutr Sci, Wilhelmstr 20, D-35392 Giessen, Germany	University of Cologne; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen	Hanisch, FG (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	franz.hanisch@uni-koeln.de		Hansman, Grant/0000-0001-8735-4618	CHS Foundation; Helmholtz-Chinese Academy of Sciences [HCJRG-202]; Deutsche Forschungsgemeinschaft (DFG) [FOR2327]; Koln-Fortune Programme	CHS Foundation; Helmholtz-Chinese Academy of Sciences(Chinese Academy of Sciences); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Koln-Fortune Programme	This work was supported in part by the CHS Foundation, Helmholtz-Chinese Academy of Sciences Grant HCJRG-202, and Deutsche Forschungsgemeinschaft (DFG) Grant FOR2327 (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Koln-Fortune Programme.	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dotz V, 2014, GLYCOBIOLOGY, V24, P185, DOI 10.1093/glycob/cwt099; EGGE H, 1983, ARCH BIOCHEM BIOPHYS, V224, P235, DOI 10.1016/0003-9861(83)90207-2; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Fiege B, 2017, GLYCOCONJUGATE J, V34, P679, DOI 10.1007/s10719-017-9792-5; Hansman GS, 2007, J CLIN MICROBIOL, V45, P1347, DOI 10.1128/JCM.01854-06; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Koromyslova A, 2017, VIROLOGY, V508, P81, DOI 10.1016/j.virol.2017.04.032; Kunz C, 1996, J CHROMATOGR B, V685, P211, DOI 10.1016/S0378-4347(96)00181-8; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu Y, 2016, J VIROL, V90, P9983, DOI 10.1128/JVI.01494-16; Lopman BA, 2015, J INFECT DIS, V211, P1813, DOI 10.1093/infdis/jiu672; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Moonens K, 2016, CELL HOST MICROBE, V19, P55, DOI 10.1016/j.chom.2015.12.004; Nasir W, 2017, ACS CHEM BIOL, V12, P1288, DOI 10.1021/acschembio.7b00152; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Purohit S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02747-y; Rademacher C, 2011, CHEM-EUR J, V17, P7442, DOI 10.1002/chem.201003432; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Schroten H, 2016, J VIROL, V90, P5855, DOI 10.1128/JVI.00317-16; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Singh BK, 2015, J VIROL, V89, P2024, DOI 10.1128/JVI.02968-14; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Weichert S, 2016, J VIROL, V90, P4843, DOI 10.1128/JVI.03223-15; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	30	25	26	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11955	11965		10.1074/jbc.RA117.001369	http://dx.doi.org/10.1074/jbc.RA117.001369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29858242	hybrid, Green Published			2022-12-26	WOS:000440134500026
J	Grignaschi, E; Cereghetti, G; Grigolato, F; Kopp, MRG; Caimi, S; Faltova, L; Saad, S; Peter, M; Arosio, P				Grignaschi, Erica; Cereghetti, Gea; Grigolato, Fulvio; Kopp, Marie R. G.; Caimi, Stefano; Faltova, Lenka; Saad, Shady; Peter, Matthias; Arosio, Paolo			A hydrophobic low-complexity region regulates aggregation of the yeast pyruvate kinase Cdc19 into amyloid-like aggregates in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; protein self-assembly; protein-nucleic acid interaction; protein-protein interaction; stress granule; cell compartmentalization; A42; amyloidogenic protein; functional amyloids; hydrophobic-hydrophilic interface; stress granule	PROTEIN-MISFOLDING DISEASES; PHASE-TRANSITIONS; FIBRIL FORMATION; LAG PHASE; GRANULES; RNA; MECHANISM; KINETICS; INSULIN; DOMAIN	Cells form stress granules (SGs) upon stress stimuli to protect sensitive proteins and RNA from degradation. In the yeast Saccharomyces cerevisiae, specific stresses such as nutrient starvation and heat-shock trigger recruitment of the yeast pyruvate kinase Cdc19 into SGs. This RNA-binding protein was shown to form amyloid-like aggregates that are physiologically reversible and essential for cell cycle restart after stress. Cellular Cdc19 exists in an equilibrium between a homotetramer and monomer state. Here, we show that Cdc19 aggregation in vitro is governed by protein quaternary structure, and we investigate the physical-chemical basis of Cdc19's assembly properties. Equilibrium shift toward the monomer state exposes a hydrophobic low-complexity region (LCR), which is prone to induce intermolecular interactions with surrounding proteins. We further demonstrate that hydrophobic/hydrophilic interfaces can trigger Cdc19 aggregation in vitro. Moreover, we performed in vitro biophysical analyses to compare Cdc19 aggregates with fibrils produced by two known dysfunctional amyloidogenic peptides. We show that the Cdc19 aggregates share several structural features with pathological amyloids formed by human insulin and the Alzheimer's disease-associated A42 peptide, particularly secondary -sheet structure, thermodynamic stability, and staining by the thioflavin T dye. However, Cdc19 aggregates could not seed aggregation. These results indicate that Cdc19 adopts an amyloid-like structure in vitro that is regulated by the exposure of a hydrophobic LCR in its monomeric form. Together, our results highlight striking structural similarities between functional and dysfunctional amyloids and reveal the crucial role of hydrophobic/hydrophilic interfaces in regulating Cdc19 aggregation.	[Grignaschi, Erica; Grigolato, Fulvio; Kopp, Marie R. G.; Caimi, Stefano; Faltova, Lenka; Arosio, Paolo] Swiss Fed Inst Technol, Inst Chem & Bioengn, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Cereghetti, Gea; Saad, Shady; Peter, Matthias] Swiss Fed Inst Technol, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Arosio, P (corresponding author), Stanford Univ, Dept Chem & Syst Biol, 269 Campus Dr, Stanford, CA 94305 USA.	paolo.arosio@chem.ethz.ch	Cereghetti, Gea/GQH-3208-2022	Cereghetti, Gea/0000-0001-7732-9435; Peter, Matthias/0000-0002-2160-6824; Caimi, Stefano/0000-0003-3898-559X; Saad, Shady/0000-0003-1062-2906; Arosio, Paolo/0000-0002-2740-1205; Grigolato, Fulvio/0000-0001-5989-7260	ETH Zurich; European Research Council; Synapsis Foundation; Swiss National Science Foundation; ETH Zurich Research Grant [ETH-33 17-2]; Novartis Foundation for Biomedical and Biological Research	ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission); Synapsis Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich Research Grant(ETH Zurich); Novartis Foundation for Biomedical and Biological Research	This work was supported by ETH Zurich, the European Research Council, the Synapsis Foundation, and Swiss National Science Foundation (to M. P.) and by ETH Zurich Research Grant ETH-33 17-2, the Synapsis Foundation, and the Novartis Foundation for Biomedical and Biological Research (to P. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Arosio P, 2014, TRENDS PHARMACOL SCI, V35, P127, DOI 10.1016/j.tips.2013.12.005; Arosio P, 2014, J AM CHEM SOC, V136, P219, DOI 10.1021/ja408765u; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00423, 10.3339/fncel.2015.00423]; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/nphys3532, 10.1038/NPHYS3532]; Brangwynne CP, 2011, SOFT MATTER, V7, P3052, DOI 10.1039/c0sm00981d; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Grigolato F, 2017, ACS NANO, V11, P11358, DOI 10.1021/acsnano.7b05895; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Macindoe I, 2012, P NATL ACAD SCI USA, V109, pE804, DOI 10.1073/pnas.1114052109; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mateju D, 2017, EMBO J, V36, P1669, DOI 10.15252/embj.201695957; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Owczarz M, 2014, BIOPHYS J, V107, P197, DOI 10.1016/j.bpj.2014.05.030; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pham CLL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25288; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Saad S, 2017, NAT CELL BIOL, V19, P1202, DOI 10.1038/ncb3600; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Taylor JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24656; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	44	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11424	11432		10.1074/jbc.RA117.001628	http://dx.doi.org/10.1074/jbc.RA117.001628			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29853641	hybrid, Green Published			2022-12-26	WOS:000439449700013
J	Bender, O; Llorent-Martinez, EJ; Zengin, G; Mollica, A; Ceylan, R; Molina-Garcia, L; Fernandez-de Cordova, ML; Atalay, A				Bender, Onur; Llorent-Martinez, Eulogio J.; Zengin, Gokhan; Mollica, Adriano; Ceylan, Ramazan; Molina-Garcia, Lucia; Fernandez-de Cordova, Maria Luisa; Atalay, Arzu			Integration of in vitro and in silico perspectives to explain chemical characterization, biological potential and anticancer effects of Hypericum salsugineum: A pharmacologically active source for functional drug formulations	PLOS ONE			English	Article							BREAST-CANCER THERAPY; PHENOLIC-COMPOUNDS; ANTIOXIDANT ACTIVITIES; BIOACTIVE COMPOUNDS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ALPHA-AMYLASE; CELL-LINE; CONSTITUENTS; IDENTIFICATION	The genus Hypericum is one of the most popular genera in both traditional medicine and scientific platform. This study is designed to provide conceptual insights on the biological potential and chemical characterization of H. salsugineum, which is endemic to Turkey. The qualitative and quantitative phenolic content of the extracts was characterized by HPLC-ESI-MSn. Biological efficiency was investigated by enzyme inhibitory assays (cholinesterases, tyrosinase, amylase, and glucosidase) and anti-cancer efficacy tests (anti-proliferative activities with the iCELLigence technology, colony formation and wound healing scratch assays). Phenolic acids (3-O-caffeoylquinic, 5-O-caffeoylquinic, and 4-O-caffeoylquinic acids) were the predominant group in the studied extracts, although several flavonoids were also detected and quantified. The extracts exhibited good inhibitory effects on tyrosinase and glucosidase, while they had weak ability against cholinesterases and amylase. Computational studies were also performed to explain the interactions between the major phenolics and these enzymes. The extracts displayed significant anti-cancer effects on breast carcinoma cell lines. Our findings suggest that Hypericum salsugineum could be valued as a potential source of biologically-active compounds for designing novel products.	[Bender, Onur; Atalay, Arzu] Ankara Univ, Biotechnol Inst, Ankara, Turkey; [Llorent-Martinez, Eulogio J.; Molina-Garcia, Lucia; Fernandez-de Cordova, Maria Luisa] Univ Jaen, Dept Phys & Analyt Chem, Campus Las Lagunillas S-N, Jaen, Spain; [Zengin, Gokhan; Ceylan, Ramazan] Selcuk Univ, Sci Fac, Dept Biol, Konya, Turkey; [Mollica, Adriano] Univ G dAnnunzio, Dept Pharm, Chieti, Italy	Ankara University; Universidad de Jaen; Selcuk University; G d'Annunzio University of Chieti-Pescara	Atalay, A (corresponding author), Ankara Univ, Biotechnol Inst, Ankara, Turkey.	gokhanzengin@selcuk.edu.tr; arzu.atalay@ankara.edu.tr	Ceylan, Ramazan/ABI-7598-2020; Zengin, Gokhan/GLS-8806-2022; atalay, arzu/O-1601-2014; Bender, Onur/D-5917-2018; de Córdova, María Luisa Fernández/H-7686-2015; Zengin, Gokhan/K-9393-2015	Zengin, Gokhan/0000-0001-6548-7823; atalay, arzu/0000-0003-1309-5291; Bender, Onur/0000-0003-0691-3508; de Córdova, María Luisa Fernández/0000-0002-4500-4246; Zengin, Gokhan/0000-0001-6548-7823; Ceylan, Ramazan/0000-0002-7795-8482				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Antognoni F, 2017, J ETHNOPHARMACOL, V195, P255, DOI 10.1016/j.jep.2016.11.029; Arung ET, 2011, Z NATURFORSCH C, V66, P209, DOI 10.5560/ZNC.2011.66c0209; Aztopal N, 2016, J FOOD BIOCHEM, V40, P559, DOI 10.1111/jfbc.12248; Bange J, 2001, NAT MED, V7, P548, DOI 10.1038/87872; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bejaoui A, 2017, PHARM BIOL, V55, P906, DOI 10.1080/13880209.2016.1270973; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bird C., 2009, NAT METHODS, V6, pv, DOI [10.1038/nmeth.f.263, DOI 10.1038/NMETH.F.263]; Brudzynski K, 2011, FOOD CHEM, V127, P1023, DOI 10.1016/j.foodchem.2011.01.075; Brunakova K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00558; Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q; Crockett Sara L, 2011, Med Aromat Plant Sci Biotechnol, V5, P1; de Freitas MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163130; Duman R., 2012, African Journal of Biotechnology, V11, P1240; Ferlay J., 2015, INT J CANC, V136; Ferreres F, 2003, PHYTOCHEM ANALYSIS, V14, P352, DOI 10.1002/pca.727; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Haefeli WE, 2014, EXPERT OPIN DRUG MET, V10, P359, DOI 10.1517/17425255.2014.873786; Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Jabeur I, 2016, FOOD RES INT, V89, P422, DOI 10.1016/j.foodres.2016.08.040; Jiang L, 2015, MOLECULES, V20, P11257, DOI 10.3390/molecules200611257; Jiao De, 2016, Oncol Rep, V36, P342, DOI 10.3892/or.2016.4777; Kang SJ, 2015, FOOD SCI BIOTECHNOL, V24, P1897, DOI 10.1007/s10068-015-0249-y; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kleemann B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103762; Kumar Sunil, 2011, Pharmacogn Rev, V5, P19, DOI 10.4103/0973-7847.79096; Silva ELE, 2016, MOLECULES, V21, DOI 10.3390/molecules21060782; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Levandi T, 2009, EUR J LIPID SCI TECH, V111, P715, DOI 10.1002/ejlt.200800286; Li X, 2011, RAPID COMMUN MASS SP, V25, P2439, DOI 10.1002/rcm.5123; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Llorent-Martinez EJ, 2016, RSC ADV, V6, P88996, DOI 10.1039/c6ra17170b; Madunic J, 2016, J ENVIRON SCI HEAL A, V51, P1157, DOI 10.1080/10934529.2016.1206385; Maltas E, 2013, FRESEN ENVIRON BULL, V22, P862; Mandrone M, 2015, IND CROP PROD, V76, P402, DOI 10.1016/j.indcrop.2015.07.012; Meng YH, 2016, PLANT FOOD HUM NUTR, V71, P444, DOI 10.1007/s11130-016-0581-2; Mileo AM, 2012, J CELL PHYSIOL, V227, P3301, DOI 10.1002/jcp.24029; Mocan A, 2017, J ENZYM INHIB MED CH, V32, P153, DOI 10.1080/14756366.2016.1243535; Mocan A, 2016, J ENZYM INHIB MED CH, V31, P200, DOI 10.1080/14756366.2016.1222585; Mocan A, 2016, J FUNCT FOODS, V25, P94, DOI 10.1016/j.jff.2016.05.010; Nachon F, 2013, BIOCHEM J, V453, P393, DOI 10.1042/BJ20130013; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m; Ozturk N, 2009, PHARM BIOL, V47, P120, DOI 10.1080/13880200802437073; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pesaresi A., TORPEDO CALIFORNICA; Picot MCN, 2017, BIOMED PHARMACOTHER, V89, P342, DOI 10.1016/j.biopha.2017.02.031; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rainha N, 2013, PHYTOCHEMISTRY, V86, P83, DOI 10.1016/j.phytochem.2012.10.006; Ranganathan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141370; Sabatier R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-228; Sakar M., 1990, FITOTERAPIA, V61; Santos J, 2014, J CHROMATOGR A, V1327, P118, DOI 10.1016/j.chroma.2013.12.085; Sarimahmut M, 2016, REGUL TOXICOL PHARM, V74, P137, DOI 10.1016/j.yrtph.2015.11.010; Savran A, 2016, FOOD FUNCT, V7, P3252, DOI [10.1039/C6FO00695G, 10.1039/c6fo00695g]; Scheggi S, 2016, PHARM BIOL, V54, P1782, DOI 10.3109/13880209.2015.1127979; Sentkowska A, 2016, FOOD SCI BIOTECHNOL, V25, P965, DOI 10.1007/s10068-016-0157-9; Shao WL, 2004, BREAST CANCER RES, V6, P39, DOI 10.1186/bcr742; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Siddiqui JA, 2015, CURR CANCER DRUG TAR, V15, P116, DOI 10.2174/1568009615666141229152256; Simirgiotis MJ, 2013, MOLECULES, V18, P2061, DOI 10.3390/molecules18022061; Spinola V, 2014, J AGR FOOD CHEM, V62, P9722, DOI 10.1021/jf503540s; Steiner JL, 2014, CANCER BIOL THER, V15, P1456, DOI 10.4161/15384047.2014.955444; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tusevski O, 2014, ACTA PHYSIOL PLANT, V36, P2555, DOI 10.1007/s11738-014-1627-4; Van Hoyweghen L, 2014, PHYTOTHER RES, V28, P224, DOI 10.1002/ptr.4978; Verardo G, 2009, RAPID COMMUN MASS SP, V23, P1607, DOI 10.1002/rcm.4047; Wang J, 2014, ANAL BIOANAL CHEM, V406, P7379, DOI 10.1007/s00216-014-8132-x; Wolfle U, 2014, PLANTA MED, V80, P109, DOI 10.1055/s-0033-1351019; Xavier CPR, 2012, FOOD FUNCT, V3, P844, DOI 10.1039/c2fo10226a; Yamamoto K, 2011, J BIOSCI BIOENG, V112, P545, DOI 10.1016/j.jbiosc.2011.08.016; Zengin G, 2017, FOOD CHEM TOXICOLOGY; Zengin G, 2017, BIOMED PHARMACOTHER, V87, P27, DOI 10.1016/j.biopha.2016.12.063; Zhang LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104058; Zhang YC, 2010, J CHROMATOGR B, V878, P3149, DOI 10.1016/j.jchromb.2010.09.027; Zhao J, 2015, CHEM BIODIVERS, V12, P309, DOI 10.1002/cbdv.201300304; Zheleva-Dimitrova D, 2013, PHARMACOGN MAG, V9, P1, DOI 10.4103/0973-1296.117846; Zhuo HY, 2004, PROTEIN J, V23, P379, DOI 10.1023/B:JOPC.0000039552.94529.95	83	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197815	10.1371/journal.pone.0197815	http://dx.doi.org/10.1371/journal.pone.0197815			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864137	Green Published, gold, Green Submitted			2022-12-26	WOS:000434097100010
J	Betz, KJ; Maier, EA; Amarachintha, S; Wu, D; Karmele, EP; Kinder, JM; Steinbrecher, KA; McNeal, MM; Luzader, DH; Hogan, SP; Moore, SR				Betz, Kristina J.; Maier, Elizabeth A.; Amarachintha, Surya; Wu, David; Karmele, Erik P.; Kinder, Jeremy M.; Steinbrecher, Kris A.; McNeal, Monica M.; Luzader, Deborah H.; Hogan, Simon P.; Moore, Sean R.			Enhanced survival following oral and systemic Salmonella enterica serovar Typhimurium infection in polymeric immunoglobulin receptor knockout mice	PLOS ONE			English	Article							DEFICIENT MICE; SECRETORY IGA; MUCOSAL SURFACES; CELL HOMEOSTASIS; EPITHELIAL-CELLS; DEATH RATES; IN-VIVO; BACTERIA; RESPONSES; ANTIBODY	Background Polymeric immunoglobulin receptor (pIgR) transport of secretory immunoglobulin A (SIgA) to mucosal surfaces is thought to promote gut integrity and immunity to Salmonella enterica serovar Typhimurium (S. Typhimurium), an invasive pathogen in mice. To elucidate potential mechanisms, we assessed intestinal barrier function and both oral and systemic S. Typhimurium virulence in pIgR knockout (KO) and wildtype (WT) mice. Methods In uninfected animals, we harvested jejunal segments for Ussing chamber analyses of transepithelial resistance (TER); mesenteric lymph nodes (mLN) for bacterial culture; and serum and stool for IgA. Separately, we infected mice either orally or intravenously (IV) with S. Typhimurium to compare colonization, tissue dynamics, and inflammation between KOs and WTs. Results Uninfected KOs displayed decreased TER and dramatically increased serum IgA and decreased fecal IgA vs. WT; however, KO mLNs yielded fewer bacterial counts. Remarkably, WTs challenged orally with S. Typhimurium exhibited increased splenomegaly, tissue colonization, and pro-inflammatory cytokines vs. pIgR KOs, which showed increased survival following either oral or IV infection. Conclusions Absence of pIgR compromises gut integrity but does not exacerbate bacterial translocation nor S. Typhimurium infection. These findings raise the possibility that immune adaptation to increased gut permeability and elevated serum IgA in the setting of SIgA deficiency provides compensatory protection against invasive gut pathogens.	[Betz, Kristina J.; Maier, Elizabeth A.; Amarachintha, Surya; Steinbrecher, Kris A.; Moore, Sean R.] Cincinnati Childrens Hosp Med Ctr, Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Wu, David; Hogan, Simon P.] Cincinnati Childrens Hosp Med Ctr, Allergy & Immunol, Cincinnati, OH 45229 USA; [Karmele, Erik P.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Kinder, Jeremy M.; McNeal, Monica M.] Cincinnati Childrens Hosp Med Ctr, Infect Dis, Cincinnati, OH 45229 USA; [Luzader, Deborah H.; Moore, Sean R.] Univ Virginia, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Charlottesville, VA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Virginia	Betz, KJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA.	weagekj@mail.uc.edu	Amarachintha, Surya/AAV-6777-2020	McNeal, Monica/0000-0002-3784-9062; Amarachintha, Surya/0000-0003-1076-2802; Betz, Kristina/0000-0003-3138-4193	Bill & Melinda Gates Foundation [OPP1109785]; Fogarty International Center/National Institutes of Health Independent Scientist in Global Health Award [K02TW008767]; University of Cincinnati Medical Scientist Training Program [NIGMS T32GM063483]; Cincinnati Children's Hospital Medical Center Digestive Health Center and Cores [National Institutes of Health] [P30DK078392]; FOGARTY INTERNATIONAL CENTER [K02TW008767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fogarty International Center/National Institutes of Health Independent Scientist in Global Health Award; University of Cincinnati Medical Scientist Training Program; Cincinnati Children's Hospital Medical Center Digestive Health Center and Cores [National Institutes of Health]; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Phase 1 and 2 Grand Challenges Explorations Award from the Bill & Melinda Gates Foundation [grant number OPP1109785 to S.R.M.], a Fogarty International Center/National Institutes of Health Independent Scientist in Global Health Award [grant number K02TW008767 to S.R.M.], the University of Cincinnati Medical Scientist Training Program [grant number NIGMS T32GM063483]; and the Cincinnati Children's Hospital Medical Center Digestive Health Center and Cores [National Institutes of Health grant number P30DK078392].	Asano Masatake, 2011, J Oral Sci, V53, P147; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Borrego A, 2006, MICROBES INFECT, V8, P2766, DOI 10.1016/j.micinf.2006.08.005; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; CHILDERS NK, 1989, ANNU REV MICROBIOL, V43, P503, DOI 10.1146/annurev.mi.43.100189.002443; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Corthesy B, 1999, CURR TOP MICROBIOL, V236, P93; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Corthesy B, 2013, AUTOIMMUN REV, V12, P661, DOI 10.1016/j.autrev.2012.10.012; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Forbes SJ, 2008, INFECT IMMUN, V76, P4137, DOI 10.1128/IAI.00416-08; HORMAECHE CE, 1980, IMMUNOLOGY, V41, P973; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kato-Nagaoka N, 2015, IMMUNOLOGY, V146, P59, DOI 10.1111/imm.12480; Loomis WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111763; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; MAW J, 1968, BRIT J EXP PATHOL, V49, P597; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; PLANT J, 1979, CLIN EXP IMMUNOL, V37, P1; Reikvam DH, 2012, EUR J IMMUNOL, V42, P2959, DOI 10.1002/eji.201242543; Robinson JK, 2001, J IMMUNOL, V166, P3688, DOI 10.4049/jimmunol.166.6.3688; Rogier EW, 2014, PATHOGENS, V3, P390, DOI 10.3390/pathogens3020390; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Tam MA, 2008, IMMUNOL REV, V225, P140, DOI 10.1111/j.1600-065X.2008.00679.x; Tilg H, 2015, GASTROENTEROLOGY, V148, P1107, DOI 10.1053/j.gastro.2014.12.036; Ueno PM, 2011, AM J PHYSIOL-GASTR L, V301, pG612, DOI 10.1152/ajpgi.00531.2010; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; WARD RL, 1986, J INFECT DIS, V154, P871, DOI 10.1093/infdis/154.5.871; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198434	10.1371/journal.pone.0198434	http://dx.doi.org/10.1371/journal.pone.0198434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856838	Green Submitted, gold, Green Published			2022-12-26	WOS:000433900800125
J	Franch-Nadal, J; Caballeria, L; Mata-Cases, M; Mauricio, D; Giraldez-Garcia, C; Mancera, J; Goday, A; Mundet-Tuduri, X; Regidor, E				Franch-Nadal, Josep; Caballeria, Llorenc; Mata-Cases, Manel; Mauricio, Didac; Giraldez-Garcia, Carolina; Mancera, Jose; Goday, Albert; Mundet-Tuduri, Xavier; Regidor, Enrique		PREDAPS Study Grp	Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; INSULIN-RESISTANCE; AMINOTRANSFERASE LEVELS; CARDIOVASCULAR-DISEASE; GLUCOSE-METABOLISM; HEPATIC STEATOSIS; FASTING GLUCOSE; FOLLOW-UP; PREVALENCE; RISK	Objectives We evaluated the ability of the Fatty Liver Index (FLI), a surrogate marker of hepatic steatosis, to predict the development of type 2 diabetes (T2D) at 3 years follow-up in a Spanish cohort with prediabetes from a prospective observational study in primary care (PREDAPS). Methods FLI was calculated at baseline for 1,142 adult subjects with prediabetes attending primary care centers, and classified into three categories: FLI <30 (no steatosis), FLI 30-60 (intermediate) and FLI >= 60 (hepatic steatosis). We estimated the incidence rate of T2D in each FLI category at 3 years of follow-up. The association between FLI and incident T2D was calculated using Cox regression models adjusted for age, sex, educational level, family history of diabetes, lifestyles, hypertension, lipid profile and transaminases. Results The proportion of subjects with prediabetes and hepatic steatosis (FLI >= 60) at baseline was 55.7%. The incidence rate of T2D at 3 years follow-up was 1.3, 2.9 and 6.0 per 100 person-years for FLI<30, FLI 30->60 and FLI >= 60, respectively. The most significant variables increasing the risk of developing T2D were metabolic syndrome (hazard ratio [HR] = 3.02; 95% confidence interval [ CI] = 2.14-4.26) and FLI >= 60 (HR = 4.52; 95% CI = 2.10-9.72). Moreover, FLI >= 60 was independently associated with T2D incidence: the HR was 4.97 (95% CI: 2.28-10.80) in the base regression model adjusted by sex, age and educational level, and 3.21 (95% CI: 1.45-7.09) in the fully adjusted model. Conclusions FLI may be considered an easy and valuable early indicator of high risk of incident T2D in patients with prediabetes attended in primary care, which could allow the adoption of effective measures needed to prevent and reduce the progression of the disease.	[Franch-Nadal, Josep; Mata-Cases, Manel; Mauricio, Didac; Giraldez-Garcia, Carolina; Mancera, Jose; Goday, Albert; Mundet-Tuduri, Xavier; Regidor, Enrique] RedGDPS Fdn, Madrid, Spain; [Franch-Nadal, Josep; Mata-Cases, Manel; Mauricio, Didac; Mundet-Tuduri, Xavier] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona Ciutat, Barcelona, Spain; [Franch-Nadal, Josep; Mata-Cases, Manel; Mauricio, Didac] Diabet & Associated Metab Dis Networking Biomed R, Madrid, Spain; [Franch-Nadal, Josep; Caballeria, Llorenc] Univ Barcelona, Dept Med, Barcelona, Spain; [Caballeria, Llorenc] Liver & Digest Dis Networking Biomed Res Ctr CIBE, Madrid, Spain; [Caballeria, Llorenc] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelones Nord, Barcelona, Spain; [Mauricio, Didac] Hlth Sci Res Inst, Dept Endocrinol & Nutr, Badalona, Spain; [Mauricio, Didac] Univ Hosp Germans Trias i Pujol, Badalona, Spain; [Giraldez-Garcia, Carolina] Univ Hosp Infanta Elena, Prevent Med Serv, Madrid, Spain; [Giraldez-Garcia, Carolina; Regidor, Enrique] Univ Complutense Madrid, Prevent Med Publ Hlth & Hist Sci Dept, Madrid, Spain; [Mancera, Jose] Hlth Ctr Ciudad Jardin, Malaga, Spain; [Goday, Albert] Hosp del Mar, Endocrinol Serv, Barcelona, Spain; [Mundet-Tuduri, Xavier] Autonomous Univ Barcelona, Bellaterra, Spain; [Regidor, Enrique] Epidemiol & Publ Hlth Networking Biomed Res Ctr C, Madrid, Spain; [Regidor, Enrique] Hosp Clin San Carlos IdISSC, Hlth Res Inst, Madrid, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Complutense University of Madrid; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Hospital Clinico San Carlos	Franch-Nadal, J; Mundet-Tuduri, X (corresponding author), RedGDPS Fdn, Madrid, Spain.; Franch-Nadal, J; Mundet-Tuduri, X (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona Ciutat, Barcelona, Spain.; Franch-Nadal, J (corresponding author), Diabet & Associated Metab Dis Networking Biomed R, Madrid, Spain.; Franch-Nadal, J (corresponding author), Univ Barcelona, Dept Med, Barcelona, Spain.; Mundet-Tuduri, X (corresponding author), Autonomous Univ Barcelona, Bellaterra, Spain.	joseph.franch@gmail.com; 16274xmt@comb.cat	Mauricio, Didac/B-7951-2009; Franch-Nadal, Josep/AAC-1945-2019; mata-cases, manel/W-9485-2019; Garcia, Antonio Ruiz/J-2613-2015	Mauricio, Didac/0000-0002-2868-0250; Franch-Nadal, Josep/0000-0002-5175-1555; mata-cases, manel/0000-0003-3693-3622; Garcia, Antonio Ruiz/0000-0002-7902-5504; Mundet-Tuduri, Xavier/0000-0002-0318-8657	Sanofi; Novartis	Sanofi; Novartis(Novartis)	This study received financial support from Sanofi and Novartis for the development of the data collection platform, for meetings researchers, and for monitoring of the information collected at baseline. Sanofi and Novartis had no role in the study design, analysis, interpretation of data, the writing of the manuscript, nor the decision to submit the manuscript for publication.	Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS13, DOI 10.2337/dc16-S005; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Arase Y, 2009, J GASTROENTEROL, V44, P1064, DOI 10.1007/s00535-009-0091-1; Athyros VG, 2017, METABOLISM, V71, P17, DOI 10.1016/j.metabol.2017.02.014; Bae JC, 2011, DIABETES CARE, V34, P727, DOI 10.2337/dc10-1991; Bae JC, 2010, AM J GASTROENTEROL, V105, P2389, DOI 10.1038/ajg.2010.275; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Bansal A, 2016, J CLIN EXPT HEPATOLO, V6, pS23, DOI [10.1016/j.jceh.2016.06.043, DOI 10.1016/J.JCEH.2016.06.043]; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Berkowitz SA, 2014, JAMA INTERN MED, V174, P1955, DOI 10.1001/jamainternmed.2014.5294; Bonnet F, 2017, J HYPERTENS, V35, P493, DOI 10.1097/HJH.0000000000001204; Bozkurt L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032710; Bril F, 2017, DIABETES CARE, V40, P419, DOI 10.2337/dc16-1787; Bril F, 2016, ENDOCRIN METAB CLIN, V45, P765, DOI 10.1016/j.ecl.2016.06.005; Caballeria L, 2010, EUR J GASTROEN HEPAT, V22, P24, DOI 10.1097/MEG.0b013e32832fcdf0; Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Du TT, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0146-3; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Er LK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149731; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fan JG, 2007, J GASTROEN HEPATOL, V22, P1086, DOI 10.1111/j.1440-1746.2006.04781.x; Forlani G, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2931985; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Goessling W, 2008, GASTROENTEROLOGY, V135, P1935, DOI 10.1053/j.gastro.2008.09.018; Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288; Hazlehurst JM, 2016, METABOLISM, V65, P1096, DOI 10.1016/j.metabol.2016.01.001; Jager S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124749; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Jung CH, 2013, DIABETIC MED, V30, P428, DOI 10.1111/dme.12104; Kahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094059; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Lee DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163465; Lee DH, 2003, DIABETOLOGIA, V46, P359, DOI 10.1007/s00125-003-1036-5; Leutner M, 2017, J AM COLL NUTR, V36, P287, DOI 10.1080/07315724.2016.1262802; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Mata-Cases M, 2015, REV CLIN ESP, V215, P117, DOI 10.1016/j.rce.2014.10.012; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Mostafa SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050931; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nishi T, 2015, J DIABETES INVEST, V6, P309, DOI 10.1111/jdi.12290; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Papagianni M, 2015, WORLD J HEPATOL, V7, P638, DOI 10.4254/wjh.v7.i4.638; Portillo-Sanchez P, 2015, J CLIN ENDOCR METAB, V100, P2231, DOI 10.1210/jc.2015-1966; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rogulj D, 2012, CLIN BIOCHEM, V45, P68, DOI 10.1016/j.clinbiochem.2011.10.014; Ryu S, 2010, METABOLISM, V59, P683, DOI 10.1016/j.metabol.2009.08.024; Saponaro C, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0607-4; Sato F, 2007, J CLIN ENDOCR METAB, V92, P3326, DOI 10.1210/jc.2006-2384; Serrano R, 2013, REV ESP SALUD PUBLIC, V87, P121, DOI [10.4321/S1135-57272013000200003, 10.4321/s1135-57272013000200003]; Simental-Mendia Luis E., 2008, Metabolic Syndrome and Related Disorders, V6, P299, DOI 10.1089/met.2008.0034; Singh SP, 2014, J DIABETES MELLITUS, V4, P290, DOI [10.4236/jdm.2014.44040, DOI 10.4236/JDM.2014.44040]; Sinn DH, 2012, AM J GASTROENTEROL, V107, P561, DOI 10.1038/ajg.2011.400; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Targher G, 2010, DIABETOLOGIA, V53, P1341, DOI 10.1007/s00125-010-1720-1; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Viljanen APM, 2009, J CLIN ENDOCR METAB, V94, P50, DOI 10.1210/jc.2008-1689; Wong VWS, 2006, ALIMENT PHARM THER, V24, P1215, DOI 10.1111/j.1365-2036.2006.03112.x; Yadav D, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004447; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Yamazaki H, 2015, DIABETES CARE, V38, P1673, DOI 10.2337/dc15-0140; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zelber-Sagi S, 2013, LIVER INT, V33, P1406, DOI 10.1111/liv.12200; Zhang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116110	73	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e019827	10.1371/journal.pone.0198327	http://dx.doi.org/10.1371/journal.pone.0198327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856820	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800101
J	Mishchenko, MA; Gerasimova, SA; Lebedeva, AV; Lepekhina, LS; Pisarchik, AN; Kazantsev, VB				Mishchenko, Mikhail A.; Gerasimova, Svetlana A.; Lebedeva, Albina, V; Lepekhina, Lyubov S.; Pisarchik, Alexander N.; Kazantsev, Victor B.			Optoelectronic system for brain neuronal network stimulation	PLOS ONE			English	Article							MACHINE INTERFACES; SILICON NEURONS; NEURAL-NETWORKS; DYNAMICS; SPIKING; IMPLEMENTATION	We propose an optoelectronic system for stimulation of living neurons. The system consists of an electronic circuit based on the FitzHugh-Nagumo model, an optical fiber, and a photoelectrical converter. We used this system for electrical stimulation of hippocampal living neurons in acute hippocampal brain slices (350-mu m thick) obtained from a 20 +/- 28 days old C57BL/6 mouse or a Wistar rat. The main advantage of our system over other similar stimulators is that it contains an optical fiber for signal transmission instead of metallic wires. The fiber is placed between the electronic circuit and stimulated neurons and provides galvanic isolation from external electrical and magnetic fields. The use of the optical fiber allows avoiding electromagnetic noise and current flows which could affect metallic wires. Furthermore, it gives us the possibility to simulate "synaptic plasticity" by adaptive signal transfer through optical fiber. The proposed optoelectronic system (hybrid neural circuit) provides a very high efficiency in stimulating hippocampus neurons and can be used for restoring brain activity in particular regions or replacing brain parts (neuroprosthetics) damaged due to a trauma or neurodegenerative diseases.	[Mishchenko, Mikhail A.; Gerasimova, Svetlana A.; Lebedeva, Albina, V; Lepekhina, Lyubov S.; Kazantsev, Victor B.] Natl Res Lobachevsky State Univ Nizhny Novgorod, Nizhnii Novgorod, Russia; [Pisarchik, Alexander N.] Tech Univ Madrid, Ctr Biomed Technol, Campus Montegancedo, Madrid, Spain	Lobachevsky State University of Nizhni Novgorod; Universidad Politecnica de Madrid	Mishchenko, MA (corresponding author), Natl Res Lobachevsky State Univ Nizhny Novgorod, Nizhnii Novgorod, Russia.	mishchenko@neuro.nnov.ru	Kazantsev, Victor B/L-1424-2013; Pisarchik, Alexander N./K-9704-2019; Lebedeva, Albina V./O-8955-2017; Pisarchik, Alexander N./E-7545-2011; Mishchenko, Mikhail A./J-9280-2013; Lebedeva, Albina/ABD-5842-2020; Gerasimova, Svetlana/O-9483-2017	Pisarchik, Alexander N./0000-0003-2471-2507; Lebedeva, Albina V./0000-0002-9194-4896; Pisarchik, Alexander N./0000-0003-2471-2507; Mishchenko, Mikhail A./0000-0001-8801-7664; Lebedeva, Albina/0000-0002-9194-4896; Kazantsev, Viktor/0000-0002-2881-6648	Russian Foundation for Basic Research [16-31-60080 mol_a_dk]; Russian President grant [MK-2726.2017.2]; President scholarship [Pi-2458.2018.5]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian President grant; President scholarship	This study was supported by the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) within scientific project no. 16-31-60080 mol_a_dk (to MAM) and the Russian President grant (https://grants.extech.ru/) MK-2726.2017.2 (to MAM); and President scholarship Pi-2458.2018.5 (https://grants.extech.ru/) (to AVL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, ANALOG VLSI IMPLEMEN; [Anonymous], 2013, MEMRISTOR NETWORKS; Bartolozzi C, 2007, NEURAL COMPUT, V19, P2581, DOI 10.1162/neco.2007.19.10.2581; Binczak S, 2006, NEURAL NETWORKS, V19, P684, DOI 10.1016/j.neunet.2005.07.011; Chader GJ, 2009, PROG BRAIN RES, V175, P317, DOI 10.1016/S0079-6123(09)17522-2; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Gerasimova SA, 2015, J COMMUN TECHNOL EL+, V60, P900, DOI 10.1134/S1064226915070062; Horsch K.W, 2004, NEUROPROSTHETICS THE; Indiveri G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00073; Kohno T, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00273; Lebedev M., 2015, RECENT ADV MODULAR O, P407, DOI DOI 10.1007/978-94-017-9900-3_21; MAHOWALD M, 1991, NATURE, V354, P515, DOI 10.1038/354515a0; Mishchenko MA, 2017, TECH PHYS LETT+, V43, P596, DOI 10.1134/S1063785017070100; Misra J, 2010, NEUROCOMPUTING, V74, P239, DOI 10.1016/j.neucom.2010.03.021; Nakada K, 2016, IEICE NONLINEAR THEO, V7, P95, DOI 10.1587/nolta.7.95; Ngouonkadi EBM, 2016, CHAOS SOLITON FRACT, V85, P151, DOI 10.1016/j.chaos.2016.02.001; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Pinto RD, 2000, PHYS REV E, V62, P2644, DOI 10.1103/PhysRevE.62.2644; Pisarchik AN, 2011, OPT LASER ENG, V49, P736, DOI 10.1016/j.optlaseng.2011.01.020; Pisarchik AN, 2013, SENSORS-BASEL, V13, P17322, DOI 10.3390/s131217322; Savino GV, 2009, BIOSYSTEMS, V97, P9, DOI 10.1016/j.biosystems.2009.03.005; Shahdoost S, 2014, IEEE ENG MED BIO, P486, DOI 10.1109/EMBC.2014.6943634; Simoni ME, 2004, IEEE T BIO-MED ENG, V51, P342, DOI 10.1109/TBME.2003.820390; Tanaka H., 2006, INT CONGR SER, V1291, P217; van Schaik A, 2001, NEURAL NETWORKS, V14, P617, DOI 10.1016/S0893-6080(01)00067-3; Wan CJ, 2016, ACS APPL MATER INTER, V8, P9762, DOI 10.1021/acsami.5b12726; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005	28	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198396	10.1371/journal.pone.0198396	http://dx.doi.org/10.1371/journal.pone.0198396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856855	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800115
J	Osawa, M				Osawa, Masaki			A repetitive mutation and selection system for bacterial evolution to increase the specific affinity to pancreatic cancer cells	PLOS ONE			English	Article							AUREUS ALPHA-HEMOLYSIN; P-BAD PROMOTER; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; EXPRESSION; THERAPY; PROTEIN; IDENTIFICATION; TUMORS	It is difficult to target and kill cancer cells. One possible approach is to mutate bacteria to enhance their binding to cancer cells. In the present study, Gram-negative Escherichia coli and Gram-positive Bacillus subtilis were randomly mutated, and then were positively and negatively selected for binding cancer vs normal cells. With repetitive mutation and selection both bacteria successfully evolved to increase affinity to the pancreatic cancer cell line (Mia PaCa-2) but not normal cells (HPDE: immortalized human pancreatic ductal epithelial cells). The mutant E. coli and B. subtilis strains bound to Mia PaCa-2 cells about 10 and 25 times more than to HPDE cells. The selected E. coli strain had mutations in biofilm-related genes and the regulatory region for a type I pilus gene. Consistent with type I pili involvement, mannose could inhibit the binding to cells. The results suggest that weak but specific binding is involved in the initial step of adhesion. To test their ability to kill Mia PaCa-2 cells, hemolysin was expressed in the mutant strain. The hemolysin released from the mutant strain was active and could kill Mia PaCa-2 cells. In the case of B. subtilis, the initial binding to the cells was a weak interaction of the leading pole of the motile bacteria. The frequency of this interaction to Mia PaCa-2 cells dramatically increased in the evolved mutant strain. This mutant strain could also specifically invade beneath Mia PaCa-2 cells and settle there. This type of mutation/selection strategy may be applicable to other combinations of cancer cells and bacterial species.	[Osawa, Masaki] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Osawa, M (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	masaki.osawa@duke.edu		, Masaki/0000-0003-1671-4246				Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; ERICKSON HP, 1989, J MOL BIOL, V206, P465, DOI 10.1016/0022-2836(89)90494-4; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Karsten U, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-301; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; King I, 2002, HUM GENE THER, V13, P1225, DOI 10.1089/104303402320139005; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Liang XQ, 2006, J PROTEOME RES, V5, P2632, DOI 10.1021/pr060125o; Liu SC, 2002, GENE THER, V9, P291, DOI 10.1038/sj.gt.3301659; Llado V, 2014, BBA-BIOMEMBRANES, V1838, P1619, DOI 10.1016/j.bbamem.2014.01.027; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Mirouze N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002048; Nallar SC, 2017, CYTOKINE, V89, P160, DOI 10.1016/j.cyto.2016.01.002; Ojkic N, 2016, ELIFE, V5, DOI 10.7554/eLife.18657; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Ray P, 2012, J CLIN INVEST, V122, P1734, DOI 10.1172/JCI62385; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Sanchez B, 2009, MICROBIOL-SGM, V155, P1708, DOI 10.1099/mic.0.025288-0; Sanchez-Vizuete P, 2015, APPL ENVIRON MICROB, V81, P109, DOI 10.1128/AEM.02473-14; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; St Jean AT, 2014, MOL THER, V22, P1266, DOI 10.1038/mt.2014.36; Stern C, 2015, INT J CANCER, V137, P2019, DOI 10.1002/ijc.29567; Stritzker J, 2007, INT J MED MICROBIOL, V297, P151, DOI 10.1016/j.ijmm.2007.01.008; Swofford CA, 2014, BIOTECHNOL BIOENG, V111, P1233, DOI 10.1002/bit.25184; Sznol M, 2000, J CLIN INVEST, V105, P1027, DOI 10.1172/JCI9818; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Zhang YL, 2012, APPL ENVIRON MICROB, V78, P7603, DOI 10.1128/AEM.01390-12	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e019815	10.1371/journal.pone.0198157	http://dx.doi.org/10.1371/journal.pone.0198157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851969	Green Published, Green Submitted, gold			2022-12-26	WOS:000433893200036
J	Saleem, MR; Ashraf, W; Zia, S; Ali, I; Qamar, S				Saleem, M. Rehan; Ashraf, Waqas; Zia, Saqib; Ali, Ishtiaq; Qamar, Shamsul			A kinetic flux vector splitting scheme for shallow water equations incorporating variable bottom topography and horizontal temperature gradients	PLOS ONE			English	Article							SAINT-VENANT SYSTEM; TIME CE/SE METHOD; HYPERBOLIC CONSERVATION-LAWS; CENTRAL-UPWIND SCHEMES; FINITE-VOLUME METHODS; SOURCE TERMS; EULER EQUATIONS; IDEAL MAGNETOHYDRODYNAMICS; HYDRODYNAMICAL MODELS; FLOWS	This paper is concerned with the derivation of a well-balanced kinetic scheme to approximate a shallow flow model incorporating non-flat bottom topography and horizontal temperature gradients. The considered model equations, also called as Ripa system, are the non-homogeneous shallow water equations considering temperature gradients and non-uniform bottom topography. Due to the presence of temperature gradient terms, the steady state at rest is of primary interest from the physical point of view. However, capturing of this steady state is a challenging task for the applied numerical methods. The proposed well-balanced kinetic flux vector splitting (KFVS) scheme is non-oscillatory and second order accurate. The second order accuracy of the scheme is obtained by considering a MUSCL-type initial reconstruction and Runge-Kutta time stepping method. The scheme is applied to solve the model equations in one and two space dimensions. Several numerical case studies are carried out to validate the proposed numerical algorithm. The numerical results obtained are compared with those of staggered central NT scheme. The results obtained are also in good agreement with the recently published results in the literature, verifying the potential, efficiency, accuracy and robustness of the suggested numerical scheme.	[Saleem, M. Rehan; Zia, Saqib; Ali, Ishtiaq; Qamar, Shamsul] COMSATS Inst Informat Technol, Pk Rd, Chak Shahzad Islamabad, Pakistan; [Ashraf, Waqas] Inst Space Technol, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Saleem, MR (corresponding author), COMSATS Inst Informat Technol, Pk Rd, Chak Shahzad Islamabad, Pakistan.	Rehanmathematician@gmail.com		Saleem, Muhammad Rehan/0000-0001-5183-0053				[Anonymous], 1998, LECT SERIESVAN KAREM; Audusse E, 1998, THESIS; Caleffi V, 2006, J COMPUT PHYS, V218, P228, DOI 10.1016/j.jcp.2006.02.001; Cercignani C., 1988, BOLTZMANN EQUATION I; CHANG SC, 1995, J COMPUT PHYS, V119, P295, DOI 10.1006/jcph.1995.1137; Chertock A, 2014, NUMER MATH, V127, P595, DOI 10.1007/s00211-013-0597-6; Dellar PJ, 2003, PHYS FLUIDS, V15, P292, DOI 10.1063/1.1530576; Desveaux V, 2016, MATH COMPUT, V85, P1571, DOI 10.1090/mcom/3069; Dutykh D, 2016, APPL MATH MODEL, V40, P9767, DOI 10.1016/j.apm.2016.06.033; Godlewski E., 1996, APPL MATH SCI; Greenberg JM, 1996, SIAM J NUMER ANAL, V33, P1, DOI 10.1137/0733001; Guner O, 2017, NONLIN SCI LETT A, V8, P405; Hubbard ME, 2000, J COMPUT PHYS, V165, P89, DOI 10.1006/jcph.2000.6603; Javeed S, 2013, CHEM ENG SCI, V90, P17, DOI 10.1016/j.ces.2012.12.014; Jin S, 2001, ESAIM-MATH MODEL NUM, V35, P631, DOI 10.1051/m2an:2001130; Kupferman R, 1997, P NATL ACAD SCI USA, V94, P4848, DOI 10.1073/pnas.94.10.4848; Kurganov A, 2002, ESAIM-MATH MODEL NUM, V36, P397, DOI 10.1051/m2an:2002019; Kurganov A, 2007, COMMUN MATH SCI, V5, P133; Liu HY, 2016, THERM SCI, V20, P889, DOI 10.2298/TSCI1603889L; MANDAL JC, 1994, COMPUT FLUIDS, V23, P447, DOI 10.1016/0045-7930(94)90050-7; NESSYAHU H, 1990, J COMPUT PHYS, V87, P408, DOI 10.1016/0021-9991(90)90260-8; Nisar UA, 2016, COMPUT PHYS COMMUN, V205, P69, DOI 10.1016/j.cpc.2016.04.013; Perthame B, 2001, CALCOLO, V38, P201, DOI 10.1007/s10092-001-8181-3; Qamar S, 2014, COMPUT FLUIDS, V96, P136, DOI 10.1016/j.compfluid.2014.03.015; Qamar S, 2014, INT J COMP METH-SING, V11, DOI 10.1142/S0219876213500485; Qamar S, 2013, COMPUT PHYS COMMUN, V184, P1349, DOI 10.1016/j.cpc.2012.12.021; Qamar S, 2012, IND ENG CHEM RES, V51, P9173, DOI 10.1021/ie3005622; Qamar S, 2010, COMPUT PHYS COMMUN, V181, P1109, DOI 10.1016/j.cpc.2010.02.019; Qamar S, 2009, J COMPUT PHYS, V228, P9059, DOI 10.1016/j.jcp.2009.09.010; RIPA P, 1995, J FLUID MECH, V303, P169, DOI 10.1017/S0022112095004228; Saint-Venant A., 1871, CR HEBD ACAD SCI, V73, P147; Saurel R, 1999, J COMPUT PHYS, V150, P425, DOI 10.1006/jcph.1999.6187; SAVAGE SB, 1991, ACTA MECH, V86, P201, DOI 10.1007/BF01175958; SAVAGE SB, 1989, J FLUID MECH, V199, P177, DOI 10.1017/S0022112089000340; Shu C.W., 1998, NASACR97206253; Singh H., 2017, NONLINEAR SCI LETT A, V8, P397; Tang HZ, 2000, J COMPUT PHYS, V165, P69, DOI 10.1006/jcph.2000.6597; Tang HZ, 2000, COMPUT FLUIDS, V29, P917, DOI 10.1016/S0045-7930(99)00042-0; Tang HZ, 2004, Z ANGEW MATH PHYS, V55, P365, DOI 10.1007/s00033-003-1119-7; Toro E.F., 2001, SHOCK CAPTURING METH; Touma R, 2015, APPL NUMER MATH, V97, P42, DOI 10.1016/j.apnum.2015.07.001; van Leer B., 1982, LECTURE NOTES PHYSIC, V170, P507, DOI [DOI 10.1007/3-540-11948-5_66, 10.1007/3-540-11948-5_66]; WEATHERILL NP, 1994, INT J NUMER METH ENG, V37, P623, DOI 10.1002/nme.1620370406; Xu K, 1999, J COMPUT PHYS, V153, P334, DOI 10.1006/jcph.1999.6280; XU K, 1995, J COMPUT PHYS, V120, P48, DOI 10.1006/jcph.1995.1148; Xu K, 2002, J COMPUT PHYS, V178, P533, DOI 10.1006/jcph.2002.7040; Zhou JG, 2001, J COMPUT PHYS, V168, P1, DOI 10.1006/jcph.2000.6670; Zia S, 2014, COMPUT MATH APPL, V67, P1271, DOI 10.1016/j.camwa.2014.01.015	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197500	10.1371/journal.pone.0197500	http://dx.doi.org/10.1371/journal.pone.0197500			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851978	Green Published, gold, Green Submitted			2022-12-26	WOS:000433893200016
J	Cugmas, M; Ferligoj, A; Ziberna, A				Cugmas, Marjan; Ferligoj, Anuska; Ziberna, Ales			Generating global network structures by triad types	PLOS ONE			English	Article							MODELS; PSEUDOLIKELIHOOD; COMMUNICATION; KNOWLEDGE; DYNAMICS; BALANCE	This paper addresses the question of whether one can generate networks with a given global structure (defined by selected blockmodels, i.e., cohesive, core-periphery, hierarchical, and transitivity), considering only different types of triads. Two methods are used to generate networks: (i) the newly proposed method of relocating links; and (ii) the Monte Carlo Multi Chain algorithm implemented in the ergm package in R. Most of the selected blockmodel types can be generated by considering all types of triads. The selection of only a subset of triads can improve the generated networks' blockmodel structure. Yet, in the case of a hierarchical blockmodel without complete blocks on the diagonal, additional local structures are needed to achieve the desired global structure of generated networks. This shows that blockmodels can emerge based only on local processes that do not take attributes into account.	[Cugmas, Marjan; Ferligoj, Anuska; Ziberna, Ales] Univ Ljubljana, Fac Social Sci, Ljubljana, Slovenia	University of Ljubljana	Cugmas, M (corresponding author), Univ Ljubljana, Fac Social Sci, Ljubljana, Slovenia.	marjan.cugmas@fdv.uni-lj.si	Cugmas, Marjan/AAQ-1751-2020; Žiberna, Aleš/C-3809-2008; Ferligoj, Anuska/A-3675-2009	Cugmas, Marjan/0000-0002-1715-2460; Žiberna, Aleš/0000-0003-1534-6971; 	Slovenian Research Agency [P5-0168, J7-8279]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The project was financially supported by the Slovenian Research Agency (www.arrs.gov.si) within the "Young researchers" program, the research program P5-0168 and under the research project J7-8279 (Blockmodeling multilevel and temporal networks).	Ahuja MK, 1999, ORGAN SCI, V10, P741, DOI 10.1287/orsc.10.6.741; Alderson AS, 2004, AM J SOCIOL, V109, P811, DOI 10.1086/378930; [Anonymous], [No title captured]; BARNETT GA, 1992, HUM COMMUN RES, V19, P264, DOI 10.1111/j.1468-2958.1992.tb00302.x; Batagelj V, 1997, SOC NETWORKS, V19, P143, DOI 10.1016/S0378-8733(96)00297-3; BATAGELJ V, 1992, SOC NETWORKS, V14, P63, DOI 10.1016/0378-8733(92)90014-X; Batagelj V., 1998, DATA SCI CLASSIFICAT, P199; Batagelj V., 2004, METODOLOSKI ZVEZKI, V1, P455; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Borgatti SP, 1999, SOC NETWORKS, V21, P375; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Cattani G, 2008, ORGAN SCI, V19, P824, DOI 10.1287/orsc.1070.0350; CHASE ID, 1982, BEHAVIOUR, V80, P218, DOI 10.1163/156853982X00364; Chinchilla-Rodriguez Z, 2012, SCIENTOMETRICS, V93, P699, DOI 10.1007/s11192-012-0794-6; Corander J, 1998, MAXIMUM LIKELIHOOD E; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Cugmas M, 2016, SCIENTOMETRICS, V106, P163, DOI 10.1007/s11192-015-1790-4; Da Silva MR, 2008, P IEEE, V96, P1411, DOI 10.1109/JPROC.2008.925418; DAVIS JA, 1967, HUM RELAT, V20, P181, DOI 10.1177/001872676702000206; Davis JA, 1967, STRUCTURE POSITIVE I; DOREIAN P, 1994, J MATH SOCIOL, V19, P1, DOI 10.1080/0022250X.1994.9990133; FARARO TJ, 1986, AM SOCIOL REV, V51, P591, DOI 10.2307/2095486; Faust K., 2006, METODOLOSKI ZVEZKI A, V3, P185, DOI DOI 10.1002/SMJ.444; Gluckler J, 2016, SOC NETWORKS, V47, P156, DOI 10.1016/j.socnet.2016.07.002; Hedstrom P, 2010, ANNU REV SOCIOL, V36, P49, DOI 10.1146/annurev.soc.012809.102632; Hedstrom P, 1996, ACTA SOCIOL, V39, P281, DOI 10.1177/000169939603900302; Hedstrom P, 2015, SOCIOL METHOD RES, V44, P179, DOI 10.1177/0049124115581211; HOLLAND PW, 1971, COMP GROUP STUD, V2, P107, DOI 10.1177/104649647100200201; Homans G. C., 1950, HUMAN GROUP; Hu C, 2008, INT J HOSP MANAG, V27, P302, DOI 10.1016/j.ijhm.2007.01.002; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Hyvarinen A, 2007, IEEE T NEURAL NETWOR, V18, P1529, DOI 10.1109/TNN.2007.895819; JOHNSEN EC, 1985, SOC NETWORKS, V7, P203, DOI 10.1016/0378-8733(85)90015-2; Kejzar N, 2007, EVOLUTION NETWORKS; Kogut B, 2000, STRATEGIC MANAGE J, V21, P405, DOI 10.1002/(SICI)1097-0266(200003)21:3<405::AID-SMJ103>3.0.CO;2-5; Kronegger L, 2011, QUAL QUANT, V45, P989, DOI 10.1007/s11135-011-9484-3; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; LEINHARDT S, 1973, BEHAV SCI, V18, P260, DOI 10.1002/bs.3830180405; Lewin K., 1936, PRINCIPLES TOPOLOGIC, DOI [https://doi.org/10.1037/10019-000, DOI 10.1037/10019-000]; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250X.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250x.1971.9989788]; Luczkovich JJ, 2003, J THEOR BIOL, V220, P303, DOI 10.1006/jtbi.2003.3147; Matias C, 2017, J ROYAL STAT SOC B, V79; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nadel S. F., 1957, THEORY SOCIAL STRUCT; Oberg A, 2008, SCAND J MANAG, V24, P183, DOI 10.1016/j.scaman.2008.03.011; Prota L, 2016, SOC NETWORKS, V45, P1, DOI 10.1016/j.socnet.2015.10.005; Prota L, 2013, MODELING COOPERATIVE; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Schaefer DR, 2010, SOC NETWORKS, V32, P61, DOI 10.1016/j.socnet.2009.04.003; Shen K, 2015, J NEUROSCI, V35, P5579, DOI 10.1523/JNEUROSCI.4903-14.2015; Skvoretz J, 1996, J MATH SOCIOL, V21, P57, DOI 10.1080/0022250X.1996.9990174; SNIJDERS TAB, 1981, SOC NETWORKS, V3, P163, DOI 10.1016/0378-8733(81)90014-9; STRAUSS D, 1990, J AM STAT ASSOC, V85, P204, DOI 10.2307/2289546; Team R. C., 2000, R LANG DEF; Toivonen R, 2009, SOC NETWORKS, V31, P240, DOI 10.1016/j.socnet.2009.06.004; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WHITE HC, 1976, AM J SOCIOL, V81, P730, DOI 10.1086/226141; Xing EP, 2010, ANN APPL STAT, V4, P535, DOI 10.1214/09-AOAS311; Xu Kevin S., 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P201, DOI 10.1007/978-3-642-37210-0_22; Ziberna A, BLOCKMODELING 01 7 R; Ziberna A, 2016, METHODS SER, V12, P173, DOI 10.1007/978-3-319-24520-1_8	61	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197514	10.1371/journal.pone.0197514	http://dx.doi.org/10.1371/journal.pone.0197514			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847563	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800035
J	Drent, E; Poels, R; Mulders, MJ; van de Donk, NWCJ; Themeli, M; Lokhorst, HM; Mutis, T				Drent, Esther; Poels, Renee; Mulders, Manon J.; van de Donk, Niels W. C. J.; Themeli, Maria; Lokhorst, Henk M.; Mutis, Tuna			Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design	PLOS ONE			English	Article							ANTIGEN RECEPTORS; SUICIDE GENE; THERAPY; SAFETY; RECOGNITION; PERSISTENCE; MANAGEMENT; IMPROVE; CD19	Recent clinical advances with chimeric antigen receptor (CAR) T cells have led to the accelerated clinical approval of CD19-CARs to treat acute lymphoblastic leukemia. The CAR T cell therapy is nevertheless associated with toxicities, especially if the CARs are not entirely tumor-specific. Therefore, strategies for controlling the CAR T cell activity are required to improve their safety profile. Here, by using the multiple myeloma (MM)-associated CD38 molecule as target molecule, we tested the feasibility and utility of a doxycycline (DOX) inducible Tet-on CD38-CAR design to control the off-target toxicities of CAR T cells. Using CARs with high affinity to CD38, we demonstrate that this strategy allows the proper induction of CD38-CARs and CAR-mediated T cell cytotoxicity in a DOX-dose dependent manner. Especially when the DOX dose was limited to 10ng/ml, its removal resulted in a relatively rapid decay of CAR-related off-tumor effects within 24 hours, indicating the active controllability of undesired CAR activity. This Tet-on CAR design also allowed us to induce the maximal anti-MM cytotoxic activity of affinity-optimized CD38-CAR T cells, which already display a low toxicity profile, hereby adding a second level of safety to these cells. Collectively, these results indicate the possibility to utilize this DOX inducible CAR-design to actively regulate the CAR-mediated activities of therapeutic T cells. We therefore conclude that the Tet-on system may be more advantageous above suicide-genes to control the potential toxicities of CAR T cells without the need to destroy them permanently.	[Drent, Esther; Poels, Renee; Mulders, Manon J.; van de Donk, Niels W. C. J.; Themeli, Maria; Lokhorst, Henk M.; Mutis, Tuna] Vrije Univ Amsterdam Med Ctr, Dept Hematol, De Boelelaan, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Drent, E (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Hematol, De Boelelaan, Amsterdam, Netherlands.	e.drent@vumc.nl		van de Donk, Niels/0000-0002-7445-2603; Themeli, Maria/0000-0003-0585-7786	'Fonds Stimulans', a Dutch non-profit foundation stimulating Multiple Myeloma research, The Netherlands	'Fonds Stimulans', a Dutch non-profit foundation stimulating Multiple Myeloma research, The Netherlands	Esther Drent and Tuna Mutis received financial support from 'Fonds Stimulans', a Dutch non-profit foundation stimulating Multiple Myeloma research, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Drent E, 2017, MOL THER, V25, P1946, DOI 10.1016/j.ymthe.2017.04.024; Drent E, 2016, HAEMATOLOGICA, V101, P616, DOI 10.3324/haematol.2015.137620; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; FREEMAN SM, 1993, CANCER RES, V53, P5274; Griffioen M, 2009, HAEMATOL-HEMATOL J, V94, P1316, DOI 10.3324/haematol.2008.001677; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Holloway PA, 2005, BRIT J HAEMATOL, V128, P73, DOI 10.1111/j.1365-2141.2004.05283.x; Juillerat A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39833; Juillerat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18950; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kim MS, 2015, J AM CHEM SOC, V137, P2832, DOI 10.1021/jacs.5b00106; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Krejcik J, 2016, BLOOD, V128, P384, DOI 10.1182/blood-2015-12-687749; Lamers CHJ, 2006, J CLIN ONCOL, V24, P904, DOI [10.1200/JCO.2005.03.1955, DOI 10.1200/JCO.2005.03.1955]; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Li H, 2017, PROTEIN CELL, V8, P573, DOI 10.1007/s13238-017-0411-9; Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035; Mesnil M, 2000, CANCER RES, V60, P3989; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Namuduri M, 2016, EXPERT REV HEMATOL, V9, P511, DOI 10.1080/17474086.2016.1183479; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Rozemuller H, 2008, HAEMATOL-HEMATOL J, V93, P1049, DOI 10.3324/haematol.12349; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sakemura R, 2016, CANCER IMMUNOL RES, V4, P658, DOI 10.1158/2326-6066.CIR-16-0043; Sun J, 2015, CELL RES, V25, P1281, DOI 10.1038/cr.2015.131; Tey SK, 2007, BIOL BLOOD MARROW TR, V13, P913, DOI 10.1016/j.bbmt.2007.04.005; van der Stegen SJC, 2013, J IMMUNOL, V191, P4589, DOI 10.4049/jimmunol.1301523; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077	44	43	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197349	10.1371/journal.pone.0197349	http://dx.doi.org/10.1371/journal.pone.0197349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847570	Green Submitted, Green Published, gold			2022-12-26	WOS:000433634800030
J	Sheng, XZ; Liu, M; Liu, HB; Tang, XQ; Xing, J; Zhan, WB				Sheng, Xiuzhen; Liu, Min; Liu, Haibo; Tang, Xiaoqian; Xing, Jing; Zhan, Wenbin			Identification of immunogenic proteins and evaluation of recombinant PDHA1 and GAPDH as potential vaccine candidates against Streptococcus iniae infection in flounder (Paralichthys olivaceus)	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; EDWARDSIELLA-TARDA; PROTECTIVE EFFICACY; SUBUNIT VACCINE; DNA VACCINE; IMMUNOPROTECTIVE ANALYSIS; LACTATE-DEHYDROGENASE; IMMUNE ENHANCEMENT; VIBRIO-ANGUILLARUM; CHANNEL CATFISH	Streptococcus iniae is a major Gram-positive pathogen that causes invasive disease in fish worldwide. In this study, in order to identify immunogenic proteins for developing highly effective vaccine against S. iniae, whole-cell lysate proteins of S. iniae were analyzed by western blotting using flounder anti-S. iniae antibodies, and two positive protein bands of molecular weight 37 kDa and 40 kDa were screened, which were identified as pyruvate dehydrogenase E1 subunit alpha (PDHA1), BMP family ABC transporter substrate-binding protein (BMP) and L-lactate dehydrogenase (LDH), as well as ornithine carbamoyltransferase (OCT), lactate oxidas (LOx) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by mass spectrometry. Subsequently, the six recombinant proteins were produced and used to immunize healthy flounder, and the relative percent survival (RPS) value was 72.73%, 27.27%, 36.36%, 9.09%, 36.36% and 63.64% respectively after intraperitoneal challenge with live S. iniae, revealing that rPDHA1 and rGAPDH produced higher relative percent survival than formalin-killed S. iniae (36.36%). To further investigate the protective efficacy of rPDHA1 and rGAPDH, the proliferation of surface membrane immunoglobulin-positive (sIg(+)) lymphocytes in peripheral blood leucocytes, the total serum IgM, specific IgM against S. iniae and RPS were detected. The results showed that rPDHA1, rGAPDH and formalin-killed S. iniae significantly induced the proliferation of sIg(+) lymphocytes, the production of total serum IgM and specific IgM as compared with the control group, and rGAPDH and rPDHA1 provide higher RPS (62.5% and 75%, respectively) again. These results demonstrated that rPDHA1 and rGAPDH are promising vaccine candidates against S. iniae infection in flounder.	[Sheng, Xiuzhen; Liu, Min; Liu, Haibo; Tang, Xiaoqian; Xing, Jing; Zhan, Wenbin] Ocean Univ China, Lab Pathol & Immunol Aquat Anim, KLMME, Qingdao, Peoples R China; [Zhan, Wenbin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Zhan, WB (corresponding author), Ocean Univ China, Lab Pathol & Immunol Aquat Anim, KLMME, Qingdao, Peoples R China.; Zhan, WB (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	wbzhan@ouc.edu.cn			National Natural Science Foundations of China [31472295, 31730101, 31672685]; Taishan Scholar Program of Shandong Province	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program of Shandong Province	This work was supported by grants from the National Natural Science Foundations of China (31472295, 31730101 and 31672685) and Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Aviles F, 2013, VET MICROBIOL, V162, P151, DOI 10.1016/j.vetmic.2012.08.018; Baiano JCF, 2009, EMERG INFECT DIS, V15, P1891, DOI 10.3201/eid1512.090232; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Cheng S, 2010, VACCINE, V28, P2636, DOI 10.1016/j.vaccine.2010.01.016; El Aamri F, 2010, J FISH DIS, V33, P901, DOI 10.1111/j.1365-2761.2010.01191.x; Eldar A, 1997, VET IMMUNOL IMMUNOP, V56, P175, DOI 10.1016/S0165-2427(96)05738-8; Facklam R, 2005, J CLIN MICROBIOL, V43, P933, DOI 10.1128/JCM.43.2.933-937.2005; Gao YL, 2015, DIS AQUAT ORGAN, V116, P111, DOI 10.3354/dao02909; He Y, 2014, VACCINE, V32, P7025, DOI 10.1016/j.vaccine.2014.08.017; Heppell J, 2000, ADV DRUG DELIVER REV, V43, P29, DOI 10.1016/S0169-409X(00)00075-2; Jiang J, 2015, INT J MOL SCI, V16, P28001, DOI 10.3390/ijms161226082; Kayansamruaj P, 2017, AQUACULTURE, V468, P102, DOI 10.1016/j.aquaculture.2016.10.001; KIM MS, 2015, J FISH PATHOL, V28, P9, DOI DOI 10.7847/jfp.2015.28.1.009; Klesius PH, 2000, AQUACULTURE, V188, P237, DOI 10.1016/S0044-8486(00)00345-8; LaFrentz BR, 2011, VET MICROBIOL, V152, P346, DOI 10.1016/j.vetmic.2011.04.033; Li CC, 2014, VACCINE, V32, P6115, DOI 10.1016/j.vaccine.2014.08.077; Li Q, 2007, FISH SHELLFISH IMMUN, V23, P982, DOI 10.1016/j.fsi.2007.03.008; Liu FG, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071117; Liu FG, 2017, VET IMMUNOL IMMUNOP, V185, P38, DOI 10.1016/j.vetimm.2017.01.008; Locke JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002824; Membrebe JD, 2016, VET IMMUNOL IMMUNOP, V170, P25, DOI 10.1016/j.vetimm.2016.01.004; Nho SW, 2009, FEMS MICROBIOL LETT, V293, P20, DOI 10.1111/j.1574-6968.2009.01491.x; Pang HY, 2013, AQUAC RES, V44, P472, DOI 10.1111/j.1365-2109.2012.03150.x; Perez-Casal J, 2016, VACCINE, V34, P1012, DOI 10.1016/j.vaccine.2015.11.072; Schaap D, 2004, PARASITOLOGY, V128, P603, DOI 10.1017/S0031182004005104; Shoemaker CA, 2001, AM J VET RES, V62, P174, DOI 10.2460/ajvr.2001.62.174; Soltani M, 2007, IRAN J FISH SCI, V7, P129; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Song HY, 2010, EXP PARASITOL, V126, P224, DOI 10.1016/j.exppara.2010.05.015; Sun K, 2009, VACCINE, V27, P2733, DOI 10.1016/j.vaccine.2009.03.012; Sun M, 2015, STUDIES ANTIGENICITY; Sun Y, 2010, VACCINE, V28, P3905, DOI 10.1016/j.vaccine.2010.03.071; Tafalla C, 2013, FISH SHELLFISH IMMUN, V35, P1740, DOI 10.1016/j.fsi.2013.02.029; Tang XQ, 2017, MICROB PATHOGENESIS, V113, P152, DOI 10.1016/j.micpath.2017.10.043; Tonheim TC, 2008, FISH SHELLFISH IMMUN, V25, P1, DOI 10.1016/j.fsi.2008.03.007; Verjan N, 2005, APPL ENVIRON MICROB, V71, P5654, DOI 10.1128/AEM.71.9.5654-5658.2005; Wang C, 2012, J PROTEOMICS, V75, P1263, DOI 10.1016/j.jprot.2011.11.001; Wang YT, 2014, FISH SHELLFISH IMMUN, V41, P250, DOI 10.1016/j.fsi.2014.09.008; Xing J, 2017, VACCINE, V35, P3196, DOI 10.1016/j.vaccine.2017.04.071; Xing J, 2017, MICROB PATHOGENESIS, V107, P155, DOI 10.1016/j.micpath.2017.03.027; Xu GJ, 2013, FISH SHELLFISH IMMUN, V35, P653, DOI 10.1016/j.fsi.2013.05.024; Yamasaki M, 2015, FISH SHELLFISH IMMUN, V45, P437, DOI 10.1016/j.fsi.2015.04.038; Zamri-Saad M., 2014, Pertanika Journal of Tropical Agricultural Science, V37, P389; Zhang Z, 2012, FISH SHELLFISH IMMUN, V32, P391, DOI 10.1016/j.fsi.2011.11.014; Zou LL, 2011, VACCINE, V29, P391, DOI 10.1016/j.vaccine.2010.10.062	47	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0195450	10.1371/journal.pone.0195450	http://dx.doi.org/10.1371/journal.pone.0195450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847601	Green Submitted, Green Published, gold			2022-12-26	WOS:000433634800006
J	Qian, JJ; Akcay, E				Qian, Jimmy J.; Akcay, Erol			Competition and niche construction in a model of cancer metastasis	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR-CELLS; GROWTH; HETEROGENEITY; PROGRESSION; ANGIOGENESIS; EVOLUTION; MICROENVIRONMENT; DETERMINANT; RECRUITMENT	Niche construction theory states that not only does the environment act on populations to generate Darwinian selection, but organisms reciprocally modify the environment and the sources of natural selection. Cancer cells participate in niche construction as they alter their microenvironments and create pre-metastatic niches; in fact, metastasis is a product of niche construction. Here, we present a mathematical model of niche construction and metastasis. Our model contains producers, which pay a cost to contribute to niche construction that benefits all tumor cells, and cheaters, which reap the benefits without paying the cost. We derive expressions for the conditions necessary for metastasis, showing that the establishment of a mutant lineage that promotes metastasis depends on niche construction specificity and strength of interclonal competition. We identify a tension between the arrival and invasion of metastasis-promoting mutants, where tumors composed only of cheaters remain small but are susceptible to invasion whereas larger tumors containing producers may be unable to facilitate metastasis depending on the level of niche construction specificity. Our results indicate that even if metastatic subclones arise through mutation, metastasis may be hindered by interclonal competition, providing a potential explanation for recent surprising findings that most metastases are derived from early mutants in primary tumors.	[Qian, Jimmy J.; Akcay, Erol] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Akcay, E (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	eakcay@sas.upenn.edu		Qian, Jimmy/0000-0002-7871-8333	Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences at the University of Pennsylvania	Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences at the University of Pennsylvania	J.J.Q. was supported by a summer stipend from the Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences at the University of Pennsylvania (http://www.sas.upenn.edu/biochem/vspmls.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Archetti M, 2013, BRIT J CANCER, V109, P1056, DOI 10.1038/bjc.2013.336; Archetti M, 2015, P NATL ACAD SCI USA, V112, P1833, DOI 10.1073/pnas.1414653112; Barar J, 2013, BIOIMPACTS, V3, P149, DOI 10.5681/bi.2013.036; Basanta D, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0020; Bergman A, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15203-5; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bodnar M, 2009, J BIOL SYST, V17, P1, DOI 10.1142/S0218339009002739; Bragado Paloma, 2012, Recent Results Cancer Res, V195, P25, DOI 10.1007/978-3-642-28160-0_3; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Cos S, 1996, LIFE SCI, V58, P811, DOI 10.1016/0024-3205(95)02359-3; Daenen LGM, 2011, CANCER RES, V71, P6976, DOI 10.1158/0008-5472.CAN-11-0627; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Ferreira SC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021907; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gerlee P, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/5/056001; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ibrahim-Hashim A, 2017, ECOLOGY EVOLUTION CA, P111; Iskandar R., 2016, THEORETICAL MODEL BR; Jackson AL, 1998, GENETICS, V148, P1483; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kareva Irina, 2015, Biology Theory, V10, P283, DOI 10.1007/s13752-015-0226-y; Klein CA, 2006, CELL CYCLE, V5, P1788, DOI 10.4161/cc.5.16.3097; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Korolev KS, 2014, NAT REV CANCER, V14, P371, DOI 10.1038/nrc3712; Krepkin K., 2010, ROLE COOPERATION PRE; Krepkin K, 2011, J THEOR BIOL, V285, P36, DOI 10.1016/j.jtbi.2011.06.035; Laland K, 2016, EVOL ECOL, V30, P191, DOI 10.1007/s10682-016-9821-z; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; LEVINS R, 1966, AM SCI, V54, P421; Liu YL, 2010, AM J PATHOL, V176, P2490, DOI 10.2353/ajpath.2010.090777; Lloyd M.C., 2017, ECOLOGY EVOLUTION CA, P153, DOI [10.1016/B978-0-12-804310-3. 00011-9, DOI 10.1016/B978-0-12-804310-3.00011-9, 10.1016/b978-0-12-804310-3.00011-9]; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Nakamura T, 2007, CANCER RES, V67, P7597, DOI 10.1158/0008-5472.CAN-07-0874; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; NERI A, 1982, J NATL CANCER I, V68, P507; Odling-Smee F. J., 2003, NICHE CONSTRUCTION N, V37; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pescarmona GP, 1999, MED HYPOTHESES, V53, P497, DOI 10.1054/mehy.1999.0798; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Roodhart JM, 2010, NEOPLASIA, V12, P87, DOI 10.1593/neo.91460; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Scalerandi M, 1999, PHYS REV E, V59, P2206, DOI 10.1103/PhysRevE.59.2206; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Servedio MR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002017; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wey Jane S, 2004, Clin Adv Hematol Oncol, V2, P37; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang KR, 2014, J CELL BIOCHEM, V115, P1478, DOI 10.1002/jcb.24813; Zhao ZM, 2016, P NATL ACAD SCI USA, V113, P2140, DOI 10.1073/pnas.1525677113	71	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198163	10.1371/journal.pone.0198163	http://dx.doi.org/10.1371/journal.pone.0198163			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813117	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800052
J	Tsai, CK; Kao, TW; Lee, JT; Wang, CC; Chou, CH; Liang, CS; Yang, FC; Chen, WL				Tsai, Chia-Kuang; Kao, Tung-Wei; Lee, Jiunn-Tay; Wang, Chung-Ching; Chou, Chung-Hsing; Liang, Chih-Sung; Yang, Fu-Chi; Chen, Wei-Liang			Global-cognitive health metrics: A novel approach for assessing cognition impairment in adult population	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; C-REACTIVE PROTEIN; CARDIOVASCULAR HEALTH; AEROBIC FITNESS; CARDIORESPIRATORY FITNESS; HIPPOCAMPAL VOLUME; HEARING IMPAIRMENT; OLDER-ADULTS; EXERCISE; EDUCATION	Dementia is the supreme worldwide burden for welfare and the health care system in the 21st century. The early identification and control of the modifiable risk factors of dementia are important. Global-cognitive health (GCH) metrics, encompassing controllable cardiovascular health (CVH) and non-CVH risk factors of dementia, is a newly developed approach to assess the risk of cognitive impairment. The components of ideal GCH metrics includes better education, non-obesity, normal blood pressure, no smoking, no depression, ideal physical activity, good social integration, normal glycated hemoglobin (HbA1c), and normal hearing. This study focuses on the association between ideal GCH metrics and the cognitive function in young adults by investigating the Third Health and Nutrition Examination Survey (NHANES III) database, which has not been reported previously. A total of 1243 participants aged 17 to 39 years were recruited in this study. Cognitive functioning was evaluated by the simple reaction time test (SRTT), symbol-digit substitution test (SDST), and serial digit learning test (SDLT). Participants with significantly higher scores of GCH metrics had better cognitive performance (p for trend < 0.01 in three cognitive tests). Moreover, better education, ideal physical activity, good social integration and normal glycated hemoglobin were the optimistic components of ideal GCH metrics associated with better cognitive performance after adjusting for covariates (p < 0.05 in three cognitive tests). These findings emphasize the importance of a preventive strategy for modifiable dementia risk factors to enhance cognitive functioning during adulthood.	[Tsai, Chia-Kuang; Lee, Jiunn-Tay; Chou, Chung-Hsing] Triserv Gen Hosp, Dept Neurol, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Chia-Kuang; Chou, Chung-Hsing; Liang, Chih-Sung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Kao, Tung-Wei; Wang, Chung-Ching; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Kao, Tung-Wei; Wang, Chung-Ching; Liang, Chih-Sung; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Liang, Chih-Sung] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Liang, Chih-Sung] Triserv Gen Hosp, Natl Def Med Ctr, Beitou Branch, Dept Psychiat, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.	weiliang0508@gmail.com	Liang, Chih-Sung/V-6720-2019; Tsai, Chia-Kuang/AAR-8144-2021	Liang, Chih-Sung/0000-0003-1138-5586; Yang, Fu-Chi/0000-0001-6831-3634; Tsai, Chia-Kuang/0000-0001-7693-1408	Ministry of Science and Technology [MOST-106-2314-B-016-010]; Ministry of National Defense Medical Affairs Bureau [MAB-106-044]; Tri-Service General Hospital [TSGH-C105-082]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of National Defense Medical Affairs Bureau; Tri-Service General Hospital	This study was partially supported by grants from the Ministry of Science and Technology (MOST-106-2314-B-016-010 to CKT), Ministry of National Defense Medical Affairs Bureau (MAB-106-044 to CKT), Tri-Service General Hospital (TSGH-C105-082 to CKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Almeida RP, 2015, JAMA NEUROL, V72, P699, DOI 10.1001/jamaneurol.2015.0098; Alzheimer's Disease International, 2013, GLOB IMP DEM 2013 20; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Corral M, 2006, DEV NEUROPSYCHOL, V29, P479, DOI 10.1207/s15326942dn2903_6; Deal JA, 2017, J GERONTOL A-BIOL, V72, P703, DOI 10.1093/gerona/glw069; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ford ES, 2006, ANN EPIDEMIOL, V16, P78, DOI 10.1016/j.annepidem.2005.08.005; Gonzalez HM, 2016, J ALZHEIMERS DIS, V53, P955, DOI 10.3233/JAD-151125; Gopinath B, 2009, J AM GERIATR SOC, V57, P1306, DOI 10.1111/j.1532-5415.2009.02317.x; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Herting MM, 2012, BEHAV BRAIN RES, V233, P517, DOI 10.1016/j.bbr.2012.05.012; Hwang J, 2017, PHYSIOL BEHAV, V179, P75, DOI 10.1016/j.physbeh.2017.05.011; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Intlekofer KA, 2013, NEUROPSYCHOPHARMACOL, V38, P2027, DOI 10.1038/npp.2013.104; Jonas BS, 2010, DISABIL HEALTH J, V3, P171, DOI 10.1016/j.dhjo.2009.11.001; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Krieg EF, 2001, NEUROTOXICOL TERATOL, V23, P569, DOI 10.1016/S0892-0362(01)00177-5; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Lin FR, 2014, NEUROIMAGE, V90, P84, DOI 10.1016/j.neuroimage.2013.12.059; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Marcus AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173370; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Milgram NW, 2006, AGEING RES REV, V5, P354, DOI 10.1016/j.arr.2006.04.004; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; Ngandu T, 2007, NEUROLOGY, V69, P1442, DOI 10.1212/01.wnl.0000277456.29440.16; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Piras F, 2011, HUM BRAIN MAPP, V32, P282, DOI 10.1002/hbm.21018; Plan and operation of the Third National Health and Nutrition Examination Survey, 1988, VITAL HLTH STAT, V1, P1; Prince M, 2015, WORLD ALZHEIMERS REP; Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836; Schultz SA, 2017, NEUROLOGY, V88, P1650, DOI 10.1212/WNL.0000000000003862; Scott SP, 2016, MED SCI SPORT EXER, V48, P1994, DOI 10.1249/MSS.0000000000000974; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Springer MV, 2005, NEUROPSYCHOLOGY, V19, P181, DOI 10.1037/0894-4105.19.2.181; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stewart R, 2008, PSYCHOSOM MED, V70, P936, DOI 10.1097/PSY.0b013e3181870aec; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; Taljaard DS, 2016, CLIN OTOLARYNGOL, V41, P718, DOI 10.1111/coa.12607; Tsai CK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004791; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Whiteman AS, 2016, NEUROIMAGE, V126, P229, DOI 10.1016/j.neuroimage.2015.11.049; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zhang N, 2016, EUR J NEUROL, V23, P1447, DOI 10.1111/ene.13056	54	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197691	10.1371/journal.pone.0197691	http://dx.doi.org/10.1371/journal.pone.0197691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813084	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800025
J	Ksionda, O; Mues, M; Wandler, AM; Donker, L; Tenhagen, M; Jun, J; Ducker, GS; Matlawska-Wasowska, K; Shannon, K; Shokat, KM; Roose, JP				Ksionda, Olga; Mues, Marsilius; Wandler, Anica M.; Donker, Lisa; Tenhagen, Milou; Jun, Jesse; Ducker, Gregory S.; Matlawska-Wasowska, Ksenia; Shannon, Kevin; Shokat, Kevan M.; Roose, Jeroen P.			Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HYPERACTIVE RAS; MEK INHIBITION; CANCER; 3-KINASE; RESISTANCE; RESPONSES; NOTCH1; PTEN; PI3K-GAMMA	T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic cancer. Poly-chemotherapy with cytotoxic and genotoxic drugs causes substantial toxicity and more specific therapies targeting the underlying molecular lesions are highly desired. Perturbed Ras signaling is prevalent in T-ALL and occurs via oncogenic RAS mutations or through overexpression of the Ras activator RasGRP1 in similar to 65% of T-ALL patients. Effective small molecule inhibitors for either target do not currently exist. Genetic and biochemical evidence link phosphoinositide 3-kinase (PI3K) signals to T-ALL, PI3Ks are activated by Ras-dependent and Ras-independent mechanisms, and potent PI3K inhibitors exist. Here we performed comprehensive analyses of PI3K-Akt signaling in T-ALL with a focus on class I PI3K. We developed a multiplex, multiparameter flow cytometry platform with pan-and isoform-specific PI3K inhibitors. We find that pan-PI3K and PI3K gamma-specific inhibitors effectively block basal and cytokine-induced PI3K-Akt signals. Despite such inhibition, GDC0941 (pan-PI3K) or AS-605240 (PI3K gamma-specific) as single agents did not efficiently induce death in T-ALL cell lines. Combination of GDC0941 with AS-605240, maximally targeting all p110 isoforms, exhibited potent synergistic activity for clonal T-ALL lines in vitro, which motivated us to perform preclinical trials in mice. In contrast to clonal T-ALL lines, we used a T-ALL cancer model that recapitulates the multi-step pathogenesis and inter- and intratumoral genetic heterogeneity, a hallmark of advanced human cancers. We found that the combination of GDC0941 with AS-605240 fails in such trials. Our results reveal that PI3K inhibitors are a promising avenue for molecular therapy in T-ALL, but predict the requirement for methods that can resolve biochemical signals in heterogeneous cell populations so that combination therapy can be designed in a rational manner.	[Ksionda, Olga; Mues, Marsilius; Donker, Lisa; Tenhagen, Milou; Jun, Jesse; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Wandler, Anica M.; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Ducker, Gregory S.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol Pharmacol, San Francisco, CA USA; [Matlawska-Wasowska, Ksenia] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Ksionda, Olga] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Ducker, Gregory S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of New Mexico; University of New Mexico's Health Sciences Center; University of Auckland; Princeton University	Roose, JP (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	jeroen.roose@ucsf.edu		Ducker, Gregory/0000-0002-8651-6846; Matlawska-Wasowska, Ksenia/0000-0002-9903-5793; Roose, Jeroen/0000-0003-4746-2811	Gabrielle's Angel Foundation; Alex's Lemonade Stand Foundation Innovator Award; NIH/NCI [R01 - CA187318]; NIH/NHLBI [R01 - HL120724]; Leukemia & Lymphoma Society grant; KWF (Dutch Cancer Society); American Cancer Society [PF-14-070-01-TBG]; NIH [R01AI099245]; NATIONAL CANCER INSTITUTE [R01CA187318] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120724] Funding Source: NIH RePORTER	Gabrielle's Angel Foundation; Alex's Lemonade Stand Foundation Innovator Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leukemia & Lymphoma Society grant; KWF (Dutch Cancer Society)(KWF Kankerbestrijding); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research support for this study came from a Gabrielle's Angel Foundation grant, an Alex's Lemonade Stand Foundation Innovator Award, the NIH/NCI (R01 - CA187318), and the NIH/NHLBI (R01 - HL120724) (all to JPR). Further support came from a Leukemia & Lymphoma Society grant (MM) and the KWF (Dutch Cancer Society) (MT). AMW is supported by a Postdoctoral Fellowship, PF-14-070-01-TBG, from the American Cancer Society including a supplement from the Hillcrest Committee. KMS would like to thank NIH R01AI099245 for funding.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bressanin D, 2012, ONCOTARGET, V3, P811; Burgess MR, 2014, BLOOD, V124, P3947, DOI 10.1182/blood-2014-05-574582; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chiarini F, 2009, CANCER RES, V69, P3520, DOI 10.1158/0008-5472.CAN-08-4884; Dail M, 2014, NATURE, V513, P512, DOI 10.1038/nature13495; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; Deangelo D., 2006, J CLIN ONCOL, V24, P6585; Downward J, 2006, NATURE, V439, P274, DOI 10.1038/439274a; Floris G, 2013, CLIN CANCER RES, V19, P620, DOI 10.1158/1078-0432.CCR-12-2853; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Garcia-Martinez JM, 2011, BRIT J CANCER, V104, P1116, DOI 10.1038/bjc.2011.83; Gautam P, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0517-3; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hartzell C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003848; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kang S, 2005, CELL CYCLE, V4, P578, DOI 10.4161/cc.4.4.1593; Ksionda O, 2016, ONCOGENE, V35, P3658, DOI 10.1038/onc.2015.431; Ksionda Olga, 2013, Front Biol (Beijing), V8, P508; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Lonetti A, 2014, LEUKEMIA, V28, P1196, DOI 10.1038/leu.2013.369; Lonetti A, 2015, ONCOTARGET, V6, P10399, DOI 10.18632/oncotarget.3295; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martini M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00108; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Munugalavadla V, 2014, ONCOGENE, V33, P316, DOI 10.1038/onc.2012.594; Oki T, 2012, LEUKEMIA, V26, P1038, DOI 10.1038/leu.2011.328; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Subramaniam PS, 2012, CANCER CELL, V21, P459, DOI 10.1016/j.ccr.2012.02.029; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; von Lintig FC, 2000, CLIN CANCER RES, V6, P1804; Wallin JJ, 2012, CLIN CANCER RES, V18, P3901, DOI 10.1158/1078-0432.CCR-11-2088; Williams O, 2010, CHEM BIOL, V17, P123, DOI 10.1016/j.chembiol.2010.01.010	44	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0193849	10.1371/journal.pone.0193849	http://dx.doi.org/10.1371/journal.pone.0193849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799846	gold, Green Published, Green Submitted			2022-12-26	WOS:000433153400001
J	Rohena-Rivera, K; Bhowmick, NA				Rohena-Rivera, Krizia; Bhowmick, Neil A.			Notch inhibitor screening reveals an unexpected HES1 heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROHIBITIN 2; CANCER	Notch signaling plays critical roles in cancer progression, motivating efforts to identify inhibitors of this pathway. Perron et al. report a small-molecule screen intended to discover compounds that could interfere with the downstream transcription factor HES1. Target validation of their compounds unexpectedly identified a novel HES1-interacting protein, prohibitin 2. This highlights a new mechanism to block Notch signaling and prompting further exploration of HES1 biology.	[Rohena-Rivera, Krizia; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Bhowmick, Neil A.] Greater Los Angeles Vet Affairs Hosp, Dept Res, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019	Bhowmick, Neil/0000-0001-8747-5989	NCI, National Institutes of Health [CA098912]; U. S. Department of Veterans Affairs [I01BX001040]; NATIONAL CANCER INSTITUTE [P01CA098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007770] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001040] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NCI, National Institutes of Health Grant CA098912 and U. S. Department of Veterans Affairs Grant I01BX001040. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Kumar R, 2016, J MED CHEM, V59, P7719, DOI 10.1021/acs.jmedchem.5b01516; Liu ZH, 2015, CANCER BIOL THER, V16, P353, DOI 10.1080/15384047.2015.1016662; Locatelli MA, 2017, ONCOTARGET, V8, P2320, DOI 10.18632/oncotarget.13727; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Perron A, 2018, J BIOL CHEM, V293, P8285, DOI 10.1074/jbc.RA118.002316; Schnell SA, 2015, BLOOD, V125, P2806, DOI 10.1182/blood-2014-10-608448; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808; Yuan X, 2015, CANCER LETT, V369, P20, DOI 10.1016/j.canlet.2015.07.048	10	2	3	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8295	8296		10.1074/jbc.H118.002880	http://dx.doi.org/10.1074/jbc.H118.002880			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29802140	Green Published, hybrid			2022-12-26	WOS:000433224600033
J	Mallow, M; Gary, L; Jeng, T; Bongomin, B; Aschkenasy, MT; Wallis, P; Cranmer, HH; Debasu, E; Levine, AC				Mallow, Michaela; Gary, Lee; Jeng, Timmy; Bongomin, Bob, Jr.; Aschkenasy, Miriam Tamar; Wallis, Peter; Cranmer, Hilarie H.; Debasu, Estifanos; Levine, Adam C.			WASH activities at two Ebola treatment units in Sierra Leone	PLOS ONE			English	Article							WEST-AFRICA; OUTBREAK	Purpose The 2014 outbreak of Ebola virus disease (EVD) in West Africa was the largest in history. Starting in September 2014, International Medical Corps (IMC) operated five Ebola treatment units (ETUs) in Sierra Leone and Liberia. This paper explores how future infectious disease outbreak facilities in resource-limited settings can be planned, organized, and managed by analyzing data collected on water, sanitation, and hygiene (WASH) and infection prevention control (IPC) protocols. Design/Methodology/Approach We conducted a retrospective cohort study by analyzing WASH/IPC activity data routinely recorded on paper forms or white boards at ETUs during the outbreak and later merged into a database from two IMC-run ETUs in Sierra Leone between December 2014 and December 2015. Findings The IMC WASH/IPC database contains data from over 369 days. Our results highlight parameters key to designing and maintaining an ETU. High concentration chlorine solution usage was highly correlated with both daily patient occupancy and high-risk zone staff entries; low concentration chlorine usage was less well explained by these measures. There is high demand for laundering and disinfecting of personal protective equipment (PPE) on a daily basis and approximately 1 (0-4) piece of PPE is damaged each day. Research limitations/Implications Lack of standardization in the type and format of data collected at ETUs made constructing the WASH/IPC database difficult. However, the data presented here may help inform humanitarian response operations in future epidemics.	[Mallow, Michaela; Gary, Lee; Bongomin, Bob, Jr.; Aschkenasy, Miriam Tamar; Wallis, Peter; Cranmer, Hilarie H.; Debasu, Estifanos; Levine, Adam C.] Int Med Corps, Los Angeles, CA 90025 USA; [Gary, Lee] Tulane Univ, Payson Ctr Int Dev, New Orleans, LA 70118 USA; [Jeng, Timmy; Levine, Adam C.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Aschkenasy, Miriam Tamar; Cranmer, Hilarie H.] Massachusetts Gen Hosp, Global Hlth, Global Disaster Response, Boston, MA 02114 USA	Tulane University; Brown University; Harvard University; Massachusetts General Hospital	Levine, AC (corresponding author), Int Med Corps, Los Angeles, CA 90025 USA.; Levine, AC (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	adam_levine@brown.edu	; Levine, Adam/F-1813-2016	, Timmy Jeng/0000-0002-8161-4762; Levine, Adam/0000-0003-3982-3824				Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; CDC, 2015, REV HUM TO HUM TRANS; Dallatomasina S, 2015, TROP MED INT HEALTH, V20, P448, DOI 10.1111/tmi.12454; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Gleason B, 2014, ESTABLISHMENT EBOLA; Lu HJ, 2015, EMERG INFECT DIS, V21, P1921, DOI 10.3201/eid2111.150582; Roshania R, 2015, GLOBAL HLTH SCI PRAC; Sterk E, 2008, FILOVIRUS HAEMORRHAG; WHO, 2016, EB VIR DIS FACT SHEE; WHO, 2014, 3 M IHR EM COMM REG; World Health Organization, 2014, CLIN MAN PAT VIR HAE; World Health Organization, 2016, BERLIN HAYOM	12	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198235	10.1371/journal.pone.0198235	http://dx.doi.org/10.1371/journal.pone.0198235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795676	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300135
J	Monnahan, CC; Kristensen, K				Monnahan, Cole C.; Kristensen, Kasper			No-U-turn sampling for fast Bayesian inference in ADMB and TMB: Introducing the adnuts and tmbstan R packages	PLOS ONE			English	Article							STOCK ASSESSMENT; MODEL BUILDER; FRAMEWORK	Statistical inference is a widely-used, powerful tool for learning about natural processes in diverse fields. The statistical software platforms AD Model Builder (ADMB) and Template Model Builder (TMB) are particularly popular in the ecological literature, where they are typically used to perform frequentist inference of complex models. However, both lack capabilities for flexible and efficient Markov chain Monte Carlo (MCMC) integration. Recently, the no-U-turn sampler (NUTS) MCMC algorithm has gained popularity for Bayesian inference through the software Stan because it is efficient for high dimensional, complex hierarchical models. Here, we introduce the R packages adnuts and tmbstan, which provide NUTS sampling in parallel and interactive diagnostics with ShinyStan. The ADMB source code was modified to provide NUTS, while TMB models are linked directly into Stan. We describe the packages, provide case studies demonstrating their use, and contrast performance against Stan. For TMB models, we show how to test the accuracy of the Laplace approximation using NUTS. For complex models, the performance of ADMB and TMB was typically within +/-50% the speed of Stan. In one TMB case study we found inaccuracies in the Laplace approximation, potentially leading to biased inference. adnuts provides a new method for estimating hierarchical ADMB models which previously were infeasible. TMB users can fit the same model in both frequentist and Bayesian paradigms, including using NUTS to test the validity of the Laplace approximation of the marginal likelihood for arbitrary subsets of parameters. These software developments extend the available statistical methods of the ADMB and TMB user base with no additional effort by the user.	[Monnahan, Cole C.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Monnahan, Cole C.] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Kristensen, Kasper] Tech Univ Denmark, Natl Inst Aquat Resources, Kemitorvet, Denmark	University of Washington; University of Washington Seattle; Universidad de Concepcion; Technical University of Denmark	Monnahan, CC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.; Monnahan, CC (corresponding author), Univ Concepcion, Dept Oceanog, Concepcion, Chile.	monnahc@uw.edu		Monnahan, Cole/0000-0003-0871-6700; Kristensen, Kasper/0000-0003-3425-3762	Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement [NA150AR4320063, 2018-0128]; Washington Sea Grant, University of Washington [NA140AR4170078]	Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement; Washington Sea Grant, University of Washington(University of Washington)	This publication is partially funded by the Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement NA150AR4320063, Contribution No. 2018-0128. This work was partially funded in part by a grant from Washington Sea Grant, University of Washington, pursuant to National Oceanic and Atmospheric Administration Award No. NA140AR4170078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt M., 2016, ARXIV160100225; Betancourt M., 2017, ARXIV170102434; Betancourt M., 2015, CURRENT TRENDS BAYES; Bolker BM, 2013, METHODS ECOL EVOL, V4, P501, DOI 10.1111/2041-210X.12044; Brooks S, 2011, CH CRC HANDB MOD STA, pXIX; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Crone EE, 2004, ECOLOGY, V85, P1944, DOI 10.1890/03-0256; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Fournier DA, 1998, CAN J FISH AQUAT SCI, V55, P2105, DOI 10.1139/cjfas-55-9-2105; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Gelman A., 2021, BAYESIAN DATA ANAL; Griewank A., 2008, EVALUATING DERIVATIV, P37; Gruebler MU, 2010, J ANIM ECOL, V79, P334, DOI 10.1111/j.1365-2656.2009.01650.x; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Korner-Nievergelt F., 2015, BAYESIAN DATA ANAL E, DOI DOI 10.1007/S13398-014-0173-7.2; Kristensen K., 2018, TMB GEN RANDOM EFFEC; Kristensen K., 2018, TMBSTAN MCMC SAMPLIN; Kristensen K, 2016, J STAT SOFTW, V70, P1; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Monnahan CC, 2018, ADNUTS NO U TURN SAM; Monnahan CC, 2017, METHODS ECOL EVOL, V8, P339, DOI 10.1111/2041-210X.12681; Neal Radford M, 2011, HDB MARKOV CHAIN MON, V2, P2, DOI DOI 10.1201/B10905-6; Papaspiliopoulos O, 2007, STAT SCI, V22, P59, DOI 10.1214/088342307000000014; Plummer M., 2003, P 3 INT WORKSH DISTR, P125, DOI DOI 10.1038/S41598-018-29599-W; Royle J. A., 2008, HIERARCHICAL MODELIN; SKAUG H., 2012, GEN LINEAR MIXED MOD; Skaug HJ, 2006, COMPUT STAT DATA AN, V51, P699, DOI 10.1016/j.csda.2006.03.005; Stan Development Team, 2018, STAN MOD LANG US GUI; Stan Development Team, 2018, RSTAN R INT STAN R P; Stan Development Team, 2018, SHIN INT VIS NUM DIA	30	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197954	10.1371/journal.pone.0197954	http://dx.doi.org/10.1371/journal.pone.0197954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795657	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300102
J	Seo, J; Lee, EW; Shin, J; Seong, D; Nam, YW; Jeong, M; Lee, SH; Lee, C; Song, J				Seo, Jinho; Lee, Eun-Woo; Shin, Jihye; Seong, Daehyeon; Nam, Young Woo; Jeong, Manhyung; Lee, Seon-Hyeong; Lee, Cheolju; Song, Jaewhan			K6 linked polyubiquitylation of FADD by CHIP prevents death inducing signaling complex formation suppressing cell death	ONCOGENE			English	Article							UBIQUITIN LIGASE CHIP; CONTAINING PROTEIN; APOPTOSIS; FAS; PHOSPHORYLATION; KINASE; DOMAIN; CASPASE-8; RECEPTOR; CHAINS	Fas-associated death domain (FADD) is an adaptor protein recruiting complexes of caspase 8 to death ligand receptors to induce extrinsic apoptotic cell death in response to a TNF superfamily member. Although, formation of the complex of FADD and caspase 8 upon death stimuli has been studied in detail, posttranslational modifications fine-tuning these processes have yet to be identified. Here we revealed that K6-linked polyubiquitylation of FADD on lysines 149 and 153 mediated by C terminus HSC70-interacting protein (CHIP) plays an important role in preventing formation of the death inducing signaling complex (DISC), thus leading to the suppression of cell death. Cells depleted of CHIP showed higher sensitivity toward death ligands such as FasL and TRAIL, leading to upregulation of DISC formation composed of a death receptor, FADD, and caspase 8. CHIP was able to bind to FADD, induce K6-linked polyubiquitylation of FADD, and suppress DISC formation. By mass spectrometry, lysines 149 and 153 of FADD were found to be responsible for CHIP-mediated FADD ubiquitylation. FADD mutated at these sites was capable of more potent cell death induction as compared with the wild type and was no longer suppressed by CHIP. On the other hand, CHIP deficient in E3 ligase activity was not capable of suppressing FADD function and of FADD ubiquitylation. CHIP depletion in ME-180 cells induced significant sensitization of these cells toward TRAIL in xenograft analyses. These results imply that K6-linked ubiquitylation of FADD by CHIP is a crucial checkpoint in cytokine-dependent extrinsic apoptosis.	[Seo, Jinho; Seong, Daehyeon; Nam, Young Woo; Jeong, Manhyung; Song, Jaewhan] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea; [Lee, Eun-Woo] KRIBB, Metab Regulat Res Ctr, Daejeon 34141, South Korea; [Shin, Jihye; Lee, Cheolju] Korea Inst Sci & Technol, Ctr Theragnosis, 5 Hwarang Ro 14 Gil, Seoul 02792, South Korea; [Lee, Seon-Hyeong] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Div Canc Biol, Goyang 10408, South Korea	Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Science & Technology (KIST); National Cancer Center - Korea (NCC)	Song, J (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea.	jso678@yonsei.ac.kr	Lee, Eun-Woo/AAP-9603-2020	Song, Jaewhan/0000-0001-8152-9210; Lee, Eun-Woo/0000-0002-5156-0003	Ministry of Science, ICT, and Future Planning [2015R1A3A2066581]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1A6A3A11035262]; BK21 Plus project of the National Research Foundation of Korea Grant	Ministry of Science, ICT, and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); BK21 Plus project of the National Research Foundation of Korea Grant(National Research Foundation of Korea)	This research was supported by a grant from the Ministry of Science, ICT, and Future Planning (2015R1A3A2066581) (Jaewhan S.) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) Funded by the Ministry of Education (2017R1A6A3A11035262) (Jinho S.). Additionally, this research was partly supported by the BK21 Plus project of the National Research Foundation of Korea Grant (Jinho S., D.S., M.J., and Y.W. N.), and C.L. acknowledges institutional support by KIST.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Alappat EC, 2003, J BIOL CHEM, V278, P41585, DOI 10.1074/jbc.C300385200; Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Algeciras-Schimnich A, 1999, J IMMUNOL, V162, P5205; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fulda S, 2000, CANCER RES, V60, P3947; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Jeong M, 2017, ONCOGENE, V36, P458, DOI 10.1038/onc.2016.215; Kalia LV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014695; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim C, 2016, CELL DEATH DIFFER, V23, P333, DOI 10.1038/cdd.2015.103; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Lee EW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1981; Lees MJ, 2003, J BIOL CHEM, V278, P35878, DOI 10.1074/jbc.M302430200; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Mert U, 2017, CELL MOL LIFE SCI, V74, P245, DOI 10.1007/s00018-016-2321-z; Morgan MJ, 2009, J IMMUNOL, V183, P3278, DOI 10.4049/jimmunol.0803428; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ohta T, 2011, FEBS LETT, V585, P2836, DOI 10.1016/j.febslet.2011.05.005; Paul I, 2015, INT J BIOCHEM CELL B, V58, P37, DOI 10.1016/j.biocel.2014.10.027; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Seo J, 2016, NAT CELL BIOL, V18, P291, DOI 10.1038/ncb3314; Shimamoto S, 2013, J BIOL CHEM, V288, P7158, DOI 10.1074/jbc.M112.436758; Srivastava D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.1; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	48	24	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					4994	5006		10.1038/s41388-018-0323-z	http://dx.doi.org/10.1038/s41388-018-0323-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29795330				2022-12-26	WOS:000443823600007
J	Fraseur, JG; Kinzer-Ursem, TL				Fraseur, Julia G.; Kinzer-Ursem, Tamara L.			Next generation calmodulin affinity purification: Clickable calmodulin facilitates improved protein purification	PLOS ONE			English	Article							AZIDE-ALKYNE CYCLOADDITION; KINASE-II; EXPRESSION SYSTEM; ESCHERICHIA-COLI; CALCIUM; BIOCONJUGATION; BINDING; CAMKII; ALPHA; FUNCTIONALIZATION	As the proteomics field continues to expand, scientists are looking to integrate cross-disciplinary tools for studying protein structure, function, and interactions. Protein purification remains a key tool for many characterization studies. Calmodulin (CaM) is a calcium-binding messenger protein with over a hundred downstream binding partners, and is involved in a host of physiological processes, from learning and memory to immune and cardiac function. To facilitate biophysical studies of calmodulin, researchers have designed a site-specific labeling process for use in bioconjugation applications while maintaining high levels of protein activity. Here, we present a platform for selective conjugation of calmodulin directly from clarified cell lysates under bioorthogonal reaction conditions. Using a chemoenzymatically modified calmodulin, we employ popular click chemistry reactions for the conjugation of calmodulin to Sepharose resin, thereby streamlining a previously multi-step purification and conjugation process. We show that this "next-generation" calmodulin-Sepharose resin is not only easy to produce, but is also able to purify more calmodulin-binding proteins per volume of resin than traditional calmodulin-Sepharose resins. We expect these methods to be translatable to other proteins of interest and to other conjugation applications such as surface-based assays for the characterization of protein-protein interaction dynamics.	[Fraseur, Julia G.; Kinzer-Ursem, Tamara L.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kinzer-Ursem, TL (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	tursem@purdue.edu			Purdue University; Ralph M. and Grace W. Showalter Research Trust; National Institute of Neurological Disorders and Stroke (NINDS) of the National Institute of Health (NIH) [R21NS095218]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS095218] Funding Source: NIH RePORTER	Purdue University; Ralph M. and Grace W. Showalter Research Trust; National Institute of Neurological Disorders and Stroke (NINDS) of the National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge support from Purdue University, the Ralph M. and Grace W. Showalter Research Trust (http://www.purdue.edu/research/funding-and-grant-writing/funding/showalter-awardees.php), and the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institute of Health (NIH) under award number R21NS095218. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; DEVADAS B, 1992, J BIOL CHEM, V267, P7224; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hang HC, 2011, CHEM REV, V111, P6341, DOI 10.1021/cr2001977; Heal WP, 2012, NAT PROTOC, V7, P105, DOI 10.1038/nprot.2011.425; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Kulkami C, 2015, BIOCONJUGATE CHEM, V26, P2153, DOI 10.1021/acs.bioconjchem.5b00449; Kulkarni C, 2013, CHEMBIOCHEM, V14, P1958, DOI 10.1002/cbic.201300453; LUKAS TJ, 1988, METHOD ENZYMOL, V157, P328; MEANS AR, 1988, CELL CALCIUM, V9, P313, DOI 10.1016/0143-4160(88)90012-7; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Praseeda M, 2004, PROTEIN PEPTIDE LETT, V11, P175, DOI 10.2174/0929866043478275; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; RHYNER JA, 1992, BIOCHEMISTRY-US, V31, P12826, DOI 10.1021/bi00166a017; SCHNAPP J, 1976, BIOCHEM BIOPH RES CO, V70, P8, DOI 10.1016/0006-291X(76)91101-3; Stratton MM, 2013, CURR OPIN STRUC BIOL, V23, P292, DOI 10.1016/j.sbi.2013.04.002; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Walker D, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500501; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647	31	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2018	13	6							e0197120	10.1371/journal.pone.0197120	http://dx.doi.org/10.1371/journal.pone.0197120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI0YU	29864125	gold, Green Published, Green Submitted			2022-12-26	WOS:000434097100002
J	Mekuchi, M; Asakura, T; Sakata, K; Yamaguchi, T; Teruya, K; Kikuchi, J				Mekuchi, Miyuki; Asakura, Taiga; Sakata, Kenji; Yamaguchi, Tomofumi; Teruya, Kazuhisa; Kikuchi, Jun			Intestinal microbiota composition is altered according to nutritional biorhythms in the leopard coral grouper (Plectropomus leopardus)	PLOS ONE			English	Article							GUT MICROBIOME; FISH; METABOLISM; DIET; ABSORPTION	Aquaculture is currently a major source of fish and has the potential to become a major source of protein in the future. These demands require efficient aquaculture. The intestinal microbiota plays an integral role that benefits the host, providing nutrition and modulating the immune system. Although our understanding of microbiota in fish gut has increased, comprehensive studies examining fish microbiota and host metabolism remain limited. Here, we investigated the microbiota and host metabolism in the coral leopard grouper, which is traded in Asian markets as a superior fish and has begun to be produced via aquaculture. We initially examined the structural changes of the gut microbiota using next-generation sequencing and found that the composition of microbiota changed between fasting and feeding conditions. The dominant phyla were Proteobacteria in fasting and Firmicutes in feeding; interchanging the dominant bacteria required 12 hours. Moreover, microbiota diversity was higher under feeding conditions than under fasting conditions. Multivariate analysis revealed that Proteobacteria are the key bacteria in fasting and Firmicutes and Fusobacteria are the key bacteria in feeding. Subsequently, we estimated microbiota functional capacity. Microbiota functional structure was relatively stable throughout the experiment; however, individual function activity changed according to feeding conditions. Taken together, these findings indicate that the gut microbiota could be a key factor to understanding fish feeding conditions and play a role in interactions with host metabolism. In addition, the composition of microbiota in ambient seawater directly affects the fish; therefore, it is important to monitor the microbiota in rearing tanks and seawater circulating systems.	[Mekuchi, Miyuki; Asakura, Taiga; Sakata, Kenji; Kikuchi, Jun] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Mekuchi, Miyuki] Fishery Res & Educ Org, Natl Fishery Res Inst Fishery Sci, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Yamaguchi, Tomofumi; Teruya, Kazuhisa] Res Ctr Subtrop Fisheries, Ishikagi, Japan; [Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi, Japan	RIKEN; Yokohama City University; Nagoya University	Kikuchi, J (corresponding author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan.; Kikuchi, J (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan.; Kikuchi, J (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi, Japan.	jun.kikuchi@riken.jp	Kikuchi, Jun/O-4725-2019; Kikuchi, Jun/M-5512-2015	Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X				Asakura T, 2014, PEERJ, V2, DOI 10.7717/peerj.550; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmona-Antonanzas G, 2014, GENE, V534, P1, DOI 10.1016/j.gene.2013.10.040; Cronan Jr. J.E., 2005, ECOSAL PLUS, V1; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Etyemez M, 2015, RES VET SCI, V100, P8, DOI 10.1016/j.rvsc.2015.03.026; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; Grosell M, 2006, AM J PHYSIOL-REG I, V291, pR1145, DOI 10.1152/ajpregu.00818.2005; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Ito K, 2014, ANAL CHEM, V86, P1098, DOI 10.1021/ac402869b; Iwai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166104; Jiang PP, 2017, J PROTEOME RES, V16, P3547, DOI 10.1021/acs.jproteome.7b00263; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; Kohonen T., 1998, Neurocomputing, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Krogdahl A, 2004, AQUACULTURE, V229, P335, DOI 10.1016/S0044-8486(03)00396-X; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lin H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21618; Mathiesen A., 2012, STATE WORLD FISHERIE; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mekuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09531-4; Mekuchi M, 2010, FISHERIES SCI, V76, P199, DOI 10.1007/s12562-009-0199-5; Misawa T, 2015, J PROTEOME RES, V14, P1526, DOI 10.1021/pr501194k; Motegi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15710; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Ramirez C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00271; Sanchez A, 2012, MOL CELL BIOL, V32, P4445, DOI 10.1128/MCB.01062-12; Schmidt VT, 2015, MOL ECOL, V24, P2537, DOI 10.1111/mec.13177; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Sugahara H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13548; Tarnecki AM, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0864-7; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Xia JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-266; Xie J, 2011, P NATL ACAD SCI USA, V108, pE1381, DOI 10.1073/pnas.1111043108; Xing MX, 2013, FEMS MICROBIOL ECOL, V86, P432, DOI 10.1111/1574-6941.12174; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yeoman CJ, 2011, ENTROPY-SWITZ, V13, P570, DOI 10.3390/e13030570; Yoseda K, 2008, AQUACULTURE, V279, P55, DOI 10.1016/j.aquaculture.2008.04.002; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhao Y, 2013, ANAL CHEM, V85, P1053, DOI 10.1021/ac302915a	52	23	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197256	10.1371/journal.pone.0197256	http://dx.doi.org/10.1371/journal.pone.0197256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856743	gold, Green Submitted, Green Published			2022-12-26	WOS:000433900800013
J	Munkholm, SB; Krogholt, T; Ebbesen, F; Szecsi, PB; Kristensen, SR				Munkholm, Sarah B.; Krogholt, Tobias; Ebbesen, Finn; Szecsi, Pal B.; Kristensen, Soren R.			The smartphone camera as a potential method for transcutaneous bilirubin measurement	PLOS ONE			English	Article							SKIN COLOR; JAUNDICE; TERM; HYPERBILIRUBINEMIA; NEWBORNS; NOMOGRAM; CARE	Background Hyperbilirubinemia is a common problem in neonates that can progress into kernicterus. Suspected neonatal hyperbilirubinemia is a common reason for contact with the healthcare system. The severity and management of jaundice are determined based on estimated bilirubin levels. However, no easy and accessible tool for self-assessing neonatal jaundice is currently available. Smartphones could potentially be transformed into a medical device that could be used by both patients and practitioners. Objective To investigate whether a digital image produced by a camera embedded on a smartphone can be a used as a screening tool for neonatal hyperbilirubinemia. Study design A total of 64 randomly selected newborns were enrolled. The inclusion criteria were healthy Caucasians, gestational age >35 weeks, age >24 hours and <= 14 days old, and parental informed consent. The exclusion criteria were facial skin lesions and light treatment. Images of the glabella were obtained with an iPhone 6 via i) directly applied pressure, ii) a dermatoscope, or iii) a dermatoscope equipped with a Wratten No. 11 filter. The red, green and blue colour intensities of each image were compared to bilirubin levels. Results Only the dermatoscope-acquired intensities of the green and blue channels were significantly correlated (p < 0.001) with bilirubin measurements (Pearson's r: 0.59 and 0.48, respectively). For the green and blue channels, discrimination limits of 212 and 190, respectively, revealed a sensitivity and specificity of 100% and 62.5%, respectively, for green and 90.9% and 60%, respectively, for blue for a plasma bilirubin above 205 mu mol/L. Conclusions The results of this study indicate that a smartphone equipped with a consistent light source in the form of a dermatoscope may be a simple screening tool for neonatal hyperbilirubinemia. However, the method requires some improvement before clinical application.	[Munkholm, Sarah B.] Randers Reg Hosp, Dept Acute Med, Randers, Denmark; [Krogholt, Tobias] Aalborg Univ, Aalborg, Denmark; [Ebbesen, Finn] Aalborg Univ Hosp, Dept Paediat, Aalborg, Denmark; [Szecsi, Pal B.] Copenhagen Univ Hosp Holbaek, Dept Clin Biochem, Holbaek, Denmark; [Kristensen, Soren R.] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	Aarhus University; Aalborg University; Aalborg University; Aalborg University Hospital; University of Copenhagen; Aalborg University; Aalborg University Hospital	Munkholm, SB (corresponding author), Randers Reg Hosp, Dept Acute Med, Randers, Denmark.	sarahbachmunkholm@gmail.com		Bach Munkholm, Sarah/0000-0002-7450-3271; Szecsi, Pal/0000-0003-3446-0411				Afanetti M, 2014, EARLY HUM DEV, V90, P417, DOI 10.1016/j.earlhumdev.2014.05.009; Alla SK, 2011, IEEE T BIO-MED ENG, V58, P777, DOI 10.1109/TBME.2010.2093132; Boo NY, 2007, J PAEDIATR CHILD H, V43, P306, DOI 10.1111/j.1440-1754.2007.01062.x; Bosschaart N, 2012, PEDIATRICS, V129, P689, DOI 10.1542/peds.2011-2586; Bosschaart N, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3622629; Chawla D, 2012, INDIAN J PEDIATR, V79, P198, DOI 10.1007/s12098-011-0409-x; Dayer L, 2013, J AM PHARM ASSOC, V53, P172, DOI 10.1331/JAPhA.2013.12202; de Greef L, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P331, DOI 10.1145/2632048.2632076; De Luca D, 2008, ACTA PAEDIATR, V97, P146, DOI 10.1111/j.1651-2227.2007.00622.x; Ebbesen F, 2012, ACTA PAEDIATR, V101, P1128, DOI 10.1111/j.1651-2227.2012.02797.x; Falaki H., 2010, DIVERSITY SMARTPHONE; Fouzas S, 2010, J PEDIATR-US, V157, P762, DOI 10.1016/j.jpeds.2010.04.076; Gallegos D, 2013, LAB CHIP, V13, P2124, DOI 10.1039/c3lc40991k; Gorten MK, 2013, NCIIA PROJ PROPOS, P101; Hemmati F, 2013, IRAN J MED SCI, V38, P122; Kaynak-Turkmen M, 2011, TURKISH J PEDIATR, V53, P67; Keren R, 2009, ARCH DIS CHILD-FETAL, V94, pF317, DOI 10.1136/adc.2008.150714; KNUDSEN A, 1990, EARLY HUM DEV, V22, P23, DOI 10.1016/0378-3782(90)90022-B; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Lane ND, 2012, IEEE INTERNET COMPUT, V16, P60, DOI 10.1109/MIC.2012.48; LEE KS, 1976, PEDIATR RES, V10, P782, DOI 10.1203/00006450-197609000-00004; Lee S, 2014, LAB CHIP, V14, P1437, DOI 10.1039/c3lc51375k; Ochoa Sangrador C, 2000, An Esp Pediatr, V52, P561; Penhaker M, 2013, ELEKTRON ELEKTROTECH, V19, P47, DOI 10.5755/j01.eee.19.3.3696; Randeberg LL, 2005, ACTA PAEDIATR, V94, P65, DOI 10.1080/08035250410023179; SAIDI IS, 1995, APPL OPTICS, V34, P7410, DOI 10.1364/AO.34.007410; Samiee-Zafarghandy S, 2014, ARCH DIS CHILD-FETAL, V99, pF480, DOI 10.1136/archdischild-2013-305699; Shen L, 2012, LAB CHIP, V12, P4240, DOI [10.1039/c2lc40741h, 10.1039/c2lc40741]; Tayaba R, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.3.e28; Taylor JA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0312; Yu ZB, 2014, J PEDIAT-BRAZIL, V90, P273, DOI 10.1016/j.jped.2013.08.013	31	13	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0197938	10.1371/journal.pone.0197938	http://dx.doi.org/10.1371/journal.pone.0197938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856793	Green Published, gold, Green Submitted			2022-12-26	WOS:000433900800054
J	Palau-Rodriguez, M; Tulipani, S; Marco-Ramell, A; Minarro, A; Jauregui, O; Sanchez-Pla, A; Ramos-Molina, B; Tinahones, FJ; Andres-Lacueva, C				Palau-Rodriguez, Magali; Tulipani, Sara; Marco-Ramell, Anna; Minarro, Antonio; Jauregui, Olga; Sanchez-Pla, Alex; Ramos-Molina, Bruno; Tinahones, Francisco J.; Andres-Lacueva, Cristina			Metabotypes of response to bariatric surgery independent of the magnitude of weight loss	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; INSULIN-RESISTANCE; URIC-ACID; METABOLIC SURGERY; OBESE-PATIENTS; MARKERS; PROFILE; IMPROVEMENT; BIOMARKERS; OXIDATION	Objective Bariatric surgery is considered the most efficient treatment for morbid obesity and its related diseases. However, its role as a metabolic modifier is not well understood. We aimed to determine biosignatures of response to bariatric surgery and elucidate short-term metabolic adaptations. Methods We used a LC- and FIA-ESI-MS/MS approach to quantify acylcarnitines, (lyso)phosphatidylcholines, sphingomyelins, amino acids, biogenic amines and hexoses in serum samples of subjects with morbid obesity (n = 39) before and 1, 3 and 6 months after bariatric surgery. K-means cluster analysis allowed to distinguish metabotypes of response to bariatric surgery. Results For the first time, global metabolic changes following bariatric surgery independent of the baseline health status of the subjects have been revealed. We identify two metabolic phenotypes (metabotypes) at the interval 6 months-baseline after surgery, which presented differences in the levels of compounds of urea metabolism, gluconeogenic precursors and (lyso) phospholipid particles. Clinically, metabotypes were different in terms of the degree of improvement in insulin resistance, cholesterol, low-density lipoproteins and uric acid independent of the magnitude of weight loss. Conclusions This study opens new perspectives and new hypotheses on the metabolic benefits of bariatric surgery and understanding of the biology of obesity and its associated diseases.	[Palau-Rodriguez, Magali; Tulipani, Sara; Marco-Ramell, Anna; Jauregui, Olga; Andres-Lacueva, Cristina] Univ Barcelona, Fac Pharm & Food Sci, Dept Food Sci & Gastron, XaRTA,INSA UB,Nutr,Biomarkers & Nutrimetabol Lab, Campus Torribera, Barcelona, Spain; [Palau-Rodriguez, Magali; Marco-Ramell, Anna; Andres-Lacueva, Cristina] ISCIII, CIBER Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain; [Tulipani, Sara; Ramos-Molina, Bruno; Tinahones, Francisco J.] Biomed Res Inst IBIMA, Serv Endocrinol & Nutr, Malaga Hosp Complex Virgen de la Victoria, Malaga, Spain; [Minarro, Antonio; Sanchez-Pla, Alex] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Barcelona, Spain; [Jauregui, Olga] Univ Barcelona CCIT UB, Sci & Technol Ctr, Barcelona, Spain; [Sanchez-Pla, Alex] Vall dHebron Inst Recerca VHIR, Stat & Bioinformat Unit, Barcelona, Spain; [Ramos-Molina, Bruno; Tinahones, Francisco J.] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Instituto de Salud Carlos III; Universidad de Malaga; University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Andres-Lacueva, C (corresponding author), Univ Barcelona, Fac Pharm & Food Sci, Dept Food Sci & Gastron, XaRTA,INSA UB,Nutr,Biomarkers & Nutrimetabol Lab, Campus Torribera, Barcelona, Spain.	candres@ub.edu	Ramos-Molina, Bruno/K-8303-2019; Sánchez-Pla, Alex/H-8310-2015; Tulipani, Sara/K-8285-2019; Miñarro, Antonio/G-1740-2015; Molina, Bruno Ramos/A-4574-2017; Andres-Lacueva, Cristina/J-3377-2012; Tinahones, Francisco José/AAB-2882-2020	Ramos-Molina, Bruno/0000-0001-6804-5449; Sánchez-Pla, Alex/0000-0002-8673-7737; Tulipani, Sara/0000-0001-5658-8462; Miñarro, Antonio/0000-0001-7747-5299; Molina, Bruno Ramos/0000-0001-6804-5449; Andres-Lacueva, Cristina/0000-0002-8494-4978; Tinahones, Francisco J/0000-0001-6871-4403; Jauregui, Olga/0000-0002-5834-3829	ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fundacion Progreso y Salud; Consejeria de Salud y Bienestar Social; Junta de Andalucia; CIBERfes; CIBERobn; Fondo Europeo de Desarrollo Regional (FEDER); MINECO/ FEDER [MTM2015/64465-C2-1-R]; Generalitat de Catalunya's Agency AGAUR [2017 SGR 1546, 2017 SGR 622]; APIF fellowship [INSA-UB]; Juan de la Cierva fellowship [MINECO]; Sara Borrell postdoctoral fellowship, ISCIII, Spain [CD16/0003];  [PI13/01172];  [PI-0557-2013]	ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fundacion Progreso y Salud; Consejeria de Salud y Bienestar Social; Junta de Andalucia(Junta de Andalucia); CIBERfes; CIBERobn; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); MINECO/ FEDER; Generalitat de Catalunya's Agency AGAUR; APIF fellowship [INSA-UB]; Juan de la Cierva fellowship [MINECO]; Sara Borrell postdoctoral fellowship, ISCIII, Spain; ; 	This research was supported by Project PI13/01172 (Plan N de I+D+i 2013-2016), co-funded by ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Project PI-0557-2013, co-funded by Fundacion Progreso y Salud, Consejeria de Salud y Bienestar Social, Junta de Andalucia, CIBERfes and CIBERobn, co-funded by Fondo Europeo de Desarrollo Regional (FEDER) and MTM2015/64465-C2-1-R (MINECO/ FEDER). 2017 SGR 1546 and 2017 SGR 622 award from Generalitat de Catalunya's Agency AGAUR. MPR acknowledges the APIF fellowship [INSA-UB]; ST and AMR acknowledge the Juan de la Cierva fellowship [MINECO] and BRM acknowledges the Sara Borrell postdoctoral fellowship, ISCIII, Spain (CD16/0003).	Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogumil R, APPL NOTE 1004 PLUSM; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cicerchi C, 2014, FASEB J, V28, P3339, DOI 10.1096/fj.13-243634; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dogan S, 2013, OBES SURG, V23, P1973, DOI 10.1007/s11695-013-1011-2; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Garrido-Sanchez L, 2012, SURG OBES RELAT DIS, V8, P145, DOI 10.1016/j.soard.2011.03.010; Gralka E, 2015, AM J CLIN NUTR, V102, P1313, DOI 10.3945/ajcn.115.110536; Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382; Jia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078284; Jullig M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096489; Kanbay M, 2016, EUR J INTERN MED, V29, P3, DOI 10.1016/j.ejim.2015.11.026; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Li XY, 2016, ARTERIOSCL THROM VAS, V36, P1090, DOI 10.1161/ATVBAHA.115.306964; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Luo P, 2016, J PROTEOME RES, V15, P1288, DOI 10.1021/acs.jproteome.6b00022; Martinez-Ramirez M, 2016, CLIN CHIM ACTA, V454, P77, DOI 10.1016/j.cca.2015.12.039; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Rauschert S, 2016, J CLIN ENDOCR METAB, V101, P871, DOI 10.1210/jc.2015-3525; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Schlesinger S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165811; Shahbazov R, 2016, DIABETES-METAB RES, V32, P268, DOI 10.1002/dmrr.2714; She P, 2007, NIH PUBLIC ACCESS, V293, pE1552, DOI [10.1152/ajpendo.00134.2007, DOI 10.1152/AJPENDO.00134.2007]; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Stiko A, 1996, ARTERIOSCLER THROMB, P16; Tinahones FJ, 2013, SURG OBES RELAT DIS, V9, P213, DOI 10.1016/j.soard.2011.08.022; Tulipani S, 2016, OBESITY, V24, P2451, DOI 10.1002/oby.21686; Tulipani S, 2016, CLIN CHIM ACTA, V463, P53, DOI 10.1016/j.cca.2016.10.005; Tulipani S, 2015, ANAL CHEM, V87, P2639, DOI 10.1021/ac503031d; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Yuan H, 2017, MOL CELL ENDOCRINOL, V443, P138, DOI 10.1016/j.mce.2016.12.025	43	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198214	10.1371/journal.pone.0198214	http://dx.doi.org/10.1371/journal.pone.0198214			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856816	Green Published, Green Submitted, gold			2022-12-26	WOS:000433900800087
J	Zhou, L; Zhou, J; Xiong, YH; Liu, CX; Wang, JG; Wang, GQ; Cai, YL				Zhou, Lian; Zhou, Jing; Xiong, Yuhan; Liu, Chaoxian; Wang, Jiuguang; Wang, Guoqiang; Cai, Yilin			Overexpression of a maize plasma membrane intrinsic protein ZmPIP1;1 confers drought and salt tolerance in Arabidopsis	PLOS ONE			English	Article							AQUAPORIN GENE; PLANT AQUAPORINS; WATER-UPTAKE; STRESS; CHANNELS; ROOTS; PEROXIDE; FAMILY; GROWTH; WHEAT	Drought and salt stress are major abiotic stress that inhibit plants growth and development, here we report a plasma membrane intrinsic protein ZmPIP1;1 from maize and identified its function in drought and salt tolerance in Arabidopsis. ZmPIP1;1 was localized to the plasma membrane and endoplasmic reticulum in maize protoplasts. Treatment with PEG or NaCl resulted in induced expression of ZmPIP1;1 in root and leaves. Constitutive overexpression of ZmPIP1;1 in transgenic Arabidopsis plants resulted in enhanced drought and salt stress tolerance compared to wild type. A number of stress responsive genes involved in cellular osmoprotection in ZmPIP1;1 overexpression plants were up-regulated under drought or salt condition. ZmPIP1;1 overexpression plants showed higher activities of reactive oxygen species (ROS) scavenging enzymes such as catalase and superoxide dismutase, lower contents of stress-induced ROS such as superoxide, hydrogen peroxide and malondialdehyde, and higher levels of proline under drought and salt stress than did wild type. ZmPIP1;1 may play a role in drought and salt stress tolerance by inducing of stress responsive genes and increasing of ROS scavenging enzymes activities, and could provide a valuable gene for further plant breeding.	[Zhou, Lian; Zhou, Jing; Xiong, Yuhan; Liu, Chaoxian; Wang, Jiuguang; Wang, Guoqiang; Cai, Yilin] Southwest Univ, Coll Agron & Biotechnol, Key Lab Biotechnol & Crop Qual Improvement, Maize Res Inst, Chongqing, Peoples R China	Southwest University - China	Cai, YL (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Key Lab Biotechnol & Crop Qual Improvement, Maize Res Inst, Chongqing, Peoples R China.	caiyilin@swu.edu.cn		ZHOU, Jing/0000-0002-1762-6179	National Natural Science Foundation of China [31601312]; Chongqing Postdoctoral Special Foundation [Xm2015047]; Fundamental Research Funds for the Central Universities [SWU114035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Postdoctoral Special Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (31601312, https://isisn.nsfc.gov.cn/egrantweb/, to L.Z.), Chongqing Postdoctoral Special Foundation (Xm2015047, http://www.cstc.gov.cn/, to L.Z.), Fundamental Research Funds for the Central Universities (SWU114035, to L.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Alleva K, 2010, J EXP BOT, V61, P3935, DOI 10.1093/jxb/erq210; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Bellati J, 2010, PLANT MOL BIOL, V74, P105, DOI 10.1007/s11103-010-9658-8; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chaumont F, 1998, PLANT PHYSIOL, V117, P1143, DOI 10.1104/pp.117.4.1143; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chen W, 2013, PLANT MOL BIOL, V83, P219, DOI 10.1007/s11103-013-0084-6; ELSTNER EF, 1976, PLANTA, V130, P175, DOI 10.1007/BF00384416; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Hachez C, 2013, TRENDS PLANT SCI, V18, P344, DOI 10.1016/j.tplants.2012.12.003; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; Hundertmark M, 2011, BBA-BIOMEMBRANES, V1808, P446, DOI 10.1016/j.bbamem.2010.09.010; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; Katsuhara M, 2003, PLANT CELL PHYSIOL, V44, P1378, DOI 10.1093/pcp/pcg167; KNEPPER MA, 1994, P NATL ACAD SCI USA, V91, P6255, DOI 10.1073/pnas.91.14.6255; Krishnamurthy P, 2009, PLANTA, V230, P119, DOI 10.1007/s00425-009-0930-6; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Liu CW, 2013, PLANT PHYSIOL BIOCH, V63, P151, DOI 10.1016/j.plaphy.2012.11.018; Ma N, 2008, PLANT PHYSIOL, V148, P894, DOI 10.1104/pp.108.120154; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Maurel C, 2015, PHYSIOL REV, V95, P1321, DOI 10.1152/physrev.00008.2015; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; SAGISAKA S, 1976, PLANT PHYSIOL, V57, P308, DOI 10.1104/pp.57.2.308; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; SENGUPTA A, 1993, PLANT PHYSIOL, V103, P1067, DOI 10.1104/pp.103.4.1067; Siefritz F, 2001, J EXP BOT, V52, P1953, DOI 10.1093/jexbot/52.363.1953; Sreedharan S, 2013, PLANT BIOTECHNOL J, V11, P942, DOI 10.1111/pbi.12086; Steudle E, 2000, J EXP BOT, V51, P1531, DOI 10.1093/jexbot/51.350.1531; Steudle E, 2000, PLANT SOIL, V226, P45, DOI 10.1023/A:1026439226716; TROLL W, 1955, J BIOL CHEM, V215, P655; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Xu Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-59; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yaneff A, 2014, P NATL ACAD SCI USA, V111, P231, DOI 10.1073/pnas.1316537111; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]; Zhou L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-181; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhuo CL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0814-4	52	10	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198639	10.1371/journal.pone.0198639	http://dx.doi.org/10.1371/journal.pone.0198639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	29856862	Green Submitted, Green Published, gold			2022-12-26	WOS:000433900800145
J	Molinero, JC; Tseng, LC; Abbate, CL; Ramirez-Romero, E; Hwang, JS				Molinero, Juan Carlos; Tseng, Li-Chun; Lopez Abbate, Celeste; Ramirez-Romero, Eduardo; Hwang, Jiang-Shiou			Interannual changes in zooplankton echo subtropical and high latitude climate effects in the southern East China Sea	PLOS ONE			English	Article							CALANUS-SINICUS COPEPODA; YELLOW SEA; ABUNDANCE	Climate variability plays a central role in the dynamics of marine pelagic ecosystems shaping the structure and abundance changes of plankton communities, thereby affecting energy pathways and biogeochemical fluxes in the ocean. Here we have investigated complex interactions driven a climate-hydrology-plankton system in the southern East China Sea over the period 2000 to 2012. In particular, we aimed at quantifying the influence of climate phenomena playing out in tropical (El Nino 3.4) and middle-high latitudes (East Asia Winter Monsoon, EAWM, and Pacific Decadal Oscillation, PDO) on pelagic copepods. We found that the EAWM and El Nino 3.4 showed a non-stationary and non-linear relationship with local temperature variability. In the two cases, the strength of the relationship, as indexed by the wavelet coherence analysis, decreased along with the positive phase of the PDO. Likewise, the influence of EAWM and El Nino 3.4 on copepods exhibited a non-stationary link that changed along with the PDO state. Indeed, copepods and EAWM were closely related during the positive phase, while the link copepods-El Nino 3.4 was stronger during the negative phase. Our results pointed out cascading effects from climate to plankton driven by the positive phase of the PDO through its effect on temperature conditions, and likely through a larger southward transport of nutrient-rich water masses to northern Taiwan and the Taiwan Strait. We suggest a chain of mechanisms whereby the PDO shapes interannual dynamics of pelagic copepods and highlight that these results have implications for integrative management measures, as pelagic copepods plays a prominent role in food web dynamics and for harvested fish in the East China Sea.	[Molinero, Juan Carlos] GEOMAR Helmholtz Ctr Ocean Res, Marine Ecol Food Webs, Duesternbrooker Weg 20, Kiel, Germany; [Molinero, Juan Carlos] Univ Montpellier, IRD, CNRS, IFREMER,MARBEC, Montpellier, France; [Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Lopez Abbate, Celeste] UNS, Inst Argentino Oceanog, CONICET, Camino La Carrindanga, Bahia Blanca, Buenos Aires, Argentina; [Ramirez-Romero, Eduardo] UIB, CSIC, Inst Mediterraneo Estudios Avanzados, Fish Ecol Grp,IMEDEA, C Miquel Marques 21, Esporles, Illes Balears, Spain	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; National Taiwan Ocean University; National Taiwan Ocean University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	jshwang@mail.ntou.edu.tw	Ramirez-Romero, Eduardo/I-2563-2019	Ramirez-Romero, Eduardo/0000-0002-7228-6939; Tseng, Li-Chun/0000-0003-0251-565X; Lopez-Abbate, Maria Celeste/0000-0003-0264-5833	Ministry of Science and Technology (MOST) Taiwan [MOST 104-2621-M-019-002, MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 106-2621-M-019-001]; Center of Excellence for the Oceans of National Taiwan Ocean University [CMBB 99529001A]; Taiwan Power Company, Taiwan [106A32401]; European Commission (OCEAN-CERTAIN) [FP7-ENV-2013-6.1-1, 603773]	Ministry of Science and Technology (MOST) Taiwan(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans of National Taiwan Ocean University; Taiwan Power Company, Taiwan; European Commission (OCEAN-CERTAIN)(European Commission)	Financial support was provided by the Ministry of Science and Technology (MOST) Taiwan, through the grants no. MOST 104-2621-M-019-002, MOST 104-2611-M-019-004, MOST 105-2621-M-019-001 and MOST 106-2621-M-019-001, the Center of Excellence for the Oceans of National Taiwan Ocean University (CMBB 99529001A), Taiwan Power Company, Taiwan (106A32401) to JSH, and the grant European Commission (OCEAN-CERTAIN, FP7-ENV-2013-6.1-1; no: 603773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsterberg C, 2013, P NATL ACAD SCI USA, V110, P8603, DOI 10.1073/pnas.1303797110; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chiba S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052912; d'Orgeville M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031584; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Fang CF, 2014, ADV ATMOS SCI, V31, P118, DOI 10.1007/s00376-013-2260-7; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hidalgo M, 2011, MAR ECOL PROG SER, V426, P1, DOI 10.3354/meps09077; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; Hong J, 2008, ECOL MODEL, V212, P492, DOI 10.1016/j.ecolmodel.2007.10.048; Hsieh CH, 2009, FISH OCEANOGR, V18, P102, DOI 10.1111/j.1365-2419.2008.00498.x; Hsieh RJ, 2016, ZOOL STUD, V55, DOI 10.6620/ZS.2016.55-46; Huo YZ, 2008, J PLANKTON RES, V30, P723, DOI 10.1093/plankt/fbn034; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lan KW, 2014, CLIMATIC CHANGE, V126, P189, DOI 10.1007/s10584-014-1208-y; Marques SC, 2018, ECOSYSTEMS, V21, P56, DOI 10.1007/s10021-017-0134-z; Molinero JC, 2016, FISH OCEANOGR, V25, P555, DOI 10.1111/fog.12172; Oey LY, 2013, GEOPHYS RES LETT, V40, P6288, DOI 10.1002/2013GL058202; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Sakamoto TT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023384; Siswanto E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037883; Solomon S., 2007, PHYS SCI BASIS WORKI; van de Waal DB, 2010, FRONT ECOL ENVIRON, V8, P145, DOI 10.1890/080178; Wang R, 2003, J PLANKTON RES, V25, P169, DOI 10.1093/plankt/25.2.169; Wu ZW, 2011, CLIM DYNAM, V37, P1661, DOI 10.1007/s00382-010-0938-4; Yin JQ, 2011, CONT SHELF RES, V31, P1447, DOI 10.1016/j.csr.2011.06.010; Zhou L-T., 2010, J GEOPHYS RES, DOI [10.1029/2009JD012502, DOI 10.1029/2009JD012502]	29	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2018	13	5							e0197382	10.1371/journal.pone.0197382	http://dx.doi.org/10.1371/journal.pone.0197382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8CD	29851995	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000433893200013
J	Bataille, CP; von Holstein, ICC; Laffoon, JE; Willmes, M; Liu, XM; Davies, GR				Bataille, Clement P.; von Holstein, Isabella C. C.; Laffoon, Jason E.; Willmes, Malte; Liu, Xiao-Ming; Davies, Gareth R.			A bioavailable strontium isoscape for Western Europe: A machine learning approach	PLOS ONE			English	Article							BIOLOGICALLY AVAILABLE STRONTIUM; ISOTOPES SR-87/SR-86; SPATIAL VARIATION; STABLE-ISOTOPES; SR ISOTOPES; SOIL; LAND; MIGRATION; PATTERNS; RATIOS	Strontium isotope ratios (Sr-87/Sr-86) are gaining considerable interest as a geolocation tool and are now widely applied in archaeology, ecology, and forensic research. However, their application for provenance requires the development of baseline models predicting surficial Sr-87/Sr-86 variations ("isoscapes"). A variety of empirically-based and process-based models have been proposed to build terrestrial Sr-87/Sr-86 isoscapes but, in their current forms, those models are not mature enough to be integrated with continuous-probability surface models used in geographic assignment. In this study, we aim to overcome those limitations and to predict Sr-87/Sr-86 variations across Western Europe by combining process-based models and a series of remote-sensing geospatial products into a regression framework. We find that random forest regression significantly outperforms other commonly used regression and interpolation methods, and efficiently predicts the multi-scale patterning of Sr-87/Sr-86 variations by accounting for geological, geomorphological and atmospheric controls. Random forest regression also provides an easily interpretable and flexible framework to integrate different types of environmental auxiliary variables required to model the multi-scale patterning of Sr-87/Sr-86 variability. The method is transferable to different scales and resolutions and can be applied to the large collection of geospatial data available at local and global levels. The isoscape generated in this study provides the most accurate Sr-87/Sr-86 predictions in bioavailable strontium for Western Europe (R-2 = 0.58 and RMSE = 0.0023) to date, as well as a conservative estimate of spatial uncertainty by applying quantile regression forest. We anticipate that the method presented in this study combined with the growing numbers of bioavailable Sr-87/Sr-86 data and satellite geospatial products will extend the applicability of the Sr-87/Sr-86 geo-profiling tool in provenance applications.	[Bataille, Clement P.] Univ Ottawa, Dept Earth & Environm Sci, Ottawa, ON, Canada; [Bataille, Clement P.; Liu, Xiao-Ming] Univ N Carolina, Dept Geol Sci, Chapel Hill, NC 27515 USA; [von Holstein, Isabella C. C.; Laffoon, Jason E.; Davies, Gareth R.] Vrije Univ Amsterdam, Dept Earth Sci, Fac Sci, Amsterdam, Netherlands; [Laffoon, Jason E.] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Willmes, Malte] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of Ottawa; University of North Carolina; University of North Carolina Chapel Hill; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Davis	Bataille, CP (corresponding author), Univ Ottawa, Dept Earth & Environm Sci, Ottawa, ON, Canada.; Bataille, CP (corresponding author), Univ N Carolina, Dept Geol Sci, Chapel Hill, NC 27515 USA.	cbataille@uottawa.ca	Laffoon, Jason E/T-4302-2018; Willmes, Malte/J-3710-2015; Liu, Xiao-Ming/E-4095-2012	Laffoon, Jason E/0000-0002-8821-805X; Willmes, Malte/0000-0001-8734-5324; Bataille, Clement P./0000-0001-8625-4658; Davies, Gareth Rees/0000-0002-6136-9202; Liu, Xiao-Ming/0000-0001-7904-1056	University of North Carolina; ERC-Synergy project under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC [NEXUS1492, 319209]; U.S. National Science Foundation [EF-01241286]	University of North Carolina; ERC-Synergy project under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC; U.S. National Science Foundation(National Science Foundation (NSF))	CPB and XML were supported by the University of North Carolina start-up fund awarded to Xiao-Ming Liu (http://www.unc.edu/). GRD, ICCvH and JEL were supported by the ERC-Synergy project NEXUS1492 under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 319209 (https://ec.europa.eu/research/fp7/index_en.cfm). Partial support for this work was provided by U.S. National Science Foundation grant EF-01241286 (https://www.nsf.gov/). No individual employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal J, 2008, APPL GEOCHEM, V23, P2658, DOI 10.1016/j.apgeochem.2008.05.016; Balmino G, 2012, J GEODESY, V86, P499, DOI 10.1007/s00190-011-0533-4; Bataille CP, 2014, CHEM GEOL, V389, P1, DOI 10.1016/j.chemgeo.2014.08.030; Bataille CP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00155.1; Bataille CP, 2012, CHEM GEOL, V304, P39, DOI 10.1016/j.chemgeo.2012.01.028; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Begueria S, 2013, J SOIL WATER CONSERV, V68, P172, DOI 10.2489/jswc.68.3.172; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Blum JD, 1997, GEOCHIM COSMOCHIM AC, V61, P3193, DOI 10.1016/S0016-7037(97)00148-8; Bowen GJ, 2008, TERR ECOL SER, V2, P79, DOI 10.1016/S1936-7961(07)00004-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan SR, 2017, ECOL APPL, V27, P363, DOI 10.1002/eap.1474; Brennan SR, 2016, GEOPHYS RES LETT, V43, P5043, DOI 10.1002/2016GL068904; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; Capo RC, 1999, EARTH PLANET SC LETT, V170, P61, DOI 10.1016/S0012-821X(99)00090-4; Coelho I, 2017, TRAC-TREND ANAL CHEM, V90, P45, DOI 10.1016/j.trac.2017.02.005; Copeland SR, 2016, QUATERNARY SCI REV, V141, P65, DOI 10.1016/j.quascirev.2016.04.002; Copeland SR, 2011, NATURE, V474, P76, DOI 10.1038/nature10149; Crowley BE, 2017, BIOL REV, V92, P43, DOI 10.1111/brv.12217; Defourny P., 2012, GLOBAL LAND COVER MA; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Evans JA, 2009, J GEOL SOC LONDON, V166, P617, DOI 10.1144/0016-76492008-043; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; Frei R, 2013, APPL GEOCHEM, V38, P147, DOI 10.1016/j.apgeochem.2013.09.007; Genuer R, 2015, R J, V7, P19; Hartman G, 2014, GEOCHIM COSMOCHIM AC, V126, P250, DOI 10.1016/j.gca.2013.11.015; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodell DA, 2004, J ARCHAEOL SCI, V31, P585, DOI 10.1016/j.jas.2003.10.009; Hoogewerff J, 2017, 19 EGU GEN ASS EGU20, P10317; Jarvis A, 2008, CGIAR CSI CONS SPAT, P1; Knipper C, 2012, MIGRATIONS PREHISTOR, P293; Knipper C, 2014, J ARCHAEOL SCI, V41, P818, DOI 10.1016/j.jas.2013.09.019; Kootker LM, 2016, J ARCHAEOL SCI-REP, V6, P1, DOI 10.1016/j.jasrep.2016.01.015; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Laffoon JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172562; Laffoon JE, 2012, J ARCHAEOL SCI, V39, P2371, DOI 10.1016/j.jas.2012.02.002; Lequy E, 2012, FOREST ECOL MANAG, V267, P240, DOI 10.1016/j.foreco.2011.12.005; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; McManus E, 2013, J ISL COAST ARCHAEOL, V8, P255, DOI 10.1080/15564894.2013.787565; Mooney WD, 1998, J GEOPHYS RES-SOL EA, V103, P727, DOI 10.1029/97JB02122; Negrel P, 2004, WATER AIR SOIL POLL, V151, P261, DOI 10.1023/B:WATE.0000009912.04798.b7; Negrel P, 2003, J HYDROL, V277, P248, DOI 10.1016/S0022-1694(03)00125-2; Oelze VM, 2012, ARCHAEOMETRY, V54, P752, DOI 10.1111/j.1475-4754.2011.00644.x; Pelletier JD, 2016, J ADV MODEL EARTH SY, V8, P41, DOI 10.1002/2015MS000526; Pierson-Wickmann AC, 2009, GEOCHIM COSMOCHIM AC, V73, P4688, DOI 10.1016/j.gca.2009.05.051; Poszwa A, 2004, BIOGEOCHEMISTRY, V67, P1, DOI 10.1023/B:BIOG.0000015162.12857.3e; Semhi K, 2000, CHEM GEOL, V168, P173, DOI 10.1016/S0009-2541(00)00226-6; Shand P, 2009, APPL GEOCHEM, V24, P574, DOI 10.1016/j.apgeochem.2008.12.011; Viner S, 2010, J ARCHAEOL SCI, V37, P2812, DOI 10.1016/j.jas.2010.06.017; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; Warham J, 2011, MAPPING BIOSPHERE ST; Widga Chris, 2017, Open Quaternary, V3, DOI 10.5334/oq.32; Wilkinson BH, 2009, GEOL SOC AM BULL, V121, P760, DOI 10.1130/B26457.1; Willmes M, 2014, EARTH SYST SCI DATA, V6, P117, DOI 10.5194/essd-6-117-2014; Willmes M, 2018, APPL GEOCHEM, V90, P75, DOI 10.1016/j.apgeochem.2017.12.025; Wunder MB, 2012, J MAMMAL, V93, P360, DOI 10.1644/11-MAMM-S-182.1; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	62	77	77	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197386	10.1371/journal.pone.0197386	http://dx.doi.org/10.1371/journal.pone.0197386			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH7NG	29847595	Green Published, gold			2022-12-26	WOS:000433634800032
J	de Bakker, DM; Webb, AE; van den Bogaart, LA; van Heuven, SMAC; Meesters, EH; van Duyl, FC				de Bakker, Didier M.; Webb, Alice E.; van den Bogaart, Lisanne A.; van Heuven, Steven M. A. C.; Meesters, Erik H.; van Duyl, Fleur C.			Quantification of chemical and mechanical bioerosion rates of six Caribbean excavating sponge species found on the coral reefs of Curacao	PLOS ONE			English	Article							CLIONA-ORIENTALIS THIELE; OCEAN ACIDIFICATION; CLIMATE-CHANGE; BUILDING CORALS; BORING SPONGES; EROSION; PORIFERA; ECOLOGY; FUTURE; BUDGET	Excavating sponges are among the most important macro-eroders of carbonate substrates in marine systems. Their capacity to remove substantial amounts of limestone makes these animals significant players that can unbalance the reef carbonate budget of tropical coral reefs. Nevertheless, excavating sponges are currently rarely incorporated in standardized surveys and experimental work is often restricted to a few species. Here were provide chemical and mechanical bioerosion rates for the six excavating sponge species most commonly found on the shallow reef of Curacao (southern Caribbean): Cliona caribbaea, C. aprica, C. delitrix, C. amplicavata, Siphonodictyon brevitubulatum and Suberea flavolivescens. Chemical, mechanical and total bioerosion rates were estimated based on various experimental approaches applied to sponge infested limestone cores. Conventional standing incubation techniques were shown to strongly influence the chemical dissolution signal. Final rates, based on the change in alkalinity of the incubation water, declined significantly as a function of incubation time. This effect was mitigated by the use of a flow-through incubation system. Additionally, we found that mechanically removed carbonate fragments collected in the flow-through chamber (1 h) as well as a long-term collection method (1 wk) generally yielded comparable estimates for the capacity of these sponges to mechanically remove substratum. Observed interspecific variation could evidently be linked to the adopted boring strategy (i.e. gallery-forming, cavity-forming or network-working) and presence or absence of symbiotic zooxanthellae. Notably, a clear diurnal pattern was found only in species that harbour a dense photosymbiotic community. In these species chemical erosion was substantially higher during the day. Overall, the sum of individually acquired chemical and mechanical erosion using flow-through incubations was comparable to rates obtained gravimetrically. Such consistency is a first in this field of research. These findings support the much needed confirmation that, depending on the scientific demand, the different approaches presented here can be implemented concurrently as standardized methods.	[de Bakker, Didier M.; Meesters, Erik H.] Wageningen Marine Res, Den Helder, Netherlands; [de Bakker, Didier M.; van Duyl, Fleur C.] NIOZ Royal Netherlands Inst Sea Res, Marine Microbiol & Biogeochem, Texel, Netherlands; [de Bakker, Didier M.; Webb, Alice E.; van Heuven, Steven M. A. C.; van Duyl, Fleur C.] Univ Utrecht, Texel, Netherlands; [Webb, Alice E.; van Heuven, Steven M. A. C.] NIOZ Royal Netherlands Inst Sea Res, Ocean Syst, Texel, Netherlands; [van den Bogaart, Lisanne A.] Univ Ghent, Marine Biol Res Grp, Ghent, Belgium	Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ghent University	de Bakker, DM (corresponding author), Wageningen Marine Res, Den Helder, Netherlands.; de Bakker, DM (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Marine Microbiol & Biogeochem, Texel, Netherlands.; de Bakker, DM (corresponding author), Univ Utrecht, Texel, Netherlands.	didier.debakker@wur.nl	van Duyl, Fleur C./P-9711-2016; de Bakker, Didier/P-3237-2019	van Duyl, Fleur C./0000-0002-8410-4151; de Bakker, Didier/0000-0003-2188-6827; Meesters, Erik/0000-0002-3877-1164	Dutch Ministry of Economic Affairs [BO-11-019.02-038]; Royal Netherlands Institute for Sea Research (NIOZ); Netherlands Organization for Scientific Research (NWO) [858.14.021, 858.14.022]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Royal Netherlands Institute for Sea Research (NIOZ); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Dutch Ministry of Economic Affairs (BO-11-019.02-038), the Royal Netherlands Institute for Sea Research (NIOZ) and the Netherlands Organization for Scientific Research (NWO grants 858.14.021 and 858.14.022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achlatis M, 2017, SCI REPORTS, P7; Acker KL, 1985, J SEDIMENTARY RES, V55; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Bak R., 1976, NETHERLANDS J SEA RE, V10; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Bak RP., 1977, CORAL REEFS THEIR ZO; BAK RPM, 1973, MAR BIOL, V20, P45, DOI 10.1007/BF00387673; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BRELAND JA, 1993, DEEP-SEA RES PT I, V40, P629, DOI 10.1016/0967-0637(93)90149-W; Calcinai Barbara, 2007, V28, P203; Carballo JL, 2017, MARINE ECOLOGY, V38; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chaves-Fonnegra A, 2007, SERIE LIVROS, P28; Chaves-Fonnegra A, 2015, MOL ECOL, V24, P1447, DOI 10.1111/mec.13134; Chaves-Fonnegra A, 2011, MAR ECOL-EVOL PERSP, V32, P162, DOI 10.1111/j.1439-0485.2010.00416.x; COBB WR, 1969, AM ZOOL, V9, P783; DAVIES PS, 1989, MAR BIOL, V101, P389; de Bakker DM, 2017, CORAL REEFS, V36, P355, DOI 10.1007/s00338-016-1534-9; De Bakker DM, 2017, FRONT MAR SCI, V4, DOI [10.3389/fmars.2016.00247, 10.3389/fmars.2017.00171]; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fang JKH, 2014, GLOBAL CHANGE BIOL, V20, P1043, DOI 10.1111/gcb.12369; Fang JKH, 2013, GLOBAL CHANGE BIOL, V19, P3581, DOI 10.1111/gcb.12334; Fang JKH, 2013, MAR ECOL-EVOL PERSP, V34, P193, DOI 10.1111/maec.12005; Fang JK, 1900, MAR BIOL, V163, P1; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glynn Peter W., 1997, P68; Glynn PW, 1997, REV BIOL TROP, V45, P1033; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; GOREAU TF, 1959, BIOL BULL, V116, P59, DOI 10.2307/1539156; Granados C, 2008, MOL PHYLOGENET EVOL, V49, P554, DOI 10.1016/j.ympev.2008.07.023; Hill MS, 1996, MAR BIOL, V125, P649, DOI 10.1007/BF00349246; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holmes G, 2009, FACIES, V55, P203, DOI 10.1007/s10347-008-0165-1; Hudson J, 1977, P 3 INT COR REEF S; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP., 1987, MARINE ECOLOGY PROGR, P259; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Hydes D., 2010, DETERMINATION DISSOL; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JACQUES TG, 1980, MAR BIOL, V60, P167, DOI 10.1007/BF00389160; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Liu XW, 2015, MAR CHEM, V174, P141, DOI 10.1016/j.marchem.2015.06.008; MACGEACHY J K, 1976, Internationale Revue der Gesamten Hydrobiologie, V61, P715, DOI 10.1002/iroh.19760610602; Mueller Benjamin, 2017, Marine Biodiversity Records, V10, P10, DOI 10.1186/s41200-017-0111-4; Mueller B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090152; Murphy GN, 2016, CORAL REEFS, V35, P1109, DOI 10.1007/s00338-016-1442-z; Nava H, 2008, J EXP BIOL, V211, P2827, DOI 10.1242/jeb.019216; NEUMANN AC, 1966, LIMNOL OCEANOGR, V11, P92, DOI 10.4319/lo.1966.11.1.0092; Ogden J., 1977, STUDIES GEOLOGY, V4, P281; PANG RK, 1973, B MAR SCI, V23, P227; Perry CT, 2012, CORAL REEFS, V31, P853, DOI 10.1007/s00338-012-0901-4; Perry CT, 2015, GLOBAL CHANGE BIOL, V21, P1153, DOI 10.1111/gcb.12792; Pomponi S.A., 1980, International Review of Cytology, V65, P301; R Core Team, 2021, R LANGUAGE ENV STAT; Rix L, 2017, FUNCT ECOL, V31, P778, DOI 10.1111/1365-2435.12758; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; RUTZLER K, 1973, MAR BIOL, V21, P144, DOI 10.1007/BF00354611; Rutzler K., 2002, Acta Geologica Hispanica, V37, P61; RUTZLER K, 1975, OECOLOGIA, V19, P203, DOI 10.1007/BF00345306; Rutzler K, 1974, BURROWING SPONGES BE; Schonberg CHL, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P165, DOI 10.1007/978-3-540-77598-0_9; Schonberg C, 2002, P 9 INT COR REEF S; Schonberg C, 2006, P 10 INT COR REEF S; Schonberg CHL, 2002, MAR ECOL-P S Z N I, V23, P313, DOI 10.1046/j.1439-0485.2002.02811.x; Schonberg CHL, 2017, CLIMATE CHANGE OCEAN, P179, DOI DOI 10.1007/978-3-319-59008-0_7; Schonberg CHL, 2017, ICES J MAR SCI, V74, P895, DOI 10.1093/icesjms/fsw254; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Smith JE, 2013, MAR BIOL, V160, P2437, DOI 10.1007/s00227-013-2239-z; VACELET J, 1995, NATURE, V373, P333, DOI 10.1038/373333a0; VANDUYL FC, 1985, ATLAS LIVING REEFS C, P117; Webb AE, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00311; Weisz JB, 2010, BIOL BULL-US, V219, P189, DOI 10.1086/BBLv219n3p189; Wilkinson C.R., 2008, STATUS CORAL REEFS W; Wisshak M, 2014, HELGOLAND MAR RES, V68, P253, DOI 10.1007/s10152-014-0385-4; Wisshak M, 2013, AQUAT BIOL, V19, P111, DOI 10.3354/ab00527; Wisshak M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045124; Yao WS, 1998, DEEP-SEA RES PT I, V45, P1383, DOI 10.1016/S0967-0637(98)00018-1; Zea S, 2003, CARIBB J SCI, V39, P348; Zundelevich A, 2007, J EXP BIOL, V210, P91, DOI 10.1242/jeb.02627	82	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2018	13	5							e0197824	10.1371/journal.pone.0197824	http://dx.doi.org/10.1371/journal.pone.0197824			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH7NG	29847572	Green Published, Green Submitted, gold			2022-12-26	WOS:000433634800042
J	Chamoso, P; Rivas, A; Sanchez-Torres, R; Rodriguez, S				Chamoso, Pablo; Rivas, Alberto; Sanchez-Torres, Ramiro; Rodriguez, Sara			Social computing for image matching	PLOS ONE			English	Article								One of the main technological trends in the last five years is mass data analysis. This trend is due in part to the emergence of concepts such as social networks, which generate a large volume of data that can provide added value through their analysis. This article is focused on a business and employment-oriented social network. More specifically, it focuses on the analysis of information provided by different users in image form. The images are analyzed to detect whether other existing users have posted or talked about the same image, even if the image has undergone some type of modification such as watermarks or color filters. This makes it possible to establish new connections among unknown users by detecting what they are posting or whether they are talking about the same images. The proposed solution consists of an image matching algorithm, which is based on the rapid calculation and comparison of hashes. However, there is a computationally expensive aspect in charge of revoking possible image transformations. As a result, the image matching process is supported by a distributed forecasting system that enables or disables nodes to serve all the possible requests. The proposed system has shown promising results for matching modified images, especially when compared with other existing systems.	[Chamoso, Pablo; Rivas, Alberto; Sanchez-Torres, Ramiro; Rodriguez, Sara] Univ Salamanca, BISITE Digital Innovat Hub, Edificio Multiusos IDi, Salamanca 37007, Spain	University of Salamanca	Chamoso, P (corresponding author), Univ Salamanca, BISITE Digital Innovat Hub, Edificio Multiusos IDi, Salamanca 37007, Spain.	chamoso@usal.es	Chamoso, Pablo/A-7274-2016; González, Sara Rodríguez/N-4457-2013	Chamoso, Pablo/0000-0001-5109-3583; González, Sara Rodríguez/0000-0002-3081-5177	projects "MOVIURBAN: Maquina social para la gestion sostenible de ciudades inteligentes: movilidad urbana, datos abiertos, sensores moviles" [SA070U 16]; Junta Castilla y Leon; Consejeria de Educacion; European Social Fund [RTC-2016-5642-6, EDU/310/2015]; Ministry of Economy, Industry and Competitivity (Spain); Regional Ministry of Education in Castilla y Leon	projects "MOVIURBAN: Maquina social para la gestion sostenible de ciudades inteligentes: movilidad urbana, datos abiertos, sensores moviles"; Junta Castilla y Leon(Junta de Castilla y Leon); Consejeria de Educacion; European Social Fund(European Social Fund (ESF)); Ministry of Economy, Industry and Competitivity (Spain); Regional Ministry of Education in Castilla y Leon	This work has been supported by projects "MOVIURBAN: Maquina social para la gestion sostenible de ciudades inteligentes: movilidad urbana, datos abiertos, sensores moviles", SA070U 16, project co-financed with Junta Castilla y Leon to SR, Consejeria de Educacion; and ii) "BeEMP: Inteligencia social para la dinamizacion de la empleabilidad", RTC-2016-5642-6, project co-financed by European Social Fund and Ministry of Economy, Industry and Competitivity (Spain). The research of Pablo Chamoso has been financed by the Regional Ministry of Education in Castilla y Leon and the European Social Fund grant EDU/310/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghav S., 2014, INT J COMPUT SCI TRE, V2, P28; Argente E, 2006, ELECTRON NOTES THEOR, V150, P55, DOI 10.1016/j.entcs.2006.03.005; Argente-Villaplana E., 2008, GORMAS GUIAS DESARRO; Barrow D, 2016, EUROPEAN J OPERATION; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; beBee, 2017, AFF NETW; BURKHARD WA, 1973, COMMUN ACM, V16, P230, DOI 10.1145/362003.362025; CHAMBERS JC, 1971, HARVARD BUS REV, V49, P45; Charron C., 2006, SOCIAL COMPUTING; Deng HL, 2007, PROC CVPR IEEE, P25; Erickson T., 2000, ACM Transactions on Computer-Human Interaction, V7, P59, DOI 10.1145/344949.345004; Foster I, 2001, INT J HIGH PERFORM C, V15, P200, DOI 10.1177/109434200101500302; Coria JAG, 2014, EXPERT SYST APPL, V41, P1189, DOI 10.1016/j.eswa.2013.08.003; Garcia-Fornes A, 2011, ENG APPL ARTIF INTEL, V24, P1095, DOI 10.1016/j.engappai.2011.06.012; Heras S, 2012, PROG ARTIF INTELL, V1, P277, DOI 10.1007/s13748-012-0031-9; Heras S, 2013, INT J APPROX REASON, V54, P82, DOI 10.1016/j.ijar.2012.06.005; Hong WC, 2011, APPL SOFT COMPUT, V11, P1881, DOI 10.1016/j.asoc.2010.06.003; Kambatla K, 2014, J PARALLEL DISTR COM, V74, P2561, DOI 10.1016/j.jpdc.2014.01.003; Krawetz N., 2013, HACKER FACTOR BLOG; Krawetz N., 2011, HACKER FACTOR BLOG; Mahmud T, 2016, IEEE IMAGE PROC, P3339, DOI 10.1109/ICIP.2016.7532978; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Norouzi M., 2012, ADV NEURAL INFORM PR, P1070, DOI DOI 10.5555/2999134.2999253; Pixabay, 2017, FREE IM PIX; Razavi R., 2004, Massively Multi-Agent Systems I. First International Workshop, MMAS 2004. Revised Selected and Invited Papers (Lecture Notes in Artificial Intelligence Vol. 3446), P136; Reitmayr Gerhard, 2006, 2006 IEEE/ACM International Symposium on Mixed and Augmented Reality, P109, DOI 10.1109/ISMAR.2006.297801; Robertson D, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0379; Rodriguez S, 2011, ENG APPL ARTIF INTEL, V24, P895, DOI 10.1016/j.engappai.2011.02.003; Rodriguez S, 2011, EXPERT SYST APPL, V38, P13005, DOI 10.1016/j.eswa.2011.04.101; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Russell S.J., 1995, PRENTICE HALL SERIES; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; TinEye, 2017, TINEYE REV IM SEARCH; Wang FY, 2007, IEEE INTELL SYST, V22, P79, DOI 10.1109/MIS.2007.41; Weinberg J, 2007, J AM STAT ASSOC, V102, P1185, DOI 10.1198/016214506000001455	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0197576	10.1371/journal.pone.0197576	http://dx.doi.org/10.1371/journal.pone.0197576			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813082	Green Published, gold, Green Submitted			2022-12-26	WOS:000433521800022
J	Marina, TI; Saravia, LA; Cordone, G; Salinas, V; Doyle, SR; Momo, FR				Ignacio Marina, Tomas; Saravia, Leonardo A.; Cordone, Georgina; Salinas, Vanesa; Doyle, Santiago R.; Momo, Fernando R.			Architecture of marine food webs: To be or not be a 'small-world'	PLOS ONE			English	Article							NETWORK STRUCTURE; TOPOLOGICAL PROPERTIES; BIODIVERSITY LOSS; ECOSYSTEM; ROBUSTNESS; PATTERNS; MODELS; GULF; COMPARTMENTS; CONNECTANCE	The search for general properties in network structure has been a central issue for food web studies in recent years. One such property is the small-world topology that combines a high clustering and a small distance between nodes of the network. This property may increase food web resilience but make them more sensitive to the extinction of connected species. Food web theory has been developed principally from freshwater and terrestrial ecosystems, largely omitting marine habitats. If theory needs to be modified to accommodate observations from marine ecosystems, based on major differences in several topological characteristics is still on debate. Here we investigated if the small-world topology is a common structural pattern in marine food webs. We developed a novel, simple and statistically rigorous method to examine the largest set of complex marine food webs to date. More than half of the analyzed marine networks exhibited a similar or lower characteristic path length than the random expectation, whereas 39% of the webs presented a significantly higher clustering than its random counterpart. Our method proved that 5 out of 28 networks fulfilled both features of the small-world topology: short path length and high clustering. This work represents the first rigorous analysis of the small-world topology and its associated features in high-quality marine networks. We conclude that such topology is a structural pattern that is not maximized in marine food webs; thus it is probably not an effective model to study robustness, stability and feasibility of marine ecosystems.	[Ignacio Marina, Tomas] Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient CADIC, Ushuaia, Argentina; [Ignacio Marina, Tomas; Saravia, Leonardo A.; Cordone, Georgina; Salinas, Vanesa; Doyle, Santiago R.; Momo, Fernando R.] Univ Nacl Gen Sarmiento, Inst Ciencias, Los Polvorines, Argentina; [Ignacio Marina, Tomas; Saravia, Leonardo A.; Momo, Fernando R.] Univ Nacl Lujan, INEDES, Lujan, Argentina; [Cordone, Georgina] Ctr Nacl Patagon CENPAT, Ctr Estudio Sistemas Marinos CESIMAR, Puerto Madryn, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Lujan; Centro Nacional Patagonico (CENPAT)	Marina, TI (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient CADIC, Ushuaia, Argentina.; Marina, TI (corresponding author), Univ Nacl Gen Sarmiento, Inst Ciencias, Los Polvorines, Argentina.; Marina, TI (corresponding author), Univ Nacl Lujan, INEDES, Lujan, Argentina.	tomasimarina@gmail.com	Momo, Fernando R/E-3426-2012; Saravia, Leonardo A./AAM-3461-2021; Marina, Tomas Ignacio/U-3460-2018	Momo, Fernando R/0000-0003-0710-1149; Saravia, Leonardo A./0000-0002-7911-4398; Marina, Tomas Ignacio/0000-0002-9203-7411; Cordone, Georgina Florencia/0000-0003-2883-7964; Salinas, Vanesa/0000-0002-2049-3450	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina); Universidad Nacional de General Sarmiento; Universidad Nacional de Lujan; CONICET Argentina [PIO 14420140100035C0]; Marie Curie Action IRSES (FP7 IRSES) [319718]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de General Sarmiento; Universidad Nacional de Lujan; CONICET Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Marie Curie Action IRSES (FP7 IRSES)	This research was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina), Universidad Nacional de General Sarmiento and Universidad Nacional de Lujan. The work was partially funded by PIO 14420140100035C0 CONICET Argentina and conducted in the frame of TIM Ph.D. studies, whose scholarship (CONICET, Argentina) supported the rest of the study. The work was conducted in the frames of the EU research network IMCONet funded by the Marie Curie Action IRSES (FP7 IRSES, Action No. 319718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Torres MA, 2013, ECOL MODEL, V265, P26, DOI 10.1016/j.ecolmodel.2013.05.019; Angelini R, 2011, SCI MAR, V75, P309, DOI 10.3989/scimar.2011.75n2309; Banaru D, 2013, J MARINE SYST, V111, P45, DOI 10.1016/j.jmarsys.2012.09.010; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Bodini A, 2009, PHILOS T R SOC B, V364, P1725, DOI 10.1098/rstb.2008.0278; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Bornatowski H, 2016, MARINE ECOLOGY, P38; Bornatowski H, 2014, ICES J MAR SCI, V71, P1586, DOI 10.1093/icesjms/fsu025; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camacho J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228102; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; COHEN JE, 1985, PROC R SOC SER B-BIO, V224, P449, DOI 10.1098/rspb.1985.0043; Criales-Hernandez MI, 2006, REV BIOL TROP, V54, P1257; D'Alelio D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21806; Dambacher JM, 2010, PROG OCEANOGR, V86, P152, DOI 10.1016/j.pocean.2010.04.011; de Santana CN, 2013, MAR ECOL PROG SER, V474, P15, DOI 10.3354/meps10073; Digel C, 2014, OIKOS, V123, P1157, DOI 10.1111/oik.00865; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dunne JA, 2002, 2002C SFI; Dunne JA, 2009, ENCY COMPLEXITY SYST, P3661, DOI DOI 10.1007/978-0-387-30440-3_216; Dunne JA, 2006, SFI S SCI C, P27; Dunne JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21179; Estrada E, 2007, J THEOR BIOL, V244, P296, DOI 10.1016/j.jtbi.2006.08.002; Navia AF, 2016, ECOL MODEL, V328, P23, DOI 10.1016/j.ecolmodel.2016.02.009; Filgueira R, 2011, CONT SHELF RES, V31, P476, DOI 10.1016/j.csr.2010.10.010; Gaichas SK, 2008, CAN J FISH AQUAT SCI, V65, P1965, DOI 10.1139/F08-104; Gardmark A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0262; Gilarranz LJ, 2017, SCIENCE, V357, P199, DOI 10.1126/science.aal4122; Gilarranz LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10737; GLYNN PETER W., 1965, BEAUFORTIA, V12, P1; Hardy AC, 1924, FISH INVEST-LONDON, V2, P53; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jacob U., 2005, THESIS; Johnson S, 2014, P NATL ACAD SCI USA, V111, P17923, DOI 10.1073/pnas.1409077111; Kefi S, 2015, ECOLOGY, V96, P291, DOI 10.1890/13-1424.1; KOEPCKE H.-W, 1952, PUBL MUS HIST NAT JAVIER PRADO" SER A ZOOL, V8, P1; Kortsch S, 2015, P ROY SOC B-BIOL SCI, V282, P31, DOI 10.1098/rspb.2015.1546; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Link J, 2002, MAR ECOL PROG SER, V230, P1, DOI 10.3354/meps230001; Link JS, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P98; Marina TI, 2018, ESTUAR COAST SHELF S, V200, P141, DOI 10.1016/j.ecss.2017.10.015; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Mccallum Hamish, 2008, POPULATION PARAMETER, DOI 10.1002/9780470757468; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Opitz S, 1996, TROPHIC INTERACTIONS; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perez-Matus A, 2017, MAR ECOL PROG SER, V567, P1, DOI 10.3354/meps12057; PETERSEN CGJ, 1918, REP DAN BIOL STN, V25, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Riccialdelli L, 2017, POLAR BIOL, V40, P807, DOI 10.1007/s00300-016-2007-x; Riede JO, 2010, ADV ECOL RES, V42, P139, DOI 10.1016/S0065-2504(10)42003-6; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Rooney N, 2008, ECOL LETT, V11, P867, DOI 10.1111/j.1461-0248.2008.01193.x; Roopnarine PD, 2013, DATASET PAPERS SCI; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thompson RM, 2000, FRESHWATER BIOL, V44, P413, DOI 10.1046/j.1365-2427.2000.00579.x; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2010, ADV ECOL RES, V43, P211, DOI 10.1016/B978-0-12-385005-8.00006-X; Yletyinen J, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2569; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x	81	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198217	10.1371/journal.pone.0198217	http://dx.doi.org/10.1371/journal.pone.0198217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813120	Green Submitted, Green Published, gold			2022-12-26	WOS:000433521800058
J	Li, J; Li, YH; Deng, YL; Chen, P; Feng, F; Chen, WW; Zhou, XJ; Wang, YD				Li, Jie; Li, Yihao; Deng, Yanling; Chen, Ping; Feng, Fen; Chen, Wanwan; Zhou, Xiaojin; Wang, Yingdian			A calcium-dependent protein kinase, ZmCPK32, specifically expressed in maize pollen to regulate pollen tube growth	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; GENE FAMILY; ARABIDOPSIS; CA2+; STRESS; RICE; GERMINATION; GRADIENT; PROMOTER; CHANNEL	Calcium-dependent protein kinases (CPKs) play an essential role in the regulation of pollen tube growth. Although CPK genes have been identified in maize, and some have been functionally characterized, the molecular function of ZmCPKs associated with pollen tube development remains less well studied. Here, we report that a pollen-specific CPK, ZmCPK32, is involved in the regulation of pollen germination and tube extension. ZmCPK32 exhibited CPK activity and was localized on the plasma membrane and punctate internal membrane compartments via N-terminal acylation. In situ hybridization and real-time PCR revealed that ZmCPK32 transcripts accumulated in pollen and expression was dramatically upregulated during shedding. To elucidate the function of this gene, we transiently expressed a ZmCPK32-GFP fusion protein in tobacco pollen using microparticle bombardment. ZmCPK32 accumulation inhibited pollen germination and reduced pollen tube growth, but this effect was abolished when the kinase-inactive variant was expressed, indicating that kinase activity is critical for its regulatory function. In addition, the plasma membrane localization of ZmCPK32 is essential for regulating polar growth, as pollen expressing the cytosol-localized kinase displayed reduced tube length but germinated well. Moreover, the constitutively active form of ZmCPK32 enhanced the reduction in the germination rate, indicating that the specific activation of ZmCPK32 via calcium ions at the cortical growth point is essential for regulating appropriate germination. The results suggest that ZmCPK32 is functionally associated with pollen tube growth, and could represent a potential target for breeding male-sterile maize.	[Li, Jie; Li, Yihao; Deng, Yanling; Chen, Ping; Feng, Fen; Chen, Wanwan; Zhou, Xiaojin; Wang, Yingdian] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing, Peoples R China; [Zhou, Xiaojin] Chinese Acad Agr Sci, Biotechnol Res Inst, Dept Crop Genom & Genet Improvement, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhou, XJ; Wang, YD (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing, Peoples R China.; Zhou, XJ (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Dept Crop Genom & Genet Improvement, Beijing, Peoples R China.	zhouxiaojin@caas.cn; ydwang@bnu.edu.cn			National Natural Science Foundation of China [31771707]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 31771707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Chae K, 2011, ANN BOT-LONDON, V108, P627, DOI 10.1093/aob/mcr015; Chao Q, 2016, PLANT MOL BIOL, V91, P287, DOI 10.1007/s11103-016-0466-7; Chen YX, 2017, BIOCHEM BIOPH RES CO, V493, P1450, DOI 10.1016/j.bbrc.2017.09.166; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Ding YF, 2013, J EXP BOT, V64, P871, DOI 10.1093/jxb/ers366; Dong X, 2013, J EXP BOT, V64, P2359, DOI 10.1093/jxb/ert093; ESTRUCH JJ, 1994, P NATL ACAD SCI USA, V91, P8837, DOI 10.1073/pnas.91.19.8837; FEIJO JA, 1995, PROTOPLASMA, V187, P155, DOI 10.1007/BF01280244; Ge L, 2004, PLANT PHYSIOL, V135, P1502, DOI 10.1104/pp.104.041996; Guo Feng, 2013, Plants (Basel), V2, P72, DOI 10.3390/plants2010072; Gutermuth T, 2013, PLANT CELL, V25, P4525, DOI 10.1105/tpc.113.118463; Hamilton DA, 1998, PLANT MOL BIOL, V38, P663, DOI 10.1023/A:1006083725102; HAMILTON DA, 1992, PLANT MOL BIOL, V18, P211, DOI 10.1007/BF00034950; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Jiang SS, 2013, PLANT PHYSIOL BIOCH, V71, P112, DOI 10.1016/j.plaphy.2013.07.004; Kong XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-433; Ma PD, 2013, APPL BIOCHEM BIOTECH, V169, P2111, DOI 10.1007/s12010-013-0125-2; Messerli M, 1997, J CELL SCI, V110, P1269; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; MILLER DD, 1992, J CELL SCI, V101, P7; Moutinho A, 1998, PLANT CELL, V10, P1499, DOI 10.1105/tpc.10.9.1499; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Di Giorgio JAP, 2016, PLANT CELL, V28, P1053, DOI 10.1105/tpc.15.00776; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; Steinhorst L, 2013, BBA-MOL CELL RES, V1833, P1573, DOI 10.1016/j.bbamcr.2012.10.009; Stelpflug SC, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0025; Szczegielniak J, 2005, PLANT PHYSIOL, V139, P1970, DOI 10.1104/pp.105.066472; Szczegielniak J, 2012, PHYSIOL PLANTARUM, V146, P1, DOI 10.1111/j.1399-3054.2012.01587.x; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Wang H, 2011, NAT PROTOC, V6, P419, DOI 10.1038/nprot.2011.309; Weckwerth P, 2015, PLANT CELL ENVIRON, V38, P544, DOI 10.1111/pce.12414; Xu ZN, 2006, GENETICS, V172, P1251, DOI 10.1534/genetics.105.050237; Ye SF, 2009, PLANT MOL BIOL, V70, P311, DOI 10.1007/s11103-009-9475-0; Yoon GM, 2006, PLANT CELL, V18, P867, DOI 10.1105/tpc.105.037135; Zhao LN, 2013, PLANT CELL, V25, P649, DOI 10.1105/tpc.112.103184; Zhou L, 2017, INT J CHRONIC OBSTR, V12, P1, DOI DOI 10.1016/J.M0LP.2017.01.012; Zhou LM, 2014, MOL PLANT, V7, P369, DOI 10.1093/mp/sst125; Zhou XJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-238; Zhu Y, 2011, ACTA PHYSIOL PLANT, V33, P1467, DOI 10.1007/s11738-010-0683-7	46	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0195787	10.1371/journal.pone.0195787	http://dx.doi.org/10.1371/journal.pone.0195787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813101	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800003
J	Luong, D; Perez, L; Jemc, JC				Luong, Diana; Perez, Luselena; Jemc, Jennifer C.			Identification of raw as a regulator of glial development	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; DROSOPHILA-MELANOGASTER; GONAD MORPHOGENESIS; TRANSGENIC RNAI; PERIPHERAL GLIA; MIDLINE GLIA; C-JUN; PATHWAY	Glial cells perform numerous functions to support neuron development and function, including axon wrapping, formation of the blood brain barrier, and enhancement of synaptic transmission. We have identified a novel gene, raw, which functions in glia of the central and peripheral nervous systems in Drosophila. Reducing Raw levels in glia results in morphological defects in the brain and ventral nerve cord, as well as defects in neuron function, as revealed by decreased locomotion in crawling assays. Examination of the number of glia along peripheral nerves reveals a reduction in glial number upon raw knockdown. The reduced number of glia along peripheral nerves occurs as a result of decreased glial proliferation. As Raw has been shown to negatively regulate Jun N-terminal kinase (JNK) signaling in other developmental contexts, we examined the expression of a JNK reporter and the downstream JNK target, matrix metalloproteinase 1 (mmp1), and found that raw knockdown results in increased reporter activity and Mmp1 levels. These results are consistent with previous studies showing increased Mmp levels lead to nerve cord defects similar to those observed upon raw knockdown. In addition, knockdown of puckered, a negative feedback regulator of JNK signaling, also causes a decrease in glial number. Thus, our studies have resulted in the identification of a new regulator of gliogenesis, and demonstrate that increased JNK signaling negatively impacts glial development.	[Luong, Diana; Perez, Luselena; Jemc, Jennifer C.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	Loyola University Chicago	Jemc, JC (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jmierisch@luc.edu		Luong, Diana/0000-0003-0283-6453	Loyola University Chicago	Loyola University Chicago	DL LP and JCJ were recipients of funding from Loyola University Chicago to support this research. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Awad TA, 1997, DEV BIOL, V187, P283, DOI 10.1006/dbio.1997.8587; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Bates KL, 2008, GENETICS, V178, P1989, DOI 10.1534/genetics.107.086298; Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Byars CL, 1999, DEVELOPMENT, V126, P4913; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Chen HW, 2002, MOL CELL BIOL, V22, P1792, DOI 10.1128/MCB.22.6.1792-1803.2002; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Rios-Barrera LD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004927; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Domingues HS, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00071; Eliazer S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004200; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Enomoto M, 2015, DEV BIOL, V403, P162, DOI 10.1016/j.ydbio.2015.05.001; Fang XL, 2010, DEV BIOL, V341, P360, DOI 10.1016/j.ydbio.2010.02.029; HEATH RV, 1990, ZOOL J LINN SOC-LOND, V98, P259, DOI 10.1111/j.1096-3642.1990.tb01210.x; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hilu-Dadia R, 2018, GLIA, V66, P1520, DOI 10.1002/glia.23322; Jack J, 1997, GENETICS, V147, P243; Jemc JC, 2012, DEV BIOL, V367, P114, DOI 10.1016/j.ydbio.2012.04.027; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Lee J, 2015, DEVELOPMENT, V142, P162, DOI 10.1242/dev.113423; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Ma XJ, 2017, P NATL ACAD SCI USA, V114, P1934, DOI 10.1073/pnas.1621359114; MacDonald JM, 2013, CELL DEATH DIFFER, V20, P1140, DOI 10.1038/cdd.2013.30; Matzat T, 2015, DEVELOPMENT, V142, P1336, DOI 10.1242/dev.116616; Meyer S, 2014, MECH DEVELOP, V133, P105, DOI 10.1016/j.mod.2014.05.003; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nussbaum-Krammer CI, 2015, JOVE-J VIS EXP, DOI 10.3791/52321; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Ohayon D, 2009, EMBO J, V28, P3228, DOI 10.1038/emboj.2009.247; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Reddy BVVG, 2011, DEVELOPMENT, V138, P5201, DOI 10.1242/dev.069385; Sarkissian T, 2014, METHODS, V68, P89, DOI 10.1016/j.ymeth.2014.02.033; Sasse S, 2015, WIRES DEV BIOL, V4, P623, DOI 10.1002/wdev.198; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Schwabe T, 2017, BIOL OPEN, V6, P232, DOI 10.1242/bio.020669; SONNENFELD MJ, 1995, DEVELOPMENT, V121, P569; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Stork Tobias, 2012, Cold Spring Harb Protoc, V2012, P1, DOI 10.1101/pdb.top067587; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tan SWS, 2018, REDOX BIOL, V15, P125, DOI 10.1016/j.redox.2017.12.002; Tsai YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120236; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Unhavaithaya Y, 2012, GENE DEV, V26, P31, DOI 10.1101/gad.177436.111; von Hilchen CM, 2008, MECH DEVELOP, V125, P337, DOI 10.1016/j.mod.2007.10.010; von Hilchen CM, 2013, DEVELOPMENT, V140, P3657, DOI 10.1242/dev.093245; Von Stetina Jessica R, 2018, Development, V145, DOI 10.1242/dev.157115; Weyers JJ, 2011, DEV BIOL, V353, P217, DOI 10.1016/j.ydbio.2011.02.023; Xie XJ, 2011, DEVELOPMENT, V138, P3813, DOI 10.1242/dev.064816; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhou J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14289; ZHOU L, 1995, CURR BIOL, V5, P784, DOI 10.1016/S0960-9822(95)00155-2	61	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198161	10.1371/journal.pone.0198161	http://dx.doi.org/10.1371/journal.pone.0198161			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6AR	29813126	Green Published, Green Submitted, gold			2022-12-26	WOS:000433521800051
J	Teichroeb, JA; Smeltzer, EA				Teichroeb, Julie Annette; Smeltzer, Eve Ann			Vervet monkey (Chlorocebus pygerythrus) behavior in a multi-destination route: Evidence for planning ahead when heuristics fail	PLOS ONE			English	Article							RATS RATTUS-NORVEGICUS; HUMAN-PERFORMANCE; SPATIAL MEMORY; FUTURE; OPTIMIZATION; MOVEMENT; RULES	Animal paths are analogous to intractable mathematical problems like the Traveling Salesman Problem (TSP) and the shortest path problem (SPP). Both the TSP and SPP require an individual to find the shortest path through multiple targets but the TSP demands a return to the start, while the SPP does not. Vervet monkeys are very efficient in solving TSPs but this species is a multiple central place forager that does not always return to the same sleeping site and thus theoretically should be selected to find solutions to SPPs rather than TSPs. We examined path choice by wild vervets in an SPP experimental array where the shortest paths usually differed from those consistent with common heuristic strategies, the nearest-neighbor rule (NNR-go to the closest resource that has not been visited), and the convex hull (put a mental loop around sites, adding inner targets in order of distance from the edge)-an efficient strategy for TSPs but not SPPs. In addition, humans solving SPPs use an initial segment strategy (ISS-choose the straightest path at the beginning, only turning when necessary) and we looked at vervet paths consistent with this strategy. In 615 trials by single foragers, paths usually conformed to the NNR and rarely the slightly more efficient convex hull, supporting that vervets may be selected to solve SPPs. Further, like humans solving SPPs, vervets showed a tendency to use the ISS. Paths consistent with heuristics dropped off sharply, and use of the shortest path increased, when heuristics led to longer paths showing trade-offs in efficiency versus cognitive load. Two individuals out of 17, found the shortest path most often, showing inter-individual variation in path planning. Given support for the NNR and the ISS, we propose a new rule-of-thumb termed the "region heuristic " that vervets may apply in multi-destination routes.	[Teichroeb, Julie Annette] Univ Toronto Scarborough, Dept Anthropol, Toronto, ON, Canada; [Teichroeb, Julie Annette; Smeltzer, Eve Ann] Univ Toronto, Dept Anthropol, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; University of Toronto	Teichroeb, JA (corresponding author), Univ Toronto Scarborough, Dept Anthropol, Toronto, ON, Canada.; Teichroeb, JA (corresponding author), Univ Toronto, Dept Anthropol, Toronto, ON, Canada.	jteichroeb@utsc.utoronto.ca			start up grant; University of Toronto	start up grant; University of Toronto(University of Toronto)	This work was funded by a start up grant given to Julie Teichroeb upon commencement of her job as an assistant professor at the University of Toronto Scarborough. The funder had no role in the study design, data collection, analyses, decision to publish or preparation of the manuscript.; The authors would like to thank the Uganda Wildlife Authority (Permit #: UWA/TDO/33/02) and the Uganda National Council for Science and Technology (Permit #: NS537) for permission to conduct this research. The methods were approved by the McGill University Animal Care Committee (Protocol # 2061). C. Chapman and D. Twinomugisha provided assistance. Funding for this research was provided by the University of Toronto. We are grateful to three anonymous reviewers that helped improve this manuscript.	[Anonymous], 2000, NON TRADITIONAL REF; Bailenson JN, 2000, MEM COGNITION, V28, P306, DOI 10.3758/BF03213808; Bailenson JN, 1988, J ENVIRON PSYCHOL, V18, P251; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benhamou S, 1998, J COMP PSYCHOL, V112, P317, DOI 10.1037/0735-7036.112.3.317; Bures J, 2006, BEHAV BRAIN RES, V52, P133; CHAPMAN CA, 1989, OECOLOGIA, V79, P506, DOI 10.1007/BF00378668; Cheng K, 2005, CONNECT SCI, V17, P5, DOI 10.1080/09540090500138077; CHRISTENFELD N, 1995, PSYCHOL SCI, V6, P50, DOI 10.1111/j.1467-9280.1995.tb00304.x; Chronicle EP, 2006, Q J EXP PSYCHOL, V59, P783, DOI 10.1080/02724980543000033; Cramer AE, 1997, NATURE, V387, P464, DOI 10.1038/387464a0; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; DOWNS RM, 1988, ANN ASSOC AM GEOGR, V78, P680, DOI 10.1111/j.1467-8306.1988.tb00238.x; Ekstrom AD, 2017, J NEUROPHYSIOL, V118, P3328, DOI 10.1152/jn.00531.2017; Gibson BM, 2007, J EXP PSYCHOL ANIM B, V33, P244, DOI 10.1037/0097-7403.33.3.244; Gigerenzer G., 2001, BOUNDED RATIONALITY; Golden B.L., 1985, TRAVELING SALESMAN P, P207; GROSS JE, 1995, LANDSCAPE ECOL, V10, P209, DOI 10.1007/BF00129255; Hauser MD, 2000, WILD MINDS; Helsgaun K, 2000, EUR J OPER RES, V126, P106, DOI 10.1016/S0377-2217(99)00284-2; Janson C, 2014, AM J PRIMATOL, V76, P410, DOI 10.1002/ajp.22186; Janson CH, 2007, ANIM COGN, V10, P341, DOI 10.1007/s10071-007-0079-2; KINGDON J, 2008, IUCN RED LIST THREAT; Layton O. W., 2009, J VISION, V9, P1145, DOI [10.1167/9.8.1145, DOI 10.1167/9.8.1145]; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Lihoreau M, 2012, BIOL LETTERS, V8, P13, DOI 10.1098/rsbl.2011.0661; Lihoreau M, 2011, FUNCT ECOL, V25, P1284, DOI 10.1111/j.1365-2435.2011.01881.x; MACDONALD SE, 1990, J COMP PSYCHOL, V104, P382, DOI 10.1037/0735-7036.104.4.382; MacGregor JN, 2011, J PROBL SOLVING, V3, P1, DOI 10.7771/1932-6246.1090; MacGregor JN, 2006, J PROBL SOLVING, V1, P33, DOI 10.7771/1932-6246.1005; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Orians G.H., 1979, P155; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; PYKE GH, 1981, ANIM BEHAV, V29, P889, DOI 10.1016/S0003-3472(81)80025-5; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Reynolds AM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002938; SADALLA EK, 1980, J EXP PSYCHOL-HUM L, V6, P516, DOI 10.1037/0278-7393.6.5.516; Saleh N, 2007, OECOLOGIA, V151, P719, DOI 10.1007/s00442-006-0607-9; SCHOENER TW, 1979, AM NAT, V114, P902, DOI 10.1086/283537; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; STERN E, 1988, GEOGR ANAL, V20, P140; Suddendorf T, 2010, BEHAV BRAIN RES, V215, P292, DOI 10.1016/j.bbr.2009.11.044; Sulikowski D, 2015, ANIM BEHAV, V102, P149, DOI 10.1016/j.anbehav.2015.01.005; Teichroeb JA, 2016, ANIM BEHAV, V115, P1, DOI 10.1016/j.anbehav.2016.02.020; Teichroeb JA, 2015, ECOL EVOL, V5, P4706, DOI 10.1002/ece3.1755; Teichroeb JA, 2014, ANIM COGN, V17, P517, DOI 10.1007/s10071-013-0683-2; Todd P.M., 1999, SIMPLE HEURISTICS MA; Visalberghi E, 2009, PRIMATES, V50, P95, DOI 10.1007/s10329-008-0127-9; WARD D, 1992, OIKOS, V63, P312, DOI 10.2307/3545394; Weiner JM, 2006, DAGSTUHL SEMIN P, V5491, P1; Wiener JM., 2003, SPAT COGN COMPUT, V3, P331, DOI [10.1207/s15427633scc0304_5, DOI 10.1207/S15427633SCC0304_5]	52	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2018	13	5							e0198076	10.1371/journal.pone.0198076	http://dx.doi.org/10.1371/journal.pone.0198076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6AR	29813105	Green Submitted, gold, Green Published			2022-12-26	WOS:000433521800042
J	Boxhammer, T; Taucher, J; Bach, LT; Achterberg, EP; Alguero-Muniz, M; Bellworthy, J; Czerny, J; Esposito, M; Haunost, M; Hellemann, D; Ludwig, A; Yong, JC; Zark, M; Riebesell, U; Anderson, LG				Boxhammer, Tim; Taucher, Jan; Bach, Lennart T.; Achterberg, Eric P.; Alguero-Muniz, Maria; Bellworthy, Jessica; Czerny, Jan; Esposito, Mario; Haunost, Mathias; Hellemann, Dana; Ludwig, Andrea; Yong, Jaw C.; Zark, Maren; Riebesell, Ulf; Anderson, Leif G.			Enhanced transfer of organic matter to higher trophic levels caused by ocean acidification and its implications for export production: A mass balance approach	PLOS ONE			English	Article							PELAGIC CARBON FLUXES; TECHNICAL NOTE; COMMUNITY PRODUCTION; NITROGEN-FIXATION; ELEVATED CO2; FRESH-WATER; BALTIC SEA; MARINE; MESOCOSM; SEAWATER	Ongoing acidification of the ocean through uptake of anthropogenic CO2 is known to affect marine biota and ecosystems with largely unknown consequences for marine food webs. Changes in food web structure have the potential to alter trophic transfer, partitioning, and biogeochemical cycling of elements in the ocean. Here we investigated the impact of realistic end-of-the-century CO2 concentrations on the development and partitioning of the carbon, nitrogen, phosphorus, and silica pools in a coastal pelagic ecosystem (Gullmar Fjord, Sweden). We covered the entire winter-to-summer plankton succession (100 days) in two sets of five pelagic mesocosms, with one set being CO2 enriched (similar to 760 mu atm pCO(2)) and the other one left at ambient CO2 concentrations. Elemental mass balances were calculated and we highlight important challenges and uncertainties we have faced in the closed mesocosm system. Our key observations under high CO2 were: (1) A significantly amplified transfer of carbon, nitrogen, and phosphorus from primary producers to higher trophic levels, during times of regenerated primary production. (2) A prolonged retention of all three elements in the pelagic food web that significantly reduced nitrogen and phosphorus sedimentation by about 11 and 9%, respectively. (3) A positive trend in carbon fixation (relative to nitrogen) that appeared in the particulate matter pool as well as the downward particle flux. This excess carbon counteracted a potential reduction in carbon sedimentation that could have been expected from patterns of nitrogen and phosphorus fluxes. Our findings highlight the potential for ocean acidification to alter partitioning and cycling of carbon and nutrients in the surface ocean but also show that impacts are temporarily variable and likely depending upon the structure of the plankton food web.	[Boxhammer, Tim; Taucher, Jan; Bach, Lennart T.; Achterberg, Eric P.; Czerny, Jan; Esposito, Mario; Haunost, Mathias; Hellemann, Dana; Ludwig, Andrea; Yong, Jaw C.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Alguero-Muniz, Maria] Biol Inst Helgoland, Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Helgoland, Germany; [Bellworthy, Jessica; Esposito, Mario] Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Hellemann, Dana] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Zark, Maren] Carl von Ossietzky Univ Oldenburg, ICBM MPI Bridging Grp, Inst Chem & Biol Marine Environm ICBM, Oldenburg, Germany; [Anderson, Leif G.] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Southampton; University of Helsinki; Carl von Ossietzky Universitat Oldenburg; University of Gothenburg	Boxhammer, T (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	tboxhammer@geornar.de	Boxhammer, Tim/GLN-6190-2022; Bellworthy, Jessica/ABG-6390-2020; Yong, Jaw Chuen/P-5836-2017; Achterberg, Eric P/C-5820-2009; Taucher, Jan/AAA-9195-2019; Riebesell, Ulf/AAC-9717-2020; Algueró-Muñiz, María/AAA-9748-2020; Boxhammer, Tim/AAE-6416-2020	Boxhammer, Tim/0000-0002-9632-5947; Yong, Jaw Chuen/0000-0003-3823-8930; Achterberg, Eric P/0000-0002-3061-2767; Algueró-Muñiz, María/0000-0001-8064-6212; Boxhammer, Tim/0000-0002-9632-5947; Bach, Lennart/0000-0003-0202-3671; Taucher, Jan/0000-0001-9944-0775	German Federal Ministry of Science and Education (BMBF): BIOACID II project [FKZ 03F06550]; Leibniz Award German Science Foundation (DFG); Hasselblad Foundation; European marine biological laboratories (ASSEMBLE) [227799]; UK Ocean Acidification research programme (UKOA) [NE/H017348/1]	German Federal Ministry of Science and Education (BMBF): BIOACID II project; Leibniz Award German Science Foundation (DFG); Hasselblad Foundation; European marine biological laboratories (ASSEMBLE); UK Ocean Acidification research programme (UKOA)	Support was provided by the German Federal Ministry of Science and Education (BMBF, https/www.bmbf.de): BIOACID II project (FKZ 03F06550). U. Riebesell received additional funding from the Leibniz Award 2012 by the German Science Foundation (DFG, http://www.dfg.de). The carbonate chemistry measurements were supported by a grant from the Hasselblad Foundation (http://www.hasselbladfoundation.org). M. Zark was supported by the association of European marine biological laboratories (ASSEMBLE, grant no. 227799, http://www.assemblemarine.org), M. Alguero-Muniz by the Royal Swedish Academy of Sciences (http://www.kva.se), and E. P. Achterberg received funding from the UK Ocean Acidification research programme (UKOA, grant no. NE/H017348/1, httpliwww.oceanacidification.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguero-Muniz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175851; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bach LT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188198; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Bellerby RGJ, 2008, BIOGEOSCIENCES, V5, P1517, DOI 10.5194/bg-5-1517-2008; Benitez-Nelson CR, 1999, NATURE, V398, P502, DOI 10.1038/19061; Biard T, 2016, NATURE, V532, P504, DOI 10.1038/nature17652; Boxhammer T, 2016, BIOGEOSCIENCES, V13, P2849, DOI 10.5194/bg-13-2849-2016; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Garijo JC, 2015, J PLANKTON RES, V37, P923, DOI 10.1093/plankt/fbv056; Chen CC, 1997, MAR ECOL PROG SER, V155, P1, DOI 10.3354/meps155001; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Crawfurd KJ, 2017, BIOGEOSCIENCES, V14, P3831, DOI 10.5194/bg-14-3831-2017; Czerny J, 2013, BIOGEOSCIENCES, V10, P3109, DOI 10.5194/bg-10-3109-2013; Czerny J, 2013, BIOGEOSCIENCES, V10, P1937, DOI 10.5194/bg-10-1937-2013; Czerny J, 2013, BIOGEOSCIENCES, V10, P1379, DOI 10.5194/bg-10-1379-2013; Del Amo Y, 1999, J PHYCOL, V35, P1162; DEMASTER DJ, 1992, OCEANOGRAPHY, V5, P146, DOI DOI 10.5670/OCEANOG.1992.03; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Eberlein T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172594; Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228; Engel A, 2013, BIOGEOSCIENCES, V10, P1291, DOI 10.5194/bg-10-1291-2013; Engel A, 2014, J PLANKTON RES, V36, P641, DOI 10.1093/plankt/fbt125; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Gismervik I, 1997, J PLANKTON RES, V19, P279, DOI 10.1093/plankt/19.2.279; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Hansell DA, 1998, GLOBAL BIOGEOCHEM CY, V12, P443, DOI 10.1029/98GB01928; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hernandez-Leon S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002887; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Horn HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165800; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; JOHNSON KM, 1987, MAR CHEM, V21, P117, DOI 10.1016/0304-4203(87)90033-8; Kattner G, 1999, MAR CHEM, V67, P61, DOI 10.1016/S0304-4203(99)00049-3; Kim JM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047346; Kiorboe T, 2013, LIMNOL OCEANOGR, V58, P1843, DOI 10.4319/lo.2013.58.5.1843; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Lehette P, 2009, LIMNOL OCEANOGR-METH, V7, P304, DOI 10.4319/lom.2009.7.304; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Nelson DM, 1996, J GEOPHYS RES-OCEANS, V101, P18519, DOI 10.1029/96JC01573; Ohlendieck U, 2007, BIOGEOSCIENCES, V4, P63, DOI 10.5194/bg-4-63-2007; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; R_Core_Team, 2015, R LANG ENV STAT COMP; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2010, GUIDE BEST PRACTICES, P95, DOI DOI 10.2777/58454; Riebesell U, 2017, NAT GEOSCI, V10, P19, DOI [10.1038/ngeo2854, 10.1038/NGEO2854]; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; SAMBROTTO RN, 1993, NATURE, V363, P248, DOI 10.1038/363248a0; Sanders R, 2014, PROG OCEANOGR, V129, P200, DOI 10.1016/j.pocean.2014.05.005; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Schulz KG, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00064; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; Silyakova A, 2013, BIOGEOSCIENCES, V10, P4847, DOI 10.5194/bg-10-4847-2013; Spilling K, 2016, BIOGEOSCIENCES, V13, P6081, DOI 10.5194/bg-13-6081-2016; Sswat M, 2018, NAT ECOL EVOL, V10, P1, DOI [10.1038/341559-018.0514-6, DOI 10.1038/341559-018.0514-6]; Stal LJ, 2003, CONT SHELF RES, V23, P1695, DOI 10.1016/j.csr.2003.06.001; Strong AL, 2016, DEEP-SEA RES PT II, V130, P88, DOI 10.1016/j.dsr2.2016.05.003; Taucher J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169737; Thamatrakoln K, 2008, PLANT PHYSIOL, V146, P1397, DOI 10.1104/pp.107.107094; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Thornton DCO, 2014, EUR J PHYCOL, V49, P20, DOI 10.1080/09670262.2013.875596; TOGGWEILER JR, 1993, NATURE, V363, P210, DOI 10.1038/363210a0; van Heuven S., 2011, MATLAB PROGRAM DEV C; White AE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00276; Zark M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500531	77	4	4	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0197502	10.1371/journal.pone.0197502	http://dx.doi.org/10.1371/journal.pone.0197502			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799856	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400014
J	Philipponnet, C; Cassagnes, L; Pereira, B; Kemeny, JL; Devouassoux-Shisheboran, M; Lautrette, A; Guerin, C; Souweine, B				Philipponnet, Carole; Cassagnes, Lucie; Pereira, Bruno; Kemeny, Jean-Louis; Devouassoux-Shisheboran, Mojgan; Lautrette, Alexandre; Guerin, Claude; Souweine, Bertrand			Diagnostic yield and therapeutic impact of open lung biopsy in the critically ill patient	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MECHANICALLY VENTILATED PATIENTS; BERLIN DEFINITION; MANAGEMENT; SURVIVAL; ETIOLOGY; SAFETY; ARDS	Background Open lung biopsy (OLB) is a rare procedure in intensive care units (ICUs) for therapeutic management of acute respiratory failure (ARF). The purpose of this study was to analyze the diagnostic yield, therapeutic contribution and complications of OLB in ICU patients with ARF of unclear etiology, including acute respiratory distress syndrome (ARDS) and ARDS mimics. Methods Retrospective study conducted in a 10-bed ICU over a 13-year period. Patients undergoing OLB for ARF with undiagnosed infiltrates on CT scan were included. ARDS was defined according to Berlin criteria, and ARDS mimics as a condition looking like ARDS except for the presence of a known cause. OLB was contributive when the OLB findings yielded a specific diagnosis resulting in a change in the patients' treatment or management. Results Forty six patients were included (sex ratio = 2.5, median and [interquartile range] age = 69 [59-77] years, and admission SAPS II = 42 [33-50]. ARF corresponded to ARDS in 22 patients and to ARDS mimics in 16. OLB yielded 61 diagnoses in 45 patients including diffuse alveolar damage (N = 21), lung fibrosis (N = 18), and organizing pneumonia (N = 11). OLB was contributive in 37 patients (80%), including 13/16 ARDS mimickers. The main contributions of OLB were the introduction or maintenance of steroids (N = 32) and discontinuation of antibiotics (N = 9). In 4 patients OLB resulted directly in the decision to forgo life sustaining treatment. OLB complications occurred in 16 patients (35%), in one case associated with fatal outcome. Conclusion OLB can play a useful role in the management of ICU patients with ARF of undetermined origin, including ARDS mimickers. Further studies should be done to identify the groups of ICU patients likely to benefit from the procedure with minimum risk.	[Philipponnet, Carole; Lautrette, Alexandre; Souweine, Bertrand] CHU Clermont Ferrand, Serv Reanimat Med, Clermont Ferrand, France; [Cassagnes, Lucie] Univ Clermont Auvergne, CNRS, CHU Clermont Ferrand, Serv Radiol, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, INSERM, Ctr Invest Clin, Clermont Ferrand, France; [Kemeny, Jean-Louis] Univ Clermont Auvergne, CHU Clermont Ferrand, Lab Anatomopathol, Clermont Ferrand, France; [Devouassoux-Shisheboran, Mojgan] Univ Lyon, Hop Croix Rousse, Hosp Civils Lyon, Lab Anat Pathol, Lyon, France; [Guerin, Claude] Univ Lyon, Hop Croix Rousse, Hosp Civils Lyon, Serv Reanimat Med, Lyon, France	CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Lyon; CHU Lyon	Philipponnet, C (corresponding author), CHU Clermont Ferrand, Serv Reanimat Med, Clermont Ferrand, France.	cphilipponnet@chu-clermontferrand.fr	guerin, claude/H-5692-2014; souweine, bertrand/HHR-8972-2022	guerin, claude/0000-0003-4700-6672; Philipponnet, Carole/0000-0002-6116-1452				Almotairi A, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/8715024; Arabi Y, 2007, MED SCI MONITOR, V13, pCR365; Aublanc M, 2017, CURR OPIN CRIT CARE, V23, P24, DOI 10.1097/MCC.0000000000000373; Baumann HJ, 2008, SURGERY, V143, P426, DOI 10.1016/j.surg.2007.06.003; CANVER CC, 1994, J CARDIOVASC SURG, V35, P151; Cardinal-Fernandez P, 2016, CHEST, V149, P1155, DOI 10.1016/j.chest.2016.02.635; Charbonney E, 2009, J CRIT CARE, V24, P122, DOI 10.1016/j.jcrc.2008.01.008; Chuang Ming-Lung, 2003, J Intensive Care Med, V18, P21, DOI 10.1177/0885066602239121; de Prost N, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0281-6; Depuydt OE, 2013, ANAESTH INTENS CARE, V41, P610, DOI 10.1177/0310057X1304100506; Flabouris A, 1999, CHEST, V115, P811, DOI 10.1378/chest.115.3.811; Gibelin A, 2016, INTENS CARE MED, V42, P164, DOI 10.1007/s00134-015-4064-y; Guerin C, 2015, INTENS CARE MED, V41, P222, DOI 10.1007/s00134-014-3583-2; Kao KC, 2006, CRIT CARE, V10, DOI 10.1186/cc4981; Kao KC, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0949-y; Libby LJ, 2014, ANN THORAC SURG, V98, P1254, DOI 10.1016/j.athoracsur.2014.05.029; Lim SY, 2007, CRIT CARE, V11, DOI 10.1186/cc6106; Papazian L, 1998, ANESTHESIOLOGY, V88, P935, DOI 10.1097/00000542-199804000-00013; Papazian L, 2007, CRIT CARE MED, V35, P755, DOI 10.1097/01.CCM.0000257325.88144.30; Patel SR, 2004, CHEST, V125, P197, DOI 10.1378/chest.125.1.197; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; WARNER DO, 1988, AM REV RESPIR DIS, V137, P90, DOI 10.1164/ajrccm/137.1.90; Wells AU, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-S1-S2; Wong AK, 2015, ANN AM THORAC SOC, V12, P1226, DOI 10.1513/AnnalsATS.201502-077BC	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0196795	10.1371/journal.pone.0196795	http://dx.doi.org/10.1371/journal.pone.0196795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799835	Green Submitted, Green Published, gold			2022-12-26	WOS:000433153400006
J	Zhang, Y; Sun, JB; Xia, H; Zhao, CZ; Hou, L; Wang, BS; Li, AQ; Chen, M; Zhao, SZ; Wang, XJ				Zhang, Ye; Sun, Jinbo; Xia, Han; Zhao, Chuanzhi; Hou, Lei; Wang, Baoshan; Li, Aiqin; Chen, Min; Zhao, Shuzhen; Wang, Xingjun			Characterization of peanut phytochromes and their possible regulating roles in early peanut pod development	PLOS ONE			English	Article							GENE-EXPRESSION; LIGHT; ARABIDOPSIS; DEGRADATION; PIF3; PHOSPHORYLATION; LOCALIZATION; TRANSDUCTION; INVOLVEMENT; INITIATION	Arachis hypogaea L. geocarpy is a unique feature different from other legume plants. Flowering and fertilization occur above ground, while the following processes of pod formation and development proceed in the soil. The zygote divides only few times to develop into pre embryo and then further embryo developmental process stops when the gynoecium is exposed to light condition or normal day/night period. In this study, eight phytochrome genes were identified in two wild peanuts (four in Arachis duranensis and four in Arachis ipaensis). Using RACE and homologous cloning, the full CDS of AhphyA, AhphyA-like, AhphyB and AhphyE were acquired in cultivated peanut. Protein structure analysis showed that the conservative coding domains of phytochromes from a number of other plant species were found in these proteins. The C-terminal of AhphyA, AhphyA-like and AhphyB could interact with phytochrome-interacting factor 3 in vitro. The expression patterns of these genes in various tissues were analyzed by qRT-PCR, and significant differences were observed. Interestingly, the expression levels of AhphyA-like changed significantly during gynophore growth and early pod development. Furthermore, protein accumulation patterns of AhphyA and AhphyB in gynophore were different during early pod development stages in that AhphyA and AhphyB proteins were not detected in Si and S2 gynophores, while significant accumulation of AhphyA and AhphyB were detected in S3 gynophore. These results provided evidence that phytochromes mediated light signal transduction may play key roles in peanut geocarpy development.	[Zhang, Ye; Sun, Jinbo; Xia, Han; Zhao, Chuanzhi; Hou, Lei; Li, Aiqin; Zhao, Shuzhen; Wang, Xingjun] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China; [Zhang, Ye; Sun, Jinbo; Xia, Han; Zhao, Chuanzhi; Hou, Lei; Li, Aiqin; Zhao, Shuzhen; Wang, Xingjun] Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Shandong, Peoples R China; [Sun, Jinbo; Xia, Han; Zhao, Chuanzhi; Wang, Baoshan; Chen, Min; Zhao, Shuzhen; Wang, Xingjun] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Normal University	Zhao, SZ; Wang, XJ (corresponding author), Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China.; Zhao, SZ; Wang, XJ (corresponding author), Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Shandong, Peoples R China.; Zhao, SZ; Wang, XJ (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China.	zhaoshuzhen51@126.com; xingjunw@hotmail.com	Zhao, Chuanzhi/AAC-9232-2022		National Natural Science Foundation of China [31471526, 31500217]; Ministry of Science and Technology of China [2013AA102602, 2012BADB607]; Shandong Academy of Agricultural Sciences [2014CGPY10]; Open Project of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture [2017003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shandong Academy of Agricultural Sciences; Open Project of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture	This work is supported by the National Natural Science Foundation of China (31471526, 31500217), the Ministry of Science and Technology of China (2013AA102602, 2012BADB607), and fund of Shandong Academy of Agricultural Sciences (2014CGPY10), and the Open Project of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture (2017003).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Canton FR, 1999, PLANT PHYSIOL, V121, P1207, DOI 10.1104/pp.121.4.1207; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Debrieux D, 2013, PLANT PHYSIOL, V161, P2136, DOI 10.1104/pp.112.213280; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Fraser DP, 2016, CURR OPIN PLANT BIOL, V33, P1, DOI 10.1016/j.pbi.2016.03.008; Genoud T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000143; Heschel MS, 2007, NEW PHYTOL, V174, P735, DOI 10.1111/j.1469-8137.2007.02044.x; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Klose C, 2015, NEW PHYTOL, V206, P965, DOI 10.1111/nph.13207; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Li J, 2011, ARABIDOPSIBOOK AM, V9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Qiu YJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02062-6; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Rausenberger J, 2011, CELL, V146, P813, DOI 10.1016/j.cell.2011.07.023; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Shen H, 2005, PLANT J, V44, P1023, DOI 10.1111/j.1365-313X.2005.02606.x; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; SHLAMOVITZ N, 1995, PLANT GROWTH REGUL, V16, P37, DOI 10.1007/BF00040505; SMITH BW, 1950, AM J BOT, V37, P802, DOI 10.2307/2437758; Tepperman JM, 2006, PLANT J, V48, P728, DOI 10.1111/j.1365-313X.2006.02914.x; THOMPSON LK, 1992, AM J BOT, V79, P828, DOI 10.2307/2444950; THOMPSON LK, 1985, PLANT PHYSIOL, V78, P370, DOI 10.1104/pp.78.2.370; Pham VN, 2018, PLANT PHYSIOL, V176, P1025, DOI 10.1104/pp.17.01384; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; Wang F, 2016, PLANT PHYSIOL, V170, P459, DOI 10.1104/pp.15.01171; Wang Q, 2013, MOL PLANT, V6, P5, DOI 10.1093/mp/sss102; WANG YC, 1991, PLANTA, V184, P96, DOI 10.1007/BF00208242; XU Y, 1995, PLANT CELL, V7, P1433, DOI 10.1105/tpc.7.9.1433; Zhang Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2857-1; Zharare GE, 1998, ANN BOT-LONDON, V81, P391, DOI 10.1006/anbo.1997.0569; Zhong SW, 2012, CURR BIOL, V22, P1530, DOI 10.1016/j.cub.2012.06.039; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	42	6	8	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2018	13	5							e0198041	10.1371/journal.pone.0198041	http://dx.doi.org/10.1371/journal.pone.0198041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH1HI	29799880	Green Published, Green Submitted, gold			2022-12-26	WOS:000433153400037
J	Becker, F; Vogel, T; Voss, T; Mehdorn, AS; Schutte-Nutgen, K; Reuter, S; Mohr, A; Kabar, I; Bormann, E; Vowinkel, T; Palmes, D; Senninger, N; Bahde, R; Kebschull, L				Becker, Felix; Vogel, Thomas; Voss, Thekla; Mehdorn, Anne-Sophie; Schuette-Nuetgen, Katharina; Reuter, Stefan; Mohr, Annika; Kabar, Iyad; Bormann, Eike; Vowinkel, Thorsten; Palmes, Daniel; Senninger, Norbert; Bahde, Ralf; Kebschull, Linus			The weekend effect in liver transplantation	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; PULMONARY-EMBOLISM; WEEKDAY ADMISSIONS; UNITED-STATES; OUTCOMES; GRAFT; ASSOCIATION; SURVIVAL; STROKE; DONORS	Background The weekend effect describes a phenomenon whereby patients admitted to hospitals on weekends are at higher risk of complications compared to those admitted during weekdays. However, if a weekend effect exists in orthotopic liver transplantation (oLT). Methods We analyzed oLT between 2006 and 2016 and stratified patients into weekday (Monday to Friday) and weekend (Saturday, Sunday) groups. Primary outcome measures were one-year patient and graft survival. Results 364 deceased donor livers were transplanted into 329 patients with 246 weekday (74.77%) and 83 weekend (25.23%) patients. Potential confounders (e.g. age, ischemia time, MELD score) were comparable. One-year patient and graft survival were similar. Frequencies of rejections, primary-non function or re-transplantation were not different. The day of transplantation was not associated with one-year patient and graft survival in multivariate analysis. Conclusions We provide the first data for the Eurotransplant region on oLT stratified for weekend and weekday procedures and our findings suggest there was no weekend effect on oLT. While we hypothesize that the absent weekend effect is due to standardized transplant procedures and specialized multidisciplinary transplant teams, our results are encouraging showing oLT is a safe and successful procedure, independent from the day of the week.	[Becker, Felix; Vogel, Thomas; Voss, Thekla; Mehdorn, Anne-Sophie; Mohr, Annika; Vowinkel, Thorsten; Palmes, Daniel; Senninger, Norbert; Bahde, Ralf; Kebschull, Linus] Univ Hosp Munster, Dept Gen Visceral & Transplant Surg, Munster, Germany; [Schuette-Nuetgen, Katharina; Reuter, Stefan] Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Internal Med D, Munster, Germany; [Kabar, Iyad] Univ Hosp Munster, Dept Internal Med Gastroenterol & Hepatol B, Munster, Germany; [Bormann, Eike] Univ Hosp Munster, Inst Biostat & Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Becker, F (corresponding author), Univ Hosp Munster, Dept Gen Visceral & Transplant Surg, Munster, Germany.	felix.becker@ukmuenster.de	Becker, Felix/AFJ-0777-2022; Becker, Felix/AAF-4456-2022	Becker, Felix/0000-0002-1945-3128	Open Access Publication Fund of University of Munster	Open Access Publication Fund of University of Munster	We acknowledge support by Open Access Publication Fund of University of Munster. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adil MM, 2016, STROKE, V47, P1436, DOI 10.1161/STROKEAHA.116.013453; Anderson BM, 2017, TRANSPLANTATION, V101, P2244, DOI 10.1097/TP.0000000000001522; Baid-Agrawal S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010482; Becker David J, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P23, DOI 10.1586/14737167.8.1.23; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bell CM, 2004, AM J MED, V117, P175, DOI 10.1016/j.amjmed.2004.02.047; Blok JJ, 2012, LIVER TRANSPLANT, V18, P113, DOI 10.1002/lt.22447; Cohen JB, 2018, AM J TRANSPLANT, V18, P391, DOI 10.1111/ajt.14449; Coleman CI, 2015, INT J CARDIOL, V194, P72, DOI 10.1016/j.ijcard.2015.05.098; Cortes MB, 2017, ACTA MEDICA PORT, V30, P361, DOI 10.20344/amp.8029; Deshmukh A, 2012, AM J CARDIOL, V110, P208, DOI 10.1016/j.amjcard.2012.03.011; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Gallerani M, 2018, ANGIOLOGY, V69, P236, DOI 10.1177/0003319717718706; Groves EM, 2014, J VASC SURG, V60, P318, DOI 10.1016/j.jvs.2014.02.052; Hoehn RS, 2018, J GASTROINTEST SURG, V22, P321, DOI 10.1007/s11605-017-3592-x; Khoshchehreh M, 2016, INT J CARDIOL, V210, P164, DOI 10.1016/j.ijcard.2016.02.087; Kolhe NV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186048; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Lustbader D, 2011, NEUROLOGY, V76, P119, DOI 10.1212/WNL.0b013e3182061b0c; Mohan S, 2016, KIDNEY INT, V90, P157, DOI 10.1016/j.kint.2016.03.007; Nijboer W, 2013, TRANSPL INT, V26, P120; Orman ES, 2012, LIVER TRANSPLANT, V18, P558, DOI 10.1002/lt.23395; Rinella ME, 2001, LIVER TRANSPLANT, V7, P409, DOI 10.1053/jlts.2001.23787; Roberts SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131836; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Schutte-Nutgen K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190227; Stratigopoulou P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174173; Tekin K, 2004, TRANSPLANTATION, V77, P411, DOI 10.1097/01.TP.0000110318.70879.20	28	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198035	10.1371/journal.pone.0198035	http://dx.doi.org/10.1371/journal.pone.0198035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795690	Green Submitted, Green Published, gold			2022-12-26	WOS:000433084300118
J	Mascia, C; Pozzetto, I; Kertusha, B; Marocco, R; Del Borgo, C; Tieghi, T; Vita, S; Savinelli, S; Iannetta, M; Vullo, V; Lichtner, M; Mastroianni, CM				Mascia, Claudia; Pozzetto, Irene; Kertusha, Blerta; Marocco, Raffaella; Del Borgo, Cosmo; Tieghi, Tiziana; Vita, Serena; Savinelli, Stefano; Iannetta, Marco; Vullo, Vincenzo; Lichtner, Miriam; Mastroianni, Claudio Maria			Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection	PLOS ONE			English	Article							SOLUBLE CD163; ZAMBIAN CHILDREN; MONOCYTES; RNA; IMMUNOSUPPRESSION; COINFECTION; LYMPHOCYTES; ACTIVATION; RECEPTORS; MORTALITY	Background and aims Measles is an infectious disease that represents a serious public health problem worldwide, being associated with increased susceptibility to secondary infections, especially in the respiratory and gastrointestinal tracts. The aim of this study was to evaluate sCD163 and sCD14 levels in measles virus (MV) infected patients, as markers of immune activation, in order to better understand their role in the pathogenesis of the disease. TNF-alpha plasma levels were also evaluated. Methods sCD163, sCD14 and TNF-alpha were measured by ELISA in plasma samples of 27 MV infected patients and 27 healthy donors (HD) included as controls. Results At the time of hospital admission, sCD163 and sCD14 levels were significantly higher in MV infected patients than in HD, while a decrease in TNF-a levels were found even if without statistical significance. sCD163 and sCD14 levels were significantly decreased after two months from acute infection compared to hospital admission although they remained significantly higher compared to HD. TNF-alpha levels increased significantly during the follow-up period. Considering clinical parameters, sCD163 levels positively correlated with aspartate aminotransferase, white blood cell count and neutrophils rate, while negatively correlated with the lymphocyte percentage. sCD14 levels positively correlated with the neutrophil and lymphocyte percentages. Conclusions These results indicate that, despite the resolution of symptoms, an important macrophage/ monocyte activation persists in measles patients, even after two months from infection.	[Mascia, Claudia; Pozzetto, Irene; Kertusha, Blerta; Tieghi, Tiziana; Savinelli, Stefano; Vullo, Vincenzo; Lichtner, Miriam; Mastroianni, Claudio Maria] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Pozzetto, Irene; Kertusha, Blerta; Marocco, Raffaella; Del Borgo, Cosmo; Tieghi, Tiziana; Vita, Serena; Lichtner, Miriam] Sapienza Univ, SM Goretti Hosp, Infect Dis Unit, Latina, Italy; [Iannetta, Marco] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Lazzaro Spallanzani	Mascia, C (corresponding author), Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.	claumascia@tiscali.it; claumascia@tiscali.it	Iannetta, Marco/B-5596-2017; Iannetta, Marco/M-4619-2019; MASTROIANNI, Claudio Maria/O-9741-2019; Vita, Serena/AAC-3345-2022	Iannetta, Marco/0000-0002-6938-8627; Iannetta, Marco/0000-0002-6938-8627; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; 				Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; ARNEBORN P, 1983, INFECT IMMUN, V39, P29, DOI 10.1128/IAI.39.1.29-37.1983; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P200; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; de Vries RD, 2015, VIRUSES-BASEL, V7, P699, DOI 10.3390/v7020699; de Vries RD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002885; de Vries RD, 2010, J VIROL, V84, P4714, DOI 10.1128/JVI.02633-09; EKBOM A, 1994, LANCET, V344, P508, DOI 10.1016/S0140-6736(94)91898-8; ESOLEN LM, 1993, J INFECT DIS, V168, P47, DOI 10.1093/infdis/168.1.47; GRIFFIN DE, 1989, NEW ENGL J MED, V320, P1667, DOI 10.1056/NEJM198906223202506; GRIFFIN DE, 1987, CLIN IMMUNOL IMMUNOP, V45, P375, DOI 10.1016/0090-1229(87)90090-0; Indoh T, 2007, VIROLOGY, V361, P294, DOI 10.1016/j.virol.2006.11.002; Istituto Superiore di Sanita (ISS). EpiCentro portal, 2017, MORB IT B SETT; Laksono BM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080210; LEOPARDI R, 1992, J IMMUNOL, V149, P2397; LEWIN J, 1995, GUT, V36, P564, DOI 10.1136/gut.36.4.564; Lin WHW, 2017, J INFECT DIS, V215, P830, DOI 10.1093/infdis/jix012; Lin WHW, 2012, P NATL ACAD SCI USA, V109, P14989, DOI 10.1073/pnas.1211138109; Mascia C, 2017, CLIN RES HEPATOL GAS, V41, P644, DOI 10.1016/j.clinre.2017.04.007; Mascia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179400; Mesman AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049573; Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662; MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Nelson AN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10965-z; Riddell MA, 2007, J CLIN VIROL, V39, P312, DOI 10.1016/j.jcv.2007.05.006; Ryon JJ, 2002, CLIN DIAGN LAB IMMUN, V9, P994, DOI 10.1128/CDLI.9.5.994-1003.2002; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Shaheen SO, 1996, BRIT MED J, V313, P969, DOI 10.1136/bmj.313.7063.969; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Vinante F, 1999, HAEMATOLOGICA, V84, P683; Vita S, 2017, JAIDS-J ACQ IMM DEF, V74, P347, DOI 10.1097/QAI.0000000000001232; World Health Organization, 2017, MEASL WHO JUL 2017; Yanagi Y, 2006, J GEN VIROL, V87, P2767, DOI 10.1099/vir.0.82221-0; Zanni MV, 2012, CLIN ENDOCRINOL, V77, P385, DOI 10.1111/j.1365-2265.2011.04284.x	35	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0198174	10.1371/journal.pone.0198174	http://dx.doi.org/10.1371/journal.pone.0198174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	29795672	Green Published, gold, Green Submitted			2022-12-26	WOS:000433084300132
